PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ros, S; Floter, J; Kaymak, I; Da Costa, C; Houddane, A; Dubuis, S; Griffiths, B; Mitter, R; Walz, S; Blake, S; Behrens, A; Brindle, KM; Zamboni, N; Rider, MH; Schulze, A				Ros, S.; Floeter, J.; Kaymak, I.; Da Costa, C.; Houddane, A.; Dubuis, S.; Griffiths, B.; Mitter, R.; Walz, S.; Blake, S.; Behrens, A.; Brindle, K. M.; Zamboni, N.; Rider, M. H.; Schulze, A.			6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells	ONCOGENE			English	Article							REGULATES GLUCOSE-METABOLISM; WILD-TYPE P53; TRANSCRIPTIONAL REPRESSION; TUMOR; GLYCOLYSIS; EXPRESSION; BIOSYNTHESIS; ACTIVATION; SURVIVAL; HYPOXIA	The bifunctional enzyme 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-4 (PFKFB4) controls metabolic flux through allosteric regulation of glycolysis. Here we show that p53 regulates the expression of PFKFB4 and that p53-deficient cancer cells are highly dependent on the function of this enzyme. We found that p53 downregulates PFKFB4 expression by binding to its promoter and mediating transcriptional repression via histone deacetylases. Depletion of PFKFB4 from p53-deficient cancer cells increased levels of the allosteric regulator fructose-2,6-bisphosphate, leading to increased glycolytic activity but decreased routing of metabolites through the oxidative arm of the pentose-phosphate pathway. PFKFB4 was also required to support the synthesis and regeneration of nicotinamide adenine dinucleotide phosphate (NADPH) in p53-deficient cancer cells. Moreover, depletion of PFKFB4-attenuated cellular biosynthetic activity and resulted in the accumulation of reactive oxygen species and cell death in the absence of p53. Finally, silencing of PFKFB4-induced apoptosis in p53-deficient cancer cells in vivo and interfered with tumour growth. These results demonstrate that PFKFB4 is essential to support anabolic metabolism in p53-deficient cancer cells and suggest that inhibition of PFKFB4 could be an effective strategy for cancer treatment.	[Ros, S.; Griffiths, B.; Schulze, A.] Canc Res UK London Res Inst, Gene Express Anal Lab, London, England; [Ros, S.; Brindle, K. M.] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England; [Floeter, J.; Kaymak, I.; Schulze, A.] Theodor Boveri Inst, Bioctr, D-97074 Wurzburg, Germany; [Da Costa, C.; Blake, S.; Behrens, A.] Francis Crick Inst, Adult Stem Cell Lab, London, England; [Houddane, A.; Rider, M. H.] Catholic Univ Louvain, de Duve Inst, Prot Phosphorylat Unit, Brussels, Belgium; [Dubuis, S.; Zamboni, N.] ETH, Inst Mol Syst Biol, Zurich, Switzerland; [Mitter, R.] Francis Crick Inst, Bioinformat & Biostat, London, England; [Walz, S.] Comprehens Canc Ctr, Core Unit Bioinformat, Bioctr, Wurzburg, Germany; [Behrens, A.] Kings Coll London, Fac Life Sci & Med, Guys Campus, London, England	Cancer Research UK; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Wurzburg; Francis Crick Institute; Universite Catholique Louvain; Swiss Federal Institutes of Technology Domain; ETH Zurich; Francis Crick Institute; University of Wurzburg; University of London; King's College London	Schulze, A (corresponding author), Theodor Boveri Inst, Bioctr, D-97074 Wurzburg, Germany.	almut.schulze@uni-wuerzburg.de	Zamboni, Nicola/K-3042-2012; Schulze, Almut/AAX-8257-2020; Ros, Susana/B-6350-2019	Zamboni, Nicola/0000-0003-1271-1021; Schulze, Almut/0000-0002-8199-6422; Behrens, Axel/0000-0002-1557-1143; Da Costa, Clive/0000-0002-0435-6747; Mitter, Richard/0000-0002-1279-3760; Ros, Susana/0000-0002-5451-1880	Cancer Research UK; German Cancer Aid [111917]; German Research Foundation [FOR 2314]; CRUK-EPSRC Imaging Centre in Cambridge and Manchester [16465]; The Francis Crick Institute [10039, 10002] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); German Cancer Aid(Deutsche Krebshilfe); German Research Foundation(German Research Foundation (DFG)); CRUK-EPSRC Imaging Centre in Cambridge and Manchester; The Francis Crick Institute	We thank C. Esnault (LRI) for advice on ChIP and H. Miess for help with Seahorse Analysis, C. Watkins and J. Bee (LRI, BRU) for help with animal experimentation, F. Lassailly, P. Johnson and T. Snoeks (In vivo imaging facility, LRI) for assistance with in vivo imaging and the LRI research services for technical support. We also thank C. Ade and Barbara Bauer (Theodor-Boveri-Institute, Wurzburg) for help with RNAseq analysis and histology, Beatrice Dankworth for help with cell line generation and W. Schmitz for insightful discussions. Cancer Research UK, the German Cancer Aid (grant 111917), the German Research Foundation (FOR 2314), and the CRUK-EPSRC Imaging Centre in Cambridge and Manchester (grant 16465) supported this work.	Bengoechea-Alonso MT, 2007, CURR OPIN CELL BIOL, V19, P215, DOI 10.1016/j.ceb.2007.02.004; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Buescher JM, 2010, ANAL CHEM, V82, P4403, DOI 10.1021/ac100101d; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; CASCIARI JJ, 1992, J CELL PHYSIOL, V151, P386, DOI 10.1002/jcp.1041510220; Chesney J, 2014, ONCOTARGET, V5, P6670, DOI 10.18632/oncotarget.2213; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Goswami Chirayu Pankaj, 2013, J Clin Bioinforma, V3, P22, DOI 10.1186/2043-9113-3-22; Hitosugi T, 2012, CANCER CELL, V22, P585, DOI 10.1016/j.ccr.2012.09.020; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776; Jiang P, 2011, NAT CELL BIOL, V13, P310, DOI 10.1038/ncb2172; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; Kim HR, 2013, BIOCHEM BIOPH RES CO, V437, P225, DOI 10.1016/j.bbrc.2013.06.043; Kruiswijk F, 2015, NAT REV MOL CELL BIO, V16, P393, DOI 10.1038/nrm4007; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lee ES, 2008, CLIN CANCER RES, V14, P7397, DOI 10.1158/1078-0432.CCR-07-4937; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Maddocks ODK, 2011, J MOL MED, V89, P237, DOI 10.1007/s00109-011-0735-5; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mayers JR, 2015, TRENDS BIOCHEM SCI, V40, P130, DOI 10.1016/j.tibs.2015.01.004; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Okar DO, 2001, TRENDS BIOCHEM SCI, V26, P30, DOI 10.1016/S0968-0004(00)01699-6; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Rinn JL, 2011, TRENDS CELL BIOL, V21, P344, DOI 10.1016/j.tcb.2011.04.002; Ros S, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-8; Ros S, 2012, CANCER DISCOV, V2, P328, DOI 10.1158/2159-8290.CD-11-0234; Ruhl M, 2012, BIOTECHNOL BIOENG, V109, P763, DOI 10.1002/bit.24344; Schwartzenberg-Bar-Yoseph F, 2004, CANCER RES, V64, P2627, DOI 10.1158/0008-5472.CAN-03-0846; Strohecker AM, 2015, ONCOGENE, V34, P5662, DOI 10.1038/onc.2015.23; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swinnen JV, 2000, ONCOGENE, V19, P5173, DOI 10.1038/sj.onc.1203889; VANSCHAFTINGEN E, 1982, EUR J BIOCHEM, V129, P191; Willis A, 2004, ONCOGENE, V23, P2330, DOI 10.1038/sj.onc.1207396; Yahagi N, 2003, J BIOL CHEM, V278, P25395, DOI 10.1074/jbc.M302364200; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	45	43	43	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 8	2017	36	23					3287	3299		10.1038/onc.2016.477	http://dx.doi.org/10.1038/onc.2016.477			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EW9WJ	28092678	Green Submitted			2022-12-26	WOS:000402869800008
J	Mohammed, SG; Arjona, FJ; Latta, F; Bindels, RJM; Roepman, R; Hoenderop, JGJ				Mohammed, Sami G.; Arjona, Francisco J.; Latta, Femke; Bindels, Rene J. M.; Roepman, Ronald; Hoenderop, Joost G. J.			Fluid shear stress increases transepithelial transport of Ca2+ in ciliated distal convoluted and connecting tubule cells	FASEB JOURNAL			English	Article						renal tubules; mechanosensation; primary cilia; Ca2+ reabsorption	CORTICAL COLLECTING DUCT; PRIMARY CILIUM; EPITHELIAL CA2+; ENDOTHELIN-1 PRODUCTION; CALCIUM REABSORPTION; PROSTAGLANDIN E-2; FLOW REGULATION; CHANNEL FAMILY; KIDNEY-DISEASE; POLYCYSTIN-1	In kidney, transcellular transport of Ca2+ is mediated by transient receptor potential vanilloid 5 and Na+-Ca2+ exchanger 1 proteins in distal convoluted and connecting tubules (DCTs and CNTs, respectively). It is not yet understood howDCT/CNT cells can adapt to differences in tubular flow rate and, consequently, Ca2+ load. This study aims to elucidate the molecular mechanisms by which DCT/CNT cells sense fluid dynamics to control transepithelial Ca2+ reabsorption and whether their primary cilia play an active role in this process. Mouse primary DCT/CNT cultures were subjected to a physiologic fluid shear stress (FSS) of 0.12 dyn/cm(2). Transient receptor potential vanilloid 5 and Na+-Ca2+ exchanger 1 mRNA levels were significantly increased upon FSS exposure compared with static controls. Functional studies with Ca-45(2+) demonstrated a significant stimulation of transepithelial Ca2+ transport under FSS comparedwith static conditions. Primary cilia removal decreased Ca2+ transport in both static and FSS conditions, a finding that correlated with decreased expression of genes involved in transepithelial Ca2+ transport; however, FSS-induced stimulation of Ca2+ transport was still observed. These results indicate that nephron DCT and CNT segments translate FSS into a physiologic response that implicates an increased Ca-2+ reabsorption. Moreover, primary cilia influence transepithelial Ca2+ transport in DCTs/CNTs, yet this process is not distinctly coupled to FSS sensing by these organelles.-Mohammed, S. G., Arjona, F. J., Latta, F., Bindels, R. J. M., Roepman, R., Hoenderop, J. G. J. Fluid shear stress increases transepithelial transport of Ca2+ in ciliated distal convoluted and connecting tubule cells.	[Mohammed, Sami G.; Arjona, Francisco J.; Latta, Femke; Bindels, Rene J. M.; Hoenderop, Joost G. J.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Physiol, POB 9101, NL-6500 HB Nijmegen, Netherlands; [Roepman, Ronald] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Human Genet, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Hoenderop, JGJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Physiol, POB 9101, NL-6500 HB Nijmegen, Netherlands.	joost.hoenderop@radboudumc.nl	Mohammed, Sami Gemal/F-3894-2016; Bindels, René JM/B-9824-2013; Arjona, Francisco J/P-6059-2015; Roepman, Ronald/B-1339-2014; Hoenderop, Joost G.J./H-8047-2014	Mohammed, Sami Gemal/0000-0002-0903-8131; Bindels, René JM/0000-0003-1167-1339; Arjona, Francisco J/0000-0002-2479-0735; Roepman, Ronald/0000-0002-5178-8163; Hoenderop, Joost G.J./0000-0002-1816-8544	Radboud Institute for Molecular Life Sciences; Netherlands Organization for Scientific Research [NWO] [Vici-865.12.005, Vici-016.130.668]	Radboud Institute for Molecular Life Sciences; Netherlands Organization for Scientific Research [NWO](Netherlands Organization for Scientific Research (NWO))	This work was supported by grants from the Radboud Institute for Molecular Life Sciences (to J.G.J.H. and R.R.) and The Netherlands Organization for Scientific Research [NWO Vici-865.12.005 (to R. R.) and NWO Vici-016.130.668 (to J.G.J.H.)]. The authors thank the COPAS sorting team: Caro Bos, Marla Lavrijsen, and Daisy Ermers. The authors also thank Dr. Jeppe Praetorius for the TRPV5-GFP mouse strain and Rico Bongaarts from Union Biometrica for technical assistance with the COPAS; the Radboud animal facility for breeding and maintaining animals; the Microscope Imaging Centre in Nijmegen for providing the FV1000 confocal laser scanning microscope; and Louis Wolf for ImageJ software assistance. The authors declare no conflicts of interest.	Berrout J, 2012, J BIOL CHEM, V287, P8782, DOI 10.1074/jbc.M111.308411; Boehlke C, 2010, NAT CELL BIOL, V12, P1115, DOI 10.1038/ncb2117; Bonny O, 2013, AM J PHYSIOL-RENAL, V304, pF585, DOI 10.1152/ajprenal.00493.2012; Boros S, 2009, PFLUG ARCH EUR J PHY, V458, P99, DOI 10.1007/s00424-008-0602-6; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; de Groot T, 2009, J AM SOC NEPHROL, V20, P1693, DOI 10.1681/ASN.2008080873; Delaine-Smith RM, 2014, FASEB J, V28, P430, DOI 10.1096/fj.13-231894; Delling M, 2016, NATURE, V531, P656, DOI 10.1038/nature17426; Dimke H, 2011, J PHYSIOL-LONDON, V589, P1535, DOI 10.1113/jphysiol.2010.199869; Flores D, 2012, AM J PHYSIOL-RENAL, V303, pF632, DOI 10.1152/ajprenal.00169.2012; Flores D, 2011, NEPHRON PHYSIOL, V117, P27, DOI 10.1159/000321640; Hill-Eubanks DC, 2014, PHYSIOLOGY, V29, P343, DOI 10.1152/physiol.00009.2014; Hoenderop JGJ, 2002, FASEB J, V16, P1398, DOI 10.1096/fj.02-0225com; Hoenderop JGJ, 2001, J PHYSIOL-LONDON, V537, P747; Hofmeister MV, 2009, AM J PHYSIOL-RENAL, V296, pF194, DOI 10.1152/ajprenal.90495.2008; Jang KJ, 2013, INTEGR BIOL-UK, V5, P1119, DOI 10.1039/c3ib40049b; KUNAU RT, 1974, J CLIN INVEST, V54, P1488, DOI 10.1172/JCI107897; Lambers TT, 2006, EMBO J, V25, P2978, DOI 10.1038/sj.emboj.7601186; Lambers TT, 2006, KIDNEY INT, V69, P650, DOI 10.1038/sj.ki.5000169; Liu W, 2003, AM J PHYSIOL-RENAL, V285, pF998, DOI 10.1152/ajprenal.00067.2003; Liu Y, 2014, AM J PHYSIOL-RENAL, V306, pF214, DOI 10.1152/ajprenal.00327.2013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyon-Roberts B, 2011, AM J PHYSIOL-RENAL, V300, pF650, DOI 10.1152/ajprenal.00530.2010; Markadieu N, 2012, AM J PHYSIOL-RENAL, V303, pF886, DOI 10.1152/ajprenal.00114.2012; MILLS JN, 1951, J PHYSIOL-LONDON, V113, P528, DOI 10.1113/jphysiol.1951.sp004593; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nauli SM, 2008, CIRCULATION, V117, P1161, DOI 10.1161/CIRCULATIONAHA.107.710111; Nauli SM, 2006, J AM SOC NEPHROL, V17, P1015, DOI 10.1681/ASN.2005080830; Nilius B, 2001, BRIT J PHARMACOL, V134, P453, DOI 10.1038/sj.bjp.0704272; O'Neil RG, 2005, PFLUG ARCH EUR J PHY, V451, P193, DOI 10.1007/s00424-005-1424-4; Pandit MM, 2015, AM J PHYSIOL-RENAL, V308, pF541, DOI 10.1152/ajprenal.00456.2014; Patel A, 2015, PFLUG ARCH EUR J PHY, V467, P157, DOI 10.1007/s00424-014-1516-0; Pluznick JL, 2015, CLIN J AM SOC NEPHRO, V10, P1626, DOI 10.2215/CJN.00730114; Pochynyuk O, 2013, PFLUG ARCH EUR J PHY, V465, P177, DOI 10.1007/s00424-012-1190-z; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Praetorius HA, 2003, J MEMBRANE BIOL, V191, P69, DOI 10.1007/s00232-002-1042-4; Praetorius HA, 2015, AM J PHYSIOL-CELL PH, V308, pC198, DOI 10.1152/ajpcell.00336.2014; Praetorius HA, 2013, SEMIN CELL DEV BIOL, V24, P3, DOI 10.1016/j.semcdb.2012.10.003; Raghavan V, 2014, P NATL ACAD SCI USA, V111, P8506, DOI 10.1073/pnas.1402195111; Renkema KY, 2008, ANN MED, V40, P82, DOI 10.1080/07853890701689645; RESNICK N, 1995, FASEB J, V9, P874, DOI 10.1096/fasebj.9.10.7615157; Rydholm S, 2010, AM J PHYSIOL-RENAL, V298, pF1096, DOI 10.1152/ajprenal.00657.2009; Satlin LM, 2006, AM J PHYSIOL-RENAL, V291, pF923, DOI 10.1152/ajprenal.00192.2006; Satlin LM, 2001, AM J PHYSIOL-RENAL, V280, pF1010, DOI 10.1152/ajprenal.2001.280.6.F1010; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; SIROTA JH, 1950, J CLIN INVEST, V29, P187, DOI 10.1172/JCI102245; Sooy K, 2000, CURR OPIN NEPHROL HY, V9, P341, DOI 10.1097/00041552-200007000-00004; Srivastava T, 2014, AM J PHYSIOL-RENAL, V307, pF1323, DOI 10.1152/ajprenal.00335.2014; van der Hagen EAE, 2014, PFLUG ARCH EUR J PHY, V466, P2077, DOI 10.1007/s00424-014-1470-x; van Loon EPM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153483; vanBaal J, 1996, J PHYSIOL-LONDON, V497, P229, DOI 10.1113/jphysiol.1996.sp021763; Weimbs T, 2007, AM J PHYSIOL-RENAL, V293, pF1423, DOI 10.1152/ajprenal.00275.2007; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; Weinbaum S, 2010, AM J PHYSIOL-RENAL, V299, pF1220, DOI 10.1152/ajprenal.00453.2010; Woda CB, 2001, AM J PHYSIOL-RENAL, V280, pF786, DOI 10.1152/ajprenal.2001.280.5.F786; Woudenberg-Vrenken TE, 2009, NAT REV NEPHROL, V5, P441, DOI 10.1038/nrneph.2009.100; Zhou XZ, 2010, J BIOMECH, V43, P1598, DOI 10.1016/j.jbiomech.2009.12.028	57	12	12	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1796	1806		10.1096/fj.201600687RRR	http://dx.doi.org/10.1096/fj.201600687RRR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28100643				2022-12-26	WOS:000399195500005
J	Deevska, GM; Dotson, PP; Karakashian, AA; Isaac, G; Wrona, M; Kelly, SB; Merrill, AH; Nikolova-Karakashian, MN				Deevska, Gergana M.; Dotson, Patrick P., II; Karakashian, Alexander A.; Isaac, Giorgis; Wrona, Mark; Kelly, Samuel B.; Merrill, Alfred H., Jr.; Nikolova-Karakashian, Mariana N.			Novel Interconnections in Lipid Metabolism Revealed by Overexpression of Sphingomyelin Synthase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; RAT-LIVER MICROSOMES; DIACYLGLYCEROL ACYLTRANSFERASE; TRIACYLGLYCEROL SYNTHESIS; DE-NOVO; QUANTITATIVE-ANALYSIS; MEMBRANE TOPOLOGY; GOLGI-APPARATUS; FATTY-ACIDS; CERAMIDE	This study investigates the consequences of elevating sphingomyelin synthase 1 (SMS1) activity, which generates the main mammalian sphingolipid, sphingomyelin. HepG2 cells stably transfected with SMS1 (HepG2-SMS1) exhibit elevated enzyme activity in vitro and increased sphingomyelin content ( mainly C22:0-and C24:0-sphingomyelin) but lower hexosylceramide (Hex-Cer) levels. HepG2-SMS1 cells have fewer triacylglycerols than controls but similar diacylglycerol acyltransferase activity, triacylglycerol secretion, and mitochondrial function. Treatment with 1mM palmitate increases de novo ceramide synthesis in both cell lines to a similar degree, causing accumulation of C16:0-ceramide (and some C18:0-,C20:0-, and C22: 0-ceramides) as well as C16: 0- and C18: 0- Hex-Cers. In these experiments, the palmitic acid is delivered as a complex with delipidated BSA(2:1,mol/mol) and does not induce significant lipotoxicity. Based on precursor labeling, the flux through SM synthase also increases, which is exacerbated in HepG2-SMS1 cells. In contrast, palmitate-induced lipid droplet formation is significantly reduced in HepG2-SMS1 cells. [C-14] Choline and [H-3] palmitate tracking shows that SMS1 overexpression apparently affects the partitioning of palmitate- enriched diacylglycerol between the phosphatidylcholine and triacylglycerol pathways, to the benefit of the former. Furthermore, triacylglycerols from HepG2-SMS1 cells are enriched in polyunsaturated fatty acids, which is indicative of active remodeling. Together, these results delineate novel metabolic interactions between glycerolipids and sphingolipids.	[Deevska, Gergana M.; Dotson, Patrick P., II; Karakashian, Alexander A.; Nikolova-Karakashian, Mariana N.] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; [Isaac, Giorgis; Wrona, Mark] Waters Corp, Pharmaceut Discovery & Life Sci, Milford, MA 01757 USA; [Kelly, Samuel B.; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Kelly, Samuel B.; Merrill, Alfred H., Jr.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University of Kentucky; Waters Corporation; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Nikolova-Karakashian, MN (corresponding author), Chandler Med Ctr, MS513,800 Rose St, Lexington, KY 40536 USA.	mariana.karakashian@uky.edu	Wrona, Mark D/AAV-7476-2020	Wrona, Mark D/0000-0001-7172-1073	NCI [P30CA177558]; National Institutes of Health [P30CA177558]; NATIONAL CANCER INSTITUTE [P30CA177558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019223] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr. J. Holthuis (Utrecht University) for providing the SMS1 construct that was used as a reference and Dr. M. Mitov (University of Kentucky) for measuring the OCR in the Redox Metabolism Shared Resource Facility of the University of Kentucky Markey Cancer Center (supported by NCI, National Institutes of Health, Grant P30CA177558).	Abo-Hashema KAH, 1999, J BIOL CHEM, V274, P35577, DOI 10.1074/jbc.274.50.35577; Adada M, 2016, CHEM PHYS LIPIDS, V197, P45, DOI 10.1016/j.chemphyslip.2015.07.008; Bagnato C, 2003, J BIOL CHEM, V278, P52203, DOI 10.1074/jbc.M305760200; Bijl N, 2009, HEPATOLOGY, V50, P1431, DOI 10.1002/hep.23175; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chaurasia B, 2015, TRENDS ENDOCRIN MET, V26, P538, DOI 10.1016/j.tem.2015.07.006; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; COLEMAN R, 1976, J BIOL CHEM, V251, P4537; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Cornell RB, 2000, TRENDS BIOCHEM SCI, V25, P441, DOI 10.1016/S0968-0004(00)01625-X; De Clercq N., 2008, LIPID TECHNOL, V20, P232, DOI [10.1002/lite.200800060, DOI 10.1002/LITE.200800060]; DECLERCQ PE, 1984, J BIOL CHEM, V259, P9064; Deevska GM, 2009, J BIOL CHEM, V284, P8359, DOI 10.1074/jbc.M807800200; Fagone P, 2013, BBA-MOL CELL BIOL L, V1831, P523, DOI 10.1016/j.bbalip.2012.09.009; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650; Hanada K, 2010, P JPN ACAD B-PHYS, V86, P426, DOI 10.2183/pjab.86.426; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Jackowski S, 2000, BBA-MOL CELL BIOL L, V1483, P301, DOI 10.1016/S1388-1981(99)00203-6; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; KAHOVCOVA J, 1969, J CHROMATOGR, V40, P90, DOI 10.1016/S0021-9673(01)96622-1; KENNEDY EP, 1957, ANNU REV BIOCHEM, V26, P119, DOI 10.1146/annurev.bi.26.070157.001003; Leonardi R, 2009, J BIOL CHEM, V284, P27077, DOI 10.1074/jbc.M109.031336; Li ZY, 2012, COMPUT ENG APPL, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0040132; LIPSKY NG, 1985, SCIENCE, V228, P745, DOI 10.1126/science.2581316; Luberto C, 1998, J BIOL CHEM, V273, P14550, DOI 10.1074/jbc.273.23.14550; Martinez L, 2015, ONCOTARGET, V6, P41479, DOI 10.18632/oncotarget.6286; Mehra VC, 2014, AM J PATHOL, V184, P1562, DOI 10.1016/j.ajpath.2014.01.009; MERRILL AH, 1995, J BIOL CHEM, V270, P13834, DOI 10.1074/jbc.270.23.13834; MERRILL AH, 1986, J BIOL CHEM, V261, P3764; Mora G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049269; Nikolova-Karakashian M, 2000, METHOD ENZYMOL, V311, P31; Osawa Y, 2011, FASEB J, V25, P1133, DOI 10.1096/fj.10-168351; Rojas C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113929; ROSENWALD AG, 1992, BIOCHEMISTRY-US, V31, P3581, DOI 10.1021/bi00129a005; Schmid PC, 1997, LIPIDS, V32, P1181, DOI 10.1007/s11745-997-0152-7; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; SHAYMAN JA, 1991, J BIOL CHEM, V266, P22968; SPERRY WM, 1950, J BIOL CHEM, V187, P97; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; Tafesse FG, 2007, J BIOL CHEM, V282, P17537, DOI 10.1074/jbc.M702423200; ULLMAN MD, 1974, J BIOL CHEM, V249, P1506; Villani M, 2008, BIOCHEM J, V414, P31, DOI 10.1042/BJ20071240; Waterman IJ, 2002, J LIPID RES, V43, P1555, DOI 10.1194/jlr.M200051-JLR200; WILLIAMS RD, 1984, ARCH BIOCHEM BIOPHYS, V228, P282, DOI 10.1016/0003-9861(84)90069-9; Wright MM, 2002, LIPIDS, V37, P663, DOI 10.1007/s11745-002-0947-6; Wurie HR, 2011, J BIOL CHEM, V286, P36238, DOI 10.1074/jbc.M111.251900; Yamaji T, 2015, TRAFFIC, V16, P101, DOI 10.1111/tra.12239; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200	49	12	13	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					5110	5122		10.1074/jbc.M116.751602	http://dx.doi.org/10.1074/jbc.M116.751602			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28087695	Green Published, hybrid			2022-12-26	WOS:000397590400030
J	Ano, Y; Dohata, A; Taniguchi, Y; Hoshi, A; Uchida, K; Takashima, A; Nakayama, H				Ano, Yasuhisa; Dohata, Atsushi; Taniguchi, Yoshimasa; Hoshi, Ayaka; Uchida, Kazuyuki; Takashima, Akihiko; Nakayama, Hiroyuki			Iso--acids, Bitter Components of Beer, Prevent Inflammation and Cognitive Decline Induced in a Mouse Model of Alzheimer's Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; inflammation; microglia; neuroinflammation; phagocytosis	PPAR-GAMMA AGONISTS; RECEPTOR-GAMMA; ALCOHOL-CONSUMPTION; THERAPEUTIC TARGET; MURINE MODEL; CD36; ISOHUMULONES; RESVERATROL; ALPHA; HOPS	Alongside the rapid growth in aging populations worldwide, prevention and therapy for age-related memory decline and dementia are in great demand to maintain a long, healthy life. Here we found that iso--acids, hop-derived bitter compounds in beer, enhance microglial phagocytosis and suppress inflammation via activation of the peroxisome proliferator-activated receptor . In normal mice, oral administration of iso--acids led to a significant increase both in CD11b and CD206 double-positive anti-inflammatory type microglia (p < 0.05) and in microglial phagocytosis in the brain. In Alzheimer's model 5xFAD mice, oral administration of iso--acids resulted in a 21% reduction in amyloid in the cerebral cortex as observed by immunohistochemical analysis, a significant reduction in inflammatory cytokines such as IL-1 and chemokines including macrophage inflammatory protein-1 in the cerebral cortex (p < 0.05) and a significant improvement in a novel object recognition test (p < 0.05), as compared with control-fed 5xFAD mice. The differences in iso--acid-fed mice were due to the induction of microglia to an anti-inflammatory phenotype. The present study is the first to report that amyloid deposition and inflammation are suppressed in a mouse model of Alzheimer's disease by a single component, iso--acids, via the regulation of microglial activation. The suppression of neuroinflammation and improvement in cognitive function suggests that iso--acids contained in beer may be useful for the prevention of dementia.	[Ano, Yasuhisa] Kirin Co Ltd, Res Labs Hlth Sci & Food Technol, Atsugi, Kanagawa 2360004, Japan; [Taniguchi, Yoshimasa; Hoshi, Ayaka] Kirin Co Ltd, Cent Labs Key Technol, Atsugi, Kanagawa 2360004, Japan; [Dohata, Atsushi; Uchida, Kazuyuki; Nakayama, Hiroyuki] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; [Takashima, Akihiko] Natl Ctr Geriatr & Gerontol, Dept Neurobiol, Obu 4748511, Japan	University of Tokyo; National Center for Geriatrics & Gerontology	Ano, Y (corresponding author), Kirin Co Ltd, Res Labs Hlth Sci & Food Technol, Kanazawa Ku, 1-13-5 Fukuura, Yokohama, Kanagawa 2360004, Japan.	Yasuhisa_Ano@kirin.co.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT); Scientific Research on Innovation Area (Brain Protein Aging and Dementia control); Japan Agency for Medical Research and Development (AMED) DEMENTIA Research and Development Project [16dk0207026h0301]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Scientific Research on Innovation Area (Brain Protein Aging and Dementia control); Japan Agency for Medical Research and Development (AMED) DEMENTIA Research and Development Project(Japan Agency for Medical Research and Development (AMED))	This work was supported by a Ministry of Education, Culture, Sports, Science and Technology (MEXT) Grant-in-aid Project, Scientific Research on Innovation Area (Brain Protein Aging and Dementia control (to A. T.)) and by Japan Agency for Medical Research and Development (AMED) DEMENTIA Research and Development Project 16dk0207026h0301 (to A. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Abumrad NA, 2005, J CLIN INVEST, V115, P2965, DOI 10.1172/JCI26955; Agarwal S., 2016, BIOCH BIOPH IN PRESS; Ano Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118512; Arntzen KA, 2010, ACTA NEUROL SCAND, V122, P23, DOI 10.1111/j.1600-0404.2010.01371.x; Ballesteros I, 2014, J LEUKOCYTE BIOL, V95, P587, DOI 10.1189/jlb.0613326; Bonen A, 2004, P NUTR SOC, V63, P245, DOI 10.1079/PNS2004331; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Cho YC, 2010, INT IMMUNOPHARMACOL, V10, P556, DOI 10.1016/j.intimp.2010.02.002; Horvat P, 2015, NEUROLOGY, V84, P287, DOI 10.1212/WNL.0000000000001164; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Li XW, 2015, AM J PATHOL, V185, P230, DOI 10.1016/j.ajpath.2014.09.016; Lynes MD, 2011, LIFE SCI, V88, P384, DOI 10.1016/j.lfs.2010.12.015; Mandrekar-Colucci S, 2012, J NEUROSCI, V32, P10117, DOI 10.1523/JNEUROSCI.5268-11.2012; Matsui Toshifumi, 2011, Nihon Rinsho, V69 Suppl 10 Pt 2, P217; Modi KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130398; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Murphy GJ, 2000, TRENDS PHARMACOL SCI, V21, P469, DOI 10.1016/S0165-6147(00)01559-5; Namikoshi T, 2007, HYPERTENS RES, V30, P175, DOI 10.1291/hypres.30.175; Neafsey EJ, 2011, NEUROPSYCH DIS TREAT, V7, P465, DOI 10.2147/NDT.S23159; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Obara K, 2009, CLIN NUTR, V28, P278, DOI 10.1016/j.clnu.2009.03.012; Olefsky JM, 2000, TRENDS ENDOCRIN MET, V11, P362, DOI 10.1016/S1043-2760(00)00306-4; Olefsky JM, 2000, J CLIN INVEST, V106, P467, DOI 10.1172/JCI10843; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Panigrahy D, 2005, CANCER BIOL THER, V4, P687, DOI 10.4161/cbt.4.7.2014; Petrovski G, 2011, ANN NY ACAD SCI, V1215, P22, DOI 10.1111/j.1749-6632.2010.05843.x; Porquet D, 2014, J ALZHEIMERS DIS, V42, P1209, DOI 10.3233/JAD-140444; Samovski D, 2015, DIABETES, V64, P353, DOI 10.2337/db14-0582; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Schmidt MV, 2010, THESCIENTIFICWORLDJO, V10, P2181, DOI 10.1100/tsw.2010.213; Sundaresan S, 2015, J NUTR, V145, P2195, DOI 10.3945/jn.115.215483; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Taniguchi Y, 2013, J AGR FOOD CHEM, V61, P3121, DOI 10.1021/jf3047187; Vidavalur Ramesh, 2006, Exp Clin Cardiol, V11, P217; Witte AV, 2014, J NEUROSCI, V34, P7862, DOI 10.1523/JNEUROSCI.0385-14.2014; Yajima H, 2005, INT J OBESITY, V29, P991, DOI 10.1038/sj.ijo.0802965; Yajima H, 2004, J BIOL CHEM, V279, P33456, DOI 10.1074/jbc.M403456200; Yamanaka M, 2012, J NEUROSCI, V32, P17321, DOI 10.1523/JNEUROSCI.1569-12.2012; Yu Y, 2015, CELL MOL NEUROBIOL, V35, P71, DOI 10.1007/s10571-014-0101-6	39	57	60	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3720	3728		10.1074/jbc.M116.763813	http://dx.doi.org/10.1074/jbc.M116.763813			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28087694	Green Published, hybrid			2022-12-26	WOS:000395542500015
J	Cheng, ZS; Landry, AP; Wang, YM; Ding, HE				Cheng, Zishuo; Landry, Aaron P.; Wang, Yiming; Ding, Huangen			Binding of Nitric Oxide in CDGSH-type [2Fe-2S] Clusters of the Human Mitochondrial Protein Miner2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						EPR; iron-sulfur protein; mitochondria; mitochondrial disease; mitochondrial metabolism; nitric oxide; Miner2; mitoNEET	DINITROSYL-IRON COMPLEXES; ZINC-FINGER PROTEIN; ESCHERICHIA-COLI; MEMBRANE PROTEIN; CRYSTAL-STRUCTURE; SULFUR CLUSTERS; HUMAN MITONEET; DIHYDROXYACID DEHYDRATASE; 4FE-4S CLUSTER; BREAST-CANCER	Iron-sulfur proteins are among the primary targets of nitric oxide in cells. Previous studies have shown that iron-sulfur clusters hosted by cysteine residues in proteins are readily disrupted by nitric oxide forming a protein-bound dinitrosyl iron complex, thiolate-bridged di-iron tetranitrosyl complex, or octanitrosyl cluster. Here we report that human mitochondrial protein Miner2 [2Fe-2S] clusters can bind nitric oxide without disruption of the clusters. Miner2 is a member of a new CDGSH iron-sulfur protein family that also includes two mitochondrial proteins: the type II diabetes-related mitoNEET and the Wolfram syndrome 2-linked Miner1. Miner2 contains two CDGSH motifs, and each CDGSH motif hosts a [2Fe-2S] cluster via three cysteine and one histidine residues. Binding of nitric oxide in the reduced Miner2 [2Fe-2S] clusters produces a major absorption peak at 422 nm without releasing iron or sulfide from the clusters. The EPR measurements and mass spectrometry analyses further reveal that nitric oxide binds to the reduced [2Fe-2S] clusters in Miner2, with each cluster binding one nitric oxide. Although the [2Fe-2S] cluster in purified human mitoNEET and Miner1 fails to bind nitric oxide, a single mutation of Asp-96 to Val in mitoNEET or Asp-123 to Val in Miner1 facilitates nitric oxide binding in the [2Fe-2S] cluster, indicating that a subtle change of protein structure may switch mitoNEET and Miner1 to bind nitric oxide. The results suggest that binding of nitric oxide in the CDGSH-type [2Fe-2S] clusters in mitochondrial protein Miner2 may represent a new nitric oxide signaling mode in cells.	[Cheng, Zishuo; Landry, Aaron P.; Wang, Yiming; Ding, Huangen] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Ding, HE (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	hding@lsu.edu	Ding, Huangen/AAJ-8550-2020; Cheng, Zishuo/U-6010-2017; Cheng, Zishuo/AAD-6861-2020	Ding, Huangen/0000-0002-4815-7336; 	National Institutes of Health [R15GM109399]; American Heart Association [13GRNT16890014]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM109399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by National Institutes of Health Grant R15GM109399 and American Heart Association Grant 13GRNT16890014. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amr S, 2007, AM J HUM GENET, V81, P673, DOI 10.1086/520961; Bai F, 2015, P NATL ACAD SCI USA, V112, P3698, DOI 10.1073/pnas.1502960112; Bak DW, 2013, BIOCHEMISTRY-US, V52, P4687, DOI 10.1021/bi400540m; Bak DW, 2009, BIOCHEMISTRY-US, V48, P10193, DOI 10.1021/bi9016445; Brown GC, 2007, FRONT BIOSCI-LANDMRK, V12, P1024, DOI 10.2741/2122; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Conlan AR, 2009, J MOL BIOL, V392, P143, DOI 10.1016/j.jmb.2009.06.079; Cooper CE, 1999, BBA-BIOENERGETICS, V1411, P290, DOI 10.1016/S0005-2728(99)00021-3; COWART RE, 1993, ANAL BIOCHEM, V211, P151, DOI 10.1006/abio.1993.1246; Crack JC, 2015, J BIOL CHEM, V290, P12689, DOI 10.1074/jbc.M115.643072; Crack JC, 2014, ACCOUNTS CHEM RES, V47, P3196, DOI 10.1021/ar5002507; Crack JC, 2011, J AM CHEM SOC, V133, P1112, DOI 10.1021/ja109581t; Dicus MM, 2010, J AM CHEM SOC, V132, P2037, DOI 10.1021/ja909359g; Ding HG, 2000, P NATL ACAD SCI USA, V97, P5146, DOI 10.1073/pnas.97.10.5146; Duan XW, 2009, BIOCHEM J, V417, P783, DOI 10.1042/BJ20081423; Fitzpatrick J, 2015, ACCOUNTS CHEM RES, V48, P2453, DOI 10.1021/acs.accounts.5b00246; Golinelli-Cohen MP, 2016, J BIOL CHEM, V291, P7583, DOI 10.1074/jbc.M115.711218; Grabarczyk DB, 2014, J AM CHEM SOC, V136, P11236, DOI 10.1021/ja505291j; Hou XW, 2007, J BIOL CHEM, V282, P33242, DOI 10.1074/jbc.C700172200; Huang LX, 1999, BIOCHEMISTRY-US, V38, P1912, DOI 10.1021/bi981954t; Hyduke DR, 2007, P NATL ACAD SCI USA, V104, P8484, DOI 10.1073/pnas.0610888104; Iwasaki T, 2009, J AM CHEM SOC, V131, P13659, DOI 10.1021/ja903228w; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kennedy MC, 1997, J BIOL CHEM, V272, P20340, DOI 10.1074/jbc.272.33.20340; Kusminski CM, 2016, DIABETES, V65, P1534, DOI 10.2337/db15-1323; Landry AP, 2017, FREE RADICAL BIO MED, V102, P240, DOI 10.1016/j.freeradbiomed.2016.12.001; Landry AP, 2015, FREE RADICAL BIO MED, V81, P119, DOI 10.1016/j.freeradbiomed.2015.01.017; Landry AP, 2014, J BIOL CHEM, V289, P4307, DOI 10.1074/jbc.M113.542050; Landry AP, 2011, FREE RADICAL BIO MED, V50, P1582, DOI 10.1016/j.freeradbiomed.2011.03.005; Lin JZ, 2007, P NATL ACAD SCI USA, V104, P14640, DOI 10.1073/pnas.0702426104; Lin JZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024790; Meyer J, 2008, J BIOL INORG CHEM, V13, P157, DOI 10.1007/s00775-007-0318-7; Paddock ML, 2007, P NATL ACAD SCI USA, V104, P14342, DOI 10.1073/pnas.0707189104; Partridge JD, 2009, MOL MICROBIOL, V73, P680, DOI 10.1111/j.1365-2958.2009.06799.x; Ren BB, 2008, MOL MICROBIOL, V70, P953, DOI 10.1111/j.1365-2958.2008.06464.x; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Shimberg GD, 2016, P NATL ACAD SCI USA, V113, P4700, DOI 10.1073/pnas.1517620113; SIEGEL LM, 1965, ANAL BIOCHEM, V11, P126, DOI 10.1016/0003-2697(65)90051-5; Sohn YS, 2013, P NATL ACAD SCI USA, V110, P14676, DOI 10.1073/pnas.1313198110; Tamir S, 2015, BBA-MOL CELL RES, V1853, P1294, DOI 10.1016/j.bbamcr.2014.10.014; Tinberg CE, 2010, J AM CHEM SOC, V132, P18168, DOI 10.1021/ja106290p; Tonzetich ZJ, 2009, J AM CHEM SOC, V131, P7964, DOI 10.1021/ja9030159; Tsai ML, 2015, ACCOUNTS CHEM RES, V48, P1184, DOI 10.1021/ar500459j; Watanabe S, 2008, P NATL ACAD SCI USA, V105, P4121, DOI 10.1073/pnas.0709188105; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Wu G, 2015, BIOCHEMISTRY-US, V54, P7098, DOI 10.1021/acs.biochem.5b00994; Yang JJ, 2010, FREE RADICAL BIO MED, V49, P268, DOI 10.1016/j.freeradbiomed.2010.04.012; Zuris JA, 2011, P NATL ACAD SCI USA, V108, P13047, DOI 10.1073/pnas.1109986108	48	17	17	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3146	3153		10.1074/jbc.M116.766774	http://dx.doi.org/10.1074/jbc.M116.766774			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28082676	Green Published, hybrid			2022-12-26	WOS:000395538800008
J	Martin, M; Hua, LQ; Wang, BL; Wei, H; Prabhu, L; Hartley, AV; Jiang, GL; Liu, YL; Lu, T				Martin, Matthew; Hua, Laiqing; Wang, Benlian; Wei, Han; Prabhu, Lakshmi; Hartley, Antja-Voy; Jiang, Guanglong; Liu, Yunlong; Lu, Tao			Novel Serine 176 Phosphorylation of YBX1 Activates NF-B in Colon Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						colon cancer; NF-B; phosphorylation; posttranslational modification (PTM); serine; YBX1	BOX-BINDING PROTEIN-1; KAPPA-B; BREAST-CANCER; KINASE CK2; P65 SUBUNIT; YB-1; RECEPTOR; GROWTH; BINDING-PROTEIN-1; MARKER	Y box protein 1 (YBX1) is a well known oncoprotein that has tumor-promoting functions. YBX1 is widely considered to be an attractive therapeutic target in cancer. To develop novel therapeutics to target YBX1, it is of great importance to understand how YBX1 is finely regulated in cancer. Previously, we have shown that YBX1 could function as a tumor promoter through phosphorylation of its Ser-165 residue, leading to the activation of the NF-B signaling pathway (1). In this study, using mass spectrometry analysis, we discovered a distinct phosphorylation site, Ser-176, on YBX1. Overexpression of the YBX1-S176A (serine-to-alanine) mutant in either HEK293 cells or colon cancer HT29 cells showed dramatically reduced NF-B-activating ability compared with that of WT-YBX1, confirming that Ser-176 phosphorylation is critical for the activation of NF-B by YBX1. Importantly, the mutant of Ser-176 and the previously reported Ser-165 sites regulate distinct groups of NF-B target genes, suggesting the unique and irreplaceable function of each of these two phosphorylated serine residues. Our important findings could provide a novel cancer therapy strategy by blocking either Ser-176 or Ser-165 phosphorylation or both of YBX1 in colon cancer.	[Martin, Matthew; Hua, Laiqing; Wei, Han; Prabhu, Lakshmi; Hartley, Antja-Voy; Lu, Tao] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, 635 Barnhill Dr, Indianapolis, IN 46202 USA; [Lu, Tao] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Jiang, Guanglong; Liu, Yunlong; Lu, Tao] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Wang, Benlian] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Case Western Reserve University	Lu, T (corresponding author), Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	lut@iupui.edu	Jiang, Guanglong/N-5980-2019; Prabhu, Lakshmi/AAK-8659-2020	Prabhu, Lakshmi/0000-0002-2093-1115	American Cancer Society [4186265]; V Foundation Kay Yow Cancer Fund [068058-00002B]; Showalter Trust Fund [4486233]; Biomedical Research Grant [2286229]	American Cancer Society(American Cancer Society); V Foundation Kay Yow Cancer Fund; Showalter Trust Fund; Biomedical Research Grant	This work was supported by Grants 4186265 (to T. L.) from the American Cancer Society, 068058-00002B (to T. L.) from the V Foundation Kay Yow Cancer Fund, and 4486233 (to T. L.) from the Showalter Trust Fund, as well as Biomedical Research Grant 2286229 (to T. L.). The authors declare that they have no conflicts of interest with the contents of this article.	BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; Basaki Y, 2007, ONCOGENE, V26, P2736, DOI 10.1038/sj.onc.1210084; Bidere N, 2009, NATURE, V458, P92, DOI 10.1038/nature07613; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Caffarel MM, 2014, J PATHOL, V232, P386, DOI 10.1002/path.4305; Eliseeva IA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1402, DOI 10.1134/S0006297911130049; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; Filhol O, 2015, CELL MOL LIFE SCI, V72, P3305, DOI 10.1007/s00018-015-1929-8; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Garaud S, 2015, IMMUNOL CELL BIOL, V93, P425, DOI 10.1038/icb.2015.39; Gopal SK, 2015, ONCOTARGET, V6, P13718, DOI 10.18632/oncotarget.3764; Hagan CR, 2013, NUCLEIC ACIDS RES, V41, P8926, DOI 10.1093/nar/gkt706; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hirner H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029709; Knippschild U, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00096; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; Kuwano M, 2004, MOL CANCER THER, V3, P1485; Lasham A, 2013, BIOCHEM J, V449, P11, DOI 10.1042/BJ20121323; Li XL, 2014, J BIOL CHEM, V289, P11927, DOI 10.1074/jbc.M113.539965; Lu T, 2004, CELL CYCLE, V3, P1114; Lu T, 2015, CANCER RES, V75, P3692, DOI 10.1158/0008-5472.CAN-15-1022; Lu T, 2010, P NATL ACAD SCI USA, V107, P46, DOI 10.1073/pnas.0912493107; Lu T, 2009, P NATL ACAD SCI USA, V106, P16339, DOI 10.1073/pnas.0908560106; Mattioli I, 2006, J BIOL CHEM, V281, P6175, DOI 10.1074/jbc.M508045200; Min CY, 2008, J CELL BIOCHEM, V104, P733, DOI 10.1002/jcb.21695; Montenarh M, 2014, ADV CLIN EXP MED, V23, P153, DOI 10.17219/acem/37040; Narayan S, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0311-2; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Prabhu L, 2015, GENES DIS, V2, P240, DOI 10.1016/j.gendis.2015.05.001; Prabhu L, 2015, ONCOTARGET, V6, P29396, DOI 10.18632/oncotarget.5120; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Ryan SL, 2012, ACTA NEUROPATHOL, V123, P501, DOI 10.1007/s00401-011-0923-y; Shibao K, 1999, INT J CANCER, V83, P732; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; Wang BL, 2015, J BIOL CHEM, V290, P20336, DOI 10.1074/jbc.M115.639849; Wei H, 2013, P NATL ACAD SCI USA, V110, P13516, DOI 10.1073/pnas.1311784110; Wu J, 2006, CANCER RES, V66, P4872, DOI 10.1158/0008-5472.CAN-05-3561; Zheng Y, 2013, CLIN CANCER RES, V19, P6484, DOI 10.1158/1078-0432.CCR-13-0265	41	43	43	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3433	3444		10.1074/jbc.M116.740258	http://dx.doi.org/10.1074/jbc.M116.740258			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28077578	hybrid, Green Published			2022-12-26	WOS:000395538800032
J	Zhong, XZ; Zou, YJ; Sun, X; Dong, GF; Cao, Q; Pandey, A; Rainey, JK; Zhu, XJ; Dong, XP				Zhong, Xi Zoe; Zou, Yuanjie; Sun, Xue; Dong, Gaofeng; Cao, Qi; Pandey, Aditya; Rainey, Jan K.; Zhu, Xiaojuan; Dong, Xian-Ping			Inhibition of Transient Receptor Potential Channel Mucolipin-1 (TRPML1) by Lysosomal Adenosine Involved in Severe Combined Immunodeficiency Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adenosine; calcium; calcium channel; lysosome; trafficking; TRPML1; lysosomal Ca2+	EQUILIBRATIVE NUCLEOSIDE TRANSPORTER-3; HUMAN FIBROBLAST LYSOSOMES; PLASMA-MEMBRANE REPAIR; DEAMINASE DEFICIENCY; FUNCTIONAL-CHARACTERIZATION; STORAGE DISEASES; CATION CHANNELS; GENE-THERAPY; LUMINAL PH; CA2+	Impaired adenosine homeostasis has been associated with numerous human diseases. Lysosomes are referred to as the cellular recycling centers that generate adenosine by breaking down nucleic acids or ATP. Recent studies have suggested that lysosomal adenosine overload causes lysosome defects that phenocopy patients with mutations in transient receptor potential channel mucolipin-1 (TRPML1), a lysosomal Ca2+ channel, suggesting that lysosomal adenosine overload may impair TRPML1 and then lead to subsequent lysosomal dysfunction. In this study, we demonstrate that lysosomal adenosine is elevated by deleting adenosine deaminase (ADA), an enzyme responsible for adenosine degradation. We also show that lysosomal adenosine accumulation inhibits TRPML1, which is rescued by overexpressing ENT3, the adenosine transporter situated in the lysosome membrane. Moreover, ADA deficiency results in lysosome enlargement, alkalinization, and dysfunction. These are rescued by activating TRPML1. Importantly, ADA-deficient B-lymphocytes are more vulnerable to oxidative stress, and this was rescued by TRPML1 activation. Our data suggest that lysosomal adenosine accumulation impairs lysosome function by inhibiting TRPML1 and subsequently leads to cell death in B-lymphocytes. Activating TRPML1 could be a new therapeutic strategy for those diseases.	[Zhong, Xi Zoe; Zou, Yuanjie; Sun, Xue; Dong, Gaofeng; Cao, Qi; Dong, Xian-Ping] Dalhousie Univ, Dept Physiol & Biophys, Sir Charles Tupper Med Bldg,5850 Coll St, Halifax, NS B3H 4R2, Canada; [Pandey, Aditya; Rainey, Jan K.] Dalhousie Univ, Dept Biochem & Mol Biol, Sir Charles Tupper Med Bldg,5850 Coll St, Halifax, NS B3H 4R2, Canada; [Sun, Xue; Zhu, Xiaojuan] Northeast Normal Univ, Inst Cytol & Genet, Minist Educ, Key Lab Mol Epigenet, Changchun 130024, Jilin, Peoples R China; [Rainey, Jan K.] Dalhousie Univ, Dept Chem, 6274 Coburg Rd, Halifax, NS B3H 4R2, Canada	Dalhousie University; Dalhousie University; Northeast Normal University - China; Dalhousie University	Dong, XP (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, Sir Charles Tupper Med Bldg,5850 Coll St, Halifax, NS B3H 4R2, Canada.	xpdong@dal.ca	Rainey, Jan K/C-1927-2008	Rainey, Jan K/0000-0003-0793-5573; Pandey, Aditya/0000-0002-7549-985X; Dong, Xianping/0000-0002-4496-7104	Department of Physiology and Biophysics, Dalhousie University; Dalhousie Medical Research Foundation (DMRF); DMRF; Canadian Institutes of Health Research (CIHR) [MOP-119349]; CIHR [201109MSH-261462-208625, MSH-122807]; Nova Scotia Health Research Foundation [MED-PRO-2011-7485]; Canada Foundation for Innovation Leaders Opportunity Fund [29291]; Natural Sciences and Engineering Research Council of Canada	Department of Physiology and Biophysics, Dalhousie University; Dalhousie Medical Research Foundation (DMRF); DMRF; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Nova Scotia Health Research Foundation; Canada Foundation for Innovation Leaders Opportunity Fund(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported in part by start-up funds (to X.-P. D.) from the Department of Physiology and Biophysics, Dalhousie University; a Dalhousie Medical Research Foundation (DMRF) equipment grant; a DMRF new investigator award; Canadian Institutes of Health Research (CIHR) Grant MOP-119349; CIHR New Investigator Awards 201109MSH-261462-208625 (to X.-P. D.) and MSH-122807 (to J. K. R.); Nova Scotia Health Research Foundation Establishment Grant MED-PRO-2011-7485; Canada Foundation for Innovation Leaders Opportunity Fund-Funding for Research Infrastructure Grant 29291; and a Natural Sciences and Engineering Research Council of Canada research tools and instruments grant (to J. K. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Aits S, 2013, J CELL SCI, V126, P1905, DOI 10.1242/jcs.091181; Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Apasov SG, 2001, J CLIN INVEST, V108, P131, DOI 10.1172/JCI10360; ARSENIS C, 1970, J BIOL CHEM, V245, P205; Bach G, 1999, CLIN CHIM ACTA, V280, P173, DOI 10.1016/S0009-8981(98)00183-1; Baldwin SA, 2005, J BIOL CHEM, V280, P15880, DOI 10.1074/jbc.M414337200; Barnes K, 2006, CIRC RES, V99, P510, DOI 10.1161/01.RES.0000238359.18495.42; Blackburn MR, 2005, ADV IMMUNOL, V86, P1, DOI 10.1016/S0065-2776(04)86001-2; Blackburn MR, 2003, TRENDS PHARMACOL SCI, V24, P66, DOI 10.1016/S0165-6147(02)00045-7; Boison D, 2010, CELL DEATH DIFFER, V17, P1071, DOI 10.1038/cdd.2009.131; Cao Q, 2015, DEV CELL, V33, P427, DOI 10.1016/j.devcel.2015.04.010; Cao Q, 2014, J BIOL CHEM, V289, P23189, DOI 10.1074/jbc.M114.567107; Cheng XP, 2014, NAT MED, V20, P1187, DOI 10.1038/nm.3611; Cheng XP, 2010, FEBS LETT, V584, P2013, DOI 10.1016/j.febslet.2009.12.056; COHEN A, 1978, P NATL ACAD SCI USA, V75, P472, DOI 10.1073/pnas.75.1.472; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Govindarajan R, 2009, AM J PHYSIOL-GASTR L, V296, pG910, DOI 10.1152/ajpgi.90672.2008; Grimm C, 2010, CHEM BIOL, V17, P135, DOI 10.1016/j.chembiol.2009.12.016; Haggie PM, 2009, J BIOL CHEM, V284, P7681, DOI 10.1074/jbc.M809161200; HEYDRICK SJ, 1991, J BIOL CHEM, V266, P8790; HIRSCHHORN R, 1991, AM J HUM GENET, V49, P878; Hsu CL, 2012, SCIENCE, V335, P89, DOI 10.1126/science.1213682; Huang P, 2014, J BIOL CHEM, V289, P17658, DOI 10.1074/jbc.M114.552158; Huynh C, 2004, P NATL ACAD SCI USA, V101, P16795, DOI 10.1073/pnas.0405905101; Johnson DE, 2016, J CELL BIOL, V212, P677, DOI 10.1083/jcb.201507112; Kang N, 2010, J BIOL CHEM, V285, P28343, DOI 10.1074/jbc.M110.109199; Kurz T, 2008, BBA-GEN SUBJECTS, V1780, P1291, DOI 10.1016/j.bbagen.2008.01.009; Lai YR, 2004, J BIOL CHEM, V279, P4490, DOI 10.1074/jbc.M307938200; LINDLEY ER, 1993, BIOCHEM J, V290, P457, DOI 10.1042/bj2900457; Lloyd-Evans E, 2011, CELL CALCIUM, V50, P200, DOI 10.1016/j.ceca.2011.03.010; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Mohsenin A, 2006, CURR OPIN PULM MED, V12, P54, DOI 10.1097/01.mcp.0000199002.46038.cb; Molina-Arcas M, 2009, CURR VASC PHARMACOL, V7, P426, DOI 10.2174/157016109789043892; Morgan AJ, 2011, BIOCHEM J, V439, P349, DOI 10.1042/BJ20110949; Morgan NV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000833; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Obata T, 2002, LIFE SCI, V71, P2083, DOI 10.1016/S0024-3205(02)01993-8; Parkinson K, 2014, NAT CELL BIOL, V16, P87, DOI 10.1038/ncb2887; PISONI RL, 1989, J BIOL CHEM, V264, P4850; Pittman JK, 2011, CELL CALCIUM, V50, P139, DOI 10.1016/j.ceca.2011.01.004; Pryor PR, 2000, J CELL BIOL, V149, P1053, DOI 10.1083/jcb.149.5.1053; Puertollano R, 2009, AM J PHYSIOL-RENAL, V296, pF1245, DOI 10.1152/ajprenal.90522.2008; Puntambekar P, 2004, J NEUROSCI, V24, P3663, DOI 10.1523/JNEUROSCI.4773-03.2004; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Ribeiro JA, 2002, PROG NEUROBIOL, V68, P377, DOI 10.1016/S0301-0082(02)00155-7; Samie M, 2013, DEV CELL, V26, P511, DOI 10.1016/j.devcel.2013.08.003; Sauer AV, 2009, CURR OPIN ALLERGY CL, V9, P496, DOI 10.1097/ACI.0b013e3283327da5; Shen DB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1735; Shin K, 2013, FEBS OPEN BIO, V3, P328, DOI 10.1016/j.fob.2013.08.001; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; Sun T, 2011, AUTOPHAGY, V7, P1308, DOI 10.4161/auto.7.11.17759; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Venkatachalam K, 2008, CELL, V135, P838, DOI 10.1016/j.cell.2008.09.041; Vergarajauregui S, 2006, TRAFFIC, V7, P337, DOI 10.1111/j.1600-0854.2006.00387.x; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592; ZIMMERMANN H, 1992, BIOCHEM J, V285, P345, DOI 10.1042/bj2850345	59	16	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3445	3455		10.1074/jbc.M116.743963	http://dx.doi.org/10.1074/jbc.M116.743963			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28087698	hybrid, Green Published			2022-12-26	WOS:000395538800033
J	Tostes, RO; Rodrigues, TC; da Silva, JB; Schanoski, AS; Oliveira, MLS; Miyaji, EN				Tostes, Rafaella O.; Rodrigues, Tasson C.; da Silva, Josefa B.; Schanoski, Alessandra S.; Oliveira, Maria Leonor S.; Miyaji, Eliane N.			Protection Elicited by Nasal Immunization with Recombinant Pneumococcal Surface Protein A (rPspA) Adjuvanted with Whole-Cell Pertussis Vaccine (wP) against Co-Colonization of Mice with Streptococcus pneumoniae	PLOS ONE			English	Article							PSPA FRAGMENTS; ANTIBODIES; SEROTYPES; RESPONSES; POPULATION; COMPLEMENT; DEPOSITION; CARRIAGE; DISEASE	A promising alternative vaccine candidate to reduce the burden of pneumococcal diseases is the protein antigen PspA (Pneumococcal surface protein A). Since concomitant colonization with two or more pneumococcal strains is very common in children, we aimed to determine if immunization with PspA would be able to control co-colonization. We evaluated nasal immunization with recombinant PspA (rPspA) in a model of co-colonization with two strains expressing different PspAs. Mice were immunized intranasally with rPspAs from clades 1 to 4 (rPspA1, rPspA2, rPspA3 or rPspA4) using whole-cell pertussis vaccine (wP) as adjuvant. Mice were then challenged with a mixture of two serotype 6B isolates St491/00 (PspA1) and St472/96 (PspA4). Immunization with rPspA1+wP and rPspA4+wP reduced colonization with both strains and the mixture of rPspA1+rPspA4+wP induced greater reduction than a single antigen. Immunization rPspA1+rPspA4+wP also reduced colonization when challenge experiments were performed with a mixture of isolates of serotypes 6B (PspA3) and 23F (PspA2). Furthermore, none of the tested formulations led to a pronounced increase in colonization of one isolate over the other, showing that the vaccine strategy would not favor replacement. Interestingly, the adjuvant wP by itself already led to some reduction in pneumococcal colonization, indicating the induction of non-specific immune responses. Anti-rPspA IgG was observed in serum, nasal wash (NW) and bronch-oalveolar lavage fluid (BALF) samples, whereas animals inoculated with formulations containing the adjuvant wP (with or without rPspA) showed higher levels of IL-6 and KC in NW and increase in tissue macrophages, B cells and CD4(+)T cells in BALF.	[Tostes, Rafaella O.; Rodrigues, Tasson C.; da Silva, Josefa B.; Schanoski, Alessandra S.; Oliveira, Maria Leonor S.; Miyaji, Eliane N.] Inst Butantan, Lab Bacteriol, Sao Paulo, SP, Brazil	Instituto Butantan	Miyaji, EN (corresponding author), Inst Butantan, Lab Bacteriol, Sao Paulo, SP, Brazil.	eliane.miyaji@butantan.gov.br	Miyaji, Eliane N/D-7642-2012; da Silva, Josefa Bezerra/I-3515-2015; Oliveira, Maria Leonor S/F-4988-2012; da Costa Rodrigues, Tasson/F-7229-2019; Soares Schanoski, Alessandra/H-8144-2014	Miyaji, Eliane N/0000-0003-1689-5366; da Costa Rodrigues, Tasson/0000-0002-1481-0691; Oliveira, Maria Leonor/0000-0003-4849-3062; Soares Schanoski, Alessandra/0000-0002-6514-8458	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [303198/2014-1]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/17699-7]; Fundacao Butantan (Brazil)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao Butantan (Brazil)	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - 303198/2014-1), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - 2013/17699-7) and Fundacao Butantan (Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103293; Adetifa IMO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030548; AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Berstad AKH, 2000, VACCINE, V18, P2323, DOI 10.1016/S0264-410X(00)00024-4; Berstad AKH, 2000, J MED MICROBIOL, V49, P157, DOI 10.1099/0022-1317-49-2-157; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Briles DE, 2000, J INFECT DIS, V182, P1694, DOI 10.1086/317602; Brugger SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011638; Croucher NJ, 2013, NAT GENET, V45, P656, DOI 10.1038/ng.2625; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Darrieux M, 2008, J MED MICROBIOL, V57, P273, DOI 10.1099/jmm.0.47661-0; Fenoll A, 2009, J ANTIMICROB CHEMOTH, V64, P1338, DOI 10.1093/jac/dkp376; Frazao N, 2005, PEDIATR INFECT DIS J, V24, P243, DOI 10.1097/01.inf.0000154326.77617.3e; Hollingshead SK, 2000, INFECT IMMUN, V68, P5889, DOI 10.1128/IAI.68.10.5889-5900.2000; Huang SS, 2005, PEDIATRICS, V116, pE408, DOI 10.1542/peds.2004-2338; Kamng'ona AW, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0980-2; Kuipers K, 2016, J INFECT DIS; Lima FA, 2012, CLIN VACCINE IMMUNOL, V19, P1382, DOI 10.1128/CVI.00171-12; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Malley R, 2004, INFECT IMMUN, V72, P4290, DOI 10.1128/IAI.72.7.4290-4292.2004; Moreno AT, 2010, CLIN VACCINE IMMUNOL, V17, P439, DOI 10.1128/CVI.00430-09; Mubarak A, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.05.017; Oliveira MLS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010863; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Ren B, 2004, INFECT IMMUN, V72, P114, DOI 10.1128/IAI.72.1.114-122.2004; Ross PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003264; Surman SL, 2011, J IMMUNOL, V187, P835, DOI 10.4049/jimmunol.1100125; TRZCINSKI K, 2015, MBIO, V6, DOI DOI 10.1128/MBI0.00902-15; Turner P, 2011, J CLIN MICROBIOL, V49, P1784, DOI 10.1128/JCM.00157-11; Waight PA, 2015, LANCET INFECT DIS, V15, P535, DOI 10.1016/S1473-3099(15)70044-7; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Wright AKA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003274; Wyllie AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102045; YOTHER J, 1992, J BACTERIOL, V174, P601, DOI 10.1128/jb.174.2.601-609.1992; Zhang Z, 2009, J CLIN INVEST, V119, P1899, DOI 10.1172/JCI36731	35	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170157	10.1371/journal.pone.0170157	http://dx.doi.org/10.1371/journal.pone.0170157			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103277	Green Submitted, Green Published, gold			2022-12-26	WOS:000392381100040
J	Gonzalez-Wevar, CA; Nakano, T; Palma, A; Poulin, E				Gonzalez-Wevar, Claudio A.; Nakano, Tomoyuki; Palma, Alvaro; Poulin, Elie			Biogeography in Cellana (Patellogastropoda, Nacellidae) with Special Emphasis on the Relationships of Southern Hemisphere Oceanic Island Species	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; ANTARCTIC CIRCUMPOLAR CURRENT; HISTORICAL BIOGEOGRAPHY; BENTHIC INVERTEBRATES; MOLECULAR PHYLOGENY; GENETIC-DIVERGENCE; PLANKTONIC LARVAE; LIMPETS; DNA; PATTERNS	Oceanic islands lacking connections to other land are extremely isolated from sources of potential colonists and have acquired their biota mainly through dispersal from geographically distant areas. Hence, isolated island biota constitutes interesting models to infer biogeographical mechanisms of dispersal, colonization, differentiation, and speciation. Limpets of the genus Cellana (Nacellidae: Patellogastropoda) show limited dispersal capacity but are broadly distributed across the Indo-Pacific including many endemic species in isolated oceanic islands. Here, we examined main distributional patterns and geographic boundaries among Cellana lineages with special emphasis in the relationships of Southern Hemisphere oceanic islands species. Phylogenetic reconstructions based on mtDNA (COI) recognized three main clades in Cellana including taxa from different provinces of the Indo-Pacific. Clear genetic discontinuities characterize the biogeography of Cellana and several lineages are associated to particular areas of the Indo-Pacific supporting the low dispersal capacity of the genus across recognized biogeographical barriers in the region. However, evolutionary relationships within Cellana suggest that long-distance dispersal processes have been common in the history of the genus and probably associated to the origin of the species in Hawaii and Juan Fernandez Archipelago. Therefore, the presence of Cellana species in geographically distant Southern Hemisphere oceanic islands, such as the Juan Fernandez Archipelago, suggests that long-distance dispersal mediated by rafting may have played an important role in the biogeography of the genus.	[Gonzalez-Wevar, Claudio A.; Poulin, Elie] Univ Magallanes, GAIA Antart, Punta Arenas, Chile; [Gonzalez-Wevar, Claudio A.] Univ Chile, Fac Ciencias, Dept Ciencias Ecol, IEB, Santiago, Chile; [Nakano, Tomoyuki] Kyoto Univ, Seto Marine Biol Lab, Field Sci Educ & Res Ctr, Wakayama, Japan; [Palma, Alvaro] Univ Gabriela Mistral, Fac Ingn & Negocios, Santiago, Chile	Universidad de Magallanes; Universidad de Chile; Kyoto University; Universidad Gabriela Mistral	Gonzalez-Wevar, CA (corresponding author), Univ Magallanes, GAIA Antart, Punta Arenas, Chile.; Gonzalez-Wevar, CA (corresponding author), Univ Chile, Fac Ciencias, Dept Ciencias Ecol, IEB, Santiago, Chile.	claudio.gonzalez@umag.cl	Poulin, Elie/C-2654-2012; González-Wevar, Claudio Alejandro/AAD-6513-2021	Poulin, Elie/0000-0001-7736-0969; 	Initiation Fondecyt Project [11140087]; Regular Fondecyt Projects [1151336, 10800009]; Japan Society for Promotion of Science Research Program [207024, 0273]; Instituto de Ecologia y Biodiversidad IEB [P05-002 ICM, PFB 023]; CAG-W	Initiation Fondecyt Project; Regular Fondecyt Projects; Japan Society for Promotion of Science Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Instituto de Ecologia y Biodiversidad IEB; CAG-W	This study was partially funded by different projects and institutions including an Initiation Fondecyt Project (11140087) to CAG-W and Regular Fondecyt Projects 1151336 to EP and 10800009 to AP. Grant-in-Aid for JSPS Fellows No. 207024 to TN from the Japan Society for Promotion of Science Research Program 0273. At the same time, this research was supported by the projects P05-002 ICM and PFB 023 (Instituto de Ecologia y Biodiversidad IEB) to EP and CAG-W. New Cellana specimens from Campbell Island, French Polynesia and Juan Fernandez Archipelago included in this study were collected following International legislations. Samples of C. ardosidea from Robinson Crusoe Island were collected under the Technical Memorandum P.INV No 011/2010 SUBPESCA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Aronson RB, 2007, ANNU REV ECOL EVOL S, V38, P129, DOI 10.1146/annurev.ecolsys.38.091206.095525; Barker PF, 2004, EARTH-SCI REV, V66, P143, DOI 10.1016/j.earscirev.2003.10.003; Bird CE, 2011, MOL ECOL, V20, P2128, DOI 10.1111/j.1365-294X.2011.05081.x; Borsa P, 1996, MAR BIOL, V125, P531; Burridge CP, 2006, SYST BIOL, V55, P566, DOI 10.1080/10635150600812585; Castilla JC, 2000, REV CHIL HIST NAT, V73, P585; CHIN NKM, 1991, HYDROBIOLOGIA, V215, P1, DOI 10.1007/BF00005895; Collin R, 2003, MAR ECOL PROG SER, V247, P103, DOI 10.3354/meps247103; Corpuz GC, 1984, ACQUACULTURE, V24, P219; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Cowie RH, 2006, J BIOGEOGR, V33, P193, DOI 10.1111/j.1365-2699.2005.01383.x; CREESE RG, 1981, J EXP MAR BIOL ECOL, V51, P145, DOI 10.1016/0022-0981(81)90126-X; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Queiroz A, 2005, TRENDS ECOL EVOL, V20, P68, DOI 10.1016/j.tree.2004.11.006; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; DeVriesi TJ, 2008, VELIGER, V50, P274; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; FELL FJ, 1975, J ROY SOC NEW ZEAL, V5, P179, DOI 10.1080/03036758.1975.10419371; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Filatov DA, 2009, BIOINFORMATICS, V25, P3189, DOI 10.1093/bioinformatics/btp572; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fraser CI, 2011, P ROY SOC B-BIOL SCI, V278, P649, DOI 10.1098/rspb.2010.1117; Fraser CI, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-203; Fraser CI, 2009, P NATL ACAD SCI USA, V106, P3249, DOI 10.1073/pnas.0810635106; Frey MA, 2008, MOL PHYLOGENET EVOL, V48, P1067, DOI 10.1016/j.ympev.2008.05.009; Gillespie RG, 2012, TRENDS ECOL EVOL, V27, P47, DOI 10.1016/j.tree.2011.08.009; Goldstien SJ, 2006, MOL PHYLOGENET EVOL, V38, P261, DOI 10.1016/j.ympev.2005.09.002; Gonzalez-Wevar CA, J BIOGEOGR IN PRESS; Gonzalez-Wevar CA, 2010, MOL PHYLOGENET EVOL, V56, P115, DOI 10.1016/j.ympev.2010.02.001; GRIGG RW, 1992, SCIENCE, V255, P172, DOI 10.1126/science.255.5041.172; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HOFMANN EE, 1985, J GEOPHYS RES-OCEANS, V90, P7087, DOI 10.1029/JC090iC04p07087; HUELSENBECK JP, 2001, BIOMETRICS, V17, P754, DOI [DOI 10.1093/BIOINFORMATICS/17.8.754, DOI 10.1093/BI0INF0RMATICS/17.8.754]; JABLONSKI D, 1986, B MAR SCI, V39, P565; JOKIEL PL, 1990, ENDEAVOUR, V14, P66, DOI 10.1016/0160-9327(90)90074-2; Jonkers HA, 1998, J GEOL SOC LONDON, V155, P737, DOI 10.1144/gsjgs.155.5.0737; Kay EA, 1977, THE BIOL OF OPIHI, P46; Kennett J, 1990, P ODP SCI RESULTS, V113, P938; Lessios HA, 2006, P ROY SOC B-BIOL SCI, V273, P2201, DOI 10.1098/rspb.2006.3543; Lindberg D, 2008, PHYLOGENY EVOLUTION, P240; LINDBERG DR, 1986, J PALEONTOL, V60, P661, DOI 10.1017/S0022336000022186; Liu ZH, 2009, SCIENCE, V323, P1187, DOI 10.1126/science.1166368; Macaya EC, 2010, J PHYCOL, V46, P736, DOI 10.1111/j.1529-8817.2010.00845.x; McKay R, 2012, P NATL ACAD SCI USA, V109, P6423, DOI 10.1073/pnas.1112248109; Nakano T, 2009, J MOLLUS STUD, V75, P87, DOI 10.1093/mollus/eyn036; Nakano T, 2010, MARINE BIODIVERSITY, V3, P1; Nakano T, 2007, J MOLLUS STUD, V73, P79, DOI 10.1093/mollus/eym001; Pequeno G, 2000, GLOBAL ECOL BIOGEOGR, V9, P431, DOI 10.1046/j.1365-2699.2000.00207.x; POWELL A W B, 1973, Indo-Pacific Mollusca, V3, P75; Putman NF, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0979; Ramirez Maria Eliana, 2000, Investigaciones Marinas Universidad Catolica de Valparaiso, V28, P1; Reisser CMO, 2011, MOL ECOL, V20, P3399, DOI 10.1111/j.1365-294X.2011.05185.x; Santelices B., PAC SCI, V46, P438; SCHELTEMA RS, 1971, BIOL BULL-US, V140, P284, DOI 10.2307/1540075; SCHELTEMA RS, 1983, B MAR SCI, V33, P545; SCHELTEMA RS, 1986, B MAR SCI, V39, P290; Scher HD, 2015, NATURE, V523, P580, DOI 10.1038/nature14598; Stilwell J.D., 1992, ANTARCT RES SER, V55, P1, DOI DOI 10.1029/AR055; STUESSY TF, 1984, SCIENCE, V225, P49, DOI 10.1126/science.225.4657.49; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thiel M, 2005, OCEANOGR MAR BIOL, V42, P181, DOI DOI 10.1201/9780203507810.CH6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valdovinos C, 2005, REV CHIL HIST NAT, V78, P497; Waters JM, 2008, J BIOGEOGR, V35, P417, DOI 10.1111/j.1365-2699.2007.01724.x; WEBB PN, 1991, QUATERNARY SCI REV, V10, P215, DOI 10.1016/0277-3791(91)90020-U; Williams ST, 2003, MOL PHYLOGENET EVOL, V28, P60, DOI 10.1016/S1055-7903(03)00038-1; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	68	4	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170103	10.1371/journal.pone.0170103	http://dx.doi.org/10.1371/journal.pone.0170103			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099466	gold, Green Published, Green Submitted			2022-12-26	WOS:000392380100055
J	Sun, MH; Yang, M; Xie, FY; Wang, W; Zhang, LL; Shen, W; Yin, S; Ma, JY				Sun, Ming-Hong; Yang, Mo; Xie, Feng-Yun; Wang, Wei; Zhang, Lili; Shen, Wei; Yin, Shen; Ma, Jun-Yu			DNA Double-Strand Breaks Induce the Nuclear Actin Filaments Formation in Cumulus-Enclosed Oocytes but Not in Denuded Oocytes	PLOS ONE			English	Article							SPINDLE ASSEMBLY CHECKPOINT; GERM-CELLS; DAMAGE; MATURATION; ARREST	As a gamete, oocyte needs to maintain its genomic integrity and passes this haploid genome to the next generation. However, fully-grown mouse oocyte cannot respond to DNA double-strand breaks (DSBs) effectively and it is also unable to repair them before the meiosis resumption. To compensate for this disadvantage and control the DNA repair events, oocyte needs the cooperation with its surrounding cumulus cells. Recently, evidences have shown that nuclear actin filament formation plays roles in cellular DNA DSB repair. To explore whether these nuclear actin filaments are formed in the DNA-damaged oocytes, here, we labeled the filament actins in denuded oocytes (DOs) and cumulus-enclosed oocytes (CEOs). We observed that the nuclear actin filaments were formed only in the DNA damaged CEOs, but not in DOs. Formation of actin filaments in the nucleus was an event downstream to the DNA damage response. Our data also showed that the removal of cumulus cells led to a reduction in the nuclear actin filaments in oocytes. Knocking down of the Adcy1 gene in cumulus cells did not affect the formation of nuclear actin filaments in oocytes. Notably, we also observed that the nuclear actin filaments in CEOs could be induced by inhibition of gap junctions. From our results, it was confirmed that DNA DSBs induce the nuclear actin filament formation in oocyte and which is controlled by the cumulus cells.	[Sun, Ming-Hong; Xie, Feng-Yun; Wang, Wei; Zhang, Lili; Shen, Wei; Yin, Shen; Ma, Jun-Yu] Qingdao Agr Univ, Coll Anim Sci & Technol, Key Lab Anim Reprod & Germplasm Enhancement Univ, Qingdao, Peoples R China; [Yang, Mo] Peking Univ, Hosp 3, Dept Obstet & Gynecol, Ctr Reprod Med, Beijing, Peoples R China; [Shen, Wei; Yin, Shen; Ma, Jun-Yu] Qingdao Agr Univ, Inst Reprod Sci, Qingdao, Peoples R China	Qingdao Agricultural University; Peking University; Qingdao Agricultural University	Ma, JY (corresponding author), Qingdao Agr Univ, Coll Anim Sci & Technol, Key Lab Anim Reprod & Germplasm Enhancement Univ, Qingdao, Peoples R China.; Ma, JY (corresponding author), Qingdao Agr Univ, Inst Reprod Sci, Qingdao, Peoples R China.	jun_yu_ma@aliyun.com			Basic Research Program of Shandong Province [2014B5B01356]; Doctoral Fund of Qingdao Agricultural University [631401]	Basic Research Program of Shandong Province; Doctoral Fund of Qingdao Agricultural University	This project is supported by the Basic Research Program of Shandong Province (2014B5B01356) and Doctoral Fund of Qingdao Agricultural University to JYM (631401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belin B.J., 2015, BIOARCHITECTURE, V4, P1, DOI [10.1080/19490992.2014.1047714, DOI 10.7554/ELIFE.07735]; Bettinger BT, 2004, NAT REV MOL CELL BIO, V5, P410, DOI 10.1038/nrm1370; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Collins JK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9553; GOUGEON A, 1986, HUM REPROD, V1, P81, DOI 10.1093/oxfordjournals.humrep.a136365; Griffin Jeanine, 2006, J Exp Clin Assist Reprod, V3, P2, DOI 10.1186/1743-1050-3-2; Lei L, 2016, SCIENCE, V352, P95, DOI 10.1126/science.aad2156; Lei L, 2013, DEVELOPMENT, V140, P2075, DOI 10.1242/dev.093864; Ma JY, 2013, CELL CYCLE, V12, P1233, DOI 10.4161/cc.24311; Marangos P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9706; Marangos P, 2012, CURR BIOL, V22, P989, DOI 10.1016/j.cub.2012.03.063; Morgan MA, 2010, CANCER RES, V70, P4972, DOI 10.1158/0008-5472.CAN-09-3573; Qiao J, 2014, MOL ASPECTS MED, V38, P54, DOI 10.1016/j.mam.2013.06.001; Rimon-Dahari N, 2016, RESULTS PROBL CELL D, V58, P167, DOI 10.1007/978-3-319-31973-5_7; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Sun MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143223; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Yi KX, 2012, CYTOSKELETON, V69, P727, DOI 10.1002/cm.21048; Yuen WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043875	20	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170308	10.1371/journal.pone.0170308	http://dx.doi.org/10.1371/journal.pone.0170308			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099474	gold, Green Published, Green Submitted			2022-12-26	WOS:000392380100072
J	Dyrvig, M; Qvist, P; Lichota, J; Larsen, K; Nyegaard, M; Borglum, AD; Christensen, JH				Dyrvig, Mads; Qvist, Per; Lichota, Jacek; Larsen, Knud; Nyegaard, Mette; Borglum, Anders D.; Christensen, Jane H.			DNA Methylation Analysis of BRD1 Promoter Regions and the Schizophrenia rs138880 Risk Allele	PLOS ONE			English	Article							BIPOLAR DISORDER; GENE; ACETYLATION; EXPRESSION; COMPLEX; FAMILY; MODEL	The bromodomain containing 1 gene, BRD1 is essential for embryogenesis and CNS development. It encodes a protein that participates in histone modifying complexes and thereby regulates the expression of a large number of genes. Genetic variants in the BRD1 locus show association with schizophrenia and bipolar disorder and risk alleles in the promoter region correlate with reduced BRD1 expression. Insights into the transcriptional regulation of BRD1 and the pathogenic mechanisms associated with BRD1 risk variants, however, remain sparse. By studying transcripts in human HeLa and SH-SY5Y cells we provide evidence for differences in relative expression of BRD1 transcripts with three alternative 5' UTRs (exon 1C, 1B, and 1A). We further show that expression of these transcript variants covaries negatively with DNA methylation proportions in their upstream promoter regions suggesting that promoter usage might be regulated by DNA methylation. In line with findings that the risk allele of the rs138880 SNP in the BRD1 promoter region correlates with reduced BRD1 expression, we find that it is also associated with moderate regional BRD1 promoter hypermethylation in both adipose tissue and blood. Importantly, we demonstrate by inspecting available DNA methylation and expression data that these regions undergo changes in methylation during fetal brain development and that differences in their methylation proportions in fetal compared to postnatal frontal cortex correlate significantly with BRD1 expression. These findings suggest that BRD1 may be dysregulated in both the developing and mature brain of risk allele carriers. Finally, we demonstrate that commonly used mood stabilizers Lithium, Valproate, and Carbamazepine affect the expression of BRD1 in SH-SY5Y cells. Altogether this study indicates a link between genetic risk and epigenetic dysregulation of BRD1 which raises interesting perspectives for targeting the mechanisms pharmacologically.	[Dyrvig, Mads; Qvist, Per; Nyegaard, Mette; Borglum, Anders D.; Christensen, Jane H.] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Dyrvig, Mads; Qvist, Per; Nyegaard, Mette; Borglum, Anders D.; Christensen, Jane H.] Aarhus Univ, Lundbeck Fdn Initiat Integrat Psychiat Res, iPSYCH, Aarhus, Denmark; [Dyrvig, Mads; Lichota, Jacek] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark; [Qvist, Per; Nyegaard, Mette; Borglum, Anders D.; Christensen, Jane H.] Aarhus Univ, iSEQ, Ctr Integrat Sequencing, Aarhus, Denmark; [Larsen, Knud] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark	Aarhus University; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Aalborg University; Aarhus University; Aarhus University	Christensen, JH (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.; Christensen, JH (corresponding author), Aarhus Univ, Lundbeck Fdn Initiat Integrat Psychiat Res, iPSYCH, Aarhus, Denmark.; Christensen, JH (corresponding author), Aarhus Univ, iSEQ, Ctr Integrat Sequencing, Aarhus, Denmark.	jhc@biomed.au.dk	Nyegaard, Mette/M-3379-2019; Lichota, Jacek/R-1788-2019; Qvist, Per/H-4238-2019	Nyegaard, Mette/0000-0003-4973-8543; Lichota, Jacek/0000-0002-9943-5201; Qvist, Per/0000-0002-0750-0089; Borglum, Anders/0000-0001-8627-7219; Christensen, Jane Hvarregaard/0000-0002-0009-2991	Danish Council for Independent Research Medical Sciences; Lundbeck Foundation; Novo Nordisk Foundation; Family Hede Nielsen Foundation; Grosserer L.F. Foght Foundation; Aarhus University; Aalborg University; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish	Danish Council for Independent Research Medical Sciences(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Family Hede Nielsen Foundation; Grosserer L.F. Foght Foundation; Aarhus University; Aalborg University; Lundbeck Foundation(Lundbeckfonden)	The study was supported by grants from The Danish Council for Independent Research Medical Sciences, The Lundbeck Foundation, The Novo Nordisk Foundation, The Family Hede Nielsen Foundation, The Grosserer L.F. Foght Foundation, Aarhus University and Aalborg University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg KA, 2013, JAMA PSYCHIAT, V70, P573, DOI 10.1001/jamapsychiatry.2013.288; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Andreassen OA, 2014, SCHIZOPHRENIA BULL, V40, P13, DOI 10.1093/schbul/sbt168; Asai T, 2013, INT J NEUROPSYCHOPH, V16, P2285, DOI 10.1017/S1461145713000710; Bjarkam CR, 2009, BRAIN STRUCT FUNCT, V214, P37, DOI 10.1007/s00429-009-0219-3; Christensen JH, 2012, EUR NEUROPSYCHOPHARM, V22, P651, DOI 10.1016/j.euroneuro.2012.01.005; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dyrvig M, 2014, GENE, V539, P8, DOI 10.1016/j.gene.2014.01.072; Fryland T, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0308-x; Fryland T, 2012, NEUROSCI LETT, V516, P110, DOI 10.1016/j.neulet.2012.03.069; Grundberg E, 2013, AM J HUM GENET, V93, P876, DOI 10.1016/j.ajhg.2013.10.004; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Hashimshony T, 2003, NAT GENET, V34, P187, DOI 10.1038/ng1158; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hitchins MP, 2011, CANCER CELL, V20, P200, DOI 10.1016/j.ccr.2011.07.003; Jaffe AE, 2016, NAT NEUROSCI, V19, P40, DOI 10.1038/nn.4181; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Jorgensen TH, 2002, AM J MED GENET, V114, P245, DOI 10.1002/ajmg.10191; Kass SU, 1997, CURR BIOL, V7, P157, DOI 10.1016/S0960-9822(97)70086-1; Kelly TK, 2010, MOL CELL, V39, P901, DOI 10.1016/j.molcel.2010.08.026; Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McGrath JJ, 2003, ANN MED, V35, P86, DOI 10.1080/07853890310010005; Mishima Y, 2011, BLOOD, V118, P2443, DOI 10.1182/blood-2011-01-331892; Nyegaard M, 2010, AM J MED GENET B, V153B, P582, DOI 10.1002/ajmg.b.31023; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Qvist P., 2016, BIOL PSYCHIAT; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Severinsen JE, 2006, MOL PSYCHIATR, V11, P1126, DOI 10.1038/sj.mp.4001885; Shen LL, 2007, BIOTECHNIQUES, V42, P48, DOI 10.2144/000112312; Spiers H, 2015, GENOME RES, V25, P338, DOI 10.1101/gr.180273.114; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005	40	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0170121	10.1371/journal.pone.0170121	http://dx.doi.org/10.1371/journal.pone.0170121			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095495	Green Published, Green Submitted, gold			2022-12-26	WOS:000392372300056
J	Lopez-Varela, E; Garcia-Basteiro, AL; Augusto, OJ; Fraile, O; Bulo, H; Ira, T; Gondo, K; van Ingen, J; Naniche, D; Sacarlal, J; Alonso, PL				Lopez-Varela, Elisa; Garcia-Basteiro, Alberto L.; Augusto, Orvalho J.; Fraile, Oscar; Bulo, Helder; Ira, Tasmiya; Gondo, Kizito; van Ingen, Jakko; Naniche, Denise; Sacarlal, Jahit; Alonso, Pedro L.			High Rates of Non-Tuberculous Mycobacteria Isolation in Mozambican Children with Presumptive Tuberculosis	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; DIAGNOSIS; TB; INFECTIONS; DIVERSITY; HEALTH; ZAMBIA	Introduction Non-tuberculous mycobacteria (NTM) can cause disease which can be clinically and radio logically undistinguishable from tuberculosis (TB), posing a diagnostic and therapeutic challenge in high TB settings. We aim to describe the prevalence of NTM isolation and its clinical characteristics in children from rural Mozambique. Methods This study was part of a community TB incidence study in children <3 years of age. Gastric aspirate and induced sputum sampling were performed in all presumptive TB cases and processed for smear testing using fluorochrome staining and LED Microscopy, liquid and solid culture, and molecular identification by GenoType (R) Mycobacterium CM/AS assays. Results NTM were isolated in 26.3% (204/775) of children. The most prevalent NTM species was M. intracellulare (N = 128), followed by M. scrofulaceum (N = 35) and M. fortuitum (N = 9). Children with NTM were significantly less symptomatic and less likely to present with an abnormal chest radiograph than those with M. tuberculosis. NTM were present in 21.6% of followup samples and 25 children had the same species isolated from >= 2 separate samples. All were considered clinically insignificant and none received specific treatment. Children with NTM isolates had equal all cause mortality and likelihood of TB treatment as those with negative culture although they were less likely to have TB ruled out. Conclusions NTM isolation is frequent in presumptive TB cases but was not clinically significant in this patient cohort. However, it can contribute to TB misdiagnosis. Further studies are needed to understand the epidemiology and the clinical significance of NTM in children.	[Lopez-Varela, Elisa; Garcia-Basteiro, Alberto L.; Augusto, Orvalho J.; Fraile, Oscar; Bulo, Helder; Ira, Tasmiya; Gondo, Kizito; Sacarlal, Jahit; Alonso, Pedro L.] CISM, Maputo, Mozambique; [Lopez-Varela, Elisa; Garcia-Basteiro, Alberto L.; Fraile, Oscar; Naniche, Denise; Alonso, Pedro L.] Univ Barcelona, Hosp Clin Barcelona, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Garcia-Basteiro, Alberto L.] AIGHD, Amsterdam, Netherlands; [van Ingen, Jakko] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands; [Sacarlal, Jahit] Univ Eduardo Mondlane, Fac Med, Dept Microbiol, Maputo, Mozambique	Centro de Investigacao em Saude de Manhica; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Radboud University Nijmegen; Eduardo Mondlane University	Lopez-Varela, E (corresponding author), CISM, Maputo, Mozambique.; Lopez-Varela, E; Naniche, D (corresponding author), Univ Barcelona, Hosp Clin Barcelona, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.	Elisa.lopez@isglobal.org; denise.naniche@isglobal.org	van Ingen, Jakko/D-5526-2014; Alonso, Pedro L/AAZ-3645-2020; varela, elisa lopez/ABE-4092-2020; Naniche, Denise S/S-1814-2018; Sacarlal, Jahit/R-3172-2016; Augusto, Orvalho/J-8767-2019	van Ingen, Jakko/0000-0002-0581-2003; Alonso, Pedro L/0000-0003-3292-3443; varela, elisa lopez/0000-0002-6725-5687; Naniche, Denise S/0000-0002-4495-6325; Sacarlal, Jahit/0000-0003-1059-217X; Augusto, Orvalho/0000-0002-0005-3968	European & Developing Countries Clinical Trials Partnership [IP_07_32080_003]	European & Developing Countries Clinical Trials Partnership	This work was supported by the European & Developing Countries Clinical Trials Partnership [IP_07_32080_003]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliyu G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063170; Asiimwe BB, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-88; Blyth CC, 2009, PEDIATR INFECT DIS J, V28, P801, DOI 10.1097/INF.0b013e31819f7b3f; Buijtels PCAM, 2010, CLIN MICROBIOL INFEC, V16, P1142, DOI 10.1111/j.1469-0691.2009.03072.x; Buijtels PCAM, 2009, EMERG INFECT DIS, V15, P242, DOI 10.3201/eid1502.080006; Cruciani M, 2004, J CLIN MICROBIOL, V42, P2321, DOI 10.1128/JCM.42.5.2321-2325.2004; Cruz AT, 2010, PEDIATR INFECT DIS J, V29, P772, DOI 10.1097/INF.0b013e3181da5795; Garcia-Basteiro AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127323; Gopinath K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000615; Graham SM, 2012, J INFECT DIS, V205, pS199, DOI 10.1093/infdis/jis008; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hatherill M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000021; Hoefsloot W, 2013, EUR RESP J J EU 0418; Hoza Abubakar S, 2016, BMC Res Notes, V9, P109, DOI 10.1186/s13104-016-1928-3; Kordy F, 2014, PEDIAT INFECT DIS J; Lanaspa M, 2015, ACTA TROP, V149, P262, DOI 10.1016/j.actatropica.2015.06.007; Loapez-Varela E, 2015, EUR RESPIR J; Lopez-Varela E, 2014, EUR RESPIR J, V04; Looez-Varela E, 2015, PEDIATR INFECT DIS J, V34, P686, DOI 10.1097/INF.0000000000000710; Lopez-Varela E, 2015, LANCET RESP MED, V3, P244, DOI 10.1016/S2213-2600(15)00062-4; Maiga M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036902; Nunes EA, 2008, J BRAS PNEUMOL, V34, P10; Perez-Velez CM, 2012, NEW ENGL J MED, V367, P348, DOI 10.1056/NEJMra1008049; Pham-Huy A, 2010, PAED CHILD HEALT-CAN, V15, P276, DOI 10.1093/pch/15.5.276; Poyntz HC, 2014, TUBERCULOSIS, V94, P226, DOI 10.1016/j.tube.2013.12.006; Raju RM, 2016, EMERG INFECT DIS, V22, P365, DOI 10.3201/eid2203.151643; Sacoor C, 2013, INT J EPIDEMIOL, V42, P1309, DOI 10.1093/ije/dyt148; Thom M, 2008, TUBERCULOSIS, V88, P324, DOI 10.1016/j.tube.2007.12.002; Workalemahu Bereket, 2013, BMC Res Notes, V6, P352, DOI 10.1186/1756-0500-6-352	29	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0169757	10.1371/journal.pone.0169757	http://dx.doi.org/10.1371/journal.pone.0169757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095429	Green Published, gold, Green Submitted			2022-12-26	WOS:000392372300031
J	Jahn, O; Ganchev, TD; Marques, MI; Schuchmann, KL				Jahn, Olaf; Ganchev, Todor D.; Marques, Marinez I.; Schuchmann, Karl-L.			Automated Sound Recognition Provides Insights into the Behavioral Ecology of a Tropical Bird	PLOS ONE			English	Article							LAPWINGS VANELLUS-CHILENSIS; GULL LARUS-CALIFORNICUS; SOUTHERN LAPWINGS; REPRODUCTIVE EFFORT; FEEDING STRATEGIES; PARENTAL BEHAVIOR; MICROPHONE ARRAY; CALLING ACTIVITY; IDENTIFICATION; ENVIRONMENT	Computer-assisted species recognition facilitates the analysis of relevant biological information in continuous audio recordings. In the present study, we assess the suitability of this approach for determining distinct life-cycle phases of the Southern Lapwing Vanellus chilensis lampronotus based on adult vocal activity. For this purpose we use passive 14-min and 30-min soundscape recordings (n = 33 201) collected in 24/7 mode between November 2012 and October 2013 in Brazil's Pantanal wetlands. Time-stamped detections of V. chilensis call events (n = 62 292) were obtained with a species-specific sound recognizer. We demonstrate that the breeding season fell in a three-month period from mid-May to early August 2013, between the end of the flood cycle and the height of the dry season. Several phases of the lapwing's life history were identified with presumed error margins of a few days: pre-breeding, territory establishment and egg-laying, incubation, hatching, parental defense of chicks, and post-breeding. Diurnal time budgets confirm high acoustic activity levels during midday hours in June and July, indicative of adults defending young. By August, activity patterns had reverted to nonbreeding mode, with peaks around dawn and dusk and low call frequency during midday heat. We assess the current technological limitations of the V. chilensis recognizer through a comprehensive performance assessment and scrutinize the usefulness of automated acoustic recognizers in studies on the distribution pattern, ecology, life history, and conservation status of sound-producing animal species.	[Jahn, Olaf; Ganchev, Todor D.; Marques, Marinez I.; Schuchmann, Karl-L.] Fed Univ Mato Grosso UFMT, Sci Borders Program, Natl Inst Sci & Technol Wetlands INAU, Cuiaba, MG, Brazil; [Jahn, Olaf; Schuchmann, Karl-L.] Zool Res Museum A Koenig ZFMK, Bonn, North Rhine Wes, Germany; [Ganchev, Todor D.] Tech Univ Varna, Dept Comp Sci & Engn, Varna, Varna, Bulgaria; [Marques, Marinez I.; Schuchmann, Karl-L.] Univ Fed Mato Grosso, Inst Biosci, Cuiaba, Mato Grosso, Brazil; [Schuchmann, Karl-L.] Univ Bonn, Bonn, North Rhine Wes, Germany	Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso do Sul; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Technical University Varna; Universidade Federal de Mato Grosso; University of Bonn	Jahn, O (corresponding author), Fed Univ Mato Grosso UFMT, Sci Borders Program, Natl Inst Sci & Technol Wetlands INAU, Cuiaba, MG, Brazil.; Jahn, O (corresponding author), Zool Res Museum A Koenig ZFMK, Bonn, North Rhine Wes, Germany.	o.jahn@zfmk.de	Ganchev, Todor/AAF-4129-2020; Ganchev, Todor/A-1915-2017; Schuchmann, Karl-L/GON-8135-2022	Ganchev, Todor/0000-0003-0384-4033; Schuchmann, Karl-L/0000-0002-3233-8917; Jahn, Olaf/0000-0001-7936-033X	Brazilian Science Council (CNPq); National Institute for Science and Technology in Wetlands (INAU/UFMT); "Science without Borders" Program (CsF); Mato Grosso State Research Foundation (FAPEMAT/PRONEX) [009/2009, 838265/2009]; Brehm Foundation for International Bird Conservation, Germany; project OP "Competitiveness" - Structural Funds of the European Union [BG161P0003-1.2.04-0044-C0001]; project ISP1 - Technical University of Varna, Bulgaria	Brazilian Science Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institute for Science and Technology in Wetlands (INAU/UFMT); "Science without Borders" Program (CsF); Mato Grosso State Research Foundation (FAPEMAT/PRONEX); Brehm Foundation for International Bird Conservation, Germany; project OP "Competitiveness" - Structural Funds of the European Union; project ISP1 - Technical University of Varna, Bulgaria	This work was funded by the Brazilian Science Council (CNPq), National Institute for Science and Technology in Wetlands (INAU/UFMT: www.inau.org.br, 2011-2016), "Science without Borders" Program (CsF: www.cienciasemfronteiras.gov.br/web/csf), Mato Grosso State Research Foundation (FAPEMAT/PRONEX, Edit 009/2009, Process 838265/2009), Brehm Foundation for International Bird Conservation, Germany, and the project OP "Competitiveness" BG161P0003-1.2.04-0044-C0001 financed by the Structural Funds of the European Union, and the project ISP1 financed by the Technical University of Varna, Bulgaria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo MA, 2006, WILDLIFE SOC B, V34, P211, DOI 10.2193/0091-7648(2006)34[211:UADRSA]2.0.CO;2; Acevedo MA, 2009, ECOL INFORM, V4, P206, DOI 10.1016/j.ecoinf.2009.06.005; Aide TM, 2013, PEERJ, V1, DOI 10.7717/peerj.103; [Anonymous], 2014, BIOLOGICA, V17, P60; BARASH DP, 1975, WILSON BULL, V87, P367; Bardeli R, 2010, PATTERN RECOGN LETT, V31, P1524, DOI 10.1016/j.patrec.2009.09.014; Bardeli R, 2009, IEEE T MULTIMEDIA, V11, P68, DOI 10.1109/TMM.2008.2008920; Berg KS, 2006, P ROY SOC B-BIOL SCI, V273, P999, DOI 10.1098/rspb.2005.3410; BirdLife International, 2015, SPEC FACTSH VAN CHIL; Blumstein DT, 2011, J APPL ECOL, V48, P758, DOI 10.1111/j.1365-2664.2011.01993.x; Borker AL, 2014, CONSERV BIOL, V28, P1100, DOI 10.1111/cobi.12264; Briggs F, 2012, J ACOUST SOC AM, V131, P4640, DOI 10.1121/1.4707424; BRUNTON DH, 1990, BEHAV ECOL SOCIOBIOL, V26, P181; Buxton RT, 2012, J FIELD ORNITHOL, V83, P47, DOI 10.1111/j.1557-9263.2011.00355.x; Callil C., 2011, PANTANAL ECOLOGY BIO, P693; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; Costa LCM, 2002, REV ETOL, V4, P95; de Oliveira AG, 2015, APPL ACOUST, V98, P34, DOI 10.1016/j.apacoust.2015.04.014; Digby A, 2013, METHODS ECOL EVOL, V4, P675, DOI 10.1111/2041-210X.12060; Erdogan S, 2015, ACTA ZOOL-STOCKHOLM, V96, P264, DOI 10.1111/azo.12075; Farnsworth A, 2007, J FIELD ORNITHOL, V78, P279, DOI 10.1111/j.1557-9263.2007.00115.x; Frommolt KH, 2014, ECOL INFORM, V21, P4, DOI 10.1016/j.ecoinf.2013.12.009; Ganchev T, 2007, BIOACOUSTICS, V16, P281, DOI 10.1080/09524622.2007.9753582; Ganchev T, 2011, SPRINGERBRIEF SPEECH, P1, DOI 10.1007/978-1-4419-8447-0; Ganchev TD, 2015, EXPERT SYST APPL, V42, P6098, DOI 10.1016/j.eswa.2015.03.036; Gantz A, 2016, GAYANA, V80, P61; Gantz Alberto, 2009, Boletin Chileno de Ornitologia, V15, P87; GREER JK, 1967, AUK, V84, P121, DOI 10.2307/4083264; Gregory RD, 2004, TECH ECOL CONSERVAT, P17; Henriquez A, 2014, EXPERT SYST APPL, V41, P5451, DOI 10.1016/j.eswa.2014.02.021; Hilje B, 2012, TROP CONSERV SCI, V5, P25, DOI 10.1177/194008291200500104; Jahn O, 2011, BONN ZOOL MONOGR, P15; Jimenez JJ, 2000, BIOL FERT SOILS, V32, P463, DOI 10.1007/s003740000277; Jimenez JJ, 2006, ACTA OECOL, V30, P299, DOI 10.1016/j.actao.2006.06.008; Johnsgard PA., 1981, PLOVERS SANDPIPERS S; Junk WJ, 2005, ECOL ENG, V24, P391, DOI 10.1016/j.ecoleng.2004.11.012; Kaewtip K, 2013, INT CONF ACOUST SPEE, P768, DOI 10.1109/ICASSP.2013.6637752; Kalan AK, 2015, ECOL INDIC, V54, P217, DOI 10.1016/j.ecolind.2015.02.023; Kindermann L., 2008, BUNDESAMT NAT SKR, V234, P15; Lasseck M., 2015, CEUR, V1391; Lee CH, 2013, IEEE T MULTIMEDIA, V15, P454, DOI 10.1109/TMM.2012.2229969; LENINGTON S, 1980, WILSON BULL, V92, P8; LopezLanus B, 2009, BIRD SOUNDS SO S AM; Lourenco PM, 2008, ACTA OECOL, V34, P122, DOI 10.1016/j.actao.2008.04.005; Lourenco Pedro M., 2012, Wader Study Group Bulletin, V119, P61; Lourival R, 2009, WETLANDS, V29, P1189, DOI 10.1672/08-118.1; Luther DA, 2008, BIOL LETTERS, V4, P651, DOI 10.1098/rsbl.2008.0406; MACHIN J, 1967, J ZOOL, V152, P55; MACLEAN GL, 1972, AUK, V89, P299, DOI 10.2307/4084208; Marchant J., 1986, SHOREBIRDS IDENTIFIC; Marques TA, 2013, BIOL REV, V88, P287, DOI 10.1111/brv.12001; Maruyama PK, 2010, J ETHOL, V28, P339, DOI 10.1007/s10164-009-0193-5; MCNEIL R, 1992, BIOL REV, V67, P381, DOI 10.1111/j.1469-185X.1992.tb01188.x; Mellinger DK, 2007, OCEANOGRAPHY, V20, P36, DOI 10.5670/oceanog.2007.03; Mellinger DK, 2004, MAR MAMMAL SCI, V20, P48, DOI 10.1111/j.1748-7692.2004.tb01140.x; Mennill DJ, 2012, METHODS ECOL EVOL, V3, P704, DOI 10.1111/j.2041-210X.2012.00209.x; Minns J, 2010, BIRDS BRAZIL SONGS C, V1; Moore JV., 2013, BIRD SOUNDS ECUADOR; Morais HC, 1999, REV BIOL TROP, V47, P1025; Muralidhar Adithi, 2013, Indian Birds, V8, P6; MYERS JP, 1978, AUK, V95, P419; Naranjo Luis G., 1991, Ornitologia Neotropical, V2, P95; Obrist MK, 2004, MAMMALIA, V68, P307, DOI 10.1515/mamm.2004.030; Ospina OE, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00258.1; da Silva NAP, 2011, REV BRAS ENTOMOL, V55, P79, DOI 10.1590/S0085-56262011000100013; Potamitis I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096936; PUGESEK BH, 1981, SCIENCE, V212, P822, DOI 10.1126/science.212.4496.822; PUGESEK BH, 1990, BEHAV ECOL SOCIOBIOL, V27, P211; PUGESEK BH, 1983, BEHAV ECOL SOCIOBIOL, V13, P161, DOI 10.1007/BF00299919; Reynolds JD, 1997, BEHAV ECOL, V8, P126, DOI 10.1093/beheco/8.2.126; Risch D, 2014, MOV ECOL, V2, DOI 10.1186/s40462-014-0024-3; ROBERT M, 1989, IBIS, V131, P69, DOI 10.1111/j.1474-919X.1989.tb02745.x; Rojas LM, 1999, BRAIN BEHAV EVOLUT, V53, P29, DOI 10.1159/000006580; Samaran Flore, 2010, Endangered Species Research, V12, P157, DOI 10.3354/esr00302; Santos ESA, 2011, ETHOLOGY, V117, P547, DOI 10.1111/j.1439-0310.2011.01905.x; Saracura V, 2008, CONDOR, V110, P554, DOI 10.1525/cond.2008.8477; Schuchmann K.-L., 2014, BIOL REV CONSELHO RE, V29; Sick H., 1993, BIRDS BRAZIL NATURAL; Silveira TS, 2016, AUSTRAL ECOL, V41, P549, DOI 10.1111/aec.12344; Steelman CK, 2010, J HERPETOL, V44, P61, DOI 10.1670/08-329.1; Towsey M, 2014, ECOL INFORM, V21, P110, DOI 10.1016/j.ecoinf.2013.11.007; Towsey M, 2012, BIOACOUSTICS, V21, P107, DOI 10.1080/09524622.2011.648753; Van Parijs SM, 2009, MAR ECOL PROG SER, V395, P21, DOI 10.3354/meps08123; Ventura TM, 2015, EXPERT SYST APPL; Villanueva-Rivera LJ, 2014, PEERJ, V2, DOI 10.7717/peerj.496; Waldon J, 2011, TROP CONSERV SCI, V4, P254, DOI 10.1177/194008291100400303; Wall C. C., 2014, J ACOUST SOC AM, V135, P2152, DOI DOI 10.1121/1.4876976; WALTERS J, 1980, IBIS, V122, P505, DOI 10.1111/j.1474-919X.1980.tb00906.x; Walters J.R., 1984, SHOREBIRDS BREEDING, P243; WALTERS JR, 1990, WILSON BULL, V102, P49; WALTERS JR, 1982, EVOLUTION, V36, P1030, DOI 10.1111/j.1558-5646.1982.tb05471.x; Wiersma P., 1996, HDB BIRDS WORLD HOAT, V3, P420; Wilson DR, 2014, BIOACOUSTICS, V23, P99, DOI 10.1080/09524622.2013.827588; WWF, 2016, LIVING PLANET REPORT; [No title captured]	95	16	17	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0169041	10.1371/journal.pone.0169041	http://dx.doi.org/10.1371/journal.pone.0169041			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085893	Green Published, Green Submitted, gold			2022-12-26	WOS:000391972600012
J	Boothroyd, LG; Gray, AW; Headland, TN; Uehara, RT; Waynforth, D; Burt, DM; Pound, N				Boothroyd, Lynda G.; Gray, Alan W.; Headland, Thomas N.; Uehara, Ray T.; Waynforth, David; Burt, D. Michael; Pound, Nicholas			Male Facial Appearance and Offspring Mortality in Two Traditional Societies	PLOS ONE			English	Article							MENS FACES; MASCULINITY; PREFERENCES; HEALTH; TESTOSTERONE; IMMUNOCOMPETENCE; ATTRACTIVENESS; PARASITES; HUMANS	It has been hypothesised that facial traits such as masculinity and a healthy appearance may indicate heritable qualities in males (e.g. immunocompetence) and that, consequently, female preferences for such traits may function to increase offspring viability and health. However, the putative link between paternal facial features and offspring health has not previously been tested empirically in humans. Here we present data from two traditional societies with little or no access to modern medicine and family planning technologies. Data on offspring number and offspring survival were analysed for the Agta of the Philippines and the Maya of Belize, and archive facial photographs were assessed by observers for attractiveness and masculinity. While there was no association between attractiveness and offspring survival in either population, a quadratic relationship was observed between masculinity and offspring survival in both populations, such that intermediate levels of masculinity were associated with the lowest offspring mortality, with both high and low levels of masculinity being associated with increased mortality. Neither attractiveness nor masculinity were related to fertility (offspring number) in either population. We consider how these data may or may not reconcile with current theories of female preferences for masculinity in male faces and argue that further research and replication in other traditional societies should be a key priority for the field.	[Boothroyd, Lynda G.; Gray, Alan W.; Burt, D. Michael] Univ Durham, Dept Psychol, Durham, England; [Headland, Thomas N.; Uehara, Ray T.] SIL Int, Dept Anthropol, Dallas, TX USA; [Waynforth, David] Bond Univ, Fac Hlth Sci & Med, Southport, Qld 4229, Australia; [Pound, Nicholas] Brunel Univ, Dept Life Sci, Div Psychol, Uxbridge, Middx, England	Durham University; Bond University; Brunel University	Boothroyd, LG (corresponding author), Univ Durham, Dept Psychol, Durham, England.	l.g.boothroyd@dur.ac.uk	Burt, Michael/D-6684-2013; Pound, Nicholas/B-5453-2008; Boothroyd, Lynda/B-9168-2009	Burt, Michael/0000-0001-5627-6012; Pound, Nicholas/0000-0003-2170-9943; Boothroyd, Lynda/0000-0001-6660-5828; Waynforth, David/0000-0001-8566-1876				Apicella CL, 2007, BIOL LETTERS, V3, P682, DOI 10.1098/rsbl.2007.0410; Apicella CL, 2016, CURR OPIN PSYCHOL, V7, P92, DOI 10.1016/j.copsyc.2015.08.015; BOOTH A, 1993, SOC FORCES, V72, P463, DOI 10.2307/2579857; Boothroyd LG, 2007, PERS INDIV DIFFER, V43, P1161, DOI 10.1016/j.paid.2007.03.008; Boothroyd LG, 2013, EVOL PSYCHOL-US, V11, P1044, DOI 10.1177/147470491301100508; Cornwell RE, 2008, ANIM BEHAV, V76, P1843, DOI 10.1016/j.anbehav.2008.07.031; DeBruine LM, 2006, P ROY SOC B-BIOL SCI, V273, P1355, DOI 10.1098/rspb.2005.3445; Early J. D., 1998, POPULATION DYNAMICS; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Furman D, 2014, P NATL ACAD SCI USA, V111, P869, DOI 10.1073/pnas.1321060111; Gangestad SW, 2008, P ROY SOC B-BIOL SCI, V275, P991, DOI 10.1098/rspb.2007.1425; Gangestad SW, 2000, BEHAV BRAIN SCI, V23, P624, DOI 10.1017/S0140525X00653372; Getty T, 2002, AM NAT, V159, P363, DOI 10.1086/338992; Gildersleeve K, 2014, PSYCHOL BULL, V140, P1205, DOI 10.1037/a0035438; Gray P., 2009, ENDOCRINOLOGY SOCIAL; Griffin P. B., 1992, FATHER CHILD RELATIO, P297; Hagen EH, 2001, J BIOSOC SCI, V33, P503, DOI 10.1017/S002193200100503X; HEADLAND T N, 1989, American Journal of Human Biology, V1, P59, DOI 10.1002/ajhb.1310010111; Headland T. N., 2011, AGTA DEMOGRAPHIC DAT; HEADLAND TN, 1987, ETHNOLOGY, V26, P261, DOI 10.2307/3773591; Lie HC, 2008, EVOLUTION, V62, P2473, DOI 10.1111/j.1558-5646.2008.00478.x; Little AC, 2002, P ROY SOC B-BIOL SCI, V269, P1095, DOI 10.1098/rspb.2002.1984; Mazur A, 1998, SOC FORCES, V77, P315, DOI 10.2307/3006019; Mueller U, 1997, BEHAV ECOL, V8, P569; Penton-Voak IS, 1999, NATURE, V399, P741, DOI 10.1038/21557; Prokop P, 2011, J ETHOL, V29, P453, DOI 10.1007/s10164-011-0274-0; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Scott IM, 2014, P NATL ACAD SCI USA, V111, P14388, DOI 10.1073/pnas.1409643111; Scott IML, 2013, BEHAV ECOL, V24, P579, DOI 10.1093/beheco/ars092; Scott IML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013585; Silva AS, 2012, EVOL HUM BEHAV, V33, P491, DOI 10.1016/j.evolhumbehav.2012.01.002; Stephen ID, 2012, EVOL HUM BEHAV, V33, P260, DOI 10.1016/j.evolhumbehav.2011.10.003; Tybur JM, 2011, PHILOS T R SOC B, V366, P3375, DOI 10.1098/rstb.2011.0136; Volk AA, 2013, EVOL HUM BEHAV, V34, P182, DOI 10.1016/j.evolhumbehav.2012.11.007; Waynforth D, 1998, EVOL HUM BEHAV, V19, P369, DOI 10.1016/S1090-5138(98)00031-2	35	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169181	10.1371/journal.pone.0169181	http://dx.doi.org/10.1371/journal.pone.0169181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH7JQ	28081562	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000391949500030
J	Jiang, XD; Park, CO; Sweeney, JG; Yoo, MJ; Gaide, O; Kupper, TS				Jiang, Xiaodong; Park, Chang Ook; Sweeney, Jenna Geddes; Yoo, Min Jae; Gaide, Olivier; Kupper, Thomas Seth			Dermal gamma delta T Cells Do Not Freely Re-Circulate Out of Skin and Produce IL-17 to Promote Neutrophil Infiltration during Primary Contact Hypersensitivity	PLOS ONE			English	Article							RESIDENT MEMORY; IMMUNE EVENTS; DERMATITIS; INFLAMMATION; RESPONSES; MECHANISMS; INFECTION; MIGRATION; MICE; INTERLEUKIN-17	The role of mouse dermal gamma delta T cells in inflammatory skin disorders and host defense has been studied extensively. It is known that dendritic epidermal T cells (DETC) have a monomorphic gamma delta T cell receptor (TCR) and reside in murine epidermis from birth. We asked if dermal gamma delta cells freely re-circulated out of skin, or behaved more like dermal resident memory T cells (T-RM) in mice. We found that, unlike epidermal gamma delta T cells (DETC), dermal gamma delta cells are not homogeneous with regard to TCR, express the tissue resident T cell markers CD69 and CD103, bear skin homing receptors, and produce IL-17 and IL-22. We created GFP(+): GFP(-) parabiotic mice and found that dermal gamma delta T cells re-circulate very slowly-more rapidly than authentic alpha beta TCR T-RM, but more slowly than the recently described dermal alpha beta TCR T migratory memory cells (T-MM). Mice lacking the TCR delta gene (delta(-/-)) had a significant reduction of 2,4-dinitrofluorobenzene (DNFB)-induced contact hypersensitivity (CHS). We created mice deficient in dermal gamma delta T cells but not DETC, and these mice also showed a markedly reduced CHS response after DNFB challenge. The infiltration of effector T cells during CHS was not reduced in dermal gamma delta T cell-deficient mice; however, infiltration of Gr-1(+) CD11b(+) neutrophils, as well as ear swelling, was reduced significantly. We next depleted Gr-1(+) neutrophils in vivo, and demonstrated that neutrophils are required for ear swelling, the accepted metric for a CHS response. Depletion of IL-17-producing dermal V gamma 4(+) cells and neutralization of IL-17 in vivo, respectively, also led to a significantly reduced CHS response and diminished neutrophil infiltration. Our findings here suggest that dermal gamma delta T cells have an intermediate phenotype of T cell residence, and play an important role in primary CHS through producing IL-17 to promote neutrophil infiltration.	[Jiang, Xiaodong; Park, Chang Ook; Sweeney, Jenna Geddes; Yoo, Min Jae; Gaide, Olivier; Kupper, Thomas Seth] Harvard Med Sch, Brigham & Womens Hosp, Dept Dermatol, Harvard Skin Dis Res Ctr, Boston, MA 02115 USA; [Gaide, Olivier] Univ Lausanne Hosp, Dept Dermatol, Lausanne, Switzerland	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Kupper, TS (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Dermatol, Harvard Skin Dis Res Ctr, Boston, MA 02115 USA.	tkupper@partners.org	Kupper, Thomas/O-4962-2019		National Institutes of Health [AR065807, AI097128]; grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI14C1799]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041707, R01AI097128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065807] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by the National Institutes of Health Grants AR065807 and AI097128 (to TSK). COP was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI14C1799).	Albanesi C, 2000, J INVEST DERMATOL, V115, P81, DOI 10.1046/j.1523-1747.2000.00041.x; Becher B, 2012, NAT MED, V18, P1748, DOI 10.1038/nm.3016; Cai YH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4986; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Christensen AD, 2012, APMIS, V120, P1, DOI 10.1111/j.1600-0463.2011.02832.x; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Fink DR, 2010, MOL IMMUNOL, V47, P1710, DOI 10.1016/j.molimm.2010.03.002; Gaide O, 2015, NAT MED, V21, P647, DOI 10.1038/nm.3860; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Girardi M, 2002, J EXP MED, V195, P855, DOI 10.1084/jem.20012000; Gray EE, 2013, NAT IMMUNOL, V14, P584, DOI 10.1038/ni.2585; Gray EE, 2011, J IMMUNOL, V186, P6091, DOI 10.4049/jimmunol.1100427; Guan HB, 2002, J INVEST DERMATOL, V119, P137, DOI 10.1046/j.1523-1747.2002.01830.x; He DG, 2009, J IMMUNOL, V183, P1463, DOI 10.4049/jimmunol.0804108; Honda T, 2013, J INVEST DERMATOL, V133, P303, DOI 10.1038/jid.2012.284; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Jiang XD, 2010, P NATL ACAD SCI USA, V107, P7443, DOI 10.1073/pnas.0912943107; Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Krstic A, 2012, IMMUNOL RES, V52, P34, DOI 10.1007/s12026-012-8276-8; Mabuchi T, 2011, J IMMUNOL, V187, P5026, DOI 10.4049/jimmunol.1101817; MacLeod AS, 2011, CELL MOL LIFE SCI, V68, P2399, DOI 10.1007/s00018-011-0702-x; Malhotra N, 2013, IMMUNITY, V38, P681, DOI 10.1016/j.immuni.2013.01.010; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nanno M, 2007, IMMUNOL REV, V215, P103, DOI 10.1111/j.1600-065X.2006.00474.x; Nielsen MM, 2014, J IMMUNOL, V192, P2975, DOI 10.4049/jimmunol.1301689; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Park CO, 2015, NAT MED, V21, P688, DOI 10.1038/nm.3883; Peiser M, 2012, CELL MOL LIFE SCI, V69, P763, DOI 10.1007/s00018-011-0846-8; Sheridan BS, 2011, NAT IMMUNOL, V12, P485, DOI 10.1038/ni.2029; Sumaria N, 2011, J EXP MED, V208, P505, DOI 10.1084/jem.20101824; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Watanabe R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010302; Weber FC, 2015, J EXP MED, V212, P15, DOI 10.1084/jem.20130062	37	30	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169397	10.1371/journal.pone.0169397	http://dx.doi.org/10.1371/journal.pone.0169397			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081153	Green Submitted, Green Published, gold			2022-12-26	WOS:000391949500044
J	Kroll-Desrosiers, AR; Ronnenberg, AG; Zagarins, SE; Houghton, SC; Takashima-Uebelhoer, BB; Bertone-Johnson, ER				Kroll-Desrosiers, Aimee R.; Ronnenberg, Alayne G.; Zagarins, Sofija E.; Houghton, Serena C.; Takashima-Uebelhoer, Biki B.; Bertone-Johnson, Elizabeth R.			Recreational Physical Activity and Premenstrual Syndrome in Young Adult Women: A Cross-Sectional Study	PLOS ONE			English	Article							CONDITIONING EXERCISE; AEROBIC EXERCISE; MENSTRUAL-CYCLE; AGED WOMEN; SYMPTOMS; RISK; ASSOCIATION; DISTRESS	Introduction It is estimated that up to 75% of premenopausal women experience at least one premenstrual symptom and 8-20% meet clinical criteria for premenstrual syndrome. Premenstrual syndrome substantially reduces quality of life for many women of reproductive age, with pharmaceutical treatments having limited efficacy and substantial side effects. Physical activity has been recommended as a method of reducing menstrual symptom severity. However, this recommendation is based on relatively little evidence, and the relationship between physical activity, premenstrual symptoms, and premenstrual syndrome remains unclear. Methods We evaluated the relationship between physical activity and premenstrual syndrome and premenstrual symptoms among 414 women aged 18-31. Usual premenstrual symptom experience was assessed with a modified version of the Calendar of Premenstrual Experiences. Total, physical, and affective premenstrual symptom scores were calculated for all participants. Eighty women met criteria for moderate-to-severe premenstrual syndrome, while 89 met control criteria. Physical activity, along with dietary and lifestyle factors, was assessed by self-report. Results Physical activity was not significantly associated with total, affective, or physical premenstrual symptom score. Compared to the women with the lowest activity, women in tertiles 2 and 3 of activity, classified as metabolic equivalent task hours, had prevalence odds ratios for premenstrual syndrome of 1.5 (95% CI: 0.6-3.7) and 0.9 (95% CI: 0.4-2.4), respectively (p-value for trend = 0.85). Conclusions We found no association between physical activity and either premenstrual symptom scores or the prevalence of premenstrual syndrome.	[Kroll-Desrosiers, Aimee R.] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA 01655 USA; [Ronnenberg, Alayne G.; Zagarins, Sofija E.; Houghton, Serena C.; Takashima-Uebelhoer, Biki B.; Bertone-Johnson, Elizabeth R.] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Amherst	Kroll-Desrosiers, AR (corresponding author), Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA 01655 USA.	aimee.kroll@umassmed.edu		Houghton, Serena/0000-0001-8833-9065; Kroll-Desrosiers, Aimee/0000-0002-0026-7499	Departments of Public Health and Nutrition; Faculty Research Grant, University of Massachusetts Amherst	Departments of Public Health and Nutrition; Faculty Research Grant, University of Massachusetts Amherst	This study was funded by the Departments of Public Health and Nutrition and by a Faculty Research Grant, University of Massachusetts Amherst. ERBJ AGR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGANOFF JA, 1994, J PSYCHOSOM RES, V38, P183, DOI 10.1016/0022-3999(94)90114-7; AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Bertol E, 2017, AM J DRUG ALCOHOL AB, V43, P341, DOI 10.1080/00952990.2016.1216556; Bertone-Johnson E R, 2014, HUM REPROD, P1; Bertone-Johnson ER, 2008, AM J EPIDEMIOL, V168, P938, DOI 10.1093/aje/kwn194; Bertone-Johnson ER, 2007, J REPROD MED, V52, P779; Bertone-Johnson ER, 2010, J WOMENS HEALTH, V19, P1955, DOI 10.1089/jwh.2010.2128; Bertone-Johnson ER, 2010, J STEROID BIOCHEM, V121, P434, DOI 10.1016/j.jsbmb.2010.03.076; Bertone-Johnson ER, 2009, J WOMENS HEALTH, V18, P1945, DOI 10.1089/jwh.2009.1468; Bertone-Johnson ER, 2005, ARCH INTERN MED, V165, P1246, DOI 10.1001/archinte.165.11.1246; Chocano-Bedoya PO, 2013, AM J EPIDEMIOL, V177, P1118, DOI 10.1093/aje/kws363; Chocano-Bedoya PO, 2011, AM J CLIN NUTR, V93, P1080, DOI 10.3945/ajcn.110.009530; CHOI PYL, 1995, BRIT J CLIN PSYCHOL, V34, P447, DOI 10.1111/j.2044-8260.1995.tb01479.x; Teixeira ALD, 2013, REV BRAS GINECOL OBS, V35, P210, DOI 10.1590/S0100-72032013000500004; Daley A, 2009, J WOMENS HEALTH, V18, P895, DOI 10.1089/jwh.2008.1098; Dell DL, 2004, CLIN OBSTET GYNECOL, V47, P568, DOI 10.1097/01.grf.0000135298.39050.b3; Deuster PA, 1999, ARCH FAM MED, V8, P122, DOI 10.1001/archfami.8.2.122; El-Lithy A, 2014, J OBSTET GYNAECOL, P1; GANNON L, 1988, WOMEN HEALTH, V14, P105, DOI 10.1300/J013v14n02_07; Gelman A, 2013, INCONNU, P1; JOHNSON WG, 1995, PSYCHOSOM MED, V57, P324, DOI 10.1097/00006842-199507000-00003; Kaunitz AM, 2008, MANAGING PREMENSTRUA; Kritz-Silverstein D, 1999, J WOMEN HEALTH GEN-B, V8, P1185, DOI 10.1089/jwh.1.1999.8.1185; Lopez LM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006586.pub4; Masho SW, 2005, J PSYCHOSOM OBST GYN, V26, P33, DOI 10.1080/01443610400023049; MORTOLA JF, 1990, OBSTET GYNECOL, V76, P302; MORTOLA JF, 1992, CURR OPIN OBSTET GYN, V4, P877; O'Brien PMS, 2011, ARCH WOMEN MENT HLTH, V14, P13, DOI 10.1007/s00737-010-0201-3; PRIOR JC, 1986, EUR J APPL PHYSIOL O, V55, P349, DOI 10.1007/BF00422732; PRIOR JC, 1987, FERTIL STERIL, V47, P402; PRIOR JC, 1987, J REPROD MED, V32, P423; Purdue-Smithe AC, 2016, AM J CLIN NUTR, V104, P499, DOI 10.3945/ajcn.115.127027; Rapkin Andrea J, 2009, Expert Rev Pharmacoecon Outcomes Res, V9, P157, DOI 10.1586/erp.09.14; Rasheed P, 2003, ANN SAUDI MED, V23, P381, DOI 10.5144/0256-4947.2003.381; References The American Congress of Obstetricians and Gynecologists-Office of Communications, 2011, 2011 WOM HLTH STATS; STEEGE JF, 1993, J PSYCHOSOM RES, V37, P127, DOI 10.1016/0022-3999(93)90079-U; Stoddard JL, 2007, EUR J APPL PHYSIOL, V99, P27, DOI 10.1007/s00421-006-0313-7; The American College of Obstetricians and Gynecologists, 2011, PREM SYNDR FAQ057 GY; TIMONEN S, 1971, ACTA OBSTET GYN SCAN, V50, P331, DOI 10.3109/00016347109157334; Willett W, 2012, NUTR EPIDEMIOLOGY; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Zagarins SE, 2010, J CLIN DENSITOM, V13, P392, DOI 10.1016/j.jocd.2010.07.006	42	19	20	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169728	10.1371/journal.pone.0169728	http://dx.doi.org/10.1371/journal.pone.0169728			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH7JQ	28081191	Green Published, Green Submitted, gold			2022-12-26	WOS:000391949500068
J	Sancho, AI; Wallner, M; Hauser, M; Nagi, B; Himly, M; Asam, C; Ebner, C; Jahn-Schmidt, B; Bohle, B; Ferreira, F				Sancho, Ana I.; Wallner, Michael; Hauser, Michael; Nagi, Birgit; Himly, Martin; Asam, Claudia; Ebner, Christof; Jahn-Schmidt, Beatrice; Bohle, Barbara; Ferreira, Fatima			T Cell Epitope-Containing Domains of Ragweed Amb a 1 and Mugwort Art v 6 Modulate Immunologic Responses in Humans and Mice	PLOS ONE			English	Article							ALLERGEN-SPECIFIC IMMUNOTHERAPY; POLLEN IMMUNOTHERAPY; SENSITIZATION; STANDARDIZATION; REACTIVITY; MECHANISMS; VACCINES; IGE	Background Ragweed (Ambrosia artemisiifolia) and mugwort (Artemisia vulgaris) are the major cause of pollen allergy in late summer. Allergen-specific lymphocytes are crucial for immune modulation during immunotherapy. We sought to generate and pre-clinically characterise highly immunogenic domains of the homologous pectate lyases in ragweed (Amb a 1) and mugwort pollen (Art v 6) for immunotherapy. Methods Domains of Amb a 1 (Amb a 1 alpha) and Art v 6 (Art v 6 alpha) and a hybrid molecule, consisting of both domains, were designed, expressed in E. coli and purified. Human IgE reactivity and allergenicity were assessed by ELISA and mediator release experiments using ragweed and mugwort allergic patients. Moreover, T cell proliferation was determined. Blocking IgG antibodies and cytokine production in BALB/c mice were studied by ELISA and ELISPOT. Results The IgE binding capacity and in vitro allergenic activity of the Amb a 1 and Art v 6 domains and the hybrid were either greatly reduced or abolished. The recombinant proteins induced T cell proliferative responses comparable to those of the natural allergens, indicative of retained allergen-specific T cell response. Mice immunisation with the hypoallergens induced IL-4, IL-5, IL-13 and IFN-gamma production after antigen-specific in vitro re-stimulation of splenocytes. Moreover, murine IgG antibodies that inhibited specific IgE binding of ragweed and mugwort pollen allergic patients were detected. Conclusion Accumulation of T cell epitopes and deletion of IgE reactive areas of Amb a 1 and Art v 6, modulated the immunologic properties of the allergen immuno-domains, leading to promising novel candidates for therapeutic approach.	[Sancho, Ana I.; Wallner, Michael; Hauser, Michael; Himly, Martin; Asam, Claudia; Ferreira, Fatima] Salzburg Univ, Dept Mol Biol, Christian Doppler Lab Allergy Diag & Therapy, Salzburg, Austria; [Nagi, Birgit; Jahn-Schmidt, Beatrice; Bohle, Barbara] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Vienna, Austria; [Ebner, Christof] Allergieambulatorium, Reumannpl, Vienna, Austria; [Bohle, Barbara] Med Univ Vienna, Christian Doppler Lab Immunomodulat, Dept Pathophysiol & Allergy Res, Vienna, Austria	Salzburg University; Medical University of Vienna; Medical University of Vienna	Sancho, AI (corresponding author), Salzburg Univ, Dept Mol Biol, Christian Doppler Lab Allergy Diag & Therapy, Salzburg, Austria.	ana.sancho@sbg.ac.at	Ferreira, Fatima/E-4889-2011; Hauser, Michael/P-6148-2017; Ferreira, Fatima/AAB-4321-2019; Himly, Martin/D-1568-2015	Ferreira, Fatima/0000-0003-0989-2335; Hauser, Michael/0000-0001-6558-755X; Ferreira, Fatima/0000-0003-0989-2335; Himly, Martin/0000-0001-5416-085X; Sancho, Ana/0000-0002-6064-6159; Bohle, Barbara/0000-0002-5105-7985	European Commission Marie Curie Actions-Intra-European Fellowships Project [PIEF-GA-2009-253281]; Christian Doppler Laboratory; Austrian Science Fund (FWF) [SFB F4610]; Sparkling Science Project Bio KoSMoS [SPA-193]	European Commission Marie Curie Actions-Intra-European Fellowships Project; Christian Doppler Laboratory; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Sparkling Science Project Bio KoSMoS	This work was supported by the European Commission Marie Curie Actions-Intra-European Fellowships Project PIEF-GA-2009-253281 (http://ec.europa.eu/research/mariecurieactions/index_en.htm) AIS; the Christian Doppler Laboratory (https://www.uni-salzburg.at/index.php?id=25814&L=1) BB, BN, BJS, MW, M. Himly, FF, CA, M. Hause; the Austrian Science Fund (FWF) project SFB F4610) (https://www.fwf.ac.at/en/) BB, BN, BJS, MW, M. Himly, FF, CA, M. Hause, CE, and the Sparkling Science Project Bio KoSMoS SPA-193) (https://www.sparklingscience.at/) MW.	Akdis CA, 2011, J ALLERGY CLIN IMMUN, V127, P18, DOI 10.1016/j.jaci.2010.11.030; Akdis M, 2009, NAT REV DRUG DISCOV, V8, P645, DOI 10.1038/nrd2653; Arbes SJ, 2005, J ALLERGY CLIN IMMUN, V116, P377, DOI 10.1016/j.jaci.2005.05.017; Asero R, 2006, CLIN EXP ALLERGY, V36, P658, DOI 10.1111/j.1365-2222.2006.02477.x; Asero R, 2011, INT ARCH ALLERGY IMM, V155, P149, DOI 10.1159/000318864; Asero R, 2014, ANN ALLERG ASTHMA IM, V113, P307, DOI 10.1016/j.anai.2014.06.009; Bohle B, 2008, FRONT BIOSCI-LANDMRK, V13, P6079, DOI 10.2741/3139; Burbach GJ, 2009, ALLERGY, V64, P664, DOI 10.1111/j.1398-9995.2009.01975.x; Flicker S, 2011, CURR TOP MICROBIOL, V352, P141, DOI 10.1007/82_2011_143; Gentile D, 2011, CURR ALLERGY ASTHM R, V11, P131, DOI 10.1007/s11882-011-0176-9; Himly M, 2009, ALLERGY, V64, P1038, DOI 10.1111/j.1398-9995.2009.01957.x; HogenEsch H, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00406; Jahn-Schmid B, 2012, J IMMUNOL, V188, P1559, DOI 10.4049/jimmunol.1102445; Jahn-Schmid B, 2010, J ALLERGY CLIN IMMUN, V126, P1068, DOI 10.1016/j.jaci.2010.05.038; Kanter U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061518; Kool Mirjam, 2012, F1000 Biol Rep, V4, P6, DOI 10.3410/B4-6; Larche M, 2006, NAT REV IMMUNOL, V6, P761, DOI 10.1038/nri1934; Pichler U, 2014, CLIN EXP ALLERGY, V44, P438, DOI 10.1111/cea.12250; Salo PM, 2011, J ALLERGY CLIN IMMUN, V127, P1226, DOI 10.1016/j.jaci.2010.12.1106; Valenta R, 2012, J INTERN MED, V272, P144, DOI 10.1111/j.1365-2796.2012.02556.x; Vogel L, 2005, ALLERGY, V60, P1021, DOI 10.1111/j.1398-9995.2005.00803.x; Wallner M, 2013, IMMUNOTHERAPY-UK, V5, P1323, DOI 10.2217/imt.13.114; Wallner M, 2011, J ALLERGY CLIN IMMUN, V127, P1571, DOI 10.1016/j.jaci.2011.01.064; Wopfner N, 2005, INT ARCH ALLERGY IMM, V138, P337, DOI 10.1159/000089188; Wopfner N, 2009, MOL IMMUNOL, V46, P2090, DOI 10.1016/j.molimm.2009.02.005	25	5	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169784	10.1371/journal.pone.0169784	http://dx.doi.org/10.1371/journal.pone.0169784			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081194	Green Published, gold, Green Submitted			2022-12-26	WOS:000391949500079
J	Niewolik, D; Peter, I; Butscher, C; Schwarz, K				Niewolik, Doris; Peter, Ingrid; Butscher, Carmen; Schwarz, Klaus			Autoinhibition of the Nuclease ARTEMIS Is Mediated by a Physical Interaction between Its Catalytic and C-terminal Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA repair; DNA-dependent serine; threonine protein kinase (DNA-PK); immunodeficiency; protein phosphorylation; protein-protein interaction; ARTEMIS; autoinhibition; NHEJ; V(D)J recombination	WISKOTT-ALDRICH-SYNDROME; DNA-LIGASE IV; B-CELL DIFFERENTIATION; STRAND BREAK REPAIR; V(D)J RECOMBINATION; DISEASE ALLELE; PROTEIN; PHOSPHORYLATION; MUTATIONS; COMPLEX	The nuclease ARTEMIS is essential for the development of B and T lymphocytes. It is required for opening DNA hairpins generated during antigen receptor gene assembly from variable (V), diversity (D), and joining (J) subgenic elements (V(D)J recombination). As a member of the non-homologous end-joining pathway, it is also involved in repairing a subset of pathological DNA double strand breaks. Loss of ARTEMIS function therefore results in radiosensitive severe combined immunodeficiency (RS-SCID). The hairpin opening activity is dependent on the DNA-dependent protein kinase catalytic subunit (DNA-PKcs), which can bind to and phosphorylate ARTEMIS. The ARTEMIS C terminus is dispensable for cellular V(D)J recombination and in vitro nuclease assays with C-terminally truncated ARTEMIS showing DNA-PKcs-independent hairpin opening activity. Therefore, it has been postulated that ARTEMIS is regulated via autoinhibition by its C terminus. To obtain evidence for the autoinhibition model, we performed co-immunoprecipitation experiments with combinations of ARTEMIS mutants. We show that an N-terminal fragment comprising the catalytic domain can interact both with itself and with a C-terminal fragment. Amino acid exchanges N456A+S457A+E458Q in the C terminus of full-length ARTEMIS resulted in unmasking of the N terminus and in increased ARTEMIS activity in cellular V(D)J recombination assays. Mutations in ARTEMIS-deficient patients impaired the interaction with the C terminus and also affected protein stability. The interaction between the N- and C-terminal domains was not DNA-PKcs-dependent, and phosphomimetic mutations in the C-terminal domain did not result in unmasking of the catalytic domain. Our experiments provide strong evidence that a physical interaction between the C-terminal and catalytic domains mediates ARTEMIS autoinhibition.	[Niewolik, Doris; Schwarz, Klaus] Univ Ulm, Inst Transfus Med, D-89081 Ulm, Germany; [Peter, Ingrid; Butscher, Carmen; Schwarz, Klaus] German Red Cross Blood Serv Baden Wuerttemberg He, Inst Clin Transfus Med & Immunogenet Ulm, D-89081 Ulm, Germany	Ulm University	Niewolik, D (corresponding author), Univ Ulm, Inst Transfus Med, D-89081 Ulm, Germany.	doris.niewolik@uni-ulm.de			Bundesministerium fuer Bildung und Forschung [01GM1517B]	Bundesministerium fuer Bildung und Forschung	Supported by Bundesministerium fuer Bildung und Forschung, Grant 01GM1517B.	Baretic D, 2014, CURR OPIN STRUC BIOL, V29, P134, DOI 10.1016/j.sbi.2014.11.003; Callebaut I, 2002, NUCLEIC ACIDS RES, V30, P3592, DOI 10.1093/nar/gkf470; Chang HHY, 2016, NUCLEIC ACIDS RES, V44, P4991, DOI 10.1093/nar/gkw456; Chen L, 2005, CANCER SCI, V96, P134, DOI 10.1111/j.1349-7006.2005.00019.x; De Ioannes P, 2012, CELL REP, V2, P1505, DOI 10.1016/j.celrep.2012.11.004; de Miranda NFCC, 2013, J EXP MED, V210, P1729, DOI 10.1084/jem.20122842; de Miranda NFCC, 2011, ANN NY ACAD SCI, V1246, P50, DOI 10.1111/j.1749-6632.2011.06322.x; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Ege M, 2005, BLOOD, V105, P4179, DOI 10.1182/blood-2004-12-4861; Furgason JM, 2013, PHARMACOL THERAPEUT, V137, P298, DOI 10.1016/j.pharmthera.2012.10.009; Goodarzi AA, 2006, EMBO J, V25, P3880, DOI 10.1038/sj.emboj.7601255; Huang Y, 2009, J EXP MED, V206, P893, DOI 10.1084/jem.20082396; Jacobs C, 2011, HUM MOL GENET, V20, P806, DOI 10.1093/hmg/ddq524; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Lagresle-Peyrou C, 2008, MOL THER, V16, P396, DOI 10.1038/sj.mt.6300353; Li SC, 2014, J BIOL CHEM, V289, P7825, DOI 10.1074/jbc.M113.544874; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Ma YM, 2005, J BIOL CHEM, V280, P33839, DOI 10.1074/jbc.M507113200; Malu S, 2012, J EXP MED, V209, P955, DOI 10.1084/jem.20111437; Massaad MJ, 2013, ANN NY ACAD SCI, V1285, P26, DOI 10.1111/nyas.12049; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Moshous D, 2003, J CLIN INVEST, V111, P381, DOI 10.1172/JCI200316774; Niewolik D, 2006, J BIOL CHEM, V281, P33900, DOI 10.1074/jbc.M606023200; Noordzij JG, 2003, BLOOD, V101, P1446, DOI 10.1182/blood-2002-01-0187; Ochi T, 2014, DNA REPAIR, V17, P98, DOI 10.1016/j.dnarep.2014.02.010; Ochi T, 2013, STRUCTURE, V21, P672, DOI 10.1016/j.str.2013.02.014; Pannicke U, 2004, EMBO J, V23, P1987, DOI 10.1038/sj.emboj.7600206; Pannicke U, 2010, HUM MUTAT, V31, P197, DOI 10.1002/humu.21168; Perez-Becker Niehuis T, 2009, 26 ANN M ARB PAD IMM; Poinsignon C, 2004, EUR J IMMUNOL, V34, P3146, DOI 10.1002/eji.200425455; Poinsignon C, 2004, J EXP MED, V199, P315, DOI 10.1084/jem.20031142; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Rivera-Munoz P, 2016, GENE THER, V23, P176, DOI 10.1038/gt.2015.95; Soubeyrand S, 2006, J MOL BIOL, V358, P1200, DOI 10.1016/j.jmb.2006.02.061; SUWA A, 1994, P NATL ACAD SCI USA, V91, P6904, DOI 10.1073/pnas.91.15.6904; van der Burg M, 2009, J CLIN INVEST, V119, P91, DOI 10.1172/JCI37141; Wang JH, 2005, DNA REPAIR, V4, P556, DOI 10.1016/j.dnarep.2005.02.001; Wang JD, 2014, GENE DEV, V28, P2693, DOI 10.1101/gad.252478.114; Woodbine L, 2010, DNA REPAIR, V9, P1003, DOI 10.1016/j.dnarep.2010.07.001; Zhang XS, 2004, MOL CELL BIOL, V24, P9207, DOI 10.1128/MCB.24.20.9207-9220.2004	42	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3351	3365		10.1074/jbc.M116.770461	http://dx.doi.org/10.1074/jbc.M116.770461			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28082683	Green Published, hybrid			2022-12-26	WOS:000395538800025
J	Yang, S; Qiang, L; Sample, A; Shah, P; He, YY				Yang, Seungwon; Qiang, Lei; Sample, Ashley; Shah, Palak; He, Yu-Ying			NF-B Signaling Activation Induced by Chloroquine Requires Autophagosome, p62 Protein, and c-Jun N-terminal Kinase (JNK) Signaling and Promotes Tumor Cell Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; melanoma; NF-B; p62 (sequestosome 1(SQSTM1)); tumor cell biology; chloroquine	KAPPA-B; CANCER; APOPTOSIS; SURVIVAL; TUMORIGENESIS; P62/SQSTM1; THERAPY; NRF2; ELIMINATION; INHIBITION	Macroautophagy (hereafter autophagy) is a catabolic cellular self-eating process by which unwanted organelles or proteins are delivered to lysosomes for degradation through autophagosomes. Although the role of autophagy in cancer has been shown to be context-dependent, the role of autophagy in tumor cell survival has attracted great interest in targeting autophagy for cancer therapy. One family of potential autophagy blockers is the quinoline-derived antimalarial family, including chloroquine (CQ). However, the molecular basis for tumor cell response to CQ remains poorly understood. We show here that in both squamous cell carcinoma cells and melanoma tumor cells, CQ induced NF-B activation and the expression of its target genes HIF-1, IL-8, BCL-2, and BCL-XL through the accumulation of autophagosomes, p62, and JNK signaling. The activation of NF-B further increased p62 gene expression. Either genetic knockdown of p62 or inhibition of NF-B sensitized tumor cells to CQ, resulting in increased apoptotic cell death following treatment. Our findings provide new molecular insights into the CQ response in tumor cells and CQ resistance in cancer therapy. These findings may facilitate development of improved therapeutic strategies by targeting the p62/NF-B pathway.	[Yang, Seungwon; Qiang, Lei; Sample, Ashley; Shah, Palak; He, Yu-Ying] Univ Chicago, Dept Med, Dermatol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Sample, Ashley; He, Yu-Ying] Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	He, YY (corresponding author), Univ Chicago, Dept Med, Dermatol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.	yyhe@medicine.bsd.uchicago.edu	Qiang, Lei/B-2763-2012; Yang, Seungwon/AAM-7585-2021	Qiang, Lei/0000-0002-7164-3164; 	National Institutes of Health [ES024373]; NIEHS [ES016936]; American Cancer Society [RSG-13-078-01]; University of Chicago Cancer Research Center [P30 CA014599]; CTSA [UL1 TR000430]; University of Chicago Friends of Dermatology Endowment Fund; NATIONAL CANCER INSTITUTE [P30CA014599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024373, R01ES016936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); American Cancer Society(American Cancer Society); University of Chicago Cancer Research Center; CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); University of Chicago Friends of Dermatology Endowment Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants ES024373 and ES016936 from NIEHS (to Y.-Y.H.), American Cancer Society Grant RSG-13-078-01 (to Y.-Y.H.), University of Chicago Cancer Research Center Grant P30 CA014599, CTSA Grant UL1 TR000430, and the University of Chicago Friends of Dermatology Endowment Fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; CANN HM, 1961, PEDIATRICS, V27, P95; CANN HM, 1960, AM J DIS CHILD, V100, P797; Chang MA, 2014, PROSTATE, V74, P149, DOI 10.1002/pros.22737; Cheong H, 2012, NAT BIOTECHNOL, V30, P671, DOI 10.1038/nbt.2285; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; Encyclopaedia Britannica, 2009, LEAF NOS BAT; Eng CH, 2016, P NATL ACAD SCI USA, V113, P182, DOI 10.1073/pnas.1515617113; Galluzzi L, 2015, EMBO J, V34, P856, DOI 10.15252/embj.201490784; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; LaGory EL, 2016, NAT CELL BIOL, V18, P356, DOI 10.1038/ncb3330; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Lee HM, 2011, J IMMUNOL, V186, P1248, DOI 10.4049/jimmunol.1001954; Maes H, 2014, CANCER CELL, V26, P190, DOI 10.1016/j.ccr.2014.06.025; Maes H, 2013, TRENDS MOL MED, V19, P428, DOI 10.1016/j.molmed.2013.04.005; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moscat J, 2012, TRENDS BIOCHEM SCI, V37, P230, DOI 10.1016/j.tibs.2012.02.008; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; OCHSENDORF FR, 1991, HAUTARZT, V42, P140; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Plowe CV, 2005, CURR TOP MICROBIOL, V295, P55; Qiang L, 2016, AUTOPHAGY, V12, P357, DOI 10.1080/15548627.2015.1110667; Qiang L, 2014, P NATL ACAD SCI USA, V111, P9241, DOI 10.1073/pnas.1322913111; Rebecca VW, 2016, ONCOGENE, V35, P1, DOI 10.1038/onc.2015.99; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Rynes RI, 1997, BRIT J RHEUMATOL, V36, P799; Salas E, 2016, ONCOGENE, V35, P2913, DOI 10.1038/onc.2015.348; Selvaag E, 1997, J TOXICOL-CUTAN OCUL, V16, P5, DOI 10.3109/15569529709048883; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Son YO, 2014, J BIOL CHEM, V289, P28660, DOI 10.1074/jbc.M114.595496; Trocoli A, 2014, CELL DEATH DIFFER, V21, P1852, DOI 10.1038/cdd.2014.102; Uhlemann AC, 2005, CURR TOP MICROBIOL, V295, P39; Vadlamudi RK, 1998, FEBS LETT, V435, P138, DOI 10.1016/S0014-5793(98)01021-7; Vessoni AT, 2013, CELL DEATH DIFFER, V20, P1444, DOI 10.1038/cdd.2013.103; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Yang S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088489; Yang S, 2012, BIOMATERIALS, V33, P2902, DOI 10.1016/j.biomaterials.2011.12.051; Yang S, 2011, BIOMATERIALS, V32, P2851, DOI 10.1016/j.biomaterials.2011.01.015; Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047; Zhao BZ, 2014, J BIOL CHEM, V289, P35806, DOI 10.1074/jbc.M114.595397; Zhi Xiaoyong, 2015, F1000Prime Rep, V7, P18, DOI 10.12703/P7-18; Zhong ZY, 2016, CELL, V164, P896, DOI 10.1016/j.cell.2015.12.057	53	44	47	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3379	3388		10.1074/jbc.M116.756536	http://dx.doi.org/10.1074/jbc.M116.756536			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28082672	Green Published, hybrid			2022-12-26	WOS:000395538800027
J	Grossi, G; Lanzarotti, R; Lin, JY				Grossi, Giuliano; Lanzarotti, Raffaella; Lin, Jianyi			Orthogonal Procrustes Analysis for Dictionary Learning in Sparse Linear Representation	PLOS ONE			English	Article							IMAGE REPRESENTATIONS; ALGORITHMS; DECOMPOSITION; COMPRESSION; REGRESSION	In the sparse representation model, the design of overcomplete dictionaries plays a key role for the effectiveness and applicability in different domains. Recent research has produced several dictionary learning approaches, being proven that dictionaries learnt by data examples significantly outperform structured ones, e.g. wavelet transforms. In this context, learning consists in adapting the dictionary atoms to a set of training signals in order to promote a sparse representation that minimizes the reconstruction error. Finding the best fitting dictionary remains a very difficult task, leaving the question still open. A well -established heuristic method for tackling this problem is an iterative alternating scheme, adopted for instance in the well-known K-SVD algorithm. Essentially, it consists in repeating two stages; the former promotes sparse coding of the training set and the latter adapts the dictionary to reduce the error. In this paper we present R-SVD, a new method that, while maintaining the alternating scheme, adopts the Orthogonal Procrustes analysis to update the dictionary atoms suitably arranged into groups. Comparative experiments on synthetic data prove the effectiveness of R-SVD with respect to well known dictionary learning algorithms such as K-SVD, ILSDLA and the online method OSDL. Moreover, experiments on natural data such as ECG compression, EEG sparse representation, and image modeling confirm R-SVD's robustness and wide applicability.	[Grossi, Giuliano; Lanzarotti, Raffaella] Univ Milan, Dept Comp Sci, Via Comelico 39, I-20135 Milan, Italy; [Lin, Jianyi] Khalifa Univ, Dept Appl Math & Sci, Al Saada St,POB 127788, Abu Dhabi, U Arab Emirates	University of Milan; Khalifa University of Science & Technology	Lanzarotti, R (corresponding author), Univ Milan, Dept Comp Sci, Via Comelico 39, I-20135 Milan, Italy.	lanzarotti@di.unimi.it	Lin, Jianyi/G-9130-2015; Grossi, Giuliano/AAB-9247-2022; Lin, Jianyi/AAT-9024-2020	Lin, Jianyi/0000-0002-3299-448X; Lin, Jianyi/0000-0002-3299-448X; Lanzarotti, Raffaella/0000-0002-8534-4413; GROSSI, GIULIANO/0000-0001-9274-4047	Italian Ministry of Education, University and Research [G41J12001100001]	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR))	This work was funded by the Italian Ministry of Education, University and Research under the FIRB2012 (G41J12001100001) Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo A, 2016, THEORETICAL IN PRESS; Adamo A, 2015, BIOMED SIGNAL PROCES, V15, P11, DOI 10.1016/j.bspc.2014.09.002; Aharon M, 2006, IEEE T SIGNAL PROCES, V54, P4311, DOI 10.1109/TSP.2006.881199; Chen SSB, 1998, SIAM J SCI COMPUT, V20, P33, DOI 10.1137/S1064827596304010; Daubechies Ingrid, 1992, 10 LECT WAVELETS, V61; Dornhege G, 2004, IEEE T BIO-MED ENG, V51, P993, DOI 10.1109/TBME.2004.827088; Easley G, 2008, APPL COMPUT HARMON A, V25, P25, DOI 10.1016/j.acha.2007.09.003; Elad M., 2006, IEEE COMP SOC C COMP, P895, DOI DOI 10.1109/CVPR.2006.142; Engan K, 1999, INT CONF ACOUST SPEE, P2443, DOI 10.1109/ICASSP.1999.760624; Engan K, 1998, INT CONF ACOUST SPEE, P1817; Engan K, 2007, DIGIT SIGNAL PROCESS, V17, P32, DOI 10.1016/j.dsp.2006.02.002; Fira CM, 2011, EUR SIGNAL PR CONF, P1573; Golub GH., 2013, MATRIX COMPUTATIONS; Gower J. C., 2004, PROCRUSTES PROBLEMS, V3; Grossi G, 2015, DIGIT SIGNAL PROCESS, V45, P96, DOI 10.1016/j.dsp.2015.06.006; Guleryuz OG, 2006, IEEE T IMAGE PROCESS, V15, P539, DOI 10.1109/TIP.2005.863057; Halko N, 2011, SIAM REV, V53, P217, DOI 10.1137/090771806; Hou CP, 2014, IEEE T CYBERNETICS, V44, P793, DOI 10.1109/TCYB.2013.2272642; Huang K., 2006, ADV NEURAL INFORM PR, P609, DOI DOI 10.7551/MITPRESS/7503.001.0001; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kreutz-Delgado K, 2003, NEURAL COMPUT, V15, P349, DOI 10.1162/089976603762552951; Li FF, 2007, COMPUT VIS IMAGE UND, V106, P59, DOI 10.1016/j.cviu.2005.09.012; MALLAT SG, 1993, IEEE T SIGNAL PROCES, V41, P3397, DOI 10.1109/78.258082; Martin D, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL II, PROCEEDINGS, P416, DOI 10.1109/ICCV.2001.937655; Mohimani H, 2009, IEEE T SIGNAL PROCES, V57, P289, DOI 10.1109/TSP.2008.2007606; Moody G. B., 1990, COMPUT CARDIOL, P185, DOI DOI 10.1109/CIC.1990.144205; Nie F., 2010, ADV NEURAL INFORM PR, V2, P1813; Olshausen BA, 1997, VISION RES, V37, P3311, DOI 10.1016/S0042-6989(97)00169-7; Pati YC, 1993, SIGN SYST COMP 1993, P40, DOI DOI 10.1109/ACSSC.1993.342465; Rubinstein R, 2010, P IEEE, V98, P1045, DOI 10.1109/JPROC.2010.2040551; SCHONEMA.PH, 1966, PSYCHOMETRIKA, V31, P1, DOI 10.1007/BF02289451; Shin Y, 2015, COMPUT BIOL MED, V66, P29, DOI 10.1016/j.compbiomed.2015.08.017; Skretting K, 2010, IEEE T SIGNAL PROCES, V58, P2121, DOI 10.1109/TSP.2010.2040671; Sulam J, 2016, IEEE T SIGNAL PROCES, V64, P3180, DOI 10.1109/TSP.2016.2540599; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wright J, 2010, P IEEE, V98, P1031, DOI 10.1109/JPROC.2010.2044470; Xu M, 2012, 2012 IEEE VISUAL COMMUNICATIONS AND IMAGE PROCESSING (VCIP); Zhou W, 2012, I C CONT AUTOMAT ROB, P1582, DOI 10.1109/ICARCV.2012.6485382	40	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0169663	10.1371/journal.pone.0169663	http://dx.doi.org/10.1371/journal.pone.0169663			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103283	gold, Green Published, Green Submitted			2022-12-26	WOS:000392381100018
J	Kasiotis, KM; Anastasiadou, P; Papadopoulos, A; Machera, K				Kasiotis, Konstantinos M.; Anastasiadou, Pelagia; Papadopoulos, Antonis; Machera, Kyriaki			Revisiting Greek Propolis: Chromatographic Analysis and Antioxidant Activity Study	PLOS ONE			English	Article							TOTAL PHENOLIC CONTENT; ANTIMICROBIAL ACTIVITIES; FLAVONOID PHYTOALEXIN; CHEMICAL-COMPOSITION; ANTICANCER ACTIVITY; IN-VITRO; CONSTITUENTS; EXTRACTS; CELLS; IDENTIFICATION	Propolis is a bee product that has been extensively used in alternative medicine and recently has gained interest on a global scale as an essential ingredient of healthy foods and cosmetics. Propolis is also considered to improve human health and to prevent diseases such as inflammation, heart disease, diabetes and even cancer. However, the claimed effects are anticipated to be correlated to its chemical composition. Since propolis is a natural product, its composition is consequently expected to be variable depending on the local flora alignment. In this work, we present the development of a novel HPLC-PDA-ESI/MS targeted method, used to identify and quantify 59 phenolic compounds in Greek propolis hydroalcoholic extracts. Amongst them, nine phenolic compounds are herein reported for the first time in Greek propolis. Alongside GC-MS complementary analysis was employed, unveiling eight additional newly reported compounds. The antioxidant activity study of the propolis samples verified the potential of these extracts to effectively scavenge radicals, with the extract of Imathia region exhibiting comparable antioxidant activity to that of quercetin.	[Kasiotis, Konstantinos M.; Anastasiadou, Pelagia; Machera, Kyriaki] Benaki Phytopathol Inst, Dept Pesticides Control & Phytopharm, Lab Pesticides Toxicol, Athens, Greece; [Papadopoulos, Antonis] Benaki Phytopathol Inst, Dept Phytopathol, Lab Nonparasit Dis, Athens, Greece		Kasiotis, KM; Machera, K (corresponding author), Benaki Phytopathol Inst, Dept Pesticides Control & Phytopharm, Lab Pesticides Toxicol, Athens, Greece.	K.Kasiotis@bpi.gr; K.Machera@bpi.gr		Papadopoulos, Antonis V./0000-0002-1912-8747				Abdelwahab SI, 2011, J ETHNOPHARMACOL, V137, P963, DOI 10.1016/j.jep.2011.07.010; Ambarsing P. R., 2012, Journal of Chemical and Pharmaceutical Research, V4, P3959; Bankova V, 2005, EVID-BASED COMPL ALT, V2, P29, DOI 10.1093/ecam/neh059; Bankova V, 2005, J ETHNOPHARMACOL, V100, P114, DOI 10.1016/j.jep.2005.05.004; BANKOVA V, 1992, J CHROMATOGR, V607, P150, DOI 10.1016/0021-9673(92)87067-I; Bankova VS, 1998, PHYTOCHEMISTRY, V49, P1411, DOI 10.1016/S0031-9422(98)00108-3; Benedek P., 1996, Acta Horticulturae, P169; Benhanifia Mokhtar, 2015, Anti-Infective Agents, V13, P17; Betz JM, 2011, FITOTERAPIA, V82, P44, DOI 10.1016/j.fitote.2010.09.011; Calderon-Montano JM, 2011, MINI-REV MED CHEM, V11, P298, DOI 10.2174/138955711795305335; Chauzat MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079018; CHRISTOV R, 1992, J CHROMATOGR, V623, P182, DOI 10.1016/0021-9673(92)85316-L; Cocconi E, 2016, J MASS SPECTROM, V51, P742, DOI 10.1002/jms.3818; Conde E, 1995, CHROMATOGRAPHIA, V41, P657, DOI 10.1007/BF02688103; Coppo E, 2014, CURR PHARM BIOTECHNO, V15, P380, DOI 10.2174/138920101504140825121142; de Figueiredo SM, 2014, RECENT PATENTS ENDOC, V8, P85, DOI 10.2174/1872214808666140619115319; Del Bano MJ, 2004, J AGR FOOD CHEM, V52, P4987, DOI 10.1021/jf040078p; DOWD LE, 1959, ANAL CHEM, V31, P1184, DOI 10.1021/ac60151a033; EBEL J, 1970, PHYTOCHEMISTRY, V9, P1529, DOI 10.1016/S0031-9422(00)85270-X; Economou A, 2009, J CHROMATOGR A, V1216, P5856, DOI 10.1016/j.chroma.2009.06.031; Falcao SI, 2013, PHYTOCHEM ANALYSIS, V24, P309, DOI 10.1002/pca.2412; Falcao SI, 2010, ANAL BIOANAL CHEM, V396, P887, DOI 10.1007/s00216-009-3232-8; Firdous S, 2014, REC NAT PROD, V8, P51; Freise C, 2013, J NUTR BIOCHEM, V24, P550, DOI 10.1016/j.jnutbio.2012.02.004; Freise C, 2012, INVEST NEW DRUG, V30, P2087, DOI 10.1007/s10637-011-9762-x; Furtado MA, 2008, MUTAT RES-GEN TOX EN, V657, P150, DOI 10.1016/j.mrgentox.2008.09.003; Gattuso G, 2007, MOLECULES, V12, P1641, DOI 10.3390/12081641; Gordo J, 2012, NAT PROD COMMUN, V7, P1491; Graikou K, 2016, LWT-FOOD SCI TECHNOL, V65, P261, DOI 10.1016/j.lwt.2015.08.025; Guimaraes NSS, 2012, FOOD CHEM TOXICOL, V50, P1091, DOI 10.1016/j.fct.2011.11.014; Hardej D, 2010, EUR J MED CHEM, V45, P5827, DOI 10.1016/j.ejmech.2010.09.045; Jaramillo S, 2010, J AGR FOOD CHEM, V58, P10869, DOI 10.1021/jf102669p; Jnawali HN, 2014, J NAT PROD, V77, P258, DOI 10.1021/np400803n; JUNG H, 2016, INT J MOL SCI, V17; Kalogeropoulos N, 2009, FOOD CHEM, V116, P452, DOI 10.1016/j.foodchem.2009.02.060; Kanchev VD, 2013, CURR MED CHEM, V20, P4784, DOI 10.2174/09298673113209990161; Khalil Mahmoud Lotfy, 2006, Asian Pac J Cancer Prev, V7, P22; Kim DH, 2005, J BIOTECHNOL, V119, P155, DOI 10.1016/j.jbiotec.2005.04.004; Lagouri V, 2014, INT J FOOD PROP, V17, P511, DOI 10.1080/10942912.2012.654561; Li SY, 2013, BIOORG MED CHEM LETT, V23, P6682, DOI 10.1016/j.bmcl.2013.10.040; Lin JH, 2002, J NAT PROD, V65, P638, DOI 10.1021/np010548z; Lin JT, 2006, J AGR FOOD CHEM, V54, P7564, DOI 10.1021/jf0616762; Lopez-Lazaro M, 2009, MINI-REV MED CHEM, V9, P31, DOI 10.2174/138955709787001712; Madaan R, 2011, INDIAN J PHARM SCI, V73, P666, DOI 10.4103/0250-474X.100242; McKay DL, 2006, PHYTOTHER RES, V20, P519, DOI 10.1002/ptr.1900; Medana C, 2008, PHYTOCHEM ANALYSIS, V19, P32, DOI 10.1002/pca.1010; Medic-Saric M, 2013, FOOD TECHNOL BIOTECH, V51, P159; Melliou E, 2007, FOOD CHEM, V103, P375, DOI 10.1016/j.foodchem.2006.07.033; Miron TL, 2011, J CHROMATOGR A, V1218, P4918, DOI 10.1016/j.chroma.2010.11.055; Moreno S, 2006, FREE RADICAL RES, V40, P223, DOI 10.1080/10715760500473834; Naik DG, 2013, CHEM BIODIVERS, V10, P649, DOI 10.1002/cbdv.201200165; Omene CO, 2012, INVEST NEW DRUG, V30, P1279, DOI 10.1007/s10637-011-9667-8; Saad MA, 2015, PHARMACOL REP, V67, P115, DOI 10.1016/j.pharep.2014.08.014; Said Sobhi A, 2006, Pak J Pharm Sci, V19, P58; Shimizu T, 2012, BIOENGINEERED, V3, P352, DOI 10.4161/bioe.21546; Shimizu T, 2012, J BIOL CHEM, V287, P19315, DOI 10.1074/jbc.M112.351270; Shukla S, 2009, FOOD CHEM TOXICOL, V47, P2338, DOI 10.1016/j.fct.2009.06.024; Shukla S, 2009, FOOD CHEM TOXICOL, V47, P1848, DOI 10.1016/j.fct.2009.04.040; Sun LP, 2012, J AGR FOOD CHEM, V60, P11748, DOI 10.1021/jf303261r; Szabo MR, 2007, CHEM PAP, V61, P214, DOI 10.2478/s11696-007-0022-7; Szliszka E, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/976415; Tan EC, 2012, PLANT CELL TISS ORG, V111, P219, DOI 10.1007/s11240-012-0188-8; Thippeswamy G, 2008, EUR J PHARMACOL, V588, P141, DOI 10.1016/j.ejphar.2008.04.027; Varoni EM, 2012, CURR MED CHEM, V19, P1706; von Kovats E, 1958, HELV CHIM ACTA, V41, P1915; Wu J, 2011, CANCER LETT, V308, P43, DOI 10.1016/j.canlet.2011.04.012; Yang HS, 2011, MOLECULES, V16, P3444, DOI 10.3390/molecules16043444; Yayli N, 2006, TURK J CHEM, V30, P71; Zhu LP, 2014, CHEM-BIOL INTERACT, V224, P149, DOI 10.1016/j.cbi.2014.10.027	69	39	39	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170077	10.1371/journal.pone.0170077	http://dx.doi.org/10.1371/journal.pone.0170077			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103258	Green Submitted, Green Published, gold			2022-12-26	WOS:000392381100036
J	Craig, CE; Doumas, M				Craig, Chesney E.; Doumas, Michail			Anodal Transcranial Direct Current Stimulation Shows Minimal, Measure-Specific Effects on Dynamic Postural Control in Young and Older Adults: A Double Blind, Sham-Controlled Study	PLOS ONE			English	Article							SENSORIMOTOR INTEGRATION; LOCOMOTOR ADAPTATION; MAGNETIC STIMULATION; DC STIMULATION; TASK PRIORITY; MOTOR CORTEX; GAIT; INFORMATION; VARIABILITY; BALANCE	We investigated whether stimulating the cerebellum and primary motor cortex (M1) using transcranial direct current stimulation (tDCS) could affect postural control in young and older adults. tDCS was employed using a double-blind, sham-controlled design, in which young (aged 18-35) and older adults (aged 65+) were assessed over three sessions, one for each stimulatory condition M1, cerebellar and sham. The effect of tDCS on postural control was assessed using a sway-referencing paradigm, which induced platform rotations in proportion to the participant's body sway, thus assessing sensory reweighting processes. Task difficulty was manipulated so that young adults experienced a support surface that was twice as compliant as that of older adults, in order to minimise baseline age differences in postural sway. Effects of tDCS on postural control were assessed during, immediately after and 30 minutes after tDCS. Additionally, the effect of tDCS on corticospinal excitability was measured by evaluating motor evoked potentials using transcranial magnetic stimulation immediately after and 30 minutes after tDCS. Minimal effects of tDCS on postural control were found in the eyes open condition only, and this was dependent on the measure assessed and age group. For young adults, stimulation had only offline effects, as cerebellar stimulation showed higher mean power frequency (MPF) of sway 30 minutes after stimulation. For older adults, both stimulation conditions delayed the increase in sway amplitude witnessed between blocks one and two until stimulation was no longer active. In conclusion, despite tDCS' growing popularity, we would caution researchers to consider carefully the type of measures assessed and the groups targeted in tDCS studies of postural control.	[Craig, Chesney E.; Doumas, Michail] Queens Univ Belfast, Sch Psychol, Belfast, Antrim, North Ireland; [Craig, Chesney E.] Manchester Metropolitan Univ, Dept Exercise & Sport Sci, Res Ctr Hlth Exercise & Act Living, Crewe, Cheshire, England	Queens University Belfast; Manchester Metropolitan University	Craig, CE (corresponding author), Queens Univ Belfast, Sch Psychol, Belfast, Antrim, North Ireland.; Craig, CE (corresponding author), Manchester Metropolitan Univ, Dept Exercise & Sport Sci, Res Ctr Hlth Exercise & Act Living, Crewe, Cheshire, England.	c.craig@mmu.ac.uk	Doumas, M/A-4494-2009; Craig, Chesney Elizabeth/V-6388-2019	Doumas, M/0000-0002-5323-6258; Craig, Chesney Elizabeth/0000-0002-9492-1294	Department of Employment and Learning PhD studentship; British Academy/Leverhulme Small Research Grant [R1067PSY]	Department of Employment and Learning PhD studentship; British Academy/Leverhulme Small Research Grant	This work was supported by a Department of Employment and Learning PhD studentship to C. Craig and a British Academy/Leverhulme Small Research Grant R1067PSY to M. Doumas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Taib Nordeyn Oulad, 2009, J Neurosurg, V111, P796, DOI 10.3171/2008.2.17679; Benninger DH, 2010, J NEUROL NEUROSUR PS, V81, P1105, DOI 10.1136/jnnp.2009.202556; Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Carpenter MG, 2001, EXP BRAIN RES, V138, P210, DOI 10.1007/s002210100681; Carson RG, 2013, BRAIN STIMUL, V6, P760, DOI 10.1016/j.brs.2013.01.016; Duarte NDC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105777; Censor N, 2011, J PHYSIOL-LONDON, V589, P21, DOI 10.1113/jphysiol.2010.198077; Clark S, 2007, EXP BRAIN RES, V176, P299, DOI 10.1007/s00221-006-0620-6; de Berker AO, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00613; Demain A, 2014, J NEUROL, V261, P196, DOI 10.1007/s00415-013-7174-x; Dilda V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112131; Doumas M, 2008, EXP BRAIN RES, V187, P275, DOI 10.1007/s00221-008-1302-3; Doumas M, 2015, J GERONTOL B-PSYCHOL, V70, P377, DOI 10.1093/geronb/gbt105; Doumas M, 2010, J NEUROPHYSIOL, V104, P1969, DOI 10.1152/jn.00345.2010; Doumas M, 2009, J GERONTOL B-PSYCHOL, V64, P193, DOI 10.1093/geronb/gbp009; Dutta A, 2012, 2 IASTED INT C; Dutta A, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-13; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferrucci R, 2014, NEUROIMAGE, V85, P918, DOI 10.1016/j.neuroimage.2013.04.122; Galea JM, 2011, CEREB CORTEX, V21, P1761, DOI 10.1093/cercor/bhq246; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Goodwill AM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00087; Guo CC, 2010, J NEUROSCI, V30, P16241, DOI 10.1523/JNEUROSCI.3569-10.2010; Horak F, 1996, HDB PHYSIOL 12, V12, P255; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; HORAK FB, 1990, EXP BRAIN RES, V82, P167; HORAK FB, 1989, NEUROBIOL AGING, V10, P727, DOI 10.1016/0197-4580(89)90010-9; Horvath JC, 2014, NEUROPSYCHOLOGIA; Hummel FC, 2010, NEUROBIOL AGING, V31, P2160, DOI 10.1016/j.neurobiolaging.2008.12.008; Iyer MB, 2005, NEUROLOGY; Jayaram G, 2012, J NEUROPHYSIOL, V107, P2950, DOI 10.1152/jn.00645.2011; Kaski D, 2014, CLIN REHABIL, V28, P1115, DOI 10.1177/0269215514534277; Kaski D, 2012, J NEUROPHYSIOL, V107, P2493, DOI 10.1152/jn.00223.2011; Kaski D, 2013, NEUROREHAB NEURAL RE, V27, P864, DOI 10.1177/1545968313496328; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kurlowicz L, 1999, Director, V7, P62; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Lindenberg R, 2010, NEUROLOGY, V75, P2176, DOI 10.1212/WNL.0b013e318202013a; LORD SR, 1991, J GERONTOL, V46, pM69, DOI 10.1093/geronj/46.3.M69; Lord SR, 1999, J AM GERIATR SOC, V47, P1077, DOI 10.1111/j.1532-5415.1999.tb05230.x; Manor B, 2016, J COGNITIVE NEUROSCI, V28, P275, DOI 10.1162/jocn_a_00897; Manto M, 2012, CEREBELLUM, V11, P457, DOI 10.1007/s12311-011-0331-9; McChesney JW, 2000, J GERONTOL A-BIOL, V55, pM658, DOI 10.1093/gerona/55.11.M658; Melzer I, 2004, AGE AGEING, V33, P602, DOI 10.1093/ageing/afh218; Montero-Odasso M, 2012, ARCH PHYS MED REHAB, V93, P293, DOI 10.1016/j.apmr.2011.08.026; NASHNER LM, 1982, J NEUROSCI, V2, P536; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2007, J NEUROPHYSIOL, P97; Nitsche MA, 2011, RESTOR NEUROL NEUROS, V29, P463, DOI 10.3233/RNN-2011-0618; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Parazzini M, 2014, CLIN NEUROPHYSIOL, V125, P577, DOI 10.1016/j.clinph.2013.09.039; Peterka RJ, 2004, J NEUROPHYSIOL, V91, P410, DOI 10.1152/jn.00516.2003; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Pijnenburg M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100666; Prado JM, 2007, GERONTOLOGY, V53, P274, DOI 10.1159/000102938; Rampersad SM, 2014, IEEE T NEUR SYS REH, V22, P441, DOI 10.1109/TNSRE.2014.2308997; Rankin JK, 2000, J GERONTOL A-BIOL, V55, pM112, DOI 10.1093/gerona/55.3.M112; Reis J, 2008, BRAIN STIMUL, V1, P363, DOI 10.1016/j.brs.2008.08.001; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rossini PM, 1994, ELECTROENCEPHALOGR C, V91, P2198; Ruffini G, 2014, NEUROIMAGE, V89, P216, DOI 10.1016/j.neuroimage.2013.12.002; STELMACH GE, 1989, INT J AGING HUM DEV, V29, P205, DOI 10.2190/KKP0-W3Q5-6RDN-RXYT; Vallence AM, 2014, J NEUROPHYSIOL, V111, P1, DOI 10.1152/jn.00088.2013; Wang Y, 2015, EUR J NEUROSCI, V42, P1933, DOI 10.1111/ejn.12953; Warnica MJ, 2014, GAIT POSTURE, V39, P1115, DOI 10.1016/j.gaitpost.2014.01.019; Wechsler D, 1997, WAIS 3 ADM SCOR MAN; Woods AJ, 2016, CLIN NEUROPHYSIOL, V127, P1031, DOI 10.1016/j.clinph.2015.11.012; WOOLLACOTT MH, 1986, INT J AGING HUM DEV, V23, P97, DOI 10.2190/VXN3-N3RT-54JB-X16X; Zhou JH, 2014, EUR J NEUROSCI, V39, P1343, DOI 10.1111/ejn.12492; Zimerman M, 2013, ANN NEUROL, V73, P10, DOI 10.1002/ana.23761; Zimerman M, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00149	72	22	24	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170331	10.1371/journal.pone.0170331	http://dx.doi.org/10.1371/journal.pone.0170331			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099522	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000392380100074
J	Huss, AR; Schumacher, LL; Cochrane, RA; Poulsen, E; Bai, JF; Woodworth, JC; Dritz, SS; Stark, CR; Jones, CK				Huss, Anne R.; Schumacher, Loni L.; Cochrane, Roger A.; Poulsen, Elizabeth; Bai, Jianfa; Woodworth, Jason C.; Dritz, Steve S.; Stark, Charles R.; Jones, Cassandra K.			Elimination of Porcine Epidemic Diarrhea Virus in an Animal Feed Manufacturing Facility	PLOS ONE			English	Article							INFECTION	Porcine Epidemic Diarrhea Virus (PEDV) was the first virus of wide scale concern to be linked to possible transmission by livestock feed or ingredients. Measures to exclude pathogens, prevent cross-contamination, and actively reduce the pathogenic load of feed and ingredients are being developed. However, research thus far has focused on the role of chemicals or thermal treatment to reduce the RNA in the actual feedstuffs, and has not addressed potential residual contamination within the manufacturing facility that may lead to continuous contamination of finished feeds. The purpose of this experiment was to evaluate the use of a standardized protocol to sanitize an animal feed manufacturing facility contaminated with PEDV. Environmental swabs were collected throughout the facility during the manufacturing of a swine diet inoculated with PEDV. To monitor facility contamination of the virus, swabs were collected at: 1) baseline prior to inoculation, 2) after production of the inoculated feed, 3) after application of a quaternary ammonium-glutaraldehyde blend cleaner, 4) after application of a sodium hypochlorite sanitizing solution, and 5) after facility heat-up to 60 degrees C for 48 hours. Decontamination step, surface, type, zone and their interactions were all found to impact the quantity of detectable PEDV RNA (P<0.05). As expected, all samples collected from equipment surfaces contained PEDV RNA after production of the contaminated feed. Additionally, the majority of samples collected from non-direct feed contact surfaces were also positive for PEDV RNA after the production of the contaminated feed, emphasizing the potential role dust plays in cross-contamination of pathogen throughout a manufacturing facility. Application of the cleaner, sanitizer, and heat were effective at reducing PEDV genomic material (P<0.05), but did not completely eliminate it.	[Huss, Anne R.; Stark, Charles R.] Kansas State Univ, Dept Grain Sci & Ind, Manhattan, KS 66506 USA; [Schumacher, Loni L.; Poulsen, Elizabeth; Bai, Jianfa; Dritz, Steve S.] Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA; [Cochrane, Roger A.; Woodworth, Jason C.; Jones, Cassandra K.] Kansas State Univ, Dept Anim Sci & Ind, Manhattan, KS 66506 USA; [Huss, Anne R.] BioMatrix Int, Princeton, MN USA; [Schumacher, Loni L.] Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Ames, IA USA	Kansas State University; Kansas State University; Kansas State University; Iowa State University	Jones, CK (corresponding author), Kansas State Univ, Dept Anim Sci & Ind, Manhattan, KS 66506 USA.	jonesc@ksu.edu	Bai, Jianfa/M-7830-2019	Bai, Jianfa/0000-0002-0021-3036; Dritz, Steve/0000-0001-6371-0729	National Pork Board [14-273]	National Pork Board	National Pork Board -JCW - 14-273. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso C, 2014, VET RES, V45, DOI 10.1186/s13567-014-0073-z; Bowman AS, 2015, VET MICROBIOL, V179, P213, DOI 10.1016/j.vetmic.2015.05.027; Cima G., 2013, J AM VET MED ASSOC, V243, P467; Davies RH, 2010, J APPL MICROBIOL, V109, P1430, DOI 10.1111/j.1365-2672.2010.04767.x; Dee S, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0176-9; Food International Feed Industry Federation, 2010, GOOD PRACT FEED IND, V9; Goede D, 2013, P 40 AD LEMAN SWIN C; Greiner L., 2014, EVALUATION RISK FEED; Huss AR, 2015, J FOOD PROTECT, V78, P1682, DOI 10.4315/0362-028X.JFP-15-052; Jones FT, 2011, J APPL POULTRY RES, V20, P102, DOI 10.3382/japr.2010-00281; Lowe J, 2014, EMERG INFECT DIS, V20, P872, DOI 10.3201/eid2005.131628; Pasick J, 2014, TRANSBOUND EMERG DIS, V61, P397, DOI 10.1111/tbed.12269; Schumacher LL, 2015, AM DAIR SCI ASS AM S; Thomas JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139266; Thomas P, 2014, 22 ANN SWIN DIS C SW	15	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0169612	10.1371/journal.pone.0169612	http://dx.doi.org/10.1371/journal.pone.0169612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099453	gold, Green Published, Green Submitted			2022-12-26	WOS:000392380100028
J	Nam, JY; Lee, JH; Kim, HY; Kim, JE; Lee, DH; Chang, Y; Cho, H; Yoo, JJ; Lee, M; Cho, YY; Cho, Y; Cho, E; Yu, SJ; Kim, YJ; Yoon, JH				Nam, Joon Yeul; Lee, Jeong-Hoon; Kim, Hwi Young; Kim, Jieun E.; Lee, Dong Hyeon; Chang, Young; Cho, Hyeki; Yoo, Jeong-Ju; Lee, Minjong; Cho, Young Youn; Cho, Yuri; Cho, Eunju; Yu, Su Jong; Kim, Yoon Jun; Yoon, Jung-Hwan			Oral Medications Enhance Adherence to Surveillance for Hepatocellular Carcinoma and Survival in Chronic Hepatitis B Patients	PLOS ONE			English	Article							CAUSAL MEDIATION ANALYSIS; HEALTH BELIEF MODEL; ALPHA-FETOPROTEIN	Background/Aims Regular surveillance for hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients is essential to detect HCC earlier and to improve prognosis. This study investigated whether prescription of oral medication contributes to adherence to surveillance, early tumor detection, and overall survival (OS). Methods A total of 401 CHB patients who were newly diagnosed with HCC were included: 134 patients received no medication (group 1), 151 received hepatoprotective agents such as ursodeoxycholic acid and silymarin (group 2), and 116 received antiviral agents (group 3) at two years before HCC diagnosis. The primary endpoint was OS, and secondary endpoints were compliance to regular surveillance and HCC status at diagnosis. Results Compared to group 1, both group 2 and 3 had higher rates of good compliance to regular surveillance (defined as participation in >80% of imaging intervals being <= 6 months) (58.2%, 90.1%, and 97.4%, respectively; P<0.001), more HCC diagnosed at a very early stage (20.9%, 32.5%, and 36.2%; P = 0.019) and smaller tumor size (2.8+/-2.4cm, 1.9+/-1.1cm, and 1.8+/-0.9cm; P<0.001). Finally, compared to group 1, both group 2 (hazard ratio, 0.63; 95% confidence interval, 0.41 - 0.97; P = 0.035) and group 3 (hazard ratio, 0.40; 95% confidence interval, 0.22-0.71; P = 0.002) had significantly longer OS. In mediation analysis, prolonged OS is resulted considerably from indirect effect mediated by shorter imaging interval (>100% in group 2 and 14.5% in group 3) rather than direct effect of medication itself. Conclusions Prescription of oral medication improves compliance to surveillance and enables early detection of HCC, which is associated with enhanced survival.	[Nam, Joon Yeul; Lee, Jeong-Hoon; Chang, Young; Cho, Hyeki; Cho, Young Youn; Cho, Eunju; Yu, Su Jong; Kim, Yoon Jun; Yoon, Jung-Hwan] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Nam, Joon Yeul; Lee, Jeong-Hoon; Chang, Young; Cho, Hyeki; Cho, Young Youn; Cho, Eunju; Yu, Su Jong; Kim, Yoon Jun; Yoon, Jung-Hwan] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea; [Kim, Hwi Young] Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea; [Kim, Hwi Young] Ewha Womans Univ, Sch Med, Ctr Liver, Seoul, South Korea; [Kim, Jieun E.] Ewha Womans Univ, Dept Brain & Cognit Sci, Seoul, South Korea; [Lee, Dong Hyeon] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Internal Med, Seoul, South Korea; [Yoo, Jeong-Ju] Soonchunhyang Univ, Bucheon Hosp, Ctr Digest Dis, Asan, South Korea; [Yoo, Jeong-Ju] Soonchunhyang Univ, Bucheon Hosp, Res Inst, Dept Gastroenterol & Hepatol, Asan, South Korea; [Lee, Minjong] Kangwon Natl Univ Hosp, Dept Internal Med, Chunchon, South Korea; [Cho, Yuri] CHA Univ, CHA Gangnam Med Ctr, Dept Internal Med, Pochon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Ewha Womans University; Ewha Womans University; Ewha Womans University; Seoul National University (SNU); Seoul National University Hospital; Soonchunhyang University; Soonchunhyang University; Kangwon National University; Kangwon National University Hospital; Pochon Cha University	Lee, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Lee, JH (corresponding author), Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea.; Kim, HY (corresponding author), Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea.; Kim, HY (corresponding author), Ewha Womans Univ, Sch Med, Ctr Liver, Seoul, South Korea.	pindra@empal.com; hwiyoung@ewha.ac.kr	Lee, Jeong-Hoon/Q-1055-2018	Lee, Jeong-Hoon/0000-0002-0315-2080; Kim, Yoon Jun/0000-0001-9141-7773; Cho, Young Youn/0000-0002-9384-5357; Cho, Hyeki/0000-0003-3694-8111; Yoo, Jeong-Ju/0000-0002-7802-0381; Yoon, Jung-Hwan/0000-0002-9128-3610; Cho, Eun Ju/0000-0002-2677-3189; , minjong/0000-0002-3159-5444; Yu, Su Jong/0000-0001-8888-7977	National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea [1420050]; Seoul National University Hospital Research Fund [03-2016-0380]	National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea; Seoul National University Hospital Research Fund	This study was supported by grants from the National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea (1420050), and from Seoul National University Hospital Research Fund (03-2016-0380).	Andersson KL, 2008, CLIN GASTROENTEROL H, V6, P1418, DOI 10.1016/j.cgh.2008.08.005; BECKER MH, 1978, PUBLIC HEALTH REP, V93, P268; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; CERKONEY KAB, 1980, DIABETES CARE, V3, P594, DOI 10.2337/diacare.3.5.594; Daniele B, 2004, GASTROENTEROLOGY, V127, pS108, DOI 10.1053/j.gastro.2004.09.023; DiMatteo MR, 2007, MED CARE, V45, P521, DOI 10.1097/MLR.0b013e318032937e; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Fjeldsoe BS, 2009, AM J PREV MED, V36, P165, DOI 10.1016/j.amepre.2008.09.040; Glanz K, 2008, HLTH BEHAV HLTH ED T, V4th; Hochbaum G., 1952, HLTH BELIEF MODEL; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jung KS, 2011, HEPATOLOGY, V53, P885, DOI 10.1002/hep.24121; KASL, 2012, CLIN MOL HEPATOL, V18, P109, DOI 10.3350/cmh.2012.18.2.109; Kim DY, 2009, DIGEST DIS SCI, V54, P1758, DOI 10.1007/s10620-008-0541-2; Koteish A, 2002, J VASC INTERV RADIOL, V13, pS185, DOI 10.1016/S1051-0443(07)61785-0; Lok AS, 2015, HEPATOLOGY; Nguyen VTT, 2009, J VIRAL HEPATITIS, V16, P453, DOI 10.1111/j.1365-2893.2009.01117.x; Oldridge NB, 1990, MED SCI SPORTS EXERC; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Park B, 2012, CANCER RES TREAT, V44, P113, DOI 10.4143/crt.2012.44.2.113; PECK CL, 1982, JAMA-J AM MED ASSOC, V248, P2874, DOI 10.1001/jama.248.21.2874; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Pruett KD, 2010, PEDIAT PSYCHOPHARMAC, P422; Ross S, 2004, J HUM HYPERTENS, V18, P607, DOI 10.1038/sj.jhh.1001721; Sangiovanni A, 2004, GASTROENTEROLOGY, V126, P1005, DOI 10.1053/j.gastro.2003.12.049; SCHWARTZ M, 1961, CANCER, V14, P1272, DOI 10.1002/1097-0142(196111/12)14:6<1272::AID-CNCR2820140618>3.0.CO;2-H; Singal A, 2009, ALIMENT PHARM THER, V30, P37, DOI 10.1111/j.1365-2036.2009.04014.x; Trinchet JC, 2011, HEPATOLOGY, V54, P1987, DOI 10.1002/hep.24545; Valeri L, 2015, EPIDEMIOLOGY, V26, pE23, DOI 10.1097/EDE.0000000000000253; van Meer S, 2015, J HEPATOL, V63, P1156, DOI 10.1016/j.jhep.2015.06.012; VanderWeele TJ, 2011, EPIDEMIOLOGY, V22, P582, DOI 10.1097/EDE.0b013e31821db37e; Wong CR, 2009, DIGEST DIS SCI, V54, P2712, DOI 10.1007/s10620-009-1015-x; Wong GLH, 2014, HEPATOLOGY, V59, P986, DOI 10.1002/hep.26739; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0	37	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0166188	10.1371/journal.pone.0166188	http://dx.doi.org/10.1371/journal.pone.0166188			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099520	Green Published, Green Submitted, gold			2022-12-26	WOS:000392380100001
J	Zhou, JQ; Deng, B; Zhang, YJ; Cobb, AB; Zhang, Z				Zhou, Jiqiong; Deng, Bo; Zhang, Yingjun; Cobb, Adam B.; Zhang, Zhao			Molybdate in Rhizobial Seed-Coat Formulations Improves the Production and Nodulation of Alfalfa	PLOS ONE			English	Article							PHASEOLUS-VULGARIS L; PLANT-GROWTH; BRADYRHIZOBIUM-JAPONICUM; INOCULANT PRODUCTION; NITROGENASE ACTIVITY; MOLYBDENUM; FIXATION; SURVIVAL; BACTERIA; SOIL	Rhizobia-legume symbiosis is the most well researched biological nitrogen fixation system. Coating legume seeds with rhizobia is now a recognized practical measure for improving the production of legume corp. However, the efficacy of some commercial rhizobia inoculants cannot be guaranteed in China due to the low rate of live rhizobia in these products. A greenhouse experiment was conducted to assess the effects of different rhizobial inoculant formulations on alfalfa productivity and nitrogen fixation. Two rhizobia strains, (ACCC17631 and ACCC17676), that are effective partners with alfalfa variety Zhongmu No. 1 were assessed with different concentrations of ammonium molybdate in seed-coat formulations with two different coating adhesives. Our study showed that the growth, nodulation, and nitrogen fixation ability of the plants inoculated with the ACCC17631 rhizobial strain were greatest when the ammonium molybdate application was0.2% of the formulation. An ammonium molybdate concentration of 0.1% was most beneficial to the growth of the plants inoculated with the ACCC17676 rhizobial strain. The sodium carboxymethyl cellulose and sodium alginate, used as coating adhesives, did not have a significant effect on alfalfa biomass and nitrogen fixation. However, the addition of skimmed milk to the adhesive improved nitrogenase activity. These results demonstrate that a new rhizobial seed-coat formulation benefitted alfalfa nodulation and yield.	[Zhou, Jiqiong; Deng, Bo; Zhang, Yingjun] China Agr Univ, Coll Anim Sci & Technol, Dept Grassland Sci, Beijing, Peoples R China; [Cobb, Adam B.] Oklahoma State Univ, Stillwater, OK 74078 USA; [Zhang, Zhao] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing, Peoples R China	China Agricultural University; Oklahoma State University System; Oklahoma State University - Stillwater; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS	Deng, B (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Dept Grassland Sci, Beijing, Peoples R China.	dengbo67@cau.edu.cn		Zhang, Yingjun/0000-0001-5776-4392	China Forage and Grass Research System [CARS-35]; "the twelfth five -Year" plan of national science and technology projects in rural areas: research on the supporting technology and adaptive management mode of the pastoral area [2012BAD13B07]	China Forage and Grass Research System; "the twelfth five -Year" plan of national science and technology projects in rural areas: research on the supporting technology and adaptive management mode of the pastoral area	This study was funded by China Forage and Grass Research System (CARS-35) and "the twelfth five -Year" plan of national science and technology projects in rural areas: research on the supporting technology and adaptive management mode of the pastoral area (2012BAD13B07). The website of the program is http://www.forage.org.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albino UB, 2001, PESQUI AGROPECU BRAS, V36, P527, DOI 10.1590/S0100-204X2001000300018; Allen L, 2013, ANSELS PHARM DOSAGE; [Anonymous], 1949, EFFICIENCY ISOLATES; [Anonymous], 2009, STUDY SCREENING HIGH; [Anonymous], 1973, MOLYBDENUM INVESTIGA; BASHAN Y, 1987, J GEN MICROBIOL, V133, P3473; Bashan Y, 1998, BIOTECHNOL ADV, V16, P729, DOI 10.1016/S0734-9750(98)00003-2; Bashan Y, 2002, BIOL FERT SOILS, V35, P359, DOI 10.1007/s00374-002-0481-5; Bashan Y, 2014, PLANT SOIL, V378, P1, DOI 10.1007/s11104-013-1956-x; BERGERSEN FJ, 1976, BIOCHIM BIOPHYS ACTA, V444, P164, DOI 10.1016/0304-4165(76)90233-6; BROCKWELL J, 1980, AUST J AGR RES, V31, P47, DOI 10.1071/AR9800047; BRODRICK SJ, 1991, J EXP BOT, V42, P1339, DOI 10.1093/jxb/42.10.1339; Brodrick SJ, 1995, TROP AGRIC, V72, P277; BRODRICK SJ, 1992, BIOL FERT SOILS, V13, P39, DOI 10.1007/BF00337236; BURTON JC, 1966, AGRON J, V58, P327, DOI 10.2134/agronj1966.00021962005800030024x; Campo RJ, 2009, FIELD CROP RES, V110, P219, DOI 10.1016/j.fcr.2008.09.001; Cassidy MB, 1996, J IND MICROBIOL, V16, P79, DOI 10.1007/BF01570068; Chang S, 2012, PLOSE ONE, V7; Chawla PR, 2009, FOOD TECHNOL BIOTECH, V47, P107; Cody WL, 2008, J MICROBIOL METH, V75, P135, DOI 10.1016/j.mimet.2008.05.006; Deaker R, 2004, SOIL BIOL BIOCHEM, V36, P1275, DOI 10.1016/j.soilbio.2004.04.009; Almeida FFD, 2013, REV BRAS CIENC SOLO, V37, P367, DOI 10.1590/S0100-06832013000200008; DOERGE TA, 1985, AGRON J, V77, P895, DOI 10.2134/agronj1985.00021962007700060015x; Eldin MNA, 1989, INT BIOSYSTEMS; Ewusi-Mensah N, 2015, BRIT J OPHTHALMOL, V80, P63; FAGES J, 1990, APPL MICROBIOL BIOT, V32, P473, DOI 10.1007/BF00903786; Fernandes Jr P, 2014, AFRICAN J BIOTECHNOL, V11, P2945; Fernandes Junior P. I., 2012, African Journal of Biotechnology, V11, P2945; Fernandes PI, 2009, PESQUI AGROPECU BRAS, V44, P1184, DOI 10.1590/S0100-204X2009000900017; FRANCO AA, 1981, SOIL SCI SOC AM J, V45, P1144, DOI 10.2136/sssaj1981.03615995004500060027x; GAULT RR, 1980, AUST J EXP AGR, V20, P63, DOI 10.1071/EA9800063; GENDY A. S. H., 2013, MIDDLE E J AGR RES, V2, P84; Guo YL, 1998, PLANT PHYSIOL BIOCH, V36, P269, DOI 10.1016/S0981-9428(98)80040-5; HARRIS H. B., 1965, AGRON J, V57, P397; Hynes RK, 2001, CAN J MICROBIOL, V47, P595, DOI 10.1139/cjm-47-7-595; Jayanand B, 2003, IN VITRO CELL DEV-PL, V39, P171, DOI 10.1079/IVP2002387; Kai wei XU, 2005, PLANT NUTR FERTILIZ, V11; [康俊梅 Kang Junmei], 2010, [中国草地学报, Chinese Journal of Grassland], V32, P5; LEE KK, 1977, PLANT SOIL, V47, P519, DOI 10.1007/BF00011022; Mendel RR, 2002, J EXP BOT, V53, P1689, DOI 10.1093/jxb/erf038; Minaxi JS, 2011, APPL SOIL ECOL, V48, P301, DOI 10.1016/j.apsoil.2011.04.007; MUGNIER J, 1985, APPL ENVIRON MICROB, V50, P108, DOI 10.1128/AEM.50.1.108-114.1985; OLSEN RA, 1987, MICROB ECOL, V13, P59, DOI 10.1007/BF02014963; Parengam M, 2010, J FOOD COMPOS ANAL, V23, P340, DOI 10.1016/j.jfca.2009.12.012; Quilliam RS, 2013, PLANT SOIL, V366, P83, DOI 10.1007/s11104-012-1411-4; Rahman MM, 2008, EFFECT PHOSPHORUS MO; Revellin C, 2000, APPL MICROBIOL BIOT, V54, P206, DOI 10.1007/s002530000373; Rivera Diego, 2014, Univ. Sci., V19, P265, DOI 10.11144/Javeriana.SC19-3.eplr; Roughley R, 1977, PREPARATION LEGUME S; Sanz T, 2005, FOOD HYDROCOLLOID, V19, P141, DOI 10.1016/j.foodhyd.2004.04.023; Sedberry J, 1973, MOLYBDENUM INVESTIGA; Silva Daoliveira MF, 2009, PESQUISA AGROPECUARI, V65, P71; SOMASEGARAN P, 1985, APPL ENVIRON MICROB, V50, P398, DOI 10.1128/AEM.50.2.398-405.1985; Ssali H, 1985, P SURG, V33, P154; Stephens JHG, 2000, FIELD CROP RES, V65, P249, DOI 10.1016/S0378-4290(99)00090-8; Suvorova AI, 1999, J ENVIRON POLYM DEGR, V7, P35, DOI 10.1023/A:1021842118866; Temprano F. J., 2002, International Microbiology, V5, P81, DOI 10.1007/s10123-002-0067-y; TONG ZK, 1994, APPL ENVIRON MICROB, V60, P581, DOI 10.1128/AEM.60.2.581-586.1994; Trivedi P, 2005, WORLD J MICROB BIOT, V21, P941, DOI 10.1007/s11274-004-6820-y; Tuo Y, 2004, ACTA PRATACULTURAL S, V3; VANCE CP, 1991, ANNU REV PLANT PHYS, V42, P373, DOI 10.1146/annurev.pp.42.060191.002105; Vieira RF, 2011, AGRON J, V103, P1843, DOI 10.2134/agronj2011.0115; Vieira RF, 2005, J PLANT NUTR, V28, P363, DOI 10.1081/PLN-200047631; Vieira RF, 1998, J PLANT NUTR, V21, P2141, DOI 10.1080/01904169809365550; Wigley K, 2012, NZ GRASSLAND ASS, V57, P113; Xu KW, 2013, APPL MICROBIOL BIOT, V97, P783, DOI 10.1007/s00253-012-4246-2; Yabur R, 2007, J APPL PHYCOL, V19, P43, DOI 10.1007/s10811-006-9109-8	67	13	13	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170179	10.1371/journal.pone.0170179	http://dx.doi.org/10.1371/journal.pone.0170179			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099471	Green Submitted, gold, Green Published			2022-12-26	WOS:000392380100061
J	Satten, GA; Tyx, RE; Rivera, AJ; Stanfill, S				Satten, Glen A.; Tyx, Robert E.; Rivera, Angel J.; Stanfill, Stephen			Restoring the Duality between Principal Components of a Distance Matrix and Linear Combinations of Predictors, with Application to Studies of the Microbiome	PLOS ONE			English	Article							COMMUNITIES	Appreciation of the importance of the microbiome is increasing, as sequencing technology has made it possible to ascertain the microbial content of a variety of samples. Studies that sequence the 16S rRNA gene, ubiquitous in and nearly exclusive to bacteria, have proliferated in the medical literature. After sequences are binned into operational taxonomic units (OTUs) or species, data from these studies are summarized in a data matrix with the observed counts from each OTU for each sample. Analysis often reduces these data further to a matrix of pairwise distances or dissimilarities; plotting the first two or three principal components (PCs) of this distance matrix often reveals meaningful groupings in the data. However, once the distance matrix is calculated, it is no longer clear which OTUs or species are important to the observed clustering; further, the PCs are hard to interpret and cannot be calculated for subsequent observations. We show how to construct approximate decompositions of the data matrix that pair PCs with linear combinations of OTU or species frequencies, and show how these decompositions can be used to construct biplots, select important OTUs and partition the variability in the data matrix into contributions corresponding to PCs of an arbitrary distance or dissimilarity matrix. To illustrate our approach, we conduct an analysis of the bacteria found in 45 smokeless tobacco samples.	[Satten, Glen A.] Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA; [Tyx, Robert E.; Rivera, Angel J.; Stanfill, Stephen] Ctr Dis Control & Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Satten, GA (corresponding author), Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.	gsatten@cdc.gov	Rivera, Ángel/GRJ-2093-2022; Rivera, Angel J/ABF-3918-2021	Rivera, Angel J/0000-0002-0715-6273; Tyx, Robert/0000-0002-7514-9286; Satten, Glen/0000-0001-7275-5371				Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Everson R., 1998, ORTHOGONAL NOT ORTHO; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Gower JC, 2004, DIJKSTERHUIS GB PROC; KOSCHAT MA, 1991, PSYCHOMETRIKA, V56, P229, DOI 10.1007/BF02294460; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Tyx RE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146939; Watson G., 1994, ADV COMPUT MATH, V2, P393, DOI [10.1007/BF02521606, DOI 10.1007/BF02521606]	12	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0168131	10.1371/journal.pone.0168131	http://dx.doi.org/10.1371/journal.pone.0168131			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085878	Green Published, gold, Green Submitted			2022-12-26	WOS:000391972600003
J	Zhao, XF; Hao, YQ; Zhang, QG				Zhao, Xin-Feng; Hao, Yi-Qi; Zhang, Quan-Guo			Stability of A Coevolving Host-parasite System Peaks at Intermediate Productivity	PLOS ONE			English	Article							PREDATOR-PREY INTERACTIONS; GENE-FOR-GENE; ANTAGONISTIC COEVOLUTION; RED QUEEN; RAPID EVOLUTION; EXPLOITATION ECOSYSTEMS; POPULATION-DYNAMICS; ENRICHMENT; BACTERIOPHAGE; ADAPTATION	Habitat productivity may affect the stability of consumer-resource systems, through both ecological and evolutionary mechanisms. We hypothesize that coevolving consumer resource systems show more stable dynamics at intermediate resource availability, while very low-level resource supply cannot support sufficiently large populations of resource and consumer species to avoid stochastic extinction, and extremely resource-rich environments may promote escalatory arms-race-like coevolution that can cause strong fluctuations in species abundance and even extinction of one or both trophic levels. We tested these ideas by carrying out an experimental evolution study with a model bacterium-phage system (Pseudomonas fluorescens SBW25 and its phage SBW25 phi 2). Consistent with our hypothesis, this system was most stable at intermediate resource supply (fewer extinction events and smaller magnitude of population fluctuation). In our experiment, the rate of coevolution between bacterial resistance and phage infectivity was correlated with the magnitude of population fluctuation, which may explain the different in stability between levels of resource supply. Crucially, our results are consistent with a suggestion that, among the two major modes of antagonistic coevolution, arms race is more likely than fluctuation selection dynamics to cause extinction events in consumer-resource systems. This study suggests an important role of environment-dependent coevolutionary dynamics for the stability of consumer -resource species systems, therefore highlights the importance to consider contemporaneous evolutionary dynamics when studying the stability of ecosystems, particularly those under environmental changes.	[Zhao, Xin-Feng] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource, Beijing, Peoples R China; Beijing Normal Univ, MOE Key Lab Biodivers Sci & Ecol Engn, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University	Zhao, XF (corresponding author), Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource, Beijing, Peoples R China.	zhaoxfbnu@mail.bnu.edu.cn	Zhang, Quan-Guo/D-5244-2015	Zhang, Quan-Guo/0000-0001-7128-2664; Zhao, Xin-Feng/0000-0002-8110-0008	National Natural Science Foundation of China [31670376, 31421063]; 111 project [B13008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 project(Ministry of Education, China - 111 Project)	This study was funded by the National Natural Science Foundation of China 31670376 and 31421063 (http://www.nsfc.gov.cn/publish/portal1/) and the 111 project B13008 (http://en.safea.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 1997, EVOL ECOL, V11, P1, DOI 10.1023/A:1018445517101; Abrams PA, 1997, EVOLUTION, V51, P1742, DOI 10.1111/j.1558-5646.1997.tb05098.x; Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Agrawal A, 2002, EVOL ECOL RES, V4, P79; [Anonymous], 2014, R LANG ENV STAT COMP; BATSCHELET E, 1976, GENE, V1, P27, DOI 10.1016/0378-1119(76)90004-4; Berger RL, 1996, AM STAT, V50, P314, DOI 10.2307/2684927; Bohannan BJM, 1997, ECOLOGY, V78, P2303; Boots M, 2011, AM NAT, V178, P214, DOI 10.1086/660833; Brockhurst MA, 2003, ECOL LETT, V6, P975, DOI 10.1046/j.1461-0248.2003.00531.x; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; Buckling A, 2012, ADV EXP MED BIOL, V751, P347, DOI 10.1007/978-1-4614-3567-9_16; Chao L, 2002, J VIROL, V76, P3276, DOI 10.1128/JVI.76.7.3276-3281.2002; Cortez MH, 2015, THEOR ECOL-NETH, V8, P369, DOI 10.1007/s12080-015-0256-x; DIECKMANN U, 1995, J THEOR BIOL, V176, P91, DOI 10.1006/jtbi.1995.0179; DRAKE JW, 1993, P NATL ACAD SCI USA, V90, P4171, DOI 10.1073/pnas.90.9.4171; Duffy MA, 2007, ECOL LETT, V10, P44, DOI 10.1111/j.1461-0248.2006.00995.x; Fenton A, 2009, AM NAT, V174, pE230, DOI 10.1086/645087; Gandon S, 2008, J EVOLUTION BIOL, V21, P1861, DOI 10.1111/j.1420-9101.2008.01598.x; HASSELL MP, 1973, J ANIM ECOL, V42, P693, DOI 10.2307/3133; Hesse E, 2016, EVOLUTION, V70, P235, DOI 10.1111/evo.12837; Hiltunen T, 2014, ECOL LETT, V17, P915, DOI 10.1111/ele.12291; Hite JL, 2016, ECOLOGY, V97, P439, DOI 10.1890/15-1065.1; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Lauring AS, 2013, NAT REV MICROBIOL, V11, P327, DOI 10.1038/nrmicro3003; Lazaro E, 2003, P NATL ACAD SCI USA, V100, P10830, DOI 10.1073/pnas.1332668100; Lopez-Pascua LDC, 2008, J EVOLUTION BIOL, V21, P853, DOI 10.1111/j.1420-9101.2008.01501.x; MAY RM, 1972, SCIENCE, V177, P900, DOI 10.1126/science.177.4052.900; MAY RM, 1978, J ANIM ECOL, V47, P249, DOI 10.2307/3934; Morgan AD, 2005, NATURE, V437, P253, DOI 10.1038/nature03913; Morgan AD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-1; Mougi A, 2010, P ROY SOC B-BIOL SCI, V277, P3163, DOI 10.1098/rspb.2010.0691; Pal C, 2007, NATURE, V450, P1079, DOI 10.1038/nature06350; Pascua LL, 2014, ECOL LETT, V17, P1380, DOI 10.1111/ele.12337; PIMENTEL D, 1978, AM NAT, V112, P119, DOI 10.1086/283256; Post DM, 2002, TRENDS ECOL EVOL, V17, P269, DOI 10.1016/S0169-5347(02)02455-2; Rainey PB, 1996, MOL MICROBIOL, V19, P521, DOI 10.1046/j.1365-2958.1996.391926.x; ROSENZWE.ML, 1971, SCIENCE, V171, P385, DOI 10.1126/science.171.3969.385; ROSENZWEIG ML, 1978, THEOR POPUL BIOL, V14, P158, DOI 10.1016/0040-5809(78)90009-6; Sasaki A, 1999, P ROY SOC B-BIOL SCI, V266, P455, DOI 10.1098/rspb.1999.0659; SCHAFFER WM, 1978, THEOR POPUL BIOL, V14, P135, DOI 10.1016/0040-5809(78)90008-4; STENSETH NC, 1984, EVOLUTION, V38, P870, DOI 10.1111/j.1558-5646.1984.tb00358.x; THOMPSON JN, 1992, NATURE, V360, P121, DOI 10.1038/360121a0; Turner PE, 2012, MICROBES AND EVOLUTION: THE WORLD THAT DARWIN NEVER SAW, P71, DOI 10.1128/9781555818470.ch10; Wright RCT, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0808-8; Yamamichi M, 2015, OIKOS, V124, P960, DOI 10.1111/oik.02388; Yamauchi A, 2005, ECOLOGY, V86, P2513, DOI 10.1890/04-1524; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767; Yoshida T, 2007, PLOS BIOL, V5, P1868, DOI 10.1371/journal.pbio.0050235; Zhang QG, 2016, ECOLOGY, V97, P1319, DOI 10.1890/15-1408.1; Zhang QG, 2011, ECOL LETT, V14, P282, DOI 10.1111/j.1461-0248.2010.01586.x	51	0	0	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0168560	10.1371/journal.pone.0168560	http://dx.doi.org/10.1371/journal.pone.0168560			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076419	Green Submitted, Green Published, gold			2022-12-26	WOS:000391857100014
J	Gao, SB; Geng, CL; Song, TY; Lin, XR; Liu, JY; Cai, Z; Cang, Y				Gao, Shaobing; Geng, Chenlu; Song, Tianyu; Lin, Xuanru; Liu, Jiye; Cai, Zhen; Cang, Yong			Activation of c-Abl Kinase Potentiates the Anti-myeloma Drug Lenalidomide by Promoting DDA1 Protein Recruitment to the CRL4 Ubiquitin Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; cancer therapy; molecular cell biology; ubiquitin ligase; ubiquitylation (ubiquitination); CRL4; DDA1; c-Abl; lenalidomide	TYROSINE KINASE; V-PROTEIN; DEGRADATION; BINDING; DESTRUCTION; CRL4(CDT2); COMPLEX; TARGETS; UBIQUITYLATION	Cullin-RING ligase 4 (CRL4), a complex of Cul4 and DDB1, regulates the cell cycle, DNA damage repair, and chromatin replication by targeting a variety of substrates for ubiquitination. CRL4 is also hijacked by viral proteins or thalidomide-derived compounds to degrade host restriction factors. Here we report that the c-Abl non-receptor kinase phosphorylates DDB1 at residue Tyr-316 to recruit a small regulatory protein, DDA1, leading to increased substrate ubiquitination. Pharmacological inhibition or genetic ablation of the Abl-DDB1-DDA1 axis decreases the ubiquitination of CRL4 substrates, including IKZF1 and IKZF3, in lenalidomide-treated multiple myeloma cells. Importantly, panobinostat, a recently approved anti-myeloma drug, and dexamethasone enhance lenalidomide-induced substrate degradation and cytotoxicity by activating c-Abl, therefore providing a mechanism underlying their combination with lenalidomide to treat multiple myeloma.	[Gao, Shaobing; Geng, Chenlu; Song, Tianyu; Liu, Jiye; Cang, Yong] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Gao, Shaobing; Geng, Chenlu; Song, Tianyu; Liu, Jiye; Cang, Yong] Zhejiang Univ, Innovat Ctr Cell Signaling Networks, Hangzhou 310058, Zhejiang, Peoples R China; [Lin, Xuanru; Cai, Zhen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Cang, Y (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.; Cang, Y (corresponding author), Zhejiang Univ, Innovat Ctr Cell Signaling Networks, Hangzhou 310058, Zhejiang, Peoples R China.	cangyong@zju.edu.cn	Song, Tianyu/AAN-3792-2020; Liu, Jiye/N-2843-2018; 高, 绍冰/GQA-8216-2022	Song, Tianyu/0000-0001-9834-6795; Liu, Jiye/0000-0001-7970-7508; 高, 绍冰/0000-0002-8307-9281; Cang, Yong/0000-0002-1148-7008	National 973 Plan for Basic Research [2015CB553803]; National Natural Science Foundation [91429302]; Fundamental Research Funds for the Central Universities; Key Construction Program of the National 985 Project	National 973 Plan for Basic Research; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Key Construction Program of the National 985 Project	This work was supported in part by National 973 Plan for Basic Research Grant 2015CB553803, National Natural Science Foundation Grant 91429302, and Fundamental Research Funds for the Central Universities and Key Construction Program of the National 985 Project. The authors declare that they have no conflicts of interest with the contents of this article.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Avigan D, 2014, NEW ENGL J MED, V371, P961, DOI 10.1056/NEJMe1407442; Chamberlain PP, 2014, NAT STRUCT MOL BIOL, V21, P803, DOI 10.1038/nsmb.2874; Chen XA, 2001, J BIOL CHEM, V276, P48175, DOI 10.1074/jbc.M106808200; Chen XA, 2006, MOL CELL, V22, P489, DOI 10.1016/j.molcel.2006.04.021; Cong F, 2002, J BIOL CHEM, V277, P34870, DOI 10.1074/jbc.M204416200; Decorsiere A, 2016, NATURE, V531, P386, DOI 10.1038/nature17170; Didcock L, 1999, J VIROL, V73, P9928, DOI 10.1128/JVI.73.12.9928-9933.1999; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Han JH, 2013, CELL, V155, P817, DOI 10.1016/j.cell.2013.10.014; Havens CG, 2011, GENE DEV, V25, P1568, DOI 10.1101/gad.2068611; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kaidi A, 2013, NATURE, V498, DOI 10.1038/nature12201; Kapetanaki MG, 2006, P NATL ACAD SCI USA, V103, P2588, DOI 10.1073/pnas.0511160103; KHARBANDA S, 1995, NATURE, V376, P785, DOI 10.1038/376785a0; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Laubach JP, 2015, CLIN CANCER RES, V21, P4767, DOI 10.1158/1078-0432.CCR-15-0530; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; Liu JY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4924; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Meijer E, 2009, NAT REV CLIN ONCOL, V6, P247, DOI 10.1038/nrclinonc.2009.50; Nakagawa T, 2015, MOL CELL, V57, P247, DOI 10.1016/j.molcel.2014.12.002; Olma MH, 2009, J CELL SCI, V122, P1035, DOI 10.1242/jcs.043539; Parisien JP, 2001, VIROLOGY, V283, P230, DOI 10.1006/viro.2001.0856; Petzold G, 2016, NATURE, V532, P127, DOI 10.1038/nature16979; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Ulane CM, 2002, VIROLOGY, V304, P160, DOI 10.1006/viro.2002.1773; Van Nguyen T, 2016, MOL CELL, V61, P809, DOI 10.1016/j.molcel.2016.02.032; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433	40	6	6	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3683	3691		10.1074/jbc.M116.761551	http://dx.doi.org/10.1074/jbc.M116.761551			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28087699	Green Published, hybrid			2022-12-26	WOS:000395542500012
J	Lo, M; Kim, HS; Tong, RK; Bainbridge, TW; Vernes, JM; Zhang, Y; Lin, YL; Chung, S; Dennis, MS; Zuchero, YJY; Watts, RJ; Couch, JA; Meng, YG; Atwal, JK; Brezski, RJ; Spiess, C; Ernst, JA				Lo, Megan; Kim, Hok Seon; Tong, Raymond K.; Bainbridge, Travis W.; Vernes, Jean-Michel; Zhang, Yin; Lin, Yuwen Linda; Chung, Shan; Dennis, Mark S.; Zuchero, Y. Joy Yu; Watts, Ryan J.; Couch, Jessica A.; Meng, Y. Gloria; Atwal, Jasvinder K.; Brezski, Randall J.; Spiess, Christoph; Ernst, James A.			Effector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody engineering; complement; Fc receptor; Fc- receptor; protein stability; recombinant protein expression; aglycosylation; antibody-dependent; cell-mediated cytotoxicity (ADCC); bispecific antibody; complement-dependent cytotoxicity (CDC)	FC-GAMMA RECEPTORS; HUMAN IGG1; BINDING-SITE; MOUSE; COMPLEMENT; IMMUNOGLOBULIN; VARIANTS; OLIGOSACCHARIDE; IDENTIFICATION; AFFINITY	The antibody Fc region regulates antibody cytotoxic activities and serum half-life. In a therapeutic context, however, the cytotoxic effector function of an antibody is often not desirable and can create safety liabilities by activating native host immune defenses against cells expressing the receptor antigens. Several amino acid changes in the Fc region have been reported to silence or reduce the effector function of antibodies. These earlier studies focused primarily on the interaction of human antibodies with human Fc- receptors, and it remains largely unknown how such changes to Fc might translate to the context of a murine antibody. We demonstrate that the commonly used N297G (NG) and D265A, N297G (DANG) variants that are efficacious in attenuating effector function in primates retain potent complement activation capacity in mice, leading to safety liabilities in murine studies. In contrast, we found an L234A, L235A, P329G (LALA-PG) variant that eliminates complement binding and fixation as well as Fc--dependent, antibody-dependent, cell-mediated cytotoxity in both murine IgG2a and human IgG1. These LALA-PG substitutions allow a more accurate translation of results generated with an effectorless antibody between mice and primates. Further, we show that both human and murine antibodies containing the LALA-PG variant have typical pharmacokinetics in rodents and retain thermostability, enabling efficient knobs-into-holes bispecific antibody production and a robust path to generating highly effector-attenuated bispecific antibodies for preclinical studies.	[Lo, Megan; Tong, Raymond K.; Bainbridge, Travis W.; Ernst, James A.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Kim, Hok Seon; Zhang, Yin; Dennis, Mark S.; Brezski, Randall J.; Spiess, Christoph] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Vernes, Jean-Michel; Meng, Y. Gloria] Genentech Inc, Dept Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA; [Lin, Yuwen Linda; Chung, Shan] Genentech Inc, Dept BioAnalyt Sci, San Francisco, CA 94080 USA; [Zuchero, Y. Joy Yu; Watts, Ryan J.; Couch, Jessica A.; Atwal, Jasvinder K.; Ernst, James A.] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; [Couch, Jessica A.] Genentech Inc, Dept Safety Assessment, San Francisco, CA 94080 USA; [Lo, Megan] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Lo, Megan] Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA 94143 USA; [Lo, Megan] Univ Calif San Francisco, Program Craniofacial Biol, San Francisco, CA 94143 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Spiess, C; Ernst, JA (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	spiess.christoph@gene.com; ernst.james@gene.com	Chung, Shan/AAK-5790-2021	Lo, Megan/0000-0002-6387-8182; Spiess, Christoph/0000-0002-0570-9700	Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	This work was funded by Genentech, Inc. All authors are present or former paid employees of Genentech Inc.	Arduin E, 2015, MOL IMMUNOL, V63, P456, DOI 10.1016/j.molimm.2014.09.017; Atwell S, 1997, J MOL BIOL, V270, P26, DOI 10.1006/jmbi.1997.1116; Bakema JE, 2014, CURR TOP MICROBIOL, V382, P373, DOI 10.1007/978-3-319-07911-0_17; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; CHAPPEL MS, 1991, P NATL ACAD SCI USA, V88, P9036, DOI 10.1073/pnas.88.20.9036; Couch JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005338; DANGL JL, 1988, EMBO J, V7, P1989, DOI 10.1002/j.1460-2075.1988.tb03037.x; EATON DL, 1986, BIOCHEMISTRY-US, V25, P8343, DOI 10.1021/bi00374a001; EPSTEIN SL, 1977, J IMMUNOL, V118, P935; Ernst LK, 2002, J MOL MED, V80, P248, DOI 10.1007/s00109-001-0294-2; Gelderman KA, 2004, TRENDS IMMUNOL, V25, P158, DOI 10.1016/j.it.2004.01.008; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001; Hristodorov D, 2013, MOL BIOTECHNOL, V54, P1056, DOI 10.1007/s12033-012-9612-x; Idusogie EE, 2000, J IMMUNOL, V164, P4178, DOI 10.4049/jimmunol.164.8.4178; Lazar G. A., 2009, THERAPEUTIC MONOCLON, P350; Leabman MK, 2013, MABS-AUSTIN, V5, P896, DOI 10.4161/mabs.26436; Lu YM, 2011, J IMMUNOL METHODS, V365, P132, DOI 10.1016/j.jim.2010.12.014; Lund J, 1996, J IMMUNOL, V157, P4963; MCKAY EJ, 1981, IMMUNOL LETT, V3, P303, DOI 10.1016/0165-2478(81)90010-9; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Mimura Y, 2001, J BIOL CHEM, V276, P45539, DOI 10.1074/jbc.M107478200; Nesspor TC, 2012, J MOL RECOGNIT, V25, P147, DOI 10.1002/jmr.2155; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Reichert JM, 2012, MABS-AUSTIN, V4, P413, DOI 10.4161/mabs.19931; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Sazinsky SL, 2008, P NATL ACAD SCI USA, V105, P20167, DOI 10.1073/pnas.0809257105; Schlothauer T, 2016, PROTEIN ENG DES SEL, V29, P457, DOI 10.1093/protein/gzw040; Shatz W, 2013, MABS-AUSTIN, V5, P872, DOI 10.4161/mabs.26307; Sheridan C, 2015, NAT BIOTECHNOL, V33, P219, DOI 10.1038/nbt0315-219; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Spiess C, 2015, MOL IMMUNOL, V67, P95, DOI 10.1016/j.molimm.2015.01.003; Spiess C, 2013, NAT BIOTECHNOL, V31, P753, DOI 10.1038/nbt.2621; TAO MH, 1989, J IMMUNOL, V143, P2595; Vermeer AWP, 2000, BIOPHYS J, V78, P394, DOI 10.1016/S0006-3495(00)76602-1; Walsh G, 2014, NAT BIOTECHNOL, V32, P992, DOI 10.1038/nbt.3040; Weiner GJ, 2015, NAT REV CANCER, V15, P361, DOI 10.1038/nrc3930; Welfle K, 1999, BBA-PROTEIN STRUCT M, V1431, P120, DOI 10.1016/S0167-4838(99)00046-1; Wong AW, 2010, BIOTECHNOL BIOENG, V106, P751, DOI 10.1002/bit.22749; Yu YJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009835; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230	44	115	133	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3900	3908		10.1074/jbc.M116.767749	http://dx.doi.org/10.1074/jbc.M116.767749			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28077575	Green Published, hybrid			2022-12-26	WOS:000395542500030
J	Bruender, NA; Bandarian, V				Bruender, Nathan A.; Bandarian, Vahe			The Creatininase Homolog MftE from Mycobacterium smegmatis Catalyzes a Peptide Cleavage Reaction in the Biosynthesis of a Novel Ribosomally Synthesized Post-translationally Modified Peptide (RiPP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOETHER BOND FORMATION; RADICAL SAM; PSEUDOMONAS-PUTIDA; CROSS-LINK; PYRROLOQUINOLINE QUINONE; NATURAL-PRODUCTS; PROTEIN; MATURATION; INTERMEDIATE; PURIFICATION	Most ribosomally synthesized and post-translationally modified peptide (RiPP) natural products are processed by tailoring enzymes to create complex natural products that are still recognizably peptide-based. However, some tailoring enzymes dismantle the peptide en route to synthesis of small molecules. A small molecule natural product of as yet unknown structure, mycofactocin, is thought to be synthesized in this way via the mft gene cluster found in many strains of mycobacteria. This cluster harbors at least six genes, which appear to be conserved across species. We have previously shown that one enzyme from this cluster, MftC, catalyzes the oxidative decarboxylation of the C-terminal Tyr of the substrate peptide MftA in a reaction that requires the MftB protein. Herein we show that mftE encodes a creatininase homolog that catalyzes cleavage of the oxidatively decarboxylated MftA peptide to liberate its final two residues, including the C-terminal decarboxylated Tyr (VY*). Unlike MftC, which requires MftB for function, MftE catalyzes the cleavage reaction in the absence of MftB. The identification of this novel metabolite, VY*, supports the notion that the mft cluster is involved in generating a small molecule from the MftA peptide. The ability to produce VY* from MftA by in vitro reconstitution of the activities of MftB, MftC, and MftE sets the stage for identification of the novel metabolite that results from the proteins encoded by the mft cluster.	[Bandarian, Vahe] Univ Utah, Dept Chem, 315 S 1400 E, Salt Lake City, UT 84112 USA; [Bruender, Nathan A.] St Cloud State Univ, Dept Chem & Biochem, St Cloud, MN 56301 USA	Utah System of Higher Education; University of Utah; Minnesota State Colleges & Universities; Saint Cloud State University	Bandarian, V (corresponding author), Univ Utah, Dept Chem, 315 S 1400 E, Salt Lake City, UT 84112 USA.	vahe@chem.utah.edu			NIGMS, National Institutes of Health [R01 GM120638, GM72623]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120638, R01GM072623] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grants R01 GM120638 and GM72623 (to V.B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADACHI H, 1989, J BIOCHEM-TOKYO, V105, P957, DOI 10.1093/oxfordjournals.jbchem.a122787; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Barr I, 2016, J BIOL CHEM, V291, P8877, DOI 10.1074/jbc.C115.699918; Beuth B, 2003, J MOL BIOL, V332, P287, DOI 10.1016/S0022-2836(03)00860-X; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; Bruender NA, 2016, BIOCHEMISTRY-US, V55, P4131, DOI 10.1021/acs.biochem.6b00598; Bruender NA, 2016, BIOCHEMISTRY-US, V55, P2813, DOI 10.1021/acs.biochem.6b00355; Bruender NA, 2016, BIOCHEMISTRY-US, V55, P2122, DOI 10.1021/acs.biochem.6b00145; Cummings JA, 2010, BIOCHEMISTRY-US, V49, P611, DOI 10.1021/bi901935y; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Fluhe E, 2012, NAT CHEM BIOL, V8, P350, DOI [10.1038/NCHEMBIO.798, 10.1038/nchembio.798]; Fluhe L, 2013, J AM CHEM SOC, V135, P959, DOI 10.1021/ja310542g; Freeman MF, 2012, SCIENCE, V338, P387, DOI 10.1126/science.1226121; GOOSEN N, 1989, J BACTERIOL, V171, P447, DOI 10.1128/jb.171.1.447-455.1989; Haft DH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-21; Khaliullin B, 2016, FEBS LETT, V590, P2538, DOI 10.1002/1873-3468.12249; McCarty RM, 2013, BIOCHEMISTRY-US, V52, P188, DOI 10.1021/bi301156w; Morinaka BI, 2014, ANGEW CHEM INT EDIT, V53, P8503, DOI 10.1002/anie.201400478; Nakai T, 2015, J BIOL CHEM, V290, P11144, DOI 10.1074/jbc.M115.638320; Ono K, 2006, J BIOL CHEM, V281, P13672, DOI 10.1074/jbc.M600029200; Schramma KR, 2015, NAT CHEM, V7, P431, DOI [10.1038/NCHEM.2237, 10.1038/nchem.2237]; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Thoden JB, 2005, J BIOL CHEM, V280, P32784, DOI 10.1074/jbc.M505730200; Toyama H, 1997, MICROBIOL-SGM, V143, P595, DOI 10.1099/00221287-143-2-595; TSURU D, 1976, AGR BIOL CHEM TOKYO, V40, P1011, DOI 10.1080/00021369.1976.10862151; VELTEROP JS, 1995, J BACTERIOL, V177, P5088, DOI 10.1128/jb.177.17.5088-5098.1995; Wieckowski BM, 2015, FEBS LETT, V589, P1802, DOI 10.1016/j.febslet.2015.05.032; Yoshimoto T, 2004, J MOL BIOL, V337, P399, DOI 10.1016/j.jmb.2004.01.022; YOSHIMOTO T, 1976, ARCH BIOCHEM BIOPHYS, V177, P508, DOI 10.1016/0003-9861(76)90462-8	31	9	11	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4371	4381		10.1074/jbc.M116.762062	http://dx.doi.org/10.1074/jbc.M116.762062			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28077628	Green Published, hybrid			2022-12-26	WOS:000395837100036
J	Li, Y; Mayer, FP; Hasenhuetl, PS; Burtscher, V; Schicker, K; Sitte, HH; Freissmuth, M; Sandtner, W				Li, Yang; Mayer, Felix P.; Hasenhuetl, Peter S.; Burtscher, Verena; Schicker, Klaus; Sitte, Harald H.; Freissmuth, Michael; Sandtner, Walter			Occupancy of the Zinc-binding Site by Transition Metals Decreases the Substrate Affinity of the Human Dopamine Transporter by an Allosteric Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILSONS-DISEASE; MANGANESE; PARKINSONISM; ZN2+; MONOTHERAPY; MUTATIONS; PROTEINS; SPECTRUM; CYCLE	The human dopamine transporter (DAT) has a tetrahedral Zn2+-binding site. Zn2+-binding sites are also recognized by other first-row transition metals. Excessive accumulation of manganese or of copper can lead to parkinsonism because of dopamine deficiency. Accordingly, we examined the effect of Mn2+, Co2+, Ni2+, and Cu2+ on transport-associated currents through DAT and DAT-H193K, a mutant with a disrupted Zn2+-binding site. All transition metals except Mn2+ modulated the transport cycle of wild-type DAT with affinities in the low micromolar range. In this concentration range, they were devoid of any action on DAT-H193K. The active transition metals reduced the affinity of DAT for dopamine. The affinity shift was most pronounced for Cu2+, followed by Ni2+ and Zn2+ (= Co2+). The extent of the affinity shift and the reciprocal effect of substrate on metal affinity accounted for the different modes of action: Ni2+ and Cu2+ uniformly stimulated and inhibited, respectively, the substrate-induced steady-state currents through DAT. In contrast, Zn2+ elicited biphasic effects on transport, i.e. stimulation at 1 mu M and inhibition at 10 mu M. A kinetic model that posited preferential binding of transition metal ions to the outward-facing apo state of DAT and a reciprocal interaction of dopamine and transition metals recapitulated all experimental findings. Allosteric activation of DAT via the Zn2+-binding site may be of interest to restore transport in loss-of-function mutants.	[Li, Yang; Mayer, Felix P.; Hasenhuetl, Peter S.; Burtscher, Verena; Schicker, Klaus; Sitte, Harald H.; Freissmuth, Michael; Sandtner, Walter] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Waehringerstrasse 13a, A-1090 Vienna, Austria	Medical University of Vienna	Sandtner, W (corresponding author), Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Waehringerstrasse 13a, A-1090 Vienna, Austria.	walter.sandtner@meduniwien.ac.at	Sitte, Harald/N-2681-2013; Hasenhuetl, Peter/AAG-6335-2019	Sitte, Harald/0000-0002-1339-7444; Hasenhuetl, Peter/0000-0002-3121-9502; Mayer, Felix/0000-0001-9837-8973; Burtscher, Verena/0000-0002-0464-0799; Schicker, Klaus/0000-0002-3068-7830; Freissmuth, Michael/0000-0001-9398-1765	Austrian Science Fund/FWF Project [P28090]; Project Program Grant [SFB35, F3506, F3510, W1232]; Chinese Scholarship Council Grant [201308310446]	Austrian Science Fund/FWF Project(Austrian Science Fund (FWF)); Project Program Grant; Chinese Scholarship Council Grant	This work was supported by the Austrian Science Fund/FWF Project P28090 (to W.S.), Project Program Grant SFB35 (Grants F3506 to H.H.S. and F3510 to M.F.), Project W1232 (to H.H.S.), and Chinese Scholarship Council Grant 201308310446 (to Y.L.). The authors declare that they have no conflicts of interest with the contents of this article.	Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Auld DS, 2009, BIOMETALS, V22, P141, DOI 10.1007/s10534-008-9184-1; Bandmann O, 2015, LANCET NEUROL, V14, P103, DOI 10.1016/S1474-4422(14)70190-5; Bjorklund NL, 2007, EUR J PHARMACOL, V565, P17, DOI 10.1016/j.ejphar.2007.02.027; Couper J., 1837, BR ANN MED PHARM, V1, P41, DOI DOI 10.1002/JCP.22692; Foster AW, 2014, J BIOL CHEM, V289, P28095, DOI 10.1074/jbc.R114.588145; Guilarte TR, 2008, J NEUROCHEM, V107, P1236, DOI 10.1111/j.1471-4159.2008.05695.x; Hamilton PJ, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0002-7; Hasenhuetl PS, 2015, MOL PHARMACOL, V88, P12, DOI 10.1124/mol.115.099036; HECKMANN JM, 1994, J NEUROL NEUROSUR PS, V57, P1273, DOI 10.1136/jnnp.57.10.1273; Hermann W, 2002, J NEUROL, V249, P1082, DOI 10.1007/s00415-002-0795-0; IRVING H, 1948, NATURE, V162, P746, DOI 10.1038/162746a0; Ishida S, 2012, INTERNAL MED, V51, P1759, DOI 10.2169/internalmedicine.51.7341; Jeon B, 1998, J NEUROL NEUROSUR PS, V65, P60, DOI 10.1136/jnnp.65.1.60; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Laeuger P., 1991, ELECTROGENIC ION PUM; Leyva-Illades D, 2014, J NEUROSCI, V34, P14079, DOI 10.1523/JNEUROSCI.2329-14.2014; Li Y, 2015, J BIOL CHEM, V290, P31069, DOI 10.1074/jbc.M115.688275; Linn FHH, 2009, HEPATOLOGY, V50, P1442, DOI 10.1002/hep.23182; Loland CJ, 1999, J BIOL CHEM, V274, P36928, DOI 10.1074/jbc.274.52.36928; Maret W, 2012, J INORG BIOCHEM, V111, P110, DOI 10.1016/j.jinorgbio.2011.11.018; Meinild AK, 2004, J BIOL CHEM, V279, P49671, DOI 10.1074/jbc.M407660200; MURPHY GF, 1961, SCIENCE, V133, P1706, DOI 10.1126/science.133.3465.1706-a; Ng J, 2014, BRAIN, V137, P1107, DOI 10.1093/brain/awu022; Norregaard L, 1998, EMBO J, V17, P4266, DOI 10.1093/emboj/17.15.4266; Pifl C, 2009, NEUROPHARMACOLOGY, V56, P531, DOI 10.1016/j.neuropharm.2008.10.009; Rodier J, 1955, BRIT J IND MED, V12, P21; Sandtner W, 2014, BRIT J PHARMACOL, V171, P1007, DOI 10.1111/bph.12520; Schicker K, 2012, J BIOL CHEM, V287, P438, DOI 10.1074/jbc.M111.304261; Schilsky M, 2009, HEPATOLOGY, V50, P1341, DOI 10.1002/hep.23355; Schmid D, 2015, BRIT J PHARMACOL, V172, P4775, DOI 10.1111/bph.12766; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; Scholze P, 2002, J BIOL CHEM, V277, P21505, DOI 10.1074/jbc.M112265200; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Sitte HH, 2015, TRENDS PHARMACOL SCI, V36, P41, DOI 10.1016/j.tips.2014.11.006; Srinivas K, 2008, J NEUROL SCI, V266, P104, DOI 10.1016/j.jns.2007.09.009; Stockner T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002909; Tuschl K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11601; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Wang P, 2007, CLIN NUCL MED, V32, P844, DOI 10.1097/RLU.0b013e318156baf8	40	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4235	4243		10.1074/jbc.M116.760140	http://dx.doi.org/10.1074/jbc.M116.760140			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28096460	hybrid, Green Published			2022-12-26	WOS:000395837100021
J	Eidel, O; Burth, S; Neumann, JO; Kieslich, PJ; Sahm, F; Jungk, C; Kickingereder, P; Bickelhaupt, S; Mundiyanapurath, S; Baumer, P; Wick, W; Schlemmer, HP; Kiening, K; Unterberg, A; Bendszus, M; Radbruch, A				Eidel, Oliver; Burth, Sina; Neumann, Jan-Oliver; Kieslich, Pascal J.; Sahm, Felix; Jungk, Christine; Kickingereder, Philipp; Bickelhaupt, Sebastian; Mundiyanapurath, Sibu; Baeumer, Philipp; Wick, Wolfgang; Schlemmer, Heinz-Peter; Kiening, Karl; Unterberg, Andreas; Bendszus, Martin; Radbruch, Alexander			Tumor Infiltration in Enhancing and Non-Enhancing Parts of Glioblastoma: A Correlation with Histopathology	PLOS ONE			English	Article							RESPONSE ASSESSMENT; MALIGNANT GLIOMAS; CLINICAL-TRIALS; RESECTION; EXTENT; BRAIN; MULTIFORME; BIOPSIES; CRITERIA; SURGERY	Purpose To correlate histopathologic findings from biopsy specimens with their corresponding location within enhancing areas, non-enhancing areas and necrotic areas on contrast enhanced T1-weighted MRI scans (cT1). Materials and Methods In 37 patients with newly diagnosed glioblastoma who underwent stereotactic biopsy, we obtained a correlation of 561 1mm(3) biopsy specimens with their corresponding position on the intraoperative cT1 image at 1.5 Tesla. Biopsy points were categorized as enhancing (CE), non-enhancing (NE) or necrotic (NEC) on cT1 and tissue samples were categorized as "viable tumor cells", "blood" or "necrotic tissue (with or without cellular component)". Cell counting was done semi-automatically. Results NE had the highest content of tissue categorized as viable tumor cells (89% vs. 60% in CE and 30% NEC, respectively). Besides, the average cell density for NE (3764 +/- 2893 cells/mm(2)) was comparable to CE (3506 +/- 3116 cells/mm(2)), while NEC had a lower cell density with 2713 +/- 3239 cells/mm(2). If necrotic parts and bleeds were excluded, cell density in biopsies categorized as "viable tumor tissue" decreased from the center of the tumor (NEC, 5804 3480 cells/mm(2)) to CE (4495 +/- 3209 cells/mm(2)) and NE (4130 +/- 2817 cells/mm(2)). Discussion The appearance of a glioblastoma on a cT1 image (circular enhancement, central necrosis, peritumoral edema) does not correspond to its diffuse histopathological composition. Cell density is elevated in both CE and NE parts. Hence, our study suggests that NE contains considerable amounts of infiltrative tumor with a high cellularity which might be considered in resection planning.	[Eidel, Oliver; Burth, Sina; Kickingereder, Philipp; Bendszus, Martin; Radbruch, Alexander] Heidelberg Univ, Med Ctr, Dept Neuroradiol, Heidelberg, Germany; [Eidel, Oliver; Burth, Sina; Bickelhaupt, Sebastian; Baeumer, Philipp; Schlemmer, Heinz-Peter; Radbruch, Alexander] German Canc Res Ctr, Dept Radiol, Heidelberg, Germany; [Eidel, Oliver; Burth, Sina; Radbruch, Alexander] German Canc Consortium DKTK, Radiol, Heidelberg, Germany; [Neumann, Jan-Oliver; Jungk, Christine; Kiening, Karl; Unterberg, Andreas] Heidelberg Univ, Med Ctr, Dept Neurosurg, Div Stereotact Neurosurg, Heidelberg, Germany; [Kieslich, Pascal J.] Univ Mannheim, Sch Social Sci, Dept Psychol, Mannheim, Germany; [Sahm, Felix] Heidelberg Univ, Med Ctr, Dept Neuropathol, Heidelberg, Germany; [Mundiyanapurath, Sibu; Wick, Wolfgang] Heidelberg Univ, Med Ctr, Dept Neurol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Mannheim; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Radbruch, A (corresponding author), Heidelberg Univ, Med Ctr, Dept Neuroradiol, Heidelberg, Germany.; Radbruch, A (corresponding author), German Canc Res Ctr, Dept Radiol, Heidelberg, Germany.; Radbruch, A (corresponding author), German Canc Consortium DKTK, Radiol, Heidelberg, Germany.	a.radbruch@dkfz.de	Vollmuth, Philipp/AAK-3267-2021; Wick, Wolfgang/AAA-2545-2020; Radbruch, Alexander/ABA-6277-2021; Sahm, Felix/GQY-8202-2022	Wick, Wolfgang/0000-0002-6171-634X; Sahm, Felix/0000-0001-5441-1962; Vollmuth (ne Kickingereder), Philipp/0000-0002-6224-0064; Kieslich, Pascal J./0000-0002-0853-9364; Radbruch, Alexander/0000-0001-6238-6525	Mildred-Scheel-Doktorandenprogramm of the German Cancer Aid [111583]	Mildred-Scheel-Doktorandenprogramm of the German Cancer Aid	S. Burth is supported by the Mildred-Scheel-Doktorandenprogramm of the German Cancer Aid (grant: 111583). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barajas RF, 2012, NEURO-ONCOLOGY, V14, P942, DOI 10.1093/neuonc/nos128; Barajas RF, 2010, RADIOLOGY, V254, P564, DOI 10.1148/radiol.09090663; Chen LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079008; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Deroulers C, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-92; Eidel O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160250; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Gill BJ, 2014, P NATL ACAD SCI USA, V111, P12550, DOI 10.1073/pnas.1405839111; Hardesty Douglas A, 2012, Front Neurol, V3, P140, DOI 10.3389/fneur.2012.00140; Hess KR, 1999, J NEURO-ONCOL, V42, P227, DOI 10.1023/A:1006118018770; Jain R, 2011, AM J NEURORADIOL, V32, P388, DOI 10.3174/ajnr.A2280; KELLY PJ, 1987, J NEUROSURG, V66, P865, DOI 10.3171/jns.1987.66.6.0865; Kubben Pieter L, 2012, Surg Neurol Int, V3, P158, DOI 10.4103/2152-7806.105097; Radbruch A, 2012, NEURO-ONCOLOGY, V14, P222, DOI 10.1093/neuonc/nor200; Sahm F, 2012, ARCH NEUROL-CHICAGO, V69, P523, DOI 10.1001/archneurol.2011.2910; Sanai N, 2008, NEUROSURGERY, V62, P753, DOI 10.1227/01.neu.0000318159.21731.cf; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Senft C, 2011, LANCET ONCOL, V12, P997, DOI 10.1016/S1470-2045(11)70196-6; Silbergeld DL, 1997, J NEUROSURG, V86, P525, DOI 10.3171/jns.1997.86.3.0525; SIMPSON JR, 1993, INT J RADIAT ONCOL, V26, P239, DOI 10.1016/0360-3016(93)90203-8; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wen PY, 2010, CURR ONCOL REP, V12, P68, DOI 10.1007/s11912-009-0078-3; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541	24	80	83	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0169292	10.1371/journal.pone.0169292	http://dx.doi.org/10.1371/journal.pone.0169292			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103256	Green Published, Green Submitted, gold			2022-12-26	WOS:000392381100011
J	Li, SY; Li, XL; Zhang, DZ; Zhou, LY				Li, Shuangyan; Li, Xialian; Zhang, Dezhi; Zhou, Lingyun			Joint Optimization of Distribution Network Design and Two-Echelon Inventory Control with Stochastic Demand and CO2 Emission Tax Charges	PLOS ONE			English	Article							SUPPLY CHAIN MANAGEMENT; LOCATION MODEL; FACILITY LOCATION; WAREHOUSE LOCATION; LOGISTICS NETWORK; DECISIONS; FRAMEWORK; ISSUES	This study develops an optimization model to integrate facility location and inventory control for a three-level distribution network consisting of a supplier, multiple distribution centers (DCs), and multiple retailers. The integrated model addressed in this study simultaneously determines three types of decisions: (1) facility location (optimal number, location, and size of DCs); (2) allocation (assignment of suppliers to located DCs and retailers to located DCs, and corresponding optimal transport mode choices); and (3) inventory control decisions on order quantities, reorder points, and amount of safety stock at each retailer and opened DC. A mixed-integer programming model is presented, which considers the carbon emission taxes, multiple transport modes, stochastic demand, and replenishment lead time. The goal is to minimize the total cost, which covers the fixed costs of logistics facilities, inventory, transportation, and CO2 emission tax charges. The aforementioned optimal model was solved using commercial software LINGO 11. A numerical example is provided to illustrate the applications of the proposed model. The findings show that carbon emission taxes can significantly affect the supply chain structure, inventory level, and carbon emission reduction levels. The delay rate directly affects the replenishment decision of a retailer.	[Li, Shuangyan] Cent South Univ Forestry & Technol, Sch Transportat & Logist, Changsha, Hunan, Peoples R China; [Li, Xialian; Zhang, Dezhi] Cent S Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China; [Zhou, Lingyun] Huaiyin Inst Technol, Sch Management Engn, Huaian, Jiangsu, Peoples R China	Central South University of Forestry & Technology; Central South University; Huaiyin Institute of Technology	Zhang, DZ (corresponding author), Cent S Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China.	dzzhang@csu.edu.cn			Central South University Teacher Research Fund [2015]; Innovation of graduate students of Central South University [2016zzts329]; Hunan Province Science and Technology Development Funds [2015RS4045]; Excellent youth project of Hunan Provincial Department of Education [15B261]; National Natural Science Foundation of China [71403096, 71672193]	Central South University Teacher Research Fund; Innovation of graduate students of Central South University; Hunan Province Science and Technology Development Funds; Excellent youth project of Hunan Provincial Department of Education; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work that is described in this paper was supported by Central South University Teacher Research Fund (NO. 2015, DZZ receives funding), Innovation of graduate students of Central South University (NO. 2016zzts329, DZZ receives funding), Hunan Province Science and Technology Development Funds (NO. 2015RS4045, SYL receives funding), Excellent youth project of Hunan Provincial Department of Education (NO. 15B261, SYL receives funding), and National Natural Science Foundation of China (NO. 71403096, LYZ receives funding, & NO. 71672193, DZZ receives funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Alhaj M, 2016, RESOUR CONSERV RECY, V108, P82, DOI 10.1016/j.resconrec.2015.11.011; Ambrosino D, 2005, EUR J OPER RES, V165, P610, DOI 10.1016/j.ejor.2003.04.009; Archetti C, 2006, TRANSPORT SCI, V40, P64, DOI 10.1287/trsc.1040.0103; Brandenburg M, 2014, EUR J OPER RES, V233, P299, DOI 10.1016/j.ejor.2013.09.032; Cabrera G, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/670528; Carter CR, 2008, INT J PHYS DISTR LOG, V38, P360, DOI 10.1108/09600030810882816; Chen CH, 2008, TRANSPORT RES E-LOG, V44, P1099, DOI 10.1016/j.tre.2007.09.001; Diabat A, 2015, COMPUT OPER RES, V61, P170, DOI 10.1016/j.cor.2014.03.006; Diabat A, 2015, COMPUT OPER RES, V54, P245, DOI 10.1016/j.cor.2013.08.023; Kutanoglu E, 2009, EUR J OPER RES, V194, P728, DOI 10.1016/j.ejor.2007.12.032; Lemmens S, 2016, CHEM ENG RES DES, V109, P366, DOI 10.1016/j.cherd.2016.02.015; Li ZC, 2014, J ADV TRANSPORT, V48, P1066, DOI 10.1002/atr.1246; Liao SH, 2011, ANN OPER RES, V186, P213, DOI 10.1007/s10479-010-0801-3; Luathep P, 2011, TRANSPORT RES B-METH, V45, P808, DOI 10.1016/j.trb.2011.02.002; Mangiaracina R, 2015, INT J PHYS DISTR LOG, V45, P506, DOI 10.1108/IJPDLM-02-2014-0035; Masoumik SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143115; Melo MT, 2009, EUR J OPER RES, V196, P401, DOI 10.1016/j.ejor.2008.05.007; Miranda PA, 2004, TRANSPORT RES E-LOG, V40, P183, DOI 10.1016/j.tre.2003.08.006; Miranda PA, 2008, TRANSPORT RES E-LOG, V44, P47, DOI 10.1016/j.tre.2006.04.002; Miranda PA, 2006, NETW SPAT ECON, V6, P39, DOI 10.1007/s11067-006-7684-5; Nagy G, 2007, EUR J OPER RES, V177, P649, DOI 10.1016/j.ejor.2006.04.004; Ozsen L, 2008, NAV RES LOG, V55, P295, DOI 10.1002/nav.20282; Park S, 2010, TRANSPORT RES E-LOG, V46, P563, DOI 10.1016/j.tre.2009.12.004; Qu H, 2015, EXPERT SYST APPL, V42, P2061, DOI 10.1016/j.eswa.2014.10.017; Romeijn HE, 2007, EUR J OPER RES, V178, P449, DOI 10.1016/j.ejor.2006.02.016; Seuring S, 2008, J CLEAN PROD, V16, P1699, DOI 10.1016/j.jclepro.2008.04.020; Shen ZJM, 2003, TRANSPORT SCI, V37, P40, DOI 10.1287/trsc.37.1.40.12823; Shu J, 2006, J IND MANAG OPTIM, V2, P339; Shu J, 2010, ANN OPER RES, V181, P233, DOI 10.1007/s10479-010-0732-z; Snyder LV, 2007, EUR J OPER RES, V179, P1221, DOI 10.1016/j.ejor.2005.03.076; Tancrez JS, 2012, TRANSPORT RES E-LOG, V48, P485, DOI 10.1016/j.tre.2011.10.005; Teo CP, 2001, IIE TRANS, V33, P99, DOI 10.1080/07408170108936811; Tsao YC, 2012, EUR J OPER RES, V222, P216, DOI 10.1016/j.ejor.2012.04.033; Turkay M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147502; Uster H, 2008, IIE TRANS, V40, P718, DOI 10.1080/07408170701598132; Wang Y, 2015, EXPERT SYST APPL, V42, P5019, DOI 10.1016/j.eswa.2015.02.058; Wang Y, 2014, EXPERT SYST APPL, V41, P521, DOI 10.1016/j.eswa.2013.07.078; Wu T, 2015, INT J PROD ECON, V169, P343, DOI 10.1016/j.ijpe.2015.08.018	38	13	14	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0168526	10.1371/journal.pone.0168526	http://dx.doi.org/10.1371/journal.pone.0168526			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103246	gold, Green Published, Green Submitted			2022-12-26	WOS:000392381100003
J	Arrieta, A; Page, TF; Veledar, E; Nasir, K				Arrieta, Alejandro; Page, Timothy F.; Veledar, Emir; Nasir, Khurram			Economic Evaluation of PCSK9 Inhibitors in Reducing Cardiovascular Risk from Health System and Private Payer Perspectives	PLOS ONE			English	Article							COST-EFFECTIVENESS; DISEASE; HYPERCHOLESTEROLEMIA; PREVENTION; INSURANCE; THERAPY; ERA	The introduction of Proprotein covertase subtilisin/kexin type 9 (PCSK9) inhibitors has been heralded as a major advancement in reducing low-density lipoprotein cholesterol levels by nearly 50%. However, concerns have been raised on the added value to the health care system in terms of their costs and benefits. We assess the cost-effectiveness of PCSK9 inhibitors based on a decision-analytic model with existing clinical evidence. The model compares a lipid-lowering therapy based on statin plus PCSK9 inhibitor treatment with statin treatment only (standard therapy). From health system perspective, incremental cost per quality adjusted life years (QALYs) gained are presented. From a private payer perspective, return-on-investment and net present values over patient lifespan are presented. At the current annual cost of $14,000 to $15,000, PCSK9 inhibitors are not cost-effective at an incremental cost of about $350,000 per QALY. Moreover, for every dollar invested in PCSK9 inhibitors, the private payer loses $1.98. Our study suggests that the annual treatment price should be set at $4,250 at a societal willingness-to-pay of $100,000 per QALY. However, we estimate the breakeven price for private payer is only $600 per annual treatment. At current prices, our study suggests that PCSK9 inhibitors do not add value to the U.S. health system and their provision is not profitable for private payers. To be the breakthrough drug in the fight against cardiovascular disease, the current price of PCSK9 inhibitors must be reduced by more than 70%.	[Arrieta, Alejandro; Page, Timothy F.] Florida Int Univ, Dept Hlth Policy & Management, Robert Stempel Coll Publ Hlth & Social Work, Miami, FL 33199 USA; [Veledar, Emir; Nasir, Khurram] Baptist Hlth South Florida, Ctr Healthcare Adv & Outcomes, Miami, FL USA; [Veledar, Emir; Nasir, Khurram] Baptist Hlth South Florida, Miami Cardiac & Vasc Inst, Miami, FL USA; [Veledar, Emir; Nasir, Khurram] Florida Int Univ, Dept Med, Herbert Wertheim Coll Med, Miami, FL 33199 USA; [Veledar, Emir; Nasir, Khurram] Florida Int Univ, Dept Epidemiol, Robert Stempel Coll Publ Hlth & Social Work, Miami, FL 33199 USA; [Nasir, Khurram] Johns Hopkins Ciccarone Ctr Prevent Heart Dis, Baltimore, MD USA	State University System of Florida; Florida International University; Baptist Cardiac & Vascular Institute; State University System of Florida; Florida International University; State University System of Florida; Florida International University; Johns Hopkins University; Johns Hopkins Medicine	Arrieta, A (corresponding author), Florida Int Univ, Dept Hlth Policy & Management, Robert Stempel Coll Publ Hlth & Social Work, Miami, FL 33199 USA.	alejarri@fiu.edu	Veledar, Emir/L-6637-2019; Veledar, Emir/K-2808-2012	Veledar, Emir/0000-0002-3831-5433; Arrieta, Alejandro/0000-0002-7628-8894				Arbel R, 2016, INT J CARDIOL, V220, P242, DOI 10.1016/j.ijcard.2016.06.126; Arrieta A, 2014, HYPERTENSION, V64, P891, DOI 10.1161/HYPERTENSIONAHA.114.03780; Caffrey M, 2015, AM J MANAG CARE, V21, pSP456; Centers for Medicare and Medicaid Services, 2015, MED ADV RAT STAT; Chapman MJ, 2015, CURR OPIN LIPIDOL, V26, P511, DOI 10.1097/MOL.0000000000000239; Cutler DM, 2009, NEW ENGL J MED, V360, P1740, DOI 10.1056/NEJMsa0804668; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Davis KE, 2012, AGENCY FOR HEALTHCAR, V381, P6; Desai R, 2016, HLTH PLANS ARE INTER; Erickson KF, 2013, J AM COLL CARDIOL, V61, P1250, DOI 10.1016/j.jacc.2012.12.034; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; Gandra SR, 2016, CLIN CARDIOL; Giugliano RP, 2015, J AM COLL CARDIOL, V65, P2638, DOI 10.1016/j.jacc.2015.05.001; Kaiser Family Foundation, 2014, THE MED D; Kazi DS, 2016, JAMA-J AM MED ASSOC, V316, P743, DOI 10.1001/jama.2016.11004; Lakdawalla D, 2016, BUDGET CRITERIA DRUG; Lazar LD, 2011, CIRCULATION, V124, P146, DOI 10.1161/CIRCULATIONAHA.110.986349; Leatherman S, 2003, HEALTH AFFAIR, V22, P17, DOI 10.1377/hlthaff.22.2.17; Navarese EP, 2015, ANN INTERN MED, V163, P40, DOI 10.7326/M14-2957; Neumann PJ, 2015, NEW ENGL J MED, V373, P2595, DOI 10.1056/NEJMp1512009; Sabatine MS, 2015, NEW ENGL J MED, V372, P1500, DOI 10.1056/NEJMoa1500858; Schulman KA, 2015, NEW ENGL J MED, V373, P1591, DOI 10.1056/NEJMp1509863; Shrank W, 2015, DEBATE COST EFFICACY; Sullivan PW, 2006, MED DECIS MAKING, V26, P410, DOI 10.1177/0272989X06290495; Tice JA, 2015, PCSK9 INHIBITORS TRE; Tice JA, 2016, JAMA INTERN MED, V176, P107, DOI 10.1001/jamainternmed.2015.7248	26	54	55	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169761	10.1371/journal.pone.0169761	http://dx.doi.org/10.1371/journal.pone.0169761			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081164	Green Published, Green Submitted, gold			2022-12-26	WOS:000391949500072
J	Azzi, J; Thueson, L; Moore, R; Abdoli, R; Reijonen, H; Abdi, R				Azzi, Jamil; Thueson, Lindsay; Moore, Robert; Abdoli, Rozita; Reijonen, Helena; Abdi, Reza			PI3K gamma Deficient NOD-Mice Are Protected from Diabetes by Restoring the Balance of Regulatory to Effector-T-Cells	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; TYPE-1; INFLAMMATION; ACTIVATION; MECHANISMS; SURVIVAL	With a steady increase in its incidence and lack of curative treatment, type 1 diabetes (T1D) has emerged as a major health problem worldwide. To design novel effective therapies, there is a pressing need to identify regulatory targets controlling the balance of autoreactive to regulatory-T-cells (Tregs). We previously showed that the inhibition of the gamma-subunit of the Phosphoinositide-3-kinase (PI3K), significantly suppress autoimmune-diabetes. To further delineate the mechanisms and the selectivity of specific immune modulation by PI3K gamma-inhibition, we developed a new NOD mouse model of T1D lacking the.-subunit of PI3K gamma Strikingly, the loss of PI3K. protected 92% of the NOD-mice from developing spontaneous diabetes. The NOD. PI3K gamma(-/-) mice are protected from insulitis secondary to a defect in CD4 and CD8 autoreactive-T-cells activation and survival. In addition, PI3K gamma-deficiency promoted Treg generation in-vitro and in-vivo. Furthermore, PI3K gamma-inhibitor (AS605240) inhibited proliferation and cytokine production of a human CD4(+) T-cell clone specific for GAD555-567 peptide that was isolated from a patient with T1D. These studies demonstrate the key role of the PI3K gamma pathway in regulating autoimmune-diabetes and provide rationales for future devise of anti-PI3K gamma therapy in T1D.	[Azzi, Jamil; Moore, Robert; Abdoli, Rozita; Abdi, Reza] Harvard Med Sch, Brigham & Womens Hosp, Div Renal, Transplantat Res Ctr, Boston, MA 02115 USA; [Thueson, Lindsay; Reijonen, Helena] Benaroya Res Inst, Seattle, WA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Benaroya Research Institute	Azzi, J; Abdi, R (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Renal, Transplantat Res Ctr, Boston, MA 02115 USA.	jazzi@rics.bwh.harvard.edu; rabdi@rics.bwh.harvard.edu		Reijonen, Helena/0000-0002-9386-3918	American Heart Association Grant; Juvenile Diabetes Research Foundation JDRF Grant [4-2007-1065]; JDRF Regular Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI126596, R01AI091930, R56AI123270] Funding Source: NIH RePORTER	American Heart Association Grant(American Heart Association); Juvenile Diabetes Research Foundation JDRF Grant; JDRF Regular Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by American Heart Association Grant (to JA), Juvenile Diabetes Research Foundation JDRF Grant 4-2007-1065 and a JDRF Regular Grant (to RA).	Alcazar I, 2007, J EXP MED, V204, P2977, DOI 10.1084/jem.20070366; Azzi J, 2012, DIABETES, V61, P1509, DOI 10.2337/db11-0134; Barber DF, 2006, J IMMUNOL, V176, P589, DOI 10.4049/jimmunol.176.1.589; Barbier M, 2001, NATURE, V413, P796, DOI 10.1038/35101660; Ben Nasr M, 2015, PHARMACOL RES, V98, P31, DOI 10.1016/j.phrs.2014.07.004; Bour-Jordan H, 2004, J CLIN INVEST, V114, P979, DOI 10.1172/JCI200420483; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Buckner JH, 2010, NAT REV IMMUNOL, V10, P849, DOI 10.1038/nri2889; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Guleria I, 2007, CLIN IMMUNOL, V125, P16, DOI 10.1016/j.clim.2007.05.013; La Rocca E, 2000, CELL TRANSPLANT, V9, P929, DOI 10.1177/096368970000900621; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; Mayer-Davis EJ, 2009, DIABETES CARE, V32, pS99, DOI 10.2337/dc09-S201; Reijonen H, 2004, DIABETES, V53, P1987, DOI 10.2337/diabetes.53.8.1987; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Secchi A, 1998, LANCET, V352, P65, DOI 10.1016/S0140-6736(05)79546-5; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Vergani A, 2010, DIABETES, V59, P2253, DOI 10.2337/db09-1264	20	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169695	10.1371/journal.pone.0169695	http://dx.doi.org/10.1371/journal.pone.0169695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081180	Green Published, gold, Green Submitted			2022-12-26	WOS:000391949500065
J	Cho, EY; Myoung, C; Park, HS; Kim, AJ; Ro, H; Chang, JH; Lee, HH; Chung, W; Jung, JY				Cho, Eun Yeong; Myoung, Chana; Park, Hong-suk; Kim, Ae Jin; Ro, Han; Chang, Jae Hyun; Lee, Hyun Hee; Chung, Wookyung; Jung, Ji Yong			Efficacy of Statin Treatment in Early-Stage Chronic Kidney Disease	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CARDIOVASCULAR EVENTS; DIALYSIS THERAPY; RENAL-FUNCTION; RISK-FACTORS; OUTCOMES; ROSUVASTATIN; ATORVASTATIN; METAANALYSIS; PRAVASTATIN	Chronic kidney disease (CKD) represents a major medical challenge and frequently coexists with cardiovascular disease (CVD), which can be treated by statin trerapy. However, whether statin treatment affects renal progression and outcomes in CKD patients remains unclear. We retrospectively reviewed CKD patients at Gachon University Gil Medical Center from 2003-2013. From a total of 14,497 CKD patients, 858 statin users were paired with non-users and analyze with propensity score matching was performed. The outcomes of this study were creatinine doubling, renal death, all-cause mortality, and interactive factors for composite outcomes. Statins were prescribed to 13.5% of the study subjects. Hazard ratios (HRs) [95% confidence intervals (CIs)] for statin treatment for the doubling of serum creatinine levels were significant only in CKD patients with an estimated glomerular filtration rate (eGFR) >= 30 mL/min/1.73 m(2), and were 0.744 (0.635-0.873) in the unmatched cohort and 0.767 (0.596-0.986) in the matched cohort. In analyses of secondary outcomes, the HRs (95% CIs) for all-cause mortality were 0.655 (0.502-0.855) in the unmatched cohort and 0.537 (0.297-0.973) in the matched cohort. The HRs (95% CIs) for statin therapy for composite outcomes among patients with and without an eGFR > 30 mL/min/1.73 m(2) were 0.764 (0.613-0.952) and 1.232 (0.894-1.697), respectively (P for interaction, 0.017). Thus, statin treatment may have beneficial effects on renal progression and all-cause mortality only for the patients with early-stage CKD.	[Cho, Eun Yeong; Myoung, Chana; Park, Hong-suk; Kim, Ae Jin; Ro, Han; Chang, Jae Hyun; Lee, Hyun Hee; Chung, Wookyung; Jung, Ji Yong] Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Nephrol, Inchon, South Korea; [Kim, Ae Jin; Ro, Han; Chang, Jae Hyun; Lee, Hyun Hee; Chung, Wookyung; Jung, Ji Yong] Gachon Univ, Sch Med, Dept Internal Med, Div Nephrol, Inchon, South Korea	Gachon University; Gachon University	Jung, JY (corresponding author), Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Nephrol, Inchon, South Korea.; Jung, JY (corresponding author), Gachon Univ, Sch Med, Dept Internal Med, Div Nephrol, Inchon, South Korea.	jyjung@gachon.ac.kr		Jung, Ji Yong/0000-0003-1271-8012				Athyrost VG, 2015, EXPERT OPIN PHARMACO, V16, P1449, DOI 10.1517/14656566.2015.1053464; Baigent C, 2010, AM HEART J, V160, P785, DOI 10.1016/j.ahj.2010.08.012; Barylski M, 2013, PHARMACOL RES, V72, P35, DOI 10.1016/j.phrs.2013.03.007; Collins AJ, 2003, AM J KIDNEY DIS, V41, pV, DOI 10.1016/S0272-6386(03)80001-X; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; de Zeeuw D, 2015, LANCET DIABETES ENDO, V3, P181, DOI 10.1016/S2213-8587(14)70246-3; Deedwania PC, 2015, DRUG AGING, V32, P1055, DOI 10.1007/s40266-015-0328-z; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Epstein M, 2005, AM J KIDNEY DIS, V45, P2, DOI 10.1053/j.ajkd.2004.08.040; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Gluba A, 2010, EXPERT OPIN PHARMACO, V11, P2665, DOI 10.1517/14656566.2010.512419; James MT, 2010, LANCET, V375, P1296, DOI 10.1016/S0140-6736(09)62004-3; Jungers P, 1997, NEPHROL DIAL TRANSPL, V12, P2597, DOI 10.1093/ndt/12.12.2597; Kim AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104179; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; Mallamaci F, 2002, KIDNEY INT, V61, P609, DOI 10.1046/j.1523-1755.2002.00144.x; Nikolic D, 2013, INT J CARDIOL, V168, P5437, DOI 10.1016/j.ijcard.2013.08.060; ODriscoll G, 1997, CIRCULATION, V95, P1126, DOI 10.1161/01.cir.95.5.1126; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Rodriguez CJ, 2014, JAMA INTERN MED, V174, P1252, DOI 10.1001/jamainternmed.2014.2482; Rysz J, 2015, INT UROL NEPHROL, V47, P805, DOI 10.1007/s11255-015-0937-9; Sanguankeo A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132970; Schaeffner ES, 2003, J AM SOC NEPHROL, V14, P2084, DOI 10.1681/ASN.V1482084; Sharma K, 2008, J CLIN INVEST, V118, P1645, DOI 10.1172/JCI32691; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Tonelli M, 2004, CIRCULATION, V110, P1557, DOI 10.1161/01.CIR.0000143892.84582.60; Tonelli M, 2003, J AM SOC NEPHROL, V14, P1605, DOI 10.1097/01.ASN.0000068461.45784.2F; Tonelli M, 2006, ANN INTERN MED, V145, P147, DOI 10.7326/0003-4819-145-2-200607180-00015; Uhlig K, 2003, SEMIN DIALYSIS, V16, P118, DOI 10.1046/j.1525-139X.2003.16028.x; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Wanner C, 2014, KIDNEY INT, V85, P1303, DOI 10.1038/ki.2014.31; Zoja C, 2002, KIDNEY INT, V61, P1635, DOI 10.1046/j.1523-1755.2002.00332.x	33	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0170017	10.1371/journal.pone.0170017	http://dx.doi.org/10.1371/journal.pone.0170017			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081262	Green Submitted, gold, Green Published			2022-12-26	WOS:000391949500119
J	Gliem, M; Lee, JI; Barckhan, A; Turowski, B; Hartung, HP; Jander, S				Gliem, Michael; Lee, John-Ih; Barckhan, Aurica; Turowski, Bernd; Hartung, Hans-Peter; Jander, Sebastian			Outcome and Treatment Effects in Stroke Associated with Acute Cervical ICA Occlusion	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; CAROTID-ARTERY OCCLUSION; INTRAVENOUS THROMBOLYSIS; ENDOVASCULAR THERAPY; THROMBECTOMY	Background Endovascular therapy (EVT) with stent retrievers in addition to i.v. thrombolysis (IVT) has proven effective in acute stroke patients with middle cerebral artery (MCA, M1 segment) and distal internal carotid artery (ICA) occlusion. Limited data exist concerning acute cervical ICA occlusion, either alone or in combination with intracranial ICA occlusion (tandem occlusion). Therefore we analyzed outcome and treatment effects in stroke associated with cervical ICA occlusion, with specific focus on the impact of intracranial ICA or M1 patency. Methods Seventy-eight patients with cervical ICA occlusion from our local stroke unit registry were analyzed retrospectively. Thrombolysis in Cerebral Infarction (TICI) classification, infarct size, modified Rankin scale (mRS), symptomatic intracerebral hemorrhage (ICH), and death were assessed as outcome parameters. Results Forty-three patients had isolated cervical ICA occlusion whereas 35 patients presented with extra-/intracranial tandem occlusion. Patients underwent IVT alone (n = 23), combined IVT/ EVT (n = 28) or no treatment (n = 27). Treated and untreated patients with tandem occlusion had a worse outcome after 90 days compared to isolated cervical occlusion (OR for moderate outcome 0.29, 0.27-0.88, p = 0.01). Additional EVT improved outcome in patients with tandem occlusion (OR for moderate outcome: 15.43, 1.60-148.90, p = 0.008) but not isolated cervical occlusion (OR 1.33, 0.38-11.60, NS). Conclusions In contrast to tandem occlusion, stroke outcome in patients with isolated cervical ICA occlusion was generally more benign and not improved by combined IVT/EVT compared to IVT alone. Intracranial vessel patency may be critical for treatment decision in acute cervical ICA occlusion.	[Gliem, Michael; Lee, John-Ih; Barckhan, Aurica; Hartung, Hans-Peter; Jander, Sebastian] Heinrich Heine Univ, Dept Neurol, Fac Med, Dusseldorf, Germany; [Turowski, Bernd] Heinrich Heine Univ, Fac Med, Dept Diagnost & Intervent Radiol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Jander, S (corresponding author), Heinrich Heine Univ, Dept Neurol, Fac Med, Dusseldorf, Germany.	jander@uni-duesseldorf.de			B. Braun Foundation [BBST-D-14-00005]	B. Braun Foundation	The work was supported by B. Braun Foundation (BBST-D-14-00005).	Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Higashida RT, 2003, STROKE, V34, pE109, DOI 10.1161/01.STR.0000082721.62796.09; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Lindley RI, 2015, STROKE, V46, P746, DOI 10.1161/STROKEAHA.114.006573; Mokin M, 2012, STROKE, V43, P2362, DOI 10.1161/STROKEAHA.112.655621; Paciaroni M, 2015, J NEUROL, V262, P459, DOI 10.1007/s00415-014-7550-1; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Singer OC, 2013, NEURORADIOLOGY, V55, P1143, DOI 10.1007/s00234-013-1219-9; Tutuncu S, 2014, J VASC INTERV RADIOL, V25, P1165, DOI 10.1016/j.jvir.2014.02.027; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4	14	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0170247	10.1371/journal.pone.0170247	http://dx.doi.org/10.1371/journal.pone.0170247			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081270	Green Submitted, Green Published, gold			2022-12-26	WOS:000391949500139
J	Kocherginsky, M; Huisingh-Scheetz, M; Dale, W; Lauderdale, DS; Waite, L				Kocherginsky, Masha; Huisingh-Scheetz, Megan; Dale, William; Lauderdale, Diane S.; Waite, Linda			Measuring Physical Activity with Hip Accelerometry among US Older Adults: How Many Days Are Enough?	PLOS ONE			English	Article							STATISTICAL-METHODS; ASSESSING AGREEMENT; SEDENTARY BEHAVIOR; QUESTIONNAIRES	Introduction Accelerometers are increasingly used in research. Four to 7 days of monitoring is preferred to estimate average activity but may be burdensome for older adults. We aimed to investigate: 1) 7-day accelerometry protocol adherence, 2) demographic predictors of adherence, 3) day of the week effect, and 4) average activity calculated from 7 versus fewer days among older adults. Methods We used the 2003-2006 older adult hip accelerometry data from the National Health and Nutrition Examination Survey (NHANES) sample. We determined proportions with 1-7 valid (10-20 hours) wear days and identified wear day correlates using ordinal logistic regression. We determined the day of week effect on 5 accelerometry measures (counts per minute, CPM; % sedentary behavior; % light-lifestyle activity; % moderate-vigorous activity, MVPA; total activity counts) using multivariate linear regression and compared averages estimated over 2 or 3 versus 7 days using correlations, linear regression, and Bland-Altman plots. Results Among 2,208 participants aged 65+, 85% of participants had >= 2 and 44% had 7 valid wear days. Increasing age (p= 0.01) and non-white race (p< 0.001) were associated with fewer days. Daily CPM, % MVPA, and total daily activity counts were similar Monday through Saturday, but significantly lower on Sundays (p < 0.001). Daily % sedentary behavior and % light-lifestyle activity were significantly different on Saturdays (p = 0.04-0.045) and Sundays (p < 0.001) compared to weekdays. Among participants with 7 valid days, 2 or 3 day averages were highly correlated with 7 day averages for all 5 accelerometry measures (2 versus 7 days: r= 0.90-0.93, 3 versus 7 days: r= 0.94-0.96). Conclusions Protocols of 2-3 days, adjusting for Sundays (average CPM, % moderate-vigorous activity, and average total daily activity counts) or weekends (% sedentary behavior and % light-lifestyle activity), give reliable estimates of older adult activity.	[Kocherginsky, Masha; Lauderdale, Diane S.] Univ Chicago Med, Dept Publ Hlth Sci, Chicago, IL USA; [Huisingh-Scheetz, Megan; Dale, William] Univ Chicago Med, Sect Geriatr & Palliat Med, Chicago, IL 60637 USA; [Waite, Linda] Univ Chicago Med, Dept Sociol, Chicago, IL USA		Huisingh-Scheetz, M (corresponding author), Univ Chicago Med, Sect Geriatr & Palliat Med, Chicago, IL 60637 USA.	megan.huisingh-scheetz@uchospitals.edu	Waite, Linda/AAD-9406-2020	Huisingh-Scheetz, Megan/0000-0002-3997-5791; Dale, William/0000-0001-8674-9394	National Institute on Aging [K23 AG049106]; National Institute on Health [R01 AG051175]; NATIONAL INSTITUTE ON AGING [K23AG049106, R01AG051175] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institute on Aging K23 AG049106 to MHS and National Institute on Health R01 AG051175 to DL.	Adams MA, 2015, AM J PREV MED; Atienza AA, 2011, MED SCI SPORT EXER, V43, P815, DOI 10.1249/MSS.0b013e3181fdfc32; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bonnefoy M, 2001, J AM GERIATR SOC, V49, P28, DOI 10.1046/j.1532-5415.2001.49006.x; Diaz KM, 2015, MED SCI SPORTS EXERC; Dillon CB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0109913; Gemmill E, 2011, J PHYS ACT HEALTH, V8, P1152, DOI 10.1123/jpah.8.8.1152; Hart TL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-62; Hassani M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110816; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Lin L, 2002, J AM STAT ASSOC, V97, P257, DOI 10.1198/016214502753479392; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Lumley T., 2020, SURVEY ANAL COMPLEX; NHANES, 2015, NAT HLTH NUTR EX SUR; Papadopoulos A, 2015, CURR AGING SCI; R Development Core Team, 2012, R LANG ENV STAT COMP; Seymour DG, 2001, J EVAL CLIN PRACT, V7, P411, DOI 10.1046/j.1365-2753.2001.00296.x; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Tung JY, 2014, GAIT POSTURE, V39, P991, DOI 10.1016/j.gaitpost.2013.11.015; Van Domelen D, 2015, NHANESDATA CONTAINS; Van Domelen DR, 2014, NHANESACCEL PROCESS; Wallen MB, 2015, PHYS THER, V95, P1135, DOI 10.2522/ptj.20140374; Yu Y, 2012, AGREEMENT STAT TOOLS	24	30	30	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0170082	10.1371/journal.pone.0170082	http://dx.doi.org/10.1371/journal.pone.0170082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081249	Green Published, gold, Green Submitted			2022-12-26	WOS:000391949500129
J	Yang, JJ; Williams, LK; Buu, A				Yang, James J.; Williams, L. Keoki; Buu, Anne			Identifying Pleiotropic Genes in Genome-Wide Association Studies for Multivariate Phenotypes with Mixed Measurement Scales	PLOS ONE			English	Article							FAMILY-BASED DESIGNS; INFLATED COUNT DATA; ASYMPTOTIC OPTIMALITY; REGRESSION-MODELS; FISHERS METHOD; DISEASES; TRAITS; TESTS; AGE	We propose a multivariate genome-wide association test for mixed continuous, binary, and ordinal phenotypes. A latent response model is used to estimate the correlation between phenotypes with different measurement scales so that the empirical distribution of the Fisher's combination statistic under the null hypothesis is estimated efficiently. The simulation study shows that our proposed correlation estimation methods have high levels of accuracy. More importantly, our approach conservatively estimates the variance of the test statistic so that the type I error rate is controlled. The simulation also shows that the proposed test maintains the power at the level very close to that of the ideal analysis based on known latent phenotypes while controlling the type I error. In contrast, conventional approaches-dichotomizing all observed phenotypes or treating them as continuous variables-could either reduce the power or employ a linear regression model unfit for the data. Furthermore, the statistical analysis on the database of the Study of Addiction: Genetics and Environment (SAGE) demonstrates that conducting a multivariate test on multiple phenotypes can increase the power of identifying markers that may not be, otherwise, chosen using marginal tests. The proposed method also offers a new approach to analyzing the Fagerstrom Test for Nicotine Dependence as multivariate phenotypes in genome-wide association studies.	[Yang, James J.] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; [Williams, L. Keoki] Henry Ford Hlth Syst, Dept Internal Med, Detroit, MI USA; [Williams, L. Keoki] Henry Ford Hlth Syst, Ctr Hlth Policy & Hlth Serv Res, Detroit, MI USA; [Buu, Anne] Univ Michigan, Dept Hlth Behav & Biol Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; University of Michigan System; University of Michigan	Yang, JJ (corresponding author), Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA.	jjyang@umich.edu			National Institutes of Health (NIH) [K01 AA016591, R01 DA035183, R01 AI079139, R01 HL118267]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118267] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by National Institutes of Health (NIH) grants, K01 AA016591 & R01 DA035183 to A. Buu, and R01 AI079139 & R01 HL118267 to L. K. Williams. The funding agencies had no role in study design, analysis, interpretation of results, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Agresti A, 2002, WILEY SERIES PROBABI, DOI 10.1002/0471249688; Allison DB, 1998, AM J HUM GENET, V63, P1190, DOI 10.1086/302038; Anderson CA, 2010, NAT PROTOC, V5, P1564, DOI 10.1038/nprot.2010.116; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; BEDRICK EJ, 1992, PSYCHOMETRIKA, V57, P183, DOI 10.1007/BF02294504; BROGDEN HE, 1949, PSYCHOMETRIKA, V14, P169, DOI DOI 10.1007/BF02289151; BROWN MB, 1975, BIOMETRICS, V31, P987, DOI 10.2307/2529826; Buu A, 2012, STAT MED, V31, P4074, DOI 10.1002/sim.5510; Buu A, 2011, STAT MED, V30, P2326, DOI 10.1002/sim.4268; Casella G, 1990, DUXBURY ADV SERIES; COX NJ, 1983, EARTH SURF PROC LAND, V8, P89, DOI 10.1002/esp.3290080109; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Fitzmaurice GM, 1997, BIOMETRICS, V53, P110, DOI 10.2307/2533101; Flory JD, 2009, PSYCHOSOM MED, V71, P431, DOI 10.1097/PSY.0b013e3181988c2d; Good I. J., 2006, J STAT COMPUT SIM, V76, P737, DOI [10.1080/10629360500108186, DOI 10.1080/10629360500108186]; Guisan A, 2000, J VEG SCI, V11, P617, DOI 10.2307/3236568; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; HOEFFDING W, 1952, ANN MATH STAT, V23, P169, DOI 10.1214/aoms/1177729436; Kendall M.G., 1990, RANK CORRELATION MET, V5th; KENDALL MG, 1949, BIOMETRIKA, V36, P177, DOI 10.2307/2332540; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Laird NM, 2009, STAT SCI, V24, P388, DOI 10.1214/08-STS280; Laird NM, 2006, NAT REV GENET, V7, P385, DOI 10.1038/nrg1839; LITTELL RC, 1973, J AM STAT ASSOC, V68, P193, DOI 10.2307/2284167; LITTELL RC, 1971, J AM STAT ASSOC, V66, P802, DOI 10.2307/2284230; LORD FM, 1963, PSYCHOMETRIKA, V28, P81, DOI 10.1007/BF02289550; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; OLSSON U, 1982, PSYCHOMETRIKA, V47, P337, DOI 10.1007/BF02294164; OLSSON U, 1979, PSYCHOMETRIKA, V44, P443, DOI 10.1007/BF02296207; Ott J, 2011, NAT REV GENET, V12, P465, DOI 10.1038/nrg2989; Pearson K, 1922, BIOMETRIKA, V14, P127, DOI 10.2307/2331858; Pearson K, 1909, BIOMETRIKA, V7, P96, DOI 10.2307/2345365; Pearson K., 1896, PHILOS T ROYAL SOC A, V187, P253, DOI [DOI 10.1098/RSTA.1896.0007, 10.1098/rsta.1896.0007]; Pesarin F., 2010, PERMUTATION TESTS CO; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; SCHAEFFER MS, 1956, PSYCHOL BULL, V53, P338, DOI 10.1037/h0045013; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; TATE RF, 1955, BIOMETRIKA, V42, P205, DOI 10.1093/biomet/42.1-2.205; Teixeira-Pinto A, 2009, STAT MED, V28, P1753, DOI 10.1002/sim.3588; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Yang JJ, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-015-0868-6; Yang JJ, 2010, J STAT COMPUT SIM, V80, P1, DOI 10.1080/00949650802412607; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhou X, 2014, NAT METHODS, V11, P407, DOI [10.1038/nmeth.2848, 10.1038/NMETH.2848]; Zollner S, 2007, AM J HUM GENET, V80, P605, DOI 10.1086/512821; ZUCKER RA, 1994, DEV ALCOHOL PROBLEMS, P255	48	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169893	10.1371/journal.pone.0169893	http://dx.doi.org/10.1371/journal.pone.0169893			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081206	Green Published, Green Submitted, gold			2022-12-26	WOS:000391949500099
J	Guerrero, A; Lizarraga-Partida, ML; Rodriguez, BGG; Licea-Navarro, AF; Revilla-Castellanos, VJ; Wong-Chang, I; Gonzalez-Sanchez, R				Guerrero, Abraham; Leonardo Lizarraga-Partida, Marcial; Gil Rodriguez, Bruno Gomez; Fedorovish Licea-Navarro, Alexei; Jeanette Revilla-Castellanos, Valeria; Wong-Chang, Irma; Gonzalez-Sanchez, Ricardo			Genetic Analysis of Vibrio parahaemolyticus O3:K6 Strains That Have Been Isolated in Mexico Since 1998	PLOS ONE			English	Article							O3-K6; SEQUENCE; DIARRHEA; SHELLFISH; SEROTYPE; SPREAD; CLONE; PCR; GASTROENTERITIS	Vibrio parahaemolyticus is an important human pathogen that has been isolated worldwide from clinical cases, most of which have been associated with seafood consumption. Environmental and clinical toxigenic strains of V. parahaemolyticus that were isolated in Mexico from 1998 to 2012, including those from the only outbreak that has been reported in this country, were characterized genetically to assess the presence of the O3:K6 pandemic clone, and their genetic relationship to strains that are related to the pandemic clonal complex (CC3). Pathogenic tdh(+) and tdh(+)Itrh(+) strains were analyzed by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). Also, the entire genome of a Mexican O3:K6 strain was sequenced. Most of the strains were tdh/ORF8-positive and corresponded to the O3:K6 serotype. By PFGE and MLST, there was very close genetic relationship between ORF8/O3:K6 strains, and very high genetic diversities from non-pandemic strains. The genetic relationship is very close among O3:K6 strains that were isolated in Mexico and sequences that were available for strains in the CC3, based on the PubMLST database. The whole-genome sequence of CICESE-170 strain had high similarity with that of the reference RIMD 2210633 strain, and harbored 7 pathogenicity islands, including the 4 that denote O3:K6 pandemic strains. These results indicate that pandemic strains that have been isolated in Mexico show very close genetic relationship among them and with those isolated worldwide.	[Guerrero, Abraham; Leonardo Lizarraga-Partida, Marcial; Fedorovish Licea-Navarro, Alexei; Jeanette Revilla-Castellanos, Valeria; Gonzalez-Sanchez, Ricardo] CICESE, Ensenada, Baja California, Mexico; [Gil Rodriguez, Bruno Gomez] CIAD AC, Mazatlan Unit Aquaculture & Environm Management, Mazatlan, Sinaloa, Mexico; [Wong-Chang, Irma] Univ Nacl Autonoma Mexico, ICMyL, Mexico City, DF, Mexico	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Universidad Nacional Autonoma de Mexico	Lizarraga-Partida, ML (corresponding author), CICESE, Ensenada, Baja California, Mexico.	lizarra@cicese.mx	Guerrero, Abraham/C-5996-2016; Guerrero, Abraham/AAQ-5299-2021; Navaro, Alexei Fedorovish Licea/B-4106-2016	Guerrero, Abraham/0000-0003-2550-6764; Navaro, Alexei Fedorovish Licea/0000-0003-4022-7405	Fondo Sectorial Salud-CONACyT [S008-2009-1114024]; CICESE [682110]	Fondo Sectorial Salud-CONACyT; CICESE	Funding was provided by Fondo Sectorial Salud-CONACyT under grant number S008-2009-1114024 and CICESE internal project 682110. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansaruzzaman M, 2005, J CLIN MICROBIOL, V43, P2559, DOI 10.1128/JCM.43.6.2559-2562.2005; Bej AK, 1999, J MICROBIOL METH, V36, P215, DOI 10.1016/S0167-7012(99)00037-8; Cabanillas-Beltran H, 2006, FEMS MICROBIOL LETT, V265, P76, DOI 10.1111/j.1574-6968.2006.00475.x; Centers for Disease Control and Prevention, 2006, RAP STAND LAB PROT M; Chen YS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-294; Chowdhury NR, 2000, EMERG INFECT DIS, V6, P631, DOI 10.3201/eid0606.000612; Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Hernandez-Diaz LD, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00221; DePaola A, 2000, APPL ENVIRON MICROB, V66, P4649, DOI 10.1128/AEM.66.11.4649-4654.2000; Drummond AJ, 2010, GENEIOUS 4 8; FDA BAM, 2004, BACT AN MAN; Food and Agriculture Organization of the United Nations/Word Health Organization (FAO/WHO), 2011, MICR RISK ASS SER, V16; Food and Drug Administratition (FAO), 2005, QUANT RISK ASS PUBL; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Fuenzalida L, 2006, ENVIRON MICROBIOL, V8, P675, DOI 10.1111/j.1462-2920.2005.00946.x; Gil AI, 2007, INT J INFECT DIS, V11, P324, DOI 10.1016/j.ijid.2006.08.003; Gonzalez-Escalona N, 2008, J BACTERIOL, V190, P2831, DOI 10.1128/JB.01808-07; Han HH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-570; Honda T., 1993, REV MED MICROBIOL, V4, P106, DOI DOI 10.1097/00013542-199304000-00006; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hurley CC, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-104; Iida T, 2001, EMERG INFECT DIS, V7, P477, DOI 10.3201/eid0703.017325; Leal NC, 2008, J APPL MICROBIOL, V105, P691, DOI 10.1111/j.1365-2672.2008.03782.x; LEE CY, 1995, APPL ENVIRON MICROB, V61, P1311, DOI 10.1128/AEM.61.4.1311-1317.1995; Lizarraga-Partida ML, 2009, J CLIN MICROBIOL, V47, P1364, DOI 10.1128/JCM.00720-08; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Martinez-Urtaza J, 2010, FOOD RES INT, V43, P1780, DOI 10.1016/j.foodres.2010.04.001; Matsumoto C, 2000, J CLIN MICROBIOL, V38, P578, DOI 10.1128/JCM.38.2.578-585.2000; Myers ML, 2003, APPL ENVIRON MICROB, V69, P2194, DOI 10.1128/AEM.69.4.2194-2200.2003; Nair GB, 2007, CLIN MICROBIOL REV, V20, P39, DOI 10.1128/CMR.00025-06; Nasu H, 2000, J CLIN MICROBIOL, V38, P2156; NISHIBUCHI M, 1995, INFECT IMMUN, V63, P2093, DOI 10.1128/IAI.63.6.2093-2099.1995; Okada N, 2009, INFECT IMMUN, V77, P904, DOI 10.1128/IAI.01184-08; Okuda N, 1997, J CLIN MICROBIOL, V35, P3150, DOI 10.1128/JCM.35.12.3150-3155.1997; Park KS, 2004, INFECT IMMUN, V72, P6659, DOI 10.1128/IAI.72.11.6659-6665.2004; Powell DR, 2013, BIOINFORMATICS, V29, P264, DOI 10.1093/bioinformatics/bts664; Quilici ML, 2005, EMERG INFECT DIS, V11, P1148; Revilla-Castellanos VJ, 2015, BIOFOULING, V31, P275, DOI 10.1080/08927014.2015.1038526; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turner JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055726; Velazquez-Roman J, 2012, APPL ENVIRON MICROB, V78, P1794, DOI 10.1128/AEM.06953-11; Wong HC, 2000, APPL ENVIRON MICROB, V66, P3981, DOI 10.1128/AEM.66.9.3981-3986.2000; Wong HC, 2007, INT J FOOD MICROBIOL, V114, P280, DOI 10.1016/j.ijfoodmicro.2006.09.024; Yeung PSM, 2002, APPL ENVIRON MICROB, V68, P2901, DOI 10.1128/AEM.68.6.2901-2909.2002	46	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0169722	10.1371/journal.pone.0169722	http://dx.doi.org/10.1371/journal.pone.0169722			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099500	Green Published, gold, Green Submitted			2022-12-26	WOS:000392380100030
J	Naruse, H; Fujisawa, TX; Yatsuga, C; Kubota, M; Matsuo, H; Takiguchi, S; Shimada, S; Imai, Y; Hiratani, M; Kosaka, H; Tomoda, A				Naruse, Hiroaki; Fujisawa, Takashi X.; Yatsuga, Chiho; Kubota, Masafumi; Matsuo, Hideaki; Takiguchi, Shinichiro; Shimada, Seiichiro; Imai, Yuto; Hiratani, Michio; Kosaka, Hirotaka; Tomoda, Akemi			Increased Anterior Pelvic Angle Characterizes the Gait of Children with Attention Deficit/Hyperactivity Disorder (ADHD)	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; MOTOR DYSFUNCTION; TRUNK MOVEMENT; AGE; VARIABILITY; MEDICATION; SYMPTOMS; SPEED	Background Children with attention deficit/hyperactivity disorder (ADHD) frequently have motor problems. Previous studies have reported that the characteristic gait in children with ADHD is immature and that subjects demonstrate higher levels of variability in gait characteristics for the lower extremities than healthy controls. However, little is known about body movement during gait in children with ADHD. The purpose of this study was to identify the characteristic body movements associated with ADHD symptoms in children with ADHD. Methods Using a three-dimensional motion analysis system, we compared gait variables in boys with ADHD (n = 19; mean age, 9.58 years) and boys with typical development (TD) (n = 21; mean age, 10.71 years) to determine the specific gait characteristics related to ADHD symptoms. We assessed spatiotemporal gait variables (i.e. speed, stride length, and cadence), and kinematic gait variables (i.e. angle of pelvis, hip, knee, and ankle) to measure body movement when walking at a self-selected pace. Results In comparison with the TD group, the ADHD group demonstrated significantly higher values in cadence (t=3.33, p = 0.002) and anterior pelvic angle (t=3.08, p=0.004). In multiple regression analysis, anterior pelvic angle was associated with the ADHD rating scale hyperactive/impulsive scores (beta = 0.62, t=2.58, p = 0.025), but not other psychiatric symptoms in the ADHD group. Conclusions Our results suggest that anterior pelvic angle represents a specific gait variable related to ADHD symptoms. Our kinematic findings could have potential implications for evaluating the body movement in boys with ADHD.	[Naruse, Hiroaki; Fujisawa, Takashi X.; Kosaka, Hirotaka; Tomoda, Akemi] Univ Fukui, United Grad Sch Child Dev, Div Dev Higher Brain Funct, Eiheiji, Fukui, Japan; [Naruse, Hiroaki; Kubota, Masafumi; Matsuo, Hideaki; Shimada, Seiichiro] Univ Fukui Hosp, Div Phys Therapy & Rehabil, Eiheiji, Fukui, Japan; [Fujisawa, Takashi X.; Yatsuga, Chiho; Hiratani, Michio; Kosaka, Hirotaka; Tomoda, Akemi] Univ Fukui, Res Ctr Child Mental Dev, Eiheiji, Fukui, Japan; [Yatsuga, Chiho] Natl Hosp Org Hizen Psychiat Ctr, Saga, Japan; [Takiguchi, Shinichiro] Univ Fukui Hosp, Dept Child & Adolescent Psychol Med, Eiheiji, Fukui, Japan; [Imai, Yuto; Hiratani, Michio] Hiratani Clin Dev Disorders Children, Fukui, Fukui, Japan	University of Fukui; University of Fukui; University of Fukui; University of Fukui	Tomoda, A (corresponding author), Univ Fukui, United Grad Sch Child Dev, Div Dev Higher Brain Funct, Eiheiji, Fukui, Japan.; Tomoda, A (corresponding author), Univ Fukui, Res Ctr Child Mental Dev, Eiheiji, Fukui, Japan.	atomoda@u-fukui.ac.jp	Matsuo, Hideaki/AAO-3489-2021; Takiguchi, Shinichiro/ABR-8555-2022; Fujisawa, Takashi/Z-4461-2019; Kosaka, Hirotaka/AFG-5500-2022	Matsuo, Hideaki/0000-0002-4848-2809; Takiguchi, Shinichiro/0000-0003-0911-0022; Kosaka, Hirotaka/0000-0003-2210-5025	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (KAKENHI) [26780516, 24300149, 15K12720]; Grants-in-Aid for Scientific Research [15K12720] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (KAKENHI, https://www.jsps.go.jp/englis/index.html, grant number 26780516 to Hiroaki Naruse; grant numbers 24300149 and 15K12720 to Akemi Tomoda). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Ashtari M, 2005, BIOL PSYCHIAT, V57, P448, DOI 10.1016/j.biopsych.2004.11.047; Assaiante C, 1998, NEUROSCI BIOBEHAV R, V22, P527, DOI 10.1016/S0149-7634(97)00040-7; Auyeung B, 2008, J AUTISM DEV DISORD, V38, P1230, DOI 10.1007/s10803-007-0504-z; Berquin PC, 1998, NEUROLOGY, V50, P1087, DOI 10.1212/WNL.50.4.1087; Buderath P, 2009, GAIT POSTURE, V29, P249, DOI 10.1016/j.gaitpost.2008.08.016; Calhoun M, 2011, CLIN BIOMECH, V26, P200, DOI 10.1016/j.clinbiomech.2010.09.013; Chester VL, 2006, CLIN BIOMECH, V21, P726, DOI 10.1016/j.clinbiomech.2006.02.007; Deconinck FJA, 2006, MOTOR CONTROL, V10, P125, DOI 10.1123/mcj.10.2.125; Fukuyama H, 1997, NEUROSCI LETT, V228, P183, DOI 10.1016/S0304-3940(97)00381-9; Hart H, 2013, JAMA PSYCHIAT, V70, P185, DOI 10.1001/jamapsychiatry.2013.277; Henderson S., 2007, MOVEMENT ASSESSMENT, DOI 10.1037/t55281-000; Heyrman L, 2013, GAIT POSTURE, V38, P770, DOI 10.1016/j.gaitpost.2013.03.019; HOF AL, 1996, GAIT POSTURE, V4, P222; Ivry R B, 1989, J Cogn Neurosci, V1, P136, DOI 10.1162/jocn.1989.1.2.136; Kadesjo B, 1998, DEV MED CHILD NEUROL, V40, P796; Karatekin C, 2003, PERCEPT MOTOR SKILL, V97, P1267, DOI 10.2466/pms.2003.97.3f.1267; Konicarova J, 2014, NEUROPSYCH DIS TREAT, V10, P85, DOI 10.2147/NDT.S56017; Leitner Y, 2007, J NEUROL, V254, P1330, DOI 10.1007/s00415-006-0522-3; Manicolo O, 2016, GAIT POSTURE, V44, P245, DOI 10.1016/j.gaitpost.2015.12.012; Morton SM, 2007, CEREBELLUM, V6, P79, DOI 10.1080/14734220601187741; Nakao T, 2011, AM J PSYCHIAT, V168, P1154, DOI 10.1176/appi.ajp.2011.11020281; Nayate A, 2012, J AUTISM DEV DISORD, V42, P707, DOI 10.1007/s10803-011-1299-5; Nobile M, 2011, AUTISM, V15, P263, DOI 10.1177/1362361309356929; Papadopoulos N, 2014, PSYCHIAT RES, V218, P319, DOI 10.1016/j.psychres.2014.04.037; Patankar V C, 2012, Indian J Psychiatry, V54, P159, DOI 10.4103/0019-5545.99540; Piek JP, 2007, DEV MED CHILD NEUROL, V49, P678, DOI 10.1111/j.1469-8749.2007.00678.x; Piek JP, 2010, DEV MED CHILD NEUROL, V52, P200, DOI 10.1111/j.1469-8749.2009.03326.x; Pitcher TM, 2003, DEV MED CHILD NEUROL, V45, P525, DOI 10.1111/j.1469-8749.2003.tb00952.x; Reiersen AM, 2008, J AM ACAD CHILD PSY, V47, P662, DOI 10.1097/CHI.0b013e31816bff88; Rosengren KS, 2009, GAIT POSTURE, V29, P225, DOI 10.1016/j.gaitpost.2008.08.005; Seidman LJ, 2005, BIOL PSYCHIAT, V57, P1263, DOI 10.1016/j.biopsych.2004.11.019; SUTHERLAND DH, 1980, J BONE JOINT SURG AM, V62, P336, DOI 10.2106/00004623-198062030-00004; Takakusaki K, 2004, PROG BRAIN RES, V143, P231, DOI 10.1016/S0079-6123(03)43023-9; Teicher MH, 1996, J AM ACAD CHILD PSY, V35, P334, DOI 10.1097/00004583-199603000-00015; Tervo RC, 2002, DEV MED CHILD NEUROL, V44, P383; Thomas R, 2015, PEDIATRICS, V135, pE994, DOI 10.1542/peds.2014-3482; Thummerer Y, 2012, GAIT POSTURE, V35, P23, DOI 10.1016/j.gaitpost.2011.07.018; Tsushima Hitoshi, 2003, J Jpn Phys Ther Assoc, V6, P9, DOI 10.1298/jjpta.6.9; Valera EM, 2007, BIOL PSYCHIAT, V61, P1361, DOI 10.1016/j.biopsych.2006.06.011; Wechsler D., 1991, WISC 3 WECHSLER INTE; Wechsler D., 2003, WISC 4 WECHSLER INTE, V4th ed.; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Zhang S, 2005, INT J METH PSYCH RES, V14, P186, DOI 10.1002/mpr.7	44	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170096	10.1371/journal.pone.0170096	http://dx.doi.org/10.1371/journal.pone.0170096			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI3HH	28099484	Green Published, gold, Green Submitted			2022-12-26	WOS:000392380100054
J	Serrano-Pozo, A; Sanchez-Garcia, MA; Heras-Garvin, A; March-Diaz, R; Navarro, V; Vizuete, M; Lopez-Barneo, J; Vitorica, J; Pascual, A				Serrano-Pozo, Alberto; Sanchez-Garcia, Manuel A.; Heras-Garvin, Antonio; March-Diaz, Rosana; Navarro, Victoria; Vizuete, Marisa; Lopez-Barneo, Jose; Vitorica, Javier; Pascual, Alberto			Acute and Chronic Sustained Hypoxia Do Not Substantially Regulate Amyloid-p Peptide Generation In Vivo	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; MOUSE MODEL; STEM-CELLS; BETA; DEMENTIA; DEPOSITION; STRESS; BRAIN; RISK	Background Recent epidemiological evidence has linked hypoxia with the development of Alzheimer disease (AD). A number of in vitro and in vivo studies have reported that hypoxia can induce amyloid-beta peptide accumulation through various molecular mechanisms including the up regulation of the amyloid-beta precursor protein, the beta-secretase Bace1, or the Upsilon-secretase complex components, as well as the down-regulation of A beta-degrading enzymes. Objectives To investigate the effects of acute and chronic sustained hypoxia in A beta generation in vivo. Methods 2-3 month-old C57/BI6J wild-type mice were exposed to either normoxia (21% 02) or hypoxia (9% 02) for either 4 to 72 h (acute) or 21-30 days (chronic sustained) in a hermetic chamber. Brain mRNA levels of A beta-related genes were measured by quantitative real-time PCR, whereas levels of Bace1 protein, full length A beta PP, and its C-terminal fragments (C99/C88 ratio) were measured by Western blot. In addition, 8 and 14-month-old APP/PS1 trans genic mice were subjected to 9% 02 for 21 days and levels of A beta(40), A beta(42), full length A beta PP, and soluble A beta PP alpha (sA beta PP alpha) were measured by ELISA or WB. Results Hypoxia (either acute or chronic sustained) did not impact the transcription of any of the A beta related genes in young wild-type mice. A significant reduction of Bace1 protein level was noted with acute hypoxia for 16 h but did not correlate with an increased level of full length A beta PP or a decreased C99/C83 ratio. Chronic sustained hypoxia did not significantly alter the levels of Bace1, full length A beta PP or the C99/C83 ratio. Last, chronic sustained hypoxia did not significantly change the levels of A beta(40), A beta(42), full length ApPP, or sA beta PP alpha in either young or aged APP/PS1 mice. Discussion Our results argue against a hypoxia-induced shift of A beta PP proteolysis from the non-amyloidogenic to the amyloidogenic pathways. We discuss the possible methodological caveats of previous in vivo studies.	[Serrano-Pozo, Alberto] Univ Iowa Hosp & Clin, Dept Neurol, Iowa City, IA 52242 USA; [Serrano-Pozo, Alberto; Sanchez-Garcia, Manuel A.; Heras-Garvin, Antonio; March-Diaz, Rosana; Navarro, Victoria; Vizuete, Marisa; Lopez-Barneo, Jose; Vitorica, Javier; Pascual, Alberto] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBiS, Seville, Spain; [Navarro, Victoria; Vizuete, Marisa; Vitorica, Javier] Univ Seville, Fac Farm, Dept Bioquim & Biol Mol, Seville, Spain; [Navarro, Victoria; Vizuete, Marisa; Lopez-Barneo, Jose; Vitorica, Javier] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain	University of Iowa; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; University of Sevilla; CIBERNED	Serrano-Pozo, A (corresponding author), Univ Iowa Hosp & Clin, Dept Neurol, Iowa City, IA 52242 USA.; Serrano-Pozo, A (corresponding author), Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBiS, Seville, Spain.	alberto-serranopozo@uiowa.edu; apascual-ibis@us.es	Pascual, Alberto/L-2014-2019; Pascual, Alberto P/E-9609-2015; Navarro Garrido, Victoria/U-2291-2017; Serrano-Pozo, Alberto/L-1519-2019	Pascual, Alberto/0000-0001-5459-6207; Pascual, Alberto P/0000-0001-5459-6207; Navarro Garrido, Victoria/0000-0002-4385-9697; Serrano-Pozo, Alberto/0000-0003-0899-7530; Sanchez-Garcia, Manuel Alejandro/0000-0003-3914-2332; HERAS-GARVIN, ANTONIO/0000-0003-2231-2681	Spanish Ministries of Science and Innovation and Health [SAF2012-33816, SAF2015-64111-R, PIE13/00004]; Regional Ministry of Economia, Innovacion, Ciencia y Empleo [CTS-2138]; CEC; FEDER; Fondo de lnvestigaciones Sanitarias/lnstituto de Salud Carlos III of the Spanish Ministry of Science and Innovation [CM06/00161]; FPI program; "Sara Borrell" program; Spanish Ministry of Science and Innovation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R25NS079173] Funding Source: NIH RePORTER	Spanish Ministries of Science and Innovation and Health; Regional Ministry of Economia, Innovacion, Ciencia y Empleo; CEC; FEDER(European Commission); Fondo de lnvestigaciones Sanitarias/lnstituto de Salud Carlos III of the Spanish Ministry of Science and Innovation; FPI program; "Sara Borrell" program; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Spanish Ministries of Science and Innovation and Health (SAF2012-33816, SAF2015-64111-R and PIE13/00004) and by the grant CTS-2138 from the Regional Ministry of Economia, Innovacion, Ciencia y Empleo, co-funded by CEC and FEDER funds. AS-P was funded with a fellowship from the Fondo de lnvestigaciones Sanitarias/lnstituto de Salud Carlos III of the Spanish Ministry of Science and Innovation (CM06/00161). AH-G received a predoctoral fellowship of the FPI program, RM-D a contract from the "Sara Borrell" program, and MAS-G a predoctoral fellowship (FPU program) from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burger S, 2009, INT J DEV NEUROSCI, V27, P517, DOI 10.1016/j.ijdevneu.2009.06.011; Chen GJ, 2003, J ALZHEIMERS DIS, V5, P209, DOI 10.3233/JAD-2003-5305; Cuadrado-Tejedor M, 2012, J ALZHEIMERS DIS, V28, P567, DOI 10.3233/JAD-2011-110572; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; de Tassigny XD, 2015, HYPOXIA, V3, P15, DOI 10.2147/HP.S78248; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Esiri MM, 2001, LANCET, V357, P169; Gao LB, 2013, J MOL NEUROSCI, V51, P138, DOI 10.1007/s12031-013-9966-y; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Green KN, 2006, J NEUROSCI, V26, P9047, DOI 10.1523/JNEUROSCI.2797-06.2006; Guglielmotto M, 2009, J NEUROCHEM, V108, P1045, DOI 10.1111/j.1471-4159.2008.05858.x; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Jeong YH, 2006, FASEB J, V20, P729, DOI 10.1096/fj.05-4265fje; Kerridge C, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00426; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Li L, 2009, NEUROBIOL AGING, V30, P1091, DOI 10.1016/j.neurobiolaging.2007.10.011; Liao KM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000930; Liu H, CHRONIC HYPOXIA FACI; Nik SHM, 2012, J ALZHEIMERS DIS, V28, P515, DOI 10.3233/JAD-2011-110533; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Osorio RS, 2015, NEUROLOGY, V84, P1964, DOI 10.1212/WNL.0000000000001566; Pardal R, 2007, CELL, V131, P364, DOI 10.1016/j.cell.2007.07.043; Rosenzweig I, 2015, LANCET RESP MED, V3, P404, DOI 10.1016/S2213-2600(15)00090-9; Rusanen M, 2013, CURR ALZHEIMER RES, V10, P549, DOI 10.2174/1567205011310050011; Ryu J, 2009, J UBIQUIT CONV TECHN, V3, P13; Saido T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006379; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Sharp FR, 2004, NAT REV NEUROSCI, V5, P437, DOI 10.1038/nrn1408; Shiota S, 2013, J ALZHEIMERS DIS, V37, P325, DOI 10.3233/JAD-130419; Smith IF, 2004, J NEUROCHEM, V88, P869, DOI 10.1016/j.1471-4159.2003.02212.x; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Wang R, 2006, HIGHWAY, V2006, P1; Wilson MH, 2009, LANCET NEUROL, V8, P175, DOI 10.1016/S1474-4422(09)70014-6; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115; Zhang X, 2007, J BIOL CHEM, V282, P10873, DOI 10.1074/jbc.M608856200; Zhang X, 2013, NEUROBIOL AGING, V34, P663, DOI 10.1016/j.neurobiolaging.2012.06.012	42	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170345	10.1371/journal.pone.0170345	http://dx.doi.org/10.1371/journal.pone.0170345			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099462	gold, Green Published, Green Submitted			2022-12-26	WOS:000392380100076
J	Li, SF; Shi, YX; Zheng, K; Dai, J; Li, XB; Yuan, S; Chen, L; Huang, JC				Li, Shufen; Shi, Yongxia; Zheng, Kui; Dai, Jun; Li, Xiaobo; Yuan, Shuai; Chen, Ling; Huang, Jicheng			Morphologic and Molecular Characterization of a Strain of Zika Virus Imported into Guangdong, China	PLOS ONE			English	Article							SOUTH-PACIFIC; DENGUE; MOSQUITOS; EPIDEMIC	The recent outbreaks of Zika virus (ZIKV) disease have caused worldwide concerns. Guangdong province is one of the commercial centers in China and communicates frequently with the epidemic areas. To date, 65.2% of the ZIKV infection cases in China were imported via port of entry in Guangdong. The continuous surveillance of imported cases is crucial for the prevention and control of potential ZIKV infection outbreak in China. In this study, a strain of ZIKV was isolated from the serum of a 6-year-old child returning from Venezuela. The morphology of the ZIKV was analyzed in vivo and in vitro by electron microscopy, and clusters of virus particles were found in the loose cytoplasmic membrane structures. The genomic sequence of the isolated ZIKV was determined, and the alignment and phylogenetic analysis identified one unique amino acid substitution occurring in the non-structural protein 4B (NS4B), and the isolated virus belonged to the Asian lineage.	[Li, Shufen; Shi, Yongxia; Zheng, Kui; Dai, Jun; Li, Xiaobo; Yuan, Shuai; Huang, Jicheng] Guangdong Entry Exit Inspect & Quarantine Bur, Inspect & Quarantine Technol Ctr, Guangzhou, Guangdong, Peoples R China; [Li, Shufen; Chen, Ling] Guangzhou Med Univ, State Key Lab Resp Dis, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Huang, JC (corresponding author), Guangdong Entry Exit Inspect & Quarantine Bur, Inspect & Quarantine Technol Ctr, Guangzhou, Guangdong, Peoples R China.	jichenghuang@126.com			China Postdoctoral Science Foundation [2016M592458]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was funded by China Postdoctoral Science Foundation (Grant No. 2016M592458).	Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107; Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607; Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816; Chatel-Chaix L, 2015, J VIROL, V89, P7170, DOI 10.1128/JVI.00867-15; Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5; Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553; Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636; Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894; Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI 10.3201/eid2011.141253; HASE T, 1987, ARCH VIROL, V96, P135, DOI 10.1007/BF01320956; Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017; Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792; MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1; Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9; MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Moron AF, 2016, BJOG-INT J OBSTET GY, V123, P1265, DOI 10.1111/1471-0528.14072; Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021; Naik NG, 2015, J VIROL, V89, P6746, DOI 10.1128/JVI.00423-15; Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929; SRIURAIRATNA S, 1973, INFECT IMMUN, V8, P1017, DOI 10.1128/IAI.8.6.1017-1028.1973; Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5; Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4; Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007	30	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0169256	10.1371/journal.pone.0169256	http://dx.doi.org/10.1371/journal.pone.0169256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095443	Green Published, gold, Green Submitted			2022-12-26	WOS:000392372300018
J	Olivares-Navarrete, R; Lee, EM; Smith, K; Hyzy, SL; Doroudi, M; Williams, JK; Gall, K; Boyan, BD; Schwartz, Z				Olivares-Navarrete, Rene; Lee, Erin M.; Smith, Kathryn; Hyzy, Sharon L.; Doroudi, Maryam; Williams, Joseph K.; Gall, Ken; Boyan, Barbara D.; Schwartz, Zvi			Substrate Stiffness Controls Osteoblastic and Chondrocytic Differentiation of Mesenchymal Stem Cells without Exogenous Stimuli	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; OSTEOGENIC DIFFERENTIATION; ARTICULAR CHONDROCYTES; PERICELLULAR MATRIX; DENTAL IMPLANTS; BONE-MARROW; CARTILAGE; RUNX2; BETA-1-INTEGRINS; ELASTICITY	Stem cell fate has been linked to the mechanical properties of their underlying substrate, affecting mechanoreceptors and ultimately leading to downstream biological response. Studies have used polymers to mimic the stiffness of extracellular matrix as well as of individual tissues and shown mesenchymal stem cells (MSCs) could be directed along specific lineages. In this study, we examined the role of stiffness in MSC differentiation to two closely related cell phenotypes: osteoblast and chondrocyte. We prepared four methyl acrylate/methyl methacrylate (MA/MMA) polymer surfaces with elastic moduli ranging from 0.1 MPa to 310 MPa by altering monomer concentration. MSCs were cultured in media without exogenous growth factors and their biological responses were compared to committed chondrocytes and osteoblasts. Both chondrogenic and osteogenic markers were elevated when MSCs were grown on substrates with stiffness <10 MPa. Like chondrocytes, MSCs on lower stiffness substrates showed elevated expression of ACAN, SOX9, and COL2 and proteoglycan content; COMP was elevated in MSCs but reduced in chondrocytes. Substrate stiffness altered levels of RUNX2 mRNA, alkaline phosphatase specific activity, osteocalcin, and osteoprotegerin in osteoblasts, decreasing levels on the least stiff substrate. Expression of integrin subunits alpha 1, alpha 2, alpha 5, alpha v, beta 1, and beta 3 changed in a stiffness-and cell type-dependent manner. Silencing of integrin subunit beta 1 (ITGB1) in MSCs abolished both osteoblastic and chondrogenic differentiation in response to substrate stiffness. Our results suggest that substrate stiffness is an important mediator of osteoblastic and chondrogenic differentiation, and integrin beta 1 plays a pivotal role in this process.	[Olivares-Navarrete, Rene; Hyzy, Sharon L.; Boyan, Barbara D.; Schwartz, Zvi] Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA 23284 USA; [Lee, Erin M.; Boyan, Barbara D.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Smith, Kathryn; Gall, Ken] Medshape Inc, Atlanta, GA USA; [Doroudi, Maryam] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Williams, Joseph K.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Gall, Ken] Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27706 USA; [Schwartz, Zvi] Univ Texas Hlth Sci Ctr San Antonio, Dept Periodont, San Antonio, TX 78229 USA	Virginia Commonwealth University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Children's Healthcare of Atlanta (CHOA); Duke University; University of Texas System; University of Texas Health San Antonio	Boyan, BD (corresponding author), Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA 23284 USA.; Boyan, BD (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	bboyan@vcu.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [AR054339, AR052102]; MedShape, Inc.	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); MedShape, Inc.	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (http://www.niams.nih.gov/) under Award Numbers AR054339 received by KG and BDB and AR052102 received by BDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KS is an employee of MedShape, Inc. KS and KG have equity in MedShape, Inc. MedShape, Inc. provided support in the form of salary for author KS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhami MD, 2014, CONNECT TISSUE RES, V55, P102, DOI 10.3109/03008207.2014.923873; Alexopoulos LG, 2005, J BIOMECH, V38, P509, DOI 10.1016/j.jbiomech.2004.04.012; Angele P, 2009, J BIOMED MATER RES A, V91A, P416, DOI 10.1002/jbm.a.32236; Bayati V, 2013, J MATER SCI-MATER M, V24, P2439, DOI 10.1007/s10856-013-4983-5; Bougault C, 2013, J BIOMECH, V46, P1633, DOI 10.1016/j.jbiomech.2013.04.013; Bruderer M, 2014, EUR CELLS MATER, V28, P269, DOI 10.22203/eCM.v028a19; Chandler EM, 2011, BIOTECHNOL BIOENG, V108, P1683, DOI 10.1002/bit.23079; Chung C, 2008, TISSUE ENG PT A, V14, P1121, DOI [10.1089/ten.tea.2007.0291, 10.1089/tea.2007.0291]; Darling EM, 2010, BIOPHYS J, V98, P2848, DOI 10.1016/j.bpj.2010.03.037; Dieudonne FX, 2013, STEM CELLS, V31, P1340, DOI 10.1002/stem.1380; Du J, 2011, P NATL ACAD SCI USA, V108, P9466, DOI 10.1073/pnas.1106467108; Elisseeff J, 2004, EXPERT OPIN BIOL TH, V4, P1849, DOI 10.1517/14712598.4.12.1849; ENGEL FE, 1990, J DENT RES, V69, P1753, DOI 10.1177/00220345900690110801; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; ENOMOTO M, 1993, EXP CELL RES, V205, P276, DOI 10.1006/excr.1993.1087; Frith JE, 2012, STEM CELLS DEV, V21, P2442, DOI 10.1089/scd.2011.0615; Genes NG, 2004, ARCH BIOCHEM BIOPHYS, V422, P161, DOI 10.1016/j.abb.2003.11.023; Guillemot F, 2005, EXPERT REV MED DEVIC, V2, P741, DOI 10.1586/17434440.2.6.741; Her GJ, 2013, ACTA BIOMATER, V9, P5170, DOI 10.1016/j.actbio.2012.10.012; Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]; Keogh MB, 2010, ACTA BIOMATER, V6, P4305, DOI 10.1016/j.actbio.2010.06.001; Keselowsky BG, 2007, J BIOMED MATER RES A, V80A, P700, DOI 10.1002/jbm.a.30898; Kitaoka E, 2001, J CELL BIOCHEM, V81, P571, DOI 10.1002/jcb.1075; Lee HJ, 2015, J PERIODONTAL IMPLAN, V45, P94, DOI 10.5051/jpis.2015.45.3.94; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Li XM, 2014, J BIOMED MATER RES A, V102, P1092, DOI 10.1002/jbm.a.34774; LOESER RF, 1995, EXP CELL RES, V217, P248, DOI 10.1006/excr.1995.1084; Lohan A, 2011, HISTOCHEM CELL BIOL, V136, P57, DOI 10.1007/s00418-011-0822-2; Lohan A, 2014, ANN ANAT, V196, P317, DOI 10.1016/j.aanat.2014.03.002; Calvo-Guirado JL, 2015, CLIN ORAL IMPLAN RES, V26, P507, DOI 10.1111/clr.12433; Marletta G, 2007, BIOMATERIALS, V28, P1132, DOI 10.1016/j.biomaterials.2006.10.027; Munoz-Pinto DJ, 2012, TISSUE ENG PT A, V18, P1710, DOI [10.1089/ten.TEA.2011.0348, 10.1089/ten.tea.2011.0348]; Murphy CM, 2012, J MECH BEHAV BIOMED, V11, P53, DOI 10.1016/j.jmbbm.2011.11.009; Nava MM, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/797410; Olivares-Navarrete R, 2008, P NATL ACAD SCI USA, V105, P15767, DOI 10.1073/pnas.0805420105; Olivares-Navarrete R, 2012, J BONE MINER RES, V27, P1773, DOI 10.1002/jbmr.1628; Olivares-Navarrete R, 2010, BIOMATERIALS, V31, P2728, DOI 10.1016/j.biomaterials.2009.12.029; Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019; Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009; Rho JY, 1997, BIOMATERIALS, V18, P1325, DOI 10.1016/S0142-9612(97)00073-2; Sanz-Ramos P, 2012, OSTEOARTHR CARTILAGE, V20, P931, DOI 10.1016/j.joca.2012.04.022; Sartoretto SC, 2015, J APPL ORAL SCI, V23, P279, DOI 10.1590/1678-775720140483; SCHWARTZ Z, 1988, ENDOCRINOLOGY, V123, P2878, DOI 10.1210/endo-123-6-2878; Schwarz F, 2009, J BIOMED MATER RES B, V88B, P544, DOI 10.1002/jbm.b.31233; Seib FP, 2009, BIOCHEM BIOPH RES CO, V389, P663, DOI 10.1016/j.bbrc.2009.09.051; Shih YRV, 2011, J BONE MINER RES, V26, P730, DOI 10.1002/jbmr.278; Smith KE, 2011, ACTA BIOMATER, V7, P558, DOI 10.1016/j.actbio.2010.09.001; Smith KE, 2010, BIOMATERIALS, V31, P6131, DOI 10.1016/j.biomaterials.2010.04.033; Steward AJ, 2013, EUR CELLS MATER, V25, P167, DOI 10.22203/eCM.v025a12; Sun J, 2012, CELLS TISSUES ORGANS, V196, P510, DOI 10.1159/000339245; Thompson ID, 1998, P I MECH ENG H, V212, P127, DOI 10.1243/0954411981533908; Viswanathan P, 2015, BIOMATERIALS, V52, P140, DOI 10.1016/j.biomaterials.2015.01.034; Wang JR, 2014, GROWTH HORM IGF RES, V24, P245, DOI 10.1016/j.ghir.2014.10.003; Willems NMBK, 2014, MAT SCI ENG C-MATER, V42, P15, DOI 10.1016/j.msec.2014.05.006; Witkowska-Zimny M, 2012, ACTA BIOCHIM POL, V59, P261; Xu JW, 2004, PLAST RECONSTR SURG, V113, P1361, DOI 10.1097/01.PRS.0000111594.52661.29; Xue RY, 2013, J ORTHOP RES, V31, P1360, DOI 10.1002/jor.22374; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041	58	90	94	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0170312	10.1371/journal.pone.0170312	http://dx.doi.org/10.1371/journal.pone.0170312			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095466	Green Published, gold, Green Submitted			2022-12-26	WOS:000392372300078
J	Kiseleva, R; Greineder, CF; Villa, CH; Hood, ED; Shuvaev, VV; Sung, J; Chacko, AM; Abraham, V; DeLisser, HM; Muzykantov, VR				Kiseleva, Raisa; Greineder, Colin F.; Villa, Carlos H.; Hood, Elizabeth D.; Shuvaev, Vladimir V.; Sung, Jing; Chacko, Ann-Marie; Abraham, Valsamma; DeLisser, Horace M.; Muzykantov, Vladimir R.			Mechanism of Collaborative Enhancement of Binding of Paired Antibodies to Distinct Epitopes of Platelet Endothelial Cell Adhesion Molecule-1	PLOS ONE			English	Article							PECAM-TARGETED DELIVERY; CONFORMATIONAL-CHANGES; HEMOPHILIC BINDING; IN-VITRO; DOMAINS; NANOCARRIERS; OXIDASE; ICAM-1; GENE; CD31	Monoclonal antibodies (mAbs) directed to extracellular epitopes of human and mouse Platelet Endothelial Cell Adhesion Molecule-1 (CD31 or PECAM-1) stimulate binding of other mAbs to distinct adjacent PECAM-1 epitopes. This effect, dubbed Collaborative Enhancement of Paired Affinity Ligands, or CEPAL, has been shown to enhance delivery of mAb-targeted drugs and nanoparticles to the vascular endothelium. Here we report new insights into the mechanism underlying this effect, which demonstrates equivalent amplitude in the following models: i) cells expressing a full length PECAM-1 and mutant form of PECAM-1 unable to form homodimers; ii) isolated fractions of cellular membranes; and, iii) immobilized recombinant PECAM-1. These results indicate that CEPAL is mediated not by interference in cellular functions or homophilic PECAM-1 interactions, but rather by conformational changes within the cell adhesion molecule induced by ligand binding. This mechanism, mediated by exposure of partially occult epitopes, is likely to occur in molecules other than PECAM-1 and may represent a generalizable phenomenon with valuable practical applications.	[Kiseleva, Raisa; Greineder, Colin F.; Villa, Carlos H.; Hood, Elizabeth D.; Shuvaev, Vladimir V.; Muzykantov, Vladimir R.] Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sung, Jing; Abraham, Valsamma; DeLisser, Horace M.] Univ Penn, Pulm Allergy & Crit Care Div, Perelman Sch Med, Philadelphia, PA 19104 USA; [Chacko, Ann-Marie] Duke NUS Med Sch, Lab Translat & Mol Imaging, Singapore, Singapore; [Abraham, Valsamma; DeLisser, Horace M.] Corporal Michael J Crescenz Vet Affairs Med Ctr P, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; National University of Singapore	Muzykantov, VR (corresponding author), Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA.	muzykant@mail.med.upenn.edu	DeLisser, Horace/AFM-1942-2022	Kiseleva, Raisa/0000-0001-8065-3551; Chacko, Ann-Marie/0000-0001-5140-2622; Greineder, Colin/0000-0001-9740-7672	National Institutes of Health [R01-HL126874, R01-HL128398]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007439, T32HL007775, K08HL130430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant R01-HL126874 (V.R.M.) and R01-HL128398 (V.R.M.).	ALBELDA SM, 1990, J CELL BIOL, V110, P1227, DOI 10.1083/jcb.110.4.1227; BALDWIN HS, 1994, DEVELOPMENT, V120, P2539; BRADEN BC, 1995, FASEB J, V9, P9, DOI 10.1096/fasebj.9.1.7821765; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Carnemolla R, 2011, IUBMB LIFE, V63, P632, DOI 10.1002/iub.474; Chacko AM, 2015, ACS NANO, V9, P6785, DOI 10.1021/nn505672x; Chacko AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034958; Christofidou-Solomidou M, 2000, AM J PHYSIOL-LUNG C, V278, pL794, DOI 10.1152/ajplung.2000.278.4.L794; Dan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081051; Ding BS, 2005, BLOOD, V106, P4191, DOI 10.1182/blood-2005-05-2002; Dupont B, 1989, IMMUNOBIOLOGY OF HLA; Greineder CF, 2015, FASEB J, V29, P3483, DOI 10.1096/fj.15-271213; Guo P, 2014, P NATL ACAD SCI USA, V111, P14710, DOI 10.1073/pnas.1408556111; Hood ED, 2012, J CONTROL RELEASE, V163, P161, DOI 10.1016/j.jconrel.2012.08.031; LEAVESLEY DI, 1994, J IMMUNOL, V153, P4673; Li S, 2000, AM J PHYSIOL-LUNG C, V278, pL504, DOI 10.1152/ajplung.2000.278.3.L504; Liao F, 2002, CANCER RES, V62, P2567; Lu E, 2003, CIRCULATION, P108; Muro S, 2003, J CELL SCI, V116, P1599, DOI 10.1242/jcs.00367; Muro S, 2006, J PHARMACOL EXP THER, V317, P1161, DOI 10.1124/jpet.105.098970; Newton JP, 1997, J BIOL CHEM, V272, P20555, DOI 10.1074/jbc.272.33.20555; Nieva JL, 2011, J MOL RECOGNIT, V24, P642, DOI 10.1002/jmr.1092; Oda M, 2003, INT IMMUNOL, V15, P417, DOI 10.1093/intimm/dxg036; Paddock C, 2016, BLOOD, V127, P1052, DOI 10.1182/blood-2015-07-660092; Rabelink TJ, 2012, AM J PHYSIOL-RENAL, V302, p1630 ; Sagawa T, 2005, MOL IMMUNOL, V42, P9, DOI 10.1016/j.molimm.2004.07.004; Shamay Y, 2016, SCI TRANSL MED, P8; Shuvaev V V., 2007, J PHARMACOL EXP THER, P323; Shuvaev VV, 2011, FASEB J, V25, P348, DOI 10.1096/fj.10-169789; Shuvaev VV, 2009, J PHARMACOL EXP THER, V331, P404, DOI 10.1124/jpet.109.156877; SMYTHE WR, 1994, CANCER RES, V54, P2055; Sun J, 1996, J BIOL CHEM, V271; Sun QH, 1996, J BIOL CHEM, V271, P11090, DOI 10.1074/jbc.271.19.11090; YAN HC, 1995, CELL ADHES COMMUN, V3, P45, DOI 10.3109/15419069509081277	34	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0169537	10.1371/journal.pone.0169537	http://dx.doi.org/10.1371/journal.pone.0169537			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085903	Green Published, gold, Green Submitted			2022-12-26	WOS:000391972600022
J	Trevizani, R; Custodio, FL; dos Santos, KB; Dardenne, LE				Trevizani, Raphael; Custodio, Fabio Lima; dos Santos, Karina Baptista; Dardenne, Laurent Emmanuel			Critical Features of Fragment Libraries for Protein Structure Prediction	PLOS ONE			English	Article							I-TASSER; ROSETTA; SERVER; CONFORMATION; SEQUENCES; PROSPECTS; DATABASE; DESIGN; MOTIFS; FOLDS	The use of fragment libraries is a popular approach among protein structure prediction methods and has proven to substantially improve the quality of predicted structures. However, some vital aspects of a fragment library that influence the accuracy of modeling a native structure remain to be determined. This study investigates some of these features. Particularly, we analyze the effect of using secondary structure prediction guiding fragments selection, different fragments sizes and the effect of structural clustering of fragments within libraries. To have a clearer view of how these factors affect protein structure prediction, we isolated the process of model building by fragment assembly from some common limitations associated with prediction methods, e.g., imprecise energy functions and optimization algorithms, by employing an exact structure-based objective function under a greedy algorithm. Our results indicate that shorter fragments reproduce the native structure more accurately than the longer. Libraries composed of multiple fragment lengths generate even better structures, where longer fragments show to be more useful at the beginning of the simulations. The use of many different fragment sizes shows little improvement when compared to predictions carried out with libraries that comprise only three different fragment sizes. Models obtained from libraries built using only sequence similarity are, on average, better than those built with a secondary structure prediction bias. However, we found that the use of secondary structure prediction allows greater reduction of the search space, which is invaluable for prediction methods. The results of this study can be critical guidelines for the use of fragment libraries in protein structure prediction.	[Trevizani, Raphael] Fundacao Oswaldo Cruz, FIOCRUZ, Fortaleza, Ceara, Brazil; [Custodio, Fabio Lima; dos Santos, Karina Baptista; Dardenne, Laurent Emmanuel] Lab Nacl Computacao Cient, Grp Modelagem Mol Sistemas Biol, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Laboratorio Nacional de Computacao Cientifica (LNCC)	Trevizani, R (corresponding author), Fundacao Oswaldo Cruz, FIOCRUZ, Fortaleza, Ceara, Brazil.	raphael.trevizani@fiocruz.br		Trevizani, Raphael/0000-0002-9029-5329; Baptista dos Santos, Karina/0000-0001-9202-4584; Dardenne, Laurent/0000-0001-8518-8062	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro [FAPERJ - N. E-26/010.001229/2015]	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was funded by Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (www.faperj.br/, FAPERJ - N. E-26/010.001229/2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbass J, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0576-2; [Anonymous], 2015, THE 16TH INTERNATION; Baeten L, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000083; Bonneau R, 2001, ANNU REV BIOPH BIOM, V30, P173, DOI 10.1146/annurev.biophys.30.1.173; Bradley P, 2003, PROTEINS, V53, P457, DOI 10.1002/prot.10552; Custodio FL, 2014, APPL SOFT COMPUT, V15, P88, DOI 10.1016/j.asoc.2013.10.029; FIDELIS K, 1994, PROTEIN ENG, V7, P953, DOI 10.1093/protein/7.8.953; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gront D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023294; HAN KF, 1995, J MOL BIOL, V251, P176, DOI 10.1006/jmbi.1995.0424; Handl J, 2012, PROTEINS, V80, P490, DOI 10.1002/prot.23215; Haspel N, 2003, PROTEIN SCI, V12, P1177, DOI 10.1110/ps.0232903; Holmes JB, 2004, PROTEIN SCI, V13, P1636, DOI 10.1110/ps.03494504; Jones DT, 2003, PROTEINS, V53, P480, DOI 10.1002/prot.10542; Jones DT, 2001, PROTEINS, P127; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jones DT, 1997, PROTEINS, P185; JONES TA, 1986, EMBO J, V5, P819, DOI 10.1002/j.1460-2075.1986.tb04287.x; Kalev I, 2011, BIOINFORMATICS, V27, P3110, DOI 10.1093/bioinformatics/btr541; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kolodny R, 2002, J MOL BIOL, V323, P297, DOI 10.1016/S0022-2836(02)00942-7; LEVITT M, 1992, J MOL BIOL, V226, P507, DOI 10.1016/0022-2836(92)90964-L; Liu JF, 2007, NAT BIOTECHNOL, V25, P850, DOI 10.1038/nbt0807-849; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; Rohl CA, 2004, PROTEINS, V55, P656, DOI 10.1002/prot.10629; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Unger R, 2004, CELL ORIGIN LIFE EXT, V8, P177; Vanhee P, 2011, NUCLEIC ACIDS RES, V39, pD435, DOI 10.1093/nar/gkq972; VENKATACHALAM CM, 1968, BIOPOLYMERS, V6, P1425, DOI 10.1002/bip.1968.360061006; Verschueren E, 2011, CURR OPIN STRUC BIOL, V21, P452, DOI 10.1016/j.sbi.2011.05.002; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Xu D, 2013, PROTEINS, V81, P229, DOI 10.1002/prot.24179; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zemla A, 1999, PROTEINS, P22; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	42	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0170131	10.1371/journal.pone.0170131	http://dx.doi.org/10.1371/journal.pone.0170131			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085928	Green Submitted, Green Published, gold			2022-12-26	WOS:000391972600065
J	Castronovo, G; Clemente, AM; Antonelli, A; D'Andrea, MM; Tanturli, M; Perissi, E; Paccosi, S; Parenti, A; Cozzolino, F; Rossolini, GM; Torcia, MG				Castronovo, Giuseppe; Clemente, Ann Maria; Antonelli, Alberto; D'Andrea, Marco Maria; Tanturli, Michele; Perissi, Eloise; Paccosi, Sara; Parenti, Astrid; Cozzolino, Federico; Rossolini, Gian Maria; Torcia, Maria Gabriella			Differences in Inflammatory Response Induced by Two Representatives of Clades of the Pandemic ST258 Klebsiella pneumoniae Clonal Lineage Producing KPC-Type Carbapenemases	PLOS ONE			English	Article							SEQUENCE TYPE 258; NF-KAPPA-B; CAPSULAR POLYSACCHARIDE; DENDRITIC CELLS; HOST-DEFENSE; ACTIVATION; INFECTION; EPIDEMIOLOGY; MECHANISMS; RESISTANCE	ST258-K. pneumoniae (ST258-KP) strains, the most widespread multidrug-resistant hospital -acquired pathogens, belong to at least two clades differing in a 215 Kb genomic region that includes the cluster of capsule genes. To investigate the effects of the different capsular phenotype on host-pathogen interactions, we studied representatives of ST258-KP clades, KKBO-1 and KK207-1, for their ability to activate monocytes and myeloid dendritic cells from human immune competent hosts. The two ST258-KP strains strongly induced the production of inflammatory cytokines. Significant differences between the strains were found in their ability to induce the production of IL-1 beta: KK207-1/clade I was much less effective than KKBO-1/clade II in inducing IL-1 beta production by monocytes and dendritic cells. The activation of NLRP3 inflammasome pathway by live cells and/or purified capsular polysaccharides was studied in monocytes and dendritic cells. We found that glibenclamide, a NLRP3 inhibitor, inhibits more than 90% of the production of mature IL-1 beta induced by KKBO1 and KK207-1. KK207-1 was always less efficient compared to KKBO-1 in: a) inducing NLRP3 and pro-IL-1 beta gene and protein expression; b) in inducing caspase-1 activation and prod L113 cleavage. Capsular composition may play a role in the differential inflammatory response induced by the ST258-KP strains since capsular polysaccharides purified from bacterial cells affect NLRP3 and pro-IL-1 beta gene expression through p38MAPK-and NF-kappa B-mediated pathways. In each of these functions, capsular polysaccharides from KK207-1 were significantly less efficient compared to those purified from KKBO-1. On the whole, our data suggest that the change in capsular phenotype may help bacterial cells of Glade Ito partially escape innate immune recognition and IL-1 beta-mediated inflammation.	[Castronovo, Giuseppe; Clemente, Ann Maria; Antonelli, Alberto; D'Andrea, Marco Maria; Perissi, Eloise; Rossolini, Gian Maria; Torcia, Maria Gabriella] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Antonelli, Alberto; D'Andrea, Marco Maria; Rossolini, Gian Maria] Univ Siena, Dept Med Biotechnol, Siena, Italy; [Tanturli, Michele; Cozzolino, Federico] Univ Florence, Dept Expt & Clin Biomed Sci, Florence, Italy; [Paccosi, Sara; Parenti, Astrid] Univ Florence, Dept Hlth Sci, Florence, Italy; [Rossolini, Gian Maria] Careggi Univ Hosp, Clin Microbiol & Virol Unit, Florence, Italy; [Rossolini, Gian Maria] IRCCS Don Carlo Gnocchi Fdn, Florence, Italy	University of Florence; University of Siena; University of Florence; University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi	Torcia, MG (corresponding author), Univ Florence, Dept Expt & Clin Med, Florence, Italy.	torcia@unifi.it	Antonelli, Alberto/V-8418-2017; Torcia, Maria Gabriella G/K-1840-2018; D'Andrea, Marco Maria/H-6351-2019	Antonelli, Alberto/0000-0003-0295-6877; Torcia, Maria Gabriella G/0000-0003-4740-4646; D'Andrea, Marco Maria/0000-0003-3187-3210; Cozzolino, Federico/0000-0002-2800-640X; Tanturli, Michele/0000-0002-2642-1706; Clemente, Ann Maria/0000-0003-0386-590X; CASTRONOVO, GIUSEPPE/0000-0003-2237-6765	Cassa di Risparmio di Firenze -CDRF- foundation [2014.0740]	Cassa di Risparmio di Firenze -CDRF- foundation	GC was supported by Cassa di Risparmio di Firenze -CDRF- foundation, grant number 2014.0740 (http://www.entecarifirenze.it/aree-di-intervento/ricerca-scientifica-e-innovazione-tecnologica/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arena F, 2016, ANTIMICROB AGENTS CH; Ben-David D, 2012, CLIN MICROBIOL INFEC, V18, P54, DOI 10.1111/j.1469-0691.2011.03478.x; Borer A, 2009, INFECT CONT HOSP EP, V30, P972, DOI 10.1086/605922; Brereton CF, 2011, J IMMUNOL, V186, P5896, DOI 10.4049/jimmunol.1003789; Cai S, 2016, MUCOSAL IMMUNOL, V9, P503, DOI 10.1038/mi.2015.80; Campos MA, 2004, INFECT IMMUN, V72, P7107, DOI 10.1128/IAI.72.12.7107-7114.2004; Cannatelli A, 2013, ANTIMICROB AGENTS CH, V57, P5521, DOI 10.1128/AAC.01480-13; Cassel SL, 2009, SEMIN IMMUNOL, V21, P194, DOI 10.1016/j.smim.2009.05.002; Cesaretti M, 2003, CARBOHYD POLYM, V54, P59, DOI 10.1016/S0144-8617(03)00144-9; Chen L, 2014, MBIO, V5, DOI 10.1128/mBio.01355-14; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Clemente AM, 2013, INFECT IMMUN, V81, P1842, DOI 10.1128/IAI.01226-12; Clemente A, 2011, CELL MICROBIOL, V13, P1328, DOI 10.1111/j.1462-5822.2011.01622.x; Conos SA, 2016, CELL DEATH DIFFER; Conte V, 2016, J ANTIMICROB CHEMOTH; D'Andrea MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096827; Deleo FR, 2014, P NATL ACAD SCI USA, V111, P4988, DOI 10.1073/pnas.1321364111; Diago-Navarro E, 2014, J INFECT DIS, V210, P803, DOI 10.1093/infdis/jiu157; Dinarello CA, 2005, CRIT CARE MED, V33, pS460, DOI 10.1097/01.CCM.0000185500.11080.91; Giani T, 2013, EURO SURVEILL, V18; Giani T, 2009, J CLIN MICROBIOL, V47, P3793, DOI 10.1128/JCM.01773-09; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Hua KF, 2015, INFECT IMMUN, V83, P3396, DOI 10.1128/IAI.00125-15; Kang SM, 2014, PHARMACOL REP, V66, P471, DOI 10.1016/j.pharep.2013.08.015; Karin Michael, 2005, Proc Am Thorac Soc, V2, P386, DOI 10.1513/pats.200504-034SR; Kobayashi SD, 2016, J INFECT DIS, V213, P1615, DOI 10.1093/infdis/jiw001; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Lauvau G, 2015, SEMIN IMMUNOL, V27, P397, DOI 10.1016/j.smim.2016.03.014; Lee GC, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-32; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7; Parker D, 2016, PHYSIOL REV, V96, P19, DOI 10.1152/physrev.00009.2015; Patel G, 2008, INFECT CONT HOSP EP, V29, P1099, DOI 10.1086/592412; Penaloza H, 2016, AM J RESP CRIT CARE, P193; Pitout JDD, 2015, ANTIMICROB AGENTS CH, V59, P5873, DOI 10.1128/AAC.01019-15; Rathinam VAK, 2016, CELL, V165, P792, DOI 10.1016/j.cell.2016.03.046; Rescigno M, 2014, IMMUNOL REV, V260, P118, DOI 10.1111/imr.12181; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Saklatvala J, 2003, BIOCHEM SOC SYMP, V70, P95, DOI 10.1042/bss0700095; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sharma D, 2016, J CELL BIOL, V213, P617, DOI 10.1083/jcb.201602089; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Storek KM, 2015, IMMUNOL REV, V265, P112, DOI 10.1111/imr.12289; Sutterwala FS, 2014, ANN NY ACAD SCI, V1319, P82, DOI 10.1111/nyas.12458; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Szijarto V, 2016, INT J MED MICROBIOL, V306, P89, DOI 10.1016/j.ijmm.2015.12.002; Tangden T, 2015, J INTERN MED, V277, P501, DOI 10.1111/joim.12342; Tzouvelekis LS, 2013, ANTIMICROB AGENTS CH, V57, P5144, DOI 10.1128/AAC.01052-13; van Duin D, 2014, ANTIMICROB AGENTS CH, V58, P4035, DOI 10.1128/AAC.02636-14; Watanabe T, 2004, P NATL ACAD SCI USA, V101, P3563, DOI 10.1073/pnas.0400557101; Willingham SB, 2009, J IMMUNOL, V183, P2008, DOI 10.4049/jimmunol.0900138; Wright MS, 2014, ANTIMICROB AGENTS CH, V58, P4961, DOI 10.1128/AAC.00125-14; Xiong HZ, 2016, CELL, V165, P679, DOI 10.1016/j.cell.2016.03.017; Xiong HZ, 2015, INFECT IMMUN, V83, P3418, DOI 10.1128/IAI.00678-15; Zhong Y, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00333	55	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0170125	10.1371/journal.pone.0170125	http://dx.doi.org/10.1371/journal.pone.0170125			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081233	Green Published, Green Submitted, gold			2022-12-26	WOS:000391949500134
J	Cilibrasi, C; Riva, G; Romano, G; Cadamuro, M; Bazzoni, R; Butta, V; Paoletta, L; Dalpra, L; Strazzabosco, M; Lavitrano, M; Giovannoni, R; Bentivegna, A				Cilibrasi, Chiara; Riva, Gabriele; Romano, Gabriele; Cadamuro, Massimiliano; Bazzoni, Riccardo; Butta, Valentina; Paoletta, Laura; Dalpra, Leda; Strazzabosco, Mario; Lavitrano, Marialuisa; Giovannoni, Roberto; Bentivegna, Angela			Resveratrol Impairs Glioma Stem Cells Proliferation and Motility by Modulating the Wnt Signaling Pathway	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; TUMOR-INITIATING CELLS; GLIOBLASTOMA-MULTIFORME; PROMOTER HYPERMETHYLATION; GENE-EXPRESSION; LIGAND TRAIL; CANCER; METHYLATION; TUMORIGENICITY; IDENTIFICATION	Glioblastoma multiforme (GBM) is a grade IV astrocytoma and the most common form of malignant brain tumor in adults. GBM remains one of the most fatal and least successfully treated solid tumors: current therapies provide a median survival of 12-15 months after diagnosis, due to the high recurrence rate. Glioma Stem Cells (GSCs) are believed to be the real driving force of tumor initiation, progression and relapse. Therefore, better therapeutic strategies GSCs-targeted are needed. Resveratrol is a polyphenolic phytoalexin found in fruits and vegetables displaying pleiotropic health benefits. Many studies have highlighted its chemo-preventive and chemotherapeutic activities in a wide range of solid tumors. In this work, we analyzed the effects of Resveratrol exposure on cell viability, proliferation and motility in seven GSC lines isolated from GBM patients. For the first time in our knowledge, we investigated Resveratrol impact on Wnt signaling pathway in GSCs, evaluating the expression of seven Wnt signaling pathway-related genes and the protein levels of c-Myc and beta-catenin. Finally, we analyzed Twist1 and Snail1 protein levels, two pivotal activators of epithelial-mesenchymal transition (EMT) program. Results showed that although response to Resveratrol exposure was highly heterogeneous among GSC lines, generally it was able to inhibit cell proliferation, increase cell mortality, and strongly decrease cell motility, modulating the Wnt signaling pathway and the EMT activators. Treatment with Resveratrol may represent a new interesting therapeutic approach, in order to affect GSCs proliferation and motility, even if further investigations are needed to deeply understand the GSCs heterogeneous response.	[Cilibrasi, Chiara; Riva, Gabriele; Romano, Gabriele; Cadamuro, Massimiliano; Bazzoni, Riccardo; Butta, Valentina; Paoletta, Laura; Dalpra, Leda; Strazzabosco, Mario; Lavitrano, Marialuisa; Giovannoni, Roberto; Bentivegna, Angela] Univ Milano Bicocca, Sch Med & Surg, Via Cadore, Monza, Italy; [Cilibrasi, Chiara; Riva, Gabriele; Butta, Valentina] Univ Milano Bicocca, PhD Program Neurosci, Via Cadore, Monza, Italy; [Cilibrasi, Chiara; Riva, Gabriele; Bentivegna, Angela] Univ Milano Bicocca, San Gerardo Hosp, Milan Ctr Neurosci, Dept Neurol & Neurosci,NeuroMI, Via Pergolesi, Monza, Italy; [Romano, Gabriele] Univ Milano Bicocca, PhD Program Translat & Mol Med DIMET, Via Cadore, Monza, Italy	University of Milano-Bicocca; University of Milano-Bicocca; San Gerardo Hospital; University of Milano-Bicocca; University of Milano-Bicocca	Bentivegna, A (corresponding author), Univ Milano Bicocca, Sch Med & Surg, Via Cadore, Monza, Italy.; Bentivegna, A (corresponding author), Univ Milano Bicocca, San Gerardo Hosp, Milan Ctr Neurosci, Dept Neurol & Neurosci,NeuroMI, Via Pergolesi, Monza, Italy.	angela.bentivegna@unimib.it	Bentivegna, Angela/J-3478-2018; Cadamuro, Massimiliano/AAC-6169-2022; Giovannoni, Roberto/A-1413-2009	Bentivegna, Angela/0000-0001-7535-846X; Cadamuro, Massimiliano/0000-0002-0899-7613; Giovannoni, Roberto/0000-0002-7706-0672; Lavitrano, Marialuisa/0000-0003-4852-1318; Romano, Gabriele/0000-0001-8023-8657	University of Milano-Bicocca [2013-ATE-0406, 2013-ATE-0489]; Ministry of University and Scientific Research [RBAP06LAHL]; Fondazione Cariplo [2014-1099]	University of Milano-Bicocca; Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariplo(Fondazione Cariplo)	2013-ATE-0406 and 2013-ATE-0489 grants from University of Milano-Bicocca (to AB) have supported the purchase of materials and reagents for the experimental work, http://www.unimib.it; FIRB project no RBAP06LAHL from Ministry of University and Scientific Research (to ML) has supported the purchase of materials and reagents for the experimental work, http://www.istruzione.it; grant no 2014-1099 from Fondazione Cariplo (to MC) has supported the purchase of materials and reagents for the experimental work, http://www.fondazionecariplo.it/.	Alaminos M, 2005, CANCER RES, V65, P2565, DOI 10.1158/0008-5472.CAN-04-4283; Amatya VJ, 2005, ACTA NEUROPATHOL, V110, P178, DOI 10.1007/s00401-005-1041-5; Baeza N, 2003, ACTA NEUROPATHOL, V106, P479, DOI 10.1007/s00401-003-0748-4; Baronchelli S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057462; BRUNI J, 1979, ARCH NEUROL-CHICAGO, V36, P393, DOI 10.1001/archneur.1979.00500430023002; Cadamuro M, 2016, CANC RES; Cheema TA, 2011, CLIN CANC RES; Chen TC, 2011, CANCER LETT, V302, P100, DOI 10.1016/j.canlet.2010.11.008; Costello JF, 1996, CANCER RES, V56, P2405; de Tayrac M, 2009, GENE CHROMOSOME CANC, V48, P55, DOI 10.1002/gcc.20618; Dirks PB, 2008, J CLIN ONCOL, V26, P2916, DOI 10.1200/JCO.2008.17.6792; Dorsey JF, 2009, MOL CANCER THER, V8, P3285, DOI 10.1158/1535-7163.MCT-09-0415; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Etcheverry A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-701; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Gotze S, 2010, INT J CANCER, V126, P2584, DOI 10.1002/ijc.24981; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Iser IC, 2016, MED RES REV; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kahlert UD, 2012, CANCER LETT, V325, P42, DOI 10.1016/j.canlet.2012.05.024; Kargiotis O, 2011, CANCER CHEMOTH PHARM, V67, P489, DOI 10.1007/s00280-011-1569-0; Karmakar S, 2007, APOPTOSIS, V12, P2077, DOI 10.1007/s10495-007-0116-2; Karsy M, 2016, WORLD NEUROSURG, V88, P222, DOI 10.1016/j.wneu.2015.12.032; Kim KH, 2013, NEURO-ONCOLOGY, V15, P161, DOI 10.1093/neuonc/nos299; Korshunov A, 2006, ACTA NEUROPATHOL, V111, P465, DOI 10.1007/s00401-006-0057-9; Kubelt C, 2015, INT J ONCOL, V46, P2515, DOI 10.3892/ijo.2015.2944; Laffaire J, 2011, NEURO-ONCOLOGY, V13, P84, DOI 10.1093/neuonc/noq110; Lee Y, 2016, LAB INVEST, V96, P137, DOI 10.1038/labinvest.2015.140; Liu C, 2011, CLIN EXP MED, V11, P105, DOI 10.1007/s10238-010-0110-9; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Martinez R, 2007, CARCINOGENESIS, V28, P1264, DOI 10.1093/carcin/bgm014; Otsuki A, 2008, MOL THER, V16, P1546, DOI 10.1038/mt.2008.155; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Paul Indranil, 2013, Genes Cancer, V4, P427, DOI 10.1177/1947601913503341; Perucca E, 2002, CNS DRUGS, V16, P695, DOI 10.2165/00023210-200216100-00004; Piccirillo SGM, 2009, ONCOGENE, V28, P1807, DOI 10.1038/onc.2009.27; Rao SK, 2010, J NEURO-ONCOL, V96, P169, DOI 10.1007/s11060-009-9959-4; Rodriguez J, 2006, CANCER RES, V66, P8462, DOI 10.1158/0008-5472.CAN-06-0293; Rosato RR, 2003, MOL CANCER THER, V2, P1273; Ruano Y, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-39; Sanchez-Tillo E, 2012, CELL MOL LIFE SCI, V69, P3429, DOI 10.1007/s00018-012-1122-2; Sandberg CJ, 2013, EXP CELL RES, V319, P2230, DOI 10.1016/j.yexcr.2013.06.004; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smith LA, 2010, J AFFECT DISORDERS, V122, P1, DOI 10.1016/j.jad.2009.10.033; Stupp R, 2010, ANN ONCOL, V21, pv190, DOI 10.1093/annonc/mdq187; Torres S, 2011, MOL CANCER THER, V10, P90, DOI 10.1158/1535-7163.MCT-10-0688; Waha A, 2005, NEOPLASIA, V7, P193, DOI 10.1593/neo.04490; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yi GZ, 2016, J NEUROL SCI, V367, P101, DOI 10.1016/j.jns.2016.05.054; Yin D, 2009, MOL CANCER RES, V7, P665, DOI 10.1158/1541-7786.MCR-08-0270	53	78	79	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169854	10.1371/journal.pone.0169854	http://dx.doi.org/10.1371/journal.pone.0169854			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081224	Green Published, Green Submitted, gold			2022-12-26	WOS:000391949500091
J	Li, ZQ; He, P; Zhang, YN; Dong, SL				Li, Zhao-Qun; He, Peng; Zhang, Ya-Nan; Dong, Shuang-Lin			Molecular and Functional Characterization of Three Odorant-Binding Protein from Periplaneta americana	PLOS ONE			English	Article							VOLATILE COMPOUNDS; SOLUBLE-PROTEINS; APPLE; IDENTIFICATION; PROFILE	The American cockroach, Periplaneta americana, is a vector of many pathogenic organisms associated with human diseases. Olfaction plays a crucial role in guiding cockroach behaviors and contributes to their ability to transmit pathogens. Odorant binding proteins (OBPs), abundant in the insect olfactory sensilla, are important for insect olfaction. In this study, three OBP genes, PameOBP1, 2 and 3, were cloned from P. americana. Sequence alignment and phylogenetic analysis revealed that PameOBP1, 2 and 3 belong to the Minus-C OBP, Classic OBP, and Plus-C OBP subfamilies, respectively. Expression pattern and ligand-binding analysis showed that PameOBP1 and 2 were specifically expressed in antennae, and exhibited high binding affinities (Ki < 2 mu M) to farnesene, farnesol, 2-tridecanone, and tetradecane, suggesting roles in volatile perception. Conversely, PameOBP3 was ubiquitously expressed in most of the tissues examined at high levels and displayed very weak binding affinities (Ki > 40 mu M) for all 87 ligands tested. Our study provides insights into the functional diversity of PameOBP genes and provides some volatiles that can potentially be used in behavioral interference of P. americana.	[Li, Zhao-Qun] Chinese Acad Agr Sci, Tea Res Inst, Key Lab Tea Biol & Resource Utilizat, Minist Agr, Hangzhou, Zhejiang, Peoples R China; [He, Peng] Guizhou Univ, State Key Lab Green Pesticide & Agr Bioengn, Minist Educ, Guiyang, Peoples R China; [Zhang, Ya-Nan] Huaibei Normal Univ, Coll Life Sci, Huaibei, Peoples R China; [Dong, Shuang-Lin] Nanjing Agr Univ, Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Guizhou University; Huaibei Normal University; Nanjing Agricultural University	Dong, SL (corresponding author), Nanjing Agr Univ, Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China.	sldong@njau.edu.cn	He, Peng/ABF-9928-2020	He, Peng/0000-0003-2934-0044	National Natural Science Foundation of China [31071978]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by research grants from the National Natural Science Foundation of China (31071978).	Arruda LK, 2001, J ALLERGY CLIN IMMUN, V107, P419, DOI 10.1067/mai.2001.112854; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep27495; Nobre ACD, 2015, MOLECULES, V20, P9803, DOI 10.3390/molecules20069803; Fan J, 2011, GENET MOL RES, V10, P3056, DOI 10.4238/2011.December.8.2; GORA J, 1983, NAHRUNG, V27, P413, DOI 10.1002/food.19830270509; Guo F, 2012, INSECT BIOCHEM MOLEC, V42, P708, DOI 10.1016/j.ibmb.2012.06.004; He M, 2014, COMP BIOCHEM PHYS B, V174, P1, DOI 10.1016/j.cbpb.2014.04.008; He P, 2014, INSECT MOL BIOL, V23, P475, DOI 10.1111/imb.12095; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Li KM, 2014, J CHEM ECOL, V40, P541, DOI 10.1007/s10886-014-0458-5; Li ZQ, 2015, J CHEM ECOL, V41, P473, DOI 10.1007/s10886-015-0574-x; Li ZQ, 2015, COMP BIOCHEM PHYS A, V185, P51, DOI 10.1016/j.cbpa.2015.03.011; Li ZQ, 2013, J INSECT PHYSIOL, V59, P263, DOI 10.1016/j.jinsphys.2012.12.004; Liu NY, 2015, INSECT MOL BIOL, V24, P167, DOI 10.1111/imb.12143; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pelosi P, 2005, CHEM SENSES, V30, pI291, DOI 10.1093/chemse/bjh229; PELOSI P, 1995, COMP BIOCHEM PHYS B, V111, P503, DOI 10.1016/0305-0491(95)00019-5; Pelosi P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00320; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Riu-Aumatell M, 2005, J AGR FOOD CHEM, V53, P7837, DOI 10.1021/jf051397z; Rossi S, 2014, J SCI FOOD AGR, V94, P919, DOI 10.1002/jsfa.6336; Rotte C, 2009, NEUROSCIENCE, V162, P1120, DOI 10.1016/j.neuroscience.2009.05.066; Salama EM, 2015, J ECON ENTOMOL, V108, P2620, DOI 10.1093/jee/tov239; Sun MJ, 2013, J INSECT PHYSIOL, V59, P46, DOI 10.1016/j.jinsphys.2012.10.020; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsuji H, 2010, J FOOD SCI, V75, pC79, DOI 10.1111/j.1750-3841.2009.01428.x; Venthur H, 2016, ENTOMOL SCI; Vrhovsek U, 2014, J CHROMATOGR B, V966, P132, DOI 10.1016/j.jchromb.2014.01.009; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WERKHOFF P, 1993, Z LEBENSM UNTERS FOR, V196, P307, DOI 10.1007/BF01197930; Xu YL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-632; Ye MQ, 2016, FOOD CHEM, V190, P701, DOI 10.1016/j.foodchem.2015.05.112; Zhou JJ, 2010, VITAM HORM, V83, P241, DOI 10.1016/S0083-6729(10)83010-9	36	19	27	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0170072	10.1371/journal.pone.0170072	http://dx.doi.org/10.1371/journal.pone.0170072			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081263	gold, Green Submitted, Green Published			2022-12-26	WOS:000391949500127
J	Nicholson, T; Roser, M; Bach, P				Nicholson, Toby; Roser, Matt; Bach, Patric			Understanding the Goals of Everyday Instrumental Actions Is Primarily Linked to Object, Not Motor-Kinematic, Information: Evidence from fMRI	PLOS ONE			English	Article							OCCIPITOTEMPORAL CORTEX; MIRROR NEURONS; TOOL USE; CATEGORY; PERCEPTION; SYSTEMS; REPRESENTATION; ORGANIZATION; INTENTIONS; ACTIVATION	Prior research conceptualised action understanding primarily as a kinematic matching of observed actions to own motor representations but has ignored the role of object information. The current study utilized fMRI to identify (a) regions uniquely involved in encoding the goal of others' actions, and (b) to test whether these goal understanding processes draw more strongly on regions involved in encoding object semantics or movement kinematics. Participants watched sequences of instrumental actions while attending to either the actions' goal (goal task), the movements performed (movement task) or the objects used (object task). The results confirmed, first, a unique role of the inferior frontal gyrus, middle temporal gyrus and medial frontal gyrus in action goal understanding. Second, they show for the first time that activation in the goal task overlaps directly with object-but not movement-related activation. Moreover, subsequent parametric analyses revealed that movement-related regions become activated only when goals are unclear, or observers have little action experience. In contrast to motor theories of action understanding, these data suggest that objects-rather than movement kinematics-carry the key information about others' actions. Kinematic information is additionally recruited when goals are ambiguous or unfamiliar.	[Nicholson, Toby; Roser, Matt; Bach, Patric] Univ Plymouth, Sch Psychol, Drake Circus, Devon, England	University of Plymouth	Nicholson, T (corresponding author), Univ Plymouth, Sch Psychol, Drake Circus, Devon, England.	toby.nicholson@plymouth.ac.uk	Bach, Patric/AAP-6513-2020	Bach, Patric/0000-0003-4493-2080	"One step ahead: Prediction of other people's behavior in healthy and autistic individuals" [ES/J019178/1]; Plymouth University grant; Economic and Social Research Council [ES/J019178/1] Funding Source: researchfish; ESRC [ES/J019178/1] Funding Source: UKRI	"One step ahead: Prediction of other people's behavior in healthy and autistic individuals"; Plymouth University grant; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study was funded by http://www. esrc.ac.uk/, http://gtr.rcuk.ac.uk/project/2ABED193-1046-4849-9E15-4098E8549C8C, grant number: ES/J019178/1, "One step ahead: Prediction of other people's behavior in healthy and autistic individuals." ESRC had no role in the experiment.; The study was supported by a Plymouth University grant to Patric Bach and Matt Roser. Thanks to John Fulford and Abdelmalek Benattayallah for aiding with scanning, and Amy Boyson, Sandra Thomas and Peter Thomas for helping with the filming the stimuli.	Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; Avenanti A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00185; Bach P, 2005, J EXP PSYCHOL HUMAN, V31, P465, DOI 10.1037/0096-1523.31.3.465; Bach P, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00254; Bach P, 2011, PSYCHON B REV, V18, P171, DOI 10.3758/s13423-010-0029-x; Bach P, 2010, CEREB CORTEX, V20, P2798, DOI 10.1093/cercor/bhq026; Bracci S, 2012, J NEUROPHYSIOL, V107, P1443, DOI 10.1152/jn.00619.2011; Brass M, 2007, CURR BIOL, V17, P2117, DOI 10.1016/j.cub.2007.11.057; Buxbaum LJ, 2002, BRAIN LANG, V82, P179, DOI 10.1016/S0093-934X(02)00014-7; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Caramazza A, 2014, ANNU REV NEUROSCI, V37, P1, DOI 10.1146/annurev-neuro-071013-013950; Casby M. W., 2003, COMMUN DISORD Q, V24, P163, DOI [DOI 10.1177/15257401030240040201, 10.1177/15257401030240040201]; Chambon V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017133; Chong TTJ, 2008, NEUROIMAGE, V40, P298, DOI 10.1016/j.neuroimage.2007.11.030; Csibra G., 2008, SENSORIMOTOR FDN HIG, VXXII, P435, DOI DOI 10.1093/ACPROF:OSO/9780199231447.003.0020; De Lange FP, 2008, CURR BIOL, V18, P454, DOI 10.1016/j.cub.2008.02.057; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Gallivan JP, 2013, EUR J NEUROSCI, V38, P2408, DOI 10.1111/ejn.12215; Grafton ST, 2007, HUM MOVEMENT SCI, V26, P590, DOI 10.1016/j.humov.2007.05.009; Greenlee M W, 2000, Int Rev Neurobiol, V44, P269; Hamilton AFD, 2009, J CHILD PSYCHOL PSYC, V50, P881, DOI 10.1111/j.1469-7610.2009.02098.x; Hernik M, 2015, J EXP CHILD PSYCHOL, V130, P176, DOI 10.1016/j.jecp.2014.10.004; Hernik M, 2009, CURR OPIN NEUROBIOL, V19, P34, DOI 10.1016/j.conb.2009.05.003; Hodges JR, 1999, P NATL ACAD SCI USA, V96, P9444, DOI 10.1073/pnas.96.16.9444; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Jacob P, 2005, TRENDS COGN SCI, V9, P21, DOI 10.1016/j.tics.2004.11.003; Jacquet PO, 2016, SCI REP-UK, V6, DOI 10.1038/srep26995; Jacquet PO, 2015, CEREB CORTEX, V25, P598, DOI 10.1093/cercor/bht242; Jacquet PO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039629; James J. Gibson, 1977, PERCEIVING ACTING KN; Kelemen D, 1999, COGNITION, V70, P241, DOI 10.1016/S0010-0277(99)00010-4; Kilner JM, 2011, TRENDS COGN SCI, V15, P352, DOI 10.1016/j.tics.2011.06.005; Kilner JM, 2009, J NEUROSCI, V29, P10153, DOI 10.1523/JNEUROSCI.2668-09.2009; Knoblich G, 2006, CURR DIR PSYCHOL SCI, V15, P99, DOI 10.1111/j.0963-7214.2006.00415.x; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Lingnau A, 2015, TRENDS COGN SCI, V19, P268, DOI 10.1016/j.tics.2015.03.006; Manthey S, 2003, COGNITIVE BRAIN RES, V15, P296, DOI 10.1016/S0926-6410(02)00201-X; Morrison I, 2013, HUM BRAIN MAPP, V34, P1982, DOI 10.1002/hbm.22040; Mukamel R, 2010, CURR BIOL, V20, P750, DOI 10.1016/j.cub.2010.02.045; Oosterhof NN, 2013, TRENDS COGN SCI, V17, P311, DOI 10.1016/j.tics.2013.04.012; Oosterhof NN, 2010, J NEUROPHYSIOL, V104, P1077, DOI 10.1152/jn.00326.2010; Osiurak F, 2010, PSYCHOL REV, V117, P517, DOI 10.1037/a0019004; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Peelen MV, 2005, HUM BRAIN MAPP, V25, P402, DOI 10.1002/hbm.20116; Peeters R, 2009, J NEUROSCI, V29, P11523, DOI 10.1523/JNEUROSCI.2040-09.2009; Reynaud E, 2016, NEUROSCI BIOBEHAV R, V64, P421, DOI 10.1016/j.neubiorev.2016.03.009; Rizzolatti G, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0420; Rizzolatti G, 2014, PHYSIOL REV, V94, P655, DOI 10.1152/physrev.00009.2013; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Schubotz RI, 2014, FRONT PSYCHOL, P5; Schwarzlose RF, 2008, P NATL ACAD SCI USA, V105, P4447, DOI 10.1073/pnas.0800431105; Spiridon M, 2006, HUM BRAIN MAPP, V27, P77, DOI 10.1002/hbm.20169; Thioux M, 2015, NEUROIMAGE, V105, P380, DOI 10.1016/j.neuroimage.2014.10.035; Urgesi C, 2014, FRONT HUM NEUROSCI, P8; van Elk M, 2014, PHYS LIFE REV, V11, P220, DOI 10.1016/j.plrev.2013.11.005; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x; Weisberg J, 2007, CEREB CORTEX, V17, P513, DOI 10.1093/cercor/bhj176; Wheatley T, 2007, PSYCHOL SCI, V18, P469, DOI 10.1111/j.1467-9280.2007.01923.x; Wyk BCV, 2009, PSYCHOL SCI, V20, P771, DOI 10.1111/j.1467-9280.2009.02359.x	62	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169700	10.1371/journal.pone.0169700	http://dx.doi.org/10.1371/journal.pone.0169700			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081175	gold, Green Published, Green Submitted			2022-12-26	WOS:000391949500066
J	Vernazzani, BG; Jackson, JA; Cabrera, E; Carlson, CA; Brownell, RL				Vernazzani, Barbara Galletti; Jackson, Jennifer A.; Cabrera, Elsa; Carlson, Carole A.; Brownell, Robert L., Jr.			Estimates of Abundance and Trend of Chilean Blue Whales off Isla de Chiloe, Chile	PLOS ONE			English	Article							EASTERN NORTH PACIFIC; BALAENOPTERA-MUSCULUS LINNAEUS; HUMPBACK WHALES; CAPTURE-RECAPTURE; POPULATION-STRUCTURE; GENETIC-STRUCTURE; SIGHTINGS; MOVEMENTS; FIDELITY; INSIGHTS	Since 1970, blue whales (Balaenoptera musculus) have been seen feeding in the waters off southern Chile during the summer and autumn (December to May). Investigation of the genetic, acoustic and morphological characteristics of these blue whales shows that they are a distinct but unnamed subspecies, called the Chilean blue whales. Photo-identification surveys have been conducted in the waters off northwestern Isla Grande de Chiloe, southern Chile from 2004-2012 and Isla Chanaral, central Chile in 2012. Over this time, 1,070 blue whales were encountered yielding, after photo-quality control, 318 and 267 unique photographs of the left and right side of the flank respectively. Using mark-recapture analysis of left and right side photographs collected from Isla Grande de Chiloe (2004-2012), open population models estimate that similar to 570-760 whales are feeding seasonally in this region. POPAN superpopulation abundance estimates for the same feeding ground in 2012 are 762 (95% confidence intervals, CI = 638-933) and 570 (95% CI 475-705) for left and right side datasets respectively, very similar to results from closed population models. Estimates of trend revealed strong variation in abundance, peaking in 2009 and [suggesting] fluctuating use in the survey area over time, likely related to the density of their prey. High inter-annual return rates suggest a degree of site-fidelity of individuals to Isla Grande de Chiloe and that the number of whales using this feeding ground is relatively small.	[Vernazzani, Barbara Galletti; Cabrera, Elsa] Ctr Conservac Cetacea, Casilla 19178 Correo 19, Santiago, Chile; [Jackson, Jennifer A.] British Antarctic Survey, Madingley Rd, Cambridge, England; [Carlson, Carole A.] Coll Atlantic, Bar Harbor, ME USA; [Brownell, Robert L., Jr.] NOAA, Southwest Fisheries Sci Ctr, Monterey, CA USA	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; National Oceanic Atmospheric Admin (NOAA) - USA	Jackson, JA (corresponding author), British Antarctic Survey, Madingley Rd, Cambridge, England.	jennifer.jackson@bas.ac.uk		Jackson, Jennifer/0000-0003-4158-1924	Directorate General of the Maritime Territory and Merchant Marine (DIRECTEMAR) from the Chilean Navy; Ministry of Foreign Affairs; Global Greengrants Fund; Rufford Foundation; Mohamed Bin Zayed Species Conservation Fund; Pacific Whale Foundation; British Antarctic Survey Polar Science for Planet Earth Programme - Natural Environment Research Council; Natural Environment Research Council [bas0100035] Funding Source: researchfish; NERC [bas0100035] Funding Source: UKRI	Directorate General of the Maritime Territory and Merchant Marine (DIRECTEMAR) from the Chilean Navy; Ministry of Foreign Affairs(Ministry of Foreign Affairs and International Cooperation (Italy)); Global Greengrants Fund; Rufford Foundation; Mohamed Bin Zayed Species Conservation Fund; Pacific Whale Foundation; British Antarctic Survey Polar Science for Planet Earth Programme - Natural Environment Research Council; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The Directorate General of the Maritime Territory and Merchant Marine (DIRECTEMAR) from the Chilean Navy and the Ministry of Foreign Affairs have provided Official Support to the Alfaguara (Chilean blue whale) Project. Additionally the Alfaguara project has been supported by the Global Greengrants Fund, Rufford Foundation, Mohamed Bin Zayed Species Conservation Fund and Pacific Whale Foundation. This study has been supported by the British Antarctic Survey Polar Science for Planet Earth Programme, funded by the Natural Environment Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson José Z, 2010, Anales Instituto Patagonia (Chile), V38, P107; Aguayo A.L., 1974, P209; Andriolo A., 2006, Journal of Cetacean Research and Management, V8, P307; Attard CRM, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.1037; Bailey Helen, 2010, Endangered Species Research, V10, P93, DOI 10.3354/esr00239; Baker CS, 2013, MAR ECOL PROG SER, V494, P291, DOI 10.3354/meps10508; BEST PB, 1993, ICES J MAR SCI, V50, P169, DOI 10.1006/jmsc.1993.1018; Best Peter B., 2001, Journal of Cetacean Research and Management Special Issue, V2, P161; Branch TA, 2007, MAR MAMMAL SCI, V23, P803, DOI 10.1111/j.1748-7692.2007.00137.x; Brownell Jr RL, 2014, IWC SCI COMM M UNPUB; Cabrera E, 2006, IWC SCI COMM M UNPUB; Cabrera Elsa, 2005, Latin American Journal of Aquatic Mammals, V4, P73; Calambokidis J, 2004, MAR MAMMAL SCI, V20, P63, DOI 10.1111/j.1748-7692.2004.tb01141.x; Calambokidis J, 2009, MAR MAMMAL SCI, V25, P816, DOI 10.1111/j.1748-7692.2009.00298.x; Carroll EL, 2013, ECOL APPL, V23, P1677, DOI 10.1890/12-1657.1; Choquet R., 2005, U CARE 2 2 USERS MAN; Clarke R., 1962, Norsk Hvalfangsttidende Sandefjord, V51, P265; Committee on Taxonomy, LIST MAR MAMM SPEC S; Constantine R, 2012, MAR ECOL PROG SER, V453, P249, DOI 10.3354/meps09613; Cooke JG, 2016, IWC SCI COMM J UNPUB; CUMMINGS WC, 1971, ANTARCT J US, V6, P158; CUMMINGS WC, 1971, J ACOUST SOC AM, V50, P1193, DOI 10.1121/1.1912752; de Vos Asha, 2016, Taprobanica, V8, P21; Donovan GP, 1984, REPORT INT WHALING C, V34, P473; Findlay K, 1998, IWC SCI COMM M UNPUB; Forsterra G, 2012, SPIXIANA, V35, P237; Friday N, 2000, MAR MAMMAL SCI, V16, P355, DOI 10.1111/j.1748-7692.2000.tb00930.x; Friday NA, 2008, MAR MAMMAL SCI, V24, P253, DOI 10.1111/j.1748-7692.2008.00187.x; Galletti Vernazzani Barbara, 2012, Journal of Cetacean Research and Management, V12, P353; Gilmore RM, 1971, ANTARCTIC J, VX, P10; Hammond P., 1986, REPORT INT WHALING C, V8, P252; Hucke-Gaete R, 2004, P ROY SOC B-BIOL SCI, V271, pS170, DOI 10.1098/rsbl.2003.0132; Hucke-Gaete R., 2004, THESIS; IWC, J CETCEAN S IN PRESS, P18; Jackson T, 2011, ICES J MAR SCI, V68, P729, DOI 10.1093/icesjms/fsq181; Jenner C, 2008, IWC SCI COMM M UNPUB; Lang AR, 2014, MAR MAMMAL SCI, V30, P1473, DOI 10.1111/mms.12129; Leduc R.G., 2007, Journal of Cetacean Research and Management, V9, P73; Mate BR, 1999, MAR MAMMAL SCI, V15, P1246, DOI 10.1111/j.1748-7692.1999.tb00888.x; McDonald Mark A., 2006, Journal of Cetacean Research and Management, V8, P55; NASU KEIJI, 1966, SCI REP WALES RES INST, V20, P157; Niquen M, 2004, DEEP-SEA RES PT II, V51, P563, DOI 10.1016/j.dsr2.2004.03.001; Noad Michael J., 2011, Journal of Cetacean Research and Management, P243; OTIS DL, 1978, WILDLIFE MONOGR, P1; Pike Daniel G., 2009, NAMMCO Scientific Publications, V7, P19; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; Pradel R, 1996, BIOMETRICS, V52, P703, DOI 10.2307/2532908; Pradel R, 1997, BIOMETRICS, V53, P60, DOI 10.2307/2533097; Punt AE, 2010, J CETACEAN RES MA S2, V11, P129; Rasmussen K, 2007, BIOLOGY LETT, V3, P302, DOI 10.1098/rsbl.2007.0067; REILLY SB, 1990, MAR MAMMAL SCI, V6, P265, DOI 10.1111/j.1748-7692.1990.tb00357.x; RICE DW, 1998, MARINE MAMMALS SCI, V4, P67; Schwarz CJ, 1996, BIOMETRICS, V52, P860, DOI 10.2307/2533048; Sears RJ, 1990, REPORT INT WHALING C, P335; Torres-Florez JP, 2014, MOL ECOL, V23, P5998, DOI 10.1111/mec.12990; Torres-Florez JP, 2014, ECOL EVOL, V4, P1398, DOI 10.1002/ece3.998; Torres-Florez JP, 2015, MAR MAMMAL SCI, V31, P1580, DOI 10.1111/mms.12239; Vernazzani B Galletti, 2012, IWC SCI COMM M UNPUB; Williams R, 2011, CONSERV BIOL, V25, P526, DOI 10.1111/j.1523-1739.2011.01656.x	59	22	24	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0168646	10.1371/journal.pone.0168646	http://dx.doi.org/10.1371/journal.pone.0168646			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081160	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000391949500015
J	Kim, SY; Lee, JH; Merrins, MJ; Gavrilova, O; Bisteau, X; Kaldis, P; Satin, LS; Rane, SG				Kim, So Yoon; Lee, Ji-Hyeon; Merrins, Matthew J.; Gavrilova, Oksana; Bisteau, Xavier; Kaldis, Philipp; Satin, Leslie S.; Rane, Sushil G.			Loss of Cyclin-dependent Kinase 2 in the Pancreas Links Primary -Cell Dysfunction to Progressive Depletion of -Cell Mass and Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta cell (B-cell); cell cycle; cyclin-dependent kinase (CDK); diabetes; FOXO; beta cell function; beta cell mass; CDK2; foxo1	SCALE ASSOCIATION ANALYSIS; ISLET BETA-CELL; EXPRESSION; FAILURE; PROGENITORS; GLUCOSE; MOUSE; FOXO1; MICE; CDK4	The failure of pancreatic islet -cells is a major contributor to the etiology of type 2 diabetes. -Cell dysfunction and declining -cell mass are two mechanisms that contribute to this failure, although it is unclear whether they are molecularly linked. Here, we show that the cell cycle regulator, cyclin-dependent kinase 2 (CDK2), couples primary -cell dysfunction to the progressive deterioration of -cell mass in diabetes. Mice with pancreas-specific deletion of Cdk2 are glucose-intolerant, primarily due to defects in glucose-stimulated insulin secretion. Accompanying this loss of secretion are defects in -cell metabolism and perturbed mitochondrial structure. Persistent insulin secretion defects culminate in progressive deficits in -cell proliferation, reduced -cell mass, and diabetes. These outcomes may be mediated directly by the loss of CDK2, which binds to and phosphorylates the transcription factor FOXO1 in a glucose-dependent manner. Further, we identified a requirement for CDK2 in the compensatory increases in -cell mass that occur in response to age- and diet-induced stress. Thus, CDK2 serves as an important nexus linking primary -cell dysfunction to progressive -cell mass deterioration in diabetes.	[Kim, So Yoon; Lee, Ji-Hyeon; Rane, Sushil G.] NIDDK, Cell Growth & Metab Sect, Diabet Endocrinol & Obes Branch, NIH,Clin Res Ctr, 5-5940,10 Ctr Dr, Bethesda, MD 20892 USA; [Gavrilova, Oksana] NIDDK, Mouse Metab Core Lab, NIH, Clin Res Ctr, Bethesda, MD 20892 USA; [Merrins, Matthew J.] Univ Wisconsin, Dept Med, Div Endocrinol Diabet & Metab, Madison, WI 53705 USA; [Bisteau, Xavier; Kaldis, Philipp] ASTAR, IMCB, 61 Biopolis Dr,Proteos 3-09, Singapore 138673, Singapore; [Bisteau, Xavier; Kaldis, Philipp] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore; [Satin, Leslie S.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48105 USA; [Satin, Leslie S.] Univ Michigan, Sch Med, Brehm Ctr Diabet Res, Ann Arbor, MI 48105 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Wisconsin System; University of Wisconsin Madison; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Rane, SG (corresponding author), NIDDK, Cell Growth & Metab Sect, Diabet Endocrinol & Obes Branch, NIH,Clin Res Ctr, 5-5940,10 Ctr Dr, Bethesda, MD 20892 USA.	ranes@mail.nih.gov	Bisteau, Xavier/Q-7239-2018; Bisteau, Xavier/AAH-6744-2021; Kaldis, Philipp/G-2714-2010	Bisteau, Xavier/0000-0002-8896-5098; Kaldis, Philipp/0000-0002-7247-7591	National Institutes of Health (NIH) [R01-DK46409]; NIH [K01-DK101683, R21-AG050135]; American Diabetes Association [1-16-IBS-212]; Biomedical Research Council of A*STAR (Agency for Science, Technology, and Research), Singapore; NIH Intramural Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK055105, ZIADK075073, P30DK020572, ZICDK070002, R01DK046409, K01DK101683, ZIADK055107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG050135] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Biomedical Research Council of A*STAR (Agency for Science, Technology, and Research), Singapore(Agency for Science Technology & Research (A*STAR)); NIH Intramural Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) Grant R01-DK46409 (to L. S. S.); NIH Grants K01-DK101683 and R21-AG050135 and American Diabetes Association Grant 1-16-IBS-212 (to M. J. M.); the Biomedical Research Council of A*STAR (Agency for Science, Technology, and Research), Singapore (to P. K.); and the NIH Intramural Program (to S. G. R.). The authors declare that they have no conflicts with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Butler PC, 2007, NAT CLIN PRACT ENDOC, V3, P758, DOI 10.1038/ncpendmet0647; Calbo J, 2004, CELL DEATH DIFFER, V11, P1055, DOI 10.1038/sj.cdd.4401481; Campaner S, 2010, NAT CELL BIOL, V12, P54, DOI 10.1038/ncb2004; Cheng ZY, 2011, ANTIOXID REDOX SIGN, V14, P649, DOI 10.1089/ars.2010.3370; Cousin SP, 2001, ENDOCRINOLOGY, V142, P229, DOI 10.1210/en.142.1.229; Folli F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028050; Goldfine AB, 2012, DIABETES OBES METAB, V14, P152, DOI 10.1111/j.1463-1326.2012.01647.x; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; Helman A, 2016, NAT MED, V22, P412, DOI 10.1038/nm.4054; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Honig G, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-82; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Hydbring P, 2016, NAT REV MOL CELL BIO, V17, P280, DOI 10.1038/nrm.2016.27; Ishii H, 2011, ENDOCR J, V58, P519, DOI 10.1507/endocrj.EJ11-0064; Jayapal SR, 2015, HAEMATOLOGICA, V100, P434, DOI 10.3324/haematol.2014.106468; Jiang H, 1998, MOL CELL BIOL, V18, P5284, DOI 10.1128/MCB.18.9.5284; Kim SY, 2011, DEVELOPMENT, V138, P1903, DOI 10.1242/dev.061481; Kim YC, 2011, EMBO J, V30, P1563, DOI 10.1038/emboj.2011.57; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Lane ME, 2001, CANCER RES, V61, P6170; Lee JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008653; Magnuson MA, 2013, CELL METAB, V18, P9, DOI 10.1016/j.cmet.2013.06.011; Marselli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011499; Martinez SC, 2006, DIABETES, V55, P1581, DOI 10.2337/db05-0678; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; McConnell BB, 1999, MOL CELL BIOL, V19, P1981; Merrins MJ, 2013, J BIOL CHEM, V288, P33312, DOI 10.1074/jbc.M113.508127; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Rane SG, 2000, FRONT BIOSCI, V5, pD1, DOI 10.2741/Rane; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Song JH, 2010, GENESIS, V48, P628, DOI 10.1002/dvg.20672; Talchai C, 2009, DIABETES OBES METAB, V11, P38, DOI 10.1111/j.1463-1326.2009.01115.x; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624	46	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3841	3853		10.1074/jbc.M116.754077	http://dx.doi.org/10.1074/jbc.M116.754077			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28100774	hybrid, Green Published			2022-12-26	WOS:000395542500025
J	Guo, HB; Zhang, B; Nairn, AV; Nagy, T; Moremen, KW; Buckhaults, P; Pierce, M				Guo, Huabei; Zhang, Bing; Nairn, Alison V.; Nagy, Tamas; Moremen, Kelley W.; Buckhaults, Phillip; Pierce, Michael			O-Linked N-Acetylglucosamine (O-GlcNAc) Expression Levels Epigenetically Regulate Colon Cancer Tumorigenesis by Affecting the Cancer Stem Cell Compartment via Modulating Expression of Transcriptional Factor MYBL1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; IN-VITRO PROPAGATION; A-MYB; DNA METHYLATION; GENE-EXPRESSION; TRANSFERASE OGT; HYPERMETHYLATION PROFILE; 3'-UNTRANSLATED REGION; UP-REGULATION; C-MYC	To study the regulation of colorectal adenocarcinoma progression by O-GlcNAc, we have focused on the O-GlcNAcmediated epigenetic regulation of human colon cancer stem cells (CCSC). Xenograft tumors from colon tumor cells with O-linked N-acetylglucosamine transferase (OGT) knockdown grew significantly slower than those formed from control cells, indicating a reduced proliferation of tumor cells due to inhibition ofOGTexpression. Significant reduction of the CCSC population was observed in the tumor cells after OGT knockdown, whereas tumor cells treated with the O-GlcNAcase inhibitor showed an increased CCSC population, indicating that O-GlcNAc levels regulated the CCSC compartment. When grown in suspension, tumor cells withOGTknockdown showed a reduced ability to form tumorspheres, indicating a reduced self-renewal of CCSC due to reduced levels of O-GlcNAc. ChIP-sequencing experiments using an anti-O-GlcNAc antibody revealed significant chromatin enrichment of O-GlcNAcmodified proteins at the promoter of the transcription factor MYBL1, which was also characterized by the presence of H3K27me3. RNA-sequencing analysis showed an increased expression of MYBL1 in tumor cells with OGT knockdown. Forced overexpression of MYBL1 led to a reduced population of CCSC and tumor growth in vivo, similar to the effects of OGT silencing. Moreover, two CpG islands near the transcription start site of MYBL1 were identified, and O-GlcNAc levels regulated their methylation status. These results strongly argue that O-GlcNAc epigenetically regulates MYBL1, functioning similarly to H3K27me3. The aberrant CCSC compartment observed after modulatingO-GlcNAc levels is therefore likely to result, at least in part, from the epigenetic regulation of MYBL1 expression by O-GlcNAc, thereby significantly affecting tumor progression.	[Guo, Huabei; Nairn, Alison V.; Moremen, Kelley W.; Pierce, Michael] Univ Georgia, Dept Biochem & Mol Biol, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA; [Nagy, Tamas] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA; [Zhang, Bing] Harvard Univ, Boston Childrens Hosp, Boston, MA 02115 USA; [Buckhaults, Phillip] Univ South Carolina, South Carolina Coll Pharm, Columbia, SC 29208 USA; [Zhang, Bing] Jiaotong Univ, Shanghai Ctr Syst Biomed, 800 Dongchuan Rd, Shanghai 200240, Peoples R China	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Harvard University; Boston Children's Hospital; Medical University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Shanghai Jiao Tong University	Pierce, M (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	hawkeye@uga.edu	Moremen, Kelley/AAD-4661-2019	Nairn, Alison/0000-0002-4453-7593	National Institutes of Health [U01CA128454, P41-GM103490]; NATIONAL CANCER INSTITUTE [U01CA128454, U01CA158428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490, P41GM103390] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants U01CA128454 and P41-GM103490 (to M.P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137640; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Aloia L, 2013, DEVELOPMENT, V140, P2525, DOI 10.1242/dev.091553; Arsura M, 2000, BLOOD, V96, P1013, DOI 10.1182/blood.V96.3.1013.015k06_1013_1020; Baysan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094045; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brayer KJ, 2016, CANCER DISCOV, V6, P176, DOI 10.1158/2159-8290.CD-15-0859; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chen CL, 2003, EUR J CANCER, V39, P517, DOI 10.1016/S0959-8049(02)00175-2; Dey A, 2012, SCIENCE, V337, P1541, DOI 10.1126/science.1221711; Dong CF, 2012, J CLIN INVEST, V122, P1469, DOI 10.1172/JCI57349; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Esteller M, 2001, CANCER RES, V61, P3225; Ferrer CM, 2014, MOL CELL, V54, P820, DOI 10.1016/j.molcel.2014.04.026; Fujii S, 2016, ONCOTARGET, V7, P81571, DOI 10.18632/oncotarget.13147; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; George OL, 2014, CANCERS, V6, P2049, DOI 10.3390/cancers6042049; Ghiaur G, 2012, STEM CELLS, V30, P89, DOI 10.1002/stem.769; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; GOLAY J, 1994, ONCOGENE, V9, P2469; Golay J, 1998, J IMMUNOL, V160, P2786; Gu YC, 2010, CANCER RES, V70, P6344, DOI 10.1158/0008-5472.CAN-09-1887; Guo HB, 2014, J BIOL CHEM, V289, P31534, DOI 10.1074/jbc.M114.602680; HALTIWANGER RS, 1990, J BIOL CHEM, V265, P2563; Hammoud SS, 2013, CURR OPIN CELL BIOL, V25, P177, DOI 10.1016/j.ceb.2013.01.007; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; HOLT GD, 1986, J BIOL CHEM, V261, P8049; Hou ZJ, 2015, ONCOTARGET, V6, P6326, DOI 10.18632/oncotarget.3436; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Ishiwata T, 2016, PATHOL INT, V66, P601, DOI 10.1111/pin.12447; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Jeon JH, 2014, STEM CELLS DEV, V23, P2067, DOI 10.1089/scd.2013.0583; Jones MF, 2015, P NATL ACAD SCI USA, V112, pE1550, DOI 10.1073/pnas.1503370112; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kanwar SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-212; Kassis JA, 2010, MOL CELL BIOL, V30, P2581, DOI 10.1128/MCB.00231-10; KEARSE KP, 1991, P NATL ACAD SCI USA, V88, P1701, DOI 10.1073/pnas.88.5.1701; Kerppola TK, 2009, TRENDS CELL BIOL, V19, P692, DOI 10.1016/j.tcb.2009.10.001; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kriegl L, 2012, ONCOTARGET, V3, P1182; Krzeslak A, 2010, INT J MOL MED, V25, P643, DOI 10.3892/ijmm_00000387; Lewis BA, 2014, J BIOL CHEM, V289, P34440, DOI 10.1074/jbc.R114.595439; Lin L, 2011, CANCER RES, V71, P7226, DOI 10.1158/0008-5472.CAN-10-4660; Lind GE, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-28; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Love DC, 2010, SEMIN CELL DEV BIOL, V21, P646, DOI 10.1016/j.semcdb.2010.05.001; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Ma JF, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-8; Ma ZY, 2014, J BIOL CHEM, V289, P34457, DOI 10.1074/jbc.R114.577718; Malaterre J, 2016, ONCOGENE, V35, P2475, DOI 10.1038/onc.2015.305; Malumbres M, 1999, ONCOGENE, V18, P385, DOI 10.1038/sj.onc.1202299; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Maussion G, 2014, EPIGENETICS-US, V9, P1061, DOI 10.4161/epi.29068; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Mi WY, 2011, BBA-MOL BASIS DIS, V1812, P514, DOI 10.1016/j.bbadis.2011.01.009; Mitani Y, 2016, CLIN CANCER RES, V22, P725, DOI 10.1158/1078-0432.CCR-15-2867-T; Myers SA, 2011, P NATL ACAD SCI USA, V108, P9490, DOI 10.1073/pnas.1019289108; Nairn AV, 2010, METHOD ENZYMOL, V479, P73, DOI 10.1016/S0076-6879(10)79004-2; Ng JMK, 2015, INT J MOL SCI, V16, P2472, DOI 10.3390/ijms16022472; Oh IH, 1997, J BIOL CHEM, V272, P21432, DOI 10.1074/jbc.272.34.21432; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Okugawa Y, 2015, GASTROENTEROLOGY, V149, P1204, DOI 10.1053/j.gastro.2015.07.011; Onodera Y, 2014, J CLIN INVEST, V124, P367, DOI 10.1172/JCI63146; Paz MF, 2003, CANCER RES, V63, P1114; Pieraccioli M, 2013, CELL CYCLE, V12, P2309, DOI 10.4161/cc.25405; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ramkissoon LA, 2013, P NATL ACAD SCI USA, V110, P8188, DOI 10.1073/pnas.1300252110; RAMSAY RG, 1992, CELL GROWTH DIFFER, V3, P723; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rushton JJ, 2003, ONCOGENE, V22, P308, DOI 10.1038/sj.onc.1206131; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Sato R, 2016, STEM CELLS, V34, P1997, DOI 10.1002/stem.2406; Shi FT, 2013, J BIOL CHEM, V288, P20776, DOI 10.1074/jbc.M113.460386; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Singh JP, 2015, CANCER LETT, V356, P244, DOI 10.1016/j.canlet.2014.04.014; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Vella P, 2013, MOL CELL, V49, P645, DOI 10.1016/j.molcel.2012.12.019; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Weige CC, 2014, MOL CANCER RES, V12, P1029, DOI 10.1158/1541-7786.MCR-13-0286-T; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wu YA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041001; Wu ZQ, 2012, P NATL ACAD SCI USA, V109, P11312, DOI 10.1073/pnas.1203015109; Yang XJ, 2014, CANCER CELL, V26, P577, DOI 10.1016/j.ccr.2014.07.028; Yang YR, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.24; Yang YR, 2015, ONCOTARGET, V6, P12529, DOI 10.18632/oncotarget.3725; Yeung TM, 2010, P NATL ACAD SCI USA, V107, P3722, DOI 10.1073/pnas.0915135107; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zeilstra J, 2008, CANCER RES, V68, P3655, DOI 10.1158/0008-5472.CAN-07-2940; Zhang XL, 2015, MOL CELL BIOCHEM, V410, P101, DOI 10.1007/s11010-015-2542-8; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao P, 2012, J BIOL CHEM, V287, P25230, DOI 10.1074/jbc.M112.339465; Zhao ST, 2016, CANCER MED-US, V5, P837, DOI 10.1002/cam4.650; Zhou Y, 2011, FRONT BIOSCI-LANDMRK, V16, P1109, DOI 10.2741/3738; Zucchi I, 2007, P NATL ACAD SCI USA, V104, P10476, DOI 10.1073/pnas.0703071104	103	35	35	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4123	4137		10.1074/jbc.M116.763201	http://dx.doi.org/10.1074/jbc.M116.763201			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28096468	hybrid, Green Published			2022-12-26	WOS:000395837100014
J	Young, BM; Nguyen, E; Chedrawe, MAJ; Rainey, JK; Dupre, DJ				Young, Brent M.; Nguyen, Elaine; Chedrawe, Matthew A. J.; Rainey, Jan K.; Dupre, Denis J.			Differential Contribution of Transmembrane Domains IV, V, VI, and VII to Human Angiotensin II Type 1 Receptor Homomer Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						angiotensin II; bioluminescence resonance energy transfer (BRET); dimerization; G protein-coupled receptor (GPCR); oligomerization; protein structure; transmembrane domain; angiotensin II type 1 receptor (AT1R)	PROTEIN-COUPLED RECEPTORS; FUNCTIONAL SELECTIVITY; ADRENERGIC-RECEPTORS; CRYSTAL-STRUCTURE; OPIOID RECEPTOR; IN-VIVO; ANTAGONIST; ACTIVATION; INHIBITION; TARGETS	G protein-coupled receptors (GPCRs) play an important role in drug therapy and represent one of the largest families of drug targets. The angiotensin II type 1 receptor (AT1R) is notable as it has a central role in the treatment of cardiovascular disease. Blockade of AT1R signaling has been shown to alleviate hypertension and improve outcomes in patients with heart failure. Despite this, it has become apparent that our initial understanding of AT1R signaling is oversimplified. There is considerable evidence to suggest that AT1R signaling is highly modified in the presence of receptor-receptor interactions, but there is very little structural data available to explain this phenomenon even with the recent elucidation of the AT1R crystal structure. The current study investigates the involvement of transmembrane domains in AT1R homomer assembly with the goal of identifying hydrophobic interfaces that contribute to receptor-receptor affinity. A recently published crystal structure of the AT1R was used to guide site-directed mutagenesis of outward-facing hydrophobic residues within the transmembrane region of the AT1R. Bioluminescence resonance energy transfer was employed to analyze how receptor mutation affects the assembly of AT1R homomers with a specific focus on hydrophobic residues. Mutations within transmembrane domains IV, V, VI, and VII had no effect on angiotensin-mediated -arrestin1 recruitment; however, they exhibited differential effects on the assembly of AT1R into oligomeric complexes. Our results demonstrate the importance of hydrophobic amino acids at the AT1R transmembrane interface and provide the first glimpse of the requirements for AT1R complex assembly.	[Young, Brent M.; Nguyen, Elaine; Chedrawe, Matthew A. J.; Dupre, Denis J.] Dalhousie Univ, Fac Med, Dept Pharmacol, Sir Charles Tupper Med Bldg,Rm 6C,5850 Coll St, Halifax, NS B3H 4R2, Canada; [Rainey, Jan K.] Dalhousie Univ, Fac Med, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada; [Rainey, Jan K.] Dalhousie Univ, Fac Med, Dept Chem, Halifax, NS B3H 4R2, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Dupre, DJ (corresponding author), Dalhousie Univ, Fac Med, Dept Pharmacol, Sir Charles Tupper Med Bldg,Rm 6C,5850 Coll St, Halifax, NS B3H 4R2, Canada.	denis.dupre@dal.ca	Rainey, Jan K/C-1927-2008; Dupre, Denis J/AAI-2631-2021	Rainey, Jan K/0000-0003-0793-5573; Dupre, Denis J/0000-0001-6401-6157	NIGMS, National Institutes of Health [P41-GM103311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Chimera was developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIGMS, National Institutes of Health Grant P41-GM103311).	AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; Balakumar P, 2014, J MOL ENDOCRINOL, V53, pR71, DOI 10.1530/JME-14-0125; Barki-Harrington L, 2003, CIRCULATION, V108, P1611, DOI 10.1161/01.CIR.0000092166.30360.78; BARNES PJ, 1995, AM J RESP CRIT CARE, V152, P838, DOI 10.1164/ajrccm.152.3.7663795; Barnett AH, 2004, NEW ENGL J MED, V351, P1952, DOI 10.1056/NEJMoa042274; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Chun HJ, 2008, J CLIN INVEST, V118, P3343, DOI 10.1172/JCI34871; Cvijic Mary Ellen, 2015, Drug Discov Today Technol, V18, P30, DOI 10.1016/j.ddtec.2015.10.005; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Hansen JL, 2004, J BIOL CHEM, V279, P24108, DOI 10.1074/jbc.M400092200; Harikumar KG, 2016, J BIOL CHEM, V291, P17332, DOI 10.1074/jbc.M116.730754; Hu JX, 2012, FASEB J, V26, P604, DOI 10.1096/fj.11-191510; Huang JY, 2013, NAT STRUCT MOL BIOL, V20, P419, DOI 10.1038/nsmb.2504; Johnston JM, 2011, BIOCHEMISTRY-US, V50, P1682, DOI 10.1021/bi101474v; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; KOUTALOS Y, 1986, PHOTOCHEM PHOTOBIOL, V44, P809; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Lee LTO, 2014, FASEB J, V28, P2632, DOI 10.1096/fj.13-246868; Liu Y, 2016, CANCER LETT, V376, P226, DOI 10.1016/j.canlet.2016.03.031; MAGGIO R, 1993, P NATL ACAD SCI USA, V90, P3103, DOI 10.1073/pnas.90.7.3103; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rodrigues-Ferreira S, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00024; Unal H, 2013, J BIOL CHEM, V288, P540, DOI 10.1074/jbc.M112.392514; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Zhang HT, 2015, J BIOL CHEM, V290, P29127, DOI 10.1074/jbc.M115.689000; Zhang HT, 2015, CELL, V161, P833, DOI 10.1016/j.cell.2015.04.011	29	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3341	3350		10.1074/jbc.M116.750380	http://dx.doi.org/10.1074/jbc.M116.750380			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28096461	hybrid, Green Published			2022-12-26	WOS:000395538800024
J	Wu, R; Feng, JF; Yang, YW; Dai, CM; Lu, AY; Li, J; Liao, Y; Xiang, M; Huang, QM; Wang, D; Du, XB				Wu, Rong; Feng, Jiafu; Yang, Yuwei; Dai, Chunmei; Lu, Anyang; Li, Jie; Liao, Yao; Xiang, Miao; Huang, Qingmei; Wang, Dong; Du, Xiao-Bo			Significance of Serum Total Oxidant/Antioxidant Status in Patients with Colorectal Cancer	PLOS ONE			English	Article							OXIDATIVE STRESS; LIPID-PEROXIDATION; BREAST-CANCER; ALCOHOL; ANTIOXIDANTS; MECHANISMS; BIOMARKERS; CAPACITY; MARKERS; RISK	Oxidative stress is involved in a variety of diseases. Prospective studies investigating the relationship between oxidative stress biomarkers and the status and development of colorectal cancer (CRC) are scarce; previous studies have failed to establish a relationship between the serum total oxidant/antioxidant status and CRC. Therefore, we compared the total serum oxidant/antioxidant levels of CRC patients and healthy subjects, and analyzed their clinical significance in the CRC. Fasting blood samples from 132 CRC patients and 64 healthy subjects were collected. Oxidative stress parameters, including total oxidant status (TOS) and total antioxidant status (TAS), were measured, and the oxidative stress index (OSI) was calculated. The TOS and OSI levels increased significantly (P<0.001) and the TAS level significantly decreased (P<0.001) in the CRC group compared to those in the healthy control group. Oxidative stress parameters differed significantly depending on the patient's smoking and drinking status (P<0.05). The preoperative and postoperative levels of TOS, TAS, and OSI did not differ significantly between primary sites (colon/rectum) and clinical stages (P>0.05).However, the levels of TOS, TAS, and OSI were significantly different between patients with no metastasis and those with metastases to two organs (P<0.05) Finally, the parameters are affected by smoking and drinking, and subsequent research should be conducted excluding the relevant influencing factors.	[Wu, Rong; Li, Jie; Liao, Yao; Xiang, Miao; Huang, Qingmei; Du, Xiao-Bo] MianYang Cent Hosp, Dept Oncol, Mianyang, Sichuan, Peoples R China; [Wu, Rong; Wang, Dong] Southwest Med Univ, Dept Surg, Luzhou, Sichuan, Peoples R China; [Feng, Jiafu; Yang, Yuwei; Dai, Chunmei] MianYang Cent Hosp, Dept Clin Lab, Mianyang, Sichuan, Peoples R China; [Lu, Anyang] MianYang Cent Hosp, Emergency Dept, Mianyang, Sichuan, Peoples R China; [Wang, Dong] MianYang Cent Hosp, Dept Surg, Mianyang, Sichuan, Peoples R China	Southwest Medical University	Du, XB (corresponding author), MianYang Cent Hosp, Dept Oncol, Mianyang, Sichuan, Peoples R China.; Wang, D (corresponding author), Southwest Med Univ, Dept Surg, Luzhou, Sichuan, Peoples R China.; Wang, D (corresponding author), MianYang Cent Hosp, Dept Surg, Mianyang, Sichuan, Peoples R China.	1572612023@qq.com; duxiaobo2005@126.com	Yang, Yu-wei/AAK-8147-2020	Yang, Yu-wei/0000-0002-0908-1228; Feng, Jiafu/0000-0001-8829-1516				Aycicek A, 2007, J PEDIAT-BRAZIL, V83, P319, DOI 10.2223/JPED.1645; Bai XL, 2010, NEW MED, V41, P666; Bongaerts BWC, 2006, ALCOHOL, V38, P147, DOI 10.1016/j.alcohol.2006.06.003; Bukan MH, 2004, TOHOKU J EXP MED, V202, P51, DOI 10.1620/tjem.202.51; Cejas P, 2004, CANCER CAUSE CONTROL, V15, P707, DOI 10.1023/B:CACO.0000036189.61607.52; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Durackova Z, 2010, PHYSIOL RES, V59, P459, DOI 10.33549/physiolres.931844; Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015; Erel O, 2005, CLIN BIOCHEM, V38, P1103, DOI 10.1016/j.clinbiochem.2005.08.008; Eroglu M, 2013, KAOHSIUNG J MED SCI, V29, P368, DOI 10.1016/j.kjms.2012.11.004; Feng JF, 2016, CLIN BIOCHEM, V49, P692, DOI 10.1016/j.clinbiochem.2016.02.005; Feng JF, 2012, INT J CLIN ONCOL, V17, P575, DOI 10.1007/s10147-011-0327-y; Harma M, 2003, SWISS MED WKLY, V133, P563; Inokuma T, 2009, HEPATO-GASTROENTEROL, V56, P343; Inokuma T, 2012, HEPATO-GASTROENTEROL, V59, P2480, DOI 10.5754/hge10383; International Agency for Research on Cancer, 2004, IARC MONOGR EVAL CAR, V83, P1; Kasap S, 2007, J CLIN BIOCHEM NUTR, V41, P50, DOI 10.3164/jcbn.2007007; Katsoulis K, 2005, RESPIRATION, V72, P381, DOI 10.1159/000086252; Kontoulis TM, 2012, J SURG RES, V175, P259, DOI 10.1016/j.jss.2011.09.030; Leufkens AM, 2012, AM J EPIDEMIOL, V175, P653, DOI 10.1093/aje/kwr418; Luo Chiao-Fen, 2011, Acta Anaesthesiol Taiwan, V49, P46, DOI 10.1016/j.aat.2011.05.010; MacNee W, 2001, TRENDS MOL MED, V7, P55, DOI 10.1016/S1471-4914(01)01912-8; Maffei F, 2011, MUTAT RES-FUND MOL M, V714, P88, DOI 10.1016/j.mrfmmm.2011.06.016; Martin LJ, 2008, J NEUROPATH EXP NEUR, V67, P377, DOI 10.1097/NEN.0b013e31816ff780; Mena S, 2009, MUTAT RES-GEN TOX EN, V674, P36, DOI 10.1016/j.mrgentox.2008.09.017; Nam SM, 2009, DIABETES RES CLIN PR, V83, P176, DOI 10.1016/j.diabres.2008.10.007; Osterreicher CH, 2007, MUTAGENESIS, V22, P305, DOI 10.1093/mutage/gem017; Perse M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/725710; Salaspuro MP, 2003, BEST PRACT RES CL GA, V17, P679, DOI 10.1016/S1521-6918(03)00035-0; Santiago-Arteche R, 2012, MOL BIOL REP, V39, P9355, DOI 10.1007/s11033-012-1760-3; Seitz HK, 2007, NAT REV CANCER, V7, P599, DOI 10.1038/nrc2191; Seitz HK, 2001, ALCOHOL CLIN EXP RES, V25, p137S, DOI 10.1097/00000374-200105051-00024; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Simanowski UA, 2001, GUT, V49, P418, DOI 10.1136/gut.49.3.418; Srivastava S., 2009, Indian Journal of Cancer, V46, P297, DOI 10.4103/0019-509X.55549; Stipancic I, 2005, J LAPAROENDOSC ADV S, V15, P347, DOI 10.1089/lap.2005.15.347; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Wang D, 2011, ENDOCR-RELAT CANCER, V18, P773, DOI 10.1530/ERC-11-0230; Zhang Guang-liang, 2004, Di Yi Jun Yi Da Xue Xue Bao, V24, P907; Zhang WZ, 2006, HYPERTENSION, V48, P278, DOI 10.1161/01.HYP.0000231509.27406.42	40	55	55	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170003	10.1371/journal.pone.0170003	http://dx.doi.org/10.1371/journal.pone.0170003			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103261	Green Published, gold, Green Submitted			2022-12-26	WOS:000392381100032
J	Beek, TF; Cohen-Kettenis, PT; Bouman, WP; de Vries, ALC; Steensma, TD; Witcomb, GL; Arcelus, J; Richards, C; De Cuypere, G; Kreukels, BPC				Beek, Titia F.; Cohen-Kettenis, Peggy T.; Bouman, Walter P.; de Vries, Annelou L. C.; Steensma, Thomas D.; Witcomb, Gemma L.; Arcelus, Jon; Richards, Christina; De Cuypere, Griet; Kreukels, Baudewijntje P. C.			Gender Incongruence of Childhood: Clinical Utility and Stakeholder Agreement with the World Health Organization's Proposed ICD-11 Criteria	PLOS ONE			English	Article							DYSPHORIA; DUTCH	The World Health Organization (WHO) is revising the tenth version of the International Classification of Diseases and Related Health Problems (ICD-10). This includes a reconceptualization of the definition and positioning of Gender Incongruence of Childhood (GIC). This study aimed to: 1) collect the views of transgender individuals and professionals regarding the retention of the diagnosis; 2) see if the proposed GIC criteria were acceptable to transgender individuals and health care providers; 3) compare results between two countries with two different healthcare systems to see if these differences influence opinions regarding the GIC diagnosis; and 4) determine whether healthcare providers from high-income countries feel that the proposed criteria are clinically useful and easy to use. A total of 628 participants were included in the study: 284 from the Netherlands (NL; 45.2%), 8 from Flanders (Belgium; 1.3%), and 336 (53.5%) from the United Kingdom (UK). Most participants were transgender people (or their partners/relatives; TG) (n = 522), 89 participants were healthcare providers (HCPs) and 17 were both HCP and TG individuals. Participants completed an online survey developed for this study. Overall, the majority response from transgender participants (42.9%) was that if the diagnosis would be removed from the mental health chapter it should also be removed from the ICD-11 completely, while 33.6% thought it should remain in the ICD-11. Participants were generally satisfied with other aspects of the proposed ICD- 11 GIC diagnosis: most TG participants (58.4%) thought the term Gender Identity Disorder should change, and most thought Gender Incongruence was an improvement (63.0%). Furthermore, most participants (76.1%) did not consider GIC to be a psychiatric disorder and placement in a separate chapter dealing with Gender and Sexual Health (the majority response in the NL and selected by 37.5% of the TG participants overall) or as a Z-code (the majority response in the UK and selected by 26.7% of the TG participants overall) would be preferable. In the UK, the majority response (35.8%) was that narrowing the GIC diagnosis was an improvement, while the NL majority response (49.5%) was that this was not an improvement. Although generally the results from HCPs were in line with the results from TG participants some differences were found. This study suggests that, although in an ideal world a diagnosis is not welcomed, several participants felt the diagnosis should not be removed. This is likely due to concerns about restricting access to reimbursed healthcare. The choice for positioning of a diagnosis of GIC within the ICD-11 was as a separate chapter dealing with symptoms and/or disorders regarding sexual and gender health. This was the overall first choice for NL participants and second choice for UK participants, after the use of a Z-code. The difference reflects that in the UK, Z-codes carry no negative implications for reimbursement of treatment costs. These findings highlight the challenges faced by the WHO in their attempt to integrate research findings from different countries, with different cultures and healthcare systems in their quest to create a manual that is globally applicable.	[Beek, Titia F.; Cohen-Kettenis, Peggy T.; de Vries, Annelou L. C.; Steensma, Thomas D.; Kreukels, Baudewijntje P. C.] Vrije Univ Amsterdam, Ctr Expertise Gender Dysphoria, Med Ctr, Amsterdam, Netherlands; [Beek, Titia F.; Cohen-Kettenis, Peggy T.; Steensma, Thomas D.; Kreukels, Baudewijntje P. C.] Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, Amsterdam, Netherlands; [Bouman, Walter P.; Arcelus, Jon; Richards, Christina] Nottingham Ctr Gender Dysphoria, Nottingham, England; [de Vries, Annelou L. C.] Vrije Univ Amsterdam, Med Ctr, Dept Child & Adolescent Psychiat, Amsterdam, Netherlands; [Witcomb, Gemma L.] Univ Loughborough, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England; [Arcelus, Jon] Univ Nottingham, Fac Med & Hlth Sci, Div Psychiat & Appl Psychol, Nottingham, England; [De Cuypere, Griet] Ghent Univ Hosp, Ctr Sexol & Gender, Ghent, Belgium	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Loughborough University; University of Nottingham; Ghent University; Ghent University Hospital	Beek, TF; Kreukels, BPC (corresponding author), Vrije Univ Amsterdam, Ctr Expertise Gender Dysphoria, Med Ctr, Amsterdam, Netherlands.; Beek, TF; Kreukels, BPC (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, Amsterdam, Netherlands.	t.beek@vumc.nl; b.kreukels@vumc.nl	de Vries, Annelou L.C./D-5524-2011	Kreukels, Baudewijntje/0000-0002-9713-4835; Steensma, Thomas/0000-0003-1330-3644; Witcomb, Gemma/0000-0003-4668-2441; Arcelus, Jon/0000-0002-3805-0180	Ministerie Buitenlandse Zaken (Foreign Affairs); Ministerie van Onderwijs, Cultuur en Wetenschap (Education, Culture and Science); Ministerie van Volksgezondheid, Welzijn en Sport (Health, Welfare and Sport); Nottinghamshire Healthcare NHS Foundation Trust	Ministerie Buitenlandse Zaken (Foreign Affairs); Ministerie van Onderwijs, Cultuur en Wetenschap (Education, Culture and Science); Ministerie van Volksgezondheid, Welzijn en Sport (Health, Welfare and Sport); Nottinghamshire Healthcare NHS Foundation Trust	This work was supported by organizations in the Netherlands - Ministerie Buitenlandse Zaken (Foreign Affairs); Ministerie van Onderwijs, Cultuur en Wetenschap (Education, Culture and Science); Ministerie van Volksgezondheid, Welzijn en Sport (Health, Welfare and Sport). This work was supported in the United Kingdom by Nottinghamshire Healthcare NHS Foundation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, CLIN CHILD PSYCHOL P, V16, P499, DOI DOI 10.1177/1359104510378303; Beek TF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160066; Drescher J, 2012, INT REV PSYCHIATR, V24, P568, DOI 10.3109/09540261.2012.741575; Enthoven AC, 2007, NEW ENGL J MED, V357, P2421, DOI 10.1056/NEJMp078199; European Parliament, 2011, 28 SEPT 2011 HUM RIG; GATE Civil Society Expert Working Group, 2013, CRIT ALT PROP GEND I; Hendriks M, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-167; KIRK SA, 1988, SOC SERV REV, V62, P225, DOI 10.1086/644544; Reed GM, 2011, WORLD PSYCHIATRY, V10, P118; Reed GM, 2010, PROF PSYCHOL-RES PR, V41, P457, DOI 10.1037/a0021701; Ristori J, 2016, INT REV PSYCHIATR, V28, P13, DOI 10.3109/09540261.2015.1115754; Rost K, 1994, Arch Fam Med, V3, P333, DOI 10.1001/archfami.3.4.333; Steensma TD, 2015, J AM ACAD CHILD PSY, V54, P147, DOI 10.1016/j.jaac.2014.10.016; Steensma TD, 2013, J AM ACAD CHILD PSY, V52, P582, DOI 10.1016/j.jaac.2013.03.016; STP International Campaign Stop Trans Pathologization, 2013, REFL STP REG ICD REV; Winter S, 2016, ARCH SEX BEHAV, V45, P1605, DOI 10.1007/s10508-016-0811-6; World Health Organization, 1992, INT STAT CLASS DIS R; World Health Organization WHO, CID 11 BET IN PRESS; WPATH, 2013, WPATH ICD 11 CONS M	19	17	17	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0168522	10.1371/journal.pone.0168522	http://dx.doi.org/10.1371/journal.pone.0168522			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH7JQ	28081569	Green Published, gold			2022-12-26	WOS:000391949500014
J	Hsu, YY; Chou, JY				Hsu, Yu-Yi; Chou, Jui-Yu			Environmental Factors Can Influence Mitochondrial Inheritance in the Saccharomyces Yeast Hybrids	PLOS ONE			English	Article							FUNGUS CRYPTOCOCCUS-NEOFORMANS; DNA MUTATIONS; CHLAMYDOMONAS-REINHARDTII; OXIDATIVE STRESS; MULLERS RATCHET; CHLOROPLAST DNA; HUMAN-DISEASE; CEREVISIAE; GENES; DYSFUNCTION	Mitochondria play a critical role in the generation of metabolic energy and are crucial for eukaryotic cell survival and proliferation. In most sexual eukaryotes, mitochondrial DNA (mtDNA) is inherited from only one parent in non-Mendelian inheritance in contrast to the inheritance of nuclear DNA. The model organism Saccharomyces cerevisiae is commonly used to study mitochondrial biology. It has two mating types: MATa and MATa. Previous studies have suggested that the mtDNA inheritance patterns in hybrid diploid cells depend on the genetic background of parental strains. However, the underlying mechanisms remain unclear. To elucidate the mechanisms, we examined the effects of environmental factors on the mtDNA inheritance patterns in hybrids obtained by crossing S. cerevisiae with its close relative S. paradoxus. The results demonstrated that environmental factors can influence mtDNA transmission in hybrid diploids, and that the inheritance patterns are strain dependent. The fitness competition assay results showed that the fitness differences can explain the mtDNA inheritance patterns under specific conditions. However, in this study, we found that fitness differences cannot fully be explained by mitochondrial activity in hybrids under stress conditions.	[Hsu, Yu-Yi; Chou, Jui-Yu] Natl Changhua Univ Educ, Dept Biol, Changhua, Taiwan	National Changhua University of Education	Chou, JY (corresponding author), Natl Changhua Univ Educ, Dept Biol, Changhua, Taiwan.	jackyjau@cc.ncue.edu.tw			Ministry of Science and Technology [MOST 104-2311-B-018-001, MOST 105-2311-B-018-001 -MY3]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by grants from the Ministry of Science and Technology (MOST 104-2311-B-018-001 and MOST 105-2311-B-018-001 -MY3 to J-YC).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank members of the Chou labs for their contribution to the manuscript. This work was supported by grants from the Ministry of Science and Technology (MOST 104-2311-B-018-001 and MOST 105-2311-B-018-001 -MY3 to J.-Y. Chou).	Aerts AM, 2009, FEBS LETT, V583, P113, DOI 10.1016/j.febslet.2008.11.028; Al-Mehdi AB, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002712; Albertin W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075121; AnkelSimons F, 1996, P NATL ACAD SCI USA, V93, P13859, DOI 10.1073/pnas.93.24.13859; Basse CW, 2010, CURR OPIN MICROBIOL, V13, P712, DOI 10.1016/j.mib.2010.09.003; Bendich AJ, 2010, MOL CELL, V39, P831, DOI 10.1016/j.molcel.2010.09.005; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; Bonnefoy N, 2007, METHOD CELL BIOL, V80, P525, DOI 10.1016/S0091-679X(06)80026-9; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708; Chial H, 2008, NAT ED, V1, P217; Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; GRANT DM, 1980, P NATL ACAD SCI-BIOL, V77, P6067, DOI 10.1073/pnas.77.10.6067; Jones SK, 2015, MBIO, V6, DOI 10.1128/mBio.01604-15; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lee HY, 2008, CELL, V135, P1065, DOI 10.1016/j.cell.2008.10.047; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Loewe L, 2006, GENET RES, V87, P133, DOI 10.1017/S0016672306008123; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Lynch M, 1996, MOL BIOL EVOL, V13, P209, DOI 10.1093/oxfordjournals.molbev.a025557; MacAlpine DM, 2001, EMBO J, V20, P1807, DOI 10.1093/emboj/20.7.1807; MALESZKA R, 1991, EMBO J, V10, P3923, DOI 10.1002/j.1460-2075.1991.tb04962.x; Marinoni G, 1999, J BACTERIOL, V181, P6488, DOI 10.1128/JB.181.20.6488-6496.1999; Michaelis S, 2012, MICROBIOL MOL BIOL R, V76, P626, DOI 10.1128/MMBR.00010-12; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; MIYAKAWA I, 1987, J CELL SCI, V88, P431; Piskur J, 2006, TRENDS GENET, V22, P183, DOI 10.1016/j.tig.2006.02.002; Piskur J, 1998, INT J SYST BACTERIOL, V48, P1015, DOI 10.1099/00207713-48-3-1015; Pulvirenti A, 2000, ANN MICROBIOL, V50, P61; SAGER R, 1967, P NATL ACAD SCI USA, V58, P931, DOI 10.1073/pnas.58.3.931; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Sato M, 2013, BBA-MOL CELL RES, V1833, P1979, DOI 10.1016/j.bbamcr.2013.03.010; Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350; Solieri L, 2008, YEAST, V25, P485, DOI 10.1002/yea.1600; Solieri L, 2010, TRENDS MICROBIOL, V18, P521, DOI 10.1016/j.tim.2010.08.001; STRAUSBERG RL, 1978, MOL GEN GENET, V163, P131, DOI 10.1007/BF00267404; Sun PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114196; Sutovsky P, 2000, BIOL REPROD, V63, P582, DOI 10.1095/biolreprod63.2.582; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; THRAILKILL KM, 1980, GENETICS, V96, P237; Umen JG, 2001, GENE DEV, V15, P2585, DOI 10.1101/gad.906701; Xu JP, 2005, GENOME, V48, P951, DOI [10.1139/g05-082, 10.1139/G05-082]; Xu JP, 2000, CURR MICROBIOL, V40, P269, DOI 10.1007/s002849910053; Yan Z, 2003, GENETICS, V163, P1315; Yan Z, 2007, FUNGAL GENET BIOL, V44, P315, DOI 10.1016/j.fgb.2006.10.002; Zeyl C, 2005, EVOLUTION, V59, P910; Zuin A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002842	51	10	11	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169953	10.1371/journal.pone.0169953	http://dx.doi.org/10.1371/journal.pone.0169953			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081193	Green Submitted, Green Published, gold			2022-12-26	WOS:000391949500107
J	Robles, M; Gautier, C; Mendoza, L; Peugnet, P; Dubois, C; Dahirel, M; Lejeune, JP; Caudron, I; Guenon, I; Camous, S; Tarrade, A; Wimel, L; Serteyn, D; Bouraima-Lelong, H; Chavatte-Palmer, P				Robles, Morgane; Gautier, Camille; Mendoza, Luis; Peugnet, Pauline; Dubois, Cedric; Dahirel, Michele; Lejeune, Jean-Philippe; Caudron, Isabelle; Guenon, Isabelle; Camous, Sylvaine; Tarrade, Anne; Wimel, Laurence; Serteyn, Didier; Bouraima-Lelong, Helene; Chavatte-Palmer, Pascale			Maternal Nutrition during Pregnancy Affects Testicular and Bone Development, Glucose Metabolism and Response to Overnutrition in Weaned Horses Up to Two Years	PLOS ONE			English	Article							POSTNATAL OBESOGENIC DIET; INSULIN SENSITIVITY; LATE-GESTATION; FETAL-GROWTH; DIFFERENTIAL IMPACTS; PRENATAL EXPOSURE; EMBRYO-TRANSFER; SERTOLI-CELLS; MINIMAL-MODEL; WEIGHT-GAIN	Introduction Pregnant mares and post-weaning foals are often fed concentrates rich in soluble carbohydrates, together with forage. Recent studies suggest that the use of concentrates is linked to alterations of metabolism and the development of osteochondrosis in foals. The aim of this study was to determine if broodmare diet during gestation affects metabolism, osteoarticular status and growth of yearlings overfed from 20 to 24 months of age and/or sexual maturity in prepubertal colts. Material and methods Twenty-four saddlebred mares were fed forage only (n = 12, group F) or cracked barley and forage (n = 12, group B) from mid-gestation until foaling. Colts were gelded at 12 months of age. Between 20 and 24 months of age, all yearlings were overfed (+140% of requirements) using an automatic concentrate feeder. Offspring were monitored for growth between 6 and 24 months of age, glucose homeostasis was evaluated via modified frequently sampled intra veinous glucose tolerance test (FSIGT) at 19 and 24 months of age and osteoarticular status was investigated using radiographic examinations at 24 months of age. The structure and function of testicles from prepubertal colts were analyzed using stereology and RTqPCR. Results Post-weaning weight growth was not different between groups. Testicular maturation was delayed in F colts compared to B colts at 12 months of age. From 19 months of age, the cannon bone was wider in B vs F yearlings. F yearlings were more insulin resistant at 19 months compared to B yearlings but B yearlings were affected more severely by overnutrition with reduced insulin sensitivity. The osteoarticular status at 24 months of age was not different between groups. Conclusion In conclusion, nutritional management of the pregnant broodmare and the growing foal may affect sexual maturity of colts and the metabolism of foals until 24 months of age. These effects may be deleterious for reproductive and sportive performances in older horses.	[Robles, Morgane; Peugnet, Pauline; Dahirel, Michele; Camous, Sylvaine; Tarrade, Anne; Chavatte-Palmer, Pascale] Univ Paris Saclay, ENVA, INRA, UMR BDR, Jouy En Josas, France; [Gautier, Camille; Guenon, Isabelle] Normandie Univ, UNICAEN, EA2608, OeReCa,USC INRA, Caen, France; [Mendoza, Luis; Lejeune, Jean-Philippe; Caudron, Isabelle; Serteyn, Didier] Univ Liege, Fac Med Vet, Equine Clin, Liege, Belgium; [Dubois, Cedric; Wimel, Laurence] IFCE, Stn Expt Valade, Chamberet, France	Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universite de Caen Normandie; University of Liege	Chavatte-Palmer, P (corresponding author), Univ Paris Saclay, ENVA, INRA, UMR BDR, Jouy En Josas, France.	pascala.chavatte@jouy.inra.fr	Chavatte-Palmer, Pascale/K-7349-2012; Robles, Morgane/AAA-4407-2020	Chavatte-Palmer, Pascale/0000-0002-4581-6092; Robles, Morgane/0000-0003-4821-4684; Gautier, Camille/0000-0002-3604-4836; Couturier-Tarrade, Anne/0000-0003-1559-5476	"Institut Francais du Cheval et de l'Equitation"; "Fonds Eperon" (FOETALIM project)	"Institut Francais du Cheval et de l'Equitation"; "Fonds Eperon" (FOETALIM project)	This work was funded by grants from the "Institut Francais du Cheval et de l'Equitation" and by the "Fonds Eperon" (FOETALIM project). The funders had no role in study design, data collection and analysis, decision to publish, nor preparation of the manuscript.	Allen WR, 2004, REPRODUCTION, V127, P67, DOI 10.1530/rep.1.00024; Allen WR, 2002, REPRODUCTION, V123, P445, DOI 10.1530/rep.0.1230445; Almeida J, 2012, THERIOGENOLOGY, V77, P847, DOI 10.1016/j.theriogenology.2011.09.007; Almeida J, 2011, REPRODUCTION, V141, P841, DOI 10.1530/REP-10-0499; [Anonymous], 2015, ANNUAIRE ECUS, V68; Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009; Arnaud MG., 1997, NOTATION ETAT CORPOR, V1, P40; Attig L, 2008, AM J PHYSIOL-ENDOC M, V295, pE1117, DOI 10.1152/ajpendo.90542.2008; Ball BA, 2008, ANIM REPROD SCI, V107, P257, DOI 10.1016/j.anireprosci.2008.04.014; Bamford NJ, 2016, VET J; BARKER DJP, 1989, LANCET, V2, P577; Bell RA, 2001, J ANIM SCI, V79, P1142; Bergin W. C, 1970, Biology Reprod., V3, P82; Bergman RN, 2005, HORM RES, V64, P8, DOI 10.1159/000089312; BERGMAN RN, 1989, DIABETES, V38, P1512, DOI 10.2337/diabetes.38.12.1512; BERGMAN RN, 1981, J CLIN INVEST, V68, P1456, DOI 10.1172/JCI110398; Bielli A, 2002, REPROD FERT DEVELOP, V14, P333, DOI 10.1071/RD02046; Boston Ray C, 2003, Diabetes Technol Ther, V5, P1003, DOI 10.1089/152091503322641060; Bouret SG, 2006, CLIN GENET, V70, P295, DOI 10.1111/j.1399-0004.2006.00684.x; Carter RA, 2009, AM J VET RES, V70, P1250, DOI 10.2460/ajvr.70.10.1250; Cavinder C. A., 2012, Professional Animal Scientist, V28, P344; Chavatte-Palmer P, 2014, ANIM PROD SCI, V54, P1166, DOI 10.1071/AN14470; CLEMMONS AJ, 1995, BIOL REPROD, V52, P1258, DOI 10.1095/biolreprod52.6.1258; Da Silva P, 2001, REPRODUCTION, V122, P375, DOI 10.1530/rep.0.1220375; Denoix JM, 2013, VET J, V197, P44, DOI 10.1016/j.tvjl.2013.03.040; Denoix J. M., 1990, Pratique Veterinaire Equine, V22, P14; Dupont C, 2014, J DEV ORIG HLTH DIS, V5, P183, DOI 10.1017/S2040174414000087; ESCOFIER B, 1994, COMPUT STAT DATA AN, V18, P121, DOI 10.1016/0167-9473(94)90135-X; FactoMineR, EXPL MULT DAT AN R; Forhead AJ, 2004, J ENDOCRINOL, V181, P459, DOI 10.1677/joe.0.1810459; Fowden AL, 2013, J EQUINE VET SCI, V33, P295, DOI 10.1016/j.jevs.2013.03.005; Fowden AL, 2005, J ENDOCRINOL, V186, P467, DOI 10.1677/joe.1.06176; Gao Y, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00188; Gardner DS, 2005, AM J PHYSIOL-REG I, V289, pR947, DOI 10.1152/ajpregu.00120.2005; Genovese P, 2010, REPROD DOMEST ANIM, V45, P233, DOI 10.1111/j.1439-0531.2008.01244.x; George LA, 2009, DOMEST ANIM ENDOCRIN, V37, P23, DOI 10.1016/j.domaniend.2009.01.003; Giussani DA, 2003, J PHYSIOL-LONDON, V547, P67, DOI 10.1113/jphysiol.2002.027409; Glade M. J., 1986, Journal of Equine Veterinary Science, V6, P151, DOI 10.1016/S0737-0806(86)80066-1; Gluckman PD, 2008, TRENDS ENDOCRIN MET, V19, P109, DOI 10.1016/j.tem.2008.02.002; Hanson MA, 2014, PHYSIOL REV, V94, P1027, DOI 10.1152/physrev.00029.2013; Hoffman RM, 2003, J ANIM SCI, V81, P2333; JOHNSON L, 1995, MICROSC RES TECHNIQ, V32, P385, DOI 10.1002/jemt.1070320504; Khanal P, 2015, ACTA PHYSIOL, V213, P519, DOI 10.1111/apha.12391; Khanal P, 2014, ACTA PHYSIOL, V210, P110, DOI 10.1111/apha.12129; Kotsampasi B, 2009, ANIM REPROD SCI, V114, P135, DOI 10.1016/j.anireprosci.2008.08.017; Kroll A, 2001, PFERDEHEILKUNDE, V17, P489, DOI 10.21836/PEM20010511; Laporte-Broux B, 2011, J ANIM SCI, V89, P2154, DOI 10.2527/jas.2010-3374; Laporte-Broux B, 2012, PHYSIOL BEHAV, V106, P178, DOI 10.1016/j.physbeh.2012.02.001; Long NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122152; Martin-Rosset W, 2012, NUTR ALIMENTATION CH, P624; National Research Council (U.S.), 2007, NUTR REQUIREMENTS HO; Ousey JC, 2008, EQUINE VET J, V40, P673, DOI 10.2746/042516408X322175; Painter RC, 2005, REPROD TOXICOL, V20, P345, DOI 10.1016/j.reprotox.2005.04.005; Peugnet P, J EQUINE VET SCI; Peugnet P, 2016, J EQUINE VET SCI, V37, P24, DOI 10.1016/j.jevs.2015.11.008; Peugnet P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122596; Peugnet P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102044; Pitetti JL, 2013, MOL ENDOCRINOL, V27, P814, DOI 10.1210/me.2012-1258; Rae MT, 2002, REPRODUCTION, V124, P33, DOI 10.1530/rep.0.1240033; Ralston SL, 1996, PFERDEHEILKUNDE, V12, P320; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Rhind SM, 2004, ANIM REPROD SCI, V82-3, P169, DOI 10.1016/j.anireprosci.2004.04.003; Rode K, 2015, THERIOGENOLOGY, V84, P763, DOI 10.1016/j.theriogenology.2015.05.009; Rodriguez-Gonzalez GL, 2012, J DEV ORIG HLTH DIS, V3, P321, DOI 10.1017/S2040174412000360; Russ J.C., 2013, PRACTICAL STEREOLOGY; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; SHERMAN KM, 1995, EQUINE VET J, V27, P135, DOI 10.1111/j.2042-3306.1995.tb03050.x; Simitzis PE, 2015, PHYSIOL BEHAV, V141, P172, DOI 10.1016/j.physbeh.2015.01.025; Steelman SM, 2006, J ANIM SCI, V84, P2391, DOI 10.2527/jas.2005-281; SUTTON EI, 1977, CAN J ANIM SCI, V57, P551, DOI 10.4141/cjas77-071; Symeon GK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118259; Symonds ME, 2016, THERIOGENOLOGY, V86, P120, DOI 10.1016/j.theriogenology.2016.04.023; Thorson JF, 2010, J ANIM SCI, V88, P982, DOI 10.2527/jas.2008-1646; van Weeren P R, 1999, Equine Vet J Suppl, P26; Vander Heyden L, 2013, VET REC, V172, P68, DOI 10.1136/vr.101034; Vickers MH, 2008, ENDOCRINOLOGY, V149, P1906, DOI 10.1210/en.2007-0981; Vickers MH, 2003, AM J PHYSIOL-REG I, V285, pR271, DOI 10.1152/ajpregu.00051.2003; Weeren P. R. van, 2006, Clinical Techniques in Equine Practice, V5, P248, DOI 10.1053/j.ctep.2006.08.002; Weller MMDCA, 2016, J DAIRY SCI, V99, P3056, DOI 10.3168/jds.2015-9673; Wilsher S, 2006, EQUINE VET J, V38, P549, DOI 10.2746/042516406X156497	80	23	23	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169295	10.1371/journal.pone.0169295	http://dx.doi.org/10.1371/journal.pone.0169295			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081146	Green Submitted, gold, Green Published			2022-12-26	WOS:000391949500041
J	Bawankule, R; Singh, A; Kumar, K; Shetye, S				Bawankule, Rahul; Singh, Abhishek; Kumar, Kaushalendra; Shetye, Sadanand			Does Measles Vaccination Reduce the Risk of Acute Respiratory Infection (ARI) and Diarrhea in Children: A Multi-Country Study?	PLOS ONE			English	Article							CHILDHOOD PNEUMONIA; EPIDEMIOLOGY; DETERMINANTS; MORTALITY; BRAZIL; DHAKA	Background Pneumonia and diarrhea occur either as complications or secondary infections in measles affected children. So, the integrated Global Action Plan for Pneumonia and Diarrhea (GAPPD) by WHO and UNICEF includes measles vaccination as preventive measure in children. The objective of the study is to examine the effect of measles vaccination on Acute Respiratory Infection (ARI) and diarrhea in children in the Democratic Republic of Congo, Ethiopia, India, Nigeria, and Pakistan. Methods We analyzed data from the most recent rounds of Demographic and Health Surveys (DHS) in the selected countries. We included children age 12-59 months in the analysis. We used multivariable binary logistic regression to examine the effect of measles vaccination on ARI and diarrhea in children. We also estimated Vaccination Effectiveness (VE). Findings More than 60 percent of the children age 12-59 months were given measles vaccine before the survey in the Democratic Republic of Congo, Ethiopia, India and Pakistan. Children who were given the measles vaccine were less likely to suffer from ARI than unvaccinated children in India and Pakistan. Children who were given the measles vaccine had a lower risk of diarrhea than those who did not receive it in all the selected countries except Ethiopia. Measles vaccination was associated with reduction in ARI cases by 15-30 percent in India and Pakistan, and diarrhea cases by 12-22 percent in the Democratic Republic of Congo, India, Nigeria and Pakistan. Conclusion The receipt of the measles vaccine was associated with decrease in ARI and diarrhea in children. The immunization program must ensure that each child gets the recommended doses of measles vaccine at the appropriate age. The measles vaccination should be given more attention as a preventive intervention under the Global Action Plan for Pneumonia and Diarrhea (GAPPD) in all low and middle-income countries.	[Bawankule, Rahul] Int Inst Populat Sci, Bombay, Maharashtra, India; [Singh, Abhishek; Kumar, Kaushalendra] Int Inst Populat Sci, Dept Publ Hlth & Mortal Studies, Bombay, Maharashtra, India; [Shetye, Sadanand] BKL Walawalkar Rural Med Coll, Derwan, India	International Institute for Population Sciences; International Institute for Population Sciences	Bawankule, R (corresponding author), Int Inst Populat Sci, Bombay, Maharashtra, India.	rahulbams2010@gmail.com	Bawankule, Rahul/HII-4191-2022; Singh, Abhishek/ABC-7813-2020; Kumar, Kaushalendra/ABC-7943-2020	Singh, Abhishek/0000-0001-6263-4410; Kumar, Kaushalendra/0000-0001-5913-0297				[Anonymous], 2009, Wkly Epidemiol Rec, V84, P349; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P1; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P220; [Anonymous], 2014, NIG DEM HLTH SURV 20; [Anonymous], 2009, DIARRH WHY CHILDR AR; Arnold BF, 2013, AM J EPIDEMIOL, V177, P361, DOI 10.1093/aje/kws281; Baker KK, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002010; Bezatu Mengistie, 2013, Open Journal of Preventive Medicine, V3, P446, DOI 10.4236/ojpm.2013.37060; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Cardoso AM, 2013, TROP MED INT HEALTH, V18, P596, DOI 10.1111/tmi.12081; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; CLEMENS JD, 1988, AM J EPIDEMIOL, V128, P1330, DOI 10.1093/oxfordjournals.aje.a115086; Donahue JG, 2014, VACCINE, V32, P6440, DOI 10.1016/j.vaccine.2014.09.051; du Plan et Suivi de la Mise en de la Revolution de la Modernite (MPSMRM) de la Sante Publique (MSP) et ICF International, 2014, DEM SANT REP DEM CON; Edmond K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031239; Etiler N, 2004, PUBLIC HEALTH, V118, P62, DOI 10.1016/S0033-3506(03)00132-X; Ferdous F, 2014, TROP MED INT HEALTH, V19, P1170, DOI 10.1111/tmi.12357; Ferdous F, 2013, AM J TROP MED HYG, V89, P223, DOI 10.4269/ajtmh.12-0743; Fonseca W, 1996, B WORLD HEALTH ORGAN, V74, P199; Grimwood K, 2015, PNEUMONIA, V6, P101, DOI 10.15172/pneu.2015.6/671; Hamborsky J, 2015, EPIDEMIOLOGY PREVENT, P209; IIPS and Macro International, 2007, NATL FAMILY HLTH SUR, V1; IIPS Macro International., 2007, NAT FAM HLTH SURV NF, VII; International Vaccine Access Center (IVAC), 2015, PNEUM DIARRH PROGR R; Isere E E, 2014, Ann Ib Postgrad Med, V12, P15; Jain DL, 2013, INDIAN PEDIATR, V50, P787; Johnson W, 2013, AFRICAN J RESP MED, V8; Kosai H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125009; Kvestad I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121743; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Mahalanabis D, 2002, EPIDEMIOL INFECT, V129, P65, DOI 10.1017/S0950268802006817; Mancini S, 2014, CONFL HEALTH, V8, P9, DOI [DOI 10.1186/1752-1505-8-9, 10.1186/1752-1505-8-9]; Marufu T, 2001, East Afr Med J, V78, P135; Mihrete TS, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-102; MoHFW, 2015, UN IMM PROGR; Molbak K, 1997, AM J EPIDEMIOL, V146, P273, DOI 10.1093/oxfordjournals.aje.a009263; Moss WJ, 2012, LANCET, V379, P153, DOI 10.1016/S0140-6736(10)62352-5; Murhekar MV, 2011, J INFECT DIS, V204, pS421, DOI 10.1093/infdis/jir061; National Institute of Population Studies (NIPS) [Pakistan] Macro International Inc, 2013, PAK DEM HLTH SURV 20; Niazi AK, 2014, ANN MED HEALTH SCI R, V4, P1, DOI 10.4103/2141-9248.126600; Perry Robert T., 2004, Journal of Infectious Diseases, V189, pS4, DOI 10.1086/377712; Ram PK, 2014, AM J TROP MED HYG, V90, P968, DOI 10.4269/ajtmh.13-0532; Santos CAST, 2012, EPIDEMIOL INFECT, V140, P689, DOI 10.1017/S0950268811000690; Sehgal V, 1997, Indian Pediatr, V34, P213; Sheikh S, 2011, VACCINE, V29, P3419, DOI 10.1016/j.vaccine.2011.02.087; UNICEF WHO, 2013, IMM SUMM STAT REF CO; United Nations Children Fund (UNICEF), 2007, WAT ENV SAN CHILDR W; United Nations Children's Fund (UNICEF), 2012, PNEUM DIARRH TACKL D; Upadhyay AK, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1631-7; van den Ent M, 2009, INDIAN PEDIATR, V46, P933; Weinberg GA, 2010, J INFECT DIS, V201, P1607, DOI 10.1086/652404; WHO, 2013, WHO MEASL DEATHS DEC; WHO, 2016, PNEUMONIA; World Health Organization, 2004, CONS M REV EV RES PR; World Health Organization, 2009, IMM BAS IMM SER MOD; World Health Organization UNICEF, 2013, END PREV CHILD DEATH; World Health Organization (WHO), 2015, STRAT PLAN MEASL EL; World of Organization-WHO, 2016, DIARRH DIS; Zodpey SP, 1998, PUBLIC HEALTH, V112, P233, DOI 10.1038/sj.ph.1900450	60	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169713	10.1371/journal.pone.0169713	http://dx.doi.org/10.1371/journal.pone.0169713			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076428	Green Submitted, Green Published, gold			2022-12-26	WOS:000391857100049
J	Bronsveld, HK; Jensen, V; Vahl, P; De Bruin, ML; Cornelissen, S; Sanders, J; Auvinen, A; Haukka, J; Andersee, M; Vestergaard, P; Schmidt, MK				Bronsveld, Heleen K.; Jensen, Vibeke; Vahl, Pernille; De Bruin, Marie L.; Cornelissen, Sten; Sanders, Joyce; Auvinen, Anssi; Haukka, Jari; Andersee, Morten; Vestergaard, Peter; Schmidt, Marjanka K.			Diabetes and Breast Cancer Subtypes	PLOS ONE			English	Article							BODY-MASS INDEX; INSULIN ANALOGS; GENE-EXPRESSION; RISK; MELLITUS; ASSOCIATION; MORTALITY; METAANALYSIS; IMPACT; MAMMOGRAPHY	Background Women with diabetes have a worse survival after breast cancer diagnosis compared to women without diabetes. This may be due to a different etiological profile, leading to the development of more aggressive breast cancer subtypes. Our aim was to investigate whether insulin and non-insulin treated women with diabetes develop specific clinicopathological breast cancer subtypes compared to women without diabetes. Methods and Findings This cross-sectional study included randomly selected patients with invasive breast cancer diagnosed in 2000-2010. Stratified by age at breast cancer diagnosis (<= 50 and >50 years), women with diabetes were 2:1 frequency-matched on year of birth and age at breast cancer diagnosis (both in 10-year categories) to women without diabetes, to select similar to 300 patients with tumor tissue available. Tumor MicroArrays were stained by immunohistochemistry for estrogen and progesterone receptor (ER, PR), HER2, Ki67, CK5/6, CK14, and p63. A pathologist scored all stains and revised morphology and grade. Associations between diabetes/insulin treatment and clinicopathological subtypes were analyzed using multivariable logistic regression. Morphology and grade were not significantly different between women with diabetes (n = 211) and women without diabetes (n = 101), irrespective of menopausal status. Premenopausal women with diabetes tended to have more often PR-negative (OR = 2.44(95%C1:1.07-5.55)), HER2-negative (OR = 2.84(95%C1:1.11-7.22)), and basal-like (OR = 3.14(95%C1:1.03-9.60) tumors than the women without diabetes, with non-significantly increased frequencies of ER-negative (OR = 2.48(95`)/X1:0.95-6.45)) and triple negative (OR = 2.60(95%CI:0.88-7.67) tumors. After adjustment for age and BMI, the associations remained similar in size but less significant. We observed no evidence for associations of clinicopathological subtypes with diabetes in postmenopausal women, or with insulin treatment in general. Conclusions We found no compelling evidence that women with diabetes, treated with or without insulin, develop different breast cancer subtypes than women without diabetes. However, premenopausal women with diabetes tended to develop breast tumors that do not express hormonal receptors, which are typically associated with poor prognosis.	[Bronsveld, Heleen K.; Cornelissen, Sten; Schmidt, Marjanka K.] Netherlands Canc Inst, Div Mol Pathol, Amsterdam, Netherlands; [Bronsveld, Heleen K.; Schmidt, Marjanka K.] Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, Amsterdam, Netherlands; [Jensen, Vibeke; Vahl, Pernille] Aarhus Univ, Hosp THG, Dept Pathol, Aarhus, Denmark; [De Bruin, Marie L.] Univ Utrecht, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [Sanders, Joyce] Netherlands Canc Inst, Div Pathol, Amsterdam, Netherlands; [Auvinen, Anssi] Univ Tampere, Sch Publ Hlth, Tampere, Finland; [Haukka, Jari] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Andersee, Morten] Karolinska Inst, Dept Med, Stockholm, Sweden; [Vestergaard, Peter] Aalborg Univ, Inst Clin, Aalborg, Denmark	Netherlands Cancer Institute; Netherlands Cancer Institute; Aarhus University; Utrecht University; Netherlands Cancer Institute; Tampere University; University of Helsinki; Karolinska Institutet; Aalborg University	Schmidt, MK (corresponding author), Netherlands Canc Inst, Div Mol Pathol, Amsterdam, Netherlands.; Schmidt, MK (corresponding author), Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, Amsterdam, Netherlands.	mk.schmidt@nki.nl	Schmidt, Marjanka K/G-9058-2011; Auvinen, Anssi/AAL-2111-2020; Seitz, Hermann/G-1657-2015; Auvinen, Anssi/AAD-9311-2020; De Bruin, Marie Louise/O-5349-2016; Haukka, Jari/G-1484-2014; Andersen, Morten/H-3555-2011	Schmidt, Marjanka K/0000-0002-2228-429X; Auvinen, Anssi/0000-0003-1125-4818; Seitz, Hermann/0000-0003-3401-0090; De Bruin, Marie Louise/0000-0001-9197-7068; Haukka, Jari/0000-0003-1450-6208; Andersen, Morten/0000-0001-7029-2860	European Community's Seventh Framework Programme (FP-7), the CARING project [282526]	European Community's Seventh Framework Programme (FP-7), the CARING project	The research leading to the results of this study has received funding from the European Community's Seventh Framework Programme (FP-7) under grant agreement number 282526, the CARING project. The funding source had no role in study design, data collection, data analysis, data interpretation or writing of the report.	[Anonymous], 2013, DIAB ATL; Berstein LM, 2011, MED ONCOL, V28, P1260, DOI 10.1007/s12032-010-9572-6; Besic Nikola, 2013, BMC Res Notes, V6, P416, DOI 10.1186/1756-0500-6-416; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; Brand JS, 2015, HUM REPROD, V30, P1491, DOI 10.1093/humrep/dev054; Bronsveld HK, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0611-2; Cleveland RJ, 2012, CANCER CAUSE CONTROL, V23, P1193, DOI 10.1007/s10552-012-9989-7; Currie CJ, 2013, J CLIN ENDOCR METAB, V98, P668, DOI 10.1210/jc.2012-3042; Diabetes Atlas, 2015, DIAB ATL; Erickson K, 2011, J CLIN ONCOL, V29, P54, DOI 10.1200/JCO.2010.29.3183; Fleming ST, 1999, MED CARE, V37, P601, DOI 10.1097/00005650-199906000-00009; Flores- Lopez LA, 2016, CELL ONCOL DORDR; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Gillespie EF, 2010, ANN SURG ONCOL, V17, P752, DOI 10.1245/s10434-009-0797-6; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Goodwin PJ, 2002, J CLIN ONCOL, V20, P42, DOI 10.1200/JCO.20.1.42; Grimaldi-Bensouda L, 2014, DIABETES CARE, V37, P134, DOI 10.2337/dc13-0695; Hellmann SS, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1296-8; Hou GF, 2013, BREAST CANCER RES TR, V137, P807, DOI 10.1007/s10549-012-2404-y; International Agency for Research on Cancer (IARC) WHO, 2012, SECT CANC SURV; Kaplan MA, 2012, MED ONCOL, V29, P1576, DOI 10.1007/s12032-011-0109-4; Karlstad O, 2013, CURR DRUG SAF, V8, P333, DOI 10.2174/15680266113136660067; Larsson SC, 2007, INT J CANCER, V121, P856, DOI 10.1002/ijc.22717; Liao SC, 2011, ASIAN PAC J CANCER P, V12, P1061; Liao SC, 2010, ASIAN PAC J CANCER P, V11, P933; Liu XD, 2012, CANCER-AM CANCER SOC, V118, P1353, DOI 10.1002/cncr.26420; Luo JH, 2014, BREAST CANCER RES TR, V148, P153, DOI 10.1007/s10549-014-3146-9; Mauro L, 2001, BIOCHEM BIOPH RES CO, V288, P685, DOI 10.1006/bbrc.2001.5815; Mengel M, 2002, J PATHOL, V198, P292, DOI 10.1002/path.1218; Moller S, 2008, ACTA ONCOL, V47, P506, DOI 10.1080/02841860802059259; Njor SH, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1064; O'Leary TJ, 2001, APPL IMMUNOHISTO M M, V9, P3, DOI 10.1097/00022744-200103000-00002; Panno ML, 1996, J CANCER RES CLIN, V122, P745, DOI 10.1007/BF01209122; Peairs KS, 2011, J CLIN ONCOL, V29, P40, DOI 10.1200/JCO.2009.27.3011; Phipps AI, 2012, ANN EPIDEMIOL, V22, P340, DOI 10.1016/j.annepidem.2012.02.002; Redaniel MTM, 2012, CANCER CAUSE CONTROL, V23, P1785, DOI 10.1007/s10552-012-0057-0; Renehan AG, 2012, DIABETOLOGIA, V55, P1619, DOI 10.1007/s00125-012-2526-0; Rose DP, 2012, ENDOCR-RELAT CANCER, V19, pR225, DOI 10.1530/ERC-12-0203; Schrauder MG, 2011, J CANCER RES CLIN, V137, P975, DOI 10.1007/s00432-010-0960-2; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Sihto H, 2008, CLIN CANCER RES, V14, P4103, DOI 10.1158/1078-0432.CCR-07-5003; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Srokowski TP, 2009, J CLIN ONCOL, V27, P2170, DOI 10.1200/JCO.2008.17.5935; Starup-Linde J, 2013, CURR DRUG SAF, V8, P296, DOI 10.2174/15748863113086660071; van Buuren S, 2011, J STAT SOFTW, V45, P1; Westley RL, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/632461; Wolf I, 2006, EUR J CANCER, V42, P1077, DOI 10.1016/j.ejca.2006.01.027; Xue F, 2007, AM J CLIN NUTR, V86, p823S, DOI 10.1093/ajcn/86.3.823S; Yang XR, 2011, JNCI-J NATL CANCER I, V103, P250, DOI 10.1093/jnci/djq526; Yeh HC, 2012, DIABETES CARE, V35, P113, DOI 10.2337/dc11-0255; Zhou XH, 2010, DIABETOLOGIA, V53, P1867, DOI 10.1007/s00125-010-1796-7	51	38	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0170084	10.1371/journal.pone.0170084	http://dx.doi.org/10.1371/journal.pone.0170084			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076434	Green Published, gold, Green Submitted			2022-12-26	WOS:000391857100087
J	Taing, KD; O'Brien, TJ; Williams, DA; French, CR				Kim Det Taing; O'Brien, Terence J.; Williams, David A.; French, Chris R.			Anti-Epileptic Drug Combination Efficacy in an In Vitro Seizure Model - Phenytoin and Valproate, Lamotrigine and Valproate	PLOS ONE			English	Article							EPILEPTIFORM ACTIVITY; INTERICTAL SPIKING; MECHANISMS; ANTICONVULSANT; LEVETIRACETAM; PATTERNS; THERAPY; SUBSTITUTION; PHARMACOLOGY; POLYTHERAPY	In this study, we investigated the relative efficacy of different classes of commonly used anti-epileptic drugs (AEDs) with different mechanisms of action, individually and in combination, to suppress epileptiform discharges in an in vitro model. Extracellular field potential were recorded in 450 mu m thick transverse hippocampal slices prepared from juvenile Wistar rats, in which "epileptiform discharges" (ED's) were produced with a high-K+ (8.5 mM) bicarbonate-buffered saline solution. Single and dual recordings in stratum pyramidale of CA1 and CA3 regions were performed with 3-5 M Omega glass microelectrodes. All drugs-lamotrigine (LTG), phenytoin (PHT) and valproate (VPA)-were applied to the slice by superfusion at a rate of 2 ml/min at 32 degrees C. Effects upon frequency of ED's were assessed for LTG, PHT and VPA applied at different concentrations, in isolation and in combination. We demonstrated that high-K+ induced ED frequency was reversibly reduced by LTG, PHT and VPA, at concentrations corresponding to human therapeutic blood plasma concentrations. With a protocol using several applications of drugs to the same slice, PHT and VPA in combination displayed additivity of effect with 50 mu M PHT and 350 mu M VPA reducing SLD frequency by 44% and 24% individually (n = 19), and together reducing SLD frequency by 66% (n = 19). 20 mu M LTG reduced SLD frequency by 32% and 350 mu M VPA by 16% (n = 18). However, in combination there was a supra-linear suppression of ED's of 64% (n = 18). In another independent set of experiments, similar results of drug combination responses were also found. In conclusion, a combination of conventional AEDs with different mechanisms of action, PHT and VPA, displayed linear additivity of effect on epileptiform activity. More intriguingly, a combination of LTG and VPA considered particularly efficacious clinically showed a supra-additive suppression of ED's. This approach may be useful as an in vitro platform for assessing drug combination efficacy.	[Kim Det Taing; O'Brien, Terence J.; Williams, David A.; French, Chris R.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic, Australia	Royal Melbourne Hospital; University of Melbourne	Taing, KD (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic, Australia.	k.taing2@student.unimelb.edu.au	O'Brien, Terence/L-8102-2013; O'Brien, Terence/AAU-5525-2021; French, Chris/AHA-1801-2022	O'Brien, Terence/0000-0002-7198-8621; French, Christopher/0000-0002-1445-8704				Albus H, 1998, EPILEPSIA, V39, P124, DOI 10.1111/j.1528-1157.1998.tb01350.x; Antonio LL, 2016, J NEUROSCI METH, V260, P33, DOI 10.1016/j.jneumeth.2015.08.014; Apetoh L, 2015, ANN ONCOL, V26, P1813, DOI 10.1093/annonc/mdv209; Barker-Haliski M, 2014, ADV EXP MED BIOL, V813, P295, DOI 10.1007/978-94-017-8914-1_24; Behr C, 2015, EPILEPSY RES, V115, P8, DOI 10.1016/j.eplepsyres.2015.05.006; Behr C, 2014, INT REV NEUROBIOL, V114, P63, DOI 10.1016/B978-0-12-418693-4.00004-2; Brigo F, 2013, EPILEPSY BEHAV, V27, P439, DOI 10.1016/j.yebeh.2013.03.010; Brodie MJ, 1997, EPILEPSY RES, V26, P423, DOI 10.1016/S0920-1211(96)01007-8; Chopp S, 2015, AM J HEALTH-SYST PH, V72, P1445, DOI 10.2146/ajhp140290; Colombo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055329; Andraus MEC, 2012, ARQ NEURO-PSIQUIAT, V70, P145, DOI 10.1590/S0004-282X2012000200014; Coulter DA, 1997, J CHILD NEUROL, V12, pS2, DOI 10.1177/0883073897012001031; Czuczwar SJ, 2009, EXPERT OPIN DRUG MET, V5, P131, DOI [10.1517/17425250802677826, 10.1517/17425250802677826 ]; Eadie MJ, 2012, EXPERT REV NEUROTHER, V12, P1419, DOI [10.1586/ern.12.129, 10.1586/ERN.12.129]; Englund M, 2011, CELL MOL NEUROBIOL, V31, P645, DOI 10.1007/s10571-011-9660-y; Fisher RS, 2014, ADV EXP MED BIOL, V813, P3, DOI 10.1007/978-94-017-8914-1_1; Flemming A, 2015, NAT REV DRUG DISCOV, V14, P13, DOI 10.1038/nrd4524; Foucquier J, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.149; French JA, 2009, EPILEPSIA, V50, P63, DOI 10.1111/j.1528-1167.2009.02238.x; Fueta Y, 2005, NEUROSCIENCE, V132, P335, DOI 10.1016/j.neuroscience.2004.12.044; Garzon E, 2001, NEUROLOGY, V57, P1175, DOI 10.1212/WNL.57.7.1175; Huberfeld G, 2015, REV NEUROL-FRANCE, V171, P236, DOI 10.1016/j.neurol.2015.01.563; JAWAD S, 1986, BRIT J CLIN PHARMACO, V22, P191, DOI 10.1111/j.1365-2125.1986.tb05249.x; Johannessen CU, 2000, NEUROCHEM INT, V37, P103, DOI 10.1016/S0197-0186(00)00013-9; Kuo CC, 1998, MOL PHARMACOL, V54, P712; Kwan P, 2000, SEIZURE-EUR J EPILEP, V9, P464, DOI 10.1053/seiz.2000.0442; Kwan P, 2010, LANCET NEUROL, V9, P27, DOI 10.1016/S1474-4422(09)70304-7; Lee CY, 2008, EPILEPSIA, V49, P888, DOI 10.1111/j.1528-1167.2007.01526.x; LESCHINGER A, 1993, EXP BRAIN RES, V96, P230; Levesque M, 2015, SEIZURE-EUR J EPILEP, V25, P18, DOI 10.1016/j.seizure.2014.11.008; Libenson MH, 2001, PEDIATR NEUROL, V24, P214, DOI 10.1016/S0887-8994(00)00271-X; Liu JS, 2013, NEUROSCI BULL, V29, P28, DOI 10.1007/s12264-013-1304-4; Loscher W, 1999, PROG NEUROBIOL, V58, P31, DOI 10.1016/S0301-0082(98)00075-6; Loscher W, 2002, CNS DRUGS, V16, P669; Luszczki JJ, 2006, EPILEPSIA, V47, P10, DOI 10.1111/j.1528-1167.2006.00364.x; Luszczki JJ, 2003, EPILEPSIA, V44, P1003, DOI 10.1046/j.1528-1157.2003.10003.x; Margolis JM, 2014, JAMA NEUROL, V71, P985, DOI 10.1001/jamaneurol.2014.808; Matsumura N, 2014, EUR J PHARMACOL, V741, P237, DOI 10.1016/j.ejphar.2014.08.001; McCabe PH, 2015, EPILEPSY BEHAV, V45, P147, DOI 10.1016/j.yebeh.2015.02.010; Peltola J, 2008, SEIZURE-EUR J EPILEP, V17, P276, DOI 10.1016/j.seizure.2007.08.001; Perucca P, 2014, BRAIN, V137, P183, DOI 10.1093/brain/awt299; Pisani A, 2004, EPILEPSIA, V45, P719, DOI 10.1111/j.0013-9580.2004.02204.x; Pisani F, 1999, EPILEPSIA, V40, P1141, DOI 10.1111/j.1528-1157.1999.tb00832.x; POCH G, 1980, J PHARMACOL METHOD, V4, P179, DOI 10.1016/0160-5402(80)90036-4; Privitera Michael, 2011, Am J Manag Care, V17 Suppl 7, pS195; Rambeck B, 2006, EPILEPSIA, V47, P681, DOI 10.1111/j.1528-1167.2006.00504.x; Rogawski MA, 2004, NAT REV NEUROSCI, V5, P553, DOI 10.1038/nrn1430; RUTECKI PA, 1985, J NEUROPHYSIOL, V54, P1363, DOI 10.1152/jn.1985.54.5.1363; Shandra A, 2013, EPILEPSIA, V54, P1167, DOI 10.1111/epi.12237; SPENCER SS, 1992, EPILEPSIA, V33, P537, DOI 10.1111/j.1528-1157.1992.tb01706.x; Tallarida RJ, 2006, J PHARMACOL EXP THER, V319, P1, DOI 10.1124/jpet.106.104117; Taverna S, 1998, EPILEPSY RES, V32, P304, DOI 10.1016/S0920-1211(98)00060-6; TRAYNELIS SF, 1988, J NEUROPHYSIOL, V59, P259, DOI 10.1152/jn.1988.59.1.259; Tse WF, 2015, CLINICOECONOMIC OUTC, V7, P431, DOI 10.2147/CEOR.S85535; Vajda FJE, 2014, EPILEPTIC DISORD, V16, P395, DOI 10.1684/epd.2014.0704; Yin YH, 2013, IRAN J BASIC MED SCI, V16, P1119; Zaccara G, 2014, EPILEPTIC DISORD, V16, P409, DOI 10.1684/epd.2014.0714; Ziburkus J, 2013, J NEUROPHYSIOL, V109, P1296, DOI 10.1152/jn.00232.2012	58	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169974	10.1371/journal.pone.0169974	http://dx.doi.org/10.1371/journal.pone.0169974			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076384	gold, Green Published			2022-12-26	WOS:000391857100072
J	Amar, D; Izraeli, S; Shamir, R				Amar, D.; Izraeli, S.; Shamir, R.			Utilizing somatic mutation data from numerous studies for cancer research: proof of concept and applications	ONCOGENE			English	Article							HEDGEHOG SIGNALING PATHWAY; GENE-EXPRESSION PROFILES; INTEGRATED ANALYSIS; IDENTIFICATION; CYTOSCAPE; ONTOLOGY; BIOLOGY; SMAD4; KRAS	Large cancer projects measure somatic mutations in thousands of samples, gradually assembling a catalog of recurring mutations in cancer. Many methods analyze these data jointly with auxiliary information with the aim of identifying subtype-specific results. Here, we show that somatic gene mutations alone can reliably and specifically predict cancer subtypes. Interpretation of the classifiers provides useful insights for several biomedical applications. We analyze the COSMIC database, which collects somatic mutations from The Cancer Genome Atlas (TCGA) as well as from many smaller scale studies. We use multi-label classification techniques and the Disease Ontology hierarchy in order to identify cancer subtype-specific biomarkers. Cancer subtype classifiers based on TCGA and the smaller studies have comparable performance, and the smaller studies add a substantial value in terms of validation, coverage of additional subtypes, and improved classification. The gene sets of the classifiers are used for threefold contribution. First, we refine the associations of genes to cancer subtypes and identify novel compelling candidate driver genes. Second, using our classifiers we successfully predict the primary site of metastatic samples. Third, we provide novel hypotheses regarding detection of subtype-specific synthetic lethality interactions. From the cancer research community perspective, our results suggest that curation efforts, such as COSMIC, have great added and complementary value even in the era of large international cancer projects.	[Amar, D.; Shamir, R.] Tel Aviv Univ, Blavatnik Sch Comp Sci, Tel Aviv Univ Campus, IL-69978 Tel Aviv, Israel; [Izraeli, S.] Sheba Med Ctr, Safra Childrens Hosp, Dept Pediat Hematol Oncol, Ramat Gan, Israel; [Izraeli, S.] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel	Tel Aviv University; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Shamir, R (corresponding author), Tel Aviv Univ, Blavatnik Sch Comp Sci, Tel Aviv Univ Campus, IL-69978 Tel Aviv, Israel.	rshamir@tau.ac.il	Shamir, Ron/E-6514-2011	Shamir, Ron/0000-0003-1889-9870	Israel Science Foundation [317/13]; IDEA grant from the Dotan Center in Hemato-Oncology; Israeli Center of Research Excellence (I-CORE), Gene Regulation in Complex Human Disease [41/11]; Azrieli Foundation; Edmond J. Safra Center for Bioinformatics at Tel Aviv University	Israel Science Foundation(Israel Science Foundation); IDEA grant from the Dotan Center in Hemato-Oncology; Israeli Center of Research Excellence (I-CORE), Gene Regulation in Complex Human Disease; Azrieli Foundation; Edmond J. Safra Center for Bioinformatics at Tel Aviv University	This study was supported in part by the Israel Science Foundation (grant 317/13), an IDEA grant from the Dotan Center in Hemato-Oncology, and the Israeli Center of Research Excellence (I-CORE), Gene Regulation in Complex Human Disease, Center No 41/11. DA is grateful to the Azrieli Foundation for the award of an Azrieli Fellowship. DA was also supported in part by fellowships from the Edmond J. Safra Center for Bioinformatics at Tel Aviv University. Part of the work was done while DA and RS were visiting the Simons Institute for the Theory of Computing.	Amar D, 2015, NUCLEIC ACIDS RES, V43, P7779, DOI 10.1093/nar/gkv810; Amar D, 2014, NUCLEIC ACIDS RES, V42, P4208, DOI 10.1093/nar/gku102; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cancer Genome Atlas Research Network, 2013, Nat Genet, V45, P1113, DOI 10.1038/ng.2764; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Ding JR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9554; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Eser S, 2014, BRIT J CANCER, V111, P1; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Furth N, 2015, GENE DEV, V29, P2325, DOI 10.1101/gad.268185.115; Gonzalez-Perez A, 2013, NAT METHODS, V10, P723, DOI 10.1038/nmeth.2562; Guo J, 2016, NUCLEIC ACIDS RES, V44, pD1011, DOI 10.1093/nar/gkv1108; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hofree M, 2013, NAT METHODS, V10, P1108, DOI [10.1038/NMETH.2651, 10.1038/nmeth.2651]; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Jerby-Arnon L, 2014, CELL, V158, P1199, DOI 10.1016/j.cell.2014.07.027; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; Kelleher FC, 2011, CARCINOGENESIS, V32, P445, DOI 10.1093/carcin/bgq280; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lan A, 2011, NUCLEIC ACIDS RES, V39, pW424, DOI 10.1093/nar/gkr359; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee YS, 2013, BIOINFORMATICS, V29, P3036, DOI 10.1093/bioinformatics/btt529; Leiserson MDM, 2015, NAT GENET, V47, P106, DOI 10.1038/ng.3168; Liu Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep10204; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Onishi H, 2014, WORLD J GASTROENTERO, V20, P2335, DOI 10.3748/wjg.v20.i9.2335; Raphael BJ, 2014, GENOME MED, V6, DOI 10.1186/gm524; Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tascilar M, 2001, CLIN CANCER RES, V7, P4115; Torgo L, 2011, DATA MINING R LEARNI, P289; Truty MJ, 2007, PANCREATOLOGY, V7, P423, DOI 10.1159/000108959; Tsoumakas G, 2011, J MACH LEARN RES, V12, P2411; Turner NC, 2008, EMBO J, V27, P1368, DOI 10.1038/emboj.2008.61; Ulitsky I, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-8; Vandin F, 2012, BIOCOMPUT-PAC SYM, P55; Visser S, 2010, CELL CYCLE, V9, P3892, DOI 10.4161/cc.9.19.13386; Vlasblom J, 2014, BIOINFORMATICS, P1; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Wright M. N., 2015, RANGER FAST IMPLEMEN; Zhang ML, 2007, PATTERN RECOGN, V40, P2038, DOI 10.1016/j.patcog.2006.12.019; Zhang ML, 2014, IEEE T KNOWL DATA EN, V26, P1819, DOI 10.1109/TKDE.2013.39; Zhao ZM, 2016, P NATL ACAD SCI USA, V113, P2140, DOI 10.1073/pnas.1525677113	51	10	10	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 15	2017	36	24					3375	3383		10.1038/onc.2016.489	http://dx.doi.org/10.1038/onc.2016.489			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EX6GL	28092680	Green Published, hybrid			2022-12-26	WOS:000403340700002
J	Rink, C; Gnyawali, S; Stewart, R; Teplitsky, S; Harris, H; Roy, S; Sen, CK; Khanna, S				Rink, Cameron; Gnyawali, Surya; Stewart, Richard; Teplitsky, Seth; Harris, Hallie; Roy, Sashwati; Sen, Chandan K.; Khanna, Savita			Glutamate oxaloacetate transaminase enables anaplerotic refilling of TCA cycle intermediates in stroke-affected brain	FASEB JOURNAL			English	Article						anaplerosis; hypoglycemia; ischemia; oxygen	ACUTE ISCHEMIC-STROKE; NEURONAL CELL-LINE; CITRIC-ACID CYCLE; INDUCED NEURODEGENERATION; OXIDATIVE STRESS; HYPOGLYCEMIA; DEATH; NEUROPROTECTION; 12-LIPOXYGENASE; METABOLISM	Ischemic stroke results in excessive release of glutamate, which contributes to neuronal cell death. Here, we test the hypothesis that otherwise neurotoxic glutamate can be productively metabolized by glutamate oxaloacetate transaminase (GOT) to maintain cellular energetics and protect the brain from ischemic stroke injury. The GOT-dependent metabolismof glutamatewas studied in primary neural cells and in stroke-affected C57-BL6mice usingmagnetic resonance spectroscopy andGC-MS. ExtracellularGlu sustained cell viability under hypoglycemic conditions and increased GOT-mediated metabolism in vitro. Correction of stroke-induced hypoxia using supplemental oxygen in vivo lowered Glu levels as measured by 1H magnetic resonance spectroscopy. GOT knockdown abrogated this effect and caused ATP loss in the stroke-affected brain. GOT overexpression increased anaplerotic refilling of tricarboxylic acid cycle intermediates in mouse brain during ischemic stroke. Furthermore, GOT overexpression not only reduced ischemic stroke lesion volume but also attenuated neurodegeneration and improved poststroke sensorimotor function. Taken together, our results show that GOT enables metabolism of otherwise neurotoxic extracellular Glu through a truncated tricarboxylic acid cycle under hypoglycemic conditions.-Rink, C., Gnyawali, S., Stewart, R., Teplitsky, S., Harris, H., Roy, S., Sen, C. K., Khanna, S. Glutamate oxaloacetate transaminase enables anaplerotic refilling of TCA cycle intermediates in stroke-affected brain. FASEB J. 31, 1709-1718 (2017). www.fasebj.org	[Rink, Cameron; Gnyawali, Surya; Stewart, Richard; Teplitsky, Seth; Harris, Hallie; Roy, Sashwati; Sen, Chandan K.; Khanna, Savita] Ohio State Univ, Dept Surg, Davis Heart & Lung Res Inst, Wexner Med Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Rink, C; Khanna, S (corresponding author), 473 W 12th Ave, Columbus, OH 43210 USA.	cameron.rink@osumc.edu; savita.khanna@osumc.edu	Gnyawali, Surya/AAC-3082-2020; Rink, Cameron/AAA-4484-2021; Gnyawali, Surya/AAC-3082-2020	Gnyawali, Surya/0000-0001-8980-4889; Rink, Cameron/0000-0002-3149-3624; Gnyawali, Surya/0000-0002-4214-8068; Teplitsky, Seth/0000-0001-9242-1360	U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke [R01NS085272]; American Heart Association [12SDG11780023, NS42617]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085272, R01NS042617] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke Grant R01NS085272 (to C.R. and S.K.), and by American Heart Association Grants 12SDG11780023 (to C.R.) and NS42617 (to C.K.S.). The authors thank Jessica Weist (The Ohio State University Wexner Medical Center) for technical support with in vivo experiments.	Bakken IJ, 1998, J NEUROSCI RES, V51, P636, DOI 10.1002/(SICI)1097-4547(19980301)51:5<636::AID-JNR11>3.0.CO;2-0; BUTCHER SP, 1987, NEUROSCI LETT, V76, P296, DOI 10.1016/0304-3940(87)90418-6; Campos F, 2011, J CEREBR BLOOD F MET, V31, P1378, DOI 10.1038/jcbfm.2011.3; ENGELSEN B, 1986, J NEUROCHEM, V47, P1634, DOI 10.1111/j.1471-4159.1986.tb00806.x; Fukui M, 2009, EUR J PHARMACOL, V617, P1, DOI 10.1016/j.ejphar.2009.06.059; HAYASHI T, 1954, KEIO J MED, V3, P192, DOI DOI 10.2302/KJM.3.183; Hofmeijer J, 2012, STROKE, V43, P607, DOI 10.1161/STROKEAHA.111.632943; Jamaluddin MS, 2009, ARTERIOSCL THROM VAS, V29, P2146, DOI 10.1161/ATVBAHA.109.194134; Khanna S, 2005, STROKE, V36, pE144, DOI 10.1161/01.STR.0000181082.70763.22; Khanna S, 2003, J BIOL CHEM, V278, P43508, DOI 10.1074/jbc.M307075200; Khanna S, 2002, METHOD ENZYMOL, V352, P191; Khanna S, 2007, J BIOL CHEM, V282, P23482, DOI 10.1074/jbc.M611269200; Khanna S, 2015, FASEB J, V29, P828, DOI 10.1096/fj.14-263723; Khanna S, 2015, ANTIOXID REDOX SIGN, V22, P175, DOI 10.1089/ars.2014.6106; Khanna S, 2013, J CEREBR BLOOD F MET, V33, P1197, DOI 10.1038/jcbfm.2013.68; KREBS HANS ADOLF, 1935, BIOCHEM JOUR, V29, P1620; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; MIYAMOTO M, 1989, J PHARMACOL EXP THER, V250, P1132; MURPHY TH, 1990, FASEB J, V4, P1624, DOI 10.1096/fasebj.4.6.2180770; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; Olney J W, 1986, Adv Exp Med Biol, V203, P631; Park HA, 2009, CELL DEATH DIFFER, V16, P1167, DOI 10.1038/cdd.2009.37; Park HA, 2011, STROKE, V42, P2308, DOI 10.1161/STROKEAHA.110.608547; Perez-Mato M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.507; Puchowicz MA, 2008, J CEREBR BLOOD F MET, V28, P1907, DOI 10.1038/jcbfm.2008.79; Rink C, 2011, ANTIOXID REDOX SIGN, V14, P1777, DOI 10.1089/ars.2011.3930; Rink C, 2010, J CEREBR BLOOD F MET, V30, P1275, DOI 10.1038/jcbfm.2010.7; Sherwood TW, 2011, J NEUROSCI, V31, P9723, DOI 10.1523/JNEUROSCI.1665-11.2011; Sonnewald U, 1996, NEUROCHEM RES, V21, P987, DOI 10.1007/BF02532408; Tan Shirlee, 2001, Current Topics in Medicinal Chemistry, V1, P497, DOI 10.2174/1568026013394741; Tang YX, 2009, BLOOD, V113, P744, DOI 10.1182/blood-2008-03-145219; WIELOCH T, 1985, SCIENCE, V230, P681, DOI 10.1126/science.2996146; Yang LL, 2008, J BIOL CHEM, V283, P21988, DOI 10.1074/jbc.M803455200; Yang L, 2006, METABOLOMICS, V2, P85, DOI 10.1007/s11306-006-0019-1; Zhu MY, 2003, CELL MOL NEUROBIOL, V23, P865, DOI 10.1023/A:1025069407173	35	23	25	2	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1709	1718		10.1096/fj.201601033R	http://dx.doi.org/10.1096/fj.201601033R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28096234	Green Published			2022-12-26	WOS:000398504300035
J	Xiao, YT; Dai, Q; Hu, RQ; Pacheco, S; Yang, YB; Liang, GM; Soberon, M; Bravo, A; Liu, KY; Wu, KM				Xiao, Yutao; Dai, Qing; Hu, Ruqin; Pacheco, Sabino; Yang, Yongbo; Liang, Gemei; Soberon, Mario; Bravo, Alejandra; Liu, Kaiyu; Wu, Kongming			A Single Point Mutation Resulting in Cadherin Mislocalization Underpins Resistance against Bacillus thuringiensis Toxin in Cotton Bollworm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUROPEAN CORN-BORER; HELICOVERPA-ARMIGERA; BT TOXIN; INSECT RESISTANCE; ENDOPLASMIC-RETICULUM; HELIOTHIS-VIRESCENS; HUBNER LEPIDOPTERA; CRY1AC RESISTANCE; PINK-BOLLWORM; CROPS	Transgenic plants that produce Bacillus thuringiensis (Bt) crystalline (Cry) toxins are cultivated worldwide to control insect pests. Resistance to B. thuringiensis toxins threatens this technology, and although different resistance mechanisms have been identified, some have not been completely elucidated. To gain new insights into these mechanisms, we performed multiple back-crossing from a 3000-fold Cry1Ac-resistant BtR strain from cotton bollworm (Helicoverpa armigera), isolating a 516-fold Cry1Ac-resistant strain (96CAD). Cry1Ac resistance in 96CAD was tightly linked to a mutant cadherin allele (mHaCad) that contained 35 amino acid substitutions compared with HaCad from a susceptible strain (96S). We observed significantly reduced levels of the mHaCad protein on the surface of the midgut epithelium in 96CAD as compared with 96S. Expression of both cadherin alleles from 96CAD and 96S in insect cells and immunofluorescence localization in insect midgut tissue sections showed that the HaCAD protein from 96S localizes on the cell membrane, whereas the mutant 96CAD-mHaCad was retained in the endoplasmic reticulum (ER). Mapping of the mutations identified a D172G substitution mainly responsible for cadherin mislocalization. Our finding of a mutation affecting membrane receptor trafficking represents an unusual and previously unrecognized B. thuringiensis resistance mechanism.	[Xiao, Yutao; Hu, Ruqin; Liang, Gemei; Wu, Kongming] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, West Yuanmingyuan Rd, Beijing 100193, Peoples R China; [Xiao, Yutao] Chinese Acad Agr Sci, Agr Genom Inst Shenzhen, Shenzhen 518120, Peoples R China; [Dai, Qing; Hu, Ruqin; Yang, Yongbo; Liu, Kaiyu] Cent China Normal Univ, Coll Life Sci, 152 Luoyu Ave, Wuhan 430079, Peoples R China; [Pacheco, Sabino; Soberon, Mario; Bravo, Alejandra] Univ Nacl Autonoma Mexico, Inst Biotecnol, Apdo Postal 510-3, Cuernavaca 62250, Morelos, Mexico	Chinese Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS; Central China Normal University; Universidad Nacional Autonoma de Mexico	Wu, KM (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, West Yuanmingyuan Rd, Beijing 100193, Peoples R China.; Liu, KY (corresponding author), Cent China Normal Univ, Coll Life Sci, 152 Luoyu Ave, Wuhan 430079, Peoples R China.	liukaiyu@mail.ccnu.edu.cn; wukongming@caas.cn	Pacheco, Sabino/AFJ-9017-2022; de la Parra, Maria Alejandra Bravo/R-6740-2017	Bravo, Alejandra/0000-0002-7573-7475; wu, kongming/0000-0003-2499-1032; Pacheco, Sabino/0000-0002-0208-0046	National Natural Science Foundation [31321004, 31601646]; Key Project for Breeding Genetic Modified Organisms Grant [2016ZX0812-004]; PAPIIT-UNAM [IA202616]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Key Project for Breeding Genetic Modified Organisms Grant; PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico)	This work was supported by National Natural Science Foundation Grants 31321004 and 31601646, Key Project for Breeding Genetic Modified Organisms Grant 2016ZX0812-004, and PAPIIT-UNAM Grant IA202616. M.S. and A.B. are coauthors of a patent on modified B. thuringiensis toxins, "Suppression of resistance in insects to Bacillus thuringiensis Cry toxins, using toxins that do not require the cadherin receptor" (patent numbers CA2690188A1, CN101730712A, EP2184293A2, EP2184293A4, EP2184293B1, WO2008150150A2, and WO2008150150A3).	Bagla P, 2010, SCIENCE, V327, P1439, DOI 10.1126/science.327.5972.1439; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Cao GC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05629; Carriere Y, 2010, EVOL APPL, V3, P561, DOI 10.1111/j.1752-4571.2010.00129.x; Castagnola A, 2011, DIFFERENTIATION, V81, P192, DOI 10.1016/j.diff.2010.12.001; Chen WC, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/462929; CICCARELLI E, 1993, EUR J BIOCHEM, V213, P271, DOI 10.1111/j.1432-1033.1993.tb17759.x; Console L, 2015, BBA-MOL CELL RES, V1853, P1636, DOI 10.1016/j.bbamcr.2015.03.017; D'Arcangelo JG, 2013, BBA-MOL CELL RES, V1833, P2464, DOI 10.1016/j.bbamcr.2013.02.003; Dalecky A, 2006, PLOS BIOL, V4, P1048, DOI 10.1371/journal.pbio.0040181; Downes S, 2010, EVOL APPL, V3, P574, DOI 10.1111/j.1752-4571.2010.00146.x; FIELD MC, 1994, J BIOL CHEM, V269, P10830; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Guo Z.-W., 2015, DATABASE, V2015, P1, DOI DOI 10.1371/J0URNAL.PGEN.1005124; Guo ZJ, 2015, INSECT BIOCHEM MOLEC, V59, P30, DOI 10.1016/j.ibmb.2015.01.009; Hua G, 2004, J BIOL CHEM, V279, P28051, DOI 10.1074/jbc.M400237200; Jin L, 2015, NAT BIOTECHNOL, V33, P169, DOI 10.1038/nbt.3100; Jurat-Fuentes JL, 2004, EUR J BIOCHEM, V271, P3127, DOI 10.1111/j.1432-1033.2004.04238.x; Jurat-Fuentes JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017606; Kaniakova M, 2012, J NEUROCHEM, V123, P385, DOI 10.1111/jnc.12002; Khajuria C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-286; Kilisch M, 2015, PFLUG ARCH EUR J PHY, V467, P1105, DOI 10.1007/s00424-014-1672-2; LANKFORD SP, 1993, J BIOL CHEM, V268, P4814; Liang GM, 2008, J INVERTEBR PATHOL, V97, P142, DOI 10.1016/j.jip.2007.09.007; Liang GeMei, 1999, Plant Protection, V25, P15; Liu CX, 2009, J INSECT PHYSIOL, V55, P686, DOI 10.1016/j.jinsphys.2009.05.001; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Park Y, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-46; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Rabiau N, 2009, IN VIVO, V23, P203; Ray-Sinha A, 2009, MOL MEMBR BIOL, V26, P448, DOI 10.3109/09687680903333839; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; Siqueira HAA, 2006, APPL ENVIRON MICROB, V72, P5318, DOI 10.1128/AEM.00219-06; Tabashnik BE, 2002, J ECON ENTOMOL, V95, P1018, DOI 10.1603/0022-0493-95.5.1018; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005646; Tay WT, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005534; WOLFERSBERGER MG, 1993, ARCH INSECT BIOCHEM, V24, P139, DOI 10.1002/arch.940240304; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Xiao YT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06184; Xu P, 2016, CYTOTECHNOLOGY, V68, P481, DOI 10.1007/s10616-014-9801-5; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; Zhang HN, 2013, PESTIC BIOCHEM PHYS, V107, P148, DOI 10.1016/j.pestbp.2013.06.007; Zhang HN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053418; Zhang HN, 2012, P NATL ACAD SCI USA, V109, P10275, DOI 10.1073/pnas.1200156109; Zhang SP, 2009, INSECT BIOCHEM MOLEC, V39, P421, DOI 10.1016/j.ibmb.2009.04.003; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103	50	30	36	1	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2933	2943		10.1074/jbc.M116.768671	http://dx.doi.org/10.1074/jbc.M116.768671			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28082675	Green Published, hybrid			2022-12-26	WOS:000395535100033
J	Lappchen, T; Tonnesmann, R; Eersels, J; Meyer, PT; Maecke, HR; Rylova, SN				Laeppchen, Tilman; Toennesmann, Roswitha; Eersels, Jos; Meyer, Philipp T.; Maecke, Helmut R.; Rylova, Svetlana N.			Radioiodinated Exendin-4 Is Superior to the Radiometal-Labelled Glucagon-Like Peptide-1 Receptor Probes Overcoming Their High Kidney Uptake	PLOS ONE			English	Article							GLP-1 RECEPTOR; INSULINOMAS; PET/CT; ANTAGONIST; ANALOGS; GA-68-NOTA-EXENDIN-4; LOCALIZATION; CELLS	GLP-1 receptors are ideal targets for preoperative imaging of benign insulinoma and for quantifying the beta cell mass. The existing clinical tracers targeting GLP-1R are all agonists with low specific activity and very high kidney uptake. In order to solve those issues we evaluated GLP-1R agonist Ex-4 and antagonist Ex(9-39) radioiodinated at Tyr(40) side by side with [Nle(14),Lys(40)(Ahx-DOTA-Ga-68)NH2]Ex-4 (Ga-68-Ex-4) used in the clinic. The Kd, Bmax, internalization and binding kinetics of [Nle(14),(125)l-Tyr(40)-NH2]Ex-4 and [Nle(14),(125)l-Tyr(40)-NH2]Ex (9-39) were studied in vitro using Ins-1E cells. Biodistribution and imaging studies were performed in nude mice bearing Ins-1E xenografts. In vitro evaluation demonstrated high affinity binding of the [Nle(14),I-125-Tyr(40)-NH2]Ex-4 agonist to the 1ns-1E cells with fast internalization kinetics reaching a plateau after 30 min. The antagonist [Nle(14),(125)l-Tyr(40)-NH2]Ex(9-39) did not internalize and had a 4 fold higher Kd value compared to the agonist. In contrast to [Nle(14),(125)l-Tyr(40)-NH2]Ex(9-39), which showed low and transient tumor uptake, [Nle(14),(125)l-Tyr(40)-NH2]Ex-4 demonstrated excellent in vivo binding properties with tumor uptake identical to that of 68Ga-Ex-4, but substantially lower kidney uptake resulting in a tumor-to-kidney ratio of 9.7 at 1 h compared to 0.3 with 68Ga-Ex-4. Accumulation of activity in thyroid and stomach for both peptides, which was effectively blocked by irenat, confirms that in vivo deiodination is the mechanism behind the low kidney retention of iodinated peptides. The 1241 congener of [Nle(14),(125)l-Tyr(40)-NH2]Ex-4 demonstrated a similar favourable biodistribution profile in the PET imaging studies in contrast to the typical biodistribution pattern of [Nle(14),Lys(40)(Ahx-DOTA-Ga-68)NH2]Ex-4. Our results demonstrate that iodinated Ex-4 is a very promising tracer for imaging of benign insulinomas. It solves the problem of high kidney uptake of the radiometal-labelled tracers by improving the tumor-to-kidney ratio measured for [Nle(14),Lys(40)(AhxDOTA-Ga-68)NH2]Ex-4 by 32 fold.	[Laeppchen, Tilman; Toennesmann, Roswitha; Meyer, Philipp T.; Maecke, Helmut R.; Rylova, Svetlana N.] Univ Freiburg, Fac Med, Med Ctr, Dept Nucl Med, Freiburg, Germany; [Laeppchen, Tilman] Univ Hosp Bern, Inselspital, Dept Nucl Med, Bern, Switzerland; [Laeppchen, Tilman] Univ Bern, Bern, Switzerland; [Eersels, Jos] Vrije Univ Amsterdam Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands; [Meyer, Philipp T.; Maecke, Helmut R.; Rylova, Svetlana N.] German Canc Consortium DKTK, Heidelberg, Germany; [Rylova, Svetlana N.] German Canc Res Ctr, Heidelberg, Germany	University of Freiburg; University of Bern; University Hospital of Bern; University of Bern; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Rylova, SN (corresponding author), Univ Freiburg, Fac Med, Med Ctr, Dept Nucl Med, Freiburg, Germany.; Rylova, SN (corresponding author), German Canc Consortium DKTK, Heidelberg, Germany.; Rylova, SN (corresponding author), German Canc Res Ctr, Heidelberg, Germany.	svetlana.rylova@uniklinik-freiburg.de		Lappchen, Tilman/0000-0002-7746-1572; Eersels, Jos Leon/0000-0001-7521-583X	 [Der Sonderforschungsbereich SFB 850];  [Z2]	; 	Der Sonderforschungsbereich SFB 850 (project Z2) to PM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiraj K, 2011, J NUCL MED, V52, P1970, DOI 10.2967/jnumed.111.094375; Antunes P, 2007, BIOCONJUGATE CHEM, V18, P84, DOI 10.1021/bc0601673; Antwi K, 2015, J NUCL MED, V56, P1075, DOI 10.2967/jnumed.115.157768; Bauman A, 2015, J NUCL MED, V56, P1569, DOI 10.2967/jnumed.115.159186; Brom M, 2012, CONTRAST MEDIA MOL I, V7, P160, DOI 10.1002/cmmi.475; Brom M, 2010, EUR J NUCL MED MOL I, V37, P1345, DOI 10.1007/s00259-009-1363-y; Christ E, 2013, LANCET DIABETES ENDO, V1, P115, DOI 10.1016/S2213-8587(13)70049-4; Christ E, 2009, J CLIN ENDOCR METAB, V94, P4398, DOI 10.1210/jc.2009-1082; Eriksson O, 2014, J CLIN ENDOCR METAB, V99, P1519, DOI 10.1210/jc.2013-3541; Gao HK, 2011, MOL PHARMACEUT, V8, P1775, DOI 10.1021/mp200141x; Ginj M, 2006, P NATL ACAD SCI USA, V103, P16436, DOI 10.1073/pnas.0607761103; GOKE R, 1993, J BIOL CHEM, V268, P19650; Gotthardt M, 2002, EUR J NUCL MED MOL I, V29, P597, DOI 10.1007/s00259-002-0761-1; Hubalewska-Dydejczyk A, 2015, Q J NUCL MED MOL IM, V59, P152; Jodal A, 2014, EJNMMI RES, V4, DOI 10.1186/s13550-014-0031-9; Kiesewetter DO, 2012, EUR J NUCL MED MOL I, V39, P463, DOI 10.1007/s00259-011-1980-0; Korner M, 2007, J NUCL MED, V48, P736, DOI 10.2967/jnumed.106.038679; Luo YP, 2016, J NUCL MED, V57, P715, DOI 10.2967/jnumed.115.167445; Luo YP, 2015, EUR J NUCL MED MOL I, V42, P531, DOI 10.1007/s00259-014-2946-9; Mikkola K, 2014, MOL IMAGING BIOL, V16, P255, DOI 10.1007/s11307-013-0691-2; Pattou F, 2010, NEW ENGL J MED, V363, P1289, DOI 10.1056/NEJMc1004547; Rylova SN, 2016, J NUCL MED, V57, P1282, DOI 10.2967/jnumed.115.168948; Selvaraju RK, 2013, J NUCL MED, V54, P1458, DOI 10.2967/jnumed.112.114066; SINGH G, 1994, REGUL PEPTIDES, V53, P47, DOI 10.1016/0167-0115(94)90158-9; Sowa-Staszczak A, 2013, EUR J NUCL MED MOL I, V40, P524, DOI 10.1007/s00259-012-2299-1; Vaidyanathan G, 1990, BIOCONJUGATE CHEM, V1, P269, DOI 10.1021/bc00004a007; Vegt E, 2010, J NUCL MED, V51, P1049, DOI 10.2967/jnumed.110.075101; Wang Y, 2012, NUCL MED BIOL, V39, P167, DOI 10.1016/j.nucmedbio.2011.07.011; Waser B, 2014, EUR J NUCL MED MOL I, V41, P1166, DOI 10.1007/s00259-013-2684-4; Wild D, 2008, NEW ENGL J MED, V359, P766, DOI 10.1056/NEJMc0802045; Wild D, 2006, J NUCL MED, V47, P2025; Wild D, 2010, J NUCL MED, V51, P1059, DOI 10.2967/jnumed.110.074914; Wu ZH, 2014, THERANOSTICS, V4, P770, DOI 10.7150/thno.7759; Wu ZH, 2013, J NUCL MED, V54, P244, DOI 10.2967/jnumed.112.109694	34	20	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170435	10.1371/journal.pone.0170435	http://dx.doi.org/10.1371/journal.pone.0170435			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103285	Green Published, Green Submitted, gold			2022-12-26	WOS:000392381100065
J	Ogutu, JO; Kuloba, B; Piepho, HP; Kanga, E				Ogutu, Joseph O.; Kuloba, Bernard; Piepho, Hans-Peter; Kanga, Erustus			Wildlife Population Dynamics in Human-Dominated Landscapes under Community-Based Conservation: The Example of Nakuru Wildlife Conservancy, Kenya	PLOS ONE			English	Article							DIFFERENCE VEGETATION INDEX; NAIROBI NATIONAL-PARK; SOUTHERN RIFT-VALLEY; LAND-USE CHANGES; WATERBIRD NUMBERS; LAKE NAIVASHA; HERBIVORE DYNAMICS; RANGE CONTRACTION; AFRICAN BUFFALO; RAINFALL	Wildlife conservation is facing numerous and mounting challenges on private and communal lands in Africa, including in Kenya. We analyze the population dynamics of 44 common wildlife species in relation to rainfall variation in the Nakuru Wildlife Conservancy (NWC), located in the Nakuru-Naivasha region of Kenya, based on ground total counts carried out twice each year from March 1996 to May 2015. Rainfall in the region was quasi-periodic with cycle periods dependent on the rainfall component and varying from 2.8 years for the dry season to 10.9 years for the wet season. These oscillations are associated with frequent severe droughts and food scarcity for herbivores. The trends for the 44 wildlife species showed five general patterns during 1996-2015. 1) Steinbuck, bushbuck, hartebeest and greater kudu numbers declined persistently and significantly throughout 1996-2015 and thus merit the greatest conservation attention. 2) Klipspringer, mongoose, oribi, porcupine, cheetah, leopard, ostrich and Sykes monkey numbers also decreased noticeably but not significantly between 1996 and 2015.3) Dik dik, eland, African hare, Jackal, duiker, hippo and Thom son's gazelle numbers first increased and then declined between 1996 and 2015 but only significantly for duiker and hippo. 4) Aardvark, serval cat, colobus monkey, bat-eared fox, reedbuck, hyena and baboon numbers first declined and then increased but only the increases in reedbuck and baboon numbers were significant. 5) Grant's gazelle, Grevy's zebra, lion, spring hare, Burchell's zebra, bushpig, white rhino, rock hyrax, topi, oryx, vervet monkey, guinea fowl, giraffe, and wildebeest numbers increased consistently between 1996 and 2015. The increase was significant only for rock hyrax, topi, vervet monkey, guinea fowl, giraffe and wildebeest. 6) Impala, buffalo, warthog, and waterbuck, numbers increased significantly and then seemed to level off between 1996 and 2015. The aggregate biomass of primates and carnivores increased overall whereas that of herbivores first increased from 1996 to 2006 and then levelled off thereafter. Aggregate herbivore biomass increased linearly with increasing cumulative wet season rainfall. The densities of the 30 most abundant species were either strongly positively or negatively correlated with cumulative past rainfall, most commonly with the early wet season component. The collaborative wildlife conservation and management initiatives undertaken on the mosaic of private, communal and public lands were thus associated with increase or no decrease in numbers of 32 and decrease in numbers of 12 of the 44 species. Despite the decline by some species, effective community based conservation is central to the future of wildlife in the NWC and other rangelands of Kenya and beyond and is crucially dependent on the good will, effective engagement and collective action of local communities, working in partnerships with various organizations, which, in NWC, operated under the umbrella of the Nakuru Wildlife Forum.	[Ogutu, Joseph O.; Piepho, Hans-Peter] Univ Hohenheim, Biostat Unit, Inst Crop Sci, Stuttgart, Germany; [Kuloba, Bernard; Kanga, Erustus] KWS, Nairobi, Kenya	University Hohenheim	Ogutu, JO (corresponding author), Univ Hohenheim, Biostat Unit, Inst Crop Sci, Stuttgart, Germany.	jogutu2007@gmail.com		Ogutu, Joseph O/0000-0002-7379-0387; Piepho, Hans-Peter/0000-0001-7813-2992	German Research Foundation (DFG) [OG 83/1-1]; European Union's Horizon 2020 research and innovation programme [641918]	German Research Foundation (DFG)(German Research Foundation (DFG)); European Union's Horizon 2020 research and innovation programme	JO Ogutu was supported by a grant from the German Research Foundation (DFG # OG 83/1-1). This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 641918. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiya I.O., 1996, Lakes & Reservoirs Research and Management, V2, P231, DOI 10.1111/j.1440-1770.1996.tb00067.x; Agustina SR, 2008, THESIS; [Anonymous], 1957, KENYA DIARY 1902 190, P82; Bennun L, 2000, OSTRICH, V71, P220, DOI 10.1080/00306525.2000.9639917; Bhola N, 2012, BIODIVERS CONSERV, V21, P1509, DOI 10.1007/s10531-012-0261-y; BOUTTON TW, 1988, AFR J ECOL, V26, P103, DOI 10.1111/j.1365-2028.1988.tb00961.x; BOUTTON TW, 1988, AFR J ECOL, V26, P89, DOI 10.1111/j.1365-2028.1988.tb00960.x; BROWN JR, 1989, OECOLOGIA, V80, P19, DOI 10.1007/BF00789926; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Chapman A., 1908, ON SAFARI; COE MJ, 1976, OECOLOGIA, V22, P341, DOI 10.1007/BF00345312; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; DAVENPORT ML, 1993, INT J REMOTE SENS, V14, P2369, DOI 10.1080/01431169308954042; De Boor C., 2001, PRACTICAL GUIDE SPLI; DESHMUKH IK, 1984, AFR J ECOL, V22, P181, DOI 10.1111/j.1365-2028.1984.tb00693.x; Dublin HT, 2015, WILDLIFE RES, V42, P382, DOI 10.1071/WR14205; EAST R, 1984, AFR J ECOL, V22, P245, DOI 10.1111/j.1365-2028.1984.tb00700.x; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Eliot C., 1905, E AFRICAN PROTECTORA; Evans M. A., 2004, THESIS; Everard M, 2002, HYDROBIOLOGIA, V488, P191, DOI 10.1023/A:1023390430571; Everard M, 2002, HYDROBIOLOGIA, V488, P13, DOI 10.1023/A:1023349724553; FOSTER J B, 1968, East African Wildlife Journal, V6, P152; FOSTER J. B., 1967, EAST AFR WILDLIFE J, V5, P112; FOSTER JB, 1968, J ZOOL, V155, P413, DOI 10.1111/j.1469-7998.1968.tb03059.x; FRITZ H, 1994, P ROY SOC B-BIOL SCI, V256, P77, DOI 10.1098/rspb.1994.0052; GEORGIADIS NJ, 1990, J APPL ECOL, V27, P623, DOI 10.2307/2404307; GOSLING L M, 1969, Oryx, V10, P173; Harper DM, 2002, HYDROBIOLOGIA, V488, P171, DOI 10.1023/A:1023390800872; Hilbe JM, 2007, NEGATIVE BINOMIAL RE; Homewood K, 2001, P NATL ACAD SCI USA, V98, P12544, DOI 10.1073/pnas.221053998; Hudak AT, 1999, HUM ECOL, V27, P55, DOI 10.1023/A:1018705300730; IUCN-EARP, 2003, MAN INV SPEC WAT HAB; Janis MW, 2002, J WILDLIFE MANAGE, V66, P839, DOI 10.2307/3803148; KELLNER K, 1992, J ARID ENVIRON, V22, P99, DOI 10.1016/S0140-1963(18)30661-X; Kruger JM, 2008, WILDLIFE RES, V35, P371, DOI 10.1071/WR07084; KUTILEK M J, 1974, East African Wildlife Journal, V12, P201; KUTILEK MJ, 1979, J WILDLIFE MANAGE, V43, P899, DOI 10.2307/3808273; Mailu S, 2010, EFFECT CROPPINGPOLIC; Marker LL, 2003, CONSERV BIOL, V17, P1290, DOI 10.1046/j.1523-1739.2003.02077.x; MCLAUGHLIN R T, 1970, East African Wildlife Journal, V8, P203; Metzger KL, 2010, BIODIVERS CONSERV, V19, P3431, DOI 10.1007/s10531-010-9904-z; MILLS MGL, 1995, WILDLIFE RES, V22, P75, DOI 10.1071/WR9950075; Milton SJ, 1995, ENVIRON MONIT ASSESS, V37, P245, DOI 10.1007/BF00546893; Mwangi EM, 1998, AFR J ECOL, V36, P276, DOI 10.1046/j.1365-2028.1998.00133.x; MYERS N, 1974, J ENVIRON ECON MANAG, V1, P319, DOI 10.1016/S0095-0696(74)80004-5; Norton-Griffiths M, 2000, NAT RESOUR MODEL, V13, P1; Odada E, 2003, EXPERIENCES LESSONS; Ogutu JO, 2008, AFR J ECOL, V46, P132, DOI 10.1111/j.1365-2028.2007.00821.x; Ogutu JO, 2011, J ZOOL, V285, P99, DOI 10.1111/j.1469-7998.2011.00818.x; Ogutu JO, 2009, J ZOOL, V278, P1, DOI 10.1111/j.1469-7998.2008.00536.x; Ogutu JO, 2005, AFR J ECOL, V43, P332, DOI 10.1111/j.1365-2028.2005.00587.x; Ogutu JO, 2003, ECOL LETT, V6, P412, DOI 10.1046/j.1461-0248.2003.00447.x; Ogutu JO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163249; Ogutu Joseph O., 2014, Open Ecology Journal, V7, P9; Ogutu Joseph O., 2013, Open Conservation Biology Journal, V7, P11, DOI 10.2174/1874839201307010011; Ogutu JO, 2012, BIODIVERS CONSERV, V21, P1033, DOI 10.1007/s10531-012-0239-9; Ottichilo Wilber K., 2000, Conservation Biology Series (Dordrecht), V12, P203; Ottichilo WK, 2001, BIOL CONSERV, V97, P271, DOI 10.1016/S0006-3207(00)00090-2; Owen-Smith N, 2006, ECOL MONOGR, V76, P73, DOI 10.1890/04-1101; OWENSMITH N, 1990, J ANIM ECOL, V59, P893, DOI 10.2307/5021; Owino AO, 2001, HYDROBIOLOGIA, V458, P45, DOI 10.1023/A:1013115724138; Owino AO, 2002, WATERBIRDS, V25, P191, DOI 10.1675/1524-4695(2002)025[0191:TIWNIT]2.0.CO;2; Percival A.B., 1928, GAME RANGER SAFARI, V1st Edition; Percival AB, 1924, GAME RANGERS NOTE BO; Reid Robin S., 2008, P1, DOI 10.1007/978-1-4020-4906-4_1; Ruppert D, 2003, SEMIPARAMETRIC REGRE; RUTHERFORD MC, 1980, S AFR J SCI, V76, P53; SAS Institute, 2016, SAS SYST WIND 9 4; Scholte P, 2011, TROP CONSERV SCI, V4, P1, DOI 10.1177/194008291100400102; Sikes HL, 1989, J EASTAFRICA UGANDA, V13, P74; Simon N., 1962, SUNLIGHT THUNDER WIL; SPARVS Agency Ltd, 2008, FIN REP THREAT RED A; Verschuren D, 2000, NATURE, V403, P410, DOI 10.1038/35000179; Were KO, 2008, THESIS; Western D., 2015, PARKS, V21; Western D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006140; WOLFINGER R, 1993, J STAT COMPUT SIM, V48, P233, DOI 10.1080/00949659308811554	79	30	31	1	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0169730	10.1371/journal.pone.0169730	http://dx.doi.org/10.1371/journal.pone.0169730			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103269	Green Submitted, Green Published, gold			2022-12-26	WOS:000392381100020
J	Barnes, L; Saurat, JH; Kaya, G				Barnes, Laurent; Saurat, Jean-Hilaire; Kaya, Gurkan			Senescent Atrophic Epidermis Retains Lrig1+Stem Cells and Loses Wnt Signaling, a Phenotype Shared with CD44KO Mice	PLOS ONE			English	Article							KERATINOCYTE DIFFERENTIATION; HAIR FOLLICLE; EXPRESSION; SKIN; STEM; PROLIFERATION; INFLAMMATION; HYALURONATE; HOMEOSTASIS; MAINTAINS	Lrig1 is known to repress the epidermal growth through its inhibitory activity on EGFR, while CD44 promotes it. We analyzed the expression of these molecules in senescent atrophic human epidermis and in the epidermis of CD44KO mice. In normal human epidermis, Lrig1 + cells form clusters located in the basal layer in which CD44 expression is downregulated and Lef1 expression reflects an active Wnt signaling. In senescent atrophic human epidermis, we found retention of Lrig1(high)+ cells all along the basal layer, forming no clusters, with decrease of CD44 and lef1 expression. In vitro silencing of CD44 indicated that CD44 may be required for Wnt signaling. However, if looking at the ear epidermis of CD44KO mice, we only found a limited interfollicular epidermal atrophy and unchanged Lrig1(high)+ cells in the hair follicle. Cell lineage tracing further revealed that interfollicular epidermis did lost its self renewing capacity but that its homeostasis relied on Lrig1-derived keratinocytes migrating from the hair follicle. Therefore, we conclude that CD44 downregulation is part of the phenotype of senescent atrophic human epidermis, and contributes to reduce Wnt signaling and to alter Lrig1(high)+ stem cell distribution.	[Barnes, Laurent; Kaya, Gurkan] Univ Geneva, Univ Hosp Geneva, Dept Dermatol, Geneva, Switzerland; [Saurat, Jean-Hilaire] Univ Geneva, Swiss Ctr Appl Human Toxicol, Geneva, Switzerland	University of Geneva; University of Geneva	Barnes, L (corresponding author), Univ Geneva, Univ Hosp Geneva, Dept Dermatol, Geneva, Switzerland.	Laurent.Barnes@unige.ch			Fondation Eugene et Georges Gelbert, Geneva, Switzerland	Fondation Eugene et Georges Gelbert, Geneva, Switzerland	Funded by Fondation Eugene et Georges Gelbert, Geneva, Switzerland.	Akamatsu H, 2015, J DERMATOL; Barnes L, 2015, DERMATOLOGY; Barnes L, 2013, J INVEST DERMATOL, V133, P1017, DOI 10.1038/jid.2012.439; Barnes L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014372; Bourguignon LYW, 2006, J INVEST DERMATOL, V126, P1356, DOI 10.1038/sj.jid.5700260; Calikoglu E, 2006, PHOTOCHEM PHOTOBIOL, V82, P1342, DOI 10.1562/2006-02-10-RA-801; Campbell P, 2014, J INVEST DERMATOL, V134, P2570, DOI 10.1038/jid.2014.164; Choi YS, 2013, CELL STEM CELL, V13, P720, DOI 10.1016/j.stem.2013.10.003; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Doupe DP, 2010, DEV CELL, V18, P317, DOI 10.1016/j.devcel.2009.12.016; Fischer H, 2014, J INVEST DERMATOL, V134, P2579, DOI 10.1038/jid.2014.197; Franzke CW, 2012, J EXP MED, V209, P1105, DOI 10.1084/jem.20112258; Fullgrabe A, 2015, STEM CELL REPORTS; Gomez C, 2013, STEM CELL REP, V1, P19, DOI 10.1016/j.stemcr.2013.04.001; Gur G, 2004, EMBO J, V23, P3270, DOI 10.1038/sj.emboj.7600342; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Kaya G, 1997, GENE DEV, V11, P996, DOI 10.1101/gad.11.8.996; Kaya G, 2006, PLOS MED, V3, P2291, DOI 10.1371/journal.pmed.0030493; Kaya G, 2007, DERMATOLOGY, V215, P284, DOI 10.1159/000107621; Kirschner N, 2010, J INVEST DERMATOL; Kirschner N, 2011, J INVEST DERMATOL, V131, P932, DOI 10.1038/jid.2010.390; Page ME, 2013, CELL STEM CELL; Protin U, 1999, J IMMUNOL, V163, P4917; Saurat JH, 2007, DERMATOLOGY, V215, P271, DOI 10.1159/000107618; Schmitt M, 2015, CELL DEATH DIFFER, V22, P677, DOI 10.1038/cdd.2014.156; Schmitt M., 2014, CELL DEATH DIFFER; Siiskonen H, 2011, J HISTOCHEM CYTOCHEM; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Suzuki Y, 2002, FEBS LETT, V521, P67, DOI 10.1016/S0014-5793(02)02824-7; WONG VW, 2012, NAT CELL BIOL	31	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0169452	10.1371/journal.pone.0169452	http://dx.doi.org/10.1371/journal.pone.0169452			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099467	gold, Green Published, Green Submitted			2022-12-26	WOS:000392380100022
J	Chicote, JU; DeSalle, R; Segarra, J; Sun, TT; Garcia-Espana, A				Chicote, Javier U.; DeSalle, Rob; Segarra, Jose; Sun, Tung-Tien; Garcia-Espana, Antonio			The Tetraspanin-Associated Uroplakins Family (UPK2/3) Is Evolutionarily Related to PTPRQ, a Phosphotyrosine Phosphatase Receptor	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; VERTEBRATE EVOLUTION; MEMBRANE; SEQUENCE; ALIGNMENT; BIOLOGY; IDENTIFICATION; PREDICTION; ANIMALS; DISEASE	Uroplakins are a widespread group of vertebrate integral membrane proteins that belong to two different families: UPK1a and UPK1b belong to the large tetraspanin (TSPAN) gene family, and UPK3a, UPK3b, UPK3c, UPK3d, UPK2a and UPK2b form a family of their own, the UPK2/3 tetraspanin-associated family. In a previous study, we reported that uroplakins first appeared invertebrates, and that uroplakin tetraspanins (UPK1a and UPK1b) should have originated by duplication of an ancestor tetraspanin gene. However, the evolutionary origin of the UPK2/3 family remains unclear. In this study, we provide evidence that the UPK2/3 family originated by gene duplication and domain loss from a protoPTPRQ-like basal deuterostome gene. PTPRQs are members of the subtype R3 tyrosine phosphatase receptor (R3 PTPR) family, which are characterized by having a unique modular composition of extracellular fibronectin (FN3) repeats, a transmembrane helix, and a single intracytoplasmic phosphotyrosine phophatase (PIP) domain. Our assumption of a deuterostome protoPTPRQ-like gene as an ancestor of the UPK2/3 family by gene duplication and loss of its PIP and fibronectin (FN3) domains, excluding the one closest to the transmembrane helix, is based on the following: (i) phylogenetic analyses, (ii) the existence of an identical intron/exon gene pattern between UPK2/3 and the corresponding genetic region in R3 PTPRs, (iii) the conservation of cysteine patterns and protein motifs between UPK2/3 and PTPRQ proteins and, (iv) the existence in tunicates, the closest organisms to vertebrates, of two sequences related to PTPRQ; one with the full subtype R3 modular characteristic and another without the PIP domain but with a short cytoplasmic tail with some sequence similarity to that of UPK3a. This finding will facilitate further studies on the structure and function of these important proteins with implications in human diseases.	[Chicote, Javier U.; Garcia-Espana, Antonio] Univ Rovira & Virgili, Inst Invest Sanitaria Pere Virgili, Hosp Univ Tarragona Joan 23, Res Unit, Tarragona, Spain; [DeSalle, Rob] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Segarra, Jose] Univ Rovira & Virgili, Inst Invest Sanitaria Pere Virgili, Hosp Univ Tarragona Joan 23, Dept Urol, Tarragona, Spain; [Sun, Tung-Tien] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Sun, Tung-Tien] NYU, Sch Med, Dept Dermatol, New York, NY USA; [Sun, Tung-Tien] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA; [Sun, Tung-Tien] NYU, Sch Med, Dept Urol, New York, NY 10003 USA	Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); American Museum of Natural History (AMNH); Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); New York University; New York University; New York University; New York University	Garcia-Espana, A (corresponding author), Univ Rovira & Virgili, Inst Invest Sanitaria Pere Virgili, Hosp Univ Tarragona Joan 23, Res Unit, Tarragona, Spain.	antonio.garciaespana@urv.cat	Sun, Tung-Tien/J-4425-2015; garcia-espana, antonio/I-4756-2015	Sun, Tung-Tien/0000-0002-6841-1063; Segarra Tomas, Jose/0000-0001-9506-3204; UGARTE CHICOTE, JAVIER/0000-0001-6771-8584; garcia-espana, antonio/0000-0002-9957-3161	Ministerio de Economia y Competitividad (MICINN) [CONSOLIDER 2010 CSD00065]; National Institutes of Health [DK52206, DK39753]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039753, P01DK052206] Funding Source: NIH RePORTER	Ministerio de Economia y Competitividad (MICINN); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support was provided by Ministerio de Economia y Competitividad (MICINN) - CONSOLIDER 2010 CSD00065 (AGE) and the National Institutes of Health DK52206 and DK39753 (TTS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Apic G, 2001, J MOL BIOL, V310, P311, DOI 10.1006/jmbi.2001.4776; Aricescu AR, 2007, SCIENCE, V317, P1217, DOI 10.1126/science.1144646; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Byrum CA, 2006, DEV BIOL, V300, P194, DOI 10.1016/j.ydbio.2006.08.050; Camp E, 2009, STEM CELLS, V27, P2081, DOI 10.1002/stem.133; CARMO AM, 1995, EUR J IMMUNOL, V25, P2090, DOI 10.1002/eji.1830250743; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Deng FM, 2002, J CELL BIOL, V159, P685, DOI 10.1083/jcb.200204102; DeSalle R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-13; DeSalle R, 2010, MOL PHYLOGENET EVOL, V56, P486, DOI 10.1016/j.ympev.2010.02.015; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Garcia-Espana A, 2008, GENOMICS, V91, P326, DOI 10.1016/j.ygeno.2007.12.005; Garcia-Espana A, 2006, MOL PHYLOGENET EVOL, V41, P355, DOI 10.1016/j.ympev.2006.04.023; Garcia-Espana A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004680; Hasan AKMM, 2014, DEVELOPMENT, V141, P1705, DOI 10.1242/dev.105510; Hendriks WJAJ, 2013, FEBS J, V280, P708, DOI 10.1111/febs.12000; Henriques A, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-25; Hu CCA, 2005, MOL BIOL CELL, V16, P3937, DOI 10.1091/mbc.E05-02-0136; Hu CCA, 2008, BIOCHEM J, V414, P195, DOI 10.1042/BJ20080550; Irimia M, 2008, NUCLEIC ACIDS RES, V36, P1703, DOI 10.1093/nar/gkn012; Jenkins D, 2007, KIDNEY INT, V71, P195, DOI 10.1038/sj.ki.5002053; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Khandelwal P, 2009, AM J PHYSIOL-RENAL, V297, pF1477, DOI 10.1152/ajprenal.00327.2009; KREISBERG R, 1995, PROTEIN SCI, V4, P2405, DOI 10.1002/pro.5560041119; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; LIN JH, 1994, J BIOL CHEM, V269, P1775; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Min GW, 2006, J CELL BIOL, V173, P975, DOI 10.1083/jcb.200602086; Mitra S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041816; Ohno S, 1999, SEMIN CELL DEV BIOL, V10, P517, DOI 10.1006/scdb.1999.0332; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Sun T-T, 2013, TETRASPANINS PROTEIN, P299; Thumbikat P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000415; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; Tu LY, 2002, MOL BIOL CELL, V13, P4221, DOI 10.1091/mbc.E02-04-0211; van Eekelen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012573; Wright MB, 1998, J BIOL CHEM, V273, P23929, DOI 10.1074/jbc.273.37.23929; WU XR, 1993, J CELL SCI, V106, P31; WU XR, 1994, J BIOL CHEM, V269, P13716; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; YU J, 1994, J CELL BIOL, V125, P171, DOI 10.1083/jcb.125.1.171	48	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170196	10.1371/journal.pone.0170196	http://dx.doi.org/10.1371/journal.pone.0170196			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099513	Green Submitted, Green Published, gold			2022-12-26	WOS:000392380100062
J	Al-Shujairi, WH; Clarke, JN; Davies, LT; Alsharifi, M; Pitson, SM; Carr, JM				Al-Shujairi, Wisam H.; Clarke, Jennifer N.; Davies, Lorena T.; Alsharifi, Mohammed; Pitson, Stuart M.; Carr, Jillian M.			Intracranial Injection of Dengue Virus Induces Interferon Stimulated Genes and CD8(+) T Cell Infiltration by Sphingosine Kinase 1 Independent Pathways	PLOS ONE			English	Article							MURINE CORONAVIRUS; VIRAL ENCEPHALITIS; IN-VIVO; INFECTION; RESPONSES; ROLES; BRAIN; MICE; RNA; PATHOGENESIS	We have previously reported that the absence of sphingosine kinase 1 (SK1) affects both dengue virus (DENV) infection and innate immune responses in vitro. Here we aimed to define SK1-dependancy of DENV-induced disease and the associated innate responses in vivo. The lack of a reliable mouse model with a fully competent interferon response for DENV infection is a challenge, and here we use an experimental model of DENV infection in the brain of immunocompetent mice. Intracranial injection of DENV-2 into C57BL/6 mice induced body weight loss and neurological symptoms which was associated with a high level of DENV RNA in the brain. Body weight loss and DENV RNA level tended to be greater in SK14(-/-) compared with wildtype (WT) mice. Brain infection with DENV-2 is associated with the induction of interferon-beta (IFN-beta) and IFN-stimulated gene (ISG) expression including viperin, Ifi2712a, IRF7, and CXCL10 without any significant differences between WT and SK1(-/-) mice. The SK2 and sphingosine-1-phosphate (S1P) levels in the brain were unchanged by DENV infection or the lack of SK1. Histological analysis demonstrated the presence of a cellular infiltrate in DENV-infected brain with a significant increase in mRNA for CD8 but not CD4 suggesting this infiltrate is likely CD8(+) but not CD4(+) T-lymphocytes. This increase in T-cell infiltration was not affected by the lack of SK1. Overall, DENV-infection in the brain induces IFN and T-cell responses but does not influence the SK/S1P axis. In contrast to our observations in vitro, SK1 has no major influence on these responses following DENV-infection in the mouse brain.	[Al-Shujairi, Wisam H.; Clarke, Jennifer N.; Carr, Jillian M.] Flinders Univ S Australia, Sch Med, Microbiol & Infect Dis, Adelaide, SA, Australia; [Davies, Lorena T.; Pitson, Stuart M.] Univ South Australia, Ctr Canc Biol, Adelaide, SA, Australia; [Davies, Lorena T.; Pitson, Stuart M.] SA Pathol, Adelaide, SA, Australia; [Alsharifi, Mohammed] Univ Adelaide, Res Ctr Infect Dis, Vaccine Res Lab, Adelaide, SA, Australia; [Alsharifi, Mohammed] Univ Adelaide, Sch Biol Sci, Dept Mol & Cellular Biol, Adelaide, SA, Australia	Flinders University South Australia; Centre for Cancer Biology; University of South Australia; SA Pathology; University of Adelaide; University of Adelaide	Al-Shujairi, WH (corresponding author), Flinders Univ S Australia, Sch Med, Microbiol & Infect Dis, Adelaide, SA, Australia.	alsh0246@flinders.edu.au	Pitson, Stuart/B-9342-2009; Shujairi, Wisam H Al/F-1921-2019	Pitson, Stuart/0000-0002-9527-2740; Shujairi, Wisam H Al/0000-0002-7727-3707; Carr, Jillian/0000-0002-1080-1472; Davies, Lorena/0000-0002-3143-1247	National Health and Medical Research Council (NHMRC) Project [GNT1044212]; Fay Fuller Foundation; NHMRC Senior Research Fellowship [GNT1042589]	National Health and Medical Research Council (NHMRC) Project(National Health and Medical Research Council (NHMRC) of Australia); Fay Fuller Foundation; NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council (NHMRC) Project Grant GNT1044212, the Fay Fuller Foundation, and a NHMRC Senior Research Fellowship (GNT1042589).	Alemany R, 2007, N-S ARCH PHARMACOL, V374, P413, DOI 10.1007/s00210-007-0132-3; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Alvarez SE, 2007, TRENDS ENDOCRIN MET, V18, P300, DOI 10.1016/j.tem.2007.07.005; Amaral DCG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-23; Baeyens A, 2015, TRENDS IMMUNOL, V36, P778, DOI 10.1016/j.it.2015.10.005; Bassi MR, 2015, J IMMUNOL, V194, P1141, DOI 10.4049/jimmunol.1402605; Bente Dennis A, 2006, Drug Discov Today Dis Models, V3, P97, DOI 10.1016/j.ddmod.2006.03.014; Blondeau N, 2007, J NEUROCHEM, V103, P509, DOI 10.1111/j.1471-4159.2007.04755.x; Bryan L, 2008, BBA-MOL CELL BIOL L, V1781, P459, DOI 10.1016/j.bbalip.2008.04.008; Calvert JK, 2015, J INTERFERON CYTOKIN; Carr JM, 2013, J GEN VIROL, V94, P2437, DOI 10.1099/vir.0.055616-0; Carr JM, 2013, REV MED VIROL, V23, P73, DOI 10.1002/rmv.1718; Chen HW, 2013, J IMMUNOL, V191, P4194, DOI 10.4049/jimmunol.1300799; Chesler DA, 2002, CYTOKINE GROWTH F R, V13, P441, DOI 10.1016/S1359-6101(02)00044-8; Cho H, 2013, NAT MED, V19, P458, DOI 10.1038/nm.3108; Clarke JN, 2015, J GEN VIROL; Daffis S, 2007, PLOS PATHOG, V3, P1005, DOI 10.1371/journal.ppat.0030106; Dalrymple NA, 2012, J VIROL, V86, P6408, DOI 10.1128/JVI.00213-12; Fujii Y, 2008, JPN J INFECT DIS, V61, P40; Gack MU, 2016, CURR OPIN VIROL, V20, P119, DOI 10.1016/j.coviro.2016.09.013; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; Glass WG, 2005, J EXP MED, V202, P1087, DOI 10.1084/jem.20042530; Gonzalez-Cabrera Pedro J, 2014, F1000Prime Rep, V6, P109, DOI 10.12703/P6-109; Grin'kina NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036475; Gualano RC, 1998, J GEN VIROL, V79, P437, DOI 10.1099/0022-1317-79-3-437; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3; Harikumar KB, 2014, NAT IMMUNOL, V15, P231, DOI 10.1038/ni.2810; Helbig KJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002178; Hsieh MF, 2006, J IMMUNOL, V177, P1855, DOI 10.4049/jimmunol.177.3.1855; Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9; Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999; Kapil P, 2012, GLIA, V60, P1555, DOI 10.1002/glia.22375; Klein RS, 2005, J VIROL, V79, P11457, DOI 10.1128/JVI.79.17.11457-11466.2005; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304; Leclercq TM, 2008, J BIOL CHEM, V283, P9606, DOI 10.1074/jbc.M708782200; Lin RJ, 2009, J IMMUNOL, V183, P8035, DOI 10.4049/jimmunol.0902728; Lucas TM, 2016, J VIROL, V90, P2600, DOI 10.1128/JVI.02463-15; Machesky NJ, 2008, J BIOL CHEM, V283, P26148, DOI 10.1074/jbc.M710181200; Michaud J, 2006, FEBS LETT, V580, P4607, DOI 10.1016/j.febslet.2006.07.035; Michlmayr D, 2014, J VIROL, V88, P9553, DOI 10.1128/JVI.03421-13; Nascimento EJM, 2014, CRIT REV IMMUNOL, V34, P227, DOI 10.1615/CritRevImmunol.2014010212; Nayak D, 2010, NEUROSCIENCE, V166, P132, DOI 10.1016/j.neuroscience.2009.12.020; Neubauer HA, 2013, FEBS J, V280, P5317, DOI 10.1111/febs.12314; Oliveira ERA, 2016, VIROLOGY, V489, P95, DOI 10.1016/j.virol.2015.12.006; Perelygin AA, 2002, P NATL ACAD SCI USA, V99, P9322, DOI 10.1073/pnas.142287799; Pitman Melissa R, 2012, Methods Mol Biol, V874, P21, DOI 10.1007/978-1-61779-800-9_2; Pitson SM, 2011, TRENDS BIOCHEM SCI, V36, P97, DOI 10.1016/j.tibs.2010.08.001; Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Seo YJ, 2010, J VIROL, V84, P8124, DOI 10.1128/JVI.00510-10; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Simmons CP, 2005, J VIROL, V79, P5665, DOI 10.1128/JVI.79.9.5665-5675.2005; Siow DL, 2011, ADV ENZYME REGUL, V51, P229, DOI 10.1016/j.advenzreg.2010.09.004; Tsai TT, 2016, SCI REP-UK, V6, DOI 10.1038/srep27670; Velandia-Romero ML, 2012, J NEUROVIROL, V18, P374, DOI 10.1007/s13365-012-0117-y; Vijayan M, 2014, VIROLOGY, V450, P55, DOI 10.1016/j.virol.2013.11.039; Wang Y, 2003, J VIROL, V77, P13323, DOI [10.1128/JVI.77.24.13323-13334.2003, 10.1128/JVi.77.24.13323-13334.2003]; Wati S, 2011, J GEN VIROL, V92, P807, DOI 10.1099/vir.0.028159-0; Winkelmann ER, 2016, F1000RESEARCH, V5; Yamane D, 2009, J BIOL CHEM, V284, P13648, DOI 10.1074/jbc.M807498200; Zhao L, 2013, J VIROL, V87, P8408, DOI 10.1128/JVI.00769-13; Zhao L, 2011, J VIROL, V85, P10058, DOI 10.1128/JVI.05075-11; Zheng SL, 2015, EXP NEUROL, V272, P160, DOI 10.1016/j.expneurol.2015.03.012; Zhou L, 2009, NEUROSCIENCE, V159, P629, DOI 10.1016/j.neuroscience.2008.12.036	67	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0169814	10.1371/journal.pone.0169814	http://dx.doi.org/10.1371/journal.pone.0169814			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095439	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000392372300033
J	Sumiya, M; Fujioka, E; Motoi, K; Kondo, M; Hiryu, S				Sumiya, Miwa; Fujioka, Emyo; Motoi, Kazuya; Kondo, Masaru; Hiryu, Shizuko			Coordinated Control of Acoustical Field of View and Flight in Three-Dimensional Space for Consecutive Capture by Echolocating Bats during Natural Foraging	PLOS ONE			English	Article							BIG BROWN BATS; SONAR BEAM PATTERN; EPTESICUS-FUSCUS; PREY-CAPTURE; PIPISTRELLUS-ABRAMUS; HUNTING BEHAVIOR; SOUND BEAM; EXPERTISE; ATTENTION; STRATEGY	Echolocating bats prey upon small moving insects in the dark using sophisticated sonar techniques. The direction and directivity pattern of the ultrasound broadcast of these bats are important factors that affect their acoustical field of view, allowing us to investigate how the bats control their acoustic attention (pulse direction) for advanced flight maneuvers. The purpose of this study was to understand the behavioral strategies of acoustical sensing of wild Japanese house bats Pipistrellus abramus in three-dimensional (3D) space during consecutive capture flights. The results showed that when the bats successively captured multiple airborne insects in short time intervals (less than 1.5 s), they maintained not only the immediate prey but also the subsequent one simultaneously within the beam widths of the emitted pulses in both horizontal and vertical planes before capturing the immediate one. This suggests that echolocating bats maintain multiple prey within their acoustical field of view by a single sensing using a wide directional beam while approaching the immediate prey, instead of frequently shifting acoustic attention between multiple prey. We also numerically simulated the bats' flight trajectories when approaching two prey successively to investigate the relationship between the acoustical field of view and the prey direction for effective consecutive captures. This simulation demonstrated that acoustically viewing both the immediate and the subsequent prey simultaneously increases the success rate of capturing both prey, which is considered to be one of the basic axes of efficient route planning for consecutive capture flight. The bat's wide sonar beam can incidentally cover multiple prey while the bat forages in an area where the prey density is high. Our findings suggest that the bats then keep future targets within their acoustical field of view for effective foraging. In addition, in both the experimental results and the numerical simulations, the acoustic sensing and flights of the bats showed narrower vertical ranges than horizontal ranges. This suggests that the bats control their acoustic sensing according to different schemes in the horizontal and vertical planes according to their surroundings. These findings suggest that echolocating bats coordinate their control of the acoustical field of view and flight for consecutive captures in 3D space during natural foraging.	[Sumiya, Miwa; Fujioka, Emyo; Motoi, Kazuya; Kondo, Masaru; Hiryu, Shizuko] Doshisha Univ, Fac Life & Med Sci, Kyotanabe, Kyoto, Japan; [Fujioka, Emyo] Doshisha Univ, Org Res Initiat & Dev, Kyotanabe, Kyoto, Japan; [Hiryu, Shizuko] JST PRESTO, Kawaguchi, Saitama, Japan	Doshisha University; Doshisha University; Japan Science & Technology Agency (JST)	Hiryu, S (corresponding author), Doshisha Univ, Fac Life & Med Sci, Kyotanabe, Kyoto, Japan.; Hiryu, S (corresponding author), JST PRESTO, Kawaguchi, Saitama, Japan.	shiryu@mail.doshisha.ac.jp			Japan Society for the Promotion of Science (JSPS) [JP24686050, JP16H06542, 27-3861]; Japan Science and Technology Agency (JST) PRESTO program	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency (JST) PRESTO program(Japan Science & Technology Agency (JST))	This work was supported by Japan Society for the Promotion of Science (JSPS, https://www.jsps.go.ip) KAKENHI Grant Numbers JP24686050 (Grant-in-Aid for Young Scientists (A)), JP16H06542 (Grant-in-Aid for Scientific Research on Innovative Areas) to SH, and No. 27-3861 (Grant-in-Aid for JSPS Research Fellow) to MS, and the Japan Science and Technology Agency (JST, http://www.jst.go.jp/) PRESTO program to SH. We conducted the microphone array measurement using custom made microphone-array units, microphones, recording devices purchased with these research funds.	Aihara I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068635; Aytekin M, 2004, J ACOUST SOC AM, V116, P3594, DOI 10.1121/1.1811412; Brinklov S, 2011, J ACOUST SOC AM, V129, P427, DOI 10.1121/1.3519396; Britton ARC, 1999, J EXP BIOL, V202, P1793; Chiu C, 2010, J EXP BIOL, V213, P3348, DOI 10.1242/jeb.044818; Crompton B, 2003, P ROY SOC B-BIOL SCI, V270, P1991, DOI 10.1098/rspb.2003.2477; Crundall D, 1999, PERCEPTION, V28, P1075, DOI 10.1068/p281075; Eckmeier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003956; Fujioka E, 2016, P NATL ACAD SCI USA, V113, P4848, DOI 10.1073/pnas.1515091113; Fujioka E, 2014, J ACOUST SOC AM, V136, P3389, DOI 10.1121/1.4898428; Fujioka E, 2011, J ACOUST SOC AM, V129, P1081, DOI 10.1121/1.3523300; Ghose K, 2006, J NEUROSCI, V26, P1704, DOI 10.1523/JNEUROSCI.4315-05.2006; Ghose K, 2003, J ACOUST SOC AM, V114, P1120, DOI 10.1121/1.1589754; Ghose K, 2009, J EXP BIOL, V212, P693, DOI 10.1242/jeb.019380; Hirai Toshiaki, 2004, Japanese Journal of Ecology (Otsu), V54, P159; Hiryu S, 2008, J COMP PHYSIOL A, V194, P841, DOI 10.1007/s00359-008-0355-x; Hiryu S, 2008, J ACOUST SOC AM, V124, pEL51, DOI 10.1121/1.2947629; Jakobsen L., 2014, FRONT PHYSIOL, V89, P1; Jakobsen L, 2015, P NATL ACAD SCI USA, V112, P8118, DOI 10.1073/pnas.1419943112; Jakobsen L, 2010, P NATL ACAD SCI USA, V107, P13930, DOI 10.1073/pnas.1006630107; KALKO EKV, 1989, BEHAV ECOL SOCIOBIOL, V24, P225, DOI 10.1007/BF00295202; KICK SA, 1982, J COMP PHYSIOL, V145, P431, DOI 10.1007/BF00612808; Kounitsky P, 2015, P NATL ACAD SCI USA, V112, P6724, DOI 10.1073/pnas.1422843112; Matsuta N, 2013, J EXP BIOL, V216, P1210, DOI 10.1242/jeb.081398; Ryu DH, 2015, J EXP PSYCHOL HUMAN, V41, P167, DOI 10.1037/a0038306; SCHNITZLER HU, 1987, J COMP PHYSIOL A, V161, P267, DOI 10.1007/BF00615246; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Seibert AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060752; Surlykke A, 2000, J ACOUST SOC AM, V108, P2419, DOI 10.1121/1.1315295; Surlykke A, 2009, J EXP BIOL, V212, P1011, DOI 10.1242/jeb.024620; Surlykke A, 2009, P ROY SOC B-BIOL SCI, V276, P853, DOI 10.1098/rspb.2008.1505; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Williams AM, 1998, RES Q EXERCISE SPORT, V69, P111, DOI 10.1080/02701367.1998.10607677; Wotton JM, 1997, J ACOUST SOC AM, V101, P1723, DOI 10.1121/1.418271; Yovel Y, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001150	35	12	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0169995	10.1371/journal.pone.0169995	http://dx.doi.org/10.1371/journal.pone.0169995			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085936	Green Published, Green Submitted, gold			2022-12-26	WOS:000391972600051
J	Wei, XL; Si, N; Zhang, YF; Zhao, HY; Yang, J; Wang, HJ; Wang, LM; Han, LY; Bian, BL				Wei, Xiaolu; Si, Nan; Zhang, Yuefei; Zhao, Haiyu; Yang, Jian; Wang, Hongjie; Wang, Lianmei; Han, Linyu; Bian, Baolin			Evaluation of Bufadienolides as the Main Antitumor Components in Cinobufacin Injection for Liver and Gastric Cancer Therapy	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; CHROMATOGRAPHY; GEMCITABINE; CARCINOMA	Background Cinobufacin injection, also known as huachansu, is a preparation form of Cinobufacini made from Cinobufacin extract liquid. Despite that Cinobufacin injection is shown to shrink liver and gastric tumors, improving patient survival and life quality, the effective components in Cinobufacin remain elusive. In this study, we aim to screen antitumor components from Cinobufacin injection to elucidate the most effective antitumor components for treatment of liver and gastric cancers. Materials and Methods High performance liquid chromatography (HPLC) and LC-MS/MS analysis were used to separate and determine the components in Cinobufacin injection. Inhibition rates of various components in Cinobufacin injection on liver and gastric cancer cells were determined with MTT assay; Hepatocellular carcinoma and gastric cancer models were used to assess the antitumor effect of the compounds in vivo. Results The major constituents in Cinobufacin injection include peptides, nucleic acids, tryptamines and bufotalins. MTT assay revealed that bufadienolides had the best antitumor activity, with peptides being the second most effective components. Bufadienolides showed significant inhibition rates on gastric and hepatocellular tumour growth in vivo. Conclusion Bufadienolides are the most effective components in Cinobufacini injection for the treatment of liver and gastric cancers. This discovery can greatly facilitate further research in improving the therapeutic effects of Cinobufacin injection, meanwhile reducing its adverse reaction.	[Wei, Xiaolu; Si, Nan; Zhao, Haiyu; Yang, Jian; Wang, Hongjie; Wang, Lianmei; Han, Linyu; Bian, Baolin] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China; [Zhang, Yuefei] China Resources Sanjiu Pharmaceut Co Ltd, Shenzhen, Guangdong, Peoples R China	China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS; China Resources Group	Bian, BL (corresponding author), China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China.	baolinbian2376@163.com			Special Program for New Drug Innovation of the Ministry of Science and Technology [2013ZX09102025]; China Resource Sanjiu Pharmaceutical Co. Ltd.	Special Program for New Drug Innovation of the Ministry of Science and Technology; China Resource Sanjiu Pharmaceutical Co. Ltd.	This work was supported by the Special Program for New Drug Innovation of the Ministry of Science and Technology (2013ZX09102025). Yuefei Zhang is affiliated with China Resource Sanjiu Pharmaceutical Co. Ltd., which is one of the funded entities of the grant. Yuefei Zhang and the company supplied materials used in this study, and therefore contributed to this work. The funder provided support in the form of salaries for all authors listed, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao X-t, 2009, J SHENYANG PHARM U, V10; Han LY, 2014, ACTA PHARMACOL SIN, V49, P4; Jiang YF., 2011, CHINA J CHINESE MED, V26, P1082; Liu Jun-qiu, 2014, Yaoxue Xuebao, V49, P244; Meng Z, 2012, BRIT J CANCER, V107, P411, DOI 10.1038/bjc.2012.283; Niu K, 2013, SHANXI J TCM, V29, P47; Qin TJ, 2008, WORLD J GASTROENTERO, V14, P5210, DOI 10.3748/wjg.14.5210; reaction The research on cinobufacini injection adverse, 2011, NEIMENGGU TRADITIONA, V30, P111; Shuai YF, 2012, W CHINA MED J, V27, P1329; [苏永华 Su Yonghua], 2003, [中成药, Chinese Traditional Patent Medicine], V25, P24; Takai N, 2008, INT J MOL MED, V21, P637; Thomas M, 2009, J GASTROENTEROL, V44, P136, DOI 10.1007/s00535-008-2252-z; Wang H.-j., 2012, ZHONGGUO SHIYAN FANG, V18, P66; Wang W, 2008, EXPT RES ANTICANCER; Wang ZL, 2009, CHINESE ARCH TRADITI, V27, P141; Wu X, 2015, BIOMED CHROMATOGR, V29, P138, DOI 10.1002/bmc.3250; Wu X, 2012, J SEP SCI, V35, P1893, DOI 10.1002/jssc.201200036; Yang LX, 2013, CHIN J EXP TRADIT ME, V19, P87; Yuan BF, 2009, GUIDE CHINA MED, P33; Zhao HY, 2013, J SEP SCI, V36, P492, DOI 10.1002/jssc.201200762; Zhu XY, 2006, TUMOR J WORLD, V5, P272	21	25	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169141	10.1371/journal.pone.0169141	http://dx.doi.org/10.1371/journal.pone.0169141			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081155	Green Submitted, Green Published, gold			2022-12-26	WOS:000391949500029
J	Tse, BWC; Volpert, M; Ratther, E; Stylianou, N; Nouri, M; McGowan, K; Lehman, ML; McPherson, SJ; Roshan-Moniri, M; Butler, MS; Caradec, J; Gregory-Evans, CY; McGovern, J; Das, R; Takhar, M; Erho, N; Alshalafa, M; Davicioni, E; Schaeffer, EM; Jenkins, RB; Ross, AE; Karnes, RJ; Den, RB; Fazli, L; Gregory, PA; Gleave, ME; Williams, ED; Rennie, PS; Buttyan, R; Gunter, JH; Selth, LA; Russell, PJ; Nelson, CC; Hollier, BG				Tse, B. W. C.; Volpert, M.; Ratther, E.; Stylianou, N.; Nouri, M.; McGowan, K.; Lehman, M. L.; McPherson, S. J.; Roshan-Moniri, M.; Butler, M. S.; Caradec, J.; Gregory-Evans, C. Y.; McGovern, J.; Das, R.; Takhar, M.; Erho, N.; Alshalafa, M.; Davicioni, E.; Schaeffer, E. M.; Jenkins, R. B.; Ross, A. E.; Karnes, R. J.; Den, R. B.; Fazli, L.; Gregory, P. A.; Gleave, M. E.; Williams, E. D.; Rennie, P. S.; Buttyan, R.; Gunter, J. H.; Selth, L. A.; Russell, P. J.; Nelson, C. C.; Hollier, B. G.			Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; RECEPTOR SPLICE VARIANTS; CANCER-CELLS; DEPRIVATION THERAPY; BREAST-CANCER; CASTRATION; EXPRESSION; GROWTH; MECHANISMS; BINDING	Recent evidence has implicated the transmembrane co-receptor neuropilin-1 (NRP1) in cancer progression. Primarily known as a regulator of neuronal guidance and angiogenesis, NRP1 is also expressed in multiple human malignancies, where it promotes tumor angiogenesis. However, non-angiogenic roles of NRP1 in tumor progression remain poorly characterized. In this study, we define NRP1 as an androgen-repressed gene whose expression is elevated during the adaptation of prostate tumors to androgen-targeted therapies (ATTs), and subsequent progression to metastatic castration-resistant prostate cancer (mCRPC). Using short hairpin RNA (shRNA)-mediated suppression of NRP1, we demonstrate that NRP1 regulates the mesenchymal phenotype of mCRPC cell models and the invasive and metastatic dissemination of tumor cells in vivo. In patients, immunohistochemical staining of tissue microarrays and mRNA expression analyses revealed a positive association between NRP1 expression and increasing Gleason grade, pathological T score, positive lymph node status and primary therapy failure. Furthermore, multivariate analysis of several large clinical prostate cancer (PCa) cohorts identified NRP1 expression at radical prostatectomy as an independent prognostic biomarker of biochemical recurrence after radiation therapy, metastasis and cancer-specific mortality. This study identifies NRP1 for the first time as a novel androgen-suppressed gene upregulated during the adaptive response of prostate tumors to ATTs and a prognostic biomarker of clinical metastasis and lethal PCa.	[Tse, B. W. C.; Volpert, M.; Ratther, E.; Stylianou, N.; McGowan, K.; Lehman, M. L.; McPherson, S. J.; Williams, E. D.; Gunter, J. H.; Russell, P. J.; Nelson, C. C.; Hollier, B. G.] Queensland Univ Technol, Australian Prostate Canc Res Ctr, Inst Hlth & Biomed Innovat, Sch Biomed Sci,Princess Alexandra Hosp,Translatio, 37 Kent St, Brisbane, Qld 4102, Australia; [Nouri, M.; Roshan-Moniri, M.; Butler, M. S.; Caradec, J.; Fazli, L.; Gleave, M. E.; Rennie, P. S.; Buttyan, R.] Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC, Canada; [Gregory-Evans, C. Y.] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC, Canada; [McGovern, J.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Tissue Repair & Regenerat Program, Brisbane, Qld, Australia; [Das, R.; Selth, L. A.] Univ Adelaide, Dame Roma Mitchell Canc Res Labs, Adelaide, SA, Australia; [Das, R.; Selth, L. A.] Univ Adelaide, Freemasons Fdn Ctr Mens Hlth, Discipline Med, Adelaide, SA, Australia; [Takhar, M.; Erho, N.; Alshalafa, M.; Davicioni, E.] GenomeDX Biosci, Vancouver, BC, Canada; [Schaeffer, E. M.] Northwestern Univ, Dept Urol, Chicago, IL 60611 USA; [Jenkins, R. B.] Mayo Clin, Dept Pathol, Rochester, MN USA; [Den, R. B.] Mayo Clin, Lab Med, Rochester, MN USA; [Ross, A. E.] Johns Hopkins Univ, Dept Urol, Brady Urol Inst, Baltimore, MD USA; [Karnes, R. J.] Mayo Clin, Dept Urol, Rochester, MN USA; [Den, R. B.] Thomas Jefferson Univ Hosp, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Gregory, P. A.] SA Pathol & Univ South Australia, Ctr Canc Biol, Adelaide, SA, Australia	Queensland University of Technology (QUT); University of British Columbia; University of British Columbia; Queensland University of Technology (QUT); University of Adelaide; University of Adelaide; GenomeDx Biosciences; Northwestern University; Mayo Clinic; Mayo Clinic; Johns Hopkins University; Mayo Clinic; Jefferson University; Centre for Cancer Biology; SA Pathology; University of South Australia	Hollier, BG (corresponding author), Queensland Univ Technol, Australian Prostate Canc Res Ctr, Inst Hlth & Biomed Innovat, Sch Biomed Sci,Princess Alexandra Hosp,Translatio, 37 Kent St, Brisbane, Qld 4102, Australia.	b.hollier@qut.edu.au	Gregory-Evans, Cheryl Y/G-9550-2011; Gregory, Philip/F-4089-2013; Gunter, Jennifer H/B-8960-2016; Selth, Luke/AAH-4823-2021; Williams, Elizabeth D/B-1538-2008; Russell, Pamela/O-8504-2019; Stylianou, Nataly/GOP-1782-2022; Tse, Brian/X-8909-2019	Gregory, Philip/0000-0002-0999-0632; Gunter, Jennifer H/0000-0003-2447-5732; Selth, Luke/0000-0002-4686-1418; Williams, Elizabeth D/0000-0002-3364-6655; Tse, Brian/0000-0002-5982-8369; Nouri, Mannan/0000-0002-7442-9251; Gleave, Martin/0000-0003-4235-0167; Stylianou, Nataly/0000-0002-8006-5730; Volpert, Marianna/0000-0002-6537-0729; Butler, Miriam/0000-0002-1582-8383; Den, Robert/0000-0002-8653-1763	Cure Cancer Australia Foundation; Cancer Australia PdCCRS grant [108878]; Australian Government Department of Health; Queensland Government National and International Research Alliance Program; Movember Foundation; Prostate Cancer Foundation of Australia through a Movember Revolutionary Team Award; Prostate Cancer Foundation of Australia	Cure Cancer Australia Foundation; Cancer Australia PdCCRS grant; Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing); Queensland Government National and International Research Alliance Program; Movember Foundation; Prostate Cancer Foundation of Australia through a Movember Revolutionary Team Award; Prostate Cancer Foundation of Australia	We thank Dr Leland Chung and Dr Simon Hayward for kindly providing the C4-2B and BPH-1 cell lines, respectively, used in this study. This research was supported by Cure Cancer Australia Foundation, Prostate Cancer Foundation of Australia and Cancer Australia PdCCRS grant 108878 and the Australian Government Department of Health, Queensland Government National and International Research Alliance Program funding to the Australian-Canadian Prostate Cancer Research Alliance, as well as by the Movember Foundation and the Prostate Cancer Foundation of Australia through a Movember Revolutionary Team Award.	Best CJM, 2005, CLIN CANCER RES, V11, P6823, DOI 10.1158/1078-0432.CCR-05-0585; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chen MQ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-89; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; Den RB, 2014, INT J RADIAT ONCOL, V89, P1038, DOI 10.1016/j.ijrobp.2014.04.052; Erho N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066855; Ettinger SL, 2004, CANCER RES, V64, P2212, DOI 10.1158/0008-5472.CAN-2148-2; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Glinka Y, 2011, CARCINOGENESIS, V32, P613, DOI 10.1093/carcin/bgq281; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hansel DE, 2004, AM J SURG PATHOL, V28, P347, DOI 10.1097/00000478-200403000-00007; Heidenreich A, 2014, EUR UROL, V65, P467, DOI 10.1016/j.eururo.2013.11.002; Hollier BG, 2013, CANCER RES, V73, P1981, DOI 10.1158/0008-5472.CAN-12-2962; Hong TM, 2007, CLIN CANCER RES, V13, P4759, DOI 10.1158/1078-0432.CCR-07-0001; James ND, 2016, LANCET, V387, P1163, DOI 10.1016/S0140-6736(15)01037-5; Jia H, 2010, BRIT J CANCER, V102, P541, DOI 10.1038/sj.bjc.6605539; Karantanos T, 2013, ONCOGENE, V32, P5501, DOI 10.1038/onc.2013.206; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Latil A, 2000, INT J CANCER, V89, P167, DOI 10.1002/(SICI)1097-0215(20000320)89:2<167::AID-IJC11>3.0.CO;2-9; Lin D, 2015, ONCOTARGET, V6, P1806, DOI 10.18632/oncotarget.2809; Locke JA, 2008, CANCER RES, V68, P6407, DOI 10.1158/0008-5472.CAN-07-5997; Lu J, 2015, J UROLOGY, V193, P690, DOI 10.1016/j.juro.2014.08.043; Mak P, 2010, CANCER CELL, V17, P319, DOI 10.1016/j.ccr.2010.02.030; McShane LM, 2005, EUR J CANCER, V41, P1690, DOI 10.1016/j.ejca.2005.03.032; Miao HQ, 2000, FASEB J, V14, P2532, DOI 10.1096/fj.00-0250com; Nouri M, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00370; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Patel P, 2010, MATRIX BIOL, V29, P97, DOI 10.1016/j.matbio.2009.10.004; Patnaik A, 2014, CANCER CHEMOTH PHARM, V73, P951, DOI 10.1007/s00280-014-2426-8; Peng Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094422; Pepe MS, 2008, J NATL CANCER I, V100, P1432, DOI 10.1093/jnci/djn326; Pomerantz MM, 2015, NAT GENET, V47, P1346, DOI 10.1038/ng.3419; Qi JF, 2013, CANCER CELL, V23, P332, DOI 10.1016/j.ccr.2013.02.016; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Ross AE, 2015, EUR UROL; Snuderl M, 2013, CELL, V152, P1065, DOI 10.1016/j.cell.2013.01.036; Soker S, 2002, J CELL BIOCHEM, V85, P357, DOI 10.1002/jcb.10140; Sprenger CCT, 2014, HORM CANCER-US, V5, P207, DOI 10.1007/s12672-014-0177-y; Stephenson JM, 2002, INT J CANCER, V101, P409, DOI 10.1002/ijc.10611; Sun YT, 2012, CANCER RES, V72, P527, DOI 10.1158/0008-5472.CAN-11-3004; Sweeney CJ, 2015, NEW ENGL J MED, V373, P737, DOI 10.1056/NEJMoa1503747; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Teng Y, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-453; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Vanaja DK, 2003, CANCER RES, V63, P3877; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; West DC, 2005, J BIOL CHEM, V280, P13457, DOI 10.1074/jbc.M410924200; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Yuan X, 2014, ONCOGENE, V33, P2815, DOI 10.1038/onc.2013.235; Yuan X, 2009, UROL ONCOL-SEMIN ORI, V27, P36, DOI 10.1016/j.urolonc.2008.03.021; Zhang SM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-9	53	47	48	2	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 15	2017	36	24					3417	3427		10.1038/onc.2016.482	http://dx.doi.org/10.1038/onc.2016.482			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EX6GL	28092670	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000403340700006
J	Amit, M; Na'ara, S; Leider-Trejo, L; Binenbaum, Y; Kulish, N; Fridman, E; Shabtai-Orbach, A; Wong, RJ; Gil, Z				Amit, M.; Na'ara, S.; Leider-Trejo, L.; Binenbaum, Y.; Kulish, N.; Fridman, E.; Shabtai-Orbach, A.; Wong, R. J.; Gil, Z.			Upregulation of RET induces perineurial invasion of pancreatic adenocarcinoma	ONCOGENE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; CANCER CELL INVASION; NEUROTROPHIC FACTOR; NEURAL INVASION; NEURONAL PLASTICITY; LIGAND COMPLEXES; NEUROPATHIC PAIN; TYROSINE KINASE; CARCINOMA CELLS; BREAST-CANCER	Tumor spread along nerves, a phenomenon known as perineurial invasion, is common in various cancers including pancreatic ductal adenocarcinoma PDAC). Neural invasion is associated with poor outcome, yet its mechanism remains unclear. Using the transgenic Pdx1- Cre/KrasG12D/p53R172H (KPC) mouse model, we investigated the mechanism of neural invasion in PDAC. To detect tissue-specific factors that influence neural invasion by cancer cells, we characterized the perineurial microenvironment using a series of bone marrow transplantation (BMT) experiments in transgenic mice expressing single mutations in the Cx3cr1, GDNF and CCR2 genes. Immunolabeling of tumors in KPC mice of different ages and analysis of human cancer specimens revealed that RET expression is upregulated during PDAC tumorigenesis. BMT experiments revealed that BM-derived macrophages expressing the RET ligand GDNF are highly abundant around nerves invaded by cancer. Inhibition of perineurial macrophage recruitment, using the CSF-1R antagonist GW2580 or BMT from CCR2-deficient donors, reduced perineurial invasion. Deletion of GDNF expression by perineurial macrophages, or inhibition of RET with shRNA or a small-molecule inhibitor, reduced perineurial invasion in KPC mice with PDAC. Taken together, our findings show that RET is upregulated during pancreas tumorigenesis and its activation induces cancer perineurial invasion. Trafficking of BM-derived macrophages to the perineurial microenvironment and secretion of GDNF are essential for pancreatic cancer neural spread.	[Amit, M.] Univ Texas MD Anderson Canc Ctr, Head & Neck Surg Dept, Houston, TX 77030 USA; [Amit, M.; Na'ara, S.; Binenbaum, Y.; Kulish, N.; Fridman, E.; Shabtai-Orbach, A.; Gil, Z.] Technion Israel Inst Technol, Rappaport Inst Med & Res, Clin Res Inst Rambam, Lab Appl Canc Res, Haifa, Israel; [Amit, M.; Na'ara, S.; Fridman, E.; Gil, Z.] Technion Israel Inst Technol, Dept Otolaryngol Head & Neck Surg,Head & Neck Ctr, Rappaport Inst Med & Res,Rambam Med Ctr, Rambam Healthcare Campus,Clin Res Inst Rambam, 8 HaAliya St,POB 9602, IL-31096 Haifa, Israel; [Leider-Trejo, L.] Tel Aviv Med Ctr & Sch Med, Dept Pathol, Tel Aviv, Israel; [Wong, R. J.] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA	University of Texas System; UTMD Anderson Cancer Center; Technion Israel Institute of Technology; Rambam Health Care Campus; Technion Israel Institute of Technology; Tel Aviv University; Sackler Faculty of Medicine; Memorial Sloan Kettering Cancer Center	Gil, Z (corresponding author), Technion Israel Inst Technol, Dept Otolaryngol Head & Neck Surg,Head & Neck Ctr, Rappaport Inst Med & Res,Rambam Med Ctr, Rambam Healthcare Campus,Clin Res Inst Rambam, 8 HaAliya St,POB 9602, IL-31096 Haifa, Israel.	ziv@baseofskull.org			Israeli Science Foundation; Binational US-Israel Science Foundation; Barbara S Goodman ICRF grant; Israel Cancer Association; Rappaport Research Institute; Clinical Research Institute	Israeli Science Foundation(Israel Science Foundation); Binational US-Israel Science Foundation(US-Israel Binational Science Foundation); Barbara S Goodman ICRF grant; Israel Cancer Association; Rappaport Research Institute; Clinical Research Institute	We thank Cindy Cohen for her editorial assistance. We also thank Dr Inna Narodezky for her assistance in reviewing pathological specimens. This study was supported by grants from the Israeli Science Foundation, Binational US-Israel Science Foundation, Barbara S Goodman ICRF grant, Israel Cancer Association, the Rappaport Research Institute and the Clinical Research Institute at Rambam.	Amit M, 2016, NAT REV CANCER, V16, P399, DOI 10.1038/nrc.2016.38; Amit M, 2013, CANCER MED-US, V2, P155, DOI 10.1002/cam4.45; Beatty GL, 2015, GASTROENTEROLOGY, V149, P201, DOI 10.1053/j.gastro.2015.04.010; Ben QW, 2010, ANN SURG ONCOL, V17, P2213, DOI 10.1245/s10434-010-0955-x; Cavel O, 2012, CANCER RES, V72, P5733, DOI 10.1158/0008-5472.CAN-12-0764; Ceyhan GO, 2010, ANN SURG, V251, P923, DOI 10.1097/SLA.0b013e3181d974d4; Ceyhan GO, 2009, GASTROENTEROLOGY, V136, P177, DOI 10.1053/j.gastro.2008.09.029; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Conway JG, 2005, P NATL ACAD SCI USA, V102, P16078, DOI 10.1073/pnas.0502000102; Cullen-McEwen LA, 2001, KIDNEY INT, V60, P31, DOI 10.1046/j.1523-1755.2001.00767.x; Demir IE, 2010, NEUROGASTROENT MOTIL, V22, P480, DOI 10.1111/j.1365-2982.2009.01428.x; Demir IE, 2016, GUT, V65, P1001, DOI 10.1136/gutjnl-2015-309784; Demir IE, 2015, NAT REV GASTRO HEPAT, V12, P649, DOI 10.1038/nrgastro.2015.166; Demir IE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060529; Demir Ihsan Ekin, 2010, Cancers (Basel), V2, P1513, DOI 10.3390/cancers2031513; Edstrom E, 2000, INT J MOL MED, V6, P469; Esseghir S, 2007, CANCER RES, V67, P11732, DOI 10.1158/0008-5472.CAN-07-2343; Frisk T, 2000, EUR J ENDOCRINOL, V142, P643, DOI 10.1530/eje.0.1420643; Fukuda T, 2002, J BIOL CHEM, V277, P19114, DOI 10.1074/jbc.M200643200; Giehl K, 2000, ONCOGENE, V19, P2930, DOI 10.1038/sj.onc.1203612; Gil Z, 2010, J NATL CANCER I, V102, P107, DOI 10.1093/jnci/djp456; Gil Z, 2009, ARCH OTOLARYNGOL, V135, P173, DOI 10.1001/archoto.2008.525; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; He SZ, 2015, MOL CANCER RES, V13, P380, DOI 10.1158/1541-7786.MCR-14-0303; Jamieson NB, 2012, ANN SURG ONCOL, V19, P3581, DOI 10.1245/s10434-012-2370-y; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kang J, 2009, ONCOGENE, V28, P2034, DOI 10.1038/onc.2009.66; Kelly DJ, 2005, J AM SOC NEPHROL, V16, P1654, DOI 10.1681/ASN.2004070578; Kelly K, 2008, FASEB J, V22, P1839, DOI 10.1096/fj.07-097808; Kieseier BC, 2006, CURR OPIN NEUROL, V19, P437, DOI 10.1097/01.wco.0000245365.51823.72; Kim-Fuchs C, 2014, BRAIN BEHAV IMMUN, V40, P40, DOI 10.1016/j.bbi.2014.02.019; Liebl F, 2014, ANN SURG, V260, P900, DOI 10.1097/SLA.0000000000000968; Liebl F, 2013, CLIN CANCER RES, V19, P50, DOI 10.1158/1078-0432.CCR-12-2392; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mitchem JB, 2013, CANCER RES, V73, P1128, DOI 10.1158/0008-5472.CAN-12-2731; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Pahler J, 2008, NEOPLASIA, V10, P329, DOI 10.1593/neo.07871; Patwardhan PP, 2014, CLIN CANCER RES, V20, P3146, DOI 10.1158/1078-0432.CCR-13-2576; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Qiao S, 2009, CLIN NEUROPATHOL, V28, P105; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Sawai H, 2005, CANCER RES, V65, P11536, DOI 10.1158/0008-5472.CAN-05-2843; Stahle M, 2003, J CELL SCI, V116, P3835, DOI 10.1242/jcs.00679; Tang MJ, 1998, J CELL BIOL, V142, P1337, DOI 10.1083/jcb.142.5.1337; Torres MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080580; Veit C, 2004, CANCER RES, V64, P5291, DOI 10.1158/0008-5472.CAN-04-1112; Wang K, 2014, CARCINOGENESIS, V35, P103, DOI 10.1093/carcin/bgt312; Yamaguchi R, 2002, BRIT J SURG, V89, P1130, DOI 10.1046/j.1365-2168.2002.02184.x; Yoshikawa K, 2012, CANCER SCI, V103, P2012, DOI 10.1111/j.1349-7006.2012.02411.x; Zeng LJ, 2014, J CANCER, V5, P754, DOI 10.7150/jca.10238; Zhang J, 2010, JNCI-J NATL CANCER I, V102, P522, DOI 10.1093/jnci/djq044	53	34	43	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 8	2017	36	23					3232	3239		10.1038/onc.2016.483	http://dx.doi.org/10.1038/onc.2016.483			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EW9WJ	28092668				2022-12-26	WOS:000402869800003
J	Meng, X; Wang, YT; Wang, XM; Wrennall, JA; Rimington, TL; Li, HY; Cai, ZW; Ford, RC; Sheppard, DN				Meng, Xin; Wang, Yiting; Wang, Xiaomeng; Wrennall, Joe A.; Rimington, Tracy L.; Li, Hongyu; Cai, Zhiwei; Ford, Robert C.; Sheppard, David N.			Two Small Molecules Restore Stability to a Subpopulation of the Cystic Fibrosis Transmembrane Conductance Regulator with the Predominant Disease-causing Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; chloride channel; cystic fibrosis; cystic fibrosis transmembrane conductance regulator (CFTR); protein purification; protein stability; ivacaftor; lumacaftor	NUCLEOTIDE-BINDING DOMAIN; CFTR POTENTIATOR; THERMODYNAMIC STABILITY; ENDOPLASMIC-RETICULUM; DELTA-F508 MUTATION; CHANNEL FUNCTION; PLASMA-MEMBRANE; IN-VITRO; F508DEL-CFTR; MECHANISM	Cystic fibrosis (CF) is caused by mutations that disrupt the plasma membrane expression, stability, and function of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel. Two small molecules, the CFTR corrector lumacaftor and the potentiator ivacaftor, are now used clinically to treat CF, although some studies suggest that they have counteracting effects on CFTR stability. Here, we investigated the impact of these compounds on the instability of F508del-CFTR, the most common CF mutation. To study individual CFTR Cl- channels, we performed single-channel recording, whereas to assess entire CFTR populations, we used purified CFTR proteins and macroscopic CFTR Cl- currents. At 37 degrees C, low temperature-rescued F508del-CFTR more rapidly lost function in cell-free membrane patches and showed altered channel gating and current flow through open channels. Compared with purified wild-type CFTR, the full-length F508del-CFTR was about 10 degrees C less thermostable. Lumacaftor partially stabilized purified full-length F508del-CFTR and slightly delayed deactivation of individual F508del-CFTR Cl- channels. By contrast, ivacaftor further destabilized full-length F508del-CFTR and accelerated channel deactivation. Chronic (prolonged) co-incubation of F508del-CFTR-expressing cells with lumacaftor and ivacaftor deactivated macroscopic F508del-CFTR Cl- currents. However, at the single-channel level, chronic co-incubation greatly increased F508del-CFTR channel activity and temporal stability in most, but not all, cell-free membrane patches. We conclude that chronic lumacaftor and ivacaftor co-treatment restores stability in a small subpopulation of F508del-CFTR Cl- channels but that the majority remain destabilized. A fuller understanding of these effects and the characterization of the small F508del-CFTR subpopulation might be crucial for CF therapy development.	[Meng, Xin; Wang, Xiaomeng; Rimington, Tracy L.; Ford, Robert C.] Univ Manchester, Sch Biol Sci, Fac Biol Med & Hlth, Michael Smith Bldg,Oxford Rd, Manchester M13 9PL, Lancs, England; [Wang, Yiting; Wrennall, Joe A.; Li, Hongyu; Cai, Zhiwei; Sheppard, David N.] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Biomed Sci Bldg,Univ Walk, Bristol BS8 1TD, Avon, England	University of Manchester; University of Bristol	Ford, RC (corresponding author), Univ Manchester, Sch Biol Sci, Fac Biol Med & Hlth, Michael Smith Bldg,Oxford Rd, Manchester M13 9PL, Lancs, England.; Sheppard, DN (corresponding author), Univ Bristol, Sch Physiol Pharmacol & Neurosci, Biomed Sci Bldg,Univ Walk, Bristol BS8 1TD, Avon, England.	robert.ford@manchester.ac.uk; D.N.Sheppard@bristol.ac.uk	wang, yiting/GYU-5306-2022; Sheppard, David N/AAV-4187-2021	Sheppard, David N/0000-0001-5533-9130; Rimington, Tracy/0000-0002-0059-123X	Cystic Fibrosis Foundation Therapeutics [FORD13XX0]; Cystic Fibrosis Trust; Beijing Sun-Hope Intellectual Property Ltd.; Medical Research Council (DTG) [MR/K501359/1]; China Scholarship Council; University of Manchester; Engineering and Physical Sciences Research Council [EP/J00961X/1]; Cystic Fibrosis Foundation Therapeutics Grant [SHEPPA14XX0]; EPSRC [EP/J00961X/1] Funding Source: UKRI; Medical Research Council [1373338] Funding Source: researchfish; Cystic Fibrosis Trust [SRC005] Funding Source: researchfish	Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); Cystic Fibrosis Trust; Beijing Sun-Hope Intellectual Property Ltd.; Medical Research Council (DTG)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); China Scholarship Council(China Scholarship Council); University of Manchester; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cystic Fibrosis Foundation Therapeutics Grant; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Cystic Fibrosis Trust	This work was supported by Cystic Fibrosis Foundation Therapeutics Grant FORD13XX0 and the Cystic Fibrosis Trust. This work was also supported by scholarships from Beijing Sun-Hope Intellectual Property Ltd. (to Y. W.), the Medical Research Council (DTG Grant MR/K501359/1) (to J. A. W.), and the Cystic Fibrosis Trust (to T. L. R.). R. C. F. consulted for Vertex Pharmaceuticals in 2015 and 2016.; Supported by the China Scholarship Council and the University of Manchester (President's Award).; Supported by Engineering and Physical Sciences Research Council Grant EP/J00961X/1.; Supported in part by Cystic Fibrosis Foundation Therapeutics Grant SHEPPA14XX0.	Abu-Arish A, 2015, BIOPHYS J, V109, P85, DOI 10.1016/j.bpj.2015.04.042; Aleksandrov AA, 2012, J MOL BIOL, V419, P41, DOI 10.1016/j.jmb.2012.03.001; Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; Baroni D, 2014, EUR BIOPHYS J BIOPHY, V43, P341, DOI 10.1007/s00249-014-0956-y; Birket SE, 2016, AM J PHYSIOL-LUNG C, V310, pL928, DOI 10.1152/ajplung.00395.2015; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; BROUILLETTE CG, 1982, J BIOL CHEM, V257, P12; Cai ZW, 2006, J BIOL CHEM, V281, P1970, DOI 10.1074/jbc.M510576200; Chen JH, 2009, J BIOL CHEM, V284, P35495, DOI 10.1074/jbc.M109.072678; Cholon DM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008680; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Cui GY, 2013, J BIOL CHEM, V288, P20758, DOI 10.1074/jbc.M113.476226; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Eckford PDW, 2014, CHEM BIOL, V21, P666, DOI 10.1016/j.chembiol.2014.02.021; Eckford PDW, 2012, J BIOL CHEM, V287, P36639, DOI 10.1074/jbc.M112.393637; Farinha CM, 2013, FEBS J, V280, P4396, DOI 10.1111/febs.12392; Farinha CM, 2013, CHEM BIOL, V20, P943, DOI 10.1016/j.chembiol.2013.06.004; Farinha CM, 2002, BIOCHEM J, V366, P797, DOI 10.1042/BJ20011717; Flume PA, 2012, CHEST, V142, P718, DOI 10.1378/chest.11-2672; Frizzell R. A., 2012, PERSPECT MED, V2; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Gao XL, 2015, P NATL ACAD SCI USA, V112, P2461, DOI 10.1073/pnas.1420676112; GREGORY RJ, 1991, MOL CELL BIOL, V11, P3886, DOI 10.1128/MCB.11.8.3886; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; He LH, 2013, FASEB J, V27, P536, DOI 10.1096/fj.12-216119; Hong H, 2014, ARCH BIOCHEM BIOPHYS, V564, P297, DOI 10.1016/j.abb.2014.07.031; Hughes LK, 2008, MOL MEMBR BIOL, V25, P528, DOI 10.1080/09687680802487967; Hunt J. F., 2013, PERSPECT MED, V3; Jih KY, 2013, P NATL ACAD SCI USA, V110, P4404, DOI 10.1073/pnas.1215982110; Jih KY, 2011, J PHYSIOL-LONDON, V589, P2719, DOI 10.1113/jphysiol.2010.202861; Kopeikin Z, 2014, J CYST FIBROS, V13, P508, DOI 10.1016/j.jcf.2014.04.003; Lansdell KA, 2000, J PHYSIOL-LONDON, V524, P317, DOI 10.1111/j.1469-7793.2000.t01-1-00317.x; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Li HY, 2012, AM J PHYSIOL-RENAL, V303, pF1176, DOI 10.1152/ajprenal.00130.2012; Li HY, 2004, KIDNEY INT, V66, P1926, DOI 10.1111/j.1523-1755.2004.00967.x; Liu XH, 2012, BIOCHEMISTRY-US, V51, P5113, DOI 10.1021/bi300018e; Loo TW, 2013, BIOCHEM PHARMACOL, V86, P612, DOI 10.1016/j.bcp.2013.06.028; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Matthes E, 2016, BRIT J PHARMACOL, V173, P459, DOI 10.1111/bph.13365; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Meng X., 2016, THESIS; Miki H, 2010, J BIOL CHEM, V285, P19967, DOI 10.1074/jbc.M109.092684; Moran O, 2005, CELL MOL LIFE SCI, V62, P446, DOI 10.1007/s00018-004-4422-3; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; O'Ryan L, 2012, JOVE-J VIS EXP, DOI 10.3791/3860; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Pollock N, 2014, JOVE-J VIS EXP, DOI 10.3791/51447; Protasevich I, 2010, PROTEIN SCI, V19, P1917, DOI 10.1002/pro.479; Qu BH, 1996, J BIOL CHEM, V271, P7261, DOI 10.1074/jbc.271.13.7261; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Ratjen F, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.10; Ren HY, 2013, MOL BIOL CELL, V24, P3016, DOI 10.1091/mbc.E13-05-0240; RIORDAN JR, 1989, SCIENCE, V245, P1066; Schmidt A, 2008, BRIT J PHARMACOL, V153, P1311, DOI 10.1038/sj.bjp.0707663; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; Sheppard DN, 1997, J PHYSIOL-LONDON, V503, P333, DOI 10.1111/j.1469-7793.1997.333bh.x; Stoltz DA, 2015, NEW ENGL J MED, V372, P351, DOI 10.1056/NEJMra1300109; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Van Goor F, 2014, J CYST FIBROS, V13, P29, DOI 10.1016/j.jcf.2013.06.008; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Veit G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008889; Vergani P, 2003, J GEN PHYSIOL, V121, P17, DOI 10.1085/jgp.20028673; Wainwright CE, 2015, NEW ENGL J MED, V373, P220, DOI 10.1056/NEJMoa1409547; Wang C, 2010, PROTEIN SCI, V19, P1932, DOI 10.1002/pro.480; Wang F, 2000, J PHYSIOL-LONDON, V524, P637, DOI 10.1111/j.1469-7793.2000.00637.x; Wang W, 2011, J BIOL CHEM, V286, P41937, DOI 10.1074/jbc.M111.296061; Wang Y. C., 2016, THESIS; Wang YT, 2014, BRIT J PHARMACOL, V171, P4490, DOI 10.1111/bph.12791; Xu Z, 2014, J PHYSIOL-LONDON, V592, P1931, DOI 10.1113/jphysiol.2014.271817; Zegarra-Moran O, 2002, BRIT J PHARMACOL, V137, P504, DOI 10.1038/sj.bjp.0704882	77	32	34	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3706	3719		10.1074/jbc.M116.751537	http://dx.doi.org/10.1074/jbc.M116.751537			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28087700	Green Published, hybrid			2022-12-26	WOS:000395542500014
J	Kleiman, SC; Bulik-Sullivan, EC; Glenny, EM; Zerwas, SC; Huh, EY; Tsilimigras, MCB; Fodor, AA; Bulik, CM; Carroll, IM				Kleiman, Susan C.; Bulik-Sullivan, Emily C.; Glenny, Elaine M.; Zerwas, Stephanie C.; Huh, Eun Young; Tsilimigras, Matthew C. B.; Fodor, Anthony A.; Bulik, Cynthia M.; Carroll, Ian M.			The Gut-Brain Axis in Healthy Females: Lack of Significant Association between Microbial Composition and Diversity with Psychiatric Measures	PLOS ONE			English	Article							ANXIETY-LIKE BEHAVIOR; QUESTIONNAIRE EDE-Q; IRRITABLE-BOWEL-SYNDROME; DEPRESSION INVENTORY-II; FALSE DISCOVERY RATE; INTESTINAL MICROBIOTA; PERCEIVED STRESS; EATING-DISORDERS; PSYCHOMETRIC PROPERTIES; COLLEGE-STUDENTS	Objective This study examined associations between the composition and diversity of the intestinal microbiota and measures of depression, anxiety, eating disorder psychopathology, stress, and personality in a group of healthy adult females. Methods Female participants (n = 91) ages 19-50 years with BMI 18.5-25 kg/m(2) were recruited from central North Carolina between July 2014 and March 2015. Participants provided a single fecal sample and completed an online psychiatric questionnaire that included five measures: (i) Beck Anxiety Inventory; (ii) Beck Depression Inventory-II; (iii) Eating Disorder Examination-Questionnaire; (iv) Perceived Stress Scale; and (v) Mini International Personality Item Pool. Bacterial composition and diversity were characterized by Illumina sequencing of the 16S rRNA gene, and associations were examined using Kendall's tau-b correlation coefficient, in conjunction with Benjamini and Hochberg's False Discovery Rate procedure. Results We found no significant associations between microbial markers of gut composition and diversity and scores on psychiatric measures of anxiety, depression, eating-related thoughts and behaviors, stress, or personality in a large cohort of healthy adult females. Discussion This study was the first specifically to examine associations between the intestinal micro biota and psychiatric measures in healthy females, and based on 16S rRNA taxonomic abundances and diversity measures, our results do not suggest a strong role for the enteric microbe-gut-brain axis in normal variation on responses to psychiatric measures in this population. However, the role of the intestinal microbiota in the pathophysiology of psychiatric illness may be limited to more severe psychopathology.	[Kleiman, Susan C.; Glenny, Elaine M.; Bulik, Cynthia M.] Univ North Carolina Chapel Hill, Dept Nutr, Chapel Hill, NC USA; [Bulik-Sullivan, Emily C.; Carroll, Ian M.] Univ North Carolina Chapel Hill, Dept Med, Chapel Hill, NC 27514 USA; [Zerwas, Stephanie C.; Huh, Eun Young; Bulik, Cynthia M.] Univ North Carolina Chapel Hill, Dept Psychiat, Chapel Hill, NC USA; [Tsilimigras, Matthew C. B.; Fodor, Anthony A.] Univ North Carolina Chapel Hill, Dept Bioinformat & Genom, Chapel Hill, NC USA; [Bulik, Cynthia M.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Carroll, Ian M.] Univ North Carolina Chapel Hill, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Karolinska Institutet; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Carroll, IM (corresponding author), Univ North Carolina Chapel Hill, Dept Med, Chapel Hill, NC 27514 USA.; Carroll, IM (corresponding author), Univ North Carolina Chapel Hill, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27514 USA.	ian_carroll@med.unc.edu	Zerwas, Stephanie/AAG-1595-2020	Zerwas, Stephanie/0000-0002-8927-3755; Bulik, Cynthia/0000-0001-7772-3264	Foundation of Hope; UNC Center of Excellence for Eating Disorders Board of Visitors Fund; TJ's Fund for Eating Disorders Research (Academy for Eating Disorders); CGIBD pilot feasibility grant [P30DK03498]; Swedish Research Council (VR) [538-2013-8864];  [K01 DK 092330];  [R01 MH 105684]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350, T32DK007686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH100435, R01MH105684] Funding Source: NIH RePORTER	Foundation of Hope; UNC Center of Excellence for Eating Disorders Board of Visitors Fund; TJ's Fund for Eating Disorders Research (Academy for Eating Disorders); CGIBD pilot feasibility grant; Swedish Research Council (VR)(Swedish Research Council); ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by the Foundation of Hope, the UNC Center of Excellence for Eating Disorders Board of Visitors Fund, and TJ's Fund for Eating Disorders Research (Academy for Eating Disorders; Bulik: Principal Investigator) and partially supported by a K01 DK 092330, an R01 MH 105684, and a CGIBD pilot feasibility grant P30DK03498 awarded to Dr. Carroll. Dr. Bulik acknowledges funding from the Swedish Research Council (VR Dnr: 538-2013-8864). The remaining authors reported no financial disclosures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck A., 1993, MANUAL BECK ANXIETY; Beck A.T., 1996, PSYCHOL ASSESS, V2, DOI DOI 10.1037/T00742-000; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bercik P, 2011, GASTROENTEROLOGY, V141, P599, DOI 10.1053/j.gastro.2011.04.052; Birks Y, 2009, BMC MED EDUC, V9, DOI 10.1186/1472-6920-9-61; Blazquez AB, 2016, TRANSL RES; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carmody DP, 2005, INT J PSYCHIAT CLIN, V9, P22, DOI 10.1080/13651500510014800; Carroll IM, 2012, NEUROGASTROENT MOTIL, V24, P521, DOI 10.1111/j.1365-2982.2012.01891.x; Carroll IM, 2011, AM J PHYSIOL-GASTR L, V301, pG799, DOI 10.1152/ajpgi.00154.2011; CDC, 2015, AD BMI DIV NUTR PHYS; Christian LM, 2015, BRAIN BEHAV IMMUN, V45, P118, DOI 10.1016/j.bbi.2014.10.018; Clarke G, 2013, MOL PSYCHIATR, V18, P666, DOI 10.1038/mp.2012.77; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cohen S., 1988, SOCIAL PSYCHOL HLTH; Cole SR, 1999, J EPIDEMIOL COMMUN H, V53, P319, DOI 10.1136/jech.53.5.319; Cooper AJ, 2010, PERS INDIV DIFFER, V48, P688, DOI 10.1016/j.paid.2010.01.004; CREAMER M, 1995, BEHAV RES THER, V33, P477, DOI 10.1016/0005-7967(94)00082-U; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dean OM, 2014, CLIN PSYCHOPHARM NEU, V12, P180, DOI 10.9758/cpn.2014.12.3.180; Desbonnet L, 2010, NEUROSCIENCE, V170, P1179, DOI 10.1016/j.neuroscience.2010.08.005; Dinan TG, 2015, CURR OPIN CLIN NUTR, V18, P552, DOI 10.1097/MCO.0000000000000221; Donnellan MB, 2006, PSYCHOL ASSESSMENT, V18, P192, DOI 10.1037/1040-3590.18.2.192; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503; Friedrich MJ, 2015, JAMA-J AM MED ASSOC, V313, P1699, DOI 10.1001/jama.2015.2159; Gillis MM, 1995, PSYCHOL ASSESSMENT, V7, P450, DOI 10.1037/1040-3590.7.4.450; Goehler LE, 2008, BRAIN BEHAV IMMUN, V22, P354, DOI 10.1016/j.bbi.2007.08.009; Guinane CM, 2013, MBIO, V4, DOI 10.1128/mBio.00366-12; Haegeman B, 2013, ISME J, V7, P1092, DOI 10.1038/ismej.2013.10; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hoban AE, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.42; Hunt M, 2003, J PERS ASSESS, V80, P26, DOI 10.1207/S15327752JPA8001_10; Jiang HY, 2015, BRAIN BEHAV IMMUN, V48, P186, DOI 10.1016/j.bbi.2015.03.016; Julian LJ, 2011, ARTHRIT CARE RES, V63, pS467, DOI 10.1002/acr.20561; Kleiman SC, 2015, PSYCHOSOM MED, V77, P969, DOI 10.1097/PSY.0000000000000247; Kristensen NB, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0300-5; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Lyte M, 1998, PHYSIOL BEHAV, V65, P63, DOI 10.1016/S0031-9384(98)00145-0; Lyte M, 2006, PHYSIOL BEHAV, V89, P350, DOI 10.1016/j.physbeh.2006.06.019; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701; Messaoudi M, 2011, BRIT J NUTR, V105, P755, DOI 10.1017/S0007114510004319; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mond JM, 2004, BEHAV RES THER, V42, P551, DOI 10.1016/S0005-7967(03)00161-X; Mond JM, 2006, BEHAV RES THER, V44, P53, DOI 10.1016/j.brat.2004.12.003; Mond JM, 2008, BEHAV RES THER, V46, P612, DOI 10.1016/j.brat.2008.02.003; Naseribafrouei A, 2014, NEUROGASTROENT MOTIL, V26, P1155, DOI 10.1111/nmo.12378; Neufeld KM, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01620.x; Neufeld Karen-Anne M, 2011, Commun Integr Biol, V4, P492, DOI 10.4161/cib.4.4.15702; Osman A, 1997, J CLIN PSYCHOL, V53, P7, DOI 10.1002/(SICI)1097-4679(199701)53:1<7::AID-JCLP2>3.0.CO;2-S; Quick VM, 2013, EAT WEIGHT DISORD-ST, V18, P29, DOI 10.1007/s40519-013-0015-1; R Foundation for Statistical Computing, 2015, R LANG ENV STAT COMP; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Sampson TR, 2015, CELL HOST MICROBE, V17, P565, DOI 10.1016/j.chom.2015.04.011; Schmidt K, 2015, PSYCHOPHARMACOLOGY, V232, P1793, DOI 10.1007/s00213-014-3810-0; Steenbergen L, 2015, BRAIN BEHAV IMMUN, V48, P258, DOI 10.1016/j.bbi.2015.04.003; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Tarr AJ, 2015, BRAIN BEHAV IMMUN, V50, P166, DOI 10.1016/j.bbi.2015.06.025; Taylor JM, 2015, PSYCHOL ASSESSMENT, V27, P90, DOI 10.1037/a0038100; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang YP, 2013, REV BRAS PSIQUIATR, V35, P416, DOI 10.1590/1516-4446-2012-1048; Welch E, 2011, BEHAV RES THER, V49, P85, DOI 10.1016/j.brat.2010.10.010; Werner JJ, 2012, ISME J, V6, P1273, DOI 10.1038/ismej.2011.186; Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369	71	28	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170208	10.1371/journal.pone.0170208	http://dx.doi.org/10.1371/journal.pone.0170208			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI3HP	28103291	Green Submitted, Green Published, gold			2022-12-26	WOS:000392381100042
J	Westphal, S; McGeary, A; Rudloff, S; Wilke, A; Penack, O				Westphal, Sabine; McGeary, Aleixandria; Rudloff, Sandra; Wilke, Andrea; Penack, Olaf			The Green Tea Catechin Epigallocatechin Gallate Ameliorates Graft-versus-Host Disease	PLOS ONE			English	Article							REGULATORY T-CELLS; ENDOTHELIAL GROWTH-FACTOR; POTENTIAL ROLE; MURINE MODEL; POLYPHENOL; INHIBITION; EGCG; BIOAVAILABILITY; ANGIOGENESIS; INFLAMMATION	Allogeneic hematopoetic stem cell transplantation (allo-HSCT) is a standard treatment for leukemia and other hematologic malignancies. The major complication of allo-HSCT is graft-versus-host-disease (GVHD), a progressive inflammatory illness characterized by donor immune cells attacking the organs of the recipient. Current GVHD prevention and treatment strategies use immune suppressive drugs and/or anti-T cell reagents these can lead to increased risk of infections and tumor relapse. Recent research demonstrated that epigallocatechin gallate (EGCG), a component found in green tea leaves at a level of 2535% at dry weight, may be useful in the inhibition of GVHD due to its immune modulatory, anti-oxidative and anti-angiogenic capacities. In murine allo-HSCT recipients treated with EGCG, we found significantly reduced GVHD scores, reduced target organ GVHD and improved survival. EGCG treated allo-HSCT recipients had significantly higher numbers of regulatory T cells in GVHD target organs and in the blood. Furthermore, EGCG treatment resulted in diminished oxidative stress indicated by significant changes of glutathione blood levels as well as glutathione peroxidase in the colon. In summary, our study provides novel evidence demonstrating that EGCG ameliorates lethal GVHD and reduces GVHD-related target organ damage. Possible mechanisms are increased regulatory T cell numbers and reduced oxidative stress.	[Westphal, Sabine; McGeary, Aleixandria; Rudloff, Sandra; Wilke, Andrea; Penack, Olaf] Charite Campus Virchow, Dept Hematol Oncol & Tumorimmunol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Penack, O (corresponding author), Charite Campus Virchow, Dept Hematol Oncol & Tumorimmunol, Berlin, Germany.	olaf.penack@charite.de	Penack, Olaf/L-1068-2016	Penack, Olaf/0000-0003-4876-802X	Stefan-Morsch-Stiftung	Stefan-Morsch-Stiftung	This work was funded by the Stefan-Morsch-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud PA, 2008, EUR J PHARMACOL, V579, P411, DOI 10.1016/j.ejphar.2007.10.053; Afzal M, 2015, INFLAMMOPHARMACOLOGY, V23, P151, DOI 10.1007/s10787-015-0236-1; Alho AC, 2015, BLOOD; Amer J, 2007, ANN HEMATOL, V86, P753, DOI 10.1007/s00277-007-0321-7; Balentine DA, 1997, CRIT REV FOOD SCI, V37, P693, DOI 10.1080/10408399709527797; Bruckner M, 2012, J CROHNS COLITIS, V6, P226, DOI 10.1016/j.crohns.2011.08.012; Byun EH, 2010, J IMMUNOL, V185, P33, DOI 10.4049/jimmunol.0903742; Cavet ME, 2011, MOL VIS, V17, P533; Cerezo-Guisado MI, 2015, FOOD CHEM TOXICOL, V84, P125, DOI 10.1016/j.fct.2015.08.017; Choi J, 2014, CELL TRANSPLANT, V23, P1163, DOI 10.3727/096368913X667691; Dann JM, 2009, GYNECOL ONCOL, V113, P374, DOI 10.1016/j.ygyno.2009.02.014; Dona M, 2003, J IMMUNOL, V170, P4335, DOI 10.4049/jimmunol.170.8.4335; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Friedman M, 2007, MOL NUTR FOOD RES, V51, P116, DOI 10.1002/mnfr.200600173; Gitto E, 2001, PEDIATR RES, V50, P756, DOI 10.1203/00006450-200112000-00021; Hoffmann P, 2006, SEMIN HEMATOL, V43, P62, DOI 10.1053/j.seminhematol.2005.09.006; Johnson R, 2012, MATURITAS, V73, P280, DOI 10.1016/j.maturitas.2012.08.008; Kanamune J, 2012, CELL TRANSPLANT, V21, P909, DOI 10.3727/096368911X623934; Kuo CL, 2014, IMMUNOPHARM IMMUNOT, V36, P364, DOI 10.3109/08923973.2014.953637; Lambert JD, 2004, J NUTR, V134, P1948, DOI 10.1093/jn/134.8.1948; Lamoral-Theys D, 2010, CURR MED CHEM, V17, P812, DOI 10.2174/092986710790712183; LERNER KG, 1974, TRANSPLANT P, V6, P367; Ma YC, 2014, ONCOL REP, V31, P1343, DOI 10.3892/or.2013.2933; Matsuoka K, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005265; Niedzwiecki A, 2010, CANCER METAST REV, V29, P529, DOI 10.1007/s10555-010-9244-1; Ohga N, 2009, CANCER SCI, V100, P1963, DOI 10.1111/j.1349-7006.2009.01255.x; Penack O, 2011, BLOOD, V117, P4181, DOI 10.1182/blood-2010-10-312934; Penack O, 2010, JNCI-J NATL CANCER I, V102, P894, DOI 10.1093/jnci/djq172; Riesner K, 2015, BONE MARROW TRANSPLA; Salzano S, 2014, P NATL ACAD SCI USA, V111, P12157, DOI 10.1073/pnas.1401712111; Sari I, 2008, ANN CLIN LAB SCI, V38, P120; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Singh R, 2010, LIFE SCI, V86, P907, DOI 10.1016/j.lfs.2010.04.013; Suh JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088868; Thielecke F, 2009, PHYTOCHEMISTRY, V70, P11, DOI 10.1016/j.phytochem.2008.11.011; Van Aller GS, 2011, BIOCHEM BIOPH RES CO, V406, P194, DOI 10.1016/j.bbrc.2011.02.010; Wang JP, 2012, AM J PATHOL, V180, P221, DOI 10.1016/j.ajpath.2011.09.007; Wang PW, 2012, FOOD FUNCT, V3, P635, DOI 10.1039/c2fo10254d; Wang Y, 2013, ONCOL REP, V30, P2691, DOI 10.3892/or.2013.2743; Wang YQ, 2015, BASIC CLIN PHARMACOL, V117, P164, DOI 10.1111/bcpt.12383; Wong CP, 2011, IMMUNOL LETT, V139, P7, DOI 10.1016/j.imlet.2011.04.009; Wu DY, 2012, MOL ASPECTS MED, V33, P107, DOI 10.1016/j.mam.2011.10.001; Xu H, 2011, FERTIL STERIL, V96, P1021, DOI 10.1016/j.fertnstert.2011.07.008; Yang CS, 2008, MOL NUTR FOOD RES, V52, pS139, DOI 10.1002/mnfr.200700234; YANG CS, 1993, J NATL CANCER I, V85, P1038, DOI 10.1093/jnci/85.13.1038; Yang EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086062	46	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0169630	10.1371/journal.pone.0169630	http://dx.doi.org/10.1371/journal.pone.0169630			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103249	Green Published, Green Submitted, gold			2022-12-26	WOS:000392381100016
J	Faden, DL; Asthana, S; Tihan, T; DeRisi, J; Kliot, M				Faden, Daniel L.; Asthana, Saurabh; Tihan, Tarik; DeRisi, Joseph; Kliot, Michel			Whole Exome Sequencing of Growing and Non-Growing Cutaneous Neurofibromas from a Single Patient with Neurofibromatosis Type 1	PLOS ONE			English	Article							NF1 GENE; MUTATIONAL SPECTRUM; CANCER; TUMORIGENESIS; EXPRESSION; CHILDREN; TUMORS; RISK	The growth behaviors of cutaneous neurofibromas in patients with Neurofibromatosis type 1 are highly variable. The role of the germline NF1 mutation, somatic NF1 mutation and mutations at modifying loci, are poorly understood. We performed whole exome sequencing of three growing and three non-growing neurofibromas from a single individual to assess the role of acquired somatic mutations in neurofibroma growth behavior. 1-11 mutations were identified in each sample, including two deleterious NF1 mutations. No trends were present between the types of somatic mutations identified and growth behavior. Mutations in the HIPPO signaling pathway appeared to be overrepresented.	[Faden, Daniel L.] Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USA; [Asthana, Saurabh] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Tihan, Tarik] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [DeRisi, Joseph] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Kliot, Michel] Northwestern Univ, Dept Neurosurg, Feinberg Sch Med, Chicago, IL 60611 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Northwestern University; Feinberg School of Medicine	Faden, DL (corresponding author), Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USA.	DLFaden@gmail.com	Tihan, Tarik/AAU-6371-2021; Faden, Daniel Lawrence/AAX-5743-2020	Faden, Daniel Lawrence/0000-0001-5284-7762; Tihan, Tarik/0000-0003-4551-2555				Alkindy A, 2012, HUM GENOMICS, V6, DOI 10.1186/1479-7364-6-12; [Anonymous], ALIGNING SEQUENCE RE, DOI DOI 10.48550/ARXIV.1303.3997; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; DeBella K, 2000, PEDIATRICS, V105, P608, DOI 10.1542/peds.105.3.608; EASTON DF, 1993, AM J HUM GENET, V53, P305; Emmerich D, 2015, EUR J HUM GENET, V23, P870, DOI 10.1038/ejhg.2014.210; George J, 2015, NATURE, V524, P47, DOI 10.1038/nature14664; Handa K, 2007, J VIROL, V81, P1379, DOI 10.1128/JVI.01712-06; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Kaneko K, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-454; Lammert M, 2005, ARCH DERMATOL, V141, P71, DOI 10.1001/archderm.141.1.71; Laycock-van Spyk Sebastian, 2011, Human Genomics, V5, P623; Mauviel A, 2012, ONCOGENE, V31, P1743, DOI 10.1038/onc.2011.363; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Plouffe SW, 2015, TRENDS MOL MED, V21, P212, DOI 10.1016/j.molmed.2015.01.003; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Spurlock G, 2007, FAM CANCER, V6, P463, DOI 10.1007/s10689-007-9149-5; Tabbekh M, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22841; Talevich E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004873; Thomas L, 2012, EUR J HUM GENET, V20, P411, DOI 10.1038/ejhg.2011.207; Thomas L, 2010, NEUROGENETICS, V11, P391, DOI 10.1007/s10048-010-0240-y; Upadhyaya M, 2007, AM J HUM GENET, V80, P140, DOI 10.1086/510781; Upadhyaya M, 1998, HUM GENET, V102, P591, DOI 10.1007/s004390050746; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Wong YH, 2010, J NEUROSCI, V30, P4428, DOI 10.1523/JNEUROSCI.0473-10.2010; Yeung B, 2016, INT J CANCER, V138, P533, DOI 10.1002/ijc.29457	30	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170348	10.1371/journal.pone.0170348	http://dx.doi.org/10.1371/journal.pone.0170348			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099461	Green Submitted, Green Published, gold			2022-12-26	WOS:000392380100078
J	Kim, EJ; Choi, MJ; Lee, JH; Oh, JE; Seo, JW; Lee, YK; Yoon, JW; Kim, HJ; Noh, JW; Koo, JR				Kim, Eun-Jung; Choi, Myung-Jin; Lee, Jeoung-Hwan; Oh, Ji-Eun; Seo, Jang-Won; Lee, Young-Ki; Yoon, Jong-Woo; Kim, Hyung-Jik; Noh, Jung-Woo; Koo, Ja-Ryong			Extracellular Fluid/Intracellular Fluid Volume Ratio as a Novel Risk Indicator for All-Cause Mortality and Cardiovascular Disease in Hemodialysis Patients	PLOS ONE			English	Article							ATHEROSCLEROSIS MIA SYNDROME; CHRONIC KIDNEY-DISEASE; BIOIMPEDANCE SPECTROSCOPY; DIALYSIS PATIENTS; MALNUTRITION; INFLAMMATION; HEART; ASSOCIATION; DEPRESSION; FAILURE	Background In hemodialysis patients, fluid overload and malnutrition are accompanied by extracellular fluid (ECF) expansion and intracellular fluid (ICF) depletion, respectively. We investigated the relationship between ECF/ICF ratio (as an integrated marker reflecting both fluid overload and malnutrition) and survival and cardiovascular disease (CVD) in the context of malnutrition -inflammation-arteriosclerosis (MIA) complex. Methods Seventy-seven patients from a single hemodialysis unit were prospectively enrolled. The ECF/ICF volume was measured by segmental multi-frequency bioimpedance analysis. MIA and volume status were measured by serum albumin, C-reactive protein (CRP), pulse wave velocity (PWV) and plasma B-type natriuretic peptide (BNP), respectively. Results The mean ECF/ICF ratio was 0.56+/-0.06 and the cut-off value for maximum discrimination of survival was 0.57. Compared with the low ECF/ICF group, the high ECF/ICF group (ratio >= 0.57, 42%) had higher all-cause mortality, CVD, CRP, PWV, and BNP, but lower serum albumin. During the 5-year follow-up, 24 all-cause mortality and 38 CVD occurred (18 and 24, respectively, in the high ECF/ICF group versus 6 and 14 respectively in the low ECF/ICF group, P<0.001). In the adjusted Cox analysis, the ECF/ICF ratio nullifies the effects of the MIA and volume status on survival and CVD and was an independent predictor of all-cause mortality and CVD: hazard ratio (95% confidence interval); 1.12 (1.01-1.25) and 1.09 (1.01-1.18) for a 0.01 increase in the ECF/ICF ratio. The degree of malnutrition (albumin), inflammation (CRP), arteriosclerosis (PWV), and fluid overload (BNP) were correlated well with the ECF/ICF ratio. Conclusions Hemodialysis patients with high ECF/ICF ratio are not only fluid overloaded, but malnourished and have stiff artery with more inflammation. The ECF/ICF ratio is highly related to the MIA complex, and is a major risk indicator for all-cause mortality and CVD.	[Kim, Eun-Jung; Choi, Myung-Jin; Lee, Jeoung-Hwan; Oh, Ji-Eun; Seo, Jang-Won; Lee, Young-Ki; Yoon, Jong-Woo; Kim, Hyung-Jik; Noh, Jung-Woo; Koo, Ja-Ryong] Hallym Univ, Coll Med, Hallym Kidney Res Inst, Dept Internal Med, Chunchon, South Korea; [Kim, Eun-Jung; Seo, Jang-Won; Koo, Ja-Ryong] Hallym Univ, Med Ctr, Dongtan Sacred Heart Hosp, Div Nephrol, Hwaseong Si, South Korea	Hallym University; Hallym University	Koo, JR (corresponding author), Hallym Univ, Coll Med, Hallym Kidney Res Inst, Dept Internal Med, Chunchon, South Korea.; Koo, JR (corresponding author), Hallym Univ, Med Ctr, Dongtan Sacred Heart Hosp, Div Nephrol, Hwaseong Si, South Korea.	jrkoo@hallym.ac.kr	; Lee, Jeonghwan/C-5214-2011	CHOI, MYUNG JIN/0000-0002-2761-7161; Lee, Jeonghwan/0000-0003-3199-635X				Achinger SG, 2013, NEPHROL DIAL TRANSPL, V28, P770, DOI 10.1093/ndt/gfs480; CHA KC, 1995, J APPL PHYSIOL, V79, P1316, DOI 10.1152/jappl.1995.79.4.1316; Chazot C, 2012, NEPHROL DIAL TRANSPL, V27, P2404, DOI 10.1093/ndt/gfr678; Choi MJ, 2012, NEPHRON CLIN PRACT, V122, P44, DOI 10.1159/000348509; Churchill DN, 1996, J AM SOC NEPHROL, V7, P198; De Lorenzo A, 2003, CURR OPIN CLIN NUTR, V6, P551, DOI [10.1097/00075197-200309000-00008, 10.1097/01.mco.000087970.83880.41]; Earthman C, 2007, NUTR CLIN PRACT, V22, P389, DOI 10.1177/0115426507022004389; Fan S, 2012, INT J ARTIF ORGANS, V35, P338, DOI 10.5301/ijao.5000080; Hung SC, 2014, KIDNEY INT, V85, P703, DOI 10.1038/ki.2013.336; Hur E, 2013, AM J KIDNEY DIS, V61, P957, DOI 10.1053/j.ajkd.2012.12.017; Johansen KL, 2014, J AM SOC NEPHROL, V25, P381, DOI 10.1681/ASN.2013040431; Kim YJ, 2015, KIDNEY RES CLIN PRAC, V34, P212, DOI 10.1016/j.krcp.2015.10.006; Koo JR, 2005, AM J MED SCI, V329, P1, DOI 10.1097/00000441-200501000-00001; Martola L, 2005, BLOOD PURIFICAT, V23, P203, DOI 10.1159/000084890; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; Mulasi U, 2015, NUTR CLIN PRACT, V30, P180, DOI 10.1177/0884533614568155; Niebauer J, 1999, LANCET, V353, P1838, DOI 10.1016/S0140-6736(98)09286-1; Onofriescu M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135691; Pecoits R, 2002, NEPHROL DIAL TRANSPL, V17, P28, DOI 10.1093/ndt/17.suppl_11.28; Pupim LB, 2004, KIDNEY INT, V66, P2054, DOI 10.1111/j.1523-1755.2004.00978.x; Qureshi AR, 2002, J AM SOC NEPHROL, V13, pS28; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Stenvinkel P, 2000, NEPHROL DIAL TRANSPL, V15, P953, DOI 10.1093/ndt/15.7.953; Tai R, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-189; Vuurmans JLT, 2002, J AM SOC NEPHROL, V13, P177, DOI 10.1681/ASN.V131177; Wizemann V, 2009, NEPHROL DIAL TRANSPL, V24, P1574, DOI 10.1093/ndt/gfn707; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Zhu F, 1998, ASAIO J, V44, pM541, DOI 10.1097/00002480-199809000-00045	28	35	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170272	10.1371/journal.pone.0170272	http://dx.doi.org/10.1371/journal.pone.0170272			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099511	Green Published, gold, Green Submitted			2022-12-26	WOS:000392380100067
J	Seiler, R; Kirchner, JW; Krusic, PJ; Tognetti, R; Houlie, N; Andronico, D; Cullotta, S; Egli, M; D'Arrigo, R; Cherubini, P				Seiler, Ruedi; Kirchner, James W.; Krusic, Paul J.; Tognetti, Roberto; Houlie, Nicolas; Andronico, Daniele; Cullotta, Sebastiano; Egli, Markus; D'Arrigo, Rosanne; Cherubini, Paolo			Insensitivity of Tree-Ring Growth to Temperature and Precipitation Sharpens the Puzzle of Enhanced Pre-Eruption NDVI on Mt. Etna (Italy)	PLOS ONE			English	Article							MAY-JUNE PRECIPITATION; MOUNT-ETNA; VOLCANIC SOILS; MEDITERRANEAN FOREST; MAMMOTH MOUNTAIN; CLIMATE; CO2; CARBON; PINE; RECONSTRUCTION	On Mt. Etna (Italy), an enhanced Normalized Difference in Vegetation Index (NDVI) signature was detected in the summers of 2001 and 2002 along a distinct line where, in November 2002, a flank eruption subsequently occurred. These observations suggest that preeruptive volcanic activity may have enhanced photosynthesis along the future eruptive fissure. If a direct relation between NDVI and future volcanic eruptions could be established, it would provide a straightforward and low-cost method for early detection of upcoming eruptions. However, it is unclear if, or to what extent, the observed enhancement of NDVI can be attributed to volcanic activity prior to the subsequent eruption. We consequently aimed at determining whether an increase in ambient temperature or additional water availability owing to the rise of magma and degassing of water vapour prior to the eruption could have increased photosynthesis of Mt. Etna's trees. Using dendro-climatic analyses we quantified the sensitivity of tree ring widths to temperature and precipitation at high elevation stands on Mt. Etna. Our findings suggest that tree growth at high elevation on Mt. Etna is weakly influenced by climate, and that neither an increase in water availability nor an increase in temperature induced by pre-eruptive activity is a plausible mechanism for enhanced photosynthesis before the 2002/2003 flank eruption. Our findings thus imply that other, yet unknown, factors must be sought as causes of the pre-eruption enhancement of NDVI on Mt. Etna.	[Seiler, Ruedi; Kirchner, James W.; Cherubini, Paolo] Swiss Fed Inst Forest Snow & Landscape Res WSL, Birmensdorf, Switzerland; [Seiler, Ruedi; Egli, Markus; Cherubini, Paolo] Univ Zurich, Dept Geog, Zurich, Switzerland; [Kirchner, James W.] Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland; [Krusic, Paul J.] Navarino Environm Observ, Messinia, Greece; [Krusic, Paul J.] Stockholm Univ, Inst Nat Geog, Stockholm, Sweden; [Tognetti, Roberto] Univ Molise, Dipartimento Biosci & Terr, Contrada Fonte Lappone, Pesche, Italy; [Houlie, Nicolas] ETH, Dept Earth Sci, Zurich, Switzerland; [Andronico, Daniele] Osservatorio Etneo, INGV, Sez Catania, Catania, Italy; [Cullotta, Sebastiano] Univ Palermo, Palermo, Italy; [D'Arrigo, Rosanne; Cherubini, Paolo] Lamont Doherty Earth Observ, Palisades, NY USA	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Stockholm University; University of Molise; Swiss Federal Institutes of Technology Domain; ETH Zurich; Istituto Nazionale Geofisica e Vulcanologia (INGV); University of Palermo; Columbia University	Seiler, R (corresponding author), Swiss Fed Inst Forest Snow & Landscape Res WSL, Birmensdorf, Switzerland.; Seiler, R (corresponding author), Univ Zurich, Dept Geog, Zurich, Switzerland.	ruedi.seiler@wsl.ch	Kirchner, James W/B-6126-2009; Cherubini, Paolo/N-9702-2013; Cherubini, Paolo/AAC-3121-2021; Tognetti, Roberto/C-4962-2008; Kirchner, James/AAC-4707-2019; Houlié, Nicolas/D-4022-2013	Kirchner, James W/0000-0001-6577-3619; Cherubini, Paolo/0000-0002-9809-250X; Cherubini, Paolo/0000-0002-9809-250X; Tognetti, Roberto/0000-0002-7771-6176; Kirchner, James/0000-0001-6577-3619; Houlié, Nicolas/0000-0001-7471-4020; Egli, Markus/0000-0002-1528-3440; Andronico, Daniele/0000-0002-8333-1547	Swiss National Foundation [205321_143479]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Foundation (Grant Number: 205321_143479) www.snf.ch. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Aiuppa A, 2007, GEOLOGY, V35, P1115, DOI 10.1130/G24149A.1; Akkemik U, 2008, INT J CLIMATOL, V28, P173, DOI 10.1002/joc.1522; ALLARD P, 1991, NATURE, V351, P387, DOI 10.1038/351387a0; Allard P, 1997, GEOPHYS RES LETT, V24, P2219, DOI 10.1029/97GL02101; Allard V, 2008, GLOBAL CHANGE BIOL, V14, P714, DOI 10.1111/j.1365-2486.2008.01539.x; Aloui A, 1982, THESIS; Andronico D, 2005, B VOLCANOL, V67, P314, DOI 10.1007/s00445-004-0372-8; Andronico D, 2009, J VOLCANOL GEOTH RES, V180, P123, DOI 10.1016/j.jvolgeores.2008.10.019; Aubert M, 1999, J VOLCANOL GEOTH RES, V92, P413, DOI 10.1016/S0377-0273(99)00088-8; Battaglia M, 1999, SCIENCE, V285, P2119, DOI 10.1126/science.285.5436.2119; Begum S, 2013, PHYSIOL PLANTARUM, V147, P46, DOI 10.1111/j.1399-3054.2012.01663.x; Biondi F, 1999, ECOLOGY, V80, P2420, DOI 10.2307/176921; Bolle HJ, 2006, REG CLIM STUD, VXXVIII; BONNEVILLE A, 1992, GEOPHYS RES LETT, V19, P725, DOI 10.1029/92GL00580; Branca S, 2008, INT J EARTH SCI, V97, P135, DOI 10.1007/s00531-006-0152-0; Briffa KR, 2013, QUATERNARY SCI REV, V72, P83, DOI 10.1016/j.quascirev.2013.04.008; Briffa KR, 1998, PHILOS T ROY SOC B, V353, P65, DOI 10.1098/rstb.1998.0191; Buntgen U, 2012, CLIMATIC CHANGE, V114, P651, DOI 10.1007/s10584-012-0450-4; Buntgen U, 2006, TREES-STRUCT FUNCT, V20, P99, DOI 10.1007/s00468-005-0017-3; Buntgen U, 2005, J CLIMATOL, V9, P5606; Burga C, 2004, GEBIRGE ERDE LANDSCH; Cai Q, 2014, CLIM PAST, V10, P509, DOI 10.5194/cp-10-509-2014; Campelo F, 2007, ANN FOREST SCI, V64, P229, DOI 10.1051/forest:2006107; Carrer M, 2010, OIKOS, V119, P1515, DOI 10.1111/j.1600-0706.2010.18293.x; Certini G, 2001, GEODERMA, V102, P239, DOI 10.1016/S0016-7061(01)00017-9; Cherubini P, 2003, BIOL REV, V78, P119, DOI 10.1017/S1464793102006000; Christensen JH, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1217; Cook AC, 2001, CHEM GEOL, V177, P117, DOI 10.1016/S0009-2541(00)00386-7; Cook ER, 2011, DEV PALEOENVIRON RES, V11, P77, DOI 10.1007/978-1-4020-5725-0_4; Cook ER, 1990, METHODS DENDROCHRONO, DOI DOI 10.1007/978-94-015-7879-0; Cotrufo MF, 2011, BIOGEOSCIENCES, V8, P2729, DOI 10.5194/bg-8-2729-2011; Dazzi C, 2007, SOILS VOLCANIC REGIO; Dobbertin M, 2005, EUR J FOREST RES, V124, P319, DOI 10.1007/s10342-005-0085-3; Doglioni C, 2002, GNGTS ATT 17 CONV NA; Donders TH, 2013, INT J GREENH GAS CON, V19, P387, DOI 10.1016/j.ijggc.2013.09.017; Eckstein D., 1981, MITTEILUNGEN FORSTLI, V142, P391; Egli M, 2008, GEODERMA, V143, P101, DOI 10.1016/j.geoderma.2007.10.020; Egli M, 2007, SOIL SCI, V172, P673, DOI 10.1097/ss.0b013e31809eda23; Egli M, 2012, CATENA, V88, P14, DOI 10.1016/j.catena.2011.08.006; Fritts H.C, 1976, TREE RINGS CLIMATE; GAMON JA, 1995, ECOL APPL, V5, P28, DOI 10.2307/1942049; Garcia-Suarez AM, 2009, DENDROCHRONOLOGIA, V27, P183, DOI 10.1016/j.dendro.2009.05.003; Gartner H, 2015, JOVE-J VIS EXP, V97; Gea-Izquierdo G, 2011, FOREST ECOL MANAG, V262, P1807, DOI 10.1016/j.foreco.2011.07.025; Giammanco S, 1998, B VOLCANOL, V60, P252, DOI 10.1007/s004450050231; Goetz SJ, 2005, P NATL ACAD SCI USA, V102, P13521, DOI 10.1073/pnas.0506179102; GRAUMLICH LJ, 1987, ANN ASSOC AM GEOGR, V77, P19, DOI 10.1111/j.1467-8306.1987.tb00142.x; Griggs C, 2007, INT J CLIMATOL, V27, P1075, DOI 10.1002/joc.1459; Griggs C, 2014, INT J CLIMATOL, V34, P2702, DOI 10.1002/joc.3869; Grissino-Mayer, 2001, TREE-RING RES, V57, P205, DOI DOI 10.1016/J.DENDRO.2010.12.002; Hermes K, 1955, KOLNER GEOGRAPHISCHE, V5; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Hooper A, 2012, P IEEE, V100, P2908, DOI 10.1109/JPROC.2012.2199269; Houlie N, 2006, EARTH PLANET SC LETT, V246, P231, DOI 10.1016/j.epsl.2006.03.039; Hughes Malcolm K., 2002, Dendrochronologia, V20, P95, DOI 10.1078/1125-7865-00011; Hughes MK, 2001, TREE-RING RES, V57, P438; Jong SM, 1998, ITC J, P1; Camarero JJ, 2013, ANN FOREST SCI, V70, P769, DOI 10.1007/s13595-013-0321-9; Klein T, 2016, J ECOL, V104, P1720, DOI 10.1111/1365-2745.12621; Knapp PA, 2001, GLOBAL CHANGE BIOL, V7, P903, DOI 10.1046/j.1365-2486.2001.00452.x; Koppen W, 1923, GRUNDRISS KLIMAKUNDE; Korner C, 1998, OECOLOGIA, V115, P445, DOI 10.1007/s004420050540; Korner C, 2003, J ECOL, V91, P4, DOI 10.1046/j.1365-2745.2003.00742.x; Kose N, 2013, INT J BIOMETEOROL, V57, P691, DOI 10.1007/s00484-012-0595-x; Kose N, 2011, QUATERNARY RES, V75, P438, DOI 10.1016/j.yqres.2010.12.005; Kutner M., 2005, APPL LINEAR STAT MOD; Lana-Renault N, 2010, CUAD INVESTIG GEOGR, V36, P99, DOI 10.18172/cig.1240; Lebourgeois F, 1998, ANN SCI FOREST, V55, P287, DOI 10.1051/forest:19980302; Leonelli G, 2009, PHYS GEOGR, V30, P338, DOI 10.2747/0272-3646.30.4.338; Limm EB, 2009, OECOLOGIA, V161, P449, DOI 10.1007/s00442-009-1400-3; Liuzzo M, 2015, GEOCHEM GEOPHYS GEOS, V16; Ludeke MKB, 1996, ECOL MODEL, V91, P255, DOI 10.1016/0304-3800(95)00192-1; Lulli L, 2007, SOILS VOLCANIC REGIO, P51; Ma SY, 2007, AGR FOREST METEOROL, V147, P157, DOI 10.1016/j.agrformet.2007.07.008; Maeda T., 1977, Advances irn Agronomy, V29, P229, DOI 10.1016/S0065-2113(08)60220-5; Maselli F, 2004, REMOTE SENS ENVIRON, V89, P423, DOI 10.1016/j.rse.2003.10.020; Maselli F, 2014, AGR FOREST METEOROL, V194, P197, DOI 10.1016/j.agrformet.2014.04.006; McNutt SR, 2000, ENCY VOLCANOES, P1167; McNutt SR, 1996, SEISMIC MONITORING E; Mitchell T. D., 2004, 55 TYND CTR; Navarro-Cerrillo RM, 2014, TREE-RING RES, V70, P145, DOI 10.3959/1536-1098-70.2.145; Norby RJ, 1999, PLANT CELL ENVIRON, V22, P683, DOI 10.1046/j.1365-3040.1999.00391.x; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Olivar J, 2012, DENDROCHRONOLOGIA, V30, P35, DOI 10.1016/j.dendro.2011.06.001; Poli Marchese E, 2004, GEBIRGE ERDE LANDSCH, P291; R Core Team, 2021, R LANGUAGE ENV STAT; Reisser M, 2014, THESIS; Saurer M, 2003, TREE PHYSIOL, V23, P997, DOI 10.1093/treephys/23.14.997; Scarascia-Mugnozza G, 2000, FOREST ECOL MANAG, V132, P97, DOI 10.1016/S0378-1127(00)00383-2; SCHWEINGRUBER FH, 1987, NATURWISSENSCHAFTEN, V74, P205, DOI 10.1007/BF00424589; Seim A, 2012, CLIM RES, V51, P217, DOI 10.3354/cr01076; Serre-Bachet F, 1987, NATO ASI SER C-MATH, V216, P89; Sherburn S, 2007, NEW ZEAL J GEOL GEOP, V50, P1, DOI 10.1080/00288300709509814; Shinohara H, 2008, REV GEOPHYS, V46, DOI 10.1029/2007RG000244; Sicali S, 2015, J VOLCANOL GEOTH RES, V304, P11, DOI 10.1016/j.jvolgeores.2015.08.004; Sparks RSJ, 2012, SCIENCE, V335, P1310, DOI 10.1126/science.1219485; Tardif J, 2003, ECOL MONOGR, V73, P241, DOI 10.1890/0012-9615(2003)073[0241:SVITGI]2.0.CO;2; Tessier L, 1984, THESIS; Todaro L, 2007, BIOL CONSERV, V137, P507, DOI 10.1016/j.biocon.2007.03.010; Tognetti R, 2000, NEW PHYTOL, V146, P59, DOI 10.1046/j.1469-8137.2000.00620.x; Tognetti R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113136; Tome AR, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019100; Touchan R, 2007, QUATERNARY RES, V68, P196, DOI 10.1016/j.yqres.2007.07.001; Touchan R, 2014, HOLOCENE, V24, P381, DOI 10.1177/0959683613518594; Walter H., 1960, KLIMADIAGRAMM WELTAT; Watt SFL, 2007, ENVIRON POLLUT, V148, P48, DOI 10.1016/j.envpol.2006.11.007; Wessel P., 1998, EOS T AM GEOPHYS UN, V79, P579, DOI [10.1029/98EO00426, DOI 10.1029/98EO00426, DOI 10.1029/98E000426]; Williams-Jones G, 2002, J VOLCANOL GEOTH RES, V113, P379, DOI 10.1016/S0377-0273(01)00272-4	109	8	8	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0169297	10.1371/journal.pone.0169297	http://dx.doi.org/10.1371/journal.pone.0169297			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099435	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000392380100017
J	Al-Saleh, MAQ; Punithakumar, K; Lagravere, M; Boulanger, P; Jaremko, JL; Major, PW				Al-Saleh, Mohammed A. Q.; Punithakumar, Kumaradevan; Lagravere, Manuel; Boulanger, Pierre; Jaremko, Jacob L.; Major, Paul W.			Three-Dimensional Assessment of Temporomandibular Joint Using MRI-CBCT Image Registration	PLOS ONE			English	Article							BEAM COMPUTED-TOMOGRAPHY; DISK STATUS; PROTON DENSITY; DISPLACEMENT; CLASSIFICATION; DISORDERS; CONTOUR	Purpose To introduce a new approach to reconstruct a 3D model of the TMJ using magnetic resonance imaging (MRI) and cone-beam computed tomography (CBCT) registered images, and to evaluate the intra-examiner reproducibility values of reconstructing the 3D models of the TMJ. Methods MRI and CBCT images of five patients (10 TMJs) were obtained. Multiple MRIs and CBCT images were registered using a mutual information based algorithm. The articular disc, condylar head and glenoid fossa were segmented at two different occasions, at least one-week apart, by one investigator, and 3D models were reconstructed. Differences between the segmentation at two occasions were automatically measured using the surface contours (Average Perpendicular Distance) and the volume overlap (Dice Similarity Index) of the 3D models. Descriptive analysis of the changes at 2 occasions, including means and standard deviation (SD) were reported to describe the intra-examiner reproducibility. Results The automatic segmentation of the condyle revealed maximum distance change of 1.9 0.93 mm, similarity index of 98% and root mean squared distance of 0.1 +/- 0.08 mm, and the glenoid fossa revealed maximum distance change of 2+/-0.52 mm, similarity index of 96% and root mean squared distance of 0.2 +/- 0.04 mm. The manual segmentation of the articular disc revealed maximum distance change of 3.6 +/- 0.32 mm, similarity index of 80% and root mean squared distance of 0.3 +/- 0.1 mm. Conclusion The MRI-CBCT registration provides a reliable tool to reconstruct 3D models of the changes with associated differences of the condylar head and glenoid fossa, and facilitates measuring tissue changes over time.	[Al-Saleh, Mohammed A. Q.; Lagravere, Manuel; Major, Paul W.] Univ Alberta, Fac Med & Dent, Dept Dent, Edmonton, AB, Canada; [Punithakumar, Kumaradevan; Boulanger, Pierre] Univ Alberta, Servier Virtual Cardiac Ctr, Edmonton, AB, Canada; [Punithakumar, Kumaradevan; Boulanger, Pierre] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada; [Jaremko, Jacob L.] Univ Alberta, Fac Sci, Dept Radiol & Diagnost Imaging, Edmonton, AB, Canada	University of Alberta; Servier; University of Alberta; University of Alberta; University of Alberta	Al-Saleh, MAQ (corresponding author), Univ Alberta, Fac Med & Dent, Dept Dent, Edmonton, AB, Canada.	m.alsaleh@ualberta.ca	Punithakumar, Kumaradevan/U-3182-2017; Boulanger, Pierre/AFV-2750-2022	Punithakumar, Kumaradevan/0000-0003-3835-1079; Al-Saleh, Mohamed A.Q./0000-0001-5620-2873				Al-Saleh MAQ, 2015, DENTOMAXILLOFAC RAD, V44, DOI 10.1259/dmfr.20140244; Al-Saleh MAQ, 2016, J OTOLARYNGOL-HEAD N, V45, DOI 10.1186/s40463-016-0144-4; Al-Saleh MAQ, 2016, OR SURG OR MED OR PA, V121, P316, DOI 10.1016/j.oooo.2015.10.029; Alkhader M, 2010, DENTOMAXILLOFAC RAD, V39, P270, DOI 10.1259/dmfr/25151578; [Anonymous], 2011, 34 INT C TEL SIGN PR; Chirani RA, 2004, ORAL SURG ORAL MED O, V97, P756, DOI 10.1016/j.tripleo.2004.02.073; Goshtasby AAA, 2012, ADV COMPUTER VISION; Hayakawa Y, 2007, DENTOMAXILLOFAC RAD, V36, P341, DOI 10.1259/dmfr/12894471; HUTTENLOCHER DP, 1993, IEEE T PATTERN ANAL, V15, P850, DOI 10.1109/34.232073; Katzberg RW, 1996, J ORAL MAXIL SURG, V54, P147, DOI 10.1016/S0278-2391(96)90435-8; KATZBERG RW, 1983, J PROSTHET DENT, V49, P250, DOI 10.1016/0022-3913(83)90511-5; Kober C, 2007, INT J COMPUT ASS RAD, V2, P203, DOI 10.1007/s11548-007-0130-4; Krebs M., 1995, Annals Academy of Medicine Singapore, V24, P11; Krebs M, 1994, Technol Health Care, V2, P193, DOI 10.3233/THC-1994-2303; Larheim TA, 2005, CELLS TISSUES ORGANS, V180, P6, DOI 10.1159/000086194; Li T, 2003, MAGN RESON IMAGING, V21, P741, DOI 10.1016/S0730-725X(03)00177-2; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Maes F, 2003, P IEEE, V91, P1699, DOI 10.1109/JPROC.2003.817864; Maintz J B, 1998, Med Image Anal, V2, P1, DOI 10.1016/S1361-8415(01)80026-8; Major PW, 2002, AM J ORTHOD DENTOFAC, V121, P152, DOI 10.1067/mod.2002.120641; Mikulka J, 2012, MEAS SCI REV, V12, P153, DOI 10.2478/v10048-012-0023-8; Mikulka J., 2010, PIERS ONLINE, V6, P204; Motoyoshi M, 1999, J Oral Sci, V41, P5; Murguia M, 2003, ANN BOT FENN, V40, P415; Nebbe B, 1998, ORAL SURG ORAL MED O, V86, P746, DOI 10.1016/S1079-2104(98)90215-3; Nebbe B, 2000, ORAL SURG ORAL MED O, V90, P102, DOI 10.1067/moe.2000.106300; Price C, 1992, Dentomaxillofac Radiol, V21, P148; Pullinger AG, 2001, J PROSTHET DENT, V86, P407, DOI 10.1067/mpr.2001.118563; Sano T, 2003, CRANIO, V21, P253, DOI 10.1080/08869634.2003.11746259; Schilling J, 2014, DENTOMAXILLOFACIAL R, V43; Sylvester DC, 2011, CRANIO, V29, P117, DOI 10.1179/crn.2011.020; Tasaki MM, 1996, AM J ORTHOD DENTOFAC, V109, P249, DOI 10.1016/S0889-5406(96)70148-8; TASAKI MM, 1993, ORAL SURG ORAL MED O, V76, P231, DOI 10.1016/0030-4220(93)90210-U; Westesson P L, 1993, Adv Dent Res, V7, P137; WESTESSON PL, 1987, AM J ROENTGENOL, V148, P1165, DOI 10.2214/ajr.148.6.1165; Widmalm SE, 2006, DENTOMAXILLOFAC RAD, V35, P334, DOI 10.1259/dmfr/23427399	36	7	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0169555	10.1371/journal.pone.0169555	http://dx.doi.org/10.1371/journal.pone.0169555			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095486	Green Published, Green Submitted, gold			2022-12-26	WOS:000392372300024
J	Eloi, M; Horvath, DV; Ortega, JC; Prado, MS; Andrade, LEC; Szejnfeld, VL; Castro, CHD				Eloi, Marina; Horvath, Daniela Vargas; Ortega, Joao Carlos; Prado, Monica Simon; Coelho Andrade, Luis Eduardo; Szejnfeld, Vera Lucia; de Moura Castro, Charlles Heiden			25-Hydroxivitamin D Serum Concentration, Not Free and Bioavailable Vitamin D, Is Associated with Disease Activity in Systemic Lupus Erythematosus Patients	PLOS ONE			English	Article							BONE-MINERAL DENSITY; D-BINDING PROTEIN; D DEFICIENCY; POSTMENOPAUSAL WOMEN; D INSUFFICIENCY; SAO-PAULO; PREVALENCE; HEALTH; SUPPLEMENTATION; COMMUNITY	We aim to evaluate the prevalence of vitamin D deficiency in patients with systemic lupus erythematosus (SLE) and investigate the association between total, free and bioavailable vitamin D serum concentrations and disease activity. Patients with SLE (ACR 1997) consecutively seen at UNIFESP's outpatient's clinics had disease activity measured after clinical and laboratory evaluation using SLEDAI (Systemic Lupus Erythematosus Disease Activity Index). 25-hydroxyvitamin D (25(OH) D) serum concentrations measured by chemiluminescence and vitamin D binding protein (DBP) measured by ELISA were used to calculate free and bioavailable vitamin D. Healthy blood donors were used as controls. A total of 142 patients (71.4%) had 25(OH) D serum concentrations below 30 ng/mL. Total 25(OH) D serum concentration was associated with disease activity categorized in 5 continuous groups of SLEDAI. 25(OH) D serum concentrations were higher among patients with SLEDAI 1-5 and lower in those with severe activity (SLEDAI >= 20) (p < 0.05). On the other hand, no statistically significant difference was observed for DBP, free and bioavailable vitamin D measurements in the disease activity subgroups evaluated. Vitamin D deficiency is highly prevalent among patients with SLE and was associated with higher disease activity. DBP serum level and calculation of free and bioavailable vitamin D were not associated with SLE disease activity.	[Eloi, Marina; Horvath, Daniela Vargas; Ortega, Joao Carlos; Prado, Monica Simon; Coelho Andrade, Luis Eduardo; Szejnfeld, Vera Lucia; de Moura Castro, Charlles Heiden] Univ Fed Sao Paulo, Div Rheumatol, Escola Paulista Med Unifesp EPM, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Castro, CHD (corresponding author), Univ Fed Sao Paulo, Div Rheumatol, Escola Paulista Med Unifesp EPM, Sao Paulo, Brazil.	cheidan@uol.com.br	Castro, Charlles HM/C-1594-2012; Andrade, Luis Eduardo C/D-1245-2012	Castro, Charlles HM/0000-0001-9144-996X; Andrade, Luis Eduardo C/0000-0001-8742-9931				Abou-Raya A, 2013, J RHEUMATOL, V40, P265, DOI 10.3899/jrheum.111594; Amital H, 2010, ANN RHEUM DIS, V69, P1155, DOI 10.1136/ard.2009.120329; Arantes HP, 2013, OSTEOPOROSIS INT, V24, P2707, DOI 10.1007/s00198-013-2366-x; Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Bandeira F, 2010, ARQ BRAS ENDOCRINOL, V54, P227, DOI 10.1590/S0004-27302010000200020; Behrens JR, 2015, EUROPEAN J NEUROLOGY; BIKLE DD, 1986, J CLIN ENDOCR METAB, V63, P954, DOI 10.1210/jcem-63-4-954; Bonakdar ZS, 2011, LUPUS, V20, P1155, DOI 10.1177/0961203311405703; Borba VZC, 2009, OSTEOPOROSIS INT, V20, P427, DOI 10.1007/s00198-008-0676-1; Casella CB, 2012, LUPUS, V21, P1335, DOI 10.1177/0961203312454929; Cook RJ, 2000, J RHEUMATOL, V27, P1892; Costenbader KH, 2008, ANN RHEUM DIS, V67, P530, DOI 10.1136/ard.2007.072736; Cutolo M, 2009, RHEUMATOLOGY, V48, P210, DOI 10.1093/rheumatology/ken394; Denburg MR, 2016, J BONE MINER RES, V31, P1128, DOI 10.1002/jbmr.2829; Denburg MR, 2013, PEDIATR NEPHROL, V28, P1843, DOI 10.1007/s00467-013-2493-9; Glendenning P, 2013, BONE, V56, P271, DOI 10.1016/j.bone.2013.06.012; Gordon C, 2009, ANN RHEUM DIS, V68, P470, DOI 10.1136/ard.2007.083022; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Lopes JB, 2014, MATURITAS, V78, P335, DOI 10.1016/j.maturitas.2014.05.023; Monticielo OA, 2012, CLIN RHEUMATOL, V31, P1411, DOI 10.1007/s10067-012-2021-5; Peracchi OAB, 2014, BRAZ J MED BIOL RES, V47, P721, DOI 10.1590/1414-431X20143948; Ritterhouse LL, 2011, ANN RHEUM DIS, V70, P1569, DOI 10.1136/ard.2010.148494; Ruiz-Irastorza G, 2008, RHEUMATOLOGY, V47, P920, DOI 10.1093/rheumatology/ken121; Sakthiswary R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055275; Saraiva GL, 2007, ARQ BRAS ENDOCRINOL, V51, P437, DOI 10.1590/S0004-27302007000300012; Souto MID, 2011, LUPUS, V20, P1019, DOI 10.1177/0961203311401457; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Wright TB, 2009, J PEDIATR-US, V155, P260, DOI 10.1016/j.jpeds.2009.02.033; Yeap SS, 2012, INT J RHEUM DIS, V15, P17, DOI 10.1111/j.1756-185X.2011.01653.x	30	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0170323	10.1371/journal.pone.0170323	http://dx.doi.org/10.1371/journal.pone.0170323			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085957	Green Published, Green Submitted, gold			2022-12-26	WOS:000391972600083
J	Gong, CC; Klumpp, S				Gong, Chen Chris; Klumpp, Stefan			Modeling sRNA-Regulated Plasmid Maintenance	PLOS ONE			English	Article							TOXIN-ANTITOXIN SYSTEMS; ESCHERICHIA-COLI; ANTISENSE RNA; GENE-EXPRESSION; TARGET RNAS; HOK; MECHANISM; ELEMENTS; IDENTIFICATION; REPLICATION	We study a theoretical model for the toxin-antitoxin (hok/sok) mechanism for plasmid maintenance in bacteria. Toxin-antitoxin systems enforce the maintenance of a plasmid through post-segregational killing of cells that have lost the plasmid. Key to their function is the tight regulation of expression of a protein toxin by an sRNA antitoxin. Here, we focus on the non-linear nature of the regulatory circuit dynamics of the toxin-antitoxin mechanism. The mechanism relies on a transient increase in protein concentration rather than on the steady state of the genetic circuit. Through a systematic analysis of the parameter dependence of this transient increase, we confirm some known design features of this system and identify new ones: for an efficient toxin-antitoxin mechanism, the synthesis rate of the toxin's mRNA template should be lower that of the sRNA antitoxin, the mRNA template should be more stable than the sRNA antitoxin, and the mRNA-sRNA complex should be more stable than the sRNA antitoxin. Moreover, a short half-life of the protein toxin is also beneficial to the function of the toxin-antitoxin system. In addition, we study a therapeutic scenario in which a competitor mRNA is introduced to sequester the sRNA antitoxin, causing the toxic protein to be expressed.	[Gong, Chen Chris; Klumpp, Stefan] Max Planck Inst Colloids & Interfaces, Dept Theory & Biosyst, Potsdam, Germany; [Gong, Chen Chris] Univ Potsdam, Inst Phys & Astron, Potsdam, Germany; [Klumpp, Stefan] Georg August Univ Gottingen, Inst Nonlinear Dynam, Gottingen, Germany	Max Planck Society; University of Potsdam; University of Gottingen	Gong, CC (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Theory & Biosyst, Potsdam, Germany.; Gong, CC (corresponding author), Univ Potsdam, Inst Phys & Astron, Potsdam, Germany.	cgong@uni-potsdam.de	Klumpp, Stefan/AAC-3936-2019; Klumpp, Stefan/C-2966-2008	Klumpp, Stefan/0000-0003-0584-2146; Klumpp, Stefan/0000-0003-0584-2146				Altuvia S, 2007, CURR OPIN MICROBIOL, V10, P257, DOI 10.1016/j.mib.2007.05.003; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; BRENNER M, 1991, P NATL ACAD SCI USA, V88, P405, DOI 10.1073/pnas.88.2.405; Catozzi S, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0303-2; EGUCHI Y, 1991, ANNU REV BIOCHEM, V60, P631, DOI 10.1146/annurev.bi.60.070191.003215; Faridani OR, 2006, NUCLEIC ACIDS RES, V34, P5915, DOI 10.1093/nar/gkl750; GERDES K, 1992, J MOL BIOL, V226, P637, DOI 10.1016/0022-2836(92)90621-P; GERDES K, 1990, MOL MICROBIOL, V4, P1807, DOI 10.1111/j.1365-2958.1990.tb02029.x; GERDES K, 1986, EMBO J, V5, P2023, DOI 10.1002/j.1460-2075.1986.tb04459.x; GERDES K, 1988, J MOL BIOL, V203, P119, DOI 10.1016/0022-2836(88)90096-4; Gerdes K, 2007, CURR OPIN MICROBIOL, V10, P117, DOI 10.1016/j.mib.2007.03.003; HJALT T, 1992, NUCLEIC ACIDS RES, V20, P6723, DOI 10.1093/nar/20.24.6723; Jasiecki J, 2003, EMBO REP, V4, P172, DOI 10.1038/sj.embor.embor733; Legewie S, 2008, BIOPHYS J, V95, P3232, DOI 10.1529/biophysj.108.133819; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Levine E, 2007, PLOS BIOL, V5, P1998, DOI 10.1371/journal.pbio.0050229; Levine E, 2008, CURR OPIN MICROBIOL, V11, P574, DOI 10.1016/j.mib.2008.09.016; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Liang ST, 1999, J MOL BIOL, V292, P19, DOI 10.1006/jmbi.1999.3056; LINCHAO S, 1991, CELL, V65, P1233, DOI 10.1016/0092-8674(91)90018-T; LINCHAO S, 1987, J BACTERIOL, V169, P1217, DOI 10.1128/jb.169.3.1217-1222.1987; Livny J, 2007, CURR OPIN MICROBIOL, V10, P96, DOI 10.1016/j.mib.2007.03.005; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Mitarai N, 2009, P NATL ACAD SCI USA, V106, P10655, DOI 10.1073/pnas.0901466106; Nedelec F, 2002, J CELL BIOL, V158, P1005, DOI 10.1083/jcb.200202051; Nordgren S, 2001, J MOL BIOL, V310, P1125, DOI 10.1006/jmbi.2001.4802; Paulsson J, 2001, Q REV BIOPHYS, V34, P1, DOI 10.1017/S0033583501003663; STOUGAARD P, 1981, P NATL ACAD SCI-BIOL, V78, P6008, DOI 10.1073/pnas.78.10.6008; Summers D.K., 1996, BIOL PLASMIDS; Wagner EGH, 2002, ADV GENET, V46, P361; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Weaver KE, 2004, J BACTERIOL, V186, P6400, DOI 10.1128/JB.186.19.6400-6408.2004; Williams JJ, 2012, TRENDS MICROBIOL, V20, P291, DOI 10.1016/j.tim.2012.02.005	33	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0169703	10.1371/journal.pone.0169703	http://dx.doi.org/10.1371/journal.pone.0169703			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085919	Green Published, gold, Green Submitted			2022-12-26	WOS:000391972600034
J	Jabbari, R; Glinge, C; Jabbari, J; Risgaard, B; Winkel, BG; Terkelsen, CJ; Tilsted, HH; Jensen, LO; Hougaard, M; Haunso, S; Engstrom, T; Albert, CM; Tfelt-Hansen, J				Jabbari, Reza; Glinge, Charlotte; Jabbari, Javad; Risgaard, Bjarke; Winkel, Bo Gregers; Terkelsen, Christian Juhl; Tilsted, Hans-Henrik; Jensen, Lisette Okkels; Hougaard, Mikkel; Haunso, Stig; Engstrom, Thomas; Albert, Christine M.; Tfelt-Hansen, Jacob			A Common Variant in SCN5A and the Risk of Ventricular Fibrillation Caused by First ST-Segment Elevation Myocardial Infarction	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUDDEN CARDIAC DEATH; ADENOVIRUS RECEPTOR; GENES; COXSACKIE; DURATION; DISEASE; LOCUS; 21Q21	Background Several common genetic variants have been associated with either ventricular fibrillation (VF) or sudden cardiac death (SCD). However, replication efforts have been limited. Therefore, we aimed to analyze whether such variants may contribute to VF caused by first ST-elevation myocardial infarction (STEMI). Methods We analyzed 27 single nucleotide polymorphisms (SNP) previously associated with SCD/ VF in other cohorts, and examined whether these SNPs were associated with VF caused by first STEMI in the GEnetic causes of Ventricular Arrhythmias in patients with first ST-elevation Myocardial Infarction (GEVAMI) study on ethnical Danes. The GEVAMI study is a prospective case-control study involving 257 cases (STEMI with VF) and 537 controls (STEMI without VF). Results Of the 27 candidate SNPs, one SNP (rs11720524) located in intron 1 of SCN5A which was previously associated with SCD was significantly associated with VF caused by first STEMI. The major C-allele of rs11720524 was present in 64% of the cases and the C/C genotype was significantly associated with VF with an odds ratio (OR) of 1.87 (95% CI: 1.12-3.12; P = 0.017). After controlling for clinical differences between cases and controls such as age, sex, family history of sudden death, alcohol consumption, previous atrial fibrillation, statin use, angina, culprit artery, and thrombolysis in myocardial infarction (TIMI) flow, the C/C genotype of rs11720524 was still significantly associated with VF with an OR of 1.9 (95% CI: 1.05-3.43; P = 0.032). Marginal associations with VF were also found for rs9388451 in HEY2 gene. The CC genotype showed an insignificant risk for VF with OR = 1.50 (95% CI: 0.96-2.40; P = 0.070). Conclusion One common intronic variant in SCN5A suggested an association with VF caused by first STEMI. Further studies into the functional abnormalities associated with the noncoding variant in SCN5A may lead to important insights into predisposition to VF during STEMI.	[Jabbari, Reza; Glinge, Charlotte; Jabbari, Javad; Risgaard, Bjarke; Winkel, Bo Gregers; Haunso, Stig; Engstrom, Thomas; Tfelt-Hansen, Jacob] Rigshosp, Copenhagen Univ Hosp, Dept Cardiol, Ctr Heart, Copenhagen, Denmark; [Terkelsen, Christian Juhl] Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark; [Tilsted, Hans-Henrik] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Jensen, Lisette Okkels; Hougaard, Mikkel] Odense Univ Hosp, Dept Cardiol, Odense, Denmark; [Haunso, Stig] Rigshosp, Copenhagen Univ Hosp, Dept Cardiol, Mol Cardiol Lab, Copenhagen, Denmark; [Albert, Christine M.] Harvard Med Sch, Brigham & Womens Hosp, Ctr Arrhythmia Prevent, Div Prevent Med,Cardiovasc Div,Dept Med, Boston, MA USA	Rigshospitalet; University of Copenhagen; Aarhus University; Aalborg University; Aalborg University Hospital; University of Southern Denmark; Odense University Hospital; Rigshospitalet; University of Copenhagen; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Jabbari, R (corresponding author), Rigshosp, Copenhagen Univ Hosp, Dept Cardiol, Ctr Heart, Copenhagen, Denmark.	rezajabbari77@gmail.com	Glinge, Charlotte/C-4983-2018; Tfelt-Hansen, Jacob/AAU-8691-2020; terkelsen, christian/ABD-6294-2021; Jabbari, Reza/AAM-6649-2021; Winkel, Bo/AAZ-9190-2021	Glinge, Charlotte/0000-0003-0406-256X; Tfelt-Hansen, Jacob/0000-0003-3895-9316; Jabbari, Reza/0000-0002-9432-0632; terkelsen, christian juhl/0000-0003-0205-9551; Albert, Christine/0000-0002-2081-1121; Hougaard, Mikkel/0000-0001-5390-6912; Winkel, Bo Gregers/0000-0002-3063-4712; Jensen, Lisette Okkels/0000-0002-4838-2429	Novo Nordisk; Research Foundation of the Heart Centre at Rigshospitalet; Research Foundation of the University Hospital of Copenhagen, Rigshospitalet; Novo Nordisk Fonden [NNF14OC0011573, NNF13OC0007521] Funding Source: researchfish	Novo Nordisk(Novo Nordisk); Research Foundation of the Heart Centre at Rigshospitalet; Research Foundation of the University Hospital of Copenhagen, Rigshospitalet; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by research grants from the Novo Nordisk to Dr. Tfelt-Hansen, The Research Foundation of the Heart Centre at Rigshospitalet, and The Research Foundation of the University Hospital of Copenhagen, Rigshospitalet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CM, 2010, CIRC-ARRHYTHMIA ELEC, V3, P222, DOI 10.1161/CIRCEP.110.944934; Arking DE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002158; Arking DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009879; Aydin A, 2005, J MOL MED, V83, P159, DOI 10.1007/s00109-004-0595-3; Bezzina CR, 2013, NAT GENET, V45, P1044, DOI 10.1038/ng.2712; Bezzina CR, 2010, NAT GENET, V42, P688, DOI 10.1038/ng.623; Bugert P, 2011, CLIN CHEM LAB MED, V49, P1237, DOI 10.1515/CCLM.2011.190; Dekker LRC, 2006, CIRCULATION, V114, P1140, DOI 10.1161/CIRCULATIONAHA.105.606145; Deo R, 2012, CIRCULATION, V125, P620, DOI 10.1161/CIRCULATIONAHA.111.023838; deVreedeSwagemakers JJM, 1997, J AM COLL CARDIOL, V30, P1500, DOI 10.1016/S0735-1097(97)00355-0; Gavin MC, 2011, HEART RHYTHM, V8, P704, DOI 10.1016/j.hrthm.2011.01.003; GILLUM RF, 1989, CIRCULATION, V79, P756, DOI 10.1161/01.CIR.79.4.756; Gouas L, 2007, EUR J HUM GENET, V15, P974, DOI 10.1038/sj.ejhg.5201866; Huertas-Vazquez A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059905; Huertas-Vazquez A, 2013, HEART RHYTHM, V10, P994, DOI 10.1016/j.hrthm.2013.03.020; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Jabbari R., 2016, DAN MED J, V2016, P63; Jabbari R, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001399; Jabbari R, 2013, HEART, V99, P938, DOI 10.1136/heartjnl-2012-303534; JANSE MJ, 1989, PHYSIOL REV, V69, P1049, DOI 10.1152/physrev.1989.69.4.1049; Jouven X, 1999, CIRCULATION, V99, P1978, DOI 10.1161/01.CIR.99.15.1978; Kao WHL, 2009, CIRCULATION, V119, P940, DOI 10.1161/CIRCULATIONAHA.108.791723; Lahtinen AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041675; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Lemaitre RN, 2014, HEART RHYTHM, V11, P471, DOI 10.1016/j.hrthm.2014.01.008; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marcsa B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132137; Marsman RF, 2014, NAT REV CARDIOL, V11, P96, DOI 10.1038/nrcardio.2013.186; Marsman RFJ, 2014, J AM COLL CARDIOL, V63, P549, DOI 10.1016/j.jacc.2013.10.062; Newton-Cheh C, 2009, CIRCULATION, V120, P2062, DOI 10.1161/CIRCULATIONAHA.109.879049; Noutsias M, 2001, CIRCULATION, V104, P275; Pfeufer A, 2010, NAT GENET, V42, P153, DOI 10.1038/ng.517; Priori SG, 2013, HEART RHYTHM, V10, P1932, DOI 10.1016/j.hrthm.2013.05.014; Sotoodehnia N, 2006, CIRCULATION, V113, P1842, DOI 10.1161/CIRCULATIONAHA.105.582833; Sotoodehnia N, 2010, NAT GENET, V42, P1068, DOI 10.1038/ng.716; Tfelt-Hansen J, 2010, J CARDIOVASC ELECTR, V21, P107, DOI 10.1111/j.1540-8167.2009.01633.x; Westaway SK, 2011, CIRC-CARDIOVASC GENE, V4, P397, DOI 10.1161/CIRCGENETICS.111.959916; Wilde AAM, 2013, NAT REV CARDIOL, V10, P571, DOI 10.1038/nrcardio.2013.108	38	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0170193	10.1371/journal.pone.0170193	http://dx.doi.org/10.1371/journal.pone.0170193			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085969	Green Published, gold, Green Submitted			2022-12-26	WOS:000391972600074
J	Stenz, L; Escoffier, J; Rahban, R; Nef, S; Paoloni-Giacobino, A				Stenz, Ludwig; Escoffier, Jessica; Rahban, Rita; Nef, Serge; Paoloni-Giacobino, Ariane			Testicular Dysgenesis Syndrome and Long-Lasting Epigenetic Silencing of Mouse Sperm Genes Involved in the Reproductive System after Prenatal Exposure to DEHP	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ENDOCRINE DISRUPTORS; TRANSGENERATIONAL ACTIONS; HUMAN SPERMATOZOA; KNOCKOUT MICE; FACTOR-ALPHA; PPAR-GAMMA; IN-VITRO; EXPRESSION; RNA	The endocrine disruptor bis(2-ethylhexyl) phthalate (DEHP) has been shown to exert adverse effects on the male animal reproductive system. However, its mode of action is unclear and a systematic analysis of its molecular targets is needed. In the present study, we investigated the effects of prenatal exposure to 300 mg/kg/day DEHP during a critical period for gonads differentiation to testes on male mice offspring reproductive parameters, including the genome-wide RNA expression and associated promoter methylation status in the sperm of the first filial generation. It was observed that adult male offspring displayed symptoms similar to the human testicular dysgenesis syndrome. A combination of sperm transcriptome and methylome data analysis allowed to detect a long-lasting DEHP-induced and robust promoter methylation-associated silencing of almost the entire cluster of the seminal vesicle secretory proteins and antigen genes, which are known to play a fundamental role in sperm physiology. It also resulted in the detection of a DEHP-induced promoter demethylation associated with an up-regulation of three genes apparently not relevant for sperm physiology and partially related to the immune system. As previously reported, DEHP induced an increase in mir-615 microRNA expression and a genome-wide decrease in microRNA promoter methylation. A functional analysis revealed DEHPinduced enrichments in down-regulated gene transcripts coding for peroxisome proliferator-activated receptors and tumor necrosis factor signaling pathways, and in up-regulated gene transcripts coding for calcium binding and numerous myosin proteins. All these enriched pathways and networks have been described to be associated in some way with the reproductive system. This study identifies a large new array of genes dysregulated by DEHP that may play a role in the complex system controlling the development of the male reproductive system.	[Stenz, Ludwig; Escoffier, Jessica; Rahban, Rita; Nef, Serge; Paoloni-Giacobino, Ariane] Univ Geneva, Fac Med, Dept Genet Med & Dev, Geneva, Switzerland; [Stenz, Ludwig; Escoffier, Jessica; Rahban, Rita; Nef, Serge; Paoloni-Giacobino, Ariane] Swiss Ctr Appl Human Toxicol, Basel, Switzerland	University of Geneva	Stenz, L (corresponding author), Univ Geneva, Fac Med, Dept Genet Med & Dev, Geneva, Switzerland.; Stenz, L (corresponding author), Swiss Ctr Appl Human Toxicol, Basel, Switzerland.	Ludwig.stenz@unige.ch	Nef, Serge/AAV-6445-2020; Stenz, L/N-7605-2017; Giacobino, Ariane/AHC-7144-2022; Escoffier, jessica/T-9857-2019; Escoffier, jessica/E-9498-2017	Nef, Serge/0000-0001-5462-0676; Stenz, L/0000-0002-2339-9451; Escoffier, jessica/0000-0001-8166-5845; Rahban, Rita/0000-0002-4694-8994; Giacobino, Ariane/0000-0001-9432-1785	Swiss Center for Applied Human Toxicology (SCANT); Swiss Centre for Applied Human Toxicology	Swiss Center for Applied Human Toxicology (SCANT); Swiss Centre for Applied Human Toxicology	The grant of this project initially called "Impact of prenatal exposure to di-(2-ethylhexyl) phthalate on epigenetically dysregulated RNA in mice sperm associated with fertility decrease was successfully granted the 7th September 2015 by the Swiss Center for Applied Human Toxicology (SCANT, http://www.scaht.org/).; We thank the Geneva Animal Core Facility and the Fasteris SA company for their collaboration in this study. This work was funded by a grant from the Swiss Centre for Applied Human Toxicology.	Anway MD, 2006, ENDOCRINOLOGY, V147, pS43, DOI 10.1210/en.2005-1058; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Aquila S, 2006, J CELL PHYSIOL, V209, P977, DOI 10.1002/jcp.20807; Araki N, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.120642; Brennan J, 2004, NAT REV GENET, V5, P509, DOI 10.1038/nrg1381; Chalmel F, 2007, P NATL ACAD SCI USA, V104, P8346, DOI 10.1073/pnas.0701883104; Chen SS, 2013, J TOXICOL SCI, V38, P783; de Lamirande E, 2007, SEMIN THROMB HEMOST, V33, P60, DOI 10.1055/s-2006-958463; Desdoits-Lethimonier C, 2012, HUM REPROD, V27, P1451, DOI 10.1093/humrep/des069; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; EISERMANN J, 1989, J ANDROL, V10, P270; Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273; Georgiadis AP, 2015, J UROLOGY, V193, P352, DOI 10.1016/j.juro.2014.07.107; Grunewald S, 2005, ANDROLOGIA, V37, P69, DOI 10.1111/j.1439-0272.2005.00656.x; Guibert E, 2013, ENVIRON SCI POLLUT R, V20, P2771, DOI 10.1007/s11356-013-1487-2; Hong CY, 2003, MOL CELL BIOL, V23, P6000, DOI 10.1128/MCB.23.17.6000-6012.2003; HONG CY, 1984, LANCET, V2, P1449; Hong GN, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0950; Hu GX, 2009, TRENDS ENDOCRIN MET, V20, P139, DOI 10.1016/j.tem.2008.12.001; Huang X, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0052-8; Johnson GD, 2011, MOL HUM REPROD, V17, P721, DOI 10.1093/molehr/gar054; Kadivar A, 2016, VET RES FORUM, V7, P27; Kambia N, 2008, J ENZYM INHIB MED CH, V23, P611, DOI [10.1080/14756360802205059, 10.1080/14756360802205059 ]; Kawano N, 2014, P NATL ACAD SCI USA, V111, P4145, DOI 10.1073/pnas.1320715111; Koscielny G, 2014, NUCLEIC ACIDS RES, V42, pD802, DOI 10.1093/nar/gkt977; Larsen L, 2000, HUM REPROD, V15, P1562, DOI 10.1093/humrep/15.7.1562; Li YR, 2016, GENE, V576, P195, DOI 10.1016/j.gene.2015.10.022; Liu WM, 2012, P NATL ACAD SCI USA, V109, P490, DOI 10.1073/pnas.1110368109; Lu KY, 2004, TOXICOLOGY, V200, P113, DOI 10.1016/j.tox.2004.03.018; Lu SH, 2010, J CELL BIOCHEM, V111, P1188, DOI 10.1002/jcb.22844; McKee CM, 2006, APOPTOSIS, V11, P2237, DOI 10.1007/s10495-006-0288-1; Mendiola J, 2011, INT J ANDROL, V34, P369, DOI 10.1111/j.1365-2605.2010.01095.x; Metafora V, 2008, FEBS J, V275, P3870, DOI 10.1111/j.1742-4658.2008.06534.x; Morel L, 2001, J ANDROL, V22, P549; Muczynski V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048266; Ostermeier GC, 2004, NATURE, V429, P154, DOI 10.1038/429154a; Peng HY, 2012, CELL RES, V22, P1609, DOI 10.1038/cr.2012.141; Perera F, 2011, REPROD TOXICOL, V31, P363, DOI 10.1016/j.reprotox.2010.12.055; Pittoggi C, 2001, MOL REPROD DEV, V60, P97, DOI 10.1002/mrd.1066; Prados J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132136; Puchner R, 2012, CLIN EXP RHEUMATOL, V30, P765; Quah S, 2015, EVODEVO, V6, DOI 10.1186/s13227-015-0027-1; Santoro M, 2013, J EXP BIOL, V216, P1085, DOI 10.1242/jeb.079327; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Sheikh IA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151444; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; Skinner MK, 2007, PEDIATR RES, V61, p48R, DOI 10.1203/pdr.0b013e3180457671; Skinner MK, 2016, NAT REV ENDOCRINOL, V12, P68, DOI 10.1038/nrendo.2015.206; Suh JH, 2008, J STEROID BIOCHEM, V112, P117, DOI 10.1016/j.jsbmb.2008.09.003; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Takano N, 2004, BIOL REPROD, V71, P1785, DOI 10.1095/biolreprod.104.030452; Thankamony A., 2016, ANDROLOGY; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Ward JM, 1998, TOXICOL PATHOL, V26, P240, DOI 10.1177/019262339802600208; Yuan SQ, 2016, DEVELOPMENT, V143, P635, DOI 10.1242/dev.131755	55	37	40	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0170441	10.1371/journal.pone.0170441	http://dx.doi.org/10.1371/journal.pone.0170441			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085963	gold, Green Published, Green Submitted			2022-12-26	WOS:000391972600084
J	Ullberg, M; Luthje, P; Molling, P; Stralin, K; Ozenci, V				Ullberg, Mans; Luthje, Petra; Molling, Paula; Stralin, Kristoffer; Ozenci, Volkan			Broad-Range Detection of Microorganisms Directly from Bronchoalveolar Lavage Specimens by PCR/Electrospray Ionization-Mass Spectrometry	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; RESISTANT STAPHYLOCOCCUS-AUREUS; CRITICALLY-ILL; IDENTIFICATION; MANAGEMENT; INFECTION; ACCURACY; BACTERIA; ETIOLOGY; IMPACT	The clinical demand on rapid microbiological diagnostic is constantly increasing. PCR coupled to electrospray ionization-mass spectrometry, PCR/ESI-MS, offers detection and identification of over 750 bacteria and Candida species directly from clinical specimens within 6 hours. In this study, we investigated the clinical performance of the IRIDICA BAC LRT Assay for detection of bacterial pathogens in 121 bronchoalveolar lavage (BAL) samples that were received consecutively at our bacterial laboratory for BAL culture. Commensal or pathogenic microorganisms were detected in 118/121 (98%) BAL samples by PCR/ESIMS, while in 104/121 (86%) samples by routine culture (P<0.01). Detection of potentially pathogenic microorganisms by PCR/ESI-MS was evaluated in comparison with conventional culture-based or molecular methods. The agreement between positive findings was overall good. Most Staphylococcus aureus-positive PCR/ESI-MS results were confirmed by culture or species-specific PCR (27/33, 82%). The identity of Streptococcus pneumoniae could however be confirmed for only 6/17 (35%) PCR/ESI-MS-positive samples. Non-cultivable and fastidious pathogens, which were not covered by standard culture procedures were readily detected by PCR/ESI-MS, including Legionella pneumophila, Bordetella pertussis, Norcadia species and Mycoplasma pneumoniae. In conclusion, PCR/ESI-MS detected a broad range of potential pathogens with equal or superior sensitivity compared to conventional methods within few hours directly from BAL samples. This novel method might thus provide a relevant tool for diagnostics in critically ill patients.	[Ullberg, Mans; Luthje, Petra; Ozenci, Volkan] Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden; [Ullberg, Mans; Luthje, Petra; Ozenci, Volkan] Karolinska Inst, Div Clin Microbiol, Dept Lab Med, Stockholm, Sweden; [Molling, Paula] Univ Orebro, Fac Med & Hlth, Dept Lab Med, Orebro, Sweden; [Stralin, Kristoffer] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Stralin, Kristoffer] Karolinska Inst, Dept Med Huddinge, Infect Dis Unit, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Orebro University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Ozenci, V (corresponding author), Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden.; Ozenci, V (corresponding author), Karolinska Inst, Div Clin Microbiol, Dept Lab Med, Stockholm, Sweden.	volkan.ozenci@karolinska.se	Özenci, Volkan/H-3116-2019	Özenci, Volkan/0000-0002-8069-4027				Arbique JC, 2004, J CLIN MICROBIOL, V42, P4686, DOI 10.1128/JCM.42.10.4686-4696.2004; Arnold FW, 2013, RESP MED, V107, P1101, DOI 10.1016/j.rmed.2013.04.003; Baudel JL, 2014, ANN INTENSIVE CARE, V4, DOI 10.1186/s13613-014-0035-7; Berglund C, 2005, CLIN MICROBIOL INFEC, V11, P447, DOI 10.1111/j.1469-0691.2005.01150.x; Brown JS, 2009, RESPIROLOGY, V14, P1068, DOI 10.1111/j.1440-1843.2009.01641.x; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Cilloniz C, 2012, EUR RESPIR J, V40, P931, DOI 10.1183/09031936.00168811; Gadsby NJ, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.05.004; Hedberg ST, 2009, APMIS, V117, P856, DOI 10.1111/j.1600-0463.2009.02539.x; Huttner A, 2014, CLIN MICROBIOL INFEC, V20, pO1059, DOI 10.1111/1469-0691.12749; Jeng K, 2013, J CLIN MICROBIOL, V51, P3300, DOI 10.1128/JCM.01443-13; Johnson AP, 2011, J ANTIMICROB CHEMOTH, V66, pIV43, DOI 10.1093/jac/dkr076; Jones RN, 2010, CLIN INFECT DIS, V51, pS81, DOI 10.1086/653053; Jordana-Lluch E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/501214; Kottmann RM, 2011, THORAX, V66, P823, DOI 10.1136/thx.2010.145540; Kunze N, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0091-3; Laupland KB, 2013, CLIN MICROBIOL INFEC, V19, P465, DOI 10.1111/j.1469-0691.2012.03903.x; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Nilsson P, 2006, J CLIN MICROBIOL, V44, P3334, DOI 10.1128/JCM.00880-06; Nurjadi D, 2012, J INFECTION, V65, P310, DOI 10.1016/j.jinf.2012.05.011; Prina E, 2015, LANCET, V386, P1097, DOI 10.1016/S0140-6736(15)60733-4; Souweine B, 1998, CRIT CARE MED, V26, P236, DOI 10.1097/00003246-199802000-00017; Stralin K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159694; Torres A, 2009, INTENS CARE MED, V35, P9, DOI 10.1007/s00134-008-1336-9; Vincent JL, 2015, CRIT CARE MED, V43, P2283, DOI 10.1097/CCM.0000000000001249; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502	26	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0170033	10.1371/journal.pone.0170033	http://dx.doi.org/10.1371/journal.pone.0170033			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085931	Green Published, Green Submitted, gold			2022-12-26	WOS:000391972600054
J	Yang, JCS; Chen, HC; Lai, YS; Cheng, CK				Yang, Jesse Chieh-Szu; Chen, Hsin-Chang; Lai, Yu-Shu; Cheng, Cheng-Kung			Measurement of Tip Apex Distance and Migration of Lag Screws and Novel Blade Screw Used for the Fixation of Intertrochanteric Fractures	PLOS ONE			English	Article							DYNAMIC HIP SCREW; CEMENT AUGMENTATION; GAMMA-NAIL; CUTOUT; RESISTANCE; FAILURE; PLATE	Fixation with a dynamic hip screw (DHS) is one of the most common methods for stabilizing intertrochanteric fractures, except for unstable and reverse oblique fracture types. However, failure is often observed in osteoporotic patients whereby the lag screw effectively 'cuts out' through the weak bone. Novel anti-migration blades have been developed to be used in combination with a lag screw ('Blade Screw') to improve the fixation strength in osteoporotic intertrochanteric fractures. An in-vitro biomechanical study and a retrospective clinical study were performed to evaluate lag screw migration when using the novel Blade Screw and a traditional threaded DHS. The biomechanical study showed both the Blade Screw and DHS displayed excessive migration (>= 10 mm) before reaching 20,000 loading cycles in mild osteoporotic bone, but overall migration of the Blade Screw was significantly less (p <= 0.03). Among the patients implanted with a Blade Screw in the clinical study, there was no significant variation in screw migration at 3-months follow-up (P = 0.12). However, the patient's implanted with a DHS did display significantly greater migration (P<0.001) than those implanted with the Blade Screw. In conclusion, the Blade Screw stabilizes the bone fragments during dynamic loading so as to provide significantly greater resistance to screw migration in patients with mild osteoporosis.	[Yang, Jesse Chieh-Szu] Taipei Vet Gen Hosp, Dept Orthopaed, Div Joint Reconstruct, Taipei, Taiwan; [Chen, Hsin-Chang; Cheng, Cheng-Kung] Natl Yang Ming Univ, Dept Biomed Engn, Taipei, Taiwan; [Chen, Hsin-Chang] Taipei City Hosp, Dept Orthopaed, Taipei, Taiwan; [Lai, Yu-Shu] Natl Yang Ming Univ, Orthopaed Device Res Ctr, Taipei, Taiwan; [Lai, Yu-Shu] Natl Yang Ming Univ, Orthopaed Device Res Ctr, Taipei, Taiwan; [Cheng, Cheng-Kung] Natl Yang Ming Univ, Dept Biomed Engn, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei City Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Cheng, CK (corresponding author), Natl Yang Ming Univ, Dept Biomed Engn, Taipei, Taiwan.; Lai, YS (corresponding author), Natl Yang Ming Univ, Orthopaed Device Res Ctr, Taipei, Taiwan.; Lai, YS (corresponding author), Natl Yang Ming Univ, Orthopaed Device Res Ctr, Taipei, Taiwan.; Cheng, CK (corresponding author), Natl Yang Ming Univ, Dept Biomed Engn, Taipei, Taiwan.	yslai@ym.edu.tw; ckcheng@ym.edu.tw		Lai, Yu-Shu/0000-0002-6288-1697				Adams CI, 2001, J ORTHOP TRAUMA, V15, P394, DOI 10.1097/00005131-200108000-00003; BRIDLE SH, 1991, J BONE JOINT SURG BR, V73, P330, DOI 10.1302/0301-620X.73B2.2005167; Brown Douglas, TRACKER VIDEO ANAL M; CHENG CL, 1989, INJURY, V20, P134, DOI 10.1016/0020-1383(89)90082-X; Chua YP, 2011, MALAYS ORTHOP J, V5, P24, DOI 10.5704/MOJ.1107.006; COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; Ehmke LW, 2005, J ORTHOP RES, V23, P1329, DOI 10.1016/j.orthres.2005.05.002; Geller JA, 2010, INT ORTHOP, V34, P719, DOI 10.1007/s00264-009-0837-7; Gibson D, 2011, BOA IOA COMB M DUBL; Hsueh KK, 2010, INT ORTHOP, V34, P1273, DOI 10.1007/s00264-009-0866-2; Kim WY, 2001, INT ORTHOP, V25, P360, DOI 10.1007/s002640100287; Kouvidis George K, 2009, J Orthop Surg Res, V4, P16, DOI 10.1186/1749-799X-4-16; LARSSON S, 1990, CLIN ORTHOP RELAT R, P130; Lee PC, 2010, J TRAUMA, V68, P954, DOI 10.1097/TA.0b013e3181c995ec; Lobo-Escolar A, 2010, INJURY, V41, P1312, DOI 10.1016/j.injury.2010.08.009; Luo Q, 2013, SCI WORLD J, DOI 10.1155/2013/351936; Madsen JE, 1998, J ORTHOP TRAUMA, V12, P241, DOI 10.1097/00005131-199805000-00005; Mohan NS, 2014, IOSR JDMS, V13, P54; O'Neill F, 2011, J BONE JOINT SURG BR, V93B, P616, DOI 10.1302/0301-620X.93B5.25539; Ozkayin N, 2010, J BONE JOINT SU B S4, V92-B, P555; Pervez H, 2004, INJURY, V35, P994, DOI 10.1016/j.injury.2003.10.028; Sommers MB, 2004, J ORTHOP TRAUMA, V18, P361, DOI 10.1097/00005131-200407000-00006; Szpalski M, 2004, J ORTHOP TRAUMA, V18, P34, DOI 10.1097/00005131-200401000-00007; Wu Meng-Huang, 2012, Chang Gung Med J, V35, P345	24	1	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0170048	10.1371/journal.pone.0170048	http://dx.doi.org/10.1371/journal.pone.0170048			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085930	Green Published, gold, Green Submitted			2022-12-26	WOS:000391972600055
J	Bin Gwag, H; Park, TK; Song, YB; Kim, EK; Jang, WJ; Yang, JH; Hahn, JY; Choi, SH; Choi, JH; Lee, SH; Choe, YH; Ahn, J; Carriere, KC; Gwon, HC				Bin Gwag, Hye; Park, Taek Kyu; Song, Young Bin; Kim, Eun Kyoung; Jang, Woo Jin; Yang, Jeong Hoon; Hahn, Joo-Yong; Choi, Seung-Hyuk; Choi, Jin-Ho; Lee, Sang Hoon; Choe, Yeon Hyeon; Ahn, Joonghyun; Carriere, Keumhee Chough; Gwon, Hyeon-Cheol			Morphine Does Not Affect Myocardial Salvage in ST-Segment Elevation Myocardial Infarction	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; MAGNETIC-RESONANCE; CLINICAL-OUTCOMES; DOUBLE-BLIND; CLOPIDOGREL; IMPACT; ASSOCIATION; REPERFUSION	Recent studies have proposed intravenous (IV) morphine is associated with delayed action of antiplatelet agents in acute myocardial infarction. However, it is unknown whether morphine results in increased myocardial damage in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI). We investigated myocardial salvage index (MSI) to determine whether IV morphine affects myocardial injury adversely in STEMI patients undergoing primary PCI. 299 STEMI patients underwent contrast-enhanced magnetic resonance imaging a median of 3 days after PCI. Infarct size was measured on delayed-enhancement imaging, and area at risk was quantified on T2-weighted imaging. MSI was calculated as [area at risk infarct size] X 100 / area at risk'. IV morphine was administrated in 32.1% of patients. Patients treated with morphine had shorter symptom to balloon time and higher prevalence of Thrombolysis in Myocardial Infarction flow grade 0 or 1. The morphine group showed a trend toward larger MSI and infarct size and significantly greater area at risk than the non-morphine group. After propensity score matching (90 pairs), MSI was similar between the morphine and non-morphine group (46.1% versus 43.5%, P=.11), and infarct size and area at risk showed no difference. In propensity score-matched analysis, IV morphine prior to primary PCI in STEMI patients did not cause adverse impacts on myocardial salvage.	[Bin Gwag, Hye; Park, Taek Kyu; Song, Young Bin; Kim, Eun Kyoung; Yang, Jeong Hoon; Hahn, Joo-Yong; Choi, Seung-Hyuk; Choi, Jin-Ho; Lee, Sang Hoon; Gwon, Hyeon-Cheol] Sungkyunkwan Univ, Heart Vasc Stroke Inst, Div Cardiol, Samsung Med Ctr,Sch Med,Dept Internal Med, Seoul, South Korea; [Jang, Woo Jin] Sungkyunkwan Univ, Samsung Changwon Hosp, Div Cardiol, Dept Internal Med,Sch Med, Chang Won, South Korea; [Choe, Yeon Hyeon] Sungkyunkwan Univ, Dept Radiol, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Ahn, Joonghyun; Carriere, Keumhee Chough] Samsung Med Ctr, Dept Biostat & Clin Epidemiol, Seoul, South Korea; [Carriere, Keumhee Chough] Univ Alberta, Dept Math & Stat Sci, Edmonton, AB, Canada	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Alberta	Song, YB (corresponding author), Sungkyunkwan Univ, Heart Vasc Stroke Inst, Div Cardiol, Samsung Med Ctr,Sch Med,Dept Internal Med, Seoul, South Korea.	youngbin.song@gmail.com	Hahn, Joo-Yong/AAU-7250-2020; Choe, Yeon Hyeon/F-1422-2010	Hahn, Joo-Yong/0000-0002-4412-377X; Choe, Yeon Hyeon/0000-0002-9983-048X				Ahn KT, 2013, INT J CARDIOVAS IMAG, V29, P835, DOI 10.1007/s10554-012-0155-9; Cuisset T, 2006, J AM COLL CARDIOL, V48, P1339, DOI 10.1016/j.jacc.2006.06.049; Dall'Armellina E, 2010, NAT REV CARDIOL, V7, P624, DOI 10.1038/nrcardio.2010.140; de Waha S, 2015, CLIN RES CARDIOL, V104, P727, DOI 10.1007/s00392-015-0835-2; Eitel I, 2010, J AM COLL CARDIOL, V55, P2470, DOI 10.1016/j.jacc.2010.01.049; Ganame J, 2009, EUR HEART J, V30, P1440, DOI 10.1093/eurheartj/ehp093; Gerson Lauren B, 2013, Curr Gastroenterol Rep, V15, P329, DOI 10.1007/s11894-013-0329-1; Hobl EL, 2016, CLIN RES CARDIOL, V105, P349, DOI 10.1007/s00392-015-0927-z; Hobl EL, 2014, J AM COLL CARDIOL, V63, P630, DOI 10.1016/j.jacc.2013.10.068; Iakobishvili Zaza, 2011, Acute Card Care, V13, P76, DOI 10.3109/17482941.2011.575165; Ichikawa Y, 2005, J AM COLL CARDIOL, V45, P901, DOI 10.1016/j.jacc.2004.11.058; Janik M, 2008, J HYPERTENS, V26, P1677, DOI 10.1097/HJH.0b013e328302ca14; Kim EK, 2015, INT J CARDIOVAS IMAG, V31, P629, DOI 10.1007/s10554-015-0589-y; Kubica J, 2016, EUR HEART J, V37, P245, DOI 10.1093/eurheartj/ehv547; Meine TJ, 2005, AM HEART J, V149, P1043, DOI 10.1016/j.ahj.2005.02.010; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Parodi G, 2015, CIRC-CARDIOVASC INTE, P8; Puymirat E, 2016, EUR HEART J, V37, P1063, DOI 10.1093/eurheartj/ehv567; ROUBY JJ, 1981, CIRCULATION, V64, P53, DOI 10.1161/01.CIR.64.1.53; Silvain J, 2016, THROMB HAEMOSTASIS, V116, P369, DOI 10.1160/TH15-12-0944; Song YB, 2012, AM HEART J, V163, P500, DOI 10.1016/j.ahj.2011.12.007; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; van't Hof AWJ, 1998, CIRCULATION, V97, P2302, DOI 10.1161/01.CIR.97.23.2302	23	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0170115	10.1371/journal.pone.0170115	http://dx.doi.org/10.1371/journal.pone.0170115			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081269	Green Published, Green Submitted, gold			2022-12-26	WOS:000391949500132
J	Chen, YL; Cui, J; Tian, XH; Zhao, AQ; Li, M; Wang, SX; Li, XS; Jia, Z; Liu, K				Chen, Yanlong; Cui, Juan; Tian, Xiaohong; Zhao, Aiqing; Li, Meng; Wang, Shaoxia; Li, Xiushaung; Jia, Zhou; Liu, Ke			Effect of Straw Amendment on Soil Zn Availability and Ageing of Exogenous Water-Soluble Zn Applied to Calcareous Soil	PLOS ONE			English	Article							HEAVY-METALS; CHEMICAL-PROPERTIES; ZINC FERTILIZATION; MICROBIAL BIOMASS; INORGANIC CARBON; AMENDED SOIL; DIFFUSION; ACID; BIOFORTIFICATION; BIOAVAILABILITY	Organic matter plays a key role in availability and transformation of soil Zn (zinc), which greatly controls Zn concentrations in cereal grains and human Zn nutrition level. Accordingly, soils homogenized with the wheat straw (0, 12 g straw kg(-1)) and Zn fertilizer (0, 7 mg Zn kg(-1)) were buried and incubated in the field over 210 days to explore the response of soil Zn availability and the ageing of exogenous Zn to straw addition. Results indicated that adding straw alone scarcely affected soil DTPA-Zn concentration and Zn fractions because of the low Zn concentration of wheat straw and the high soil pH, and large clay and calcium carbonate contents. However, adding exogenous Zn plus straw increased the DTPA-Zn abundance by about 5-fold and had the similar results to adding exogenous Zn alone, corresponding to the increased Zn fraction loosely bounded to organic matter, which had a more dominant presence in Zn reaction than soil other constituents such as carbonate and minerals in calcareous soil. The higher relative amount of ineffective Zn (similar to 50%) after water soluble Zn addition also occurred, and at the days of 120-165 and 180-210 when the natural temperature and rainfall changed mildly, the ageing process of exogenous Zn over time was well evaluated by the diffusion equation, respectively. Consequently, combining crop residues with exogenous water soluble Zn application is promising strategy to maximize the availability of Zn in calcareous soil, but the higher ageing rate of Zn caused by the higher Zn mobility should be considered.	[Chen, Yanlong; Cui, Juan; Tian, Xiaohong; Zhao, Aiqing; Li, Meng; Wang, Shaoxia; Li, Xiushaung; Jia, Zhou; Liu, Ke] Northwest A&F Univ, Coll Nat Resources & Environm, Key Lab Plant Nutr & Agrienvironm Northwest China, Minist Agr, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Tian, XH (corresponding author), Northwest A&F Univ, Coll Nat Resources & Environm, Key Lab Plant Nutr & Agrienvironm Northwest China, Minist Agr, Yangling, Shaanxi, Peoples R China.	txhong@hotmail.com	Chen, Yanlong/U-1885-2019	Chen, Yanlong/0000-0001-8657-5590	National Natural Sciences Foundation of China [41371288, 31662233]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financed by the National Natural Sciences Foundation of China (41371288, 31662233). Their recipient was Prof. Tian Xiaohong, who gave us some important suggestion about the conception, design, and perforation of the experiment, and the writing of the manuscript.	ADAM AI, 1983, PLANT SOIL, V72, P77, DOI 10.1007/BF02185096; Aghili F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101487; Alloway BJ, 2009, ENVIRON GEOCHEM HLTH, V31, P537, DOI 10.1007/s10653-009-9255-4; [Anonymous], 2006, KEYS SOIL TAXONOMY; Baldwin KR, 1999, BIORESOURCE TECHNOL, V69, P1, DOI 10.1016/S0960-8524(98)00174-6; BLAIR GJ, 1995, AUST J AGR RES, V46, P1459, DOI 10.1071/AR9951459; Cakmak I, 2008, PLANT SOIL, V302, P1, DOI 10.1007/s11104-007-9466-3; Chami ZA, 2013, ENVIRON SCI POLLUT R, V20, P4766, DOI [10.1007/s11356-012-1439-2, DOI 10.1007/S11356-012-1439-2]; CHAND M, 1980, PLANT SOIL, V55, P17, DOI 10.1007/BF02149704; Crank J., 1975, MATH DIFFUSION; Degryse F, 2008, PLANT SOIL, V306, P69, DOI 10.1007/s11104-007-9449-4; Degryse F, 2012, PLANT PHYSIOL, V160, P1097, DOI 10.1104/pp.112.202200; Donisa C, 2003, GEODERMA, V111, P75, DOI 10.1016/S0016-7061(02)00254-9; ELLIS ROSCOE Jr., 1964, SOIL SCI SOC AMER PROC, V28, P83; FAO, 1998, WORLD REF BAS SOILRE; Fuente C, 2011, Journal of Hazardous Materials, V186, P1283; Guo Z, 2013, PLANT SOIL ENVIRON, V59, P524, DOI 10.17221/489/2013-PSE; Habiby H, 2014, BIOL FERT SOILS, V50, P1061, DOI 10.1007/s00374-014-0926-7; Jalali M, 2008, GEODERMA, V143, P26, DOI 10.1016/j.geoderma.2007.10.002; Khan KS, 2009, SOIL BIOL BIOCHEM, V41, P309, DOI 10.1016/j.soilbio.2008.11.001; LEITA L, 1995, BIOL FERT SOILS, V19, P103, DOI 10.1007/BF00336144; Lu XC, 2012, AGRON J, V104, P963, DOI 10.2134/agronj2011.0417; LYLES L, 1970, SOIL SCI, V109, P207, DOI 10.1097/00010694-197003000-00011; Ma YB, 2006, NUTR CYCL AGROECOSYS, V76, P11, DOI 10.1007/s10705-006-9036-8; Ma YB, 1997, GEODERMA, V75, P89, DOI 10.1016/S0016-7061(96)00080-8; MODAIHSH AS, 1990, FERT RES, V25, P85, DOI 10.1007/BF01095087; Montalvo D, 2016, ADV AGRON, V139, P215, DOI 10.1016/bs.agron.2016.05.004; Perez-Esteban J, 2012, EUR J SOIL SCI, V63, P733, DOI 10.1111/j.1365-2389.2012.01468.x; SAHRAWAT KL, 1982, PLANT SOIL, V69, P73, DOI 10.1007/BF02185705; SINHA MK, 1977, PLANT SOIL, V48, P599, DOI 10.1007/BF00145770; Smith SR, 2009, ENVIRON INT, V35, P142, DOI 10.1016/j.envint.2008.06.009; SNYDER JD, 1984, COMMUN SOIL SCI PLAN, V15, P587, DOI 10.1080/00103628409367499; Tan WF, 2014, CATENA, V121, P22, DOI 10.1016/j.catena.2014.04.014; Tella M, 2016, ENVIRON POLLUT, V212, P299, DOI 10.1016/j.envpol.2016.01.077; Uygur V, 2000, EUR J SOIL SCI, V51, P511, DOI 10.1046/j.1365-2389.2000.00318.x; [王洋 WANG Yang], 2007, [地理与地理信息科学, Geography and Geo-information Science], V23, P91; Wei XR, 2006, SOIL TILL RES, V91, P120, DOI 10.1016/j.still.2005.11.009; Zhou GX, 2016, PEDOSPHERE, V26, P386, DOI 10.1016/S1002-0160(15)60051-0; Zou CQ, 2012, PLANT SOIL, V361, P119, DOI 10.1007/s11104-012-1369-2	39	13	16	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169776	10.1371/journal.pone.0169776	http://dx.doi.org/10.1371/journal.pone.0169776			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081179	Green Published, gold, Green Submitted			2022-12-26	WOS:000391949500075
J	Mu, XY; Zhao, LC; Zhang, ZX				Mu, Xian-Yun; Zhao, Liang-Cheng; Zhang, Zhi-Xiang			Molecular Analysis of Chinese Celastrus and Tripterygium and Implications in Medicinal and Pharmacological Studies	PLOS ONE			English	Article							PHYLOGENETIC UTILITY; ORBICULATUS; AMPLIFICATION; CONSTITUENTS; REGIONS; TESTS; CELLS; DNA	Celastrus and Tripterygium species, which are used in traditional Chinese medicine, have attracted much attention due to their anti-tumor promoting and neuroprotective activities, in addition to their applications in autoimmune disorders. However, systematic relationships between them and among species are unclear, and it may disturb their further medicinal utilization. In the present study, the molecular analysis of combined chloroplast and nuclear markers of all Chinese Celastrus and Tripterygium was performed, and clear inter-and intra-genus relationships were presented. The result suggests that Tripterygium constitute a natural monophyletic clade within Celastrus with strong support value. Fruit and seed type are better than inflorescence in subgeneric classification. Chinese Celastrus are classified for three sections: Sect. Sempervirentes (Maxim.) CY Cheng & TC Kao, Sect. Lunatus XY Mu & ZX Zhang, sect. nov., and Sect. Ellipticus XY Mu & ZX Zhang, sect. nov. The phylogenetic data was consistent with their chemical components reported previously. Owing to the close relationship, several evergreen Celastrus species are recommended for chemical and pharmacological studies. Our results also provide reference for molecular identification of Chinese Celastrus and Tripterygium.	[Mu, Xian-Yun; Zhao, Liang-Cheng; Zhang, Zhi-Xiang] Beijing Forestry Univ, Lab Systemat Evolut & Biogeog Woody Plants, Coll Nat Conservat, Beijing, Peoples R China	Beijing Forestry University	Mu, XY; Zhang, ZX (corresponding author), Beijing Forestry Univ, Lab Systemat Evolut & Biogeog Woody Plants, Coll Nat Conservat, Beijing, Peoples R China.	xymu85@bjfu.edu.cn; zxzhang@bjfu.edu.cn		Mu, Xian-Yun/0000-0001-5434-3875	Natural Science Foundation of China [31400193, J1310002]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work received financial support from the Natural Science Foundation of China (31400193 and J1310002 to XYM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, SE AL SEQUENCE ALIGN; Antonoff MB, 2009, SURGERY, V146, P282, DOI 10.1016/j.surg.2009.04.023; Ao Y, 2012, ANN BOT FENN, V49, P267, DOI 10.5735/085.049.0409; BALANDRIN MF, 1985, SCIENCE, V228, P1154, DOI 10.1126/science.3890182; Baldwin BG, 1998, MOL PHYLOGENET EVOL, V10, P449, DOI 10.1006/mpev.1998.0545; Brinker AM, 2007, PHYTOCHEMISTRY, V68, P732, DOI 10.1016/j.phytochem.2006.11.029; Cheng JR, 1999, FLORA REIPUBLICAE 3, V45, P96; Cunningham CW, 1997, MOL BIOL EVOL, V14, P733, DOI 10.1093/oxfordjournals.molbev.a025813; Di WZ, 1978, J NW U CHINA, V1, P81; Farris J.S., 1994, NEW SPECIES SYNDROME, V10, P315, DOI DOI 10.1111/J.1096-0031.1994.TB00181.X; Hamilton MB, 1999, MOL ECOL, V8, P521; Hu XQ, 2014, PHYTOCHEM LETT, V7, P169, DOI 10.1016/j.phytol.2013.11.015; Kelchner SA, 1997, MOL PHYLOGENET EVOL, V8, P385, DOI 10.1006/mpev.1997.0432; Law SKY, 2011, PHYTOCHEMISTRY, V72, P21, DOI 10.1016/j.phytochem.2010.10.015; Li XJY, 2014, J ETHNOPHARMACOL, V155, P67, DOI 10.1016/j.jep.2014.06.006; [刘惠玲 Liu Huiling], 2010, [中成药, Chinese Traditional Patent Medicine], V32, P1169; Liu JL, 2015, CELL, V161, P999, DOI 10.1016/j.cell.2015.05.011; Lledo MD, 1998, SYST BOT, V23, P21, DOI 10.2307/2419571; Luo YG, 2014, J NAT PROD, V77, P1650, DOI 10.1021/np500280x; Mu XY, 2012, J PLANT RES, V125, P619, DOI 10.1007/s10265-012-0484-8; Mu XY, 2012, NORD J BOT, V30, P53, DOI 10.1111/j.1756-1051.2011.01231.x; Mu XY, 2012, THESIS; Nuin P, 2005, MRMTGUI 10 VERSION 1; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sharma A, 2012, MINI-REV ORG CHEM, V9, P341, DOI 10.2174/157019312804699500; Simmons MP, 2004, MOL PHYLOGENET EVOL, V31, P874, DOI 10.1016/j.ympev.2003.10.008; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Su XH, 2009, CHEM BIODIVERS, V6, P146, DOI 10.1002/cbdv.200700403; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tang WH, 2014, BIOCHEM SYST ECOL, V54, P78, DOI 10.1016/j.bse.2014.01.001; Techen N, 2014, CURR OPIN BIOTECH, V25, P103, DOI 10.1016/j.copbio.2013.09.010; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang LY, 2013, J NAT PROD, V76, P745, DOI 10.1021/np3008182; Wang XJ, 2013, PHYTOMEDICINE, V20, P1064, DOI 10.1016/j.phymed.2013.04.017; Weng JR, 2013, PHYTOCHEMISTRY, V94, P211, DOI 10.1016/j.phytochem.2013.05.022; White TJ, 1990, PCR PROTOCOLS GUIDE, DOI [DOI 10.1016/B978-0-12-372180-8.50042-1, 10.1016/B978-0-12-372180-8.50042-1]; Wu J, 2012, PHYTOCHEMISTRY, V75, P159, DOI 10.1016/j.phytochem.2011.11.023; Zhang HY, 2014, PHYTOCHEM LETT, V7, P101, DOI 10.1016/j.phytol.2013.10.002; Zhu Yaodong, 2014, BMC Complement Altern Med, V14, P433, DOI 10.1186/1472-6882-14-433	42	5	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169973	10.1371/journal.pone.0169973	http://dx.doi.org/10.1371/journal.pone.0169973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081198	Green Published, gold, Green Submitted			2022-12-26	WOS:000391949500110
J	Kujawska, M; Hilgert, NI; Keller, HA; Gil, G				Kujawska, Monika; Hilgert, Norma I.; Keller, Hector A.; Gil, Guillermo			Medicinal Plant Diversity and Inter-Cultural Interactions between Indigenous Guarani, Criollos and Polish Migrants in the Subtropics of Argentina	PLOS ONE			English	Article							KNOWLEDGE; ETHNOBOTANY; CONSENSUS	Numerous studies highlight the importance of phytotherapy for indigenous and non-indigenous people in different parts of the world. In this work we analyze the richness (number of species), diversity (plant identity and the number of illnesses for which it is used) and similarity of plant species and illnesses treated with them, in order to contribute new data and insight into the importance of plant medicines to the local medical systems of people living in Misiones province, in the subtropics of Argentina. Three sympatric groups were compared: Guarani Indians, Criollos (mestizos) and Polish migrants. Quantitative scrutiny was focused on both primary and secondary sources. The similarity and diversity of medicinal plants and uses between groups was calculated by applying the Sorensen quantitative coefficient and the Shannon-Wiener index, respectively. In order to identify the characteristic plant species used by each group, the Cultural Importance and Prevalence Value (CIPV) was calculated based on the species Indicator Value (IndVal), which combines a species relative abundance with its relative frequency of occurrence in the various groups, and modified according to the type of the analyzed data. The important finding is a great variation in the number of species used by the study groups. Altogether, 509 botanical species were registered: Guarani (397), Criollos (243) and Polish migrants (137). For all groups, the use of native medicinal plants prevailed. The Guarani appear to be the local experts in use of medicinal plants. There is the significant difference in the number of treated illnesses by each taxon among three groups. Criollos and Polish migrants exhibit the greatest similarity in illnesses treated with medicinal plants. These groups share a corpus of knowledge related to illness nosology, and have a symptomatic approach to illness treatment. The Guarani have an etiological approach to illness diagnosis and healing, which may be viewed as a barrier to the exchange of knowledge about home medicine with other ethnic groups of Misiones.	[Kujawska, Monika] Univ Lodz, Inst Ethnol & Cultural Anthropol, Lodz, Poland; [Hilgert, Norma I.] Univ Nacl Misiones, Ctr Invest Bosque Atlantico, CONICET, Inst Biol Subtrop, Iguazu, Misiones, Argentina; [Hilgert, Norma I.] Univ Nacl Misiones, Fac Ciencias Forest, Eldorado, Misiones, Argentina; [Keller, Hector A.] Consejo Nacl Invest Cient & Tecn, Inst Bot Nordeste, Corrientes, Corrientes, Argentina; [Gil, Guillermo] Adm Parques Nacl, Ctr Invest Ecol Subtrop, Delegac Reg Nordeste, Iguazu, Misiones, Argentina	University of Lodz; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Hilgert, NI (corresponding author), Univ Nacl Misiones, Ctr Invest Bosque Atlantico, CONICET, Inst Biol Subtrop, Iguazu, Misiones, Argentina.; Hilgert, NI (corresponding author), Univ Nacl Misiones, Fac Ciencias Forest, Eldorado, Misiones, Argentina.	normahilgert@yahoo.com.ar	Hilgert, Norma I./I-3866-2015	Hilgert, Norma I./0000-0002-7359-3535; Kujawska, Monika/0000-0002-5643-3417	Ministry of Science and Higher Education; National Science Centre in Poland [NN109 05 11 38, 2013/09/N/HS3/02226]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Centre in Poland(National Science Centre, Poland)	MK received two research grants from Ministry of Science and Higher Education and from National Science Centre in Poland [https://www.ncn.gov.pl/?language=en], grant numbers: NN109 05 11 38; 2013/09/N/HS3/02226. The first grant is already finished. The funding from grants were destined for field research in Argentina and the data analysis. MK and the rest of the authors did not receive special funding for paying this publication. Therefore, after contacting Billing Office, we have decided to pay the publication, if it is accepted, from mixed sources: MK will pay from institutional sources her current employer, Lodz University, agrees to pay a half, and NIH and HK will pay from their current employer, Universidad Nacional de Misiones, the second half.	Amat A. G., 1998, FARMACOBOTANICA FARM, P119; Arasaratnam LA, 2013, INT J INTERCULT REL, V37, P676, DOI 10.1016/j.ijintrel.2013.09.006; ARENAS P, 1987, J ETHNOPHARMACOL, V21, P279, DOI 10.1016/0378-8741(87)90104-8; Balee W., 1994, FOOTPRINTS FOREST KA; Bartolome L. J., 1982, COLONIAS COLONIZADOR; Begossi A, 1996, ECON BOT, V50, P280, DOI 10.1007/BF02907333; Begossi A, 2002, HUM ECOL, V30, P281, DOI 10.1023/A:1016564217719; Bogado M., 2005, REPRESENTACIONES PRA; Bourdy G, 2004, J ETHNOPHARMACOL, V91, P189, DOI 10.1016/j.jep.2003.09.013; Cadogan L., 1959, AYVU RAPYTA; Collins S, 2006, ECON BOT, V60, P347, DOI 10.1663/0013-0001(2006)60[347:QEOTET]2.0.CO;2; de Boer H, 2009, J ETHNOBIOL ETHNOMED, V5, DOI 10.1186/1746-4269-5-25; de Boer HJ, 2012, J ETHNOPHARMACOL, V141, P481, DOI 10.1016/j.jep.2012.03.017; Abreu DBD, 2015, J ETHNOPHARMACOL, V175, P124, DOI 10.1016/j.jep.2015.09.019; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Ferreira Junior WS., 2015, EVOLUTIONARY ETHNOBI, P105, DOI DOI 10.1007/978-3-319-19917-7; Ferrero B., 2005, ESTUDIO GESTION TERR; FILIPOV A, 1994, J ETHNOPHARMACOL, V44, P181, DOI 10.1016/0378-8741(94)01185-0; FOSTER GM, 1976, AM ANTHROPOL, V78, P773, DOI 10.1525/aa.1976.78.4.02a00030; Furlong SJ, 1962, MISIONES SUS PUEBLOS; Galvez Lucia, 1995, GUARANIES JESUITAS T; Giovannini P, 2011, SOC SCI MED, V72, P928, DOI 10.1016/j.socscimed.2011.01.007; Giraudo AR, 2003, STATE HOTS, P160; Heckler SL, 2007, MED ANTHROPOL Q, V21, P41, DOI 10.1525/maq.2007.21.1.41; Heinrich M, 1998, SOC SCI MED, V47, P1859, DOI 10.1016/S0277-9536(98)00181-6; Hernandez P., 1913, ORG SOCIAL DOCTRINAS; Hilgert NI, 2008, BOL LATINOAM CARIBE, V7, P130; Hilgert NI, 2007, J ETHNOBIOL ETHNOMED, V3, DOI 10.1186/1746-4269-3-19; Holz S, 2003, STATE HOTS, P207; Keller H.A., 2006, BONPLANDIA, V15, P125, DOI [10.30972/bon.153-4103, DOI 10.30972/BON.153-4103]; Keller H.A., 2011, AVA, V18, P25; Keller H. A., 2007, SUPLEMENTO ANTROPOLO, V42, P345; Keller HA, 2008, THESIS; KELLER HA, 2013, BONPLADIA, V22, P171; Kujawska M, 2016, ANTHROPOL MED, V23, P205, DOI 10.1080/13648470.2016.1180580; Kujawska M, 2015, J ETHNOPHARMACOL, V172, P347, DOI 10.1016/j.jep.2015.06.037; Kujawska M, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/579350; Kujawska M, 2014, J ETHNOPHARMACOL, V153, P810, DOI 10.1016/j.jep.2014.03.044; Lambert J., 1997, World Bank Technical Paper; Leonti M, 2003, J ETHNOPHARMACOL, V88, P119, DOI 10.1016/S0378-8741(03)00188-0; Leonti M, 2009, J ETHNOPHARMACOL, V121, P55, DOI 10.1016/j.jep.2008.10.027; Moerman DE, 2007, J ETHNOPHARMACOL, V112, P451, DOI 10.1016/j.jep.2007.04.001; Molares S, 2009, J ETHNOPHARMACOL, V122, P251, DOI 10.1016/j.jep.2009.01.003; Moreau D., 2006, MEMOIRE DIPLOME U ET; Moreno CE, 2001, METODOS MEDIR BIODIV; Morris Brian, 2011, Anthropol Med, V18, P245, DOI 10.1080/13648470.2011.591200; Muniz de Medeiros P., 2015, EVOLUTIONARY ETHNOBI, P163; Nolan JM, 1999, HUM ORGAN, V58, P67, DOI 10.17730/humo.58.1.k1854516076003p6; Pieroni A, 2005, J ETHNOPHARMACOL, V101, P258, DOI 10.1016/j.jep.2005.04.028; PLACCI G, 2006, SITUACION AMBIENTAL, P197; Pouliot M, 2011, SOC SCI MED, V73, P1498, DOI 10.1016/j.socscimed.2011.08.037; Quinlan MB, 2007, MED ANTHROPOL Q, V21, P169, DOI [10.1525/maq.2007.21.2.169, 10.1525/MAQ.2007.21.2.169]; SCHMEDAHIRSCHMANN G, 1993, J ETHNOPHARMACOL, V39, P105, DOI 10.1016/0378-8741(93)90025-Z; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Smith JW, 2012, HUM ECOL, V40, P341, DOI 10.1007/s10745-012-9470-y; Sorensen T., 1948, K DAN VIDENSK SELSK, V5, P1; Stampella PC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/868394; Tardio J, 2008, ECON BOT, V62, P24, DOI 10.1007/s12231-007-9004-5; Torres V.E., 2014, FOLIA HIST NORDESTE, V22, P89; Trotter R.T., 1986, PLANTS INDIGENOUS ME, P91, DOI DOI 10.4324/9781315060385-6; van Andel T, 2012, J ETHNOPHARMACOL, V143, P840, DOI 10.1016/j.jep.2012.08.008; Vandebroek I, 2010, ECON BOT, V64, P303, DOI 10.1007/s12231-010-9135-y; Zamudio F., 2010, OPEN COMPLEMENTARY M, V2, P58, DOI [10.2174/1876391X01002020058, DOI 10.2174/1876391X01002020058]; Zar J. H., 1996, BIOSTATISTICAL ANAL	64	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169373	10.1371/journal.pone.0169373	http://dx.doi.org/10.1371/journal.pone.0169373			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH6BJ	28076407	gold, Green Submitted, Green Published			2022-12-26	WOS:000391857100035
J	Van Rossom, S; Smith, CR; Zevenbergen, L; Thelen, DG; Vanwanseele, B; Van Assche, D; Jonkers, I				Van Rossom, Sam; Smith, Colin Robert; Zevenbergen, Lianne; Thelen, Darryl Gerard; Vanwanseele, Benedicte; Van Assche, Dieter; Jonkers, Ilse			Knee Cartilage Thickness, T1 rho and T2 Relaxation Time Are Related to Articular Cartilage Loading in Healthy Adults	PLOS ONE			English	Article							DISEASE SEVERITY; MRI TECHNIQUES; OSTEOARTHRITIS; CONTACT; T1RHO; MORPHOLOGY; MODEL; JOINT; GAIT; MECHANOBIOLOGY	Cartilage is responsive to the loading imposed during cyclic routine activities. However, the local relation between cartilage in terms of thickness distribution and biochemical composition and the local contact pressure during walking has not been established. The objective of this study was to evaluate the relation between cartilage thickness, proteoglycan and collagen concentration in the knee joint and knee loading in terms of contact forces and pressure during walking. 3D gait analysis and MRI (3D-FSE, T1 rho relaxation time and T2 relaxation time sequence) of fifteen healthy subjects were acquired. Experimental gait data was processed using musculoskeletal modeling to calculate the contact forces, impulses and pressure distribution in the tibiofemoral joint. Correlates to local cartilage thickness and mean T1 rho and T2 relaxation times of the weight-bearing area of the femoral condyles were examined. Local thickness was significantly correlated with local pressure: medial thickness was correlated with medial condyle contact pressure and contact force, and lateral condyle thickness was correlated with lateral condyle contact pressure and contact force during stance. Furthermore, average T1 rho and T2 relaxation time correlated significantly with the peak contact forces and impulses. Increased T1 rho relaxation time correlated with increased shear loading, decreased T1 rho and T2 relaxation time correlated with increased compressive forces and pressures. Thicker cartilage was correlated with higher condylar loading during walking, suggesting that cartilage thickness is increased in those areas experiencing higher loading during a cyclic activity such as gait. Furthermore, the proteoglycan and collagen concentration and orientation derived from T1 rho and T2 relaxation measures were related to loading.	[Van Rossom, Sam; Zevenbergen, Lianne; Vanwanseele, Benedicte; Jonkers, Ilse] Katholieke Univ Leuven, Dept Kinesiol, Human Movement Biomech Res Grp, Leuven, Belgium; [Smith, Colin Robert; Thelen, Darryl Gerard] Univ Wisconsin, Dept Mech Engn, Madison, WI 53706 USA; [Thelen, Darryl Gerard] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA; [Thelen, Darryl Gerard] Univ Wisconsin, Dept Orthoped & Rehabil, Madison, WI 53706 USA; [Van Assche, Dieter] Katholieke Univ Leuven, Dept Rehabil Sci, Musculoskeletal Rehabil Res Grp, Leuven, Belgium	KU Leuven; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; KU Leuven	Van Rossom, S (corresponding author), Katholieke Univ Leuven, Dept Kinesiol, Human Movement Biomech Res Grp, Leuven, Belgium.	sam.vanrossam@kuleuven.be	jonkers, ilse/J-9544-2015; Vanwanseele, Benedicte/AAQ-1706-2021; Van+Rossom, Sam/L-2255-2019; Van Assche, Dieter/AAB-3950-2020	jonkers, ilse/0000-0001-7611-3747; Vanwanseele, Benedicte/0000-0002-6158-9483; Van+Rossom, Sam/0000-0002-3206-9796; Zevenbergen, Willy Johanna/0000-0002-8891-7571; Thelen, Darryl/0000-0002-7873-2477	KU Leuven research council [OT/13/083]; Whitaker International Summer Program; NIH [EB015410]	KU Leuven research council(KU Leuven); Whitaker International Summer Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research was supported by funding of the KU Leuven research council (OT/13/083), Whitaker International Summer Program (CS) and NIH Grant EB015410. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann B, 2005, OSTEOARTHR CARTILAGE, V13, P906, DOI 10.1016/j.joca.2005.06.001; Andriacchi TP, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0463-2; Andriacchi TP, 2004, ANN BIOMED ENG, V32, P447, DOI 10.1023/B:ABME.0000017541.82498.37; Arnold EM, 2010, ANN BIOMED ENG, V38, P269, DOI 10.1007/s10439-009-9852-5; BLANKEVOORT L, 1991, J BIOMECH, V24, P1019, DOI 10.1016/0021-9290(91)90019-J; Blazek K, 2014, J ORTHOP RES, V32, P394, DOI 10.1002/jor.22530; Bleuel J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119816; Burstein D, 2000, INVEST RADIOL, V35, P622, DOI 10.1097/00004424-200010000-00008; Carter DR, 2004, CLIN ORTHOP RELAT R, pS69, DOI 10.1097/01.blo.0000144970.05107.7e; Chaudhari AMW, 2008, MED SCI SPORT EXER, V40, P215, DOI 10.1249/mss.0b013e31815cbb0e; Chen C, 2013, AM J PHYSIOL-CELL PH, V305, pC1202, DOI 10.1152/ajpcell.00242.2013; D'Lima DD, 2008, J ORTHOP RES, V26, P1549, DOI 10.1002/jor.20670; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; Delp Scott L, 2000, COMPUT SCI ENG, P46; Draper CE, 2006, OSTEOARTHR CARTILAGE, V14, P931, DOI 10.1016/j.joca.2006.03.006; Eckstein F, 2006, ANN RHEUM DIS, V65, P433, DOI 10.1136/ard.2005.039370; Erhart-Hledik JC, 2015, J BIOMECH, V48, P3868, DOI 10.1016/j.jbiomech.2015.09.033; Felson DT, 2000, ANN INTERN MED, V133, P637; Freemont AJ, 2007, J PATHOL, V211, P252, DOI 10.1002/path.2097; Fregly Benjamin J, 2009, Int J Comput Vis Biomech, V2, P145; Fregly BJ, 2012, J ORTHOP RES, V30, P503, DOI 10.1002/jor.22023; Goto H, 2012, J MED IMAG RADIAT ON, V56, P318, DOI 10.1111/j.1754-9485.2012.02388.x; Hudelmaier M, 2003, ANAT REC PART A, V270A, P175, DOI 10.1002/ar.a.10001; Hurwitz DE, 2002, J ORTHOPAED RES, V20, P101, DOI 10.1016/S0736-0266(01)00081-X; Jones G, 2003, PEDIATR RES, V54, P230, DOI 10.1203/01.PDR.0000072781.93856.E6; Keenan KE, 2011, OSTEOARTHR CARTILAGE, V19, P171, DOI 10.1016/j.joca.2010.11.009; Koli J, 2015, MED SCI SPORT EXER, V47, P1767, DOI 10.1249/MSS.0000000000000629; Koo S, 2007, J BIOMECH, V40, P2961, DOI 10.1016/j.jbiomech.2007.02.005; Koo S, 2011, J BIOMECH, V44, P1405, DOI 10.1016/j.jbiomech.2010.11.020; Kumar D, 2013, J ORTHOP SPORT PHYS, V43, P881, DOI 10.2519/jospt.2013.4486; Lenhart RL, 2015, ANN BIOMED ENG, V43, P2675, DOI 10.1007/s10439-015-1326-3; Li G, 2005, CLIN BIOMECH, V20, P736, DOI 10.1016/j.clinbiomech.2005.04.001; Li G, 2001, J BIOMECH ENG-T ASME, V123, P341, DOI 10.1115/1.1385841; Li X, 2007, OSTEOARTHR CARTILAGE, V15, P789, DOI 10.1016/j.joca.2007.01.011; Li XJ, 2011, MAGN RESON IMAGING, V29, P324, DOI 10.1016/j.mri.2010.09.004; LOHMANDER LS, 1994, J ANAT, V184, P477; Lu TW, 1999, J BIOMECH, V32, P129, DOI 10.1016/S0021-9290(98)00158-4; Luke AC, 2010, AM J SPORT MED, V38, P2273, DOI 10.1177/0363546510372799; Matzat SJ, 2013, QUANT IMAGING MED SU, V3, P162, DOI 10.3978/j.issn.2223-4292.2013.06.04; Meireles S, 2016, GAIT POSTURE, V45, P115, DOI 10.1016/j.gaitpost.2016.01.016; Moyer R, 2016, OSTEOARTHR CARTILAGE, V24, P254, DOI 10.1016/j.joca.2015.08.016; Munukka M, 2016, OSTEOARTHR CARTILAGE, V24, P1708, DOI 10.1016/j.joca.2016.05.007; Smith RC, 2016, COMPUT METHODS BIOME; Souza RB, 2010, OSTEOARTHR CARTILAGE, V18, P1557, DOI 10.1016/j.joca.2010.10.001; Souza RB, 2014, OSTEOARTHR CARTIL, V22; Souza RB, 2012, J ORTHOP SPORT PHYS, V42, P511, DOI 10.2519/jospt.2012.3975; Souza RB, 2012, CLIN BIOMECH, V27, P403, DOI 10.1016/j.clinbiomech.2011.10.015; Stahl R, 2009, EUR RADIOL, V19, P132, DOI 10.1007/s00330-008-1107-6; Thelen DG, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026358; Vanwanseele B, 2004, MAGN RESON MED, V51, P1026, DOI 10.1002/mrm.20068; Vanwanseele B, 2003, ARTHRITIS RHEUM, V48, P3377, DOI 10.1002/art.11367; Vanwanseele B, 2002, OSTEOARTHR CARTILAGE, V10, P408, DOI 10.1053/joca.2002.0529; Wang LG, 2012, EUR J RADIOL, V81, P2329, DOI 10.1016/j.ejrad.2011.07.017; Winby CR, 2009, J BIOMECH, V42, P2294, DOI 10.1016/j.jbiomech.2009.06.019	54	29	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0170002	10.1371/journal.pone.0170002	http://dx.doi.org/10.1371/journal.pone.0170002			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076431	Green Submitted, Green Published, gold			2022-12-26	WOS:000391857100076
J	Wang, P; Chen, WH; Liao, JW; Matsuo, T; Ito, K; Fowles, J; Shusterman, D; Mendell, M; Kumagai, K				Wang, Ping; Chen, Wenhao; Liao, Jiawen; Matsuo, Toshiki; Ito, Kazuhide; Fowles, Jeff; Shusterman, Dennis; Mendell, Mark; Kumagai, Kazukiyo			A Device-Independent Evaluation of Carbonyl Emissions from Heated Electronic Cigarette Solvents	PLOS ONE			English	Article							PUFF TOPOGRAPHY; HEATING COIL; TEMPERATURE; PYROLYSIS; GLYCEROL	Objectives To investigate how the two main electronic (e-) cigarette solvents-propylene glycol (PG) and glycerol (GL)-modulate the formation of toxic volatile carbonyl compounds under precisely controlled temperatures in the absence of nicotine and flavor additives. Methods PG, GL, PG: GL = 1: 1 (wt/wt) mixture, and two commercial e-cigarette liquids were vaporized in a stainless steel, tubular reactor in flowing air ranging up to 318 degrees C to simulate e-cigarette vaping. Aerosols were collected and analyzed to quantify the amount of volatile carbonyls produced with each of the five e-liquids. Results Significant amounts of formaldehyde and acetaldehyde were detected at reactor temperatures >= 215 degrees C for both PG and GL. Acrolein was observed only in e-liquids containing GL when reactor temperatures exceeded 270 degrees C. At 318 degrees C, 2.03 +/- 0.80 mu g of formaldehyde, 2.35 +/- 0.87 mu g of acetaldehyde, and a trace amount of acetone were generated per milligram of PG; at the same temperature, 21.1 +/- 3.80 mu g of formaldehyde, 2.40 +/- 0.99 mu g of acetaldehyde, and 0.80 +/- 0.50 mu g of acrolein were detected per milligram of GL. Conclusions We developed a device-independent test method to investigate carbonyl emissions from different e-cigarette liquids under precisely controlled temperatures. PG and GL were identified to be the main sources of toxic carbonyl compounds from e-cigarette use. GL produced much more formaldehyde than PG. Besides formaldehyde and acetaldehyde, measurable amounts of acrolein were also detected at >= 270 degrees C but only when GL was present in the e-liquid. At 215 degrees C, the estimated daily exposure to formaldehyde from e-cigarettes, exceeded United States Environmental Protection Agency (USEPA) and California Office of Environmental Health Hazard Assessment (OEHHA) acceptable limits, which emphasized the need to further examine the potential cancer and non-cancer health risks associated with e-ciga-rette use.	[Wang, Ping; Chen, Wenhao; Liao, Jiawen; Matsuo, Toshiki; Mendell, Mark; Kumagai, Kazukiyo] Calif Dept Publ Hlth, Environm Hlth Lab, Indoor Air Qual Program, Richmond, CA 94804 USA; [Liao, Jiawen] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA; [Matsuo, Toshiki; Ito, Kazuhide] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka, Japan; [Fowles, Jeff] Calif Dept Publ Hlth, Environm Hlth Invest Branch, Exposure Assessment Sect, Richmond, CA USA; [Shusterman, Dennis] Univ Calif San Francisco, Sch Med, Div Occupat & Environm Med, San Francisco, CA 94143 USA	California Department of Public Health; University of California System; University of California Berkeley; Kyushu University; California Department of Public Health; University of California System; University of California San Francisco	Wang, P; Kumagai, K (corresponding author), Calif Dept Publ Hlth, Environm Hlth Lab, Indoor Air Qual Program, Richmond, CA 94804 USA.	Ping.Wang@cdph.ca.gov; Kazukiyo.Kumagai@cdph.ca.gov	Kumagai, Kazukiyo/F-5616-2012; Ito, Kazuhide/J-3550-2019	Kumagai, Kazukiyo/0000-0002-0425-9410; Ito, Kazuhide/0000-0002-7715-7896	California Department of Public Health	California Department of Public Health	Funding was provided internally through California Department of Public Health.	ANTAL MJ, 1985, J ANAL APPL PYROL, V8, P291, DOI 10.1016/0165-2370(85)80032-2; Bekki K, 2014, INT J ENV RES PUB HE, V11, P11192, DOI 10.3390/ijerph111111192; Brown CJ, 2014, TOB CONTROL, V23, P4, DOI 10.1136/tobaccocontrol-2013-051476; Buhler W, 2002, J SUPERCRIT FLUID, V22, P37, DOI 10.1016/S0896-8446(01)00105-X; Chapman R., 2015, COMMUNITY HLTH THREA; Chen W, 2013, P HLTH BUILD BOULD 1; Counts ME, 2005, REGUL TOXICOL PHARM, V41, P185, DOI 10.1016/j.yrtph.2004.12.002; Diaz E, 2010, CHEMSUSCHEM, V3, P1063, DOI 10.1002/cssc.201000142; EL-Hellani A, 2016, NICOTINE CARBONYL EM; EPA, 1998, FORMALDEHYDE CASRN 5; Etter JF, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-231; Flouris AD, 2013, INHAL TOXICOL, V25, P91, DOI 10.3109/08958378.2012.758197; Geiss O, 2016, INT J HYG ENVIR HEAL, V219, P268, DOI 10.1016/j.ijheh.2016.01.004; IARC (International Agency for Research on Cancer), 2012, AG CLASS IARC MON, V1-104; Khlystov A, 2016, ENV SCI TECHNOLOGY; King BA, 2013, NICOTINE TOB RES, V15, P1623, DOI 10.1093/ntr/ntt013; Kosmider L, 2014, NICOTINE TOB RES, V16, P1319, DOI 10.1093/ntr/ntu078; Nimlos MR, 2006, J PHYS CHEM A, V110, P6145, DOI 10.1021/jp060597q; OEHHA, 2013, SIGNIFICANT RISK LEV; RAMAYYA S, 1987, FUEL, V66, P1364, DOI 10.1016/0016-2361(87)90183-9; Schripp T, 2013, INDOOR AIR, V23, P25, DOI 10.1111/j.1600-0668.2012.00792.x; Sleiman M., 2016, ENV SCI TECHNOL; STEIN YS, 1983, J ANAL APPL PYROL, V4, P283, DOI 10.1016/0165-2370(83)80003-5; Talih S, 2015, NICOTINE TOB RES, V17, P150, DOI 10.1093/ntr/ntu174; Vardavas CI, 2012, CHEST, V141, P1400, DOI 10.1378/chest.11-2443; Westenberger BJ, 2009, EVALUATION E CIGARET; Zhao TK, 2016, ATMOS ENVIRON, V134, P61, DOI 10.1016/j.atmosenv.2016.03.027	27	84	89	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169811	10.1371/journal.pone.0169811	http://dx.doi.org/10.1371/journal.pone.0169811			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076380	Green Submitted, Green Published, gold			2022-12-26	WOS:000391857100058
J	Bai, J; Chow, BKC				Bai, Juan; Chow, Billy K. C.			Secretin is involved in sodium conservation through the renin-angiotensin-aldosterone system	FASEB JOURNAL			English	Article						SCTR; epithelial sodium channels; CYP11B2	EPITHELIAL NA+ CHANNEL; PY MOTIF; ENAC; CHOLESTEROL; METABOLISM; DISORDERS; MECHANISM	Secretin (SCT) and its receptor (SCTR) are important in fluid regulation at multiple levels via the modulation of expression and translocation of renal aquaporin 2 and functions of central angiotensin II (ANGII). The functional interaction of SCT with peripheral ANGII, however, remains unknown. As the ANGII-aldosterone axis dominates the regulation of renal epithelial sodium channel (ENaC) function, we therefore tested whether SCT/SCTR can regulate sodium homeostasis via the renin-angiotensin-aldosterone system. SCTR-knockout (SCTR2/2) mice showed impaired aldosterone synthase (CYP11B2) expression and, consequently, aldosterone release upon intraperitoneal injection of ANGII. Endogenous ANGII production induced by dietary sodium restriction was higher in SCTR2/2 than in C57BL/6N [wild-type (WT)] mice, but CYP11B2 and aldosterone synthesis were not elevated. Reduced accumulation of cholesteryl ester-theprecursor of aldosterone-wasobservedinadrenal glands ofSCTR2/2 mice that were fed a low-sodium diet. Absence ofSCTRresulted in elevated basal transcript levels of adrenal CYP11B2 and renal ENaCs. Although transcript and protein levels of ENaCs were similar in WT and SCTR2/2 mice under sodium restriction, ENaCs in SCTR2/2 mice were less sensitive to amiloride hydrochloride. In summary, the SCT/SCTR axis is involved in aldosterone precursor uptake, and the knockout of SCTR results in defective aldosterone biosynthesis/release and altered sensitivity of ENaCs to amiloride.- Bai, J., Chow, B. K. C. Secretin is involved in sodiumconservation through the renin-angiotensin-aldosterone system. FASEBJ. 31, 1689-1697 ( 2017). www.fasebj.org	[Bai, Juan; Chow, Billy K. C.] Univ Hong Kong, Sch Biol Sci, 4N-12,Kardoorie Biol Sci Bldg,Pokfulam Rd, Sai Ying Pun, Hong Kong, Peoples R China	University of Hong Kong	Chow, BKC (corresponding author), Univ Hong Kong, Sch Biol Sci, 4N-12,Kardoorie Biol Sci Bldg,Pokfulam Rd, Sai Ying Pun, Hong Kong, Peoples R China.	bkcc@hku.hk	Chow, Billy/D-3064-2009	Chow, Billy/0000-0003-3390-0307	Hong Kong Research Council [764510M, 765011M, 764812M, 765113M]; Collaborative Research Fund [HKU6/CRF/11G]	Hong Kong Research Council(Hong Kong Research Grants Council); Collaborative Research Fund	This work was supported by Hong Kong Research Council Grants (GRF 764510M, 765011M, 764812M, and 765113M) and Collaborative Research Fund Grant HKU6/CRF/11G (to B.K.C.C.). The authors thank Sharon Mar (University of British Columbia, Vancouver, BC, Canada) and Chong Tan (University of Hong Kong) for their help in editing the manuscript.	Bader M, 2010, ANNU REV PHARMACOL, V50, P439, DOI 10.1146/annurev.pharmtox.010909.105610; Bai JJ, 2017, AM J PHYSIOL-RENAL, V312, pF852, DOI 10.1152/ajprenal.00191.2015; Bassett MH, 2004, MOL CELL ENDOCRINOL, V217, P67, DOI 10.1016/j.mce.2003.10.011; Calhoun DA, 2006, PROG CARDIOVASC DIS, V48, P387, DOI 10.1016/j.pcad.2006.02.002; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Capponi AM, 2004, MOL CELL ENDOCRINOL, V217, P113, DOI 10.1016/j.mce.2003.10.055; Cherradi N, 1998, EUR J ENDOCRINOL, V139, P249, DOI 10.1530/eje.0.1390249; Chu JYS, 2007, MOL CELL BIOL, V27, P2499, DOI 10.1128/MCB.01088-06; Chu JYS, 2009, P NATL ACAD SCI USA, V106, P15961, DOI 10.1073/pnas.0903695106; Epstein M, 2011, J CLIN HYPERTENS, V13, P644, DOI 10.1111/j.1751-7176.2011.00511.x; Fitzsimons JT, 1998, PHYSIOL REV, V78, P583, DOI 10.1152/physrev.1998.78.3.583; GWYNNE JT, 1980, J BIOL CHEM, V255, P875; Hattangady NG, 2012, MOL CELL ENDOCRINOL, V350, P151, DOI 10.1016/j.mce.2011.07.034; Kaiser E., 1880, BOTANISCH ZENTRALB, V180, P25; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200; Kraemer FB, 2007, MOL CELL ENDOCRINOL, V265, P42, DOI 10.1016/j.mce.2006.12.001; Lee LTO, 2014, FASEB J, V28, P2632, DOI 10.1096/fj.13-246868; Lee VHY, 2010, FASEB J, V24, P5024, DOI 10.1096/fj.10-165399; Lu B, 2009, NEUROSCIENCE, V164, P1303, DOI 10.1016/j.neuroscience.2009.08.064; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Lumbers ER, 1999, REGUL PEPTIDES, V80, P91, DOI 10.1016/S0167-0115(99)00026-9; Malendowicz K, 1996, HORM METAB RES, V28, P613, DOI 10.1055/s-2007-979865; Malendowicz LK, 1997, BIOMED RES-TOKYO, V18, P139, DOI 10.2220/biomedres.18.139; Mamenko M, 2012, J BIOL CHEM, V287, P660, DOI 10.1074/jbc.M111.298919; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; McEwan PE, 1999, AM J PHYSIOL-ENDOC M, V276, pE303, DOI 10.1152/ajpendo.1999.276.2.E303; Mecawi AS, 2013, J NEUROENDOCRINOL, V25, P281, DOI 10.1111/j.1365-2826.2012.02388.x; Mironova E, 2012, P NATL ACAD SCI USA, V109, P10095, DOI 10.1073/pnas.1201978109; Noda M, 2013, TRENDS NEUROSCI, V36, P661, DOI 10.1016/j.tins.2013.08.004; Nogueira EF, 2009, MOL CELL ENDOCRINOL, V302, P230, DOI 10.1016/j.mce.2008.08.024; Oh YS, 1999, J CLIN INVEST, V104, P849, DOI 10.1172/JCI8378; Okubo S, 1997, J CLIN INVEST, V99, P855, DOI 10.1172/JCI119249; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Peters J, 2012, PEPTIDES, V34, P427, DOI 10.1016/j.peptides.2012.01.023; Reynolds RM, 2006, BMJ-BRIT MED J, V332, P702, DOI 10.1136/bmj.332.7543.702; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rossier BC, 2013, FEBS LETT, V587, P1929, DOI 10.1016/j.febslet.2013.05.013; Schild L, 1996, EMBO J, V15, P2381, DOI 10.1002/j.1460-2075.1996.tb00594.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sekar R, 2014, J LIPID RES, V55, P190, DOI 10.1194/jlr.M038042; Spyroglou A, 2009, J MOL ENDOCRINOL, V42, P407, DOI 10.1677/JME-08-0167; Verbalis JG, 2003, BEST PRACT RES CL EN, V17, P471, DOI 10.1016/S1521-690X(03)00049-6; VIDT DG, 1981, PHARMACOTHERAPY, V1, P179; Xing YW, 2011, ENDOCRINOLOGY, V152, P751, DOI 10.1210/en.2010-1049; Xue C, 2005, HYPERTENSION, V46, P584, DOI 10.1161/01.HYP.0000175814.18550.c0; Ye P, 2003, ENDOCRINOLOGY, V144, P3321, DOI 10.1210/en.2003-0109; Zhou ZH, 2001, AM J PHYSIOL-CELL PH, V281, pC1118, DOI 10.1152/ajpcell.2001.281.4.C1118	49	4	4	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1689	1697		10.1096/fj.201600911R	http://dx.doi.org/10.1096/fj.201600911R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28082350				2022-12-26	WOS:000398504300033
J	Nadeau, SA; An, W; Mohapatra, BC; Mushtaq, I; Bielecki, TA; Luan, HT; Zutshi, N; Ahmad, G; Storck, MD; Sanada, M; Ogawa, S; Band, V; Band, H				Nadeau, Scott A.; An, Wei; Mohapatra, Bhopal C.; Mushtaq, Insha; Bielecki, Timothy A.; Luan, Haitao; Zutshi, Neha; Ahmad, Gulzar; Storck, Matthew D.; Sanada, Masashi; Ogawa, Seishi; Band, Vimla; Band, Hamid			Structural Determinants of the Gain-of-Function Phenotype of Human Leukemia-associated Mutant CBL Oncogene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; leukemia; mutagenesis; oncogene; receptor tyrosine kinase; CBL; proline-Rich region; tyrosine kinase binding domain	PHOSPHOTYROSINE-BINDING DOMAIN; ACQUIRED UNIPARENTAL DISOMY; PROTEIN-TYROSINE KINASE; RING FINGER MUTATIONS; HOMOLOGY 3 DOMAIN; LIGASE C-CBL; NEGATIVE REGULATION; DOWN-REGULATION; PHOSPHATIDYLINOSITOL 3-KINASE; PROTOONCOGENE PRODUCT	Mutations of the tyrosine kinase-directed ubiquitin ligase CBL cause myeloid leukemias, but the molecular determinants of the dominant leukemogenic activity of mutant CBL oncogenes are unclear. Here, we first define a gain-of-function attribute of the most common leukemia-associated CBL mutant, Y371H, by demonstrating its ability to increase proliferation of hematopoietic stem/progenitor cells (HSPCs) derived from CBL-null and CBL/CBL-B-null mice. Next, we express second-site point/deletion mutants of CBL-Y371H in CBL/CBL-B-null HSPCs or the cytokine-dependent human leukemic cell line TF-1 to show that individual or combined Tyr Phe mutations of established phosphotyrosine residues (Tyr-700, Tyr-731, and Tyr-774) had little impact on the activity of the CBL-Y371H mutant in HSPCs, and the triple Tyr Phe mutant was only modestly impaired in TF-1 cells. In contrast, intact tyrosine kinase-binding (TKB) domain and proline-rich region (PRR) were critical in both cell models. PRR deletion reduced the stem cell factor (SCF)-induced hyper-phosphorylation of the CBL-Y371H mutant and the c-KIT receptor and eliminated the sustained p-ERK1/2 and p-AKT induction by SCF. GST fusion protein pulldowns followed by phospho-specific antibody array analysis identified distinct CBL TKB domains or PRR-binding proteins that are phosphorylated in CBL-Y371H-expressing TF-1 cells. Our results support a model of mutant CBL gain-of-function in which mutant CBL proteins effectively compete with the remaining wild type CBL-B and juxtapose TKB domain-associated PTKs with PRR-associated signaling proteins to hyper-activate signaling downstream of hematopoietic growth factor receptors. Elucidation of mutant CBL domains required for leukemogenesis should facilitate targeted therapy approaches for patients with mutant CBL-driven leukemias.	[Nadeau, Scott A.; An, Wei; Mohapatra, Bhopal C.; Mushtaq, Insha; Bielecki, Timothy A.; Luan, Haitao; Zutshi, Neha; Ahmad, Gulzar; Storck, Matthew D.; Band, Vimla; Band, Hamid] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Nadeau, Scott A.; An, Wei; Luan, Haitao; Band, Vimla; Band, Hamid] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [Mohapatra, Bhopal C.; Band, Hamid] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Mushtaq, Insha; Zutshi, Neha; Band, Hamid] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Coll Med, Omaha, NE 68198 USA; [Band, Vimla; Band, Hamid] Univ Nebraska Med Ctr, Fred & Pamela Buffet Canc Ctr, Omaha, NE 68198 USA; [Sanada, Masashi; Ogawa, Seishi] Kyoto Univ, Dept Pathol & Tumor Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Kyoto University	Band, H (corresponding author), Univ Nebraska Med Ctr, Eppley Inst, 985950 Nebraska Med Ctr, Omaha, NE 68198 USA.	hband@unmc.edu	Band, Hamid/AAF-4701-2020; Ogawa, Seishi/AAE-7088-2019	Mohapatra, Bhopal/0000-0003-3434-4306; Bielecki, Timothy/0000-0003-4561-0892; Storck, Matthew/0000-0002-4029-8943	National Institutes of Health NCI Cancer Center [P30CA036727]; NATIONAL CANCER INSTITUTE [R01CA096844, P30CA036727, R01CA144027, T32CA009476, R01CA099163, R01CA116552, R01CA105489, R01CA087986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106397] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26221308, 15H05909] Funding Source: KAKEN	National Institutes of Health NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Dr. Inder Verma (Salk Institute) for the gift of pCL-Eco plasmid and Dr. David Root (Broad Institute) for plK plasmid. We thank the Band laboratory members for discussion and the staff of the University of Nebraska Medical Center Flow Cytometry Research Facility and the Center for Comparative Medicine for assistance. The University of Nebraska Medical Center Confocal, Flow Cytometry, and other Core facilities were supported by National Institutes of Health NCI Cancer Center Support Grant P30CA036727 (to the Fred and Pamela Buffett Cancer Center and the Nebraska Research Initiative).	Adapala NS, 2010, J BIOL CHEM, V285, P36745, DOI 10.1074/jbc.M110.124628; An W, 2015, ONCOTARGET, V6, P10498, DOI 10.18632/oncotarget.3403; Andoniou CE, 2000, MOL CELL BIOL, V20, P851, DOI 10.1128/MCB.20.3.851-867.2000; ANDONIOU CE, 1994, EMBO J, V13, P4515, DOI 10.1002/j.1460-2075.1994.tb06773.x; Aranaz P, 2012, HAEMATOL-HEMATOL J, V97, P1234, DOI 10.3324/haematol.2011.052605; Bacher U, 2010, ANN HEMATOL, V89, P643, DOI 10.1007/s00277-010-0920-6; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Bao J, 2003, P NATL ACAD SCI USA, V100, P2438, DOI 10.1073/pnas.0437945100; Bard F, 2002, EUR J CELL BIOL, V81, P26, DOI 10.1078/0171-9335-00217; Bartkiewicz M, 1999, J BIOL CHEM, V274, P30887, DOI 10.1074/jbc.274.43.30887; Bonita DP, 1997, MOL CELL BIOL, V17, P4597, DOI 10.1128/MCB.17.8.4597; Bunda S, 2015, ONCOGENE, V34, P789, DOI 10.1038/onc.2013.596; Bunda S, 2013, CANCER RES, V73, P2540, DOI 10.1158/0008-5472.CAN-12-3425; Caligiuri MA, 2007, BLOOD, V110, P1022, DOI 10.1182/blood-2006-12-061176; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Davies GC, 2004, ONCOGENE, V23, P7104, DOI 10.1038/sj.onc.1207952; DONOVAN JA, 1994, J BIOL CHEM, V269, P22921; Duan L, 2011, J BIOL CHEM, V286, P620, DOI 10.1074/jbc.M110.188086; Dunbar AJ, 2008, CANCER RES, V68, P10349, DOI 10.1158/0008-5472.CAN-08-2754; Duyvestyn JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094717; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; Fernandes MS, 2010, J BIOL CHEM, V285, P32596, DOI 10.1074/jbc.M110.106161; FUKAZAWA T, 1995, J BIOL CHEM, V270, P19141, DOI 10.1074/jbc.270.32.19141; Ghosh AK, 2004, J BIOL CHEM, V279, P36132, DOI 10.1074/jbc.M404189200; Graham LJ, 1998, BIOCHEM BIOPH RES CO, V249, P537, DOI 10.1006/bbrc.1998.9177; Grand FH, 2009, BLOOD, V113, P6182, DOI 10.1182/blood-2008-12-194548; Griffiths EK, 2003, MOL CELL BIOL, V23, P7708, DOI 10.1128/MCB.23.21.7708-7718.2003; Javadi M, 2013, J BIOL CHEM, V288, P19459, DOI 10.1074/jbc.M113.475087; Kales SC, 2012, NAT STRUCT MOL BIOL, V19, P131, DOI 10.1038/nsmb.2241; Kassenbrock CK, 2004, J BIOL CHEM, V279, P28017, DOI 10.1074/jbc.M404114200; LANGDON WY, 1989, P NATL ACAD SCI USA, V86, P1168, DOI 10.1073/pnas.86.4.1168; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Lill NL, 2000, J BIOL CHEM, V275, P367, DOI 10.1074/jbc.275.1.367; Loh ML, 2009, BLOOD, V114, P1859, DOI 10.1182/blood-2009-01-198416; Lupher ML, 1998, J BIOL CHEM, V273, P35273, DOI 10.1074/jbc.273.52.35273; Lupher ML, 1996, J BIOL CHEM, V271, P24063, DOI 10.1074/jbc.271.39.24063; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; Makishima H, 2012, LEUKEMIA, V26, P1547, DOI 10.1038/leu.2012.7; Marengere LEM, 1997, J IMMUNOL, V159, P70; Masson K, 2006, BIOCHEM J, V399, P59, DOI 10.1042/BJ20060464; MEISNER H, 1995, MOL CELL BIOL, V15, P3571; Miura-Shimura Y, 2003, J BIOL CHEM, V278, P38495, DOI 10.1074/jbc.M305656200; Miyake S, 1998, P NATL ACAD SCI USA, V95, P7927, DOI 10.1073/pnas.95.14.7927; Mohapatra B, 2013, BBA-MOL CELL RES, V1833, P122, DOI 10.1016/j.bbamcr.2012.10.010; Muramatsu H, 2010, BLOOD, V115, P1969, DOI 10.1182/blood-2009-06-226340; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Nadeau S, 2012, BIOCH ANAL BIOCH, P7921, DOI DOI 10.4172/2161-1009.S6-001; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Naramura M, 2010, P NATL ACAD SCI USA, V107, P16274, DOI 10.1073/pnas.1007575107; Niemeyer CM, 2010, NAT GENET, V42, P794, DOI 10.1038/ng.641; Ota S, 2000, J BIOL CHEM, V275, P414, DOI 10.1074/jbc.275.1.414; Panchamoorthy G, 1996, J BIOL CHEM, V271, P3187, DOI 10.1074/jbc.271.6.3187; Rao N, 2001, EMBO J, V20, P7085, DOI 10.1093/emboj/20.24.7085; Rao N, 2000, J IMMUNOL, V164, P4616, DOI 10.4049/jimmunol.164.9.4616; Rao NV, 2002, P NATL ACAD SCI USA, V99, P3794, DOI 10.1073/pnas.062055999; Rathinam C, 2008, GENE DEV, V22, P992, DOI 10.1101/gad.1651408; Rathinam C, 2010, CANCER CELL, V18, P341, DOI 10.1016/j.ccr.2010.09.008; Reddi AL, 2007, J BIOL CHEM, V282, P29336, DOI 10.1074/jbc.M701797200; Reedquist KA, 1996, J BIOL CHEM, V271, P8435, DOI 10.1074/jbc.271.14.8435; REEDQUIST KA, 1994, P NATL ACAD SCI USA, V91, P4135, DOI 10.1073/pnas.91.10.4135; Ribon V, 1998, J BIOL CHEM, V273, P4073, DOI 10.1074/jbc.273.7.4073; RIVEROLEZCANO OM, 1994, J BIOL CHEM, V269, P17363; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Sanjay A, 2006, FEBS J, V273, P5442, DOI 10.1111/j.1742-4658.2006.05535.x; Sargin B, 2007, BLOOD, V110, P1004, DOI 10.1182/blood-2007-01-066076; SAWASDIKOSOL S, 1995, J BIOL CHEM, V270, P2893, DOI 10.1074/jbc.270.7.2893; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Tezuka T, 1996, J EXP MED, V183, P675, DOI 10.1084/jem.183.2.675; Thien CBF, 2001, MOL CELL, V7, P355, DOI 10.1016/S1097-2765(01)00183-6; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Wang HY, 2001, J BIOL CHEM, V276, P26004, DOI 10.1074/jbc.M010738200; Wang L, 2002, ONCOGENE, V21, P5346, DOI 10.1038/sj.onc.1205670; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; YEE NS, 1994, J BIOL CHEM, V269, P31991; Zeng S, 2005, BLOOD, V105, P226, DOI 10.1182/blood-2004-05-1768	77	8	8	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3666	3682		10.1074/jbc.M116.772723	http://dx.doi.org/10.1074/jbc.M116.772723			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28082680	Green Published, hybrid			2022-12-26	WOS:000395542500011
J	Vitale, S; Partida-Hanon, A; Serrano, S; Martinez-del-Pozo, A; Di Pietro, A; Turra, D; Bruix, M				Vitale, Stefania; Partida-Hanon, Angelica; Serrano, Soraya; Martinez-del-Pozo, Alvaro; Di Pietro, Antonio; Turra, David; Bruix, Marta			Structure-Activity Relationship of Mating Pheromone from the Fungal Pathogen Fusarium oxysporum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell division; fungi; G protein-coupled receptor (GPCR); peptides; pheromone; Fusarium oxysporum; chemotropism; hyphal growth inhibition	NMR CHEMICAL-SHIFTS; CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; ALPHA-FACTOR; YEAST-CELLS; PROTEIN; RECEPTOR; GENE; PEPTIDES; IDENTIFICATION	During sexual development ascomycete fungi produce two types of peptide pheromones termed a and . The pheromone from the budding yeast Saccharomyces cerevisiae, a 13-residue peptide that elicits cell cycle arrest and chemotropic growth, has served as paradigm for the interaction of small peptides with their cognate G protein-coupled receptors. However, no structural information is currently available for pheromones from filamentous ascomycetes, which are significantly shorter and share almost no sequence similarity with the S. cerevisiae homolog. High resolution structure of synthetic -pheromone from the plant pathogenic ascomycete Fusarium oxysporum revealed the presence of a central -turn resembling that of its yeast counterpart. Disruption of the-fold by d-alanine substitution of the conserved central Gly(6)-Gln(7) residues or by random sequence scrambling demonstrated a crucial role for this structural determinant in chemoattractant activity. Unexpectedly, the growth inhibitory effect of F. oxysporum -pheromone was independent of the cognate G protein-coupled receptors Ste2 and of the central -turn but instead required two conserved Trp(1)-Cys(2) residues at the N terminus. These results indicate that, despite their reduced size, fungal -pheromones contain discrete functional regions with a defined secondary structure that regulate diverse biological processes such as polarity reorientation and cell division.	[Vitale, Stefania; Di Pietro, Antonio; Turra, David] Univ Cordoba, Dept Genet, Campus Excelencia Int Agroalimentario CeiA3, E-14071 Cordoba, Spain; [Partida-Hanon, Angelica; Serrano, Soraya; Bruix, Marta] CSIC, Inst Phys Chem Rocasolano, Dept Biol Phys Chem, Serrano 119, Madrid 28006, Spain; [Martinez-del-Pozo, Alvaro] Univ Complutense, Fac Chem, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain	Universidad de Cordoba; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Complutense University of Madrid	Turra, D (corresponding author), Univ Cordoba, Dept Genet, Campus Excelencia Int Agroalimentario CeiA3, E-14071 Cordoba, Spain.; Bruix, M (corresponding author), CSIC, Inst Phys Chem Rocasolano, Dept Biol Phys Chem, Serrano 119, Madrid 28006, Spain.	ge3tutud@uco.es; mbruix@iqfr.csic.es	Di Pietro, Antonio/K-9220-2014; Vitale, Stefania/AAO-1929-2021; Bruix, Marta/H-4161-2011; Turra, David/AAC-9453-2020; Martinez-del-Pozo, Alvaro/L-8556-2014; Turrà, David/G-1193-2016	Di Pietro, Antonio/0000-0001-5930-5763; Bruix, Marta/0000-0002-0096-3558; Martinez-del-Pozo, Alvaro/0000-0003-0043-5939; Turrà, David/0000-0002-0687-6754; Vitale, Stefania/0000-0002-3580-2885; Partida-Hanon, Angelica/0000-0003-4367-2117	Spanish Ministerio de Economia y Competitividad (MINECO) [CTQ2014-52633-P, BFU2012-32404, BIO2013-47870-R]; Marie Curie ITN FUNGIBRAIN from the European Commission [FP7-PEOPLE-ITN-607963]; CONACYT (Consejo Nacional de Ciencia y Tecnologia) [579971]	Spanish Ministerio de Economia y Competitividad (MINECO); Marie Curie ITN FUNGIBRAIN from the European Commission; CONACYT (Consejo Nacional de Ciencia y Tecnologia)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the Spanish Ministerio de Economia y Competitividad (MINECO) through projects CTQ2014-52633-P, BFU2012-32404, and BIO2013-47870-R. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Marie Curie ITN FUNGIBRAIN (FP7-PEOPLE-ITN-607963) from the European Commission.; Recipient of a predoctoral fellowship 579971 from CONACYT (Consejo Nacional de Ciencia y Tecnologia).	Alby K, 2011, P NATL ACAD SCI USA, V108, P2510, DOI 10.1073/pnas.1017234108; Arkowitz RA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001958; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; BUCKINGTHROM E, 1973, EXP CELL RES, V76, P99, DOI 10.1016/0014-4827(73)90424-2; Ruiz-Roldan MC, 2010, EUKARYOT CELL, V9, P1216, DOI 10.1128/EC.00040-10; CHOU PY, 1979, BIOPHYS J, V26, P367, DOI 10.1016/S0006-3495(79)85259-5; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; de Antonio C, 2000, PROTEINS, V41, P350, DOI 10.1002/1097-0134(20001115)41:3<350::AID-PROT70>3.0.CO;2-V; de Jesus AJ, 2013, BBA-BIOMEMBRANES, V1828, P864, DOI 10.1016/j.bbamem.2012.09.009; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Di Pietro A, 2001, MOL MICROBIOL, V39, P1140, DOI 10.1111/j.1365-2958.2001.02307.x; Dignard D, 2006, EUKARYOT CELL, V5, P192, DOI 10.1128/EC.5.1.192-202.2006; ELION EA, 1993, MOL BIOL CELL, V4, P495, DOI 10.1091/mbc.4.5.495; Gelin-Licht R, 2012, CELL REP, V1, P483, DOI 10.1016/j.celrep.2012.03.004; Goddard T. D., 2005, SPARKY, P3; GRATHWOHL C, 1976, BIOPOLYMERS, V15, P2043, DOI 10.1002/bip.1976.360151013; Grieco P, 2011, J PEPT SCI, V17, P358, DOI 10.1002/psc.1350; Guntert Peter, 2004, Methods Mol Biol, V278, P353; JIMENEZ MA, 1993, EUR J BIOCHEM, V211, P569, DOI 10.1111/j.1432-1033.1993.tb17584.x; Jones SK, 2015, MBIO, V6, DOI 10.1128/mBio.01604-15; Jones SK, 2011, FUNGAL GENET BIOL, V48, P668, DOI 10.1016/j.fgb.2011.04.001; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KURJAN J, 1982, CELL, V30, P933, DOI 10.1016/0092-8674(82)90298-7; Lee BK, 2001, J BIOL CHEM, V276, P37950; Lin CH, 2011, MOL BIOL CELL, V22, P4918, DOI 10.1091/mbc.E11-09-0749; MANNEY TR, 1983, J BACTERIOL, V155, P291, DOI 10.1128/JB.155.1.291-301.1983; Markley JL, 1998, EUR J BIOCHEM, V256, P1, DOI 10.1046/j.1432-1327.1998.2560001.x; Martin SH, 2011, MOL BIOL EVOL, V28, P1987, DOI 10.1093/molbev/msr022; Naider F, 2004, PEPTIDES, V25, P1441, DOI 10.1016/j.peptides.2003.11.028; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Panwar SL, 2003, EUKARYOT CELL, V2, P1350, DOI 10.1128/EC.2.6.1350-1360.2003; PERKINS SJ, 1979, BIOCHIM BIOPHYS ACTA, V576, P409, DOI 10.1016/0005-2795(79)90416-1; Poggeler S., 2011, EVOLUTION FUNGI FUNG, P73; RENEKE JE, 1988, CELL, V55, P221, DOI 10.1016/0092-8674(88)90045-1; Roccatano D, 2002, P NATL ACAD SCI USA, V99, P12179, DOI 10.1073/pnas.182199699; ROTHEMUND S, 1995, BIOCHEMISTRY-US, V34, P12954, DOI 10.1021/bi00040a005; Schaefer D, 2007, EUKARYOT CELL, V6, P907, DOI 10.1128/EC.00090-07; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; SEGALL JE, 1993, P NATL ACAD SCI USA, V90, P8332, DOI 10.1073/pnas.90.18.8332; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SHENBAGAMURTHI P, 1985, BIOCHEMISTRY-US, V24, P7070, DOI 10.1021/bi00346a008; Turra D, 2016, SEMIN CELL DEV BIOL, V57, P69, DOI 10.1016/j.semcdb.2016.04.020; Turra D, 2015, NATURE, V527, P521, DOI 10.1038/nature15516; Turra D, 2015, CURR OPIN PLANT BIOL, V26, P135, DOI 10.1016/j.pbi.2015.07.004; VENKATACHALAM CM, 1968, BIOPOLYMERS, V6, P1425, DOI 10.1002/bip.1968.360061006; WADE D, 1990, P NATL ACAD SCI USA, V87, P4761, DOI 10.1073/pnas.87.12.4761; Wirth J, 1997, ARCH BIOCHEM BIOPHYS, V343, P188, DOI 10.1006/abbi.1997.0175; WISHART DS, 1995, J BIOMOL NMR, V5, P332, DOI 10.1007/BF00211764; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wuthrich K, 1986, NMR PROTEINS NUCL AC	52	6	6	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3591	3602		10.1074/jbc.M116.766311	http://dx.doi.org/10.1074/jbc.M116.766311			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28100777	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000395542500005
J	Boels, MGS; van Faassen, EEH; Avramut, MC; van der Vlag, J; van den Berg, BM; Rabelink, TJ				Boels, Margien G. S.; van Faassen, Ernst E. H.; Avramut, M. Cristina; van der Vlag, Johan; van den Berg, Bernard M.; Rabelink, Ton J.			Direct Observation of Enhanced Nitric Oxide in a Murine Model of Diabetic Nephropathy	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; FLUID SHEAR-STRESS; ENDOTHELIAL GLYCOCALYX; IRON-DITHIOCARBAMATE; RENAL-ALLOGRAFTS; SYNTHASE; CELLS; EXPRESSION; MELLITUS; MICE	Uncoupling of nitric oxide synthase (NOS) secondary to redox signaling is a central mechanism in endothelial and macrophage activation. To date studies on the production of nitric oxide (NO) during the development of diabetic complications show paradoxical results. We previously showed that recoupling eNOS by increasing the eNOS cofactor tetrahydrobiopterin (BH4) could restore endothelial function and prevent kidney injury in experimental kidney transplantation. Here, we employed a diabetic mouse model to investigate the effects of diabetes on renal tissue NO bioavailability. For this, we used in vivo NO trapping, followed by electron paramagnetic resonance spectroscopy. In addition, we investigated whether coupling of NOS by supplying the cofactor BH4 could restore glomerular endothelial barrier function. Our data show that overall NO availability at the tissue level is not reduced sixteen weeks after the induction of diabetes in apoE knockout mice, despite the presence of factors that cause endothelial dysfunction, and the presence of the endogenous NOS inhibitor ADMA. Targeting uncoupled NOS with the BH4 precursor sepiapterin further increases NO availability, but did not modify renal glomerular injury. Notably, glomerular heparanase activity as a driver for loss of glomerular barrier function was not reduced, pointing towards NOS independent mechanisms. This was confirmed by unaltered increased glomerular presence of cathepsin L, the protease that activates heparanase.	[Boels, Margien G. S.; van Faassen, Ernst E. H.; van den Berg, Bernard M.; Rabelink, Ton J.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Dept Internal Med Nephrol, Leiden, Netherlands; [Avramut, M. Cristina] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [van der Vlag, Johan] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, Nijmegen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen		m.g.s.boels@lumc.nl	Van der Vlag, Johan/E-4636-2010; Avramut, Mihaela Cristina/Y-2444-2018; van den berg, bernard m/D-8444-2014; Rabelink, Ton J./A-5316-2008	Van der Vlag, Johan/0000-0001-7843-5918; Avramut, Mihaela Cristina/0000-0002-2399-1746; Rabelink, Ton J./0000-0001-6780-5186; van den Berg, Bernard/0000-0002-5726-5777	Glycoren consortium grant of the Dutch Kidney Foundation [CP09.03]; AbbVie [REN-11-0026]	Glycoren consortium grant of the Dutch Kidney Foundation; AbbVie(AbbVie)	This study was supported by the Glycoren consortium grant of the Dutch Kidney Foundation (CP09.03) and an AbbVie study grant (REN-11-0026).	Adela R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125270; Arya A, 2011, MOL CELL BIOCHEM, V354, P57, DOI 10.1007/s11010-011-0805-6; AVASTHI PS, 1988, ANAT REC, V220, P258, DOI 10.1002/ar.1092200306; Boels MGS, 2016, DIABETES, V65, P2429, DOI 10.2337/db15-1413; BUCALA R, 1991, J CLIN INVEST, V87, P432, DOI 10.1172/JCI115014; Cai SJ, 2005, CARDIOVASC RES, V65, P823, DOI 10.1016/j.cardiores.2004.10.040; Chappell D, 2010, SHOCK, V34, P133, DOI 10.1097/SHK.0b013e3181cdc363; Cheng HF, 2012, KIDNEY INT, V82, P1176, DOI 10.1038/ki.2012.248; Constantinescu AA, 2003, ARTERIOSCL THROM VAS, V23, P1541, DOI 10.1161/01.ATV.0000085630.24353.3D; Dellamea BS, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-17; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Faas FGA, 2012, J CELL BIOL, V198, P457, DOI 10.1083/jcb.201201140; Florian JA, 2003, CIRC RES, V93, pE136, DOI 10.1161/01.RES.0000101744.47866.D5; Garsen M, 2016, KIDNEY INT; Garsen M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160894; Gil N, 2012, DIABETES, V61, P208, DOI 10.2337/db11-1024; Goldberg R, 2014, DIABETES, V63, P4302, DOI 10.2337/db14-0001; Gouverneur M, 2006, J INTERN MED, V259, P393, DOI 10.1111/j.1365-2796.2006.01625.x; Hohenstein B, 2008, NEPHROL DIAL TRANSPL, V23, P1346, DOI 10.1093/ndt/gfm797; Huisman A, 2002, FASEB J, V16, P1135, DOI 10.1096/fj.01-0890fje; Jover B, 2001, J CARDIOVASC PHARM, V38, pS65, DOI 10.1097/00005344-200111002-00016; Kanetsuna Y, 2007, AM J PATHOL, V170, P1473, DOI 10.2353/ajpath.2007.060481; Kashem A, 1996, KIDNEY INT, V50, P392, DOI 10.1038/ki.1996.328; Keynan S, 2000, KIDNEY INT, V58, P740, DOI 10.1046/j.1523-1755.2000.00220.x; Klessens CQ, 2016, NEPHROLOGY DIALYSIS; Koeners MP, 2007, HYPERTENSION, V50, P1077, DOI 10.1161/HYPERTENSIONAHA.107.095794; Komers R, 2003, AM J PHYSIOL-RENAL, V284, pF1121, DOI 10.1152/ajprenal.00265.2002; Lassila M, 2004, J AM SOC NEPHROL, V15, P2125, DOI 10.1097/01.ASN.0000133025.23732.46; Lucotti P, 2006, AM J PHYSIOL-ENDOC M, V291, pE906, DOI 10.1152/ajpendo.00002.2006; McNeill E, 2015, FREE RADICAL BIO MED, V79, P206, DOI 10.1016/j.freeradbiomed.2014.10.575; MOHAUPT MG, 1994, KIDNEY INT, V46, P653, DOI 10.1038/ki.1994.318; Mulivor AW, 2002, AM J PHYSIOL-HEART C, V283, pH1282, DOI 10.1152/ajpheart.00117.2002; Nakagawa T, 2007, AM J PHYSIOL-RENAL, V292, pF1665, DOI 10.1152/ajprenal.00495.2006; Nguyen D, 2006, NEPHROLOGY, V11, P226, DOI 10.1111/j.1440-1797.2006.00576.x; Nieuwdorp M, 2007, DIABETOLOGIA, V50, P1288, DOI 10.1007/s00125-007-0666-4; Noordzij MJ, 2008, J REN CARE, V34, P207, DOI 10.1111/j.1755-6686.2008.00038.x; Ohnishi ST, 1998, METH MOL B, V100, P129; Pahakis MY, 2007, BIOCHEM BIOPH RES CO, V355, P228, DOI 10.1016/j.bbrc.2007.01.137; Pflueger AC, 1999, AM J PHYSIOL-REG I, V277, pR725, DOI 10.1152/ajpregu.1999.277.3.R725; Prabhakar S, 2007, J AM SOC NEPHROL, V18, P2945, DOI 10.1681/ASN.2006080895; Rabelink TJ, 2006, ARTERIOSCL THROM VAS, V26, P267, DOI 10.1161/01.ATV.0000196554.85799.77; Rabelink TJ, 2015, NAT REV NEPHROL, V11, P667, DOI 10.1038/nrneph.2015.162; Rops AL, 2008, KIDNEY INT, V73, P52, DOI 10.1038/sj.ki.5002573; Schott U, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0239-y; Shafat I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017312; Shiekh Gazalla Ayub, 2011, J Cardiovasc Dis Res, V2, P172, DOI 10.4103/0975-3583.85264; Singh A, 2007, J AM SOC NEPHROL, V18, P2885, DOI 10.1681/ASN.2007010119; Tarbell JM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.140pt8; Tessari P, 2013, DIABETES, V62, P2699, DOI 10.2337/db12-1127; Tessari P, 2010, DIABETES, V59, P2152, DOI 10.2337/db09-1772; Tran TN, 1997, BLOOD, V90, P4979, DOI 10.1182/blood.V90.12.4979.4979_4979_4986; van den Berg BM, 2009, PFLUG ARCH EUR J PHY, V457, P1199, DOI 10.1007/s00424-008-0590-6; van den Berg BM, 2003, CIRC RES, V92, P592, DOI 10.1161/01.RES.0000065917.53950.75; van den Hoven MJ, 2006, KIDNEY INT, V70, P2100, DOI 10.1038/sj.ki.5001985; van Faassen EE, 2008, NITRIC OXIDE-BIOL CH, V18, P279, DOI 10.1016/j.niox.2008.02.003; Vanin AF, 2002, METHOD ENZYMOL, V359, P27; Vanin AF, 2006, NITRIC OXIDE-BIOL CH, V15, P295, DOI 10.1016/j.niox.2005.11.007; Vanin Anatoly F., 2007, P383, DOI 10.1016/B978-044452236-8/50018-6; Vlassara H, 2011, NAT REV ENDOCRINOL, V7, P526, DOI 10.1038/nrendo.2011.74; Vlassara H, 2009, SEMIN NEPHROL, V29, P594, DOI 10.1016/j.semnephrol.2009.07.013; Vos IHC, 2001, J AM SOC NEPHROL, V12, P361, DOI 10.1681/ASN.V122361; Weinbaum S, 2003, P NATL ACAD SCI USA, V100, P7988, DOI 10.1073/pnas.1332808100; Xu B, 2005, CLIN SCI, V109, P439, DOI 10.1042/CS20050183; Yan SF, 2008, NAT CLIN PRACT ENDOC, V4, P285, DOI 10.1038/ncpendmet0786; Zeng GY, 2000, CIRCULATION, V101, P1539, DOI 10.1161/01.CIR.101.13.1539	65	7	8	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170065	10.1371/journal.pone.0170065	http://dx.doi.org/10.1371/journal.pone.0170065			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103268	Green Published, gold, Green Submitted			2022-12-26	WOS:000392381100035
J	Yang, MZ; Du, JT; Li, ZW; Huang, S; Zhou, D				Yang, Mingzhi; Du, Juntao; Li, Zhiwei; Huang, Sha; Zhou, Dan			Moving Model Test of High-Speed Train Aerodynamic Drag Based on Stagnation Pressure Measurements	PLOS ONE			English	Article							WIND-TUNNEL EXPERIMENTS; REYNOLDS-NUMBER	A moving model test method based on stagnation pressure measurements is proposed to measure the train aerodynamic drag coefficient. Because the front tip of a high-speed train has a high pressure area and because a stagnation point occurs in the center of this region, the pressure of the stagnation point is equal to the dynamic pressure of the sensor tube based on the obtained train velocity. The first derivation of the train velocity is taken to calculate the acceleration of the train model ejected by the moving model system without additional power. According to Newton's second law, the aerodynamic drag coefficient can be resolved through many tests at different train speeds selected within a relatively narrow range. Comparisons are conducted with wind tunnel tests and numerical simulations, and good agreement is obtained, with differences of less than 6.1%. Therefore, the moving model test method proposed in this paper is feasible and reliable.	[Yang, Mingzhi; Du, Juntao; Li, Zhiwei; Huang, Sha; Zhou, Dan] Cent S Univ, Key Lab Rail Traff Safety, Minist Educ, Changsha, Hunan, Peoples R China; [Du, Juntao] CRRC QINGDAO SIFANG CO LTD, Qingdao, Shandong, Peoples R China	Central South University; CRRC Corporation	Li, ZW (corresponding author), Cent S Univ, Key Lab Rail Traff Safety, Minist Educ, Changsha, Hunan, Peoples R China.	lzhw1205@163.com			Project of Innovation-driven Plan in Central South University [2015CX003]; Major Programs of the National Science Foundation [U1134203, U1334205]; Key Laboratory of Aerodynamics Grant [201202]; Major Program of China Railway Engineering Corporation [2015T002-A]; National Science Foundation [11372360]; CRRC QINGDAO SIFANG CO., LTD	Project of Innovation-driven Plan in Central South University; Major Programs of the National Science Foundation; Key Laboratory of Aerodynamics Grant; Major Program of China Railway Engineering Corporation; National Science Foundation(National Science Foundation (NSF)); CRRC QINGDAO SIFANG CO., LTD	The funding of Project of Innovation-driven Plan in Central South University (2015CX003) and Major Programs of the National Science Foundation (U1134203, U1334205) provided support for the study design, data collection and analysis; the funding of The Key Laboratory of Aerodynamics Grant (201202) provided financial support in the form of research materials; the funding of the Major Program of China Railway Engineering Corporation (2015T002-A) and National Science Foundation Grant (11372360) provided support for the manuscript preparation and publication. In addition, CRRC QINGDAO SIFANG CO., LTD, provided support in the form of salaries for author [JTD], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of the author is articulated in the author contributions section.	Baker C. J., 1983, FACT AND FRICTION, P86; BAKER CJ, 1991, J WIND ENG IND AEROD, V38, P23, DOI 10.1016/0167-6105(91)90024-Q; Baron A, 2001, J WIND ENG IND AEROD, V89, P365, DOI 10.1016/S0167-6105(00)00071-4; BROCKIE NJW, 1990, J WIND ENG IND AEROD, V34, P273, DOI 10.1016/0167-6105(90)90156-7; Chen Y, 1998, CHINA RAILWAY, V2, P43; Gawthorpe R.G., 1978, RAILW ENG INT, V3, P7; Golovanevskiy VA, 2012, J WIND ENG IND AEROD, V107, P131, DOI 10.1016/j.jweia.2012.03.035; He Q., 1994, SCI FDN CHINA, V3, P30; Hemida H, 2010, J FLUID ENG-T ASME, V132, DOI 10.1115/1.4001447; HUMPHREYS ND, 1992, J WIND ENG IND AEROD, V44, P2673, DOI 10.1016/0167-6105(92)90059-J; Ido A., 2001, Q REP, V42, P94; Ido A, 1993, RTRI JNR, V7, P7; Johnson T, 2002, NOTE N FL MECH MUL D, V79, P123; Kwon H.-b., 2010, J FLUID SCI TECHNOLO, V5, P56; Kwon HB, 2001, J WIND ENG IND AEROD, V89, P1179, DOI 10.1016/S0167-6105(01)00107-6; Lu G., 2006, ROLLING STOCK, V44, P44; Lu G., 2006, RAILWAY VEHICLES, V44, P1; Lukaszewicz P, 2007, P I MECH ENG F-J RAI, V221, P331, DOI 10.1243/09544097JRRT88; Maeda T., 1989, Q REV RTRI, V30, P48; [缪新乐 Miao Xinle], 2012, [铁道科学与工程学报, Journal of Rail Way Science and Engineering], V9, P94; Peters J., 1983, INT J VEHICLE DES, VSP3, P308; Pope CW, 1991, 7 INT S AER VENT VEH, P48; Rochard BP, 2000, P I MECH ENG F-J RAI, V214, P185, DOI 10.1243/0954409001531306; Schetz JA, 2001, ANNU REV FLUID MECH, V33, P371, DOI 10.1146/annurev.fluid.33.1.371; Schober M, 2010, J WIND ENG IND AEROD, V98, P345, DOI 10.1016/j.jweia.2009.12.004; Shen Z., 1997, ACAD DYNAMIC REPORT, V3, P5; Shen Z., 2012, SCIENCE, V57, P594; Sun Pengpeng, 2012, RES AERODYNAMIC DRAG; Takagi R, 2005, W TECHNOLOGY, V4, P44; Tian H. Q., 2007, TRAIN AERODYNAMICS, P160; Willemsen E, 1997, J WIND ENG IND AEROD, V71, P437; Wood R. M., 2003, AIAA PAPER, P2003	32	23	27	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0169471	10.1371/journal.pone.0169471	http://dx.doi.org/10.1371/journal.pone.0169471			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095441	Green Submitted, Green Published, gold			2022-12-26	WOS:000392372300019
J	Batrel, C; Huet, A; Hasselmann, F; Wang, J; Desmadryl, G; Nouvian, R; Puel, JL; Bourien, J				Batrel, Charlene; Huet, Antoine; Hasselmann, Florian; Wang, Jing; Desmadryl, Gilles; Nouvian, Regis; Puel, Jean-Luc; Bourien, Jerome			Mass Potentials Recorded at the Round Window Enable the Detection of Low Spontaneous Rate Fibers in Gerbil Auditory Nerve	PLOS ONE			English	Article							NEURAL PHASE-LOCKING; GUINEA-PIG; COCHLEAR NERVE; MONGOLIAN GERBIL; RESPONSES; CAT; FREQUENCY; TONES; PATTERNS	Auditory nerve fibers (ANFs) transmit acoustic information from the sensory hair cells to the cochlear nuclei. In experimental and clinical audiology, probing the whole ANF population remains a difficult task, as the ANFs differ greatly in their threshold and onset response to sound. Thus, low spontaneous rate (SR) fibers, which have rather higher thresholds, delay and larger jitter in their first spike latency are not detectable in the far-field compound action potential of the auditory nerve. Here, we developed a new protocol of acoustic stimulation together with electrophysiological signal processing to track the steady state activity of ANFs. Mass potentials at the round window were recorded in response to repetitive 300-ms bursts of 1/3 octave band noise centered on a frequency probe. Analysis was assessed during the last 200-ms of the response to capture the steady-state response of ANFs. To eliminate the microphonic component reflecting the sensory cells activity, repetitive pairs of sounds of opposite polarities were used. The spectral analysis was calculated on the average of two consecutive responses, and the neural gain was calculated by dividing point-by-point the spectrum to sound over unstimulated condition. In response to low-sound-level stimulation, neural gain predominated in the low-frequency cochlear regions, while a second component of responses centered on higher cochlear frequency regions appeared beyond 30 dB SPL. At 60 dB SPL, neural gain showed a bimodal shape, with a notch near 5.6 kHz. In addition to correlate with the functional mapping of ANFs along the tonotopic axis, the deletion of low-SR fibers leads to a reduction in the high-frequency response, where the low-SR fibers are preferentially located. Thus, mass potentials at the round window may provide a useful tool to probe the SR-based distribution of ANFs in humans and in other species in which direct single-unit recordings are difficult to achieve or not feasible.	[Batrel, Charlene; Huet, Antoine; Hasselmann, Florian; Wang, Jing; Desmadryl, Gilles; Nouvian, Regis; Puel, Jean-Luc; Bourien, Jerome] INSERM, UMR 1051, Inst Neurosci Montpellier, Montpellier, France; [Batrel, Charlene; Huet, Antoine; Hasselmann, Florian; Wang, Jing; Desmadryl, Gilles; Nouvian, Regis; Puel, Jean-Luc; Bourien, Jerome] Univ Montpellier, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier	Puel, JL (corresponding author), INSERM, UMR 1051, Inst Neurosci Montpellier, Montpellier, France.; Puel, JL (corresponding author), Univ Montpellier, Montpellier, France.	jean-luc.puel@inserm.fr	Nouvian, Regis/AFQ-8065-2022; Huet, Antoine/GVS-4047-2022; Nouvian, Regis/AAW-4207-2021	Nouvian, Regis/0000-0002-0901-4666; Huet, Antoine/0000-0001-6151-7183; Nouvian, Regis/0000-0002-0901-4666; Puel, jean-luc/0000-0002-3772-5190; Bourien, Jerome/0000-0001-5860-5772	Inserm grant [U1051 -Dot 02-2014]; Cochlear France award [R11055FF/RVF11006FFA]; Fondation de l'Avenir [Et2-675]	Inserm grant(Institut National de la Sante et de la Recherche Medicale (Inserm)); Cochlear France award; Fondation de l'Avenir	This work was supported by Inserm grant (U1051 -Dot 02-2014), by Cochlear France award (R11055FF/RVF11006FFA) and by the Fondation de l'Avenir (Et2-675). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourien J, 2014, J NEUROPHYSIOL, V112, P1025, DOI 10.1152/jn.00738.2013; Cazals Y, 1998, J NEUROPHYSIOL, V80, P2113, DOI 10.1152/jn.1998.80.4.2113; COOPER NP, 1993, J NEUROPHYSIOL, V70, P370, DOI 10.1152/jn.1993.70.1.370; COSTALUPES JA, 1984, J NEUROPHYSIOL, V51, P1326, DOI 10.1152/jn.1984.51.6.1326; DALLOS P, 1973, AUDITORY PERIPHERY; DOLAN DF, 1990, J ACOUST SOC AM, V87, P2621, DOI 10.1121/1.399054; Eggermont J J, 1976, Rev Laryngol Otol Rhinol (Bord), V97 Suppl, P487; Forgues M, 2014, J NEUROPHYSIOL, V111, P580, DOI 10.1152/jn.00446.2013; Galambos R, 1943, J NEUROPHYSIOL, V6, P39, DOI 10.1152/jn.1943.6.1.39; HARRIS DM, 1979, J NEUROPHYSIOL, V42, P1083, DOI 10.1152/jn.1979.42.4.1083; Hayes M.H., 1996, STAT DIGITAL SIGNAL; Huet A, 2016, HEAR RES; JOHNSON DH, 1980, J ACOUST SOC AM, V68, P1115, DOI 10.1121/1.384982; JORIS PX, 1992, J ACOUST SOC AM, V91, P215, DOI 10.1121/1.402757; Joris PX, 2004, PHYSIOL REV, V84, P541, DOI 10.1152/physrev.00029.2003; Joris PX, 2003, J NEUROSCI, V23, P6345; Kiang N.Y.S., 1976, ELECTROCOCHLEOGRAPHY, P95; Kiang NYS, 1965, DISCHARGE PATTERNS S; LIBERMAN MC, 1978, J ACOUST SOC AM, V63, P442, DOI 10.1121/1.381736; Lichtenhan JT, 2013, EAR HEARING, V34, P42, DOI 10.1097/AUD.0b013e31825f9bd3; MARTIN WH, 1993, LARYNGOSCOPE, V103, P600; McMahon CM, 2002, HEARING RES, V173, P134, DOI 10.1016/S0378-5955(02)00281-2; Meyer AC, 2009, NAT NEUROSCI, V12, P444, DOI 10.1038/nn.2293; Muller M, 1996, HEARING RES, V94, P148, DOI 10.1016/0378-5955(95)00230-8; OHLEMILLER KK, 1990, J COMP PHYSIOL A, V167, P329; PALMER AR, 1986, HEARING RES, V24, P1, DOI 10.1016/0378-5955(86)90002-X; PRIJS VF, 1986, HEARING RES, V21, P127, DOI 10.1016/0378-5955(86)90034-1; RHODE WS, 1994, J NEUROPHYSIOL, V71, P1797, DOI 10.1152/jn.1994.71.5.1797; RHODE WS, 1985, HEARING RES, V18, P159, DOI 10.1016/0378-5955(85)90008-5; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; ROSE JE, 1967, J NEUROPHYSIOL, V30, P769, DOI 10.1152/jn.1967.30.4.769; SCHMIEDT RA, 1989, HEARING RES, V42, P23, DOI 10.1016/0378-5955(89)90115-9; Taberner AM, 2005, J NEUROPHYSIOL, V93, P557, DOI 10.1152/jn.00574.2004; TASAKI I, 1954, J NEUROPHYSIOL, V17, P97, DOI 10.1152/jn.1954.17.2.97; Verschooten E, 2015, J NEUROSCI, V35, P2255, DOI 10.1523/JNEUROSCI.2979-14.2015; Verschooten E, 2014, JARO-J ASSOC RES OTO, V15, P767, DOI 10.1007/s10162-014-0465-9; VERSNEL H, 1992, HEARING RES, V59, P138, DOI 10.1016/0378-5955(92)90111-Y; Versteegh CPC, 2011, JARO-J ASSOC RES OTO, V12, P301, DOI 10.1007/s10162-010-0255-y; WEISS TF, 1988, HEARING RES, V33, P175, DOI 10.1016/0378-5955(88)90030-5; WESTERMAN LA, 1984, HEARING RES, V15, P249, DOI 10.1016/0378-5955(84)90032-7	40	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0169890	10.1371/journal.pone.0169890	http://dx.doi.org/10.1371/journal.pone.0169890			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085968	gold, Green Published, Green Submitted			2022-12-26	WOS:000391972600042
J	Ettinger, G; Burton, JP; Gloor, GB; Reid, G				Ettinger, Grace; Burton, Jeremy P.; Gloor, Gregory B.; Reid, Gregor			Lactobacillus rhamnosus GR-1 Attenuates Induction of Hypertrophy in Cardiomyocytes but Not through Secreted Protein MSP-1 (p75)	PLOS ONE			English	Article							INDUCED CARDIAC-HYPERTROPHY; MYOCARDIAL-INFARCTION; GENE-EXPRESSION; HEART-FAILURE; INHIBITION; ACTIVATION; GROWTH; RAT	Previous animal studies have shown that the administration of probiotic Lactobacillus rhamnosus can provide a protective effect against ischemia/reperfusion and necrotic injury to the intestine, liver, and heart, as well as a therapeutic effect to the outcome of ischemic injury to the heart, including cardiac hypertrophy and heart failure. We hypothesized that L. rhamnosus GR-1 major secreted protein 1 (MSP-1), also known as p75, plays a major role in this phenomenon. Experiments using neonatal rat ventricular cardiomyocytes showed that live and dead GR-1 bacteria, probiotic-conditioned media, and other probiotic species and strains inhibited the alpha 1-adrenergic receptor agonist phenylephrine-induced hypertrophy as assessed by markers atrial natriuretic peptide and alpha-skeletal actin. However, using a mutant strain, we showed that this MSP-1 was not required for the inhibition. The ability of factors produced by lactobacilli to improve cardiac function warrants further study for the management of cardiac hypertrophy and heart failure.	[Ettinger, Grace; Burton, Jeremy P.; Gloor, Gregory B.; Reid, Gregor] Lawson Hlth Res Inst, London, ON, Canada; [Ettinger, Grace; Burton, Jeremy P.; Reid, Gregor] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada; [Burton, Jeremy P.; Reid, Gregor] Univ Western Ontario, Dept Surg Urol, London, ON, Canada; [Gloor, Gregory B.] Univ Western Ontario, Dept Biochem, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Reid, G (corresponding author), Lawson Hlth Res Inst, London, ON, Canada.; Reid, G (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada.; Reid, G (corresponding author), Univ Western Ontario, Dept Surg Urol, London, ON, Canada.	gregor@uwo.ca	Reid, Gregor/ABE-8327-2020; Gloor, Greg B/D-1671-2013; Burton, Jeremy/AAR-8902-2020	Reid, Gregor/0000-0001-9658-5696; Burton, Jeremy/0000-0002-3591-6436; Gloor, Gregory/0000-0001-5803-3380				CARRIER L, 1992, CIRC RES, V70, P999, DOI 10.1161/01.RES.70.5.999; CHIEN KR, 1991, FASEB J, V5, P3037, DOI 10.1096/fasebj.5.15.1835945; Claes IJJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031588; Fernandes AD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-15; Flynn S, 2002, MICROBIOL-SGM, V148, P973, DOI 10.1099/00221287-148-4-973; Gan XHT, 2005, J PHARMACOL EXP THER, V312, P27, DOI 10.1124/jpet.104.073122; Gan XT, 2014, CIRC-HEART FAIL, V7, P491, DOI 10.1161/CIRCHEARTFAILURE.113.000978; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Javadov S, 2006, J PHARMACOL EXP THER, V317, P1036, DOI 10.1124/jpet.105.100107; Lam V, 2012, FASEB J, V26, P1727, DOI 10.1096/fj.11-197921; Miyatake S, 2007, J CARDIOVASC PHARM, V50, P548, DOI 10.1097/FJC.0b013e318145ae2e; Moey M, 2012, CIRC-HEART FAIL, V5, P504, DOI 10.1161/CIRCHEARTFAILURE.112.967489; Moey M, 2011, J PHARMACOL EXP THER, V339, P746, DOI 10.1124/jpet.111.182600; Parameswaran S, 2013, CAN J PHYSIOL PHARM, V91, P985, DOI 10.1139/cjpp-2013-0161; SCHILLINGER U, 1989, APPL ENVIRON MICROB, V55, P1901, DOI 10.1128/AEM.55.8.1901-1906.1989; Siddiqui RA, 2004, J CELL BIOCHEM, V92, P1141, DOI 10.1002/jcb.20135; Yan F, 2002, J BIOL CHEM, V277, P50959, DOI 10.1074/jbc.M207050200; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Yan F, 2012, GUT MICROBES, V3, P25, DOI 10.4161/gmic.19245; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhao BJ, 2012, J PHYSIOL BIOCHEM, V68, P485, DOI 10.1007/s13105-012-0161-3	21	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0168622	10.1371/journal.pone.0168622	http://dx.doi.org/10.1371/journal.pone.0168622			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085895	Green Published, gold, Green Submitted			2022-12-26	WOS:000391972600007
J	Hinke, JT; Cossio, AM; Goebel, ME; Reiss, CS; Trivelpiece, WZ; Watters, GM				Hinke, Jefferson T.; Cossio, Anthony M.; Goebel, Michael E.; Reiss, Christian S.; Trivelpiece, Wayne Z.; Watters, George M.			Identifying Risk: Concurrent Overlap of the Antarctic Krill Fishery with Krill-Dependent Predators in the Scotia Sea	PLOS ONE			English	Article							SOUTH SHETLAND ISLANDS; SCALE MANAGEMENT UNITS; CHINSTRAP PENGUINS; EUPHAUSIA-SUPERBA; FUR SEALS; ARCTOCEPHALUS-GAZELLA; PYGOSCELID PENGUINS; MARINE ECOSYSTEM; DIVING BEHAVIOR; ARGOS LOCATIONS	Mitigating direct and indirect interactions between marine predators and fisheries is a motivating factor for ecosystem-based fisheries management (EBFM), especially where predators and fisheries compete for a shared resource. One difficulty in advancing EBFM is parameterizing clear functional responses of predators to indices of prey availability. Alternative characterizations of fishery-predator interactions may therefore benefit the implementation of EBFM. Telemetry data identify foraging areas used by predators and, therefore, represent critical information to mitigate potential competition between predators and fisheries. We analyzed six years (2009-2014) of telemetry data collected at Cape Shirreff, Livingston Island and Admiralty Bay, King George Island, Antarctica, on three species of Pygoscelid penguins and female Antarctic fur seals. In this region, all four species are primarily dependent on Antarctic krill. The tracking data demonstrate local movements near breeding colonies during the austral summer and dispersal from breeding colonies during the winter. We then assessed overlap between predators and the Antarctic krill fishery on a suite of spatiotemporal scales to examine how different data aggregations affect the extent and location of overlap. Concurrent overlap was observed on all spatiotemporal scales considered throughout the Antarctic Peninsula and South Orkney Islands region, including near tagging locations and in distant areas where recent fishing activity has concentrated. Overlap occurred at depths where mean krill densities were relatively high. Our results demonstrate that direct overlap of krill-dependent predators with the krill fishery on small spatiotemporal scales is relatively common throughout the Antarctic Peninsula region. As the krill fishery continues to develop and efforts to implement ecosystem-based management mature, indices of overlap may provide a useful metric for indicating where the risks of fishing are highest. A precautionary approach to allocating krill catches in space would be to avoid large increases in catch where overlap on small spatiotemporal scales is common.	[Hinke, Jefferson T.; Cossio, Anthony M.; Goebel, Michael E.; Reiss, Christian S.; Trivelpiece, Wayne Z.; Watters, George M.] Natl Marine Fisheries Serv, Antarctic Ecosyst Res Div, Southwest Fisheries Sci Ctr, NOAA, La Jolla, CA 92038 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Hinke, JT (corresponding author), Natl Marine Fisheries Serv, Antarctic Ecosyst Res Div, Southwest Fisheries Sci Ctr, NOAA, La Jolla, CA 92038 USA.	Jefferson.Hinke@noaa.gov	, Jefferson/AAG-1702-2021	, Jefferson/0000-0002-3600-1414				Agnew DJ, 1997, ANTARCT SCI, V9, P235, DOI 10.1017/S095410209700031X; [Anonymous], 2013, CONTRIBUTION WORKING, P1535; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; BENGTSON JL, 1993, ANTARCT SCI, V5, P9, DOI 10.1017/S0954102093000033; Betrand S, 2012, J APPL ECOL, V49, P1168; BOYD IL, 1994, J ANIM ECOL, V63, P703, DOI 10.2307/5235; Boyd IL, 2001, J ANIM ECOL, V70, P747, DOI 10.1046/j.0021-8790.2001.00534.x; Boyd IL, 1998, CAN J FISH AQUAT SCI, V55, P845, DOI 10.1139/cjfas-55-4-845; Commission for the Conservation of Antarctic Marine Living Resources, 2015, CONS MEAS 51 07 INT; Commission for the Conservation of Antarctic Marine Living Resources, 2016, STAT B, V28; Commission for the Conservation of Antarctic Marine Living Resources, 2010, 29 M COMM HOB; Commission for the Conservation of Antarctic Marine Living Resources, 2010, 10 M COMM HOB; Commission for the Conservation of Antarctic Marine Living Resources, 2013, 32 M COMM HOB; Constable AJ, 2004, B MAR SCI, V74, P583; Constable AJ, 2002, CCAMLR SCI, V9, P117; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; Costa Daniel P., 2000, P77; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; DANERI GA, 1992, POLAR BIOL, V11, P565; Daunt F, 2008, CAN J FISH AQUAT SCI, V65, P362, DOI 10.1139/F07-164; Demer DA, 2005, ICES J MAR SCI, V62, P25, DOI 10.1016/j.icesjms.2004.07.027; Dunn MJ, 2011, POLAR BIOL, V34, P205, DOI 10.1007/s00300-010-0870-4; Fach BA, 2006, DEEP-SEA RES PT I, V53, P987, DOI 10.1016/j.dsr.2006.03.006; Forcada J, 2009, GLOBAL CHANGE BIOL, V15, P1618, DOI 10.1111/j.1365-2486.2009.01909.x; Fraser W.R., 1996, FDN ECOLOGICAL RES W, P273; Freitas C, 2008, MAR MAMMAL SCI, V24, P315, DOI 10.1111/j.1748-7692.2007.00180.x; Goebel ME, 2014, AMLR 2010 11 FIELD S, P50; Hewitt Roger P., 2002, Oceanography, V15, P26; Hewitt RP, 2004, CCAMLR SCI, V11, P81; Hinke JT, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00287.1; Hinke JT, 2014, POLAR BIOL, V37, P1797, DOI 10.1007/s00300-014-1562-2; Hinke JT, 2007, OECOLOGIA, V153, P845, DOI 10.1007/s00442-007-0781-4; Hofmann EE, 1998, ANTARCT SCI, V10, P406, DOI 10.1017/S0954102098000492; Hucke-Gaete R, 2004, POLAR BIOL, V27, P304, DOI 10.1007/s00300-003-0587-8; Ichii T, 1998, DEEP-SEA RES PT I, V45, P1235, DOI 10.1016/S0967-0637(98)00011-9; Jiang MS, 2013, DEEP-SEA RES PT II, V90, P15, DOI 10.1016/j.dsr2.2013.02.029; Johnson DS, 2008, ECOLOGY, V89, P1208, DOI 10.1890/07-1032.1; Kawaguchi S, 2009, FISHERIES MANAG ECOL, V16, P424, DOI 10.1111/j.1365-2400.2009.00686.x; Krag LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102168; Lynch HJ, 2012, ECOLOGY, V93, P1367; MACARTHUR RH, 1958, ECOLOGY, V39, P599, DOI 10.2307/1931600; Miller AK, 2008, MAR BIOL, V154, P201, DOI 10.1007/s00227-008-0909-z; Murphy EJ, 1998, FISH OCEANOGR, V7, P381, DOI 10.1046/j.1365-2419.1998.00081.x; Nicol S, 2012, FISH FISH, V13, P30, DOI 10.1111/j.1467-2979.2011.00406.x; Nowacek DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019173; Pichegru L, 2010, BIOL LETTERS, V6, P498, DOI 10.1098/rsbl.2009.0913; Pikitch E, 2012, LITTLE FISH BIG IMPA; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Pinones A, 2013, MAR ECOL PROG SER, V481, P69, DOI 10.3354/meps10256; Plaganyi EE, 2012, ECOL APPL, V22, P748, DOI 10.1890/11-0441.1; REID K, 1995, ANTARCT SCI, V7, P241, DOI 10.1017/S0954102095000344; Reid K, 2005, ICES J MAR SCI, V62, P366, DOI 10.1016/j.icesjms.2004.11.003; Reid K, 2004, DEEP-SEA RES PT II, V51, P1383, DOI 10.1016/j.dsr2.2004.06.007; Reiss CS, 2008, ICES J MAR SCI, V65, P497, DOI 10.1093/icesjms/fsn033; Rice J, 2014, ICES J MAR SCI, V71, P143, DOI 10.1093/icesjms/fst151; Santora JA, 2014, POLAR BIOL, V37, P1083, DOI 10.1007/s00300-014-1502-1; Santora JA, 2013, MAR ECOL PROG SER, V487, P287, DOI 10.3354/meps10350; Santora JA, 2011, MAR BIOL, V158, P2527, DOI 10.1007/s00227-011-1753-0; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Scientific Committee for the Conservation of Antarctic Marine Living Resource, 2004, 23 M SCI COMM HOB CO; Scientific Committee for the Conservation of Antarctic Marine Living Resource, 2010, 29 M SCI COMM ANN 5; Sherley RB, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0237; Smith ADM, 2011, SCIENCE, V333, P1147, DOI 10.1126/science.1209395; Trivelpiece WZ, 2007, POLAR BIOL, V30, P1231, DOI 10.1007/s00300-007-0283-1; Trivelpiece WZ, 2011, P NATL ACAD SCI USA, V108, P7625, DOI 10.1073/pnas.1016560108; VOLKMAN NJ, 1980, CONDOR, V82, P373, DOI 10.2307/1367558; Watters GM, 2013, ECOL APPL, V23, P710, DOI 10.1890/12-1371.1; Wilson RP, 2010, FUNCT ECOL, V24, P646, DOI 10.1111/j.1365-2435.2009.01654.x	68	59	60	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0170132	10.1371/journal.pone.0170132	http://dx.doi.org/10.1371/journal.pone.0170132			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085943	gold, Green Submitted, Green Published			2022-12-26	WOS:000391972600066
J	Chen, YA; Lien, HM; Kao, MC; Lo, UG; Lin, LC; Lin, CJ; Chang, SJ; Chen, CC; Hsieh, JT; Lin, H; Tang, CH; Lai, CH				Chen, Yu-An; Lien, Hsiu-Man; Kao, Min-Chuan; Lo, U-Ging; Lin, Li-Chiung; Lin, Chun Jung; Chang, Sheau-Jiun; Chen, Chia-Chang; Hsieh, Jer-Tsong; Lin, Ho; Tang, Chih-Hsin; Lai, Chih-Ho			Sensitization of Radioresistant Prostate Cancer Cells by Resveratrol Isolated from Arachis hypogaea Stems	PLOS ONE			English	Article							CYTOLETHAL DISTENDING TOXIN; GENE-EXPRESSION; DOWN-REGULATION; DNA-DAMAGE; DAB2IP; APOPTOSIS; PEANUTS; RADIOTHERAPY; PATHWAYS; INFLAMMATION	Resveratrol (RV, 3,4' ,5-trihydroxystilbene) is naturally produced by a wide variety of plants including grapes and peanuts (Arachis hypogaea). However, the yield of RV from peanut stem and its potential radiosensitizing effects in prostate cancer (PCa) have not been well investigated. In this study, we characterized RV in peanut stem extract (PSE) for the first time and showed that both RV and PSE dose-dependently induced cell death in DOC-2/DAB2 interactive protein (DAB2IP)-deficient PCa cells with the radio-resistant phenotype. Furthermore, the combination of radiation with either RV or PSE induced the death of radioresistant PCa cells through delayed repair of radiation-induced DNA double-strand break (DSB) and prolonged G2/M arrest, which induced apoptosis. The administration of RV and PSE effectively enhanced radiation therapy in the shDAB2IP PCa xenograft mouse model. These results demonstrate the promising synergistic effect of RV and PSE combined with radiation in the treatment of radioresistant PCa.	[Chen, Yu-An; Tang, Chih-Hsin; Lai, Chih-Ho] China Med Univ, Grad Inst Basic Med Sci, Sch Med, Taichung, Taiwan; [Lien, Hsiu-Man] Hungkuang Univ, Biotechnol Res Inst, Taichung, Taiwan; [Kao, Min-Chuan; Lai, Chih-Ho] Chang Gung Univ, Grad Inst Biomed Sci, Dept Microbiol & Immunol, Coll Med, Taoyuan, Taiwan; [Lo, U-Ging; Lin, Li-Chiung; Lin, Chun Jung; Hsieh, Jer-Tsong] Univ Texas Southwestern Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA; [Lin, Li-Chiung; Lin, Ho] Natl Chung Hsing Univ, Dept Life Sci, Taichung, Taiwan; [Chang, Sheau-Jiun] Dachien Gen Hosp, Dept Rehabil, Miaoli, Taiwan; [Chen, Chia-Chang] Feng Chia Univ, Sch Management, Taichung, Taiwan; [Lai, Chih-Ho] Asia Univ, Dept Nursing, Taichung, Taiwan; [Lai, Chih-Ho] Chang Gung Mem Hosp, Mol Infect Dis Res Ctr, Taoyuan, Taiwan	China Medical University Taiwan; Hungkuang University; Chang Gung University; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Chung Hsing University; Feng Chia University; Asia University Taiwan; Chang Gung Memorial Hospital	Lai, CH (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA.	jt.hsieh@utsouthwestern.edu; hlin@dragen.nchu.edu.tw; chtang@mail.cmu.edu.tw; chlai@mail.cgu.edu.tw		Lin, Ho/0000-0001-7849-9137; Lin, Chun-Jung/0000-0002-2955-6913	Central Taiwan Science Park [103-RB04]; Ministry of Science and Technology [104-2911-I-005-501, 104-2320-B-182-040, 105-2313-B-182-001]; Chang Gung Memorial Hospital [CMRPD1F0011-3, CMRPD1F0431-3, BMRPE90]; Tomorrow Medical Foundation	Central Taiwan Science Park; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Tomorrow Medical Foundation	This study was supported by grants from Central Taiwan Science Park (103-RB04), Ministry of Science and Technology (104-2911-I-005-501, 104-2320-B-182-040, and 105-2313-B-182-001), Chang Gung Memorial Hospital (CMRPD1F0011-3, CMRPD1F0431-3, and BMRPE90), and the Tomorrow Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif GA, 2015, SCI REP-UK, V5, DOI 10.1038/srep12054; Angele S, 2004, AM J CLIN PATHOL, V121, P231, DOI 10.1309/JTKGGGKURFX3XMGT; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Benitez DA, 2009, PROSTATE, V69, P1045, DOI 10.1002/pros.20953; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Chen H, 2002, GENOMICS, V79, P573, DOI 10.1006/geno.2002.6739; Chen RS, 2013, N-S ARCH PHARMACOL, V386, P1047, DOI 10.1007/s00210-013-0905-9; Clement MV, 1998, BLOOD, V92, P996; de la Lastra CA, 2005, MOL NUTR FOOD RES, V49, P405; Dearnaley DP, 1999, LANCET, V353, P267, DOI 10.1016/S0140-6736(98)05180-0; DORNER JW, 1989, MYCOPATHOLOGIA, V105, P117, DOI 10.1007/BF00444034; Eisenberger MA, 1998, NEW ENGL J MED, V339, P1036, DOI 10.1056/NEJM199810083391504; Francisco MLDL, 2008, CRIT REV FOOD SCI, V48, P715, DOI 10.1080/10408390701640718; Gao Y, 2015, J ETHNOPHARMACOL, V169, P24, DOI 10.1016/j.jep.2015.03.074; Giovinazzo G, 2012, PLANT FOOD HUM NUTR, V67, P191, DOI 10.1007/s11130-012-0299-8; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jasinski M, 2013, CENT EUR J UROL, V66, P144, DOI 10.5173/ceju.2013.02.art8; Kma L, 2013, ASIAN PAC J CANCER P, V14, P6197, DOI 10.7314/APJCP.2013.14.11.6197; Kong ZL, 2010, CANCER RES, V70, P2829, DOI 10.1158/0008-5472.CAN-09-2919; Lai CK, 2015, FUTURE MICROBIOL, V10, P489, DOI [10.2217/FMB.14.119, 10.2217/fmb.14.119]; Lai CK, 2014, NANOMEDICINE-UK, V9, P803, DOI [10.2217/NNM.13.54, 10.2217/nnm.13.54]; Lai CH, 2014, ONCOTARGET, V5, P5523, DOI 10.18632/oncotarget.2133; Lien HM, 2013, J ETHNOPHARMACOL, V145, P397, DOI 10.1016/j.jep.2012.11.015; Lin CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146432; Lin HJ, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00341; Liu HH, 2014, BIOMEDICINE-TAIWAN, V4, P7, DOI 10.7603/s40681-014-0002-5; McMillan TJ, 2001, INT J RADIAT ONCOL, V49, P373, DOI 10.1016/S0360-3016(00)01467-X; Pong RC, 2006, CANCER RES, V66, P8822, DOI 10.1158/0008-5472.CAN-05-4672; Rao YK, 2012, FOOD CHEM, V132, P780, DOI 10.1016/j.foodchem.2011.11.037; Rashid A, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-144; Romero-Perez AI, 1999, J AGR FOOD CHEM, V47, P1533, DOI 10.1021/jf981024g; Sanders TH, 2000, J AGR FOOD CHEM, V48, P1243, DOI 10.1021/jf990737b; Selvaraj S, 2016, MOL CARCINOGEN, V55, P818, DOI 10.1002/mc.22324; Sim HG, 2005, EUR J CANCER, V41, P834, DOI 10.1016/j.ejca.2004.12.033; Smoliga JM, 2011, MOL NUTR FOOD RES, V55, P1129, DOI 10.1002/mnfr.201100143; Sobolev VS, 1999, J AGR FOOD CHEM, V47, P1435, DOI 10.1021/jf9809885; Su JL, 2007, J BIOL CHEM, V282, P19385, DOI 10.1074/jbc.M702452200; Surh YJ, 1999, CANCER LETT, V140, P1, DOI 10.1016/S0304-3835(99)00039-7; Tang FY, 2008, MOL NUTR FOOD RES, V52, P683, DOI 10.1002/mnfr.200700325; Tsai YS, 2014, ONCOTARGET, V5, P6425, DOI 10.18632/oncotarget.2228; Tsunoda T, 2014, ANTICANCER RES, V34, P4551; Tyagi A, 2011, CLIN CANCER RES, V17, P5402, DOI 10.1158/1078-0432.CCR-11-1072; Vergara D, 2012, MOL BIOSYST, V8, P1078, DOI 10.1039/c2mb05486h; Wang Y, 2002, J AGR FOOD CHEM, V50, P431, DOI 10.1021/jf010812u; Xie DX, 2010, P NATL ACAD SCI USA, V107, P2485, DOI 10.1073/pnas.0908133107; Xie DX, 2009, P NATL ACAD SCI USA, V106, P19878, DOI 10.1073/pnas.0908458106; Yu YH, 2013, ONCOGENE, V32, P431, DOI 10.1038/onc.2012.74; Yun EJ, 2014, ONCOGENE; Yun EJ, 2016, CLIN CANCER RES, V22, P670, DOI 10.1158/1078-0432.CCR-15-0190; Zhou J, 2003, J BIOL CHEM, V278, P6936, DOI 10.1074/jbc.M210628200	50	33	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169204	10.1371/journal.pone.0169204	http://dx.doi.org/10.1371/journal.pone.0169204			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081154	Green Published, gold, Green Submitted			2022-12-26	WOS:000391949500031
J	Tabish, AM; Poels, K; Byun, HM; Iuyts, K; Baccarelli, AA; Martens, J; Kerkhofs, S; Seys, S; Hoet, P; Godderis, L				Tabish, Ali M.; Poels, Katrien; Byun, Hyang-Min; Iuyts, Katrien; Baccarelli, Andrea A.; Martens, Johan; Kerkhofs, Stef; Seys, Sven; Hoet, Peter; Godderis, Lode			Changes in DNA Methylation in Mouse Lungs after a Single Intra-Tracheal Administration of Nanomaterials	PLOS ONE			English	Article							MULTIWALL CARBON NANOTUBES; GOLD NANOPARTICLES; PULMONARY EXPOSURE; TOXICITY; COMPLEX; BIOCOMPATIBILITY; CYTOTOXICITY; PARTICLES; SIZE	Aims This study aimed to investigate the effects of nanomaterial (NM) exposure on DNA methylation. Methods and Results Intra-tracheal administration of NM: gold nanoparticles (AuNPs) of 5-, 60-and 250-nm diameter; single-walled carbon nanotubes (SWCNTs) and multi-walled carbon nanotubes (MWCNTs) at high dose of 2.5 mg/kg and low dose of 0.25 mg/kg for 48 h to BALB/c mice. Study showed deregulations in immune pathways in NM-induced toxicity in vivo. NM administration had the following DNA methylation effects: AuNP 60 nm induced CpG hypermethylation in Atm, Cdk and Gsr genes and hypomethylation in Gpx; Gsr and Trp53 showed changes in methylation between low-and high-dose AuNP, 60 and 250 nm respectively, and AuNP had size effects on methylation for Trp53. Conclusion Epigenetics may be implicated in NM-induced disease pathways.	[Tabish, Ali M.; Poels, Katrien; Iuyts, Katrien; Hoet, Peter; Godderis, Lode] Katholieke Univ Leuven, Ctr Environm & Hlth, Leuven, Belgium; [Tabish, Ali M.] Integrated Cardio Metab Ctr, Huddinge, Sweden; [Byun, Hyang-Min; Baccarelli, Andrea A.] Harvard Sch Publ Hlth, Lab Environm Epigenet, Exposure Epidemiol & Risk Program, Boston, MA USA; [Martens, Johan; Kerkhofs, Stef] Katholieke Univ Leuven, Ctr Oppervlaktechemie & Katalyse, Leuven, Belgium; [Seys, Sven] Katholieke Univ Leuven, Clin Immunol Lab, Leuven, Belgium; [Godderis, Lode] IDEWE, External Serv Prevent & Protect Work, Heverlee, Belgium	KU Leuven; Harvard University; Harvard T.H. Chan School of Public Health; KU Leuven; KU Leuven	Tabish, AM (corresponding author), Katholieke Univ Leuven, Ctr Environm & Hlth, Leuven, Belgium.; Tabish, AM (corresponding author), Integrated Cardio Metab Ctr, Huddinge, Sweden.	ali.mustaffa.tabish@gmail.com	Byun, Hyang-Min/X-2843-2018; Hoet, Peter/H-9987-2013; Godderis, Lode/AAE-5880-2019	Byun, Hyang-Min/0000-0002-6278-3165; Hoet, Peter/0000-0002-0292-6603; Godderis, Lode/0000-0003-4764-8835; Martens, Johan/0000-0002-9292-2357; Seys, Sven/0000-0002-4399-9892	Fonds Wetenschappelijk Onderzoek (FWO), Belgium [3M090531]; National Institutes of Environmental Health Sciences, US [R01ES021733]	Fonds Wetenschappelijk Onderzoek (FWO), Belgium(FWO); National Institutes of Environmental Health Sciences, US	The research was funded by grants from Fonds Wetenschappelijk Onderzoek (FWO) (3M090531), Belgium and National Institutes of Environmental Health Sciences (R01ES021733), US.	Al Sharif M, 2014, PPAR RES, V2014, DOI 10.1155/2014/432647; Alkilany AM, 2010, J NANOPART RES, V12, P2313, DOI 10.1007/s11051-010-9911-8; Baccarelli A, 2009, CURR OPIN PEDIATR, V21, P243, DOI 10.1097/MOP.0b013e32832925cc; Boczkowski J, 2012, ADV DRUG DELIVER REV, V64, P1694, DOI 10.1016/j.addr.2012.05.011; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Chen YS, 2009, NANOSCALE RES LETT, V4, P858, DOI 10.1007/s11671-009-9334-6; Coccini T, 2014, J NANOMEDICINE NANOT, V2014; Dao T, 2014, Curr Environ Health Rep, V1, P1; De Vooght V, 2009, TOXICOLOGY, V259, P84, DOI 10.1016/j.tox.2009.02.007; Ding LH, 2005, NANO LETT, V5, P2448, DOI 10.1021/nl051748o; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Fedulov AV, 2008, AM J RESP CELL MOL, V38, P57, DOI 10.1165/rcmb.2007-0124OC; Godderis L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/845041; Godderis L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039205; Gong CM, 2012, TOXICOL LETT, V209, P264, DOI 10.1016/j.toxlet.2012.01.007; Gong CM, 2010, BIOCHEM BIOPH RES CO, V397, P397, DOI 10.1016/j.bbrc.2010.05.076; Hill PS, 2014, GENOMICS, V104, P324, DOI 10.1016/j.ygeno.2014.08.012; Hussain S, 2011, EUR RESPIR J, V37, P299, DOI 10.1183/09031936.00168509; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Khan JA, 2007, CHEMBIOCHEM, V8, P1237, DOI 10.1002/cbic.200700165; Li SC, 2011, BIOMATERIALS, V32, P9021, DOI 10.1016/j.biomaterials.2011.08.033; Lu X., 2015, NAT COMMUN, P1; Luconi M, 2010, STEROIDS, V75, P585, DOI 10.1016/j.steroids.2009.10.012; Luyts K, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0061-5; Luyts K, 2013, ENVIRON SCI-PROC IMP, V15, P23, DOI 10.1039/c2em30237c; Ma-Hock L, 2009, TOXICOL SCI; Manke A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/942916; Meng J, 2011, NANOTOXICOLOGY, V5, P583, DOI 10.3109/17435390.2010.523483; Napierska D, 2012, CHEM RES TOXICOL, V25, P828, DOI 10.1021/tx200361v; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Pan Y, 2007, SMALL, V3, P1941, DOI 10.1002/smll.200700378; Pogribny IP, 2014, CANCER LETT, V342, P223, DOI 10.1016/j.canlet.2012.01.038; Poirier LA, 2002, ENVIRON HEALTH PERSP, V110, P793, DOI 10.1289/ehp.02110s5793; Powers KW, 2007, NANOTOXICOLOGY, V1, P42, DOI 10.1080/17435390701314902; Ravichandran P, 2011, J BIOL CHEM, V286, P29725, DOI 10.1074/jbc.M111.251884; Sabella S, 2011, J NANOPART RES, V13, P6821, DOI 10.1007/s11051-011-0590-x; Sadauskas E, 2009, CHEM CENT J, V3, DOI 10.1186/1752-153X-3-16; Shukla R, 2005, LANGMUIR, V21, P10644, DOI 10.1021/la0513712; Smulders S, 2015, TOXICOL LETT, V232, P333, DOI 10.1016/j.toxlet.2014.11.030; Suliman YA, 2015, ENVIRON TOXICOL, V30, P149, DOI 10.1002/tox.21880; Tabish AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034674; Terzano C, 2010, EUR REV MED PHARMACO, V14, P809; WAAGE A, 1989, J EXP MED, V169, P333, DOI 10.1084/jem.169.1.333; Yang M, 2012, THERANOSTICS, V2, P258, DOI 10.7150/thno.3629	44	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169886	10.1371/journal.pone.0169886	http://dx.doi.org/10.1371/journal.pone.0169886			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081255	Green Published, Green Submitted, gold			2022-12-26	WOS:000391949500096
J	Perren, BB; Axford, Y; Kaufman, DS				Perren, Bianca B.; Axford, Yarrow; Kaufman, Darrell S.			Alder, Nitrogen, and Lake Ecology: Terrestrial-Aquatic Linkages in the Postglacial History of Lone Spruce Pond, Southwestern Alaska	PLOS ONE			English	Article							NUTRIENT LIMITATION; SOIL DEVELOPMENT; NORTH-AMERICAN; GLACIER BAY; CLIMATE; DEPOSITION; RECORD; COMMUNITIES; SUCCESSION; RESPONSES	Diatoms, combined with a multiproxy study of lake sediments (organic matter, N, delta N-15, delta C-13, biogenic silica, grain size, Cladocera and chironomids, Alnus pollen) from Lone Spruce Pond, Alaska detail the late-glacial to Holocene history of the lake and its response to regional climate and landscape change over the last 14.5 cal ka BP. We show that the immigration of alder (Alnus viridis) in the early Holocene marks the rise of available reactive nitrogen (Nr) in the lake as well as the establishment of a primarily planktonic diatom community. The later establishment of diatom Discostella stelligera is coupled to a rise of sedimentary delta N-15, indicating diminished competition for this nutrient. This terrestrial-aquatic linkage demonstrates how profoundly vegetation may affect soil geochemistry, lake development, and lake ecology over millennial timescales. Furthermore, the response of the diatom community to strengthened stratification and N levels in the past confirms the sensitivity of planktonic diatom communities to changing thermal and nutrient regimes. These past ecosystem dynamics serve as an analogue for the nature of threshold-type ecological responses to current climate change and atmospheric nitrogen (Nr) deposition, but also for the larger changes we should anticipate under future climate, pollution, and vegetation succession scenarios in high-latitude and high-elevation regions.	[Perren, Bianca B.] British Antarct Survey, High Cross, Cambridge, England; [Axford, Yarrow] Northwestern Univ, Dept Earth & Planetary Sci, Evanston, IL USA; [Kaufman, Darrell S.] No Arizona Univ, Sch Earth Sci & Environm Sustainabil, Flagstaff, AZ USA	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Northwestern University; Northern Arizona University	Perren, BB (corresponding author), British Antarct Survey, High Cross, Cambridge, England.	biaper@bas.ac.uk	Kaufman, Darrell/A-2471-2008; Axford, Yarrow/N-4151-2014	Kaufman, Darrell/0000-0002-7572-1414; Axford, Yarrow/0000-0002-8033-358X; Perren, Bianca/0000-0001-6089-6468	National Science Foundation (USA) [ARC-0909332]; Natural Environment Research Council [bas0100030] Funding Source: researchfish; NERC [bas0100030] Funding Source: UKRI	National Science Foundation (USA)(National Science Foundation (NSF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by the National Science Foundation (USA) in the form of grant #ARC-0909332 to DK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott MB, 2010, QUATERNARY RES, V74, P156, DOI 10.1016/j.yqres.2010.03.007; Alley RB, 2000, QUATERNARY SCI REV, V19, P213, DOI 10.1016/S0277-3791(99)00062-1; Barley EM, 2006, J PALEOLIMNOL, V36, P295, DOI 10.1007/s10933-006-0014-6; BATTARBEE RW, 1982, LIMNOL OCEANOGR, V27, P184, DOI 10.4319/lo.1982.27.1.0184; Bennett KD, 1996, NEW PHYTOL, V132, P155, DOI 10.1111/j.1469-8137.1996.tb04521.x; Bergstrom AK, 2006, GLOBAL CHANGE BIOL, V12, P635, DOI 10.1111/j.1365-2486.2006.01129.x; Bergstrom AK, 2005, LIMNOL OCEANOGR, V50, P987, DOI 10.4319/lo.2005.50.3.0987; Besonen MR, 2008, HOLOCENE, V18, P169, DOI 10.1177/0959683607085607; Bobbink R, 2010, ECOL APPL, V20, P30, DOI 10.1890/08-1140.1; Bonilla S, 2005, J PHYCOL, V41, P1120, DOI 10.1111/j.1529-8817.2005.00154.x; Brodersen KP, 2004, LIMNOL OCEANOGR, V49, P1549; CROCKER RL, 1955, J ECOL, V43, P427, DOI 10.2307/2257005; Engstrom DR, 2006, J PALEOLIMNOL, V35, P873, DOI 10.1007/s10933-005-5858-7; ENGSTROM DR, 1990, SCIENCE, V250, P1383, DOI 10.1126/science.250.4986.1383; Engstrom DR, 2000, NATURE, V408, P161, DOI 10.1038/35041500; Fee EJ, 1996, LIMNOL OCEANOGR, V41, P912, DOI 10.4319/lo.1996.41.5.0912; Fritz SC, 2013, J PALEOLIMNOL, V49, P349, DOI 10.1007/s10933-013-9684-z; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; GRIMM EC, 1987, COMPUT GEOSCI, V13, P13, DOI 10.1016/0098-3004(87)90022-7; Hastings MG, 2009, SCIENCE, V324, P1288, DOI 10.1126/science.1170510; Hobbs WO, 2016, GLOBAL BIOGEOCHEM CY, V30, P514, DOI 10.1002/2015GB005228; Hogan EJ, 2014, POLAR BIOL, V37, P1331, DOI 10.1007/s00300-014-1524-8; Holland MM, 2003, CLIM DYNAM, V21, P221, DOI 10.1007/s00382-003-0332-6; Holtgrieve GW, 2011, SCIENCE, V334, P1545, DOI 10.1126/science.1212267; Hu FS, 2001, ECOSYSTEMS, V4, P358, DOI 10.1007/s10021-001-0017-0; Juggins S., 2003, C2 USER GUIDE SOFTWA, DOI DOI 10.1016/j.ecolind.2004.01.004; Kaufman DS, 2016, QUATERNARY SCI REV, V147, P312, DOI 10.1016/j.quascirev.2015.10.021; Kaufman DS, 2011, DEV QUATER SCI, V15, P427, DOI 10.1016/B978-0-444-53447-7.00033-7; Kaufman DS, 2012, J PALEOLIMNOL, V48, P9, DOI 10.1007/s10933-012-9607-4; Kaufman DS, 2010, QUATERNARY SCI REV, V29, P1445, DOI 10.1016/j.quascirev.2010.02.025; Kaufman DS, 2004, QUATERNARY SCI REV, V23, P529, DOI 10.1016/j.quascirev.2003.09.007; Lotter AF, 1992, CLIM DYNAM, V6, P233, DOI 10.1007/BF00193536; Malik HI, 2016, J PLANKTON RES, V38, P431, DOI 10.1093/plankt/fbw002; Mitchell JS, 2009, BIOGEOCHEMISTRY, V95, P215, DOI 10.1007/s10533-009-9332-x; Perren BB, 2003, ARCT ANTARCT ALP RES, V35, P271, DOI 10.1657/1523-0430(2003)035[0271:RLRTRH]2.0.CO;2; Perren BB, 2012, J PALEOLIMNOLOGY, V48; Perren BB, 2012, GEOLOGY, V40, P1003, DOI 10.1130/G33621.1; Ramrath A, 1999, J PALEOLIMNOL, V21, P423, DOI 10.1023/A:1008006424706; RENBERG I, 1990, Journal of Paleolimnology, V4, P87; Rhoades C, 2001, ECOSCIENCE, V8, P89, DOI 10.1080/11956860.2001.11682634; Rioja, 2015, ANAL QUATERNARY SCI; Ruhland KM, 2015, J PALEOLIMNOL, V54, P1, DOI 10.1007/s10933-015-9837-3; Ruess RW, 2009, ECOSYSTEMS, V12, P489, DOI 10.1007/s10021-009-9237-5; Ruhland K, 2008, GLOBAL CHANGE BIOL, V14, P2740, DOI 10.1111/j.1365-2486.2008.01670.x; Saros JE, 2015, BIOL REV, V90, P522, DOI 10.1111/brv.12120; Saros JE, 2012, ECOLOGY, V93, P2155, DOI 10.1890/11-2218.1; Saros JE, 2016, LIMNOLOGY OCEANOGRAP; Serreze MC, 2009, CRYOSPHERE, V3, P11, DOI 10.5194/tc-3-11-2009; Smol JP, 2005, P NATL ACAD SCI USA, V102, P4397, DOI 10.1073/pnas.0500245102; Stocker TF, 2013, CONTRIBUTION WORKING; Trenberth KE, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; WALKER LR, 1989, ARCTIC ALPINE RES, V21, P341, DOI 10.2307/1551644; Western Regional Climate Center (WRCC), 2008, DILL FAA AIRP; Winder M, 2009, P ROY SOC B-BIOL SCI, V276, P427, DOI 10.1098/rspb.2008.1200; Wolfe AP, EARTH SCI	56	9	9	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169106	10.1371/journal.pone.0169106	http://dx.doi.org/10.1371/journal.pone.0169106			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076393	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000391857100021
J	Kim, HS; Jung, M; Kang, HN; Kim, H; Park, CW; Kim, SM; Shin, SJ; Kim, SH; Kim, SG; Kim, EK; Yun, MR; Zheng, Z; Chung, KY; Greenbowe, J; Ali, SM; Kim, TM; Cho, BC				Kim, H. S.; Jung, M.; Kang, H. N.; Kim, H.; Park, C-W; Kim, S-M; Shin, S. J.; Kim, S. H.; Kim, S. G.; Kim, E. K.; Yun, M. R.; Zheng, Z.; Chung, K. Y.; Greenbowe, J.; Ali, S. M.; Kim, T-M; Cho, B. C.			Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibition	ONCOGENE			English	Article							SEQUENCING DATA; IMPROVED SURVIVAL; TARGETED THERAPY; MUTATED MELANOMA; MUTANT MELANOMA; MEK INHIBITION; RAF INHIBITORS; GENE FUSIONS; CANCER; MUTATIONS	Despite remarkable progress in cutaneous melanoma genomic profiling, the mutational landscape of primary mucosal melanomas (PMM) remains unclear. Forty-six PMMs underwent targeted exome sequencing of 111 cancer-associated genes. Seventy-six somatic nonsynonymous mutations in 42 genes were observed, and recurrent mutations were noted on eight genes, including TP53 (13%), NRAS (13%), SNX31 (9%), NF1 (9%), KIT (7%) and APC (7%). Mitogen-activated protein kinase (MAPK; 37%), cell cycle (20%) and phosphatidylinositol 3-kinase (PI3K)-mTOR (15%) pathways were frequently mutated. We biologically characterized a novel ZNF767-BRAF fusion found in a vemurafenib-refractory respiratory tract PMM, from which cell line harboring ZNF767-BRAF fusion were established for further molecular analyses. In an independent data set, NFIC-BRAF fusion was identified in an oral PMM case and TMEM178B-BRAF fusion and DGKI-BRAF fusion were identified in two malignant melanomas with a low mutational burden (number of mutation per megabase, 0.8 and 4, respectively). Subsequent analyses revealed that the ZNF767-BRAF fusion protein promotes RAF dimerization and activation of the MAPK pathway. We next tested the in vitro and in vivo efficacy of vemurafenib, trametinib, BKM120 or LEE011 alone and in combination. Trametinib effectively inhibited tumor cell growth in vitro, but the combination of trametinib and BKM120 or LEE011 yielded more than additive anti-tumor effects both in vitro and in vivo in a melanoma cells harboring the BRAF fusion. In conclusion, BRAF fusions define a new molecular subset of PMM that can be targeted therapeutically by the combination of a MEK inhibitor with PI3K or cyclin-dependent kinase 4/ 6 inhibitors.	[Kim, H. S.; Jung, M.; Shin, S. J.; Cho, B. C.] Yonsei Univ, Div Med Oncol, Dept Internal Med, Coll Med,Yonsei Canc Ctr, 50 Yonsei Ro, Seoul 120752, South Korea; [Kim, H. S.] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Dept Pharmacol, Seoul, South Korea; [Kang, H. N.; Kim, H.; Park, C-W; Kim, S-M; Kim, S. G.; Yun, M. R.] JEUK Co Ltd, JEUK Inst Canc Res, Gumi, Kyungbuk, South Korea; [Kim, S. H.; Kim, E. K.] Yonsei Univ, Dept Pathol, Coll Med, Seoul, South Korea; [Kim, S. H.] Seegene Med Fdn, Anat Pathol Reference Lab, Seoul, South Korea; [Zheng, Z.] Yanbian Univ Hosp, Dept Dermatol, Yanji, Peoples R China; [Chung, K. Y.] Yonsei Univ, Coll Med, Dept Dermatol, Seoul, South Korea; [Greenbowe, J.; Ali, S. M.] Fdn Med Inc, Cambridge, MA 02141 USA; [Kim, T-M] Catholic Univ Korea, Dept Med Informat, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yanbian University; Yonsei University; Yonsei University Health System; Foundation Medicine; Catholic University of Korea	Cho, BC (corresponding author), Yonsei Univ, Div Med Oncol, Dept Internal Med, Coll Med,Yonsei Canc Ctr, 50 Yonsei Ro, Seoul 120752, South Korea.; Ali, SM (corresponding author), Fdn Med Inc, Cambridge, MA 02141 USA.; Kim, TM (corresponding author), Catholic Univ Korea, Seoul 137701, South Korea.	sali@foundationmedicine.com; tmkim@catholic.ac.kr; cbc1971@yuhs.ac	Kim, Han Sang/R-3768-2019; Ali, Siraj/AAE-2958-2019; Kim, Eun-Kyung/E-5211-2017	Kim, Han Sang/0000-0002-6504-9927; Jung, Minkyu/0000-0001-8281-3387; Kim, Eun-Kyung/0000-0002-3368-5013; Shin, Sang Joon/0000-0001-5350-7241; Cho, Byoung Chul/0000-0002-5562-270X; Chung, Kee Yang/0000-0003-3257-0297	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2014R1A1A1004823]; NRF by the Korean government (MEST) [2012R1A2A2A01046927]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning; NRF by the Korean government (MEST)	This study was supported in part by a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT and Future Planning (2014R1A1A1004823 to M Jung), and the NRF by the Korean government (MEST; 2012R1A2A2A01046927 to B Cho). The results of the analysis of mutation frequencies in cutaneous melanomas compared with corresponding frequencies in PMM were based on TCGA Research Network generated data (http://cancergenome.nih.gov/).	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Campbell PM, 2004, SEMIN CANCER BIOL, V14, P105, DOI 10.1016/j.semcancer.2003.09.015; Chang AE, 1998, CANCER, V83, P1664, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Ciampi R, 2005, J CLIN INVEST, V115, P94, DOI 10.1172/JCI200523237; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Cutler RE, 1998, P NATL ACAD SCI USA, V95, P9214, DOI 10.1073/pnas.95.16.9214; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dessars B, 2007, J INVEST DERMATOL, V127, P1468, DOI 10.1038/sj.jid.5700725; Deuker MM, 2015, CANCER DISCOV, V5, P143, DOI 10.1158/2159-8290.CD-14-0856; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Ge HY, 2011, BIOINFORMATICS, V27, P1922, DOI 10.1093/bioinformatics/btr310; Ghai R, 2011, P NATL ACAD SCI USA, V108, P7763, DOI 10.1073/pnas.1017110108; Giehl K, 2005, BIOL CHEM, V386, P193, DOI 10.1515/BC.2005.025; Girotti MR, 2015, CANCER CELL, V27, P85, DOI 10.1016/j.ccell.2014.11.006; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hutchinson KE, 2013, CLIN CANCER RES, V19, P6696, DOI 10.1158/1078-0432.CCR-13-1746; Iyer MK, 2011, BIOINFORMATICS, V27, P2903, DOI 10.1093/bioinformatics/btr467; Jeuken JWM, 2010, J PATHOL, V222, P324, DOI 10.1002/path.2780; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Kwong LN, 2012, NAT MED, V18, P1503, DOI 10.1038/nm.2941; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Mihajlovic M, 2012, INT J CLIN EXP PATHO, V5, P739; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Posch C, 2013, P NATL ACAD SCI USA, V110, P4015, DOI 10.1073/pnas.1216013110; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Ross JS, 2016, INT J CANCER, V138, P881, DOI 10.1002/ijc.29825; Seetharamu N, 2010, ONCOLOGIST, V15, P772, DOI 10.1634/theoncologist.2010-0067; Stark MS, 2012, NAT GENET, V44, P165, DOI 10.1038/ng.1041; Sullivan RJ, 2013, ONCOGENE, V32, P2373, DOI 10.1038/onc.2012.345; The National Comprehensive Cancer Network (NCCN), 2018, NCCN CLIN PRACT GUID; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Van Allen EM, 2014, NAT MED, V20, P682, DOI 10.1038/nm.3559; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433; Worm J, 2004, ONCOGENE, V23, P5215, DOI 10.1038/sj.onc.1207647; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Zhang C, 2015, NATURE, V526, P583, DOI 10.1038/nature14982	52	57	59	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 8	2017	36	23					3334	3345		10.1038/onc.2016.486	http://dx.doi.org/10.1038/onc.2016.486			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EW9WJ	28092667				2022-12-26	WOS:000402869800012
J	Bauer, B; Wotapek, T; Zoller, T; Rutkowski, E; Steinle, A				Bauer, Bjoern; Wotapek, Tanja; Zoeller, Tobias; Rutkowski, Emilia; Steinle, Alexander			The Activating C-type Lectin-like Receptor NKp65 Signals through a Hemi-immunoreceptor Tyrosine-based Activation Motif (hemITAM) and Spleen Tyrosine Kinase (Syk)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell surface receptor; innate immunity; lectin; natural killer cells (NK cells); signal transduction; spleen tyrosine kinase (Syk); NKp65; hemITAM	KILLER GENE-COMPLEX; CUTTING EDGE; NK CELLS; DISTINCT PATHWAYS; NKP80 DEFINES; SH2 DOMAINS; CLEC-2; LIGAND; PLATELETS; GLYCOSYLATION	NKp65 is an activating human C-type lectin-like receptor (CTLR) triggering cellular cytotoxicity and cytokine secretion upon high-affinity interaction with the cognate CTLR keratinocyte-associated C-type lectin (KACL) selectively expressed by human keratinocytes. Previously, we demonstrated that NKp65-mediated cellular cytotoxicity depends on tyrosine 7, located in a cytoplasmic sequence motif of NKp65 resembling a hemi-immunoreceptor tyrosine-based activation motif (hemITAM). HemITAMs have been reported for a few activating myeloid-specific CTLRs, including Dectin-1 and CLEC-2, and consist of a single tyrosine signaling unit preceded by a triacidic motif. Upon receptor engagement, the hemITAM undergoes phosphotyrosinylation and specifically recruits spleen tyrosine kinase (Syk), initiating cellular activation. In this study, we addressed the functionality of the putative hemITAM of NKp65. We show that NKp65 forms homodimers and is phosphorylated at the hemITAM-embedded tyrosine 7 upon engagement by antibodies or KACL homodimers. HemITAM phosphotyrosinylation initiates a signaling pathway involving and depending on Syk, leading to cellular activation and natural killer (NK) cell degranulation. However, although NKp65 utilizes Syk for NK cell activation, a physical association of Syk with the NKp65 hemITAM could not be detected, unlike shown previously for the hemITAM of myeloid CTLR. Failure of NKp65 to recruit Syk is not due to an alteration of the triacidic motif, which rather affects the efficiency of hemITAM phosphotyrosinylation. In summary, NKp65 utilizes a hemITAM-like motif for cellular activation that requires Syk, although Syk appears not to be recruited to NKp65.	[Bauer, Bjoern; Wotapek, Tanja; Zoeller, Tobias; Rutkowski, Emilia; Steinle, Alexander] Goethe Univ, Inst Mol Med, Theodor Stern Kai 7, D-60590 Frankfurt, Germany	Goethe University Frankfurt	Steinle, A (corresponding author), Goethe Univ, Inst Mol Med, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	alexander.steinle@kgu.de		Steinle, Alexander/0000-0001-5081-8503	Deutsche Forschungsgemeinschaft (DFG) [STE 828/6-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by a grant of the Deutsche Forschungsgemeinschaft (DFG; STE 828/6-2) (to A. S.). A. S. holds a patent on NKp65.	Aldemir H, 2005, J IMMUNOL, V175, P7791, DOI 10.4049/jimmunol.175.12.7791; AOKI Y, 1995, J BIOL CHEM, V270, P15658, DOI 10.1074/jbc.270.26.15658; Bartel Y, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00362; Bauer B, 2015, IMMUNOLOGY, V145, P114, DOI 10.1111/imm.12432; Cerwenka A, 2016, NAT REV IMMUNOL, V16, P112, DOI 10.1038/nri.2015.9; Chang VT, 2016, NAT IMMUNOL, V17, P574, DOI 10.1038/ni.3392; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; Dennehy KM, 2011, J IMMUNOL, V186, P657, DOI 10.4049/jimmunol.0904117; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Freud AG, 2016, CELL REP, V16, P379, DOI 10.1016/j.celrep.2016.05.095; Fuller GLJ, 2007, J BIOL CHEM, V282, P12397, DOI 10.1074/jbc.M609558200; GONG JH, 1994, LEUKEMIA, V8, P652; Hao L, 2006, P NATL ACAD SCI USA, V103, P3192, DOI 10.1073/pnas.0511280103; Hartmann J, 2012, J BIOL CHEM, V287, P31527, DOI 10.1074/jbc.M111.304238; Hughes CE, 2013, J BIOL CHEM, V288, P5127, DOI 10.1074/jbc.M112.411462; Hughes CE, 2010, BLOOD, V115, P2947, DOI 10.1182/blood-2009-08-237834; Kerrigan AM, 2010, IMMUNOL REV, V234, P335, DOI 10.1111/j.0105-2896.2009.00882.x; Kerrigan AM, 2009, J IMMUNOL, V182, P4150, DOI 10.4049/jimmunol.0802808; Klimosch SN, 2013, BLOOD, V122, P2380, DOI 10.1182/blood-2013-01-479790; Kuttruff S, 2009, BLOOD, V113, P358, DOI [10.1182/blood-2008-04-145615, 10.1182/blood-2008-03-145615]; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li YL, 2013, P NATL ACAD SCI USA, V110, P11505, DOI 10.1073/pnas.1303300110; MALEK SN, 1993, J BIOL CHEM, V268, P22557; Manne BK, 2015, J BIOL CHEM, V290, P11557, DOI 10.1074/jbc.M114.629527; Orange JS, 2008, NAT REV IMMUNOL, V8, P713, DOI 10.1038/nri2381; Rajasekaran K, 2013, NAT IMMUNOL, V14, P1127, DOI 10.1038/ni.2708; Rosen DB, 2005, J IMMUNOL, V175, P7796, DOI 10.4049/jimmunol.175.12.7796; Ruckrich T, 2013, J BIOL CHEM, V288, P17725, DOI 10.1074/jbc.M113.453548; Sancho D, 2012, ANNU REV IMMUNOL, V30, P491, DOI 10.1146/annurev-immunol-031210-101352; Severin S, 2011, J BIOL CHEM, V286, P4107, DOI 10.1074/jbc.M110.167502; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Spalton JC, 2009, J THROMB HAEMOST, V7, P1192, DOI 10.1111/j.1538-7836.2009.03451.x; Spreu J, 2007, IMMUNOGENETICS, V59, P903, DOI 10.1007/s00251-007-0263-1; Spreu J, 2010, P NATL ACAD SCI USA, V107, P5100, DOI 10.1073/pnas.0913108107; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Vitale M, 2001, EUR J IMMUNOL, V31, P233, DOI 10.1002/1521-4141(200101)31:1<233::AID-IMMU233>3.3.CO;2-W; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478; Vogler I, 2011, J INNATE IMMUN, V3, P227, DOI 10.1159/000324112; Waldhauer I, 2008, ONCOGENE, V27, P5932, DOI 10.1038/onc.2008.267; Welte S, 2006, NAT IMMUNOL, V7, P1334, DOI 10.1038/ni1402; YANAGA F, 1995, BIOCHEM J, V311, P471, DOI 10.1042/bj3110471	44	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3213	3223		10.1074/jbc.M116.759977	http://dx.doi.org/10.1074/jbc.M116.759977			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28082678	Green Published, hybrid			2022-12-26	WOS:000395538800014
J	Neal, S; Mak, R; Bennett, EJ; Hampton, R				Neal, Sonya; Mak, Raymond; Bennett, Eric J.; Hampton, Randolph			A Cdc48 "Retrochaperone" Function Is Required for the Solubility of Retrotranslocated, Integral Membrane Endoplasmic Reticulum-associated Degradation (ERAD-M) Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; endoplasmic reticulum (ER); endoplasmic-reticulum-associated protein degradation (ERAD); ubiquitin; ubiquitin ligase; Cdc48; Hmg2; Npl4; Retrotranslocation; Ufd1	CYTOSOLIC QUALITY-CONTROL; COENZYME-A REDUCTASE; HMG-COA REDUCTASE; UBIQUITIN-LIGASE; AAA-ATPASE; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; REGULATED DEGRADATION; PROTEIN DISLOCATION; MISFOLDED PROTEINS; YEAST	A surprising feature of endoplasmic reticulum (ER)-associated degradation (ERAD) is the movement, or retrotranslocation, of ubiquitinated substrates from the ER lumen or membrane to the cytosol where they are degraded by the 26S proteasome. Multispanning ER membrane proteins, called ERAD-M substrates, are retrotranslocated to the cytosol as full-length intermediates during ERAD, and we have investigated how they maintain substrate solubility. Using an in vivo assay, we show that retrotranslocated ERAD-M substrates are moved to the cytoplasm as part of the normal ERAD pathway, where they are part of a solely proteinaceous complex. Using proteomics and direct biochemical confirmation, we found that Cdc48 serves as a critical retrochaperone for these ERAD-M substrates. Cdc48 binding to retrotranslocated, ubiquitinated ERAD-M substrates is required for their solubility; removal of the polyubiquitin chains or competition for binding by addition of free polyubiquitin liberated Cdc48 from retrotranslocated proteins and rendered them insoluble. All components of the canonical Cdc48 complex Cdc48-Npl4-Ufd1 were present in solubilized ERAD-M substrates. This function of the complex was observed for both HRD and DOA pathway substrates. Thus, in addition to the long known ATP-dependent extraction of ERAD substrates during retrotranslocation, the Cdc48 complex is generally and critically needed for the solubility of retrotranslocated ERAD-M intermediates.	[Neal, Sonya; Mak, Raymond; Bennett, Eric J.; Hampton, Randolph] Univ Calif San Diego, Sect Cell & Dev Biol, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Hampton, R (corresponding author), Univ Calif San Diego, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rhampton@ucsd.edu		Mak, Raymond/0000-0002-7081-8671	National Institutes of Health [5R37DK051996-18]; National Institutes of Health Postdoctoral Fellowship [1F32GM111024-01]; Burroughs Wellcome Fund [1013987, DP2GM119132]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK051996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM119132, F32GM111024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 5R37DK051996-18 (to R. H.), National Institutes of Health Postdoctoral Fellowship 1F32GM111024-01 (to S. N.), and Burroughs Wellcome Fund 1013987 (to S. N.) and DP2GM119132 (to E. J. B). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Baldridge RD, 2016, CELL, V166, P394, DOI 10.1016/j.cell.2016.05.048; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Casson J, 2016, BIOCHEM SOC T, V44, P796, DOI 10.1042/BST20160045; CATT K, 1967, SCIENCE, V158, P1570, DOI 10.1126/science.158.3808.1570; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Claypool SM, 2006, J CELL BIOL, V174, P379, DOI 10.1083/jcb.200605043; Doolman R, 2004, J BIOL CHEM, V279, P38184, DOI 10.1074/jbc.M405935200; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Flierman D, 2003, J BIOL CHEM, V278, P34774, DOI 10.1074/jbc.M303360200; Foresti O, 2013, ELIFE, V2, DOI 10.7554/eLife.00953; Gallagher PS, 2014, J CELL SCI, V127, P1980, DOI 10.1242/jcs.141838; Gardner R, 1998, MOL BIOL CELL, V9, P2611, DOI 10.1091/mbc.9.9.2611; Garza RM, 2009, J BIOL CHEM, V284, P35368, DOI 10.1074/jbc.M109.023994; Garza RM, 2009, J BIOL CHEM, V284, P14710, DOI 10.1074/jbc.M809607200; Hampton RY, 2012, CURR OPIN CELL BIOL, V24, P460, DOI 10.1016/j.ceb.2012.05.010; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; HAMPTON RY, 1994, J CELL BIOL, V125, P299, DOI 10.1083/jcb.125.2.299; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hartman IZ, 2010, J BIOL CHEM, V285, P19288, DOI 10.1074/jbc.M110.134213; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jo Y, 2013, MOL BIOL CELL, V24, P169, DOI 10.1091/mbc.E12-07-0564; Jo Y, 2010, CRIT REV BIOCHEM MOL, V45, P185, DOI 10.3109/10409238.2010.485605; Mateja A, 2015, SCIENCE, V347, P1152, DOI 10.1126/science.1261671; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Nakatsukasa K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148327; Plemper RK, 1998, J BIOL CHEM, V273, P32848, DOI 10.1074/jbc.273.49.32848; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Pye VE, 2007, P NATL ACAD SCI USA, V104, P467, DOI 10.1073/pnas.0603408104; Pye VE, 2006, J STRUCT BIOL, V156, P12, DOI 10.1016/j.jsb.2006.03.003; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Rao H, 2002, J BIOL CHEM, V277, P11691, DOI 10.1074/jbc.M200245200; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rodrigo-Brenni MC, 2014, MOL CELL, V55, P227, DOI 10.1016/j.molcel.2014.05.025; Sato BK, 2006, YEAST, V23, P1053, DOI 10.1002/yea.1407; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Song C, 2007, BIOCHEMISTRY-US, V46, P14889, DOI 10.1021/bi700499j; Stein A, 2014, CELL, V158, P1375, DOI 10.1016/j.cell.2014.07.050; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Vangala JR, 2016, CURR BIOL, V26, pR834, DOI 10.1016/j.cub.2016.08.008; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Vashistha N, 2016, P NATL ACAD SCI USA, V113, P5934, DOI 10.1073/pnas.1603079113; Wilcox AJ, 2009, NAT CELL BIOL, V11, P1481, DOI 10.1038/ncb1997; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Wu X, 2016, J CELL BIOL, V213, P49, DOI 10.1083/jcb.201510098; Xia D, 2016, GENE, V583, P64, DOI 10.1016/j.gene.2016.02.042; Xu Y, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.40; Ye Y., 2003, J CELL BIOL, P21; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Zhang T, 2015, MOL BIOL CELL, V26, P4438, DOI 10.1091/mbc.E15-06-0354; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303	59	25	25	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3112	3128		10.1074/jbc.M116.770610	http://dx.doi.org/10.1074/jbc.M116.770610			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28077573	hybrid, Green Published			2022-12-26	WOS:000395538800005
J	Lu, Y; Ranjitkar, S; Harrison, RD; Xu, JC; Ou, XK; Ma, XL; He, J				Lu, Yang; Ranjitkar, Sailesh; Harrison, Rhett D.; Xu, Jianchu; Ou, Xiaokun; Ma, Xuelan; He, Jun			Selection of Native Tree Species for Subtropical Forest Restoration in Southwest China	PLOS ONE			English	Article							BROAD-LEAVED FORESTS; ECOLOGICAL RESTORATION; TROPICAL FOREST; RAIN-FOREST; GAOLIGONG MOUNTAINS; RESTORING FORESTS; SEED DISPERSAL; DIVERSITY; CONSERVATION; YUNNAN	The use of native species in forest restoration has been increasingly recognized as an effective means of restoring ecosystem functions and biodiversity to degraded areas across the world. However, successful selection of species adapted to local conditions requires specific knowledge which is often lacking, especially in developing countries. In order to scale up forest restoration, experimental data on the responses of native species to propagation and restoration treatments across a range of local conditions are required. In this study, the restoration potential of 34 native tree species was evaluated based on nursery research and field planting experiments at a highly degraded site in a subtropical area of southwest China. We examined species performance in terms of germination rates as well as survival rates and growth over 2 years after planting. Of the 34 species examined, 25 had a germination percentage greater than 50%. Survivorship ranged from 0 to 97% across species and was greater than 50% for 20 species. Mean monthly growth increments varied between species. Pioneer species performed well, and 14 mid-and late-successional species performed reasonably well to very well in this study. However, the remaining 16 mid-and late-successional species performed poorly. These results indicate that carefully selected mid-and late-successional species can be effectively incorporated into mixed species plantings. This data can be used to inform restoration planning, helping to identify suitable species and so enhance the biodiversity and resilience of restored forests.	[Lu, Yang; Ranjitkar, Sailesh; Harrison, Rhett D.; Xu, Jianchu; Ma, Xuelan] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China; [Lu, Yang; Ma, Xuelan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Lu, Yang; Ou, Xiaokun] Yunnan Univ, Inst Ecol & Geobot, Kunming, Yunnan, Peoples R China; [Ranjitkar, Sailesh; Xu, Jianchu] World Agroforestry Ctr, ICRAF East & Cent Asia, Kunming, Yunnan, Peoples R China; [Harrison, Rhett D.] World Agroforestry Ctr, East & Southern Africa Reg, Lusaka, Zambia; [He, Jun] Yunnan Univ, Natl Ctr Borderland Ethn Studies Southwest China, Kunming, Yunnan, Peoples R China; [He, Jun] Yunnan Univ, Sch Ethnol & Sociol, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Yunnan University; Yunnan University; Yunnan University	He, J (corresponding author), Yunnan Univ, Natl Ctr Borderland Ethn Studies Southwest China, Kunming, Yunnan, Peoples R China.; He, J (corresponding author), Yunnan Univ, Sch Ethnol & Sociol, Kunming, Yunnan, Peoples R China.	jun.he@ynu.edu.cn	He, Jun/A-5340-2019; Ranjitkar, Sailesh/I-9307-2014; Xu, Jianchu/Y-2890-2019	Ranjitkar, Sailesh/0000-0002-4741-3975; Lu, Yang/0000-0002-2564-1993; He, Jun/0000-0002-1994-8075; Harrison, Rhett/0000-0001-9055-3546	National Natural Science Foundation of China [31270524]; Darwin Initiative, MISSEORS [335-031-1015Z]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Darwin Initiative, MISSEORS	The work was supported by the National Natural Science Foundation of China (31270524) and the Darwin Initiative, MISSEORS (335-031-1015Z). The research is also part of the CGIAR (Consultative Group for International Agricultural Research) Research Program 6.2 at the World Agroforestry Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson J, 2013, RESTOR ECOL, V21, P293, DOI 10.1111/rec.12011; Ashton MS, 2001, FOREST ECOL MANAG, V154, P409, DOI 10.1016/S0378-1127(01)00512-6; Blakesley D, 2002, FOREST ECOL MANAG, V164, P31, DOI 10.1016/S0378-1127(01)00609-0; BonnChallenge, 2016, GLOB PARTN FOR LANSC; Brudvig LA, 2008, RESTOR ECOL, V16, P290, DOI 10.1111/j.1526-100X.2007.00317.x; Cao SX, 2011, EARTH-SCI REV, V104, P240, DOI 10.1016/j.earscirev.2010.11.002; CHAZDON R. L., 2015, CONSERV LETT, DOI 10.1111/conl.12220; Chazdon R.L., 2014, 2 GROWTH PROMISE TRO, DOI DOI 10.1017/CBO9781107415324.004; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Cole RJ, 2011, FOREST ECOL MANAG, V261, P1590, DOI 10.1016/j.foreco.2010.06.038; Corlett RT, 2015, ROUTLEDGE HANDBOOK OF FOREST ECOLOGY, P46; Corlett RT, 2014, Ecology of Tropical East Asia, 2nd Edition, P1, DOI 10.1093/acprof:oso/9780199681341.001.0001; Cramer JM, 2007, BIOL CONSERV, V137, P415, DOI 10.1016/j.biocon.2007.02.019; Cunningham A. B., 2001, Applied ethnobotany: people, wild plant use and conservation; Davis A.S., 2012, CHALLENGING PARADIGM, P293, DOI [10.1007/978-94-007-5326-6_15, DOI 10.1007/978-94-007-5326-6_15, DOI 10.1007/978-94-007-5326-6_]; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Elliott S, 2003, FOREST ECOL MANAG, V184, P177, DOI 10.1016/S0378-1127(03)00211-1; Erskine PD, 2006, FOREST ECOL MANAG, V233, P205, DOI 10.1016/j.foreco.2006.05.013; Friday JB, 2015, NEW FOREST, V46, P733, DOI 10.1007/s11056-015-9507-3; Grainger MJ, 2011, RESTOR ECOL, V19, P111, DOI 10.1111/j.1526-100X.2009.00630.x; Hall JS, 2011, FOREST ECOL MANAG, V261, P1675, DOI 10.1016/j.foreco.2010.09.042; Hall JS, 2011, FOREST ECOL MANAG, V261, P1553, DOI 10.1016/j.foreco.2010.12.011; Harris JA, 2006, RESTOR ECOL, V14, P170, DOI 10.1111/j.1526-100X.2006.00136.x; Harrison RD, 2016, CONSERV BIOL, V30, P972, DOI 10.1111/cobi.12785; Harrison RD, 2013, ECOL LETT, V16, P687, DOI 10.1111/ele.12102; He J, 2015, MT RES DEV, V35, P318, DOI 10.1659/MRD-JOURNAL-D-15-00046.1; He J, 2012, SMALL-SCALE FOR, V11, P147, DOI 10.1007/s11842-011-9176-9; He J, 2009, FOREST ECOL MANAG, V257, P2010, DOI 10.1016/j.foreco.2009.01.041; Hooper E, 2002, ECOL APPL, V12, P1626, DOI 10.1890/1051-0761(2002)012[1626:RONTST]2.0.CO;2; Jacobs DF, 2015, NEW FOREST, V46, P601, DOI 10.1007/s11056-015-9513-5; Jorgensen D, 2013, BIODIVERS CONSERV, V22, P2977, DOI 10.1007/s10531-013-0550-0; Keenan RJ, 2015, FOREST ECOL MANAG, V352, P9, DOI 10.1016/j.foreco.2015.06.014; Keenelyside K., 2012, ECOLOGICAL RESTORATI, VVolume 18; Kelty MJ, 2006, FOREST ECOL MANAG, V233, P195, DOI 10.1016/j.foreco.2006.05.011; Kettle CJ, 2011, CONSERV LETT, V4, P184, DOI 10.1111/j.1755-263X.2010.00161.x; Kindt R., 2016, AGROFORESTRY SPECIES; Knowles O. H., 1995, Commonwealth Forestry Review, V74, P230; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Lang AC, 2014, J APPL ECOL, V51, P224, DOI 10.1111/1365-2664.12157; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; LI H, 2000, FLORA GAOLIGONG MOUN; Li J, 2001, ACTA BOT YUNNAN, VS13, P150; Li R, 2015, CONSERV BIOL, V29, P1552, DOI 10.1111/cobi.12586; Li R, 2011, MT RES DEV, V31, P160, DOI 10.1659/MRD-JOURNAL-D-10-00056.1; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; Lu Y, 2016, FORESTS, V7, DOI 10.3390/f7010012; Martinez-Garza C, 2003, J APPL ECOL, V40, P423, DOI 10.1046/j.1365-2664.2003.00819.x; McConkey KR, 2012, BIOL CONSERV, V146, P1, DOI 10.1016/j.biocon.2011.09.018; McNamara S, 2006, FOREST ECOL MANAG, V233, P358, DOI 10.1016/j.foreco.2006.05.033; Meli P, 2014, APPL VEG SCI, V17, P744, DOI 10.1111/avsc.12096; Meng GuangTao, 2013, Scientia Silvae Sinicae, V49, P144; Mills AJ, 2015, FORESTS, V6, P4328, DOI 10.3390/f6114328; Miyawaki A, 2004, ECOL RES, V19, P83, DOI 10.1111/j.1440-1703.2003.00606.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Newton AC, 2015, NEW FOREST, V46, P645, DOI 10.1007/s11056-015-9489-1; Ostertag R, 2015, J APPL ECOL, V52, P805, DOI 10.1111/1365-2664.12413; Otsamo Riikka, 1996, Journal of Tropical Forest Science, V8, P381; Padilla FM, 2006, FRONT ECOL ENVIRON, V4, P196, DOI 10.1890/1540-9295(2006)004[0196:TRONPI]2.0.CO;2; Peng SL, 2010, ECOL MODEL, V221, P1317, DOI 10.1016/j.ecolmodel.2010.01.016; R Core Team, 2012, R LANG ENV STAT COMP; Raman TRS, 2009, RESTOR ECOL, V17, P137, DOI 10.1111/j.1526-100X.2008.00367.x; Ranjitkar S, 2016, ENVIRON MODELL SOFTW, V75, P263, DOI 10.1016/j.envsoft.2015.10.027; Ren Hai, 2007, Landscape and Ecological Engineering, V3, P1, DOI 10.1007/s11355-006-0018-4; Ren H, 2008, PROG NAT SCI-MATER, V18, P137, DOI 10.1016/j.pnsc.2007.07.008; Roman-Danobeytia FJ, 2012, RESTOR ECOL, V20, P378, DOI 10.1111/j.1526-100X.2011.00779.x; SER, 2022, US; Shen SC, 2010, MT RES DEV, V30, P205, DOI 10.1659/MRD-JOURNAL-D-09-00085.1; Shono K, 2007, J TROP FOR SCI, V19, P25; Specht MJ, 2015, GLOB ECOL CONSERV, V3, P200, DOI 10.1016/j.gecco.2014.12.002; Stanturf JA, 2015, NEW FOREST, V46, P615, DOI 10.1007/s11056-015-9500-x; Stanturf JA, 2014, FOREST ECOL MANAG, V331, P292, DOI 10.1016/j.foreco.2014.07.029; Stone R, 2009, SCIENCE, V325, P556, DOI 10.1126/science.325_556; Suding K, 2015, SCIENCE, V348, P638, DOI 10.1126/science.aaa4216; Swinfield T, 2016, FOREST ECOL MANAG, V381, P209, DOI 10.1016/j.foreco.2016.09.020; Tang CQ, 2013, ECOL RES, V28, P81, DOI 10.1007/s11284-012-1002-0; Tang CQ, 2010, ECOL RES, V25, P149, DOI 10.1007/s11284-009-0644-z; Tucker NIJ, 1997, FOREST ECOL MANAG, V99, P133, DOI 10.1016/S0378-1127(97)00200-4; van Breugel M, 2011, FOREST ECOL MANAG, V261, P1580, DOI 10.1016/j.foreco.2010.08.019; Vogel HF, 2015, TROP CONSERV SCI, V8, P912, DOI 10.1177/194008291500800404; Wang XH, 2007, FOREST ECOL MANAG, V245, P76, DOI 10.1016/j.foreco.2007.03.043; Wingfield MJ, 2015, SCIENCE, V349, P832, DOI 10.1126/science.aac6674; Wu Z.Y., 1987, VEGETATION YUNNAN; Wu ZY, 2014, FLORA CHINA; Xu JC, 2011, NATURE, V477, P370, DOI 10.1038/477371a; Yu GR, 2014, P NATL ACAD SCI USA, V111, P4910, DOI 10.1073/pnas.1317065111; Yu X, 2015, FOREST INVENTORY PLA, V40, P138	86	62	65	7	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170418	10.1371/journal.pone.0170418	http://dx.doi.org/10.1371/journal.pone.0170418			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103281	Green Published, Green Submitted, gold			2022-12-26	WOS:000392381100063
J	El Karak, F; Bou-Orm, IR; Ghosn, M; Kattan, J; Farhat, F; Ibrahim, T; Jreige, M; El Cheikh, J; Haidar, M				El Karak, Fadi; Bou-Orm, Ibrahim R.; Ghosn, Marwan; Kattan, Joseph; Farhat, Fadi; Ibrahim, Toni; Jreige, Mario; El Cheikh, Jean; Haidar, Mohamad			PET/CT Scanner and Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Diffuse Large B-Cell Lymphoma	PLOS ONE			English	Article								Evaluation of bone marrow involvement (BMI) is paramount in diffuse large B-cell lymphoma (DLBCL) for prognostic and therapeutic reasons. PET/CT scanner (PET) is now a routine examination for the staging of DLBCL with prognostic and therapeutic implications. This study evaluates the role of PET for detecting marrow involvement compared to bone marrow biopsy (BMB). This monocentric study included 54 patients diagnosed with DLBCL between 2009 and 2013 and who had FDG PET/CT in a pre-treatment setting. A correlation analysis of the detection of BMI by PET and BMB was performed. A prognostic evaluation of BMI by BMB and/or PET/CT and correlation with an overall 2-year survival were analyzed. PET was more sensitive for the detection of BMI than BMB (92.3% vs. 38.5%). It can be considered a discriminatory Pre-BMB test with a negative predictive value of 97.6%. In addition, BMI by PET had a prognostic value with strong correlation with progression-free survival (PFS) (HR = 3.81; p = 0.013) and overall survival (OS) (HR = 4.12; p = 0.03) while the BMB had not. PET shows superior performance to the BMB for the detection of marrow involvement in DLBCL. It may be considered as the first line examination of bone marrow instead of the biopsy.	[El Karak, Fadi; Bou-Orm, Ibrahim R.; Ghosn, Marwan; Kattan, Joseph; Farhat, Fadi; Ibrahim, Toni] St Joseph Univ USJ, Sch Med, Beirut, Lebanon; [Jreige, Mario] CHU Vaudois, Dept Nucl Med, Lausanne, Switzerland; [El Cheikh, Jean] Amer Univ Beirut, Med Ctr, Dept Hematol, Beirut, Lebanon; [Haidar, Mohamad] Amer Univ Beirut, Med Ctr, Dept Radiol, Beirut, Lebanon; [Haidar, Mohamad] Mt Lebanon Hosp, Dept Nucl Med, Beirut, Lebanon	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); American University of Beirut; American University of Beirut	Haidar, M (corresponding author), Amer Univ Beirut, Med Ctr, Dept Radiol, Beirut, Lebanon.; Haidar, M (corresponding author), Mt Lebanon Hosp, Dept Nucl Med, Beirut, Lebanon.	mh209@aub.edu.lb	Ibrahim, Tony/U-7004-2017	Ibrahim, Tony/0000-0001-9728-8554; HAIDAR, Mohamad/0000-0001-6431-3274; Bou-Orm, Ibrahim/0000-0003-3563-4014				Adams HJA, 2014, AM J HEMATOL, V89, P726, DOI 10.1002/ajh.23730; Adams HJA, 2014, EUR J NUCL MED MOL I, V41, P565, DOI 10.1007/s00259-013-2623-4; Bain BJ, 2006, HAEMATOLOGICA, V91, P1293; Berthet L, 2013, J NUCL MED, V54, P1244, DOI 10.2967/jnumed.112.114710; BRUNNING RD, 1975, ANN INTERN MED, V82, P365, DOI 10.7326/0003-4819-82-3-365; Flowers CR, 2010, CA-CANCER J CLIN, V60, P393, DOI 10.3322/caac.20087; Hong J, 2012, ANN HEMATOL, V91, P687, DOI 10.1007/s00277-011-1353-6; Khan AB, 2013, BLOOD, V122, P61, DOI 10.1182/blood-2012-12-473389; Ministry of Public Health. National Cancer Registry, 2015, CANC LEB 2005 2007; Tilly H, 2012, ANN ONCOL, V23, P78, DOI 10.1093/annonc/mds273	11	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170299	10.1371/journal.pone.0170299	http://dx.doi.org/10.1371/journal.pone.0170299			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099514	Green Published, Green Submitted, gold			2022-12-26	WOS:000392380100071
J	Luo, JY; Zhang, S; Peng, J; Zhu, XZ; Lv, LM; Wang, CY; Li, CH; Zhou, ZG; Cui, JJ				Luo, Jun-Yu; Zhang, Shuai; Peng, Jun; Zhu, Xiang-Zhen; Lv, Li-Min; Wang, Chun-Yi; Li, Chun-Hua; Zhou, Zhi-Guo; Cui, Jin-Jie			Effects of Soil Salinity on the Expression of Bt Toxin (Cry1Ac) and the Control Efficiency of Helicoverpa armigera in Field-Grown Transgenic Bt Cotton	PLOS ONE			English	Article							BOTTOM-UP; TOP-DOWN; STAND ESTABLISHMENT; HIGHER-PLANTS; LINT YIELD; NITROGEN; SALT; CONSEQUENCES; HERBIVORES; DYNAMICS	An increasing area of transgenic Bacillus thuringiensis (Bt) cotton is being planted in saline alkaline soil in China. The Bt protein level in transgenic cotton plants and its control efficiency can be affected by abiotic stress, including high temperature, water deficiency and other factors. However, how soil salinity affects the expression of Bt protein, thus influencing the control efficiency of Bt cotton against the cotton bollworm (CBW) Helicoverpa armigera (Hubner) in the field, is poorly understood. Our objective in the present study was to investigate the effects of soil salinity on the expression of Bt toxin (Cry1Ac) and the control efficiency of Helicoverpa armigera in field-grown transgenic Bt cotton using three natural saline levels (1.15 dS m(-1) [low soil-salinity], 6.00 dS m(-1) [medium soil-salinity] and 11.46 dS m(-1) [high soil-salinity]). We found that the Bt protein content in the transgenic Bt cotton leaves and the insecticidal activity of Bt cotton against CBW decreased with the increasing soil salinity in laboratory experiments during the growing season. The Bt protein content of Bt cotton leaves in the laboratory were negatively correlated with the salinity level. The CBW populations were highest on the Bt cotton grown in medium-salinity soil instead of the high salinity soil in field conditions. A possible mechanism may be that the relatively high-salinity soil changed the plant nutritional quality or other plant defensive traits. The results from this study may help to identify more appropriate practices to control CBW in Bt cotton fields with different soil salinity levels.	[Luo, Jun-Yu; Zhou, Zhi-Guo] Nanjing Agr Univ, Minist Agr, Key Lab Crop Physiol Ecol & Prod Management, Nanjing, Jiangsu, Peoples R China; [Luo, Jun-Yu; Zhou, Zhi-Guo] Nanjing Agr Univ, Dept Agron, Nanjing, Jiangsu, Peoples R China; [Luo, Jun-Yu; Zhang, Shuai; Peng, Jun; Zhu, Xiang-Zhen; Lv, Li-Min; Wang, Chun-Yi; Li, Chun-Hua; Cui, Jin-Jie] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Zhou, ZG (corresponding author), Nanjing Agr Univ, Minist Agr, Key Lab Crop Physiol Ecol & Prod Management, Nanjing, Jiangsu, Peoples R China.; Zhou, ZG (corresponding author), Nanjing Agr Univ, Dept Agron, Nanjing, Jiangsu, Peoples R China.; Cui, JJ (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China.	giscott@njau.edu.cn; cuijinjie@126.com		Zhang, Shuai/0000-0003-3646-1522	National Natural Science Foundation of China [31501253]; Jiangsu Collaborative Innovation Center for Modern Crop Production (JCIC-MCP); Special Fund for Agro-scientific Research in the Public Interest [201503109]; National Natural Science Foundation of China [31501253]; Jiangsu Collaborative Innovation Center for Modern Crop Production (JCIC-MCP); Special Fund for Agro-scientific Research in the Public Interest [201503109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Collaborative Innovation Center for Modern Crop Production (JCIC-MCP); Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Collaborative Innovation Center for Modern Crop Production (JCIC-MCP); Special Fund for Agro-scientific Research in the Public Interest	We are grateful for financial support from the National Natural Science Foundation of China (31501253), Jiangsu Collaborative Innovation Center for Modern Crop Production (JCIC-MCP) and the Special Fund for Agro-scientific Research in the Public Interest (201503109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Ali A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24273; Ballhorn DJ, 2014, ANN BOT-LONDON, V114, P357, DOI 10.1093/aob/mcu141; Ballhorn DJ, 2011, J ECOL, V99, P313, DOI 10.1111/j.1365-2745.2010.01747.x; Barrett-Lennard EG, 2003, PLANT SOIL, V253, P35, DOI 10.1023/A:1024574622669; Brown GS, 2007, USDA TECHNICAL B, P934; Butler CD, 2008, ENVIRON POLLUT, V156, P1, DOI 10.1016/j.envpol.2007.12.026; Chen DH, 2005, ENVIRON EXP BOT, V53, P333, DOI 10.1016/j.envexpbot.2004.04.004; Chen Y, 2012, FIELD CROP RES, V137, P141, DOI 10.1016/j.fcr.2012.08.015; Chen Y, 2012, J INTEGR AGR, V11, P1836, DOI 10.1016/S2095-3119(12)60188-9; CHEW FS, 1977, EVOLUTION, V31, P568, DOI 10.1111/j.1558-5646.1977.tb01045.x; Chilcutt CF, 2005, ENVIRON ENTOMOL, V34, P75, DOI 10.1603/0046-225X-34.1.75; Coviella CE, 2002, J EXP BOT, V53, P323, DOI 10.1093/jexbot/53.367.323; Dale D., 1988, P35; Dasgupta S., 2014, POLICY RES WORKING P, DOI DOI 10.1596/1813-9450-7140; Deguine JP, 2009, SUSTAINABLE AGRICULTURE, P411, DOI 10.1007/978-90-481-2666-8_27; DETHIER V. G., 1959, CANADIAN ENT, V91, P554; Dong H., 2012, AFRICAN J AGR RES, V7, P4707; Dong HZ, 2007, J AGRON CROP SCI, V193, P21, DOI 10.1111/j.1439-037X.2006.00240.x; Dong He-zhong, 2012, Yingyong Shengtai Xuebao, V23, P566; Dong HZ, 2008, AGRON J, V100, P1640, DOI 10.2134/agronj2008.0074; [董合忠 DONG Hezhong], 2006, [棉花学报, Cotton Science], V18, P362; EDWARDS PJ, 1983, OECOLOGIA, V59, P88, DOI 10.1007/BF00388079; Gratton C, 2003, OECOLOGIA, V134, P487, DOI 10.1007/s00442-002-1137-8; Han P, 2016, J CHEM ECOL, V42, P1293, DOI 10.1007/s10886-016-0795-7; Han P, 2016, SCI REP-UK, V6, DOI 10.1038/srep32403; Han P, 2015, ECOL EVOL, V5, P5468, DOI 10.1002/ece3.1788; Han P, 2015, J PEST SCI, V88, P685, DOI 10.1007/s10340-015-0662-2; Han P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102980; Han P, 2014, SCI REP-UK, V4, DOI 10.1038/srep04455; Hanson BR, 2006, WATER MANAGEMENT SER, V3375, P9; Huang JK, 2002, SCIENCE, V295, P674, DOI 10.1126/science.1067226; Iqbal A, 2013, INT J AGRIC BIOL, V15, P1181; Jansen MAK, 1998, TRENDS PLANT SCI, V3, P131, DOI 10.1016/S1360-1385(98)01215-1; Jiang L, 2005, AM NAT, V165, P350, DOI 10.1086/428300; Jiang LJ, 2006, ENVIRON EXP BOT, V55, P315, DOI 10.1016/j.envexpbot.2005.01.003; Kahlown MA, 2002, IRRIG DRAIN, V51, P329, DOI 10.1002/ird.62; Kanagaraj G., 2009, Plant Archives, V9, P413; Kang L., 1995, CHINESE J ECOL, V14, P51; Li M, 2014, THESIS; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Luo Z, 2008, CROP PROT, V27, P1485, DOI 10.1016/j.cropro.2008.06.006; Martins CM, 2008, ANN APPL BIOL, V152, P255, DOI 10.1111/j.1744-7348.2007.00214.x; Mavi MS, 2012, SOIL BIOL BIOCHEM, V45, P8, DOI 10.1016/j.soilbio.2011.10.003; Meloni DA, 2003, ENVIRON EXP BOT, V49, P69, DOI 10.1016/S0098-8472(02)00058-8; Moon DC, 2002, OIKOS, V98, P480, DOI 10.1034/j.1600-0706.2002.980312.x; National Soil Survey Office, 1998, CHINA AGR IN PRESS; Oline DK, 2002, LANDSCAPE ECOL, V17, P13, DOI 10.1023/A:1015276723949; Pettigrew WT, 2006, AGRON J, V98, P691, DOI 10.2134/agronj2005.0327; Rengasamy P, 2006, J EXP BOT, V57, P1017, DOI 10.1093/jxb/erj108; Rezaei MA, 2004, PAJOUHESH SAZANDEGI, V17, P81; Sairam RK, 2004, CURR SCI INDIA, V86, P407; Setia R, 2011, SOIL BIOL BIOCHEM, V43, P667, DOI 10.1016/j.soilbio.2010.12.004; Sumerford DV, 2014, J INSECT SCI, V1, P1; TABASHNIK BE, 1982, OECOLOGIA, V55, P389, DOI 10.1007/BF00376927; Tchiadje NFT, 2007, DESALINATION, V206, P524, DOI 10.1016/j.desal.2006.03.579; Torres JB, 2006, AGR FOREST ENTOMOL, V8, P191, DOI 10.1111/j.1461-9563.2006.00298.x; Wang LiuMIng, 2001, Cotton Science, V13, P87; WHITE TCR, 1984, OECOLOGIA, V63, P90, DOI 10.1007/BF00379790; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Yasir Mehmood, 2012, Journal of Agriculture and Social Sciences, V8, P109; Zhang L, 2013, J PLANT RES, V126, P293, DOI 10.1007/s10265-012-0533-3	63	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170379	10.1371/journal.pone.0170379	http://dx.doi.org/10.1371/journal.pone.0170379			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099508	Green Published, gold, Green Submitted			2022-12-26	WOS:000392380100083
J	Rattray, I; Smith, EJ; Crum, WR; Walker, TA; Gale, R; Bates, GP; Modo, M				Rattray, Ivan; Smith, Edward J.; Crum, William R.; Walker, Thomas A.; Gale, Richard; Bates, Gillian P.; Modo, Michel			Correlations of Behavioral Deficits with Brain Pathology Assessed through Longitudinal MRI and Histopathology in the HdhQ150/Q150 Mouse Model of Huntington's Disease	PLOS ONE			English	Article							KNOCK-IN MOUSE; TRANSGENIC MICE; ALZHEIMERS-DISEASE; FLUID REGISTRATION; MUTANT HUNTINGTIN; GENE-EXPRESSION; CAG REPEAT; PREMANIFEST; ABNORMALITIES; BIOMARKERS	A variety of mouse models have been developed that express mutant huntingtin (mHTT) leading to aggregates and inclusions that model the molecular pathology observed in Huntington's disease. Here we show that although homozygous HdhQ150 knock-in mice developed motor impairments (rotarod, locomotor activity, grip strength) by 36 weeks of age, cognitive dysfunction (swimming T maze, fear conditioning, odor discrimination, social interaction) was not evident by 94 weeks. Concomitant to behavioral assessments, T-2-weighted MRI volume measurements indicated a slower striatal growth with a significant difference between wild type (WT) and HdhQ150 mice being present even at 15 weeks. Indeed, MRI indicated significant volumetric changes prior to the emergence of the "clinical horizon" of motor impairments at 36 weeks of age. A striatal decrease of 27% was observed over 94 weeks with cortex (12%) and hippocampus (21%) also indicating significant atrophy. A hypothesis-free analysis using tensor-based morphometry highlighted further regions undergoing atrophy by contrasting brain growth and regional neurodegeneration. Histology revealed the widespread presence of mHTT aggregates and cellular inclusions. However, there was little evidence of correlations between these outcome measures, potentially indicating that other factors are important in the causal cascade linking the molecular pathology to the emergence of behavioral impairments. In conclusion, the HdhQ150 mouse model replicates many aspects of the human condition, including an extended pre-manifest period prior to the emergence of motor impairments.	[Rattray, Ivan; Smith, Edward J.; Modo, Michel] Kings Coll London, Inst Psychiat, Dept Neurosci, London, England; [Rattray, Ivan; Smith, Edward J.; Walker, Thomas A.; Gale, Richard; Bates, Gillian P.] Kings Coll London, Sch Med, Dept Med & Mol Genet, Guys Hosp, London, England; [Crum, William R.] Kings Coll London, Dept Neuroimaging, Inst Psychiat, London, England; [Modo, Michel] Univ Pittsburgh, Dept Radiol, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Modo, M (corresponding author), Kings Coll London, Inst Psychiat, Dept Neurosci, London, England.; Modo, M (corresponding author), Univ Pittsburgh, Dept Radiol, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA.	modomm@upmc.edu	Bates, Gillian/E-1146-2012	Bates, Gillian/0000-0002-4041-6305; Modo, Michel/0000-0003-4436-735X	Medical Research Council [G0800846]; CHDI Foundation; Medical Research Council [1252904] Funding Source: researchfish; MRC [G0800846] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CHDI Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Medical Research Council (G0800846) and the CHDI Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre R, 2014, DRUG DISCOV TODAY, V19, P972, DOI 10.1016/j.drudis.2014.03.002; Antonsen BT, 2013, BRAIN STRUCT FUNCT, V218, P767, DOI 10.1007/s00429-012-0427-0; Aylward EH, 2000, MOVEMENT DISORD, V15, P552, DOI 10.1002/1531-8257(200005)15:3<552::AID-MDS1020>3.0.CO;2-P; Barker RA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00095; Barresi M, 2012, J NEUROL SCI, V323, P16, DOI 10.1016/j.jns.2012.08.028; Bayram-Weston Z, 2012, BRAIN RES BULL, V88, P189, DOI 10.1016/j.brainresbull.2011.03.014; Bohanna I, 2008, BRAIN RES REV, V58, P209, DOI 10.1016/j.brainresrev.2008.04.001; Brooks S, 2012, BRAIN RES BULL, V88, P182, DOI 10.1016/j.brainresbull.2010.05.004; Brooks SP, 2012, BRAIN RES BULL, V88, P81, DOI 10.1016/j.brainresbull.2011.10.002; Brooks SP, 2012, BRAIN RES BULL, V88, P121, DOI 10.1016/j.brainresbull.2011.05.010; Crum WR, 2013, J NEUROSCI METH, V218, P170, DOI 10.1016/j.jneumeth.2013.05.009; Crum WR, 2013, J NEUROSCI METH, V216, P62, DOI 10.1016/j.jneumeth.2013.03.015; Crum WR, 2005, PHYS MED BIOL, V50, P5153, DOI 10.1088/0031-9155/50/21/014; Delmaire C, 2012, HUM BRAIN MAPP; Fox NC, 2001, LANCET, V358, P201, DOI 10.1016/S0140-6736(01)05408-3; Freeborough PA, 1998, J COMPUT ASSIST TOMO, V22, P838, DOI 10.1097/00004728-199809000-00031; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gil JM, 2008, EUR J NEUROSCI, V27, P2803, DOI 10.1111/j.1460-9568.2008.06310.x; Giles P, 2012, BRAIN RES BULL, V88, P199, DOI 10.1016/j.brainresbull.2011.10.001; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Harrington DL, 2014, BRAIN BEHAV, V4, P29, DOI 10.1002/brb3.185; Heikkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050717; Heng MY, 2007, J NEUROSCI, V27, P8989, DOI 10.1523/JNEUROSCI.1830-07.2007; Henley SMD, 2009, MOVEMENT DISORD, V24, P932, DOI 10.1002/mds.22485; Henley S, 2009, J NEUROL, V256, P203, DOI 10.1007/s00415-009-0052-x; Howland DS, 2014, MOVEMENT DISORD, V29, P1397, DOI 10.1002/mds.26008; Izquierdo A, 2006, J NEUROSCI, V26, P5733, DOI 10.1523/JNEUROSCI.0474-06.2006; Jiang RT, 2016, J NEUROSCI, V36, P3453, DOI 10.1523/JNEUROSCI.3693-15.2016; Jin J, 2015, HUM MOL GENET, V24, P2508, DOI 10.1093/hmg/ddv016; Khakh BS, 2014, ACS CHEM NEUROSCI, V5, P494, DOI 10.1021/cn500100r; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; Labbadia J, 2011, J CLIN INVEST, V121, P3306, DOI 10.1172/JCI57413; Lawrence AD, 2000, BRAIN, V123, P1349; Lazic SE, 2007, BRAIN RES, V1151, P219, DOI 10.1016/j.brainres.2007.03.018; Lerch JP, 2008, NEUROIMAGE, V39, P32, DOI 10.1016/j.neuroimage.2007.08.033; Li Jia Yi, 2005, NeuroRx, V2, P447, DOI 10.1602/neurorx.2.3.447; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Macbeth AH, 2009, NAT PROTOC, V4, P1574, DOI 10.1038/nprot.2009.141; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Menalled L, 2014, MOVEMENT DISORD, V29, P1375, DOI 10.1002/mds.26006; Meunier C, 2016, GLIA; Mielcarek M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005021; Mielcarek M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004550; Moffitt H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008025; Mouton PR, 2011, UNBIASED STEREOLOGY; Odish OFF, 2015, NEUROIMAGE-CLIN, V9, P32, DOI 10.1016/j.nicl.2015.07.003; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pouladi MA, 2013, NAT REV NEUROSCI, V14, P708, DOI 10.1038/nrn3570; Rattray I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084726; Rattray I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060012; Rees EM, 2013, J HUNTINGTONS DIS, V2, P21, DOI 10.3233/JHD-120030; Reilmann R, 2010, MOVEMENT DISORD, V25, P2858, DOI 10.1002/mds.23300; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; Sadikot AF, 1997, J COMP NEUROL, V389, P193; Sathasivam K, 2001, HUM MOL GENET, V10, P2425, DOI 10.1093/hmg/10.21.2425; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Stout JC, 2012, J NEUROL NEUROSUR PS, V83, P687, DOI 10.1136/jnnp-2011-301940; Tabrizi SJ, 2011, LANCET NEUROL, V10, P31, DOI 10.1016/S1474-4422(10)70276-3; Toledano A, 2016, CURR ALZHEIMER RES, V13, P321, DOI 10.2174/1567205013666151116141217; Tunez I, 2006, NEUROCHEM INT, V48, P367, DOI 10.1016/j.neuint.2005.11.011; Turner Martin R, 2010, Expert Opin Med Diagn, V4, P483, DOI 10.1517/17530059.2010.536836; Vernon AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017269; Weir DW, 2011, LANCET NEUROL, V10, P573, DOI 10.1016/S1474-4422(11)70070-9; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004; Young D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075108	69	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0168556	10.1371/journal.pone.0168556	http://dx.doi.org/10.1371/journal.pone.0168556			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099507	Green Published, gold, Green Submitted			2022-12-26	WOS:000392380100010
J	Shan, X; Wen, W; Zhu, DX; Yan, T; Cheng, WF; Huang, ZB; Zhang, L; Zhang, H; Wang, TS; Zhu, W; Zhu, YC; Zhu, J				Shan, Xia; Wen, Wei; Zhu, Danxia; Yan, Ting; Cheng, Wenfang; Huang, Zebo; Zhang, Lan; Zhang, Huo; Wang, Tongshan; Zhu, Wei; Zhu, Yichao; Zhu, Jun			miR 1296-5p Inhibits the Migration and Invasion of Gastric Cancer Cells by Repressing ERBB2 Expression	PLOS ONE			English	Article							OVEREXPRESSION; ACTIVATION	The metastasis of gastric cancer, one of the most common tumors, has a molecular mechanism that is still largely unclear. Here we investigated the role of possible tumor-suppressor miR-1296-5p in the cell migration and invasion of ERBB2-positive gastric cancer. It found that miR-1296-5p was significantly down-regulated in gastric cancer tissues. Moreover, it was down-regulated in lymph node metastatic gastric cancer tissues compared with non metastatic gastric cancer tissues. The luciferase activity of ERBB2 3'-untranslated region based reporters constructed in SNU-216 and NUGC-4 gastric cancer cells suggested that ERBB2 was the target gene of miR-1296-5p. Overexpressed miR-1296-5p reduced its target protein level and Rac1 activation, and inhibited the migration and invasion of SNU-216 and NUGC-4 gastric cancer cells. MiR-1296-5p was down-regulated in ERBB2-positive gastric cancer tissues compared with ERBB2-negative gastric cancer tissues. In ERBB2-positive gastric cancers, the miR-1296-5p expression was suppressed in a majority of metastatic lymph node tissues compared to non-metastatic gastric cancer samples. The migration and invasion of gastric cancer cells was inhibited by miR-1296-5p overexpression or herceptin treatment, and rescued by the overexpression of constitutively active Rac1-Q61 L or ERBB2. Taken together, our findings first suggest that miR-1296-5p might be involved in the regulation on the migration and invasion of human gastric cancer cells at least in part via targeting ERBB2/Rac1 signaling pathway.	[Shan, Xia] Nanjing Med Univ, Affiliated Jiangning Hosp, Dept Respirat, Nanjing, Jiangsu, Peoples R China; [Wen, Wei] Nanjing Med Univ, Affiliated Hosp 1, Dept Thorac Surg, Nanjing, Jiangsu, Peoples R China; [Zhu, Danxia] Soochow Univ, Affiliated Hosp 3, Dept Oncol, Changzhou, Peoples R China; [Yan, Ting] Nanjing Med Univ, Safety Assessment & Res Ctr Drug Pesticide & Vet, Nanjing, Jiangsu, Peoples R China; [Cheng, Wenfang] Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China; [Huang, Zebo; Zhang, Lan; Zhang, Huo; Wang, Tongshan; Zhu, Wei] Nanjing Med Univ, Dept Oncol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Zhu, Yichao] Nanjing Med Univ, Dept Physiol, Nanjing, Jiangsu, Peoples R China; [Zhu, Yichao] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Zhu, Jun] Jiangsu Canc Hosp, Dept Radiat Oncol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Soochow University - China; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Zhu, W (corresponding author), Nanjing Med Univ, Dept Oncol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.; Zhu, YC (corresponding author), Nanjing Med Univ, Dept Physiol, Nanjing, Jiangsu, Peoples R China.; Zhu, YC (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.; Zhu, J (corresponding author), Jiangsu Canc Hosp, Dept Radiat Oncol, Nanjing, Jiangsu, Peoples R China.	zhuwei@njmu.edu.cn; zhuyichao@njmu.edu.cn; belliwether@163.com			National Natural Science Foundation of China [81370516, 81472703, 81672400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (81370516, 81472703, 81672400).	Boo L, 2016, INT J BIOL SCI, V12, P427, DOI 10.7150/ijbs.12777; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Dong Z, 2014, BRIT J CANCER, V110, P1801, DOI 10.1038/bjc.2014.70; Fabi A, 2014, J MOL MED, V92, P681, DOI 10.1007/s00109-014-1169-7; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; Ishimoto T, 2016, INT J CANCER, V138, P1337, DOI 10.1002/ijc.29627; Johnson E, 2010, J BIOL CHEM, V285, P29491, DOI 10.1074/jbc.M110.136770; Liu JJ, 2013, CELL SIGNAL, V25, P447, DOI 10.1016/j.cellsig.2012.10.012; Liu ZY, 2015, ONCOTARGET, V6, P8019, DOI 10.18632/oncotarget.3139; Majid S, 2010, CANCER RES, V70, P2809, DOI 10.1158/0008-5472.CAN-09-4176; Phan B, 2016, ONCOTARGET; Tornillo G, 2011, EUR J CELL BIOL, V90, P237, DOI 10.1016/j.ejcb.2010.09.002; Verbeek BS, 1998, FEBS LETT, V425, P145, DOI 10.1016/S0014-5793(98)00224-5; Wang S., 2006, J N CHINA ELECT POWE, V1, P1, DOI DOI 10.1002/CJG2.812; Weissinger F, 2011, ONKOLOGIE, V34, P548, DOI 10.1159/000332226; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972; Zhao DS, 2013, CARDIOVASC PATHOL, V22, P444, DOI 10.1016/j.carpath.2013.04.001; Zhou L, 2016, ONCOL REP, V35, P2715, DOI 10.3892/or.2016.4627; Zhu Y-B., 2013, CHINA SOFT SCI, V02, P35, DOI DOI 10.1016/J.CELLSIG.2013.01.015; Zurleni T, 2013, WORLD J GASTRO SURG, V5, P287, DOI 10.4240/wjgs.v5.i11.287	21	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170298	10.1371/journal.pone.0170298	http://dx.doi.org/10.1371/journal.pone.0170298			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099468	Green Published, Green Submitted, gold			2022-12-26	WOS:000392380100070
J	Mi, GY; Liu, S; Zhang, J; Liang, HC; Gao, YY; Li, NM; Yu, BY; Yang, HJ; Yang, Z				Mi, Guiyun; Liu, Shuai; Zhang, Jian; Liang, Huichun; Gao, Yunyun; Li, Nuomin; Yu, Boyang; Yang, Hongju; Yang, Zheng			Levo-Tetrahydroberberrubine Produces Anxiolytic-Like Effects in Mice through the 5-HT1A Receptor	PLOS ONE			English	Article							ANXIETY-LIKE BEHAVIOR; PLUS-MAZE; DOPAMINE; BUSPIRONE; RATS; BINDING; MODELS; BRAIN; D-2; TETRAHYDROPROTOBERBERINES	Tetrahydroprotoberberines (THPBs) are isoquinoline alkaloids isolated from the Chinese herb Corydalis yanhusuo. In the present study, we performed competitive binding assays to examine the binding of l-THBr to neurotransmitter receptors known to be involved in sedation, hypnosis and anxiety. Our results show that l-THBr does not interact with GABAergic receptors but has binding affinities for dopamine and serotonin receptors. In addition, cAMP and [S-35]GTP gamma S assays were used to determine the agonist or antagonist properties of l-THBr at dopamine (D-1, D-2) or serotonin (5-HT) receptors. Our results show that l-THBr displays D-1 and D-2 antagonist and 5-HT1A agonist properties. Moreover, l-THBr-treated rodents exhibit anxiolytic-like effects in the light/dark box and elevated plus-maze tests, and the anxiolytic effect of l-THBr can be reduced by WAY-100635, a selective 5-HT1A receptor antagonist. Our results suggest that l-THBr may produce potent anxiolytic-like effects mainly through serotonin receptors.	[Mi, Guiyun; Liu, Shuai; Liang, Huichun; Li, Nuomin; Yang, Hongju; Yang, Zheng] Beijing Inst Basic Med Sci, Beijing, Peoples R China; [Zhang, Jian; Yu, Boyang] China Pharmaceut Univ, Dept Complex Prescript Tradit Chinese Med, Nanjing, Jiangsu, Peoples R China; [Gao, Yunyun] PLA, Hosp 89, Weifang, Peoples R China	Academy of Military Medical Sciences - China; China Pharmaceutical University	Yang, HJ; Yang, Z (corresponding author), Beijing Inst Basic Med Sci, Beijing, Peoples R China.	yanghongju618@sina.com; yangz236@163.com			National Natural Science Foundation of China [81473193]; National Key Project of China [2012ZX09J12201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Project of China	This project was supported by the National Natural Science Foundation of China (Grant No. 81473193), and the National Key Project of China (2012ZX09J12201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyropoulos SV, 1999, EUR NEUROPSYCHOPHARM, V9, P407, DOI 10.1016/S0924-977X(99)00052-8; Bananej M, 2012, J PSYCHOPHARMACOL, V26, P564, DOI 10.1177/0269881111405556; Bofill-Cardona E, 2000, J BIOL CHEM, V275, P32672, DOI 10.1074/jbc.M002780200; Boulay D, 2010, PHARM BIOCH BEHAV, V97, P428; Capron DW, 2012, DEPRESS ANXIETY, V29, P195, DOI 10.1002/da.20871; Carson KA, 2004, PSYCHOPHARMACOL BULL, V38, P38; Chu HY, 2008, CELL MOL NEUROBIOL, V28, P491, DOI 10.1007/s10571-007-9179-4; Cross C, 2002, NATURE, V416, P396, DOI [10.1038/416396a, DOI 10.1038/416396A]; Cuisiat S, 2007, J MED CHEM, V50, P865, DOI 10.1021/jm061180b; Dhavalshankh A G, 2007, Indian J Physiol Pharmacol, V51, P375; Dremencov E, 2004, PROG NEURO-PSYCHOPH, V28, P141, DOI 10.1016/j.pnpbp.2003.09.030; Ellenbroek BA, 2006, ACTA PHARMACOL SIN, V27, P1111, DOI 10.1111/j.1745-7254.2006.00365.x; FEIGHNER JP, 1989, PSYCHOPATHOLOGY, V22, P21, DOI 10.1159/000284623; Furmark T, 2009, ISR J PSYCHIATR REL, V46, P5; Fuxe K, 2008, BRAIN RES REV, V58, P415, DOI 10.1016/j.brainresrev.2007.11.007; GAO B, 1993, NEUROPHARMACOLOGY, V32, P93, DOI 10.1016/0028-3908(93)90134-O; GARDNER CR, 1993, PROG NEUROBIOL, V40, P1, DOI 10.1016/0301-0082(93)90047-V; Gross C, 2004, NAT REV NEUROSCI, V5, P545, DOI 10.1038/nrn1429; Guo Y, 2009, SCHIZOPHR RES, V115, P41, DOI 10.1016/j.schres.2009.08.002; Hansen RT, 2014, PSYCHOPHARMACOLOGY, V231, P2941, DOI 10.1007/s00213-014-3480-y; Hu JY, 2000, ACTA PHARMACOL SIN, V21, P439; JIN GZ, 1987, TRENDS PHARMACOL SCI, V8, P81, DOI 10.1016/0165-6147(87)90076-9; Kalueff AV, 2007, BEHAV BRAIN RES, V179, P1, DOI 10.1016/j.bbr.2007.01.023; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Loane C, 2012, BRAIN RES, V1461, P111, DOI 10.1016/j.brainres.2012.04.032; MCMILLEN BA, 1983, J NEURAL TRANSM, V57, P255, DOI 10.1007/BF01248997; Millan MJ, 2003, PROG NEUROBIOL, V70, P83, DOI 10.1016/s0301-0082(03)00087-X; Nasehi M, 2011, PHARMACOL BIOCHEM BE, V98, P468, DOI 10.1016/j.pbb.2011.02.011; Natesan S, 2008, PSYCHOPHARMACOLOGY, V199, P275, DOI 10.1007/s00213-008-1172-1; Odagaki Y, 2005, J PHARMACOL SCI, V98, P66, DOI 10.1254/jphs.FPJ05010X; PICH EM, 1986, PSYCHOPHARMACOLOGY, V89, P125; Piri M, 2013, NEUROSCI LETT, V550, P139, DOI 10.1016/j.neulet.2013.07.009; Pultrini ADM, 2006, LIFE SCI, V78, P1720, DOI 10.1016/j.lfs.2005.08.004; Rickels K, 2008, J CLIN PSYCHOPHARM, V28, P447, DOI 10.1097/JCP.0b013e31817efbac; RODGERS RJ, 1993, PSYCHOPHARMACOLOGY, V113, P237, DOI 10.1007/BF02245704; SANTIAGO M, 1993, EUR J PHARMACOL, V239, P83, DOI 10.1016/0014-2999(93)90979-R; Schneier FR, 2000, AM J PSYCHIAT, V157, P457, DOI 10.1176/appi.ajp.157.3.457; SIMON P, 1993, PHARMACOL BIOCHEM BE, V45, P685, DOI 10.1016/0091-3057(93)90525-X; STERNBACH LH, 1979, J MED CHEM, V22, P1, DOI 10.1021/jm00187a001; Sun Y, 2009, BRIT J PHARMACOL, V158, P1302, DOI 10.1111/j.1476-5381.2009.00393.x; TAYLOR DP, 1985, PHARMACOL BIOCHEM BE, V23, P687, DOI 10.1016/0091-3057(85)90438-1; THIEBOT MH, 1984, PSYCHOPHARMACOLOGY, V82, P355, DOI 10.1007/BF00427685; Timothy C, 1999, PHARMACOL BIOCHEM BE, V62, P323, DOI 10.1016/S0091-3057(98)00157-9; Wall PM, 2003, PROG NEURO-PSYCHOPH, V27, P395, DOI 10.1016/S0278-5846(02)00356-1; Wu LJ, 2008, NEUROCHEM RES, V33, P1925, DOI 10.1007/s11064-008-9679-8; Xi ZX, 2007, NEUROPHARMACOLOGY, V53, P771, DOI 10.1016/j.neuropharm.2007.08.004; XU SX, 1989, ACTA PHARM SINIC, V10, P104; Yang KC, 2007, CURR NEUROPHARMACOL, V5, P289, DOI 10.2174/157015907782793649; Yang Z, 2008, ACTA PHARMACOL SIN, V29, P781, DOI 10.1111/j.1745-7254.2008.00817.x; Youssef NA, 2008, ANN CLIN PSYCHIATRY, V20, P157, DOI 10.1080/10401230802177698; Zarrindast MR, 2015, ARCH IRAN MED, V18, P591, DOI 0151809/AIM.009	51	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0168964	10.1371/journal.pone.0168964	http://dx.doi.org/10.1371/journal.pone.0168964			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085967	Green Published, Green Submitted, gold			2022-12-26	WOS:000391972600010
J	Jones, JEC; Esler, WP; Patel, R; Lanba, A; Vera, NB; Pfefferkorn, JA; Vernochet, C				Jones, Jessica E. C.; Esler, William P.; Patel, Rushi; Lanba, Adhiraj; Vera, Nicholas B.; Pfefferkorn, Jeffrey A.; Vernochet, Cecile			Inhibition of Acetyl-CoA Carboxylase 1 (ACC1) and 2 (ACC2) Reduces Proliferation and De Novo Lipogenesis of EGFRvIII Human Glioblastoma Cells	PLOS ONE			English	Article							ACID SYNTHESIS PATHWAY; FATTY-ACID; LIPID-METABOLISM; C-MYC; GROWTH; APOPTOSIS; ACTIVATION; ENZYMES; ALPHA; LIVER	Tumor cell proliferation and migration processes are regulated by multiple metabolic pathways including glycolysis and de novo lipogenesis. Since acetyl-CoA carboxylase (ACC) is at the junction of lipids synthesis and oxidative metabolic pathways, we investigated whether use of a dual ACC inhibitor would provide a potential therapy against certain lipogenic cancers. The impact of dual ACC1/ACC2 inhibition was investigated using a dual ACC1/ACC2 inhibitor as well as dual siRNA knock down on the cellular viability and metabolism of two glioblastoma multiform cancer cell lines, U87 and a more aggressive form, U87 EGFRvIII. We first demonstrated that while ACCi inhibited DNL in both cell lines, ACCi preferentially blunted the U87 EGFRvIII cellular proliferation capacity. Metabolically, chronic treatment with ACCi significantly upregulated U87 EGFRvIII cellular respiration and extracellular acidification rate, a marker of glycolytic activity, but impaired mitochondrial health by reducing maximal respiration and decreasing mitochondrial ATP production efficiency. Moreover, ACCi treatment altered the cellular lipids content and increased apoptotic caspase activity in U87 EGFRvIII cells. Collectively these data indicate that ACC inhibition, by reducing DNL and increasing cellular metabolic rate, may have therapeutic utility for the suppression of lipogenic tumor growth and warrants further investigation.	[Jones, Jessica E. C.; Esler, William P.; Patel, Rushi; Lanba, Adhiraj; Vera, Nicholas B.; Pfefferkorn, Jeffrey A.; Vernochet, Cecile] Pfizer Inc, Res Unit, Cardiovasc Metab & Endocrine Dis CVMED, Cambridge, MA 02139 USA	Pfizer	Esler, WP; Vernochet, C (corresponding author), Pfizer Inc, Res Unit, Cardiovasc Metab & Endocrine Dis CVMED, Cambridge, MA 02139 USA.	William.Esler@pfizer.com; Cecile.Vernochet@pfizer.com		Jones, Jessica/0000-0003-2539-5697	Pfizer	Pfizer(Pfizer)	Pfizer provided support in the form of salaries for all of the authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Babic I, 2013, CELL METAB, V17, P1000, DOI 10.1016/j.cmet.2013.04.013; Beckers A, 2007, CANCER RES, V67, P8180, DOI 10.1158/0008-5472.CAN-07-0389; Brusselmans K, 2005, CANCER RES, V65, P6719, DOI 10.1158/0008-5472.CAN-05-0571; Brusslemans K, 2009, LIPOGENIC SWITCH CAN; Chajes V, 2006, CANCER RES, V66, P5287, DOI 10.1158/0008-5472.CAN-05-1489; Fan YJ, 2010, J BIOL CHEM, V285, P7324, DOI 10.1074/jbc.M109.035584; Freeman-Cook KD, 2012, J MED CHEM, V55, P935, DOI 10.1021/jm201503u; Gan HK, 2013, FEBS J, V280, P5350, DOI 10.1111/febs.12393; Gan HK, 2009, J CLIN NEUROSCI, V16, P748, DOI 10.1016/j.jocn.2008.12.005; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Guo DL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000446; Guo DL, 2009, P NATL ACAD SCI USA, V106, P12932, DOI 10.1073/pnas.0906606106; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Huang CF, 2015, INT J MOL SCI, V16, P924, DOI 10.3390/ijms16010924; Masui K, 2014, TRENDS ENDOCRIN MET, V25, P364, DOI 10.1016/j.tem.2014.04.002; Masui K, 2013, CELL METAB, V18, P726, DOI 10.1016/j.cmet.2013.09.013; Medes G, 1953, METABOLISM NEOPLASTI; Milgraum L, 1997, ENZYMES FATTY ACID S; Mounier C, 2014, INT J ONCOL, V45, P485, DOI 10.3892/ijo.2014.2441; Munday M, 2002, BIOCH SOC T, V30; NUGTEREN DH, 1965, BIOCHIM BIOPHYS ACTA, V106, P280, DOI 10.1016/0005-2760(65)90036-6; OOKHTENS M, 1984, AM J PHYSIOL, V247, pR146, DOI 10.1152/ajpregu.1984.247.1.R146; Ovcharenko D, 2007, CANCER RES, V67, P10782, DOI 10.1158/0008-5472.CAN-07-1484; Padfield E, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00005; SABINE JR, 1967, CANCER RES, V27, P793; Shu HKG, 2000, NEURO-ONCOLOGY, V2, P16, DOI 10.1093/neuonc/2.1.16; Stupp R, 2014, ANN ONCOL, V25, P93, DOI 10.1093/annonc/mdu050; Svensson RU, 2016, NAT MED; Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30; Swinnen JV, 2000, INT J CANCER, V88, P176, DOI 10.1002/1097-0215(20001015)88:2<176::AID-IJC5>3.0.CO;2-3; WAKIL SJ, 1958, J AM CHEM SOC, V80, P6465, DOI 10.1021/ja01556a086; Warburg O, 1927, J GEN PHYSL; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yahagi N, 2005, EUR J CANCER, V41, P1316, DOI 10.1016/j.ejca.2004.12.037; Zhan Y, 2008, CLIN CANCER RES, V14, P5735, DOI 10.1158/1078-0432.CCR-07-5074	35	45	48	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169566	10.1371/journal.pone.0169566	http://dx.doi.org/10.1371/journal.pone.0169566			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081256	Green Published, gold, Green Submitted			2022-12-26	WOS:000391949500054
J	Roskoden, FC; Kruger, J; Vogt, LJ; Gartner, S; Hannich, HJ; Steveling, A; Lerch, MM; Aghdassi, AA				Roskoden, Frederick Charles; Krueger, Janine; Vogt, Lena Johanna; Gaertner, Simone; Hannich, Hans Joachim; Steveling, Antje; Lerch, Markus M.; Aghdassi, Ali A.			Physical Activity, Energy Expenditure, Nutritional Habits, Quality of Sleep and Stress Levels in Shift-Working Health Care Personnel	PLOS ONE			English	Article							METABOLIC SYNDROME; DIETARY PATTERNS; CHRONIC DISEASE; ACCELEROMETER; RISK; PEDOMETER; OBESITY; ASSOCIATION; BIOMARKERS; DISORDERS	Background Among health care personnel working regular hours or rotating shifts can affect parameters of general health and nutrition. We have investigated physical activity, sleep quality, metabolic activity and stress levels in health care workers from both groups. Methods We prospectively recruited 46 volunteer participants from the workforce of a University Medical Department of which 23 worked in rotating shifts (all nursing) and 21 non-shift regular hours (10 nursing, 13 clerical staff). All were investigated over 7 days by multisensory accelerometer (SenseWear Bodymedia (R) armband) and kept a detailed food diary. Physical activity and resting energy expenditure (REE) were measured in metabolic equivalents of task (METs). Quality of sleep was assessed as Pittsburgh Sleeping Quality Index and stress load using the Trier Inventory for Chronic Stress questionnaire (TICS). Results No significant differences were found for overall physical activity, steps per minute, time of exceeding the 3 METs level or sleep quality. A significant difference for physical activity during working hours was found between shift-workers vs. non-shift-workers (p<0.01) and for shift-working nurses (median = 2.1 METs SE = 0.1) vs. non-shift-working clerical personnel (median = 1.5 METs SE = 0.07, p<0.05). Non-shift-working nurses had a significantly lower REE than the other groups (p<0.05). The proportion of fat in the diet was significantly higher (p<0.05) in the office worker group (median = 42% SE = 1.2) whereas shift-working nurses consumed significantly more carbohydrates (median = 46% SE = 1.4) than clerical staff (median = 41% SE = 1.7). Stress assessment by TICS confirmed a significantly higher level of social overload in the shift working group (p<0.05). Conclusion In this prospective cohort study shift-working had no influence on overall physical activity. Lower physical activity during working hours appears to be compensated for during off-hours. Differences in nutritional habits and stress load warrant larger scale trials to determine the effect on implicit health-associated conditions.	[Roskoden, Frederick Charles; Krueger, Janine; Vogt, Lena Johanna; Gaertner, Simone; Steveling, Antje; Lerch, Markus M.; Aghdassi, Ali A.] Univ Med Greifswald, Dept Med A, Greifswald, Germany; [Hannich, Hans Joachim] Univ Med Greifswald, Inst Med Psychol, Greifswald, Germany	Greifswald Medical School; Greifswald Medical School	Lerch, MM (corresponding author), Univ Med Greifswald, Dept Med A, Greifswald, Germany.	lerch@uni-greifswald.de	Aghdassi, Ali/X-5836-2019; Lerch, Markus M./E-2206-2016	Lerch, Markus M./0000-0002-9643-8263; Aghdassi, Ali/0000-0002-0569-7316	Baxter; Nutricia	Baxter; Nutricia(Danone Nutricia)	The authors received no specific or direct funding for this work. No direct grants were given. JK, LJV and SG were supported by unrestricted grants for the Domagk scholarship provided through donations from Baxter and Nutricia.; This study was approved by the local ethics committee and supported by unrestricted grants for the Domagk scholarship of J.K, L.J.V. and S.G. provided through donations from Baxter and Nutricia.	Ainsworth BE, 2000, MED SCI SPORTS EXERC, V32, P9; [Anonymous], 2008, WAIST CIRCUMFERENCE; Baillargeon J, 2001, OCCUP MED-STATE ART, V16, P359; Barbadoro P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063289; BELANGER CF, 1978, AM J NURS, V78, P1039, DOI 10.2307/3462013; Brocklebank LA, 2015, PREV MED, V76, P92, DOI 10.1016/j.ypmed.2015.04.013; Brown WJ, 2006, J PHYS ACT HEALTH, V3, P1, DOI DOI 10.1123/JPAH.3.1.1; Buman MP, 2014, AM J EPIDEMIOL, V179, P323, DOI 10.1093/aje/kwt292; Buysse D J, 1989, Psychiatry Res, V28, P193; Cipolla-Neto J, 2014, J PINEAL RES, V56, P371, DOI 10.1111/jpi.12137; De Bacquer D, 2009, INT J EPIDEMIOL, V38, P848, DOI 10.1093/ije/dyn360; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; FOSTER GD, 1988, METABOLISM, V37, P467, DOI 10.1016/0026-0495(88)90048-0; Fruin ML, 2004, MED SCI SPORT EXER, V36, P1063, DOI 10.1249/01.MSS.0000128144.91337.38; Fung TT, 2001, AM J CLIN NUTR, V73, P61; Geiger-Brown J, 2012, CHRONOBIOL INT, V29, P211, DOI 10.3109/07420528.2011.645752; Harris TJ, 2009, MED SCI SPORT EXER, V41, P1392, DOI 10.1249/MSS.0b013e31819b3533; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hoidrup S, 2002, EUR J CLIN NUTR, V56, P105, DOI 10.1038/sj.ejcn.1601292; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; Kinnunen TI, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-501; Knudsen VK, 2011, PUBLIC HEALTH NUTR, V14, P2110, DOI 10.1017/S1368980011001650; Knutsson A, 2003, OCCUP MED-OXFORD, V53, P103, DOI 10.1093/occmed/kqg048; Knutsson A, 2000, Rev Environ Health, V15, P359; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Loprinzi PD, 2015, PREV MED, V76, P43, DOI 10.1016/j.ypmed.2015.03.025; Lowden A, 2010, SCAND J WORK ENV HEA, V36, P150, DOI 10.5271/sjweh.2898; Morgenthaler T, 2007, SLEEP, V30, P519, DOI 10.1093/sleep/30.4.519; Mota MC, 2013, CHRONOBIOL INT, V30, P1032, DOI 10.3109/07420528.2013.796966; O'Driscoll DM, 2013, SLEEP BREATH, V17, P139, DOI 10.1007/s11325-012-0662-x; Petrowski K, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-42; Pietroiusti A, 2010, OCCUP ENVIRON MED, V67, P54, DOI 10.1136/oem.2009.046797; Ramin C, 2015, OCCUP ENVIRON MED, V72, P100, DOI 10.1136/oemed-2014-102292; Reece JD, 2015, VALIDATION SENSEWEAR, V12, P1229; ROZA AM, 1984, AM J CLIN NUTR, V40, P168, DOI 10.1093/ajcn/40.1.168; Scheers T, 2013, MED SCI SPORT EXER, V45, P481, DOI 10.1249/MSS.0b013e31827563ba; Schernhammer ES, 2006, EPIDEMIOLOGY, V17, P108, DOI 10.1097/01.ede.0000190539.03500.c1; Schulz P., 2004, TICS TRIERER INVENTA; SEGAWA K, 1987, DIGEST DIS SCI, V32, P449, DOI 10.1007/BF01296025; Seibt R, 2015, OCCUP MED-OXFORD, V65, P477, DOI 10.1093/occmed/kqv068; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tudor-Locke C, 2002, MED SCI SPORT EXER, V34, P2045, DOI 10.1097/00005768-200212000-00027; Ulas T, 2013, REV ESC ENFERM USP, V47, P462; Ulhoa MA, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/826249; Wang XS, 2011, OCCUP MED-OXFORD, V61, P78, DOI 10.1093/occmed/kqr001; Westerterp KR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004745; Wilczek A., 2002, THESIS	47	37	39	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169983	10.1371/journal.pone.0169983	http://dx.doi.org/10.1371/journal.pone.0169983			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081231	gold, Green Published, Green Submitted			2022-12-26	WOS:000391949500113
J	Kemp, JE; Ellis, AG				Kemp, Jurene E.; Ellis, Allan G.			Significant Local-Scale Plant-Insect Species Richness Relationship Independent of Abiotic Effects in the Temperate Cape Floristic Region Biodiversity Hotspot	PLOS ONE			English	Article							HERBIVOROUS INSECTS; HOST-SPECIFICITY; CICADELLIDAE CEPHALELINI; RESTIOID LEAFHOPPERS; GLOBAL PATTERNS; DIVERSITY; COMMUNITIES; LEPIDOPTERA; ASSEMBLAGES; ABUNDANCE	Globally plant species richness is a significant predictor of insect richness. Whether this is the result of insect diversity responding directly to plant diversity, or both groups responding in similar ways to extrinsic factors, has been much debated. Here we assess this relationship in the Cape Floristic Region (CFR), a biodiversity hotspot. The CFR has higher plant diversity than expected from latitude (i.e., abiotic conditions), but very little is known about the diversity of insects residing in this region. We first quantify diversity relationships at multiple spatial scales for one of the dominant plant families in the CFR, the Restionaceae, and its associated insect herbivore community. Plant and insect diversity are significantly positively correlated at the local scales (10-50 m; 0.1-3 km), but not at the regional scales (15-20 km; 50-70 km). The local scale relationship remains significantly positively correlated even when accounting for the influence of extrinsic variables and other vegetation attributes. This suggests that the diversity of local insect assemblages may be more strongly influenced by plant species richness than by abiotic variables. Further, vegetation age and plant structural complexity also influenced insect richness. The ratio of insect species per plant species in the CFR is comparable to other temperate regions around the world, suggesting that the insect diversity of the CFR is high relative to other areas of the globe with similar abiotic conditions, primarily as a result of the unusually high plant diversity in the region.	[Kemp, Jurene E.; Ellis, Allan G.] Univ Stellenbosch, Dept Bot & Zool, Matieland, South Africa	Stellenbosch University	Kemp, JE; Ellis, AG (corresponding author), Univ Stellenbosch, Dept Bot & Zool, Matieland, South Africa.	jurenekemp@yahoo.com; agellis@sun.ac.za	; Ellis, Allan/H-1105-2011	Kemp, Jurene/0000-0001-6615-6508; Ellis, Allan/0000-0001-6310-2870	National Research Foundation; South African Biosystematics Initiative [74458]; Stellenbosch University	National Research Foundation; South African Biosystematics Initiative; Stellenbosch University	National Research Foundation (ZA) provided personal funding to JEK (no grant number; URL: http://www.nrf.ac.za/). The South African Biosystematics Initiative provided project funding to AGE (grant number: 74458; URL: http://www.sassb.co.za/sab.htm). Stellenbosch University provided project funding to AGE (no grant number; URL: http://www.sun.ac.za/english). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson B, 2014, FYNBOS: ECOLOGY, EVOLUTION, AND CONSERVATION OF A MEGADIVERSE REGION, P224; Augustyn WJ, 2016, J ANIM ECOL, V85, P994, DOI 10.1111/1365-2656.12536; Augustyn WJ, 2013, J INSECT CONSERV, V17, P1267, DOI 10.1007/s10841-013-9608-2; Axmacher JC, 2009, J BIOGEOGR, V36, P337, DOI 10.1111/j.1365-2699.2008.01997.x; Basset Y, 1999, BIOL J LINN SOC, V67, P477, DOI 10.1111/j.1095-8312.1999.tb01943.x; Benton MJ, 2009, SCIENCE, V323, P728, DOI 10.1126/science.1157719; Castagneyrol B, 2014, J APPL ECOL, V51, P134, DOI 10.1111/1365-2664.12175; Castagneyrol B, 2012, ECOLOGY, V93, P2115, DOI 10.1890/11-1300.1; Collinge SK, 2000, ECOLOGY, V81, P2211, DOI 10.1890/0012-9658(2000)081[2211:EOGFOI]2.0.CO;2; Craft KJ, 2010, P NATL ACAD SCI USA, V107, P5041, DOI 10.1073/pnas.0913084107; DAVIES DM, 1988, J ENTOMOL SOC S AFR, V51, P31; Dinnage R, 2012, ECOL LETT, V15, P1308, DOI 10.1111/j.1461-0248.2012.01854.x; Dorrat-Haaksma E., 2012, RESTIOS FYNBOS; Dyer LA, 2007, NATURE, V448, P696, DOI 10.1038/nature05884; ERWIN T L, 1982, Coleopterists Bulletin, V36, P74; Frenzel M, 2003, ECOGRAPHY, V26, P723, DOI 10.1111/j.0906-7590.2003.03649.x; Giliomee JH, 2003, AFR J ECOL, V41, P237, DOI 10.1046/j.1365-2028.2003.00442.x; Gingras D, 2002, OECOLOGIA, V130, P396, DOI 10.1007/s00442-001-0819-y; Gingras D, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.2801; Goldblatt P, 2002, ANN MO BOT GARD, V89, P281, DOI 10.2307/3298566; Goldblatt P., 2000, CAPE PLANTS CONSPECT; Hawkins BA, 2003, AM NAT, V161, P40, DOI 10.1086/345479; Johnson S.D., 1992, P175; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kemp JE, 2016, ECOGRAPHY COP; Koricheva J, 2000, OECOLOGIA, V125, P271, DOI 10.1007/s004420000450; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Kuhlmann M, 2009, S AFR J BOT, V75, P726, DOI 10.1016/j.sajb.2009.06.016; Legrand A, 2003, ENVIRON ENTOMOL, V32, P1219, DOI 10.1603/0046-225X-32.5.1219; Leps J, 2001, J ECOL, V89, P186, DOI 10.1046/j.1365-2745.2001.00540.x; Lewinsohn TM, 2008, ECOL LETT, V11, P398, DOI 10.1111/j.1461-0248.2008.01155.x; Lewinsohn TM, 2005, ANNU REV ECOL EVOL S, V36, P597, DOI 10.1146/annurev.ecolsys.36.091704.175520; Linder H. P., 2002, AFRICAN RESTIONACEAE; Linder HP, 2003, BIOL REV, V78, P597, DOI 10.1017/S1464793103006171; Marques ESD, 2000, ENVIRON ENTOMOL, V29, P696, DOI 10.1603/0046-225X-29.4.696; Matenaar D, 2014, J INSECT CONSERV, V18, P447, DOI 10.1007/s10841-014-9654-4; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Novotny V, 2000, OIKOS, V89, P564, DOI 10.1034/j.1600-0706.2000.890316.x; Novotny V, 2005, J BIOGEOGR, V32, P1303, DOI 10.1111/j.1365-2699.2005.01225.x; Novotny V, 2005, P ROY SOC B-BIOL SCI, V272, P1083, DOI 10.1098/rspb.2004.3023; Novotny V, 2002, P ROY SOC B-BIOL SCI, V269, P2337, DOI 10.1098/rspb.2002.2166; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; Novotny V, 2006, SCIENCE, V313, P1115, DOI 10.1126/science.1129237; Novotny V, 2012, AM NAT, V179, P351, DOI 10.1086/664082; NWOKWU G.N., 2009, C J AGR SCI, V3, P15; Odegaard F, 2005, ECOL LETT, V8, P612, DOI 10.1111/j.1461-0248.2005.00758.x; Oliver I, 1996, CONSERV BIOL, V10, P99, DOI 10.1046/j.1523-1739.1996.10010099.x; Pellissier L, 2013, ECOGRAPHY, V36, P541, DOI 10.1111/j.1600-0587.2012.07716.x; Prendini L, 1998, ENTOMOL SCAND, V29, P11; Prendini L, 1997, AFR ENTOMOL, V5, P273; Price PW, 1998, J BIOGEOGR, V25, P581, DOI 10.1046/j.1365-2699.1998.2530581.x; Price PW, 2002, ECOL RES, V17, P241, DOI 10.1046/j.1440-1703.2002.00483.x; Proches S, 2006, GLOBAL ECOL BIOGEOGR, V15, P445, DOI 10.1111/j.1566-822x.2006.00239.x; Proches S, 2009, MOL PHYLOGENET EVOL, V51, P94, DOI 10.1016/j.ympev.2008.05.040; Pryke JS, 2008, BIODIVERS CONSERV, V17, P3027, DOI 10.1007/s10531-008-9414-4; R Core Team, 2021, R LANGUAGE ENV STAT; Santi E, 2010, J NAT CONSERV, V18, P2, DOI 10.1016/j.jnc.2009.02.003; Schaffers AP, 2008, ECOLOGY, V89, P782, DOI 10.1890/07-0361.1; Siemann E, 1997, AM MIDL NAT, V137, P349, DOI 10.2307/2426854; Siemann E, 1998, AM NAT, V152, P738, DOI 10.1086/286204; Tylianakis JM, 2005, ECOLOGY, V86, P3296, DOI 10.1890/05-0371; Verboom GA, 2009, MOL PHYLOGENET EVOL, V51, P44, DOI 10.1016/j.ympev.2008.01.037; Whitfeld TJS, 2012, ECOLOGY, V93, pS211, DOI 10.1890/11-0503.1; Winkler IS, 2009, P NATL ACAD SCI USA, V106, P18103, DOI 10.1073/pnas.0904852106; Wright MG, 1998, OECOLOGIA, V115, P427, DOI 10.1007/s004420050537; Zhu H, 2012, J APPL ECOL, V49, P1075, DOI 10.1111/j.1365-2664.2012.02195.x	66	31	31	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0168033	10.1371/journal.pone.0168033	http://dx.doi.org/10.1371/journal.pone.0168033			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076412	Green Published, gold			2022-12-26	WOS:000391857100008
J	Li, S; O'Neill, SRS; Zhang, Y; Holtzman, MJ; Takemaru, KI; Korach, KS; Winuthayanon, W				Li, Shuai; O'Neill, Sofia R. S.; Zhang, Yong; Holtzman, Michael J.; Takemaru, Ken-Ichi; Korach, Kenneth S.; Winuthayanon, Wipawee			Estrogen receptor alpha is required for oviductal transport of embryos	FASEB JOURNAL			English	Article						cilia; epithelial cells; fertility	SCANNING-ELECTRON-MICROSCOPY; CILIATED EPITHELIAL-CELLS; FALLOPIAN-TUBE EPITHELIUM; BETA-CATENIN; CLOMIPHENE CITRATE; EGG TRANSPORT; KARTAGENERS-SYNDROME; MOUSE EMBRYOS; RABBIT OVIDUCT; PROGESTERONE	Newly fertilized embryos spend the first few days within the oviduct and are transported to the uterus, where they implant onto the uterine wall. An implantation of the embryo before reaching the uterus could result in ectopic pregnancy and lead to maternal death. Estrogen is necessary for embryo transport in mammals; however, the mechanism involved in estrogen-mediated cellular function within the oviduct remains unclear. In this study, we show in mouse models that ciliary length and beat frequency of the oviductal epithelial cells are regulated through estrogen receptor alpha (ESR1) but not estrogen receptor beta (ESR2). Gene profiling indicated that transcripts in the WNT/beta-catenin (WNT/CTNNB1) signaling pathway were regulated by estrogen in mouse oviduct, and inhibition of this pathway in a whole oviduct culture system resulted in a decreased embryo transport distance. However, selective ablation of CTNNB1 from the oviductal ciliated cells did not affect embryo transport, possibly because of a compensatory mechanism via intact CTNNB1 in the adjacent secretory cells. In summary, we demonstrated that disruption of estrogen signaling in oviductal epithelial cells alters ciliary function and impairs embryo transport. Therefore, our findings may provide a better understanding of etiology of the ectopic pregnancy that is associated with alteration of estrogen signals.-Li, S., O'Neill, S. R. S., Zhang, Y., Holtzman, M. J., Takemaru, K.-I., Korach, K. S., Winuthayanon, W. Estrogen receptor alpha is required for oviductal transport of embryos.	[Li, Shuai; O'Neill, Sofia R. S.; Winuthayanon, Wipawee] Washington State Univ, Coll Vet Med, Sch Mol Biosci, Pullman, WA 99164 USA; [Zhang, Yong; Holtzman, Michael J.] Washington Univ, Sch Med, Dept Med, Pulm & Crit Care Med, St Louis, MO 63110 USA; [Takemaru, Ken-Ichi] SUNY Stony Brook, Sch Med, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Korach, Kenneth S.] NIEHS, Reprod & Dev Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA	Washington State University; Washington University (WUSTL); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Winuthayanon, W (corresponding author), Washington State Univ, Sch Mol Biosci Life Sci BLS202, Pullman, WA 99164 USA.	winuthayanonw@vetmed.wsu.edu	Winuthayanon, Wipawee/U-2153-2019	Winuthayanon, Wipawee/0000-0002-5196-8471; Korach, Kenneth/0000-0002-7765-418X; Li, Shuai/0000-0001-5889-3655	College of Veterinary Medicine (Washington State University); NIEHS [1ZIAES70065]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI130591, U19AI070489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102445, ZIAES070065] Funding Source: NIH RePORTER	College of Veterinary Medicine (Washington State University); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Sylvia Hewitt and Karina Rodriguez [U.S. National Institutes of Health, National Institute of Environmental Health Sciences (NIEHS)] for critical reading of this manuscript, Carmen Williams (NIEHS) for constructive advice for the project, Page Myers (NIEHS) for the oviduct transfer procedure, Jeff Tucker (NIEHS) for technical assistance, NIEHS Histology Core for ESR2 IHC staining, and Research Histology Core Facility (Department of Pathology, Stony Brook University School of Medicine) for the human fallopian tube samples. This work is supported by the start-up fund from College of Veterinary Medicine (Washington State University; to W.W.) and Intramural research Grant 1ZIAES70065 from NIEHS (to K.S.K.). The authors declare no conflicts of interest.	Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; AFZELIUS BA, 1978, FERTIL STERIL, V29, P72; Allen E, 1922, AM J ANAT, V30, P297, DOI 10.1002/aja.1000300303; Bae SM, 2014, MOL CELL ENDOCRINOL, V382, P46, DOI 10.1016/j.mce.2013.09.010; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; BLANDAU RJ, 1974, FERTIL STERIL, V25, P61; Brechbuhl HM, 2011, AM J PATHOL, V179, P367, DOI 10.1016/j.ajpath.2011.03.016; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; CROW J, 1994, HUM REPROD, V9, P2224, DOI 10.1093/oxfordjournals.humrep.a138428; Delling M, 2013, NATURE, V504, P311, DOI 10.1038/nature12833; Deroo BJ, 2009, MOL ENDOCRINOL, V23, P955, DOI 10.1210/me.2008-0213; Deutseher E, 2007, DEV BIOL, V307, P227, DOI 10.1016/j.ydbio.2007.04.036; DIRKSEN ER, 1972, TISSUE CELL, V4, P389, DOI 10.1016/S0040-8166(72)80017-X; ELIASSON R, 1977, NEW ENGL J MED, V297, P1, DOI 10.1056/NEJM197707072970101; GADDUMROSSE P, 1976, BIOL REPROD, V14, P605, DOI 10.1095/biolreprod14.5.605; Gifford JAH, 2009, BIOL REPROD, V80, P1282, DOI 10.1095/biolreprod.108.072280; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; GREENWALD GS, 1967, ANAT RECORD, V157, P163, DOI 10.1002/ar.1091570207; Guirao B, 2010, NAT CELL BIOL, V12, P341, DOI 10.1038/ncb2040; Gupta Nibedita, 2011, Cancers (Basel), V3, P2990, DOI 10.3390/cancers3032990; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Hagiwara H, 2008, MED MOL MORPHOL, V41, P193, DOI 10.1007/s00795-008-0421-z; HALBERT SA, 1976, GYNECOL OBSTET INVES, V7, P306, DOI 10.1159/000301391; HALBERT SA, 1976, SCIENCE, V191, P1052, DOI 10.1126/science.1251215; Halbert SA, 1997, HUM REPROD, V12, P55, DOI 10.1093/humrep/12.1.55; HALBERT SA, 1989, BIOL REPROD, V40, P1131, DOI 10.1095/biolreprod40.6.1131; HARRISON K, 1993, HUM REPROD, V8, P981, DOI 10.1093/oxfordjournals.humrep.a138178; Hess RA, 2000, J ANDROL, V21, P107; Hou XN, 2004, MOL ENDOCRINOL, V18, P3035, DOI 10.1210/me.2004-0259; HUMPHREY KW, 1968, J ENDOCRINOL, V40, P267, DOI 10.1677/joe.0.0400267; KERIN JF, 1985, J CLIN ENDOCR METAB, V61, P265, DOI 10.1210/jcem-61-2-265; Khong S Y, 2005, J Obstet Gynaecol, V25, P611, DOI 10.1080/01443610500242630; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; LEESE HJ, 1988, J REPROD FERTIL, V82, P843, DOI 10.1530/jrf.0.0820843; Li P, 2013, HUM REPROD, V28, P2363, DOI 10.1093/humrep/det246; LIPPES J, 1981, FERTIL STERIL, V36, P623; Love D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013600; LURIE M, 1989, CHEST, V95, P578, DOI 10.1378/chest.95.3.578; Lyons RA, 2006, HUM REPROD UPDATE, V12, P363, DOI 10.1093/humupd/dml012; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mathew M, 2004, SAUDI MED J, V25, P2058; MCCOMB P, 1986, FERTIL STERIL, V46, P412; Nishimura A, 2010, EXP PHYSIOL, V95, P819, DOI 10.1113/expphysiol.2010.052555; Niwa S, 2012, DEV CELL, V23, P1167, DOI 10.1016/j.devcel.2012.10.016; Ohm L. A., 2009, FERTIL STERIL, V92, pS116; Okada A, 2004, J MOL ENDOCRINOL, V32, P615, DOI 10.1677/jme.0.0320615; Okada A, 2003, J MOL ENDOCRINOL, V30, P301, DOI 10.1677/jme.0.0300301; Orihuela PA, 2003, BIOL REPROD, V68, P1225, DOI 10.1095/biolreprod.102.011395; Orihuela PA, 2001, BIOL REPROD, V65, P1238, DOI 10.1095/biolreprod65.4.1238; Plouffe L, 2000, J SOC GYNECOL INVEST, V7, pS38; Rider V, 2006, J ENDOCRINOL, V191, P537, DOI 10.1677/joe.1.07030; Rizos D, 2010, THERIOGENOLOGY, V73, P777, DOI 10.1016/j.theriogenology.2009.10.001; ROBLERO LS, 1979, J REPROD FERTIL, V57, P91, DOI 10.1530/jrf.0.0570091; ROBLERO LS, 1987, CONTRACEPTION, V36, P549, DOI 10.1016/0010-7824(87)90007-2; RUMERY RE, 1974, ANAT RECORD, V178, P83, DOI 10.1002/ar.1091780108; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shao RJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE147, DOI 10.1152/ajpendo.00101.2007; Shao RJ, 2009, BIOL REPROD, V80, P1262, DOI 10.1095/biolreprod.108.074237; Talbot P, 1999, MOL BIOL CELL, V10, P5, DOI 10.1091/mbc.10.1.5; Teilmann SC, 2006, J ENDOCRINOL, V191, P525, DOI 10.1677/joe.1.06565; Tichelaar JW, 1999, J HISTOCHEM CYTOCHEM, V47, P823, DOI 10.1177/002215549904700612; Voronina VA, 2009, J CELL BIOL, V185, P225, DOI 10.1083/jcb.200809144; Wallingford JB, 2011, GENE DEV, V25, P201, DOI 10.1101/gad.2008011; Westwood FR, 2008, TOXICOL PATHOL, V36, P375, DOI 10.1177/0192623308315665; Winuthayanon W, 2015, ELIFE, V4; Winuthayanon W, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.120170; Winuthayanon W, 2010, P NATL ACAD SCI USA, V107, P19272, DOI 10.1073/pnas.1013226107; Yang XZ, 2008, B MATH BIOL, V70, P1192, DOI 10.1007/s11538-008-9296-3; YANG YQ, 1990, CONTRACEPTION, V41, P551, DOI 10.1016/0010-7824(90)90063-2; Zhang Y, 2007, AM J RESP CELL MOL, V36, P515, DOI 10.1165/rcmb.2006-0475RC	70	34	35	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1595	1607		10.1096/fj.201601128R	http://dx.doi.org/10.1096/fj.201601128R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28082352	Green Published			2022-12-26	WOS:000398504300026
J	Singh, SK; Thirumalai, A; Pathak, A; Ngwa, DN; Agrawal, A				Singh, Sanjay K.; Thirumalai, Avinash; Pathak, Asmita; Ngwa, Donald N.; Agrawal, Alok			Functional Transformation of C-reactive Protein by Hydrogen Peroxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						host defense; immunology; inflammation; innate immunity; ligand-binding protein	LOW-DENSITY-LIPOPROTEIN; MODULATES COMPLEMENT ACTIVATION; SITE-DIRECTED MUTAGENESIS; INFLAMMATION IN-VIVO; AMYLOID P COMPONENT; OXIDATIVE STRESS; ATHEROSCLEROTIC LESIONS; PNEUMOCOCCAL INFECTION; ENDOTHELIAL-CELLS; INDUCED ARTHRITIS	C-reactive protein (CRP) is present at sites of inflammation including amyloid plaques, atherosclerotic lesions, and arthritic joints. CRP, in its native pentameric structural conformation, binds to cells and molecules that have exposed phosphocholine (PCh) groups. CRP, in its non-native pentameric structural conformation, binds to a variety of deposited, denatured, and aggregated proteins, in addition to binding to PCh-containing substances. In this study, we investigated the effects of H2O2, a prototypical reactive oxygen species that is also present at sites of inflammation, on the ligand recognition function of CRP. Controlled H2O2 treatment of native CRP did not monomerize CRP and did not affect the PCh binding activity of CRP. In solid phase ELISA-based ligand binding assays, purified pentameric H2O2-treated CRP bound to a number of immobilized proteins including oxidized LDL, IgG, amyloid peptide 1-42, C4b-binding protein, and factor H, in a CRP concentration- and ligand concentration-dependent manner. Using oxidized LDL as a representative protein ligand for H2O2-treated CRP, we found that the binding occurred in a Ca2+-independent manner and did not involve the PCh-binding site of CRP. We conclude that H2O2 is a biological modifier of the structure and ligand recognition function of CRP. Overall, the data suggest that the ligand recognition function of CRP is dependent on the presence of an inflammatory microenvironment. We hypothesize that one of the functions of CRP at sites of inflammation is to sense the inflammatory microenvironment, change its own structure in response but remain pentameric, and then bind to pathogenic proteins deposited at those sites.	[Singh, Sanjay K.; Thirumalai, Avinash; Pathak, Asmita; Ngwa, Donald N.; Agrawal, Alok] East Tennessee State Univ, Dept Biomed Sci, James H Quillen Coll Med, Johnson City, TN 37614 USA	East Tennessee State University	Agrawal, A (corresponding author), East Tennessee State Univ, Dept Biomed Sci, James H Quillen Coll Med, Johnson City, TN 37614 USA.	agrawal@etsu.edu		Thirumalai, Avinash/0000-0002-7722-7479	National Institutes of Health [AR068787, AI117730]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI117730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR068787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grants AR068787 (to A. A.) and AI117730 (to A. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AGRAWAL A, 1994, J IMMUNOL, V152, P5404; Agrawal A, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/319215; Agrawal Alok, 2010, Cardiovascular & Hematological Disorders - Drug Targets, V10, P235; Ahmed UK, 2016, J BIOL CHEM, V291, P11939, DOI 10.1074/jbc.M115.702746; Asztalos BF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109238; Bhakdi S, 2004, CIRCULATION, V109, P1870, DOI 10.1161/01.CIR.0000124228.08972.26; Bhakdi S, 1999, ARTERIOSCL THROM VAS, V19, P2348, DOI 10.1161/01.ATV.19.10.2348; Biro A, 2007, IMMUNOLOGY, V121, P40, DOI 10.1111/j.1365-2567.2007.02535.x; Bjornheden T, 1999, ARTERIOSCL THROM VAS, V19, P870, DOI 10.1161/01.ATV.19.4.870; Boguslawski G, 2007, J HEART LUNG TRANSPL, V26, P705, DOI 10.1016/j.healun.2007.04.006; Boncler M, 2011, PHARMACOL REP, V63, P464, DOI 10.1016/S1734-1140(11)70513-8; Braig D, 2014, INT IMMUNOL, V26, P467, DOI 10.1093/intimm/dxu056; Chang MK, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-42; Chang MK, 2002, P NATL ACAD SCI USA, V99, P13043, DOI 10.1073/pnas.192399699; Csincsi AI, 2015, J IMMUNOL, V194, P4963, DOI 10.4049/jimmunol.1403121; Danielsen B, 1997, BBA-PROTEIN STRUCT M, V1339, P73, DOI 10.1016/S0167-4838(96)00218-X; de Oliveira S, 2014, J IMMUNOL, V192, P5710, DOI 10.4049/jimmunol.1302902; DEBEER FC, 1982, J EXP MED, V156, P230, DOI 10.1084/jem.156.1.230; Dimitrov JD, 2013, MOL IMMUNOL, V55, P195, DOI 10.1016/j.molimm.2013.03.009; Doni A, 2015, J EXP MED, V212, P905, DOI 10.1084/jem.20141268; Dorta-Estremera S. M., 2015, J CLIN CELL IMMUNOL, V6, P332; DUCLOS TW, 1981, CLIN EXP IMMUNOL, V43, P565; Duong TH, 1997, BRAIN RES, V749, P152, DOI 10.1016/S0006-8993(96)01359-5; Eisenhardt SU, 2009, CIRC RES, V105, P128, DOI 10.1161/CIRCRESAHA.108.190611; Fu T, 2002, BIOCHEM J, V366, P195, DOI 10.1042/BJ20020045; Gang TB, 2015, INFECT IMMUN, V83, P1845, DOI 10.1128/IAI.03058-14; GITLIN JD, 1977, ARTHRITIS RHEUM, V20, P1491, DOI 10.1002/art.1780200808; Guillon C, 2015, PROTEIN PEPTIDE LETT, V22, P248, DOI 10.2174/0929866522666141231111226; Hakobyan S, 2008, J BIOL CHEM, V283, P30451, DOI 10.1074/jbc.M803648200; Hammond DJ, 2010, J BIOL CHEM, V285, P36235, DOI 10.1074/jbc.M110.142026; Hulsmans M, 2010, J CELL MOL MED, V14, P70, DOI 10.1111/j.1582-4934.2009.00978.x; Ji SR, 2007, FASEB J, V21, P284, DOI 10.1096/fj.06-6722com; Ji SR, 2006, ARTERIOSCL THROM VAS, V26, P935, DOI 10.1161/01.ATV.0000206211.21895.73; Ji SR, 2006, INT J BIOCHEM CELL B, V38, P648, DOI 10.1016/j.biocel.2005.11.004; JIANG H, 1991, IMMUNOLOGY, V74, P725; Jiang S, 2006, SCAND J RHEUMATOL, V35, P351, DOI 10.1080/03009740600757963; Jones NR, 2011, ARTHRITIS RHEUM-US, V63, P2641, DOI 10.1002/art.30444; Joseph K, 2013, J BIOL CHEM, V288, P12753, DOI 10.1074/jbc.M112.421891; Kondo T, 2009, J ATHEROSCLER THROMB, V16, P532, DOI 10.5551/jat.1255; KOTTGEN E, 1992, J IMMUNOL, V149, P445; Kovacs A, 2007, P NATL ACAD SCI USA, V104, P13768, DOI 10.1073/pnas.0706027104; KUSHNER I, 1961, J EXP MED, V114, P961, DOI 10.1084/jem.114.6.961; Laine M, 2007, J IMMUNOL, V178, P3831, DOI 10.4049/jimmunol.178.6.3831; Li HY, 2016, J BIOL CHEM, V291, P8795, DOI 10.1074/jbc.M115.695023; Millonig G, 2012, J BIOL CHEM, V287, P37472, DOI 10.1074/jbc.M112.358911; MIYAZAWA K, 1988, J IMMUNOL, V141, P570; MIYAZAWA K, 1990, J IMMUNOL, V145, P650; Motie M, 1996, J IMMUNOL, V156, P4435; Nayeri H, 2010, ARYA ATHEROSCLER, V6, P85; Okahashi N, 2016, INFECT IMMUN, V84, P2042, DOI 10.1128/IAI.00134-16; Okemefuna AI, 2010, J BIOL CHEM, V285, P1041, DOI 10.1074/jbc.M109.044495; Ottaviano FG, 2008, CIRC J, V72, P1, DOI 10.1253/circj.72.1; Ozawa D, 2016, SCI REP-UK, V6, DOI 10.1038/srep29077; Papaharalambus CA, 2007, TRENDS CARDIOVAS MED, V17, P48, DOI 10.1016/j.tcm.2006.11.005; Patel RP, 2000, FREE RADICAL BIO MED, V28, P1780, DOI 10.1016/S0891-5849(00)00235-5; Rai P, 2015, P NATL ACAD SCI USA, V112, pE3421, DOI 10.1073/pnas.1424144112; Reifenberg K, 2005, ARTERIOSCL THROM VAS, V25, P1641, DOI 10.1161/01.ATV.0000171983.95612.90; ROWE IF, 1985, J PATHOL, V145, P241, DOI 10.1002/path.1711450305; Rufail ML, 2006, FEBS LETT, V580, P5155, DOI 10.1016/j.febslet.2006.08.045; SALONEN EM, 1984, J BIOL CHEM, V259, P1496; Sato A, 2014, EUR J PHARMACOL, V745, P46, DOI 10.1016/j.ejphar.2014.10.020; Schwedler SB, 2005, CIRCULATION, V112, P1016, DOI 10.1161/CIRCULATIONAHA.105.556530; Schwedler SB, 2009, CLIN CHEM, V55, P1728, DOI 10.1373/clinchem.2009.125732; Shi P, 2014, ACTA BIOL HUNG, V65, P265, DOI 10.1556/ABiol.65.2014.3.3; Shrive AK, 1996, NAT STRUCT BIOL, V3, P346, DOI 10.1038/nsb0496-346; Simons JP, 2014, IMMUNOLOGY, V142, P414, DOI 10.1111/imm.12266; Singh SK, 2008, J IMMUNOL, V180, P4316, DOI 10.4049/jimmunol.180.6.4316; Singh SK, 2012, J BIOL CHEM, V287, P3550, DOI 10.1074/jbc.M111.310011; Singh SK, 2009, CLIN CHIM ACTA, V409, P143, DOI 10.1016/j.cca.2009.08.013; Sjoberg AP, 2007, J BIOL CHEM, V282, P10894, DOI 10.1074/jbc.M610256200; Sjoberg AP, 2006, J IMMUNOL, V176, P7612, DOI 10.4049/jimmunol.176.12.7612; SRINIVASAN N, 1994, STRUCTURE, V2, P1017, DOI 10.1016/S0969-2126(94)00105-7; Sun HJ, 2005, AM J PATHOL, V167, P1139, DOI 10.1016/S0002-9440(10)61202-3; Suresh MV, 2004, J BIOL CHEM, V279, P52552, DOI 10.1074/jbc.M409054200; Taylor KE, 2007, IMMUNOLOGY, V120, P404, DOI 10.1111/j.1365-2567.2006.02516.x; Thiele JR, 2014, CIRCULATION, V130, P35, DOI 10.1161/CIRCULATIONAHA.113.007124; Thiele M, 2015, J IMMUNOL, V195, P2343, DOI 10.4049/jimmunol.1500572; Torzewski M, 2000, ARTERIOSCL THROM VAS, V20, P2094, DOI 10.1161/01.ATV.20.9.2094; TSUJIMOTO M, 1983, J BIOCHEM, V94, P1367, DOI 10.1093/oxfordjournals.jbchem.a134483; Vassal-Stermann E, 2014, J IMMUNOL, V193, P5699, DOI 10.4049/jimmunol.1400127; VOLANAKI.JE, 1971, P SOC EXP BIOL MED, V136, P612; VOLANAKIS JE, 1979, NATURE, V281, P155, DOI 10.1038/281155a0; Wang MY, 2011, FASEB J, V25, P3186, DOI 10.1096/fj.11-182741; Zhang J, 2011, BIOCHIMIE, V93, P1710, DOI 10.1016/j.biochi.2011.06.003; Zhang R, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-42	85	19	20	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3129	3136		10.1074/jbc.M116.773176	http://dx.doi.org/10.1074/jbc.M116.773176			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28096464	Green Published, hybrid			2022-12-26	WOS:000395538800006
J	Torri, A; Carpi, D; Bulgheroni, E; Crosti, MC; Moro, M; Gruarin, P; Rossi, RL; Rossetti, G; Di Vizio, D; Hoxha, M; Bollati, V; Gagliani, C; Tacchetti, C; Paroni, M; Geginat, J; Corti, L; Venegoni, L; Berti, E; Pagani, M; Matarese, G; Abrignani, S; de Candia, P				Torri, Anna; Carpi, Donatella; Bulgheroni, Elisabetta; Crosti, Maria-Cristina; Moro, Monica; Gruarin, Paola; Rossi, Riccardo L.; Rossetti, Grazisa; Di Vizio, Dolores; Hoxha, Mirjam; Bollati, Valentina; Gagliani, Cristina; Tacchetti, Carlo; Paroni, Moira; Geginat, Jens; Corti, Laura; Venegoni, Luigia; Berti, Emilio; Pagani, Massimiliano; Matarese, Giuseppe; Abrignani, Sergio; de Candia, Paola			Extracellular MicroRNA Signature of Human Helper T Cell Subsets in Health and Autoimmunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULATING MICRORNAS; GENE-FUNCTION; EXOSOMES; BIOMARKERS; MICROVESICLES; ACTIVATION; SECRETION; MECHANISM; PATHOGENESIS; MODULATION	Upon T cell receptor stimulation, CD4 (+) T helper ( Th) lymphocytes release extracellular vesicles ( EVs) containing microRNAs. However, no data are available on whether human CD4 (+) T cell subsets release EVs containing different pattern of microRNAs. The present work aimed at filling this gap by assessing the microRNA content in EVs released upon in vitro T cell receptor stimulation of Th1, Th17, and T regulatory ( Treg) cells. Our results indicate that EVs released by Treg cells are significantly different compared with those released by the other subsets. In particular, miR-146a-5p, miR-150-5p, and miR-21-5p are enriched, whereas miR-106a-5p, miR-155-5p, and miR-19a-3p are depleted in Treg-derived EVs. The in vitro identified EV-associated microRNA signature was increased in serum of autoimmune patients with psoriasis and returned to healthy levels upon effective treatment with etanercept, a biological drug targeting the TNF pathway and suppressing inflammation. Moreover, Gene Set Enrichment Analysis showed an over-representation of genes relevant for T cell activation, such as CD40L, IRAK1, IRAK2, STAT1, and c-Myb in the list of validated targets of Treg-derived EV miRNAs. At functional level, Treg-derived ( but not Th1/ Th17-derived) EVs inhibited CD4 (+) T cell proliferation and suppressed two relevant targets of miR-146a-5p: STAT1 and IRAK2. In conclusion, our work identified the miRNAs specifically released by different human CD4 (+) T cell subsets and started to unveil the potential use of their quantity in human serum to mark the pathologicaleli citation of these cells in vivo and their biological effect in cell to cell communication during the adaptive immune response.	[Torri, Anna; Carpi, Donatella; Bulgheroni, Elisabetta; Crosti, Maria-Cristina; Moro, Monica; Gruarin, Paola; Rossi, Riccardo L.; Rossetti, Grazisa; Paroni, Moira; Geginat, Jens; Pagani, Massimiliano; Abrignani, Sergio] INGM Ist Nazl Genet Mol Romeo Enrica Invernizzi, I-20122 Milan, Italy; [Di Vizio, Dolores] Cedars Sinai Med Ctr, Div Canc Biol & Therapeut, Dept Surg, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Di Vizio, Dolores] Cedars Sinai Med Ctr, Div Canc Biol & Therapeut, Dept Biomed Sci, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Di Vizio, Dolores] Cedars Sinai Med Ctr, Div Canc Biol & Therapeut, Dept Pathol & Lab Med, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Hoxha, Mirjam; Bollati, Valentina] Univ Milan, Lab Epidemiol Mol & Epigenet Ambientale, Dipartimento Sci Clin & Comunita, I-20122 Milan, Italy; [Venegoni, Luigia] Univ Milan, Dipartimento Fisiopatol Med Chirurg & Trapianti, I-20122 Milan, Italy; [Pagani, Massimiliano] Univ Milan, Dipartimento Biotecnol Med & Med Traslaz, I-20122 Milan, Italy; [Abrignani, Sergio] Univ Milan, DISCCO Dipartimento Sci Clin & Comunita, I-20122 Milan, Italy; [Gagliani, Cristina; Tacchetti, Carlo] Univ Genoa, Dipartimento Med Sperimentale, I-16132 Genoa, Italy; [Corti, Laura; Berti, Emilio] Osped Maggiore Policlin, Fdn IRCCS Ist Ricovero & Cura Carattere Sci Ca Gr, Dipartimento Dermatol, I-20122 Milan, Italy; [Berti, Emilio] Univ Milano Bicocca, Dipartimento Med, I-20126 Milan, Italy; [Matarese, Giuseppe] Univ Napoli Federico II, Ist Endocrinol & Oncol Sperimentale, Consiglio Nazl Ric, Dipartimento Med Mol & Biotecnol Med, I-80131 Naples, Italy; [de Candia, Paola] IRCCS Ist Ricovero & Cura Carattere Sci Mu, MultiMed, I-20138 Milan, Italy	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of Milan; University of Milan; University of Milan; University of Milan; University of Genoa; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milano-Bicocca; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II	Matarese, G (corresponding author), Univ Napoli Federico II, Dipartimento Med Mol & Biotecnol Med, I-80131 Naples, Italy.; Abrignani, S (corresponding author), Via F Sforza 28, I-20122 Milan, Italy.; de Candia, P (corresponding author), Via Fantoli 16-15, I-20138 Milan, Italy.	giuseppe.matarese@unina.it; abrignani@ingm.org; paola.decandia@multimedica.it	de Candia, Paola/Z-1498-2019; de Candia, Paola/HGC-8826-2022; Matarese, Giuseppe/AAO-4077-2021; Geginat, Jens/AAA-5818-2019; rossetti, grazisa/C-3722-2015; Venegoni, Luigia/K-6085-2018; Rossi, Riccardo/M-8999-2019; Paroni, Moira/K-6470-2016	de Candia, Paola/0000-0003-4767-446X; de Candia, Paola/0000-0003-4767-446X; Matarese, Giuseppe/0000-0001-9429-0616; Geginat, Jens/0000-0003-4813-0384; rossetti, grazisa/0000-0001-6361-311X; Venegoni, Luigia/0000-0002-1846-1206; Rossi, Riccardo/0000-0002-4964-3264; Berti, Emilio/0000-0001-6753-4910; Pagani, Massimiliano/0000-0002-7017-9304; TACCHETTI, CARLO/0000-0003-4602-000X; Bollati, Valentina/0000-0002-0370-9598; Paroni, Moira/0000-0001-8199-3128; Abrignani, Sergio/0000-0002-0794-3285	European Foundation for the Study of Diabetes/Juvenile Diabetes Research Foundation/Lilly program; Institute Merieux [2009-3603]; European Research Council Advanced Grant [269022]; Fondazione Invernizzi; European Foundation for the Study of Diabetes [JDRF Lilly 2015_4] Funding Source: researchfish	European Foundation for the Study of Diabetes/Juvenile Diabetes Research Foundation/Lilly program; Institute Merieux; European Research Council Advanced Grant(European Research Council (ERC)); Fondazione Invernizzi; European Foundation for the Study of Diabetes	This work was supported by funds from the European Foundation for the Study of Diabetes/Juvenile Diabetes Research Foundation/Lilly program 2015 (to G.M. and P.d.C.); by Institute Merieux Grant 2009-3603 and European Research Council Advanced Grant 269022 (to S.A.); and by Fondazione Invernizzi. The authors declare that they have no conflicts of interest with the contents of this article.	Alexander M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8321; Bhairavabhotla R, 2016, HUM IMMUNOL, V77, P201, DOI 10.1016/j.humimm.2015.12.004; Blanchard N, 2002, J IMMUNOL, V168, P3235, DOI 10.4049/jimmunol.168.7.3235; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Bronevetsky Y, 2013, IMMUNOL REV, V253, P304, DOI 10.1111/imr.12059; Chen YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066577; Cordiali-Fei P, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/236060; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; de Candia P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075348; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Ghoreschi K, 2007, CLIN DERMATOL, V25, P574, DOI 10.1016/j.clindermatol.2007.08.012; Goretti E, 2013, INT J CARDIOL, V168, P4548, DOI 10.1016/j.ijcard.2013.06.092; Guay C, 2013, NAT REV ENDOCRINOL, V9, P513, DOI 10.1038/nrendo.2013.86; Gulinelli S, 2012, EUR J IMMUNOL, V42, P3334, DOI 10.1002/eji.201142268; Gutierrez-Vazquez C, 2013, IMMUNOL REV, V251, P125, DOI 10.1111/imr.12013; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Ismail N, 2013, BLOOD, V121, P984, DOI 10.1182/blood-2011-08-374793; Kandere-Grzybowska K, 2003, J IMMUNOL, V171, P4830, DOI 10.4049/jimmunol.171.9.4830; Karlsson M, 2001, EUR J IMMUNOL, V31, P2892, DOI 10.1002/1521-4141(2001010)31:10<2892::AID-IMMU2892>3.0.CO;2-I; Keijsers RRMC, 2015, EXP DERMATOL, V24, P65, DOI 10.1111/exd.12575; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lewis PJS, 2011, HEPATOLOGY, V54, P1767, DOI 10.1002/hep.24538; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Marabita F, 2016, BRIEF BIOINFORM, V17, P204, DOI 10.1093/bib/bbv056; Mashima R, 2015, IMMUNOLOGY, V145, P323, DOI 10.1111/imm.12468; Mattozzi C, 2013, DERMATOLOGY, V227, P134, DOI 10.1159/000353398; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Moussay E, 2011, P NATL ACAD SCI USA, V108, P6573, DOI 10.1073/pnas.1019557108; Narayanan A, 2013, J BIOL CHEM, V288, P20014, DOI 10.1074/jbc.M112.438895; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Okoye IS, 2014, IMMUNITY, V41, P89, DOI [10.1016/j.immuni.2014.05.019, 10.1016/j.immuni.2014.08.008]; Peche H, 2006, AM J TRANSPLANT, V6, P1541, DOI 10.1111/j.1600-6143.2006.01344.x; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Quaglino P, 2011, DERMATOLOGY, V223, P57, DOI 10.1159/000330330; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roderburg C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054612; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Taylor DD, 2006, J IMMUNOL, V176, P1534, DOI 10.4049/jimmunol.176.3.1534; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wahlgren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049723; Wang GJ, 2008, J IMMUNOL, V181, P5242, DOI 10.4049/jimmunol.181.8.5242; Wang JF, 2010, BIOCHEM BIOPH RES CO, V394, P184, DOI 10.1016/j.bbrc.2010.02.145; Wang J, 2016, J CELL PHYSIOL, V231, P25, DOI 10.1002/jcp.25056; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Zhang HG, 2006, J IMMUNOL, V176, P7385, DOI 10.4049/jimmunol.176.12.7385	63	49	49	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2903	2915		10.1074/jbc.M116.769893	http://dx.doi.org/10.1074/jbc.M116.769893			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28077577	Green Published, hybrid			2022-12-26	WOS:000395535100030
J	Siriphap, A; Leekitcharoenphon, P; Kaas, RS; Theethakaew, C; Aarestrup, FM; Sutheinkul, O; Hendriksen, RS				Siriphap, Achiraya; Leekitcharoenphon, Pimlapas; Kaas, Rolf S.; Theethakaew, Chonchanok; Aarestrup, Frank M.; Sutheinkul, Orasa; Hendriksen, Rene S.			Characterization and Genetic Variation of Vibrio cholerae Isolated from Clinical and Environmental Sources in Thailand	PLOS ONE			English	Article							EL-TOR VARIANT; HOSPITALIZED-PATIENTS; MOLECULAR ANALYSIS; ACUTE DIARRHEA; O1; STRAINS; RESISTANT; OUTBREAK; VIRULENCE; EPIDEMIC	Cholera is still an important public health problem in several countries, including Thailand. In this study, a collection of clinical and environmental V. cholerae serogroup 01,0139, and non-01/non-0139 strains originating from Thailand (1983 to 2013) was characterized to determine phenotypic and genotypic traits and to investigate the genetic relatedness. Using a combination of conventional methods and whole genome sequencing (WGS), 78 V. cholerae strains were identified. WGS was used to determine the serogroup, biotype, virulence, mobile genetic elements, and antimicrobial resistance genes using online bioinformatics tools. In addition, phenotypic antimicrobial resistance was determined by the minimal inhibitory concentration (MIC) test. The 78 V. cholerae strains belonged to the following serogroups 01: (n = 44), 0139 (n = 16) and non-01/non-0139 (n = 18). Interestingly, we found that the typical El Tor 01 strains were the major cause of clinical cholera during 1983-2000 with two Classical 01 strains detected in 2000. In 2004-2010, the El Tor variant strains revealed genotypes of the Classical biotype possessing either only ctxB or both ctxB and rstR while they harbored tcpA of the El Tor biotype. Thirty 01 and eleven 0139 clinical strains carried CTX4) (Cholera toxin) and tcpA as well four different pathogenic islands (PAls). Beside non-01/non-0139, the 01 environmental strains also presented chxA and Type Three Secretion System (TTSS). The in silico MultiLocus Sequence Typing (MLST) discriminated the 01 and 0139 clinical strains from other serogroups and environmental strains. ST69 was dominant in the clinical strains belonging to the 7th pandemic clone. Non01/non-0139 and environmental strains showed various novel STs indicating genetic variation. Multidrug-resistant (MDR) strains were observed and conferred resistance to ampicillin, azithromycin, nalidixic acid, sulfamethoxazole, tetracycline, and trimethoprim and harboured variants of the SXT elements. For the first time since 1986, the presence of V. cholerae 01 Classical was reported causing cholera outbreaks in Thailand. In addition, we found that V. cholerae 01 El Tor variant and 0139 were pre-dominating the pathogenic strains in Thailand. Using WGS and bioinformatic tools to analyze both historical and contemporary V. cholerae circulating in Thailand provided a more detailed understanding of the V. cholerae epidemiology, which ultimately could be applied for control measures and management of cholera in Thailand.	[Siriphap, Achiraya; Theethakaew, Chonchanok] Mahidol Univ, Fac Publ Hlth, Dept Microbiol, Bangkok, Thailand; [Leekitcharoenphon, Pimlapas; Kaas, Rolf S.; Aarestrup, Frank M.; Hendriksen, Rene S.] Tech Univ Denmark, Natl Food Inst, Res Grp Genom Epidemiol, WHO Collaborating Ctr Antimicrobial Resistance Fo, Lyngby, Denmark; [Leekitcharoenphon, Pimlapas; Kaas, Rolf S.; Aarestrup, Frank M.; Hendriksen, Rene S.] European Union Reference Lab Antimicrobial Resist, Lyngby, Denmark; [Sutheinkul, Orasa] Thammasat Univ, Rangsit Ctr, Fac Publ Hlth, Pathum Thani, Thailand	Mahidol University; Technical University of Denmark; Thammasat University	Hendriksen, RS (corresponding author), Tech Univ Denmark, Natl Food Inst, Res Grp Genom Epidemiol, WHO Collaborating Ctr Antimicrobial Resistance Fo, Lyngby, Denmark.; Hendriksen, RS (corresponding author), European Union Reference Lab Antimicrobial Resist, Lyngby, Denmark.; Sutheinkul, O (corresponding author), Thammasat Univ, Rangsit Ctr, Fac Publ Hlth, Pathum Thani, Thailand.	orasa.s@fph.tu.ac.th; rshe@food.dtu.dk	Leekitcharoenphon, Pimlapas/AAB-5487-2021	Hendriksen, Rene S./0000-0003-2934-8214; Suthienkul, Orasa/0000-0001-7264-5068; Kaas, Rolf Sommer/0000-0002-5050-8668; Leekitcharoenphon, Pimlapas/0000-0002-5674-0142; Aarestrup, Frank/0000-0002-7116-2723	Department of Microbiology grant, the China Medical Board, the Faculty of Public Health of Mahidol University; Danish Council for Strategic Research [09067103]; World Health Organization Global Food-borne Infections Network; World Health Organization, Food Safety Office [WP-12-FOS-003342]	Department of Microbiology grant, the China Medical Board, the Faculty of Public Health of Mahidol University; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); World Health Organization Global Food-borne Infections Network; World Health Organization, Food Safety Office	This work was supported in part by Department of Microbiology grant, the China Medical Board, the Faculty of Public Health of Mahidol University to Orasa Sutheinkul, the Danish Council for Strategic Research (grant number 09067103) to Frank M. Aarestrup, and in part by the World Health Organization Global Food-borne Infections Network and World Health Organization, Food Safety Office (WP-12-FOS-003342) to Rene S. Hendriksen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El Ghany M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002981; Alam M, 2007, P NATL ACAD SCI USA, V104, P17801, DOI 10.1073/pnas.0705599104; ALBERT MJ, 1993, LANCET, V341, P704; [Anonymous], 2014, ORGANIZATION; Awasthi SP, 2013, INFECT IMMUN, V81, P531, DOI 10.1128/IAI.00982-12; Bhattacharya D, 2016, MED MICROBIOL IMMUN, V205, P195, DOI 10.1007/s00430-015-0433-y; BHATTACHARYA SK, 1993, J INFECTION, V27, P11, DOI 10.1016/0163-4453(93)93488-P; Bhumiratana A, 2014, BIOCHEM RES INT, V2014, DOI 10.1155/2014/295421; Chatterjee S, 2009, J CLIN MICROBIOL, V47, P1087, DOI 10.1128/JCM.02026-08; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Cho YJ, 2010, CURR OPIN MICROBIOL, V13, P646, DOI 10.1016/j.mib.2010.08.007; Chomvarin C, 2013, J MED MICROBIOL, V62, P599, DOI 10.1099/jmm.0.053801-0; Chun J, 2009, P NATL ACAD SCI USA, V106, P15442, DOI 10.1073/pnas.0907787106; CLSI, C28A3 CLSI, V29th; Dalsgaard A, 1999, EPIDEMIOL INFECT, V122, P217, DOI 10.1017/S0950268899002137; Devault AM, 2014, NEW ENGL J MED, V370, P334, DOI 10.1056/NEJMoa1308663; Dixit SM, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-392; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; [Epidemiology Bo Department of Disease Control MoPH], 2014, ANN EP SURV REP; Faruque SM, 2004, P NATL ACAD SCI USA, V101, P2123, DOI 10.1073/pnas.0308485100; Faruque SM, 2003, TRENDS MICROBIOL, V11, P505, DOI 10.1016/j.tim.2003.09.003; Ghosh-Banerjee J, 2010, J CLIN MICROBIOL, V48, P4283, DOI 10.1128/JCM.00799-10; Hallin PF, 2008, MOL BIOSYST, V4, P363, DOI 10.1039/b717118h; Harris JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X; Hendriksen RS, 2011, MBIO, V2, DOI [10.1128/mBio.00157-11, 10.1128/mBio.00305-11]; Hochhut B, 1999, MOL MICROBIOL, V32, P99, DOI 10.1046/j.1365-2958.1999.01330.x; Hoge CW, 1996, AM J EPIDEMIOL, V143, P263, DOI 10.1093/oxfordjournals.aje.a008737; Kaas RS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155691; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Karaolis DKR, 1999, NATURE, V399, P375, DOI 10.1038/20715; Kim EJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004384; Kirn TJ, 2000, MOL MICROBIOL, V35, P896, DOI 10.1046/j.1365-2958.2000.01764.x; Kitaoka M, 2011, J MED MICROBIOL, V60, P397, DOI 10.1099/jmm.0.023051-0; Kumar P, 2009, J MED MICROBIOL, V58, P234, DOI 10.1099/jmm.0.002089-0; Kumar P, 2014, CLIN MICROBIOL INFEC, V20, pO292, DOI 10.1111/1469-0691.12393; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Li XJ, 2016, CAN J MICROBIOL, V62, P139, DOI 10.1139/cjm-2015-0443; Luo Y, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-52; Marin MA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002049; Moore S, 2014, CLIN MICROBIOL INFEC, V20, P373, DOI 10.1111/1469-0691.12610; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Na-Ubol M, 2011, INDIAN J MED RES, V133, P387; Nair GB, 2002, J CLIN MICROBIOL, V40, P3296, DOI 10.1128/JCM.40.9.3296-3299.2002; Octavia S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065342; Okada K, 2013, EMERG INFECT DIS, V19, P1015, DOI 10.3201/eid1906.120345; Onifade TJM, 2011, EUROSURVEILLANCE, V16, P10; Pang B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149742; Preeprem S, 2014, FOODBORNE PATHOG DIS, V11, P881, DOI 10.1089/fpd.2014.1772; Rivera ING, 2001, APPL ENVIRON MICROB, V67, P2421, DOI 10.1128/AEM.67.6.2421-2429.2001; Safa A, 2009, J MED MICROBIOL, V58, P105, DOI 10.1099/jmm.0.004333-0; Safa A, 2008, EMERG INFECT DIS, V14, P987, DOI 10.3201/eid1406.080129; Safa A, 2006, J MED MICROBIOL, V55, P1563, DOI 10.1099/jmm.0.46689-0; Singh DV, 2001, APPL ENVIRON MICROB, V67, P910, DOI 10.1128/AEM.67.2.910-921.2001; Sjolund-Karlsson M, 2011, EMERG INFECT DIS, V17, P2151, DOI 10.3201/eid1711.110720; Supawat Krongkaew, 2009, J Med Assoc Thai, V92 Suppl 4, pS82; TABTIENG R, 1989, AM J TROP MED HYG, V41, P680, DOI 10.4269/ajtmh.1989.41.680; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tapchaisri P, 2008, J HEALTH POPUL NUTR, V26, P79; Waldor MK, 1996, J BACTERIOL, V178, P4157, DOI 10.1128/jb.178.14.4157-4165.1996; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; World Health Organization, 1987, MAN LAB INV AC ENT I; Wozniak RAF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000786; Yamai S, 1997, Kansenshogaku Zasshi, V71, P1037; Zankari E, 2013, J ANTIMICROB CHEMOTH, V68, P771, DOI 10.1093/jac/dks496	64	42	46	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0169324	10.1371/journal.pone.0169324	http://dx.doi.org/10.1371/journal.pone.0169324			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103259	Green Published, Green Submitted, gold			2022-12-26	WOS:000392381100012
J	Allain, TJ; Aston, S; Mapurisa, G; Ganiza, TN; Banda, NP; Sakala, S; Gonani, A; Heyderman, RS; Peterson, I				Allain, Theresa J.; Aston, Stephen; Mapurisa, Gugulethu; Ganiza, Thokozani N.; Banda, Ndaziona P.; Sakala, Servace; Gonani, Andrew; Heyderman, Robert S.; Peterson, Ingrid			Age Related Patterns of Disease and Mortality in Hospitalised Adults in Malawi	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; HIV; BURDEN; BLANTYRE; AFRICA; HEALTH	Background The epidemic of non-communicable diseases (NCDs) in low and middle income countries (LMICs) is widely recognised as the next major challenge to global health. However, in many LMICs, infectious diseases are still prevalent resulting in a "double burden" of disease. With increased life expectancy and longevity with HIV, older adults may particularly be at risk of this double burden. Here we describe the relative contributions of infections and NCDs to hospital admissions and mortality, according to age, in Malawi's largest hospital. Methods Primary diagnosis on discharge/death, mortality rates, and HIV status were recorded prospectively on consecutive adult medical in-patients over 2 years using an electronic medical records system. Diagnoses were classified as infections or NCDs and analysed according to age and gender. Findings 10,191 records were analysed. Overall, infectious diseases, particularly those associated with HIV, were the leading cause of admission. However, in adults >= 55 years, NCDs were the commonest diagnoses. In adults <55 years 71% of deaths were due to infections whereas in adults >= 55 years 56% of deaths were due to NCDs. Interpretation Infectious diseases are still the leading cause of adult admission to a central hospital in Malawi but in adults aged >= 55 years NCDs are the most frequent diagnoses. HIV was an underlying factor in the majority of adults with infections and was also present in 53% of those with NCDs. These findings highlight the need for further health sector shifts to address the double burden of infectious and NCDs, particularly in the ageing population.	[Allain, Theresa J.] Univ Hosp Bristol NHS Trust, Bristol, Avon, England; [Aston, Stephen; Mapurisa, Gugulethu; Ganiza, Thokozani N.; Peterson, Ingrid] Malawi Liverpool Wellcome Trust, Clin Res Programme, Blantyre, Malawi; [Banda, Ndaziona P.] Univ Malawi, Coll Med, Blantyre, Malawi; [Sakala, Servace; Gonani, Andrew] Queen Elizabeth Hosp, Minist Hlth, Blantyre, Malawi; [Heyderman, Robert S.] UCL, London, England	University of Malawi; University of Malawi; University of Malawi; University of London; University College London	Allain, TJ (corresponding author), Univ Hosp Bristol NHS Trust, Bristol, Avon, England.	Theresa.Allain@UHBristol.nhs.uk		Heyderman, Robert/0000-0003-4573-449X; Aston, Stephen/0000-0002-0701-8364	Malawi-Liverpool-Wellcome Trust Clinical Research Programme - Strategic Award from The Wellcome Trust [101113/Z/13/Z]; Malawi-Liverpool-Wellcome Trust Clinical Research Programme - Strategic Award from The Wellcome Trust [101113/Z/13/Z]; National Institute for Health Research [CL-2016-07-002] Funding Source: researchfish	Malawi-Liverpool-Wellcome Trust Clinical Research Programme - Strategic Award from The Wellcome Trust; Malawi-Liverpool-Wellcome Trust Clinical Research Programme - Strategic Award from The Wellcome Trust; National Institute for Health Research(National Institute for Health Research (NIHR))	The SPINE system is funded by the Malawi-Liverpool-Wellcome Trust Clinical Research Programme which is supported by a Strategic Award from The Wellcome Trust, Grant number 101113/Z/13/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboderin IAG, 2015, LANCET, V385, pE9, DOI 10.1016/S0140-6736(14)61602-0; Age H, 2015, HELP AGE COUNTRY AGE; Allain TJ, 2014, MALAWI MED J, V26, P105; [Anonymous], 2015, WORLD POP PROSP 2015; Babiker AG, 2001, J CLIN EPIDEMIOL, V54, pS16, DOI 10.1016/S0895-4356(01)00456-5; Bardgett HP, 2006, TROP DOCT, V36, P129, DOI 10.1258/004947506777978217; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; CDC, 2013, HIV AIDS SURVEILLANC; Dreyer G., 2012, BR J RENAL MED, V17, P24; Guaraldi G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118531; Lawn SD, 2010, CURR OPIN HIV AIDS, V5, P18, DOI 10.1097/COH.0b013e328333850f; MacPherson P, 2012, TROP MED INT HEALTH, V17, P507, DOI 10.1111/j.1365-3156.2011.02946.x; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mathers CD, 2015, LANCET, V385, P540, DOI 10.1016/S0140-6736(14)60569-9; Mitambo CKS., 2015, IMPROVING SCREENING, P1; Msyamboza KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020316; Muula AS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-63; Office MNS, 2008, 2008 MAL POP HOUS CE; Organization WH, 2015, SUMM WORLD REP AG HL; Reid A, 2005, JAIDS-J ACQ IMM DEF, V40, P53, DOI 10.1097/01.qai.0000174251.35398.72; SanJoaquin MA, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001400; Schmid GP, 2009, B WORLD HEALTH ORGAN, V87, P162, DOI 10.2471/BLT.09.064030; Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: A collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action, 2000, RAP ADV ANT THER HIV, V355, P1131; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wajanga BMK, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0627-9; WHO, 2015, COUNTR PROF MAL; WHO, 2010, GLOB STAT REP NONC D; World Health Organization, 2010, PACK ESS NONC PEN DI	28	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0168368	10.1371/journal.pone.0168368	http://dx.doi.org/10.1371/journal.pone.0168368			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099438	Green Published, Green Submitted, gold			2022-12-26	WOS:000392380100009
J	Lokhandwala, S; Fang, X; Waghela, SD; Bray, J; Njongmeta, LM; Herring, A; Abdelsalam, KW; Chase, C; Mwangi, W				Lokhandwala, Shehnaz; Fang, Xin; Waghela, Suryakant D.; Bray, Jocelyn; Njongmeta, Leo M.; Herring, Andy; Abdelsalam, Karim W.; Chase, Christopher; Mwangi, Waithaka			Priming Cross-Protective Bovine Viral Diarrhea Virus-Specific Immunity Using Live Vectored Mosaic Antigens	PLOS ONE			English	Article							T-CELL RESPONSES; RESPIRATORY-SYNCYTIAL-VIRUS; MONOCLONAL-ANTIBODIES; E2 PROTEIN; LYMPHOCYTE RESPONSES; DISEASE COMPLEX; RHESUS-MONKEYS; MOUTH-DISEASE; CATTLE; VACCINES	Bovine viral diarrhea virus (BVDV) plays a key role in bovine respiratory disease complex, which can lead to pneumonia, diarrhea and death of calves. Current vaccines are not very effective due, in part, to immunosuppressive traits and failure to induce broad protection. There are diverse BVDV strains and thus, current vaccines contain representative genotype 1 and 2 viruses (BVDV-1 & 2) to broaden coverage. BVDV modified live virus (MLV) vaccines are superior to killed virus vaccines, but they are susceptible to neutralization and complement-mediated destruction triggered by passively acquired antibodies, thus limiting their efficacy. We generated three novel mosaic polypeptide chimeras, designated N(pro)E2(123); NS231; and NS232, which incorporate protective determinants that are highly conserved among BVDV-la, 1b, and BVDV-2 genotypes. In addition, strain-specific protective antigens from disparate BVDV strains were included to broaden coverage. We confirmed that adenovirus constructs expressing these antigens were strongly recognized by monoclonal antibodies, polyclonal sera, and IFN-gamma-secreting T cells generated against diverse BVDV strains. In a proof-of-concept efficacy study, the multi-antigen proto-type vaccine induced higher, but not significantly different, IFN-gamma spot forming cells and T-cell proliferation compared to a commercial MLV vaccine. In regards to the humoral response, the prototype vaccine induced higher BVDV-1 specific neutralizing antibody titers, whereas the MLV vaccine induced higher BVDV-2 specific neutralizing antibody titers. Following BVDV type 2a (1373) challenge, calves immunized with the proto-type or the MLV vaccine had lower clinical scores compared to nave controls. These results support the hypothesis that a broadly protective subunit vaccine can be generated using mosaic polypeptides that incorporate rationally selected and validated protective determinants from diverse BVDV strains. Furthermore, regarding biosafety of using a live vector in cattle, we showed that recombinant human adenovirus-5 was cleared within one week following intradermal inoculation.	[Lokhandwala, Shehnaz; Waghela, Suryakant D.; Bray, Jocelyn; Njongmeta, Leo M.; Mwangi, Waithaka] Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Fang, Xin; Herring, Andy] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; [Abdelsalam, Karim W.; Chase, Christopher] South Dakota State Univ, Dept Vet & Biomed Sci, Brookings, SD USA; [Njongmeta, Leo M.] Univ Illinois, Environm Hlth & Safety Off, Chicago, IL USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; South Dakota State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mwangi, W (corresponding author), Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX 77843 USA.	wmwangi@cvm.tamu.edu	Chase, Chris/U-2796-2017; Abdelsalam, Karim/GRJ-2031-2022	Chase, Chris/0000-0001-6000-4095; Lokhandwala, Shehnaz/0000-0002-0873-8611	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [CSREES 2008-35204]	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture	This work was supported by the Agriculture and Food Research Initiative Competitive Grant number CSREES 2008-35204 from the USDA National Institute of Food and Agriculture. Recipient: SDW and WM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER JC, 1995, VET CLIN N AM-FOOD A, V11, P425, DOI 10.1016/S0749-0720(15)30460-6; Barouch DH, 2013, CELL, V155, P531, DOI 10.1016/j.cell.2013.09.061; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Beer M, 1997, VET MICROBIOL, V58, P9, DOI 10.1016/S0378-1135(97)00145-4; Bell CR, 2015, VACCINE, V33, P3488, DOI 10.1016/j.vaccine.2015.05.069; Bell CR, 2013, VET IMMUNOL IMMUNOP, V151, P303, DOI 10.1016/j.vetimm.2012.12.002; Benjamin M.M., 1978, OUTLINE VET CLIN PAT; BOLIN SR, 1995, AM J VET RES, V56, P755; Bolin SR, 2004, VET CLIN N AM-FOOD A, V20, P51, DOI 10.1016/j.cvfa.2003.11.009; BOLIN SR, 1985, AM J VET RES, V46, P2385; Brock KV, 1998, J VET DIAGN INVEST, V10, P22, DOI 10.1177/104063879801000105; BROWNLIE J, 1987, ANN RECH VET, V18, P157; Campbell JR, 2004, VET CLIN N AM-FOOD A, V20, P39, DOI 10.1016/j.cvfa.2003.11.003; Carbrey EA, 1971, RECOMMENDED STANDARD; Chase CCL, 2004, VET CLIN N AM-FOOD A, V20, P95, DOI 10.1016/j.cvfa.2003.11.004; Collen T, 2000, VIRUS RES, V67, P67, DOI 10.1016/S0168-1702(00)00131-3; Collen T, 2002, VET IMMUNOL IMMUNOP, V87, P235, DOI 10.1016/S0165-2427(02)00088-0; Couvreur B, 2007, VET RES, V38, P819, DOI 10.1051/vetres:2007037; Dean HJ, 1999, VACCINE, V17, P1117, DOI 10.1016/S0264-410X(98)00329-6; Deregt D, 1998, VIRUS RES, V53, P81, DOI 10.1016/S0168-1702(97)00129-9; Deregt D, 2005, VET MICROBIOL, V108, P13, DOI 10.1016/j.vetmic.2005.02.010; Deregt D, 1998, VIRUS RES, V57, P171, DOI 10.1016/S0168-1702(98)00095-1; DONIS RO, 1988, J GEN VIROL, V69, P77, DOI 10.1099/0022-1317-69-1-77; Edwards S, 1990, Rev Sci Tech, V9, P115; El-Attar LMR, 2015, VACCINE, V33, P4004, DOI 10.1016/j.vaccine.2015.06.017; Elahi SM, 1999, FEMS MICROBIOL LETT, V177, P159, DOI 10.1111/j.1574-6968.1999.tb13727.x; Ellis J, 2001, J AM VET MED ASSOC, V219, P351, DOI 10.2460/javma.2001.219.351; Endsley JJ, 2003, BIOLOGICALS, V31, P123, DOI 10.1016/S1045-1056(03)00027-7; Fairbanks K, 2003, VET THER, V4, P24; Fairbanks KK, 2004, JAVMA-J AM VET MED A, V225, P1898, DOI 10.2460/javma.2004.225.1898; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Foucras G, 2011, J IMMUNOL, V187, P6564, DOI 10.4049/jimmunol.1102533; Fulton RW, 1997, CLIN DIAGN LAB IMMUN, V4, P380, DOI 10.1128/CDLI.4.3.380-383.1997; Fulton RW, 2000, CAN J VET RES, V64, P151; Fulton RW, 2004, VACCINE, V22, P643, DOI 10.1016/j.vaccine.2003.08.033; Giangaspero M, 2008, J VET MED SCI, V70, P571, DOI 10.1292/jvms.70.571; Grooms DL, 1998, J VET DIAGN INVEST, V10, P130, DOI 10.1177/104063879801000202; Grubman MJ, 2012, FUTURE VIROL, V7, P767, DOI 10.2217/FVL.12.65; Hegde NR, 1997, VIRUS GENES, V14, P111, DOI 10.1023/A:1007913216861; HERTIG C, 1995, GENE, V153, P191, DOI 10.1016/0378-1119(94)00748-H; HOWARD CJ, 1989, VET MICROBIOL, V19, P195, DOI 10.1016/0378-1135(89)90066-7; HOWARD CJ, 1992, VET IMMUNOL IMMUNOP, V32, P303, DOI 10.1016/0165-2427(92)90052-R; Jones C, 2010, VET CLIN N AM-FOOD A, V26, P303, DOI 10.1016/j.cvfa.2010.04.007; Kamlangdee A, 2014, J VIROL, V88, P13300, DOI 10.1128/JVI.01532-14; Kappeler A, 1996, BIOLOGICALS, V24, P131, DOI 10.1006/biol.1996.0017; Kelling CL, 2004, VET CLIN N AM-FOOD A, V20, P115, DOI 10.1016/j.cvfa.2003.11.001; Korber BT, 2009, J VIROL, V83, P8300, DOI 10.1128/JVI.00114-09; Liang R, 2006, J GEN VIROL, V87, P2971, DOI 10.1099/vir.0.81737-0; Mody KT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143507; Moraes MP, 2011, VACCINE, V29, P9431, DOI 10.1016/j.vaccine.2011.10.037; Neill JD, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-150; Neill JD, 2011, VIRUS RES, V158, P140, DOI 10.1016/j.virusres.2011.03.024; Nelson G, 2012, VACCINE, V30, P4499, DOI 10.1016/j.vaccine.2012.04.068; Njongmeta LM, 2012, VACCINE, V30, P1624, DOI 10.1016/j.vaccine.2011.12.110; Nobiron I, 2003, VACCINE, V21, P2082; O'Rourke K, 2002, J AM VET MED ASSOC, V220, P1770; OLAFSON P, 1946, CORNELL VET, V36, P205; PATON DJ, 1992, VIROLOGY, V190, P763, DOI 10.1016/0042-6822(92)90914-B; Pecora A, 2015, VACCINE, V33, P5163, DOI 10.1016/j.vaccine.2015.07.106; POTGIETER LND, 1995, VET CLIN N AM-FOOD A, V11, P501, DOI 10.1016/S0749-0720(15)30464-3; Reber AJ, 2006, COMP IMMUNOL MICROB, V29, P61, DOI 10.1016/j.cimid.2006.01.001; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reuter JD, 2012, COMPARATIVE MED, V62, P361; RIDPATH JF, 1994, VIROLOGY, V205, P66, DOI 10.1006/viro.1994.1620; Ridpath JF, 2002, J VET DIAGN INVEST, V14, P303, DOI 10.1177/104063870201400405; ROTH JA, 1983, AM J VET RES, V44, P2366; Saliki JT, 1997, J CLIN MICROBIOL, V35, P803, DOI 10.1128/JCM.35.4.803-807.1997; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108; Smith Robert A., 2009, Animal Health Research Reviews, V10, P105, DOI 10.1017/S1466252309990107; Snider M, 2014, VACCINE, V32, P6758, DOI 10.1016/j.vaccine.2014.10.010; Stokstad M, 2004, VET MICROBIOL, V102, P141, DOI 10.1016/j.vetmic.2004.06.015; Theurer ME, 2015, JAVMA-J AM VET MED A, V246, P126, DOI 10.2460/javma.246.1.126; Thomas C, 2009, VACCINE, V27, P2387, DOI 10.1016/j.vaccine.2009.02.010; van Oirschot J, 1999, VET MICROBIOL, V64, P169, DOI 10.1016/S0378-1135(98)00268-5; van Rijn PA, 2007, VET MICROBIOL, V125, P150, DOI 10.1016/j.vetmic.2007.05.001; Vilcek S, 2004, VET RES, V35, P609, DOI 10.1051/vetres:2004036; Walsh SR, 2016, J INFECT DIS, V213, P541, DOI 10.1093/infdis/jiv496; Wang F, 2013, CELL, V153, P1379, DOI 10.1016/j.cell.2013.04.049; Yusim K, 2013, CLIN VACCINE IMMUNOL, V20, P302, DOI 10.1128/CVI.00605-12	79	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170425	10.1371/journal.pone.0170425	http://dx.doi.org/10.1371/journal.pone.0170425			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099492	Green Published, gold, Green Submitted			2022-12-26	WOS:000392380100089
J	Henriksen, OM; Hansen, NL; Osler, M; Mortensen, EL; Hallam, DM; Pedersen, ET; Chappell, M; Lauritzen, MJ; Rostrup, E				Henriksen, Otto Molby; Hansen, Naja Liv; Osler, Merete; Mortensen, Erik Lykke; Hallam, Dorte Merete; Pedersen, Esben Thade; Chappell, Michael; Lauritzen, Martin Johannes; Rostrup, Egill			Sub-Clinical Cognitive Decline and Resting Cerebral Blood Flow in Middle Aged Men	PLOS ONE			English	Article							WHITE-MATTER LESIONS; ALZHEIMERS-DISEASE; GENERAL-POPULATION; BRAIN ATROPHY; PERFUSION; DEMENTIA; MODEL; MRI; QUANTIFICATION; ROTTERDAM	Background Although dementia is associated with both global and regional cerebral blood flow (CBF) changes, little is known about cerebral perfusion in the early pre-clinical stages of cognitive decline preceding overt cognitive dysfunction. The aim of this study was to investigate the association of early sub-clinical cognitive decline with CBF. Materials and Methods The study participants were recruited from a cohort of Danish men born in 1953. Based on a regression model we selected men who performed better (Group A, n = 94) and poorer (Group B, n = 95) on cognitive testing at age 57 than expected from testing at age 20. Participants underwent supplementary cognitive testing, blood sampling and MRI including measurements of regional and global CBF. Results Regional CBF was lower in group B than in group A in the posterior cingulate gyrus and the precuneus. The associations were attenuated when corrected for global atrophy, but remained significant in regions of interest based analysis adjusting for regional gray matter volume and vascular risk factors. No influence of group on global CBF was observed. Conclusions We conclude that early sub-clinical cognitive decline is associated with reduced perfusion in the precuneus and posterior cingulate gyrus independently of regional atrophy and vascular risk factors, but cannot be statistically separated from an association with global atrophy.	[Henriksen, Otto Molby; Hansen, Naja Liv; Rostrup, Egill] Rigshosp, Copenhagen Univ Hosp, Dept Clin Physiol Nucl Med & PET, Funct Imaging Unit, Glostrup, Denmark; [Henriksen, Otto Molby; Hansen, Naja Liv; Mortensen, Erik Lykke; Lauritzen, Martin Johannes; Rostrup, Egill] Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark; [Henriksen, Otto Molby] Rigshosp Blegdamsvej, Copenhagen Univ Hosp, Dept Clin Physiol Nucl Med & PET, Copenhagen, Denmark; [Hansen, Naja Liv] Copenhagen Univ Hosp Herlev, Dept Clin Physiol & Nucl Med, Herlev, Denmark; [Osler, Merete; Mortensen, Erik Lykke] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Osler, Merete] Rigshosp, Copenhagen Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Hallam, Dorte Merete] Rigshosp, Copenhagen Univ Hosp, Dept Radiol, Glostrup, Denmark; [Pedersen, Esben Thade] Copenhagen Univ Hosp, Danish Res Ctr Magnet Resonance, Hvidovre, Denmark; [Chappell, Michael] Univ Oxford, Inst Biomed Engn, Oxford, England; [Chappell, Michael] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford Ctr Funct MRI Brain, Oxford, England; [Lauritzen, Martin Johannes] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Lauritzen, Martin Johannes] Rigshosp, Copenhagen Univ Hosp, Dept Clin Neurophysiol, Glostrup, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Oxford; University of Oxford; University of Copenhagen; Rigshospitalet; University of Copenhagen	Henriksen, OM (corresponding author), Rigshosp, Copenhagen Univ Hosp, Dept Clin Physiol Nucl Med & PET, Funct Imaging Unit, Glostrup, Denmark.; Henriksen, OM (corresponding author), Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark.; Henriksen, OM (corresponding author), Rigshosp Blegdamsvej, Copenhagen Univ Hosp, Dept Clin Physiol Nucl Med & PET, Copenhagen, Denmark.	ohen0009@regionh.dk	Rostrup, Egill/D-8622-2017; Osler, Merete/AAF-7885-2019	Rostrup, Egill/0000-0001-5015-5244; Chappell, Michael/0000-0003-1802-4214; Osler, Merete/0000-0002-6921-220X; Lauritzen, Martin/0000-0002-1517-1131	Nordea Foundation; Velux Foundation [VELUX26145, 31539]	Nordea Foundation; Velux Foundation(Velux Fonden)	The Nordea Foundation (http://nordeafonden.dk) provided financial support for this study through Center for Healthy Aging, University of Copenhagen. The Copenhagen Aging and Midlife Biobank was funded by a generous grant from the Velux Foundation (http://veluxfoundations.dk) (grant VELUX26145 and 31539). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Appelman APA, 2008, J CEREBR BLOOD F MET, V28, P633, DOI 10.1038/sj.jcbfm.9600563; Bisschops RHC, 2004, J NEUROL, V251, P1481, DOI 10.1007/s00415-004-0569-y; Brundel M, 2012, J DIABETES COMPLICAT, V26, P205, DOI 10.1016/j.jdiacomp.2012.03.021; Chappell MA, 2013, MAGN RESON MED, V69, P1466, DOI 10.1002/mrm.24372; Chen JJ, 2011, NEUROIMAGE, V55, P468, DOI 10.1016/j.neuroimage.2010.12.032; de la Torre JC, 2012, J ALZHEIMERS DIS, V32, P553, DOI 10.3233/JAD-2012-120793; Filippini N, 2011, NEUROIMAGE, V54, P602, DOI 10.1016/j.neuroimage.2010.08.009; Hansen NL, 2014, HUM BRAIN MAPP, V35, P4488, DOI 10.1002/hbm.22489; Henriksen OM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097363; Henriksen OM, 2012, J MAGN RESON IMAGING, V35, P1290, DOI 10.1002/jmri.23579; Jennings JR, 2013, STROKE, V44, P2480, DOI 10.1161/STROKEAHA.113.001716; Langbaum JB, 2013, NAT REV NEUROL, V9, P371, DOI 10.1038/nrneurol.2013.107; Lunau L, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000368; Meltzer CC, 2000, J NUCL MED, V41, P1842; Mosconi L, 2010, J ALZHEIMERS DIS, V20, P843, DOI 10.3233/JAD-2010-091504; Nilsson K, 2000, AGING-CLIN EXP RES, V12, P199, DOI 10.1007/BF03339837; Okonkwo OC, 2014, CEREB CORTEX, V24, P978, DOI 10.1093/cercor/bhs381; Osler M, 2006, INT J EPIDEMIOL, V35, P541, DOI 10.1093/ije/dyi300; Osler M, 2013, EUR J PUBLIC HEALTH, V23, P974, DOI 10.1093/eurpub/cks140; Pantoni L, 2005, NEUROEPIDEMIOLOGY, V24, P51, DOI 10.1159/000081050; Pase MP, 2012, STROKE, V43, P2803, DOI 10.1161/STROKEAHA.112.666727; Petersen ET, 2010, NEUROIMAGE, V49, P104, DOI 10.1016/j.neuroimage.2009.07.068; Petersen ET, 2006, MAGN RESON MED, V55, P219, DOI 10.1002/mrm.20784; Roman G, 2012, ARCH MED RES, V43, P671, DOI 10.1016/j.arcmed.2012.10.018; Ruitenberg A, 2005, ANN NEUROL, V57, P789, DOI 10.1002/ana.20493; Sabayan B, 2013, NEUROLOGY, V81, P1922, DOI 10.1212/01.wnl.0000436618.48402.da; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Teasdale TW, 2009, SCAND J PSYCHOL, V50, P633, DOI 10.1111/j.1467-9450.2009.00789.x; Thambisetty M, 2010, ARCH NEUROL-CHICAGO, V67, P93, DOI 10.1001/archneurol.2009.913; Thomas BP, 2013, J MAGN RESON IMAGING, V38, P1177, DOI 10.1002/jmri.24090; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van der Veen PH, 2015, STROKE, V46, P1233, DOI 10.1161/STROKEAHA.114.008030; Vernooij MW, 2008, J CEREBR BLOOD F MET, V28, P412, DOI 10.1038/sj.jcbfm.9600526; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Zonneveld HI, 2015, J CEREBR BLOOD F MET, V35, P1882, DOI 10.1038/jcbfm.2015.157	40	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0169912	10.1371/journal.pone.0169912	http://dx.doi.org/10.1371/journal.pone.0169912			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095458	Green Published, gold, Green Submitted			2022-12-26	WOS:000392372300043
J	Jiang, T; Liu, F; Wang, WG; Jiang, X; Wen, X; Hu, KJ; Xue, Y				Jiang, Tao; Liu, Fen; Wang, Wei-Guang; Jiang, Xin; Wen, Xuan; Hu, Kai-Jin; Xue, Yang			Distribution of Cathepsin K in Late Stage of Tooth Germ Development and Its Function in Degrading Enamel Matrix Proteins in Mouse	PLOS ONE			English	Article								Cathepsin K (CTSK) is a member of cysteine proteinase family, and is predominantly expressed in osteoclastsfor degradationof bone matrix proteins. Given the similarity in physical properties of bone and dental mineralized tissues, including enamel, dentin and cementum, CTSK is likely to take part in mineralization process during odontogenesis. On the other hand, patients with pycnodysostosis caused by mutations of the CTSK gene dis-playedmultipledental abnormalities, such as hypoplasia of the enamel, obliterated pulp chambers, hypercementosis and periodontal disease. Thereforeitis necessary to study the metabolic role of CTSK in tooth matrix proteins. In this study, BALB/c mice at embryonic day 18 (E18), post-natal day 1 (P1), P5, P10 and P20 were used (5 mice at each time point)for systematic analyses of CTSK expression in the late stage of tooth germ development. We found that CTSK was abundantly expressed in the ameloblasts during secretory and maturation stages (P5 and P10) by immunohistochemistry stainings.During dentinogenesis, the staining was also intense in the mineralization stage (P5 and P10),but not detectable in the early stage of dentin formation (P1) and after tooth eruption (P20).Furthermore, through zymography and digestion test in vitro, CTSK was proved to be capable of hydrolyzing Emdogain and also cleaving Amelogenininto multiple products. Our resultsshed lights on revealing new functions of CTSK and pathogenesis of pycnodysostosis in oral tissues.	[Jiang, Tao; Jiang, Xin; Hu, Kai-Jin; Xue, Yang] Fourth Mil Med Univ, State Key Lab Mil Stomatol, Xian, Peoples R China; [Jiang, Tao; Jiang, Xin; Hu, Kai-Jin; Xue, Yang] Fourth Mil Med Univ, Natl Clin Res Ctr Oral Dis, Xian, Peoples R China; [Jiang, Tao; Jiang, Xin; Hu, Kai-Jin; Xue, Yang] Fourth Mil Med Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, Shaanxi Clin Res Ctr Oral Dis, Xian, Peoples R China; [Liu, Fen] Fourth Mil Med Univ, Dept Periodontol, Sch Stomatol, Xian, Peoples R China; [Liu, Fen] Northwest Womens & Childrens Hosp, Dept Stomatol, Xian, Peoples R China; [Wang, Wei-Guang] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Surg, Xian, Peoples R China; [Wang, Wei-Guang] Troops PLA, Med Unit, Liaocheng, Peoples R China; [Jiang, Xin] Hubei Univ Med, Dongfeng Hosp, Dept Oral & Maxillofacial Surg, Shiyan, Peoples R China; [Wen, Xuan] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, Xian, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Hubei University of Medicine; Air Force Military Medical University	Hu, KJ; Xue, Y (corresponding author), Fourth Mil Med Univ, State Key Lab Mil Stomatol, Xian, Peoples R China.; Hu, KJ; Xue, Y (corresponding author), Fourth Mil Med Univ, Natl Clin Res Ctr Oral Dis, Xian, Peoples R China.; Hu, KJ; Xue, Y (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, Shaanxi Clin Res Ctr Oral Dis, Xian, Peoples R China.	hukaijin@fmmu.edu.cn; xueyangfmmu@live.cn			National Natural Science Foundation of China [NSFC 81300861]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants of the National Natural Science Foundation of China (NSFC 81300861) to YX. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, HDB PROTEIN TECHNOLO; Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Balaji M S Anandi, 2014, Indian J Dent, V5, P218, DOI 10.4103/0975-962X.144738; Bartlett JD, 1999, CRIT REV ORAL BIOL M, V10, P425, DOI 10.1177/10454411990100040101; Bartlett JD, 2013, ISRN DENT, DOI [DOI 10.1155/2013/68460, 10.1155/2013/68460]; Bathi RJ, 2000, INT J ORAL MAX SURG, V29, P439, DOI 10.1016/S0901-5027(00)80076-4; Beklen A, 2015, ORAL DIS, V21, P163, DOI 10.1111/odi.12230; Berdowska I, 2004, CLIN CHIM ACTA, V342, P41, DOI 10.1016/j.cccn.2003.12.016; Bosshardt DD, 1996, ANAT RECORD, V245, P267; Bosshardt DD, 1997, PERIODONTOL 2000, V13, P41, DOI 10.1111/j.1600-0757.1997.tb00095.x; Buhling F, 1999, AM J RESP CELL MOL, V20, P612; Charadram N, 2012, BONE, V50, P265, DOI 10.1016/j.bone.2011.10.031; Chen W, 2007, HUM MOL GENET, V16, P410, DOI 10.1093/hmg/ddl474; Fukae M, 1998, J DENT RES, V77, P1580, DOI 10.1177/00220345980770080501; Gasse B, 2015, EVODEVO, V6, DOI 10.1186/s13227-015-0024-4; Gelb BD, 1996, SCIENCE, V273, P1236, DOI 10.1126/science.273.5279.1236; GOLDBERG M, 1995, INT J DEV BIOL, V39, P93; Gowen M, 1999, J BONE MINER RES, V14, P1654, DOI 10.1359/jbmr.1999.14.10.1654; Huang XL, 2015, CALCIFIED TISSUE INT, V96, P373, DOI 10.1007/s00223-015-9963-y; Ishida M, 2013, ONCOL LETT, V5, P1755, DOI 10.3892/ol.2013.1311; Kim TH, 2015, BIOCHEM BIOPH RES CO, V459, P706, DOI 10.1016/j.bbrc.2015.03.014; Lv SY, 2014, J MOL HISTOL, V45, P303, DOI 10.1007/s10735-013-9548-x; Mitsiadis TA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00477; Nagano T, 2009, J DENT RES, V88, P823, DOI 10.1177/0022034509342694; Ortegosa MV, 2014, CLEFT PALATE-CRAN J, V51, P735, DOI 10.1597/12-233; Ozdemir TR, 2013, CLIN DYSMORPHOL, V22, P102, DOI 10.1097/MCD.0b013e3283619632; Rapa I, 2006, AM J CLIN PATHOL, V125, P847, DOI 10.1309/Q96AYDAAJ3E1TNWT; RUCH JV, 1995, INT J DEV BIOL, V39, P51; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Sina C, 2013, GUT, V62, P520, DOI 10.1136/gutjnl-2011-300076; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Soliman AT, 2001, METABOLISM, V50, P905, DOI 10.1053/meta.2001.24924; Vassalle C, 2013, ATHEROSCLEROSIS, V228, P36, DOI 10.1016/j.atherosclerosis.2013.01.042; Wright JT, 2006, AM J MED GENET A, V140A, P2547, DOI 10.1002/ajmg.a.31358; Wright JT, 2009, CELLS TISSUES ORGANS, V189, P224, DOI 10.1159/000151378; Xie LN, 2011, J DERMATOL SCI, V61, P45, DOI 10.1016/j.jdermsci.2010.09.005; Xue Y, 2015, J DENT RES, V94, P674, DOI 10.1177/0022034515573964; Xue Y, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-20; Zhang Z, 2015, PLOS ONE, V3	39	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0169857	10.1371/journal.pone.0169857	http://dx.doi.org/10.1371/journal.pone.0169857			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095448	Green Published, Green Submitted, gold			2022-12-26	WOS:000392372300038
J	Van Diep, N; Norimine, J; Sueyoshi, M; Lan, NT; Yamaguchi, R				Van Diep, Nguyen; Norimine, Junzo; Sueyoshi, Masuo; Nguyen Thi Lan; Yamaguchi, Ryoji			Novel Porcine Epidemic Diarrhea Virus (PEDV) Variants with Large Deletions in the Spike (S) Gene Coexist with PEDV Strains Possessing an Intact S Gene in Domestic Pigs in Japan: A New Disease Situation	PLOS ONE			English	Article							UNITED-STATES; SEQUENCE-ANALYSIS; CELL-CULTURES; PROTEIN; IDENTIFICATION; PROPAGATION; ANTIBODIES; DIVERSITY; EVOLUTION; ORF3	Since late 2013, after an absence of seven years, outbreaks of porcine epidemic diarrhea virus (PEDV) infection have reemerged and swept rapidly across Japan, resulting in significant economic losses. In this study, we report the emergence, mixed infection, and genetic characterization of 15 novel field PEDV variants with large genomic deletions. The sizes of deletion varied between 582 nt (194 aa) and 648 nt (216 aa) at positions 28-714 (10-238) on the S gene (protein). Among 17 PEDV samples isolated from individual pigs, all of them contained at least two distinct genotypes with large genomic deletions, and 94.1% of them were found to consist of strains with an intact S gene. These variants were found in eight primary and nine recurrent outbreaks, and they might be associated with persistent PEDV infection in the farms. Full-length S and ORF3 genes of eight variants derived from 2 samples were characterized. This is the first report of mixed infections caused by various genotypes of PEDV and would be important for the studies of viral isolation, pathogenesis, and molecular epidemiology of the disease.	[Van Diep, Nguyen; Norimine, Junzo; Sueyoshi, Masuo; Yamaguchi, Ryoji] Miyazaki Univ, Lab Vet Pathol, Dept Vet, Grad Sch Med & Vet Med, Miyazaki, Japan; [Nguyen Thi Lan] Vietnam Natl Univ Agr, Dept Vet Pathol, Fac Vet Med, Hanoi, Vietnam	University of Miyazaki; Vietnam National University of Agriculture (VNUA)	Yamaguchi, R (corresponding author), Miyazaki Univ, Lab Vet Pathol, Dept Vet, Grad Sch Med & Vet Med, Miyazaki, Japan.	a0d402u@cc.miyazaki-u.ac.jp	Van Diep, Nguyen/U-3003-2019	Lan, Nguyen Thi/0000-0002-1409-9967	University of Miyazaki [2014-70]	University of Miyazaki	The study was funded by University of Miyazaki, No. 2014-70.; The work was conducted with funding from the University of Miyazaki (grant number 2014-70).	BRIDGEN A, 1993, J GEN VIROL, V74, P1795, DOI 10.1099/0022-1317-74-9-1795; Chang SH, 2002, MOL CELLS, V14, P295; Chen JF, 2013, VIRUSES-BASEL, V5, P2601, DOI 10.3390/v5102601; Chen JF, 2010, ARCH VIROL, V155, P1471, DOI 10.1007/s00705-010-0720-2; Chen X, 2012, VIRUS GENES, V45, P499, DOI 10.1007/s11262-012-0794-x; Cruz DJM, 2008, VIRUS RES, V132, P192, DOI 10.1016/j.virusres.2007.10.015; Desmarets LMB, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-71; Gallagher TM, 2001, VIROLOGY, V279, P371, DOI 10.1006/viro.2000.0757; Grasland B, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00535-15; Hanke D, 2015, EMERG INFECT DIS, V21, P493, DOI 10.3201/eid2103.141165; HUANG AS, 1970, NATURE, V226, P325, DOI 10.1038/226325a0; Jung K, 2015, VET J, V204, P134, DOI 10.1016/j.tvjl.2015.02.017; Kim SY, 2001, J VET DIAGN INVEST, V13, P516, DOI 10.1177/104063870101300611; KUSANAGI K, 1992, J VET MED SCI, V54, P313, DOI 10.1292/jvms.54.313; Lee C, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0421-2; Lee DK, 2010, VIRUS RES, V149, P175, DOI 10.1016/j.virusres.2010.01.015; Lee S, 2014, EMERG INFECT DIS, V20, P1223, DOI 10.3201/eid2007.140294; Li CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069997; Li W, 2016, VIRUS RES; Li WT, 2012, EMERG INFECT DIS, V18, P1350, DOI 10.3201/eid1808.120002; Lin CN, 2014, J VET MED SCI, V76, P1297, DOI 10.1292/jvms.14-0098; Lin CM, 2016, VIRUS RES; Marriott AC, 2010, REV MED VIROL, V20, P51, DOI 10.1002/rmv.641; Masuda T, 2015, ARCH VIROL, V160, P2565, DOI 10.1007/s00705-015-2522-z; Diep NV, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1552-z; Oka T, 2014, VET MICROBIOL, V173, P258, DOI 10.1016/j.vetmic.2014.08.012; Park SJ, 2007, VIRUS GENES, V35, P55, DOI 10.1007/s11262-006-0036-1; Park S, 2014, EMERG INFECT DIS, V20, P2089, DOI 10.3201/eid2012.131642; PENSAERT MB, 1978, ARCH VIROL, V58, P243, DOI 10.1007/BF01317606; Saif L. J., 2012, DIS SWINE, P501; SANCHEZ CM, 1992, VIROLOGY, V190, P92, DOI 10.1016/0042-6822(92)91195-Z; Sato T, 2011, VIRUS GENES, V43, P72, DOI 10.1007/s11262-011-0617-5; Song D, 2012, VIRUS GENES, V44, P167, DOI 10.1007/s11262-012-0713-1; Song DS, 2003, VACCINE, V21, P1833, DOI 10.1016/S0264-410X(03)00027-6; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; SUEYOSHI M, 1995, J COMP PATHOL, V113, P59, DOI 10.1016/S0021-9975(05)80069-6; Sun DB, 2008, VET MICROBIOL, V131, P73, DOI 10.1016/j.vetmic.2008.02.022; Suzuki T, 2015, INFECT GENET EVOL, V36, P363, DOI 10.1016/j.meegid.2015.10.017; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Temeeyasen G, 2014, INFECT GENET EVOL, V21, P205, DOI 10.1016/j.meegid.2013.11.001; Theuns S, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00506-15; Tsuda T., 1997, P JPN PIG VET SOC, V31, P21; Vlasova AN, 2014, EMERG INFECT DIS, V20, P1620, DOI 10.3201/eid2010.140491; Wang JB, 2013, EMERG INFECT DIS, V19, P2048, DOI 10.3201/eid1912.121088; Wang K, 2012, FEBS LETT, V586, P384, DOI 10.1016/j.febslet.2012.01.005; Wang LY, 2014, EMERG INFECT DIS, V20, P917, DOI 10.3201/eid2005.140195; WOOD EN, 1977, VET REC, V100, P243, DOI 10.1136/vr.100.12.243; Yang X, 2013, VIRUS GENES, V46, P337, DOI 10.1007/s11262-012-0867-x	48	15	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0170126	10.1371/journal.pone.0170126	http://dx.doi.org/10.1371/journal.pone.0170126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095455	gold, Green Published, Green Submitted			2022-12-26	WOS:000392372300058
J	Fraija-Fernandez, N; Fernandez, M; Lehnert, K; Raga, JA; Siebert, U; Aznar, FJ				Fraija-Fernandez, Natalia; Fernandez, Mercedes; Lehnert, Kristina; Antonio Raga, Juan; Siebert, Ursula; Javier Aznar, Francisco			Long-Distance Travellers: Phylogeography of a Generalist Parasite, Pholeter gastrophilus, from Cetaceans	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; GENETIC-STRUCTURE; POPULATION-GROWTH; DELPHINUS-DELPHIS; HARBOR PORPOISES; STRIPED DOLPHIN; GASTROINTESTINAL PARASITES; STENELLA-COERULEOALBA; TURSIOPS-TRUNCATUS; HELMINTH-PARASITES	We studied the phylogeography and historical demography of the most generalist digenean from cetaceans, Pholeter gastrophilus, exploring the effects of isolation by distance, ecological barriers and hosts' dispersal ability on the population structure of this parasite. The ITS2 rDNA, and the mitochondrial COI and ND1 from 68 individual parasites were analysed. Worms were collected from seven oceanic and coastal cetacean species from the south western Atlantic (SWA), central eastern Atlantic, north eastern Atlantic (NEA), and Mediterranean Sea. Pholeter gastrophilus was considered a single lineage because reciprocal monophyly was not detected in the ML cladogram of all individuals, and sequence variability was <1% for mtDNA and 0% for ITS2. These results rule out a recent suggestion that P. gastrophilus would actually be a cryptic-species complex. The genetic cohesion of P. gastrophilus could rely on the extensive exploitation of wide-ranging and highly mobile cetaceans, with a putative secondary role, if any, of intermediate hosts. Unique haplotypes were detected in SWA and NEA, and an AMOVA revealed significant population structure associated to the genetic variation in these regions. The Equator possibly acts as a significant geographical barrier for cetacean movements, possibly limiting gene flow between northern and southern populations of P. gastrophilus. A partial Mantel tests revealed that the significant isolation of NEA populations resulted from geographic clustering. Apparently, the limited mobility of cetaceans used by P. gastrophilus as definitive hosts in this region, coupled with oceanographic barriers and a patchy distribution of potential intermediate hosts could contribute to significant ecological isolation of P. gastrophilus in NEA. Rather unexpectedly, no genetic differentiation was found in the Mediterranean samples of this parasite. Historical demographic analyses suggested a recent population expansion of P. gastrophilus in the Atlantic Ocean, perhaps linked to initial association and subsequent spreading in cetaceans.	[Fraija-Fernandez, Natalia; Fernandez, Mercedes; Antonio Raga, Juan; Javier Aznar, Francisco] Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Sci Pk, Valencia, Spain; [Lehnert, Kristina; Siebert, Ursula] Univ Vet Med, Inst Terr & Aquat Wildlife Res, Werftstr, Hannover, Busum, Germany	University of Valencia; University of Veterinary Medicine Hannover, Foundation	Fraija-Fernandez, N (corresponding author), Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Sci Pk, Valencia, Spain.	natalia.fraija@uv.es	Raga, Juan Antonio/L-7669-2014; Fraija-Fernández, Natalia/L-3593-2019; Aznar, Francisco Javier/S-3427-2018; Fraija-Fernández, Natalia/F-1031-2017	Raga, Juan Antonio/0000-0003-2687-2539; Fraija-Fernández, Natalia/0000-0001-6341-4276; Aznar, Francisco Javier/0000-0002-1316-1175; Fraija-Fernández, Natalia/0000-0001-6341-4276	Ministry of Economy and Competitiveness, Spain [CGL/2009/07465, CGL/2012/39545, AGL2015-68405-R]; PROMETEO (Generalitat Valenciana, Spain) [II/2015/018]	Ministry of Economy and Competitiveness, Spain(Spanish Government); PROMETEO (Generalitat Valenciana, Spain)	This study was supported by projects CGL/2009/07465, CGL/2012/39545 and AGL2015-68405-R (Ministry of Economy and Competitiveness, Spain), and PROMETEO II/2015/018 (Generalitat Valenciana, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Romero MA, 2014, DIS AQUAT ORGAN, V108, P61, DOI 10.3354/dao02700; Alexander A, 2016, MOL ECOL, V25, P2754, DOI 10.1111/mec.13638; Alfonsi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044425; Alves F, 2013, AQUAT CONSERV, V23, P758, DOI 10.1002/aqc.2332; Anderson GR, 1998, SYST PARASITOL, V41, P87, DOI 10.1023/A:1006024128098; Aznar FJ, 2006, PARASITOLOGY, V133, P369, DOI 10.1017/S0031182006000321; AZNAR FJ, 1994, CAN J ZOOL, V72, P702, DOI 10.1139/z94-094; Aznar FJ, 1995, MAMMALIA, V59, P427, DOI 10.1515/mamm.1995.59.3.427; Baylis H. A., 1932, Discovery Reports Cambridge, V6, P393; Beron-Vera B, 2001, DIS AQUAT ORGAN, V47, P201, DOI 10.3354/dao047201; Beron-Vera B, 2008, J PARASITOL, V94, P946, DOI 10.1645/GE-1296.1; Beron-Vera B, 2007, J PARASITOL, V93, P1056, DOI 10.1645/GE-1070R.1; Berube M, 1998, MOL ECOL, V7, P585, DOI 10.1046/j.1365-294x.1998.00359.x; BEVERLEYBURTON M, 1978, J FISH RES BOARD CAN, V35, P1356, DOI 10.1139/f78-211; Birkun A., 2002, CETACEANS MEDITERRAN, P1; Blasco-Costa I, 2013, PARASITOLOGY, V140, P1316, DOI 10.1017/S0031182013000784; Cassens I, 2005, MOL ECOL, V14, P107, DOI 10.1111/j.1365-294X.2004.02407.x; Gariboldi MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132854; Cornaglia E, 2000, J VET MED A, V47, P129, DOI 10.1046/j.1439-0442.2000.00268.x; Cribb TH, 2003, ADV PARASIT, V54, P197, DOI 10.1016/S0065-308X(03)54004-0; Cribb TH, 2001, INT J PARASITOL, V31, P997, DOI 10.1016/S0020-7519(01)00204-1; Cribb TH, 2014, PARASITOL INT, V63, P285, DOI 10.1016/j.parint.2013.11.009; Dans SL, 1999, MAR MAMMAL SCI, V15, P649, DOI 10.1111/j.1748-7692.1999.tb00834.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Delyamure S. L., 1955, HELMINTHOFAUNA MARIN; Delyamure SL, 1957, J FISH RES BOARD CAN, V131, P1; Diaz- Delgado J, 2015, THESIS; Diniz JAF, 2013, GENET MOL BIOL, V36, P475, DOI 10.1590/S1415-47572013000400002; Dollfus RPh, 1973, INVEST CETACEA, V5, P331; Engelhaupt D, 2009, MOL ECOL, V18, P4193, DOI 10.1111/j.1365-294X.2009.04355.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feis ME, 2015, MAR ECOL PROG SER, V520, P85, DOI 10.3354/meps11096; Fernandez M, 2003, DIS AQUAT ORGAN, V55, P73, DOI 10.3354/dao055073; Fitzpatrick BM, 2009, MOL ECOL, V18, P3961, DOI 10.1111/j.1365-294X.2009.04314.x; Fontaine MC, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-30; Fontaine MC, 2014, MOL ECOL, V23, P3306, DOI 10.1111/mec.12817; FORRESTER DJ, 1975, J PARASITOL, V61, P922, DOI 10.2307/3279237; Fraija-Fernandez N, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1273-8; Fraija-Fernandez N, 2015, INT J PARASITOL, V45, P167, DOI 10.1016/j.ijpara.2014.10.004; Fu YX, 1997, GENETICS, V147, P915; Garcia-Martinez J, 1999, MOL ECOL, V8, P1069, DOI 10.1046/j.1365-294x.1999.00672.x; Gaspari S, 2007, MOL ECOL, V16, P2922, DOI 10.1111/j.1365-294X.2007.03295.x; GIBSON D I, 1979, Investigations on Cetacea, V10, P309; Gibson DI, 1998, J ZOOL, V244, P563, DOI 10.1111/j.1469-7998.1998.tb00061.x; Gibson DI., 2005, HOST PARASITE DATABA; Gonzalez AF, 2000, MAR MAMMAL SCI, V16, P640, DOI 10.1111/j.1748-7692.2000.tb00958.x; Goulding TC, 2014, J BIOGEOGR, V41, P965, DOI 10.1111/jbi.12260; Guillot G, 2013, METHODS ECOL EVOL, V4, P336, DOI 10.1111/2041-210x.12018; HARPENDING HC, 1994, HUM BIOL, V66, P591; Herreras MV, 1997, DIS AQUAT ORGAN, V28, P163, DOI 10.3354/dao028163; Hoelzel A. Rus, 2009, V17, P294; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Kizirian D, 2004, MOL PHYLOGENET EVOL, V32, P1072, DOI 10.1016/j.ympev.2004.05.001; Kleinertz S, 2014, PARASITOL RES, V113, P1405, DOI 10.1007/s00436-014-3781-4; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; KOIE M, 1992, J PARASITOL, V78, P338, DOI 10.2307/3283485; Kostadinova A, 2003, SYST PARASITOL, V54, P159, DOI 10.1023/A:1022681123340; L'Helguen S, 2002, DEEP-SEA RES PT I, V49, P83, DOI 10.1016/S0967-0637(01)00044-9; Lehnert K, 2005, DIS AQUAT ORGAN, V64, P265, DOI 10.3354/dao064265; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; de Castro RL, 2011, MAMM BIOL, V76, P521, DOI 10.1016/j.mambio.2011.02.004; Marigo J, 2015, J HELMINTHOL, V89, P19, DOI 10.1017/S0022149X13000540; Mateu P, 2015, DEEP-SEA RES PT I, V95, P115, DOI 10.1016/j.dsr.2014.10.012; Mattiucci S, 2008, ADV PARASIT, V66, P47, DOI 10.1016/S0065-308X(08)00202-9; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; MIGAKI G, 1971, Journal of Wildlife Diseases, V7, P281; Mirimin L, 2009, MAR BIOL, V156, P821, DOI 10.1007/s00227-008-1120-y; Morgan JAT, 1998, PARASITOLOGY, V116, P289, DOI 10.1017/S0031182097002217; Morgan JAT, 1995, PARASITOLOGY, V111, P609, DOI 10.1017/S003118200007709X; Moura AE, 2013, J EVOLUTION BIOL, V26, P63, DOI 10.1111/jeb.12032; Nadler SA, 2002, NEMATOLOGY, V4, P615, DOI 10.1163/15685410260438908; Natoli A, 2005, P ROY SOC B-BIOL SCI, V272, P1217, DOI 10.1098/rspb.2005.3076; Nolan MJ, 2005, ADV PARASIT, V60, P101, DOI 10.1016/S0065-308X(05)60002-4; ODEN NL, 1992, J CLASSIF, V9, P275, DOI 10.1007/BF02621410; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Olson PA, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P847; Oremus M, 2009, BIOL J LINN SOC, V98, P729, DOI 10.1111/j.1095-8312.2009.01325.x; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Pauly D, 1998, ICES J MAR SCI, V55, P467, DOI 10.1006/jmsc.1997.0280; Pearson J., 2008, Keys to the Trematoda, Volume 3, P113, DOI 10.1079/9780851995885.0113; PEARSON JC, 1977, PARASITOLOGY, V74, P255, DOI 10.1017/S0031182000047880; Perez-Losada M, 2002, HEREDITY, V89, P417, DOI 10.1038/sj.hdy.6800160; de Leon GPP, 2010, J PARASITOL, V96, P453, DOI 10.1645/GE-2260.1; Quinones R, 2013, J PARASITOL, V99, P576, DOI 10.1645/GE-3165.1; R Core Team, 2021, R LANGUAGE ENV STAT; Raga J.A., 1987, P195; Raga J. Antonio, 1993, Reports of the International Whaling Commission Special Issue, V14, P391; Raga JA, 1987, B MUS NATL HIST NAT, V119, P159; Raga JA, 1985, REV IBER PARASITOL; Ramirez-Soriano A, 2008, GENETICS, V179, P555, DOI 10.1534/genetics.107.083006; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Razo-Mendivil U, 2008, J PARASITOL, V94, P1371, DOI 10.1645/GE-1546.1; Reyes JC, 1993, REP INT WHAL COMM, V16, P349; Rogan E, 1997, J ZOOL, V242, P217, DOI 10.1111/j.1469-7998.1997.tb05798.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Roldan MI, 1998, HEREDITY, V81, P327, DOI 10.1046/j.1365-2540.1998.00383.x; Rosenberg NA, 2002, NAT REV GENET, V3, P380, DOI 10.1038/nrg795; SOUTHWARD AJ, 1995, J THERM BIOL, V20, P127, DOI 10.1016/0306-4565(94)00043-I; Steiner L, 2012, J MAR BIOL ASSOC UK, V92, P1751, DOI 10.1017/S0025315412000793; Stevick PT, MARINE MAMMAL BIOL E, P185; TAJIMA F, 1993, JPN J GENET, V68, P567, DOI 10.1266/jjg.68.567; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson KF, 2016, HEREDITY, V116, P277, DOI 10.1038/hdy.2015.99; Torres LG, 2003, MAR MAMMAL SCI, V19, P502, DOI 10.1111/j.1748-7692.2003.tb01317.x; Valente AL, 2014, 10 C SOC LAT ESP MAM; Van Waerebeek K, BOTTLENOSE DOLPHIN, P143; Van Waerebeek Koen, 1993, Aquatic Mammals, V19, P159; Vilas R, 2005, PARASITOLOGY, V131, P839, DOI 10.1017/S0031182005008437; Welch JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008776; Wells RS, 2009, MAR MAMMAL SCI, V25, P420, DOI 10.1111/j.1748-7692.2008.00251.x; Wells RS, 1999, MAR MAMMAL SCI, V15, P1098, DOI 10.1111/j.1748-7692.1999.tb00879.x; WOODARD JC, 1969, PATHOL VET, V6, P257, DOI 10.1177/030098586900600307; Yablokov AV, 1972, WHALES DOLPHINS 1; Zam S. G, 1971, Cetology, VNo. 2, P1; Zam S.G., 1970, P250	118	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0170184	10.1371/journal.pone.0170184	http://dx.doi.org/10.1371/journal.pone.0170184			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085945	Green Published, Green Submitted, gold			2022-12-26	WOS:000391972600073
J	O'Connell, S; Olaighin, G; Quinlan, LR				O'Connell, Sandra; Olaighin, Gearoid; Quinlan, Leo R.			When a Step Is Not a Step! Specificity Analysis of Five Physical Activity Monitors	PLOS ONE			English	Article							HEALTH-BENEFITS; VALIDITY; RELIABILITY	Introduction Physical activity is an essential aspect of a healthy lifestyle for both physical and mental health states. As step count is one of the most utilized measures for quantifying physical activity it is important that activity-monitoring devices be both sensitive and specific in recording actual steps taken and disregard non-stepping body movements. The objective of this study was to assess the specificity of five activity monitors during a variety of prescribed non-stepping activities. Methods Participants wore five activity monitors simultaneously for a variety of prescribed activities including deskwork, taking an elevator, taking a bus journey, automobile driving, washing and drying dishes; functional reaching task; indoor cycling; outdoor cycling; and indoor rowing. Each task was carried out for either a specific duration of time or over a specific distance. Activity monitors tested were the ActivPAL micro (TM), NL-2000 (TM) pedometer, Withings Smart Activity Monitor Tracker (Pulse O-2)(TM), Fitbit One (TM) and Jawbone UP (TM). Participants were video-recorded while carrying out the prescribed activities and the false positive step count registered on each activity monitor was obtained and compared to the video. Results All activity monitors registered a significant number of false positive steps per minute during one or more of the prescribed activities. The Withings (TM) activity performed best, registering a significant number of false positive steps per minute during the outdoor cycling activity only (P = 0.025). The Jawbone (TM) registered a significant number of false positive steps during the functional reaching task and while washing and drying dishes, which involved arm and hand movement (P < 0.01 for both). The ActivPAL (TM) registered a significant number of false positive steps during the cycling exercises (P < 0.001 for both). Conclusion As a number of false positive steps were registered on the activity monitors during the non-stepping activities, the authors conclude that non-stepping physical activities can result in the false detection of steps. This can negatively affect the quantification of physical activity with regard to step count as an output. The Withings (TM) activity monitor performed best with regard to specificity during the activities of daily living tested.	[O'Connell, Sandra; Quinlan, Leo R.] NUI Galway, Sch Med, Discipline Physiol, Galway, Ireland; [O'Connell, Sandra; Olaighin, Gearoid] NUI Galway, Sch Engn & Informat, Elect & Elect Engn, Galway, Ireland; [Olaighin, Gearoid; Quinlan, Leo R.] NUI Galway, Natl Ctr Biomed Engn Sci, Galway, Ireland; [Olaighin, Gearoid; Quinlan, Leo R.] NUI Galway, CURAM Ctr Res Med Devices, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Olaighin, G (corresponding author), NUI Galway, Sch Engn & Informat, Elect & Elect Engn, Galway, Ireland.; Olaighin, G (corresponding author), NUI Galway, Natl Ctr Biomed Engn Sci, Galway, Ireland.; Olaighin, G (corresponding author), NUI Galway, CURAM Ctr Res Med Devices, Galway, Ireland.	gearoid.olaighin@nuigalway.ie	ÓLaighin, Gearóid/A-5239-2009; ÓLaighin, Gearóid/AAC-2198-2019; Quinlan, Leo R/N-4117-2014	ÓLaighin, Gearóid/0000-0002-1885-814X; Quinlan, Leo R/0000-0002-4011-6732; O'Connell, Sandra/0000-0002-6722-8419	Irish Research Council [EPSPG/2012/504]	Irish Research Council(Irish Research Council for Science, Engineering and Technology)	Sandra O'Connell is supported by the Irish Research Council grant number EPSPG/2012/504, under the Enterprise Partnership Scheme. The enterprise partner was the Galway Clinic, Doughiska, Co. Galway, Ireland.	CDC, 2008 PHYS ACT GUID A; Chen M-D, 2016, MED SCI SPORTS EXERC; Colbert LH, 2011, MED SCI SPORT EXER, V43, P867, DOI 10.1249/MSS.0b013e3181fc7162; Kang M, 2009, RES Q EXERCISE SPORT, V80, P131, DOI 10.1080/02701367.2009.10599546; National Transport Authority, TAX SURV 2015; O'Connell S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154956; Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013; Sellers C, 2016, GAIT POSTURE, V43, P42, DOI 10.1016/j.gaitpost.2015.10.020; Stackpool CM, 2014, J FIT RES, V3, P32; Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001; Tudor-Locke C, 2001, INT J OBESITY, V25, P1571, DOI 10.1038/sj.ijo.0801783; Tudor-Locke C, 2011, PREV MED, V53, P31, DOI 10.1016/j.ypmed.2011.01.014; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Van Remoortel H, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-84; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; White L, 2016, PEDIATR EXERC SCI, V28, P240, DOI 10.1123/pes.2015-0123; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15	17	22	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0169616	10.1371/journal.pone.0169616	http://dx.doi.org/10.1371/journal.pone.0169616			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085918	Green Submitted, gold, Green Published			2022-12-26	WOS:000391972600029
J	Roellig, DM; Yoder, JS; Madison-Antenucci, S; Robinson, TJ; Van, TT; Collier, SA; Boxrud, D; Monson, T; Bates, LA; Blackstock, AJ; Shea, S; Larson, K; Xiao, LH; Beach, M				Roellig, Dawn M.; Yoder, Jonathan S.; Madison-Antenucci, Susan; Robinson, Trisha J.; Van, Tam T.; Collier, Sarah A.; Boxrud, Dave; Monson, Timothy; Bates, Leigh Ann; Blackstock, Anna J.; Shea, Shari; Larson, Kirsten; Xiao, Lihua; Beach, Michael			Community Laboratory Testing for Cryptosporidium: Multicenter Study Retesting Public Health Surveillance Stool Samples Positive for Cryptosporidium by Rapid Cartridge Assay with Direct Fluorescent Antibody Testing	PLOS ONE			English	Article							UNITED-STATES; DIRECT IMMUNOFLUORESCENCE; ENZYME-IMMUNOASSAY; GIARDIA-LAMBLIA; OOCYSTS; PARVUM	Cryptosporidium is a common cause of sporadic diarrheal disease and outbreaks in the United States. Increasingly, immunochromatography-based rapid cartridge assays (RCAs) are providing community laboratories with a quick cryptosporidiosis diagnostic method. In the current study, the Centers for Disease Control and Prevention (CDC), the Association of Public Health Laboratories (APHL), and four state health departments evaluated RCA-positive samples obtained during routine Cryptosporidium testing. All samples underwent "head to head" re-testing using both RCA and direct fluorescence assay (DFA). Community level results from three sites indicated that 54.4% (166/305) of Meridian ImmunoCard STAT! positives and 87.0% (67/77) of Remel Xpect positives were confirmed by DFA. When samples were retested by RCA at state laboratories and compared with DFA, 83.3% (155/186) of Meridian ImmunoCard STAT! positives and 95.2% (60/63) of Remel Xpect positives were confirmed. The percentage of confirmed community results varied by site: Minnesota, 39.0%; New York, 63.9%; and Wisconsin, 72.1%. The percentage of confirmed community results decreased with patient age; 12.5% of community positive tests could be confirmed by DFA for patients 60 years of age or older. The percentage of confirmed results did not differ significantly by sex, storage temperature, time between sample collection and testing, or season. Findings from this study demonstrate a lower confirmation rate of community RCA positives when compared to RCA positives identified at state laboratories. Elucidating the causes of decreased test performance in order to improve overall community laboratory performance of these tests is critical for understanding the epidemiology of cryptosporidiosis in the United States (US).	[Roellig, Dawn M.; Yoder, Jonathan S.; Collier, Sarah A.; Xiao, Lihua; Beach, Michael] Ctr Dis Control & Prevent, Waterborne Dis Prevent Branch, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Madison-Antenucci, Susan] New York State Dept Hlth, Parasitol Lab, Div Infect Dis, Wadsworth Ctr, Albany, NY USA; [Robinson, Trisha J.; Boxrud, Dave] Minnesota Dept Hlth, St Paul, MN USA; [Van, Tam T.; Monson, Timothy] Wisconsin State Lab Hyg, Communicable Dis Div, Madison, WI USA; [Bates, Leigh Ann] Kentucky Div Lab Serv, Frankfort, KY USA; [Blackstock, Anna J.] Ctr Dis Control & Prevent, Biostat & Informat Management Off, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Shea, Shari; Larson, Kirsten] Assoc Publ Hlth Labs, Silver Spring, MD USA	Centers for Disease Control & Prevention - USA; State University of New York (SUNY) System; Wadsworth Center; Minnesota Department of Health (MHD); Centers for Disease Control & Prevention - USA	Roellig, DM (corresponding author), Ctr Dis Control & Prevent, Waterborne Dis Prevent Branch, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA.	DMRoellig@cdc.gov	Xiao, Lihua/B-1704-2013	Xiao, Lihua/0000-0001-8532-2727; Madison-Antenucci, Susan/0000-0003-1748-9327	Association of Public Health Laboratories; Centers for Disease Control and Prevention and/or Assistant Secretary for Preparedness and Response [U60HM000803]; federal program	Association of Public Health Laboratories; Centers for Disease Control and Prevention and/or Assistant Secretary for Preparedness and Response; federal program	This publication was supported by the Association of Public Health Laboratories and by the Cooperative Agreement Number U60HM000803 from the Centers for Disease Control and Prevention and/or Assistant Secretary for Preparedness and Response. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Association of Public Health Laboratories, the Centers for Disease Control and Prevention, and/or Assistant Secretary for Preparedness and Response. This project was 100% funded with federal funds from a federal program of $1.5M.	ALLES AJ, 1995, J CLIN MICROBIOL, V33, P1632, DOI 10.1128/JCM.33.6.1632-1634.1995; Centers for Disease C Prevention, 1998, MMWR MORBIDITY AND M, V48, p4 ; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P198; Chalmers RM, 2013, TRENDS PARASITOL, V29, P237, DOI 10.1016/j.pt.2013.03.001; Checkley W, 2015, LANCET INFECT DIS, V15, P85, DOI 10.1016/S1473-3099(14)70772-8; (CSTE) CoSaTE, UPD CRYPT CAS DEF; de Lucio A, 2016, INFECT GENET EVOL, V37, P49, DOI 10.1016/j.meegid.2015.10.026; De Waele V, 2011, J CLIN MICROBIOL, V49, P76, DOI 10.1128/JCM.01424-10; El-Moamly AAR, 2012, PARASITOL RES, V110, P1037, DOI 10.1007/s00436-011-2585-z; Feng YY, 2009, J CLIN MICROBIOL, V47, P153, DOI 10.1128/JCM.01777-08; Fox LM, 2005, CLIN INFECT DIS, V40, P1173, DOI 10.1086/428839; GARCIA LS, 1992, J CLIN MICROBIOL, V30, P3255, DOI 10.1128/JCM.30.12.3255-3257.1992; Garcia LS, 1997, J CLIN MICROBIOL, V35, P1526, DOI 10.1128/JCM.35.6.1526-1529.1997; Garcia LS, 2003, J CLIN MICROBIOL, V41, P209, DOI 10.1128/JCM.41.1.209-212.2003; Hlavsa MC, 2011, MMWR SURVEILL SUMM, V60, P1; Hunter PR, 2004, EMERG INFECT DIS, V10, P1241, DOI 10.3201/eid1007.030582; Hunter PR, 2002, CLIN MICROBIOL REV, V15, P145, DOI 10.1128/CMR.15.1.145-154.2002; Johnston SP, 2003, J CLIN MICROBIOL, V41, P623, DOI 10.1128/JCM.41.2.623-626.2003; KEHL KSC, 1995, J CLIN MICROBIOL, V33, P416, DOI 10.1128/JCM.33.2.416-418.1995; National Notifiable Disease Surveillance System (NNDDSS), 2012 CRYPT CAS DEF; Painter JE, 2015, MMWR SURVEILL SUMM, V64, P1; Robinson TJ, 2010, CLIN INFECT DIS, V50, pE53, DOI 10.1086/651423; Ryan U, 2014, PARASITOLOGY, V141, P1667, DOI 10.1017/S0031182014001085; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Soenen S, 2016, CURR OPIN CLIN NUTR, V19, P12, DOI 10.1097/MCO.0000000000000238; Yoder Jonathan S., 2012, Morbidity and Mortality Weekly Report, V61, P1; ZIMMERMAN SK, 1995, J CLIN MICROBIOL, V33, P1942, DOI 10.1128/JCM.33.7.1942-1943.1995	27	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0169915	10.1371/journal.pone.0169915	http://dx.doi.org/10.1371/journal.pone.0169915			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085927	Green Submitted, gold, Green Published			2022-12-26	WOS:000391972600044
J	Burr, PC; Robinson, AC; Larsen, RT; Newman, RA; Ellis-Felege, SN				Burr, Paul C.; Robinson, Aaron C.; Larsen, Randy T.; Newman, Robert A.; Ellis-Felege, Susan N.			Sharp-Tailed Grouse Nest Survival and Nest Predator Habitat Use in North Dakota's Bakken Oil Field	PLOS ONE			English	Article							GREATER SAGE-GROUSE; CAUSE-SPECIFIC MORTALITY; LESSER PRAIRIE-CHICKENS; ENERGY DEVELOPMENT; GRASSLAND BIRDS; GAS DEVELOPMENT; SUCCESS; IMPACTS; POPULATIONS; LANDSCAPE	Recent advancements in extraction technologies have resulted in rapid increases of gas and oil development across the United States and specifically in western North Dakota. This expansion of energy development has unknown influences on local wildlife populations and the ecological interactions within and among species. Our objectives for this study were to evaluate nest success and nest predator dynamics of sharp-tailed grouse (Tympanuchus phasianellus) in two study sites that represented areas of high and low energy development intensities in North Dakota. During the summers of 2012 and 2013, we monitored 163 grouse nests using radio telemetry. Of these, 90 nests also were monitored using miniature cameras to accurately determine nest fates and identify nest predators. We simultaneously conducted predator surveys using camera scent stations and occupancy modeling to estimate nest predator occurrence at each site. American badgers (Taxidea taxus) and striped skunks (Mephitis mephitis) were the primary nest predators, accounting for 56.7% of all video recorded nest depredations. Nests in our high intensity gas and oil area were 1.95 times more likely to succeed compared to our minimal intensity area. Camera monitored nests were 2.03 times more likely to succeed than non-camera monitored nests. Occupancy of mammalian nest predators was 6.9 times more likely in our study area of minimal gas and oil intensity compared to the high intensity area. Although only a correlative study, our results suggest energy development may alter the predator community, thereby increasing nest success for sharp-tailed grouse in areas of intense development, while adjacent areas may have increased predator occurrence and reduced nest success. Our study illustrates the potential influences of energy development on the nest predator prey dynamics of sharp-tailed grouse in western North Dakota and the complexity of evaluating such impacts on wildlife.	[Burr, Paul C.; Newman, Robert A.; Ellis-Felege, Susan N.] Univ North Dakota, Dept Biol, Grand Forks, ND 58202 USA; [Robinson, Aaron C.] North Dakota Game & Fish Dept, Dickinson, ND USA; [Larsen, Randy T.] Brigham Young Univ, Dept Plant & Wildlife Sci, Provo, UT 84602 USA; [Larsen, Randy T.] Brigham Young Univ, Monte L Bean Life Sci Museum, Provo, UT 84602 USA; [Burr, Paul C.] Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Mississippi State, MS 39762 USA	University of North Dakota Grand Forks; Brigham Young University; Brigham Young University; Mississippi State University	Burr, PC (corresponding author), Univ North Dakota, Dept Biol, Grand Forks, ND 58202 USA.; Burr, PC (corresponding author), Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Mississippi State, MS 39762 USA.	pcb124@msstate.edu		Ellis-Felege, Susan/0000-0002-4534-0055	Wildlife Restoration Funds, U.S. Fish and Wildlife Service; North Dakota Game and Fish [CFDA 15-6111]; Energy Initiative Seed Funding for Non Engineering or Geology Disciplines, University of North Dakota's Institute for Energy Studies; SportDog Conservation Fund, SportDOg Brand; Pheasants Forever Scholarship, Pheasants Forever; National Science Foundation [13197000]; University of North Dakota's Faculty Seed Grant Program, UND's Research Development and Compliance; University of North Dakota Collaboratve Seed Grant; North Dakota EPSCoR; UND's Research Development and Compliance; ND Game and Fish	Wildlife Restoration Funds, U.S. Fish and Wildlife Service; North Dakota Game and Fish; Energy Initiative Seed Funding for Non Engineering or Geology Disciplines, University of North Dakota's Institute for Energy Studies; SportDog Conservation Fund, SportDOg Brand; Pheasants Forever Scholarship, Pheasants Forever; National Science Foundation(National Science Foundation (NSF)); University of North Dakota's Faculty Seed Grant Program, UND's Research Development and Compliance; University of North Dakota Collaboratve Seed Grant; North Dakota EPSCoR; UND's Research Development and Compliance; ND Game and Fish	This work was supported by Wildlife Restoration Funds, U.S. Fish and Wildlife Service (http://wsfrprograms.fws.gov/Subpages/GrantPrograms/WR/WR.htm) and North Dakota Game and Fish (http://gf.nd.gov/), Grant Number: CFDA 15-6111, SNE, RAL. It also received funding from Energy Initiative Seed Funding for Non Engineering or Geology Disciplines, University of North Dakota's Institute for Energy Studies, https://engineering.und.edu/institute-for-energy-studies/, to SNE; SportDog Conservation Fund, SportDOg Brand, http://www.sportdog.com/, to SNE; Pheasants Forever Scholarship, Pheasants Forever, http://www.pheasantsforever.org/, to PCB; National Science Foundation, http://www.nsf.gov/, Grant Number: 13197000, to SNE; University of North Dakota's Faculty Seed Grant Program, UND's Research Development and Compliance, https://und.edu/research/resources/, to SNE; University of North Dakota Collaboratve Seed Grant, North Dakota EPSCoR (https://www.ndepscor.ndus.edu/) and UND's Research Development and Compliance, https://und.edu/research/resources/, to SNE. Co-Author Aaron Robinson from funder ND Game and Fish played a role in study design, data collection, and manuscript edits.	Akcakaya HR, 2004, CONSERV BIOL, V18, P526, DOI 10.1111/j.1523-1739.2004.00520.x; ANDREN H, 1995, MOSAIC LANDSCAPES EC, P225; Ashley EP, 1996, CAN FIELD NAT, V110, P403; Ausick P, 2013, US TODAY; Barber JR, 2010, TRENDS ECOL EVOL, V25, P180, DOI 10.1016/j.tree.2009.08.002; Batary P, 2004, CONSERV BIOL, V18, P389, DOI 10.1111/j.1523-1739.2004.00184.x; Beck JL, 2009, NAT M AM SOC MIN REC, P66; Benitez-Lopez A, 2010, BIOL CONSERV, V143, P1307, DOI 10.1016/j.biocon.2010.02.009; Blickley JL, 2012, CONSERV BIOL, V26, P461, DOI 10.1111/j.1523-1739.2012.01840.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Coates PS, 2008, J FIELD ORNITHOL, V79, P421, DOI 10.1111/j.1557-9263.2008.00189.x; Connelly JW, SHARP TAILED GROUSE; Cooch E, PROGRAM MARK GENTLE, V7; Copeland HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007400; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Dijak WD, 2000, J WILDLIFE MANAGE, V64, P209, DOI 10.2307/3802992; Dinsmore SJ, 2002, ECOLOGY, V83, P3476, DOI 10.1890/0012-9658(2002)083[3476:ATFMAN]2.0.CO;2; Doherty KE, 2008, J WILDLIFE MANAGE, V72, P187, DOI 10.2193/2006-454; Doherty KE, 2011, STUD AVIAN BIOL, P505; Dyke S., 2010, POTENTIAL IMPACTS OI; Dzialak M. R., 2011, PLOS ONE, V6; Francis CD, 2009, CURR BIOL, V19, P1415, DOI 10.1016/j.cub.2009.06.052; Gaswirth S.B., 2013, FACT SHEET, DOI DOI 10.3133/FS20213058; Gehrt SD, 2005, J MAMMAL, V86, P1164, DOI 10.1644/04-MAMM-A-173R2.1; Gilbert MM, 2011, J WILDLIFE MANAGE, V75, P816, DOI 10.1002/jwmg.123; Gosselink TE, 2007, J WILDLIFE MANAGE, V71, P1862, DOI 10.2193/2006-020; Hagen C, 2010, T N AM WILDL NAT RES, P96; Hagen CA, 2011, STUD AVIAN BIOL, P63; Harris CE, 2001, CAN J ZOOL, V79, P2005, DOI 10.1139/cjz-79-11-2005; Hess JE, 2012, J WILDLIFE MANAGE, V76, P1625, DOI 10.1002/jwmg.417; Holloran MJ, 2010, J WILDLIFE MANAGE, V74, P65, DOI 10.2193/2008-291; Hovick TJ, 2014, J APPL ECOL, V51, P1680, DOI 10.1111/1365-2664.12331; KANTRUD H A, 1992, Prairie Naturalist, V24, P67; Kinley TA, 2008, J WILDLIFE MANAGE, V72, P113, DOI 10.2193/2006-406; Kirby Donald R., 1995, Rangelands, V17, P124; Korpimaki E, 1998, ECOLOGY, V79, P2448, DOI 10.2307/176834; Kuehl AK, 2002, J WILDLIFE MANAGE, V66, P1224, DOI 10.2307/3802955; Lariviere S, 1999, CONDOR, V101, P718, DOI 10.2307/1370209; Lawson AL, 2011, SOUTHEAST NAT, V10, P303, DOI 10.1656/058.010.0210; Lyon AG, 2003, WILDLIFE SOC B, V31, P486; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Manzer DL, 2005, J WILDLIFE MANAGE, V69, P110, DOI 10.2193/0022-541X(2005)069&lt;0110:RGNSAC&gt;2.0.CO;2; Marini MA, 1998, CONDOR, V100, P395, DOI 10.2307/1370284; Mason J, 2012, OIL GAS J; MAYFIELD HF, 1975, WILSON BULL, V87, P456; McNew LB, 2011, STUD AVIAN BIOL, P255; Meissner F.F., 1991, PETROLEUM GEOCHEMIST, P35; Moore D.S., 1993, INTRO PRACTICE STAT; Moynahan BJ, 2006, ECOL APPL, V16, P1529, DOI 10.1890/1051-0761(2006)016[1529:FCTPVI]2.0.CO;2; Nellemann C, 1998, CAN J ZOOL, V76, P1425, DOI 10.1139/cjz-76-8-1425; Norton M. A., 2005, THESIS; PALOMARES F, 1995, CONSERV BIOL, V9, P295, DOI 10.1046/j.1523-1739.1995.9020295.x; PATON PWC, 1994, CONSERV BIOL, V8, P17, DOI 10.1046/j.1523-1739.1994.08010017.x; Pitman JC, 2006, WILSON J ORNITHOL, V118, P23, DOI 10.1676/1559-4491(2006)118[0023:NEOLPI]2.0.CO;2; Pitman JC, 2005, J WILDLIFE MANAGE, V69, P1259, DOI 10.2193/0022-541X(2005)069[1259:LASOLP]2.0.CO;2; Richardson TW, 2009, J WILDLIFE MANAGE, V73, P287, DOI 10.2193/2007-566; Ricklefs R., 1969, SMITHSON CONTRIB ZOO, P1, DOI [10.5479/si.00810282.9, DOI 10.5479/SI.00810282.9]; Rotella J. J., 2004, Animal Biodiversity and Conservation, V27, P187; Sargeant AB, 1998, INTERPRETING EVIDENC; Sawyer H, 2006, J WILDLIFE MANAGE, V70, P396, DOI 10.2193/0022-541X(2006)70[396:WHSOMD]2.0.CO;2; SCHROEDER MA, 1991, J FIELD ORNITHOL, V62, P378; Seabloom R., 2011, MAMMALS N DAKOTA; Taylor RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071256; Thompson SJ, 2015, BIOL CONSERV, V192, P82, DOI 10.1016/j.biocon.2015.08.040; Tietje W.D., 1983, Wildlife Society Bulletin, V11, P99; Tigas LA, 2002, BIOL CONSERV, V108, P299, DOI 10.1016/S0006-3207(02)00120-9; Tucker S., STUDY NO E 11 FURBEA; U.S. Energy Information Administration, 2015, ANN EN OUTL 2015 PRO; U.S. Forest Service, 2002, REC DEC DAK PRAIR GR; vanDyke F, 1996, J MAMMAL, V77, P1028, DOI 10.2307/1382783; Walker BL, 2007, J WILDLIFE MANAGE, V71, P2644, DOI 10.2193/2006-529; Webb Stephen L., 2012, Ecological Processes, V1; Weller C., 2002, FRAGMENTING OUR LAND; White G. C., 2001, WILDLIFE LAND PEOPLE, P368; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wilke PW, 2011, C TRANSP ASS EDM ALB; Williamson RM., 2009, THESIS; Windberg LA, 1996, CAN J ZOOL, V74, P2248, DOI 10.1139/z96-255; Wiseman H., 2009, FORDHAM ENV LAW REV, V20; Wolfe SA, 2000, POLAR RES, V19, P63, DOI 10.1111/j.1751-8369.2000.tb00329.x	80	15	16	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0170177	10.1371/journal.pone.0170177	http://dx.doi.org/10.1371/journal.pone.0170177			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081245	Green Published, gold			2022-12-26	WOS:000391949500137
J	Druhan, LJ; Lance, A; Li, S; Price, AE; Emerson, JT; Baxter, SA; Gerber, JM; Avalos, BR				Druhan, Lawrence J.; Lance, Amanda; Li, Shimena; Price, Andrea E.; Emerson, Jacob T.; Baxter, Sarah A.; Gerber, Jonathan M.; Avalos, Belinda R.			Leucine Rich alpha-2 Glycoprotein: A Novel Neutrophil Granule Protein and Modulator of Myelopoiesis	PLOS ONE			English	Article							EXTRACELLULAR CYTOCHROME-C; GROWTH-FACTOR-BETA; HUMAN-SERUM; SUBCELLULAR FRACTIONATION; TGF-BETA; DIFFERENTIATION; EXPRESSION; ALPHA-2-GLYCOPROTEIN-1; ALPHA(2)-GLYCOPROTEIN; IDENTIFICATION	Leucine-rich alpha 2 glycoprotein (LRG 1), a serum protein produced by hepatocytes, has been implicated in angiogenesis and tumor promotion. Our laboratory previously reported the expression of LRG1 in murine myeloid cell lines undergoing neutrophilic granulocyte differentiation. However, the presence of LRG1 in primary human neutrophils and a role for LRG1 in regulation of hematopoiesis have not been previously described. Here we show that LRG1 is packaged into the granule compartment of human neutrophils and secreted upon neutrophil activation to modulate the microenvironment. Using immunofluorescence microscopy and direct biochemical measurements, we demonstrate that LRG1 is present in the peroxidase-negative granules of human neutrophils. Exocytosis assays indicate that LRG1 is differentially glycosylated in neutrophils, and co-released with the secondary granule protein lactoferrin. Like LRG1 purified from human serum, LRG1 secreted from activated neutrophils also binds cytochrome c. We also show that LRG1 antagonizes the inhibitory effects of TGF beta 1 on colony growth of human CD34(+) cells and myeloid progenitors. Collectively, these data invoke an additional role for neutrophils in innate immunity that has not previously been reported, and suggest a novel mechanism whereby neutrophils may modulate the microenvironment via extracellular release of LRG1.	[Druhan, Lawrence J.; Lance, Amanda; Price, Andrea E.; Emerson, Jacob T.; Baxter, Sarah A.; Gerber, Jonathan M.; Avalos, Belinda R.] Carolinas HealthCare Syst, Levine Canc Inst, Dept Hematol Oncol, Charlotte, NC 28203 USA; [Li, Shimena] Univ N Carolina, Sch Med, Chapel Hill, NC USA	Carolinas HealthCare System; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Avalos, BR (corresponding author), Carolinas HealthCare Syst, Levine Canc Inst, Dept Hematol Oncol, Charlotte, NC 28203 USA.	belinda.avalos@carolinashealthcare.org			Minority Medical Student Award Program fellowship from the American Society of Hematology	Minority Medical Student Award Program fellowship from the American Society of Hematology	This research was supported by a Minority Medical Student Award Program fellowship from the American Society of Hematology (awarded to Shimena Li; http://www.hematology.org/Awards/Medical-Student/383.aspx). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai J, 2008, J LEUKOCYTE BIOL, V83, P1277, DOI 10.1189/jlb.1107751; Andersen JD, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-21; BENTWOOD BJ, 1980, J IMMUNOL, V124, P855; Bini L, 1996, ELECTROPHORESIS, V17, P612, DOI 10.1002/elps.1150170333; BOGDAN C, 1993, ANN NY ACAD SCI, V685, P713, DOI 10.1111/j.1749-6632.1993.tb35934.x; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Clemmensen SN, 2014, METHODS MOL BIOL, V1124, P53, DOI 10.1007/978-1-62703-845-4_5; Codina R, 2010, APOPTOSIS, V15, P139, DOI 10.1007/s10495-009-0412-0; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; HAUPT H, 1977, H-S Z PHYSIOL CHEM, V358, P639, DOI 10.1515/bchm2.1977.358.1.639; Jaillon S, 2013, SEMIN IMMUNOPATHOL, V35, P377, DOI 10.1007/s00281-013-0374-8; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kharbanda AB, 2012, ACAD EMERG MED, V19, P56, DOI 10.1111/j.1553-2712.2011.01251.x; Kjeldsen L, 1999, J IMMUNOL METHODS, V232, P131, DOI 10.1016/S0022-1759(99)00171-4; Ladd JJ, 2012, CANCER PREV RES, V5, P655, DOI 10.1158/1940-6207.CAPR-11-0412; Majek P, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/178709; Muller I, 2009, TRENDS IMMUNOL, V30, P522, DOI 10.1016/j.it.2009.07.007; Nauseef William M., 2007, V412, P15, DOI 10.1007/978-1-59745-467-4_2; O'Donnell LC, 2002, J LEUKOCYTE BIOL, V72, P478; Pullerits R, 2005, RHEUMATOLOGY, V44, P32, DOI 10.1093/rheumatology/keh406; Saito K, 2002, J IMMUNOL, V168, P1050, DOI 10.4049/jimmunol.168.3.1050; Scharpfenecker M, 2012, RADIOTHER ONCOL, V105, P313, DOI 10.1016/j.radonc.2012.08.021; Shirai R, 2010, J BIOL CHEM, V285, P21607, DOI 10.1074/jbc.M110.122788; Shirai R, 2009, BIOCHEM BIOPH RES CO, V382, P776, DOI 10.1016/j.bbrc.2009.03.104; SING GK, 1988, BLOOD, V72, P1504; Soehnlein O, 2009, TRENDS IMMUNOL, V30, P546, DOI 10.1016/j.it.2009.06.006; Theilgaard-Monch K, 2006, BLOOD, V108, P353, DOI 10.1182/blood-2005-09-3890; Turley JM, 1996, CELL GROWTH DIFFER, V7, P1535; Udby L, 2002, J LEUKOCYTE BIOL, V72, P462; Wang XM, 2013, NAT PHOTONICS, V7, P888, DOI 10.1038/nphoton.2013.241; Weivoda S, 2008, J IMMUNOL METHODS, V336, P22, DOI 10.1016/j.jim.2008.03.004; WRIGHT DG, 1977, AM J PATHOL, V87, P273	32	38	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0170261	10.1371/journal.pone.0170261	http://dx.doi.org/10.1371/journal.pone.0170261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081565	Green Published, Green Submitted, gold			2022-12-26	WOS:000391949500140
J	Czernik, M; Toschi, P; Zacchini, F; Luso, D; Ptak, GE				Czernik, Marta; Toschi, Paola; Zacchini, Federica; Luso, Domenico; Ptak, Grazyna Ewa			Deregulated Expression of Mitochondrial Proteins Mfn2 and Bcnl3L in Placentae from Sheep Somatic Cell Nuclear Transfer (SCNT) Conceptuses	PLOS ONE			English	Article							APOPTOSIS; MITOFUSIN; MORTALITY; MITOPHAGY; FUSION; DEATH; DEGRADATION; AUTOPHAGY; CLONING; EMBRYO	In various animal species, the main cause of pregnancy loss in conceptuses obtained by somatic cell nuclear transfer (SCNT) are placental abnormalities. Most abnormalities described in SCNT pregnancies (such as placentomegaly, reduced vascularisation, hypoplasia of trophoblastic epithelium) suggest that placental cell degeneration may be triggered by mitochondrial failure. We hypothesized that placental abnormalities of clones obtained by SCNT are related to mitochondrial dysfunction. To test this, early SCNT and control (CTR, from pregnancies obtained by in vitro fertilization) placentae were collected from pregnant ewes (at day 20 and 22 of gestation) and subjected to morphological, mRNA and protein analysis. Here, we demonstrated swollen and fragmented mitochondria and low expression of mitofusin 2 (Mfn2), the protein which plays a crucial role in mitochondrial functionality, in SCNT early placentae. Furthermore, reduced expression of the Bcnl3L/Nix protein, which plays a crucial role in selective elimination of damaged mitochondria, was observed and reflected by the accumulation of numerous damaged mitochondria in SCNT placental cells. Likely, this accumulation of damaged organelles led to uncontrolled apoptosis in SCNT placentae, as demonstrated by the high number of apoptotic bodies, fragmented cytoplasm, condensed chromatin, lack of integrity of the nuclear membrane and the perturbed mRNA expression of apoptotic genes (BCL2 and BAX). In conclusion, our data indicate that deregulated expression of Mfn2 and Bcnl3L is responsible for placental abnormalities in SCNT conceptuses. Our results suggest that some nuclear genes, that are involved in the regulation of mitochondrial function, do not work well and consequently this influence the function of mitochondria.	[Czernik, Marta; Toschi, Paola; Luso, Domenico; Ptak, Grazyna Ewa] Univ Teramo, Fac Vet Med, Expt Embryol, Teramo, Italy; [Zacchini, Federica; Ptak, Grazyna Ewa] Polish Acad Sci, Inst Genet & Anim Breeding, Jastrzebiec, Poland; [Ptak, Grazyna Ewa] Natl Res Inst Anim Prod, Balice, Poland	University of Teramo; Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences; National Research Institute of Animal Production	Ptak, GE (corresponding author), Univ Teramo, Fac Vet Med, Expt Embryol, Teramo, Italy.; Ptak, GE (corresponding author), Polish Acad Sci, Inst Genet & Anim Breeding, Jastrzebiec, Poland.; Ptak, GE (corresponding author), Natl Res Inst Anim Prod, Balice, Poland.	grazyna.ptak@izoo.krakow.pl	Zacchini, Federica/GQY-5276-2022	Zacchini, Federica/0000-0001-7942-2625; Iuso, Domenico/0000-0001-5946-2793; CZERNIK, Marta Teresa/0000-0002-4535-4932	European Union [692185, 312097]; European Research Council [IDEAS GA 210103]; IGAB PAS project [S.III.1.3]; EU COST action [FA 1201]	European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); IGAB PAS project; EU COST action(European Cooperation in Science and Technology (COST)European Commission)	The research leading to these results received funding from the European Union's Horizon 2020 Research and Innovation Programme under grant agreement No 692185 (Acronym ERAofART) and European Union Seventh Framework Programme for research, technological development and demonstration under grant agreement no 312097 (Acronym FECUND) and the European Research Council Programme IDEAS GA 210103 (Acronym ANGIOPLACE) to GEP. This study was also partially financed by the IGAB PAS project (S.III.1.3). G.E.P. received the fellowship from EU COST action FA 1201 (Epiconcept). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Cosson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046293; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; DUELLO TM, 1986, ENDOCRINOLOGY, V119, P1351, DOI 10.1210/endo-119-3-1351; Dumollard R, 2007, DEVELOPMENT, V134, P455, DOI 10.1242/dev.02744; Fletcher CJ, 2007, REPRODUCTION, V133, P243, DOI 10.1530/rep.1.01203; Galli C, 2012, REPROD DOMEST ANIM, V47, P2, DOI 10.1111/j.1439-0531.2012.02045.x; Garry FB, 1996, THERIOGENOLOGY, V45, P141, DOI 10.1016/0093-691X(95)00363-D; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Guha M, 2013, MITOCHONDRION, V13, P577, DOI 10.1016/j.mito.2013.08.007; Hill JR, 2000, BIOL REPROD, V63, P1787, DOI 10.1095/biolreprod63.6.1787; Huang CQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020975; Igwebuike UM, 2006, ANIM REPROD SCI, V93, P185, DOI 10.1016/j.anireprosci.2005.06.003; Iuso D, 2013, CELL REPROGRAM, V15, P490, DOI 10.1089/cell.2013.0051; Kaufman DM, 2015, CURR BIOL, V25, P2171, DOI 10.1016/j.cub.2015.06.062; Kristian T, 2004, CELL CALCIUM, V36, P221, DOI 10.1016/j.ceca.2004.02.016; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Leboucher GP, 2012, MOL CELL, V47, P547, DOI 10.1016/j.molcel.2012.05.041; Loi P, 2006, THERIOGENOLOGY, V65, P1110, DOI 10.1016/j.theriogenology.2005.07.016; Loi P, 2001, NAT BIOTECHNOL, V19, P962, DOI 10.1038/nbt1001-962; Matsui M, 2006, BIOCHEM BIOPH RES CO, V339, P485, DOI 10.1016/j.bbrc.2005.11.044; Myers DA, 1988, J TISS CULT METHODS, V11, P83; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Ogonuki N, 2002, NAT GENET, V30, P253, DOI 10.1038/ng841; Ogura A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0329; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Munoz JP, 2013, EMBO J, V32, P2348, DOI 10.1038/emboj.2013.168; Palmieri C, 2008, VET PATHOL, V45, P865, DOI 10.1354/vp.45-6-865; Pang W, 2013, PLACENTA, V34, P613, DOI 10.1016/j.placenta.2013.03.013; Ptak GE, 2013, HUM REPROD, V28, P298, DOI 10.1093/humrep/des397; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Santel A, 2001, J CELL SCI, V114, P867; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Scott Chappel, 2013, OBSTET GYNECOL INT, V2013, DOI [10.1155/2013/183024, DOI 10.1155/2013/183024]; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; Spikings EC, 2006, HUM REPROD UPDATE, V12, P401, DOI 10.1093/humupd/dml011; Sugioka R, 2004, J BIOL CHEM, V279, P52726, DOI 10.1074/jbc.M408910200; Tanaka S, 2001, BIOL REPROD, V65, P1813, DOI 10.1095/biolreprod65.6.1813; Yamada M, 2015, CURR OPIN GENET DEV, V34, P29, DOI 10.1016/j.gde.2015.06.007; Yamazaki Y, 2001, P NATL ACAD SCI USA, V98, P14022, DOI 10.1073/pnas.231489398; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Ziviani E, 2010, AUTOPHAGY, V6, P660, DOI 10.4161/auto.6.5.12242	45	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169579	10.1371/journal.pone.0169579	http://dx.doi.org/10.1371/journal.pone.0169579			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076382	Green Published, Green Submitted, gold			2022-12-26	WOS:000391857100043
J	Decourtye, L; Mire, E; Clemessy, M; Heurtier, V; Ledent, T; Robinson, IC; Mollard, P; Epelbaum, J; Meaney, MJ; Garel, S; Le Bouc, Y; Kappeler, L				Decourtye, Lyvianne; Mire, Erik; Clemessy, Maud; Heurtier, Victor; Ledent, Tatiana; Robinson, Iain C.; Mollard, Patrice; Epelbaum, Jacques; Meaney, Michael J.; Garel, Sonia; Le Bouc, Yves; Kappeler, Laurent			IGF-1 Induces GHRH Neuronal Axon Elongation during Early Postnatal Life in Mice	PLOS ONE			English	Article							HYPOTHALAMIC NEURONS; MEMBRANE EXPANSION; I RECEPTOR; GROWTH; INSULIN; REGENERATION; ACTIVATION; PLASTICITY; OUTGROWTH; PEPTIDE	Nutrition during the perinatal period programs body growth. Growth hormone (GH) secretion from the pituitary regulates body growth and is controlled by Growth Hormone Releasing Hormone (GHRH) neurons located in the arcuate nucleus of the hypothalamus. We observed that dietary restriction during the early postnatal period (i.e. lactation) in mice influences postnatal growth by permanently altering the development of the somatotropic axis in the pituitary gland. This alteration may be due to a lack of GHRH signaling during this critical developmental period. Indeed, underfed pups showed decreased insulin-like growth factor I (IGF-1) plasma levels, which are associated with lower innervation of the median eminence by GHRH axons at 10 days of age relative to normally fed pups. IGF-1 preferentially stimulated axon elongation of GHRH neurons in in vitro arcuate explant cultures from 7 day-old normally fed pups. This IGF-1 stimulating effect was selective since other arcuate neurons visualized concomitantly by neurofilament labeling, or AgRP immunochemistry, did not significantly respond to IGF-1 stimulation. Moreover, GHRH neurons in explants from age matched underfed pups lost the capacity to respond to IGF-1 stimulation. Molecular analyses indicated that nutritional restriction was associated with impaired activation of AKT. These results highlight a role for IGF-1 in axon elongation that appears to be cell selective and participates in the complex cellular mechanisms that link underfeeding during the early postnatal period with programming of the growth trajectory.	[Decourtye, Lyvianne; Mire, Erik; Clemessy, Maud; Heurtier, Victor; Ledent, Tatiana; Le Bouc, Yves; Kappeler, Laurent] Sorbonne Univ, UPMC Univ Paris 06, INSERM, UMRS 938,CRSA, Paris, France; [Robinson, Iain C.] MRC, Natl Inst Med Res, Div Mol Neuroendocrinol, London, England; [Mollard, Patrice] Univ Montpellier I, Montpellier, France; [Mollard, Patrice] Univ Montpellier 2, CNRS, UMR 5203, Inst Genom Fonct, Montpellier, France; [Epelbaum, Jacques] Univ Paris 05, Sorbonne Paris Cite, INSERM, UMR 894,Ctr Psychiat & Neurosci, Paris, France; [Meaney, Michael J.] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Garel, Sonia] Ecole Normale Super, Inst Biol, IBENS, Paris, France; [Epelbaum, Jacques] CNRS, UMR 7179, MNHN MECADEV Mecanismes Adaptatifs & Evolut, Brunoy, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; MRC National Institute for Medical Research; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; McGill University; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	Kappeler, L (corresponding author), Sorbonne Univ, UPMC Univ Paris 06, INSERM, UMRS 938,CRSA, Paris, France.	laurent.kappeler@inserm.fr	Meaney, Michael/N-5931-2019; Kappeler, Laurent/N-6327-2017; Mire, Erik/AAD-3123-2020; Epelbaum, Jacques/B-2263-2013; Garel, Sonia/P-4538-2017	Kappeler, Laurent/0000-0001-7971-0838; Mire, Erik/0000-0002-6793-0566; Garel, Sonia/0000-0003-2984-3645; Decourtye Espiard, Lyvianne/0000-0003-2212-1316; Ledent, Tatiana/0000-0002-6988-8779	Institut National de la Sante et de la Recherche Medicale (INSERM); l'Universite Pierre et Marie Curie (Sorbonne Universites, UPMC Univ Paris) [06]; institute of Cardiometabolism and Nutrition (IHU ICAN); Sandoz-France laboratories; Premup foundation; ANR [ANR-2010-BLAN-1415-01]; CDD-Inserm; French Ministry for Education and Research Training; Societe Frangaise d'Endocrinologie et Diabetologie Pedatrique (SFEDP, grant Sandoz Biopharmaceuticals France)	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); l'Universite Pierre et Marie Curie (Sorbonne Universites, UPMC Univ Paris); institute of Cardiometabolism and Nutrition (IHU ICAN); Sandoz-France laboratories; Premup foundation; ANR(French National Research Agency (ANR)); CDD-Inserm; French Ministry for Education and Research Training; Societe Frangaise d'Endocrinologie et Diabetologie Pedatrique (SFEDP, grant Sandoz Biopharmaceuticals France)	This study was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), l'Universite Pierre et Marie Curie (Sorbonne Universites, UPMC Univ Paris 06), the institute of Cardiometabolism and Nutrition (IHU ICAN), Sandoz-France laboratories, and the Premup foundation. P.M. was supported by an ANR grant (ANR-2010-BLAN-1415-01). E.M. was supported by CDD-Inserm. L.D. was supported by a PhD grant from the French Ministry for Education and Research Training and from the Societe Frangaise d'Endocrinologie et Diabetologie Pedatrique (SFEDP, grant Sandoz Biopharmaceuticals France).	ADAMO M, 1989, MOL NEUROBIOL, V3, P71, DOI 10.1007/BF02935589; Balthasar N, 2003, ENDOCRINOLOGY, V144, P2728, DOI 10.1210/en.2003-0006; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Bernis ME, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00194; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Bouyer K, 2008, J NEUROENDOCRINOL, V20, P1278, DOI 10.1111/j.1365-2826.2008.01780.x; Bouyer K, 2007, J CHEM NEUROANAT, V33, P1, DOI 10.1016/j.jchemneu.2006.10.002; Bouyer K, 2013, J NEUROSCI, V33, P840, DOI 10.1523/JNEUROSCI.3215-12.2013; Caron E, 2012, J NEUROSCI, V32, P11486, DOI 10.1523/JNEUROSCI.6074-11.2012; Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209; FIOROTTO ML, 1991, AM J PHYSIOL, V260, pR1104, DOI 10.1152/ajpregu.1991.260.6.R1104; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gouty-Colomer LA, 2010, ENDOCRINOLOGY, V151, P5762, DOI 10.1210/en.2010-0298; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Hassouna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051135; Hollis ER, 2009, EXP NEUROL, V215, P53, DOI 10.1016/j.expneurol.2008.09.014; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Kappeler L, 2009, ENDOCRINOLOGY, V150, P314, DOI 10.1210/en.2008-0981; Kappeler L, 2008, PLOS BIOL, V6, P2144, DOI 10.1371/journal.pbio.0060254; Kim B, 1997, J BIOL CHEM, V272, P21268, DOI 10.1074/jbc.272.34.21268; Laurino L, 2005, J CELL SCI, V118, P3653, DOI 10.1242/jcs.02490; Liu CM, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00003; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; Lopez-Bendito G, 2006, CELL, V125, P127, DOI 10.1016/j.cell.2006.01.042; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; McArthur S, 2011, ENDOCRINOLOGY, V152, P607, DOI 10.1210/en.2010-0798; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Mire E, 2008, MOL CELL NEUROSCI, V37, P222, DOI 10.1016/j.mcn.2007.09.009; Mire E, 2012, NAT NEUROSCI, V15, P1134, DOI 10.1038/nn.3160; Mulvihill MJ, 2009, FUTURE MED CHEM, V1, P1153, DOI 10.4155/FMC.09.89; Niblock MM, 2000, J NEUROSCI, V20, P4165; Nieto-Estevez V, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00052; Ong KK, 2009, J CLIN ENDOCR METAB, V94, P1527, DOI 10.1210/jc.2008-2489; Ozdinler PH, 2006, NAT NEUROSCI, V9, P1371, DOI 10.1038/nn1789; Pfenninger KH, 2003, J CELL SCI, V116, P1209, DOI 10.1242/jcs.00285; Scolnick JA, 2008, NEURON, V57, P847, DOI 10.1016/j.neuron.2008.01.027; Solloso A, 2008, J CELL PHYSIOL, V215, P140, DOI 10.1002/jcp.21295; Sosa L, 2006, NAT NEUROSCI, V9, P993, DOI 10.1038/nn1742; Sun L, 2009, J GERONTOL A-BIOL, V64, P711, DOI 10.1093/gerona/glp051; THISSEN JP, 1994, ENDOCR REV, V15, P80, DOI 10.1210/er.15.1.80; Vogt MC, 2014, CELL, V156, P495, DOI 10.1016/j.cell.2014.01.008; Weaver ICG, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0513	43	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0170083	10.1371/journal.pone.0170083	http://dx.doi.org/10.1371/journal.pone.0170083			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076448	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000391857100086
J	Marsman, M; Maris, G; Bechger, T; Glas, C				Marsman, Maarten; Maris, Gunter; Bechger, Timo; Glas, Cees			Turning Simulation into Estimation: Generalized Exchange Algorithms for Exponential Family Models	PLOS ONE			English	Article							MONTE-CARLO; DISTRIBUTIONS; LIKELIHOODS	The Single Variable Exchange algorithm is based on a simple idea; any model that can be simulated can be estimated by producing draws from the posterior distribution. We build on this simple idea by framing the Exchange algorithm as a mixture of Metropolis transition kernels and propose strategies that automatically select the more efficient transition kernels. In this manner we achieve significant improvements in convergence rate and autocorrelation of the Markov chain without relying on more than being able to simulate from the model. Our focus will be on statistical models in the Exponential Family and use two simple models from educational measurement to illustrate the contribution.	[Marsman, Maarten; Maris, Gunter] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Maris, Gunter; Bechger, Timo] Cito, Psychometr Res Ctr, Arnhem, Netherlands; [Glas, Cees] Univ Twente, Dept Res Methodol Measurement & Data Anal, Enschede, Netherlands	University of Amsterdam; University of Twente	Marsman, M (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	m.marsman@uva.nl		marsman, maarten/0000-0001-5309-7502	CITO	CITO	The authors GM and TB are paid a salary by CITO, a nonprofit commercial educational testing company, and they worked on this paper during their salaried time. CITO provided support in the form of salaries for authors GM and TB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ALBERT JH, 1993, J AM STAT ASSOC, V88, P669, DOI 10.2307/2290350; Alquier P, 2016, STAT COMPUT, V26, P29, DOI 10.1007/s11222-014-9521-x; [Anonymous], 2021, LANG ENV STAT COMP; Caimo A, 2015, STAT COMPUT, V25, P113, DOI 10.1007/s11222-014-9516-7; Caimo A, 2011, SOC NETWORKS, V33, P41, DOI 10.1016/j.socnet.2010.09.004; Cucala L, 2013, J COMPUT GRAPH STAT, V22, P584, DOI 10.1080/10618600.2013.805652; DAWID AP, 1979, J ROY STAT SOC B MET, V41, P1; Fisher RA, 1934, P R SOC LOND A-CONTA, V144, P0285, DOI 10.1098/rspa.1934.0050; Friel N, 2011, STAT COMPUT, V21, P431, DOI 10.1007/s11222-010-9179-y; Friel N, 2013, J COMPUT GRAPH STAT, V22, P518, DOI 10.1080/10618600.2013.778780; Hunter DR, 2012, J COMPUT GRAPH STAT, V21, P856, DOI 10.1080/10618600.2012.732921; Jacob P, 2011, J COMPUT GRAPH STAT, V20, P616, DOI 10.1198/jcgs.2011.10167; Liang FM, 2016, J AM STAT ASSOC, V111, P377, DOI 10.1080/01621459.2015.1009072; Liang FM, 2010, J STAT COMPUT SIM, V80, P1007, DOI 10.1080/00949650902882162; Marjoram P, 2003, P NATL ACAD SCI USA, V100, P15324, DOI 10.1073/pnas.0306899100; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Moller J, 2006, BIOMETRIKA, V93, P451, DOI 10.1093/biomet/93.2.451; Murray I, 2006, P 22 ANN C ART INT U; Pitman EJG, 1936, P CAMB PHILOS SOC, V32, P567; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Rasch G., 1960, PROBABILISTIC MODELS; Reckase MD, 2009, STAT SOC BEHAV SC, P1, DOI 10.1007/978-0-387-89976-3_1; Ripley B.D., 1987, STOCHASTIC SIMULATIO, DOI [10.1002/9780470316726, DOI 10.1002/9780470316726]; Ross S.M., 2013, SIMULATION; RUBIN DB, 1984, ANN STAT, V12, P1151, DOI 10.1214/aos/1176346785; Scott SL, 2011, STAT PAP, V52, P87, DOI 10.1007/s00362-009-0205-0; Sisson SA, 2007, P NATL ACAD SCI USA, V104, P1760, DOI 10.1073/pnas.0607208104; Tanner MA, 1993, TOOLS STAT INFERENCE; TIERNEY L, 1994, ANN STAT, V22, P1701, DOI 10.1214/aos/1176325750; Tierney L, 1998, ANN APPL PROBAB, V8, P1; Voets E, 2015, SCI REP-UK, V5, DOI 10.1038/srep14798	33	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169787	10.1371/journal.pone.0169787	http://dx.doi.org/10.1371/journal.pone.0169787			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076429	Green Submitted, gold, Green Published			2022-12-26	WOS:000391857100055
J	Tasaki, E; Kobayashi, K; Matsuura, K; Iuchi, Y				Tasaki, Eisuke; Kobayashi, Kazuya; Matsuura, Kenji; Iuchi, Yoshihito			An Efficient Antioxidant System in a Long-Lived Termite Queen	PLOS ONE			English	Article							OXIDATIVE STRESS; LIFE-SPAN; HONEY-BEE; SUPEROXIDE-DISMUTASE; LIPID PEROXIDES; SOCIAL INSECTS; FREE-RADICALS; EXPRESSION; MECHANISMS; EXTENSION	The trade-off between reproduction and longevity is known in wide variety of animals. Social insect queens are rare organisms that can achieve a long lifespan without sacrificing fecundity. The extended longevity of social insect queens, which contradicts the trade-off, has attracted much attention because it implies the existence of an extraordinary anti-aging mechanism. Here, we show that queens of the termite Reticulitermes speratus incur significantly lower oxidative damage to DNA, protein and lipid and have higher activity of antioxidant enzymes than non-reproductive individuals (workers and soldiers). The levels of 8-hydroxy-2'-deoxyguanosine (oxidative damage marker of DNA) were lower in queens than in workers after UV irradiation. Queens also showed lower levels of protein carbonyls and malondialdehyde (oxidative damage markers of protein and lipid, respectively). The antioxidant enzymes of insects are generally composed of catalase (CAT) and peroxiredoxin (Prx). Queens showed more than two times higher CAT activity and more than seven times higher expression levels of the CAT gene RsCAT1 than workers. The CAT activity of termite queens was also markedly higher in comparison with other solitary insects and the queens of eusocial Hymenoptera. In addition, queens showed higher expression levels of the Prx gene RsPRX6. These results suggested that this efficient antioxidant system can partly explain why termite queens achieve long life. This study provides important insights into the evolutionary linkage of reproductive division of labor and the development of queens' oxidative stress resistance in social insects.	[Tasaki, Eisuke; Iuchi, Yoshihito] Tottori Univ, United Grad Sch Agr, Dept Appl Bioresources Chem, Tottori, Japan; [Tasaki, Eisuke; Iuchi, Yoshihito] Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi, Japan; [Kobayashi, Kazuya; Matsuura, Kenji] Kyoto Univ, Grad Sch Agr, Dept Appl Biosci, Kyoto, Japan; [Iuchi, Yoshihito] Yamaguchi Univ, Grad Sch Sci & Technol Innovat, Yamaguchi, Japan	Tottori University; Yamaguchi University; Kyoto University; Yamaguchi University	Iuchi, Y (corresponding author), Tottori Univ, United Grad Sch Agr, Dept Appl Bioresources Chem, Tottori, Japan.; Iuchi, Y (corresponding author), Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi, Japan.; Iuchi, Y (corresponding author), Yamaguchi Univ, Grad Sch Sci & Technol Innovat, Yamaguchi, Japan.	yiuchi@yamaguchi-u.ac.jp	kobayashi, kazuya/J-5507-2013; Tasaki, Eisuke/G-7241-2019	kobayashi, kazuya/0000-0002-9475-6807; Tasaki, Eisuke/0000-0002-6514-5134	Japan Society for the Promotion of Science [26660113, 25221206]; Grants-in-Aid for Scientific Research [17K19909, 26660113] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html, No. 26660113 to YI and No. 25221206 to KM).	Agarwal A, 2003, FERTIL STERIL, V79, P829, DOI 10.1016/S0015-0282(02)04948-8; Ahmad S., 1989, ARCH INSECT BIOCH PH, V31-49, P49; ARMSTRONG D, 1994, ADV EXP MED BIOL, V366, P43; Baker N, 2012, EXP GERONTOL, V47, P764, DOI 10.1016/j.exger.2012.05.011; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BUCALA R, 1993, P NATL ACAD SCI USA, V90, P6434, DOI 10.1073/pnas.90.14.6434; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Corona M, 2005, MECH AGEING DEV, V126, P1230, DOI 10.1016/j.mad.2005.07.004; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; CUTLER RG, 1991, ANN NY ACAD SCI, V621, P1; DeJong RJ, 2007, P NATL ACAD SCI USA, V104, P2121, DOI 10.1073/pnas.0608407104; Diaz-Albiter H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017486; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; FELTON GW, 1995, ARCH INSECT BIOCHEM, V29, P187, DOI 10.1002/arch.940290208; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Heinze J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035201; HOLM S, 1979, SCAND J STAT, V6, P65; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Ichihashi M, 2003, TOXICOLOGY, V189, P21, DOI 10.1016/S0300-483X(03)00150-1; Iuchi Y, 2007, BIOCHEM J, V402, P219, DOI 10.1042/BJ20061386; Jemielity S, 2005, AGE, V27, P241, DOI 10.1007/s11357-005-2916-z; Jemielity S, 2007, AGING CELL, V6, P225, DOI 10.1111/j.1474-9726.2007.00279.x; Jones OR, 2014, NATURE, V505, P169, DOI 10.1038/nature12789; Kamakura M, 2011, NATURE, V473, P478, DOI 10.1038/nature10093; Keller L, 1997, NATURE, V389, P958, DOI 10.1038/40130; Keller L, 2006, EXP GERONTOL, V41, P553, DOI 10.1016/j.exger.2006.04.002; Korb J, 2016, FRONT ECOL EVOL, V4, P1; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; Mitaka Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146125; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Myatt L, 2004, HISTOCHEM CELL BIOL, V122, P369, DOI 10.1007/s00418-004-0677-x; Nunes L, 1997, J INSECT PHYSIOL, V43, P749, DOI 10.1016/S0022-1910(97)00036-X; Ohkuma M, 2003, APPL MICROBIOL BIOT, V61, P1, DOI 10.1007/s00253-002-1189-z; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Page RE, 2001, EXP GERONTOL, V36, P695, DOI 10.1016/S0531-5565(00)00236-9; Parker JD, 2004, P NATL ACAD SCI USA, V101, P3486, DOI 10.1073/pnas.0400222101; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; Radyuk SN, 2001, FREE RADICAL BIO MED, V31, P1090, DOI 10.1016/S0891-5849(01)00692-X; Remolina SC, 2008, AGE, V30, P177, DOI 10.1007/s11357-008-9061-4; Rozen S, 2000, Methods Mol Biol, V132, P365; Sampayo JN, 2003, AGING CELL, V2, P319, DOI 10.1046/j.1474-9728.2003.00063.x; Sgro CM, 1999, SCIENCE, V286, P2521, DOI 10.1126/science.286.5449.2521; Sun JT, 1999, MOL CELL BIOL, V19, P216; Winston M. L. L., 1991, BIOL HONEY BEE; Yagi K, 1998, Methods Mol Biol, V108, P101	48	33	35	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0167412	10.1371/journal.pone.0167412	http://dx.doi.org/10.1371/journal.pone.0167412			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076409	Green Published, gold, Green Submitted			2022-12-26	WOS:000391857100004
J	Hifumi, E; Taguchi, H; Kato, R; Uda, T				Hifumi, Emi; Taguchi, Hiroaki; Kato, Ryuichi; Uda, Taizo			Role of the constant region domain in the structural diversity of human antibody light chains	FASEB JOURNAL			English	Article						molecular heterogeneity; electrical charge; molecular size; cation-exchange chromatography; 2D electrophoresis	BIOCHEMICAL FEATURES; MONOCLONAL-ANTIBODY; FACTOR-VIII; HETEROGENEITY; ELECTROPHORESIS; TRASTUZUMAB; HEMOPHILIA; HYDROLYSIS; SITES; HIV	Issues regarding the structural diversity (heterogeneity) of anantibody molecule have beenthe subject of discussion along with the development of antibody drugs. Research on heterogeneity has been extensive in recent years, butno clear solutionhas been reached. Heterogeneity is also observed incatalytic antibodyk light chains (CLs). In this study, we investigated how the constant region domain of CLs concerns structural diversity because it is a simple and good example for elucidating heterogeneity. Bymeans of cation-exchange chromatography, SDS-PAGE, and 2-dimensional electrophoresis for the CL, multimolecular forms consisting of different electrical charges and molecular sizes coexisted in the solution, resulting in the similar heterogeneity of the full length ofCLs. The addition of copper ion could cause the multimolecular forms to change to monomolecular forms. Copper ion contributed greatly to the enrichment of the dimer form of CL and the homogenization of the differently charged CLs. Two molecules of the CL protein bound one copper ion. The binding affinity of the ion was 48.0 mu M-1. Several divalent metal ions were examined, but only zinc showed a similar effect.-Hifumi, E., Taguchi, H., Kato, R., Uda, T. Role of the constant region domain in the structural diversity of human antibody light chains. FASEB J. 31, 1668-1677 (2017). www.fasebj.org	[Hifumi, Emi] Oita Univ, Res Promot Inst, 700 Dannoharu, Oita, Oita 8701192, Japan; [Uda, Taizo] Oita Univ, Fac Engn, Dept Appl Chem, Oita, Oita, Japan; [Taguchi, Hiroaki] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Suzuka, Japan; [Kato, Ryuichi] High Energy Accelerator Res Org KEK, Inst Mat Struct Sci, Tsukuba, Ibaraki, Japan; [Uda, Taizo] Inst Syst Informat Technol & Nanotechnol, Nanotechnol Lab, Fukuoka, Japan	Oita University; Oita University; High Energy Accelerator Research Organization (KEK)	Hifumi, E (corresponding author), Oita Univ, Res Promot Inst, 700 Dannoharu, Oita, Oita 8701192, Japan.	e-hifumi@oita-u.ac.jp		Kato, Ryuichi/0000-0003-2087-2896; Uda, Taizo/0000-0001-8146-7902	Japan Science and Technology Agency (CREST/Establishment of Innovative Manufacturing Technology Based on Nanoscience); Ministry of Education, Culture, Sports, Science and Technology of Japan [24350085, 16II02282]; "Super Highway," the accelerated research	Japan Science and Technology Agency (CREST/Establishment of Innovative Manufacturing Technology Based on Nanoscience); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); "Super Highway," the accelerated research	This study was supported by the Japan Science and Technology Agency (CREST/Establishment of Innovative Manufacturing Technology Based on Nanoscience), by "Super Highway," the accelerated research to bridge university IPs and practical use, and by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (24350085 and 16II02282). The authors thank Mr. S. Itonaga and Ms. Y. Akiyoshi (Oita University) for assistance with this study. The authors declare no conflicts of interest.	Bezuglova AM, 2011, J MOL RECOGNIT, V24, P960, DOI 10.1002/jmr.1143; Durova OM, 2009, MOL IMMUNOL, V47, P87, DOI 10.1016/j.molimm.2008.12.020; Fujimoto N., 2009, P J1 52 ANN M CHEM S; Glassy Mark C., 2009, Human Antibodies, V18, P127, DOI 10.3233/HAB-2009-0209; Harris RJ, 2001, J CHROMATOGR B, V752, P233, DOI 10.1016/S0378-4347(00)00548-X; Hifumi E, 2002, J IMMUNOL METHODS, V269, P283, DOI 10.1016/S0022-1759(02)00242-9; Hifumi E, 2008, J BIOL CHEM, V283, P899, DOI 10.1074/jbc.M705674200; Hifumi E, 2016, FASEB J, V30, P895, DOI 10.1096/fj.15-276394; Hifumi E, 2015, FASEB J, V29, P2347, DOI 10.1096/fj.14-264275; Hifumi E, 2013, J BIOL CHEM, V288, P19558, DOI 10.1074/jbc.M113.454579; Hifumi E, 2012, FASEB J, V26, P1607, DOI 10.1096/fj.11-195339; Hifumi E, 2010, FEBS J, V277, P3823, DOI 10.1111/j.1742-4658.2010.07785.x; Holm RH, 1996, CHEM REV, V96, P2239, DOI 10.1021/cr9500390; Hortobagyi GN, 2005, NEW ENGL J MED, V353, P1734, DOI 10.1056/NEJMe058196; Hunt G, 1996, J CHROMATOGR A, V744, P295, DOI 10.1016/0021-9673(96)00437-2; Kou JH, 2015, MOL NEUROBIOL, V51, P43, DOI 10.1007/s12035-014-8691-z; Lacroix-Desmazes S, 1999, NAT MED, V5, P1044, DOI 10.1038/12483; Matsuura K, 1998, BIOCHEM BIOPH RES CO, V243, P719, DOI 10.1006/bbrc.1998.8164; Meza-Junco Judith, 2011, Cancer Manag Res, V3, P57, DOI 10.2147/CMR.S12698; Nebija D, 2014, INT J MOL SCI, V15, P6399, DOI 10.3390/ijms15046399; Nishiyama Y, 2014, J BIOTECHNOL, V180, P17, DOI 10.1016/j.jbiotec.2014.03.026; Odintsova ES, 2011, J MOL RECOGNIT, V24, P45, DOI 10.1002/jmr.1022; Ohara K, 2004, BIOCHEM BIOPH RES CO, V315, P612, DOI 10.1016/j.bbrc.2004.01.094; Parkhomenko TA, 2010, BIOCHIMIE, V92, P545, DOI 10.1016/j.biochi.2010.01.022; Paul S, 2004, J BIOL CHEM, V279, P39611, DOI 10.1074/jbc.M406719200; Planque S, 2008, AUTOIMMUN REV, V7, P473, DOI 10.1016/j.autrev.2008.04.002; Radulescu RT, 1998, IMMUNOL TODAY, V19, P288, DOI 10.1016/S0167-5699(98)01262-6; RADULESCU RT, 1995, MED HYPOTHESES, V44, P137, DOI 10.1016/0306-9877(95)90087-X; Smirnov I, 2011, P NATL ACAD SCI USA, V108, P15954, DOI 10.1073/pnas.1108460108; Solomon EI, 2006, INORG CHEM, V45, P8012, DOI 10.1021/ic060450d; STEVENS FJ, 1988, P NATL ACAD SCI USA, V85, P6895, DOI 10.1073/pnas.85.18.6895; Wootla B, 2009, FEBS LETT, V583, P2565, DOI 10.1016/j.febslet.2009.07.009	32	5	5	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1668	1677		10.1096/fj.201600819R	http://dx.doi.org/10.1096/fj.201600819R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28096233				2022-12-26	WOS:000398504300031
J	Lynagh, T; Komnatnyy, VV; Pless, SA				Lynagh, Timothy; Komnatnyy, Vitaly V.; Pless, Stephan A.			Unique Contributions of an Arginine Side Chain to Ligand Recognition in a Glutamate-gated Chloride Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biophysics; glutamate; ion channel; membrane protein; neurotransmitter; Unnatural amino acids; arginine; ligand recognition; channel activation	UNNATURAL AMINO-ACIDS; SITE-DIRECTED MUTAGENESIS; TRANSFER-RNA-SYNTHETASE; IN-VIVO INCORPORATION; CYS-LOOP RECEPTOR; MOLECULAR DETERMINANTS; GLYCINE RECEPTORS; ION CHANNELS; BINDING-SITE; AGONIST	Glutamate recognition by neurotransmitter receptors often relies on Arg residues in the binding site, leading to the assumption that charge-charge interactions underlie ligand recognition. However, assessing the precise chemical contribution of Arg side chains to protein function and pharmacology has proven to be exceedingly difficult in such large and complex proteins. Using the in vivo nonsense suppression approach, we report the first successful incorporation of the isosteric, titratable Arg analog, canavanine, into a neurotransmitter receptor in a living cell, utilizing a glutamate-gated chloride channel from the nematode Haemonchus contortus. Our data unveil a surprisingly small contribution of charge at a conserved arginine side chain previously suggested to form a salt bridge with the ligand, glutamate. Instead, our data show that Arg contributes crucially to ligand sensitivity via a hydrogen bond network, where Arg interacts both with agonist and with a conserved Thr side chain within the receptor. Together, the data provide a new explanation for the reliance of neurotransmitter receptors on Arg side chains and highlight the exceptional capacity of unnatural amino acid incorporation for increasing our understanding of ligand recognition.	[Lynagh, Timothy; Komnatnyy, Vitaly V.; Pless, Stephan A.] Univ Copenhagen, Dept Drug Design & Pharmacol, Ctr Biopharmaceut, DK-2100 Copenhagen H, Denmark	University of Copenhagen	Pless, SA (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Ctr Biopharmaceut, DK-2100 Copenhagen H, Denmark.	stephan.pless@sund.ku.dk		Pless, Stephan/0000-0001-6654-114X; Lynagh, Timothy/0000-0003-4888-4098	Center for Biopharmaceuticals (University of Copenhagen); Carlsberg Foundation; Lundbeck Foundation; Danish Council for Independent Research (Det Frie Forskningsrad); Lundbeck Foundation [R139-2012-12390, R171-2014-558] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0011767] Funding Source: researchfish	Center for Biopharmaceuticals (University of Copenhagen); Carlsberg Foundation(Carlsberg Foundation); Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research (Det Frie Forskningsrad); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Center for Biopharmaceuticals (University of Copenhagen), the Carlsberg Foundation, the Lundbeck Foundation, and the Danish Council for Independent Research (Det Frie Forskningsrad). The authors declare that they have no conflicts of interest with the contents of this article.	Akahoshi A, 2011, BIOCHEM BIOPH RES CO, V414, P625, DOI 10.1016/j.bbrc.2011.09.137; Althoff T, 2014, NATURE, V512, P333, DOI 10.1038/nature13669; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; BORDERS CL, 1994, PROTEIN SCI, V3, P541; BOYAR A, 1982, J AM CHEM SOC, V104, P1995, DOI 10.1021/ja00371a033; Chen PE, 2005, MOL PHARMACOL, V67, P1470, DOI 10.1124/mol.104.008185; Chen ZL, 2004, J BIOL CHEM, V279, P876, DOI 10.1074/jbc.M307684200; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Daeffler KNM, 2014, ACS CHEM BIOL, V9, P2283, DOI 10.1021/cb500323d; Dahan DS, 2004, P NATL ACAD SCI USA, V101, P10195, DOI 10.1073/pnas.0301885101; Dougherty DA, 2014, CHEMBIOCHEM, V15, P1710, DOI 10.1002/cbic.201402080; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Hampson DR, 1999, J BIOL CHEM, V274, P33488, DOI 10.1074/jbc.274.47.33488; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Huang RQ, 1999, J NEUROPHYSIOL, V82, P1233, DOI 10.1152/jn.1999.82.3.1233; JUDICE JK, 1993, SCIENCE, V261, P1578, DOI 10.1126/science.8103944; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Kawamoto S, 1997, MOL BRAIN RES, V47, P339; Krishnakumar R, 2014, FEBS LETT, V588, P383, DOI 10.1016/j.febslet.2013.11.039; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; Le DD, 2013, J AM CHEM SOC, V135, P2879, DOI 10.1021/ja3108214; Lynagh T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08558; McCavera S, 2009, MOL PHARMACOL, V75, P1347, DOI 10.1124/mol.108.053363; Mehler EL, 2002, PROTEINS, V48, P283, DOI 10.1002/prot.10153; Moroz LL, 2014, NATURE, V510, P109, DOI 10.1038/nature13400; Nowak MW, 1998, METHOD ENZYMOL, V293, P504; Pajpanova T, 1997, AMINO ACIDS, V12, P191, DOI 10.1007/BF01386482; Pless SA, 2013, ANNU REV PHARMACOL, V53, P211, DOI 10.1146/annurev-pharmtox-011112-140343; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Smart TG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009662; WILKINSON AJ, 1983, BIOCHEMISTRY-US, V22, P3581, DOI 10.1021/bi00284a007; Wolstenholme AJ, 2012, J BIOL CHEM, V287, P40232, DOI 10.1074/jbc.R112.406280; Yu RL, 2014, BIOCHEMISTRY-US, V53, P6041, DOI 10.1021/bi500815f	36	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3940	3946		10.1074/jbc.M116.772939	http://dx.doi.org/10.1074/jbc.M116.772939			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28096462	Green Published, hybrid			2022-12-26	WOS:000395542500034
J	Carrer, A; Parris, JLD; Trefely, S; Henry, RA; Montgomery, DC; Torres, A; Viola, JM; Kuo, YM; Blair, IA; Meier, JL; Andrews, AJ; Snyder, NW; Wellen, KE				Carrer, Alessandro; Parris, Joshua L. D.; Trefely, Sophie; Henry, Ryan A.; Montgomery, David C.; Torres, AnnMarie; Viola, John M.; Kuo, Yin-Ming; Blair, Ian A.; Meier, Jordan L.; Andrews, Andrew J.; Snyder, Nathaniel W.; Wellen, Kathryn E.			Impact of a High-fat Diet on Tissue Acyl-CoA and Histone Acetylation Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acetyl-CoA; adipose tissue; diet; histone acetylation; liver	ATP-CITRATE-LYASE; ONE-CARBON METABOLISM; CELLULAR-METABOLISM; DNA METHYLATION; DYNAMICS; TRANSCRIPTION; EPIGENETICS; MECHANISMS; COENZYME; CANCER	Cellular metabolism dynamically regulates the epigenome via availability of the metabolite substrates of chromatin-modifying enzymes. The impact of diet on the metabolism-epigenome axis is poorly understood but could alter gene expression and influence metabolic health. ATP citrate-lyase produces acetyl-CoA in the nucleus and cytosol and regulates histone acetylation levels in many cell types. Consumption of a high-fat diet (HFD) results in suppression of ATP citrate-lyase levels in tissues such as adipose and liver, but the impact of diet on acetyl-CoA and histone acetylation in these tissues remains unknown. Here we examined the effects of HFD on levels of acyl-CoAs and histone acetylation in mouse white adipose tissue (WAT), liver, and pancreas. We report that mice consuming a HFD have reduced levels of acetyl-CoA and/or acetyl-CoA:CoA ratio in these tissues. In WAT and the pancreas, HFD also impacted the levels of histone acetylation; in particular, histone H3 lysine 23 acetylation was lower in HFD-fed mice. Genetic deletion of Acly in cultured adipocytes also suppressed acetyl-CoA and histone acetylation levels. In the liver, no significant effects on histone acetylation were observed with a HFD despite lower acetyl-CoA levels. Intriguingly, acetylation of several histone lysines correlated with the acetyl-CoA: (iso)butyryl-CoA ratio in liver. Butyryl-CoA and isobutyryl-CoA interacted with the acetyltransferase P300/CBP-associated factor (PCAF) in liver lysates and inhibited its activity in vitro. This study thus provides evidence that diet can impact tissue acyl-CoA and histone acetylation levels and that acetyl-CoA abundance correlates with acetylation of specific histone lysines in WAT but not in the liver.	[Carrer, Alessandro; Parris, Joshua L. D.; Trefely, Sophie; Torres, AnnMarie; Viola, John M.; Wellen, Kathryn E.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA; [Blair, Ian A.] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Trefely, Sophie; Snyder, Nathaniel W.] Drexel Univ, AJ Drexel Autism Inst, Philadelphia, PA 19104 USA; [Henry, Ryan A.; Kuo, Yin-Ming; Andrews, Andrew J.] Fox Chase Canc Ctr, Dept Canc Biol, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Montgomery, David C.; Meier, Jordan L.] NCI, Biol Chem Lab, Ctr Canc Res, NIH, Ft Detrick, MD 21702 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Drexel University; Fox Chase Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wellen, KE (corresponding author), Univ Penn, Perelman Sch Med, Dept Canc Biol, 421 Curie Blvd,BRB 2-2 Rm 653, Philadelphia, PA 19104 USA.	wellenk@exchange.upenn.edu	Trefely, Sophie/AAL-9434-2020; Carrer, Alessandro/AAE-8813-2020; Meier, Jordan/N-2608-2014	Carrer, Alessandro/0000-0002-9300-6879; Snyder, Nathaniel/0000-0001-5643-8747; Meier, Jordan/0000-0002-0537-7101; Trefely, Sophie/0000-0003-3816-6869	American Diabetes Association [7-12-JF-59]; Pancreatic Cancer Action Network-American Association; Abramson Cancer Center Basic Science Center; NCI, National Institutes of Health [R01CA174761, ZIABC011488]; National Institutes of Health [R21HD087866, K22ES26235]; Penn-PREP post-baccalaureate program; Penn-PORT IRACDA postdoctoral fellowship [K12 GM081259]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD087866] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016520, ZIABC011488, R01CA174761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES026235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102503, K12GM081259] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); Pancreatic Cancer Action Network-American Association; Abramson Cancer Center Basic Science Center; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn-PREP post-baccalaureate program; Penn-PORT IRACDA postdoctoral fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Diabetes Association Grant 7-12-JF-59, NCI, National Institutes of Health Grant R01CA174761, by a Pancreatic Cancer Action Network-American Association for Cancer Research career development award (to K. E. W.), by the Abramson Cancer Center Basic Science Center for Excellence in Cancer Metabolism (to K. E. W. and I. A. B.), by National Institutes of Health Grants R21HD087866 and K22ES26235 (to N. W. S.), and by NCI, National Institutes of Health Grant ZIABC011488-04 (to J. L. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the Penn-PREP post-baccalaureate program.; Supported by Penn-PORT IRACDA postdoctoral fellowship K12 GM081259.	Albaugh BN, 2011, CHEMBIOCHEM, V12, P290, DOI 10.1002/cbic.201000438; Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Carrer A, 2015, CURR OPIN BIOTECH, V34, P23, DOI 10.1016/j.copbio.2014.11.012; Chen WW, 2016, CELL, V166, P1324, DOI 10.1016/j.cell.2016.07.040; Cluntun AA, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0135-3; Covarrubias AJ, 2016, ELIFE, V5, DOI 10.7554/eLife.11612; Crider KS, 2012, ADV NUTR, V3, P21, DOI 10.3945/an.111.000992; Donohoe DR, 2012, MOL CELL, V48, P612, DOI 10.1016/j.molcel.2012.08.033; Etchegaray JP, 2016, MOL CELL, V62, P695, DOI 10.1016/j.molcel.2016.05.029; Evertts AG, 2013, J BIOL CHEM, V288, P12142, DOI 10.1074/jbc.M112.428318; Ezzati M, 2013, NEW ENGL J MED, V369, P954, DOI 10.1056/NEJMra1203528; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Frey AJ, 2016, ANAL BIOANAL CHEM, V408, P3651, DOI 10.1007/s00216-016-9448-5; FUKUDA H, 1992, EUR J BIOCHEM, V209, P217, DOI 10.1111/j.1432-1033.1992.tb17279.x; Gut P, 2013, NATURE, V502, P489, DOI 10.1038/nature12752; Henry RA, 2013, BIOCHEMISTRY-US, V52, P5746, DOI 10.1021/bi400684q; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Jiang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006884; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Krautkramer KA, 2016, MOL CELL, V64, P982, DOI 10.1016/j.molcel.2016.10.025; Kuo YM, 2014, METHODS, V70, P127, DOI 10.1016/j.ymeth.2014.08.003; Lee JV, 2014, CELL METAB, V20, P306, DOI 10.1016/j.cmet.2014.06.004; Liu XJ, 2015, MOL CELL PROTEOMICS, V14, P1489, DOI 10.1074/mcp.M114.044859; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Meier JL, 2013, ACS CHEM BIOL, V8, P2607, DOI 10.1021/cb400689r; Mentch SJ, 2015, CELL METAB, V22, P861, DOI 10.1016/j.cmet.2015.08.024; Montgomery DC, 2016, J AM CHEM SOC, V138, P6388, DOI 10.1021/jacs.6b03036; Montgomery DC, 2015, CHEM BIOL, V22, P1030, DOI 10.1016/j.chembiol.2015.06.015; Palladino AA, 2012, MOL GENET METAB, V107, P679, DOI 10.1016/j.ymgme.2012.10.007; Peleg S, 2016, EMBO REP, V17, P455, DOI 10.15252/embr.201541132; Peng M, 2016, SCIENCE, V354, P481, DOI 10.1126/science.aaf6284; Sabari BR, 2015, MOL CELL, V58, P203, DOI 10.1016/j.molcel.2015.02.029; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Snyder NW, 2015, ANAL BIOCHEM, V474, P59, DOI 10.1016/j.ab.2014.12.014; Stevens GA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-22; Su XY, 2016, CURR OPIN CHEM BIOL, V30, P52, DOI 10.1016/j.cbpa.2015.10.030; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Waterborg JH, 1998, J BIOL CHEM, V273, P27602, DOI 10.1074/jbc.273.42.27602; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Zhao S, 2016, CELL REP, V17, P1037, DOI 10.1016/j.celrep.2016.09.069	43	89	90	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3312	3322		10.1074/jbc.M116.750620	http://dx.doi.org/10.1074/jbc.M116.750620			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28077572	Green Published, hybrid			2022-12-26	WOS:000395538800022
J	Nguyen, TT; Savory, JGA; Brooke-Bisschop, T; Ringuette, R; Foley, T; Hess, BL; Mulatz, KJ; Trinkle-Mulcahy, L; Lohnes, D				Nguyen, Thinh T.; Savory, Joanne G. A.; Brooke-Bisschop, Travis; Ringuette, Randy; Foley, Tanya; Hess, Bradley L.; Mulatz, Kirk J.; Trinkle-Mulcahy, Laura; Lohnes, David			Cdx2 Regulates Gene Expression through Recruitment of Brg1-associated Switch-Sucrose Non-fermentable (SWI-SNF) Chromatin Remodeling Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ChiP; chromatin remodeling; intestine; MS; transcription; Brg1; SWI-SNF; Cdx; gene expression	QUANTITATIVE MASS-SPECTROMETRY; TRANSCRIPTION FACTOR CDX2; INTESTINAL STEM-CELLS; TUMOR-SUPPRESSOR; HOMEOBOX GENE; SWI/SNF COMPLEX; PRACTICAL GUIDE; HUMAN CANCER; HOX GENES; IN-VIVO	The packaging of genomic DNA into nucleosomes creates a barrier to transcription that can be relieved through ATP-dependent chromatin remodeling via complexes such as the switch-sucrose non-fermentable (SWI-SNF) chromatin remodeling complex. The SWI-SNF complex remodels chromatin via conformational or positional changes of nucleosomes, thereby altering the access of transcriptional machinery to target genes. The SWI-SNF complex has limited ability to bind to sequence-specific elements, and, therefore, its recruitment to target loci is believed to require interaction with DNA-associated transcription factors. The Cdx family of homeodomain transcript ion factors (Cdx1, Cdx2, and Cdx4) are essential for a number of developmental programs in the mouse. Cdx1 and Cdx2 also regulate intestinal homeostasis throughout life. Although a number of Cdx target genes have been identified, the basis by which Cdx members impact their transcription is poorly understood. We have found that Cdx members interact with the SWI-SNF complex and make direct contact with Brg1, a catalytic member of SWI-SNF. Both Cdx2 and Brg1 co-occupy a number of Cdx target genes, and both factors are necessary for transcriptional regulation of such targets. Finally, Cdx2 and Brg1 occupancy occurs coincident with chromatin remodeling at some of these loci. Taken together, our findings suggest that Cdx transcription factors regulate target gene expression, in part, through recruitment of Brg1-associated SWI-SNF chromatin remodeling activity.	[Nguyen, Thinh T.; Savory, Joanne G. A.; Brooke-Bisschop, Travis; Ringuette, Randy; Foley, Tanya; Hess, Bradley L.; Mulatz, Kirk J.; Trinkle-Mulcahy, Laura; Lohnes, David] Univ Ottawa, Dept Cellular & Mol Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada	University of Ottawa	Lohnes, D (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	dlohnes@uottawa.ca		Ringuette, Randy/0000-0002-7158-2904				Alexander JM, 2015, DEVELOPMENT, V142, P1418, DOI 10.1242/dev.109496; Aoyagi S, 2005, VITAM HORM, V70, P281, DOI 10.1016/S0083-6729(05)70009-1; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Beck F, 2010, BIOCHEM SOC T, V38, P353, DOI 10.1042/BST0380353; Beland M, 2004, MOL CELL BIOL, V24, P5028, DOI 10.1128/MCB.24.11.5028-5038.2004; Birchenough GMH, 2015, MUCOSAL IMMUNOL, V8, P712, DOI 10.1038/mi.2015.32; Bonhomme C, 2003, GUT, V52, P1465, DOI 10.1136/gut.52.10.1465; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Davidson AJ, 2006, DEV BIOL, V292, P506, DOI 10.1016/j.ydbio.2006.01.003; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Ferrier DEK, 2001, EVOL DEV, V3, P263, DOI 10.1046/j.1525-142x.2001.003004263.x; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Grainger S, 2012, DEV BIOL, V361, P1, DOI 10.1016/j.ydbio.2011.09.034; Grainger S, 2010, DEV BIOL, V339, P155, DOI 10.1016/j.ydbio.2009.12.025; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Holik AZ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004453; Holik AZ, 2013, STEM CELLS, V31, P2457, DOI 10.1002/stem.1498; Houle M., 2003, CDX HOMEODOMAIN PROT, P69; Hryniuk A, 2014, J BIOL CHEM, V289, P33343, DOI 10.1074/jbc.M114.583823; Hryniuk A, 2012, DEV BIOL, V363, P426, DOI 10.1016/j.ydbio.2012.01.010; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Kadoch C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500447; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lariviere N, 2014, J PROTEOME RES, V13, P3432, DOI 10.1021/pr500392m; Lee D, 2002, J BIOL CHEM, V277, P22330, DOI 10.1074/jbc.M111987200; Meier K, 2014, EPIGENETICS-US, V9, P1485, DOI 10.4161/15592294.2014.971580; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; Mudhasani R, 2005, MOL IMMUNOL, V42, P673, DOI 10.1016/j.molimm.2004.09.021; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Ohkawa Y, 2007, J BIOL CHEM, V282, P6564, DOI 10.1074/jbc.M608898200; Ohkawa Y, 2012, METHODS MOL BIOL, V798, P531, DOI 10.1007/978-1-61779-343-1_32; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Pilon N, 2006, DEV BIOL, V289, P55, DOI 10.1016/j.ydbio.2005.10.005; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Romero OA, 2012, EMBO MOL MED, V4, P603, DOI 10.1002/emmm.201200236; San Roman AK, 2015, STEM CELL REP, V5, P673, DOI 10.1016/j.stemcr.2015.09.006; Savory JGA, 2011, DEVELOPMENT, V138, P1361, DOI 10.1242/dev.056622; Savory JGA, 2009, DEVELOPMENT, V136, P4099, DOI 10.1242/dev.041582; Savory JGA, 2009, DEV BIOL, V330, P114, DOI 10.1016/j.ydbio.2009.03.016; Schenborn E T, 2000, Methods Mol Biol, V130, P135; Sif S, 2004, J CELL BIOCHEM, V91, P1087, DOI 10.1002/jcb.20005; Simmini S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6728; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; SUBRAMANIAN V, 1995, CELL, V83, P641, DOI 10.1016/0092-8674(95)90104-3; Subtil C, 2007, CANCER LETT, V247, P197, DOI 10.1016/j.canlet.2006.04.004; Takeuchi JK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1187; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Trinkle-Mulcahy L, 2012, PROTEOMICS, V12, P1623, DOI 10.1002/pmic.201100438; Trotter K., 2008, NUCL RECEPT SIGNAL, V6, P1, DOI DOI 10.1621/NRS.06004; Trotter KW, 2008, MOL CELL BIOL, V28, P1413, DOI 10.1128/MCB.01301-07; van den Akker E, 2002, DEVELOPMENT, V129, P2181; Verzi MP, 2011, MOL CELL BIOL, V31, P2026, DOI 10.1128/MCB.01250-10; Verzi MP, 2010, DEV CELL, V19, P713, DOI 10.1016/j.devcel.2010.10.006; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Wang K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010622; Wu S, 2014, CELL CYCLE, V13, P2869, DOI 10.4161/15384101.2014.946834; Yamamoto H, 2003, BIOCHEM BIOPH RES CO, V300, P813, DOI 10.1016/S0006-291X(02)02935-2; Young T, 2009, DEV CELL, V17, P516, DOI 10.1016/j.devcel.2009.08.010	64	10	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3389	3399		10.1074/jbc.M116.752774	http://dx.doi.org/10.1074/jbc.M116.752774			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28082674	hybrid, Green Published			2022-12-26	WOS:000395538800028
J	Cho, IT; Lim, Y; Golden, JA; Cho, G				Cho, Il-Taeg; Lim, Youngshin; Golden, Jeffrey A.; Cho, Ginam			Aristaless Related Homeobox (ARX) Interacts with beta-Catenin, BCL9, and P300 to Regulate Canonical Wnt Signaling	PLOS ONE			English	Article							INFANTILE SPASMS; TRANSCRIPTIONAL ACTIVATION; MENTAL-RETARDATION; GABAERGIC NEURONS; FLOOR PLATE; MOUSE MODEL; MUTATIONS; GENE; EXPRESSION; PHENOTYPES	Mutations in the Aristaless Related Homeobox (ARX) gene are associated with a spectrum of structural (lissencephaly) and functional (epilepsy and intellectual disabilities) neurodevelopmental disorders. How mutations in this single transcription factor can result in such a broad range of phenotypes remains poorly understood. We hypothesized that ARX functions through distinct interactions with specific transcription factors/cofactors to regulate unique target genes in different cell types. To identify ARX interacting proteins, we performed an unbiased proteomics screen and identified several components of the Wnt/beta-catenin signaling pathway, including beta-catenin (CTNNB1), B-cell CLL/lymphoma 9 (BCL9) and leucine rich repeat flightless interacting protein 2 (LRRFIP2), in cortical progenitor cells. Our data show that ARX positively regulates Wnt/beta-catenin signaling and that the C-terminal domain of ARX interacts with the armadillo repeats in beta-catenin to promote Wnt/beta-catenin signaling. In addition, we found BCL9 and P300 also interact with ARX to modulate Wnt/beta-catenin signaling. These data provide new insights into how ARX can uniquely regulate cortical neurogenesis, and connect the function of ARX with Wnt/beta-catenin signaling.	[Cho, Il-Taeg; Lim, Youngshin; Golden, Jeffrey A.; Cho, Ginam] Harvard Med Sch Boston, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Cho, G (corresponding author), Harvard Med Sch Boston, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA.	gpcho@bwh.harvard.edu	Lim, Youngshin/HGV-0369-2022	Lim, Youngshin/0000-0002-7842-3244; Golden, Jeffrey/0000-0001-9933-5502; Cho, Ginam/0000-0002-7262-8716	NIH [NS46616]; Ramzi Cotran Professor of Pathology Endowment, Harvard Medical School; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS100007] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ramzi Cotran Professor of Pathology Endowment, Harvard Medical School; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the NIH (NS46616 to J.A.G.) and the Ramzi Cotran Professor of Pathology Endowment, Harvard Medical School.	Buchman JJ, 2011, GENE DEV, V25, P1909, DOI 10.1101/gad.16830211; Cho G, 2014, DEV BIOL, V393, P137, DOI 10.1016/j.ydbio.2014.06.012; Cho G, 2009, J BIOL CHEM, V284, P19592, DOI 10.1074/jbc.M109.010181; Colasante G, 2008, J NEUROSCI, V28, P10674, DOI 10.1523/JNEUROSCI.1283-08.2008; Colasante G, 2015, CEREB CORTEX, V25, P322, DOI 10.1093/cercor/bht222; Colasante G, 2009, DEV BIOL, V334, P59, DOI 10.1016/j.ydbio.2009.07.014; Colombo E, 2004, DEV DYNAM, V231, P631, DOI 10.1002/dvdy.20164; Draganova K, 2015, STEM CELLS, V33, P170, DOI 10.1002/stem.1820; Durak O, 2015, MOL PSYCHIATR, V20, P388, DOI 10.1038/mp.2014.42; Friocourt G, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00004; Fulp CT, 2008, HUM MOL GENET, V17, P3740, DOI 10.1093/hmg/ddn271; Guerrini R, 2007, NEUROLOGY, V69, P427, DOI 10.1212/01.wnl.0000266594.16202.c1; Harrison-Uy SJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008094; Kato M, 2004, HUM MUTAT, V23, P147, DOI 10.1002/humu.10310; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Kitamura K, 2009, HUM MOL GENET, V18, P3708, DOI 10.1093/hmg/ddp318; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Lei QB, 2006, DEV CELL, V11, P325, DOI 10.1016/j.devcel.2006.06.013; Lim YS, 2015, ANN NEUROL, V78, P679, DOI 10.1002/ana.24488; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Marsh E, 2009, BRAIN, V132, P1563, DOI 10.1093/brain/awp107; Marsh ED, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0265-8; McKenzie O, 2007, NEUROSCIENCE, V146, P236, DOI 10.1016/j.neuroscience.2007.01.038; Miura H, 1997, MECH DEVELOP, V65, P99, DOI 10.1016/S0925-4773(97)00062-2; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Nasrallah MP, 2012, HUM MOL GENET, V21, P1090, DOI 10.1093/hmg/ddr538; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Olivetti PR, 2012, CURR OPIN NEUROBIOL, V22, P859, DOI 10.1016/j.conb.2012.04.006; Pollack AL, 1997, J CELL BIOL, V137, P1651, DOI 10.1083/jcb.137.7.1651; Price MG, 2009, J NEUROSCI, V29, P8752, DOI 10.1523/JNEUROSCI.0915-09.2009; Schuijers J, 2014, EMBO J, V33, P146, DOI 10.1002/embj.201385358; Shoubridge C, 2010, HUM MUTAT, V31, P889, DOI 10.1002/humu.21288; Simonet JC, 2015, CEREB CORTEX, V25, P2939, DOI 10.1093/cercor/bhu090; Stromme P, 2002, BRAIN DEV-JPN, V24, P266, DOI 10.1016/S0387-7604(02)00079-7; Sustmann C, 2008, MOL CELL BIOL, V28, P3526, DOI 10.1128/MCB.01986-07; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Valenta T, 2011, GENE DEV, V25, P2631, DOI 10.1101/gad.181289.111; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X	38	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170282	10.1371/journal.pone.0170282	http://dx.doi.org/10.1371/journal.pone.0170282			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103279	Green Published, Green Submitted, gold			2022-12-26	WOS:000392381100051
J	Weigt, SS; Wang, XY; Palchevskiy, V; Gregson, AL; Patel, N; DerHovanessian, A; Shino, MY; Sayah, DM; Birjandi, S; Lynch, JP; Saggar, R; Ardehali, A; Ross, DJ; Palmer, SM; Elashoff, D; Belperio, JA				Weigt, S. Samuel; Wang, Xiaoyan; Palchevskiy, Vyacheslav; Gregson, Aric L.; Patel, Naman; DerHovanessian, Ariss; Shino, Michael Y.; Sayah, David M.; Birjandi, Shirin; Lynch, Joseph P., III; Saggar, Rajan; Ardehali, Abbas; Ross, David J.; Palmer, Scott M.; Elashoff, David; Belperio, John A.			Gene Expression Profiling of Bronchoalveolar Lavage Cells Preceding a Clinical Diagnosis of Chronic Lung Allograft Dysfunction	PLOS ONE			English	Article							BRONCHIOLITIS OBLITERANS SYNDROME; SUPPORT VECTOR MACHINES; MINIMAL ACUTE REJECTION; PROBE LEVEL DATA; T-CELLS; TRANSPLANTATION; MICROARRAY; BIOINFORMATICS; CLASSIFICATION; NORMALIZATION	Background Chronic Lung Allograft Dysfunction (CLAD) is the main limitation to long-term survival after lung transplantation. Although CLAD is usually not responsive to treatment, earlier identification may improve treatment prospects. Methods In a nested case control study, 1-year post transplant surveillance bronchoalveolar lavage (BAL) fluid samples were obtained from incipient CLAD (n = 9) and CLAD free (n = 8) lung transplant recipients. Incipient CLAD cases were diagnosed with CLAD within 2 years, while controls were free from CLAD for at least 4 years following bronchoscopy. Transcription profiles in the BAL cell pellets were assayed with the HG-U133 Plus 2.0 microarray (Affymetrix). Differential gene expression analysis, based on an absolute fold change (incipient CLAD vs no CLAD) >2.0 and an unadjusted p-value <= 0.05, generated a candidate list containing 55 differentially expressed probe sets (51 up-regulated, 4 down-regulated). Results The cell pellets in incipient CLAD cases were skewed toward immune response pathways, dominated by genes related to recruitment, retention, activation and proliferation of cytotoxic lymphocytes (CD8(+) T-cells and natural killer cells). Both hierarchical clustering and a supervised machine learning tool were able to correctly categorize most samples (82.3% and 94.1% respectively) into incipient CLAD and CLAD-free categories. Conclusions These findings suggest that a pathobiology, similar to AR, precedes a clinical diagnosis of CLAD. A larger prospective investigation of the BAL cell pellet transcriptome as a biomarker for CLAD risk stratification is warranted.	[Weigt, S. Samuel; Wang, Xiaoyan; Palchevskiy, Vyacheslav; Gregson, Aric L.; Patel, Naman; DerHovanessian, Ariss; Shino, Michael Y.; Sayah, David M.; Birjandi, Shirin; Lynch, Joseph P., III; Saggar, Rajan; Ross, David J.; Elashoff, David; Belperio, John A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Ardehali, Abbas] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA; [Palmer, Scott M.] Duke Univ, Dept Med, Durham, NC USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Duke University		sweigt@mednet.ucla.edu		Palmer, Scott/0000-0002-1370-3771; Weigt, S. Samuel/0000-0001-5351-8936	National Institutes of Health [K23HL094746, R01HL112990, U01AI063594]; UCLA CTSI [UL1TR001881]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001881] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL138256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA CTSI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health grants K23HL094746 (PI: SSW), R01HL112990 (PI: JAB), U01AI063594 (PI: SMP, Co-PI JAP, Co-I SSW) and the UCLA CTSI UL1TR001881. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; BARBER EK, 1989, P NATL ACAD SCI USA, V86, P3277, DOI 10.1073/pnas.86.9.3277; Belperio JA, 2000, J IMMUNOL, V165, P461, DOI 10.4049/jimmunol.165.1.461; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Chakinala MM, 2005, J HEART LUNG TRANSPL, V24, P652, DOI 10.1016/j.healun.2004.04.002; Chen S, 2012, HUM IMMUNOL, V73, P456, DOI 10.1016/j.humimm.2012.02.018; Colombat M, 2005, HUM PATHOL, V36, P387, DOI 10.1016/j.humpath.2005.01.022; COOPER JD, 1993, J HEART LUNG TRANSPL, V12, P713; Copeland CAF, 2010, AM J RESP CRIT CARE, V182, P784, DOI 10.1164/rccm.201002-0211OC; Daniels MA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00617; Di Carlo E, 2007, AM J TRANSPLANT, V7, P201, DOI 10.1111/j.1600-6143.2006.01584.x; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibbons DL, 2011, J IMMUNOL, V187, P2067, DOI 10.4049/jimmunol.1100833; Gimino VJ, 2003, AM J RESP CRIT CARE, V168, P1237, DOI 10.1164/rccm.200305-644OC; Gregson AL, 2015, AM J RESP CRIT CARE, V192, P1490, DOI 10.1164/rccm.201503-0558OC; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hachem RR, 2005, TRANSPLANTATION, V80, P1406, DOI 10.1097/01.tp.0000181161.60638.fa; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang HL, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0463-x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kabanova S, 2009, INT J MED SCI, V6, P156; Kallies A, 2008, IMMUNOL CELL BIOL, V86, P325, DOI 10.1038/icb.2008.16; Khalifah AP, 2005, AM J TRANSPLANT, V5, P2022, DOI 10.1111/j.1600-6143.2005.00953.x; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Mosteller F., 1968, HDB SOC PSYCHOL, V2, P80; MUKHERJEE S, 2003, PRACTICAL APPROACH M, P166, DOI DOI 10.1007/0-306-47815-3_9; Onskog J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-390; Osinska E, 2014, J APPL GENET, V55, P383, DOI 10.1007/s13353-014-0213-1; Patil J, 2008, TRANSPLANTATION, V85, P224, DOI 10.1097/TP.0b013e318160268a; Pietra G, 2009, CURR PHARM DESIGN, V15, P3336, DOI 10.2174/138161209789105207; Plougastel BFM, 2006, CURR TOP MICROBIOL, V298, P77; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sato M, 2011, TRANSPLANTATION, V91, P1398, DOI 10.1097/TP.0b013e31821b2f7a; Shameli A, 2016, IMMUNOBIOLOGY, V221, P333, DOI 10.1016/j.imbio.2015.10.002; Steinmetz OM, 2005, KIDNEY INT, V67, P1616, DOI 10.1111/j.1523-1755.2005.00244.x; Stephenson Anne, 2005, Can Respir J, V12, P75; Team RC, 2015, LANG ENV STAT COMP V; Vapnik V., 1998, STAT LEARNING THEORY; Voskoboinik I, 2015, NAT REV IMMUNOL, V15, P388, DOI 10.1038/nri3839; Wallace WD, 2016, J HEART LUNG TRANSPL; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Weigt SS, 2008, AM J TRANSPLANT, V8, P1512, DOI 10.1111/j.1600-6143.2008.02280.x; Weigt SS, 2013, SEMIN RESP CRIT CARE, V34, P336, DOI 10.1055/s-0033-1348467	48	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0169894	10.1371/journal.pone.0169894	http://dx.doi.org/10.1371/journal.pone.0169894			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103284	Green Published, gold, Green Submitted			2022-12-26	WOS:000392381100028
J	Satterfield, DA; Altizer, S; Williams, MK; Hall, RJ				Satterfield, Dara A.; Altizer, Sonia; Williams, Mary-Kate; Hall, Richard J.			Environmental Persistence Influences Infection Dynamics for a Butterfly Pathogen	PLOS ONE			English	Article							PROTOZOAN PARASITE; OPHRYOCYSTIS-ELEKTROSCIRRHA; VERTICAL TRANSMISSION; NATURAL-POPULATIONS; NORTH-AMERICA; PLEXIPPUS L; MONARCH; VIRULENCE; LEPIDOPTERA; MIGRATION	Many pathogens, including those infecting insects, are transmitted via dormant stages shed into the environment, where they must persist until encountering a susceptible host. Understanding how abiotic conditions influence environmental persistence and how these factors influence pathogen spread are crucial for predicting patterns of infection risk. Here, we explored the consequences of environmental transmission for infection dynamics of a debilitating protozoan parasite (Ophryocystis elektroscirrha) that infects monarch butterflies (Danaus plexippus). We first conducted an experiment to observe the persistence of protozoan spores exposed to natural conditions. Experimental results showed that, contrary to our expectations, pathogen doses maintained high infectivity even after 16 days in the environment, although pathogens did yield infections with lower parasite loads after environmental exposure. Because pathogen longevity exceeded the time span of our experiment, we developed a mechanistic model to better explore environmental persistence for this host-pathogen system. Model analysis showed that, in general, longer spore persistence led to higher infection prevalence and slightly smaller monarch population sizes. The model indicated that typical parasite doses shed onto milkweed plants must remain viable for a minimum of 3 weeks for prevalence to increase during the summer-breeding season, and for 11 weeks or longer to match levels of infection commonly reported from the wild, assuming moderate values for parasite shedding rate. Our findings showed that transmission stages of this butterfly pathogen are long-lived and indicated that this is a necessary condition for the protozoan to persist in local monarch populations. This study provides a modeling framework for future work examining the dynamics of an ecologically important pathogen in an iconic insect.	[Satterfield, Dara A.; Altizer, Sonia; Hall, Richard J.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Williams, Mary-Kate] Univ Arkansas Little Rock, Biol Sci, Little Rock, AR USA; [Hall, Richard J.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA USA	University System of Georgia; University of Georgia; University of Arkansas System; University of Arkansas Little Rock; University System of Georgia; University of Georgia	Satterfield, DA (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.	satterfieldd@si.edu	Satterfield, Dara/N-4484-2017	Satterfield, Dara/0000-0003-3036-5580	National Science Foundation [DBI-1156707]; University of Georgia; National Science Foundation Graduate Research Fellowship Program	National Science Foundation(National Science Foundation (NSF)); University of Georgia; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF))	This work was conducted as a part of the Population Biology of Infectious Diseases REU Site, a program funded by the National Science Foundation (Grant #DBI-1156707) and the University of Georgia. Additional support was provided to DS through the National Science Foundation Graduate Research Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2015, MONARCHS CHANGING WO; Altizer SM, 2004, MONARCH BUTTERFLY BIOLOGY AND CONSERVATION, P203; Altizer SM, 1997, P ROY SOC B-BIOL SCI, V264, P807, DOI 10.1098/rspb.1997.0113; Altizer SM, 1999, J INVERTEBR PATHOL, V74, P76, DOI 10.1006/jipa.1999.4853; Altizer SM, 2000, ECOL ENTOMOL, V25, P125, DOI 10.1046/j.1365-2311.2000.00246.x; Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401; ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005; [Anonymous], 2014, R LANG ENV STAT COMP; Bartel RA, 2011, ECOLOGY, V92, P342, DOI 10.1890/10-0489.1; Bradley CA, 2005, ECOL LETT, V8, P290, DOI 10.1111/j.1461-0248.2005.00722.x; Breban R, 2013, J MATH BIOL, V66, P535, DOI 10.1007/s00285-012-0520-2; Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; Briggs CJ, 1996, THEOR POPUL BIOL, V50, P149, DOI 10.1006/tpbi.1996.0027; BRIGGS CJ, 1995, AM NAT, V145, P855, DOI 10.1086/285774; Brower LP, 2012, INSECT CONSERV DIVER, V5, P95, DOI 10.1111/j.1752-4598.2011.00142.x; BROWER LP, 1991, AM ZOOL, V31, P265; de Roode JC, 2007, PARASITOLOGY, V134, P657, DOI 10.1017/S0031182006002009; de Roode JC, 2008, P NATL ACAD SCI USA, V105, P7489, DOI 10.1073/pnas.0710909105; de Roode JC, 2010, EVOLUTION, V64, P502, DOI 10.1111/j.1558-5646.2009.00845.x; de Roode JC, 2009, OECOLOGIA, V161, P67, DOI 10.1007/s00442-009-1361-6; DOBSON AP, 1992, J ANIM ECOL, V61, P487, DOI 10.2307/5339; DWYER G, 1994, AM NAT, V143, P533, DOI 10.1086/285619; FINE PEM, 1975, ANN NY ACAD SCI, V266, P173, DOI 10.1111/j.1749-6632.1975.tb35099.x; Flockhart DTT, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1087; Fuller E, 2012, AM NAT, V179, pE70, DOI 10.1086/664488; Graystock P, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1371; HOCHBERG ME, 1989, NATURE, V337, P262, DOI 10.1038/337262a0; HOCHBERG ME, 1991, NATURE, V352, P16, DOI 10.1038/352016a0; Kaya, 1993, INSECT PATHOLOGY; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; MALCOLM SB, 1993, NAT HIS LOS-SERIES, P253; MCLAUGHLIN RE, 1970, J PROTOZOOL, V17, P300, DOI 10.1111/j.1550-7408.1970.tb02375.x; Mordecai EA, 2013, ECOL LETT, V16, P22, DOI 10.1111/ele.12015; Oberhauser K. S., 2004, MONARCH BUTTERFLY BI; Pasteur L., 1870, ETUDES MALADIE VERS, VII; Pasteur L., 1870, ETUDES MALADIE VERS, V1; Pleasants JM, 2013, INSECT CONSERV DIVER, V6, P135, DOI 10.1111/j.1752-4598.2012.00196.x; Sander Sarah E., 2013, Insects, V4, P447, DOI 10.3390/insects4030447; Satterfield DA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1734; Sauvage F, 2003, J ANIM ECOL, V72, P1, DOI 10.1046/j.1365-2656.2003.00675.x; Shapiro-Ilan DI, 2012, INSECT PATHOLOGY, 2ND EDITION, P29, DOI 10.1016/B978-0-12-384984-7.00003-8; THOMPSON CG, 1981, ENVIRON ENTOMOL, V10, P254, DOI 10.1093/ee/10.2.254; URQUHART FA, 1978, CAN J ZOOL, V56, P1759, DOI 10.1139/z78-240; Vega FE, 2012, INSECT PATHOLOGY, 2ND EDITION, P1; Vidal O, 2014, BIOL CONSERV, V180, P165, DOI 10.1016/j.biocon.2014.09.041	45	14	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0169982	10.1371/journal.pone.0169982	http://dx.doi.org/10.1371/journal.pone.0169982			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099501	Green Published, Green Submitted, gold			2022-12-26	WOS:000392380100047
J	Blais, A; Drouin, G; Chaumontet, C; Voisin, T; Couvelard, A; Even, PC; Couvineau, A				Blais, Anne; Drouin, Gaetan; Chaumontet, Catherine; Voisin, Thierry; Couvelard, Anne; Even, Patrick Christian; Couvineau, Alain			Impact of Orexin-A Treatment on Food Intake, Energy Metabolism and Body Weight in Mice	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; INDIRECT CALORIMETRY; PERIPHERAL-TISSUES; RECEPTOR OX1R; COLON-CANCER; RATS; APOPTOSIS; EXPRESSION; NEURONS; OBESITY	Orexin-A and -B are hypothalamic neuropeptides of 33 and 28-amino acids, which regulate many homeostatic systems including sleep/wakefulness states, energy balance, energy homeostasis, reward seeking and drug addiction. Orexin-A treatment was also shown to reduce tumor development in xenografted nude mice and is thus a potential treatment for carcinogenesis. The aim of this work was to explore in healthy mice the consequences on energy expenditure components of an orexin-A treatment at a dose previously shown to be efficient to reduce tumor development. Physiological approaches were used to evaluate the effect of orexin-A on food intake pattern, energy metabolism body weight and body adiposity. Modulation of the expression of brain neuropeptides and receptors including NPY, POMC, AgRP, cocaine-and amphetamine related transcript (CART), corticotropin-releasing hormone (CRH) and prepro-orexin (HCRT), and Y-2 and Y-5 neuropeptide Y, MC4 (melanocortin), OX1 and OX2 orexin receptors (Y2R, Y5R, MC4R, OX1R and OX2R, respectively) was also explored. Our results show that orexin-A treatment does not significantly affect the components of energy expenditure, and glucose metabolism but reduces intraperitoneal fat deposit, adiposity and the expression of several brain neuropeptide receptors suggesting that peripheral orexin-A was able to reach the central nervous system. These findings establish that orexin-A treatment which is known for its activity as an inducer of tumor cell death, do have minor parallel consequence on energy homeostasis control.	[Blais, Anne; Drouin, Gaetan; Chaumontet, Catherine; Even, Patrick Christian] Univ Paris Saclay, UMR Physiol Nutr & Comportement Alimentaire, AgroParisTech, INRA, Paris, France; [Voisin, Thierry; Couvelard, Anne; Couvineau, Alain] Paris Diderot Univ, Fac Med, INSERM U1149, Inflammat Res Ctr CRI,DHU UNITY, Site Bichat,16 Rue H Huchard, Paris, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Blais, A (corresponding author), Univ Paris Saclay, UMR Physiol Nutr & Comportement Alimentaire, AgroParisTech, INRA, Paris, France.	blais@agroparistech.fr	couvineau, alain/G-3641-2013; voisin, thierry/R-1241-2017; couvineau, alain/T-3466-2019; Drouin, Gaetan/A-2661-2019	couvineau, alain/0000-0003-2912-5168; voisin, thierry/0000-0002-4320-5183; couvineau, alain/0000-0003-2912-5168; Drouin, Gaetan/0000-0001-8855-1525; Anne, Couvelard/0000-0002-6316-1210	INRA; INSERM / Inflammation Research Center (CRI) [U1149]; Institut National du Cancer (INCA) [2013-213]; Ligue contre le Cancer [RS 12/75-64]	INRA; INSERM / Inflammation Research Center (CRI); Institut National du Cancer (INCA)(Institut National du Cancer (INCA) France); Ligue contre le Cancer(Ligue nationale contre le cancer)	This study was supported by INRA and INSERM U1149/ The Inflammation Research Center (CRI), The Institut National du Cancer (INCA) (Translational project N 2013-213) and the Ligue contre le Cancer (RS 12/75-64).	Acuna-Goycolea C, 2009, J NEUROSCI, V29, P1503, DOI 10.1523/JNEUROSCI.5147-08.2009; Alexandre D, 2014, EUR J CANCER, V50, P2126, DOI 10.1016/j.ejca.2014.05.008; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Chaumontet C, 2015, BRIT J NUTR, V114, P1132, DOI 10.1017/S000711451500238X; Dhuria SV, 2016, NEUROSCI LETT, V627, P155, DOI 10.1016/j.neulet.2016.05.053; Digby JE, 2006, J ENDOCRINOL, V191, P129, DOI 10.1677/joe.1.06886; Ducroc R, 2007, DIABETES, V56, P2494, DOI 10.2337/db07-0614; Ehrstrom M, 2005, REGUL PEPTIDES, V132, P9, DOI 10.1016/j.regpep.2005.07.005; Ehrstrom M, 2005, J CLIN ENDOCR METAB, V90, P2370, DOI 10.1210/jc.2004-1408; Ehrstrom M, 2004, REGUL PEPTIDES, V119, P209, DOI 10.1016/j.regpep.2004.02.004; El Firar A, 2009, FASEB J, V23, P4069, DOI 10.1096/fj.09-131367; Even PC, 2012, AM J PHYSIOL-REG I, V303, pR459, DOI 10.1152/ajpregu.00137.2012; EVEN PC, 1994, NEUROSCI BIOBEHAV R, V18, P435, DOI 10.1016/0149-7634(94)90056-6; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; Flores A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00256; Fujiki N, 2006, PEPTIDES, V27, P2326, DOI 10.1016/j.peptides.2006.03.011; Gao XB, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00142; Hao Y, 2016, EAT WEIGHT DISORD-ST, P1; Hara J, 2005, NEUROSCI LETT, V380, P239, DOI 10.1016/j.neulet.2005.01.046; Heinonen MV, 2008, ACTA PHYSIOL, V192, P471, DOI 10.1111/j.1748-1716.2008.01836.x; Karnani MM, 2011, NEURON, V72, P616, DOI 10.1016/j.neuron.2011.08.027; Kastin AJ, 1999, J PHARMACOL EXP THER, V289, P219; Kukkonen JP, 2014, BRIT J PHARMACOL, V171, P314, DOI 10.1111/bph.12324; Laburthe M, 2010, ACTA PHYSIOL, V198, P393, DOI 10.1111/j.1748-1716.2009.02035.x; Laburthe M, 2012, BRIT J PHARMACOL, V165, P1678, DOI 10.1111/j.1476-5381.2011.01510.x; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Levin BE, 1997, AM J PHYSIOL-REG I, V273, pR725, DOI 10.1152/ajpregu.1997.273.2.R725; Liu YY, 2015, INT J MOL MED, V35, P539, DOI 10.3892/ijmm.2014.2038; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; Nicole P, 2015, BRIT J PHARMACOL, V172, P5211, DOI 10.1111/bph.13287; Nixon J. P., 2012, HDB EXP PHARM, V209, P77, DOI DOI 10.1007/978-3-642-24716-3_4; Nixon JP, 2015, AGEING RES REV, V20, P63, DOI 10.1016/j.arr.2014.11.001; Nowak KW, 2005, INT J MOL MED, V15, P969; Peltonen HM, 2009, BIOCHEM BIOPH RES CO, V385, P408, DOI 10.1016/j.bbrc.2009.05.077; Perez-Leighton CE, 2013, INT J OBESITY, V37, P167, DOI 10.1038/ijo.2012.30; Rhyne DN, 2015, THER ADV DRUG SAF, V6, P189, DOI 10.1177/2042098615595359; Rouet-Benzineb P, 2004, J BIOL CHEM, V279, P45875, DOI 10.1074/jbc.M404136200; Sakamoto F, 2004, REGUL PEPTIDES, V118, P183, DOI 10.1016/j.regpep.2003.12.014; Switonska MM, 2002, REGUL PEPTIDES, V104, P69, DOI 10.1016/S0167-0115(01)00350-0; Takahashi K, 2015, PEPTIDES, V72, P184, DOI 10.1016/j.peptides.2015.04.004; Teske JA, 2006, AM J PHYSIOL-REG I, V291, pR889, DOI 10.1152/ajpregu.00536.2005; Tsunematsu T, 2012, VITAM HORM, V89, P19, DOI 10.1016/B978-0-12-394623-2.00002-0; van den Top M, 2003, J PHYSIOL-LONDON, V549, P809, DOI 10.1113/jphysiol.2002.033290; Voisin T, 2008, FASEB J, V22, P1993, DOI 10.1096/fj.07-098723; Voisin T, 2011, CANCER RES, V71, P3341, DOI 10.1158/0008-5472.CAN-10-3473; Yamada H, 2000, BIOCHEM BIOPH RES CO, V267, P527, DOI 10.1006/bbrc.1999.1998; Yamanaka A, 1999, BRAIN RES, V849, P248, DOI 10.1016/S0006-8993(99)01905-8	47	19	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0169908	10.1371/journal.pone.0169908	http://dx.doi.org/10.1371/journal.pone.0169908			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085909	Green Published, Green Submitted, gold			2022-12-26	WOS:000391972600043
J	Bahrndorff, S; de Jonge, N; Skovgard, H; Nielsen, JL				Bahrndorff, Simon; de Jonge, Nadieh; Skovgard, Henrik; Nielsen, Jeppe Lund			Bacterial Communities Associated with Houseflies (Musca domestica L.) Sampled within and between Farms	PLOS ONE			English	Article							EARLY-PHASE TRANSMISSION; GUT MICROBIOTA; PATHOGENIC MICROORGANISMS; CAMPYLOBACTER-JEJUNI; WOLBACHIA INFECTION; PLAGUE EPIZOOTICS; VECTOR COMPETENCE; LIFE STAGES; DIPTERA; DIVERSITY	The housefly feeds and reproduces in animal manure and decaying organic substances and thus lives in intimate association with various microorganisms including human pathogens. In order to understand the variation and association between bacteria and the housefly, we used 16S rRNA gene amplicon sequencing to describe bacterial communities of 90 individual houseflies collected within and between ten dairy farms in Denmark. Analysis of gene sequences showed that the most abundant classes of bacteria found across all sites included Bacilli, Clostridia, Actinobacteria, Flavobacteria, and all classes of Proteobacteria and at the genus level the most abundant genera included Corynebacterium, Lactobacillus, Staphylococcus, Vagococcus, Weissella, Lactococcus, and Aerococcus. Comparison of the microbiota of houseflies revealed a highly diverse microbiota compared to other insect species and with most variation in species richness and diversity found between individuals, but not locations. Our study is the first in-depth amplicon sequencing study of the housefly microbiota, and collectively shows that the microbiota of single houseflies is highly diverse and differs between individuals likely to reflect the lifestyle of the housefly. We suggest that these results should be taken into account when addressing the transmission of pathogens by the housefly and assessing the vector competence variation under natural conditions.	[Bahrndorff, Simon; de Jonge, Nadieh; Nielsen, Jeppe Lund] Aalborg Univ, Dept Chem & Biosci, Aalborg, Denmark; [Skovgard, Henrik] Univ Aarhus, Dept Agroecol, Slagelse, Denmark	Aalborg University; Aarhus University	Bahrndorff, S (corresponding author), Aalborg Univ, Dept Chem & Biosci, Aalborg, Denmark.	sba@bio.aau.dk	Nielsen, Jeppe Lund/V-1762-2018	Nielsen, Jeppe Lund/0000-0002-8747-6938; Bahrndorff, Simon/0000-0002-0838-4008	Danish Council for Independent Research [11-116256]; Aalborg Zoo Conservation Foundation (AZCF)	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Aalborg Zoo Conservation Foundation (AZCF)	This work was supported by the Danish Council for Independent Research (grant number 11-116256) and the Aalborg Zoo Conservation Foundation (AZCF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy E, 2014, APPL ENVIRON MICROB, V80, P4301, DOI 10.1128/AEM.00079-14; Albertsen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132783; Alexander J, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2197; Azambuja P, 2005, TRENDS PARASITOL, V21, P568, DOI 10.1016/j.pt.2005.09.011; Bahrndorff S, 2014, J MED ENTOMOL, V51, P670, DOI 10.1603/ME13220; Bahrndorff S, 2016, INT J GENOMICS, V2016, DOI 10.1155/2016/5304028; Bahrndorff S, 2013, EMERG INFECT DIS, V19, P425, DOI 10.3201/eid1903.111593; Bahrndorff S, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.7101; Beerntsen BT, 2000, MICROBIOL MOL BIOL R, V64, P115, DOI 10.1128/MMBR.64.1.115-137.2000; Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bosio CF, 1998, AM J TROP MED HYG, V59, P965, DOI 10.4269/ajtmh.1998.59.965; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; CHAO A, 1984, SCAND J STAT, V11, P265; Cirimotich CM, 2011, CELL HOST MICROBE, V10, P307, DOI 10.1016/j.chom.2011.09.006; COHEN D, 1991, LANCET, V337, P993, DOI 10.1016/0140-6736(91)92657-N; de Menezes AB, 2011, FEMS MICROBIOL ECOL, V78, P256, DOI 10.1111/j.1574-6941.2011.01151.x; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Durand AA, 2015, SCI REP-UK, V5, DOI 10.1038/srep17190; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Eisen RJ, 2006, P NATL ACAD SCI USA, V103, P15380, DOI 10.1073/pnas.0606831103; Forster M, 2009, J MED ENTOMOL, V46, P1164, DOI 10.1603/033.046.0526; FOTEDAR R, 1992, J HOSP INFECT, V20, P209, DOI 10.1016/0195-6701(92)90089-5; Graczyk TK, 2001, MICROBES INFECT, V3, P231, DOI 10.1016/S1286-4579(01)01371-5; Greenberg B, 1973, FLIES AND DIS, V2; Gupta AK, 2014, MED VET ENTOMOL, V28, P345, DOI 10.1111/mve.12054; Gupta AK, 2012, FEMS MICROBIOL ECOL, V79, P581, DOI 10.1111/j.1574-6941.2011.01248.x; Hald B, 2008, POULTRY SCI, V87, P1428, DOI 10.3382/ps.2007-00301; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Holt PS, 2007, APPL ENVIRON MICROB, V73, P6030, DOI 10.1128/AEM.00803-07; Jones RT, 2010, ISME J, V4, P223, DOI 10.1038/ismej.2009.111; Kautz S, 2013, APPL ENVIRON MICROB, V79, P525, DOI 10.1128/AEM.03107-12; Kjaersgaard A, 2015, ANIM BEHAV, V99, P123, DOI 10.1016/j.anbehav.2014.11.003; Kobayashi M, 1999, AM J TROP MED HYG, V61, P625, DOI 10.4269/ajtmh.1999.61.625; Lam K, 2010, J CHEM ECOL, V36, P141, DOI 10.1007/s10886-010-9741-2; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMeniman CJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000748; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Meister S, 2005, P NATL ACAD SCI USA, V102, P11420, DOI 10.1073/pnas.0504950102; Minard G, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00059; Morrow JL, 2015, MICROB ECOL, V70, P498, DOI 10.1007/s00248-015-0571-1; Murdock CC, 2012, NAT REV MICROBIOL, V10, P869, DOI 10.1038/nrmicro2900; Nazni W.A., 2005, Tropical Biomedicine, V22, P53; Osei-Poku J, 2012, MOL ECOL, V21, P5138, DOI 10.1111/j.1365-294X.2012.05759.x; Pie MR, 2004, J THEOR BIOL, V226, P45, DOI 10.1016/j.jtbi.2003.08.002; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Singh B, 2015, APPL MICROBIOL BIOT, V99, P869, DOI 10.1007/s00253-014-6115-7; Staubach F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070749; Stevens L, 2001, ANNU REV ECOL SYST, V32, P519, DOI 10.1146/annurev.ecolsys.32.081501.114132; Su ZJ, 2010, J ECON ENTOMOL, V103, P1832, DOI 10.1603/EC10142; Thomsen M, 1938, STUENFLUEN MUSCA DOM, P176; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; Ward DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049582; WATSON DW, 1993, J MED ENTOMOL, V30, P820, DOI 10.1093/jmedent/30.4.820; Wei T, 2014, APPL MICROBIOL BIOT, V98, P4197, DOI 10.1007/s00253-013-5498-1; Wei T, 2013, APPL MICROBIOL BIOT, V97, P1775, DOI 10.1007/s00253-012-4024-1; Weiss B, 2011, TRENDS PARASITOL, V27, P514, DOI 10.1016/j.pt.2011.05.001; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilder AP, 2008, ECOHEALTH, V5, P205, DOI 10.1007/s10393-008-0165-1; Wilder AP, 2008, VECTOR-BORNE ZOONOT, V8, P359, DOI 10.1089/vbz.2007.0181; Zheng LY, 2013, J MED ENTOMOL, V50, P647, DOI 10.1603/ME12199; Zurek L, 2000, J MED ENTOMOL, V37, P924, DOI 10.1603/0022-2585-37.6.924	72	47	50	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169753	10.1371/journal.pone.0169753	http://dx.doi.org/10.1371/journal.pone.0169753			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081167	Green Published, gold, Green Submitted			2022-12-26	WOS:000391949500071
J	Ben-Lulu, S; Ziv, T; Weisman-Shomer, P; Benhar, M				Ben-Lulu, Shani; Ziv, Tamar; Weisman-Shomer, Pnina; Benhar, Moran			Nitrosothiol-Trapping-Based Proteomic Analysis of S-Nitrosylation in Human Lung Carcinoma Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; EPITHELIAL-CELLS; PROTEIN DENITROSYLATION; THIOREDOXIN SYSTEM; CANCER-CELLS; EXPRESSION; DISEASE; TARGET; ROLES; QUANTIFICATION	Nitrosylation of cysteines residues (S-nitrosylation) mediates many of the cellular effects of nitric oxide in normal and diseased cells. Recent research indicates that S-nitrosylation of certain proteins could play a role in tumor progression and responsiveness to therapy. However, the protein targets of S-nitrosylation in cancer cells remain largely unidentified. In this study, we used our recently developed nitrosothiol trapping approach to explore the nitroso-proteome of human A549 lung carcinoma cells treated with S-nitrosocysteine or pro-inflammatory cytokines. Using this approach, we identified about 300 putative nitrosylation targets in S-nitrosocysteine-treated A549 cells and approximately 400 targets in cytokine-stimulated cells. Among the more than 500 proteins identified in the two screens, the majority represent novel targets of S-nitrosylation, as revealed by comparison with publicly available nitrosoproteomic data. By coupling the trapping procedure with differential thiol labeling, we identified nearly 300 potential nitrosylation sites in about 150 proteins. The proteomic results were validated for several proteins by an independent approach. Bioinformatic analysis highlighted important cellular pathways that are targeted by S-nitrosylation, notably, cell cycle and inflammatory signaling. Taken together, our results identify new molecular targets of nitric oxide in lung cancer cells and suggest that S-nitrosylation may regulate signaling pathways that are critically involved in lung cancer progression.	[Ben-Lulu, Shani; Ziv, Tamar] Technion Israel Inst Technol, Smoler Prote Ctr, IL-31096 Haifa, Israel; [Ben-Lulu, Shani; Ziv, Tamar] Technion Israel Inst Technol, Fac Biol, IL-31096 Haifa, Israel; [Weisman-Shomer, Pnina; Benhar, Moran] Technion Israel Inst Technol, Rappaport Fac Med, Dept Biochem, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Benhar, M (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Dept Biochem, IL-31096 Haifa, Israel.	benhar@tx.technion.ac.il	Benhar, Moran/AAV-5764-2020	Benhar, Moran/0000-0002-7094-3456; Ziv, Tamar/0000-0003-4299-7454	Israel Science Foundation [1336/10]; Israel Cancer Association; Israel Cancer Research Foundation	Israel Science Foundation(Israel Science Foundation); Israel Cancer Association; Israel Cancer Research Foundation	This work was supported by grants from the Israel Science Foundation (1336/10), the Israel Cancer Association and the Israel Cancer Research Foundation (to M.B.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda E, 2012, CURR MOL MED, V12, P50, DOI 10.2174/156652412798376099; Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; ASANO K, 1994, P NATL ACAD SCI USA, V91, P10089, DOI 10.1073/pnas.91.21.10089; Azad N, 2008, J TOXICOL ENV HEAL B, V11, P1, DOI 10.1080/10937400701436460; Ben-Lulu S, 2014, MOL CELL PROTEOMICS, V13, P2573, DOI 10.1074/mcp.M114.038166; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Benhar M, 2016, CURR MED CHEM, V23, P2602, DOI 10.2174/0929867323666160627114839; Benhar M, 2016, J CLIN INVEST, V126, P1630, DOI 10.1172/JCI85339; Benhar M, 2015, BBA-GEN SUBJECTS, V1850, P2476, DOI 10.1016/j.bbagen.2015.09.010; Benhar M, 2010, BIOCHEMISTRY-US, V49, P6963, DOI 10.1021/bi100619k; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Burke AJ, 2013, CARCINOGENESIS, V34, P503, DOI 10.1093/carcin/bgt034; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Chen YJ, 2014, J PROTEOME RES, V13, P4942, DOI 10.1021/pr5002675; Chen YJ, 2014, NUCL ACIDS RES; Collins BJ, 2004, SEMIN CANCER BIOL, V14, P357, DOI 10.1016/j.semcancer.2004.04.015; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Donnelly LE, 2002, AM J RESP CELL MOL, V26, P144, DOI 10.1165/ajrcmb.26.1.4477; Engelman R, 2016, FREE RADICAL BIO MED, V97, P375, DOI 10.1016/j.freeradbiomed.2016.06.032; Eriksson SE, 2009, FREE RADICAL BIO MED, V47, P1661, DOI 10.1016/j.freeradbiomed.2009.09.016; Forrester MT, 2009, FREE RADICAL BIO MED, V46, P119, DOI 10.1016/j.freeradbiomed.2008.09.034; Foster MW, 2012, BBA-GEN SUBJECTS, V1820, P675, DOI 10.1016/j.bbagen.2011.03.013; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Gould N, 2013, J BIOL CHEM, V288, P26473, DOI 10.1074/jbc.R113.460261; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Huerta S, 2008, INT J ONCOL, V33, P909, DOI 10.3892/ijo_00000079; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jia J, 2014, CELL, V159, P623, DOI 10.1016/j.cell.2014.09.032; Kakolyris S, 2001, CLIN CANCER RES, V7, P3087; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim J, 2014, ANTIOXID REDOX SIGN, V20, P2514, DOI 10.1089/ars.2013.5223; Kisley LR, 2002, CANCER RES, V62, P6850; Kumar S, 2010, FREE RADICAL BIO MED, V48, P851, DOI 10.1016/j.freeradbiomed.2010.01.004; Kwon S, 1999, NITRIC OXIDE-BIOL CH, V3, P348, DOI 10.1006/niox.1999.0242; Lander HM, 1997, J BIOL CHEM, V272, P4323, DOI 10.1074/jbc.272.7.4323; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; Liu CY, 1998, BRIT J CANCER, V78, P534, DOI 10.1038/bjc.1998.528; Lopez-Sanchez LM, 2014, MASS SPECTROM REV, V33, P7, DOI 10.1002/mas.21373; Lopez-Sanchez LM, 2010, ANTICANCER RES, V30, P415; Maciag AE, 2011, J PHARMACOL EXP THER, V336, P313, DOI 10.1124/jpet.110.174904; Marshall HE, 2001, BIOCHEMISTRY-US, V40, P1688, DOI 10.1021/bi002239y; Martin-Bernabe A, 2014, J PROTEOME RES, V13, P4695, DOI 10.1021/pr500327v; Murillo-Carretero M, 2009, FREE RADICAL BIO MED, V46, P471, DOI 10.1016/j.freeradbiomed.2008.10.048; Muroya M, 2012, BIOSCI TRENDS, V6, P70, DOI 10.5582/bst.2012.v6.2.70; Powis G, 2007, CURR OPIN PHARMACOL, V7, P392, DOI 10.1016/j.coph.2007.04.003; Qin Y, 2013, CANCER RES, V73, P6690, DOI 10.1158/0008-5472.CAN-13-1042; Raju K, 2012, BBA-GEN SUBJECTS, V1820, P684, DOI 10.1016/j.bbagen.2011.05.009; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Sengupta R, 2012, BBA-GEN SUBJECTS, V1820, P689, DOI 10.1016/j.bbagen.2011.08.012; Soini Y, 2001, CLIN CANCER RES, V7, P1750; Switzer CH, 2012, MOL CANCER RES, V10, P1203, DOI 10.1158/1541-7786.MCR-12-0124; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tsang AHK, 2009, P NATL ACAD SCI USA, V106, P4900, DOI 10.1073/pnas.0810595106; Wang ZQ, 2012, CANCER LETT, V320, P123, DOI 10.1016/j.canlet.2012.03.009; Wei W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000328; Wink DA, 1998, CARCINOGENESIS, V19, P711, DOI 10.1093/carcin/19.5.711; Wu CG, 2011, J PROTEOMICS, V74, P2498, DOI 10.1016/j.jprot.2011.06.001; Xu WM, 2002, CELL RES, V12, P311, DOI 10.1038/sj.cr.7290133	59	18	18	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169862	10.1371/journal.pone.0169862	http://dx.doi.org/10.1371/journal.pone.0169862			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081246	Green Published, gold, Green Submitted			2022-12-26	WOS:000391949500092
J	Withers, GS; Farley, JR; Sterritt, JR; Crane, AB; Wallace, CS				Withers, Ginger S.; Farley, Jennifer R.; Sterritt, Jeffrey R.; Crane, Andres B.; Wallace, Christopher S.			Interactions with Astroglia Influence the Shape of the Developing Dendritic Arbor and Restrict Dendrite Growth Independent of Promoting Synaptic Contacts	PLOS ONE			English	Article							HIPPOCAMPAL-NEURONS; SYNAPTOGENESIS; GLIA; ASTROCYTES; EXPRESSION; PLASTICITY; FORM	Astroglia play key roles in the development of neurons, ranging from regulating neuron survival to promoting synapse formation, yet basic questions remain about whether astrocytes might be involved in forming the dendritic arbor. Here, we used cultured hippocampal neurons as a simple in vitro model that allowed dendritic growth and geometry to be analyzed quantitatively under conditions where the extent of interactions between neurons and astrocytes varied. When astroglia were proximal to neurons, dendrites and dendritic filopodia oriented toward them, but the general presence of astroglia significantly reduced overall dendrite growth. Further, dendritic arbors in partial physical contact with astroglia developed a pronounced pattern of asymmetrical growth, because the dendrites in direct contact were significantly smaller than the portion of the arbor not in contact. Notably, thrombospondin, the astroglial factor shown previously to promote synapse formation, did not inhibit dendritic growth. Thus, while astroglia promoted the formation of presynaptic contacts onto dendrites, dendritic growth was constrained locally within a developing arbor at sites where dendrites contacted astroglia. Taken together, these observations reveal influences on spatial orientation of growth as well as influences on morphogenesis of the dendritic arbor that have not been previously identified.	[Withers, Ginger S.; Farley, Jennifer R.; Sterritt, Jeffrey R.; Crane, Andres B.; Wallace, Christopher S.] Whitman Coll, Dept Biol, Walla Walla, WA 99362 USA	Whitman College	Withers, GS (corresponding author), Whitman Coll, Dept Biol, Walla Walla, WA 99362 USA.	withergs@whitman.edu		Crane, Andres/0000-0002-0242-526X; Withers, Ginger/0000-0002-7004-7846	Eunice Kennedy Shriver National Institute of Child Health and Human Development [1R15HD061831]; National Science Foundation [DBI-1039958, DBI-0922978]	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Science Foundation(National Science Foundation (NSF))	Support was provided by the Eunice Kennedy Shriver National Institute of Child Health and Human Development [https://www.nichd.nih.gov/Pages/index.aspx] (1R15HD061831) and the National Science Foundation [http://www.nsf.gov/] (DBI-1039958 and DBI-0922978). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; BANKER G, 1998, CULTURING NERVE CELL; BANKER GA, 1980, SCIENCE, V209, P809, DOI 10.1126/science.7403847; Barker AJ, 2008, J NEUROSCI, V28, P8150, DOI 10.1523/JNEUROSCI.1744-08.2008; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Bushong EA, 2004, INT J DEV NEUROSCI, V22, P73, DOI 10.1016/j.ijdevneu.2003.12.008; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Cline H, 2008, J PHYSIOL-LONDON, V586, P1509, DOI 10.1113/jphysiol.2007.150029; Corty Megan M, 2013, J Cell Biol, V203, P395, DOI 10.1083/jcb.201306099; Drummond SP, 2008, METHOD CELL BIOL, V88, P97, DOI 10.1016/S0091-679X(08)00406-8; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Fields RD, 2014, NEUROSCIENTIST, V20, P426, DOI 10.1177/1073858413504465; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; FLETCHER TL, 1994, J NEUROSCI, V14, P6695; Freeman MR, 2010, SCIENCE, V330, P774, DOI 10.1126/science.1190928; Giaume C, 2010, NAT REV NEUROSCI, P1; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Hama H, 2004, NEURON, V41, P405, DOI 10.1016/S0896-6273(04)00007-8; Hughes EG, 2010, MOL CELL NEUROSCI, V43, P136, DOI 10.1016/j.mcn.2009.10.004; Jacobs S, 2010, J NEUROSCI, V30, P4508, DOI 10.1523/JNEUROSCI.5027-09.2010; Koulakoff A, 2008, GLIA, V56, P1299, DOI 10.1002/glia.20698; Kucukdereli H, 2011, P NATL ACAD SCI USA, V108, pE440, DOI 10.1073/pnas.1104977108; Lefebvre JL, 2015, ANNU REV CELL DEV BI, V31, P741, DOI 10.1146/annurev-cellbio-100913-013020; Leyton Lisette, 2014, Adv Neurobiol, V8, P3; Lopez-Hidalgo M, 2014, CURR OPIN NEUROBIOL, V24, P176, DOI 10.1016/j.conb.2013.11.001; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; McAllister AK, 2000, CEREB CORTEX, V10, P963, DOI 10.1093/cercor/10.10.963; MULLER HW, 1984, P NATL ACAD SCI-BIOL, V81, P1248, DOI 10.1073/pnas.81.4.1248; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; POKORNY J, 1981, BRAIN RES BULL, V7, P113, DOI 10.1016/0361-9230(81)90075-7; Risher WC, 2014, ELIFE, V3, DOI 10.7554/eLife.04047; Schreiner AE, 2014, J COMP NEUROL, V522, P204, DOI 10.1002/cne.23450; Shao ZY, 2013, CELL, V154, P337, DOI 10.1016/j.cell.2013.06.028; Sholl DA, 1956, ORG CEREBRAL CORTEX; Smith PD, 2015, EXP NEUROL, V274, P100, DOI 10.1016/j.expneurol.2015.08.004; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stevens B, 2008, NEUROSIGNALS, V16, P278, DOI 10.1159/000123038; Swanson RA, 1997, J NEUROSCI, V17, P932; Thalhammer A, 2014, NEUROPHARMACOLOGY, V78, P23, DOI 10.1016/j.neuropharm.2013.03.015; Ullian EM, 2004, GLIA, V47, P209, DOI 10.1002/glia.20082; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; Withers GS, 2000, EUR J NEUROSCI, V12, P106, DOI 10.1046/j.1460-9568.2000.00889.x; WITHERS GS, 1998, CULTURING NERVE CELL, P113; Xu CD, 2015, J NEUROSCI, V35, P14517, DOI 10.1523/JNEUROSCI.1266-15.2015; Yang Q.C., 2012, MULTIPURP UTILIZATIO, V3, P3, DOI DOI 10.1016/J.YEXMP.2012.04.009; Yang YM, 1996, J BRAIN RES, V37, P313; Yang YJ, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-22; Yang YJ, 2009, NEURON, V61, P880, DOI 10.1016/j.neuron.2009.02.010	52	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169792	10.1371/journal.pone.0169792	http://dx.doi.org/10.1371/journal.pone.0169792			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081563	Green Submitted, gold, Green Published			2022-12-26	WOS:000391949500082
J	Woods, SE; Lieberman, MT; Lebreton, F; Trowel, E; de la Fuente-Nunez, C; Dzink-Fox, J; Gilmore, MS; Fox, JG				Woods, Stephanie E.; Lieberman, Mia T.; Lebreton, Francois; Trowel, Elise; de la Fuente-Nunez, Cesar; Dzink-Fox, Joanne; Gilmore, Michael S.; Fox, James G.			Characterization of Multi-Drug Resistant Enterococcus faecalis Isolated from Cephalic Recording Chambers in Research Macaques (Macaca spp.)	PLOS ONE			English	Article							HIGH-LEVEL GENTAMICIN; BIOFILM FORMATION; SURFACE PROTEIN; SEX-PHEROMONE; MOLECULAR CHARACTERIZATION; VIRULENCE; ESP; SUSCEPTIBILITY; IDENTIFICATION; INFECTIONS	Nonhuman primates are commonly used for cognitive neuroscience research and often surgically implanted with cephalic recording chambers for electrophysiological recording. Aerobic bacterial cultures from 25 macaques identified 72 bacterial isolates, including 15 Enterococcus faecalis isolates. The E. faecalis isolates displayed multi-drug resistant phenotypes, with resistance to ciprofloxacin, enrofloxacin, trimethoprim-sulfamethoxazole, tetracycline, chloramphenicol, bacitracin, and erythromycin, as well as high-level aminoglycoside resistance. Multi-locus sequence typing showed that most belonged to two E. faecalis sequence types (ST): ST 4 and ST 55. The genomes of three representative isolates were sequenced to identify genes encoding antimicrobial resistances and other traits. Antimicrobial resistance genes identified included aac(6')-aph(2 ''), aph(3')-III, str, ant(6)-Ia, tetM, tetS, tetL, ermB, bcrABR, cat, and dfrG, and polymorphisms in parC (S80I) and gyrA (S83I) were observed. These isolates also harbored virulence factors including the cytolysin toxin genes in ST 4 isolates, as well as multiple biofilm-associated genes (esp, agg, ace, SrtA, gelE, ebpABC), hyaluronidases (hylA, hylB), and other survival genes (ElrA, tpx). Crystal violet biofilm assays confirmed that ST 4 isolates produced more biofilm than ST 55 isolates. The abundance of antimicrobial resistance and virulence factor genes in the ST 4 isolates likely relates to the loss of CRISPR-cas. This macaque colony represents a unique model for studying E. faecalis infection associated with indwelling devices, and provides an opportunity to understand the basis of persistence of this pathogen in a healthcare setting.	[Woods, Stephanie E.; Lieberman, Mia T.; Trowel, Elise; Dzink-Fox, Joanne; Fox, James G.] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Lieberman, Mia T.; de la Fuente-Nunez, Cesar; Gilmore, Michael S.; Fox, James G.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Lebreton, Francois] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA USA; [Lebreton, Francois] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Microbiol, Boston, MA USA; [Lebreton, Francois] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Immunobiol, Boston, MA USA; [de la Fuente-Nunez, Cesar] MIT, Synthet Biol Grp, MIT Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [de la Fuente-Nunez, Cesar] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [de la Fuente-Nunez, Cesar] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [de la Fuente-Nunez, Cesar] Broad Inst MIT & Harvard, Cambridge, MA USA; [de la Fuente-Nunez, Cesar] Harvard Univ, Harvard Biophys Program, Boston, MA 02115 USA; [de la Fuente-Nunez, Cesar] Ctr Microbiome Informat & Therapeut, Cambridge, MA USA; [Woods, Stephanie E.] James J Peters VA Med Ctr, Res & Dev, Bronx, NY USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Lieberman, MT (corresponding author), MIT, Div Comparat Med, Cambridge, MA 02139 USA.; Lieberman, MT (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	MTRL01@mit.edu	Lebreton, Francois/AAH-5958-2020; de la Fuente, Cesar/ABE-2369-2021	de la Fuente, Cesar/0000-0002-2005-5629; /0000-0002-2993-5198	National Institutes of Health [T32 OD010978, P30 ES02109, 5P01AI083214-07]; United States Public Health Service [AI072360, AI108710]; Harvard-wide Program on Antibiotic Resistance [AI083214]; Fundacion Ramon Areces (Spain); PHS grant [AI072360, AI108710]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072360, P01AI083214, R01AI108710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD010978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Harvard-wide Program on Antibiotic Resistance; Fundacion Ramon Areces (Spain); PHS grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by National Institutes of Health (www.nih.gov) grants T32 OD010978 and P30 ES02109 (to JGF) and 5P01AI083214-07 (to MSG). The contributions ofauthors FL and MSG were supported by United States Public Health Service (www.usphs.gov) grants AI072360, AI108710, and the Harvard-wide Program on Antibiotic Resistance AI083214. CDLF-N holds a postdoctoral scholarship from Fundacion Ramon Areces (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge Ellen Buckley and Carolyn Madden for their diagnostic microbiology expertise, and Dr. Robert Marini, Dr. Mary Patterson and Monica Siddalls for their veterinary support. We acknowledge Eric J Ma for his assistance with beeswarm plot generation. The contributions of SEW, MTL, ET, and JDF were supported by NIH grants T32 OD010978 and P30 ES02109 (to JGF). The contributions of FL and MSG were supported by PHS grant AI072360, AI108710, and the Harvard-wide Program on Antibiotic Resistance AI083214. CDLF-N holds a postdoctoral scholarship from Fundacion Ramon Areces (Spain).	An FY, 2002, J BACTERIOL, V184, P1880, DOI 10.1128/JB.184.7.1880-1887.2002; [Anonymous], 2012, M07AG CLIN LAB STAND; Antiporta MH, 2002, J BACTERIOL, V184, P1155, DOI 10.1128/jb.184.4.1155-1162.2002; BANTAR CE, 1993, J CLIN MICROBIOL, V31, P1921, DOI 10.1128/JCM.31.7.1921-1923.1993; Bergin IL, 2000, COMPARATIVE MED, V50, P530; Brinster S, 2007, INFECT IMMUN, V75, P4463, DOI 10.1128/IAI.00279-07; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Chow JW, 2000, CLIN INFECT DIS, V31, P586, DOI 10.1086/313949; CHOW JW, 1993, ANTIMICROB AGENTS CH, V37, P2474, DOI 10.1128/AAC.37.11.2474; Chuang-Smith ON, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015798; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; CLEWELL DB, 1985, J BACTERIOL, V162, P1212, DOI 10.1128/JB.162.3.1212-1220.1985; *CLIN LAB STAND I, 2009, M02A10 CLIN LAB STAN; Coenye T, 1999, INT J SYST BACTERIOL, V49, P405, DOI 10.1099/00207713-49-2-405; Costa DK, 2014, RES NURS HEALTH, V37, P326, DOI 10.1002/nur.21607; de la Fuente-Nunez C, 2015, CHEM BIOL, V22, P196, DOI 10.1016/j.chembiol.2015.01.002; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; Freitas AR, 2009, J ANTIMICROB CHEMOTH, V63, P1104, DOI 10.1093/jac/dkp103; Fremont JJ, 2008, J AM ASSOC LAB ANIM, V47, P61; Gemmell CG, 2001, J ANTIMICROB CHEMOTH, V48, P47, DOI 10.1093/jac/48.1.47; Guiton PS, 2009, INFECT IMMUN, V77, P3626, DOI 10.1128/IAI.00219-09; Hancock LE, 2004, J BACTERIOL, V186, P5629, DOI 10.1128/JB.186.17.5629-5639.2004; Hyzy RC, 2010, J HOSP MED, V5, P4, DOI 10.1002/jhm.567; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kafil Hossein S, 2015, Open Microbiol J, V9, P14, DOI 10.2174/1874285801509010014; KING A, 1989, J ANTIMICROB CHEMOTH, V24, P31, DOI 10.1093/jac/24.suppl_A.31; Kristich CJ, 2004, J BACTERIOL, V186, P154, DOI 10.1128/JB.186.1.154-163.2004; La Carbona S, 2007, MOL MICROBIOL, V66, P1148, DOI 10.1111/j.1365-2958.2007.05987.x; Leblanc M, 2013, COMPARATIVE MED, V63, P367; Lee GE, 1998, CONTEMP TOP LAB ANIM, V37, P59; Manson JM, 2004, ANTIMICROB AGENTS CH, V48, P3743, DOI 10.1128/AAC.48.10.3743-3748.2004; Miller WR, 2014, EXPERT REV ANTI-INFE, V12, P1221, DOI 10.1586/14787210.2014.956092; Minogue TD, 2014, GENOME ANNOUNCEMENTS, V2; Mohamed JA, 2007, J MED MICROBIOL, V56, P1581, DOI 10.1099/jmm.0.47331-0; NAKAYAMA J, 1995, BIOSCI BIOTECH BIOCH, V59, P703, DOI 10.1271/bbb.59.703; Nallapareddy SR, 2011, INFECT IMMUN, V79, P2901, DOI 10.1128/IAI.00038-11; Nielsen HV, 2013, J BACTERIOL, V195, P4484, DOI 10.1128/JB.00451-13; Onodera Y, 2002, ANTIMICROB AGENTS CH, V46, P1800, DOI 10.1128/AAC.46.6.1800-1804.2002; Paganelli FL, 2012, TRENDS MICROBIOL, V20, P40, DOI 10.1016/j.tim.2011.11.001; Palmer KL, 2010, MBIO, V1, DOI 10.1128/mBio.00227-10; Perretta G., 2009, SCANDINAVIAN J LAB A; Petersen A, 2004, FEMS MICROBIOL LETT, V231, P73, DOI 10.1016/S0378-1097(03)00929-7; Reffuveille F, 2014, ANTIMICROB AGENTS CH, V58, P5363, DOI 10.1128/AAC.03163-14; Ruiz-Garbajosa P, 2006, J CLIN MICROBIOL, V44, P2220, DOI 10.1128/JCM.02596-05; Schouten MA, 1999, ANTIMICROB AGENTS CH, V43, P2542, DOI 10.1128/AAC.43.10.2542; Shankar V, 1999, INFECT IMMUN, V67, P193, DOI 10.1128/IAI.67.1.193-200.1999; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Stepanovic S, 2007, QUANTIFICATION BIOFI; Sun HL, 2012, DIAGN MICR INFEC DIS, V74, P399, DOI 10.1016/j.diagmicrobio.2012.09.006; Sussmuth SD, 2000, INFECT IMMUN, V68, P4900; Tendolkar PM, 2004, INFECT IMMUN, V72, P6032, DOI 10.1128/IAI.72.10.6032-6039.2004; Toledo-Arana A, 2001, APPL ENVIRON MICROB, V67, P4538, DOI 10.1128/AEM.67.10.4538-4545.2001; Van Tyne D, 2013, TOXINS, V5, P895, DOI 10.3390/toxins5050895; Venezia J, 2012, J MED MICROBIOL, V61, P1401, DOI 10.1099/jmm.0.045377-0; VOLLAARD EJ, 1994, ANTIMICROB AGENTS CH, V38, P409, DOI 10.1128/AAC.38.3.409; Watanabe S, 2009, MICROB DRUG RESIST, V15, P185, DOI 10.1089/mdr.2009.0917; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099; Yang JX, 2015, INFECT GENET EVOL, V33, P253, DOI 10.1016/j.meegid.2015.05.012; Yu ZJ, 2015, INT J INFECT DIS, V30, P49, DOI 10.1016/j.ijid.2014.06.017; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	61	12	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169293	10.1371/journal.pone.0169293	http://dx.doi.org/10.1371/journal.pone.0169293			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081148	Green Submitted, Green Published, gold			2022-12-26	WOS:000391949500040
J	Mollo, G; Cornelissen, PL; Millman, RE; Ellis, AW; Jefferies, E				Mollo, Giovanna; Cornelissen, Piers L.; Millman, Rebecca E.; Ellis, Andrew W.; Jefferies, Elizabeth			Oscillatory Dynamics Supporting Semantic Cognition: MEG Evidence for the Contribution of the Anterior Temporal Lobe Hub and Modality-Specific Spokes	PLOS ONE			English	Article							LONG-TERM-MEMORY; OBJECT RECOGNITION; POWER CHANGES; BRAIN; REPRESENTATION; KNOWLEDGE; CORTEX; MOTOR; ACTIVATION; CATEGORIES	The "hub and spoke model" of semantic representation suggests that the multimodal features of objects are drawn together by an anterior temporal lobe (ATL) " hub", while modality-specific "spokes" capture perceptual/action features. However, relatively little is known about how these components are recruited through time to support object identification. We used magnetoencephalography to measure neural oscillations within left ATL, lateral fusiform cortex (FC) and central sulcus (CS) during word-picture matching at different levels of specificity (employing superordinate vs. specific labels) for different categories (manmade vs. animal). This allowed us to determine (i) when each site was sensitive to semantic category and (ii) whether this was modulated by task demands. In ATL, there were two phases of response: from around 100 ms post-stimulus there were phasic bursts of low gamma activity resulting in reductions in oscillatory power, relative to a baseline period, that were modulated by both category and specificity; this was followed by more sustained power decreases across frequency bands from 250 ms onwards. In the spokes, initial power increases were not stronger for specific identification, while later power decreases were stronger for specific-level identification in FC for animals and in CS for manmade objects (from around 150 ms and 200 ms, respectively). These data are inconsistent with a temporal sequence in which early sensory-motor activity is followed by later retrieval in ATL. Instead, knowledge emerges from the rapid recruitment of both hub and spokes, with early specificity and category effects in the ATL hub. The balance between these components depends on semantic category and task, with visual cortex playing a greater role in the fine-grained identification of animals and motor cortex contributing to the identification of tools.	[Mollo, Giovanna; Ellis, Andrew W.; Jefferies, Elizabeth] Univ York, Dept Psychol, York, N Yorkshire, England; [Cornelissen, Piers L.] Northumbria Univ, Sch Life Sci, Dept Psychol, Newcastle Upon Tyne, Tyne & Wear, England; [Millman, Rebecca E.] Univ York, York Neuroimaging Ctr, York Sci Pk, York, N Yorkshire, England; [Millman, Rebecca E.] Univ Manchester, Sch Psychol Sci, Audiol & Deafness Grp, Manchester, Lancs, England	University of York - UK; Northumbria University; University of York - UK; University of Manchester	Mollo, G (corresponding author), Univ York, Dept Psychol, York, N Yorkshire, England.	giovanna.mollo@york.ac.uk	Jefferies, Elizabeth/A-7981-2011; Cornelissen, Piers L/K-4914-2012	Cornelissen, Piers L/0000-0002-2695-9581; Millman, Rebecca/0000-0001-8606-0167; Jefferies, Elizabeth/0000-0002-3826-4330; Mollo, Giovanna/0000-0003-2278-9711	BBSRC [BB/J006963/1]; European Research Council (SEMBIND) [283530]; Biotechnology and Biological Sciences Research Council [BB/J006963/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council (SEMBIND); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The research was supported by BBSRC grant BB/J006963/1. Jefferies was supported by a grant from the European Research Council (SEMBIND - 283530).	Amsel BD, 2011, NEUROPSYCHOLOGIA, V49, P970, DOI 10.1016/j.neuropsychologia.2011.01.003; [Anonymous], 2006, SAS MIXED MODELS; Anzellotti S, 2011, J COGNITIVE NEUROSCI, V23, P2059, DOI 10.1162/jocn.2010.21567; Barca L, 2011, BRAIN LANG, V118, P53, DOI 10.1016/j.bandl.2010.09.003; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Bastiaansen MCM, 2008, BRAIN LANG, V106, P15, DOI 10.1016/j.bandl.2007.10.006; Bemis DK, 2013, CEREB CORTEX, V23, P1859, DOI 10.1093/cercor/bhs170; Bemis DK, 2011, J NEUROSCI, V31, P2801, DOI 10.1523/JNEUROSCI.5003-10.2011; BENTIN S, 1993, PSYCHOPHYSIOLOGY, V30, P161, DOI 10.1111/j.1469-8986.1993.tb01729.x; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Binney RJ, 2010, CEREB CORTEX, V20, P2728, DOI 10.1093/cercor/bhq019; Brookes MJ, 2008, NEUROIMAGE, V39, P1788, DOI 10.1016/j.neuroimage.2007.09.050; Brookes MJ, 2011, NEUROIMAGE, V55, P1804, DOI 10.1016/j.neuroimage.2010.10.074; Burgess AP, 2000, PSYCHOPHYSIOLOGY, V37, P596, DOI 10.1017/S0048577200981356; Carota F, 2012, J COGNITIVE NEUROSCI, V24, P1492, DOI 10.1162/jocn_a_00219; Chan AM, 2011, J NEUROSCI, V31, P18119, DOI 10.1523/JNEUROSCI.3122-11.2011; Chan AM, 2011, NEUROIMAGE, V54, P3028, DOI 10.1016/j.neuroimage.2010.10.073; Chao LL, 2002, CEREB CORTEX, V12, P545, DOI 10.1093/cercor/12.5.545; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Chen L, 2015, J COGNITIVE IN PRESS; Chouinard PA, 2010, NEUROPSYCHOLOGIA, V48, P409, DOI 10.1016/j.neuropsychologia.2009.09.032; Clarke A, 2013, CEREB CORTEX, V23, P187, DOI 10.1093/cercor/bhs002; Clarke A, 2011, J COGNITIVE NEUROSCI, V23, P1887, DOI 10.1162/jocn.2010.21544; Cornelissen PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005359; Costa A, 2005, PSYCHON B REV, V12, P125, DOI 10.3758/BF03196357; Davey J, 2015, BRAIN LANG, V142, P24, DOI 10.1016/j.bandl.2015.01.002; DERENZI E, 1994, CORTEX, V30, P3, DOI 10.1016/S0010-9452(13)80322-X; Devlin JT, 1998, J COGNITIVE NEUROSCI, V10, P77, DOI 10.1162/089892998563798; Devlin JT, 2002, NEUROIMAGE, V15, P675, DOI 10.1006/nimg.2001.1002; Devlin JT, 2002, NEUROPSYCHOLOGIA, V40, P54, DOI 10.1016/S0028-3932(01)00066-5; Dilkina K, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00333; FARAH MJ, 1991, J EXP PSYCHOL GEN, V120, P339, DOI 10.1037/0096-3445.120.4.339; Fellner MC, 2013, NEUROIMAGE, V79, P361, DOI 10.1016/j.neuroimage.2013.04.121; Fernandino L, 2016, CEREB CORTEX, V26, P2018, DOI 10.1093/cercor/bhv020; Goldberg RF, 2006, COGN AFFECT BEHAV NE, V6, P214, DOI 10.3758/CABN.6.3.214; Gonzalez J, 2006, NEUROIMAGE, V32, P906, DOI 10.1016/j.neuroimage.2006.03.037; Hanslmayr S, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00074; Hanslmayr S, 2011, J NEUROSCI, V31, P15674, DOI 10.1523/JNEUROSCI.3140-11.2011; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hillebrand A, 2005, INT REV NEUROBIOL, V68, P149, DOI 10.1016/S0074-7742(05)68006-3; HODGES JR, 1995, MEMORY, V3, P463, DOI 10.1080/09658219508253161; Hoenig K, 2008, J COGNITIVE NEUROSCI, V20, P1799, DOI 10.1162/jocn.2008.20123; Hoffman P, 2013, NEUROPSYCHOLOGIA, V51, P14, DOI 10.1016/j.neuropsychologia.2012.11.009; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Huang MX, 2004, BRAIN TOPOGR, V16, P139; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; Hymers M, 2010, NEUROIMAGE, V49, P1385, DOI 10.1016/j.neuroimage.2009.09.055; Ihara A, 2003, NEUROSCI LETT, V339, P135, DOI 10.1016/S0304-3940(03)00005-3; Ishibashi R, 2016, COGN NEUROPSYCHOL, V33, P241, DOI 10.1080/02643294.2016.1188798; Jefferies E, 2006, BRAIN, V129, P2132, DOI 10.1093/brain/awl153; Kemmerer D, 2012, CORTEX, V48, P826, DOI 10.1016/j.cortex.2010.11.001; Khader PH, 2011, PSYCHOPHYSIOLOGY, V48, P362, DOI 10.1111/j.1469-8986.2010.01063.x; Klein M, 2015, CEREB CORTEX, V25, P1715, DOI 10.1093/cercor/bht350; Kozinska D, 2001, CLIN NEUROPHYSIOL, V112, P1553, DOI 10.1016/S1388-2457(01)00556-9; Kutas M, 1980, SCIENCE; Lambon Ralph MA, 2008, ANN NY ACAD SCI, V107, P2717; Lambon Ralph MA, 1998, NEUROCASE, V3, P11; Lau EF, 2013, J NEUROSCI, V 33, P17174, DOI 10.1523/JNEUROSCI.1018-13.2013; Liljestrom M, 2008, NEUROIMAGE, V41, P1132, DOI 10.1016/j.neuroimage.2008.03.016; Liu HS, 2009, NEURON, V62, P281, DOI 10.1016/j.neuron.2009.02.025; LUPKER SJ, 1982, J EXP PSYCHOL LEARN, V8, P418, DOI 10.1037/0278-7393.8.5.418; Marinkovic K, 2003, NEURON, V38, P487, DOI 10.1016/S0896-6273(03)00197-1; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; McClelland JL, 2003, NAT REV NEUROSCI, V4, P310, DOI 10.1038/nrn1076; McClelland JL, 2003, TRENDS COGNITIVE SCI; McClelland JL, 2009, SEMANTIC COGNITION I, P1, DOI [10.1016/j.cub.2010.03.070, DOI 10.1016/J.CUB.2010.03.070]; McRae K, 2005, BEHAV RES METHODS, V37, P547, DOI 10.3758/BF03192726; Mollo G, 2016, CORTEX, V74, P262, DOI 10.1016/j.cortex.2015.10.021; Moore CJ, 1999, BRAIN, V122, P943, DOI 10.1093/brain/122.5.943; Moseley RL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01928; Moss HE, 1998, NEUROCASE, V4, P291, DOI 10.1093/neucas/4.4.291; Moss HE, 2005, CEREB CORTEX, V15, P616, DOI 10.1093/cercor/bhh163; Noonan KA, 2013, J COGNITIVE NEUROSCI, V25, P1824, DOI 10.1162/jocn_a_00442; Noppeney U, 2007, BRAIN, V130, P1138, DOI 10.1093/brain/awl344; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Piai V, 2012, BRAIN RES, V1450, P87, DOI 10.1016/j.brainres.2012.02.050; Pobric G, 2007, P NATL ACAD SCI USA, V104, P20137, DOI 10.1073/pnas.0707383104; Pobric G, 2010, CURR BIOL, V20, P964, DOI 10.1016/j.cub.2010.03.070; Pobric G, 2010, NEUROPSYCHOLOGIA, V48, P1336, DOI 10.1016/j.neuropsychologia.2009.12.036; Prendergast G, 2011, NEUROIMAGE, V54, P906, DOI 10.1016/j.neuroimage.2010.08.005; Proverbio Alice M, 2007, BMC Neurosci, V8, P24, DOI 10.1186/1471-2202-8-24; Pulvermuller F, 2005, EUR J NEUROSCI, V21, P793, DOI 10.1111/j.1460-9568.2005.03900.x; Ralph MAL, 2007, BRAIN, V130, P1127, DOI 10.1093/brain/awm025; Ralph MAL, 2010, P NATL ACAD SCI USA, V107, P2717, DOI 10.1073/pnas.0907307107; Ralph MAL, 2009, CEREB CORTEX, V19, P832, DOI 10.1093/cercor/bhn131; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Rogers TT, 2006, COGN AFFECT BEHAV NE, V6, P201, DOI 10.3758/CABN.6.3.201; Rogers TT, 2015, NEUROPSYCHOLOGIA, V76, P220, DOI 10.1016/j.neuropsychologia.2015.04.015; Rogers TT, 2008, BEHAV BRAIN SCI, V31, P689, DOI 10.1017/S0140525X0800589X; Rogers TT, 2005, J COGNITIVE NEUROSCI, V17, P434, DOI 10.1162/0898929053279531; Rogers TT, 2004, PSYCHOL REV, V111, P205, DOI 10.1037/0033-295X.111.1.205; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Rueschemeyer SA, 2010, J COGNITIVE NEUROSCI, V22, P1844, DOI 10.1162/jocn.2009.21310; SACCHETT C, 1992, COGNITIVE NEUROPSYCH, V9, P73, DOI 10.1080/02643299208252053; Schendan HE, 2009, NEUROIMAGE, V44, P1423, DOI 10.1016/j.neuroimage.2008.09.061; SCHRIEFERS H, 1990, J MEM LANG, V29, P86, DOI 10.1016/0749-596X(90)90011-N; Shtyrov Y, 2014, P NATL ACAD SCI USA, V111, pE1918, DOI 10.1073/pnas.1323158111; Singh KD, 2012, NEUROIMAGE, V62, P1121, DOI 10.1016/j.neuroimage.2012.01.028; Stockwell RG, 1996, IEEE T SIGNAL PROCES, V44, P998, DOI 10.1109/78.492555; Szekely A., 2000, CTR RES LANGUAGE NEW, V12, P1; Taylor KI, 2012, COGNITION, V122, P363, DOI 10.1016/j.cognition.2011.11.001; Thorpe SJ, 1996, LETT NATURE; Tyler LK, 2004, J COGNITIVE NEUROSCI, V16, P351, DOI 10.1162/089892904322926692; Tyler LK, 2003, NEUROIMAGE, V18, P542, DOI 10.1016/S1053-8119(02)00047-2; Tyler LK, 2013, J COGNITIVE NEUROSCI, V25, P1723, DOI 10.1162/jocn_a_00419; Urooj U, 2014, NEUROIMAGE, V87, P252, DOI 10.1016/j.neuroimage.2013.10.058; van Ackeren MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101042; van Heuven WJB, 2014, Q J EXP PSYCHOL, V67, P1176, DOI 10.1080/17470218.2013.850521; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Vartiainen J, 2009, J NEUROSCI, V29, P9271, DOI 10.1523/JNEUROSCI.5860-08.2009; Vinson DP, 2003, BRAIN LANG, V86, P347, DOI 10.1016/S0093-934X(03)00144-5; Waldhauser GT, 2012, J NEUROSCI, V32, P1953, DOI 10.1523/JNEUROSCI.4201-11.2012; WARRINGTON EK, 1984, BRAIN, V107, P829, DOI 10.1093/brain/107.3.829; WARRINGTON EK, 1987, BRAIN, V110, P1273, DOI 10.1093/brain/110.5.1273; WARRINGTON EK, 1975, Q J EXP PSYCHOL, V27, P635, DOI 10.1080/14640747508400525; Westerlund M, 2014, NEUROPSYCHOLOGIA, V57, P1, DOI [10.1162/jocn_a_00419, DOI 10.1162/JOCN_A_00419]; Wheat KL, 2010, J NEUROSCI, V30, P5229, DOI 10.1523/JNEUROSCI.4448-09.2010; Wu CT, 2015, J COGNITIVE NEUROSCI, V27, P141, DOI 10.1162/jocn_a_00701; Zhang LM, 2015, NEUROIMAGE, V111, P228, DOI 10.1016/j.neuroimage.2015.02.028	121	27	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169269	10.1371/journal.pone.0169269	http://dx.doi.org/10.1371/journal.pone.0169269			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH6BJ	28076421	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000391857100029
J	Jiang, T; Pan, CQ; Low, BC				Jiang, T.; Pan, C. Q.; Low, B. C.			BPGAP1 spatially integrates JNK/ERK signaling crosstalk in oncogenesis	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; SCAFFOLD PROTEINS; RHO-GTPASES; FUNCTIONAL PLASTICITY; CELL-PROLIFERATION; JNK ACTIVATION; CANCER CELLS; PATHWAYS; TARGETS; BINDING	Simultaneous hyperactivation of stress-activated protein kinase/c-Jun N-terminal protein kinase (SAPK/JNK) and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK/ERK) signaling cascades has been reported in carcinogenesis. However, how they are integrated to promote oncogenesis remains unknown. By analyzing breast invasive carcinoma database (The Cancer Genome Altas), we found that the mRNA expression levels of both JNK1 and ERK2 are positively correlated with the mRNA level of EEA1, an endosome associated protein, indicating the potential JNK/ERK crosstalk at endosome. Unbiased screen of different endosome-associated Rab GTPases reveals that late endosome serves as a unique platform to integrate JNK/ERK signaling. Furthermore, we identify that BPGAP1 (a BCH domain-containing, Cdc42GAP-like Rho GTPase-activating protein) promotes MEK partner 1 (MP1)-induced ERK activation on late endosome through scaffolding MP1/MEK1 complex. This regulatory function requires phosphorylation of BPGAP1 by JNK at its C terminal tail (Ser424) to unlock its autoinhibitory conformation. Consequently, phosphorylated BPGAP1 facilitates endosomal ERK signaling transduction to the nucleus, driving cell proliferation and transformation via the ERK-Myc-CyclinA axis. BPGAP1 therefore provides a crucial spatiotemporal checkpoint where JNK and MP1/MEK1 work in concert to regulate endosomal and nuclear ERK signaling in cell proliferation control.	[Jiang, T.; Low, B. C.] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore; [Pan, C. Q.; Low, B. C.] Natl Univ Singapore, Mechanobiol Inst, T Lab Level 10,5A Engn Dr 1, Singapore 117411, Singapore; [Low, B. C.] Natl Univ Singapore, Univ Scholars Programme, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Pan, CQ; Low, BC (corresponding author), Natl Univ Singapore, Mechanobiol Inst, T Lab Level 10,5A Engn Dr 1, Singapore 117411, Singapore.	mbipqc@nus.edu; dbslowbc@nus.edu.sg	Low, Boon Chuan/H-8049-2012; Low, Boon Chuan/AAU-7685-2021	Low, Boon Chuan/0000-0003-0756-096X; Low, Boon Chuan/0000-0003-0756-096X	NUS Research Scholarship, a Ministry of Education Tier 2 [R154-000-236-112]; Mechanobiology Institute of Singapore; National Research Foundation; Ministry of Education Singapore; National Medical Research Council; CBRG New Investigator Grant (CBRG-NIG) [R-714-000-115-511]	NUS Research Scholarship, a Ministry of Education Tier 2; Mechanobiology Institute of Singapore; National Research Foundation; Ministry of Education Singapore(Ministry of Education, Singapore); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CBRG New Investigator Grant (CBRG-NIG)	This work was supported by an NUS Research Scholarship (to TJ), a Ministry of Education Tier 2 grant (R154-000-236-112 to BCL) and the Mechanobiology Institute of Singapore (to BCL), funded through the National Research Foundation and the Ministry of Education Singapore. This work was also supported by National Medical Research Council, CBRG New Investigator Grant (CBRG-NIG) (R-714-000-115-511 to CQP). We thank Proteins and Proteomics Center (National University of Singapore) for mass spectrometric analysis. We thank Nisha Mohd Rafiq (National University of Singapore) for the technical support. We also thank Professor Andrew Catling (LSU Health Sciences Center), Professor Kanga Sabapathy (National Cancer Center, Singapore), and Professor Yih-Cherng Liou (National University of Singapore) for providing MP1, phospho-JNK1, CyclinA and CyclinE antibodies, respectively.	Adler V, 2005, BIOCHEMISTRY-US, V44, P10784, DOI 10.1021/bi050619j; Alsayed Y, 2005, BLOOD, V106, p150A; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Dang CV, 1999, MOL CELL BIOL, V19, P1; De Araujo ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053768; de Graauw M, 2014, ONCOGENE, V33, P2610, DOI 10.1038/onc.2013.219; Engstrom W, 2010, CELL PROLIFERAT, V43, P56, DOI 10.1111/j.1365-2184.2009.00654.x; Fujii S, 2011, ONCOGENE, V30, P4118, DOI 10.1038/onc.2011.118; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Grijelmo C, 2007, CELL SIGNAL, V19, P1722, DOI 10.1016/j.cellsig.2007.03.008; Hornberg JJ, 2006, BIOSYSTEMS, V83, P81, DOI 10.1016/j.biosystems.2005.05.014; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Johnstone CN, 2004, GENE, V336, P59, DOI 10.1016/j.gene.2004.01.025; Jun S, 2013, CELL REP, V5, P314, DOI 10.1016/j.celrep.2013.09.026; Kang JS, 2008, J CELL BIOL, V182, P497, DOI 10.1083/jcb.200801119; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Lopez-Bergami P, 2008, INT J BIOCHEM CELL B, V40, P1055, DOI 10.1016/j.biocel.2007.11.011; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Lua BL, 2005, J CELL SCI, V118, P2707, DOI 10.1242/jcs.02383; Ma CX, 2015, NAT REV CANCER, V15, P261, DOI 10.1038/nrc3920; Miaczynska M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009035; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Mingo-Sion AM, 2004, ONCOGENE, V23, P596, DOI 10.1038/sj.onc.1207147; Palfy M, 2012, TRENDS CELL BIOL, V22, P447, DOI 10.1016/j.tcb.2012.06.004; Pan CQ, 2012, CELL SIGNAL, V24, P2143, DOI 10.1016/j.cellsig.2012.06.002; Pan CQ, 2012, FEBS LETT, V586, P2674, DOI 10.1016/j.febslet.2012.04.023; Pan CQ, 2010, J CELL SCI, V123, P903, DOI 10.1242/jcs.064162; Parameswaran N, 2013, J IMMUNOL, V190, P2017, DOI 10.4049/jimmunol.1201292; Pennock S, 2003, MOL CELL BIOL, V23, P5803, DOI 10.1128/MCB.23.16.5803-5815.2003; Pullikuth A, 2005, MOL CELL BIOL, V25, P5119, DOI 10.1128/MCB.25.12.5119-5133.2005; Ramirez A, 2014, ONCOTARGET, V5, P3590, DOI 10.18632/oncotarget.1962; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; Shang X, 2003, J BIOL CHEM, V278, P45903, DOI 10.1074/jbc.M304514200; Sharma C, 2005, J CELL BIOCHEM, V94, P708, DOI 10.1002/jcb.20344; Shen YH, 2003, J BIOL CHEM, V278, P26715, DOI 10.1074/jbc.M303264200; Sirokmany G, 2006, J BIOL CHEM, V281, P6096, DOI 10.1074/jbc.M510619200; Skarpen E, 2008, FASEB J, V22, P466, DOI 10.1096/fj.07-8650com; Song JY, 2008, INT J GYNECOL CANCER, V18, P1051, DOI 10.1111/j.1525-1438.2007.01164.x; Song P, 2015, BIOMED PHARMACOTHER, V69, P70, DOI 10.1016/j.biopha.2014.11.008; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Taub N, 2007, MOL BIOL CELL, V18, P4698, DOI 10.1091/mbc.E07-02-0098; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Vomastek T, 2007, MOL CELL BIOL, V27, P8296, DOI 10.1128/MCB.00598-07; Wang Y, 2002, MOL CELL BIOL, V22, P7279, DOI 10.1128/MCB.22.20.7279-7290.2002; West RJH, 2015, J CELL BIOL, V208, P931, DOI 10.1083/jcb.201404066; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Wu P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041354; Yam CH, 2002, CELL MOL LIFE SCI, V59, P1317, DOI 10.1007/s00018-002-8510-y; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	59	10	10	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 1	2017	36	22					3178	3192		10.1038/onc.2016.466	http://dx.doi.org/10.1038/onc.2016.466			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EW6KA	28092672				2022-12-26	WOS:000402617900010
J	Alexaki, A; Clarke, BA; Gavrilova, O; Ma, YY; Zhu, HL; Ma, XR; Xu, LY; Tuymetova, G; Larman, BC; Allende, ML; Dunn, TM; Proia, RL				Alexaki, Aikaterini; Clarke, Benjamin A.; Gavrilova, Oksana; Ma, Yinyan; Zhu, Hongling; Ma, Xinran; Xu, Lingyan; Tuymetova, Galina; Larman, Bridget C.; Allende, Maria L.; Dunn, Teresa M.; Proia, Richard L.			De Novo Sphingolipid Biosynthesis Is Required for Adipocyte Survival and Metabolic Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipocyte; inflammation; lipodystrophy; serine palmitoyltransferase; sphingolipid	HUMAN ADIPOSE-TISSUE; INSULIN-RESISTANCE; OBESITY; CERAMIDE; MICE; INFLAMMATION; DYSFUNCTION; FAT; DEFICIENCY; EXPRESSION	Sphingolipids are a diverse class of essential cellular lipids that function as structural membrane components and as signaling molecules. Cells acquire sphingolipids by both de novo biosynthesis and recycling of exogenous sphingolipids. The individual importance of these pathways for the generation of essential sphingolipids in differentiated cells is not well understood. To investigate the requirement for de novo sphingolipid biosynthesis in adipocytes, a cell type with highly regulated lipid metabolism, we generated mice with an adipocyte-specific deletion of Sptlc1. Sptlc1 is an obligate subunit of serine palmitoyltransferase, the enzyme responsible for the first and rate-limiting step of de novo sphingolipid biosynthesis. These mice, which initially developed adipose tissue, exhibited a striking age-dependent loss of adipose tissue accompanied by evidence of adipocyte death, increased macrophage infiltration, and tissue fibrosis. Adipocyte differentiation was not affected by the Sptlc1 deletion. The mice also had elevated fasting blood glucose, fatty liver, and insulin resistance. Collectively, these data indicate that de novo sphingolipid biosynthesis is required for adipocyte cell viability and normal metabolic function and that reduced de novo sphingolipid biosynthesis within adipocytes is associated with adipocyte death, adipose tissue remodeling, and metabolic dysfunction.	[Alexaki, Aikaterini; Clarke, Benjamin A.; Zhu, Hongling; Ma, Xinran; Xu, Lingyan; Tuymetova, Galina; Larman, Bridget C.; Allende, Maria L.; Proia, Richard L.] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Gavrilova, Oksana; Ma, Yinyan] NIDDK, Mouse Metab Core Lab, NIH, Bethesda, MD 20892 USA; [Dunn, Teresa M.] Uniformed Serv Univ Hlth Sci, Dept Biochem, Bethesda, MD 20184 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Uniformed Services University of the Health Sciences - USA	Proia, RL (corresponding author), NIDDK, Genet Dev & Dis Branch, Bldg 10,Rm 9D-06,10 Ctr Dr,MSC 1821, Bethesda, MD 20892 USA.	proia@nih.gov	Proia, Richard L/A-7908-2012	Zhu, Hongling/0000-0003-0612-009X; Proia, Richard/0000-0003-0456-1270; Alexaki, Aikaterini/0000-0003-2511-8569	National Institutes of Health [P30CA138313, P20RR017677]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056018, ZIADK056014, ZICDK070002, ZIADK056015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Linda Raab for editorial assistance. The Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina, was the recipient of National Institutes of Health Grants P30CA138313 and P20RR017677.	Alexaki A, 2014, J LIPID RES, V55, P2521, DOI 10.1194/jlr.M051862; Bikman BT, 2011, J CLIN INVEST, V121, P4222, DOI 10.1172/JCI57144; Blachnio-Zabielska AU, 2012, OBESITY, V20, P2341, DOI 10.1038/oby.2012.126; Boon J, 2013, DIABETES, V62, P401, DOI 10.2337/db12-0686; Camell CD, 2015, J BIOL CHEM, V290, P29402, DOI 10.1074/jbc.M115.680199; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Chen M, 2010, CELL METAB, V11, P320, DOI 10.1016/j.cmet.2010.02.013; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Hojjati MR, 2005, BBA-MOL CELL BIOL L, V1737, P44, DOI 10.1016/j.bbalip.2005.08.006; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kolak M, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-115; Kono M, 2006, J BIOL CHEM, V281, P7324, DOI 10.1074/jbc.M508382200; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Li ZQ, 2009, J BIOL CHEM, V284, P27010, DOI 10.1074/jbc.M109.042028; Ma XR, 2015, CELL METAB, V22, P695, DOI 10.1016/j.cmet.2015.08.005; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Meshulam T, 2011, J LIPID RES, V52, P1526, DOI 10.1194/jlr.M015628; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Nilsson A, 2006, J LIPID RES, V47, P154, DOI 10.1194/jlr.M500357-JLR200; Patni N, 2015, NAT REV ENDOCRINOL, V11, P522, DOI 10.1038/nrendo.2015.123; Pettus BJ, 2003, FASEB J, V17, P1411, DOI 10.1096/fj.02-1038com; Rutkowski JM, 2015, J CELL BIOL, V208, P501, DOI 10.1083/jcb.201409063; Samad F, 2006, DIABETES, V55, P2579, DOI 10.2337/db06-0330; Samad F, 2011, ADV EXP MED BIOL, V721, P67, DOI 10.1007/978-1-4614-0650-1_5; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Turpin SM, 2014, CELL METAB, V20, P678, DOI 10.1016/j.cmet.2014.08.002; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Yano M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061380; Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200	36	28	29	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3929	3939		10.1074/jbc.M116.756460	http://dx.doi.org/10.1074/jbc.M116.756460			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28100772	Green Published, hybrid			2022-12-26	WOS:000395542500033
J	Vainio, L; Rantala, A; Tiainen, M; Tiippana, K; Komeilipoor, N; Vainio, M				Vainio, Lari; Rantala, Aleksi; Tiainen, Mikko; Tiippana, Kaisa; Komeilipoor, Naeem; Vainio, Martti			Systematic Influence of Perceived Grasp Shape on Speech Production	PLOS ONE			English	Article							MOTOR CORTEX; CORTICAL MECHANISMS; ACTION RECOGNITION; NUMBER MAGNITUDE; LANGUAGE; EVOLUTION; REPRESENTATION; ORGANIZATION; PERCEPTION; PRECISION	Previous research has shown that precision and power grip performance is consistently influenced by simultaneous articulation. For example, power grip responses are performed relatively fast with the open-back vowel [a], whereas precision grip responses are performed relatively fast with the close-front vowel [i]. In the present study, the participants were presented with a picture of a hand shaped to the precision or power grip. They were required to pronounce speech sounds according to the front/above perspective of the hand. The results showed that not only the grip performance is affected by simultaneously pronouncing the speech sound but also the production of speech sound can be affected by viewing an image of a grip. The precision grip stimulus triggered relatively rapid production of the front-close vowel [i]. In contrast, the effect related to the power grip stimulus was mostly linked to the vertical dimension of the pronounced vowel since this stimulus triggered relatively rapid production of the back-open vowel [a] and back-mid-open vowel [o] while production of the back-close vowel [u] was not influenced by it. The fact that production of the dorsal consonant [k] or coronal consonant [t] were not influenced by these stimuli suggests that the effect was not associated with a relative front-back tongue shape of the articulation in the absence of changes in any vertical articulatory components. These findings provide evidence for an intimate interaction between certain articulatory gestures and grip types, suggesting that an overlapping visuomotor network operates for planning articulatory gestures and grasp actions.	[Vainio, Lari; Rantala, Aleksi; Tiainen, Mikko; Tiippana, Kaisa; Komeilipoor, Naeem; Vainio, Martti] Univ Helsinki, Inst Behav Sci, Div Cognit & Neuropsychol, Helsinki, Finland; [Vainio, Martti] Univ Helsinki, Inst Behav Sci, Phonet & Speech Synth Res Grp, Helsinki, Finland	University of Helsinki; University of Helsinki	Vainio, L (corresponding author), Univ Helsinki, Inst Behav Sci, Div Cognit & Neuropsychol, Helsinki, Finland.	lari.vainio@helsinki.fi	Tiippana, Kaisa/AFQ-7636-2022	Tiippana, Kaisa/0000-0002-2305-8104; Rantala, Aleksi Johannes/0000-0003-0278-5609; Vainio, Martti/0000-0003-2570-0196; Vainio, Lari/0000-0001-7754-9745; Tiainen, Mikko/0000-0003-3245-9337	Academy of Finland [1265610]	Academy of Finland(Academy of Finland)	The research leading to these results has received funding from the Academy of Finland (http://www.aka.fi/fi/akatemia/stn/) under grant agreement numbers 1265610, received by MV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alku P, 2001, FOLIA PHONIATR LOGO, V53, P185, DOI 10.1159/000052674; Andres M, 2004, NEUROREPORT, V15, P2773; Andres M, 2008, CORTEX, V44, P414, DOI 10.1016/j.cortex.2007.08.007; Arbib MA, 2005, BEHAV BRAIN SCI, V28, P105, DOI 10.1017/S0140525X05000038; Binkofski F, 2004, BRAIN LANG, V89, P362, DOI 10.1016/S0093-934X(03)00358-4; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Desmurget M, 2014, P NATL ACAD SCI USA, V111, P5718, DOI 10.1073/pnas.1321909111; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Fant CarlGunnarMichael., 1960, ACOUSTIC THEORY SPEE; Fazio P, 2009, BRAIN, V132, P1980, DOI 10.1093/brain/awp118; Floel A, 2003, EUR J NEUROSCI, V18, P704, DOI 10.1046/j.1460-9568.2003.02774.x; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Forrester GS, 2015, COGNITION, V141, P103, DOI 10.1016/j.cognition.2015.04.012; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gentilucci M, 2004, NEUROPSYCHOLOGIA, V42, P1554, DOI 10.1016/j.neuropsychologia.2004.03.002; Gentilucci M, 2003, EUR J NEUROSCI, V17, P179, DOI 10.1046/j.1460-9568.2003.02438.x; Gentilucci M, 2001, J NEUROPHYSIOL, V86, P1685, DOI 10.1152/jn.2001.86.4.1685; Gentilucci M, 2006, NEUROSCI BIOBEHAV R, V30, P949, DOI 10.1016/j.neubiorev.2006.02.004; Gentilucci M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019793; Graziano MSA, 2007, NEURON, V56, P239, DOI 10.1016/j.neuron.2007.09.013; GREENFIELD PM, 1991, BEHAV BRAIN SCI, V14, P531, DOI 10.1017/S0140525X00071235; Halverson HM, 1931, GENET PSYCHOL MONOGR, V10, P107; HEWES GW, 1973, CURR ANTHROPOL, V14, P5, DOI 10.1086/201401; Higginbotham DR, 2008, EXP BRAIN RES, V186, P603, DOI 10.1007/s00221-007-1265-9; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iverson J. M., 1999, J CONSCIOUSNESS STUD, V6, P19, DOI DOI 10.1016/j.jvoice.2015.09.015; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; MacNeilage PF, 1998, BEHAV BRAIN SCI, V21, P499, DOI 10.1017/S0140525X98001265; Meister IG, 2003, NEUROPSYCHOLOGIA, V41, P401, DOI 10.1016/S0028-3932(02)00179-3; Moretto G, 2008, EXP BRAIN RES, V188, P505, DOI 10.1007/s00221-008-1386-9; Mukamel R, 2010, CURR BIOL, V20, P750, DOI 10.1016/j.cub.2010.02.045; NAPIER JR, 1956, J BONE JOINT SURG BR, V38, P902, DOI 10.1302/0301-620X.38B4.902; Nelissen K, 2005, SCIENCE, V310, P332, DOI 10.1126/science.1115593; Oller DK, 1993, 1 2 LANGUAGE PHONOLO, P45; Oztop E, 2002, BIOL CYBERN, V87, P116, DOI 10.1007/s00422-002-0318-1; Paget R, 1930, HUMAN SPEECH; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Salmelin R, 2002, HUM BRAIN MAPP, V16, P81, DOI 10.1002/hbm.10031; SIMON JR, 1969, J EXP PSYCHOL, V81, P174, DOI 10.1037/h0027448; Sovijarvi A., 1963, SUOMEN KIELEN AANNEK; Stout D, 2012, PHILOS T R SOC B, V367, P75, DOI 10.1098/rstb.2011.0099; Tiainen M, 2016, Q J EXP PSYCHOL, V20, P1; Tokimura H, 1996, ANN NEUROL, V40, P628, DOI 10.1002/ana.410400413; Tucker M, 2001, VIS COGN, V8, P769, DOI 10.1080/13506280042000144; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; Vainio L, 2014, EXP BRAIN RES, V232, P2359, DOI 10.1007/s00221-014-3932-y; Vainio L, 2007, BRAIN COGNITION, V65, P195, DOI 10.1016/j.bandc.2007.07.004; Vainio L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053061; Waters GS, 2002, NEUROL RES, V24, P174, DOI 10.1179/016164102101199585; WHALEN DH, 1995, J PHONETICS, V23, P349, DOI 10.1016/S0095-4470(95)80165-0	57	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170221	10.1371/journal.pone.0170221	http://dx.doi.org/10.1371/journal.pone.0170221			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI3HP	28103278	Green Published, gold			2022-12-26	WOS:000392381100043
J	Huang, YH; Hong, HF; Li, MH; Liu, JF; Jiang, C; Zhang, HB; Ye, LC; Zheng, JH				Huang, Yanhui; Hong, Haifa; Li, Minghui; Liu, Jinfen; Jiang, Chuan; Zhang, Haibo; Ye, Lincai; Zheng, Jinghao			Age-Dependent Oxidative DNA Damage Does Not Correlate with Reduced Proliferation of Cardiomyocytes in Humans	PLOS ONE			English	Article							HEART REGENERATION; CELL; ACTIVATION	Background Postnatal human cardiomyocyte proliferation declines rapidly with age, which has been suggested to be correlated with increases in oxidative DNA damage in mice and plays an important role in regulating cardiomyocyte proliferation. However, the relationship between oxidative DNA damage and age in humans is unclear. Methods Sixty right ventricular outflow myocardial tissue specimens were obtained from ventricular septal defect infant patients during routine congenital cardiac surgery. These specimens were divided into three groups based on age: group A (age 0-6 months), group B (age, 7-12 months), and group C (>12 months). Each tissue specimen was subjected to DNA extraction, RNA extraction, and immunofluorescence. Results immunofluorescence and qRT-PCR analysis revealed that DNA damage markers mitochondrial DNA copy number, oxoguanine 8, and phosphorylated ataxia telangiectasia mutated were highest in Group B. However immunofluorescence and qRT-PCR demonstrated that two cell proliferation markers, Ki67 and cyclin D2, were decreased with age. In addition, wheat germ agglutinin-staining indicated that the average size of cardiomyocytes increased with age. Conclusions Oxidative DNA damage of cardiomyocytes was not correlated positively with age in human beings. Oxidative DNA damage is unable to fully explain the reduced proliferation of human cardiomyocytes.	[Huang, Yanhui] Shanghai Jiao Tong Univ, Sch Med, Dept Anesthesiol, Shanghai Childrens Med Ctr, Shanghai, Peoples R China; [Hong, Haifa; Li, Minghui; Liu, Jinfen; Jiang, Chuan; Zhang, Haibo; Ye, Lincai; Zheng, Jinghao] Shanghai Jiao Tong Univ, Sch Med, Dept Thorac & Cardiovasc Surg, Shanghai Childrens Med Ctr, Shanghai, Peoples R China; [Hong, Haifa; Li, Minghui; Liu, Jinfen; Jiang, Chuan; Ye, Lincai] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Shanghai Inst Pediat Congenital Heart Dis, Shanghai, Peoples R China; [Ye, Lincai] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Inst Pediat Translat Med, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Ye, LC; Zheng, JH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Thorac & Cardiovasc Surg, Shanghai Childrens Med Ctr, Shanghai, Peoples R China.; Ye, LC (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Shanghai Inst Pediat Congenital Heart Dis, Shanghai, Peoples R China.; Ye, LC (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Inst Pediat Translat Med, Shanghai, Peoples R China.	ylc717@163.com; zhengjinghao@scmc.com.cn	ye, lincai/AAQ-6757-2020	ye, lincai/0000-0001-8808-2810; Hong, Haifa/0000-0002-3418-793X	National Basic Research Program of China [2013CB945304]; Natural Science Foundation of Shanghai (CN) [16ZR1421800]; Foundation of Shanghai Health and Family Planning Committee (CN) [20164Y0106]; Foundation of Pudong science and technology development [PKJ2016-Y35]; Foundation of Shanghai Children's Medical Center [YJY-SCMC2016-6]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of Shanghai (CN); Foundation of Shanghai Health and Family Planning Committee (CN); Foundation of Pudong science and technology development; Foundation of Shanghai Children's Medical Center	This work was supported by National Basic Research Program of China [grant number 2013CB945304] (http://www.most.gov.cn/); Natural Science Foundation of Shanghai (CN) (No.16ZR1421800) (http://www.stcsm.gov.cn) (http://kjc.shsmu.edu.cn/); Foundation of Shanghai Health and Family Planning Committee (CN) (No. 20164Y0106) (http://www.wsjsw.gov.cn); Foundation of Pudong science and technology development (PKJ2016-Y35) (http://www.techpudong.gov.cn/); Foundation of Shanghai Childrens Medical Center (YJY-SCMC2016-6) (www.scmc.com.cn).	Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Buggisch M, 2007, J CELL SCI, V120, P885, DOI 10.1242/jcs.03386; Canseco DC, 2015, J AM COLL CARDIOL, V65, P892, DOI 10.1016/j.jacc.2014.12.027; CHENG KC, 1992, J BIOL CHEM, V267, P166; D'Uva G, 2015, NAT CELL BIOL, V17, P627, DOI 10.1038/ncb3149; Kanvah S, 2010, ACCOUNTS CHEM RES, V43, P280, DOI 10.1021/ar900175a; Kimura W, 2015, NATURE, V523, P226, DOI 10.1038/nature14582; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Mollova M, 2013, P NATL ACAD SCI USA, V110, P1446, DOI 10.1073/pnas.1214608110; Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5; Murray TVA, 2015, J MOL CELL CARDIOL, V79, P54, DOI 10.1016/j.yjmcc.2014.10.017; Parmacek MS, 2005, CELL, V120, P295, DOI 10.1016/j.cell.2005.01.025; Phillips NR, 2014, SCI REP-UK, V4, DOI 10.1038/srep03887; Pohjoismaki JLO, 2013, P NATL ACAD SCI USA, V110, P19408, DOI 10.1073/pnas.1303046110; Polizzotti BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5171; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Puente BN, 2014, CELL, V157, P565, DOI 10.1016/j.cell.2014.03.032; ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316; Xia Y, 2013, J PROTEOMICS, V91, P620, DOI 10.1016/j.jprot.2013.10.001; Ye LC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23188; Ye LC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139712; Ying X, 2016, HYPERTENSION; Zebrowski DC, 2015, ELIFE, V4, DOI 10.7554/eLife.05563	24	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170351	10.1371/journal.pone.0170351	http://dx.doi.org/10.1371/journal.pone.0170351			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099512	Green Submitted, Green Published, gold			2022-12-26	WOS:000392380100079
J	Jani, VP; Jelvani, A; Moges, S; Nacharaju, P; Roche, C; Dantsker, D; Palmer, A; Friedman, JM; Cabrales, P				Jani, Vivek P.; Jelvani, Alborz; Moges, Selamawit; Nacharaju, Parimala; Roche, Camille; Dantsker, David; Palmer, Andre; Friedman, Joel M.; Cabrales, Pedro			Polyethylene Glycol Camouflaged Earthworm Hemoglobin	PLOS ONE			English	Article							NITRITE REDUCTASE-ACTIVITY; BLOOD-CELL TRANSFUSION; EXTREME HEMODILUTION; OXYGEN DELIVERY; IN-VITRO; OXIDE; MODEL; PEGYLATION; INFECTION; GENERATE	Nearly 21 million components of blood and whole blood and transfused annually in the United States, while on average only 13.6 million units of blood are donated. As the demand for Red Blood Cells (RBCs) continues to increase due to the aging population, this deficit will be more significant. Despite decades of research to develop hemoglobin (Hb) based oxygen (O-2) carriers (HBOCs) as RBC substitutes, there are no products approved for clinical use. Lumbricus terrestris erythrocruorin (LtEc) is the large acellular O-2 carrying protein complex found in the earthworm Lumbricus terrestris. LtEc is an extremely stable protein complex, resistant to autoxidation, and capable of transporting O-2 to tissue when transfused into mammals. These characteristics render LtEc a promising candidate for the development of the next generation HBOCs. LtEc has a short half-life in circulation, limiting its application as a bridge over days, until blood became available. Conjugation with polyethylene glycol (PEG-LtEc) can extend LtEc circulation time. This study explores PEG-LtEc pharmacokinetics and pharmacodynamics. To study PEG-LtEc pharmacokinetics, hamsters instrumented with the dorsal window chamber were subjected to a 40% exchange transfusion with 10 g/dL PEG-LtEc or LtEc and followed for 48 hours. To study the vascular response of PEG-LtEc, hamsters instrumented with the dorsal window chamber received multiple infusions of 10 g/dL PEG-LtEc or LtEc solution to increase plasma LtEc concentration to 0.5, then 1.0, and 1.5 g/dL, while monitoring the animals' systemic and microcirculatory parameters. Results confirm that PEGylation of LtEc increases its circulation time, extending the half-life to 70 hours, 4 times longer than that of unPEGylated LtEc. However, PEGylation increased the rate of LtEc oxidation in vivo. Vascular analysis verified that PEG-LtEc showed the absence of microvascular vasoconstriction or systemic hypertension. The molecular size of PEG-LtEc did not change the colloid osmotic pressure or blood volume expansion capacity compared to LtEc, due to LtEc's already large molecular size. Taken together, these results further encourage the development of PEG-LtEc as an O-2 carrying therapeutic.	[Jani, Vivek P.; Jelvani, Alborz; Cabrales, Pedro] Univ Calif San Diego, Bioengn, La Jolla, CA 92093 USA; [Moges, Selamawit; Nacharaju, Parimala; Roche, Camille; Dantsker, David; Friedman, Joel M.] Albert Einstein Coll Med, Med, Bronx, NY 10467 USA; [Palmer, Andre] Ohio State Univ, William G Lowrie Dept Chem & Biomol Engn, Columbus, OH 43210 USA	University of California System; University of California San Diego; Yeshiva University; Albert Einstein College of Medicine; University System of Ohio; Ohio State University	Cabrales, P (corresponding author), Univ Calif San Diego, Bioengn, La Jolla, CA 92093 USA.	pcabrales@ucsd.edu	Cabrales, Pedro/A-1930-2014	Cabrales, Pedro/0000-0002-8794-2839; Jani, Vivek/0000-0002-3811-4973	NIH from the Heart Lung and Blood Institute [P01-HL110900, R56-HL123015, R01-HL126945]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110900, R56HL123015, R01HL138116, R01HL126945] Funding Source: NIH RePORTER	NIH from the Heart Lung and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grants from the Heart Lung and Blood Institute, P01-HL110900, R56-HL123015, and R01-HL126945.	Acharya SA, 2005, ARTIF CELL BLOOD SUB, V33, P239, DOI 10.1081/BIO-200066365; Awasthi V, 2003, NUCL MED BIOL, V30, P159, DOI 10.1016/S0969-8051(02)00419-5; Buehler PW, 2004, TRANSFUSION, V44, P1516, DOI 10.1111/j.1537-2995.2004.04081.x; Cabrales P, 2004, AM J PHYSIOL-HEART C, V287, pH320, DOI 10.1152/ajpheart.01166.2003; Cabrales P, 2013, ANTIOXID REDOX SIGN, V18, P2284, DOI 10.1089/ars.2012.5099; Carson JL, 2012, ANN INTERN MED, V157, P49, DOI 10.7326/0003-4819-157-1-201206190-00429; COLANTUONI A, 1985, PFLUG ARCH EUR J PHY, V403, P289, DOI 10.1007/BF00583602; Cole R, 2008, MICROVASC RES, V76, P169, DOI 10.1016/j.mvr.2008.07.002; Cole RH, 2011, ADV EXP MED BIOL, V701, P85, DOI 10.1007/978-1-4419-7756-4_12; CROSBY WH, 1957, BLOOD, V12, P1132, DOI 10.1182/blood.V12.12.1132.1132; Elmer J, 2012, LIFE SCI, V91, P852, DOI 10.1016/j.lfs.2012.08.036; Elmer J, 2012, TRANSFUSION, V52, P1729, DOI 10.1111/j.1537-2995.2011.03523.x; Elmer J, 2012, J FUNCT BIOMATER, V3, P49, DOI 10.3390/jfb3010049; ENDRICH B, 1980, RES EXP MED, V177, P125, DOI 10.1007/BF01851841; Gardner PR, 2006, J INORG BIOCHEM, V100, P542, DOI 10.1016/j.jinorgbio.2005.12.012; Gladwin MT, 2005, AM J RESP CELL MOL, V32, P363, DOI 10.1165/rcmb.F294; Glynn SA, 2000, JAMA-J AM MED ASSOC, V284, P229, DOI 10.1001/jama.284.2.229; Greenwald RB, 2003, ADV DRUG DELIVER REV, V55, P217, DOI 10.1016/S0169-409X(02)00180-1; Harrington JP, 2007, ARTIF CELL BLOOD SUB, V35, P53, DOI 10.1080/10731190600974491; Hill GE, 2003, J TRAUMA, V54, P908, DOI 10.1097/01.TA.0000022460.21283.53; Hirsch RE, 1997, ARTIF CELL BLOOD SUB, V25, P429, DOI 10.3109/10731199709118932; INTAGLIETTA M, 1973, MICROVASC RES, V5, P309, DOI 10.1016/0026-2862(73)90042-3; Juszczak LJ, 2002, BIOCHEMISTRY-US, V41, P376, DOI 10.1021/bi011212r; Khan I, 2001, BIOCHEMISTRY-US, V40, P7581, DOI 10.1021/bi010051o; Li DX, 2006, PROTEIN J, V25, P263, DOI 10.1007/s10930-006-9010-y; LIPOWSKY HH, 1978, MICROVASC RES, V15, P93, DOI 10.1016/0026-2862(78)90009-2; Lui FE, 2008, BIOCHEMISTRY-US, V47, P10773, DOI 10.1021/bi801116k; Lui FE, 2009, BIOCHEMISTRY-US, V48, P11912, DOI 10.1021/bi9014105; MACDONALD VW, 1990, BIOMATER ARTIF CELL, V18, P263, DOI 10.3109/10731199009117306; Nischan N, 2014, J ORG CHEM, V79, P10727, DOI 10.1021/jo502136n; Nowbar AN, 2014, INT J CARDIOL, V174, P293, DOI 10.1016/j.ijcard.2014.04.096; Osaro E, 2010, TRANSFUSION ALTERNAT, V11, P72; Roche CJ, 2006, J BIOL CHEM, V281, P36874, DOI 10.1074/jbc.M603914200; Roche CJ, 2015, J BIOL CHEM, V290, P99, DOI 10.1074/jbc.M114.583260; Roche CJ, 2011, J BIOL CHEM, V286, P23452, DOI 10.1074/jbc.M110.183186; Stinger HK, 2008, J TRAUMA, V64, pS79, DOI 10.1097/TA.0b013e318160a57b; Taylor RW, 2002, CRIT CARE MED, V30, P2249, DOI 10.1097/00003246-200210000-00012; TOMPKINS WR, 1974, REV SCI INSTRUM, V45, P647, DOI 10.1063/1.1686705; Tsai AG, 2006, BLOOD, V108, P3603, DOI 10.1182/blood-2006-02-005272; VAMVAKAS EC, 1994, TRANSFUSION, V34, P464, DOI 10.1046/j.1537-2995.1994.34694295059.x; Winslow RM, 2004, J APPL PHYSIOL, V97, P1527, DOI 10.1152/japplphysiol.00404.2004; Winslow RM, 2013, TRANSFUSION, V53, P424, DOI 10.1111/j.1537-2995.2012.03774.x	42	14	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170041	10.1371/journal.pone.0170041	http://dx.doi.org/10.1371/journal.pone.0170041			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099525	gold, Green Published			2022-12-26	WOS:000392380100052
J	Eastwood, J; Ogbo, FA; Hendry, A; Noble, J; Page, A				Eastwood, John; Ogbo, Felix A.; Hendry, Alexandra; Noble, Justine; Page, Andrew		EYRG	The Impact of Antenatal Depression on Perinatal Outcomes in Australian Women	PLOS ONE			English	Article							POSTNATAL DEPRESSION; MATERNAL DEPRESSION; POSTPARTUM DEPRESSION; MENTAL-HEALTH; RISK-FACTORS; PRENATAL DEPRESSION; MULTIPLE IMPUTATION; CHRONIC ILLNESS; BIRTH OUTCOMES; PREVALENCE	Background In Australia, there is limited evidence on the impact of antenatal depression on perinatal outcomes. This study investigates the association between maternal depressive symptoms during pregnancy and key perinatal outcomes, including birth weight, gestational age at birth, breastfeeding indicators and postnatal depressive symptoms. Method A retrospective cohort of mothers (N = 17,564) of all infants born in public health facilities within South Western Sydney Local Health District and Sydney Local Health District in 2014, in the state of New South Wales (NSW), Australia, was enumerated from routinely collected antenatal data to investigate the risk of adverse perinatal outcomes associated with maternal depressive symptoms during pregnancy. Antenatal depressive symptoms were measured using the Edinburgh Postnatal Depression Scale (EPDS). Logistic regression models that adjusted for confounders were conducted to determine associations between antenatal depressive symptoms and low birth weight, early gestational age at birth (<37 weeks), breast feeding indicators and postnatal depressive symptoms. Results The prevalence of maternal depressive symptoms during pregnancy was 7.0% in the cohort, and was significantly associated with postnatal depressive symptoms [Adjusted Odd Ratios (AOR) = 6.4, 95% CI: 4.8-8.7, P<0.001]. Antenatal depressive symptoms was associated with a higher odds of low birth weight [AOR = 1.7, 95% CI: 1.2-2.3, P = 0.003] and a gestational age at birth of <37 weeks [AOR = 1.3, 95% CI: 1.1-1.7, P = 0.018] compared to women who reported lower EPDS scores in antenatal period. Antenatal depressive symptoms were not strongly associated with non-exclusive breast feeding in the early postnatal period. Conclusion Maternal depressive symptoms in the antenatal period are strongly associated with postnatal depressive symptoms and adverse perinatal outcomes in Australian infants. Early identification of antenatal and postnatal depressive symptoms, and referral for appropriate management could benefit not only the mother's mental health, but also the infant's health and development.	[Eastwood, John] Univ New South Wales, Sch Womens & Childrens Hlth, Kensington, NSW, Australia; [Eastwood, John] Univ Sydney, Sch Publ Hlth, Menzies Ctr Hlth Policy, Charles Perkins Ctr, Sydney, NSW, Australia; [Eastwood, John] Griffith Univ, Sch Publ Hlth, Gold Coast, Qld, Australia; [Eastwood, John; Noble, Justine] Croydon Community Hlth Ctr, Sydney Local Hlth Dist, Dept Community Paediat, Croydon, NSW, Australia; [Eastwood, John; Ogbo, Felix A.; Hendry, Alexandra; Noble, Justine; Page, Andrew] Ingham Inst Appl Med Res, Liverpool, NSW, Australia; [Ogbo, Felix A.] Univ Western Sydney, Sch Med, Ctr Hlth Res, Campbelltown Campus,Locked Bag 1797, Penrith, NSW, Australia; [Hendry, Alexandra; Page, Andrew] Childrens Hosp Westmead, Natl Ctr Immunisat Res & Surveillance, Coverage & Surveillance, Locked Bag 4001, Westmead, NSW, Australia	University of New South Wales Sydney; University of Sydney; Griffith University; Ingham Institute for Applied Medical Research; Western Sydney University; University of Sydney	Ogbo, FA (corresponding author), Ingham Inst Appl Med Res, Liverpool, NSW, Australia.; Ogbo, FA (corresponding author), Univ Western Sydney, Sch Med, Ctr Hlth Res, Campbelltown Campus,Locked Bag 1797, Penrith, NSW, Australia.	felgbo@yahoo.co.uk						Accortt EE, 2015, MATERN CHILD HLTH J, V19, P1306, DOI 10.1007/s10995-014-1637-2; Adewuya AO, 2008, J AFFECT DISORDERS, V108, P191, DOI 10.1016/j.jad.2007.09.013; Alder J, 2007, J MATERN-FETAL NEO M, V20, P189, DOI 10.1080/14767050701209560; Andersson L, 2003, AM J OBSTET GYNECOL, V189, P148, DOI 10.1067/mob.2003.336; [Anonymous], 2005, PERINATAL DEPRESSION; Australian Bureau of Statistics, 2013, TECHN PAP SOC IND AR; Banti S, 2011, COMPR PSYCHIAT, V52, P343, DOI 10.1016/j.comppsych.2010.08.003; Bennett HA, 2004, CLIN DRUG INVEST, V24, P157, DOI 10.2165/00044011-200424030-00004; beyondblue National Postnatal Depression Program, 2005, BEYONDBLUE NATL POST; Bond L, 1998, AUST NZ J PUBL HEAL, V22, P441, DOI 10.1111/j.1467-842X.1998.tb01411.x; BOYCE P, 1993, AUST NZ J PSYCHIAT, V27, P472, DOI 10.3109/00048679309075805; Brown S, 2000, BRIT J OBSTET GYNAEC, V107, P1194, DOI 10.1111/j.1471-0528.2000.tb11607.x; Brown S, 1997, J REPROD INFANT PSYC, V15, P185; CADMAN D, 1987, PEDIATRICS, V79, P805; Centre for Epidemiology and Evidence, 2016, NEW S WAL MOTH BAB 2; Centre for Epidemiology and Evidence, 2014, MOTH BAB 2012; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; David Dunt, 2009, BEYONDBLUE NATL DEPR; De Luca CR, 2013, PEDIATRICS; Dias CC, 2015, J AFFECT DISORDERS, V171, P142, DOI 10.1016/j.jad.2014.09.022; Dwyer JM, 2004, AUSTR NZ HLTH POLICY, V1, P1, DOI DOI 10.1186/1743-8462-1-1; Eberhard-Gran M, 2001, ACTA PSYCHIAT SCAND, V104, P243, DOI 10.1034/j.1600-0447.2001.00187.x; Faisal-Cury A, 2012, REV BRAS PSIQUIATR, V34, P446, DOI 10.1016/j.rbp.2012.01.003; FIELD T, 1992, DEV PSYCHOPATHOL, V4, P49, DOI 10.1017/S0954579400005551; Field T, 2010, INFANT BEHAV DEV, V33, P409, DOI 10.1016/j.infbeh.2010.04.005; Fuggle P, 2002, J REPROD INFANT PSYC, V20, P71, DOI 10.1080/02646830220134603; Gaffney KF, 2014, J PEDIATR HEALTH CAR, V28, P43, DOI 10.1016/j.pedhc.2012.10.005; Gausia K, 2007, J REPROD INFANT PSYC, V25, P308, DOI 10.1080/02646830701644896; Gentile S, 2015, NEUROSCIENCE; Gotlib I.H., 2008, HDB DEPRESSION; GOTLIB IH, 1989, J CONSULT CLIN PSYCH, V57, P269, DOI 10.1037/0022-006X.57.2.269; Gracey M, 2009, LANCET, V374, P65, DOI 10.1016/S0140-6736(09)60914-4; Grigoriadis S, 2013, J CLIN PSYCHIAT, V74, pE321, DOI 10.4088/JCP.12r07968; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Haeri S, 2013, J OBSTET GYNAECOL RE, V39, P948, DOI 10.1111/jog.12017; Hauck YL, 2011, MATERN CHILD HLTH J, V15, P260, DOI 10.1007/s10995-009-0554-2; Henderson JJ, 2003, BIRTH-ISS PERINAT C, V30, P175, DOI 10.1046/j.1523-536X.2003.00242.x; Hiscock H, 2001, PEDIATRICS, V107, P1317, DOI 10.1542/peds.107.6.1317; Huizink AC, 2004, PSYCHOL BULL, V130, P115, DOI 10.1037/0033-2909.130.1.115; Institute for Health Metrics and Evaluation (IHME), 2016, GBD 2015 U WASH IHME; KITAMURA T, 1993, PSYCHOL MED, V23, P967, DOI 10.1017/S003329170002643X; Kohlhoff J, 2015, AUSTR NZ J OBSTET GY; Kramer RA, 1998, J AM ACAD CHILD PSY, V37, P602, DOI 10.1097/00004583-199806000-00010; KUMAR R, 1984, BRIT J PSYCHIAT, V144, P35, DOI 10.1192/bjp.144.1.35; Lee AM, 2007, OBSTET GYNECOL, V110, P1102, DOI 10.1097/01.AOG.0000287065.59491.70; Leigh B, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-24; Leverton T, 2000, IS EPDS MAGIC WAND 1; Maes M, 2008, NEUROENDOCRINOL LETT, V29, P287; Marcus SM, 2008, CAN J CLIN PHARM, V16, pe15; Matthey S, 2006, ARCH WOMEN MENT HLTH, V9, P309, DOI 10.1007/s00737-006-0152-x; Mazhari S, 2007, ARCH WOMEN MENT HLTH, V10, P293, DOI 10.1007/s00737-007-0204-x; Milgrom J, 2008, J AFFECT DISORDERS, V108, P147, DOI 10.1016/j.jad.2007.10.014; Minkovitz CS, 2005, PEDIATRICS, V115, P306, DOI 10.1542/peds.2004-0341; Montazeri A, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-11; Murray D, 1990, J REPROD INFANT PSYC, V8, P99, DOI DOI 10.1080/02646839008403615; MURRAY L, 1990, BRIT J PSYCHIAT, V157, P288, DOI 10.1192/bjp.157.2.288; NEWACHECK PW, 1992, AM J PUBLIC HEALTH, V82, P364, DOI 10.2105/AJPH.82.3.364; Odalovic M, 2015, WOMEN BIRTH, V28, pE31, DOI 10.1016/j.wombi.2015.01.014; Olfson M, 2003, MED CARE, V41, P716, DOI 10.1097/00005650-200306000-00004; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Parslow RA, 2000, AUST NZ J PSYCHIAT, V34, P997, DOI 10.1080/000486700276; Rahman A, 2004, ARCH GEN PSYCHIAT, V61, P946, DOI 10.1001/archpsyc.61.9.946; Rahman A, 2002, CHILD CARE HLTH DEV, V28, P51, DOI 10.1046/j.1365-2214.2002.00239.x; Robertson E, 2004, GEN HOSP PSYCHIAT, V26, P289, DOI 10.1016/j.genhosppsych.2004.02.006; Ross LE, 2013, JAMA PSYCHIAT, V70, P436, DOI 10.1001/jamapsychiatry.2013.684; Segre LS, 2007, SOC PSYCH PSYCH EPID, V42, P316, DOI 10.1007/s00127-007-0168-1; Shakespeare J, 2004, MIDWIFERY, V20, P251, DOI 10.1016/j.midw.2003.12.011; Smith MV, 2011, MATERN CHILD HLTH J, V15, P401, DOI 10.1007/s10995-010-0595-6; South Western Sydney Local Health District, 2014, HLTH PROF LOC COMM S; South Western Sydney Local Health District, 2012, RES STRAT S W SYDN L; Spratt M, 2010, AM J EPIDEMIOL, V172, P478, DOI 10.1093/aje/kwq137; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Stewart RC, 2007, MATERN CHILD NUTR, V3, P94, DOI 10.1111/j.1740-8709.2007.00088.x; Sydney Local Health District, 2012, COMM HLTH STRAT PLAN; Szegda K, 2013, J MATERNAL FETAL NEO; Talge NM, 2007, J CHILD PSYCHOL PSYC, V48, P245, DOI 10.1111/j.1469-7610.2006.01714.x; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Vivilaki V. G., 2009, BMC Public Health, V9; Wang YQ, 2009, INT J NURS STUD, V46, P813, DOI 10.1016/j.ijnurstu.2009.01.010; Weinstock M, 2005, BRAIN BEHAV IMMUN, V19, P296, DOI 10.1016/j.bbi.2004.09.006; World Health Organization (Department of Child and Adolescent Health and Development), 2008, CONCL CONS M HELD 6; Yonkers KA, 2001, AM J PSYCHIAT; Zubaran C, 2013, SEX REPROD HEALTHC, V4, P9, DOI 10.1016/j.srhc.2012.12.001; ZUCKERMAN B, 1989, AM J OBSTET GYNECOL, V160, P1107, DOI 10.1016/0002-9378(89)90170-1	84	90	95	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0169907	10.1371/journal.pone.0169907	http://dx.doi.org/10.1371/journal.pone.0169907			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI3EK	28095461	Green Published, gold, Green Submitted			2022-12-26	WOS:000392372300042
J	Hansen, CS; Osterbye, T; Marcatili, P; Lund, O; Buus, S; Nielsen, M				Hansen, Christian Skjodt; Osterbye, Thomas; Marcatili, Paolo; Lund, Ole; Buus, Soren; Nielsen, Morten			ArrayPitope: Automated Analysis of Amino Acid Substitutions for Peptide Microarray-Based Antibody Epitope Mapping	PLOS ONE			English	Article							MOTIFS	Identification of epitopes targeted by antibodies (B cell epitopes) is of critical importance for the development of many diagnostic and therapeutic tools. For clinical usage, such epitopes must be extensively characterized in order to validate specificity and to document potential cross-reactivity. B cell epitopes are typically classified as either linear epitopes, i.e. short consecutive segments from the protein sequence or conformational epitopes adapted through native protein folding. Recent advances in high-density peptide microarrays enable high-throughput, high resolution identification and characterization of linear B cell epitopes. Using exhaustive amino acid substitution analysis of peptides originating from target antigens, these microarrays can be used to address the specificity of polyclonal antibodies raised against such antigens containing hundreds of epitopes. However, the interpretation of the data provided in such largescale screenings is far from trivial and in most cases it requires advanced computational and statistical skills. Here, we present an online application for automated identification of linear B cell epitopes, allowing the non-expert user to analyse peptide microarray data. The application takes as input quantitative peptide data of fully or partially substituted overlapping peptides from a given antigen sequence and identifies epitope residues (residues that are significantly affected by substitutions) and visualize the selectivity towards each residue by sequence logo plots. Demonstrating utility, the application was used to identify and address the antibody specificity of 18 linear epitope regions in Human Serum Albumin (HSA), using peptide micro array data consisting of fully substituted peptides spanning the entire sequence of HSA and incubated with polyclonal rabbit anti-HSA (and mouse anti-rabbit-Cy3).	[Hansen, Christian Skjodt; Marcatili, Paolo; Lund, Ole; Nielsen, Morten] Tech Univ Denmark, Dept Bio & Hlth Informat, Ctr Biol Sequence Anal, Lyngby, Denmark; [Osterbye, Thomas; Buus, Soren] Univ Copenhagen, Expt Immunol Lab, Fac Hlth Sci, Copenhagen, Denmark; [Nielsen, Morten] Univ Nacl San Martin, Inst Invest Biotecnol, Buenos Aires, DF, Argentina	Technical University of Denmark; University of Copenhagen	Nielsen, M (corresponding author), Tech Univ Denmark, Dept Bio & Hlth Informat, Ctr Biol Sequence Anal, Lyngby, Denmark.; Nielsen, M (corresponding author), Univ Nacl San Martin, Inst Invest Biotecnol, Buenos Aires, DF, Argentina.	mniel@cbs.dtu.dk	Lund, Ole/F-4437-2014; Nielsen, Morten/AAL-8700-2020; Marcatili, Paolo/G-9673-2016	Lund, Ole/0000-0003-1108-0491; Nielsen, Morten/0000-0001-7885-4311; Marcatili, Paolo/0000-0003-2615-5695	European Union Seventh Framework Programme [FP7] [278832]	European Union Seventh Framework Programme [FP7]	The research leading to these results has received funding from the European Union Seventh Framework Programme [FP7/2011] under grant agreement 278832 (HiPAD). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATASSI MZ, 1978, IMMUNOCHEMISTRY, V15, P609, DOI 10.1016/0161-5890(78)90016-0; Buus S, 2012, MOL CELLULAR PROTEOM, P1790; Carmona S, 2015, MOL CELL; Christiansen A, 2015, SCI REP-UK, V5, DOI 10.1038/srep12913; Denisov DA, 2009, MOL IMMUNOL, V46, P429, DOI 10.1016/j.molimm.2008.10.013; Hansen L, 2013, DRYAD DIGITAL REPOSI; Hansen LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068902; Kaever T, 2014, J VIROL, V88, P11339, DOI 10.1128/JVI.01491-14; Kringelum JV, 2013, MOL IMMUNOL, V53, P24, DOI 10.1016/j.molimm.2012.06.001; Legutki JB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5785; Lin J, 2009, J ALLERGY CLIN IMMUN, V124, P315, DOI 10.1016/j.jaci.2009.05.024; Menendez A, 2005, ANAL BIOCHEM, V336, P145, DOI 10.1016/j.ab.2004.09.048; Pande J, 2010, BIOTECHNOL ADV, V28, P849, DOI 10.1016/j.biotechadv.2010.07.004; Regenmortel M. H. V., 2014, J MOL RECOGNIT, V27, P627, DOI DOI 10.1002/JMR.2394; Thomsen MCF, 2012, NUCLEIC ACIDS RES, V40, pW281, DOI 10.1093/nar/gks469; Van Regenmortel M. H. V., 2008, OPEN VACCINE J, V2009, P33; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; Vodnik M, 2011, MOLECULES, V16, P790, DOI 10.3390/molecules16010790	18	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0168453	10.1371/journal.pone.0168453	http://dx.doi.org/10.1371/journal.pone.0168453			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095436	Green Published, gold, Green Submitted			2022-12-26	WOS:000392372300009
J	Hurwitz, AM; Huang, WZ; Kou, BJ; Estes, MK; Atmar, RL; Palzkill, T				Hurwitz, Amy M.; Huang, Wanzhi; Kou, Baijun; Estes, Mary K.; Atmar, Robert L.; Palzkill, Timothy			Identification and Characterization of Single-Chain Antibodies that Specifically Bind GI Noroviruses	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; MONOCLONAL-ANTIBODIES; BROAD REACTIVITY; GENOGROUP-II; GASTROENTERITIS; ANTIGEN; INFECTIONS; DIAGNOSIS; EPITOPE; SAMPLES	Norovirus infections commonly lead to outbreaks of acute gastroenteritis and spread quickly, resulting in many health and economic challenges prior to diagnosis. Rapid and reliable diagnostic tests are therefore essential to identify infections and to guide the appropriate clinical responses at the point-of-care. Existing tools, including RT-PCR and enzyme immunoassays, pose several limitations based on the significant time, equipment and expertise required to elicit results. lmmunochromatographic assays available for use at the point-of-care have poor sensitivity and specificity, especially for genogroup I noroviruses, thus requiring confirmation of results with more sensitive testing methods. Therefore, there is a clear need for novel reagents to help achieve quick and reliable results. In this study, we have identified two novel single-chain antibodies (scFvs) named NJT-R3-A2 and NJT-R3-A3 that effectively detect GI.1 and GI.7 virus-like particles (VLPs) through selection of a phage display library against the P-domain of the GI.1 major capsid protein. The limits of detection by each scFv for GI.1 and GI.7 are 0.1 and 0.2 ng, and 6.25 and 25 ng, respectively. They detect VLPs with strong specificity in multiple diagnostic formats, including ELISAs and membrane-based dot blots, and in the context of norovirus-negative stool suspensions. The scFvs also detect native virions effectively in norovirus-positive clinical stool samples. Purified scFvs bind to GI.1 and GI.7 VLPs with equilibrium constant (KD) values of 27 nM and 49 nM, respectively. Overall, the phage-based scFv reagents identified and characterized here show utility for detecting GI.1 and GI.7 noroviruses in multiple diagnostic assay formats with strong specificity and sensitivity, indicating promise for integration into existing point-of-care tests to improve future diagnostics.	[Hurwitz, Amy M.] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Hurwitz, Amy M.; Huang, Wanzhi; Palzkill, Timothy] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Kou, Baijun; Estes, Mary K.; Atmar, Robert L.; Palzkill, Timothy] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Estes, Mary K.; Atmar, Robert L.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Palzkill, T (corresponding author), Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA.; Palzkill, T (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.	timothyp@bcm.edu	Atmar, Robert/AFQ-5392-2022	Atmar, Robert/0000-0001-9989-6772	National Library of Medicine; National Institute of Allergy and Infectious Diseases [AI057788]; Keck Center for Interdisciplinary Bioscience Training of the Gulf Coast Consortia [T15 LM007093]; National Institute of General Medical Sciences [T32GM088129]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088129] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007093] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Keck Center for Interdisciplinary Bioscience Training of the Gulf Coast Consortia; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the National Library of Medicine and by the National Institute of Allergy and Infectious Diseases, grant AI057788. AMH was supported by a training fellowship from the Keck Center for Interdisciplinary Bioscience Training of the Gulf Coast Consortia (Grant No. T15 LM007093). This work was also supported in part by the National Institute of General Medical Sciences, award number T32GM088129. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambert-Balay K, 2013, J CLIN VIROL, V56, P194, DOI 10.1016/j.jcv.2012.11.001; Atmar RL, 2008, EMERG INFECT DIS, V14, P1553, DOI 10.3201/eid1410.080117; Atmar RL, 2015, CLIN VACCINE IMMUNOL, V22, P923, DOI 10.1128/CVI.00196-15; Bartsch SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151219; Bates PA, 2001, PROTEINS, P39; Battaglioli G, 2012, J CLIN VIROL, V53, P262, DOI 10.1016/j.jcv.2011.12.007; Beersma MFC, 2012, J CLIN MICROBIOL, V50, P3040, DOI 10.1128/JCM.00908-12; Bernstein DI, 2014, J INFECT DIS, V211; Bertolotti-Ciarlet A, 2002, J VIROL, V76, P4044, DOI 10.1128/JVI.76.8.4044-4055.2002; Bok K, 2012, NEW ENGL J MED, V367, P2126, DOI 10.1056/NEJMra1207742; Bruggink LD, 2015, J VIROL METHODS, V223, P82, DOI 10.1016/j.jviromet.2015.07.019; Burton-MacLeod JA, 2004, J CLIN MICROBIOL, V42, P2587, DOI 10.1128/JCM.42.6.2587-2595.2004; de Bruin E, 2006, J VIROL METHODS, V137, P259, DOI 10.1016/j.jviromet.2006.06.024; de Wildt RMT, 2000, NAT BIOTECHNOL, V18, P989, DOI 10.1038/79494; Donaldson EF, 2008, IMMUNOL REV, V225, P190, DOI 10.1111/j.1600-065X.2008.00680.x; GREEN KY, 1993, J CLIN MICROBIOL, V31, P2185, DOI 10.1128/JCM.31.8.2185-2191.1993; Hale AD, 2000, J CLIN MICROBIOL, V38, P1656, DOI 10.1128/JCM.38.4.1656-1660.2000; Hardy ME, 1996, VIROLOGY, V217, P252, DOI 10.1006/viro.1996.0112; Huang WZ, 2014, PROTEIN ENG DES SEL, V27, P339, DOI 10.1093/protein/gzu023; KAPIKIAN AZ, 1972, J VIROL, V10, P1075, DOI 10.1128/JVI.10.5.1075-1081.1972; Kitamoto N, 2002, J CLIN MICROBIOL, V40, P2459, DOI 10.1128/JCM.40.7.2459-2465.2002; Kou BJ, 2015, J CLIN MICROBIOL, V53, P3916, DOI 10.1128/JCM.02371-15; Kou B, 2015, CLIN VACCINE IMMUNOL, V22, P160, DOI 10.1128/CVI.00519-14; Lindesmith LC, 2011, J VIROL, V85, P231, DOI 10.1128/JVI.01364-10; Lopman B., 2015, GLOBAL BURDEN NOROVI; Moore C, 2013, J HOSP INFECT, V85, P1, DOI 10.1016/j.jhin.2013.06.005; O'Farrell B., 2013, IMMUNOASSAY HDB, P89, DOI [10.1016/B978-0-08-097037-0.00007-5, DOI 10.1016/B978-0-08-097037-0.00007-5]; OSHANNESSY DJ, 1993, ANAL BIOCHEM, V212, P457, DOI 10.1006/abio.1993.1355; Parker TD, 2005, J VIROL, V79, P7402, DOI 10.1128/JVI.79.12.7402-7409.2005; Parra GI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067592; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; Ramani S, 2014, CURR OPIN GASTROEN, V30, P25, DOI 10.1097/MOG.0000000000000022; Rogers JD, 2013, J CLIN MICROBIOL, V51, P1803, DOI 10.1128/JCM.00295-13; Rovida F, 2013, DIAGN MICR INFEC DIS, V75, P110, DOI 10.1016/j.diagmicrobio.2012.09.016; Shiota T, 2007, J VIROL, V81, P12298, DOI 10.1128/JVI.00891-07; Siddiq DM, 2011, J INFECTION, V63, P394, DOI 10.1016/j.jinf.2011.08.002; Teunis PFM, 2008, NORWALK VIRUS INFECT, V1476, P1468; Vinje J, 2014, J CLIN MICROBIOL; Ye X, 2015, AM J TRANSPLANT, V15, P1874, DOI 10.1111/ajt.13227; Yee EL, 2007, CLIN INFECT DIS, V44, P1032, DOI 10.1086/512195; Yoda T, 2003, J CLIN MICROBIOL, V41, P2367, DOI 10.1128/JCM.41.6.2367-2371.2003	42	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0170162	10.1371/journal.pone.0170162	http://dx.doi.org/10.1371/journal.pone.0170162			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095447	gold, Green Published, Green Submitted			2022-12-26	WOS:000392372300064
J	Mendez, F; Romero, N; Cubas, LL; Delgui, LR; Rodriguez, D; Rodriguez, JF				Mendez, Fernando; Romero, Nicolas; Cubas, Liliana L.; Delgui, Laura R.; Rodriguez, Dolores; Rodriguez, Jose F.			Non-Lytic Egression of Infectious Bursal Disease Virus (IBDV) Particles from Infected Cells	PLOS ONE			English	Article							ANION CHANNEL 2; NONSTRUCTURAL PROTEIN; INHIBITS APOPTOSIS; VIRAL REPLICATION; LIFE-CYCLE; VP5; PATHWAY; IDENTIFICATION; EVOLUTION; AUTOPHAGY	Infectious bursal disease virus (IBDV), a member of the Birnaviridae family, is responsible for a devastating immunosuppressive disease affecting juvenile domestic chickens. IBDV particles are naked icosahedrons enclosing a bipartite double-stranded RNA genome harboring three open reading frames (ORF). One of these ORFs codes for VP5, a non-structural polypeptide dispensable for virus replication in tissue culture but essential for IBDV pathogenesis. Using two previously described recombinant viruses, whose genomes differ in a single nucleotide, expressing or not the VP5 polypeptide, we have analyzed the role of this polypeptide during the IBDV replication process. Here, we show that VP5 is not involved in house-keeping steps of the virus replication cycle; i.e. genome transcription/replication, protein translation and virus assembly. Although infection with the VP5 expressing and non-expressing viruses rendered similar intracellular infective progeny yields, striking differences were detected on the ability of their progenies to exiting infected cells. Experimental data shows that the bulk of the VP5-expressing virus progeny efficiently egresses infected cells during the early phase of the infection, when viral metabolism is peaking and virus-induced cell death rates are as yet minimal, as determined by qPCR, radioactive protein labeling and quantitative real-time cell death analyses. In contrast, the release of the VP5-deficient virus progeny is significantly abridged and associated to cell death. Taken together, data presented in this report show that IBDV uses a previously undescribed VP5-dependent non-lytic egress mechanism significantly enhancing the virus dissemination speed. Ultrastructural analyses revealed that newly assembled IBDV virions associate to a vesicular network apparently facilitating their trafficking from virus assembly factories to the extracellular milieu, and that this association requires the expression of the VP5 polypeptide.	[Mendez, Fernando; Romero, Nicolas; Cubas, Liliana L.; Rodriguez, Dolores; Rodriguez, Jose F.] CSIC, Dept Biol Mol & Celular, Ctr Nacl Biotecnol, Madrid, Spain; [Delgui, Laura R.] Univ Nacl Cuyo, CONICET, Inst Histol & Embriol Mendoza, Mendoza, Argentina	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza	Rodriguez, JF (corresponding author), CSIC, Dept Biol Mol & Celular, Ctr Nacl Biotecnol, Madrid, Spain.	jfrodrig@cnb.csic.es	Rodríguez, José F/T-8500-2017; Rodriguez, Dolores/ABF-9855-2020	Rodríguez, José F/0000-0001-7944-5341; Delgui, Laura Ruth/0000-0002-3647-3593; Rodriguez, Dolores/0000-0001-6365-4501	Spanish Ministry of Economy and Competitiveness [AGL2014-60095-P]; International Fellowship Programme from La Caixa Foundation	Spanish Ministry of Economy and Competitiveness(Spanish Government); International Fellowship Programme from La Caixa Foundation	This study was supported by grant AGL2014-60095-P, Spanish Ministry of Economy and Competitiveness (http://www.idi.mineco.gob.es/portal/site/MICINN/). LLC was supported by a pre-doctoral research contract from the International Fellowship Programme from La Caixa Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist P, 2005, CURR BIOL, V15, pR465, DOI 10.1016/j.cub.2005.06.016; Atay O, 2014, MOL BIOL CELL, V25, P3445, DOI 10.1091/mbc.E14-02-0718; Bar S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000126; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Bird SW, 2015, VIROLOGY, V479, P444, DOI 10.1016/j.virol.2015.03.044; Bird SW, 2014, P NATL ACAD SCI USA, V111, P13081, DOI 10.1073/pnas.1401437111; Birghan C, 2000, EMBO J, V19, P114, DOI 10.1093/emboj/19.1.114; Bottcher B, 1997, J VIROL, V71, P325; Cory JS, 2003, ANNU REV ECOL EVOL S, V34, P239, DOI 10.1146/annurev.ecolsys.34.011802.132402; Delgui LR, 2013, J VIROL, V87, P8993, DOI 10.1128/JVI.03152-12; Delmas B, 2012, VIRUS TAXONOMY, P499; Doceul V, 2010, SCIENCE, V327, P873, DOI 10.1126/science.1183173; Feng ZD, 2013, NATURE, V496, P367, DOI 10.1038/nature12029; Fernandez-Arias A, 1998, J GEN VIROL, V79, P1047, DOI 10.1099/0022-1317-79-5-1047; Garriga D, 2006, J VIROL, V80, P6895, DOI 10.1128/JVI.00368-06; Granzow H, 1997, J VIROL, V71, P8879, DOI 10.1128/JVI.71.11.8879-8885.1997; Hu BL, 2015, AUTOPHAGY, V11, P503, DOI 10.1080/15548627.2015.1017184; HUDSON PJ, 1986, NUCLEIC ACIDS RES, V14, P5001, DOI 10.1093/nar/14.12.5001; HYATT AD, 1989, VIROLOGY, V173, P21, DOI 10.1016/0042-6822(89)90218-3; Ingrao F, 2013, DEV COMP IMMUNOL, V41, P429, DOI 10.1016/j.dci.2013.03.017; Li ZH, 2012, J VIROL, V86, P1328, DOI 10.1128/JVI.06104-11; Lin WC, 2015, J BIOL CHEM, V290, P8500, DOI 10.1074/jbc.M114.585687; Liu MH, 2006, J VIROL, V80, P3369, DOI 10.1128/JVI.80.7.3369-3377.2006; Lombardo E, 2000, VIROLOGY, V277, P345, DOI 10.1006/viro.2000.0595; Luque D, 2009, P NATL ACAD SCI USA, V106, P2148, DOI 10.1073/pnas.0808498106; Carballeda JM, 2015, VIROLOGY, V483, P312, DOI 10.1016/j.virol.2015.05.003; Mendez F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123470; Mundt E, 1997, J VIROL, V71, P5647, DOI 10.1128/JVI.71.7.5647-5651.1997; MUNDT E, 1995, J GEN VIROL, V76, P437, DOI 10.1099/0022-1317-76-2-437; Rancurel C, 2009, J VIROL, V83, P10719, DOI 10.1128/JVI.00595-09; Roizman B., 1996, MED MICROBIOLOGY; Sanchez AB, 1999, VIROLOGY, V262, P190, DOI 10.1006/viro.1999.9910; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; von Einem UI, 2004, J GEN VIROL, V85, P2221, DOI 10.1099/vir.0.19772-0; Wei L, 2011, VIROLOGY, V417, P211, DOI 10.1016/j.virol.2011.03.003; Wu YP, 2009, ARCH VIROL, V154, P1873, DOI 10.1007/s00705-009-0524-4; Yao K, 1998, J VIROL, V72, P2647, DOI 10.1128/JVI.72.4.2647-2654.1998	37	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0170080	10.1371/journal.pone.0170080	http://dx.doi.org/10.1371/journal.pone.0170080			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095450	Green Published, gold			2022-12-26	WOS:000392372300055
J	Chang, H; Smallwood, PM; Williams, J; Nathans, J				Chang, Hao; Smallwood, Philip M.; Williams, John; Nathans, Jeremy			Intramembrane Proteolysis of Astrotactins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						intramembrane proteolysis; membrane protein; protein processing; protein sequence; transmembrane domain	SIGNAL PEPTIDE PEPTIDASE; NEURONAL MIGRATION; INVARIANT CHAIN; 3 SPPL3; B-CELL; PROTEASE SPPL2A; RECEPTOR; GLYCOSYLATION; CLEAVAGE; DOMAIN	Astrotactins are vertebrate-specific membrane proteins implicated in neuron-glia interactions during central nervous system development and in hair follicle polarity during skin development. By studying epitope-tagged derivatives of mouse astrotactin-2 (Astn2) produced in transfected cells, we determined that the amino and carboxyl termini reside in the extracellular space and are initially linked by two transmembrane segments and a single cytoplasmic domain. We further show that Astn2 undergoes proteolytic cleavage in the second transmembrane domain (TM2) and that a disulfide bond holds the resulting two fragments together. Recombinant Astn1 also undergoes TM2 cleavage, as does Astn2 isolated from mouse cerebellum. Astn2 intramembrane proteolysis is insensitive to replacement of TM2 by the transmembrane domain of CD74 or by 21 alanines. However, replacement of TM2 by the transmembrane domain of CD4, the asialoglycoprotein receptor, or the transferrin receptor eliminates intramembrane proteolysis, as does leucine substitution of residues that overlap or are immediately upstream of the cleavage site. Replacement of the transmembrane domain of CD74 or the asialoglycoprotein receptor with Astn2 TM2 leads to the appearance of a carboxyl-terminal fragment consistent with intramembrane proteolysis. These experiments define a highly unusual transmembrane topology for the astrotactins, reveal intramembrane proteolysis as a feature of astrotactin maturation, and constrain the substrate sequences that are permissive for cleavage of one type 2 transmembrane segment.	[Chang, Hao; Smallwood, Philip M.; Williams, John; Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA; [Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Ophthalmol, Baltimore, MD 21205 USA; [Chang, Hao] Univ Wisconsin Madison, Dept Dermatol, 1300 Univ Ave, Madison, WI 53706 USA	Howard Hughes Medical Institute; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; University of Wisconsin System; University of Wisconsin Madison	Nathans, J (corresponding author), Johns Hopkins Univ, Sch Med, 805 PCTB,725 N Wolfe St, Baltimore, MD 21205 USA.	jnathans@jhmi.edu		Nathans, Jeremy/0000-0001-8106-5460	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by the Howard Hughes Medical Institute. The authors declare that they have no conflicts of interest with the contents of this article.	Adams NC, 2002, DEVELOPMENT, V129, P965; ALARCON C, 1994, BIOCHEM J, V301, P257, DOI 10.1042/bj3010257; Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Beisner DR, 2013, J EXP MED, V210, P23, DOI 10.1084/jem.20121072; Bergmann H, 2013, J EXP MED, V210, P31, DOI 10.1084/jem.20121076; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Chang H, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005532; Chen G, 2010, PROTEIN SCI, V19, P2015, DOI 10.1002/pro.496; DRICKAMER K, 1987, KIDNEY INT, V32, pS167; FISHELL G, 1991, DEVELOPMENT, V113, P755; Fluhrer R, 2012, J BIOL CHEM, V287, P5156, DOI 10.1074/jbc.M111.328104; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Golde TE, 2009, SEMIN CELL DEV BIOL, V20, P225, DOI 10.1016/j.semcdb.2009.02.003; HEDO JA, 1983, J BIOL CHEM, V258, P20; HERZ J, 1990, EMBO J, V9, P1769, DOI 10.1002/j.1460-2075.1990.tb08301.x; Huttl S, 2016, BIOCHEM J, V473, P1405, DOI 10.1042/BCJ20160156; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; Jurisch-Yaksi N, 2013, BBA-BIOMEMBRANES, V1828, P2815, DOI 10.1016/j.bbamem.2013.04.016; Kirkin V, 2007, CELL DEATH DIFFER, V14, P1678, DOI 10.1038/sj.cdd.4402175; Kuhn PH, 2015, MOL CELL PROTEOMICS, V14, P1584, DOI 10.1074/mcp.M115.048298; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Lionel AC, 2014, HUM MOL GENET, V23, P2752, DOI 10.1093/hmg/ddt669; Manolaridis I, 2013, NATURE, V504, P301, DOI 10.1038/nature12754; Martin L, 2009, J BIOL CHEM, V284, P5662, DOI 10.1074/jbc.M807485200; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P9746, DOI 10.1021/bi00493a034; Ni T, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160053; PARNES JR, 1987, IMMUNOL REV, V100, P109, DOI 10.1111/j.1600-065X.1987.tb00529.x; Price M, 2003, MOL BRAIN RES, V117, P58, DOI 10.1016/S0169-328X(03)00285-7; SCHNEIDER C, 1984, NATURE, V311, P675, DOI 10.1038/311675b0; Schneppenheim J, 2013, J EXP MED, V210, P41, DOI 10.1084/jem.20121069; Stumptner-Cuvelette P, 2002, BBA-MOL CELL RES, V1542, P1, DOI 10.1016/S0167-4889(01)00166-5; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Urban S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-231; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Voss M, 2014, EMBO J, V33, P2890, DOI 10.15252/embj.201488375; Voss M, 2013, BBA-BIOMEMBRANES, V1828, P2828, DOI 10.1016/j.bbamem.2013.03.033; Voss M, 2012, J BIOL CHEM, V287, P43401, DOI 10.1074/jbc.M112.371369; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Weber S, 2012, DEVELOPMENT, V139, P3693, DOI 10.1242/dev.076398; Weber S, 2011, DEVELOPMENT, V138, P495, DOI 10.1242/dev.055210; Wilson PM, 2010, J NEUROSCI, V30, P8529, DOI 10.1523/JNEUROSCI.0032-10.2010; Zahn C, 2013, FEBS J, V280, P1653, DOI 10.1111/febs.12176; ZERIAL M, 1986, EMBO J, V5, P1543, DOI 10.1002/j.1460-2075.1986.tb04395.x; Zheng C, 1996, SCIENCE, V272, P417, DOI 10.1126/science.272.5260.417	44	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3506	3516		10.1074/jbc.M116.768077	http://dx.doi.org/10.1074/jbc.M116.768077			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28100779	Green Published, hybrid			2022-12-26	WOS:000395538800038
J	Dagenais-Bellefeuille, S; Beauchemin, M; Morse, D				Dagenais-Bellefeuille, Steve; Beauchemin, Mathieu; Morse, David			miRNAs Do Not Regulate Circadian Protein Synthesis in the Dinoflagellate Lingulodinium polyedrum	PLOS ONE			English	Article							LUCIFERIN-BINDING-PROTEIN; ALGA CHLAMYDOMONAS-REINHARDTII; DOUBLE-STRANDED-RNA; GONYAULAX-POLYEDRA; MESSENGER-RNA; BIOLUMINESCENCE RHYTHM; GENE TRANSCRIPTS; EXPRESSION; MICRORNAS; SYMBIODINIUM	Dinoflagellates have been shown to express miRNA by bioinformatics and RNA blot (Northern) analyses. However, it is not yet known if miRNAs are able to alter gene expression in this class of organisms. We have assessed the possibility that miRNA may mediate circadian regulation of gene expression in the dinoflagellate Lingulodinium polyedrum using the Luciferin Binding Protein (LBP) as a specific example. LBP is a good candidate for regulation by miRNA since mRNA levels are constant over the daily cycle while protein synthesis is restricted by the circadian clock to a period of several hours at the start of the night phase. The transcriptome contains a potential DICER and an ARGONAUTE, suggesting the machinery for generating miRNAs is present. Furthermore, a probe directed against an abundant Symbiodinium miRNA cross reacts on Northern blots. However, L. polyedrum has no small RNAs detectable by ethidium bromide staining, even though higher plant miRNAs run in parallel are readily observed. Illumina sequencing of small RNAs showed that the majority of reads did not have a match in the L. polyedrum transcriptome, and those that did were almost all sense strand mRNA fragments. A direct search for 18-26 nucleotide long RNAs capable of forming duplexes with a 2 base 3' overhang detected 53 different potential miRNAs, none of which was able to target any of the known circadian regulated genes. Lastly, a microscopy-based test to assess synthesis of the naturally fluorescent LBP in single cells showed that neither double-stranded nor antisense lbp RNA introduced into cells by microparticle bombardment prior to the time of LBP synthesis were able to reduce the amount of LBP produced. Taken together, our results indicate that circadian control of protein synthesis in L. polyedrum is not mediated by miRNAs.	[Dagenais-Bellefeuille, Steve; Beauchemin, Mathieu; Morse, David] Univ Montreal, Inst Rech Biol Vegetale, Dept Sci Biol, Montreal, PQ, Canada	Universite de Montreal	Morse, D (corresponding author), Univ Montreal, Inst Rech Biol Vegetale, Dept Sci Biol, Montreal, PQ, Canada.	david.morse@umontreal.ca		Dagenais Bellefeuille, Steve/0000-0001-5281-5971; Morse, David/0000-0003-4131-4367	National Science and Engineering Research Council (NSERC) of Canada [171382-03]; Fond de Recherche du Quebec-Nature et Technologies; NSERC	National Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fond de Recherche du Quebec-Nature et Technologies; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors gratefully acknowledge support from the National Science and Engineering Research Council (NSERC) of Canada by a discovery grant (171382-03; D.M.), a summer research studentship and a doctoral studentship from the Fond de Recherche du Quebec-Nature et Technologies (S.D.-B.) and an NSERC doctoral studentship (M.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Al Riyahi A, 2006, INT J PARASITOL, V36, P1003, DOI 10.1016/j.ijpara.2006.04.014; Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Baumgarten S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-704; Beauchemin M, 2012, P NATL ACAD SCI USA, V109, P15793, DOI 10.1073/pnas.1206683109; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Chaput H, 2002, PROTIST, V153, P111, DOI 10.1078/1434-4610-00090; COLEPICOLO P, 1992, CHRONOBIOL INT, V9, P266, DOI 10.3109/07420529209064536; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; DESJARDINS M, 1993, BIOCHEM CELL BIOL, V71, P176, DOI 10.1139/o93-028; ESAIAS WE, 1973, J CELL PHYSIOL, V82, P363, DOI 10.1002/jcp.1040820306; Fagan T, 1999, BIOCHEMISTRY-US, V38, P7689, DOI 10.1021/bi9826005; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Ortiz-Matamoros MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132693; FOGEL M, 1972, P NATL ACAD SCI USA, V69, P690, DOI 10.1073/pnas.69.3.690; FRITZ L, 1990, J CELL SCI, V95, P321; Gao DH, 2013, EVOL BIOINFORM, V9, P479, DOI 10.4137/EBO.S12899; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hastings JW, 1987, J CELL SCI, V87, P189; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; JOHNSON CH, 1985, J CELL BIOL, V100, P1435, DOI 10.1083/jcb.100.5.1435; JOHNSON CH, 1984, SCIENCE, V223, P1428, DOI 10.1126/science.223.4643.1428; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Klahre U, 2002, P NATL ACAD SCI USA, V99, P11981, DOI 10.1073/pnas.182204199; Kuenne C, 2014, BIOINFORMATICS, V30, P3412, DOI 10.1093/bioinformatics/btu573; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lapointe M, 2008, BIOL CHEM, V389, P13, DOI 10.1515/BC.2008.003; Le QH, 2001, BIOL RHYTHM RES, V32, P579, DOI 10.1076/brhm.32.5.579.1290; Lin SJ, 2015, SCIENCE, V350, P691, DOI 10.1126/science.aad0408; Liu BL, 2012, SEX PLANT REPROD, V25, P205, DOI 10.1007/s00497-012-0192-5; MACHABEE S, 1994, PLANT MOL BIOL, V25, P23, DOI 10.1007/BF00024195; Mapleson D, 2013, J EXP ZOOL PART B, V320B, P47, DOI 10.1002/jez.b.22483; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Markovic P, 1996, J BIOL RHYTHM, V11, P57, DOI 10.1177/074873049601100106; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Miller M.A., 2010, P GAT COMP ENV WORKS; MITTAG M, 1994, P NATL ACAD SCI USA, V91, P5257, DOI 10.1073/pnas.91.12.5257; Mittag M, 1998, CHRONOBIOL INT, V15, P93, DOI 10.3109/07420529808998673; Mizumoto H, 2007, J VIROL, V81, P1372, DOI 10.1128/JVI.01082-06; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; MORSE D, 1989, P NATL ACAD SCI USA, V86, P172, DOI 10.1073/pnas.86.1.172; MORSE D, 1989, J BIOL CHEM, V264, P11822; Nassoury N, 2005, TRAFFIC, V6, P548, DOI 10.1111/j.1600-0854.2005.00296.x; Nassoury N, 2005, CIRCADIAN CLOCK EUKA; NICOLAS MT, 1991, PROTOPLASMA, V160, P159, DOI 10.1007/BF01539967; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Roy S, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0107-z; Roy S, 2014, PLANT PHYSIOL, V164, P966, DOI 10.1104/pp.113.229856; SCHMITTER RE, 1976, J CELL PHYSIOL, V87, P123, DOI 10.1002/jcp.1040870115; Shefi O, 2006, J NEUROSCI, V26, P6119, DOI 10.1523/JNEUROSCI.1237-06.2006; ten Lohuis MR, 1998, PLANT J, V13, P427; Tomaru Y, 2004, AQUAT MICROB ECOL, V34, P207, DOI 10.3354/ame034207; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang YL, 2006, NUCLEIC ACIDS RES, V34, P613, DOI 10.1093/nar/gkj438; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104; Zhao T, 2007, GENE DEV, V21, P1190, DOI 10.1101/gad.1543507	63	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0168817	10.1371/journal.pone.0168817	http://dx.doi.org/10.1371/journal.pone.0168817			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103286	Green Submitted, Green Published, gold			2022-12-26	WOS:000392381100006
J	Mellott, TJ; Huleatt, OM; Shade, BN; Pender, SM; Liu, YB; Slack, BE; Blusztajn, JK				Mellott, Tiffany J.; Huleatt, Olivia M.; Shade, Bethany N.; Pender, Sarah M.; Liu, Yi B.; Slack, Barbara E.; Blusztajn, Jan K.			Perinatal Choline Supplementation Reduces Amyloidosis and Increases Choline Acetyltransferase Expression in the Hippocampus of the APPswePS1 dE9 Alzheimer's Disease Model Mice	PLOS ONE			English	Article							PRENATAL ALCOHOL EXPOSURE; APPSWE/PS1DE9 MOUSE MODEL; AVAILABILITY MODULATES HIPPOCAMPAL; NEURAL-TUBE DEFECTS; DIETARY CHOLINE; APOLIPOPROTEIN-E; MEMORY DEFICITS; DOWN-SYNDROME; BEHAVIORAL ALTERATIONS; ACETYLCHOLINE-RELEASE	Prevention of Alzheimer's disease (AD) is a major goal of biomedical sciences. In previous studies we showed that high intake of the essential nutrient, choline, during gestation prevented age-related memory decline in a rat model. In this study we investigated the effects of a similar treatment on AD-related phenotypes in a mouse model of AD. We crossed wild type (WT) female mice with hemizygous APPswe/PS1dE9 (APP.PS1) AD model male mice and maintained the pregnant and lactating dams on a control AIN76A diet containing 1.1 g/kg of choline or a choline-supplemented (5 g/kg) diet. After weaning all offspring consumed the control diet. As compared to APP.PS1 mice reared on the control diet, the hippocampus of the perinatally choline-supplemented APP.PS1 mice exhibited: 1) altered levels of amyloid precursor protein (APP) metabolites specifically elevated amounts of beta-C-terminal fragment (beta-CTF) and reduced levels of solubilized amyloid A beta 40 and A beta 42 peptides; 2) reduced number and total area of amyloid plaques; 3) preserved levels of choline acetyltransferase protein (CHAT) and insulin-like growth factor II (IGF2) and 4) absence of astrogliosis. The data suggest that dietary supplementation of choline during fetal development and early postnatal life may constitute a preventive strategy for AD.	[Mellott, Tiffany J.; Huleatt, Olivia M.; Shade, Bethany N.; Pender, Sarah M.; Liu, Yi B.; Slack, Barbara E.; Blusztajn, Jan K.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA	Boston University	Mellott, TJ (corresponding author), Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA.	tmellott@bu.edu	Slack, Barbara/AAU-9917-2021	/0000-0001-8438-3122	BUADC pilot grant; Alzheimer's Association [NIRG-10-17273]; NIH [AG009525, AG045031]; NATIONAL INSTITUTE ON AGING [R01AG045031, P01AG009525] Funding Source: NIH RePORTER	BUADC pilot grant; Alzheimer's Association(Alzheimer's Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by BUADC pilot grant and NIRG-10-17273 grant from the Alzheimer's Association to TJM and NIH grants AG009525 and AG045031 to JKB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agis-Balboa RC, 2011, EMBO J, V30, P4071, DOI 10.1038/emboj.2011.293; Alberini CM, 2012, TRENDS NEUROSCI, V35, P274, DOI 10.1016/j.tins.2011.12.007; Ash JA, 2014, NEUROBIOL DIS, V70, P32, DOI 10.1016/j.nbd.2014.06.001; Bartus RT, 2000, EXP NEUROL, V163, P495, DOI 10.1006/exnr.2000.7397; Bekdash RA, 2013, ALCOHOL CLIN EXP RES; BIERI JG, 1977, J NUTR, V107, P1394; Bieri JG., 1980, J NUTR, V110, P1726, DOI [10.1093/jn/110.8.1726, DOI 10.1093/JN/110.8.1726]; Blusztajn JK, 2000, METAB BRAIN DIS, V15, P45, DOI 10.1007/BF02680013; Blusztajn JK, 2012, CHOLINE NUTR PROGR B; Bracko O, 2012, J NEUROSCI, V32, P3376, DOI 10.1523/JNEUROSCI.4248-11.2012; Burke RM, 2013, P NATL ACAD SCI USA, V110, P19567, DOI 10.1073/pnas.1319297110; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; Cho E, 2010, BRIT J CANCER, V102, P489, DOI 10.1038/sj.bjc.6605510; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Corriveau JA, 2012, PHARMACOL BIOCHEM BE, V103, P60, DOI 10.1016/j.pbb.2012.08.002; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Davison JM, 2009, J BIOL CHEM, V284, P1982, DOI 10.1074/jbc.M807651200; Demars M, 2010, J NEUROSCI RES, V88, P2103, DOI 10.1002/jnr.22387; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; FIBIGER HC, 1991, TRENDS NEUROSCI, V14, P220, DOI 10.1016/0166-2236(91)90117-D; FNB (Food and Nutrition Board) IOM (Institute of Medicine), 1998, DIET REF INT THIAM R; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Genin E, 2011, MOL PSYCHIATR, V16, P903, DOI 10.1038/mp.2011.52; Glenn MJ, 2007, EUR J NEUROSCI, V25, P2473, DOI 10.1111/j.1460-9568.2007.05505.x; Glenn MJ, 2008, BRAIN RES, V1237, P110, DOI 10.1016/j.brainres.2008.08.049; Goto Y, 2008, EUR J PHARMACOL, V583, P84, DOI 10.1016/j.ejphar.2008.01.030; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Hartley D, 2015, ALZHEIMERS DEMENT, V11, P700, DOI 10.1016/j.jalz.2014.10.007; Haydar TF, 2012, TRENDS NEUROSCI, V35, P81, DOI 10.1016/j.tins.2011.11.001; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Holmes GL, 2002, EPILEPSY RES, V48, P3, DOI 10.1016/S0920-1211(01)00321-7; Hu YS, 2010, FASEB J, V24, P1667, DOI 10.1096/fj.09-136945; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Jensen LJ, 2007, FASEB J, V21, pA519; Jiao SS, 2016, NEUROTOX RES, V29, P256, DOI 10.1007/s12640-015-9589-x; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kamphuis W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042823; Kamphuis W, 2012, GLIA, V60, P615, DOI 10.1002/glia.22295; Kar S, 1997, P NATL ACAD SCI USA, V94, P14054, DOI 10.1073/pnas.94.25.14054; Kelley CM, 2016, CURR ALZHEIMER RES, V13, P84, DOI 10.2174/1567205012666150921100515; Kelley CM, 2014, J COMP NEUROL, V522, P1390, DOI 10.1002/cne.23492; Kovacheva VP, 2007, J BIOL CHEM, V282, P31777, DOI 10.1074/jbc.M705539200; Langley EA, 2015, BEHAV BRAIN RES, V278, P210, DOI 10.1016/j.bbr.2014.09.043; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; Lemere CA, 1996, NEUROBIOL DIS, V3, P16, DOI 10.1006/nbdi.1996.0003; Lun MP, 2015, J NEUROSCI, V35, P4903, DOI 10.1523/JNEUROSCI.3081-14.2015; Lupien SB, 2003, J NEUROSCI RES, V74, P512, DOI 10.1002/jnr.10791; Machova E, 2010, NEUROBIOL DIS, V38, P27, DOI 10.1016/j.nbd.2009.12.023; Meck WH, 2008, FRONT INTEGR NEUROSC, V1, DOI 10.3389/neuro.07.007.2007; Meck WH, 1997, NEUROREPORT, V8, P3045, DOI 10.1097/00001756-199709290-00009; Meck WH, 2003, NEUROSCI BIOBEHAV R, V27, P385, DOI 10.1016/S0149-7634(03)00069-1; Mehedint MG, 2010, P NATL ACAD SCI USA, V107, P12834, DOI 10.1073/pnas.0914328107; Mellott TJ, 2007, FASEB J, V21, P1311, DOI 10.1096/fj.06-6597com; Mellott TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094287; Mitani Y, 2012, J NEUROSCI, V32, P2037, DOI 10.1523/JNEUROSCI.4264-11.2012; Moon J, 2010, BEHAV NEUROSCI, V124, P346, DOI 10.1037/a0019590; Mufson Elliott J, 2008, Expert Rev Neurother, V8, P1703, DOI 10.1586/14737175.8.11.1703; Murakami K, 2016, BRAIN RES, V1633, P73, DOI 10.1016/j.brainres.2015.12.016; Nag N, 2008, BRAIN RES, V1237, P101, DOI 10.1016/j.brainres.2008.08.042; Nag N, 2007, NEUROBIOL DIS, V26, P473, DOI 10.1016/j.nbd.2007.02.003; Nalivaeva NN, 2013, FEBS LETT, V587, P2046, DOI 10.1016/j.febslet.2013.05.010; Napoli I, 2008, BRAIN RES, V1237, P124, DOI 10.1016/j.brainres.2008.08.046; Niculescu MD, 2006, FASEB J, V20, P43, DOI 10.1096/fj.05-4707com; Niidome T, 2008, NEUROREPORT, V19, P1361, DOI 10.1097/WNR.0b013e32830e6dd6; Nikolajsen GN, 2011, NEUROBIOL AGING, V32, P1927, DOI 10.1016/j.neurobiolaging.2011.05.006; Osborn LM, 2016, PROG NEUROBIOL; Ouchi Y, 2013, J NEUROSCI, V33, P9408, DOI 10.1523/JNEUROSCI.2700-12.2013; Pedersen WA, 1996, P NATL ACAD SCI USA, V93, P8068, DOI 10.1073/pnas.93.15.8068; Perez SE, 2007, NEUROBIOL DIS, V28, P3, DOI 10.1016/j.nbd.2007.06.015; Poly C, 2011, AM J CLIN NUTR, V94, P1584, DOI 10.3945/ajcn.110.008938; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Ricceri L, 2011, BEHAV BRAIN RES, V221, P623, DOI 10.1016/j.bbr.2011.03.051; Ross RG, 2013, AM J PSYCHIAT, V170, P290, DOI 10.1176/appi.ajp.2012.12070940; Ryan SH, 2008, BRAIN RES, V1237, P91, DOI 10.1016/j.brainres.2008.08.048; Sandstrom NJ, 2002, BRAIN RES, V947, P9, DOI 10.1016/S0006-8993(02)02900-1; Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022; Schulz KM, 2014, BEHAV BRAIN RES, V268, P104, DOI 10.1016/j.bbr.2014.03.031; Shaw GM, 2009, EPIDEMIOLOGY, V20, P714, DOI 10.1097/EDE.0b013e3181ac9fe7; Shaw GM, 2004, AM J EPIDEMIOL, V160, P102, DOI 10.1093/aje/kwh187; Stern SA, 2014, LEARN MEMORY, V21, P556, DOI 10.1101/lm.029348.112; Stevens KE, 2008, PSYCHOPHARMACOLOGY, V198, P413, DOI 10.1007/s00213-008-1170-3; Stevens KE, 2014, BRAIN RES, V1552, P26, DOI 10.1016/j.brainres.2014.01.022; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Strupp BJ, 2016, CURR ALZHEIMER RES, V13, P97, DOI 10.2174/1567205012666150921100311; Tamayev R, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-19; Taniuchi N, 2007, NEUROREPORT, V18, P1801, DOI 10.1097/WNR.0b013e3282f1c9e9; Thomas JD, 2000, NEUROTOXICOL TERATOL, V22, P703, DOI 10.1016/S0892-0362(00)00097-0; Thomas JD, 2007, BEHAV NEUROSCI, V121, P120, DOI 10.1037/0735-7044.121.1.120; Thomas JD, 2012, HIPPOCAMPUS, V22, P619, DOI 10.1002/hipo.20925; Thomas JD, 2010, BIRTH DEFECTS RES A, V88, P827, DOI 10.1002/bdra.20713; Thomas JD, 2009, NEUROTOXICOL TERATOL, V31, P303, DOI 10.1016/j.ntt.2009.07.002; Tran PV, 2015, AM J PHYSIOL-REG I, V308, pR276, DOI 10.1152/ajpregu.00429.2014; Tran PV, 2016, J NUTR; Velazquez R, 2013, NEUROBIOL DIS, V58, P92, DOI 10.1016/j.nbd.2013.04.016; Vivar Carmen, 2013, Curr Top Behav Neurosci, V15, P189, DOI 10.1007/7854_2012_220; Wallace TC, 2016, J AM COLL NUTR, V35, P108, DOI 10.1080/07315724.2015.1080127; Wallace TC, 2014, J AM COLL NUTR, V33, P94, DOI 10.1080/07315724.2013.846806; Wang J, 2003, NEUROBIOL DIS, V14, P318, DOI 10.1016/j.nbd.2003.08.009; Ward BC, 2009, J NEUROCHEM, V108, P361, DOI 10.1111/j.1471-4159.2008.05768.x; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; Wong-Goodrich SJE, 2008, NEUROBIOL DIS, V30, P255, DOI 10.1016/j.nbd.2008.01.008; Wong-Goodrich SJE, 2011, HIPPOCAMPUS, V21, P584, DOI 10.1002/hipo.20783; Wong-Goodrich SJE, 2008, BRAIN RES, V1237, P153, DOI 10.1016/j.brainres.2008.08.074; Wozniak JR, 2015, AM J CLIN NUTR, V102, P1113, DOI 10.3945/ajcn.114.099168; Xu XR, 2008, FASEB J, V22, P2045, DOI 10.1096/fj.07-101279; Yang YL, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-22-j0006.2000	108	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170450	10.1371/journal.pone.0170450	http://dx.doi.org/10.1371/journal.pone.0170450			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103298	Green Published, gold, Green Submitted			2022-12-26	WOS:000392381100069
J	Shahabuddin, A; Nostlinger, C; Delvaux, T; Sarker, M; Delamou, A; Bardaji, A; Broerse, JEW; De Brouwere, V				Shahabuddin, Asm; Nostlinger, Christiana; Delvaux, Therese; Sarker, Malabika; Delamou, Alexandre; Bardaji, Azucena; Broerse, Jacqueline E. W.; De Brouwere, Vincent			Exploring Maternal Health Care-Seeking Behavior of Married Adolescent Girls in Bangladesh: A Social-Ecological Approach	PLOS ONE			English	Article							ADVERSE BIRTH OUTCOMES; RURAL BANGLADESH; PREGNANCY; SERVICES; MOTHERS; CHILDBIRTH; HOSPITALS; DISTRICTS; DELIVERY; QUALITY	Background The huge proportion of child marriage contributes to high rates of pregnancies among adolescent girls in Bangladesh. Despite substantial progress in reducing maternal mortality in the last two decades, the rate of adolescent pregnancy remains high. The use of skilled maternal health services is still low in Bangladesh. Several quantitative studies described the use of skilled maternal health services among adolescent girls. So far, very little qualitative evidence exists about attitudes and practices related to maternal health. To fill this gap, we aimed at exploring maternal health care-seeking behavior of adolescent girls and their experiences related to pregnancy and delivery in Bangladesh. Methods and Findings A prospective qualitative study was conducted among thirty married adolescent girls from three Upazilas (sub-districts) of Rangpur district. They were interviewed in two subsequent phases (2014 and 2015). To triangulate and validate the data collected from these married adolescent girls, key informant interviews (KIIs) and focus group discussions (FGDs) were conducted with different stakeholders. Data analysis was guided by the Social-Ecological Model (SEM) including four levels of factors (individual, interpersonal and family, community and social, and organizational and health systems level) which influenced the maternal health care-seeking behavior of adolescent girls. While adolescent girls showed little decision making-autonomy, interpersonal and family level factors played an important role in their use of skilled maternal health services. In addition, community and social factors and as well as organizational and health systems factors shaped adolescent girls' maternal health care-seeking behavior. Conclusions In order to improve the maternal health of adolescent girls, all four levels of factors of SEM should be taken into account while developing health interventions targeting adolescent girls.	[Shahabuddin, Asm; Delvaux, Therese; De Brouwere, Vincent] Inst Trop Med, Dept Publ Hlth, Woman & Child Hlth Res Ctr, Antwerp, Belgium; [Shahabuddin, Asm; Bardaji, Azucena] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Shahabuddin, Asm; Broerse, Jacqueline E. W.] Vrije Univ Amsterdam, Athena Inst Res Innovat & Commun Hlth & Life Sci, Amsterdam, Netherlands; [Nostlinger, Christiana] Inst Trop Med, Dept Publ Hlth, Unit HIV AIDS Policy, Antwerp, Belgium; [Sarker, Malabika] BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Delamou, Alexandre] Ctr Natl Format & Rech Sante Rurale Maferinyah, Forecariah, Guinea	Institute of Tropical Medicine (ITM); ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Vrije Universiteit Amsterdam; Institute of Tropical Medicine (ITM); Bangladesh Rural Advancement Committee BRAC; BRAC University	Shahabuddin, A (corresponding author), Inst Trop Med, Dept Publ Hlth, Woman & Child Hlth Res Ctr, Antwerp, Belgium.	shahab@itg.be	Alonso, Azucena Bardají/V-5978-2018; Bardají, Azucena/AAE-9145-2019	Alonso, Azucena Bardají/0000-0002-5135-0540; Sarker, Malabika/0000-0001-7293-8805	European Commission (EC); Department of Economy, Science and Innovation of Flemish Government, Belgium	European Commission (EC)(European CommissionEuropean Commission Joint Research Centre); Department of Economy, Science and Innovation of Flemish Government, Belgium	This study, part of a PhD research, was funded by the European Commission (EC) and the Department of Economy, Science and Innovation of Flemish Government, Belgium. Besides, Pr. Vincent De Brouwere also added funds for conducting this research.	Althabe F, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S2-S8; Amin R, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-9; Aminu M, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-130; Anwar I, 2009, J HEALTH POPUL NUTR, V27, P139, DOI 10.3329/jhpn.v27i2.3327; Assarag B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116675; Barnett S, 2006, J HEALTH POPUL NUTR, V24, P394; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Blanc AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059864; Bloom SS, 2001, DEMOGRAPHY, V38, P67, DOI 10.1353/dem.2001.0001; Butchon Rukmanee, 2014, Journal of the Medical Association of Thailand, V97, P785; Chakraborty N, 2003, HEALTH PROMOT INT, V18, P327, DOI 10.1093/heapro/dag414; Chen CW, 2010, CHILD CARE HLTH DEV, V36, P232, DOI 10.1111/j.1365-2214.2009.01039.x; Chen XK, 2007, INT J EPIDEMIOL, V36, P368, DOI 10.1093/ije/dyl284; Choudhury N, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-15; Chowdhury AMR, 2013, LANCET, V382, P1734, DOI 10.1016/S0140-6736(13)62148-0; Conde-Agudelo A, 2005, AM J OBSTET GYNECOL, V192, P342, DOI 10.1016/j.ajog.2004.10.593; De Brouwere V, 2010, TROP MED INT HEALTH, V15, P901, DOI 10.1111/j.1365-3156.2010.02558.x; El Arifeen S, 2013, LANCET, V382, P2012, DOI 10.1016/S0140-6736(13)62149-2; Ganchimeg T, 2014, BJOG-INT J OBSTET GY, V121, P40, DOI 10.1111/1471-0528.12630; Haque MN, 2009, INTERNET J HEAL, V8; Haque SE, 2012, REPROD HLTH CARE UTI, V22; ICRW Plan, 2013, PLAN AS CHILD MARR I; Islam F, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0918-9; Kamal SMM, 2015, J BIOSOC SCI, V47, P120, DOI 10.1017/S0021932013000746; Kamal SMM, 2013, J HEALTH POPUL NUTR, V31, P96; Kamal SM, 2013, ASIA PAC J PUBLIC HL; Koenig MA, 2007, INT FAM PLAN PERSPEC, V33, P75, DOI 10.1363/3307507; Medhi R, 2016, ADOLESC HEALTH MED T, V7, P37, DOI 10.2147/AHMT.S91853; National Institute of Population Research and Training (NIPORT), 2015, BANGL DEM HLTH SURV; Nove A, 2014, LANCET GLOB HEALTH, V2, pE155, DOI 10.1016/S2214-109X(13)70179-7; Oates M, 2011, BJOG-INT J OBSTET GY, V118, P132, DOI 10.1111/j.1471-0528.2010.02847.x; Rahman M Mizanur, 2004, J Ayub Med Coll Abbottabad, V16, P9; Sallis JF, 2008, HLTH BEHAV HLTH ED, P465, DOI DOI 10.7326/0003-4819-116-4-350_; Sayem AM, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-16; Shahabuddin ASM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157664; Shahabuddin ASM, 2015, TROP MED INT HEALTH, V20, P822, DOI 10.1111/tmi.12503; Simkhada B, 2008, J ADV NURS, V61, P244, DOI 10.1111/j.1365-2648.2007.04532.x; Singh P., 2012, PLOS ONE, V7; Story WT, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-28; Sulaiman S, 2013, SAJOG-S AFR J OBSTET, V19, P77, DOI 10.7196/SAJOG.679; UNICEF, 2013, WHAT AR SOC EC MOD S; United Nations Children's Fund, 2014, END CHILD MARR PROGR; United Nations Population Fund, 2013, STAT WORLD POP 2013; Wilunda C, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0018-7; World Health Organization, 2014, AD PREGN FACH SHEET; World Health Organization, 2015, TRENDS MAT MORT 1990, P1; Ye JF, 2014, BIRTH-ISS PERINAT C, V41, P237, DOI 10.1111/birt.12104	47	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0169109	10.1371/journal.pone.0169109	http://dx.doi.org/10.1371/journal.pone.0169109			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI3EK	28095432	Green Published, gold			2022-12-26	WOS:000392372300016
J	Chen, XP; Lin, YP; Dang, K; Puschner, B				Chen, Xiaopeng; Lin, Yanping; Dang, Katherine; Puschner, Birgit			Quantification of Polychlorinated Biphenyls and Polybrominated Diphenyl Ethers in Commercial Cows' Milk from California by Gas Chromatography-Triple Quadruple Mass Spectrometry	PLOS ONE			English	Article							BROMINATED FLAME RETARDANTS; DIBENZO-P-DIOXINS; DIETARY-INTAKE; ORGANOCHLORINE PESTICIDES; MARKET BASKET; HUMAN SERUM; DECABROMODIPHENYL ETHER; PCB; PBDE; METABOLISM	We determined 12 polybrominated diphenyl ethers (PBDEs) and 19 polychlorinated biphenyls (PCBs) congeners in eight different brands of commercial whole milk (WM) and fat free milk (FFM) produced and distributed in California. Congeners were extracted using a modified quick, easy, cheap, effective, rugged and safe (QuEChERS) method, purified by gel permeation chromatography, and quantified using gas chromatography-triple quadruple mass spectrometry. PBDEs and PCBs were detected in all FFM and WM samples. The most prevalent PBDE congeners in WM were BDE-47 (geometric mean: 18.0 pg/mL, 0.51 ng/g lipid), BDE-99 (geometric mean: 9.9 pg/mL, 0.28 ng/g lipid), and BDE-49 (geometric mean: 6.0 pg/mL, 0.17 ng/g lipid). The dominant PCB congeners in WM were PCB-101(geometric mean: 23.6 pg/mL, 0.67 ng/g lipid), PCB-118 (geometric mean: 25.2 pg/mL, 0.72 ng/g lipid), and PCB-138 (geometric mean: 25.3 pg/mL, 0.72 ng/g lipid). The sum of all 19 PCB congeners in FFM and WM were several orders of magnitude below the U.S. FDA tolerance. The sum of PBDEs in milk samples suggest close proximity to industrial emissions, and confirm previous findings of elevated PBDE levels in California compared to other regions in the United States.	[Chen, Xiaopeng; Lin, Yanping; Dang, Katherine; Puschner, Birgit] Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, Davis, CA 95616 USA; [Lin, Yanping] Univ Penn, Smilow Ctr Translat Res, Perelman Sch Med, Philadelphia, PA 19104 USA; [Dang, Katherine] Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA USA	University of California System; University of California Davis; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Francisco	Puschner, B (corresponding author), Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, Davis, CA 95616 USA.	bpuschner@ucdavis.edu		Puschner, Birgit/0000-0001-6765-5085	Center for Children's Environmental Health - National Institute of Environmental Health Sciences (NIEHS) [P01ES011269]; US Environmental Protection Agency (US EPA) Science to Achieve Results (STAR) program [R829388, R833292, 8354320]; NIEHS [1R01 ES020392, 2R01 ES014901, P42 ES04699]; UC Davis MIND Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES023513] Funding Source: NIH RePORTER	Center for Children's Environmental Health - National Institute of Environmental Health Sciences (NIEHS); US Environmental Protection Agency (US EPA) Science to Achieve Results (STAR) program(United States Environmental Protection Agency); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); UC Davis MIND Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study is supported by the Center for Children's Environmental Health funded by the National Institute of Environmental Health Sciences (NIEHS P01ES011269) and US Environmental Protection Agency (US EPA R829388, R833292 and 8354320) Science to Achieve Results (STAR) program. Additional support came from NIEHS 1R01 ES020392, 2R01 ES014901, and P42 ES04699, and the UC Davis MIND Institute.	Agency for Toxic Substances and Disease Registry (ATSDR), 2004, TOX PROF POL BIPH PO; Alaee M, 2003, ENVIRON INT, V29, P683, DOI 10.1016/S0160-4120(03)00121-1; Alexander BM, 2016, J OCCUP ENVIRON HYG, V13, pD148, DOI 10.1080/15459624.2016.1183016; [Anonymous], 2004, TOXICOLOGICAL PROFIL; [Anonymous], 2016, NUTR REQ BEEF CATTL; Asante K.A., 2010, INTERDISCIPLINARY ST, P191; Bae J, 1999, J PHARMACOL EXP THER, V289, P1112; Batterman S, 2009, ENVIRON POLLUT, V157, P654, DOI 10.1016/j.envpol.2008.08.015; Bozlaker A, 2008, ENVIRON POLLUT, V156, P784, DOI 10.1016/j.envpol.2008.06.008; Brambilla G, 2015, FOOD ADDIT CONTAM A, V32, P864, DOI 10.1080/19440049.2015.1029993; Brambilla G, 2011, J AGR FOOD CHEM, V59, P8513, DOI 10.1021/jf2010673; Browne EP, 2009, AQUAT TOXICOL, V92, P281, DOI 10.1016/j.aquatox.2009.02.017; Chen LJ, 2006, XENOBIOTICA, V36, P515, DOI 10.1080/00498250600674477; Chobtang J, 2011, SENSORS-BASEL, V11, P11692, DOI 10.3390/s111211692; Choi SD, 2008, ENVIRON SCI TECHNOL, V42, P7125, DOI 10.1021/es801004p; Clarke BO, 2010, ENVIRON INT, V36, P323, DOI 10.1016/j.envint.2010.01.004; Costa L.G., 2009, ACTA BIOMED ATENEI P, V79, P172; Darnerud PO, 2006, FOOD CHEM TOXICOL, V44, P1597, DOI 10.1016/j.fct.2006.03.011; Darnerud PO, 2003, ENVIRON INT, V29, P841, DOI 10.1016/S0160-4120(03)00107-7; Dodson RE, 2012, ENVIRON SCI TECHNOL, V46, P13056, DOI 10.1021/es303879n; Domingo JL, 2008, TOXICOLOGY, V248, P25, DOI 10.1016/j.tox.2008.03.006; Durand B, 2008, CHEMOSPHERE, V70, P689, DOI 10.1016/j.chemosphere.2007.06.057; E.F.S. Authority, 2010, EFSA J, V8, P1701, DOI DOI 10.2903/J.EFSA.2010.1701; EPA, 2008, TOX REV DEC ETH BDE; Erratico CA, 2012, TOXICOL SCI, V129, P280, DOI 10.1093/toxsci/kfs215; Fischer LJ, 1999, TOXICOL APPL PHARM, V159, P194, DOI 10.1006/taap.1999.8728; GRONEWALD JW, 1982, PHYTOCHEMISTRY, V21, P859, DOI 10.1016/0031-9422(82)80080-0; Guardia MJL, 2006, ENVIRON SCI TECHNOL, V40, P8; Hale RC, 2003, ENVIRON INT, V29, P771, DOI 10.1016/S0160-4120(03)00113-2; Hale RC, 2002, CHEMOSPHERE, V46, P729, DOI 10.1016/S0045-6535(01)00237-5; Hu DF, 2011, J GREAT LAKES RES, V37, P359, DOI 10.1016/j.jglr.2011.03.001; Huwe JK, 2007, ENVIRON SCI TECHNOL, V41, P2371, DOI 10.1021/es061954d; Information CL, 2015, AB 302 PUP SERV LACT; Ionescu C., 2005, DRUG METABOLISM FACT, P243; Perez JJ, 2012, CHEMOSPHERE, V89, P404, DOI 10.1016/j.chemosphere.2012.05.055; Khan MA, 2002, TOXICOL SCI, V65, P52, DOI 10.1093/toxsci/65.1.52; Kiviranta H, 2004, ENVIRON INT, V30, P923, DOI 10.1016/j.envint.2004.03.002; La Guardia MJ, 2006, ENVIRON SCI TECHNOL, V40, P6247, DOI 10.1021/es060630m; Lake IR, 2005, ENVIRON SCI TECHNOL, V39, P9033, DOI 10.1021/es051433a; Li MH, 1996, ENVIRON HEALTH PERSP, V104, P712, DOI 10.2307/3433216; Lin YP, 2013, TALANTA, V113, P41, DOI 10.1016/j.talanta.2013.04.001; Feo ML, 2013, ENVIRON HEALTH PERSP, V121, P440, DOI 10.1289/ehp.1205446; Luzardo OP, 2012, CHEMOSPHERE, V88, P307, DOI 10.1016/j.chemosphere.2012.03.002; Park JS, 2015, ENVIRON SCI TECHNOL, V49, P2948, DOI 10.1021/es5055918; Parolini M, 2012, ARCH ENVIRON CON TOX, V63, P29, DOI 10.1007/s00244-012-9753-8; Pessah IN, 2010, PHARMACOL THERAPEUT, V125, P260, DOI 10.1016/j.pharmthera.2009.10.009; Rodenburg LA, 2010, ENVIRON SCI TECHNOL, V44, P2816, DOI 10.1021/es901155h; Ruoff U, 2012, J VERBRAUCH LEBENSM, V7, P11, DOI 10.1007/s00003-011-0751-y; SAFE S, 1991, PHARMACOL TOXICOL, V69, P400, DOI 10.1111/j.1600-0773.1991.tb01321.x; Safe S, 2001, TOXICOL LETT, V120, P1, DOI 10.1016/S0378-4274(01)00301-0; SAFE SH, 1994, CRIT REV TOXICOL, V24, P87, DOI 10.3109/10408449409049308; Sandholm A, 2003, XENOBIOTICA, V33, P1149, DOI 10.1080/00498250310001609156; Sapozhnikova Y, 2015, J AGR FOOD CHEM, V63, P4429, DOI 10.1021/jf505651g; Sapozhnikova Y, 2013, ANAL CHIM ACTA, V758, P80, DOI 10.1016/j.aca.2012.10.034; Schaum J, 2003, J EXPO ANAL ENV EPID, V13, P177, DOI 10.1038/sj.jea.7500269; Schecter A, 2006, ENVIRON HEALTH PERSP, V114, P1515, DOI 10.1289/ehp.9121; Schecter A, 2010, ENVIRON HEALTH PERSP, V118, P357, DOI 10.1289/ehp.0901345; Sewart A, 1996, CHEMOSPHERE, V32, P2481, DOI 10.1016/0045-6535(96)00141-5; SHAIN W, 1991, TOXICOL APPL PHARM, V111, P33, DOI 10.1016/0041-008X(91)90131-W; Shang HT, 2014, CHEMOSPHERE, V98, P44, DOI 10.1016/j.chemosphere.2013.09.075; Shaw SD, 2013, CHEMOSPHERE, V91, P1386, DOI 10.1016/j.chemosphere.2012.12.070; Shen B, 2015, ENVIRON SCI TECHNOL, V49, P4988, DOI 10.1021/es505463g; Sjodin A, 2004, ENVIRON HEALTH PERSP, V112, P654, DOI 10.1289/ehp.6826; Stapleton HM, 2012, ENVIRON SCI TECHNOL, V46, P13432, DOI 10.1021/es303471d; Sun J, 2016, ENV SCI POLLUT RES I; Sweetman AJ, 1999, ENVIRON POLLUT, V104, P261, DOI 10.1016/S0269-7491(98)00177-8; Talsness CE, 2009, PHILOS T R SOC B, V364, P2079, DOI 10.1098/rstb.2008.0281; Thomas GO, 1999, CHEMOSPHERE, V39, P1533, DOI 10.1016/S0045-6535(99)00050-8; Thuresson K, 2006, ENVIRON HEALTH PERSP, V114, P176, DOI 10.1289/ehp.8350; Tornkvist A, 2011, CHEMOSPHERE, V83, P193, DOI 10.1016/j.chemosphere.2010.12.042; Tremolada P, 2014, SCI TOTAL ENVIRON, V487, P471, DOI 10.1016/j.scitotenv.2014.04.042; Ucar Y, 2011, FOOD ADDIT CONTAM B, V4, P141, DOI 10.1080/19440049.2011.576435; Wang S, 2011, CHEMOSPHERE, V85, P379, DOI 10.1016/j.chemosphere.2011.07.002; Wang YW, 2007, CHEMOSPHERE, V68, P1683, DOI 10.1016/j.chemosphere.2007.03.060; Webb HK, 2013, POLYMERS-BASEL, V5, P1, DOI 10.3390/polym5010001; Wehr H.M., 2004, STANDARD METHODS EXA, V17th ed.; Wong PW, 1996, MOL PHARMACOL, V49, P740; Wong PW, 1997, J BIOL CHEM, V272, P15145, DOI 10.1074/jbc.272.24.15145; Zacs D, 2015, CHEMOSPHERE, V118, P72, DOI 10.1016/j.chemosphere.2014.06.032	79	29	30	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0170129	10.1371/journal.pone.0170129	http://dx.doi.org/10.1371/journal.pone.0170129			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085917	gold, Green Published			2022-12-26	WOS:000391972600064
J	Khan, AL; Al-Harrasi, A; Asaf, S; Park, CE; Park, GS; Khan, AR; Lee, IJ; Al-Rawahi, A; Shin, JH				Khan, Abdul Latif; Al-Harrasi, Ahmed; Asaf, Sajjad; Park, Chang Eon; Park, Gun-Seok; Khan, Abdur Rahim; Lee, In-Jung; Al-Rawahi, Ahmed; Shin, Jae-Ho			The First Chloroplast Genome Sequence of Boswellia sacra, a Resin-Producing Plant in Oman	PLOS ONE			English	Article							DNA; ORGANIZATION; INHERITANCE; EXPRESSION; INFERENCE; ALIGNMENT; CELLS	Boswellia sacra (Burseraceae), a keystone endemic species, is famous for the production of fragrant oleo-gum resin. However, the genetic make-up especially the genomic information about chloroplast is still unknown. Here, we described for the first time the chloroplast (cp) genome of B. sacra. The complete cp sequence revealed a circular genome of 160,543 bp size with 37.61% GC content. The cp genome is a typical quadripartite chloroplast structure with inverted repeats (IRs 26,763 bp) separated by small single copy (SSC; 18,962 bp) and large single copy (LSC; 88,055 bp) regions. De novo assembly and annotation showed the presence of 114 unique genes with 83 protein-coding regions. The phylogenetic analysis revealed that the B. sacra cp genome is closely related to the cp genome of Azadirachta indica and Citrus sinensis, while most of the syntenic differences were found in the non-coding regions. The pairwise distance among 76 shared genes of B. sacra and A. indica was highest for atpA, rpl2, rps12 and ycf1. The cp genome of B. sacra reveals a novel genome, which could be used for further studied to understand its diversity, taxonomy and phylogeny.	[Khan, Abdul Latif; Al-Harrasi, Ahmed; Al-Rawahi, Ahmed] Univ Nizwa, UoN Chair Omans Med Plants & Marine Nat Prod, Nizwa, Oman; [Asaf, Sajjad; Park, Chang Eon; Park, Gun-Seok; Khan, Abdur Rahim; Lee, In-Jung; Shin, Jae-Ho] Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea	University of Nizwa; Kyungpook National University	Al-Harrasi, A (corresponding author), Univ Nizwa, UoN Chair Omans Med Plants & Marine Nat Prod, Nizwa, Oman.; Shin, JH (corresponding author), Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea.	aharrasi@unizwa.edu.om; jhshin@knu.ac.kr	Lee, In-Jung/GLS-0432-2022; Asaf, Sajjad/ABA-3647-2021; Park, Chang Eon/ACL-1997-2022; Khan, Abdur Rahim/N-5836-2015	Lee, In-Jung/0000-0001-7154-4820; Park, Chang Eon/0000-0001-7379-2422; Khan, Abdur Rahim/0000-0001-5370-6216; Khan, Abdul Latif/0000-0001-9700-8903	Oman Research Council [EBR/15/007]	Oman Research Council(Ministry of Higher Education, Research & Innovation, OmanThe Research Council Oman)	This work was supported by the Oman Research Council (EBR/15/007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addisalem AB, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plu086; Al-Harrasi A, 2008, MOLECULES, V13, P2181, DOI 10.3390/molecules13092181; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Asaf S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00843; Bausher MG, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-21; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Coppi A, 2010, GENET RESOUR CROP EV, V57, P1041, DOI 10.1007/s10722-010-9546-8; CORRIVEAU JL, 1988, AM J BOT, V75, P1443, DOI 10.2307/2444695; Cosner ME, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-27; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Du FK, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0942-2; Farah M, NONTIMBER FOREST PRO; Goremykin V, 2003, PLANT SYST EVOL, V242, P119, DOI 10.1007/s00606-003-0056-4; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; GUO ZY, 2016, APPL PLANT SCI, V4; Huang YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074736; HUDSON KR, 1988, CURR GENET, V13, P339, DOI 10.1007/BF00424429; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huo YJ, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01223; INAMDAR JA, 1986, ANN BOT-LONDON, V58, P425, DOI 10.1093/oxfordjournals.aob.a087221; Jansen RK, 2012, ADV PHOTOSYNTHESIS R, P103, DOI DOI 10.1007/978-94-007-2920-9_5; Jansen RK, 2008, MOL PHYLOGENET EVOL, V48, P1204, DOI 10.1016/j.ympev.2008.06.013; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Jansen RK, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-32; Jensen RG, 2013, BIOCH PLANTS, V1, P273; Jin SX, 2015, TRENDS PLANT SCI, V20, P622, DOI 10.1016/j.tplants.2015.07.004; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Khan AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158207; Krishnan NM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-464; Kumar S., 2016, MOL BIOL EVOLUTION, V33, DOI [DOI 10.1093/M0LBEV/MSW054, https://doi.org/10.1093/molbev/msw054, 10.1093/molbev/msw054]; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Leliaert F, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1418-3; Lemieux C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-857; Letsch MR, 2012, MOL PHYLOGENET EVOL, V64, P524, DOI 10.1016/j.ympev.2012.05.027; Li ZH, 2016, MITOCHONDRIAL DNA A, V27, P2635, DOI 10.3109/19401736.2015.1041130; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOWE TM, 1997, NUCL ACIDS RES, V25; Martin G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067350; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Ohtani K, 2002, P NATL ACAD SCI USA, V99, P2439, DOI 10.1073/pnas.042448499; OHYAMA K, 1986, NATURE, V322, P572, DOI 10.1038/322572a0; Qian J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057607; Qin Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144108; Raffaelli M., 2006, Webbia, V61, P245; Raffaelli M., 2003, Webbia, V58, P133; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; Saski C, 2007, THEOR APPL GENET, V115, P571, DOI 10.1007/s00122-007-0595-0; Seo TK, 2008, SYST BIOL, V57, P367, DOI 10.1080/10635150802158670; Shang C, 2016, MITOCHONDRIAL DNA B, V1, P86, DOI 10.1080/23802359.2015.1137835; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Shi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031468; Su HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113049; Sugiura M, 1995, ESSAYS BIOCHEM, V30, P49; SUGIURA M, 1992, PLANT MOL BIOL, V19, P149, DOI 10.1007/BF00015612; Sveinsson S, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0228-6; Takahashi M, 2012, CARCINOGENESIS, V33, P2441, DOI 10.1093/carcin/bgs286; Tarkka MT, 2013, NEW PHYTOL, V199, P529, DOI 10.1111/nph.12317; Tolera M, 2013, FOREST ECOL MANAG, V304, P65, DOI 10.1016/j.foreco.2013.04.036; Wang L, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-0970-6; Wang W., 2016, PLOS ONE, V11; Williams AV, 2016, MOL PHYLOGENET EVOL, V96, P1, DOI 10.1016/j.ympev.2015.11.021; Williams AV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125768; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xie QJ, 2015, TRENDS PLANT SCI, V20, P264, DOI 10.1016/j.tplants.2015.03.013; Xie ZZ, 2016, MITOCHONDRIAL DNA A, V27, P609, DOI 10.3109/19401736.2014.908369; Yang JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073053; YANG YC, 2016, FRONT PLANT SCI, V7; Yao XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129347; Yap JYS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128126; Zhang Q, 2003, PLANT CELL PHYSIOL, V44, P941, DOI 10.1093/pcp/pcg121	74	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0169794	10.1371/journal.pone.0169794	http://dx.doi.org/10.1371/journal.pone.0169794			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085925	Green Published, Green Submitted, gold			2022-12-26	WOS:000391972600037
J	Pernod, G; Caterino, J; Maignan, M; Tissier, C; Kassis, J; Lazarchick, J				Pernod, Gilles; Caterino, Jeffrey; Maignan, Maxime; Tissier, Cindy; Kassis, Jeannine; Lazarchick, John		DIET Study Grp	D-Dimer Use and Pulmonary Embolism Diagnosis in Emergency Units: Why Is There Such a Difference in Pulmonary Embolism Prevalence between the United States of America and Countries Outside USA?	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; RULE; RECOMMENDATIONS; MANAGEMENT	Objective Although diagnostic guidelines are similar, there is a huge difference in pulmonary embolism (PE) prevalence between the United States of America (US) and countries outside the USA (OUS) in the emergency care setting. In this study, we prospectively analyze patients' characteristics and differences in clinical care that may influence PE prevalence in different countries. Methods An international multicenter prospective diagnostic study was conducted in a standard-of-care setting. Consecutive outpatients presenting to the emergency unit and suspected for PE were managed using the Wells score, STA-Liatest (R) D-Dimers and imaging. Results The prevalence of PE in the study was 7.9% in low and moderate risk patients. Among the 1060 patients with low or moderate pre-test probability (PTP), PE prevalence was four times higher in OUS (10.7%) than in the US (2.5%) (P < 0.0001). The mean number of imaging procedures performed for one new PE diagnosis was 3.3 in OUS vs 17 in the US (P < 0.001). Stopping investigation in the case of negative D-dimers (DD combined) with low/moderate PTP was more frequent in OUS (92.7%) than in the US (75.7%) (P < 0.01). Moreover, the use of imaging was much higher in the US (44.4% vs 19.2% in OUS) in the case of moderate PTP combined with negative DD. Conclusion Differences between US and OUS PE prevalence in emergency setting might be explained by differences in patients' characteristics and mostly in care patterns. US physicians performed computed tomographic pulmonary angiography more often than in Europe in cases of low/moderate PTP combined with negative DD.	[Pernod, Gilles] Univ Grenoble Alpes, Grenoble Alpes Univ Hosp, Dept Vasc Med, CNRS,TIMC,IMAG,UMR Themas 5525, Grenoble, France; [Caterino, Jeffrey] Ohio State Univ, Dept Emergency Med, Columbus, OH USA; [Maignan, Maxime] Grenoble Alpes Univ Hosp, Dept Emergency Med, Grenoble, France; [Tissier, Cindy] Univ Hosp Dijon, Dept Emergency Med, Dijon, France; [Kassis, Jeannine] Univ Montreal, Dept Hematol, Hop Maisonneuve Rosemont, Montreal, PQ, Canada; [Lazarchick, John] Med Univ South Carolina, Pathol & Lab Med, Charleston, SC USA	CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); University System of Ohio; Ohio State University; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Dijon Bourgogne; Universite de Montreal; Medical University of South Carolina	Pernod, G (corresponding author), Univ Grenoble Alpes, Grenoble Alpes Univ Hosp, Dept Vasc Med, CNRS,TIMC,IMAG,UMR Themas 5525, Grenoble, France.	GPernod@chu-grenoble.fr		Maignan, Maxime/0000-0002-4301-4213	Diagnostica Stago	Diagnostica Stago	This work was supported by Diagnostica Stago. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DM, 2013, AM J MED, V126, P36, DOI 10.1016/j.amjmed.2012.05.028; Bosson JL, 2005, J THROMB HAEMOST, V3, P93, DOI 10.1111/j.1538-7836.2004.01045.x; CLSI, 2011, H59A CLSI PA USA; Cohen AT, 2014, THROMB RES, V133, P139, DOI 10.1016/j.thromres.2013.09.040; Dunn KL, 2002, J AM COLL CARDIOL, V40, P1475, DOI 10.1016/S0735-1097(02)02172-1; Fesmire FM, 2011, ANN EMERG MED, V57, P628, DOI 10.1016/j.annemergmed.2011.01.020; Kline JA, 2008, J THROMB HAEMOST, V6, P772, DOI 10.1111/j.1538-7836.2008.02944.x; Kline JA, 2009, ANN EMERG MED, V54, P41, DOI 10.1016/j.annemergmed.2008.08.015; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-00004; Le Gal G, 2004, J THROMB HAEMOST, V2, P1244, DOI 10.1111/j.1538-7836.2004.00795.x; Mos ICM, 2014, THROMB RES, V133, P1039, DOI 10.1016/j.thromres.2014.03.050; Penaloza A, 2012, J THROMB HAEMOST, V10, P375, DOI 10.1111/j.1538-7836.2012.04631.x; Pernod G, 2016, BLOOD COAGUL FIBRINO; Perrier A, 2005, NEW ENGL J MED, V352, P1760, DOI 10.1056/NEJMoa042905; Raja AS, 2015, ANN INTERN MED, V163, P701, DOI 10.7326/M14-1772; Righini M, 2014, JAMA-J AM MED ASSOC, V311, P1117, DOI 10.1001/jama.2014.2135; Stein PD, 2006, AM J MED, V119, P1048, DOI 10.1016/j.amjmed.2006.05.060; Trowbridge RL, 2004, AM J MED, V116, P84, DOI 10.1016/j.amjmed.2003.07.004; Van Es J, 2015, J THROMB HAEMOST, V13, P1428, DOI 10.1111/jth.13011; Venkatesh AK, 2012, ARCH INTERN MED, V172, P1028, DOI 10.1001/archinternmed.2012.1804; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416	22	33	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0169268	10.1371/journal.pone.0169268	http://dx.doi.org/10.1371/journal.pone.0169268			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085911	Green Published, Green Submitted, gold			2022-12-26	WOS:000391972600017
J	Hother, AL; Lykke, M; Martinussen, T; Poulsen, HD; Molgaard, C; Sangild, PT; Briend, A; Hansen, CF; Friis, H; Michaelsen, KF; Thymann, T				Hother, Anne-Louise; Lykke, Mikkel; Martinussen, Torben; Poulsen, Hanne Damgaard; Molgaard, Christian; Sangild, Per Torp; Briend, Andre; Hansen, Christian Fink; Friis, Henrik; Michaelsen, Kim F.; Thymann, Thomas			Corn-Soy-Blend Fortified with Phosphorus to Prevent Refeeding Hypophosphatemia in Undernourished Piglets	PLOS ONE			English	Article							FOODS; CHILDREN; UNDERNUTRITION; MALNUTRITION; PHOSPHATE; INFANTS	Background Phosphorus (P) levels in refeeding diets are very important as undernourished children are at risk of hypophosphatemia during refeeding. For this reason, conventional corn-soy blends (CSB) have been reformulated by the World Food Programme to obtain a mono-calcium-phosphate fortified product (CSB+) and a product further fortified with skim milk powder (CBS++). Methods Using a piglet model of undernourished children, we hypothesized that feeding of CSB+, CSB++ or CSB+ with added whey permeate (CSB+/wp) would help to prevent refeeding hypophosphatemia. Pigs were weaned at 4 weeks of age and undernutrition was induced with a nutritionally inadequate pure maize diet for 7 weeks, after which they were refed for 3 weeks with either CSB+ (n = 10), CSB++ (n = 10) or CSB+/wp (n = 10). For reference, a fourth group continued on the maize diet (REF, n = 10). Results Following induction of undernutrition, body weight and length were 29 +/- 5% and 67 +/- 4% (means SD) of values in age-matched pigs fed a nutritionally adequate diet, and the mean serum P level was 1.77 +/- 0.34 mmol/l. During the first week of refeeding, P levels in the CSB+ pigs decreased to 55% of values before refeeding (P < 0.05) while values in the CSB++ and CSB+/ wp pigs were able to maintain their plasma phosphate at a similar level as before refeeding. Conclusion We conclude that fortification of CSB with only monocalcium-phosphate does not prevent hypophosphatemia. Dairy products like skim milk powder or whey permeate may represent relevant sources of phosphorus during refeeding. The content and form of phosphorus in such diets need to be carefully evaluated, and the undernourished piglet may be used to test the efficacy of such diets.	[Hother, Anne-Louise; Lykke, Mikkel; Molgaard, Christian; Sangild, Per Torp; Briend, Andre; Friis, Henrik; Michaelsen, Kim F.; Thymann, Thomas] Univ Copenhagen, Dept Nutr Exercise & Sports, Frederiksberg, Denmark; [Lykke, Mikkel; Sangild, Per Torp; Thymann, Thomas] Univ Copenhagen, Dept Clin Vet & Anim Sci, Frederiksberg, Denmark; [Martinussen, Torben] Univ Copenhagen, Dept Publ Hlth, Frederiksberg, Denmark; [Poulsen, Hanne Damgaard] Aarhus Univ, Dept Anim Sci, Foulum, Denmark; [Briend, Andre] Univ Tampere, Dept Int Hlth, Tampere, Finland; [Hansen, Christian Fink] Univ Copenhagen, Dept Large Anim Sci, Frederiksberg, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Aarhus University; Tampere University; University of Copenhagen	Thymann, T (corresponding author), Univ Copenhagen, Dept Nutr Exercise & Sports, Frederiksberg, Denmark.; Thymann, T (corresponding author), Univ Copenhagen, Dept Clin Vet & Anim Sci, Frederiksberg, Denmark.	thomas.thymann@sund.ku.dk	Friis, Henrik/N-2047-2014; Friis, Henrik/P-2891-2019; Molgaard, Christian/D-2052-2014	Friis, Henrik/0000-0002-2848-2940; Friis, Henrik/0000-0002-2848-2940; Molgaard, Christian/0000-0002-5311-9457; Hansen, Christian Fink/0000-0001-7981-2252; Michaelsen, Kim F/0000-0003-0449-0839; Thymann, Thomas/0000-0001-7480-6064	University of Copenhagen; Arla Foods Ingredients	University of Copenhagen; Arla Foods Ingredients	This work was supported by University of Copenhagen, Arla Foods Ingredients and PhD grants from University of Copenhagen to A-LH and ML. Arla Foods Ingredients provided part of the funding for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNER YN, 1988, ANNU REV NUTR, V8, P121, DOI 10.1146/annurev.nu.08.070188.001005; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; de Pee S, 2008, SIGHT LIFE MAGAZINE; de Pee S, 2009, FOOD NUTR BULL, V30, pS434, DOI 10.1177/15648265090303S305; Golden MH, 2009, FOOD NUTR BULL, V30, pS267, DOI 10.1177/15648265090303S302; Gomez F, 2000, B WORLD HEALTH ORGAN, V78, P1275; Hansen T H, 2013, Methods Mol Biol, V953, P121, DOI 10.1007/978-1-62703-152-3_8; Hoppe C, 2008, J NUTR, V138, p145S, DOI 10.1093/jn/138.1.145S; Horwitz W, 2000, OFFICIAL METHODS ANA, V1; Kimutai D, 2009, East Afr Med J, V86, P330; KNOCHEL JP, 1977, CLIN NEPHROL, V7, P131; Lykke M, 2013, AM J TRANSL RES, V5, P543; Manary MJ, 1998, J PEDIATR-US, V133, P789, DOI 10.1016/S0022-3476(98)70153-2; MCCANCE RA, 1966, LANCET, V2, P158; Michaelsen KF, 2009, FOOD NUTR BULL, V30, pS343, DOI 10.1177/15648265090303S303; POND WG, 1992, P SOC EXP BIOL MED, V200, P555, DOI 10.3181/00379727-200-43470; Roos N, 2013, MATERN CHILD NUTR, V9, P47, DOI 10.1111/j.1740-8709.2012.00449.x; STUFFINS CB, 1967, ANALYST, V92, P107, DOI 10.1039/an9679200107; UNICEF/WHO/The World Bank, 2012, LEV TRENDS CHILD MAL; WATERLOW JC, 1960, BRIT J NUTR, V14, P183, DOI 10.1079/BJN19600024; WATERLOW JC, 1973, LANCET, V2, P87; WATERLOW JC, 1972, BRIT MED J, V3, P566, DOI 10.1136/bmj.3.5826.566	23	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0170043	10.1371/journal.pone.0170043	http://dx.doi.org/10.1371/journal.pone.0170043			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081252	Green Published, Green Submitted, gold			2022-12-26	WOS:000391949500122
J	Reuken, PA; Torres, D; Baier, M; Loffler, B; Lubbert, C; Lippmann, N; Stallmach, A; Bruns, T				Reuken, Philipp A.; Torres, Dorian; Baier, Michael; Loeffler, Bettina; Luebbert, Christoph; Lippmann, Norman; Stallmach, Andreas; Bruns, Tony			Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis	PLOS ONE			English	Article							BILIARY-TRACT; BILE; INFECTION; SPECTRUM; IMPACT	Background Acute cholangitis (AC) requires the immediate initiation of antibiotic therapy in addition to treatment for biliary obstruction. Against a background of an increasing prevalence of multi drug resistant (MDR) bacteria, the risk factors for the failure of empiric therapy must be defined. Methods Using a pathogen-based approach, 1764 isolates from positive bile duct cultures were retrospectively analyzed to characterize the respective pathogen spectra in two German tertiary centers. Using a patient-based approach, the clinical and laboratory data for 83 patients with AC were assessed to identify risk factors for AC with pathogens resistant to the applied empiric therapy. Results Bile cultures were predominantly polymicrobial, and empiric antibiotic therapies did not cover the full biliary pathogen spectrum in 78% of cases. MDR bacteria were isolated from the bile of 24/83 (29%) patients. The univariate risk factors for biliary MDR bacteria were male sex, nosocomial AC, prior antibiotic exposure and prior biliary stenting, of which biliary stenting was the only independent risk factor according to multivariate analysis (OR = 3.8; 95% CI 1.3-11.0, P=0.013). Although there were no significant differences in survival or hospital stay in AC patients with and without detected biliary MDR pathogens, the former more often had a concomitant bloodstream infection (58% vs. 24%; P= 0.019), including those involving MDR pathogens or fungi (21% vs. 2%; P= 0.007). Conclusion Patients with biliary stents who develop AC should receive empiric therapy covering enterococci and extended-spectrum beta-lactamase(ESBL)-producing Enterobacteriaceae. These patients are at an increased risk for bloodstream infections by MDR pathogens or fungi.	[Reuken, Philipp A.; Torres, Dorian; Stallmach, Andreas; Bruns, Tony] Jena Univ Hosp, Dept Internal Med Gastroenterol Hepatol & Infect, Jena, Germany; [Baier, Michael; Loeffler, Bettina] Leipzig Univ Hosp, Dept Gastroenterol & Rheumatol, Div Infect Dis & Trop Med, Leipzig, Germany; [Luebbert, Christoph] Jena Univ Hosp, Inst Med Microbiol, Jena, Germany; [Lippmann, Norman] Leipzig Univ Hosp, Inst Med Microbiol & Epidemiol Infect Dis, Leipzig, Germany; [Stallmach, Andreas; Bruns, Tony] Jena Univ Hosp, Integrated Res & Treatment Ctr Sepsis Control & C, Jena, Germany	Friedrich Schiller University of Jena; Leipzig University; Friedrich Schiller University of Jena; Leipzig University; Friedrich Schiller University of Jena	Reuken, PA (corresponding author), Jena Univ Hosp, Dept Internal Med Gastroenterol Hepatol & Infect, Jena, Germany.	philipp.reuken@med.uni-jena.de	Lübbert, Christoph/H-8991-2019; Bruns, Tony/C-5720-2011	Bruns, Tony/0000-0002-5576-6914				Basioukas P, 2014, ANN GASTROENTEROL, V27, P399; Bornscheuer Till, 2014, Viszeralmedizin, V30, P297, DOI 10.1159/000368335; Cammann S, 2016, LANGENBECKS ARCH SUR; Csendes A, 1996, HEPATO-GASTROENTEROL, V43, P800; Doi Y, 2013, CLIN INFECT DIS, V56, P641, DOI 10.1093/cid/cis942; Gargouri Dalila, 2015, Tunis Med, V93, P602; Gotthardt DN, 2013, ENDOSCOPY, V45, P890, DOI 10.1055/s-0033-1344713; Haag GM, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0399-7; Jethwa P, 2007, ALIMENT PHARM THER, V25, P1175, DOI 10.1111/j.1365-2036.2007.03289.x; Kahlmeter G, 2003, J ANTIMICROB CHEMOTH, V52, P145, DOI 10.1093/jac/dkg312; Kwon Jeong Seok, 2014, Korean J Gastroenterol, V63, P299; Lee F, 2015, ALIMENT PHARM THER, V42, P212, DOI 10.1111/apt.13253; Lee JG, 2009, NAT REV GASTRO HEPAT, V6, P533, DOI 10.1038/nrgastro.2009.126; Lee JK, 2013, J INFECT CHEMOTHER, V19, P1029, DOI 10.1007/s10156-013-0616-7; Lubbert C, 2014, INFECTION, V42, P309, DOI 10.1007/s15010-013-0547-3; Lubbert C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155479; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Negm AA, 2010, GASTROINTEST ENDOSC, V72, P284, DOI 10.1016/j.gie.2010.02.043; Park JW, 2014, CLIN RES HEPATOL GAS, V38, P300, DOI 10.1016/j.clinre.2014.02.005; Park TY, 2014, DIGEST DIS SCI, V59, P2790, DOI 10.1007/s10620-014-3233-0; Rupp C, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0562-8; Schneider J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110112; Schneider J, 2014, J ANTIMICROB CHEMOTH, V69, P519, DOI 10.1093/jac/dkt373; SCOTTCONNER CEH, 1994, J SURG RES, V57, P316, DOI 10.1006/jsre.1994.1151; Sun ZP, 2016, BIOSCI TRENDS, V10, P22, DOI 10.5582/bst.2016.01033; SUNG JY, 1992, DIGEST DIS SCI, V37, P689, DOI 10.1007/BF01296423; Tanaka A, 2007, J HEPATO-BILIARY-PAN, V14, P59, DOI 10.1007/s00534-006-1157-6; Usenko AY, KLIN KHIRURHIIA MINI; Voigtlander T, 2015, J INFECTION, V70, P483, DOI 10.1016/j.jinf.2015.01.013; Wada K, 2007, J HEPATO-BILIARY-PAN, V14, P52, DOI 10.1007/s00534-006-1156-7; Weber A, 2013, J INFECTION, V67, P111, DOI 10.1016/j.jinf.2013.04.008; Zimmer V, 2015, VISZERALMEDIZIN, V31, P166, DOI 10.1159/000430965	32	28	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169900	10.1371/journal.pone.0169900	http://dx.doi.org/10.1371/journal.pone.0169900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076388	Green Published, Green Submitted, gold			2022-12-26	WOS:000391857100064
J	Worrall, C; Suleymanova, N; Crudden, C; Drakensjo, IT; Candrea, E; Nedelcu, D; Takahashi, SI; Girnita, L; Girnita, A				Worrall, C.; Suleymanova, N.; Crudden, C.; Drakensjo, I. Trocoli; Candrea, E.; Nedelcu, D.; Takahashi, S-I; Girnita, L.; Girnita, A.			Unbalancing p53/Mdm2/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma	ONCOGENE			English	Article							GROWTH-FACTOR-I; SMALL-MOLECULE ANTAGONISTS; BETA-ARRESTIN; ULTRAVIOLET-RADIATION; PICROPODOPHYLLIN PPP; MONOCLONAL-ANTIBODY; RECEPTOR IGF-1R; UVEAL MELANOMA; TUMOR INVASION; PHASE-I	Melanoma tumors usually retain wild-type p53; however, its tumor-suppressor activity is functionally disabled, most commonly through an inactivating interaction with mouse double-minute 2 homolog (Mdm2), indicating p53 release from this complex as a potential therapeutic approach. P53 and the tumor-promoter insulin-like growth factor type 1 receptor (IGF-1R) compete as substrates for the E3 ubiquitin ligase Mdm2, making their relative abundance intricately linked. Hence we investigated the effects of pharmacological Mdm2 release from the Mdm2/p53 complex on the expression and function of the IGF-1R. Nutlin-3 treatment increased IGF-1R/Mdm2 association with enhanced IGF-1R ubiquitination and a dual functional outcome: receptor downregulation and selective downstream signaling activation confined to the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway. This Nutlin-3 functional selectivity translated into IGF-1-mediated bioactivities with biphasic effects on the proliferative and metastatic phenotype: an early increase and late decrease in the number of proliferative and migratory cells, while the invasiveness was completely inhibited following Nutlin-3 treatment through an impaired IGF-1-mediated matrix metalloproteinases type 2 activation mechanism. Taken together, these experiments reveal the biased agonistic properties of Nutlin-3 for the mitogen-activated protein kinase pathway, mediated by Mdm2 through IGF-1R ubiquitination and provide fundamental insights into destabilizing p53/Mdm2/IGF-1R circuitry that could be developed for therapeutic gain.	[Worrall, C.; Suleymanova, N.; Crudden, C.; Drakensjo, I. Trocoli; Candrea, E.; Nedelcu, D.; Girnita, L.; Girnita, A.] Karolinska Univ Hosp, Karolinska Inst, Dept Oncol & Pathol, Canc Ctr Karolinska, Stockholm, Sweden; [Drakensjo, I. Trocoli; Girnita, A.] Karolinska Univ Hosp, Dermatol Dept, Stockholm, Sweden; [Candrea, E.] Univ Med & Pharm Iuliu Hatieganu Cluj Napoca, Dept Dermatol, Cluj Napoca, Romania; [Takahashi, S-I] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Sci, Tokyo, Japan; [Takahashi, S-I] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Iuliu Hatieganu University of Medicine & Pharmacy; University of Tokyo; University of Tokyo	Girnita, L; Girnita, A (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Canc Ctr Karolinska, Dept Oncol Pathol, CCK R8 04, S-17196 Stockholm, Sweden.	Leonard.Girnita@ki.se; Ada.Girnita@ki.se	Girnita, Ada/AAC-4518-2020; Girnita, Leonard/A-4168-2008; Crudden, Caitrin/Q-5172-2018	Girnita, Leonard/0000-0003-0280-9500; Crudden, Caitrin/0000-0002-7786-112X; Takahashi, Shin-Ichiro/0000-0002-2323-2010	Swedish Research Council; Swedish Cancer Society; Swedish Childhood Cancer Foundation; Crown Princess Margareta's Foundation for the Visually Impaired; Welander Finsen Foundation; King Gustaf V Jubilee Foundation; Stockholm Cancer Society; Stockholm County; JSPS [25221204]; Karolinska Institute	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation(European Commission); Crown Princess Margareta's Foundation for the Visually Impaired; Welander Finsen Foundation; King Gustaf V Jubilee Foundation; Stockholm Cancer Society; Stockholm County(Stockholm County Council); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Karolinska Institute(Karolinska Institutet)	We thank Professor Rolf Kiessling (CCK, KI) for the BE and DFB cell lines 62, to Juan Castro (CCK, KI) for FACS analysis and to Dr Cath Drummond and Dr Sonia Lain for helpful discussions. Research support was received from the Swedish Research Council, Swedish Cancer Society, The Swedish Childhood Cancer Foundation, Crown Princess Margareta's Foundation for the Visually Impaired, Welander Finsen Foundation, King Gustaf V Jubilee Foundation, Stockholm Cancer Society, Stockholm County and Karolinska Institute. This work was also supported by Grant-in-Aid of Scientific Research (S) no. 25221204, Core-to-core program from JSPS to S-IT group.	Albino AP, 1993, MELANOMA RES, V55, P562; Box NF, 2008, PIGM CELL MELANOMA R, V21, P525, DOI 10.1111/j.1755-148X.2008.00495.x; CASTRESANA JS, 1993, INT J CANCER, V55, P562, DOI 10.1002/ijc.2910550407; CASTRO J, 1993, CYTOMETRY, V14, P793, DOI 10.1002/cyto.990140712; Crudden C, 2015, GROWTH HORM IGF RES, V25, P2, DOI 10.1016/j.ghir.2014.10.002; Cummins DL, 2006, MAYO CLIN PROC, V81, P500, DOI 10.4065/81.4.500; Davenport RJ, 2003, SCI SAGE KE, V10, P1126; Dews M, 2000, ENDOCRINOLOGY, V141, P1289, DOI 10.1210/en.141.4.1289; Economou MA, 2005, INVEST OPHTH VIS SCI, V46, P4372, DOI 10.1167/iovs.05-0322; Economou MA, 2008, INVEST OPHTH VIS SCI, V49, P2620, DOI 10.1167/iovs.07-0742; Economou MA, 2008, INVEST OPHTH VIS SCI, V49, P2337, DOI 10.1167/iovs.07-0819; Fahraeus R, 2014, ONCOGENE, V33, P4365, DOI 10.1038/onc.2013.410; FAKHARZADEH SS, 1991, EMBO J, V10, P1565, DOI 10.1002/j.1460-2075.1991.tb07676.x; Fuchs SY, 1998, ONCOGENE, V17, P2543, DOI 10.1038/sj.onc.1202200; Gasbarri A, 2003, MELANOMA RES, V13, P325, DOI 10.1097/00008390-200308000-00001; Girnita A, 2006, CLIN CANCER RES, V12, P1383, DOI 10.1158/1078-0432.CCR-05-1106; Girnita A, 2012, ONCOGENE, V31, P352, DOI 10.1038/onc.2011.239; Girnita L, 2000, CANCER RES, V60, P5278; Girnita L, 2016, PROG MOL BIOL TRANSL, V141, P277, DOI 10.1016/bs.pmbts.2016.04.001; Girnita L, 2003, P NATL ACAD SCI USA, V100, P8247, DOI 10.1073/pnas.1431613100; Girnita L, 2005, J BIOL CHEM, V280, P24412, DOI 10.1074/jbc.M501129200; Girnita L, 2007, J BIOL CHEM, V282, P11329, DOI 10.1074/jbc.M611526200; Girnita L, 2014, CELL MOL LIFE SCI, V71, P2403, DOI 10.1007/s00018-013-1514-y; Gombos A, 2012, INVEST NEW DRUG, V30, P2433, DOI 10.1007/s10637-012-9811-0; Haapajarvi T, 1999, CELL GROWTH DIFFER, V10, P163; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hocker T, 2007, HUM MUTAT, V28, P578, DOI 10.1002/humu.20481; Hongo A, 1996, ONCOGENE, V12, P1231; Houben R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022096; Iwakuma T, 2003, MOL CANCER RES, V1, P993; Ji ZY, 2012, J INVEST DERMATOL, V132, P356, DOI 10.1038/jid.2011.313; Kanavy HE, 2011, SEMIN CUTAN MED SURG, V30, P222, DOI 10.1016/j.sder.2011.08.003; Kanter-Lewensohn L, 1998, MELANOMA RES, V8, P389, DOI 10.1097/00008390-199810000-00002; Karasic TB, 2010, EXP CELL RES, V316, P1994, DOI 10.1016/j.yexcr.2010.04.014; Klein C, 2004, BRIT J CANCER, V91, P1415, DOI 10.1038/sj.bjc.6602164; Lane D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000893; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macaulay VM, 2013, ANN ONCOL, V24, P784, DOI 10.1093/annonc/mds511; Mahadevan D, 2014, CANCER CHEMOTH PHARM, V73, P467, DOI 10.1007/s00280-013-2372-x; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; Mar VJ, 2013, CLIN CANCER RES, V19, P4589, DOI 10.1158/1078-0432.CCR-13-0398; Molhoek KR, 2011, MELANOMA RES, V21, P274, DOI 10.1097/CMR.0b013e328343a1d6; Neudauer CL, 2003, EXP CELL RES, V286, P128, DOI 10.1016/S0014-4827(03)00049-1; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Puzanov I, 2015, CLIN CANCER RES, V21, P701, DOI 10.1158/1078-0432.CCR-14-0303; SalazarOnfray F, 1997, CANCER RES, V57, P4348; Sehat B, 2008, CANCER RES, V68, P5669, DOI 10.1158/0008-5472.CAN-07-6364; Sehat B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000340; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Soussi T, 2011, ADV CANCER RES, V110, P107, DOI 10.1016/B978-0-12-386469-7.00005-0; van Leeuwen IMM, 2011, CELL CYCLE, V10, P1590, DOI 10.4161/cc.10.10.15519; Vasilcanu D, 2006, ONCOGENE, V25, P3186, DOI 10.1038/sj.onc.1209339; Vasilcanu R, 2008, MOL PHARMACOL, V73, P930, DOI 10.1124/mol.107.040014; Vassilev LT, 2004, CELL CYCLE, V3, P419; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Webster NJG, 1996, CANCER RES, V56, P2781; Werner H, 2000, MOL GENET METAB, V71, P315, DOI 10.1006/mgme.2000.3044; Werner H, 1996, P NATL ACAD SCI USA, V93, P8318, DOI 10.1073/pnas.93.16.8318; Werner H, 2014, GROWTH HORM IGF RES, V24, P112, DOI 10.1016/j.ghir.2014.03.006; Yeh AH, 2006, ONCOGENE, V25, P6574, DOI 10.1038/sj.onc.1209674; Zerp SF, 1999, BRIT J CANCER, V79, P921, DOI 10.1038/sj.bjc.6690147; Zhang D, 2003, HORM METAB RES, V35, P802; Zhang DL, 2004, J BIOL CHEM, V279, P19683, DOI 10.1074/jbc.M313145200; Zhang DL, 2003, ONCOGENE, V22, P974, DOI 10.1038/sj.onc.1206197; Zheng HY, 2012, P NATL ACAD SCI USA, V109, P20620, DOI 10.1073/pnas.1216348110; Zheng HY, 2012, P NATL ACAD SCI USA, V109, P7055, DOI 10.1073/pnas.1118359109; Zwang YR, 2011, MOL CELL, V42, P524, DOI 10.1016/j.molcel.2011.04.017	68	27	28	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 8	2017	36	23					3274	3286		10.1038/onc.2016.472	http://dx.doi.org/10.1038/onc.2016.472			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EW9WJ	28092675	Green Published, hybrid			2022-12-26	WOS:000402869800007
J	Papacleovoulou, G; Nikolova, V; Oduwole, O; Chambers, J; Vazquez-Lopez, M; Jansen, E; Nicolaides, K; Parker, M; Williamson, C				Papacleovoulou, Georgia; Nikolova, Vanya; Oduwole, Olayiwola; Chambers, Jenny; Vazquez-Lopez, Marta; Jansen, Eugene; Nicolaides, Kypros; Parker, Malcolm; Williamson, Catherine			Gestational disruptions in metabolic rhythmicity of the liver, muscle, and placenta affect fetal size	FASEB JOURNAL			English	Article						circadian clock; metabolism; pregnancy; macrosomia; triglycerides	REV-ERB-ALPHA; LIPID-METABOLISM; CIRCADIAN CLOCK; SKELETAL-MUSCLE; CARBOHYDRATE-METABOLISM; LIPOPROTEIN-LIPASE; GLUCOSE-METABOLISM; NORMAL-PREGNANCY; GENE-EXPRESSION; SHIFT WORK	Maternal metabolic adaptations are essential for successful pregnancy outcomes. We investigated how metabolic gestational processes are coordinated, whether there is a functional linkwithinternal clocks, andwhether disruptions are related to metabolic abnormalities in pregnancy, by studying day/night metabolic pathways in murine models and samples from pregnant women with normally grown and large-for-gestational age infants. In early mouse pregnancy, expression of hepatic lipogenic genes was up-regulated and uncoupled from the hepatic clock. In latemouse pregnancy, rhythmicity of energymetabolism-relatedgenes inthemuscle followed the patterns of internal clock genes in this tissue, and coincided with enhanced lipid transporter expression in the fetoplacental unit. Diurnal triglyceride patterns were disrupted in human placentas from pregnancies with large-for-gestational age infants and this overlapped with an increase in BMAL1 expression. Metabolic adaptations in early pregnancy are uncoupled fromthe circadian clock, whereas in late pregnancy, energy availability is mediated by coordinated muscle-placenta metabolic adjustments linked to internal clocks. Placental triglyceride oscillations in the third trimester of human pregnancy are lost in large-for-gestational age infants and may be regulated by BMAL1. In summary, disruptions in metabolic and circadian rhythmicity are associated with increased fetal size, with implications for the pathogenesis of macrosomia.-Papacleovoulou, G., Nikolova, V., Oduwole, O., Chambers, J., Vazquez-Lopez, M., Jansen, E., Nicolaides, K., Parker, M., Williamson, C. Gestational disruptions in metabolic rhythmicity of the liver, muscle, and placenta affect fetal size. FASEB J. 31, 1698-1708 (2017). www.fasebj.org	[Papacleovoulou, Georgia; Nikolova, Vanya; Williamson, Catherine] Kings Coll London, Div Womens Hlth, Guys Campus, London, England; [Nicolaides, Kypros] Kings Coll London, Harris Birthright Ctr Fetal Med, London, England; [Oduwole, Olayiwola; Parker, Malcolm; Williamson, Catherine] Imperial Coll London, Inst Reprod & Dev Biol, London, England; [Chambers, Jenny; Vazquez-Lopez, Marta] Imperial Coll London, Fac Med, Hammersmith Hosp, Womens Hlth Res Ctr,Surg & Canc, London, England; [Jansen, Eugene] Natl Inst Publ Hlth & Environm, Ctr Hlth Protect, Bilthoven, Netherlands	University of London; King's College London; University of London; King's College London; Imperial College London; Imperial College London; Netherlands National Institute for Public Health & the Environment	Williamson, C (corresponding author), Maternal & Fetal Dis Grp, Hodgkin Bldg,Guys Campus, London SE1 1UL, England.	catherine.williamson@kcl.ac.uk		Nicolaides, Kypros/0000-0003-1266-0711; Oduwole, Olayiwola/0000-0003-3840-7335; Williamson, Catherine/0000-0002-6226-7611	Wellcome Trust; National Institute for Health Research (NIHR) Clinical Research Facilities and Biomedical Research Centers based at Imperial College; Guy's and St. Thomas' National Health Service (NHS) Foundation Trust	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research (NIHR) Clinical Research Facilities and Biomedical Research Centers based at Imperial College; Guy's and St. Thomas' National Health Service (NHS) Foundation Trust	This project was supported by the Wellcome Trust, and by the National Institute for Health Research (NIHR) Clinical Research Facilities and Biomedical Research Centers based at Imperial College, and Guy's and St. Thomas' National Health Service (NHS) Foundation Trust. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. The elective cesarean placentas were obtained from the Baby Bio Bank (Project Code 524578.100.15682; University College London), under the Material Transfer Agreement (Reference TTA0715). The authors declare no conflicts of interest.	Alvarez JJ, 1996, J LIPID RES, V37, P299; Angueira AR, 2015, DIABETES, V64, P327, DOI 10.2337/db14-0877; Baron KG, 2011, OBESITY, V19, P1374, DOI 10.1038/oby.2011.100; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Belo L, 2004, ATHEROSCLEROSIS, V177, P391, DOI 10.1016/j.atherosclerosis.2004.07.023; Bisanti L, 1996, J OCCUP ENVIRON MED, V38, P352, DOI 10.1097/00043764-199604000-00012; Brett KE, 2014, INT J MOL SCI, V15, P16153, DOI 10.3390/ijms150916153; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Casey TM, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.116137; CATALANO PM, 1993, AM J PHYSIOL, V264, pE60, DOI 10.1152/ajpendo.1993.264.1.E60; Cetin I, 2005, ACTA PAEDIATR, V94, P7, DOI 10.1080/08035320510043709; Cetin I, 2002, PEDIATR RES, V52, P750, DOI 10.1203/00006450-200211000-00023; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; COUSINS L, 1980, AM J OBSTET GYNECOL, V136, P483, DOI 10.1016/0002-9378(80)90675-4; Di Cianni G, 2005, DIABETIC MED, V22, P21, DOI 10.1111/j.1464-5491.2004.01336.x; Esquirol Y, 2009, CHRONOBIOL INT, V26, P544, DOI 10.1080/07420520902821176; Frise CJ, 2013, EUR J OBSTET GYN R B, V167, P1, DOI 10.1016/j.ejogrb.2012.10.005; Gauster M, 2007, J CLIN ENDOCR METAB, V92, P2256, DOI 10.1210/jc.2006-2403; Herrera E, 2006, HORM RES, V65, P59, DOI 10.1159/000091507; HERRERA E, 1988, AM J OBSTET GYNECOL, V158, P1575, DOI 10.1016/0002-9378(88)90193-7; Herrera E, 2006, INT J VITAM NUTR RES, V76, P216, DOI 10.1024/0300-9831.76.4.216; Herrera E, 2014, CURR PHARM BIOTECHNO, V15, P24, DOI 10.2174/1389201015666140330192345; Hodge BA, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0039-5; Kamana KC, 2015, ANN NUTR METAB, V66, P14, DOI 10.1159/000371628; Knutsson A, 2003, OCCUP MED-OXFORD, V53, P103, DOI 10.1093/occmed/kqg048; LANZAJACOBY S, 1986, J NUTR, V116, P1798, DOI 10.1093/jn/116.9.1798; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; LIN DS, 1977, AM J OBSTET GYNECOL, V128, P735, DOI 10.1016/0002-9378(77)90713-X; Linder N, 2014, ARCH DIS CHILD-FETAL, V99, pF353, DOI 10.1136/archdischild-2013-305032; Liu SH, 2013, NATURE, V502, P550, DOI 10.1038/nature12710; Milona A, 2010, HEPATOLOGY, V52, P1341, DOI 10.1002/hep.23849; Musial B, 2016, DIABETES, V65, P851, DOI 10.2337/db15-1531; Nakamura TJ, 2010, STEROIDS, V75, P203, DOI 10.1016/j.steroids.2010.01.007; Papacleovoulou G, 2013, J CLIN INVEST, V123, P3172, DOI 10.1172/JCI68927; Papacleovoulou G, 2011, BBA-MOL BASIS DIS, V1812, P879, DOI 10.1016/j.bbadis.2010.11.001; Paschos GK, 2012, NAT MED, V18, P1768, DOI 10.1038/nm.2979; Perez S, 2015, SYST BIOL REPROD MED, V61, P360, DOI 10.3109/19396368.2015.1069420; PHELPS RL, 1981, AM J OBSTET GYNECOL, V140, P730, DOI 10.1016/0002-9378(81)90731-6; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231; Smith JL, 1998, J LIPID RES, V39, P2237; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Sones JL, 2016, PHYSIOL GENOMICS, V48, P565, DOI 10.1152/physiolgenomics.00125.2015; Sugden MC, 2000, BIOCHEM J, V346, P651, DOI 10.1042/0264-6021:3460651; Timlin MT, 2008, PEDIATRICS, V121, pE638, DOI 10.1542/peds.2007-1035; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Vrijkotte TGM, 2012, J CLIN ENDOCR METAB, V97, P3917, DOI 10.1210/jc.2012-1295; Wharfe MD, 2016, AM J PHYSIOL-ENDOC M, V311, pE575, DOI 10.1152/ajpendo.00060.2016; Wharfe MD, 2016, ENDOCRINOLOGY, V157, P3320, DOI 10.1210/en.2016-1177; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yoshida S, 2005, J LIPID RES, V46, P2168, DOI 10.1194/jlr.M500096-JLR200; Zhu LR, 2015, ENDOCRINOLOGY, V156, P2114, DOI 10.1210/en.2014-1922	54	12	12	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1698	1708		10.1096/fj.201601032R	http://dx.doi.org/10.1096/fj.201601032R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28082353	Green Published			2022-12-26	WOS:000398504300034
J	Bruggisser, J; Kaser, S; Mani, J; Schneider, A				Bruggisser, Julia; Kaser, Sandro; Mani, Jan; Schneider, Andre			Biogenesis of a Mitochondrial Outer Membrane Protein in Trypanosoma brucei: TARGETING SIGNAL AND DEPENDENCE ON A UNIQUE BIOGENESIS FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						evolution; membrane biogenesis; mitochondrial transport; outer membrane; Trypanosoma brucei	BETA-BARREL PROTEINS; TOM COMPLEX; INTRACELLULAR MEMBRANES; PREPROTEIN TRANSLOCASE; ENDOPLASMIC-RETICULUM; ANCHORED PROTEINS; BACTERIAL ORIGIN; IMPORT PATHWAYS; MIM1; EVOLUTION	The mitochondrial outer membrane (OM) contains single and multiple membrane-spanning proteins that need to contain signals that ensure correct targeting and insertion into the OM. The biogenesis of such proteins has so far essentially only been studied in yeast and related organisms. Here we show that POMP10, an OM protein of the early diverging protozoan Trypanosoma brucei, is signal-anchored. Transgenic cells expressing variants of POMP10 fused to GFP demonstrate that the N-terminal membrane-spanning domain flanked by a few positively charged or neutral residues is both necessary and sufficient for mitochondrial targeting. Carbonate extraction experiments indicate that although the presence of neutral instead of positively charged residues did not interfere with POMP10 localization, it weakened its interaction with the OM. Expression of GFP-tagged POMP10 in inducible RNAi cell lines shows that its mitochondrial localization depends on pATOM36 but does not require Sam50 or ATOM40, the trypanosomal analogue of the Tom40 import pore. pATOM36 is a kinetoplastid-specific OM protein that has previously been implicated in the assembly of OM proteins and in mitochondrial DNA inheritance. In summary, our results show that although the features of the targeting signal in signal-anchored proteins are widely conserved, the protein machinery that mediates their biogenesis is not.	[Bruggisser, Julia; Kaser, Sandro; Mani, Jan; Schneider, Andre] Univ Bern, Dept Chem & Biochem, Freiestr 3, CH-3012 Bern, Switzerland	University of Bern	Schneider, A (corresponding author), Univ Bern, Dept Chem & Biochem, Freiestr 3, CH-3012 Bern, Switzerland.	andre.schneider@dcb.unibe.ch		Kaser, Sandro/0000-0002-2775-9469; Schneider, Andre/0000-0001-5421-0909	Swiss National Science Foundation [138355]; National Center of Competence in Research (NCCR) "RNA Disease"	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research (NCCR) "RNA Disease"(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Science Foundation Grant 138355 (to A. S.) and in part by the National Center of Competence in Research (NCCR) "RNA & Disease." The authors declare that they have no conflicts of interest with the contents of this article.	Becker T, 2008, BBA-BIOENERGETICS, V1777, P557, DOI 10.1016/j.bbabio.2008.03.017; Becker T, 2008, J BIOL CHEM, V283, P120, DOI 10.1074/jbc.M706997200; Becker T, 2011, J CELL BIOL, V194, P387, DOI 10.1083/jcb.201102044; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Burki F, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016147; Cavalier-Smith T, 2010, BIOL LETTERS, V6, P342, DOI 10.1098/rsbl.2009.0948; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Dimmer KS, 2012, J CELL SCI, V125, P3464, DOI 10.1242/jcs.103804; Dimmer KS, 2010, EUR J CELL BIOL, V89, P212, DOI 10.1016/j.ejcb.2009.11.002; Dukanovic J, 2011, BBA-BIOMEMBRANES, V1808, P971, DOI 10.1016/j.bbamem.2010.06.021; Eckers E, 2012, BIOL CHEM, V393, P513, DOI 10.1515/hsz-2011-0255; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Harsman A, 2012, J BIOL CHEM, V287, P31437, DOI 10.1074/jbc.M112.392118; Hauser R, 1996, J CELL SCI, V109, P517; He D, 2014, CURR BIOL, V24, P465, DOI 10.1016/j.cub.2014.01.036; Hewitt V, 2011, BBA-BIOMEMBRANES, V1808, P947, DOI 10.1016/j.bbamem.2010.07.019; Jores T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12036; Kanaji S, 2000, J CELL BIOL, V151, P277, DOI 10.1083/jcb.151.2.277; Kaser S, 2016, P NATL ACAD SCI USA, V113, pE4467, DOI 10.1073/pnas.1605497113; Lee J, 2011, PLANT CELL, V23, P1588, DOI 10.1105/tpc.110.082230; Lithgow T, 2010, PHILOS T R SOC B, V365, P799, DOI 10.1098/rstb.2009.0167; Lueder F, 2009, FEBS LETT, V583, P1475, DOI 10.1016/j.febslet.2009.03.064; Mani J, 2016, MOL BIOL EVOL, V33, P337, DOI 10.1093/molbev/msv219; Mani J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7646; MCBRIDE HM, 1992, J CELL BIOL, V119, P1451, DOI 10.1083/jcb.119.6.1451; McCulloch Richard, 2004, Methods Mol Biol, V262, P53; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Niemann M, 2013, MOL CELL PROTEOMICS, V12, P515, DOI 10.1074/mcp.M112.023093; Pusnik M, 2009, MOL BIOL EVOL, V26, P671, DOI 10.1093/molbev/msn288; Pusnik M, 2012, MOL BIOL CELL, V23, P3420, DOI 10.1091/mbc.E12-02-0107; Pusnik M, 2011, CURR BIOL, V21, P1738, DOI 10.1016/j.cub.2011.08.060; Sauerwald J, 2015, MOL CELL BIOL, V35, P3200, DOI 10.1128/MCB.00107-15; Schmitt S, 2006, PROTEOMICS, V6, P72, DOI 10.1002/pmic.200402084; Schneider Andre, 2007, Methods Mol Biol, V372, P67, DOI 10.1007/978-1-59745-365-3_5; Schneider Andre, 2007, Methods Mol Biol, V372, P379, DOI 10.1007/978-1-59745-365-3_27; Schulz C, 2015, TRENDS CELL BIOL, V25, P265, DOI 10.1016/j.tcb.2014.12.001; Sharma S, 2010, MOL BIOCHEM PARASIT, V174, P89, DOI 10.1016/j.molbiopara.2010.07.003; SHORE GC, 1995, EUR J BIOCHEM, V227, P9, DOI 10.1111/j.1432-1033.1995.tb20354.x; Stojanovski D, 2006, BBA-MOL CELL RES, V1763, P414, DOI 10.1016/j.bbamcr.2006.02.008; Suzuki H, 2002, J CELL SCI, V115, P1895; Thornton N, 2010, J MOL BIOL, V396, P540, DOI 10.1016/j.jmb.2009.12.026; Tschopp F, 2011, EMBO REP, V12, P825, DOI 10.1038/embor.2011.111; Ulrich T, 2015, INT J MED MICROBIOL, V305, P259, DOI 10.1016/j.ijmm.2014.12.009; Vogtle FN, 2015, J CELL BIOL, V210, P951, DOI 10.1083/jcb.201506085; Waizenegger T, 2003, J BIOL CHEM, V278, P42064, DOI 10.1074/jbc.M305736200; Waizengger T, 2005, EMBO REP, V6, P57, DOI 10.1038/sj.embor.7400318; Walther DM, 2009, BBA-MOL CELL RES, V1793, P42, DOI 10.1016/j.bbamcr.2008.04.013; Wattenberg B, 2001, TRAFFIC, V2, P66, DOI 10.1034/j.1600-0854.2001.20108.x; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zahedi RP, 2006, MOL BIOL CELL, V17, P1436, DOI 10.1091/mbc.E05-08-0740	52	11	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3400	3410		10.1074/jbc.M116.755983	http://dx.doi.org/10.1074/jbc.M116.755983			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28100781	Green Published, hybrid			2022-12-26	WOS:000395538800029
J	Logashina, YA; Mosharova, IV; Korolkova, YV; Shelukhina, IV; Dyachenko, IA; Palikov, VA; Palikova, YA; Murashev, AN; Kozlov, SA; Stensvag, K; Andreev, YA				Logashina, Yulia A.; Mosharova, Irina V.; Korolkova, Yulia V.; Shelukhina, Irina V.; Dyachenko, Igor A.; Palikov, Victor A.; Palikova, Yulia A.; Murashev, Arkadii N.; Kozlov, Sergey A.; Stensvag, Klara; Andreev, Yaroslav A.			Peptide from Sea Anemone Metridium senile Affects Transient Receptor Potential Ankyrin-repeat 1 (TRPA1) Function and Produces Analgesic Effect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESIDUE DISTRIBUTION ANALYSIS; ION-CHANNEL; MECHANICAL HYPERSENSITIVITY; NEUROGENIC INFLAMMATION; POLYPEPTIDE INHIBITOR; SENSORY NEURONS; C-FIBERS; ACTIVATION; PAIN; TRPV1	The transient receptor potential ankyrin-repeat 1 (TRPA1) is an important player in pain and inflammatory pathways. It is a prom-isingtargetfornoveldrugdevelopmentforthetreatmentofanum-ber of pathological states. A novel peptide producing a significant potentiating effect on allyl isothiocyanate-and diclofenac-induced currents of TRPA1 was isolated from the venom of sea anemone Metridium senile. It is a 35-amino acid peptide cross-linked by two disulfide bridges named tau-AnmTX Ms 9a-1 (short name Ms 9a-1) according to a structure similar to other sea anemone peptides belonging to structural group 9a. The structures of the two genes encoding the different precursor proteins of Ms 9a-1 were determined. PeptideMs9a-1 acted as a positive modulator of TRPA1 in vitro but did not cause pain or thermal hyperalgesia when injected into the hind paw of mice. Intravenous injection of Ms 9a-1 (0.3 mg/ kg) produced a significant decrease in the nociceptive and inflammatory response to allyl isothiocyanate (the agonist of TRPA1) and reversed CFA (Complete Freund's Adjuvant)-induced inflammation and thermal hyperalgesia. Taken together these data support the hypothesis that Ms 9a-1 potentiates the response of TRPA1 to endogenous agonists followed by persistent functional loss of TRPA1-expressing neurons. We can conclude that TRPA1 potentiating may be useful as a therapeutic approach as Ms 9a-1 produces significant analgesic and antiinflammatory effects in mice models of pain.	[Logashina, Yulia A.; Mosharova, Irina V.; Korolkova, Yulia V.; Shelukhina, Irina V.; Kozlov, Sergey A.; Andreev, Yaroslav A.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Ul Miklukho Maklaya 16-10, Moscow 117997, Russia; [Logashina, Yulia A.; Andreev, Yaroslav A.] Sechenov First Moscow State Med Univ, Inst Mol Med, Trubetskaya St 8,Bldg 2, Moscow 119991, Russia; [Dyachenko, Igor A.; Palikov, Victor A.; Palikova, Yulia A.; Murashev, Arkadii N.] Russian Acad Sci, Branch Shemyakin Ovchinnikov Inst Bioorgan Chem, 6 Nauki Ave, Moscow 142290, Russia; [Stensvag, Klara] Univ Tromso, Norwegian Coll Fishery Sci, N-9037 Tromso, Norway	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Sechenov First Moscow State Medical University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; UiT The Arctic University of Tromso	Andreev, YA (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Ul Miklukho Maklaya 16-10, Moscow 117997, Russia.; Andreev, YA (corresponding author), Sechenov First Moscow State Med Univ, Inst Mol Med, Trubetskaya St 8,Bldg 2, Moscow 119991, Russia.	ay@land.ru	Shelukhina, Irina/AHE-5496-2022; Andreev, Yaroslav A/C-6627-2012; DI Igor, Dyachenko/K-9060-2017; Kozlov, Sergey A/D-1548-2012; Palikova, Yuliya/Y-4228-2018	Shelukhina, Irina/0000-0003-3476-1441; Kozlov, Sergey A/0000-0002-0242-4240; Stensvag, Klara/0000-0002-4717-6711; Palikov, Victor/0000-0003-2989-4477; Palikova, Yuliya/0000-0001-9547-0686; Andreev, Yaroslav/0000-0002-7628-0980	Russian Science Foundation [16-15-00167]; Functional Genomics (FUGE) programme; Biotek 2021 programme of the Research Council of Norway [208546]	Russian Science Foundation(Russian Science Foundation (RSF)); Functional Genomics (FUGE) programme; Biotek 2021 programme of the Research Council of Norway	This work was supported by Russian Science Foundation Grant 16-15-00167, the Functional Genomics (FUGE) programme, and the Biotek 2021 programme of the Research Council of Norway, project XBioPepS (Grant 208546). The authors declare that they have no conflicts of interest with the contents of this article.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Andersson DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046917; Andersson DA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1559; Andre E, 2009, BRIT J PHARMACOL, V158, P1621, DOI 10.1111/j.1476-5381.2009.00438.x; Andre E, 2008, J CLIN INVEST, V118, P2574, DOI 10.1172/JCI34886; Andreev YA, 2009, DOKL BIOCHEM BIOPHYS, V424, P46, DOI 10.1134/S160767290901013X; Andreev YA, 2008, J BIOL CHEM, V283, P23914, DOI 10.1074/jbc.M800776200; Andreev YA, 2013, MAR DRUGS, V11, P5100, DOI 10.3390/md11125100; Andreev YA, 2012, RECENT PATENTS INFLA, V6, P35, DOI 10.2174/187221312798889266; Andreev YA, 2010, ANAL BIOCHEM, V407, P144, DOI 10.1016/j.ab.2010.07.023; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; Birrell MA, 2009, AM J RESP CRIT CARE, V180, P1042, DOI 10.1164/rccm.200905-0665OC; Brederson JD, 2013, EUR J PHARMACOL, V716, P61, DOI 10.1016/j.ejphar.2013.03.003; Brierley SM, 2011, J PHYSIOL-LONDON, V589, P3575, DOI 10.1113/jphysiol.2011.206789; Cassoli JS, 2013, J PROTEOMICS, V87, P89, DOI 10.1016/j.jprot.2013.05.022; Caterina MJ, 2007, NATURE, V445, P491, DOI 10.1038/nature05565; Chen J, 2011, PAIN, V152, P1165, DOI 10.1016/j.pain.2011.01.049; Chen Y, 2011, NEUROSCIENCE, V193, P440, DOI 10.1016/j.neuroscience.2011.06.085; Chi V, 2012, TOXICON, V59, P529, DOI 10.1016/j.toxicon.2011.07.016; Cruz-Orengo L, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-30; da Costa DSM, 2010, PAIN, V148, P431, DOI 10.1016/j.pain.2009.12.002; Diochot S, 2004, EMBO J, V23, P1516, DOI 10.1038/sj.emboj.7600177; Eberhardt M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5381; Eid SR, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-48; Eilers H, 2010, ANESTHESIOLOGY, V112, P1452, DOI 10.1097/ALN.0b013e3181d94e00; Gui JH, 2014, CURR BIOL, V24, P473, DOI 10.1016/j.cub.2014.01.013; Honma T, 2005, TOXICON, V45, P33, DOI 10.1016/j.toxicon.2004.09.013; Honma T, 2008, PEPTIDES, V29, P536, DOI 10.1016/j.peptides.2007.12.010; Hu HZ, 2010, PFLUG ARCH EUR J PHY, V459, P579, DOI 10.1007/s00424-009-0749-9; Hu HZ, 2009, NAT CHEM BIOL, V5, P183, DOI 10.1038/nchembio.146; Jouiaei M, 2015, TOXINS, V7, P2251, DOI 10.3390/toxins7062251; Kojima R, 2014, EUR J PHARMACOL, V723, P288, DOI 10.1016/j.ejphar.2013.11.020; Kozlov S, 2005, TOXICON, V46, P672, DOI 10.1016/j.toxicon.2005.07.009; Kozlov S A, 2012, Bioorg Khim, V38, P653; Kozlov S, 2012, PEPTIDES, V33, P240, DOI 10.1016/j.peptides.2011.12.008; Kozlov S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-88; Kozlov SA, 2007, TOXICON, V49, P721, DOI 10.1016/j.toxicon.2006.11.007; Kremeyer B, 2010, NEURON, V66, P671, DOI 10.1016/j.neuron.2010.04.030; Lennertz RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043597; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; Materazzi S, 2013, PAIN, V154, P2750, DOI 10.1016/j.pain.2013.08.002; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Namer B, 2005, NEUROREPORT, V16, P955, DOI 10.1097/00001756-200506210-00015; Osmakov DI, 2013, J BIOL CHEM, V288, P23116, DOI 10.1074/jbc.M113.485516; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Preti D, 2015, PHARM PAT ANAL, V4, P75, DOI [10.4155/ppa.14.60, 10.4155/PPA.14.60]; Raisinghani M, 2011, AM J PHYSIOL-CELL PH, V301, pC587, DOI 10.1152/ajpcell.00465.2010; Ruparel NB, 2008, PAIN, V135, P271, DOI 10.1016/j.pain.2007.06.005; Satoh JI, 2009, J ANESTH, V23, P620, DOI 10.1007/s00540-009-0786-8; Schwartz ES, 2013, J NEUROSCI, V33, P5603, DOI 10.1523/JNEUROSCI.1806-12.2013; Shelukhina I, 2015, BRAIN STRUCT FUNCT, V220, P1885, DOI 10.1007/s00429-014-0762-4; Takahashi N, 2008, CHANNELS, V2, P287, DOI 10.4161/chan.2.4.6745; Taylor-Clark TE, 2008, J PHYSIOL-LONDON, V586, P3447, DOI 10.1113/jphysiol.2008.153585; Taylor-Clark TE, 2008, MOL PHARMACOL, V73, P274, DOI 10.1124/mol.107.040832; Taylor-Clark TE, 2009, MOL PHARMACOL, V75, P820, DOI 10.1124/mol.108.054445; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Utkina LL, 2013, FEBS J, V280, P3594, DOI 10.1111/febs.12349; Weng YQ, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-75; Zaharenko AJ, 2008, COMP BIOCHEM PHYS D, V3, P219, DOI 10.1016/j.cbd.2008.04.002; Zhou YM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3399	62	28	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2992	3004		10.1074/jbc.M116.757369	http://dx.doi.org/10.1074/jbc.M116.757369			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28077580	Green Published, hybrid			2022-12-26	WOS:000395535100038
J	Cui, K; Luan, Y; Tang, Z; Wang, T; Chen, Z; Wang, SG; Liu, JH; Wang, DW				Cui, Kai; Luan, Yang; Tang, Zhe; Wang, Tao; Chen, Zhong; Wang, Shaogang; Liu, Jihong; Wang, Daowen			Involvement of DDAH/ADMA/NOS/cGMP and COX-2/PTGIS/cAMP Pathways in Human Tissue Kallikrein 1 Protecting Erectile Function in Aged Rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ENDOTHELIAL DYSFUNCTION; CORPUS CAVERNOSUM; ASYMMETRIC DIMETHYLARGININE; TRANSGENIC RATS; GENE; THERAPY; EPIDEMIOLOGY; EXPRESSION; COUNTRIES	Our previous studies had reported that Human Tissue Kallikrein 1 (hKLK1) preserved erectile function in aged transgenic rats, while the detailed mechanism of hKLK1 protecting erectile function in aged rats through activation of cGMP and cAMP was not mentioned. To explore the latent mechanism, male wild-type Sprague-Dawley rats (WTR) and transgenic rats harboring the hKLK1 gene (TGR) were fed to 4 and 18 months old and divided into four groups: young WTR (yWTR) as the control, aged WTR (aWTR), aged TGR (aTGR) and aged TGRs with HOE140 (aTGRH). Erectile function of all rats was evaluated by cavernous nerve electrostimulation method and measured by the ratio of intracavernous pressure/mean arterial pressure (ICP/MAP) in rats. Expression levels of cAMP and cGMP were assessed, and related signaling pathways were detected by western blot, immunohistochemistry and RT-PCR. Our experiment results showed erectile function of the aWTR group and aTGRH group was lower compared with those of other two groups. Also, expression levels of cAMP and cGMP were significantly lower than those of other two groups. Moreover, expressions of related signaling pathways including DDAH/ADMA/NOS/cGMP and COX-2/PTGIS/cAMP were also downregulated in the corpus cavernosum of rats in aWTR group. Our finding revealed hKLK1 played a protective role in age-related ED. The DDAH/ADMA/NOS/cGMP and COX-2/PTGIS/cAMP pathways that were linked to the mechanism hKLK1 could increase the levels of cGMP and cAMP, which might provide novel therapy targets for age-related ED.	[Cui, Kai; Luan, Yang; Tang, Zhe; Wang, Tao; Chen, Zhong; Wang, Shaogang; Liu, Jihong] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Urol, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Cui, Kai; Luan, Yang; Tang, Zhe; Wang, Tao; Chen, Zhong; Wang, Shaogang; Liu, Jihong] Huazhong Univ Sci & Technol, Inst Urol, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Wang, Daowen] Huazhong Univ Sci & Technol, Tongji Hosp, Div Cardiol, Dept Internal Med,Tongji Med Coll, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology		jhliu@tjh.tjmu.edu.cn; dwwang@tjh.tjmu.edu.cn	Tang, Z./AAH-2619-2020; Wang, Shaogang/AGO-4944-2022	Tang, Z./0000-0002-2909-3912; Wang, Shaogang/0000-0002-3206-1495	National Natural Science Foundation of China (NSFC) [81270690]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the grant from the National Natural Science Foundation of China (NSFC #81270690).	Abhary S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009462; Aversa A, 2010, INT J UROL, V17, P38, DOI 10.1111/j.1442-2042.2009.02426.x; Becker AJ, 2001, UROLOGY, V57, P193, DOI 10.1016/S0090-4295(00)00881-5; Braun M, 2000, INT J IMPOT RES, V12, P305, DOI 10.1038/sj.ijir.3900622; Burnett AL, 2005, CURR PHARM DESIGN, V11, P3987, DOI 10.2174/138161205774913381; Chao J, 2010, BIOL CHEM, V391, P345, DOI 10.1515/BC.2010.042; Chiou WF, 2010, BJU INT, V105, P674, DOI 10.1111/j.1464-410X.2009.08852.x; Emanueli C, 2002, CIRCULATION, V106, P993, DOI 10.1161/01.CIR.0000027104.33206.C8; FARACI FM, 1995, AM J PHYSIOL-HEART C, V269, pH1522, DOI 10.1152/ajpheart.1995.269.5.H1522; Garban H, 1995, AM J PHYSIOL, V268, pH467; Jiang DJ, 2006, BIOCHEM BIOPH RES CO, V349, P683, DOI 10.1016/j.bbrc.2006.08.115; Johannes CB, 2000, J UROLOGY, V163, P460, DOI 10.1016/S0022-5347(05)67900-1; Leiper J, 1999, CARDIOVASC RES, V43, P542, DOI 10.1016/S0008-6363(99)00162-5; Li R, 2016, PEERJ, V4, DOI 10.7717/peerj.2000; Lin HC, 2013, J SEX MED, V10, P1476, DOI 10.1111/jsm.12147; Lin KY, 2002, CIRCULATION, V106, P987, DOI 10.1161/01.CIR.0000027109.14149.67; Luan Y, 2016, J SEX MED, V13, P1311, DOI 10.1016/j.jsxm.2016.07.005; Lue TF, 2000, NEW ENGL J MED, V342, P1802, DOI 10.1056/NEJM200006153422407; Maggi M, 2000, EUR J ENDOCRINOL, V143, P143, DOI 10.1530/eje.0.1430143; Moreland RB, 2001, AM J PHYSIOL-HEART C, V281, pH552, DOI 10.1152/ajpheart.2001.281.2.H552; MULLINS JJ, 1990, NATURE, V344, P541, DOI 10.1038/344541a0; Nicolosi A, 2005, BJU INT, V95, P609, DOI 10.1111/j.1464-410X.2005.05348.x; Nicolosi A, 2003, UROLOGY, V61, P201, DOI 10.1016/S0090-4295(02)02102-7; Rendell MS, 1999, JAMA-J AM MED ASSOC, V281, P421, DOI 10.1001/jama.281.5.421; RH B, 2003, CARDIOVASC RES, V59, P824; RH B, 2003, CLIN CHEM LAB MED, V41, P1467, DOI [10.1515/CCLM.2003.225, DOI 10.1515/CCLM.2003.225]; Ruan YJ, 2016, J SEX MED, V13, P778, DOI 10.1016/j.jsxm.2016.02.164; Shamloul R, 2013, LANCET, V381, P153, DOI 10.1016/S0140-6736(12)60520-0; Shiri R, 2006, J UROLOGY, V175, P1812, DOI 10.1016/S0022-5347(05)01000-1; Silva JA, 2000, FASEB J, V14, P1858; Stuhlinger MC, 2001, CIRCULATION, V104, P2569, DOI 10.1161/hc4601.098514; WANG J, 1994, HYPERTENSION, V23, P236, DOI 10.1161/01.HYP.23.2.236; Wang JH, 2016, ANDROLOGIA, V48, P262, DOI 10.1111/and.12441; Wang T, 2011, INT J ANDROL, V34, P33, DOI 10.1111/j.1365-2605.2010.01052.x; Wang YH, 2014, MOL CELL BIOCHEM, V393, P77, DOI 10.1007/s11010-014-2048-9; Yang J, 2014, ANDROLOGIA, V46, P522, DOI 10.1111/and.12108; Yin GN, 2014, P NATL ACAD SCI USA, V111, pE2731, DOI 10.1073/pnas.1403471111	37	6	9	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170427	10.1371/journal.pone.0170427	http://dx.doi.org/10.1371/journal.pone.0170427			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103290	Green Published, gold, Green Submitted			2022-12-26	WOS:000392381100064
J	Parente, CC; Bezerra, FSM; Parente, PI; Neto, RVD; Xavier, SCC; Ramos, AN; Carvalho-Costa, FA; Lima, MM				Parente, Cynara Carvalho; Bezerra, Fernando S. M.; Parente, Plutarco I.; Dias-Neto, Raimundo V.; Xavier, Samanta C. C.; Ramos, Alberto N., Jr.; Carvalho-Costa, Filipe A.; Lima, Marli M.			Community-Based Entomological Surveillance Reveals Urban Foci of Chagas Disease Vectors in Sobral, State of Ceara, Northeastern Brazil	PLOS ONE			English	Article							RHODNIUS-NASUTUS; TRIATOMA-BRASILIENSIS; REDUVIIDAE; HEMIPTERA; PSEUDOMACULATA; EPIDEMIOLOGY; TRANSMISSION; POPULATIONS; AREAS	Background The aim of this work was to explore the potential risk of vector-borne Chagas disease in urban districts in northeastern Brazil, by analyzing the spatiotemporal distributions and natural infection rates with Trypanosoma cruzi of triatomine species captured in recent years. The main motivation of this work was an acute human case of Chagas disease reported in 2008 in the municipality of Sobral. Methodology/principal findings We analyzed data from community-based entomological surveillance carried out from 2010 to 2014. Triatomine natural T. cruzi infection was assessed by examination of insect feces by optical microscopy. Sites of triatomine capture were georeferenced through Google Earth and analyzed with ArcGIS. A total of 191 triatomines were collected, consisting of 82.2% Triatoma pseudomaculata, 7.9% Rhodnius nasutus, 5.8% T. brasiliensis, 3.7% Panstrongylus lutzi, and 0.5% P. megistus, with an overall natural infection index of 17.8%. Most infestations were reported in the districts of Dom Jose (36.2%), Padre Palhano (24.7%), and Alto do Cristo (10.6%). The overwhelming majority of insects (185/96.9%) were captured inside houses, and most insects tended to be collected in intermittent peaks. Moreover, captured triatomines tended to constitute colonies. The acute case reported in 2008 was found to be situated within a T. pseudomaculata hotspot. Conclusion The triatomine collection events carried out by dwellers were aggregated in time and space into distinct foci, suggesting that insects are intermittently and artificially introduced into the city, possibly via accidental migration from their natural reservoirs. The relatively high T. cruzi infection rate indicates considerable circulation of the parasite in these areas, increasing the risk of vector-borne Chagas disease infection. These data suggest a need to strengthen epidemiological surveillance and integrate appropriate control actions targeting triatomines, T. cruzi reservoirs, and human populations. Our data also identify Chagas disease transmission as a hazard in urban areas of Sobral.	[Parente, Cynara Carvalho; Parente, Plutarco I.] Univ Fed Ceara Sobral, Fac Med, Sobral, Ceara, Brazil; [Bezerra, Fernando S. M.] Univ Fed Ceara, Fac Farm Odontol & Enfermagem, Fortaleza, Ceara, Brazil; [Dias-Neto, Raimundo V.] Secretaria Municipal Saude Sobral, Ctr Controle Zoonoses, Sobral, Ceara, Brazil; [Xavier, Samanta C. C.] Fiocruz MS, Fundacao Oswaldo Cruz, Lab Biol Tripanossomatideos, Rio De Janeiro, RJ, Brazil; [Ramos, Alberto N., Jr.] Univ Fed Ceara, Fac Med, Fortaleza, Ceara, Brazil; [Carvalho-Costa, Filipe A.] Fiocruz MS, Inst Oswaldo Cruz, Lab Epidemiol & Sistemat Mol, Rio De Janeiro, Brazil; [Carvalho-Costa, Filipe A.] Escritorio Tecn Reg Fiocruz, Teresina, Piaui, Brazil; [Lima, Marli M.] Fiocruz MS, Inst Oswaldo Cruz, Lab Ecoepidemiol Doenca de Chagas, Rio De Janeiro, Brazil	Universidade Federal do Ceara; Fundacao Oswaldo Cruz; Universidade Federal do Ceara; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Lima, MM (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Ecoepidemiol Doenca de Chagas, Rio De Janeiro, Brazil.	marlilima@uol.com.br	Júnior, Alberto Novaes Ramos/A-4276-2013; Patologia, Programa/AAI-4877-2021	Júnior, Alberto Novaes Ramos/0000-0001-7982-1757; Bezerra, Fernando/0000-0003-4920-7718	Oswaldo Cruz Foundation; CAPES	Oswaldo Cruz Foundation; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors received funding from Oswaldo Cruz Foundation and CAPES.	Abad-Franch F, 2015, ACTA TROP, V15, P52; Abad-Franch F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003187; Andrade DV, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003010; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33; Assis GFM, 2007, REV SOC BRAS MED TRO, V40, P391, DOI DOI 10.1590/S0037-86822007000400003; Bezerra CM, 2008, REV SOC BRAS MED TRO, V42, P308; Borges-Pereira J, 2008, REV SOC BRAS MED TRO, V41, P345, DOI 10.1590/S0037-86822008000400005; de la Fuente ALC, 2007, ACTA TROP, V101, P115, DOI 10.1016/j.actatropica.2006.12.007; Chagas C, 1909, MEM I OSWALDO CRUZ, V1, P159, DOI DOI 10.1590/S0074-02761909000200008; Coura JR, 2015, ACTA TROP, V15, P134; de la Fuente ALC, 2008, J MED ENTOMOL, V45, P14, DOI 10.1603/0022-2585(2008)45[14:BPOTRT]2.0.CO;2; Dias JCP, 2007, MEM I OSWALDO CRUZ, V102, P11, DOI 10.1590/S0074-02762007005000092; Forattini O P, 1979, Rev Saude Publica, V13, P220, DOI 10.1590/S0034-89101979000300007; Freitas Simone Patrícia Carneiro, 2004, Cad. Saúde Pública, V20, P333, DOI 10.1590/S0102-311X2004000100052; Freitas SPC, 2005, REV SAUDE PUBL, V39, P27, DOI 10.1590/S0034-89102005000100004; Gumiel M, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0836-z; Lima MM, 2008, PARASITOL RES, V102, P797, DOI 10.1007/s00436-007-0823-1; Lima MM, 2008, AM J TROP MED HYG, V79, P750, DOI 10.4269/ajtmh.2008.79.750; Lima MM, 2015, PARASITOL RES, V114, P1687, DOI 10.1007/s00436-015-4350-1; Lima MM, 2012, T ROY SOC TROP MED H, V106, P143, DOI 10.1016/j.trstmh.2011.10.013; Martins-Melo FR, 2014, TROP MED INT HEALTH, V19, P943, DOI 10.1111/tmi.12328; Nobrega AA, 2009, EMERG INFECT DIS, V15, P653, DOI 10.3201/eid1504.081450; Ramos JR, 2001, CAD SAUDE PUBLICA, V17, P1403; Sarquis O, 2006, MEM I OSWALDO CRUZ, V101, P143, DOI 10.1590/S0074-02762006000200005; Sarquis O, 2012, PARASITOL RES, V110, P1481, DOI 10.1007/s00436-011-2651-6; Sonoda IV, 2010, MEM I OSWALDO CRUZ, V105, P348, DOI 10.1590/S0074-02762010000300019; Dias FBS, 2011, INFECT GENET EVOL, V11, P869, DOI 10.1016/j.meegid.2011.02.008; Valenca-Barbosa C, 2014, AM J TROP MED HYG, V90, P1059, DOI 10.4269/ajtmh.13-0204	28	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170278	10.1371/journal.pone.0170278	http://dx.doi.org/10.1371/journal.pone.0170278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103294	Green Published, gold, Green Submitted			2022-12-26	WOS:000392381100049
J	Jafari, N; Kim, H; Park, R; Li, LQ; Jang, MS; Morris, AJ; Park, J; Huang, C				Jafari, Naser; Kim, Hyunju; Park, Rackhyun; Li, Liqing; Jang, Minsu; Morris, Andrew J.; Park, Junsoo; Huang, Cai			CRISPR-Cas9 Mediated NOX4 Knockout Inhibits Cell Proliferation and Invasion in HeLa Cells	PLOS ONE			English	Article							NADPH OXIDASE NOX4; FOCAL ADHESION; ROS GENERATION; UP-REGULATION; CANCER-CELLS; TGF-BETA; EXPRESSION; MIGRATION; PATHWAY; KIDNEY	Increased expression of NOX4 protein is associated with cancer progression and metastasis but the role of NOX4 in cell proliferation and invasion is not fully understood. We generated NOX4 knockout HeLa cell lines using the CRISPR-Cas9 gene editing system to explore the cellular functions of NOX4. After transfection of CRISPR-Cas9 construct, we performed 17 endonuclease 1 assays and DNA sequencing to generate and identify insertion and deletion of the NOX4 locus. We confirmed the knockout of NOX4 by Western blotting. NOX4 knockout cell lines showed reduced cell proliferation with an increase of sub-G1 cell population and the decrease of S/G2/M population. Moreover, NOX4 deficiency resulted in a dramatic decrease in invadopodium formation and the invasive activity. In addition, NOX4 deficiency also caused a decrease in focal adhesions and cell migration in HeLa cells. These results suggest that NOX4 is required for both efficient proliferation and invasion of HeLa cells.	[Jafari, Naser; Kim, Hyunju; Park, Rackhyun; Li, Liqing; Jang, Minsu; Park, Junsoo; Huang, Cai] Univ Kentucky, Markey Canc Ctr, Lexington, KY USA; [Kim, Hyunju; Park, Rackhyun; Jang, Minsu; Park, Junsoo] Yonsei Univ, Div Biol Sci & Technol, Wonju, South Korea; [Morris, Andrew J.] Univ Kentucky, Dept Internal Med, Div Cardiovasc Med, Lexington, KY USA	University of Kentucky; Yonsei University; University of Kentucky	Park, J; Huang, C (corresponding author), Univ Kentucky, Markey Canc Ctr, Lexington, KY USA.; Park, J (corresponding author), Yonsei Univ, Div Biol Sci & Technol, Wonju, South Korea.	junsoo@yonsei.ac.kr; cai-huang@uky.edu	LI, LI QING/GRR-8855-2022; li, li/HII-4157-2022; li, li/GPX-3938-2022; li, li/AAT-2097-2020; Li, Li/AEM-3636-2022; LI, LI/GVS-5344-2022	Park, Junsoo/0000-0002-2355-6760	America Cancer Society Research Scholar Grant [RSG-13-184-01-CSM]; National Research Foundation of Korea (NRF) grant - Korea government [NRF-2016R1A2B4009665]	America Cancer Society Research Scholar Grant; National Research Foundation of Korea (NRF) grant - Korea government	This study was supported by America Cancer Society Research Scholar Grant (RSG-13-184-01-CSM) and by the National Research Foundation of Korea (NRF) grant funded by the Korea government (NRF-2016R1A2B4009665).	Ago T, 2010, CIRC RES, V106, P1253, DOI 10.1161/CIRCRESAHA.109.213116; Asaba K, 2005, KIDNEY INT, V67, P1890, DOI 10.1111/j.1523-1755.2005.00287.x; Babelova A, 2012, FREE RADICAL BIO MED, V53, P842, DOI 10.1016/j.freeradbiomed.2012.06.027; Bedard K, 2007, BIOCHIMIE, V89, P1107, DOI 10.1016/j.biochi.2007.01.012; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Carmona-Cuenca I, 2008, J HEPATOL, V49, P965, DOI 10.1016/j.jhep.2008.07.021; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Crosas-Molist E, 2014, FREE RADICAL BIO MED, V69, P338, DOI 10.1016/j.freeradbiomed.2014.01.040; Fitzgerald JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030712; Gill PS, 2006, ANTIOXID REDOX SIGN, V8, P1597, DOI 10.1089/ars.2006.8.1597; Gorin Y, 2005, J BIOL CHEM, V280, P39616, DOI 10.1074/jbc.M502412200; Hiraga R, 2013, ANTICANCER RES, V33, P4431; Li X, 2013, J CELL SCI, V126, P2617, DOI 10.1242/jcs.117044; Luanpitpong S, 2010, J BIOL CHEM, V285, P38832, DOI 10.1074/jbc.M110.124958; Mochizuki T, 2006, ONCOGENE, V25, P3699, DOI 10.1038/sj.onc.1209406; Nakahara H, 1997, P NATL ACAD SCI USA, V94, P7959, DOI 10.1073/pnas.94.15.7959; Qi L, 2016, J CELL SCI, V129, P3661, DOI 10.1242/jcs.185959; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ren XD, 2000, J CELL SCI, V113, P3673; Ribeiro-Pereira C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099481; Salmeen A, 2010, ONCOGENE, V29, P4473, DOI 10.1038/onc.2010.200; Sancho P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045285; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Shimada K, 2011, BMC UROL, V11, DOI 10.1186/1471-2490-11-22; Shono T, 2008, INT J CANCER, V123, P787, DOI 10.1002/ijc.23569; Tobar N, 2010, BRIT J CANCER, V103, P1040, DOI 10.1038/sj.bjc.6605847; Weyemi U, 2012, MUTAT RES-REV MUTAT, V751, P77, DOI 10.1016/j.mrrev.2012.04.002; Weyemi U, 2010, ENDOCR-RELAT CANCER, V17, P27, DOI 10.1677/ERC-09-0175; Wu ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024775; Yamaguchi H, 2011, J CELL BIOL, V193, P1275, DOI 10.1083/jcb.201009126; Yamaura M, 2009, CANCER RES, V69, P2647, DOI 10.1158/0008-5472.CAN-08-3745; Zhang CX, 2014, ONCOTARGET, V5, P4392, DOI 10.18632/oncotarget.2025; Zhang X, 2016, ONCOTARGET, V7, P30855, DOI 10.18632/oncotarget.8806	36	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170327	10.1371/journal.pone.0170327	http://dx.doi.org/10.1371/journal.pone.0170327			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099519	Green Published, gold, Green Submitted			2022-12-26	WOS:000392380100073
J	Nakazawa, H; Chang, K; Shinozaki, S; Yasukawa, T; Ishimaru, K; Yasuhara, S; Yu, YM; Martyn, JAJ; Tompkins, RG; Shimokado, K; Kaneki, M				Nakazawa, Harumasa; Chang, Kyungho; Shinozaki, Shohei; Yasukawa, Takashi; Ishimaru, Kazuhiro; Yasuhara, Shingo; Yu, Yong-Ming; Martyn, J. A. Jeevendra; Tompkins, Ronald. G.; Shimokado, Kentaro; Kaneki, Masao			iNOS as a Driver of Inflammation and Apoptosis in Mouse Skeletal Muscle after Burn Injury: Possible Involvement of Sirt1 S-Nitrosylation-Mediated Acetylation of p65 NF-kappa B and p53	PLOS ONE			English	Article							INDUCIBLE NITRIC-OXIDE; ENDOPLASMIC-RETICULUM STRESS; INSULIN-RESISTANCE; TNF-ALPHA; EXPRESSION; SYNTHASE; ACTIVATION; ATROPHY; MICE; HYPERGLYCEMIA	Inflammation and apoptosis develop in skeletal muscle after major trauma, including burn injury, and play a pivotal role in insulin resistance and muscle wasting. We and others have shown that inducible nitric oxide synthase (iNOS), a major mediator of inflammation, plays an important role in stress (e.g., burn)-induced insulin resistance. However, it remains to be determined how iNOS induces insulin resistance. Moreover, the interrelation between inflammatory response and apoptosis is poorly understood, although they often develop simultaneously. Nuclear factor (NF)-kappa B and p53 are key regulators of inflammation and apoptosis, respectively. Sirt1 inhibits p65 NF-kappa B and p53 by deacetylating these transcription factors. Recently, we have shown that iNOS induces S-nitrosylation of Sirt1, which inactivates Sirt1 and thereby increases acetylation and activity of p65 NF-kappa B and p53 in various cell types, including skeletal muscle cells. Here, we show that iNOS enhances burn-induced inflammatory response and apoptotic change in mouse skeletal muscle along with S-nitrosylation of Sirt1. Burn injury induced robust expression of iNOS in skeletal muscle and gene disruption of iNOS significantly inhibited burn induced increases in inflammatory gene expression and apoptotic change. In parallel, burn increased Sirt1 S-nitrosylation and acetylation and DNA-binding capacity of p65 NF kappa B and p53, all of which were reversed or ameliorated by iNOS deficiency. These results indicate that iNOS functions not only as a downstream effector but also as an upstream enhancer of burn-induced inflammatory response, at least in part, by Sirt1 S-nitrosylationdependent activation (acetylation) of p65 NF-kappa B. Our data suggest that Sirt1 S-nitrosylation may play a role in iNOS-mediated enhanced inflammatory response and apoptotic change, which, in turn, contribute to muscle wasting and supposedly to insulin resistance after burn injury.	[Nakazawa, Harumasa; Chang, Kyungho; Shinozaki, Shohei; Yasukawa, Takashi; Ishimaru, Kazuhiro; Yasuhara, Shingo; Martyn, J. A. Jeevendra; Kaneki, Masao] Harvard Med Sch, Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Charlestown, MA 02139 USA; [Nakazawa, Harumasa; Yasukawa, Takashi; Ishimaru, Kazuhiro; Yasuhara, Shingo; Yu, Yong-Ming; Martyn, J. A. Jeevendra; Tompkins, Ronald. G.; Kaneki, Masao] Shriners Hosp Children, Boston, MA 02114 USA; [Shinozaki, Shohei; Shimokado, Kentaro] Tokyo Med & Dent Univ, Dept Geriatr & Vasc Med, Grad Sch, Tokyo, Japan; [Yu, Yong-Ming; Tompkins, Ronald. G.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Surg, Boston, MA USA	Harvard University; Massachusetts General Hospital; Tokyo Medical & Dental University (TMDU); Harvard University; Harvard Medical School; Massachusetts General Hospital	Kaneki, M (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Charlestown, MA 02139 USA.; Kaneki, M (corresponding author), Shriners Hosp Children, Boston, MA 02114 USA.	mkaneki@helix.mgh.harvard.edu	Shinozaki, Shohei/AAT-3018-2021	Nakazawa, Harumasa/0000-0002-3258-9310; Ishimaru, Kazuhiro/0000-0002-4706-316X	National Institutes of Health (NIH) [R01DK05827, R01GM115552, R01GM117298]; Shriners Hospitals for Children [71000, 85800]; NIH [P50GM02700]; Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [16K15409] Funding Source: KAKEN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118947, P50GM021700, R01GM115552] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospitals for Children; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by research grants to MK from National Institutes of Health (NIH) (R01DK05827, R01GM115552, R01GM117298) and Shriners Hospitals for Children (71000, 85800), to RGT from NIH (P50GM02700), and to SS and KS from Japan Society for the Promotion of Science (JSPS) Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers. The funders had no role in study design, date collection and analysis, decision to publish, or preparation of the manuscript.	Authier FJ, 1997, ACTA NEUROPATHOL, V94, P272; Balasubramaniam A, 2009, AM J PHYSIOL-REG I, V296, pR893, DOI 10.1152/ajpregu.00015.2008; Borst SE, 2005, LIFE SCI, V77, P2156, DOI 10.1016/j.lfs.2005.03.021; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Cree MG, 2008, AM J PHYSIOL-ENDOC M, V294, pE1, DOI 10.1152/ajpendo.00562.2007; Cuzzocrea S, 2002, SHOCK, V18, P169, DOI 10.1097/00024382-200208000-00014; Davalos AR, 2013, J CELL BIOL, V201, P613, DOI 10.1083/jcb.201206006; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Dirks AJ, 2004, FREE RADICAL BIO MED, V36, P27, DOI 10.1016/j.freeradbiomed.2003.10.003; Duan HJ, 2009, APOPTOSIS, V14, P52, DOI 10.1007/s10495-008-0277-7; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Fujimoto M, 2005, DIABETES, V54, P1340, DOI 10.2337/diabetes.54.5.1340; Greiwe JS, 2001, FASEB J, V15, P475, DOI 10.1096/fj.00-0274com; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Hess DT, 2012, J BIOL CHEM, V287, P4411, DOI 10.1074/jbc.R111.285742; Hierholzer C, 2004, AM J PHYSIOL-GASTR L, V286, pG225, DOI 10.1152/ajpgi.00447.2002; Jeschke MG, 2012, ANN SURG, V255, P370, DOI 10.1097/SLA.0b013e31823e76e7; Jiang WW, 2007, J IMMUNOL, V178, P6495, DOI 10.4049/jimmunol.178.10.6495; Judge AR, 2007, AM J PHYSIOL-CELL PH, V292, pC372, DOI 10.1152/ajpcell.00293.2006; Kaneki M, 2007, ANTIOXID REDOX SIGN, V9, P319, DOI 10.1089/ars.2006.1464; Kashiwagi S, 2016, SHOCK; Katada K, 2009, J PHARMACOL EXP THER, V329, P919, DOI 10.1124/jpet.108.148460; Kim JS, 2015, EXP GERONTOL, V72, P261, DOI 10.1016/j.exger.2015.11.001; Koh A, 2013, MOL CELL BIOL, V33, P1608, DOI 10.1128/MCB.01447-12; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; Lee HY, 2011, SHOCK, V36, P580, DOI 10.1097/SHK.0b013e3182366872; Levy RM, 2007, AM J PHYSIOL-REG I, V293, pR1538, DOI 10.1152/ajpregu.00272.2007; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Martyn JAJ, 2008, ANESTHESIOLOGY, V109, P137, DOI 10.1097/ALN.0b013e3181799d45; Marzetti E, 2010, BBA-GEN SUBJECTS, V1800, P235, DOI 10.1016/j.bbagen.2009.05.007; Nakazawa H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116633; O'Neill BT, 2016, J CLIN INVEST, V126, P3433, DOI 10.1172/JCI86522; O'Neill ED, 2010, AGE, V32, P209, DOI 10.1007/s11357-009-9125-0; Okazaki T, 2003, BIOCHEM BIOPH RES CO, V300, P807, DOI 10.1016/S0006-291X(02)02932-7; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Plomgaard P, 2005, EXERC IMMUNOL REV, V11, P53; Quintana HT, 2015, INFLAMM RES, V64, P53, DOI 10.1007/s00011-014-0783-8; Robinson K, 2011, BEST PRACT RES CL EN, V25, P835, DOI 10.1016/j.beem.2011.04.008; Shinozaki S, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005375; Shinozaki S, 2011, J BIOL CHEM, V286, P34959, DOI 10.1074/jbc.M110.187666; Skidgel RA, 2002, J IMMUNOL, V169, P2093, DOI 10.4049/jimmunol.169.4.2093; Song JQ, 2015, SHOCK, V44, P479, DOI 10.1097/SHK.0000000000000444; Sugita H, 2005, J BIOL CHEM, V280, P14203, DOI 10.1074/jbc.M411226200; Sugita H, 2002, AM J PHYSIOL-ENDOC M, V282, pE386, DOI 10.1152/ajpendo.00087.2001; Sugita M, 2012, METABOLISM, V61, P127, DOI 10.1016/j.metabol.2011.06.001; Thompson M, 1996, J APPL PHYSIOL, V81, P2415, DOI 10.1152/jappl.1996.81.6.2415; ULLRICH SJ, 1993, P NATL ACAD SCI USA, V90, P5954, DOI 10.1073/pnas.90.13.5954; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang M, 2015, AM J RESP CELL MOL, V52, P171, DOI 10.1165/rcmb.2013-0544OC; Wang XN, 2006, ENDOCRINOLOGY, V147, P4160, DOI 10.1210/en.2006-0251; Wu CX, 2012, J SURG RES, V175, P88, DOI 10.1016/j.jss.2011.02.026; Yang HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046364; Yasuhara S, 1999, J BURN CARE REHABIL, V20, P462, DOI 10.1097/00004630-199920060-00007; Yasuhara S, 2000, AM J PHYSIOL-ENDOC M, V279, pE1114, DOI 10.1152/ajpendo.2000.279.5.E1114; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; Yin RY, 2015, FREE RADICAL BIO MED, V89, P895, DOI 10.1016/j.freeradbiomed.2015.10.406; Yu Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002086; Zhu SM, 2013, MUSCLE NERVE, V47, P711, DOI 10.1002/mus.23642	59	76	82	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170391	10.1371/journal.pone.0170391	http://dx.doi.org/10.1371/journal.pone.0170391			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099528	Green Published, Green Submitted, gold			2022-12-26	WOS:000392380100084
J	Timilshina, M; Kang, Y; Dahal, I; You, ZW; Nam, TG; Kim, KJ; Jeong, BS; Chang, JH				Timilshina, Maheshwor; Kang, Youra; Dahal, Ishmit; You, Zhiwei; Nam, Tae-Gyu; Kim, Keuk-Jun; Jeong, Byeong-Seon; Chang, Jae-Hoon			BJ-3105, a 6-Alkoxypyridin-3-ol Analog, Impairs T Cell Differentiation and Prevents Experimental Autoimmune Encephalomyelitis Disease Progression	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; IMMUNE DEVIATION; TH17 CELL; IN-VIVO; GM-CSF; CYTOKINES; IL-17; PATHOGENESIS; INDUCTION; MECHANISM	CD4(+) T cells are essential in inflammation and autoimmune diseases. Interferon-gamma (IFN-gamma) secreting T helper (Th1) and IL-17 secreting T helper (Th17) cells are critical for several autoimmune diseases. To assess the inhibitory effect of a given compound on autoimmune disease, we screened many compounds with an in vitro Th differentiation assay. BJ-3105, a 6-alkoxypyridin-3-ol analog, inhibited IFN-gamma and IL-17 production from polyclonal CD4(+) T cells and ovalbumin (OVA)-specific CD4(+) T cells which were activated by T cell receptor (TCR) engagement. BJ-3105 ameliorated the experimental autoimmune encephalomyelitis (EAE) model by reducing Th1 and Th17 generation. Notably, Th cell differentiation was significantly suppressed by BJ-3105 treatment without inhibiting in vitro proliferation of T cells or inducing programmed cell death. Mechanistically, BJ-3105 inhibited the phosphorylation of JAK and its downstream signal transducer and activator of transcription (STAT) that is critical for Th differentiation. These results demonstrated that BJ-3105 inhibits the phosphorylation of STAT in response to cytokine signals and subsequently suppressed the differentiation of Th cell responses.	[Timilshina, Maheshwor; Kang, Youra; Dahal, Ishmit; You, Zhiwei; Jeong, Byeong-Seon; Chang, Jae-Hoon] Yeungnam Univ, Coll Pharm, Gyongsan, South Korea; [Nam, Tae-Gyu] Hanyang Univ, Dept Pharm, Ansan, South Korea; [Nam, Tae-Gyu] Hanyang Univ, Inst Pharmaceut Sci & Technol, Ansan, South Korea; [Kim, Keuk-Jun] Daekyeung Coll, Dept Biomed Lab Sci, Gyongsan, South Korea	Yeungnam University; Hanyang University; Hanyang University	Chang, JH (corresponding author), Yeungnam Univ, Coll Pharm, Gyongsan, South Korea.	jeongb@ynu.ac.kr; jchang@yu.ac.kr			Yeungnam University Research Grant [213A367004]	Yeungnam University Research Grant	This work was supported by a Yeungnam University Research Grant, 213A367004, (http://www.yu.ac.kr/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Banskota S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148133; Bhattacharya P, 2015, CYTOKINE, V75, P261, DOI 10.1016/j.cyto.2015.05.030; Bhattacharya P, 2015, J INTERF CYTOK RES, V35, P585, DOI 10.1089/jir.2014.0149; Chang JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012925; Curtsinger JM, 2012, J IMMUNOL, V189, P659, DOI 10.4049/jimmunol.1102727; Domingues HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015531; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Egwuagu Charles E, 2013, JAKSTAT, V2, pe24134, DOI 10.4161/jkst.24134; Farooq SM, 2014, BRAIN BEHAV IMMUN, V42, P118, DOI 10.1016/j.bbi.2014.06.010; Farooq SM, 2014, BRAIN BEHAV IMMUN, V35, P64, DOI 10.1016/j.bbi.2013.09.016; Farooq SM, 2013, CNS NEUROSCI THER, V19, P503, DOI 10.1111/cns.12087; Flachenecker P, 2008, J NEUROL, V255, P102, DOI 10.1007/s00415-008-6019-5; Gaffen SL, 2008, CYTOKINE, V43, P402, DOI 10.1016/j.cyto.2008.07.017; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Hodge JA, 2016, CLIN EXP RHEUMATOL, V34, P318; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jadidi-Niaragh F, 2011, SCAND J IMMUNOL, V74, P1, DOI 10.1111/j.1365-3083.2011.02536.x; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kieseier Bernd C, 2010, Ther Adv Neurol Disord, V3, P277, DOI 10.1177/1756285610379885; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lee H, 2014, BIOORG MED CHEM LETT, V24, P3131, DOI 10.1016/j.bmcl.2014.05.005; Lighvani AA, P NATL ACAD SCI, V98, P15137; Liu YD, 2014, J IMMUNOL, V192, P59, DOI 10.4049/jimmunol.1301513; Lovett-Racke AE, 2011, BBA-MOL BASIS DIS, V1812, P246, DOI 10.1016/j.bbadis.2010.05.012; Lu Y, 2013, P NATL ACAD SCI USA, V110, P2258, DOI 10.1073/pnas.1222426110; Luckheeram RV, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/925135; Martinelli V, 2009, NEUROL SCI, V30, P167, DOI 10.1007/s10072-009-0142-7; Mitchell TJ, 2005, IMMUNOLOGY, V114, P301, DOI 10.1111/j.1365-2567.2005.02091.x; Moro H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024972; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Paris D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055392; Prat A, 2005, CURR OPIN NEUROL, V18, P225, DOI 10.1097/01.wco.0000169737.99040.31; Prat A, 2005, J AUTOIMMUN, V24, P119, DOI 10.1016/j.jaut.2005.01.004; Qin X, 2010, J IMMUNOL, V185, P1855, DOI 10.4049/jimmunol.0903853; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Reich Nancy C, 2013, JAKSTAT, V2, pe27080, DOI 10.4161/jkst.27080; Reiner SL, 2007, CELL, V129, P33, DOI 10.1016/j.cell.2007.03.019; Rinaldi F, 2009, MULTIPLE SCLEROSIS; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; Rowin J, 2012, MUSCLE NERVE, V46, P449, DOI 10.1002/mus.23488; Rudensky AY, 2011, IMMUNOL REV, V241, P260, DOI 10.1111/j.1600-065X.2011.01018.x; Segal BA, 2003, CURR ALLERGY ASTHM R, V3, P86, DOI 10.1007/s11882-003-0017-6; Skundric DS, 2005, CURR NEUROVASC RES, V2, P349, DOI 10.2174/156720205774322601; VARTANIAN T, 1995, MOL MED, V1, P732, DOI 10.1007/BF03401888; Wang JP, 2013, J MOL MED, V91, P485, DOI 10.1007/s00109-012-0964-2; Wang ZJ, 2007, J IMMUNOL, V179, P5958, DOI 10.4049/jimmunol.179.9.5958; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Yang J, 2013, JOURNAL OF CLINICAL; Zhao YG, 2012, J IMMUNOL, V189, P4417, DOI 10.4049/jimmunol.1200919; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	54	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0168942	10.1371/journal.pone.0168942	http://dx.doi.org/10.1371/journal.pone.0168942			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095433	Green Published, gold, Green Submitted			2022-12-26	WOS:000392372300012
J	Ihn, HJ; Lee, T; Kim, JA; Lee, D; Kim, ND; Shin, HI; Bae, YC; Park, EK				Ihn, Hye Jung; Lee, Taeho; Kim, Ju Ang; Lee, Doohyun; Kim, Nam Doo; Shin, Hong-In; Bae, Yong Chul; Park, Eui Kyun			OCLI-023, a Novel Pyrimidine Compound, Suppresses Osteoclastogenesis In Vitro and Alveolar Bone Resorption In Vivo	PLOS ONE			English	Article							CALCIUM-CHANNEL BLOCKERS; ANTIHYPERTENSIVE AGENTS; ACID-ESTERS; KAPPA-B; C-SRC; DIFFERENTIATION; RANKL; ACTIVATION; OSTEOPROTEGERIN; INFLAMMATION	An abnormal increase in osteoclast differentiation and activation results in various bone-resorptive diseases, including periodontitis, rheumatoid arthritis, and osteoporosis. Chemical compounds containing pyrimidine ring have been shown to regulate a variety of biological processes. Therefore, in order to identify an antiresorptive agent, we synthesized a series of pyrimidine ring-containing chemical compounds, and found that OCLI-023 suppressed the differentiation and activation of osteoclasts in vitro. OCLI-023 directly inhibited receptor activator of nuclear factor-kappa B ligand (RANKL)-induced differentiation of bone marrow macrophages into osteoclasts, without a cytotoxic response. OCLI-023 also downregulated the RANKL-induced mRNA expression of osteoclast markers as well as inhibited the formation of actin rings and resorption pits. OCLI-023 attenuated the RANKL-induced activation of c-Jun N-terminal kinase and nuclear factor kappa-light-chain-enhancer of activated B cell signaling pathways. In a mouse model of periodontitis, ligature induced an increase of distance between cementoenamel junction (CEJ) and alveolar bone crest (ABC) in the second molar, and OCLI-023 significantly reduced it. Histological analysis showed ligature-induced increase of osteoclast numbers was also significantly reduced by OCLI-023. These data demonstrated the inhibitory effect of OCLI-023 on osteoclast differentiation and activity of osteoclasts in vitro, as well as on ligature-induced bone loss in vivo, and OCLI-023 can be proposed as a novel anti-resorptive compound.	[Ihn, Hye Jung; Kim, Ju Ang; Shin, Hong-In; Park, Eui Kyun] Kyungpook Natl Univ, Sch Dent, Dept Oral Pathol & Regenerat Med, IHBR, Daegu, South Korea; [Lee, Taeho; Lee, Doohyun] Kyungpook Natl Univ, Pharmaceut Sci Res Inst, Coll Pharm, Daegu, South Korea; [Kim, Nam Doo] Daegu Gyeongbuk Med Innovat Fdn, New Drug Dev Ctr, Daegu, South Korea; [Bae, Yong Chul] Kyungpook Natl Univ, Sch Dent, Dept Oral Anat & Neurosci, Daegu, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University	Park, EK (corresponding author), Kyungpook Natl Univ, Sch Dent, Dept Oral Pathol & Regenerat Med, IHBR, Daegu, South Korea.	epark@knu.ac.kr			National Research Foundation of Korea (NRF) - Korea Government (MSIP) [2008-0062282]	National Research Foundation of Korea (NRF) - Korea Government (MSIP)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korea Government (MSIP) (2008-0062282). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2013, J IMMUNOL METHODS, V394, P49, DOI 10.1016/j.jim.2013.05.002; Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; ATWAL KS, 1991, J MED CHEM, V34, P806, DOI 10.1021/jm00106a048; Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; CHEN B, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/731039; Danks L, 2013, J BIOCHEM, V154, P29, DOI 10.1093/jb/mvt049; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Garlet GP, 2006, ORAL MICROBIOL IMMUN, V21, P12, DOI 10.1111/j.1399-302X.2005.00245.x; Graves DT, 2003, J PERIODONTOL, V74, P391, DOI 10.1902/jop.2003.74.3.391; GROVER GJ, 1995, J CARDIOVASC PHARM, V26, P289, DOI 10.1097/00005344-199508000-00015; Ihn HJ, 2015, EXP BIOL MED, V240, P1690, DOI 10.1177/1535370215576310; Ihn HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142201; Ikeda F, 2004, J CLIN INVEST, V114, P475, DOI 10.1172/JCI200419657; Ikeda F, 2008, J BONE MINER RES, V23, P907, DOI 10.1359/JBMR.080211; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kartsogiannis V, 2004, MOL CELL ENDOCRINOL, V228, P79, DOI 10.1016/j.mce.2003.06.002; Katada J, 1999, BIOORG MED CHEM LETT, V9, P797, DOI 10.1016/S0960-894X(99)00088-8; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lagoja IM, 2005, CHEM BIODIVERS, V2, P1, DOI 10.1002/cbdv.200490173; Missbach M, 2000, BIOORG MED CHEM LETT, V10, P945, DOI 10.1016/S0960-894X(00)00131-1; MITSUYA H, 1985, P NATL ACAD SCI USA, V82, P7096, DOI 10.1073/pnas.82.20.7096; Prakash O, 2004, EUR J MED CHEM, V39, P1073, DOI 10.1016/j.ejmech.2004.06.011; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Ralston SH, 2012, CALCIFIED TISSUE INT, V91, P97, DOI 10.1007/s00223-012-9599-0; Recchia I, 2004, BONE, V34, P65, DOI 10.1016/j.bone.2003.06.004; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; ROVNYAK GC, 1992, J MED CHEM, V35, P3254, DOI 10.1021/jm00095a023; Ruocco MG, 2005, J EXP MED, V201, P1677, DOI 10.1084/jem.20042081; Shinohara M, 2014, BONE, V60, P8, DOI 10.1016/j.bone.2013.11.025; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; TANAKA S, 1993, J CLIN INVEST, V91, P257, DOI 10.1172/JCI116179; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Vandyke K, 2010, J BONE MINER RES, V25, P1759, DOI 10.1002/jbmr.85; Xie FC, 2009, BIOORG MED CHEM LETT, V19, P275, DOI 10.1016/j.bmcl.2008.09.067; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645	37	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0170159	10.1371/journal.pone.0170159	http://dx.doi.org/10.1371/journal.pone.0170159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085946	Green Published, Green Submitted, gold			2022-12-26	WOS:000391972600070
J	Pan, CY; Tsai, TY; Su, BC; Hui, CF; Chen, JY				Pan, Chieh-Yu; Tsai, Tsung-Yu; Su, Bor-Chyuan; Hui, Cho-Fat; Chen, Jyh-Yih			Study of the Antimicrobial Activity of Tilapia Piscidin 3 (TP3) and TP4 and Their Effects on Immune Functions in Hybrid Tilapia (Oreochromis spp.)	PLOS ONE			English	Article							GROUPER EPINEPHELUS-COIOIDES; VIBRIO-VULNIFICUS INFECTION; ANTILIPOPOLYSACCHARIDE FACTOR; IMMUNOMODULATORY FUNCTIONS; ANTIBACTERIAL ACTIVITY; MOUSE MODEL; PEPTIDE; EPINECIDIN-1; RESISTANCE; GENE	To address the growing concern over antibiotic-resistant microbial infections in aquatic animals, we tested several promising alternative agents that have emerged as new drug candidates. Specifically, the tilapia piscidins are a group of peptides that possess antimicrobial, wound-healing, and antitumor functions. In this study, we focused on tilapia piscidin 3 (TP3) and TP4, which are peptides derived from Oreochromis niloticus, and investigated their inhibition of acute bacterial infections by infecting hybrid tilapia (Oreochromis spp.) with Vibrio vulnificus and evaluating the protective effects of pre-treating, co-treating, and post-treating fish with TP3 and TP4. In vivo experiments showed that co-treatment with V. vulnificus and TP3 (20 mu g/fish) or TP4 (20 mu g/fish) achieved 95.3% and 88.9% survival rates, respectively, after seven days. When we co-injected TP3 or TP4 and V. vulnificus into tilapia and then re-challenged the fish with V. vulnificus after 28 days, the tilapia exhibited survival rates of 35.6% and 42.2%, respectively. Pre-treatment with TP3 (30 mu g/fish) or TP4 (20 mu g/fish) for 30 minutes prior to V. vulnificus infection resulted in high survival rates of 28.9% and 37.8%, respectively, while post-treatment with TP3 (20 mu g/fish or 30 mu g/fish) or TP4 (20 mu g/fish) 30 minutes after V. vulnificus infection yielded high survival rates of 33.3% and 48.9%. In summary, pre-treating, co-treating, and post-treating fish with TP3 or TP4 all effectively decreased the number of V. vulnificus bacteria and promoted significantly lower mortality rates in tilapia. The minimum inhibitory concentrations (MICs) of TP3 and TP4 that were effective for treating fish infected with V. vulnificus were 7.8 and 62.5 mu g/ml, respectively, whereas the MICs of kanamycin and ampicillin were 31.2 and 3.91 mu g/ml. The antimicrobial activity of these peptides was confirmed by transmission electron microscopy (TEM) and scanning electron microscopy (SEM), both of which showed that V. vulnificus disrupted the outer membranes of cells, resulting in the loss of cell shape and integrity. We examined whether TP3 and TP4 increased the membrane permeability of V. vulnificus by measuring the fluorescence resulting from the uptake of 1-N-phenyl-naphthylamine (NPN). Treating fish with TP3 and TP4 under different pH and temperature conditions did not significantly increase MIC values, suggesting that temperature and the acid-base environment do not affect AMP function. In addition, the qPCR results showed that TP3 and TP4 influence the expression of immune-responsive genes, including interleukin (IL)-1 beta, IL-6, and IL-8. In this study, we demonstrate that TP3 and TP4 show potential for development as drugs to combat fish bacterial infections in aquaculture.	[Pan, Chieh-Yu; Tsai, Tsung-Yu] Natl Kaohsiung Marine Univ, Dept & Grad Inst Aquaculture, Kaohsiung, Taiwan; [Su, Bor-Chyuan; Hui, Cho-Fat; Chen, Jyh-Yih] Acad Sinica, Inst Cellular & Organism Biol, Marine Res Stn, Jiaushi, Ilan, Taiwan	National Kaohsiung University of Science & Technology; Academia Sinica - Taiwan	Pan, CY (corresponding author), Natl Kaohsiung Marine Univ, Dept & Grad Inst Aquaculture, Kaohsiung, Taiwan.; Chen, JY (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Marine Res Stn, Jiaushi, Ilan, Taiwan.	panjade@webmail.nkmu.edu.tw; zoocjy@gate.sinica.edu.tw	Su, Bor-Chyuan/AAU-7754-2020; Chen, Jyh-Yih/F-3412-2014	Chen, Jyh-Yih/0000-0001-7858-8236; Su, Bor-Chyuan/0000-0002-0454-0624	Ministry of Science and Technology, Taiwan [103-2313-B-001 -007 -MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants (103-2313-B-001 -007 -MY3) from the Ministry of Science and Technology, Taiwan. This research was conducted by the Marine Research Station, Institute of Cellular and Organismic Biology, Academia Sinica.	Ahmed U, 2012, INDIAN J PHARMACOL, V44, P509, DOI 10.4103/0253-7613.99332; Andersson DI, 2016, DRUG RESIST UPDATE, V26, P43, DOI 10.1016/j.drup.2016.04.002; Bier N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01179; Cabello FC, 2006, ENVIRON MICROBIOL, V8, P1137, DOI 10.1111/j.1462-2920.2006.01054.x; Chan YS, 2013, CELL BIOCHEM BIOPHYS, V66, P637, DOI 10.1007/s12013-012-9508-1; Chen WF, 2015, BIOMATERIALS, V53, P1, DOI 10.1016/j.biomaterials.2015.02.069; Chuah Li-Oon, 2016, Curr Environ Health Rep, V3, P118, DOI 10.1007/s40572-016-0091-2; Ewert KK, 2016, BIOORG MED CHEM LETT, V26, P1618, DOI 10.1016/j.bmcl.2016.01.079; Fleitas O, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00381; Fominaya J, 2015, THER DELIV, V6, P1171, DOI 10.4155/tde.15.51; Fu GH, 2014, FISH SHELLFISH IMMUN, V40, P331, DOI 10.1016/j.fsi.2014.07.019; Gallwitz M, 2007, IMMUNOGENETICS, V59, P391, DOI 10.1007/s00251-007-0202-1; Huang HN, 2015, ONCOTARGET, V6, P12955, DOI 10.18632/oncotarget.4102; Huang HN, 2015, MAR DRUGS, V13, P3241, DOI 10.3390/md13053241; Huang HC, 2015, 2015 INTERNATIONAL CONFERENCE ON INTELLIGENT INFORMATION HIDING AND MULTIMEDIA SIGNAL PROCESSING (IIH-MSP), P13, DOI 10.1109/IIH-MSP.2015.60; Igbinosa EO, 2016, MICROB DRUG RESIST, V22, P238, DOI 10.1089/mdr.2015.0169; Krishnamurthy M, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0876-3; Lee SJ, 2015, J IMMUNOL, V195, P2282, DOI 10.4049/jimmunol.1500951; Lin MC, 2013, PEPTIDES, V44, P139, DOI 10.1016/j.peptides.2013.04.004; Lin WC, 2016, FISH SHELLFISH IMMUN, V50, P200, DOI 10.1016/j.fsi.2016.01.034; Misiewicz J, 2015, BBA-BIOMEMBRANES, V1848, P833, DOI 10.1016/j.bbamem.2014.12.006; Narayana JL, 2015, PEPTIDES, V72, P88, DOI 10.1016/j.peptides.2015.05.012; Narayana JL, 2015, ONCOTARGET, V6, P12936; Nesuta O, 2016, J NAT PROD, V79, P1073, DOI 10.1021/acs.jnatprod.5b01129; Nuding S, 2014, ANTIMICROB AGENTS CH, V58, P5719, DOI 10.1128/AAC.02542-14; Pan CY, 2007, DNA CELL BIOL, V26, P403, DOI 10.1089/dna.2006.0564; Pan CY, 2015, MAR DRUGS, V13, P2287, DOI 10.3390/md13042287; Pan CY, 2012, FISH SHELLFISH IMMUN, V32, P947, DOI 10.1016/j.fsi.2012.01.023; Pan CY, 2011, FISH SHELLFISH IMMUN, V31, P1019, DOI 10.1016/j.fsi.2011.09.001; Pan CY, 2010, PEPTIDES, V31, P806, DOI 10.1016/j.peptides.2010.01.013; Pan CY, 2009, PEPTIDES, V30, P1058, DOI 10.1016/j.peptides.2009.02.006; Peng KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050263; Shi BB, 2015, WORLD J MICROB BIOT, V31, P1285, DOI 10.1007/s11274-015-1871-9; Silphaduang U, 2006, DIS AQUAT ORGAN, V72, P241, DOI 10.3354/dao072241; Skouri-Gargouri H, 2009, PEPTIDES, V30, P1798, DOI 10.1016/j.peptides.2009.06.034; Sun BJ, 2007, J FISH DIS, V30, P335, DOI 10.1111/j.1365-2761.2007.00789.x; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wang YD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1102	38	33	35	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0169678	10.1371/journal.pone.0169678	http://dx.doi.org/10.1371/journal.pone.0169678			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085905	Green Published, Green Submitted, gold			2022-12-26	WOS:000391972600033
J	Beffagna, G; Sammarco, A; Bedin, C; Romualdi, C; Mainenti, M; Mollo, A; Cavicchioli, L; Ferro, S; Trez, D; De Maria, R; Nitti, D; Saccani, A; Campanella, M; Agostini, M; Zappulli, V				Beffagna, Giorgia; Sammarco, Alessandro; Bedin, Chiara; Romualdi, Chiara; Mainenti, Marta; Mollo, Antonio; Cavicchioli, Laura; Ferro, Silvia; Trez, Davide; De Maria, Raffaella; Nitti, Donato; Saccani, Andrea; Campanella, Michelangelo; Agostini, Marco; Zappulli, Valentina			Circulating Cell-Free DNA in Dogs with Mammary Tumors: Short and Long Fragments and Integrity Index	PLOS ONE			English	Article							PLASMA DNA; PANCREATIC-CANCER; NUCLEIC-ACIDS; BLOOD-PLASMA; CANINE; BIOMARKER; SERUM; BCL-2; APOPTOSIS; ORIGIN	Circulating cell-free DNA (cfDNA) has been considered an interesting diagnostic/prognostic plasma biomarker in tumor-bearing subjects. In cancer patients, cfDNA can hypothetically derive from tumor necrosis/apoptosis, lysed circulating cells, and some yet unrevealed mechanisms of active release. This study aimed to preliminarily analyze cfDNA in dogs with canine mammary tumors (CMTs). Forty-four neoplastic, 17 non-neoplastic disease-bearing, and 15 healthy dogs were recruited. Necrosis and apoptosis were also assessed as potential source of cfDNA on 78 CMTs diagnosed from the 44 dogs. The cfDNA fragments and integrity index significantly differentiated neoplastic versus non-neoplastic dogs (P<0.05), and allowed the distinction between benign and malignant lesions (P<0.05). Even if without statistical significance, the amount of cfDNA was also affected by tumor necrosis and correlated with tumor size and apoptotic markers expression. A significant (P<0.01) increase of Bcl-2 in malignant tumors was observed, and in metastatic CMTs the evasion of apoptosis was also suggested. This study, therefore, provides evidence that cfDNA could be a diagnostic marker in dogs carrying mammary nodules suggesting that its potential application in early diagnostic procedures should be further investigated.	[Beffagna, Giorgia; Sammarco, Alessandro; Mainenti, Marta; Cavicchioli, Laura; Ferro, Silvia; Trez, Davide; Zappulli, Valentina] Univ Padua, Dept Comparat Biomed & Food Sci, Padua, Italy; [Bedin, Chiara; Nitti, Donato; Agostini, Marco] Univ Padua, Dept Surg Oncol & Gastroenterol Sci, Padua, Italy; [Bedin, Chiara; Agostini, Marco] Ist Ric Pediat Citta Speranza, Padua, Italy; [Romualdi, Chiara] Univ Padua, Dept Biol, Padua, Italy; [Mollo, Antonio] Univ Padua, Dept Anim Med Prod & Hlth, Padua, Italy; [De Maria, Raffaella] Univ Turin, Dept Vet Sci, Turin, Italy; [Saccani, Andrea] EuroClone, Milan, Italy; [Campanella, Michelangelo] Royal Vet Coll, Dept Comparat Biomed Sci, London, England; [Campanella, Michelangelo] UCL Consortium Mitochondrial Res, London, England	University of Padua; University of Padua; Fondazione Citta della Speranza; University of Padua; University of Padua; University of Turin; University of London; University of London Royal Veterinary College; University of London; University College London	Sammarco, A (corresponding author), Univ Padua, Dept Comparat Biomed & Food Sci, Padua, Italy.	alessandro.sammarco6@gmail.com	Ferro, Silvia/AAA-7772-2021; agostini, marco ma/K-2449-2018; Bedin, Chiara/K-8619-2016; mollo, antonio/A-2743-2012; Campanella, Michelangelo/K-8172-2016; Romualdi, Chiara/K-1132-2016	agostini, marco ma/0000-0001-7578-1233; Bedin, Chiara/0000-0001-7872-9828; Campanella, Michelangelo/0000-0002-6948-4184; Romualdi, Chiara/0000-0003-4792-9047; mollo, antonio/0000-0001-8304-7653; DE MARIA, RAFFAELLA/0000-0002-7028-2280	BBSRC New Investigator Award [BB/1013695/1]; PPCT; LAM Research Grant on Brain Tumours [FP7-PEOPLE-2011-CIG]; Umberto Veronesi Foundation Young Investigator Research Programme; Umberto Veronesi Foundation; BBSRC [BB/I013695/1, BB/N007042/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/N007042/1, BB/I013695/1] Funding Source: researchfish	BBSRC New Investigator Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); PPCT; LAM Research Grant on Brain Tumours; Umberto Veronesi Foundation Young Investigator Research Programme(Fondazione Umberto Veronesi); Umberto Veronesi Foundation(Fondazione Umberto Veronesi); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	G. Beffagna was supported by a fellowship from the Umberto Veronesi Foundation Young Investigator Research Programme. The activity in MC laboratory was supported by the BBSRC New Investigator Award Grant (BB/1013695/1), PPCT, LAM Research Grant on Brain Tumours, FP7-PEOPLE-2011-CIG. One of the authors (Andrea Saccani) is employed by the commercial company Euroclone. However, the authors declare that the funder provided support in the form of salary for author [A. Saccani] and provided support in the form of materials for qPCR (Master mix, probe and primers), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.; GB was supported by a fellowship from the Umberto Veronesi Foundation. Umberto Veronesi Foundation Young Investigator Research Programme. The activity in MC laboratory was supported by the BBSRC New Investigator Award Grant (BB/I013695/1), PPCT, LAM Research Grant on Brain Tumours, FP7-PEOPLE-2011-CIG.	Agassi R, 2015, AM J CLIN PATHOL, V143, P18, DOI 10.1309/AJCPI5YHG0OGFAHM; Agostini M, 2011, ANN SURG ONCOL, V18, P2461, DOI 10.1245/s10434-011-1638-y; Alix-Panabieres C, 2016, CANCER DISCOV, V6, P479, DOI 10.1158/2159-8290.CD-15-1483; Anker P, 2001, CIRCULATING DNA PLAS; Asmarinah, 2014, INT J ONCOL, V45, P1489, DOI 10.3892/ijo.2014.2576; AYALA W, 1951, J CLIN INVEST, V30, P781, DOI 10.1172/JCI102492; Baspinar S, 2013, PATHOL RES PRACT, V209, P418, DOI 10.1016/j.prp.2013.04.006; Beck J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075485; Borge KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126371; BOSTOCK DE, 1986, BRIT VET J, V142, P506, DOI 10.1016/0007-1935(86)90107-7; BRODEY RS, 1983, J AM ANIM HOSP ASSOC, V19, P61; Cargnin S, 2016, J THORAC ONCOL; CoustanSmith E, 1996, BLOOD, V87, P1140, DOI 10.1182/blood.V87.3.1140.bloodjournal8731140; El-Gayar Dina, 2016, Asian Pac J Cancer Prev, V17, P939; Ellsworth Re, 2016, SEMIN CELL DEV BIOL; Fawzy A, 2016, J EGYPT NATL CANC I; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gelaleti GB, 2014, ONCOL REP, V31, P435, DOI 10.3892/or.2013.2827; Geng M, 2013, INT J CLIN EXP PATHO, V6, P2554; Giacona MB, 1998, PANCREAS, V17, P89, DOI 10.1097/00006676-199807000-00012; Goldschmidt M, 2011, VET PATHOL, V48, P117, DOI 10.1177/0300985810393258; Gormally E, 2007, MUTAT RES-REV MUTAT, V635, P105, DOI 10.1016/j.mrrev.2006.11.002; Hao TB, 2014, BRIT J CANCER, V111, P1482, DOI 10.1038/bjc.2014.470; Hofman P, 2016, VIRCHOWS ARCH; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Imamura T, 2016, WORLD J GASTROENTERO, V22, P5627, DOI 10.3748/wjg.v22.i25.5627; Iqbal S, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1071-y; Jahr S, 2001, CANCER RES, V61, P1659; Jain MV, 2013, J CELL MOL MED, V17, P12, DOI 10.1111/jcmm.12001; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jung K, 2010, CLIN CHIM ACTA, V411, P1611, DOI 10.1016/j.cca.2010.07.032; Kumaraguruparan R, 2006, RES VET SCI, V81, P218, DOI 10.1016/j.rvsc.2005.08.002; Kumaraguruparan R, 2006, CLIN CHIM ACTA, V365, P168, DOI 10.1016/j.cca.2005.08.018; Kurien BT, 2011, METHODS MOL BIOL, V717, P55, DOI 10.1007/978-1-61779-024-9_3; Lee Chung-Ho, 2002, J Vet Sci, V3, P321; LEON SA, 1977, CANCER RES, V37, P646; Lowes LE, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091505; Madhavan D, 2014, BREAST CANCER RES TR, V146, P163, DOI 10.1007/s10549-014-2946-2; Matos AJF, 2012, VET J, V193, P24, DOI 10.1016/j.tvjl.2011.12.019; Merlo DF, 2008, J VET INTERN MED, V22, P976, DOI 10.1111/j.1939-1676.2008.0133.x; Ouyang L, 2012, CELL PROLIFERAT, V45, P487, DOI 10.1111/j.1365-2184.2012.00845.x; Pena L, 2014, VET PATHOL, V51, P127, DOI 10.1177/0300985813509388; Pena L, 2013, VET PATHOL, V50, P94, DOI 10.1177/0300985812447830; Pilichou K, 2011, CIRC-CARDIOVASC GENE, V4, P318, DOI 10.1161/CIRCGENETICS.110.959031; Qian C, 2016, ONCOTARGET; Rivera P, 2009, CANCER RES, V69, P8770, DOI 10.1158/0008-5472.CAN-09-1725; Salvianti F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049843; Schaefer DMW, 2007, VET COMP ONCOL, V5, P145, DOI 10.1111/j.1476-5829.2007.00122.x; Schwarzenbach H, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3446; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Skvortsova TE, 2006, BRIT J CANCER, V94, P1492, DOI 10.1038/sj.bjc.6603117; Sleeckx N, 2011, REPROD DOMEST ANIM, V46, P1112, DOI 10.1111/j.1439-0531.2011.01816.x; Sorenmo K, 2003, VET CLIN N AM-SMALL, V33, P573, DOI 10.1016/S0195-5616(03)00020-2; Sorenmo KU., 2013, SMALL ANIMAL CLIN ON, DOI [10.1016/B978-1-4377-2362-5.00027-X, DOI 10.1016/B978-1-4377-2362-5.00027-X]; Stewart B. W., 2003, World Cancer Report; Stroun M, 2000, ANN NY ACAD SCI, V906, P161; Stroun M, 2001, CLIN CHIM ACTA, V313, P139, DOI 10.1016/S0009-8981(01)00665-9; TAN EM, 1966, J CLIN INVEST, V45, P1732, DOI 10.1172/JCI105479; Thompson JC, 2016, CLIN CANC RES; Umetani N, 2006, J CLIN ONCOL, V24, P4270, DOI 10.1200/JCO.2006.05.9493; Umetani N, 2006, CLIN CHEM, V52, P1062, DOI 10.1373/clinchem.2006.068577; Volik S, 2016, MOL CANC RES; Wang BG, 2003, CANCER RES, V63, P3966; Wang W, 2005, GENOME RES, V15, P1798, DOI 10.1101/gr.3765505	65	21	21	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169454	10.1371/journal.pone.0169454	http://dx.doi.org/10.1371/journal.pone.0169454			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081183	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000391949500046
J	Brooks, MB; Turk, JR; Guerrero, A; Narayanan, PK; Nolan, JP; Besteman, EG; Wilson, DW; Thomas, RA; Fishman, CE; Thompson, KL; Ellinger-Ziegelbauer, H; Pierson, JB; Paulman, A; Chiang, AY; Schultze, AE				Brooks, Marjory B.; Turk, James R.; Guerrero, Abraham; Narayanan, Padma K.; Nolan, John P.; Besteman, Elizabeth G.; Wilson, Dennis W.; Thomas, Roberta A.; Fishman, Cindy E.; Thompson, Karol L.; Ellinger-Ziegelbauer, Heidrun; Pierson, Jennifer B.; Paulman, April; Chiang, Alan Y.; Schultze, Albert E.			Non-Lethal Endotoxin Injection: A Rat Model of Hypercoagulability	PLOS ONE			English	Article							DISSEMINATED INTRAVASCULAR COAGULATION; MICRORNAS; SEPSIS; PATHOPHYSIOLOGY; INFLAMMATION; BIOGENESIS; THROMBOSIS; PLATELETS; RESPONSES; EXOSOMES	Systemic inflammation co-activates coagulation, which unchecked culminates in a lethal syndrome of multi-organ microvascular thrombosis known as disseminated intravascular coagulation (DIC). We studied an endotoxin-induced inflammatory state in rats to identify biomarkers of hemostatic imbalance favoring hypercoagulability. Intraperitoneal injection of LPS at 15 mg/kg body weight resulted in peripheral leukopenia and widespread neutrophilic sequestration characteristic of an acute systemic inflammatory response. Early indicators of hemostatic pathway activation developed within 4 hours, including increased circulating concentrations of procoagulant extracellular vesicles (EVs), EVs expressing endothelial cell and platelet membrane markers, and high concentration of soluble intercellular adhesion molecule-1 (sICAM-1), plasminogen activator inhibitor-1 (PAI-1), and D-dimers. Inflammation persisted throughout the 48-hour observation period; however, increases were found in a subset of serum microRNA (miRNA) that coincided with gradual resolution of hemostatic protein abnormalities and reduction in EV counts. Dose-adjusted LPS treatment in rats provides a time-course model to develop biomarker profiles reflecting procoagulant imbalance and rebalance under inflammatory conditions.	[Brooks, Marjory B.] Cornell Univ, Dept Populat Med & Diagnost Sci, Comparat Coagulat Sect, Ithaca, NY USA; [Turk, James R.; Guerrero, Abraham; Narayanan, Padma K.] Amgen Inc, Comparat Biol & Safety Sci, Thousand Oaks, CA 91320 USA; [Nolan, John P.] Scintillon Inst, San Diego, CA USA; [Besteman, Elizabeth G.] Merck Res Labs, Dept Pathol Safety Assessment & Lab Anim Resource, West Point, PA USA; [Wilson, Dennis W.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Thomas, Roberta A.; Fishman, Cindy E.] GlaxoSmithKline, Res & Dev, King Of Prussia, PA USA; [Thompson, Karol L.] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Ellinger-Ziegelbauer, Heidrun] Bayer Pharma AG, Wuppertal, Germany; [Pierson, Jennifer B.] Hlth & Environm Sci Inst, Washington, DC USA; [Paulman, April] Covance Labs, Dept Pathol, Greenfield, IN USA; [Chiang, Alan Y.] Lilly Res Labs, Global Stat Sci, Indianapolis, IN USA; [Schultze, Albert E.] Lilly Corp Ctr, Lilly Res Labs, Dept Pathol, Indianapolis, IN 46285 USA	Cornell University; Amgen; Merck & Company; University of California System; University of California Davis; GlaxoSmithKline; US Food & Drug Administration (FDA); Bayer AG; Bayer Healthcare Pharmaceuticals; Covance; Eli Lilly; Eli Lilly	Schultze, AE (corresponding author), Lilly Corp Ctr, Lilly Res Labs, Dept Pathol, Indianapolis, IN 46285 USA.	aes@lilly.com			Lilly; HESI's corporate sponsors; HESI for hemostatic protein analyses at Cornell University	Lilly(Eli Lilly); HESI's corporate sponsors; HESI for hemostatic protein analyses at Cornell University	Lilly supported the in-life phase of this study by contracting for laboratories services, animals and reagents at the Covance facility in Greenfield, IN. All other work was provided in-kind by the ILSI HESI Cardiac Safety Committee Cardiac Biomarkers Working Group, which is supported by sponsorships from member companies. HESI's scientific initiatives are primarily supported by the in-kind contributions (from public and private sector participants) of time, expertise, and experimental effort. These contributions are supplemented by direct funding (that primarily supports program infrastructure and management) provided primarily by HESI's corporate sponsors. James R. Turk, Abraham Guerrero and Padma K. Narayanan are employed by Amgen Inc. Elizabeth G. Besteman is employed by Merck Research Laboratories. Roberta A. Thomas and Cindy E. Fishman are employed by GlaxoSmith Kline. Heidrun Ellinger-Ziegelbauer is employed by Bayer Pharma AG. April Paulman is employed by Covance Laboratories. Alan Y. Chiang and Albert E. Schultze are employed by Lilly Research Laboratories. Amgen Inc., Merck Research Laboratories, GlaxoSmith Kline, Bayer Pharma AG, Lilly Research Laboratories and Covance Laboratories provided either direct, in-direct or in-kind resources to this study and had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge Tammy Lambert and Karen Lynch (GSK) for sE-Selectin and sICAM assays, Erika Duggan and Patrick Nolan (Scintillon) for extensive work on VFC and NTA, and support of HESI for hemostatic protein analyses at Cornell University.	Ageno W, 2008, CIRCULATION, V117, P93, DOI 10.1161/CIRCULATIONAHA.107.709204; Alsaleh G, 2009, J IMMUNOL, V182, P5088, DOI 10.4049/jimmunol.0801613; Ardite E, 2012, J CELL BIOL, V196, P163, DOI 10.1083/jcb.201105013; Asakura H, 2003, BLOOD COAGUL FIBRIN, V14, P221, DOI 10.1097/01.mbc.0000061290.28953.57; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Berthelsen LO, 2011, THROMB RES, V128, P103, DOI 10.1016/j.thromres.2010.12.002; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Cheng HS, 2013, EMBO MOL MED, V5, P1017, DOI 10.1002/emmm.201202318; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Dignat-George F, 2011, ARTERIOSCL THROM VAS, V31, P27, DOI 10.1161/ATVBAHA.110.218123; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Essandoh K, 2014, BBA-MOL BASIS DIS, V1842, P2155, DOI 10.1016/j.bbadis.2014.07.021; Everett BM, 2013, AM HEART J, V166, P199, DOI 10.1016/j.ahj.2013.03.018; Feng J, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-27; Fort A, 2010, BLOOD, V116, P2608, DOI 10.1182/blood-2010-02-268011; Gardiner C, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.19671; Gidlof O, 2013, BLOOD, V121, P3908, DOI 10.1182/blood-2012-10-461798; Goni R., 2009, CONTROL, P1; Hoffmann J, 2013, CURR OPIN IMMUNOL, V25, P1, DOI 10.1016/j.coi.2013.01.008; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Laverty HG, 2011, BRIT J PHARMACOL, V163, P675, DOI 10.1111/j.1476-5381.2011.01255.x; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; Maas C, 2011, SEMIN THROMB HEMOST, V37, P375, DOI 10.1055/s-0031-1276586; Mantovani A, 2013, NAT IMMUNOL, V14, P768, DOI 10.1038/ni.2666; Marchand A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044532; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Osman A, 2011, PLATELETS, V22, P433, DOI 10.3109/09537104.2011.560305; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Sari AN, 2014, INFLAMM RES, V63, P741, DOI 10.1007/s00011-014-0747-z; Schouten M, 2008, J LEUKOCYTE BIOL, V83, P536, DOI 10.1189/jlb.0607373; Schultze AE, 2013, TOXICOL PATHOL, V41, P445, DOI 10.1177/0192623312460924; Semeraro N, 2012, THROMB RES, V129, P290, DOI 10.1016/j.thromres.2011.10.013; Sreeramkumar V, 2014, SCIENCE, V346, P1234, DOI 10.1126/science.1256478; SSS, 1965, BIOMETRIKA, V52, P591; Stoner SA, 2015, CYTOMETRY PART A THE; Suarez Y, 2010, J IMMUNOL, V184, P21, DOI 10.4049/jimmunol.0902369; Tan YH, 2014, MOL CELL, V54, P212, DOI 10.1016/j.molcel.2014.03.012; Taylor FB, 2000, CRIT CARE MED, V28, pS12, DOI 10.1097/00003246-200009001-00004; ten Cate H, 2000, CRIT CARE MED, V28, pS9, DOI 10.1097/00003246-200009001-00003; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Voves C, 2006, BLOOD COAGUL FIBRIN, V17, P445, DOI 10.1097/01.mbc.0000240916.63521.2e; Willeit P, 2013, CIRC RES, V112, P595, DOI 10.1161/CIRCRESAHA.111.300539; Wu M, 2015, EXP THER MED, V9, P1125, DOI 10.3892/etm.2015.2224; Zhang GY, 2009, J IMMUNOL, V182, P7997, DOI 10.4049/jimmunol.0802884; Zhou J, 2011, P NATL ACAD SCI USA, V108, P10355, DOI 10.1073/pnas.1107052108	45	15	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169976	10.1371/journal.pone.0169976	http://dx.doi.org/10.1371/journal.pone.0169976			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081568	Green Published, Green Submitted, gold			2022-12-26	WOS:000391949500112
J	Du, LS; Liu, HY; Yan, M; Li, JM; Li, JS				Du, Leshan; Liu, Haiyan; Yan, Ming; Li, Junmin; Li, Junsheng			Individual Plasticity of the Shade Response of the Invasive Solidago canadensis in China	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; AVOIDANCE RESPONSES; LOCAL ADAPTATION; LIGHT; LEAF; EVOLUTION; BIOLOGY; TRAITS; EUROPE	To evaluate the population variation, individual plasticity, and local adaptability of Solidago canadensis in response to shade treatment, we conducted a common pots experiment with a total of 150 ramets (5 genets, 15 populations, and 2 treatments) subjected to both control (natural light) and shady treatment (10% of natural light). Shade treatment significantly reduced growth and content of defense metabolites in S. canadensis. Compared to control, shading led to increased height, decreased basal diameter, increased leaf width, increased leaf length, increased chlorophyll content, stronger photosynthetic rate (P-n), stronger stomatal conductance (g(s)), and lower root to shoot ratio. Three-way analysis of variance revealed geographical origin to significantly affect the basal diameter of S. canadensis, while genotype significantly affected plant height, intercelluar CO2 concentration (C-1), transpiration rate (T-r), and proline content. Significant interactive effects between shade and geographic origin were prevalent for most traits. The phenotypic differentiation coefficient of the plasticity of all traits was below 0.4, indicating that most of all variations can be found among individuals within populations. Phenotypic selection analysis revealed that fitness was significantly positively related to plant height, basal diameter, C-1, total flavonoid content, as well as the plasticity of plant height, leaf length, leaf width, g(s), C-1, total flavonoid content, and malondialdehyde content under the control condition. However, subjected to shade, fitness was only significantly positively related to plant height, basal diameter, and the plasticity of basal diameter. Rather than local adaption, these results suggest that individual plasticity played a more prominent role in the shade response of the invasive S. canadensis.	[Du, Leshan; Li, Junsheng] Chinese Res Inst Environm Sci, Res Ctr Biodivers, Beijing, Peoples R China; [Du, Leshan; Liu, Haiyan; Li, Junmin] Taizhou Univ, Zhejiang Prov Key Lab Evolutionary Ecol & Conserv, Taizhou, Zhejiang, Peoples R China; [Liu, Haiyan; Yan, Ming] Shanxi Normal Univ, Sch Life Sci, Linfen, Shanxi, Peoples R China	Chinese Research Academy of Environmental Sciences; Taizhou University; Shanxi Normal University	Li, JS (corresponding author), Chinese Res Inst Environm Sci, Res Ctr Biodivers, Beijing, Peoples R China.; Li, JM (corresponding author), Taizhou Univ, Zhejiang Prov Key Lab Evolutionary Ecol & Conserv, Taizhou, Zhejiang, Peoples R China.	lijm@tzc.edu.cn; lijsh@craes.org.cn	李, 钧敏/L-7390-2019		National Natural Science Foundation of China [31270461]; National Key Research and Development Program [2016YFC1201100]; Qianjiang Talents Project of Zhejiang Province [QJD1302021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program; Qianjiang Talents Project of Zhejiang Province	This study was financially support by the National Natural Science Foundation of China (No. 31270461) for JML, the National Key Research and Development Program (2016YFC1201100) for JSL and JML, and the Qianjiang Talents Project of Zhejiang Province (type D) (No. QJD1302021) for JML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell DL, 2008, AM J BOT, V95, P59, DOI 10.3732/ajb.95.1.59; Donohue K, 2000, EVOLUTION, V54, P1956, DOI 10.1111/j.0014-3820.2000.tb01240.x; Droste T, 2010, PLANT ECOL, V207, P297, DOI 10.1007/s11258-009-9673-5; Franklin KA, 2008, NEW PHYTOL, V179, P930, DOI 10.1111/j.1469-8137.2008.02507.x; Gratani L, 2014, PHOTOSYNTHETICA, V54, P2631; Jesson L, 2010, NEW ZEAL J BOT, V38, P45; Jin ZX, 2006, J FUJIAN FORESTRY SC, V33, P7; Lake JC, 2004, BIOL CONSERV, V117, P215, DOI 10.1016/S0006-3207(03)00294-5; Legner N, 2014, TREES-STRUCT FUNCT, V28, P263, DOI 10.1007/s00468-013-0947-0; Li Z., 2002, ALIEN INVASIVE SPECI; Liang H, 1999, J PLANT RESOURCE ENV, P12; Lin ZF, 1984, J INTEGR PLANT BIOL, V5, P605; Liu Y, 2016, ANN BOT; Matesanz S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044955; Matos FS, 2009, ENVIRON EXP BOT, V67, P421, DOI 10.1016/j.envexpbot.2009.06.018; Parker IM, 2003, CONSERV BIOL, V17, P59, DOI 10.1046/j.1523-1739.2003.02019.x; Poorter L, 1999, FUNCT ECOL, V13, P396, DOI 10.1046/j.1365-2435.1999.00332.x; Puglielli G, 2015, POL J ECOL, V63, P10, DOI 10.3161/15052249PJE2015.63.1.002; Rozendaal DMA, 2006, FUNCT ECOL, V20, P207, DOI 10.1111/j.1365-2435.2006.01105.x; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Schmitt J, 2003, INTEGR COMP BIOL, V43, P459, DOI 10.1093/icb/43.3.459; Semchenko M, 2012, J ECOL, V100; Sexton JP, 2002, ECOL APPL, V12, P1652, DOI 10.1890/1051-0761(2002)012[1652:PAGDMA]2.0.CO;2; Shipley B, 2002, FUNCT ECOL, V16, P326, DOI 10.1046/j.1365-2435.2002.00626.x; Si CC, 2014, BIOL INVASIONS, V16, P2323, DOI 10.1007/s10530-014-0667-4; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Steinger T, 2003, J EVOLUTION BIOL, V16, P313, DOI 10.1046/j.1420-9101.2003.00518.x; Sultan SE, 2004, PERSPECT PLANT ECOL, V6, P227, DOI 10.1078/1433-8319-00082; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Sun Xiao-fang, 2008, Xibei Zhiwu Xuebao, V28, P752; Weber E, 1998, J BIOGEOGR, V25, P147, DOI 10.1046/j.1365-2699.1998.251119.x; Weber E, 2001, CONSERV BIOL, V15, P122, DOI 10.1046/j.1523-1739.2001.99424.x; WILLIAMS DG, 1995, ECOLOGY, V76, P1569, DOI 10.2307/1938158; WINTERMANS JF, 1965, BIOCHIM BIOPHYS ACTA, V109, P448, DOI 10.1016/0926-6585(65)90170-6; Xiong SM., 2005, CEREAL FEED IND, V8, P40, DOI DOI 10.3969/J.ISSN.1003-6202.2005.08.018; Zhu GL, 1983, J PLANT PHYSL, P35	36	12	14	6	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0170049	10.1371/journal.pone.0170049	http://dx.doi.org/10.1371/journal.pone.0170049			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081272	Green Published, Green Submitted, gold			2022-12-26	WOS:000391949500123
J	Flury, S; Peutzfeldt, A; Schmidlin, PR; Lussi, A				Flury, Simon; Peutzfeldt, Anne; Schmidlin, Patrick R.; Lussi, Adrian			Exposed Dentin: Influence of Cleaning Procedures and Simulated Pulpal Pressure on Bond Strength of a Universal Adhesive System	PLOS ONE			English	Article							IMMEDIATE	Purpose To compare various pre-treatments serving as cleaning procedures of dentin on the bond strength of resin composite promoted by a universal adhesive system applied either in the absence or presence of simulated pulpal pressure. Materials and Methods Prior to application of the adhesive system (Scotchbond Universal) and resin composite (Filtek Z250), ground dentin surfaces were given one of five pre-treatments either without or with simulated pulpal pressure: 1) no pre-treatment, adhesive system in "self-etch" mode, 2) phosphoric acid etching, adhesive system in "total-etch" mode, 3) polishing with pumice on prophylaxis cup, 4) air abrasion with AIR-FLOW PLUS powder, 5) air abrasion with AIRFLOW PERIO powder; n = 20/group of pre-treatment. After storage (37 degrees C, 100% humidity, 24 h), micro shear bond strength was measured and data analyzed with parametric ANOVA including Bonferroni-Holm correction for multiple testing followed by Student's t tests (significance level: alpha = 0.05). Results The ANOVA found type of pre-treatment and simulated pulpal pressure to have no significant effect on dentin bond strength. The explorative post-hoc tests showed a negative effect of simulated pulpal pressure for phosphoric acid etching (adhesive system in "total-etch" mode; p = 0.020), but not for the other four pre-treatments (all p = 1.000). Conclusion Air abrasion with powders containing either erythritol and chlorhexidine (AIR-FLOW PLUS) or glycine (AIR-FLOW PERIO) yielded dentin bond strengths similar to no pre-treatment, phosphoric acid etching, or polishing with pumice. Simulated pulpal pressure reduced the bond strength only when the self-etch adhesive system was used in total-etch mode.	[Flury, Simon; Peutzfeldt, Anne; Schmidlin, Patrick R.; Lussi, Adrian] Univ Bern, Sch Dent Med, Dept Prevent Restorat & Pediat Dent, Bern, Switzerland; [Schmidlin, Patrick R.] Univ Zurich, Ctr Dent Med, Clin Prevent Dent Periodontol & Cariol, Div Periodontol & Peri Implant Dis, Zurich, Switzerland	University of Bern; University of Zurich	Flury, S (corresponding author), Univ Bern, Sch Dent Med, Dept Prevent Restorat & Pediat Dent, Bern, Switzerland.	simon.flury@zmk.uribe.ch						Awada A, 1990, CARIES RES, V24, P181; Borges Alessandra Buhler, 2014, J Contemp Dent Pract, V15, P407; Falkensammer F, 2014, J PROSTHET DENT, V112, P204, DOI 10.1016/j.prosdent.2013.10.028; Frankenberger R, 2007, J ADHES DENT, V9, P381; Guan R, 2016, DENT MATER J, V35, P684, DOI 10.4012/dmj.2016-059; Hagi TT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131056; KREJCI I, 1993, J DENT RES, V72, P490, DOI 10.1177/00220345930720020401; Luque-Martinez IV, 2014, DENT MATER, V30, P1126, DOI 10.1016/j.dental.2014.07.002; Mahdan MHA, 2013, J DENT, V41, P861, DOI 10.1016/j.jdent.2013.07.002; Manfroi FB, 2016, OPEN DENT J, V10, P268, DOI 10.2174/1874210601610010268; Munoz MA, 2015, OPER DENT, V40, P282, DOI 10.2341/14-055-L; NIKAIDO T, 1995, DENT MATER, V11, P258, DOI 10.1016/0109-5641(95)80059-X; Nishimura K, 2005, DENT MATER J, V24, P59, DOI 10.4012/dmj.24.59; Petersson LG, 2013, CLIN ORAL INVEST, V17, pS63, DOI 10.1007/s00784-012-0916-9; QUIRYNEN M, 1995, J CLIN PERIODONTOL, V22, P1, DOI 10.1111/j.1600-051X.1995.tb01765.x; Sahrmann P, 2014, J PERIODONTOL, V85, P1107, DOI 10.1902/jop.2014.130629; Santschi K, 2015, J ADHES DENT, V17, P51, DOI 10.3290/j.jad.a33514; Sarr M, 2010, OPER DENT, V35, P94, DOI 10.2341/09-076-L; Schmidlin PR, 2013, CLIN ORAL INVEST, V17, pS55, DOI 10.1007/s00784-012-0912-0; Silva TM, 2016, LASER MED SCI, V31, P49, DOI 10.1007/s10103-015-1827-1; Takamizawa T, 2016, DENT MATER, V32, pE9, DOI 10.1016/j.dental.2015.11.005; Takamizawa T, 2015, J DENT, V43, P1416, DOI 10.1016/j.jdent.2015.10.018; Tay F R, 2000, J Adhes Dent, V2, P83; Tay FR, 2004, J DENT, V32, P173, DOI 10.1016/j.jdent.2003.10.009; Tay FR, 1996, J DENT RES, V75, P1034, DOI 10.1177/00220345960750040601; West N, 2014, MONOGR ORAL SCI, V25, P108, DOI 10.1159/000360749	26	10	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169680	10.1371/journal.pone.0169680	http://dx.doi.org/10.1371/journal.pone.0169680			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081572	Green Published, Green Submitted, gold			2022-12-26	WOS:000391949500062
J	Duan, JY; Bao, X; Ma, X; Zhang, Y; Ni, D; Wang, HF; Zhang, F; Du, QS; Fan, Y; Chen, JW; Wu, SP; Li, XT; Gao, Y; Zhang, X				Duan, Junyao; Bao, Xu; Ma, Xin; Zhang, Yu; Ni, Dong; Wang, Hanfeng; Zhang, Fan; Du, Qingshan; Fan, Yang; Chen, Jianwen; Wu, Shengpan; Li, Xintao; Gao, Yu; Zhang, Xu			Upregulation of Far Upstream Element-Binding Protein 1 (FUBP1) Promotes Tumor Proliferation and Tumorigenesis of Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							C-MYC; HEPATOCELLULAR-CARCINOMA; INTERACTING REPRESSOR; MESSENGER-RNA; SEQUENCE; FBP; OVEREXPRESSION; TRANSCRIPTION; EXPRESSION; P21	Objective The far upstream element (FUSE)-binding protein 1 (FUBP1) is a transactivator of human c-myc proto-oncogene transcription, with important roles in carcinogenesis. However, the expression pattern and potential biological function of FUBP1 in clear cell renal cell carcinoma (ccRCC) is yet to be established. Methods FUBP1 expression was detected in ccRCC tissues and cell lines by real-time RT-PCR, Western blot analysis, and immunohistochemistry. The correlations of FUBP1 mRNA expression levels with clinicopathological factors were evaluated. The biological function of FUBP1 during tumor cell proliferation was studied by MTS, colony formation, and soft-agar colony formation. The effects of FUBP1 on cell cycle distribution and apoptosis were analyzed by flow cytometry. Western blot analysis was used to identify the potential mechanism of FUBP1 regulating cell cycle and apoptosis. Results The levels of FUBP1 mRNA and protein expression were upregulated in human ccRCC tissues compared with adjacent noncancerous tissues. High levels of FUBP1 mRNA expression were associated with higher tumor stage and tumor size. FUBP1 knockdown inhibited cell proliferation and induced cell cycle arrest and apoptosis. Meanwhile, the expression levels of c-myc and p21 mRNA were correlated with that of FUBP1 mRNA. Conclusions FUBP1 acts as a potential oncogene in ccRCC and may be considered as a novel biomarker or an attractive treatment target of ccRCC.	[Duan, Junyao; Bao, Xu] Nankai Univ, Sch Med, Tianjin, Peoples R China; [Ma, Xin; Zhang, Yu; Ni, Dong; Wang, Hanfeng; Zhang, Fan; Du, Qingshan; Fan, Yang; Chen, Jianwen; Wu, Shengpan; Li, Xintao; Gao, Yu; Zhang, Xu] PLA Med Sch, Chinese Peoples Liberat Army Gen Hosp, State Key Lab Kidney Dis, Dept Urol, Beijing, Peoples R China	Nankai University; Chinese People's Liberation Army General Hospital	Zhang, X (corresponding author), PLA Med Sch, Chinese Peoples Liberat Army Gen Hosp, State Key Lab Kidney Dis, Dept Urol, Beijing, Peoples R China.	xzhang@tjh.tjmu.edu.cn			National High Technology Research and Development Program ("863" Program) of China [2014AA020607]; National Nature and Science Grant of China [81402109]	National High Technology Research and Development Program ("863" Program) of China(National High Technology Research and Development Program of China); National Nature and Science Grant of China	This study was supported by the National High Technology Research and Development Program ("863" Program) of China (2014AA020607) and the National Nature and Science Grant of China (81402109).	AVIGAN MI, 1990, J BIOL CHEM, V265, P18538; Baumgarten P, 2014, NEUROPATH APPL NEURO, V40, P205, DOI 10.1111/nan.12088; BAZAR L, 1995, ONCOGENE, V10, P2229; Bettegowda C, 2011, SCIENCE, V333, P1453, DOI 10.1126/science.1210557; Bouchireb N, 1999, CHROMOSOME RES, V7, P577, DOI 10.1023/A:1009201914881; Braddock DT, 2002, NATURE, V415, P1051, DOI 10.1038/4151051a; Chien HL, 2011, J VIROL, V85, P4698, DOI 10.1128/JVI.01950-10; Chin Arnold I, 2006, Rev Urol, V8, P1; Chung HJ, 2006, MOL CELL BIOL, V26, P6584, DOI 10.1128/MCB.00754-06; Dabestani S, 2014, LANCET ONCOL, V15, pE549, DOI 10.1016/S1470-2045(14)70235-9; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; DavisSmyth T, 1996, J BIOL CHEM, V271, P31679, DOI 10.1074/jbc.271.49.31679; Ding ZM, 2015, MOL CARCINOGEN, V54, P405, DOI 10.1002/mc.22114; Dixit U, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-925; Duensing S, 2016, LANCET, V387, P1973, DOI 10.1016/S0140-6736(16)00653-X; Duncan R, 1996, MOL CELL BIOL, V16, P2274; DUNCAN R, 1994, GENE DEV, V8, P465, DOI 10.1101/gad.8.4.465; Gabay M, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014241; Gartel AL, 2002, MOL CANCER THER, V1, P639; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; He LS, 2000, NUCLEIC ACIDS RES, V28, P4558, DOI 10.1093/nar/28.22.4558; He LS, 2000, EMBO J, V19, P1034, DOI 10.1093/emboj/19.5.1034; Irwin N, 1997, NUCLEIC ACIDS RES, V25, P1281, DOI 10.1093/nar/25.6.1281; Jacob AG, 2014, J BIOL CHEM, V289, P17350, DOI 10.1074/jbc.M114.554717; Jang M, 2009, ONCOGENE, V28, P1529, DOI 10.1038/onc.2009.11; Kim MJ, 2003, NAT GENET, V34, P330, DOI 10.1038/ng1182; Kroeger N, 2015, LANCET ONCOL, V16, P603, DOI 10.1016/S1470-2045(15)70227-5; Lasserre JP, 2009, J PROTEOME RES, V8, P5485, DOI 10.1021/pr900480f; Leucci E, 2016, NATURE, V531, P518, DOI 10.1038/nature17161; Li H, 2013, P NATL ACAD SCI USA, V110, pE2687, DOI 10.1073/pnas.1310607110; Liu JH, 2006, EMBO J, V25, P2119, DOI 10.1038/sj.emboj.7601101; Liu JH, 2011, EMBO J, V30, P846, DOI 10.1038/emboj.2011.11; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malz M, 2009, HEPATOLOGY, V50, P1130, DOI 10.1002/hep.23051; Man TK, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-45; Matsushita K, 2006, CANCER RES, V66, P1409, DOI 10.1158/0008-5472.CAN-04-4459; Matsushita K, 2009, FRONT BIOSCI-LANDMRK, V14, P3401, DOI 10.2741/3461; Michelotti GA, 1996, MOL CELL BIOL, V16, P2656, DOI 10.1128/mcb.16.6.2656; Olanich ME, 2011, ONCOGENE, V30, P77, DOI 10.1038/onc.2010.404; Ott G, 2014, HEMATOL-AM SOC HEMAT, P100, DOI 10.1182/asheducation-2014.1.100; Rabenhorst U, 2009, HEPATOLOGY, V50, P1121, DOI 10.1002/hep.23098; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Sahm F, 2012, ACTA NEUROPATHOL, V123, P853, DOI 10.1007/s00401-012-0993-5; Shroff EH, 2015, P NATL ACAD SCI USA, V112, P6539, DOI 10.1073/pnas.1507228112; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singer S, 2009, CANCER RES, V69, P2234, DOI 10.1158/0008-5472.CAN-08-3338; Stewart SB, 2014, J CLIN ONCOL, V32, P4059, DOI 10.1200/JCO.2014.56.5416; Tang SW, 2009, CANCER LETT, V273, P35, DOI 10.1016/j.canlet.2008.07.038; Turajlic S, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.026; Wang XJ, 1998, NEUROSCI LETT, V252, P191, DOI 10.1016/S0304-3940(98)00598-9; Weber A, 2005, MOL CELL BIOL, V25, P147, DOI 10.1128/mcb.25.1.147-161.2005; Weber A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-369; Weiss RH, 2007, J UROLOGY, V177, P63, DOI 10.1016/j.juro.2006.08.073; Whitson JM, 2009, INT J CANCER, V125, P446, DOI 10.1002/ijc.24370; Williams BY, 2000, FEBS LETT, V470, P207, DOI 10.1016/S0014-5793(00)01320-X; Yamaguchi S, 2003, CLIN GENET, V63, P184, DOI 10.1034/j.1399-0004.2003.00035.x; Zhang FC, 2013, ONKOLOGIE, V36, P650, DOI 10.1159/000355659; Zhang J, 2013, ONCOGENE, V32, P2907, DOI 10.1038/onc.2012.350; Zhang ZB, 2008, J VIROL, V82, P5761, DOI 10.1128/JVI.00064-08; Zheng YH, 2011, INT J BIOCHEM CELL B, V43, P1641, DOI 10.1016/j.biocel.2011.08.001; Zubaidah RM, 2008, PROTEOMICS, V8, P5086, DOI 10.1002/pmic.200800322	61	24	25	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169852	10.1371/journal.pone.0169852	http://dx.doi.org/10.1371/journal.pone.0169852			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076379	Green Submitted, gold, Green Published			2022-12-26	WOS:000391857100061
J	Nelissen, JL; de Graaf, L; Traa, WA; Schreurs, TJL; Moerman, KM; Nederveen, AJ; Sinkus, R; Oomens, CWJ; Nicolay, K; Strijkers, GJ				Nelissen, Jules L.; de Graaf, Larry; Traa, Willeke A.; Schreurs, Tom J. L.; Moerman, Kevin M.; Nederveen, Aart J.; Sinkus, Ralph; Oomens, Cees W. J.; Nicolay, Klaas; Strijkers, Gustav J.			A MRI-Compatible Combined Mechanical Loading and MR Elastography Setup to Study Deformation-Induced Skeletal Muscle Damage in Rats	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; DEEP TISSUE-INJURY; PRESSURE ULCERS; BREAST-LESIONS; LIVER FIBROSIS; DIFFUSION; COMPRESSION; ELASTICITY; HEALTHY; STIFFNESS	Deformation of skeletal muscle in the proximity of bony structures may lead to deep tissue injury category of pressure ulcers. Changes in mechanical properties have been proposed as a risk factor in the development of deep tissue injury and may be useful as a diagnostic tool for early detection. MRE allows for the estimation of mechanical properties of soft tissue through analysis of shear wave data. The shear waves originate from vibrations induced by an external actuator placed on the tissue surface. In this study a combined Magnetic Resonance (MR) compatible indentation and MR Elastography (MRE) setup is presented to study mechanical properties associated with deep tissue injury in rats. The proposed setup allows for MRE investigations combined with damage-inducing large strain indentation of the Tibialis Anterior muscle in the rat hind leg inside a small animal MR scanner. An alginate cast allowed proper fixation of the animal leg with anatomical perfect fit, provided boundary condition information for FEA and provided good susceptibility matching. MR Elastography data could be recorded for the Tibialis Anterior muscle prior to, during, and after indentation. A decaying shear wave with an average amplitude of approximately 2 pm propagated in the whole muscle. MRE elastograms representing local tissue shear storage modulus G(d) showed significant increased mean values due to damage-inducing indentation (from 4.2 +/- 0.1 kPa before to 5.1 +/- 0.6 kPa after, p<0.05). The proposed setup enables controlled deformation under MRI-guidance, monitoring of the wound development by MRI, and quantification of tissue mechanical properties by MRE. We expect that improved knowledge of changes in soft tissue mechanical properties due to deep tissue injury, will provide new insights in the etiology of deep tissue injuries, skeletal muscle damage and other related muscle pathologies.	[Nelissen, Jules L.; de Graaf, Larry; Schreurs, Tom J. L.; Nicolay, Klaas] Eindhoven Univ Technol, Biomed NMR, Biomed Engn, Eindhoven, Netherlands; [Nelissen, Jules L.; Schreurs, Tom J. L.; Strijkers, Gustav J.] Acad Med Ctr, Biomed Engn & Phys, Amsterdam, Netherlands; [Traa, Willeke A.; Oomens, Cees W. J.] Eindhoven Univ Technol, Soft Tissue Biomech & Engn, Biomed Engn, Eindhoven, Netherlands; [Moerman, Kevin M.] MIT, Media Lab, Ctr Extreme Bion, Cambridge, MA 02139 USA; [Nederveen, Aart J.] Acad Med Ctr, Dept Radiol, Amsterdam, Netherlands; [Sinkus, Ralph] Kings Coll London, Image Sci & Biomed Engn, London, England	Eindhoven University of Technology; University of Amsterdam; Academic Medical Center Amsterdam; Eindhoven University of Technology; Massachusetts Institute of Technology (MIT); University of Amsterdam; Academic Medical Center Amsterdam; University of London; King's College London	Nelissen, JL (corresponding author), Eindhoven Univ Technol, Biomed NMR, Biomed Engn, Eindhoven, Netherlands.; Nelissen, JL (corresponding author), Acad Med Ctr, Biomed Engn & Phys, Amsterdam, Netherlands.	j.l.nelissen@gmail.com	Moerman, Kevin/N-6597-2014	Moerman, Kevin/0000-0003-3768-4269; Sinkus, Ralph/0000-0002-6093-1654; Strijkers, Gustav/0000-0001-6700-5058; Nederveen, Aart/0000-0002-5477-973X	Dutch Technology Foundation STW, Netherlands Organisation for Scientific Research (NWO); Ministry of Economic Affairs [12398]; European Cooperation in Science and Technology (COST) MYO-MRI action [BM1304-34240]	Dutch Technology Foundation STW, Netherlands Organisation for Scientific Research (NWO); Ministry of Economic Affairs; European Cooperation in Science and Technology (COST) MYO-MRI action(European Cooperation in Science and Technology (COST))	This research is supported by the Dutch Technology Foundation STW (www.stw.nl), which is part of the Netherlands Organisation for Scientific Research (NWO), and which is partly funded by the Ministry of Economic Affairs (project number 12398). The European Cooperation in Science and Technology (COST) MYO-MRI action supported this research by funding a short term scientific mission (STSM) (project number BM1304-34240). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankrom Michael A, 2005, Adv Skin Wound Care, V18, P35, DOI 10.1097/00129334-200501000-00016; Arpan I, 2013, NMR BIOMED, V26, P320, DOI 10.1002/nbm.2851; Barnhill E, 2013, PHYSIOL MEAS, V34, P1675, DOI 10.1088/0967-3334/34/12/1675; Basford JR, 2002, ARCH PHYS MED REHAB, V83, P1530, DOI 10.1053/apmr.2002.35472; Beeckman D, 2007, J ADV NURS, V60, P682, DOI 10.1111/j.1365-2648.2007.04474.x; Bennett G, 2004, AGE AGEING, V33, P230, DOI 10.1093/ageing/afh086; Bensamoun SF, 2015, IRBM, V36, P4, DOI 10.1016/j.irbm.2014.11.002; Bensamoun SF, 2007, J MAGN RESON IMAGING, V26, P708, DOI 10.1002/jmri.21073; Bilston LE, 2015, ANN BIOMED ENG, V43, P261, DOI 10.1007/s10439-014-1186-2; Black Joyce, 2007, Dermatol Nurs, V19, P343; Black J, 2010, OSTOMY WOUND MANAG, V56, P28; Black JM, 2016, INT WOUND J, V13, P531, DOI 10.1111/iwj.12471; Bohte AE, 2014, EUR RADIOL, V24, P638, DOI 10.1007/s00330-013-3046-0; Bosboom EMH, 2003, J APPL PHYSIOL, V95, P2235, DOI 10.1152/japplphysiol.01023.2001; Bosboom EMH, 2001, J BIOMECH, V34, P1365, DOI 10.1016/S0021-9290(01)00083-5; Bosboom EMH, 2001, MED ENG PHYS, V23, P195, DOI 10.1016/S1350-4533(01)00034-0; Bouten CV, 2003, ARCH PHYS MED REHAB, V84, P616, DOI 10.1053/apmr.2003.50038; Brauck K, 2007, EUR J ENDOCRINOL, V156, P673, DOI 10.1530/EJE-06-0694; Brown Gregory, 2003, Ostomy Wound Manage, V49, P42; Bryant ND, 2014, NMR BIOMED, V27, P716, DOI 10.1002/nbm.3113; Carlier Pierre G, 2016, J Neuromuscul Dis, V3, P1; Ceelen KK, 2008, J BIOMECH, V41, P3399, DOI 10.1016/j.jbiomech.2008.09.016; Chen Q., 2008, TOUCH BRIEFINGS, P60; Chen QS, 2008, CLIN BIOMECH, V23, P623, DOI 10.1016/j.clinbiomech.2007.12.002; Coleman S, 2014, J ADV NURS, V70, P2222, DOI 10.1111/jan.12405; Dealey C, 2012, J WOUND CARE, V21, P261, DOI 10.12968/jowc.2012.21.6.261; Deprez JF, 2011, MED PHYS, V38, P1943, DOI 10.1118/1.3560421; Doyley MM, 2012, PHYS MED BIOL, V57, pR35, DOI 10.1088/0031-9155/57/3/R35; Dresner MA, 2001, J MAGN RESON IMAGING, V13, P269, DOI 10.1002/1522-2586(200102)13:2<269::AID-JMRI1039>3.3.CO;2-T; Elgeti T, 2010, INVEST RADIOL, V45, P782, DOI 10.1097/RLI.0b013e3181ec4b63; Fleck CA, 2007, WOUND CARE CANADA, V5, P10; Fleck Cynthia A, 2007, Adv Skin Wound Care, V20, P413, DOI 10.1097/01.ASW.0000280206.96378.5b; Froeling M, 2013, NMR BIOMED, V26, P1339, DOI 10.1002/nbm.2959; Garteiser P, 2012, EUR RADIOL, V22, P2169, DOI 10.1007/s00330-012-2474-6; Gefen A, 2005, J BIOMECH ENG-T ASME, V127, P512, DOI 10.1115/1.1894386; Gefen A, 2013, OSTOMY WOUND MANAG, V59, P26; Gehin C, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P6057; Green MA, 2012, NMR BIOMED, V25, P852, DOI 10.1002/nbm.1801; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Haesler E, 2014, PREVENTION TREATMENT; Heemskerk AM, 2005, MAGNET RESON MED, V53, P1333, DOI 10.1002/mrm.20476; Heemskerk AM, 2006, MAGN RESON MED, V56, P272, DOI 10.1002/mrm.20953; Hollingsworth Kieren G, 2012, Neuromuscul Disord, V22 Suppl 2, pS54, DOI 10.1016/j.nmd.2012.06.005; Honaker J, 2014, ADV SKIN WOUND CARE, V27, P133, DOI 10.1097/01.ASW.0000443267.25288.87; Huwart L, 2006, NMR BIOMED, V19, P173, DOI 10.1002/nbm.1030; Ipek-Ugay S, 2015, J MAGN RESON, V251, P13, DOI 10.1016/j.jmr.2014.11.009; Juge L, 2012, RADIOLOGY, V264, P436, DOI 10.1148/radiol.12111548; Kemper J, 2004, ROFO-FORTSCHR RONTG, V176, P1094, DOI 10.1055/s-2004-813279; Klatt D, 2010, PHYS MED BIOL, V55, P6445, DOI 10.1088/0031-9155/55/21/007; Landuyt W, 2002, J MAGN RESON IMAGING, V16, P224, DOI 10.1002/jmri.10144; Linder-Ganz E, 2003, P ANN INT IEEE EMBS, V25, P1839, DOI 10.1109/IEMBS.2003.1279775; Linder-Ganz E, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005195; Loerakker S, 2013, COMPUT METHOD BIOMEC, V16, P338, DOI 10.1080/10255842.2011.621423; Loerakker S, 2011, J APPL PHYSIOL, V111, P1168, DOI 10.1152/japplphysiol.00389.2011; Loerakker S, 2011, MAGN RESON MED, V66, P528, DOI 10.1002/mrm.22801; Loerakker S, 2012, HOW DOES MUSCLE STIF, DOI [10.1080/10255842.2011.627682, DOI 10.1080/10255842.2011.627682]; Loerakker S., 2011, THESIS; Loerakker S, 2010, ANN BIOMED ENG, V38, P2577, DOI DOI 10.1007/s10439-010-0002-x; Mannelli L, 2010, AM J ROENTGENOL, V195, P387, DOI 10.2214/AJR.09.3390; Mariappan YK, 2012, MAGN RESON MED, V67, P210, DOI 10.1002/mrm.22976; McCullough MB, 2011, MUSCLE NERVE, V43, P585, DOI 10.1002/mus.21923; Moerman KM, 2013, MED ENG PHYS, V35, P486, DOI 10.1016/j.medengphy.2012.06.014; Moerman KM, 2009, J BIOMECH, V42, P1150, DOI 10.1016/j.jbiomech.2009.02.016; Muthupillai R, 1996, NAT MED, V2, P601, DOI 10.1038/nm0596-601; Oomens CWJ, 2015, ANN BIOMED ENG, V43, P297, DOI 10.1007/s10439-014-1202-6; OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W; Oudeman J, 2016, J MAGN RESON IMAGING, V43, P773, DOI 10.1002/jmri.25016; Papazoglou S, 2006, MAGN RESON MED, V56, P489, DOI 10.1002/mrm.20993; Prompers JJ, 2006, NMR BIOMED, V19, P927, DOI 10.1002/nbm.1095; Qin EC, 2014, RADIOLOGY, V273, P726, DOI 10.1148/radiol.14132661; Qin EC, 2013, J MAGN RESON IMAGING, V37, P217, DOI 10.1002/jmri.23797; Richbourg L, 2011, J WOUND OSTOMY CONT, V38, P655, DOI 10.1097/WON.0b013e31823429e7; Riek K, 2011, J BIOMECH, V44, P1380, DOI 10.1016/j.jbiomech.2010.12.031; Ringleb SI, 2007, J MAGN RESON IMAGING, V25, P301, DOI 10.1002/jmri.20817; Rommel D, 2008, NUCL MED BIOL, V35, P571, DOI 10.1016/j.nucmedbio.2008.04.002; Rouviere O, 2006, RADIOLOGY, V240, P440, DOI 10.1148/radiol.2402050606; Rouviere O, 2011, J MAGN RESON IMAGING, V34, P880, DOI 10.1002/jmri.22670; Runge JH, 2014, COMP INTEROBSERVER A, P283, DOI [10.1007/s00261-013-0063-z, DOI 10.1007/S00261-013-0063-Z]; Sack I, 2008, NMR BIOMED, V21, P265, DOI 10.1002/nbm.1189; Salcido R., 2012, ADV SKIN WOUND CARE, V24, P374; Schreurs TJL, 2012, THESIS; Severens Johan L, 2002, Adv Skin Wound Care, V15, P72, DOI 10.1097/00129334-200203000-00008; Sinkus R, 2000, PHYS MED BIOL, V45, P1649, DOI 10.1088/0031-9155/45/6/317; Sinkus R, 2005, MAGN RESON IMAGING, V23, P159, DOI 10.1016/j.mri.2004.11.060; Sinkus R, 2005, MAGNET RESON MED, V53, P372, DOI 10.1002/mrm.20355; Sinkus R, 2007, MAGN RESON MED, V58, P1135, DOI 10.1002/mrm.21404; Stekelenburg A, 2006, J APPL PHYSIOL, V100, P1946, DOI 10.1152/japplphysiol.00889.2005; Stekelenburg A, 2006, MED ENG PHYS, V28, P331, DOI 10.1016/j.medengphy.2005.07.005; Stekelenburg A, 2008, ARCH PHYS MED REHAB, V89, P1410, DOI 10.1016/j.apmr.2008.01.012; Stekelenburg A, 2007, J APPL PHYSIOL, V102, P2002, DOI 10.1152/japplphysiol.01115.2006; Strobel K, 2010, J MAGN RESON IMAGING, V31, P747, DOI 10.1002/jmri.22090; Uffmann K, 2004, NMR BIOMED, V17, P181, DOI 10.1002/nbm.887; van Nierop BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129899; van Nierop BJ, 2010, J BIOMECH, V43, P570, DOI 10.1016/j.jbiomech.2009.07.043	94	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169864	10.1371/journal.pone.0169864	http://dx.doi.org/10.1371/journal.pone.0169864			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076414	Green Published, gold, Green Submitted			2022-12-26	WOS:000391857100062
J	Van Cauwenbergh, C; Coppieters, F; Roels, D; De Jaegere, S; Flipts, H; De Zaeytijd, J; Walraedt, S; Claes, C; Fransen, E; Van Camp, G; Depasse, F; Casteels, I; de Ravel, T; Leroy, BP; De Baere, E				Van Cauwenbergh, Caroline; Coppieters, Frauke; Roels, Dimitri; De Jaegere, Sarah; Flipts, Helena; De Zaeytijd, Julie; Walraedt, Sophie; Claes, Charlotte; Fransen, Erik; Van Camp, Guy; Depasse, Fanny; Casteels, Ingele; de Ravel, Thomy; Leroy, Bart P.; De Baere, Elfride			Mutations in Splicing Factor Genes Are a Major Cause of Autosomal Dominant Retinitis Pigmentosa in Belgian Families	PLOS ONE			English	Article							ROD-CONE DYSTROPHY; RHODOPSIN GENE; RNA HELICASE; MISSENSE MUTATIONS; PROM1 MUTATION; PROTEIN; RP1; PREVALENCE; PERIPHERIN/RDS; PRPF31	Purpose Autosomal dominant retinitis pigmentosa (adRP) is characterized by an extensive genetic heterogeneity, implicating 27 genes, which account for 50 to 70% of cases. Here 86 Belgian probands with possible adRP underwent genetic testing to unravel the molecular basis and to assess the contribution of the genes underlying their condition. Methods Mutation detection methods evolved over the past ten years, including mutation specific methods (APEX chip analysis), linkage analysis, gene panel analysis (Sanger sequencing, targeted next-generation sequencing or whole exome sequencing), high-resolution copy number screening (customized microarray-based comparative genomic hybridization). Identified variants were classified following American College of Medical Genetics and Genomics (ACMG) recommendations. Results Molecular genetic screening revealed mutations in 48/86 cases (56%). In total, 17 novel pathogenic mutations were identified: four missense mutations in RHO, five frameshift mutations in RP1, six mutations in genes encoding spliceosome components (SNRNP200, PRPF8, and PRPF31), one frameshift mutation in PRPH2, and one frameshift mutation in TOPORS. The proportion of RHO mutations in our cohort (14%) is higher than reported in a French adRP population (10.3%), but lower than reported elsewhere (16.5-30%). The prevalence of RP1 mutations (10.5%) is comparable to other populations (3.5%-10%). The mutation frequency in genes encoding splicing factors is unexpectedly high (altogether 19.8%), with PRPF31 the second most prevalent mutated gene (10.5%). PRPH2 mutations were found in 4.7% of the Belgian cohort. Two families (2.3%) have the recurrent NR2E3 mutation p.(Gly56Arg). The prevalence of the recurrent PROM1 mutation p.(Arg373Cys) was higher than anticipated (3.5%). Conclusions Overall, we identified mutations in 48 of 86 Belgian adRP cases (56%), with the highest prevalence in RHO (14%), RP1 (10.5%) and PRPF31 (10.5%). Finally, we expanded the molecular spectrum of PRPH2, PRPF8, RHO, RP1, SNRNP200, and TOPORS-associated adRP by the identification of 17 novel mutations.	[Van Cauwenbergh, Caroline; Coppieters, Frauke; De Jaegere, Sarah; Flipts, Helena; Leroy, Bart P.; De Baere, Elfride] Univ Ghent, Ctr Med Genet Ghent, Ghent, Belgium; [Van Cauwenbergh, Caroline; Coppieters, Frauke; Roels, Dimitri; De Jaegere, Sarah; Flipts, Helena; De Zaeytijd, Julie; Walraedt, Sophie; Leroy, Bart P.; De Baere, Elfride] Ghent Univ Hosp, Ghent, Belgium; [Roels, Dimitri; De Zaeytijd, Julie; Walraedt, Sophie; Leroy, Bart P.] Univ Ghent, Dept Ophthalmol, Ghent, Belgium; [Flipts, Helena; de Ravel, Thomy] Univ Hosp Leuven, Ctr Human Genet, Louvain, Belgium; [Claes, Charlotte; Fransen, Erik; Van Camp, Guy] Univ Antwerp, Ctr Med Genet Antwerp, Antwerp, Belgium; [Depasse, Fanny] Hop Erasme ULB, Dept Ophthalmol, Brussels, Belgium; [Casteels, Ingele] Univ Hosp Leuven, Dept Ophthalmol, Louvain, Belgium; [Leroy, Bart P.] Childrens Hosp Philadelphia, Div Ophthalmol, Philadelphia, PA 19104 USA; [Leroy, Bart P.] Childrens Hosp Philadelphia, Ctr Cellular & Mol Therapy, Philadelphia, PA 19104 USA	Ghent University; Ghent University; Ghent University Hospital; Ghent University; KU Leuven; University Hospital Leuven; University of Antwerp; Universite Libre de Bruxelles; KU Leuven; University Hospital Leuven; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	De Baere, E (corresponding author), Univ Ghent, Ctr Med Genet Ghent, Ghent, Belgium.; De Baere, E (corresponding author), Ghent Univ Hosp, Ghent, Belgium.	Elfride.DeBaere@UGent.be	Fransen, Erik/C-4102-2015; De Baere, Elfride/E-7405-2017; De Zaeytijd, Julie/GXA-3099-2022; Van Camp, Guy/F-3386-2013	Fransen, Erik/0000-0001-7785-4790; De Baere, Elfride/0000-0002-5609-6895; Van Camp, Guy/0000-0001-5105-9000; Coppieters, Frauke/0000-0001-7224-0992; de Ravel, Thomy/0000-0002-3361-3781; Van Cauwenbergh, Caroline/0000-0002-1948-9091; De Zaeytijd, Julie/0000-0003-4035-6389	Belspo (IAP project, Belgian Medical Genomics Initiative) [P7/43]; Ghent University Special Research Fund [BOF15/GOA/011]; Research Foundation Flanders (FWO) [G006715N]; Research in Ophthalmology (FRO); FWO	Belspo (IAP project, Belgian Medical Genomics Initiative); Ghent University Special Research Fund(Ghent University); Research Foundation Flanders (FWO)(FWO); Research in Ophthalmology (FRO); FWO(FWO)	This study was supported by Belspo (IAP project P7/43 Belgian Medical Genomics Initiative) to EDB, by the Ghent University Special Research Fund (BOF15/GOA/011) to EDB, by the Research Foundation Flanders (FWO) (EYE-splice, G006715N) to EDB and FC, by the Research in Ophthalmology (FRO) to CVC. FC is recipient of postdoctoral fellowship of the FWO, EDB and BPL are Senior Clinical Investigators of the FWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIKAWA K, 1992, J CELL BIOL, V116, P659, DOI 10.1083/jcb.116.3.659; Arrigoni FI, 2011, EUR J HUM GENET, V19, P131, DOI 10.1038/ejhg.2010.147; Audo I, 2012, HUM MUTAT, V33, P73, DOI 10.1002/humu.21640; Audo I, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-145; Audo I, 2010, INVEST OPHTH VIS SCI, V51, P3687, DOI 10.1167/iovs.09-4766; Bareil C, 1999, Ophthalmic Genet, V20, P173, DOI 10.1076/opge.20.3.173.2282; Bareil C, 2000, GENOMICS, V10, P733; Becirovic E, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005811; Benaglio P, 2011, HUM MUTAT, V32, pE2246, DOI 10.1002/humu.21485; Berson EL, 2001, INVEST OPHTH VIS SCI, V42, P2217; Boon CJF, 2007, BRIT J OPHTHALMOL, V91, P1504, DOI 10.1136/bjo.2007.115659; Bowne SJ, 2013, MOL VIS, V19, P2407; Bowne SJ, 1999, HUM MOL GENET, V8, P2121, DOI 10.1093/hmg/8.11.2121; Chakarova CF, 2007, AM J HUM GENET, V81, P1098, DOI 10.1086/521953; Chen LJ, 2010, INVEST OPHTH VIS SCI, V51, P2236, DOI 10.1167/iovs.09-4437; Coppieters F, 2007, AM J HUM GENET, V81, P147, DOI 10.1086/518426; Daiger SP, 2013, CLIN GENET, V84, P132, DOI 10.1111/cge.12203; Daiger SP, 2014, ADV EXP MED BIOL, V801, P123, DOI 10.1007/978-1-4614-3209-8_16; De Leeneer K, 2015, HUM MUTAT, V36, P379, DOI 10.1002/humu.22739; DRYJA TP, 1991, P NATL ACAD SCI USA, V88, P9370, DOI 10.1073/pnas.88.20.9370; Jose PFS, 2015, ACTA OPHTHALMOL, V93, pE38, DOI 10.1111/aos.12486; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; Gamundi MJ, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-35; Goldberg AFX, 2006, INT REV CYTOL, V253, P131, DOI 10.1016/S0074-7696(06)53004-9; Guillonneau X, 1999, HUM MOL GENET, V8, P1541, DOI 10.1093/hmg/8.8.1541; Hahn D, 2010, BIOCHEM SOC T, V38, P1105, DOI 10.1042/BST0381105; Hamel CP, 2014, CR BIOL, V337, P160, DOI 10.1016/j.crvi.2013.12.001; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; INGLEHEARN CF, 1992, HUM MOL GENET, V1, P41, DOI 10.1093/hmg/1.1.41; INGLEHEARN CF, 1991, AM J HUM GENET, V48, P26; Jacobson SG, 2000, INVEST OPHTH VIS SCI, V41, P1898; Jose PFS, 2015, INVEST OPHTH VIS SCI, V56, P2173, DOI 10.1167/iovs.14-16178; Kennedy MJ, 2001, NEURON, V31, P87, DOI 10.1016/S0896-6273(01)00340-3; KRANICH H, 1993, HUM MOL GENET, V2, P813, DOI 10.1093/hmg/2.6.813; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li ND, 2010, INVEST OPHTH VIS SCI, V51, P1036, DOI 10.1167/iovs.09-3725; Liu Q, 2004, J NEUROSCI, V24, P6427, DOI 10.1523/JNEUROSCI.1335-04.2004; Liu SB, 2006, RNA, V12, P1418, DOI 10.1261/rna.55406; Liu TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045464; Loewen CJR, 2001, J BIOL CHEM, V276, P22388, DOI 10.1074/jbc.M011710200; MACKE JP, 1993, AM J HUM GENET, V53, P80; Maeder C, 2009, NAT STRUCT MOL BIOL, V16, P42, DOI 10.1038/nsmb.1535; Makarova OV, 2002, EMBO J, V21, P1148, DOI 10.1093/emboj/21.5.1148; Manes G, 2015, AM J OPHTHALMOL, V159, P302, DOI 10.1016/j.ajo.2014.10.033; Martinez-Gimeno M, 2003, INVEST OPHTH VIS SCI, V44, P2171, DOI 10.1167/iovs.02-0871; Matias-Florentino M, 2009, CURR EYE RES, V34, P1050, DOI 10.3109/02713680903283169; McKie AB, 2001, HUM MOL GENET, V10, P1555, DOI 10.1093/hmg/10.15.1555; Michaelides M, 2010, INVEST OPHTH VIS SCI, V51, P4771, DOI 10.1167/iovs.09-4561; Mozaffari-Jovin S, 2013, SCIENCE, V341, P80, DOI 10.1126/science.1237515; Neveling K, 2012, HUM MUTAT, V33, P963, DOI 10.1002/humu.22045; Nishiguchi KM, 2013, P NATL ACAD SCI USA, V110, P16139, DOI 10.1073/pnas.1308243110; Nottrott S, 2002, EMBO J, V21, P5527, DOI 10.1093/emboj/cdf544; Oishi M, 2016, MOL VIS, V22, P150; Pan XY, 2014, MOL VIS, V20, P770; Payne A, 2000, INVEST OPHTH VIS SCI, V41, P4069; Pena V, 2009, MOL CELL, V35, P454, DOI 10.1016/j.molcel.2009.08.006; Pierce EA, 1999, NAT GENET, V22, P248, DOI 10.1038/10305; Pomares E, 2010, EUR J HUM GENET, V18, P118, DOI 10.1038/ejhg.2009.114; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Rose AM, 2016, CLIN GENET, V90, P118, DOI 10.1111/cge.12758; Sakmar TP, 2002, ANNU REV BIOPH BIOM, V31, P443, DOI 10.1146/annurev.biophys.31.082901.134348; Sharon D, 2016, OPHTHALMIC GENET, V37, P366, DOI 10.3109/13816810.2015.1081252; SHASTRY BS, 1994, AM J MED GENET, V52, P467, DOI 10.1002/ajmg.1320520413; Smailhodzic D, 2011, INVEST OPHTH VIS SCI, V52, P8908, DOI 10.1167/iovs.11-7926; Sohocki MM, 2001, HUM MUTAT, V17, P42, DOI 10.1002/1098-1004(2001)17:1<42::AID-HUMU5>3.0.CO;2-K; SOUIED E, 1994, HUM MOL GENET, V3, P1433, DOI 10.1093/hmg/3.8.1433; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Sullivan LS, 2006, INVEST OPHTH VIS SCI, V47, P3052, DOI 10.1167/iovs.05-1443; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; Nguyen THD, 2013, STRUCTURE, V21, P910, DOI 10.1016/j.str.2013.04.017; Trujillo MJ, 2001, HUM MUTAT, V12, P70; Van Cauwenbergh C, 2016, GEN MED; Waseem NH, 2007, INVEST OPHTH VIS SCI, V48, P1330, DOI 10.1167/iovs.06-0963; Whiffin N, 2016, BIORXIV; Wilkie SE, 2008, MOL VIS, V14, P683; Xu Y, 2014, HUM GENET, V133, P1255, DOI 10.1007/s00439-014-1460-2; Zhang LD, 2009, NAT STRUCT MOL BIOL, V16, P731, DOI 10.1038/nsmb.1625; Zhang LR, 1997, J BIOL CHEM, V272, P14762, DOI 10.1074/jbc.272.23.14762; Zhao C, 2009, AM J HUM GENET, V85, P617, DOI 10.1016/j.ajhg.2009.09.020; Ziviello C, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.031682	80	37	37	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0170038	10.1371/journal.pone.0170038	http://dx.doi.org/10.1371/journal.pone.0170038			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076437	Green Published, gold, Green Submitted			2022-12-26	WOS:000391857100081
J	Brown, K; Yang, P; Salvador, D; Kulikauskas, R; Ruohola-Baker, H; Robitaille, AM; Chien, AJ; Moon, RT; Sherwood, V				Brown, K.; Yang, P.; Salvador, D.; Kulikauskas, R.; Ruohola-Baker, H.; Robitaille, A. M.; Chien, A. J.; Moon, R. T.; Sherwood, V.			WNT/beta-catenin signaling regulates mitochondrial activity to alter the oncogenic potential of melanoma in a PTEN-dependent manner	ONCOGENE			English	Article							BETA-CATENIN; BRAF MUTATIONS; CLINICOPATHOLOGICAL FEATURES; DISEASE PROGRESSION; SECRETED PROTEINS; EXPRESSION; CANCER; TUMORS; PARKIN; DEGRADATION	Aberrant regulation of WNT/beta-catenin signaling has a crucial role in the onset and progression of cancers, where the effects are not always predictable depending on tumor context. In melanoma, for example, models of the disease predict differing effects of the WNT/beta-catenin pathway on metastatic progression. Understanding the processes that underpin the highly context-dependent nature of WNT/beta-catenin signaling in tumors is essential to achieve maximal therapeutic benefit from WNT inhibitory compounds. In this study, we have found that expression of the tumor suppressor, phosphatase and tensin homolog deleted on chromosome 10 (PTEN), alters the invasive potential of melanoma cells in response to WNT/beta-catenin signaling, correlating with differing metabolic profiles. This alters the bioenergetic potential and mitochondrial activity of melanoma cells, triggered through regulation of prosurvival autophagy. Thus, WNT/beta-catenin signaling is a regulator of catabolic processes in cancer cells, which varies depending on the metabolic requirements of tumors.	[Brown, K.; Sherwood, V.] Univ East Anglia, Sch Pharm, Norwich Res Pk, Norwich, Norfolk, England; [Yang, P.; Kulikauskas, R.; Robitaille, A. M.; Chien, A. J.; Moon, R. T.] Inst Stem Cell & Regenerat Med, Howard Hughes Med Inst, Dept Pharmacol, Seattle, WA USA; [Salvador, D.; Sherwood, V.] Univ Dundee, Ninewells Hosp & Med Sch, Div Canc Res, Jacqui Wood Canc Ctr, Dundee DD1 9SY, Angus, Scotland; [Ruohola-Baker, H.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Chien, A. J.] Univ Washington, Div Dermatol, Seattle, WA 98195 USA; [Brown, K.] NCI, Thorac & GI Oncol Branch, NIH, Bethesda, MD 20892 USA	University of East Anglia; Howard Hughes Medical Institute; University of Dundee; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Sherwood, V (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Div Canc Res, Jacqui Wood Canc Ctr, Dundee DD1 9SY, Angus, Scotland.	v.sherwood@dundee.ac.uk		Robitaille, Aaron Mark/0000-0003-2774-2066	Royal Society, London; British Skin Foundation; CRUK program; Howard Hughes Medical Institute; University of Washington's Proteomics Resource [UWPR95794]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097372] Funding Source: NIH RePORTER	Royal Society, London(Royal Society of London); British Skin Foundation; CRUK program; Howard Hughes Medical Institute(Howard Hughes Medical Institute); University of Washington's Proteomics Resource; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the CRUK Skin Tumor Laboratory (CRUK-STL), University of Dundee, for useful discussions throughout this work and in particular Kenneth Fernandes for technical support. We also thank Brian Johnson (Histology and Imaging core, School of Medicine, University of Washington) for help with IHC. This work was supported by start-up funding awarded to VS and grants from the Royal Society, London, and the British Skin Foundation (also awarded to VS). VS is supported by a CRUK program grant awarded to the CRUK-STL, School of Medicine, University of Dundee. RTM is an investigator of the Howard Hughes Medical Institute, which partially funded this work. This work was supported in part by the University of Washington's Proteomics Resource (UWPR95794).	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Arozarena I, 2011, ONCOGENE, V30, P4531, DOI 10.1038/onc.2011.162; Barthel A, 1999, J BIOL CHEM, V274, P20281, DOI 10.1074/jbc.274.29.20281; Bastian BC, 2003, AM J PATHOL, V163, P1765, DOI 10.1016/S0002-9440(10)63536-5; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; CLARKE JF, 1994, BIOCHEM J, V300, P631, DOI 10.1042/bj3000631; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Conde-Perez A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9093; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Damsky WE, 2011, CANCER CELL, V20, P741, DOI 10.1016/j.ccr.2011.10.030; Daniotti M, 2004, ONCOGENE, V23, P5968, DOI 10.1038/sj.onc.1207780; de Moura MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040690; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Eichhoff OM, 2011, PIGM CELL MELANOMA R, V24, P631, DOI 10.1111/j.1755-148X.2011.00871.x; Ellison DW, 2005, J CLIN ONCOL, V23, P7951, DOI 10.1200/JCO.2005.01.5479; Errafiy R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083318; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fu L, 2011, GUT, V60, P1635, DOI 10.1136/gut.2011.241638; Gallagher SJ, 2013, ONCOGENE, V32, P2230, DOI 10.1038/onc.2012.229; Gamallo C, 1999, AM J PATHOL, V155, P527, DOI 10.1016/S0002-9440(10)65148-6; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Godoy JA, 2014, J BIOL CHEM, V289, P36179, DOI 10.1074/jbc.M114.557009; Goel VK, 2006, J INVEST DERMATOL, V126, P154, DOI 10.1038/sj.jid.5700026; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ho JH, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-76; Horvath LG, 2005, INT J CANCER, V113, P415, DOI 10.1002/ijc.20599; James RG, 2013, J BIOL CHEM, V288, P34658, DOI 10.1074/jbc.M113.500314; Jemal A, 2011, J AM ACAD DERMATOL, V65, pS17, DOI 10.1016/j.jaad.2011.04.032; Jenei V, 2009, P NATL ACAD SCI USA, V106, P19473, DOI 10.1073/pnas.0909409106; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kageshita T, 2001, BRIT J DERMATOL, V145, P210, DOI 10.1046/j.1365-2133.2001.04336.x; Kaur A, 2016, NATURE, V532, P250, DOI 10.1038/nature17392; Kielhorn E, 2003, INT J CANCER, V103, P652, DOI 10.1002/ijc.10893; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kraya AA, 2015, AUTOPHAGY, V11, P60, DOI 10.4161/15548627.2014.984273; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Larue L, 2009, PATHOL BIOL, V57, P543, DOI 10.1016/j.patbio.2008.11.003; Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Lin DC, 2015, CANCER RES, V75, P1815, DOI 10.1158/0008-5472.CAN-14-1433; Maelandsmo GM, 2003, CLIN CANCER RES, V9, P3383; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Mikhail M, 2005, CLIN CANCER RES, V11, P5153, DOI 10.1158/1078-0432.CCR-05-0397; Miyamoto S, 2008, CELL DEATH DIFFER, V15, P521, DOI 10.1038/sj.cdd.4402285; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Niehrs C, 2012, EMBO J, V31, P2705, DOI 10.1038/emboj.2012.124; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Nogueira C, 2010, ONCOGENE, V29, P6222, DOI 10.1038/onc.2010.349; NUSSE R, 1984, NATURE, V307, P131, DOI 10.1038/307131a0; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Omholt K, 2003, CLIN CANCER RES, V9, P6483; Osborne JE, 2002, BRIT J DERMATOL, V146, P1104, DOI 10.1046/j.1365-2133.2002.47322.x; Pate KT, 2014, EMBO J, V33, P1454, DOI 10.15252/embj.201488598; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Persad S, 2001, J CELL BIOL, V153, P1161, DOI 10.1083/jcb.153.6.1161; Petherick KJ, 2013, EMBO J, V32, P1903, DOI 10.1038/emboj.2013.123; Ploper D, 2015, P NATL ACAD SCI USA, V112, pE420, DOI 10.1073/pnas.1424576112; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Purdue MP, 2008, J INVEST DERMATOL, V128, P2905, DOI 10.1038/jid.2008.159; Qiang YW, 2005, BLOOD, V106, P1786, DOI 10.1182/blood-2005-01-0049; Rimm DL, 1999, AM J PATHOL, V154, P325, DOI 10.1016/S0002-9440(10)65278-9; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Serrat R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067773; Sherwood V, 2015, MOL CELL BIOL, V35, P2, DOI 10.1128/MCB.00992-14; Sherwood V, 2014, CARCINOGENESIS, V35, P784, DOI 10.1093/carcin/bgt390; Silva-Alvarez C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00097; Sinnberg T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023429; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tsao H, 2004, J INVEST DERMATOL, V122, P337, DOI 10.1046/j.0022-202X.2004.22243.x; Tsao H, 2003, J AM ACAD DERMATOL, V49, P865, DOI 10.1016/S0190-9622(03)02473-3; Tsao HS, 1998, ONCOGENE, V16, P3397, DOI 10.1038/sj.onc.1201881; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779; Ulivieri A, 2008, J PATHOL, V215, P87, DOI 10.1002/path.2331; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Whiteman DC, 2002, INT J CANCER, V99, P63, DOI 10.1002/ijc.10294; Wu H, 2003, ONCOGENE, V22, P3113, DOI 10.1038/sj.onc.1206451; Yoon JC, 2010, GENE DEV, V24, P1507, DOI 10.1101/gad.1924910; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Zi XL, 2005, CANCER RES, V65, P9762, DOI 10.1158/0008-5472.CAN-05-0103	103	43	49	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 1	2017	36	22					3119	3136		10.1038/onc.2016.450	http://dx.doi.org/10.1038/onc.2016.450			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EW6KA	28092677	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000402617900005
J	Codagnone, M; Recchiuti, A; Lanuti, P; Pierdomenico, AM; Cianci, E; Patruno, S; Mari, VC; Simiele, F; Di Tomo, P; Pandolfi, A; Romano, M				Codagnone, Marilina; Recchiuti, Antonio; Lanuti, Paola; Pierdomenico, Anna Maria; Cianci, Eleonora; Patruno, Sara; Mari, Veronica Cecilia; Simiele, Felice; Di Tomo, Pamela; Pandolfi, Assunta; Romano, Mario			Lipoxin A(4) stimulates endothelial miR-126-5p expression and its transfer via microvesicles	FASEB JOURNAL			English	Article						proresolving mediators; vascular repair; microRNA; intercellular signaling; inflammation	HUMAN ATHEROSCLEROTIC PLAQUES; FORMYL PEPTIDE RECEPTOR; 15-EPI-LIPOXIN A(4); MEDIATED TRANSFER; MICRORNA MIR-126; CUTTING EDGE; CELLS; MICROPARTICLES; INFLAMMATION; ANGIOGENESIS	The proresolution lipid mediator lipoxin (LX) A(4) bestows protective bioactions on endothelial cells. We examined the impact of LXA(4) on transcellular endothelial signaling via microRNA(miR)-containing microvesicles. We report LXA(4) inhibition of MV release by TNF-alpha-treated HUVECs, associated with the down-regulation of 18 miR in endothelial microvesicles (EMVs) and the up-regulation of miR-126-5p, both in HUVECs and in EMVs. LXA(4) upregulated miR-126-5p by similar to 5-fold in HUVECs and promoted a release of microvesicles (LXA(4)-EMVs) that enhanced miR-126-5p by similar to 7-fold in recipient HUVECs. In these cells, LXA(4)-EMVs abrogated the up-regulation of VCAM-1, induced in recipient HUVECs by EMVs released by untreated or TNF-alpha-treatedHUVECs. LXA(4)-EMVs also reduced by similar to 40% the expression of SPRED1, which we validated as an miR-126-5p target, whereas they stimulated monolayer repair in an in vitro wound assay. This effect was lost when the EMVs were depleted of miR-126-5p. These results provide evidence that changes in miR expression and microvesicle packaging and transfer represent a mechanism of action of LXA(4), which may be relevant in vascular biology and inflammation.-Codagnone, M., Recchiuti, A., Lanuti, P., Pierdomenico, A. M., Cianci, E., Patruno, S., Mari, V. C., Simiele, F., Di Tomo, P., Pandolfi, A., Romano, M. Lipoxin A(4) stimulates endothelial miR-126-5p expression and its transfer via microvesicles.	[Codagnone, Marilina; Recchiuti, Antonio; Cianci, Eleonora; Patruno, Sara; Simiele, Felice; Di Tomo, Pamela; Pandolfi, Assunta; Romano, Mario] G DAnnunzio Univ Chieti Pescara, Dept Med Oral & Biotechnol Sci, Chieti, Italy; [Codagnone, Marilina; Recchiuti, Antonio; Lanuti, Paola; Pierdomenico, Anna Maria; Cianci, Eleonora; Patruno, Sara; Mari, Veronica Cecilia; Simiele, Felice; Di Tomo, Pamela; Pandolfi, Assunta; Romano, Mario] G DAnnunzio Univ Chieti Pescara, Ctr Aging Sci & Translat Med CeSI MeT, Chieti, Italy; [Lanuti, Paola; Pierdomenico, Anna Maria] G DAnnunzio Univ Chieti Pescara, Dept Med & Aging Sci, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Romano, M (corresponding author), Univ G dAnnunzio, CeSI Met, Dept Med Oral & Biotechnol Sci, Mol Med Lab, Via Luigi Polacchi 11-13, I-66013 Chieti, Italy.	mromano@unich.it	patruno, sara/P-7868-2018; Romano, Mario/I-7986-2012; PANDOLFI, Assunta/K-4595-2016	patruno, sara/0000-0002-8425-7844; Romano, Mario/0000-0001-8512-1458; PANDOLFI, Assunta/0000-0003-4135-7631	Italian Ministry of Education, University and Research [2010YK7Z5K_ 002]	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR))	The authors thank Sara Di Silvestre (Department of Medical, Oral, and Biotechnological Sciences, G. D'Annunzio University) for technical assistance with umbilical cords collection and HUVEC isolation. This work was supported, in part, by a grant from the Italian Ministry of Education, University and Research (PRIN 2010YK7Z5K_ 002; to M. R.). The authors declare no conflicts of interest.	Baker N, 2009, J IMMUNOL, V182, P3819, DOI 10.4049/jimmunol.0803175; Barry OP, 1997, J CLIN INVEST, V99, P2118, DOI 10.1172/JCI119385; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bena S, 2012, J BIOL CHEM, V287, P24690, DOI 10.1074/jbc.M112.377101; Birnbaum Y, 2006, CIRCULATION, V114, P929, DOI 10.1161/CIRCULATIONAHA.106.629907; Boulanger CM, 2010, CURR OPIN NEPHROL HY, V19, P177, DOI 10.1097/MNH.0b013e32833640fd; Brennan EP, 2013, J AM SOC NEPHROL, V24, P627, DOI 10.1681/ASN.2012060550; Cantaluppi V, 2012, KIDNEY INT, V82, P412, DOI 10.1038/ki.2012.105; Cezar-de-Mello PFT, 2006, ONCOGENE, V25, P122, DOI 10.1038/sj.onc.1209002; Chamorro-Jorganes A, 2016, CIRC RES, V118, P38, DOI 10.1161/CIRCRESAHA.115.307408; Chiang N, 2004, P NATL ACAD SCI USA, V101, P15178, DOI 10.1073/pnas.0405445101; CLARIA J, 1995, P NATL ACAD SCI USA, V92, P9475, DOI 10.1073/pnas.92.21.9475; Dahlgren C, 2000, BLOOD, V95, P1810, DOI 10.1182/blood.V95.5.1810.005k06_1810_1818; Dalli J, 2008, BLOOD, V112, P2512, DOI 10.1182/blood-2008-02-140533; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Diehl P, 2012, CARDIOVASC RES, V93, P633, DOI 10.1093/cvr/cvs007; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Fierro IM, 2003, J IMMUNOL, V170, P2688, DOI 10.4049/jimmunol.170.5.2688; Fierro IM, 2002, J PHARMACOL EXP THER, V300, P385, DOI 10.1124/jpet.300.2.385; FIORE S, 1993, BLOOD, V81, P3395; GIMBRONE MA, 1995, ANN NY ACAD SCI, V748, P122; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Gutierrez J, 2012, ARCH INTERN MED, V172, P909, DOI 10.1001/archinternmed.2012.2145; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; HIGGS EA, 1978, PROSTAGLANDINS, V16, P153, DOI 10.1016/0090-6980(78)90018-7; Jansen F, 2013, CIRCULATION, V128, P2026, DOI 10.1161/CIRCULATIONAHA.113.001720; Jansen F, 2012, ARTERIOSCL THROM VAS, V32, P1925, DOI 10.1161/ATVBAHA.112.253229; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; Kuhnert F, 2008, DEVELOPMENT, V135, P3989, DOI 10.1242/dev.029736; Kumar V, 2014, ROBBINS COTRAN PATHO; Lanuti P, 2012, J IMMUNOL METHODS, V380, P16, DOI 10.1016/j.jim.2012.03.007; Le YY, 1999, J IMMUNOL, V163, P6777; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leroyer AS, 2008, J AM COLL CARDIOL, V52, P1302, DOI 10.1016/j.jacc.2008.07.032; Leroyer AS, 2007, J AM COLL CARDIOL, V49, P772, DOI 10.1016/j.jacc.2006.10.053; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loyer X, 2014, CIRC RES, V114, P434, DOI 10.1161/CIRCRESAHA.114.302213; Maddox JE, 1996, J EXP MED, V183, P137, DOI 10.1084/jem.183.1.137; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; McCall MN, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-78; Molin DGM, 2010, CARDIOVASC RES, V86, P6, DOI 10.1093/cvr/cvq054; Norling LV, 2013, CURR OPIN PHARMACOL, V13, P570, DOI 10.1016/j.coph.2013.05.008; Norling LV, 2011, J IMMUNOL, V186, P5543, DOI 10.4049/jimmunol.1003865; Pierdomenico AM, 2015, J BIOL CHEM, V290, P3592, DOI 10.1074/jbc.M114.592352; Planaguma A, 2010, MUCOSAL IMMUNOL, V3, P270, DOI 10.1038/mi.2009.141; Recchiuti A, 2014, FASEB J, V28, P3090, DOI 10.1096/fj.13-248393; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Romano M, 2015, EUR J PHARMACOL, V760, P49, DOI 10.1016/j.ejphar.2015.03.083; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Schober A, 2014, NAT MED, V20, P368, DOI 10.1038/nm.3487; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; SERHAN CN, 1984, P NATL ACAD SCI-BIOL, V81, P5335, DOI 10.1073/pnas.81.17.5335; Shin EH, 2006, BIOCHEM BIOPH RES CO, V341, P1317, DOI 10.1016/j.bbrc.2006.01.098; Simiele F, 2012, FASEB J, V26, P1323, DOI 10.1096/fj.11-198069; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Urbich C, 2012, BLOOD, V119, P1607, DOI 10.1182/blood-2011-08-373886; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vion AC, 2013, CIRC RES, V112, P1323, DOI 10.1161/CIRCRESAHA.112.300818; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhang Q, 2016, CIVIL ENGINEERING AND URBAN PLANNING IV, P25	62	21	22	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1856	1866		10.1096/fj.201600952R	http://dx.doi.org/10.1096/fj.201600952R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28100645				2022-12-26	WOS:000399195500009
J	Juan-Mateu, J; Rech, TH; Villate, O; Lizarraga-Mollinedo, E; Wendt, A; Turatsinze, JV; Brondani, LA; Nardelli, TR; Nogueira, TC; Esguerra, JLS; Alvelos, MI; Marchetti, P; Eliasson, L; Eizirik, DL				Juan-Mateu, Jonas; Rech, Tatiana H.; Villate, Olatz; Lizarraga-Mollinedo, Esther; Wendt, Anna; Turatsinze, Jean-Valery; Brondani, Leticia A.; Nardelli, Tarlliza R.; Nogueira, Tatiane C.; Esguerra, Jonathan L. S.; Alvelos, Maria Ines; Marchetti, Piero; Eliasson, Lena; Eizirik, Decio L.			Neuron-enriched RNA-binding Proteins Regulate Pancreatic Beta Cell Function and Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alternative splicing; apoptosis; autoimmunity; beta cell (B-cell); diabetes; insulin secretion	ENDOPLASMIC-RETICULUM STRESS; SILENCING TRANSCRIPTION FACTOR; INSULIN-PRODUCING CELLS; KAPPA-B ACTIVATION; NERVOUS-SYSTEM; RESTRICTIVE SILENCER; SPLICING REGULATION; INDUCED APOPTOSIS; GENE-EXPRESSION; CANDIDATE GENE	Pancreatic beta cell failure is the central event leading to diabetes. Beta cells share many phenotypic traits with neurons, and proper beta cell function relies on the activation of several neuron-like transcription programs. Regulation of gene expression by alternative splicing plays a pivotal role in brain, where it affects neuronal development, function, and disease. The role of alternative splicing in beta cells remains unclear, but recent data indicate that splicing alterations modulated by both inflammation and susceptibility genes for diabetes contribute to beta cell dysfunction and death. Here we used RNA sequencing to compare the expression of splicing-regulatory RNA-binding proteins in human islets, brain, and other human tissues, and we identified a cluster of splicing regulators that are expressed in both beta cells and brain. Four of them, namely Elavl4, Nova2, Rbox1, and Rbfox2, were selected for subsequent functional studies in insulin-producing rat INS-1E, human EndoC-H1 cells, and in primary rat beta cells. Silencing of Elavl4 and Nova2 increased beta cell apoptosis, whereas silencing of Rbfox1 and Rbfox2 increased insulin content and secretion. Interestingly, Rbfox1 silencing modulates the splicing of the actin-remodeling protein gelsolin, increasing gelsolin expression and leading to faster glucose-induced actin depolymerization and increased insulin release. Taken together, these findings indicate that beta cells share common splicing regulators and programs with neurons. These splicing regulators play key roles in insulin release and beta cell survival, and their dysfunction may contribute to the loss of functional beta cell mass in diabetes.	[Juan-Mateu, Jonas; Rech, Tatiana H.; Villate, Olatz; Lizarraga-Mollinedo, Esther; Turatsinze, Jean-Valery; Brondani, Leticia A.; Nardelli, Tarlliza R.; Nogueira, Tatiane C.; Alvelos, Maria Ines; Eizirik, Decio L.] Univ Libre Bruxelles, ULB Ctr Diabet Res, Route Lennik 808, B-1070 Brussels, Belgium; [Wendt, Anna; Esguerra, Jonathan L. S.; Eliasson, Lena] Lund Univ, Dept Clin Sci Malmo, Unit Islets Cell Exocytosis, Ctr Diabet, SE-20502 Malmo, Sweden; [Marchetti, Piero] Univ Pisa, Dept Clin & Expt Med, Islet Cell Lab, I-56126 Pisa, Italy; [Eizirik, Decio L.] Univ Libre Bruxelles, Welbio, 808 Route Lennik,CP618, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Lund University; University of Pisa; Universite Libre de Bruxelles; WELBIO	Juan-Mateu, J; Eizirik, DL (corresponding author), Univ Libre Bruxelles, ULB Ctr Diabet Res, Route Lennik 808, B-1070 Brussels, Belgium.	mjuanmat@ulb.ac.be; deizirik@ulb.ac.be	de Araujo Nogueira, Tatiane/E-8510-2013; Eliasson, Lena/E-9294-2012; Lizárraga-Mollinedo, Esther/B-3867-2015; Esguerra, Jonathan/M-2366-2014; Rech, Tatiana/V-2711-2019	Eliasson, Lena/0000-0002-6467-5029; Lizárraga-Mollinedo, Esther/0000-0002-1059-8654; Esguerra, Jonathan/0000-0001-8454-6606; Juan-Mateu, Jonas/0000-0001-9749-6441; Villate, Olatz/0000-0002-5574-837X; Wendt, Anna/0000-0001-8807-5979	European Union of the European Commission; Fonds National de la Recherche Scientifique (FNRS) [T.0036.13]; FRFSWelbio [CR-2015A-06]; Swedish Research Council; Juvenile Diabetes Foundation; Helmsley Type 1 Diabetes Program; National Institutes of Health NIDDK-HIRN Consortium [1UC4DK104166-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UC4DK104166] Funding Source: NIH RePORTER	European Union of the European Commission; Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); FRFSWelbio(WELBIO); Swedish Research Council(Swedish Research CouncilEuropean Commission); Juvenile Diabetes Foundation(Juvenile Diabetes Research Foundation); Helmsley Type 1 Diabetes Program; National Institutes of Health NIDDK-HIRN Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by European Union Project T2DSystems in the Horizon 2020 Programme of the European Commission; Fonds National de la Recherche Scientifique (FNRS) Grants T.0036.13 and FRFSWelbio CR-2015A-06, Belgium; the Swedish Research Council project grants (to L. E.); the Juvenile Diabetes Foundation; the Helmsley Type 1 Diabetes Program; and National Institutes of Health NIDDK-HIRN Consortium 1UC4DK104166-01. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akamatsu W, 2005, P NATL ACAD SCI USA, V102, P4625, DOI 10.1073/pnas.0407523102; Andersson LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120879; Arntfield ME, 2011, BIOESSAYS, V33, P582, DOI 10.1002/bies.201100015; Atouf F, 1997, J BIOL CHEM, V272, P1929, DOI 10.1074/jbc.272.3.1929; Bhalla K, 2004, J HUM GENET, V49, P308, DOI 10.1007/s10038-004-0145-4; Bronicki LM, 2013, RNA, V19, P1019, DOI 10.1261/rna.039164.113; Brozzi F, 2016, UPSALA J MED SCI, V121, P133, DOI 10.3109/03009734.2015.1135217; Brozzi F, 2015, DIABETOLOGIA, V58, P2307, DOI 10.1007/s00125-015-3669-6; Calarco JA, 2011, RNA, V17, P775, DOI 10.1261/rna.2603911; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Cnop M, 2007, J BIOL CHEM, V282, P3989, DOI 10.1074/jbc.M607627200; DEVASKAR SU, 1994, J BIOL CHEM, V269, P8445; Eizirik DL, 2013, DIABETOLOGIA, V56, P234, DOI 10.1007/s00125-012-2762-3; Eizirik DL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002552; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; EIZIRIK DL, 1994, P NATL ACAD SCI USA, V91, P9253, DOI 10.1073/pnas.91.20.9253; EIZIRIK DL, 1988, ENDOCRINOLOGY, V123, P1001, DOI 10.1210/endo-123-2-1001; Eliasson L, 2008, J PHYSIOL-LONDON, V586, P3313, DOI 10.1113/jphysiol.2008.155317; Fogel BL, 2012, HUM MOL GENET, V21, P4171, DOI 10.1093/hmg/dds240; Gallagher TL, 2011, DEV BIOL, V359, P251, DOI 10.1016/j.ydbio.2011.08.025; Gehman LT, 2012, GENE DEV, V26, P445, DOI 10.1101/gad.182477.111; Gehman LT, 2011, NAT GENET, V43, P706, DOI 10.1038/ng.841; Gilon P, 2014, CELL CALCIUM, V56, P340, DOI 10.1016/j.ceca.2014.09.001; Giulietti M, 2013, NUCLEIC ACIDS RES, V41, pD125, DOI 10.1093/nar/gks997; Glatt SJ, 2011, AM J MED GENET B, V156B, P382, DOI 10.1002/ajmg.b.31181; Grabowski PJ, 2001, PROG NEUROBIOL, V65, P289, DOI 10.1016/S0301-0082(01)00007-7; Hartenstein V, 2015, DEV CELL, V32, P390, DOI 10.1016/j.devcel.2015.02.004; Hayashi S, 2015, J NEUROSCI RES, V93, P399, DOI 10.1002/jnr.23496; Heimberg H, 2001, DIABETES, V50, P2219, DOI 10.2337/diabetes.50.10.2219; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; HENQUIN JC, 1984, ENDOCRINOLOGY, V115, P1125, DOI 10.1210/endo-115-3-1125; Hori Y, 2005, PLOS MED, V2, P347, DOI 10.1371/journal.pmed.0020103; Jensen J, 2004, DEV DYNAM, V229, P176, DOI 10.1002/dvdy.10460; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; Juan-Mateu J, 2016, EUR J ENDOCRINOL, V174, pR225, DOI 10.1530/EJE-15-0916; Kalwat MA, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.73; Kalwat MA, 2012, MOL ENDOCRINOL, V26, P128, DOI 10.1210/me.2011-1112; Kim C, 2016, BBA-GENE REGUL MECH, V1859, P675, DOI 10.1016/j.bbagrm.2016.02.017; Kim C, 2014, J BIOL CHEM, V289, P112, DOI 10.1074/jbc.M113.474700; Lee CJ, 2003, BIOL PSYCHIAT, V54, P771, DOI 10.1016/S0006-3223(03)00375-5; Lee EK, 2012, MOL CELL, V45, P826, DOI 10.1016/j.molcel.2012.01.016; Leggere JC, 2016, ELIFE, V5, DOI 10.7554/eLife.14264; Leung YM, 2007, ENDOCR REV, V28, P653, DOI 10.1210/er.2007-0010; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Lovci MT, 2013, NAT STRUCT MOL BIOL, V20, P1434, DOI 10.1038/nsmb.2699; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Marroqui L, 2015, EBIOMEDICINE, V2, P378, DOI 10.1016/j.ebiom.2015.03.012; Martin CL, 2007, AM J MED GENET B, V144B, P869, DOI 10.1002/ajmg.b.30530; Martin D, 2008, DIABETOLOGIA, V51, P1429, DOI 10.1007/s00125-008-0984-1; Martin D, 2003, J BIOL CHEM, V278, P53082, DOI 10.1074/jbc.M306861200; Martin D, 2015, DEV BIOL, V405, P316, DOI 10.1016/j.ydbio.2015.07.002; Moore F, 2012, METHODS MOL BIOL, V820, P179, DOI 10.1007/978-1-61779-439-1_11; Moore F, 2009, DIABETES, V58, P1283, DOI 10.2337/db08-1510; Nogueira TC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003532; Ortis F, 2006, MOL ENDOCRINOL, V20, P1867, DOI 10.1210/me.2005-0268; Pedrotti S, 2015, HUM MOL GENET, V24, P2360, DOI 10.1093/hmg/ddv003; Perrone-Bizzozero Nora, 2013, Front Biosci (Schol Ed), V5, P554; Raj B, 2015, NEURON, V87, P14, DOI 10.1016/j.neuron.2015.05.004; Rasschaert J, 2005, J BIOL CHEM, V280, P33984, DOI 10.1074/jbc.M502213200; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; REGAZZI R, 1995, EMBO J, V14, P2723, DOI 10.1002/j.1460-2075.1995.tb07273.x; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; SADOUL K, 1995, J CELL BIOL, V128, P1019, DOI 10.1083/jcb.128.6.1019; Saito Y, 2016, ELIFE, V5, DOI 10.7554/eLife.14371; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Thiel G, 2015, CELL TISSUE RES, V359, P99, DOI 10.1007/s00441-014-1963-0; Tomas A, 2006, J CELL SCI, V119, P2156, DOI 10.1242/jcs.02942; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; van Arensbergen J, 2010, GENOME RES, V20, P722, DOI 10.1101/gr.101709.109; Vikman J, 2006, J MOL ENDOCRINOL, V36, P503, DOI 10.1677/jme.1.01978; Villate O, 2014, NUCLEIC ACIDS RES, V42, P11818, DOI 10.1093/nar/gku861; WALLENSTEIN S, 1980, CIRC RES, V47, P1, DOI 10.1161/01.RES.47.1.1; Wang FF, 2015, P NATL ACAD SCI USA, V112, pE4995, DOI 10.1073/pnas.1513780112; Weyn-Vanhentenryck SM, 2014, CELL REP, V6, P1139, DOI 10.1016/j.celrep.2014.02.005; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Yang YYL, 1998, P NATL ACAD SCI USA, V95, P13254, DOI 10.1073/pnas.95.22.13254; Zhang CL, 2010, SCIENCE, V329, P439, DOI 10.1126/science.1191150; Zheng S, 2013, TRENDS GENET, V29, P442, DOI 10.1016/j.tig.2013.04.003	80	34	36	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3466	3480		10.1074/jbc.M116.748335	http://dx.doi.org/10.1074/jbc.M116.748335			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28077579	Green Published, hybrid			2022-12-26	WOS:000395538800035
J	Medina-Colorado, AA; Osorio, EY; Saldarriaga, OA; Travi, BL; Kong, FP; Spratt, H; Soong, L; Melby, PC				Medina-Colorado, Audrie A.; Osorio, Elvia Y.; Saldarriaga, Omar A.; Travi, Bruno L.; Kong, Fanping; Spratt, Heidi; Soong, Lynn; Melby, Peter C.			Splenic CD4(+) T Cells in Progressive Visceral Leishmaniasis Show a Mixed Effector-Regulatory Phenotype and Impair Macrophage Effector Function through Inhibitory Receptor Expression	PLOS ONE			English	Article							DONOVANI INFECTION; INTERFERON-GAMMA; EXHAUSTION; GENE; INTERLEUKIN-10; RESISTANCE; SUSCEPTIBILITY; MECHANISMS; CYTOKINES; RESPONSES	Visceral leishmaniasis (VL), caused by infection with the intracellular protozoan Leishmania donovani, is a chronic progressive disease with a relentlessly increasing parasite burden in the spleen, liver and bone marrow. The disease is characterized by fever, splenomegaly, cachexia, and pancytopenia, and progresses to death if not treated. Control of Leishmania infection is mediated by Th1 (IFNy-producing) CD4(+) T cells, which activate macrophages to produce nitric oxide and kill intracellular parasites. However, despite expansion of CD4(+) T cells and increased IFNy expression in the spleen, humans with active VL do not control the infection. We used an experimental model of chronic progressive VL in hamsters, which mimics clinical and pathological features seen in humans, to better understand the mechanisms that lead to progressive disease. Transcriptional profiling of the spleen during chronic infection revealed expression of markers of both T cell activation and inhibition. CD4(+) T cells isolated from the spleen during chronic progressive VL showed mixed expression of Th1 and Th2 cytokines and chemokines, and were marginally effective in controlling infection in an ex vivo T cell-macrophage co-culture system. Splenic CD4(+) T cells and macrophages from hamsters with VL showed increased expression of inhibitory receptors and their ligands, respectively. Blockade of the inhibitory receptor PD-L2 led to a significant decrease in parasite burden, revealing a pathogenic role for the PD-1 pathway in chronic VL. PD-L2 blockade was associated with a dramatic reduction in expression of host arginase 1, but no change in IFNy and inducible nitric oxide synthase. Thus, the expression of counter-regulatory molecules on splenic CD4(+) T cells and macrophages promotes a more permissive macrophage phenotype and attenuates intracellular parasite control in chronic progressive VL. Host-directed adjunctive therapy targeting the PD-1 regulatory pathway may be efficacious for VL.	[Medina-Colorado, Audrie A.; Travi, Bruno L.; Soong, Lynn; Melby, Peter C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Osorio, Elvia Y.; Saldarriaga, Omar A.; Travi, Bruno L.; Melby, Peter C.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Travi, Bruno L.; Soong, Lynn; Melby, Peter C.] Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA; [Travi, Bruno L.; Soong, Lynn; Melby, Peter C.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA; [Kong, Fanping] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Spratt, Heidi] Univ Texas Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA; [Soong, Lynn; Melby, Peter C.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Melby, PC (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.; Melby, PC (corresponding author), Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA.; Melby, PC (corresponding author), Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA.; Melby, PC (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.; Melby, PC (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	pcmelby@utmb.edu	Saldarriaga, Omar/Z-1084-2019; Osorio, Elvia Janeth/AAF-4469-2020	Osorio, Elvia Janeth/0000-0001-8014-6330; Colorado, Audrie/0000-0002-4917-666X	University of Texas Medical Branch; National Institute of Allergy and Infectious Diseases [T32AI007526]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007526] Funding Source: NIH RePORTER	University of Texas Medical Branch; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by institutional funding from the University of Texas Medical Branch. AAMC was supported by Award Number T32AI007526 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER S, 1948, NATURE, V162, P256, DOI 10.1038/162256b0; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Ansari NA, 2006, CLIN IMMUNOL, V119, P339, DOI 10.1016/j.clim.2006.01.017; Ansari NA, 2011, J IMMUNOL, V186, P3977, DOI 10.4049/jimmunol.1003588; Anstead GM, 2001, INFECT IMMUNITY, V69; Babaloo Z, 2001, T ROY SOC TROP MED H, V95, P85, DOI 10.1016/S0035-9203(01)90344-X; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; CARVALHO EM, 1992, J INFECT DIS, V165, P535, DOI 10.1093/infdis/165.3.535; CARVALHO EM, 1989, J CLIN INVEST, V83, P860, DOI 10.1172/JCI113969; Cho HY, 2009, IMMUNOL LETT, V127, P39, DOI 10.1016/j.imlet.2009.08.011; Contreras I, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001148; Dons EM, 2012, HUM IMMUNOL, V73, P328, DOI 10.1016/j.humimm.2011.12.011; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Esch KJ, 2013, J IMMUNOL, V191, P5542, DOI 10.4049/jimmunol.1301810; Fabrizi F, 1999, NEPHROL DIAL TRANSPL, V14, P1929, DOI 10.1093/ndt/14.8.1929; Finot M J, 1987, Soins, pIII; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Gautam S, 2011, IL 10 NEUTRALIZATION; Gautam S, 2014, J INFECT DIS, V209, P290, DOI 10.1093/infdis/jit401; GHALIB HW, 1995, J IMMUNOL, V154, P4623; Gifawesen C, 1989, INFECT IMMUNITY, V57; Gonzalez-Quevedo R, 2002, J CLIN ONCOL, V20, P254, DOI 10.1200/JCO.20.1.254; GREEN SJ, 1990, J IMMUNOL, V144, P278; HOOVER ML, 1985, J EXP MED, V162, P1087, DOI 10.1084/jem.162.3.1087; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Joshi T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000431; KAYE PM, 1991, J IMMUNOL, V146, P2763; Lehmann J, 2000, J INTERF CYTOK RES, V20, P63, DOI 10.1089/107999000312748; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Marr AK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004419; McCoy KD, 1999, IMMUNOL CELL BIOL, V77, P1, DOI 10.1046/j.1440-1711.1999.00795.x; Melby PC, 2001, CURR PROTOC IMMUNOL, DOI DOI 10.1002/0471142735.IM1902S28; Melby PC, 1950, J IMMUNOLOGY, V166; Murray HW, 1997, J INFECT DIS, V175, P1477, DOI 10.1086/516482; Murray HW, 2006, INFECT IMMUN, V74, P2487, DOI 10.1128/IAI.74.4.2487-2490.2006; Murray HW, 1999, J EXP MED, V189, P741, DOI 10.1084/jem.189.4.741; Murray HW, 1983, J CLIN INVESTIGATION, V72; Ni L, 2011, IMMUNOL CELL BIOL, V89, P535, DOI 10.1038/icb.2010.121; Nylen S, 2007, TRENDS IMMUNOL, V28, P378, DOI 10.1016/j.it.2007.07.004; Nylen S, 2007, J EXP MED, V204, P805, DOI 10.1084/jem.20061141; Osorio EY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004165; Osorio EY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002417; Osorio Y, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000962; Owens BMJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002827; Pearson RD, 1996, CLIN INFECT DIS, V22, P1, DOI 10.1093/clinids/22.1.1; Perez LE, 2006, J IMMUNOL, V176, P5519, DOI 10.4049/jimmunol.176.9.5519; Rai K, 2013, MBIO, V4, DOI 10.1128/mBio.00611-13; Ray M, 2000, J INFECT DIS, V181, P1121, DOI 10.1086/315330; Rispo A, 2006, INFLAMM BOWEL DIS, V12, P486, DOI 10.1097/00054725-200606000-00007; Roy G, 2000, MOL BIOCHEM PARASIT, V110, P195, DOI 10.1016/S0166-6851(00)00270-X; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Sacks DL, 1950, J IMMUNOLOGY, V139; Soong L, 2012, SEMIN IMMUNOPATHOL, V34, P735, DOI 10.1007/s00281-012-0350-8; Stager S, 2006, EUR J IMMUNOL, V36, P1764, DOI 10.1002/eji.200635937; Sundar S, 1997, AM J TROP MED HYG, V56, P522, DOI 10.4269/ajtmh.1997.56.522; Vouldoukis I, 1997, EUR J IMMUNOL, V27, P860, DOI 10.1002/eji.1830270409; Wetzel D, 2015, BRIT J HAEMATOL, V168, P268, DOI 10.1111/bjh.13118; Yi JS, 2010, IMMUNOLOGY, V129, P474, DOI 10.1111/j.1365-2567.2010.03255.x; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	60	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0169496	10.1371/journal.pone.0169496	http://dx.doi.org/10.1371/journal.pone.0169496			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103263	Green Published, gold, Green Submitted			2022-12-26	WOS:000392381100014
J	Wang, J; Cui, JH; Chen, R; Deng, YC; Liao, X; Wei, YL; Li, XH; Su, M; Yu, JH; Yi, P				Wang, Jing; Cui, Jinghong; Chen, Rui; Deng, Youcai; Liao, Xi; Wei, Yanling; Li, Xiaohui; Su, Min; Yu, Jianhua; Yi, Ping			Prenatal Exposure to Lipopolysaccharide Alters Renal DNA Methyltransferase Expression in Rat Offspring	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; GENE; INTERLEUKIN-6; HYPERTENSION; METHYLATION; CANCER; BRAIN; CELLS; DNMT1	Prenatal exposure to inflammation results in hypertension during adulthood but the mechanisms are not well understood. Maternal exposure to lipopolysaccharide (LPS) alters interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) levels in the fetal environment. As reported in many recent studies, IL-6 regulates DNA methyltransferases (DNMTs) through the transcription factor friend leukemia virus integration 1 (Fli-1). The present study explores the role of intrarenal DNMTs during development of hypertension induced by prenatal exposure to LPS. Pregnant rats were randomly divided into four treatment groups: control, LPS, pyrrolidine dithiocarbamate (PDTC, a NF-kappa B inhibitor), and the combination of LPS and PDTC. Expression of IL-6, Fli-1, TNF-alpha, DNMT1 and DNMT3B was significantly increased in the offspring of LPS-treated rats. Global DNA methylation level of renal cortex also increased dramatically in rat offspring of the LPS group. Prenatal PDTC administration reversed the increases in gene expression and global DNA methylation level. These findings suggest that prenatal exposure to LPS may result in changes of intrarenal DNMTs through the IL-6/Fli-1 pathway and TNF-alpha, which probably involves hypertension in offspring due to maternal exposure to inflammation.	[Wang, Jing; Cui, Jinghong; Liao, Xi; Yu, Jianhua; Yi, Ping] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Obstet & Gynecol, Chongqing, Peoples R China; [Chen, Rui; Deng, Youcai; Li, Xiaohui; Su, Min] Third Mil Med Univ, Inst Mat Med, Coll Pharm, Chongqing, Peoples R China; [Wei, Yanling] Third Mil Med Univ, Dept Gastroenterol, Inst Surg Res, Daping Hosp, Chongqing, Peoples R China; [Yu, Jianhua] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	Army Medical University; Army Medical University; Army Medical University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University		yp_yiping@foxmail.com	Deng, Youcai/GZK-9548-2022	Deng, Youcai/0000-0001-5488-8576	National Natural Science Foundation of China [81170580]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China, Grant numbers: 81170580 (http://www.nsfc.gov.cn/) to PY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012479; Alikhani-Koopaei R, 2004, J CLIN INVEST, V114, P1146, DOI 10.1172/JCI200421647; Barouki R, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-42; Bogdarina I, 2007, CIRC RES, V100, P520, DOI 10.1161/01.RES.0000258855.60637.58; Chapman K, 2013, PHYSIOL REV, V93, P1139, DOI 10.1152/physrev.00020.2012; Chung YG, 2003, BIOL REPROD, V69, P146, DOI 10.1095/biolreprod.102.014076; Foran E, 2010, MOL CANCER RES, V8, P471, DOI 10.1158/1541-7786.MCR-09-0496; Gao M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111376; Ghoshal K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010338; Goyal R, 2010, REPROD SCI, V17, P227, DOI 10.1177/1933719109351935; Hao XQ, 2013, EXP TOXICOL PATHOL, V65, P433, DOI 10.1016/j.etp.2012.01.001; Hao XQ, 2010, HYPERTENS RES, V33, P76, DOI 10.1038/hr.2009.185; Hodge David R., 2007, Cancer Genomics & Proteomics, V4, P387; Hodge DR, 2005, CANCER RES, V65, P4673, DOI 10.1158/0008-5472.CAN-04-3589; Hodge DR, 2001, J BIOL CHEM, V276, P39508, DOI 10.1074/jbc.C100343200; Jeltsch A, 2014, TRENDS BIOCHEM SCI, V39, P310, DOI 10.1016/j.tibs.2014.05.002; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Li Y, 2012, CARCINOGENESIS, V33, P1889, DOI 10.1093/carcin/bgs214; Liao WQ, 2008, CLIN EXP PHARMACOL P, V35, P1413, DOI 10.1111/j.1440-1681.2008.05062.x; Qin XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23240; Rabadan-Diehl C, 2013, LANCET, V381, P3, DOI [10.1016/S0140-6736(12)61609-2, DOI 10.1016/S0140-6736(12)61609-2]; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Thaler R, 2011, J BIOL CHEM, V286, P5578, DOI 10.1074/jbc.M110.166181; Urakubo A, 2001, SCHIZOPHR RES, V47, P27, DOI 10.1016/S0920-9964(00)00032-3; Wei YL, 2007, ACTA PHARMACOL SIN, V28, P651, DOI 10.1111/j.1745-7254.2007.00593.x; Xiao DL, 2009, HYPERTENSION, V53, P937, DOI 10.1161/HYPERTENSIONAHA.108.121830	26	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0169206	10.1371/journal.pone.0169206	http://dx.doi.org/10.1371/journal.pone.0169206			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103274	Green Submitted, Green Published, gold			2022-12-26	WOS:000392381100009
J	Ponath, V; Kaina, B				Ponath, Viviane; Kaina, Bernd			Death of Monocytes through Oxidative Burst of Macrophages and Neutrophils: Killing in Trans	PLOS ONE			English	Article							BASE EXCISION-REPAIR; DNA-DAMAGE; MEDIATED DEFENSE; DENDRITIC CELLS; REACTIVE OXYGEN; CANCER; INFLAMMATION; RESPONSES; DISEASE; PATHWAYS	Monocytes and their descendants, macrophages, play a key role in the defence against pathogens. They also contribute to the pathogenesis of inflammatory diseases. Therefore, a mechanism maintaining a balance in the monocyte/macrophage population must be postulated. Our previous studies have shown that monocytes are impaired in DNA repair, rendering them vulnerable to genotoxic stress while monocyte-derived macrophages are DNA repair competent and genotoxic stress-resistant. Based on these findings, we hypothesized that monocytes can be selectively killed by reactive oxygen species (ROS) produced by activated macrophages. We also wished to know whether monocytes and macrophages are protected against their own ROS produced following activation. To this end, we studied the effect of the ROS burst on DNA integrity, cell death and differentiation potential of monocytes. We show that monocytes, but not macrophages, stimulated for ROS production by phorbol-12-myristate-13-acetate (PMA) undergo apoptosis, despite similar levels of initial DNA damage. Following co-cultivation with ROS producing macrophages, monocytes displayed oxidative DNA damage, accumulating DNA single-strand breaks and a high incidence of apoptosis, reducing their ability to give rise to new macrophages. Killing of monocytes by activated macrophages, termed killing in trans, was abolished by ROS scavenging and was also observed in monocytes co-cultivated with ROS producing activated granulocytes. The data revealed that monocytes, which are impaired in the repair of oxidised DNA lesions, are vulnerable to their own ROS and ROS produced by macrophages and granulocytes and support the hypothesis that this is a mechanism regulating the amount of monocytes and macrophages in a ROS-enriched inflammatory environment.	[Ponath, Viviane; Kaina, Bernd] Univ Med Ctr, Dept Toxicol, Mainz, Germany	Johannes Gutenberg University of Mainz	Kaina, B (corresponding author), Univ Med Ctr, Dept Toxicol, Mainz, Germany.	kaina@uni-mainz.de	Kaina, Bernd/AAE-4692-2020	Kaina, Bernd/0000-0002-8217-0809	German Reseach Foundation (DFG) [Ka724/20-2]	German Reseach Foundation (DFG)	This work was supported by the German Reseach Foundation (DFG) Ka724/20-2. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Aga M, 2004, AM J PHYSIOL-CELL PH, V286, pC923, DOI 10.1152/ajpcell.00417.2003; Bauer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039956; Bauer M, 2011, P NATL ACAD SCI USA, V108, P21105, DOI 10.1073/pnas.1111919109; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Briegert M, 2007, CANCER RES, V67, P26, DOI 10.1158/0008-5472.CAN-06-3712; Broussas M, 1999, J LEUKOCYTE BIOL, V66, P495, DOI 10.1002/jlb.66.3.495; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chou WC, 2004, P NATL ACAD SCI USA, V101, P4578, DOI 10.1073/pnas.0306687101; D'Errico M, 2008, MUTAT RES-REV MUTAT, V659, P4, DOI 10.1016/j.mrrev.2007.10.003; Dianov GL, 2001, PROG NUCLEIC ACID RE, V68, P285; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Evans MD, 2004, MUTAT RES-REV MUTAT, V567, P1, DOI 10.1016/j.mrrev.2003.11.001; Fialkow L, 2007, FREE RADICAL BIO MED, V42, P153, DOI 10.1016/j.freeradbiomed.2006.09.030; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Krokan HE, 2000, FEBS LETT, V476, P73, DOI 10.1016/S0014-5793(00)01674-4; Lauvau G, 2015, SEMIN IMMUNOL, V27, P397, DOI 10.1016/j.smim.2016.03.014; Leon B, 2005, SEMIN IMMUNOL, V17, P313, DOI 10.1016/j.smim.2005.05.013; Mangerich A, 2016, TOXICOL LETT, V244, P56, DOI 10.1016/j.toxlet.2015.09.010; Maynard S, 2009, CARCINOGENESIS, V30, P2, DOI 10.1093/carcin/bgn250; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Reinhardt HC, 2012, TRENDS GENET, V28, P128, DOI 10.1016/j.tig.2011.12.002; Roos WP, 2016, NAT REV CANCER, V16, P20, DOI 10.1038/nrc.2015.2; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Webster SJ, 2010, J IMMUNOL, V185, P2968, DOI 10.4049/jimmunol.1000805; Yang JY, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-1	29	33	34	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170347	10.1371/journal.pone.0170347	http://dx.doi.org/10.1371/journal.pone.0170347			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099491	Green Submitted, Green Published, gold			2022-12-26	WOS:000392380100077
J	Niu, CR; Livingston, CM; Li, L; Beran, RK; Daffis, S; Ramakrishnan, D; Burdette, D; Peiser, L; Salas, E; Ramos, H; Yu, M; Cheng, GF; Strubin, M; Delaney, WE; Fletcher, SP				Niu, Congrong; Livingston, Christine M.; Li, Li; Beran, Rudolf K.; Daffis, Stephane; Ramakrishnan, Dhivya; Burdette, Dara; Peiser, Leanne; Salas, Eduardo; Ramos, Hilario; Yu, Mei; Cheng, Guofeng; Strubin, Michel; Delaney, William E.; Fletcher, Simon P.			The Smc5/6 Complex Restricts HBV when Localized to ND10 without Inducing an Innate Immune Response and Is Counteracted by the HBV X Protein Shortly after Infection	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; GENE-EXPRESSION; EPIGENETIC REGULATION; NUCLEAR-BODIES; HUMANIZED MICE; DNA; REPLICATION; BINDING; CELLS; COMPONENTS	The structural maintenance of chromosome 5/6 complex (Smc5/6) is a restriction factor that represses hepatitis B virus (HBV) transcription. HBV counters this restriction by expressing HBV X protein (HBx), which targets Smc5/6 for degradation. However, the mechanism by which Smc5/6 suppresses HBV transcription and how HBx is initially expressed is not known. In this study we characterized viral kinetics and the host response during HBV infection of primary human hepatocytes (PHH) to address these unresolved questions. We determined that Smc5/6 localizes with Nuclear Domain 10 (ND10) in PHH. Co-localization has functional implications since depletion of ND10 structural components alters the nuclear distribution of Smc6 and induces HBV gene expression in the absence of HBx. We also found that HBV infection and replication does not induce a prominent global host transcriptional response in PHH, either shortly after infection when Smc5/6 is present, or at later times post-infection when Smc5/6 has been degraded. Notably, HBV and an HBx-negative virus establish high level infection in PHH without inducing expression of interferon-stimulated genes or production of interferons or other cytokines. Our study also revealed that Smc5/6 is degraded in the majority of infected PHH by the time cccDNA transcription could be detected and that HBx RNA is present in cell culture-derived virus preparations as well as HBV patient plasma. Collectively, these data indicate that Smc5/6 is an intrinsic antiviral restriction factor that suppresses HBV transcription when localized to ND10 without inducing a detectable innate immune response. Our data also suggest that HBx protein may be initially expressed by delivery of extracellular HBx RNA into HBV-infected cells.	[Niu, Congrong; Livingston, Christine M.; Li, Li; Beran, Rudolf K.; Daffis, Stephane; Ramakrishnan, Dhivya; Burdette, Dara; Peiser, Leanne; Salas, Eduardo; Ramos, Hilario; Yu, Mei; Cheng, Guofeng; Delaney, William E.; Fletcher, Simon P.] Gilead Sci, Foster City, CA 94404 USA; [Strubin, Michel] Univ Med Ctr, Dept Microbiol & Mol Med, Geneva, Switzerland	Gilead Sciences; University of Geneva	Fletcher, SP (corresponding author), Gilead Sci, Foster City, CA 94404 USA.	simon.fletcher@gilead.com			Helen Wills Neuroscience Institute [LSM880]	Helen Wills Neuroscience Institute	The authors gratefully acknowledge Ulrike Protzer for the HBVAX producing cell line; Hoa Truong for performing the MSD assay; Anna Celli and Jane Gordon (University of California, San Francisco) as well as Jen-Yi Lee and Holly Aaron (University of California, Berkeley Molecular Imaging Center) for technical assistance with confocal microscopy; Helen Wills Neuroscience Institute for supporting purchase of the Zeiss LSM880 at the Berkeley Molecular Imaging Center; Vivian Barry, Rosanna Win and Rhyannon Spangler for helpful discussion and sectioning the uPA-SLID mouse liver tissue; Lindsay Gamelin for the identifying the patient plasma samples; Robert Jordan, Anuj Gaggar, Peng Yue, Sarah Gilmore, Tomas Cihlar and Frank Chisari for discussions and support.	Altinel K, 2016, J VIROL; Ancey PB, 2015, ONCOTARGET, V6, P44877, DOI 10.18632/oncotarget.6270; Belloni L, 2012, J CLIN INVEST, V122, P529, DOI 10.1172/JCI58847; Belloni L, 2009, P NATL ACAD SCI USA, V106, P19975, DOI 10.1073/pnas.0908365106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Bertoletti A, 2012, GUT, V61, P1754, DOI 10.1136/gutjnl-2011-301073; Bertoletti A, 2010, ANTIVIR THER, V15, P15, DOI 10.3851/IMP1620; Boltjes A, 2015, J INFECT DIS, V211, P1268, DOI 10.1093/infdis/jiu599; Cai Dawei, 2013, Methods Mol Biol, V1030, P151, DOI 10.1007/978-1-62703-484-5_13; Carter SD, 2012, CRIT REV BIOCHEM MOL, V47, P1, DOI 10.3109/10409238.2011.614593; CHEN HS, 1993, J VIROL, V67, P1218, DOI 10.1128/JVI.67.3.1218-1226.1993; Chisari FV, 2010, PATHOL BIOL, V58, P258, DOI 10.1016/j.patbio.2009.11.001; Chung YL, 2009, MOL CANCER RES, V7, P1672, DOI 10.1158/1541-7786.MCR-09-0112; Decorsiere A, 2016, NATURE, V531, P386, DOI 10.1038/nature17170; Diner BA, 2015, J BIOL CHEM, V290, P26412, DOI 10.1074/jbc.R115.652289; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunn C, 2009, GASTROENTEROLOGY, V137, P1289, DOI 10.1053/j.gastro.2009.06.054; Durantel D, 2009, HEPATOLOGY, V50, P1692, DOI 10.1002/hep.23361; Everett RD, 2007, BIOCHIMIE, V89, P819, DOI 10.1016/j.biochi.2007.01.004; Everett RD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003386; Fletcher SP, 2013, HEPATOLOGY, V57, P13, DOI 10.1002/hep.25954; Gallego-Paeza LM, 2014, MOL BIOL CELL, V25, P302, DOI 10.1091/mbc.E13-01-0020; Giersch K, 2015, J HEPATOL, V63, P346, DOI 10.1016/j.jhep.2015.03.011; Glass M, 2013, J VIROL, V87, P2174, DOI 10.1128/JVI.02950-12; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Hosel M, 2009, HEPATOLOGY, V50, P1773, DOI 10.1002/hep.23226; Jacome A, 2015, EMBO J, V34, P2604, DOI 10.15252/embj.201591829; Ju LM, 2013, DNA REPAIR, V12, P356, DOI 10.1016/j.dnarep.2013.02.006; Kanno T, 2015, CELL REP, V12, P1471, DOI 10.1016/j.celrep.2015.07.048; Kegel A, 2010, COLD SH Q B, V75, P179, DOI 10.1101/sqb.2010.75.047; Kwon H, 2011, NAT REV GASTRO HEPAT, V8, P275, DOI 10.1038/nrgastro.2011.33; Ladner SK, 1997, ANTIMICROB AGENTS CH, V41, P1715, DOI 10.1128/AAC.41.8.1715; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Lamontagne J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005438; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Levrero M, 2016, J HEPATOL, V64, pS84, DOI 10.1016/j.jhep.2016.02.021; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luangsay S, 2015, J HEPATOL, V63, P1314, DOI 10.1016/j.jhep.2015.07.014; Lucifora J, 2011, J HEPATOL, V55, P996, DOI 10.1016/j.jhep.2011.02.015; Martin-Lluesma S, 2008, HEPATOLOGY, V48, P1467, DOI 10.1002/hep.22542; Menne S, 2015, J HEPATOL, V62, P1237, DOI 10.1016/j.jhep.2014.12.026; Murphy CM, 2016, CELL REP, V16, P2846, DOI 10.1016/j.celrep.2016.08.026; Oehler N, 2014, HEPATOLOGY, V60, P1483, DOI 10.1002/hep.27159; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Ringelhan M, 2015, CURR OPIN VIROL, V14, P109, DOI 10.1016/j.coviro.2015.08.015; Riviere L, 2015, J HEPATOL, V63, P1093, DOI 10.1016/j.jhep.2015.06.023; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sato S, 2015, IMMUNITY, V42, P123, DOI 10.1016/j.immuni.2014.12.016; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Shlomai A, 2014, P NATL ACAD SCI USA, V111, P12193, DOI 10.1073/pnas.1412631111; Simon V, 2015, NAT IMMUNOL, V16, P546, DOI 10.1038/ni.3156; Tavalai N, 2008, BBA-MOL CELL RES, V1783, P2207, DOI 10.1016/j.bbamcr.2008.08.004; Tavalai N, 2008, J VIROL, V82, P126, DOI 10.1128/JVI.01685-07; Thomsen MK, 2016, HEPATOLOGY; Tsuge M, 2010, J GEN VIROL, V91, P1854, DOI 10.1099/vir.0.019224-0; van Breugel PC, 2012, HEPATOLOGY, V56, P2116, DOI 10.1002/hep.25928; Wang J, 2016, J HEPATOL; Weitzman MD, 2010, ANNU REV MICROBIOL, V64, P61, DOI 10.1146/annurev.micro.112408.134016; Wieland S, 2004, P NATL ACAD SCI USA, V101, P6669, DOI 10.1073/pnas.0401771101; Wieland SF, 2005, J VIROL, V79, P9369, DOI 10.1128/JVI.79.15.9369-9380.2005; Wu N, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-5; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229; Yoneda M, 2016, J IMMUNOL, V197, P630, DOI 10.4049/jimmunol.1502677; ZOULIM F, 1994, J VIROL, V68, P2026, DOI 10.1128/JVI.68.3.2026-2030.1994	66	79	84	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0169648	10.1371/journal.pone.0169648	http://dx.doi.org/10.1371/journal.pone.0169648			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095508	Green Published, gold, Green Submitted			2022-12-26	WOS:000392372300028
J	Li, DD; Zhang, YZ; Song, HT; Lu, LQ; Liu, DL; Yuan, YZ				Li, Dandan; Zhang, Yunze; Song, Haitao; Lu, Liangqiu; Liu, Deli; Yuan, Yongze			Aminoalcohol-Induced Activation of Organophosphorus Hydrolase (OPH) towards Diisopropylfluorophosphate (DFP)	PLOS ONE			English	Article							CHEMICAL WARFARE AGENTS; SUBSTITUTED BETA-CYCLODEXTRIN; PSEUDOMONAS-DIMINUTA; REACTION-MECHANISMS; NERVE AGENTS; CATALYTIC MECHANISM; ACID ANHYDROLASE; DEGRADING ENZYME; LOLIGO-VULGARIS; IN-VITRO	Aminoalcohols have been addressed as activating buffers for alkaline phosphatase. However, there is no record on the buffer activation regarding organophosphorus hydrolase (OPH). Here we reported the activating effects of aminoalcohols on OPH-catalyzed hydrolysis of diisopropylfluorophosphate (DFP), an analog molecule of G-type warfare agents. The kinetic parametors k(cat), V-max and k(cat)/K-m in the OPH reaction were remarkably increased in the buffers (pH 8.0, 25 degrees C) containing aminoalcohols with C2 between nitrogen (N) and oxygen (O) in their structures, including triethanolamine (TEA), diethanolamine, monoethanolamine, 1-amino-2-propanol, 2-amino-2-methyl-1-propanol, and triisopropanolamine. In contrast, much lower or no rate-enhancing effects were observed in the adding of amines, alcohols, amine/alcohol mixtures, or 3-amino-1-propanol (C3 between N and O). The 300 mM TEA further increased DFP-degrading activities of OPH mutants F132Y and L140Y, the previously reported OPH mutants with desirable activities towards DFP. However, the treatment of ethylenediaminetetraacetate (EDTA) markedly abolished the TEA-induced activation of OPH. The product fluoride effectively inhibited OPH-catalyzed hydrolysis of DFP by a linear mixed inhibition (inhibition constant K-i similar to 3.21 mM), which was partially released by TEA adding at initial or later reaction stage. The obtained results indicate the activation of OPH by aminoalcohol buffers could be attributed to the reduction of fluoride inhibition, which would be beneficial to the hydrolase-based detoxification of organophosphofluoridate.	[Li, Dandan; Zhang, Yunze; Liu, Deli; Yuan, Yongze] Cent China Normal Univ, Sch Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Hubei, Peoples R China; [Li, Dandan] Hubei Univ Med, Sch Basic Med Sci, Dept Biochem, Shiyan, Hubei, Peoples R China; [Song, Haitao; Lu, Liangqiu] Cent China Normal Univ, Coll Chem, Key Lab Pesticide & Chem Biol, Minist Educ, Wuhan, Hubei, Peoples R China	Central China Normal University; Hubei University of Medicine; Central China Normal University	Liu, DL; Yuan, YZ (corresponding author), Cent China Normal Univ, Sch Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Hubei, Peoples R China.	deliliu2013@163.com; yuan_yongze@163.com			National Natural Science Foundation of China [31101595, 31371893]; Fundamental Research Funds for the Central Universities [CCNU10A0155]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported in part by National Natural Science Foundation of China (Grant nos. 31101595 and 31371893), and the Fundamental Research Funds for the Central Universities (Grant no. CCNU10A0155). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto ME, 2015, CHEM-EUR J, V21, P3736, DOI 10.1002/chem.201405593; BANNISTER A, 1980, EUR J BIOCHEM, V113, P199; BENNING MM, 1995, BIOCHEMISTRY-US, V34, P7973, DOI 10.1021/bi00025a002; Bierwisch A, 2014, TOXICOL LETT, V224, P209, DOI 10.1016/j.toxlet.2013.10.024; Bigley AN, 2013, BBA-PROTEINS PROTEOM, V1834, P443, DOI 10.1016/j.bbapap.2012.04.004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANDEN R, 1973, EUR J BIOCHEM, V36, P195, DOI 10.1111/j.1432-1033.1973.tb02901.x; Bromberg L, 2015, ACS APPL MATER INTER, V7, P22001, DOI 10.1021/acsami.5b06905; Cama E, 2004, BIOCHEMISTRY-US, V43, P8987, DOI 10.1021/bi0491705; Cheng TC, 1999, CHEM-BIOL INTERACT, V119, P455, DOI 10.1016/S0009-2797(99)00058-7; CHENG TC, 1993, APPL ENVIRON MICROB, V59, P3138, DOI 10.1128/AEM.59.9.3138-3140.1993; Cheng TC, 1996, APPL ENVIRON MICROB, V62, P1636, DOI 10.1128/AEM.62.5.1636-1641.1996; DEFRANK JJ, 1991, J BACTERIOL, V173, P1938, DOI 10.1128/jb.173.6.1938-1943.1991; DUMAS DP, 1989, J BIOL CHEM, V264, P19659; Elliott TW, 2006, J BRAZIL CHEM SOC, V17, P1558, DOI 10.1590/S0103-50532006000800011; Field MJ, 2014, PHYS SCR; Gab J, 2009, ANAL BIOCHEM, V385, P187, DOI 10.1016/j.ab.2008.11.012; Gomes DEB, 2011, J PHYS CHEM B, V115, P15389, DOI [10.1021/Jp208787g, 10.1021/jp208787g]; Gopal S, 2000, BIOCHEM BIOPH RES CO, V279, P516, DOI 10.1006/bbrc.2000.4004; Grimsley JK, 2005, ARCH BIOCHEM BIOPHYS, V442, P169, DOI 10.1016/j.abb.2005.08.012; HARPER LL, 1988, APPL ENVIRON MICROB, V54, P2586, DOI 10.1128/AEM.54.10.2586-2589.1988; Hawwa R, 2009, J MOL BIOL, V393, P36, DOI 10.1016/j.jmb.2009.06.083; Hill CM, 2003, J AM CHEM SOC, V125, P8990, DOI 10.1021/ja0358798; Horne I, 2002, APPL ENVIRON MICROB, V68, P3371, DOI 10.1128/AEM.68.7.3371-3376.2002; Kalakuntla RK, 2013, TOXICOL LETT, V216, P200, DOI 10.1016/j.toxlet.2012.11.020; Katsemi V, 2005, BIOCHEMISTRY-US, V44, P9022, DOI 10.1021/bi0500675; Kawahara K, 2010, J GEN APPL MICROBIOL, V56, P249, DOI 10.2323/jgam.56.249; Kennedy DJ, 2015, INORG CHIM ACTA, V436, P123, DOI 10.1016/j.ica.2015.07.035; Koziol L, 2012, INORG CHEM, V51, P6803, DOI 10.1021/ic300526b; Kranawetvogl A, 2015, TOXICOL LETT, V239, P41, DOI 10.1016/j.toxlet.2015.08.007; LAI K, 1995, ARCH BIOCHEM BIOPHYS, V318, P59, DOI 10.1006/abbi.1995.1204; Lopez-Canut V, 2012, CHEM-EUR J, V18, P9612, DOI 10.1002/chem.201103615; Melzer M, 2009, J AM CHEM SOC, V131, P17226, DOI 10.1021/ja905444g; Mitic N, 2005, ARCH BIOCHEM BIOPHYS, V439, P154, DOI 10.1016/j.abb.2005.05.013; Neri F, 1997, BIOCHEMISTRY-US, V36, P8947, DOI 10.1021/bi970248+; Ohmori T, 2013, FORENSIC TOXICOL, V31, P37, DOI 10.1007/s11419-012-0162-5; Pedroso MM, 2014, J BIOL INORG CHEM, V19, P1263, DOI 10.1007/s00775-014-1183-9; Petrikovics I, 2000, TOXICOL SCI, V57, P16, DOI 10.1093/toxsci/57.1.16; Petrikovics I, 2007, NANOTOXICOLOGY, V1, P85, DOI 10.1080/17435390500128271; Petrikovics I, 2012, AAPS PHARMSCITECH, V13, P112, DOI 10.1208/s12249-011-9728-5; Sambrook MR, 2013, CHEM SOC REV, V42, P9251, DOI 10.1039/c3cs60230c; Sekiguchi S, 2011, ENZYME MICROB TECH, V49, P171, DOI 10.1016/j.enzmictec.2011.04.019; STINSON RA, 1993, CLIN CHEM, V39, P2293; Theriot CM, 2011, APPL MICROBIOL BIOT, V89, P35, DOI 10.1007/s00253-010-2807-9; Todd MJ, 2000, BIOCHEMISTRY-US, V39, P5389, DOI 10.1021/bi992287m; Tsai PC, 2012, BIOCHEMISTRY-US, V51, P6463, DOI 10.1021/bi300811t; Watkins LM, 1997, J BIOL CHEM, V272, P25596, DOI 10.1074/jbc.272.41.25596; Wymore T, 2014, J PHYS CHEM B, V118, P4479, DOI 10.1021/jp410422c; Yang H, 2003, PROTEIN ENG, V16, P135, DOI 10.1093/proeng/gzg013	49	0	0	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0169937	10.1371/journal.pone.0169937	http://dx.doi.org/10.1371/journal.pone.0169937			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085964	Green Published, gold, Green Submitted			2022-12-26	WOS:000391972600047
J	Major, JL; Dewan, A; Salih, M; Leddy, JJ; Tuana, BS				Major, Jennifer L.; Dewan, Aaraf; Salih, Maysoon; Leddy, John J.; Tuana, Balwant S.			E2F6 Impairs Glycolysis and Activates BDH1 Expression Prior to Dilated Cardiomyopathy	PLOS ONE			English	Article							HUMAN HEART-FAILURE; HISTONE DEACETYLASE; FAILING HEART; KETONE-BODIES; TRANSCRIPTION FACTOR; CARDIAC METABOLISM; POCKET PROTEINS; CONNEXIN-43; MYOCARDIUM; COMPLEX	Rationale The E2F pathway plays a critical role in cardiac growth and development, yet its role in cardiac metabolism remains to be defined. Metabolic changes play important roles in human heart failure and studies imply the ketogenic enzyme beta-hydroxybutyrate dehydrogenase I (BDH1) is a potential biomarker. Objective To define the role of the E2F pathway in cardiac metabolism and dilated cardiomyopathy (DCM) with a focus on BDH1. Methods and Results We previously developed transgenic (Tg) mice expressing the transcriptional repressor, E2F6, to interfere with the E2F/Rb pathway in post-natal myocardium. These Tg mice present with an E2F6 dose dependent DCM and deregulated connexin-43 (CX-43) levels in myocardium. Using the Seahorse platform, a 22% decrease in glycolysis was noted in neonatal cardiomyocytes isolated from E2F6-Tg hearts. This was associated with a 39% reduction in the glucose transporter GLUT4 and 50% less activation of the regulator of glucose metabolism AKT2. The specific reduction of cyclin B1 (70%) in Tg myocardium implicates its importance in supporting glycolysis in the postnatal heart. No changes in cyclin D expression (known to regulate mitochondrial activity) were noted and lipid metabolism remained unchanged in neonatal cardiomyocytes from Tg hearts. However, E2F6 induced a 40-fold increase of the Bdh1 transcript and 890% increase in its protein levels in hearts from Tg pups implying a potential impact on ketolysis. By contrast, BDH1 expression is not activated until adulthood in normal myocardium. Neonatal cardiomyocytes from Wt hearts incubated with the ketone beta-hydroxybutyrate (beta-OHB) showed a 100% increase in CX-43 protein levels, implying a role for ketone signaling in gap junction biology. Neonatal cardiomyocyte cultures from Tg hearts exhibited enhanced levels of BDH1 and CX-43 and were not responsive to beta-OHB. Conclusions The data reveal a novel role for the E2F pathway in regulating glycolysis in the developing myocardium through a mechanism involving cyclin B1. We reveal BDH1 expression as an early biomarker of heart failure and its potential impact, through ketone signaling, on CX-43 levels in E2F6-induced DCM.	[Major, Jennifer L.; Dewan, Aaraf; Salih, Maysoon; Leddy, John J.; Tuana, Balwant S.] Univ Ottawa, Dept CMM, Ottawa, ON, Canada; [Tuana, Balwant S.] Univ Ottawa, Inst Heart, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa Heart Institute	Tuana, BS (corresponding author), Univ Ottawa, Dept CMM, Ottawa, ON, Canada.; Tuana, BS (corresponding author), Univ Ottawa, Inst Heart, Ottawa, ON, Canada.	btuana@uottawa.ca	Major, Jennifer/K-7268-2019		Heart and Stroke Foundation of Canada [540033]	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by the Heart and Stroke Foundation of Canada, 540033 to BST (http://www.heartandstroke.com/site/c. ikIQLcMWJtE/b.2796497/k.BF8B/Home.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Ai X, 2005, CIRC RES, V96, P54, DOI 10.1161/01.RES.0000152325.07495.5a; Aubert G, 2016, CIRCULATION, V133, P698, DOI 10.1161/CIRCULATIONAHA.115.017355; Baskin KK, 2015, CELL METAB, V21, P237, DOI 10.1016/j.cmet.2014.12.021; Bedi KC, 2016, CIRCULATION, V133, P706, DOI 10.1161/CIRCULATIONAHA.115.017545; Boulaksil M, 2010, EUR J HEART FAIL, V12, P913, DOI 10.1093/eurjhf/hfq092; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Chen M, 2002, CIRCULATION, V106, P2707, DOI 10.1161/01.CIR.0000038706.30661.86; Dali-Youcef N, 2007, P NATL ACAD SCI USA, V104, P10703, DOI 10.1073/pnas.0611568104; Dedkova EN, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00260; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376; Ebelt H, 2005, CIRC RES, V96, P509, DOI 10.1161/01.RES.0000159705.17322.57; Fajas L, 2011, CELL CYCLE, V10, P4193, DOI 10.4161/cc.10.24.18362; Ferguson BS, 2015, J MOL CELL CARDIOL, V83, P14, DOI 10.1016/j.yjmcc.2015.03.010; Ferreira R, 1998, P NATL ACAD SCI USA, V95, P10493, DOI 10.1073/pnas.95.18.10493; Gaubatz S, 1998, P NATL ACAD SCI USA, V95, P9190, DOI 10.1073/pnas.95.16.9190; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Ho CF, 2013, VET J, V198, P696, DOI 10.1016/j.tvjl.2013.09.069; Hsieh MCF, 2008, J BIOL CHEM, V283, P27410, DOI 10.1074/jbc.M802418200; Iglesias A, 2004, J CLIN INVEST, V113, P1398, DOI 10.1172/JCI200418879; Janardhan A, 2011, TEX HEART I J, V38, P533; Kanikarla-Marie P, 2016, FREE RADICAL BIO MED, V95, P268, DOI 10.1016/j.freeradbiomed.2016.03.020; King JC, 2008, CELL CYCLE, V7, P3775, DOI 10.4161/cc.7.23.7240; Kirshenbaum LA, 1996, DEV BIOL, V179, P402, DOI 10.1006/dbio.1996.0270; Kolwicz SC, 2016, CIRCULATION, V133, P689, DOI 10.1161/CIRCULATIONAHA.116.021230; Kolwicz SC, 2013, CIRC RES, V113, P603, DOI 10.1161/CIRCRESAHA.113.302095; Kostin S, 2004, CARDIOVASC RES, V62, P426, DOI 10.1016/j.cardiores.2003.12.010; Lin H, 2006, MOL CELL BIOCHEM, V290, P69, DOI 10.1007/s11010-006-9166-y; MacLellan WR, 2005, MOL CELL BIOL, V25, P2486, DOI 10.1128/MCB.25.6.2486-2497.2005; Major JL, 2015, J MOL CELL CARDIOL, V84, P179, DOI 10.1016/j.yjmcc.2015.04.026; Newman JC, 2014, TRENDS ENDOCRIN MET, V25, P42, DOI 10.1016/j.tem.2013.09.002; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Palomer X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019724; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; Ramjiawan A, 2013, CELL PHYSL, V304, pC1064, DOI [10.1152/ajpcell.00262.2012, DOI 10.1152/AJPCELL.00262.2012]; Sakamaki T, 2006, MOL CELL BIOL, V26, P5449, DOI 10.1128/MCB.02074-05; Sdek P, 2011, J CELL BIOL, V194, P407, DOI 10.1083/jcb.201012049; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Trimarchi JM, 2001, P NATL ACAD SCI USA, V98, P1519, DOI 10.1073/pnas.041597698; Tuunanen H, 2011, CARDIOVASC RES, V90, P251, DOI 10.1093/cvr/cvr052; van Bilsen M, 2009, CARDIOVASC RES, V81, P420, DOI 10.1093/cvr/cvn282; Vara D, 2003, J BIOL CHEM, V278, P21388, DOI 10.1074/jbc.M212612200; Westendorp B, 2012, FASEB J, V26, P2569, DOI 10.1096/fj.11-203174; Wu MH, 2015, ONCOTARGET, V6, P11252, DOI 10.18632/oncotarget.3594; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Yang WW, 2008, MOL BIOL CELL, V19, P3691, DOI 10.1091/mbc.E08-02-0171	48	9	9	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0170066	10.1371/journal.pone.0170066	http://dx.doi.org/10.1371/journal.pone.0170066			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085920	Green Published, Green Submitted, gold			2022-12-26	WOS:000391972600057
J	Jung, YR; Lee, JH; Sohn, KC; Lee, Y; Seo, YJ; Kim, CD; Lee, JH; Hong, SP; Seo, SJ; Kim, SJ; Im, M				Jung, Yu Ra; Lee, Jin-Hyup; Sohn, Kyung-Cheol; Lee, Young; Seo, Young-Joon; Kim, Chang-Deok; Lee, Jeung-Hoon; Hong, Seung-Phil; Seo, Seong-Jun; Kim, Seong-Jin; Im, Myung			Adiponectin Signaling Regulates Lipid Production in Human Sebocytes	PLOS ONE			English	Article							STRATUM-CORNEUM HYDRATION; ACTIVATED PROTEIN-KINASE; HUMAN SEBACEOUS GLAND; ATOPIC-DERMATITIS; SKIN; ADIPOKINES; PSORIASIS; CELLS; INFLAMMATION; SENSITIVITY	Adiponectin plays important roles in metabolic function, inflammation and multiple biological activities in various tissues. However, evidence for adiponectin signaling in sebaceous glands is lacking, and its role remains to be clarified. This study investigated the role of adiponectin in lipid production in sebaceous glands in an experimental study of human sebocytes. We demonstrated that human sebaceous glands in vivo and sebocytes in vitro express adiponectin receptor and that adiponectin increased cell proliferation. Moreover, based on a lipogenesis study using Oil Red O, Nile red staining and thin layer chromatography, adiponectin strongly upregulated lipid production in sebocytes. In three-dimensional culture of sebocytes, lipid synthesis was markedly enhanced in sebocytes treated with adiponectin. This study suggested that adiponectin plays a significant role in human sebaceous gland biology. Adiponectin signaling is a promising target in the clinical management of barrier disorders in which sebum production is decreased, such as in atopic dermatitis and aged skin.	[Jung, Yu Ra; Lee, Jin-Hyup; Sohn, Kyung-Cheol; Lee, Young; Seo, Young-Joon; Kim, Chang-Deok; Lee, Jeung-Hoon; Im, Myung] Chungnam Natl Univ, Coll Med, Dept Dermatol, Daejeon, South Korea; [Hong, Seung-Phil] Dankook Univ, Coll Med, Dept Dermatol, Cheonan, South Korea; [Seo, Seong-Jun] Chung Ang Univ, Coll Med, Dept Dermatol, Seoul, South Korea; [Kim, Seong-Jin] Chonnam Natl Univ, Sch Med, Dept Dermatol, Gwangju, South Korea	Chungnam National University; Dankook University; Chung Ang University; Chung Ang University Hospital; Chonnam National University	Im, M (corresponding author), Chungnam Natl Univ, Coll Med, Dept Dermatol, Daejeon, South Korea.; Kim, SJ (corresponding author), Chonnam Natl Univ, Sch Med, Dept Dermatol, Gwangju, South Korea.	seongkim@chonnam.ac.kr; im1177@hanmail.net		Seo, Young-Joon/0000-0002-4955-590X; Kim, Chang Deok/0000-0001-9341-6491; Lee, Young/0000-0001-9205-1785	Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI14C1379]	Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea. (Grant No. : HI14C1379).	Akazawa Y, 2011, CONNECT TISSUE RES, V52, P322, DOI 10.3109/03008207.2010.528566; Choi EH, 2005, J INVEST DERMATOL, V125, P288, DOI 10.1111/j.0022-202X.2005.23799.x; Deepa SS, 2009, AM J PHYSIOL-ENDOC M, V296, pE22, DOI 10.1152/ajpendo.90731.2008; Ezure T, 2007, BIOFACTORS, V31, P229, DOI 10.1002/biof.5520310310; Feingold KR, 2014, BBA-MOL CELL BIOL L, V1841, P280, DOI 10.1016/j.bbalip.2013.11.007; Fiaschi T, 2014, CELL MOL LIFE SCI, V71, P1917, DOI 10.1007/s00018-013-1537-4; Firooz A, 2007, CLIN EXP DERMATOL, V32, P321, DOI 10.1111/j.1365-2230.2007.02364.x; Fluhr JW, 2003, J INVEST DERMATOL, V120, P728, DOI 10.1046/j.1523-1747.2003.12134.x; Fu YC, 2005, J LIPID RES, V46, P1369, DOI 10.1194/jlr.M400373-JLR200; Gerdes S, 2011, EXP DERMATOL, V20, P81, DOI 10.1111/j.1600-0625.2010.01210.x; Jeong KY, 2015, ALLERGY ASTHMA IMMUN, V7, P69, DOI 10.4168/aair.2015.7.1.69; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kim EJ, 2015, J INVEST DERMATOL, V135, P2331, DOI 10.1038/jid.2015.150; Kovacs D, 2016, EXP DERMATOL, V25, P194, DOI 10.1111/exd.12879; Lago F, 2007, NAT CLIN PRACT RHEUM, V3, P716, DOI 10.1038/ncprheum0674; Li ZJ, 2013, J DERMATOL SCI, V72, P116, DOI 10.1016/j.jdermsci.2013.06.009; Lo Celso C, 2008, STEM CELLS, V26, P1241, DOI 10.1634/stemcells.2007-0651; Nagel G, 2009, PEDIAT ALLERG IMM-UK, V20, P81, DOI 10.1111/j.1399-3038.2008.00740.x; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; POCHI PE, 1979, J INVEST DERMATOL, V73, P108, DOI 10.1111/1523-1747.ep12532792; Salathia NS, 2013, J INVEST DERMATOL, V133, P812, DOI 10.1038/jid.2012.374; Shi VY, 2015, J AM ACAD DERMATOL, V73, P856, DOI 10.1016/j.jaad.2015.08.015; Shibata S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8687; Shibata S, 2012, J IMMUNOL, V189, P3231, DOI 10.4049/jimmunol.1101739; Shibata S, 2009, J DERMATOL SCI, V55, P62, DOI 10.1016/j.jdermsci.2009.02.009; Smith KR, 2008, J LIPID RES, V49, P271, DOI 10.1194/jlr.R700015-JLR200; Smith TM, 2008, J INVEST DERMATOL, V128, P1286, DOI 10.1038/sj.jid.5701155; Toth BI, 2009, J INVEST DERMATOL, V129, P329, DOI 10.1038/jid.2008.258; Werner B, 2008, AM J DERMATOPATH, V30, P93, DOI 10.1097/DAD.0b013e31816421fd; WIRTH H, 1981, ARCH DERMATOL RES, V270, P167, DOI 10.1007/BF00408228; Won CH, 2012, J INVEST DERMATOL, V132, P2849, DOI 10.1038/jid.2012.217; Yamane T, 2011, BIOCHEM BIOPH RES CO, V415, P235, DOI 10.1016/j.bbrc.2011.09.151; Yamane T, 2011, MOL NUTR FOOD RES, V55, pS186, DOI 10.1002/mnfr.201100144; Yoshida GJ, 2013, BIOCHEM BIOPH RES CO, V438, P640, DOI 10.1016/j.bbrc.2013.07.129; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zouboulis CC, 2004, CLIN DERMATOL, V22, P360, DOI 10.1016/j.clindermatol.2004.03.004; Zouboulis CC, 2001, CLIN EXP DERMATOL, V26, P600, DOI 10.1046/j.1365-2230.2001.00894.x; Zouboulis CC, 2008, EXP DERMATOL, V17, P542, DOI 10.1111/j.1600-0625.2008.00725.x	38	20	21	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169824	10.1371/journal.pone.0169824	http://dx.doi.org/10.1371/journal.pone.0169824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081218	Green Submitted, Green Published, gold			2022-12-26	WOS:000391949500086
J	Qiu, H; Jin, M; Li, Y; Lu, Y; Hou, YM; Zhou, QC				Qiu, Hong; Jin, Min; Li, Yi; Lu, You; Hou, Yingmei; Zhou, Qicun			Dietary Lipid Sources Influence Fatty Acid Composition in Tissue of Large Yellow Croaker (Larmichthys crocea) by Regulating Triacylglycerol Synthesis and Catabolism at the Transcriptional Level	PLOS ONE			English	Article							SALMON SALMO-SALAR; BASS DICENTRARCHUS-LABRAX; TROUT ONCORHYNCHUS-MYKISS; FISH-OIL REPLACEMENT; BREAM SPARUS-AURATA; COA-DIACYLGLYCEROL ACYLTRANSFERASE; PARASITES CRYPTOCARYON-IRRITANS; GENE-EXPRESSION PROFILES; IMMUNE-RELATED GENES; LONG-TERM GROWTH	An 8-week feeding trial was conducted to evaluate the effects of dietary lipid sources on growth performance, fatty acid composition, rate-limiting enzyme activities and gene expression related to lipid metabolism in large yellow croaker (Larmichthys crocea). Five iso-nitrogenous and iso-lipidic experimental diets were formulated to contain different lipid sources, such as fish oil (FO), soybean oil (SO), linseed oil (LO), rapeseed oil (RO) and peanut oil (PO), respectively. Triplicate groups of 50 fish (initial weight 13.77 +/- 0.07g) were stocked in 15 floating net cages (1.5mx1.5mx2.0m). Fish fed the diets containing RO and LO had lower weight gain and specific growth rates than those fed the FO, SO and PO diets. Survival, feed efficiency, protein efficiency ratio, hepatosomatic index, viscerasomatic index and condition factor were not significantly affected by different dietary lipid sources. Fish fed the diet containing FO had higher lipid content in whole body compared with the other groups, whereas fish fed the SO diet had the lowest muscle lipid content. Fatty acid profiles of muscle and liver reflected the fatty acid composition of the diets. Plasma glucose, triglyceride, and the enzymatic activity of aspartate aminotransferase and alanine aminotransferase were significantly influenced by different dietary lipid sources, while total protein, cholesterol, superoxide dismutase or malondialdehyde in plasma were not affected by the different dietary lipid sources. Fish fed the LO diet had lower adipose triglyceride lipase and fatty acid synthase activities in liver than those fed the diets containing FO and RO, while the LO diet resulted in the highest hepatic carnitine palmitoultransferase-1 activity. Hepatic gene relative expression of adipose triglyceride lipase and carnitine palmitoyltransferase-1 in fish fed PO diet was significantly higher than all other groups, whereas fish fed the SO and LO diets had lower relative expression levels of lipoprotein lipase than the other groups. The highest relative expression levels of fatty acid synthase and acyl-CoA diacylglycerol acyltransferase-2 were observed in the FO group, while the highest relative expression of glucose 6-phosphate dehydrogenase occurred in fish fed the FO and RO diets. In summary, based on the growth performance, FO and SO appear to be suitable lipid sources for large yellow croaker, with the findings of this study also providing a molecular insight into the role of lipid metabolic mechanism in response to different dietary lipid sources.	[Qiu, Hong; Jin, Min; Li, Yi; Lu, You; Hou, Yingmei; Zhou, Qicun] Ningbo Univ, Sch Marine Sci, Lab Fish Nutr, Ningbo, Zhejiang, Peoples R China	Ningbo University	Zhou, QC (corresponding author), Ningbo Univ, Sch Marine Sci, Lab Fish Nutr, Ningbo, Zhejiang, Peoples R China.	zhouqicun@nbu.edu.cn			National Natural Science Foundation of China [31272670, 41476125]; Major Spark Plan Project of National Ministry of Science and Technology [2014GA701001]; Open Fund of Zhejiang Provincial Top Key Discipline of Aquaculture in Ningbo University [20110506]; K. C. Wong Magna Fund; K. C. Wong Education Foundation at Ningbo University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Spark Plan Project of National Ministry of Science and Technology; Open Fund of Zhejiang Provincial Top Key Discipline of Aquaculture in Ningbo University; K. C. Wong Magna Fund; K. C. Wong Education Foundation at Ningbo University	This research was supported by National Natural Science Foundation of China (31272670, 41476125), Major Spark Plan Project of National Ministry of Science and Technology (2014GA701001), Open Fund of Zhejiang Provincial Top Key Discipline of Aquaculture in Ningbo University (20110506), and by the K. C. Wong Magna Fund and K. C. Wong Education Foundation at Ningbo University.	Association of Official Analytical Chemists, 1995, OFF METH AN OFF AN C; Bell JG, 2002, J NUTR, V132, P222, DOI 10.1093/jn/132.2.222; Bell JG, 2005, AQUACULTURE, V243, P305, DOI 10.1016/j.aquaculture.2004.10.016; Bell JG, 2001, J NUTR, V131, P1535, DOI 10.1093/jn/131.5.1535; Bell JG, 2003, J NUTR, V133, P2793, DOI 10.1093/jn/133.9.2793; Benedito-Palos L, 2008, BRIT J NUTR, V100, P992, DOI 10.1017/S0007114508966071; Borges P, 2009, BRIT J NUTR, V102, P1007, DOI 10.1017/S0007114509345262; Bouraoui L, 2011, AQUACULT NUTR, V17, P54, DOI 10.1111/j.1365-2095.2009.00706.x; Caballero MJ, 2002, AQUACULTURE, V214, P253, DOI 10.1016/S0044-8486(01)00852-3; Calvin MNI, 1997, BIOL BULL, V192, P444; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Castro C, 2016, BRIT J NUTR, V116, P19, DOI 10.1017/S000711451600163X; CLARKE SD, 1990, J NUTR, V120, P225, DOI 10.1093/jn/120.2.225; Cowey C.B., 1989, FISH NUTR, V2, P259; Drew MD, 2007, AQUACULTURE, V267, P260, DOI 10.1016/j.aquaculture.2007.01.002; Figueiredo-Silva A, 2005, AQUACULT NUTR, V11, P147, DOI 10.1111/j.1365-2095.2004.00337.x; Fountoulaki E, 2009, AQUACULTURE, V289, P317, DOI 10.1016/j.aquaculture.2009.01.023; Gonzalez-Duran E, 2008, AQUACULTURE, V276, P120, DOI 10.1016/j.aquaculture.2008.01.010; GREENE DHS, 1990, AQUACULTURE, V89, P165, DOI 10.1016/0044-8486(90)90308-A; Guillou A, 1995, AQUACULTURE, V136, P351, DOI 10.1016/0044-8486(95)00053-4; Gunstone F.D., 2010, WORLDS OILS FATS, P61; Han CY, 2013, AQUACULT INT, V21, P1209, DOI 10.1007/s10499-013-9624-y; Hardy RW, 2010, AQUAC RES, V41, P770, DOI 10.1111/j.1365-2109.2009.02349.x; HARDY RW, 1987, AQUACULTURE, V65, P267, DOI 10.1016/0044-8486(87)90240-7; Izquierdo MS, 2005, AQUACULTURE, V250, P431, DOI 10.1016/j.aquaculture.2004.12.001; Izquierdo MS, 2003, AQUACULT NUTR, V9, P397, DOI 10.1046/j.1365-2095.2003.00270.x; Kerner J, 2000, BBA-MOL CELL BIOL L, V1486, P1, DOI 10.1016/S1388-1981(00)00044-5; Kim S, 2004, GENE, V340, P99, DOI 10.1016/j.gene.2004.06.015; Kroon JTM, 2006, PHYTOCHEMISTRY, V67, P2541, DOI 10.1016/j.phytochem.2006.09.020; Li XF, 2013, AQUACULTURE, V416, P23, DOI 10.1016/j.aquaculture.2013.08.020; Liang XF, 2002, COMP BIOCHEM PHYS A, V132, P913, DOI 10.1016/S1095-6433(02)00118-6; Lin SM, 2011, FISH SHELLFISH IMMUN, V31, P788, DOI 10.1016/j.fsi.2011.07.013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Menoyo D, 2004, BRIT J NUTR, V92, P41, DOI 10.1079/BJN20041165; Menoyo D, 2006, AQUACULTURE, V261, P294, DOI 10.1016/j.aquaculture.2006.07.018; Montero D, 2005, AQUACULTURE, V248, P121, DOI 10.1016/j.aquaculture.2005.03.003; Morais S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-448; Morais S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-255; Morak M, 2012, MOL CELL PROTEOMICS, V11, P1777, DOI 10.1074/mcp.M111.015743; Mourente G, 2006, COMP BIOCHEM PHYS B, V145, P389, DOI 10.1016/j.cbpb.2006.08.012; Mourente G, 2005, AQUACULTURE, V248, P173, DOI 10.1016/j.aquaculture.2005.04.023; Nanton DA, 2007, AQUACULTURE, V265, P230, DOI 10.1016/j.aquaculture.2006.03.053; Nasopoulou C, 2012, LWT-FOOD SCI TECHNOL, V47, P217, DOI 10.1016/j.lwt.2012.01.018; National Research Council, 2011, NUTR REQ FISH SHRIMP; Ng WK, 2003, LIPIDS, V38, P1031, DOI 10.1007/s11745-006-1157-y; Olsen RE, 2005, AQUACULTURE, V250, P480, DOI 10.1016/j.aquaculture.2005.03.014; Panserat S, 2008, BRIT J NUTR, V100, P953, DOI 10.1017/S0007114508981411; Peng M, 2014, AQUACULTURE, V433, P442, DOI 10.1016/j.aquaculture.2014.07.005; Piedecausa MA, 2007, AQUACULTURE, V263, P211, DOI 10.1016/j.aquaculture.2006.09.039; Regost C, 2003, AQUACULTURE, V217, P465, DOI 10.1016/S0044-8486(02)00259-4; Richard N, 2006, AQUACULTURE, V261, P1077, DOI 10.1016/j.aquaculture.2006.07.021; Rosenlund G, 2001, AQUAC RES, V32, P323, DOI 10.1046/j.1355-557x.2001.00025.x; Sarker PK, 2016, AQUACULT NUTR, V22, P109, DOI 10.1111/anu.12230; Sarker PK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156684; Stubhaug I, 2005, LIPIDS, V40, P39, DOI 10.1007/s11745-005-1358-4; Subhadra B, 2006, AQUACULTURE, V260, P221, DOI 10.1016/j.aquaculture.2006.06.029; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Tocher DR, 2000, FISH PHYSIOL BIOCHEM, V23, P59, DOI 10.1023/A:1007807201093; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Torstensen BE, 2004, AQUACULT NUTR, V10, P175, DOI 10.1111/j.1365-2095.2004.00289.x; Torstensen BE, 2011, BRIT J NUTR, V106, P633, DOI 10.1017/S0007114511000729; Trushenski J, 2011, AQUACULT NUTR, V17, pE437, DOI 10.1111/j.1365-2095.2010.00779.x; Turchini GM, 2009, REV AQUACULT, V1, P10, DOI 10.1111/j.1753-5131.2008.01001.x; Wang JT, 2007, J ZHEJIANG OCEAN U N, V26, P237; Wang XX, 2012, AQUAC RES, V43, P281, DOI 10.1111/j.1365-2109.2011.02826.x; Wassef EA, 2009, AQUACULT INT, V17, P421, DOI 10.1007/s10499-008-9213-7; Welker TL, 2003, FISH PHYSIOL BIOCHEM, V29, P225, DOI 10.1023/B:FISH.0000045724.93156.ef; Xu ZW, 2012, CLIN NUTR, V31, P217, DOI 10.1016/j.clnu.2011.10.001; Yan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129937; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Yi XW, 2014, AQUACULTURE, V434, P355, DOI 10.1016/j.aquaculture.2014.08.035; Yi XinWen, 2013, Journal of Fisheries of China, V37, P751; Zhou PP, 2016, AQUACULTURE, V452, P45, DOI 10.1016/j.aquaculture.2015.10.010; Zuo RT, 2012, AQUACULTURE, V334, P101, DOI 10.1016/j.aquaculture.2011.12.045; Zuo RT, 2012, FISH SHELLFISH IMMUN, V32, P249, DOI 10.1016/j.fsi.2011.11.005; 季文娟, 1999, [海洋水产研究, Marine Fisheries Research], V20, P70	76	36	43	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169985	10.1371/journal.pone.0169985	http://dx.doi.org/10.1371/journal.pone.0169985			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081221	Green Published, Green Submitted, gold			2022-12-26	WOS:000391949500115
J	Sahoo, DK; Abeysekara, NS; Cianzio, SR; Robertson, AE; Bhattacharyya, MK				Sahoo, Dipak K.; Abeysekara, Nilwala S.; Cianzio, Silvia R.; Robertson, Alison E.; Bhattacharyya, Madan K.			A Novel Phytophthora sojae Resistance Rps12 Gene Mapped to a Genomic Region That Contains Several Rps Genes	PLOS ONE			English	Article							F-SP GLYCINEA; SOYBEAN PLANT INTRODUCTIONS; QUANTITATIVE TRAIT LOCI; CONFERRING RESISTANCE; MAJOR GENE; PATHOGENIC DIVERSITY; ROOT-ROT; IDENTIFICATION; SEQUENCE; INHERITANCE	Phytophthora sojae Kaufmann and Gerdemann, which causes Phytophthora root rot, is a widespread pathogen that limits soybean production worldwide. Development of Phytophthora resistant cultivars carrying Phytophthora resistance Rps genes is a cost-effective approach in controlling this disease. For this mapping study of a novel Rps gene, 290 recombinant inbred lines (RILs) (F-7 families) were developed by crossing the P. sojae resistant cultivar PI399036 with the P. sojae susceptible AR2 line, and were phenotyped for responses to a mixture of three P. sojae isolates that overcome most of the known Rps genes. Of these 290 RILs, 130 were homozygous resistant, 12 heterzygous and segregating for Phytophthora resistance, and 148 were recessive homozygous and susceptible. From this population, 59 RILs homozygous for Phytophthora sojae resistance and 61 susceptible to a mixture of P. sojae isolates R17 and Val12-11 or P7074 that overcome resistance encoded by known Rps genes mapped to Chromosome 18 were selected for mapping novel Rps gene. A single gene accounted for the 1: 1 segregation of resistance and susceptibility among the RILs. The gene encoding the Phytophthora resistance mapped to a 5.8 cM interval between the SSR markers BARCSOYSSR_18_1840 and Sat_064 located in the lower arm of Chromosome 18. The gene is mapped 2.2 cM proximal to the NBSRps4/6-like sequence that was reported to co-segregate with the Phytophthora resistance genes Rps4 and Rps6. The gene is mapped to a highly recombinogenic, gene-rich genomic region carrying several nucleotide binding site-leucine rich repeat (NBS-LRR)-like genes. We named this novel gene as Rps12, which is expected to be an invaluable resource in breeding soybeans for Phytophthora resistance.	[Sahoo, Dipak K.; Cianzio, Silvia R.; Bhattacharyya, Madan K.] Iowa State Univ, Dept Agron, Ames, IA 50011 USA; [Abeysekara, Nilwala S.; Robertson, Alison E.] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA USA	Iowa State University; Iowa State University	Bhattacharyya, MK (corresponding author), Iowa State Univ, Dept Agron, Ames, IA 50011 USA.	mbhattac@iastate.edu	Sahoo, Dipak Kumar/M-8818-2013	Sahoo, Dipak Kumar/0000-0003-3748-3395	Iowa Soybean Association grant	Iowa Soybean Association grant	This work was supported by an Iowa Soybean Association grant. No role played by the granting agency.; We are thankful to Drs. Anne Dorrance and Martin Chilvers for kindly providing us the P. sojae isolates that were used in this study. We also thank Dr. Dorrance for constructive discussion. We thank Mr. Peter Lundeen for technical assistance and Dr. Clarice L. Schmidt for technical guidance during hypocotyl inoculation technique. We also thank Ms. Jordan Baumbach for technical guidance for operating Mapmaker and MapChart programs and Dr. David Grant for critically reviewing the manuscript. This work was supported by an Iowa Soybean Association grant.	Abeysekara NS, 2016, CROP SCI, V56, P2322, DOI 10.2135/cropsci2015.09.0578; Allen GC, 2006, NAT PROTOC, V1, P2320, DOI 10.1038/nprot.2006.384; ANDERSON TR, 1992, PLANT DIS, V76, P587, DOI 10.1094/PD-76-0587; ATHOW KL, 1982, PHYTOPATHOLOGY, V72, P1564, DOI 10.1094/Phyto-72-1564; ATHOW KL, 1980, PHYTOPATHOLOGY, V70, P977, DOI 10.1094/Phyto-70-977; BERNARD R. L., 1957, AGRON JOUR, V49, P391; Bernard RL, 1981, SOYBEAN GENET NEWSL, V8, P40; Bhattacharyya MK, 1997, PLANT MOL BIOL, V34, P255, DOI 10.1023/A:1005851623493; Bhattacharyya MK, 2005, THEOR APPL GENET, V111, P75, DOI 10.1007/s00122-005-1993-9; Burnham KD, 2003, CROP SCI, V43, P101, DOI 10.2135/cropsci2003.0101; BUZZELL RI, 1992, PLANT DIS, V76, P600, DOI 10.1094/PD-76-0600; Buzzell RI, 1981, SOYBEAN GENET NEWSLE, V18, P30; Demirbas A, 2001, CROP SCI, V41, P1220, DOI 10.2135/cropsci2001.4141220x; DIERS BW, 1992, CROP SCI, V32, P377, DOI 10.2135/cropsci1992.0011183X003200020020x; Dong SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020172; Dong SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005556; Dorrance AE, 2009, PLANT DIS, V93, P875, DOI 10.1094/PDIS-93-9-0875; Dorrance A. E., 2004, PLANT HLTH PROG; Dorrance A.E., 2008, PLANT HLTH PROG, V10, P1094, DOI [10.1094/PHP-2008-0118-01-DG, DOI 10.1094/PHP-2008-0118-01-DG]; Dorrance AE, 2000, PLANT DIS, V84, P1303, DOI 10.1094/PDIS.2000.84.12.1303; Dorrance AE, 2003, PLANT DIS, V87, P139, DOI 10.1094/PDIS.2003.87.2.139; DRENTH A, 1995, PLANT PATHOL, V44, P86, DOI 10.1111/j.1365-3059.1995.tb02719.x; Drenth A, 1996, PHYTOPATHOLOGY, V86, P163, DOI 10.1094/Phyto-86-163; [范爱颖 FAN Ai-Ying], 2009, [作物学报, Acta Agronomica Sinica], V35, P1844; Gao H, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-29; Gao HY, 2005, MOL PLANT MICROBE IN, V18, P1035, DOI 10.1094/MPMI-18-1035; Gordon SG, 2007, PHYTOPATHOLOGY, V97, P113, DOI 10.1094/PHYTO-97-0113; Gordon SG, 2007, PHYTOPATHOLOGY, V97, P106, DOI 10.1094/PHYTO-97-0106; Gordon SG, 2006, CROP SCI, V46, P168, DOI 10.2135/cropsci2004.04-0024; Gordon SG, 2004, CROP SCI SOC AM ANN, P320; Grau CR, 2004, SOYBEANS IMPROVEMENT, V3, P763, DOI DOI 10.1111/J.1471-8286.2007.01758.X; IRWIN JAG, 1995, AUST J AGR RES, V46, P1311, DOI 10.1071/AR9951311; Kanazin V, 1996, P NATL ACAD SCI USA, V93, P11746, DOI 10.1073/pnas.93.21.11746; Kasuga T, 1997, MOL PLANT MICROBE IN, V10, P1035, DOI 10.1094/MPMI.1997.10.9.1035; KAUFMANN MJ, 1958, PHYTOPATHOLOGY, V48, P201; KILEN TC, 1974, CROP SCI, V14, P260, DOI 10.2135/cropsci1974.0011183X001400020027x; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lin F, 2013, THEOR APPL GENET, V126, P2177, DOI 10.1007/s00122-013-2127-4; Lohnes DG, 1997, CROP SCI, V37, P555, DOI 10.2135/cropsci1997.0011183X003700020040x; MacGregor T, 2002, GENETICS, V160, P949; Matthiesen RL, 2016, PLANT DIS, V100, P1424, DOI 10.1094/PDIS-08-15-0916-RE; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; MUELLER EH, 1978, PHYTOPATHOLOGY, V68, P1318, DOI 10.1094/Phyto-68-1318; Na R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089738; Nguyen VT, 2012, CROP SCI, V52, P2481, DOI 10.2135/cropsci2011.09.0466; Ping JQ, 2016, THEOR APPL GENET, V129, P445, DOI 10.1007/s00122-015-2638-2; PLOPER LD, 1985, PHYTOPATHOLOGY, V75, P690, DOI 10.1094/Phyto-75-690; Ryley MJ, 1998, PLANT DIS, V82, P1048, DOI 10.1094/PDIS.1998.82.9.1048; Sandhu D, 2005, J HERED, V96, P536, DOI 10.1093/jhered/esi081; Sandhu D, 2004, GENETICS, V168, P2157, DOI 10.1534/genetics.104.032037; Schmitthenner A.F., 1999, COMPENDIUM SOYBEAN D, V4th edn, P39; SCHMITTHENNER AF, 1985, PLANT DIS, V69, P362, DOI 10.1094/PD-69-362; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Song QJ, 2004, THEOR APPL GENET, V109, P122, DOI 10.1007/s00122-004-1602-3; Stewart S, 2014, PLANT DIS, V98, P614, DOI 10.1094/PDIS-05-13-0575-RE; Stewart S, 2012, CROP SCI, V52, P1181, DOI 10.2135/cropsci2011.05.0241; Sugimoto T, 2011, EUPHYTICA, V182, P133, DOI 10.1007/s10681-011-0525-8; Sugimoto T, 2011, BREEDING SCI, V61, P511, DOI 10.1270/jsbbs.61.511; Sun JT, 2014, THEOR APPL GENET, V127, P913, DOI 10.1007/s00122-014-2266-2; Sun S, 2011, PLANT BREEDING, V130, P139, DOI 10.1111/j.1439-0523.2010.01794.x; Tyler BM, 2007, MOL PLANT PATHOL, V8, P1, DOI 10.1111/j.1364-3703.2006.00373.x; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Weng C, 2001, J HERED, V92, P442, DOI 10.1093/jhered/92.5.442; Wrather J, 2009, PLANT HLTH PROG; Wrather JA, 2001, CAN J PLANT PATHOL, V23, P122, DOI 10.1080/07060660109506919; Wu X, 2011, PLANT BREEDING, V130, P144, DOI 10.1111/j.1439-0523.2010.01799.x; Wu XL, 2011, AGR SCI CHINA, V10, P1506, DOI 10.1016/S1671-2927(11)60145-4; [姚海燕 YAO Hai-yan], 2010, [植物遗传资源学报, Journal of Plant Genetic Resources], V11, P213; Yu AnLiang, 2010, Chinese Journal of Oil Crop Sciences, V32, P462; Yu YG, 1996, P NATL ACAD SCI USA, V93, P11751, DOI 10.1073/pnas.93.21.11751; Zhang J, 2013, J COMPUT, V8, P10, DOI 10.4304/jcp.8.1.10-17; Zhang JQ, 2013, THEOR APPL GENET, V126, P1555, DOI 10.1007/s00122-013-2073-1; Zhu ZhenDong, 2007, Acta Agronomica Sinica, V33, P154	75	42	44	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169950	10.1371/journal.pone.0169950	http://dx.doi.org/10.1371/journal.pone.0169950			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081566	Green Submitted, Green Published, gold			2022-12-26	WOS:000391949500106
J	Zhang, SH; Deng, ZM; Yao, C; Huang, P; Zhang, Y; Cao, SB; Li, XC				Zhang, Shihu; Deng, Zhengming; Yao, Chen; Huang, Ping; Zhang, Yi; Cao, Shibing; Li, Xiangcheng			AT7867 Inhibits Human Colorectal Cancer Cells via AKT-Dependent and AKT-Independent Mechanisms	PLOS ONE			English	Article							SPHINGOSINE KINASE 1; PI3K; PROGRESSION; APOPTOSIS; ONCOGENE; LESSONS; PATHWAY; TARGETS; DRUGS; SPHK1	AKT is often hyper-activated in human colorectal cancers (CRC). This current study evaluated the potential anti-CRC activity by AT7867, a novel AKT and p70S6K1 (S6K1) dual inhibitor. We showed that AT7867 inhibited survival and proliferation of established (HT-29, HCT116 and DLD-1 lines) and primary human CRC cells. Meanwhile, it provoked caspase-dependent apoptosis in the CRC cells. Molecularly, AT7867 blocked AKT-S6K1 activation in CRC cells. Restoring AKT-S6K1 activation, via expression of a constitutively-active AKT1 ("ca-AKT1"), only partially attenuated AT7867-induced HT-29 cell death. Further studies demonstrated that AT7867 inhibited sphingosine kinase 1 (SphK1) activity to promote proapoptotic ceramide production in HT-29 cells. Such effects by AT7867 were independent of AKT inhibition. AT7867-indued ceramide production and subsequent HT-29 cell apoptosis were attenuated by co-treatment of sphingosine-1-phosphate (S1P), but were potentiated with the glucosylceramide synthase (GCS) inhibitor PDMP. In vivo, intraperitoneal injection of AT7867 inhibited HT-29 xenograft tumor growth in nude mice. AKT activation was also inhibited in AT7867-treated HT-29 tumors. Together, the preclinical results suggest that AT7867 inhibits CRC cells via AKT-dependent and-independent mechanisms.	[Zhang, Shihu; Huang, Ping; Zhang, Yi; Li, Xiangcheng] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China; [Zhang, Shihu; Deng, Zhengming; Cao, Shibing] Nanjing Univ Chinese Med, Affiliated Hosp, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China; [Yao, Chen] Nanjing Univ Chinese Med, Affiliated Hosp, Dept Orthoped, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine	Li, XC (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China.; Cao, SB (corresponding author), Nanjing Univ Chinese Med, Affiliated Hosp, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China.	caoshibingysnj@126.com; lixiangchengyish@163.com	li, xiang/GWM-6319-2022		scientific fund of First Affiliated Hospital of Nanjing Medical University [2014-002-211]	scientific fund of First Affiliated Hospital of Nanjing Medical University	This study is supported by the scientific fund of First Affiliated Hospital of Nanjing Medical University (2014-002-211 to X.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Chen MB, 2015, BIOCHEM BIOPH RES CO, V463, P954, DOI 10.1016/j.bbrc.2015.06.041; Dijkhuis AJ, 2006, MOL CANCER THER, V5, P593, DOI 10.1158/1535-7163.MCT-05-0457; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Grimshaw KM, 2010, MOL CANCER THER, V9, P1100, DOI 10.1158/1535-7163.MCT-09-0986; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Hong JH, 2008, J INVEST DERMATOL, V128, P2166, DOI 10.1038/jid.2008.66; Huang W., 2011, INT J ADV INTELL, V3, P25, DOI DOI 10.1096/FJ.10-180190; Hubbard JM, 2015, NAT REV CLIN ONCOL, V12, P73, DOI 10.1038/nrclinonc.2014.233; Ji F., 2015, BIOCHEM BIOPH RES CO, V1, P1, DOI DOI 10.1016/J.BBRC.2015.02.007; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Ju TF, 2016, BIOCHEM BIOPH RES CO, V470, P728, DOI 10.1016/j.bbrc.2016.01.053; Kerr D, 2003, NAT REV CANCER, V3, P615, DOI 10.1038/nrc1147; Keshamouni VG, 2004, ONCOGENE, V23, P100, DOI 10.1038/sj.onc.1206885; Kondapaka SB, 2003, MOL CANCER THER, V2, P1093; Lv HQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145195; McCarthy N, 2013, NAT REV CANCER, V13, P297, DOI [10.1038/nrc3509, 10.1038/nrc3909]; Palta M, 2014, NAT REV CLIN ONCOL, V11, P182, DOI 10.1038/nrclinonc.2014.43; Pandurangan AK, 2013, ASIAN PAC J CANCER P, V14, P2201, DOI 10.7314/APJCP.2013.14.4.2201; Peng Y, 2015, BIOCHEM BIOPH RES CO, V465, P137, DOI 10.1016/j.bbrc.2015.07.147; Piwocka K, 2002, ANN NY ACAD SCI, V973, P250, DOI 10.1111/j.1749-6632.2002.tb04643.x; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Rodon J, 2013, NAT REV CLIN ONCOL, V10, P143, DOI 10.1038/nrclinonc.2013.10; Schmoll HJ, 2014, NAT REV CLIN ONCOL, V11, P79, DOI 10.1038/nrclinonc.2013.254; Shao JJ, 2015, DNA CELL BIOL, V34, P669, DOI 10.1089/dna.2015.2959; Shida D, 2008, CURR DRUG TARGETS, V9, P662, DOI 10.2174/138945008785132402; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Vadas M, 2008, BBA-MOL CELL BIOL L, V1781, P442, DOI 10.1016/j.bbalip.2008.06.007; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wadhwa R, 2013, NAT REV CLIN ONCOL, V10, P643, DOI 10.1038/nrclinonc.2013.170; Wang L, 2017, TUMOR BIOL; Wang T, 2015, BIOCHEM BIOPH RES CO, V456, P821, DOI 10.1016/j.bbrc.2014.12.019; Wen X, 2012, CELL PROLIFERAT, V45, P217, DOI 10.1111/j.1365-2184.2012.00814.x; Xu L, 2016, INT J HYPERTHER, V32, P465, DOI 10.3109/02656736.2016.1155762; Yao C, 2012, MOL ONCOL, V6, P392, DOI 10.1016/j.molonc.2012.04.002; Zhang Q, 2016, ONCOTARGET	38	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169585	10.1371/journal.pone.0169585	http://dx.doi.org/10.1371/journal.pone.0169585			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081222	Green Submitted, gold, Green Published			2022-12-26	WOS:000391949500057
J	Bitton, PP; Janisse, K; Doucet, SM				Bitton, Pierre-Paul; Janisse, Kevyn; Doucet, Stephanie M.			Assessing Sexual Dicromatism: The Importance of Proper Parameterization in Tetrachromatic Visual Models	PLOS ONE			English	Article							RETINAL OIL DROPLETS; ANIMAL COLOR-VISION; SPECTRAL SENSITIVITIES; RECEPTOR NOISE; ULTRAVIOLET VISION; SWS1 OPSIN; PLUMAGE; DICHROMATISM; EVOLUTION; BIRD	Perceptual models of animal vision have greatly contributed to our understanding of animal-animal and plant-animal communication. The receptor-noise model of color contrasts has been central to this research as it quantifies the difference between two colors for any visual system of interest. However, if the properties of the visual system are unknown, assumptions regarding parameter values must be made, generally with unknown consequences. In this study, we conduct a sensitivity analysis of the receptor-noise model using avian visual system parameters to systematically investigate the influence of variation in light environment, photoreceptor sensitivities, photoreceptor densities, and light transmission properties of the ocular media and the oil droplets. We calculated the chromatic contrast of 15 plumage patches to quantify a dichromatism score for 70 species of Galliformes, a group of birds that display a wide range of sexual dimorphism. We found that the photoreceptor densities and the wavelength of maximum sensitivity of the short-wavelength-sensitive photoreceptor 1 (SWS1) can change dichromatism scores by 50% to 100%. In contrast, the light environment, transmission properties of the oil droplets, transmission properties of the ocular media, and the peak sensitivities of the cone photoreceptors had a smaller impact on the scores. By investigating the effect of varying two or more parameters simultaneously, we further demonstrate that improper parameterization could lead to differences between calculated and actual contrasts of more than 650%. Our findings demonstrate that improper parameterization of tetrachromatic visual models can have very large effects on measures of dichromatism scores, potentially leading to erroneous inferences. We urge more complete characterization of avian retinal properties and recommend that researchers either determine whether their species of interest possess an ultraviolet or near-ultraviolet sensitive SWS1 photoreceptor, or present models for both.	[Bitton, Pierre-Paul; Janisse, Kevyn; Doucet, Stephanie M.] Univ Windsor, Dept Biol Sci, Windsor, ON, Canada; [Bitton, Pierre-Paul] Eberhard Karls Univ Tubingen, Inst Evolut & Ecol, Tubingen, Germany	University of Windsor; Eberhard Karls University of Tubingen	Bitton, PP (corresponding author), Univ Windsor, Dept Biol Sci, Windsor, ON, Canada.; Bitton, PP (corresponding author), Eberhard Karls Univ Tubingen, Inst Evolut & Ecol, Tubingen, Germany.	pierre-paul.bitton@uni-tuebingen.de		Bitton, Pierre-Paul/0000-0001-5984-2331	Natural Sciences and Engineering Research Council of Canada; Ontario Graduate Scholarship; Richard Gilder Graduate School; American Museum of Natural History	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Richard Gilder Graduate School; American Museum of Natural History	Funding was provided by the Natural Sciences and Engineering Research Council of Canada in the form of a Canada Graduate Scholarship to P-P.B. as well as Discovery and Equipment grants to S.M.D, an Ontario Graduate Scholarship to P-P.B., as well as a Field Museum Visiting Scholar Grant and a Collections Study Grant from the Richard Gilder Graduate School in association with the American Museum of Natural History to K.J.	Andersson S, 1998, P ROY SOC B-BIOL SCI, V265, P445, DOI 10.1098/rspb.1998.0315; Armenta JK, 2008, J EXP BIOL, V211, P2423, DOI 10.1242/jeb.013094; Aviles JM, 2010, J EVOLUTION BIOL, V23, P226, DOI 10.1111/j.1420-9101.2009.01890.x; Aviles JM, 2009, J EVOLUTION BIOL, V22, P376, DOI 10.1111/j.1420-9101.2008.01655.x; Aviles JM, 2008, P ROY SOC B-BIOL SCI, V275, P2345, DOI 10.1098/rspb.2008.0720; Aviles JM, 2011, BEHAV ECOL SOCIOBIOL, V65, P1721, DOI 10.1007/s00265-011-1180-8; Badyaev AV, 2000, BIOL J LINN SOC, V69, P153, DOI 10.1111/j.1095-8312.2000.tb01196.x; Beason RC, 2008, VISION RES, V48, P1, DOI 10.1016/j.visres.2007.10.006; Bleiweiss R, 2014, EVOL BIOL, V41, P404, DOI 10.1007/s11692-014-9273-8; Bloch NI, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2321; BOWMAKER JK, 1978, VISION RES, V18, P1125, DOI 10.1016/0042-6989(78)90095-0; Bridge ES, 2008, J ORNITHOL, V149, P123, DOI 10.1007/s10336-007-0253-y; Britton G., 1995, CAROTENOIDS, VVolume 1B: Spectroscopy, P13; Burns KJ, 2012, AUK, V129, P211, DOI 10.1525/auk.2012.11182; Cazetta E, 2009, EVOL ECOL, V23, P233, DOI 10.1007/s10682-007-9217-1; Cheney KL, 2009, BEHAV ECOL, V20, P459, DOI 10.1093/beheco/arp017; Cibulkova A, 2014, EVOL ECOL, V28, P427, DOI 10.1007/s10682-014-9690-2; Cole GL, 2015, AM NAT, V185, P452, DOI 10.1086/680022; Coyle BJ, 2012, J EXP BIOL, V215, P1090, DOI 10.1242/jeb.062224; Cronin T. W., 2014, VISUAL ECOLOGY; Croston R, 2014, BEHAV ECOL SOCIOBIOL, V68, P351, DOI 10.1007/s00265-013-1649-8; Dalrymple RL, 2015, BIOL J LINN SOC, V114, P69, DOI 10.1111/bij.12402; Delhey K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001689; Dorr S, 2000, J COMP PHYSIOL A, V186, P885, DOI 10.1007/s003590000141; Doucet SM, 2003, BEHAV ECOL, V14, P503, DOI 10.1093/beheco/arg035; Doucet SM, 2007, AM NAT, V169, pS62, DOI 10.1086/510162; Dunn PO, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400155; Durrer H, 1975, J ORNITHOL, V116, P94; Eaton MD, 2005, P NATL ACAD SCI USA, V102, P10942, DOI 10.1073/pnas.0501891102; ENDLER JA, 1993, ECOL MONOGR, V63, P1, DOI 10.2307/2937121; ENDLER JA, 1991, VISION RES, V31, P587, DOI 10.1016/0042-6989(91)90109-I; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Ensminger AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111854; Fleishman LJ, 2016, BEHAV ECOL SOCIOBIOL, V70, P541, DOI 10.1007/s00265-016-2072-8; Goldsmith TH, 2003, J COMP PHYSIOL A, V189, P135, DOI 10.1007/s00359-002-0385-8; Gomez D, 2007, AM NAT, V169, pS42, DOI 10.1086/510138; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Hart NS, 2005, J COMP PHYSIOL A, V191, P381, DOI 10.1007/s00359-004-0595-3; Hart NS, 2001, J COMP PHYSIOL A, V187, P685, DOI 10.1007/s00359-001-0240-3; Hart NS, 1998, J EXP BIOL, V201, P1433; Hart NS, 2001, PROG RETIN EYE RES, V20, P675, DOI 10.1016/S1350-9462(01)00009-X; Hastad O, 2008, AM NAT, V171, P831, DOI 10.1086/587529; Hastad O, 2009, J COMP PHYSIOL A, V195, P585, DOI 10.1007/s00359-009-0433-8; Holveck MJ, 2010, BIOL LETTERS, V6, P453, DOI 10.1098/rsbl.2009.1044; Huang HT, 2014, AM NAT, V184, pE101, DOI 10.1086/678054; Hunt S, 1998, P ROY SOC B-BIOL SCI, V265, P451, DOI 10.1098/rspb.1998.0316; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Knott B, 2012, J COMP PHYSIOL A, V198, P43, DOI 10.1007/s00359-011-0684-z; Knott B, 2010, P ROY SOC B-BIOL SCI, V277, P953, DOI 10.1098/rspb.2009.1805; Langmore NE, 2009, ANIM BEHAV, V78, P461, DOI 10.1016/j.anbehav.2009.06.003; Lev-Yadun S, 2013, BIOL J LINN SOC, V109, P271, DOI 10.1111/bij.12047; Limeri LB, 2014, FUNCT ECOL, V28, P1197, DOI 10.1111/1365-2435.12244; Lind O, 2015, J EVOLUTION BIOL, V28, P715, DOI 10.1111/jeb.12595; Lind O, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2209; Lind O, 2013, J EXP BIOL, V216, P1819, DOI 10.1242/jeb.082834; Lind O, 2009, VISION RES, V49, P1939, DOI 10.1016/j.visres.2009.05.003; Loew ER, 2002, J EXP BIOL, V205, P927; Macias-Sanchez E, 2013, IBIS, V155, P605, DOI 10.1111/ibi.12045; Maia R, 2013, METHODS ECOL EVOL, V4, P906, DOI 10.1111/2041-210X.12069; MAIER EJ, 1992, J COMP PHYSIOL A, V170, P709; McGraw Kevin J., 2006, P243; Melin AD, 2014, INT J PRIMATOL, V35, P258, DOI 10.1007/s10764-013-9730-8; Muchhala N, 2014, EVOLUTION, V68, P2275, DOI 10.1111/evo.12441; Niu Y, 2014, NEW PHYTOL, V203, P953, DOI 10.1111/nph.12834; Odeen A, 2003, MOL BIOL EVOL, V20, P855, DOI 10.1093/molbev/msg108; Odeen A, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-36; Odeen A, 2012, P ROY SOC B-BIOL SCI, V279, P1269, DOI 10.1098/rspb.2011.1777; Odeen A, 2009, J COMP PHYSIOL A, V195, P167, DOI 10.1007/s00359-008-0395-2; Olsson P, 2015, J EXP BIOL, V218, P184, DOI 10.1242/jeb.111187; Osorio D, 2008, VISION RES, V48, P2042, DOI 10.1016/j.visres.2008.06.018; de Lanuza GPI, 2013, J EVOLUTION BIOL, V26, P1826, DOI 10.1111/jeb.12185; Perini ES, 2009, J EXP ZOOL PART A, V311A, P289, DOI 10.1002/jez.531; Price JJ, 2014, EVOLUTION, V68, P2026, DOI 10.1111/evo.12417; R Development Core Team, 2016, R LANG ENV STAT COMP; Renoult JP, 2010, J EVOLUTION BIOL, V23, P220, DOI 10.1111/j.1420-9101.2009.01885.x; Renoult JP, 2015, BIOL REV; Rick IP, 2012, BIOL J LINN SOC, V105, P359, DOI 10.1111/j.1095-8312.2011.01796.x; Ronald KL, 2012, ANIM BEHAV, V84, P1283, DOI 10.1016/j.anbehav.2012.09.015; Schaefer HM, 2014, P ROY SOC B, V281; Schanda Jn, 2007, COLORIMETRY UNDERSTA, Vxxix; Seddon N, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1065; Seddon N, 2010, AUK, V127, P283, DOI 10.1525/auk.2009.09070; Siddiqi A, 2004, J EXP BIOL, V207, P2471, DOI 10.1242/jeb.01047; Spottiswoode CN, 2010, P NATL ACAD SCI USA, V107, P8672, DOI 10.1073/pnas.0910486107; Stavenga DG, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0041; Stoddard MC, 2011, BEHAV ECOL, V22, P1042, DOI 10.1093/beheco/arr088; Thomas DB, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0806; Uy JAC, 2004, BEHAV ECOL, V15, P1003, DOI 10.1093/beheco/arh106; VIITALA J, 1995, NATURE, V373, P425, DOI 10.1038/373425a0; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Vorobyev M, 2003, P ROY SOC B-BIOL SCI, V270, P1255, DOI 10.1098/rspb.2003.2381; Vorobyev M, 1998, J COMP PHYSIOL A, V183, P621, DOI 10.1007/s003590050286; Vorobyev M, 2001, VISION RES, V41, P639, DOI 10.1016/S0042-6989(00)00288-1; Wilby D, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0591; Wilkins L, 2016, J EXP BIOL; Willink B, 2014, BEHAV ECOL SOCIOBIOL, V68, P249, DOI 10.1007/s00265-013-1640-4; Wyszecki Gn, 2000, WILEY CLASSICS LIB, Vxv	98	24	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169810	10.1371/journal.pone.0169810	http://dx.doi.org/10.1371/journal.pone.0169810			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076391	Green Published, gold, Green Submitted			2022-12-26	WOS:000391857100057
J	Clark, GF; Stark, JS; Palmer, AS; Riddle, MJ; Johnston, EL				Clark, Graeme F.; Stark, Jonathan S.; Palmer, Anne S.; Riddle, Martin J.; Johnston, Emma L.			The Roles of Sea-Ice, Light and Sedimentation in Structuring Shallow Antarctic Benthic Communities	PLOS ONE			English	Article							COASTAL ENVIRONMENT; MCMURDO SOUND; PHYTOPLANKTON; DISTURBANCE; PHOTOSYNTHESIS; HETEROGENEITY; PENETRATION; PATTERNS; SURVIVAL; IMPACTS	On polar coasts, seasonal sea-ice duration strongly influences shallow marine environments by affecting environmental conditions, such as light, sedimentation, and physical disturbance. Sea-ice dynamics are changing in response to climate, but there is limited understanding of how this might affect shallow marine environments and benthos. Here we present a unique set of physical and biological data from a single region of Antarctic coast, and use it to gain insights into factors shaping polar benthic communities. At sites encompassing a gradient of sea-ice duration, we measured temporal and spatial variation in light and sedimentation and hard-substrate communities at different depths and substrate orientations. Biological trends were highly correlated with sea-ice duration, and appear to be driven by opposing gradients in light and sedimentation. As sea-ice duration decreased, there was increased light and reduced sedimentation, and concurrent shifts in community structure from invertebrate to algal dominance. Trends were strongest on shallower, horizontal surfaces, which are most exposed to light and sedimentation. Depth and substrate orientation appear to mediate exposure of benthos to these factors, thereby tempering effects of sea-ice and increasing biological heterogeneity. However, while light and sedimentation both varied spatially with sea-ice, their dynamics differed temporally. Light was sensitive to the site-specific date of sea-ice breakout, whereas sedimentation fluctuated at a regional scale coincident with the summer phytoplankton bloom. Sea-ice duration is clearly the overarching force structuring these shallow Antarctic benthic communities, but direct effects are imposed via light and sedimentation, and mediated by habitat characteristics.	[Clark, Graeme F.; Johnston, Emma L.] Univ New South Wales, Evolut & Ecol Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Stark, Jonathan S.; Palmer, Anne S.; Riddle, Martin J.] Dept Environm, Australian Antarctic Div, Kingston, Tasmania, Australia	University of New South Wales Sydney; Australian Antarctic Division	Clark, GF (corresponding author), Univ New South Wales, Evolut & Ecol Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	g.clark@unsw.edu.au	Johnston, Emma/AAC-2878-2022; Stark, Jonathan/ABF-4025-2020	Johnston, Emma/0000-0002-2117-366X; Stark, Jonathan/0000-0002-4268-8072	Australian Antarctic Science [2201, 2691]	Australian Antarctic Science	Research was funded by Australian Antarctic Science Grants 2201 and 2691. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2003, OCEANOGR MAR BIOL, V41, P161; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Barnes DKA, 2007, PHILOS T R SOC B, V362, P11, DOI 10.1098/rstb.2006.1951; Barnes DKA, 2011, NAT CLIM CHANGE, V1, P365, DOI 10.1038/NCLIMATE1232; BARRY JP, 1988, POLAR BIOL, V8, P367, DOI 10.1007/BF00442028; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Blight D.F., 1977, J GEOL SOC AUSTR, V24, P239, DOI [10.1080/00167617708728986., DOI 10.1080/00167617708728986]; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Brown KM, 2004, OECOLOGIA, V141, P121, DOI 10.1007/s00442-004-1648-6; BUCKLEY RG, 1987, NATURE, V326, P867, DOI 10.1038/326867a0; Clark GF, 2013, GLOBAL CHANGE BIOL; Clark GF, 2015, POLAR BIOL, V38, P1213, DOI 10.1007/s00300-015-1688-x; Clark GF, 2015, AUSTRAL ECOL, V40, P482, DOI 10.1111/aec.12237; Clark GF, 2011, POLAR BIOL, V34, P781, DOI 10.1007/s00300-010-0931-8; Clarke A, 1996, LIMNOL OCEANOGR, V41, P1281, DOI 10.4319/lo.1996.41.6.1281; Connell SD, 2005, MAR ECOL PROG SER, V289, P53, DOI 10.3354/meps289053; Connell SD, 2003, OECOLOGIA; DAWSON FH, 1981, HYDROBIOLOGIA, V77, P71, DOI 10.1007/BF00006390; Dayton P.K., 1990, P631; ECKMAN JE, 1989, J EXP MAR BIOL ECOL, V129, P173, DOI 10.1016/0022-0981(89)90055-5; Fillinger L, 2013, CURR BIOL, V23, P1330, DOI 10.1016/j.cub.2013.05.051; Glasby TM, 2001, MAR ECOL PROG SER, V214, P127, DOI 10.3354/meps214127; Glasby TM, 1999, J EXP MAR BIOL ECOL, V234, P275, DOI 10.1016/S0022-0981(98)00156-7; Gorley C.K., 2006, GETTING STARTED PRIM; Gutt J, 2001, POLAR BIOL, V24, P553, DOI 10.1007/s003000100262; HEATH R A, 1971, New Zealand Journal of Marine and Freshwater Research, V5, P497; HORNER R, 1982, ARCTIC, V35, P485; Horner RA, 1976, OCEANOGRAPHY MARINE, V14, P167; Irving AD, 2002, MAR ECOL PROG SER, V245, P83, DOI 10.3354/meps245083; Isla E, 2001, POLAR BIOL, V24, P670, DOI 10.1007/s003000100267; Johannessen OM, 1999, SCIENCE, V286, P1937, DOI 10.1126/science.286.5446.1937; JOKIEL PL, 1980, SCIENCE, V207, P1069, DOI 10.1126/science.207.4435.1069; Kelmo F, 2003, CORAL REEFS, V22, P541, DOI 10.1007/s00338-003-0343-0; Kerr RA, 2002, SCIENCE, V297, P1490, DOI 10.1126/science.297.5586.1490; Khim BK, 2007, ESTUAR COAST SHELF S, V73, P111, DOI 10.1016/j.ecss.2006.12.015; Knott NA, 2004, J MAR BIOL ASSOC UK, V84, P1117, DOI 10.1017/S0025315404010550h; Kortsch S, 2012, P NATL ACAD SCI USA, V109, P14052, DOI 10.1073/pnas.1207509109; Krause-Jensen D, 2012, GLOBAL CHANGE BIOL, V18, P2981, DOI 10.1111/j.1365-2486.2012.02765.x; Li XC, 2014, NATURE, V505, P538, DOI 10.1038/nature12945; Quartino ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058223; Lohrer AM, 2013, ECOSYSTEMS, V16, P224, DOI 10.1007/s10021-012-9610-7; McMahon KW, 2006, MAR ECOL PROG SER, V310, P1, DOI 10.3354/meps310001; McMinn A, 2004, J PHYCOL, V40, P62, DOI 10.1046/j.1529-8817.2004.02127.x; Miller RJ, 2008, ECOLOGY, V89, P452, DOI 10.1890/06-1099.1; MITCHELL BG, 1991, LIMNOL OCEANOGR, V36, P1662, DOI 10.4319/lo.1991.36.8.1662; Parkinson CL, 2004, ANTARCT SCI, V16, P387, DOI 10.1017/S0954102004002214; Peck LS, 1999, MAR ECOL PROG SER, V186, P1, DOI 10.3354/meps186001; Riddle MJ, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001327; Runcie JW, 2006, EUR J PHYCOL, V41, P223, DOI 10.1080/09670260600645824; Schloss IR, 1999, SCI MAR, V63, P99, DOI 10.3989/scimar.1999.63s199; Smale DA, 2008, SCIENCE, V321, P371, DOI 10.1126/science.1158647; Smale DA, 2007, MAR ECOL PROG SER, V349, P89, DOI 10.3354/meps07104; Stambler N, 1997, HYDROBIOLOGIA, V344, P41, DOI 10.1023/A:1002993925441; Stammerjohn S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL050874; StanwellSmith D, 1997, J EXP MAR BIOL ECOL, V212, P61, DOI 10.1016/S0022-0981(96)02754-2; Stevens CL, 2009, OCEAN SCI, V5, P435, DOI 10.5194/os-5-435-2009; Stirling I, 2006, ARCTIC, V59, P261; Wang MY, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052868; Witman JD, 1987, ECOL MONOGR, V57, P167; YOUNG CM, 1984, MAR BIOL, V81, P61, DOI 10.1007/BF00397626; Zurr A., 2009, MIXED EFFECTS MODELS	62	26	26	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0168391	10.1371/journal.pone.0168391	http://dx.doi.org/10.1371/journal.pone.0168391			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076438	Green Published, Green Submitted, gold			2022-12-26	WOS:000391857100011
J	Gerber, H; Wu, F; Dimitrov, M; Osuna, GMG; Fraering, PC				Gerber, Hermeto; Wu, Fang; Dimitrov, Mitko; Osuna, Guillermo M. Garcia; Fraering, Patrick C.			Zinc and Copper Differentially Modulate Amyloid Precursor Protein Processing by -Secretase and Amyloid- Peptide Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid precursor protein (APP); amyloid- (AB); copper; intramembrane proteolysis; neurodegeneration; zinc; biometals	NUCLEOTIDE-BINDING SITE; ACTIVE GAMMA-SECRETASE; TARGETING A-BETA; ALZHEIMERS-DISEASE; THERAPEUTIC IMPLICATIONS; SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; PLASMA-MEMBRANE; MEMORY DEFICITS; BRAIN-TISSUE	Recent evidence suggests involvement of biometal homeostasis in the pathological mechanisms in Alzheimer's disease (AD). For example, increased intracellular copper or zinc has been linked to a reduction in secreted levels of the AD-causing amyloid- peptide (A). However, little is known about whether these biometals modulate the generation of A. In the present study we demonstrate in both cell-free and cell-based assays that zinc and copper regulate A production by distinct molecular mechanisms affecting the processing by -secretase of its A precursor protein substrate APP-C99. We found that Zn2+ induces APP-C99 dimerization, which prevents its cleavage by -secretase and A production, with an IC50 value of 15 m. Importantly, at this concentration, Zn2+ also drastically raised the production of the aggregation-prone A43 found in the senile plaques of AD brains and elevated the A43:A40 ratio, a promising biomarker for neurotoxicity and AD. We further demonstrate that the APP-C99 histidine residues His-6, His-13, and His-14 control the Zn2+-dependent APP-C99 dimerization and inhibition of A production, whereas the increased A43:A40 ratio is substrate dimerization-independent and involves the known Zn2+ binding lysine Lys-28 residue that orientates the APP-C99 transmembrane domain within the lipid bilayer. Unlike zinc, copper inhibited A production by directly targeting the subunits presenilin and nicastrin in the -secretase complex. Altogether, our data demonstrate that zinc and copper differentially modulate A production. They further suggest that dimerization of APP-C99 or the specific targeting of individual residues regulating the production of the long, toxic A species, may offer two therapeutic strategies for preventing AD.	[Gerber, Hermeto; Fraering, Patrick C.] Fdn Eclos, CH-1228 Plan Les Ouates, Switzerland; [Gerber, Hermeto; Fraering, Patrick C.] Campus Biotech Innovat Pk, CH-1202 Geneva, Switzerland; [Gerber, Hermeto; Wu, Fang; Dimitrov, Mitko; Osuna, Guillermo M. Garcia; Fraering, Patrick C.] Swiss Fed Inst Technol EPFL, Brain Mind Inst, CH-1015 Lausanne, Switzerland; [Gerber, Hermeto; Wu, Fang; Dimitrov, Mitko; Osuna, Guillermo M. Garcia; Fraering, Patrick C.] Swiss Fed Inst Technol EPFL, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Gerber, Hermeto] Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland; [Wu, Fang] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Minist Educ, Key Lab Syst Biomed, Shanghai 200240, Peoples R China	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Fribourg; Shanghai Jiao Tong University	Fraering, PC (corresponding author), Fdn Eclos, CH-1228 Plan Les Ouates, Switzerland.; Fraering, PC (corresponding author), Campus Biotech Innovat Pk, CH-1202 Geneva, Switzerland.; Fraering, PC (corresponding author), Swiss Fed Inst Technol EPFL, Brain Mind Inst, CH-1015 Lausanne, Switzerland.; Fraering, PC (corresponding author), Swiss Fed Inst Technol EPFL, Sch Life Sci, CH-1015 Lausanne, Switzerland.	fraeringpatrick@hotmail.com	Wu, Fang/B-1945-2008; Gerber, Hermeto/I-8180-2018	Wu, Fang/0000-0002-4194-2243; Fraering, Patrick/0000-0002-5841-5327	Swiss National Science Foundation [31003A_152677/1]; Strauss Foundation; Foundation Eclosion; National Natural Science Foundation of China [31270853]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Strauss Foundation; Foundation Eclosion; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Swiss National Science Foundation (to H. G. and P. C. F., 31003A_152677/1), the Strauss Foundation (to H. G. and P. C. F.), the Foundation Eclosion (to H. G. and P. C. F.), and the National Natural Science Foundation of China (to F. W., 31270853). The authors declare that they have no conflicts of interest with the contents of this article.	Acevedo KM, 2011, J BIOL CHEM, V286, P8252, DOI 10.1074/jbc.M110.128512; Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; Alattia JR, 2011, FASEB J, V25, P2287, DOI 10.1096/fj.10-174078; Alvarez HM, 2010, SCIENCE, V327, P331, DOI 10.1126/science.1179907; Arnal Nathalie, 2013, Int J Alzheimers Dis, V2013, P414817, DOI 10.1155/2013/414817; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; Ayciriex S, 2016, BIOCHEM J, V473, P321, DOI 10.1042/BJ20150448; Ayton S, 2015, NEUROTHERAPEUTICS, V12, P109, DOI 10.1007/s13311-014-0312-z; Barker WW, 2002, ALZ DIS ASSOC DIS, V16, P203, DOI 10.1097/00002093-200210000-00001; Bellingham SA, 2004, J NEUROCHEM, V91, P423, DOI 10.1111/j.1471-4159.2004.02731.x; Bonda DJ, 2011, METALLOMICS, V3, P267, DOI 10.1039/c0mt00074d; Borchardt T, 1999, BIOCHEM J, V344, P461, DOI 10.1042/0264-6021:3440461; Bot N, 2011, J BIOL CHEM, V286, P2762, DOI 10.1074/jbc.M110.142521; BOUKAIBA N, 1993, AM J CLIN NUTR, V57, P566; Brewer GJ, 2000, P SOC EXP BIOL MED, V223, P39, DOI 10.1046/j.1525-1373.2000.22305.x; BUSH AI, 1993, J BIOL CHEM, V268, P16109; Bush AI, 2008, NEUROTHERAPEUTICS, V5, P421, DOI 10.1016/j.nurt.2008.05.001; Bush AI, 2013, J ALZHEIMERS DIS, V33, pS277, DOI 10.3233/JAD-2012-129011; Butterfield DA, 2003, CNS DRUGS, V17, P641, DOI 10.2165/00023210-200317090-00004; Cacquevel M, 2008, J NEUROCHEM, V104, P210, DOI 10.1111/j.1471-4159.2007.05041.x; Cacquevel M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035133; Camakaris J, 1999, BIOCHEM BIOPH RES CO, V261, P225, DOI 10.1006/bbrc.1999.1073; Cater MA, 2008, BIOCHEM J, V412, P141, DOI 10.1042/BJ20080103; Chyung JH, 2005, J BIOL CHEM, V280, P4383, DOI 10.1074/jbc.M409272200; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Costa RM, 2003, CURR BIOL, V13, P1348, DOI 10.1016/S0960-9822(03)00492-5; Crouch PJ, 2009, P NATL ACAD SCI USA, V106, P381, DOI 10.1073/pnas.0809057106; Cummings JL, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt269; Danielsson J, 2007, FEBS J, V274, P46, DOI 10.1111/j.1742-4658.2006.05563.x; Dimitrov M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3246; Donnelly PS, 2008, J BIOL CHEM, V283, P4568, DOI 10.1074/jbc.M705957200; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Faller P, 2009, DALTON T, P1080, DOI 10.1039/b813398k; Faux NG, 2010, J ALZHEIMERS DIS, V20, P509, DOI 10.3233/JAD-2010-1390; Fraering PC, 2007, CURR GENOMICS, V8, P531, DOI 10.2174/138920207783769521; Fraering PC, 2005, J BIOL CHEM, V280, P41987, DOI 10.1074/jbc.M501368200; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P323, DOI 10.1021/bi035748j; Ginet V, 2014, AUTOPHAGY, V10, P846, DOI 10.4161/auto.28264; Ha C, 2007, BIOCHEMISTRY-US, V46, P6118, DOI 10.1021/bi7000032; HARTTER DE, 1988, SYNAPSE, V2, P412, DOI 10.1002/syn.890020408; HESSE L, 1994, FEBS LETT, V349, P109, DOI 10.1016/0014-5793(94)00658-X; Hoke DE, 2005, FEBS J, V272, P5544, DOI 10.1111/j.1742-4658.2005.04950.x; Houacine J, 2012, NEUROBIOL AGING, V33, P2704, DOI 10.1016/j.neurobiolaging.2011.12.033; Hung YH, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00111; Hung YH, 2010, J BIOL INORG CHEM, V15, P61, DOI 10.1007/s00775-009-0600-y; Hung YH, 2009, J BIOL CHEM, V284, P21899, DOI 10.1074/jbc.M109.019521; Jakob-Roetne R, 2009, ANGEW CHEM INT EDIT, V48, P3030, DOI 10.1002/anie.200802808; James SA, 2012, FREE RADICAL BIO MED, V52, P298, DOI 10.1016/j.freeradbiomed.2011.10.446; Jun SM, 2007, ANGEW CHEM INT EDIT, V46, P3959, DOI 10.1002/anie.200700318; Kaether C, 2002, J CELL BIOL, V158, P551, DOI 10.1083/jcb.200201123; KARDOS J, 1989, NEUROSCI LETT, V103, P139, DOI 10.1016/0304-3940(89)90565-X; Kenche VB, 2011, BRIT J PHARMACOL, V163, P211, DOI 10.1111/j.1476-5381.2011.01221.x; Kim D, 2009, CELL, V137, P997, DOI 10.1016/j.cell.2009.05.042; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Kukar TL, 2011, J BIOL CHEM, V286, P39804, DOI 10.1074/jbc.M111.274696; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; Li Y, 2001, J NEUROPHYSIOL, V86, P2597, DOI 10.1152/jn.2001.86.5.2597; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Maynard CJ, 2002, J BIOL CHEM, V277, P44670, DOI 10.1074/jbc.M204379200; Miller Y, 2010, P NATL ACAD SCI USA, V107, P9490, DOI 10.1073/pnas.0913114107; Minicozzi V, 2008, J BIOL CHEM, V283, P10784, DOI 10.1074/jbc.M707109200; Mithu VS, 2011, BIOPHYS J, V101, P2825, DOI 10.1016/j.bpj.2011.10.023; Noda Y, 2013, NEUROSCI LETT, V547, P10, DOI 10.1016/j.neulet.2013.04.057; Page RM, 2010, J BIOL CHEM, V285, P17798, DOI 10.1074/jbc.M110.103283; Phinney AL, 2003, P NATL ACAD SCI USA, V100, P14193, DOI 10.1073/pnas.2332851100; Pithadia AS, 2012, CURR OPIN CHEM BIOL, V16, P67, DOI 10.1016/j.cbpa.2012.01.016; Quagraine EK, 2001, J INORG BIOCHEM, V85, P23, DOI 10.1016/S0162-0134(00)00227-0; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; Roberts SA, 2003, J BIOL CHEM, V278, P31958, DOI 10.1074/jbc.M302963200; Sandebring A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055847; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Schlief ML, 2006, P NATL ACAD SCI USA, V103, P14919, DOI 10.1073/pnas.0605390103; Schlief ML, 2005, J NEUROSCI, V25, P239, DOI 10.1523/JNEUROSCI.3699-04.2005; She YM, 2003, MOL CELL PROTEOMICS, V2, P1306, DOI 10.1074/mcp.M300080-MCP200; Soragni A, 2008, BIOCHEMISTRY-US, V47, P10841, DOI 10.1021/bi8008856; Squitti R, 2014, NEUROBIOL AGING, V35, pS40, DOI 10.1016/j.neurobiolaging.2014.02.031; Squitti R, 2012, J ALZHEIMERS DIS, V29, P493, DOI 10.3233/JAD-2011-111991; Strozyk D, 2009, NEUROBIOL AGING, V30, P1069, DOI 10.1016/j.neurobiolaging.2007.10.012; Takahashi Y, 2002, MOL CELL BIOL, V22, P7614, DOI 10.1128/MCB.22.21.7614-7621.2002; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Takeda A, 2009, NEUROCHEM INT, V55, P376, DOI 10.1016/j.neuint.2009.04.006; Treiber C, 2004, J BIOL CHEM, V279, P51958, DOI 10.1074/jbc.M407410200; Wang Y, 2004, P NATL ACAD SCI USA, V101, P9458, DOI 10.1073/pnas.0308126101; Wang YF, 2011, ADV NUTR, V2, P129, DOI 10.3945/an.110.000273; Welander H, 2009, J NEUROCHEM, V110, P697, DOI 10.1111/j.1471-4159.2009.06170.x; Wines-Samuelson M, 2005, NEUROSCIENTIST, V11, P441, DOI 10.1177/1073858405278922; Winkler E, 2015, BIOCHEMISTRY-US, V54, P6149, DOI 10.1021/acs.biochem.5b00986; Wu F, 2010, FASEB J, V24, P2464, DOI 10.1096/fj.09-148031; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Zhou LX, 2007, PEPTIDES, V28, P2229, DOI 10.1016/j.peptides.2007.08.022	92	50	52	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3751	3767		10.1074/jbc.M116.754101	http://dx.doi.org/10.1074/jbc.M116.754101			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28096459	Green Published, hybrid			2022-12-26	WOS:000395542500018
J	Yoo, SM; Latifkar, A; Cerione, RA; Antonyak, MA				Yoo, Sungsoo M.; Latifkar, Arash; Cerione, Richard A.; Antonyak, Marc A.			Cool-associated Tyrosine-phosphorylated Protein 1 Is Required for the Anchorage-independent Growth of Cervical Carcinoma Cells by Binding Paxillin and Promoting AKT Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP ribosylation factor (ARF); Akt PKB; CDC42; mammalian target of rapamycin (mTOR); transformation; Cat-1; Git-1; p70S6 kinase; paxillin	ADAPTER PROTEIN; LUNG-CANCER; ADHESION; METASTASIS; MIGRATION; KINASE; FAMILY; ARF6; IDENTIFICATION; TRANSFORMATION	Cool-associated tyrosine-phosphorylated protein 1 (Cat-1) is a signaling scaffold as well as an ADP-ribosylation factor-GTPase-activating protein. Although best known for its role in cell migration, we recently showed that the ability of Cat-1 to bind paxillin, a major constituent of focal complexes, is also essential for the anchorage-independent growth of HeLa cervical carcinoma cells. Here we set out to learn more about the underlying mechanism by which Cat-paxillin interactions mediate this effect. We show that knocking down paxillin expression in HeLa cells promotes their ability to form colonies in soft agar, whereas ectopically expressing paxillin in these cells inhibits this transformed growth phenotype. Although knocking down Cat-1 prevents HeLa cells from forming colonies in soft agar, when paxillin is knocked down together with Cat-1, the cells are again able to undergo anchorage-independent growth. These results suggest that the requirement of Cat-1 for this hallmark of cellular transformation is coupled to its ability to bind paxillin and abrogate its actions as a negative regulator of anchorage-independent growth. We further show that knocking down Cat-1 expression in HeLa cells leads to a reduction in Akt activation, which can be reversed by knocking down paxillin. Moreover, expression of constitutively active forms of Akt1 and Akt2 restores the anchorage-independent growth capability of HeLa cells depleted of Cat-1 expression. Together, these findings highlight a novel mechanism whereby interactions between Cat-1 and its binding partner paxillin are necessary to ensure sufficient Akt activation so that cancer cells are able to grow under anchorage-independent conditions.	[Yoo, Sungsoo M.; Latifkar, Arash; Cerione, Richard A.; Antonyak, Marc A.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Latifkar, Arash; Cerione, Richard A.] Cornell Univ, Baker Lab, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Yoo, Sungsoo M.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Cornell University; Cornell University; Jefferson University	Cerione, RA (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu			National Institutes of Health [GM040654, GM047458, CA201402]; NATIONAL CANCER INSTITUTE [R01CA201402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122575, R01GM040654, R01GM047458] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM040654, GM047458, and CA201402 (to R. A. C.) The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Azuma K, 2005, ONCOGENE, V24, P4754, DOI 10.1038/sj.onc.1208654; Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; Chan SH, 2014, ONCOGENE, V33, P4496, DOI 10.1038/onc.2014.10; Chang JS, 2015, ONCOTARGET, V6, P36278, DOI 10.18632/oncotarget.5531; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Deakin Nicholas O, 2012, Genes Cancer, V3, P362, DOI 10.1177/1947601912458582; Digman MA, 2008, BIOPHYS J, V94, P2819, DOI 10.1529/biophysj.107.104984; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Efimov A, 2008, J CELL SCI, V121, P196, DOI 10.1242/jcs.012666; Feng QY, 2010, J BIOL CHEM, V285, P18806, DOI 10.1074/jbc.M109.098079; Frank SR, 2008, SEMIN CELL DEV BIOL, V19, P234, DOI 10.1016/j.semcdb.2008.01.002; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Guadamillas MC, 2011, J CELL SCI, V124, P3189, DOI 10.1242/jcs.072165; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Huang WC, 2014, CANCER RES, V74, P751, DOI 10.1158/0008-5472.CAN-13-1297; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Jewell JL, 2015, SCIENCE, V347, P194, DOI 10.1126/science.1259472; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li L, 2010, J BIOL CHEM, V285, P19705, DOI 10.1074/jbc.C110.102483; Mazaki Y, 2001, MOL BIOL CELL, V12, P645, DOI 10.1091/mbc.12.3.645; Nagata M, 2003, INT J CANCER, V106, P683, DOI 10.1002/ijc.11283; Peng H, 2013, HEPATOLOGY, V57, P2299, DOI 10.1002/hep.26258; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Salgia R, 1999, ONCOGENE, V18, P67, DOI 10.1038/sj.onc.1202273; Torii T, 2010, J BIOL CHEM, V285, P24270, DOI 10.1074/jbc.M110.125658; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; Vitale N, 2000, J BIOL CHEM, V275, P13901, DOI 10.1074/jbc.275.18.13901; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wade R, 2011, J BIOL CHEM, V286, P37932, DOI 10.1074/jbc.M111.294504; West KA, 2001, J CELL BIOL, V154, P161, DOI 10.1083/jcb.200101039; Yoo SM, 2012, J BIOL CHEM, V287, P31462, DOI 10.1074/jbc.M112.353615; Yu JXA, 2010, CELL ADHES MIGR, V4, P342, DOI 10.4161/cam.4.3.11406; Zhao CJ, 2015, MED SCI MONITOR, V21, P1989, DOI 10.12659/MSM.893832; Zhao YQ, 2010, P NATL ACAD SCI USA, V107, P2592, DOI 10.1073/pnas.0914884107	36	1	2	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3947	3957		10.1074/jbc.M116.769190	http://dx.doi.org/10.1074/jbc.M116.769190			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28100775	Green Published, hybrid			2022-12-26	WOS:000395542500035
J	Pan, XH; He, YJ; Lei, JP; Huang, XH; Zhao, YX				Pan, Xuehua; He, Yunjiao; Lei, Jinping; Huang, Xuhui; Zhao, Yanxiang			Crystallographic Snapshots of Class A beta-Lactamase Catalysis Reveal Structural Changes That Facilitate beta-Lactam Hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ULTRAHIGH-RESOLUTION STRUCTURE; PENICILLIN-BINDING PROTEINS; TRANSITION-STATE ANALOG; STRUCTURE-BASED DESIGN; X-RAY CRYSTALLOGRAPHY; GENERAL BASE; MOLECULAR-GRAPHICS; ACTIVE-SITE; ACYL-ENZYME; 3 DECADES	beta-Lactamases confer resistance to beta-lactam-based antibiotics. There is great interest in understanding their mechanisms to enable the development of beta-lactamase-specific inhibitors. The mechanism of class A beta-lactamases has been studied extensively, revealing Lys-73 and Glu-166 as general bases that assist the catalytic residue Ser-70. However, the specific roles of these two residues within the catalytic cycle remain not fully understood. To help resolve this, we first identified an E166H mutant that is functional but is kinetically slow. We then carried out time-resolved crystallographic study of a full cycle of the catalytic reaction. We obtained structures that represent apo, ES*-acylation, and ES*-deacylation states and analyzed the conformational changes of His-166. The "in" conformation in the apo structure allows His-166 to form a hydrogen bond with Lys-73. The unexpected "flipped-out" conformation of His-166 in the ES*-acylation structure was further examined by molecular dynamics simulations, which suggested deprotonated Lys-73 serving as the general base for acylation. The "revert-in" conformation in the ES*-deacylation structure aligns His-166 toward the water molecule that hydrolyzes the acyl adduct. Finally, when the acyl adduct is fully hydrolyzed, His-166 rotates back to the "in" conformation of the apo-state, restoring the Lys-73/ His-166 interaction. Using His-166 as surrogate, our study identifies distinct conformational changes within the active site during catalysis. We suggest that the native Glu-166 executes similar changes in a less constricted way. Taken together, this structural series improves our understanding of beta-lactam hydrolysis in this important class of enzymes.	[Pan, Xuehua; He, Yunjiao; Zhao, Yanxiang] Hong Kong Polytech Univ, State Key Lab Chirosci, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China; [Pan, Xuehua] Hong Kong Polytech Univ, Shenzhen Res Inst, Shenzhen, Peoples R China; [Lei, Jinping; Huang, Xuhui] Hong Kong Univ Sci & Technol, Ctr Syst Biol & Human Hlth, Dept Chem, Clear Water Bay, Kowloon, Hong Kong, Peoples R China	Hong Kong Polytechnic University; Hong Kong Polytechnic University; Hong Kong University of Science & Technology	Zhao, YX (corresponding author), Hong Kong Polytech Univ, State Key Lab Chirosci, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China.	yanxiang.zhao@polyu.edu.hk	Huang, Xuhui/ABE-3207-2021	Huang, Xuhui/0000-0002-7119-9358; Zhao, Yanxiang/0000-0002-9408-9979	Research Grants Council GRF Grant [PolyU 5640/11M, PolyU 151043/14M]; Research Grants Council CRF Grant [C5030-14E, C6009-15G]; Research Grants Council AoE Grant [AoE/M-09/12]; Health and Medical Research Fund [14130502]; Research Committee of Hong Kong Polytechnic University	Research Grants Council GRF Grant; Research Grants Council CRF Grant; Research Grants Council AoE Grant; Health and Medical Research Fund; Research Committee of Hong Kong Polytechnic University(Hong Kong Polytechnic University)	This work was supported by Research Grants Council GRF Grants PolyU 5640/11M and PolyU 151043/14M, Research Grants Council CRF Grants C5030-14E and C6009-15G, Research Grants Council AoE Grant AoE/M-09/12, Health and Medical Research Fund Grant 14130502, and the Research Committee of Hong Kong Polytechnic University. The authors declare that they have no conflicts of interest with the contents of this article.	Adamski CJ, 2015, BIOCHEMISTRY-US, V54, P447, DOI 10.1021/bi501195g; Barends TRM, 2015, SCIENCE, V350, P445, DOI 10.1126/science.aac5492; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Case D. A., 2012, AMBER 12; Chan PH, 2008, J AM CHEM SOC, V130, P6351, DOI 10.1021/ja076111g; Chen CC, 1996, BIOCHEMISTRY-US, V35, P12251, DOI 10.1021/bi961153v; Chen CCH, 2001, BIOCHEMISTRY-US, V40, P2351, DOI 10.1021/bi002277h; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fisher JF, 2009, CURR PROTEIN PEPT SC, V10, P401, DOI 10.2174/138920309789351967; Gao Y, 2016, SCIENCE, V352, P1334, DOI 10.1126/science.aad9633; Golemi-Kotra D, 2004, J BIOL CHEM, V279, P34665, DOI 10.1074/jbc.M313143200; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Guillaume G, 1997, J BIOL CHEM, V272, P5438, DOI 10.1074/jbc.272.9.5438; Ibuka AS, 2003, BIOCHEMISTRY-US, V42, P10634, DOI 10.1021/bi0342822; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Lei JP, 2015, J AM CHEM SOC, V137, P70, DOI 10.1021/ja5112964; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Massova I, 1998, ANTIMICROB AGENTS CH, V42, P1; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Meroueh SO, 2005, J AM CHEM SOC, V127, P15397, DOI 10.1021/ja051592u; Minasov G, 2002, J AM CHEM SOC, V124, P5333, DOI 10.1021/ja0259640; Molton JS, 2013, CLIN INFECT DIS, V56, P1310, DOI 10.1093/cid/cit020; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakamura T, 2012, NATURE, V487, P196, DOI 10.1038/nature11181; Ness S, 2000, BIOCHEMISTRY-US, V39, P5312, DOI 10.1021/bi992505b; Nichols DA, 2015, J AM CHEM SOC, V137, P8086, DOI 10.1021/jacs.5b00749; Nukaga M, 2003, J MOL BIOL, V328, P289, DOI 10.1016/S0022-2836(03)00210-9; Nukaga M, 2008, J AM CHEM SOC, V130, P12656, DOI 10.1021/ja7111146; Pan XH, 2014, BIOCHEMISTRY-US, V53, P5414, DOI 10.1021/bi401609h; Papp-Wallace KM, 2011, ANTIMICROB AGENTS CH, V55, P4943, DOI 10.1128/AAC.00296-11; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Rostkowski M, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-6; Stojanoski V, 2015, J BIOL CHEM, V290, P10382, DOI 10.1074/jbc.M114.633438; Strynadka NCJ, 1996, NAT STRUCT BIOL, V3, P688, DOI 10.1038/nsb0896-688; Tomanicek SJ, 2010, J MOL BIOL, V396, P1070, DOI 10.1016/j.jmb.2009.12.036; Tremblay LV, 2010, BIOCHEMISTRY-US, V49, P9685, DOI 10.1021/bi1015088; Vandavasi VG, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01636-16, 10.1128/aac.01636-16]; Vandavasi VG, 2016, J MED CHEM, V59, P474, DOI 10.1021/acs.jmedchem.5b01215; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wong WT, 2011, J BIOL CHEM, V286, P31771, DOI 10.1074/jbc.M110.198895; Wong WT, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-15	45	19	19	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4022	4033		10.1074/jbc.M116.764340	http://dx.doi.org/10.1074/jbc.M116.764340			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28100776	Green Published, hybrid			2022-12-26	WOS:000395837100006
J	Noh, KT; Jung, ID; Cha, GS; Han, MK; Park, YM				Noh, Kyung Tae; Jung, In Duk; Cha, Gil Sun; Han, Myung-Kwan; Park, Yeong-Min			Platelet-activating Factor Mediates Endotoxin Tolerance by Regulating Indoleamine 2,3-Dioxygenase-dependent Expression of the Suppressor of Cytokine Signaling 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dendritic cell; endotoxin; glycogen synthase kinase 3 (GSK-3); immunosuppressor; indoleamine-pyrrole 2; 3-dioxygenase (IDO1)	UNITED-STATES; SEVERE SEPSIS; EPIDEMIOLOGY; ANTAGONIST	Indoleamine 2,3-dioxygenase (IDO) mediates immune tolerance, and suppressor of cytokine signaling 3 (SOCS3) negatively regulates the JAK/STAT signal transduction pathway. We determined previously that platelet-activating factor (PAF) protects mice against LPS-induced endotoxic shock, but its detailed mechanism of action was unknown. We performed survival experiments in IDO+/+ and IDO-/- mice using an LPS-induced endotoxemia model and rated organ injury (neutrophil infiltration and liver function). Using ELISA and Western blotting, we also investigated the mechanism of PAF-mediated endotoxin tolerance during endotoxemia. PAF-mediated endotoxin tolerance was dependent on IDO in vivo and in vitro and was not observed in IDO-/- mice. JAK/STAT signaling, crucial for SOCS3 expression, was also impaired in the absence of IDO. In an IDO- and STAT-dependent manner, PAF mediated a decrease in IL-12 and a dramatic increase in IL-10 and reduced mouse mortality. In addition, PAF attenuated LPS-mediated neutrophil infiltration into the lungs and interactions between neutrophil-like (THP-1) and endothelial cells (human umbilical vein endothelial cells). These results indicate that PAF-mediated endotoxin tolerance is initiated via IDO- and JAK/STAT-dependent expression of SOCS3. Our study has revealed a novel tolerogenic mechanism of IDO action and an important association between IDO and SOCS3 with respect to endotoxin tolerance.	[Noh, Kyung Tae] Armed Forces Med Res Inst, Dept Infect Dis, 90bun Jaunro, Daejeon 305878, South Korea; [Jung, In Duk; Cha, Gil Sun; Park, Yeong-Min] Konkuk Univ, Coll Med, Dept Immunol, 120 Neungdong Ro, Seoul 143701, South Korea; [Han, Myung-Kwan] Chonbuk Natl Univ, Dept Microbiol, Sch Med, Jeonju 561182, South Korea	Konkuk University; Konkuk University Medical Center; Jeonbuk National University	Park, YM (corresponding author), Konkuk Univ, Coll Med, Dept Immunol, 120 Neungdong Ro, Seoul 143701, South Korea.; Han, MK (corresponding author), Chonbuk Natl Univ, Dept Microbiol, Sch Med, Jeonju 561182, South Korea.	iamtom@chonbuk.ac.kr; immun3023@kku.ac.kr		Han, Myung-Kwan/0000-0003-1931-8898	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology [2014R1A1A2054999, 2014R1A2A1A10054634, 2015R1A2A1A13001713, 2013R1A4A1069575, 2016R1A5A2012284]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (2014R1A1A2054999, 2014R1A2A1A10054634, 2015R1A2A1A13001713, 2013R1A4A1069575, and 2016R1A5A2012284). The authors declare that they have no conflicts of interest with the contents of this article.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; CASALSSTENZEL J, 1987, EUR J PHARMACOL, V135, P117, DOI 10.1016/0014-2999(87)90602-9; Castellheim A, 2009, SCAND J IMMUNOL, V69, P479, DOI 10.1111/j.1365-3083.2009.02255.x; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Giral M, 1996, BRIT J PHARMACOL, V118, P1223, DOI 10.1111/j.1476-5381.1996.tb15527.x; HILLEGASS LM, 1990, J PHARMACOL METHOD, V24, P285, DOI 10.1016/0160-5402(90)90013-B; IMAIZUMI TA, 1995, J INTERN MED, V238, P5, DOI 10.1111/j.1365-2796.1995.tb00894.x; Jeong YI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006503; Lob S, 2009, NAT REV CANCER, V9, P445, DOI 10.1038/nrc2639; Martin GS, 2012, EXPERT REV ANTI-INFE, V10, P701, DOI [10.1586/ERI.12.50, 10.1586/eri.12.50]; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mathiak G, 1997, SHOCK, V7, P391, DOI 10.1097/00024382-199706000-00001; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Muller AJ, 2007, CURR CANCER DRUG TAR, V7, P31, DOI 10.2174/156800907780006896; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Noh KT, 2015, J BIOL CHEM, V290, P12394, DOI 10.1074/jbc.M114.628578; Noh KT, 2012, J BIOL CHEM, V287, P14226, DOI 10.1074/jbc.M111.308841; Peroval MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051243; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Sriskandan S, 2008, J PATHOL, V214, P211, DOI 10.1002/path.2274; Walterscheid JP, 2002, J EXP MED, V195, P171, DOI 10.1084/jem.20011450; Yan CG, 2013, FASEB J, V27, P2967, DOI 10.1096/fj.12-225797; Yan CG, 2010, J BIOL CHEM, V285, P37227, DOI 10.1074/jbc.M110.132084	25	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3290	3298		10.1074/jbc.M116.764464	http://dx.doi.org/10.1074/jbc.M116.764464			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28077574	Green Published, hybrid			2022-12-26	WOS:000395538800020
J	Baro, E; Galperine, T; Denies, F; Lannoy, D; Lenne, X; Odou, P; Guery, B; Dervaux, B				Baro, Emilie; Galperine, Tatiana; Denies, Fanette; Lannoy, Damien; Lenne, Xavier; Odou, Pascal; Guery, Benoit; Dervaux, Benoit			Cost-Effectiveness Analysis of Five Competing Strategies for the Management of Multiple Recurrent Community-Onset Clostridium difficile Infection in France	PLOS ONE			English	Article							FECAL MICROBIOTA TRANSPLANTATION; RANDOMIZED CLINICAL-TRIAL; SERVICES TASK-FORCE; CASE SERIES; COLORECTAL-CANCER; RETENTION ENEMA; ECONOMIC BURDEN; UNITED-STATES; FIDAXOMICIN; VANCOMYCIN	Background Clostridium difficile infection (CDI) is characterized by high rates of recurrence, resulting in substantial health care costs. The aim of this study was to analyze the cost-effectiveness of treatments for the management of second recurrence of community-onset CDI in France. Methods We developed a decision-analytic simulation model to compare 5 treatments for the management of second recurrence of community-onset CDI: pulsed-tapered vancomycin, fidaxomicin, fecal microbiota transplantation (FMT) via colonoscopy, FMT via duodenal infusion, and FMT via enema. The model outcome was the incremental cost-effectiveness ratio (ICER), expressed as cost per quality-adjusted life year (QALY) among the 5 treatments. ICERs were interpreted using a willingness-to-pay threshold of 32,000/QALY. Uncertainty was evaluated through deterministic and probabilistic sensitivity analyses. Results Three strategies were on the efficiency frontier: pulsed-tapered vancomycin, FMT via enema, and FMT via colonoscopy, in order of increasing effectiveness. FMT via duodenal infusion and fidaxomicin were dominated (i.e. less effective and costlier) by FMT via colonoscopy and FMT via enema. FMT via enema compared with pulsed-tapered vancomycin had an ICER of 18,092/QALY. The ICER for FMT via colonoscopy versus FMT via enema was 73,653/QALY. Probabilistic sensitivity analysis with 10,000 Monte Carlo simulations showed that FMT via enema was the most cost-effective strategy in 58% of simulations and FMT via colonoscopy was favored in 19% at a willingness-to-pay threshold of 32,000/QALY. Conclusions FMT via enema is the most cost-effective initial strategy for the management of second recurrence of community-onset CDI at a willingness-to-pay threshold of 32,000/QALY.	[Baro, Emilie; Dervaux, Benoit] Univ Lille, CHU Lille, EA Sante Publ Epidemiol & Qualite Soins 2694, Lille, France; [Galperine, Tatiana; Guery, Benoit] CHU Lille, Malad Infect, French Grp Faecal Microbiota Transplantat GFTF, Lille, France; [Denies, Fanette] CHU Lille, Direct Rech Sante, Lille, France; [Lannoy, Damien; Odou, Pascal] Univ Lille, EA GRITA Grp Rech Formes Injectables & Technol As, CHU Lille, Lille, France; [Lenne, Xavier] CHU Lille, Dept Med Informat, Lille, France; [Guery, Benoit] Univ Lille, CHU Lille, EA Rech Translat Relat Hote Pathogenes 7366, Lille, France	Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille	Baro, E (corresponding author), Univ Lille, CHU Lille, EA Sante Publ Epidemiol & Qualite Soins 2694, Lille, France.	emilie.baro@gmail.com	Guery, Benoit/AAP-2046-2021; Guery, Benoit/D-8089-2017; LANNOY, Damien/G-4315-2016; Dervaux, Benoit/O-6002-2016	Guery, Benoit/0000-0002-6526-0714; Galperine, Tatiana Katerina/0000-0003-4125-1845; LANNOY, Damien/0000-0002-4657-0282; Dervaux, Benoit/0000-0002-8429-2404; Baro, Emilie/0000-0002-4025-190X				Aas J, 2003, CLIN INFECT DIS, V36, P580, DOI 10.1086/367657; Aroniadis Olga C, 2014, Gastroenterol Hepatol (N Y), V10, P230; Aroniadis OC, 2013, CURR OPIN GASTROEN, V29, P79, DOI 10.1097/MOG.0b013e32835a4b3e; Bartsch SM, 2013, CLIN INFECT DIS, V57, P555, DOI 10.1093/cid/cit346; Bhangu A, 2012, BRIT J SURG, V99, P1501, DOI 10.1002/bjs.8868; Bono BR, 2014, INFECT DIS CLIN PRAC, DOI [10.1097/IPC.0b013e31829ff59b, DOI 10.1097/IPC.0B013E31829FF59B]; Borody TJ, 2013, CURR GASTROENTEROL R, V15; Byrn JC, 2008, ARCH SURG-CHICAGO, V143, P150, DOI 10.1001/archsurg.2007.46; Caisse nationale de l'Assurance maladie, 2014, NOM ACT BIOL MED; Cammarota G, 2015, ALIMENT PHARM THER, V41, P835, DOI 10.1111/apt.13144; Cammarota G, 2014, DIGEST LIVER DIS, V46, P475, DOI 10.1016/j.dld.2013.12.011; Chan M F, 1996, Gastrointest Endosc Clin N Am, V6, P287; Cornely OA, 2012, LANCET INFECT DIS, V12, P281, DOI 10.1016/S1473-3099(11)70374-7; Debast SB, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12418; Desai K, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1610-3; Di Bella S, 2015, J INFECT CHEMOTHER, V21, P230, DOI 10.1016/j.jiac.2015.01.011; Direction generale de l'offre de soins, 2014, GUID SUIV MASS SAL; Direction generale de l'offre de soins, 2013, CALC COUTS ACT; Dodin M, 2014, INT J CLIN PRACT, V68, P363, DOI 10.1111/ijcp.12320; Eiland Edward H 3rd, 2015, Infect Dis Clin Pract (Baltim Md), V23, P32; Eyre DW, 2015, EUROSURVEILLANCE, V20, P21059; Fisher DA, 2011, GASTROINTEST ENDOSC, V74, P745, DOI 10.1016/j.gie.2011.07.025; Ghantoji SS, 2010, J HOSP INFECT, V74, P309, DOI 10.1016/j.jhin.2009.10.016; Hagel AF, 2012, COLORECTAL DIS, V14, P1121, DOI 10.1111/j.1463-1318.2011.02899.x; Hamilton MJ, 2012, AM J GASTROENTEROL, V107, P761, DOI 10.1038/ajg.2011.482; Hayes JL, 2007, ANZ J SURG, V77, P782, DOI 10.1111/j.1445-2197.2007.04226.x; Henrikson Nora B, 2012, Evid Based Spine Care J, V3, P7, DOI 10.1055/s-0032-1328137; Hood G.M., 2010, POPTOOLS VERSION 3 2; Husereau D, 2013, VALUE HEALTH, V16, pE1, DOI 10.1016/j.jval.2013.02.010; Insee, 2014, TABL EC FRANC; Inspection Generale des Affaires Sociales, 2012, 2011NAN05601 INSP GE; Johnson S, 2013, CLIN INFECT DIS, V56, P309, DOI 10.1093/cid/cis833; Karas JA, 2010, J INFECTION, V61, P1, DOI 10.1016/j.jinf.2010.03.025; Kassam Z, 2013, AM J GASTROENTEROL, V108, P500, DOI 10.1038/ajg.2013.59; Kassam Z, 2012, ARCH INTERN MED, V172, P191, DOI 10.1001/archinte.172.2.191; Kelly CP, 2012, CLIN MICROBIOL INFEC, V18, P21, DOI 10.1111/1469-0691.12046; Kelly CR, 2014, AM J GASTROENTEROL, V109, P1065, DOI 10.1038/ajg.2014.133; Khan MA, 2014, CAN J GASTROENTEROL, V28, P434, DOI 10.1155/2014/695029; Knight DR, 2015, CLIN MICROBIOL REV, V28, P721, DOI 10.1128/CMR.00127-14; Konijeti GG, 2014, CLIN INFECT DIS, V58, P1507, DOI 10.1093/cid/ciu128; Lapointe-Shaw L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149521; Lee CH, 2014, EUR J CLIN MICROBIOL, V33, P1425, DOI 10.1007/s10096-014-2088-9; Lee CH, 2016, JAMA-J AM MED ASSOC, V315, P142, DOI 10.1001/jama.2015.18098; Link A, 2016, DIG LIVER DIS; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; Luning TH, 2007, SURG ENDOSC, V21, P994, DOI 10.1007/s00464-007-9251-7; Macconnachie AA, 2009, QJM-INT J MED, V102, P781, DOI 10.1093/qjmed/hcp118; Mattila E, 2012, GASTROENTEROLOGY, V142, P490, DOI 10.1053/j.gastro.2011.11.037; McFarland LV, 2002, AM J GASTROENTEROL, V97, P1769, DOI 10.1111/j.1572-0241.2002.05839.x; Miller MA, 2002, INFECT CONT HOSP EP, V23, P137, DOI 10.1086/502023; Moayyedi P, 2015, GASTROENTEROLOGY, V149, P102, DOI 10.1053/j.gastro.2015.04.001; Nathwani D, 2014, J ANTIMICROB CHEMOTH, V69, P2901, DOI 10.1093/jac/dku257; OLSON MM, 1994, INFECT CONT HOSP EP, V15, P371; Orenstein R, 2012, CLIN INFECT DIS, V55, P613, DOI 10.1093/cid/cis495; Pathak R, 2014, CLIN EXP GASTROENTER, V7, P1, DOI 10.2147/CEG.S53410; Penziner S, 2015, ANTIMICROB AGENTS CH, V59, P1781, DOI 10.1128/AAC.04268-14; Perera AD, 2010, AM SURGEON, V76, P418; Pignone M, 2002, ANN INTERN MED, V137, P96, DOI 10.7326/0003-4819-137-2-200207160-00007; Rohlke F, 2010, J CLIN GASTROENTEROL, V44, P567, DOI 10.1097/MCG.0b013e3181dadb10; Rubin TA, 2013, ANAEROBE, V19, P22, DOI 10.1016/j.anaerobe.2012.11.004; Shah DN, 2016, J HOSP INFECT, V93, P286, DOI 10.1016/j.jhin.2016.04.004; Silverman MS, 2010, CLIN GASTROENTEROL H, V8, P471, DOI 10.1016/j.cgh.2010.01.007; Sokol H, 2015, DIG LIVER DIS; Soriano MM, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu069; Stewart DB, 2013, COLORECTAL DIS, V15, P798, DOI 10.1111/codi.12134; Stouthard MEA, 1997, DISABILITY WEIGHTS D; Stranges PM, 2013, VALUE HEALTH, V16, P297, DOI 10.1016/j.jval.2012.11.004; Synnott K, 1998, BRIT J SURG, V85, P229; Tannock GW, 2010, MICROBIOL-SGM, V156, P3354, DOI 10.1099/mic.0.042010-0; TVEDE M, 1989, LANCET, V1, P1156; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Vargo CA, 2014, PHARMACOTHERAPY, V34, P901, DOI 10.1002/phar.1451; Varier R U, 2014, Clin Microbiol Infect, V20, P1343, DOI 10.1111/1469-0691.12805; Varier RU, 2015, INFECT CONT HOSP EP, V36, P438, DOI 10.1017/ice.2014.80; Vermeulen J, 2010, J GASTROINTEST SURG, V14, P651, DOI 10.1007/s11605-010-1155-5; Wagner M, 2014, CAN J INFECT DIS MED, V25, P87, DOI 10.1155/2014/793532; Wenisch JM, 2012, EUR J CLIN MICROBIOL, V31, P1923, DOI 10.1007/s10096-011-1522-5; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245; WHO Commission on Macroeconomics and Health, 2001, MACR HLTH INV HLTH E; Yoon SS, 2010, J CLIN GASTROENTEROL, V44, P562, DOI 10.1097/MCG.0b013e3181dac035; Youngster I, 2014, CLIN INFECT DIS, V58, P1515, DOI 10.1093/cid/ciu135; Zowall H, 2014, VALUE HEALTH, V17, pA676, DOI 10.1016/j.jval.2014.08.2512	82	27	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170258	10.1371/journal.pone.0170258	http://dx.doi.org/10.1371/journal.pone.0170258			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103289	Green Published, Green Submitted, gold			2022-12-26	WOS:000392381100047
J	Gu, DX; Zhen, FX; Hannaway, DB; Zhu, Y; Liu, LL; Cao, WX; Tang, L				Gu, Dongxiang; Zhen, Fengxian; Hannaway, David B.; Zhu, Yan; Liu, Leilei; Cao, Weixing; Tang, Liang			Quantitative Classification of Rice (Oryza sativa L.) Root Length and Diameter Using Image Analysis	PLOS ONE			English	Article							WATER-UPTAKE; SYSTEM ARCHITECTURE; DROUGHT STRESS; GROWTH; SOIL; MORPHOLOGY; CULTIVARS; FRAMEWORK; CROPS	Quantitative study of root morphological characteristics of plants is helpful for understanding the relationships between their morphology and function. However, few studies and little detailed and accurate information of root characteristics were reported in fine-rooted plants like rice (Oryza sativa L.). The aims of this study were to quantitatively classify fine lateral roots (FLRs), thick lateral roots (TLRs), and nodal roots (NRs) and analyze their dynamics of mean diameter (MD), lengths and surface area percentage with growth stages in rice plant. Pot experiments were carried out during three years with three rice cultivars, three nitrogen (N) rates and three water regimes. In cultivar experiment, among the three cultivars, root length of 'Yangdao 6' was longest, while the MD of its FLR was the smallest, and the mean diameters for TLR and NR were the largest, the surface area percentage (SAP) of TLRs (SAPT) was the highest, indicating that Yangdao 6 has better nitrogen and water uptake ability. High N rate increased the length of different types of roots and increased the MD of lateral roots, decreased the SAP of FLRs (SAPF) and TLRs, but increased the SAP of NRs (SAPN). Moderate decrease of water supply increased root length and diameter, water stress increased the SAPF and SAPT, but decreased SAPN. The quantitative results indicate that rice plant tends to increase lateral roots to get more surface area for nitrogen and water uptake when available assimilates are limiting under nitrogen and water stress environments.	[Gu, Dongxiang; Zhen, Fengxian; Zhu, Yan; Liu, Leilei; Cao, Weixing; Tang, Liang] Nanjing Agr Univ, Natl Engn & Technol Ctr Informat Agr, Jiangsu Key Lab Informat Agr, Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Nanjing, Jiangsu, Peoples R China; [Hannaway, David B.] Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA	Nanjing Agricultural University; Oregon State University		tangl@njau.edu.cn	Tang, Liang/L-2889-2019; Zhu, Yan/AAK-6927-2020	Tang, Liang/0000-0002-3483-0462; Zhu, Yan/0000-0002-8912-3888	National High-Tech Research and Development Program of China [2013AA100404]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) of China; Jiangsu Agriculture Science and Technology Innovation Fund of China [CX[14]2116]; National Natural Science Foundation of China [31571566]	National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) of China; Jiangsu Agriculture Science and Technology Innovation Fund of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National High-Tech Research and Development Program of China (2013AA100404), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) of China, the Jiangsu Agriculture Science and Technology Innovation Fund of China (CX[14]2116), and the National Natural Science Foundation of China (31571566). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armengaud P, 2009, PLANT SIGNAL BEHAV, V4, P139, DOI 10.4161/psb.4.2.7763; Atkinson D, 2000, ROOT METHODS: A HANDBOOK, P1; Bauhus J, 1999, AGRON J, V91, P142, DOI 10.2134/agronj1999.00021962009100010022x; Bengough AG, 2000, ROOT METHODS: A HANDBOOK, P147; Biondini M, 2008, J THEOR BIOL, V251, P35, DOI 10.1016/j.jtbi.2007.11.018; Blouin M, 2007, PLANT SOIL, V290, P371, DOI 10.1007/s11104-006-9169-1; Bohm W., 1979, METHODS STUDYING ROO; Cairns JE, 2004, PLANT SOIL, V267, P309, DOI 10.1007/s11104-005-0134-1; [陈文音 CHEN WenYin], 2007, [生态学报, Acta Ecologica Sinica], V27, P450, DOI 10.1016/S1872-2032(07)60017-1; Costa C, 2000, AGRON J, V92, P621, DOI 10.2134/agronj2000.924621x; Davies W.J, 2007, ADV MOL BREEDING DRO, P55; de Dorlodot S, 2007, TRENDS PLANT SCI, V12, P474, DOI 10.1016/j.tplants.2007.08.012; [董桂春 Dong Guichun], 2002, [作物学报, Acta Agronomica Sinica], V28, P749; Doussan C, 2009, SUSTAINABLE AGRICULTURE, P583, DOI 10.1007/978-90-481-2666-8_36; EHLERS W, 1991, IRRIGATION SCI, V12, P115, DOI 10.1007/BF00192282; Eissenstat DM., 2002, PLANT ROOTS HIDDEN H, V3, P221, DOI DOI 10.1201/9780203909423; Fan JB, 2010, PEDOSPHERE, V20, P446, DOI 10.1016/S1002-0160(10)60034-3; FELDMAN LJ, 1984, ANNU REV PLANT PHYS, V35, P223, DOI 10.1146/annurev.arplant.35.1.223; Gong JinLong, 2014, Acta Agronomica Sinica, V40, P1066; Himmelbauer ML, 2004, PLANT SOIL, V260, P111, DOI 10.1023/B:PLSO.0000030171.28821.55; Hodge A, 2009, PLANT SOIL, V321, P153, DOI 10.1007/s11104-009-9929-9; Kano M, 2011, PLANT SOIL, V342, P117, DOI 10.1007/s11104-010-0675-9; Kato Y, 2006, PLANT SOIL, V287, P117, DOI 10.1007/s11104-006-9008-4; Kawada S., 1984, ROOT SYSTEM RICE; Kondo Motohiko, 2000, Plant Production Science, V3, P437, DOI 10.1626/pps.3.437; Li Y. H, 1979, MORPHOLOGICAL ANATOM; LYNCH J, 1995, PLANT PHYSIOL, V109, P7, DOI 10.1104/pp.109.1.7; Morita S., 1996, ROOTS NITROGEN CROPP, P185; Nakazaki T, 2003, NATURE, V421, P170, DOI 10.1038/nature01219; NEWMAN EI, 1966, J APPL ECOL, V3, P139, DOI 10.2307/2401670; Pierret A, 2007, VADOSE ZONE J, V6, P269, DOI 10.2136/vzj2006.0067; Redjala T, 2011, ENVIRON EXP BOT, V71, P241, DOI 10.1016/j.envexpbot.2010.12.010; Regent Instruments Inc, 2005, WINRH 2005A B BAS RE; Richner W, 2000, ROOT METHODS: A HANDBOOK, P305; Shi JC, 2015, J HYDROL, V522, P285, DOI 10.1016/j.jhydrol.2014.12.045; TANAKA S, 1995, JPN J CROP SCI, V64, P148, DOI 10.1626/jcs.64.148; TENNANT D, 1975, J ECOL, V63, P995, DOI 10.2307/2258617; Waisel Y, 2002, PLANT ROOTS HIDDEN H, P157, DOI DOI 10.1201/9780203909423; Walch-Liu P, 2006, ANN BOT-LONDON, V97, P875, DOI 10.1093/aob/mcj601; Wang EL, 2004, AUST J AGR RES, V55, P501, DOI 10.1071/AR03201; Wang H, 2009, ENVIRON EXP BOT, V65, P338, DOI 10.1016/j.envexpbot.2008.10.002; Wang JB, 2015, J FORESTRY RES, V26, P23, DOI 10.1007/s11676-015-0017-0; WILSON JB, 1988, ANN BOT-LONDON, V61, P433, DOI 10.1093/oxfordjournals.aob.a087575; YAMAUCHI A, 1987, JPN J CROP SCI, V56, P608; Yang JC, 2012, J INTEGR AGR, V11, P920, DOI 10.1016/S2095-3119(12)60082-3; Yoshida S, 1981, FUNDAMENTALS RICE CR; Zobel RW, 2010, PLANT BIOSYST, V144, P507, DOI 10.1080/11263501003764483; Zobel RW, 2007, PLANT SOIL, V297, P243, DOI 10.1007/s11104-007-9341-2	48	20	20	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0169968	10.1371/journal.pone.0169968	http://dx.doi.org/10.1371/journal.pone.0169968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103264	Green Published, gold, Green Submitted			2022-12-26	WOS:000392381100030
J	Lagarrigue, A; Ajana, S; Capuron, L; Feart, C; Moisan, MP				Lagarrigue, Aude; Ajana, Soufiane; Capuron, Lucile; Feart, Catherine; Moisan, Marie-Pierre			Obesity in French Inmates: Gender Differences and Relationship with Mood, Eating Behavior and Physical Activity	PLOS ONE			English	Article							JAIL INMATES; RISK-FACTORS; PRISONERS; DISORDER; POPULATION; VALIDATION; SCALE	Context Inmates, notably women, are at greater risk for obesity and metabolic complications than the general population according to several studies from high income countries. Data regarding French correctional institutions are lacking so far. To fill this gap, we have assessed in a sample from a French prison (33 females and 18 males) the gender-specific effect of incarceration on weight and body mass index (BMI) and examined their current metabolic status. Furthermore, to reveal the possible determinants of increased obesity, we analyzed emotional vulnerability, eating behavior and physical activity using self-reported questionnaires. Results In this sample, obesity (BMI >= 30 kg/m(2)) was already frequent in women (18.2%) but rather scarce for men (11%) at prison entry. Incarceration worsened the rate of obesity in both genders (21.2% and 16.7% respectively). At the time of study, abdominal obesity estimated through waist circumference was particularly prevalent in women (69.7%) versus men (27.8%) and metabolic syndrome was detected in 33% of female against none in male inmates. Abdominal obesity was associated with female sex (p<0.03), low physical activity (p<0.05) and eating disorder (p = 0.07) in univariate analyses. Low physical activity remained significant as an explanatory factor of higher abdominal obesity in multivariate analysis. A marked difference between genders was found for practice of physical activity with a higher proportion of women compared to men being inactive (37.9% vs. 11.8%) and fewer women being very active (17.2% vs. 41.2%). Conclusion This study revealed that a significant proportion of women of this correctional institution combined established obesity, a metabolic syndrome and very little practice of physical activity which put them at high risk of cardiovascular disease. Thus, obesity should be better surveyed and treated in prison, especially for female inmates. Increased physical activity, adapted to obese women, would be the first mean to decrease obesity and gender differences.	[Lagarrigue, Aude] CHU Rangeuil, Serv Med Legale & Med Milieu Penitentiaire, Toulouse, France; [Ajana, Soufiane; Feart, Catherine] INSERM, Ctr INSERM Bordeaux Populat Hlth U1219, ISPED, Bordeaux, France; [Ajana, Soufiane; Feart, Catherine] Univ Bordeaux, Ctr INSERM Bordeaux Populat Hlth U1219, ISPED, Bordeaux, France; [Capuron, Lucile; Moisan, Marie-Pierre] INRA, Nutr & Neurobiol Integree, UMR 1286, Bordeaux, France; [Capuron, Lucile; Moisan, Marie-Pierre] Univ Bordeaux, Nutr & Neurobiol Integree, UMR 1286, Bordeaux, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; INRAE; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux		Marie-Pierre.Moisan@inra.fr	Moisan, Marie-Pierre/AAO-9971-2021; Ajana, Soufiane/AAH-5181-2021; FEART, Catherine/A-3339-2016	Moisan, Marie-Pierre/0000-0001-7315-5319; Capuron, Lucile/0000-0002-2060-5918; FEART, Catherine/0000-0002-7959-1610	Centre National de la Recherche Scientifique (CNRS), program "Defi genre"; Sodexo Justice Services	Centre National de la Recherche Scientifique (CNRS), program "Defi genre"; Sodexo Justice Services	This study was supported mostly by grants from Centre National de la Recherche Scientifique (CNRS), program "Defi genre" and by a grant from Sodexo Justice Services to MPM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bergua V, 2012, INT PSYCHOGERIATR, V24, P1163, DOI 10.1017/S1041610212000300; Binswanger IA, 2010, AM J PUBLIC HEALTH, V100, P476, DOI 10.2105/AJPH.2008.149591; COLLET L, 1986, Encephale, V12, P77; Drapalski AL, 2009, CRIM BEHAV MENT HEAL, V19, P193, DOI 10.1002/cbm.733; Fazel S, 2002, LANCET, V359, P545, DOI 10.1016/S0140-6736(02)07740-1; Gates ML, 2015, J OBES, V2015, DOI 10.1155/2015/532468; Green BL, 1996, PSYCHOMETRIC REV TRA; Herbert K, 2012, LANCET, V379, P1975, DOI 10.1016/S0140-6736(12)60319-5; Indig D., 2009, NSW INMATE HLTH SURV; Khavjou OA, 2007, WOMEN HEALTH ISS, V17, P193, DOI 10.1016/j.whi.2007.02.008; Nicholls W, 2016, OBES REV, V17, P30, DOI 10.1111/obr.12329; ObEpi, 2012, OBEPI ENQ EP NAT SUR; PAULHAN I, 1994, ANN MED-PSYCHOL, V152, P292; Plugge EH, 2009, HEALTH PROMOT INT, V24, P334, DOI 10.1093/heapro/dap034; Spielberger C.D., 1993, INVENTAIRE ANXIETE E; SPITZER RL, 1993, INT J EAT DISORDER, V13, P137, DOI 10.1002/1098-108X(199303)13:2&lt;161::AID-EAT2260130204&gt;3.0.CO;2-R; van Strien T, 1986, INT J EAT DISORD, V5; Vera-Remartínez E.J., 2014, Rev. esp. sanid. penit., V16, P38, DOI 10.4321/S1575-06202014000200003	20	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170413	10.1371/journal.pone.0170413	http://dx.doi.org/10.1371/journal.pone.0170413			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI3HP	28103297	Green Published, Green Submitted, gold			2022-12-26	WOS:000392381100062
J	Ousmane, S; Diallo, BA; Ouedraogo, R; Sanda, AKA; Soussou, AM; Collard, JM				Ousmane, Sani; Diallo, Bouli A.; Ouedraogo, Rasmata; Sanda, Abdel-Kader A.; Soussou, Amadou M.; Collard, Jean-Marc			Serotype Distribution and Antimicrobial Sensitivity Profile of Streptococcus pneumoniae Carried in Healthy Toddlers before PCV13 Introduction in Niamey, Niger	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; NASOPHARYNGEAL CARRIAGE; RESISTANCE; CHILDREN; REPLACEMENT; DENSITY; DISEASE; AGE	Background To mitigate the burden of pneumococcal infections in Niger, a 13-valent pneumococcal vaccine, PCV13, was introduced for routine child vaccination in July 2014. In order to provide pre-vaccine baseline data and allow appreciation of changes on carriage due to vaccination, we analyzed retrospectively pneumococcal isolates obtained from healthy, 0 to 2 year old children prior to the vaccine introduction. Methods From June 5, 2007, to May 26, 2008, 1200 nasopharyngeal swabs were collected from healthy 0 to 2 year old children and analyzed by standard microbiological methods. Serotyping was done by SM-PCR and the data were analyzed with R version 2.15.0 (2012-03-30). Results Streptococcus pneumoniae was detected in 654/1200 children (54.5%) among whom 339 (51.8%) were males. The ages of the study subjects varied from few days to 26 months (mean = 7.1, median = 6, 95% CI [6.8-7.4]). Out of 654 frozen isolates, 377 (54.8%) were able to be re-grown and analyzed. In total, 32 different serogroups/serotypes were detected of which, the most prevalent were 6/(6A/6B/6C/6D) (15.6%), 23F (10.6%), 19F (9.3%), 14 (9%), 19A (5.6%), 23B (4.0%), 25F/38 (3.7%), 18/(18A/18B/18C/18F) (2.9%) and PCR non typeable (16.4%). Eleven serogroups/serotypes accounting for 57.3% (216/377) were of PCV13 types. Of the 211/377 (56%) isolates tested for drug sensitivity, 23/211 (10.9%), 24/ 211 (11.4%), 9/211(4.3%) and 148/210 (70.5%) were respectively resistance to oxacillin, chloramphenicol, erythromycin and tetracycline. Thirteen of the oxacillin resistant isolates were additionally multidrug-resistant. No resistance was however detected to gentamycin(500 mu g) and to fluoroquinolones (phi Norfloxacin(5 mu g) <7mm). Age > 3 months and presence in family of more than one sibling aged < 6 years were significant risk factors for carriage. Conclusion A global rate of 54.5% pneumococcal carriage was detected in this study. The introduced PCV13 vaccine should cover 57.3% (216/377) of circulating serogroups/serotypes, among which were those resistant to antibiotics. Age > 3 months and presence in family of children aged < 6 years were significant factors for pneumococcal carriage. The present data should help understanding post vaccine introduction changes in pneumococcal carriage and infections for better action.	[Ousmane, Sani; Sanda, Abdel-Kader A.; Soussou, Amadou M.; Collard, Jean-Marc] CERMES, Ctr Rech Med & Sanit, Niamey, Niger; [Diallo, Bouli A.; Ouedraogo, Rasmata; Sanda, Abdel-Kader A.] Univ Abdou Moumouni, Fac Sci & Tech, Niamey, Niger; [Ouedraogo, Rasmata] Ctr Hosp Univ Pediat Charles de Gaulle, Unite Format & Rech Sci Sante, Ouagadougou, Burkina Faso; [Collard, Jean-Marc] Inst Pasteur Madagascar, Lab Bacteriol Expt, Antananarivo, Madagascar	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar	Ousmane, S (corresponding author), CERMES, Ctr Rech Med & Sanit, Niamey, Niger.	osani@cermes.org	Collard, Jean-Marc/Q-2342-2019	Collard, Jean-Marc/0000-0002-1490-3978				Adegbola RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103293; Adetifa IMO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030548; Ba F, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0627-8; Bere Leonard C, 2009, Pak J Biol Sci, V12, P1282, DOI 10.3923/pjbs.2009.1282.1286; Bouskraoui M, 2011, ARCH PEDIATRIE, V18, P1265, DOI 10.1016/j.arcped.2011.08.028; Brueggemann AB, 2003, J CLIN MICROBIOL, V41, P4966, DOI 10.1128/JCM.41.11.4966-4970.2003; Charveriat MA, 2005, MED MALADIES INFECT, V35, P500, DOI 10.1016/j.medmal.2005.08.009; Cheung YB, 2009, PEDIATR INFECT DIS J, V28, P990, DOI 10.1097/INF.0b013e3181a78185; Collard JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060432; Cornick JE, 2015, MICROB GENOMICS, V1, DOI 10.1099/mgen.0.000027; Hill PC, 2008, CLIN INFECT DIS, V46, P807, DOI 10.1086/528688; Hu FZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047983; Iliyasu G, 2015, J GLOB INFECT DIS, V7, P70, DOI 10.4103/0974-777X.154440; Klugman KP, 2002, J ANTIMICROB CHEMOTH, V50, P1, DOI 10.1093/jac/dkf500; LAGRANGE PH, 1994, MED MALADIES INFECT, V24, P927, DOI 10.1016/S0399-077X(05)80769-3; Linares J, 2010, CLIN MICROBIOL INFEC, V16, P402, DOI 10.1111/j.1469-0691.2010.03182.x; Mindy J., 2003, MANUAL LAB IDENTIFIC; Mulholland K, 2012, LANCET, V379, P1387, DOI 10.1016/S0140-6736(12)60588-1; Neill DR, 2014, AM J RESP CRIT CARE, V189, P1250, DOI 10.1164/rccm.201401-0128OC; Rinta-Kokko H, 2009, VACCINE, V27, P3831, DOI 10.1016/j.vaccine.2009.04.009; Roca A, 2012, CLIN INFECT DIS, V55, P816, DOI 10.1093/cid/cis554; Shapiro ED, 2012, JAMA-J AM MED ASSOC, V307, P847, DOI 10.1001/jama.2012.194; Usuf E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085001; Van Steenkiste M, 2013, J Pharm Belg, P4; Weinberger DM, 2013, AM J EPIDEMIOL, V178, P1488, DOI 10.1093/aje/kwt156; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8	26	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0169547	10.1371/journal.pone.0169547	http://dx.doi.org/10.1371/journal.pone.0169547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103262	Green Published, Green Submitted, gold			2022-12-26	WOS:000392381100015
J	Brandli, A; Gerhart, J; Sutera, CK; Purushothuman, S; George-Weinstein, M; Stone, J; Bravo-Nuevo, A				Brandli, Alice; Gerhart, Jacquelyn; Sutera, Christopher K.; Purushothuman, Sivaraman; George-Weinstein, Mindy; Stone, Jonathan; Bravo-Nuevo, Arturo			Role of Myo/Nog Cells in Neuroprotection: Evidence from the Light Damaged Retina	PLOS ONE			English	Article							NEURAL PROGENITOR CELLS; SKELETAL-MUSCLE LINEAGE; MYOD MESSENGER-RNA; MULLER CELLS; RAT RETINA; PHOTORECEPTOR APOPTOSIS; EPIBLAST CELLS; NOGGIN; DEGENERATION; SURVIVAL	Purpose To identify Myo/Nog cells in the adult retina and test their role in protecting retinal photoreceptors from light damage. Methods Light damage was induced by exposing albino rats raised in dim cyclic light to 1000 lux light for 24 hours. In one group of rats, Myo/Nog cells were purified from rat brain tissue by magnetic cell sorting following binding of the G8 monoclonal antibody (mAb). These cells were injected into the vitreous humour of the eye within 2 hours following bright light exposure. Retinal function was assessed using full-field, flash electroretinogram (ERG) before and after treatment. The numbers of Myo/Nog cells, apoptotic photoreceptors, and the expression of glial fibrillary acidic protein (GFAP) in Muller cells were assessed by immunohistochemistry. Results Myo/Nog cells were present in the undamaged retina in low numbers. Light induced damage increased their numbers, particularly in the choroid, ganglion cell layer and outer plexiform layer. Intravitreal injection of G8-positive (G8+) cells harvested from brain mitigated all the effects of light damage examined, i.e. loss of retinal function (ERG), death of photoreceptors and the stress-induced expression of GFAP in Muller cells. Some of the transplanted G8+ cells were integrated into the retina from the vitreous. Conclusions Myo/Nog cells are a subpopulation of cells that are present in the adult retina. They increase in number in response to light induced stress. Intravitreal injection of Myo/Nog cells was protective to the retina, in part, by reducing retinal stress as measured by the Muller cell response. These results suggest that Myo/Nog cells, or the factors they produce, are neuroprotective and may be therapeutic in neurodegenerative retinal diseases.	[Brandli, Alice; Purushothuman, Sivaraman] Univ Sydney, Bosch Inst, Sydney, NSW, Australia; [Brandli, Alice; Purushothuman, Sivaraman] Univ Sydney, Discipline Physiol, Sydney, NSW, Australia; [Gerhart, Jacquelyn; George-Weinstein, Mindy] Philadelphia Coll Osteopath Med, Philadelphia, PA USA; [Sutera, Christopher K.; Bravo-Nuevo, Arturo] Lankenau Inst Med Res, Wynnewood, PA USA	University of Sydney; University of Sydney; Lankenau Medical Center; Lankenau Institute for Medical Research	Bravo-Nuevo, A (corresponding author), Lankenau Inst Med Res, Wynnewood, PA USA.	Dr.Arturo.Bravo@gmail.com	Stone, Jonathan/GQA-9990-2022; Brandli, Alice/AAM-3803-2021; Nuevo, Arturo Bravo/AAQ-1900-2020	Nuevo, Arturo Bravo/0000-0001-8237-7802; brandli, alice/0000-0002-4842-3438; Purushothuman, Sivaraman/0000-0002-0880-5060	Sir Zelman Cowen Universities Fund; Lankenau Institute for Medical Research	Sir Zelman Cowen Universities Fund; Lankenau Institute for Medical Research	Supported by the Sir Zelman Cowen Universities Fund and Institutional Funding to ABN by the Lankenau Institute for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El-Asrar AM, 2015, EXP EYE RES, V132, P179, DOI 10.1016/j.exer.2015.01.023; Bochaton-Piallat ML, 2000, INVEST OPHTH VIS SCI, V41, P2336; Bowers F, 2001, INVEST OPHTH VIS SCI, V42, P804; Brandli A, 2015, USING ELECTRORETINOG, DOI [10.3791/52658, DOI 10.3791/52658]; Bravo-Nuevo A, 2016, EXP EYE RES, V146, P22, DOI 10.1016/j.exer.2015.11.023; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Cachafeiro M, 2013, CELL DEATH DIS, P4; Canola K, 2007, INVEST OPHTH VIS SCI, V48, P446, DOI 10.1167/iovs.06-0190; Chen C, 2011, J NEUROSCI RES, V89, P1194, DOI 10.1002/jnr.22662; Chiu Kin, 2007, J Vis Exp, P313, DOI 10.3791/313; deRaad S, 1996, OPHTHALMIC RES, V28, P99, DOI 10.1159/000267881; Dharmarajan S, 2014, MOL VIS, V20, P1085; di Marco F, 2013, AM J NEUROD IN PRESS; Egensperger R, 1996, DEV BRAIN RES, V97, P1, DOI 10.1016/S0165-3806(96)00119-8; Gao LM, 2006, DEV BIOL, V290, P277, DOI 10.1016/j.ydbio.2005.11.007; Gerhart J, 2000, J CELL BIOL, V149, P825, DOI 10.1083/jcb.149.4.825; Gerhart J, 2004, J CELL BIOL, V164, P739, DOI 10.1083/jcb.200309152; Gerhart J, 2001, J CELL BIOL, V155, P381, DOI 10.1083/jcb.200105139; Gerhart J, 2007, J CELL BIOL, V178, P649, DOI 10.1083/jcb.200703060; Gerhart J, 2006, J CELL BIOL, V175, P283, DOI 10.1083/jcb.200605037; Gerhart J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095262; Gerhart J, 2012, EXP DERMATOL, V21, P466, DOI 10.1111/j.1600-0625.2012.01503.x; Gerhart J, 2011, DEV BIOL, V359, P12, DOI 10.1016/j.ydbio.2011.08.007; Gerhart J, 2009, DEV BIOL, V336, P30, DOI 10.1016/j.ydbio.2009.09.022; GROSCHE J, 1995, NEUROSCI LETT, V185, P119, DOI 10.1016/0304-3940(94)11239-F; Guo Y, 2003, INVEST OPHTH VIS SCI, V44, P3194, DOI 10.1167/iovs.02-0875; Harada T, 2000, NEURON, V26, P533, DOI 10.1016/S0896-6273(00)81185-X; Hunter JJ, 2012, PROG RETIN EYE RES, V31, P28, DOI 10.1016/j.preteyeres.2011.11.001; Joly S, 2008, J NEUROSCI, V28, P13765, DOI 10.1523/JNEUROSCI.5114-08.2008; Lawrence JM, 2000, INVEST OPHTH VIS SCI, V41, P518; Marco-Gomariz MA, 2006, J COMP NEUROL, V498, P163, DOI 10.1002/cne.21028; Maslim J, 1997, INVEST OPHTH VIS SCI, V38, P1667; Narimatsu T, 2013, INVEST OPHTH VIS SCI, V54, P4555, DOI 10.1167/iovs.12-11572; Noell WK, 1966, INVESTIGATIVE OPHTHA, V5; Samanta J, 2010, STROKE, V41, P357, DOI 10.1161/STROKEAHA.109.565523; Shin JA, 2014, BRAIN BEHAV IMMUN, V40, P143, DOI 10.1016/j.bbi.2014.03.013; Stone J, 1999, PROG RETIN EYE RES, V18, P689, DOI 10.1016/S1350-9462(98)00032-9; Strony R, 2005, GENE EXPR PATTERNS, V5, P387, DOI 10.1016/j.modgep.2004.09.006; Takahashi M, 1998, MOL CELL NEUROSCI, V12, P340, DOI 10.1006/mcne.1998.0721; Ueki Y, 2013, GLIA, V61, P778, DOI 10.1002/glia.22472; Walker JL, 2010, P NATL ACAD SCI USA, V107, P13730, DOI 10.1073/pnas.0910382107; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002	42	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0169744	10.1371/journal.pone.0169744	http://dx.doi.org/10.1371/journal.pone.0169744			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099524	Green Published, gold			2022-12-26	WOS:000392380100033
J	Melegaro, A; Del Fava, E; Poletti, P; Merler, S; Nyamukapa, C; Williams, J; Gregson, S; Manfredi, P				Melegaro, Alessia; Del Fava, Emanuele; Poletti, Piero; Merler, Stefano; Nyamukapa, Constance; Williams, John; Gregson, Simon; Manfredi, Piero			Social Contact Structures and Time Use Patterns in the Manicaland Province of Zimbabwe	PLOS ONE			English	Article							MIXING PATTERNS; TRANSMISSION; INFLUENZA; SPREAD; PARAMETERS; EXPLAINS; MODELS	Background Patterns of person-to-person contacts relevant for infectious diseases transmission are still poorly quantified in Sub-Saharan Africa (SSA), where socio-demographic structures and behavioral attitudes are expected to be different from those of more developed countries. Methods and Findings We conducted a diary-based survey on daily contacts and time-use of individuals of different ages in one rural and one pen-urban site of Manicaland, Zimbabwe. A total of 2,490 diaries were collected and used to derive age-structured contact matrices, to analyze time spent by individuals in different settings, and to identify the key determinants of individuals' mixing patterns. Overall 10.8 contacts per person/day were reported, with a significant difference between the pen-urban and the rural site (11.6 versus 10.2). A strong age-assortativeness characterized contacts of school-aged children, whereas the high proportion of extended families and the young population age-structure led to a significant intergenerational mixing at older ages. Individuals spent on average 67% of daytime at home, 2% at work, and 9% at school. Active participation in school and work resulted the key drivers of the number of contacts and, similarly, household size, class size, and time spent at work influenced the number of home, school, and work contacts, respectively. We found that the heterogeneous nature of home contacts is critical for an epidemic transmission chain. In particular, our results suggest that, during the initial phase of an epidemic, about 50% of infections are expected to occur among individuals younger than 12 years and less than 20% among individuals older than 35 years. Conclusions With the current work, we have gathered data and information on the ways through which individuals in SSA interact, and on the factors that mostly facilitate this interaction. Monitoring these processes is critical to realistically predict the effects of interventions on infectious diseases dynamics.	[Melegaro, Alessia; Del Fava, Emanuele; Poletti, Piero] Bocconi Univ, Carlo F Dondena Ctr Res Social Dynam & Publ Polic, Milan, Italy; [Melegaro, Alessia] Bocconi Univ, Dept Policy Anal & Publ Management, Milan, Italy; [Poletti, Piero; Merler, Stefano] Bruno Kessler Fdn, Ctr Informat Technol, Trento, Italy; [Nyamukapa, Constance; Williams, John; Gregson, Simon] Imperial Coll London, Dept Infect Dis Epidemiol, London, England; [Nyamukapa, Constance; Gregson, Simon] Biomed Res & Training Inst, Harare, Zimbabwe; [Manfredi, Piero] Univ Pisa, Dept Econ & Management, Pisa, Italy	Bocconi University; Bocconi University; Fondazione Bruno Kessler; Imperial College London; Biomedical Research Training Institute; University of Pisa	Melegaro, A (corresponding author), Bocconi Univ, Carlo F Dondena Ctr Res Social Dynam & Publ Polic, Milan, Italy.; Melegaro, A (corresponding author), Bocconi Univ, Dept Policy Anal & Publ Management, Milan, Italy.	alessia.melegaro@unibocconi.it	Del Fava, Emanuele/D-6181-2014; merler, stefano/I-3557-2017	Del Fava, Emanuele/0000-0001-7352-8525; merler, stefano/0000-0002-5117-0611; Melegaro, Alessia/0000-0003-2221-8898; Gregson, Simon/0000-0003-2707-0714; Nyamukapa, Constance/0000-0001-6779-4069	European Research Council under the European Union's Seventh Framework Program (FP7)/ERC [283955]	European Research Council under the European Union's Seventh Framework Program (FP7)/ERC	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC Grant Agreement 283955 to AM, EDF, PP, JW and CN.	Abrams S, 2014, AM J EPIDEMIOL, V179, P1006, DOI 10.1093/aje/kwu014; Ajelli M, 2014, SCI REP-UK, V4, DOI 10.1038/srep07218; ANDERSON R M, 1991; Beraud G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133203; BIRD CE, 1991, J HEALTH SOC BEHAV, V32, P114, DOI 10.2307/2137147; Bongaarts J, 2013, POPUL DEV REV, V38, P153, DOI 10.1111/j.1728-4457.2013.00557.x; Child Trends, 2015, WORLD FAM MAP 2015; Danon L, 2012, J R SOC INTERFACE, V9, P2826, DOI 10.1098/rsif.2012.0357; De Cao E, 2014, BIOSTATISTICS, V15, P470, DOI 10.1093/biostatistics/kxu008; DeStefano F, 2011, EPIDEMIOL INFECT, V139, P1181, DOI 10.1017/S095026881000230X; Dodd PJ, 2015, AM J EPIDEMIOL, P1; Dorigatti I, 2013, P NATL ACAD SCI USA, V110, P13422, DOI 10.1073/pnas.1303117110; Eames KTD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002425; Edmunds WJ, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-10; Fu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045113; Fumanelli L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002673; Goeyvaerts N, 2010, J R STAT SOC C-APPL, V59, P255, DOI 10.1111/j.1467-9876.2009.00693.x; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Grijalva CG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118457; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-5; Horby P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016965; Ibuka Y, 2016, J EPIDEMIOL COMMUN H, V70, P162, DOI 10.1136/jech-2015-205777; Iozzi F, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001021; Johnstone-Robertson SP, 2011, AM J EPIDEMIOL, V174, P1246, DOI 10.1093/aje/kwr251; Kiti MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104786; Kwok KO, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0709; Melegaro A, 2011, EPIDEMICS-NETH, V3, P143, DOI 10.1016/j.epidem.2011.04.001; Merler S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002205; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Pentland WE, 2007, TIME USE RESOCIAL; Poletti P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060732; Read JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0268; Rohani P, 2010, SCIENCE, V330, P982, DOI 10.1126/science.1194134; Rolls DA, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1237-9; Stein ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113711; van Hoek AJ, 2011, VACCINE, V29, P2411, DOI 10.1016/j.vaccine.2011.01.037; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Ypma RJF, 2012, P ROY SOC B-BIOL SCI, V279, P444, DOI 10.1098/rspb.2011.0913; Zagheni E, 2008, AM J EPIDEMIOL, V168, P1082, DOI 10.1093/aje/kwn220	40	54	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170459	10.1371/journal.pone.0170459	http://dx.doi.org/10.1371/journal.pone.0170459			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099479	Green Published, gold, Green Submitted			2022-12-26	WOS:000392380100091
J	Paiatto, LN; Silva, FGD; Bier, J; Brochetto-Braga, MR; Yamada, AT; Tamashiro, WMSC; Simioni, PU				Paiatto, Lisiery N.; Silva, Fernanda G. D.; Bier, Julia; Brochetto-Braga, Marcia R.; Yamada, Aureo T.; Tamashiro, Wirla M. S. C.; Simioni, Patricia U.			Oral Tolerance Induced by OVA Intake Ameliorates TNBS-Induced Colitis in Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; DENDRITIC CELLS; II COLLAGEN; TH17 CELLS; GM-CSF; BYSTANDER SUPPRESSION; ULCERATIVE-COLITIS; INDUCED ARTHRITIS; MUCOSAL IMMUNITY; TRANSGENIC MICE	Introduction Literature data have shown that the consumption of dietary proteins may cause modulatory effects on the host immune system, process denominated oral tolerance by bystander suppression. It has been shown that the bystander suppression induced by dietary proteins can improve inflammatory diseases such as experimental arthritis. Here, we evaluated the effects of oral tolerance induced by ingestion of ovalbumin (OVA) on TNBS-induced colitis in mice, an experimental model for human Crohn's disease. Methods and Results Colitis was induced in BALB/c mice by instilling a single dose of TNBS (100 mg/kg) in ethanol into the colon. Tolerized mice received OVA (4mg/mL) dissolved in the drinking water for seven consecutive days, prior to or concomitantly with the intrarectal instillation. Control groups received protein-free water and ethanol by intrarectal route. We observed that either the prior or concomitant induction of oral tolerance were able to reduce the severity of colitis as noted by recovery of body weight gain, improvement of clinical signs and reduction of histological abnormalities. The in vitro proliferation of spleen cells from tolerant colitic mice was lower than that of control mice, the same as the frequencies of CD4(+) T cells secreting IL-17 and IFN-gamma. The frequencies of regulatory T cells and T cells secreting IL-10 have increased significantly in mice orally treated with OVA. The levels of inflammatory cytokines (IL-17A, INF-alpha, IL-6 and IFN-gamma) were lower in supernatants of cells from tolerant colitic mice, whereas IL-10 levels were higher. Conclusion Our data show that the modulation of immune response induced by oral tolerance reduces the severity of experimental colitis. Such modulation may be partially attributed to the increase of Treg cells and reduction of pro-inflammatory cytokines in peripheral lymphoid organs of tolerant mice by bystander suppression.	[Paiatto, Lisiery N.; Bier, Julia; Tamashiro, Wirla M. S. C.; Simioni, Patricia U.] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Genet Evolut & Bioagents, Sao Paulo, Brazil; [Paiatto, Lisiery N.; Brochetto-Braga, Marcia R.; Simioni, Patricia U.] Univ Estadual Paulista, UNESP, Inst Biosci, Sao Paulo, Brazil; [Silva, Fernanda G. D.] Univ Estadual Campinas, UNICAMP, Fac Food Engn, Sao Paulo, Brazil; [Yamada, Aureo T.] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Histol & Embryol, Sao Paulo, Brazil; [Simioni, Patricia U.] FAM, Fac Americana, Dept Biomed Sci, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual Paulista; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas	Simioni, PU (corresponding author), Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Genet Evolut & Bioagents, Sao Paulo, Brazil.; Simioni, PU (corresponding author), Univ Estadual Paulista, UNESP, Inst Biosci, Sao Paulo, Brazil.; Simioni, PU (corresponding author), FAM, Fac Americana, Dept Biomed Sci, Sao Paulo, Brazil.	psimioni@gmail.com	Silva, Fernanda/O-6177-2019; BRAGA, MARCIA REGINA BROCHETTO/AAE-9366-2019; Simioni, Patricia/A-3169-2009; Silva, Fernanda G.D./M-2564-2017; Tamashiro, Wirla/D-2519-2013	Silva, Fernanda/0000-0002-9615-5415; BRAGA, MARCIA REGINA BROCHETTO/0000-0002-7982-0743; Simioni, Patricia/0000-0002-6951-5040; Silva, Fernanda G.D./0000-0002-9615-5415; Bier, Julia/0000-0001-7727-1149; Tamashiro, Wirla/0000-0001-8023-9027	Sao Paulo Research Foundation (FAPESP), Brazil [2013/20258-2, 2014/086192, 2015/09326-1, 2014/167010, 2014/08591-0]; Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES)	Sao Paulo Research Foundation (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work has been supported by Sao Paulo Research Foundation (FAPESP, http://fapesp.br/), Brazil (Grant No. 2013/20258-2) and fellowships (#2014/086192, #2015/09326-1 #2014/167010 and #2014/08591-0) and by Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES, http://www.capes.gov.br) (LNP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardizzone S., INT J IMMUNOPATHOL P, V22, P63; Banks C, 2003, J PATHOL, V199, P28, DOI 10.1002/path.1245; Barone KS, 1998, J IMMUNOL, V161, P154; Bayrak S, 1998, CLIN EXP IMMUNOL, V113, P92, DOI 10.1046/j.1365-2249.1998.00638.x; Bhattacharya P, 2015, CYTOKINE, V75, P261, DOI 10.1016/j.cyto.2015.05.030; Bhattacharya P, 2015, J INTERF CYTOK RES, V35, P585, DOI 10.1089/jir.2014.0149; Bhattacharya P, 2011, J LEUKOCYTE BIOL, V89, P235, DOI 10.1189/jlb.0310154; Boden EK, 2008, CURR OPIN GASTROEN, V24, P733, DOI 10.1097/MOG.0b013e328311f26e; Cardoso CR, 2008, CLIN EXP ALLERGY, V38, P338; CARVALHO CR, 1990, BRAZ J MED BIOL RES, V23, P861; Carvalho CR, 1996, SCAND J IMMUNOL, V43, P613, DOI 10.1046/j.1365-3083.1996.d01-261.x; CARVALHO CR, 1994, SCAND J IMMUNOL, V39, P533, DOI 10.1111/j.1365-3083.1994.tb03410.x; Carvalho CR, 1997, SCAND J IMMUNOL, V45, P276, DOI 10.1046/j.1365-3083.1997.d01-394.x; Castro AB, 2012, CELL IMMUNOL, V280, P171, DOI 10.1016/j.cellimm.2012.12.004; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Da Cunha A.P., 2012, CLIN DEV IMMUNOL, V2012, P4; Duan LH, 2012, MOL MED, V18, P753, DOI 10.2119/molmed.2011.00428; Engel MA, 2010, J GASTROENTEROL, V45, P571, DOI 10.1007/s00535-010-0219-3; Eri R, 2008, INFLAMM BOWEL DIS, V14, P458, DOI 10.1002/ibd.20344; Faria AMC, 2005, IMMUNOL REV, V206, P232, DOI 10.1111/j.0105-2896.2005.00280.x; Faria AMC, 2006, CLIN DEV IMMUNOL, V13, P143, DOI 10.1080/17402520600876804; Farooq SM, 2014, BRAIN BEHAV IMMUN, V42, P118, DOI 10.1016/j.bbi.2014.06.010; Farooq SM, 2014, J CELL MOL MED, V18, P2512, DOI 10.1111/jcmm.12376; Farooq SM, 2014, BRAIN BEHAV IMMUN, V35, P64, DOI 10.1016/j.bbi.2013.09.016; Farooq SM, 2013, CNS NEUROSCI THER, V19, P503, DOI 10.1111/cns.12087; Farooq SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048635; Feng T, 2011, J IMMUNOL, V186, P6313, DOI 10.4049/jimmunol.1001454; Fujihashi K, 2004, MECH AGEING DEV, V125, P889, DOI 10.1016/j.mad.2004.05.009; Garside P, 2001, SEMIN IMMUNOL, V13, P177, DOI 10.1006/smim.2001.0310; Gathungu G, 2013, INFLAMM BOWEL DIS, V19, P1671, DOI 10.1097/MIB.0b013e318281f506; Geremia A, 2014, AUTOIMMUN REV, V13, P3, DOI 10.1016/j.autrev.2013.06.004; Glocker EO, 2011, ANN NY ACAD SCI, V1246, P102, DOI 10.1111/j.1749-6632.2011.06339.x; Gomes-Santos AC, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/560817; Gotsman I, 2001, J PHARMACOL EXP THER, V297, P926; Goubier A, 2008, IMMUNITY, V29, P464, DOI 10.1016/j.immuni.2008.06.017; Guo B., 2016, J CLIN CELL IMMUNOL, V7, P1367; Guo BC, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00242; Haddad CS, 2016, AUTOIMMUNITY, V49, P298, DOI 10.1080/08916934.2016.1183657; Harbour SN, 2015, P NATL ACAD SCI USA, V112, P7061, DOI 10.1073/pnas.1415675112; Huang H, 2010, J IMMUNOL, V185, P5003, DOI 10.4049/jimmunol.0903446; Hyun JG, 2006, AM J GASTROENTEROL, V101, P569, DOI 10.1111/j.1572-0241.2006.00437.x; Jiang WY, 2014, INFLAMM RES, V63, P943, DOI 10.1007/s00011-014-0768-7; Kiesler P, 2015, CELL MOL GASTROENTER, V1, P154, DOI 10.1016/j.jcmgh.2015.01.006; Ko HJ, 2010, J AUTOIMMUN, V34, P111, DOI 10.1016/j.jaut.2009.07.006; Kobayashi T, 2008, GUT, V57, P1682, DOI 10.1136/gut.2007.135053; Kraus TA, 2005, CURR OPIN GASTROEN, V21, P692, DOI 10.1097/01.mog.0000182862.88798.28; Lee SK, 2006, IMMUNOLOGY, V119, P479, DOI 10.1111/j.1365-2567.2006.02459.x; Lindsay J, 2002, GENE THER, V9, P1715, DOI 10.1038/sj.gt.3301841; Liu ZJ, 2009, WORLD J GASTROENTERO, V15, P5784, DOI 10.3748/wjg.15.5784; Majewska-szczepanik M., 2012, EPICUTANEOUS IMMUNIZ, P1497; Marth T, 1996, J IMMUNOL, V157, P2348; Matteoli G, 2010, GUT, V59, P595, DOI 10.1136/gut.2009.185108; Min SY, 2006, ARTHRITIS RHEUM-US, V54, P887, DOI 10.1002/art.21647; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Mowat AM, 2004, ANN NY ACAD SCI, V1029, P1, DOI 10.1196/annals.1309.001; Muzes G, 2012, WORLD J GASTROENTERO, V18, P5848, DOI 10.3748/wjg.v18.i41.5848; Neurath B.M.E., 1995, ANTIBODIES INTERLEUK, V182; Neurath B.M.F., 1996, EXPT GRANULOMATOUS C, V183; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Neurath MF, 1996, J EXP MED, V183, P2605, DOI 10.1084/jem.183.6.2605; Oefner CM, 2012, J ALLERGY CLIN IMMUN, V129, P1647, DOI 10.1016/j.jaci.2012.02.037; Oh SY, 2014, INT J MOL MED, V33, P333, DOI 10.3892/ijmm.2013.1569; Okamoto T, 2012, J PHARMACOL EXP THER, V341, P340, DOI 10.1124/jpet.111.190447; Pabst O, 2012, MUCOSAL IMMUNOL, V5, P232, DOI 10.1038/mi.2012.4; Pletinckx K, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00039; Ramos De Mattos B.R., INFLAMMATORY BOWEL D; Ramsdell F, 2003, IMMUNITY, V19, P165, DOI 10.1016/S1074-7613(03)00207-3; Rodrigues CM, 2006, IMMUNOLOGY, V117, P517, DOI 10.1111/j.1365-2567.2006.02327.x; Rowin J, 2012, MUSCLE NERVE, V46, P449, DOI 10.1002/mus.23488; Ruberti M, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/208054; Scheiffele Frank, 2002, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1519s49; Shen W, 2010, NEUROCHEM RES, V35, P940, DOI 10.1007/s11064-009-0091-9; Siewert C, 2008, J IMMUNOL, V180, P146, DOI 10.4049/jimmunol.180.1.146; Simioni PU, 2010, BRAZ J MED BIOL RES, V43, P68, DOI 10.1590/S0100-879X2009007500024; Simioni PU, 2004, SCAND J IMMUNOL, V60, P257, DOI 10.1111/j.0300-9475.2004.01454.x; Sinha S, 2009, J NEUROSCI, V29, P3816, DOI 10.1523/JNEUROSCI.5812-08.2009; Srinivasan M, 2009, CLIN IMMUNOL, V133, P411, DOI 10.1016/j.clim.2009.09.001; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Takamatsu M, 2013, J IMMUNOL, V191, P3057, DOI 10.4049/jimmunol.1203306; Talero E, 2008, PEPTIDES, V29, P2001, DOI 10.1016/j.peptides.2008.07.013; Thomas Saskia, 2012, Inflammopharmacology, V20, P1, DOI 10.1007/s10787-011-0104-6; Thome R, 2012, CELL IMMUNOL, V280, P113, DOI 10.1016/j.cellimm.2012.11.017; Velde AAT, 2006, INFLAMM BOWEL DIS, V12, P995, DOI 10.1097/01.mib.0000227817.54969.5e; von Herrath MG, 2003, NAT REV IMMUNOL, V3, P223, DOI 10.1038/nri1029; Walker LSK, 2013, J AUTOIMMUN, V45, P49, DOI 10.1016/j.jaut.2013.06.006; Wang XM, 2013, ADV DRUG DELIVER REV, V65, P759, DOI 10.1016/j.addr.2012.10.013; Weiner H.L., 1994, ORAL TOLERANCE IMMUN; Weiner H.L., 1997, ORAL TOLERANCE TREAT; WEINER HL, 1994, ANNU REV IMMUNOL, V12, P809, DOI 10.1146/annurev.immunol.12.1.809; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Whitacre CC, 1996, CLIN IMMUNOL IMMUNOP, V80, pS31, DOI 10.1006/clin.1996.0139; Wu XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083013; Zhang SS, 2009, EUR J GASTROEN HEPAT, V21, P1145, DOI 10.1097/MEG.0b013e32830edb29	95	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170205	10.1371/journal.pone.0170205	http://dx.doi.org/10.1371/journal.pone.0170205			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099498	Green Submitted, Green Published, gold			2022-12-26	WOS:000392380100064
J	Aksoy, P; Meneses, PI				Aksoy, Pinar; Meneses, Patricio I.			The Role of DCT in HPV1 6 Infection of HaCaTs	PLOS ONE			English	Article							MINOR CAPSID PROTEIN; HUMAN-PAPILLOMAVIRUS 16; TRANS-GOLGI NETWORK; B16 MELANOMA-CELLS; OXIDATIVE STRESS; HEPARAN-SULFATE; GAMMA SECRETASE; L2; NEUTRALIZATION; INHIBITION	Persistent infection with high-risk human papillomavirus (HPV) genotype is a major factor leading to many human cancers. Mechanisms of HPV entry into host cells and genome trafficking towards the nucleus are incompletely understood. Dopachrome tautomerase (DCT) was identified as a cellular gene required for HPV infection in HeLa cells on a siRNA screen study. Here, we confirm that DCT knockdown significantly decreases HPV infection in the human keratinocyte HaCaT cells as was observed in HeLas. We investigated the effects of DCT knockdown and found that DCT depletion caused increased reactive oxygen species (ROS) levels, DNA damage and altered cell cycle in HaCaT cells. We observed increased viral DNA localization at the endoplasmic reticulum but an overall decrease in infection in DCT knockdown cells. This observation suggests that viral DNA might be retained in the ER due to altered cell cycle, and viral particles are incapable of further movement towards the nucleus in DCT knockdown cells.	[Aksoy, Pinar; Meneses, Patricio I.] Fordham Univ, Dept Biol Sci, Bronx, NY 10458 USA	Fordham University	Meneses, PI (corresponding author), Fordham Univ, Dept Biol Sci, Bronx, NY 10458 USA.	pmeneses@fordham.edu	Meneses, Patricio/CAF-6333-2022		American Cancer Society [RSG-12-021-01-MPC]; National Institutes of Health/National Cancer Institute [R21CA153096]	American Cancer Society(American Cancer Society); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support was provided by RSG-12-021-01-MPC from the American Cancer Society [http://www.cancer.org/] and R21CA153096 from the National Institutes of Health/National Cancer Institute [http://www.cancer.gov/].	Abban CY, 2010, VIROLOGY, V403, P1, DOI 10.1016/j.virol.2010.04.007; Abdel-Malek ZS, 1993, CONTRIBUTION MELANOG; Aroca PG-B, 1990, REGULATION MAMMALIAN; Aydin I, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004162; Baker TS NW, 1991, STRUCTURES BOVINE HU; Barzilai A, 2004, DNA REPAIR, V3, P1109, DOI 10.1016/j.dnarep.2004.03.002; Ben David Y., 2000, TYROSINASE RELATED P; Bienkowska-Haba M, 2012, J VIROL, V86, P9875, DOI 10.1128/JVI.00980-12; Bienkowska-Haba M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000524; Buck CB, 2005, METH MOLEC MED, V119, P445; Buck CB, 2008, J VIROL, V82, P5190, DOI 10.1128/JVI.02726-07; Culp TD, 2006, VIROLOGY, V347, P147, DOI 10.1016/j.virol.2005.11.025; Day PM, 2008, J VIROL, V82, P4638, DOI 10.1128/JVI.00143-08; Day PM, 2007, J VIROL, V81, P8784, DOI 10.1128/JVI.00552-07; Day PM, 2013, J VIROL, V87, P3862, DOI 10.1128/JVI.03222-12; Day PM, 2008, J VIROL, V82, P12565, DOI 10.1128/JVI.01631-08; Day PM, 2004, P NATL ACAD SCI USA, V101, P14252, DOI 10.1073/pnas.0404229101; del Marmol V BF, 1996, TYROSINASE RELATED P; DiGiuseppe S, 2014, VIROLOGY, V458, P93, DOI 10.1016/j.virol.2014.04.024; Fay A, 2004, J VIROL, V78, P13447, DOI 10.1128/JVI.78.24.13447-13454.2004; Florin L, 2006, J VIROL, V80, P6691, DOI 10.1128/JVI.00057-06; Fragkos M, 2009, MOL CELL BIOL, V29, P2828, DOI 10.1128/MCB.01830-08; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Giroglou T FL, 2001, HUMAN PAPILLOMAVIRUS; Gottschalk EY, 2015, J VIROL, V89, P9103, DOI 10.1128/JVI.01183-15; Huang HS, 2010, VIROLOGY, V407, P391, DOI 10.1016/j.virol.2010.09.002; Johnson KM, 2009, J VIROL, V83, P2067, DOI 10.1128/JVI.02190-08; Joyce JG TJ, 1999, L1 MAJOR CAPSID PROT; Karanam B, 2010, J VIROL, V84, P10661, DOI 10.1128/JVI.01081-10; Laniosz V, 2009, J VIROL, V83, P8221, DOI 10.1128/JVI.00576-09; Lipovsky A PA, 2013, GENOME WIDE SIRNA SC; Lipovsky Alex, 2015, Methods Mol Biol, V1270, P437, DOI 10.1007/978-1-4939-2309-0_30; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Michard Q, 2008, FREE RADICAL BIO MED, V44, P1023, DOI 10.1016/j.freeradbiomed.2007.11.021; Murphy D. M., 2001, DISTINCT PROTEIN SOR; Negroiu G, 2005, BIOCHEM BIOPH RES CO, V328, P914, DOI 10.1016/j.bbrc.2005.01.040; Negroiu G, 2003, J BIOL CHEM, V278, P27035, DOI 10.1074/jbc.M303167200; Pak BJ, 2004, ONCOGENE, V23, P30, DOI 10.1038/sj.onc.1207007; Pak BJL, 2000, TYRP2 MEDIATED RESIS; Pyo CW, 2013, BBA-GEN SUBJECTS, V1830, P5316, DOI 10.1016/j.bbagen.2013.07.030; Rad HH, 2004, EXP CELL RES, V298, P317, DOI 10.1016/j.yexcr.2004.04.045; Richards RM, 2006, P NATL ACAD SCI USA, V103, P1522, DOI 10.1073/pnas.0508815103; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Selinka HC GT, 2003, FURTHER EVIDENCE PAP; Urabe KA, 1994, INHERENT CYTOTOXICIT; Wang RS, 2006, P NATL ACAD SCI USA, V103, P353, DOI 10.1073/pnas.0509822102; Yang RC, 2003, J VIROL, V77, P3531, DOI 10.1128/JVI.77.6.3531-3541.2003; Zhang WJ, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-16; Zimmermann M, 2012, J BIOL CHEM, V287, P22838, DOI 10.1074/jbc.M112.376855	49	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0170158	10.1371/journal.pone.0170158	http://dx.doi.org/10.1371/journal.pone.0170158			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095444	gold, Green Published, Green Submitted			2022-12-26	WOS:000392372300063
J	de Oliveira, RR; de Mattos, RM; Rebelo, LM; Ferreira, FGM; Tovar-Moll, F; Nasciutti, LE; Brito, GAD				de Oliveira, Rodrigo Ribeiro; de Mattos, Romulo Medina; Rebelo, Luciana Magalhaes; Meireles Ferreira, Fernanda Guimaraes; Tovar-Moll, Fernanda; Nasciutti, Luiz Eurico; de Castro Brito, Gerly Anne			Experimental Diabetes Alters the Morphology and Nano-Structure of the Achilles Tendon	PLOS ONE			English	Article							RAT MODEL; TENDINOPATHY; MELLITUS; FOOT	Although of several studies that associate chronic hyperglycemia with tendinopathy, the connection between morphometric changes as witnessed by magnetic resonance (MR) images, nanostructural changes, and inflammatory markers have not yet been fully established. Therefore, the present study has as a hypothesis that the Achilles tendons of rats with diabetes mellitus (DM) exhibit structural changes. The animals were randomly divided into two experimental groups: Control Group (n = 06) injected with a vehicle (sodium citrate buffer solution) and Diabetic Group (n = 06) consisting of rats submitted to intraperitoneal administration of streptozotocin. MR was performed 24 days after the induction of diabetes and images were used for morphometry using ImageJ software. Morphology of the collagen fibers within tendons was examined using Atomic Force microscopy (AFM). An increase in the dimension of the coronal plane area was observed in the diabetic group (8.583 +/- 0.646 mm(2)/100g) when compared to the control group (4.823 +/- 0.267 mm(2)/100g) resulting in a significant difference (p = 0.003) upon evaluating the Achilles tendons. Similarly, our analysis found an increase in the size of the transverse section area in the diabetic group (1.328 +/- 0.103 mm(2)/100g) in comparison to the control group (0.940 +/- 0.01 mm(2)/100g) p = 0.021. The tendons of the diabetic group showed great irregularity in fiber bundles, including modified grain direction and jagged junctions and deformities in the form of collagen fibrils bulges. Despite the morphological changes observed in the Achilles tendon of diabetic animals, IL1 and TNF-alpha did not change. Our results suggest that DM promotes changes to the Achilles tendon with important structural modifications as seen by MR and AFM, excluding major inflammatory changes.	[de Oliveira, Rodrigo Ribeiro; Nasciutti, Luiz Eurico; de Castro Brito, Gerly Anne] Univ Fed Rio de Janeiro, Fed Univ Ceara, Interinst Doctorate Program Morphol Sci, Rio De Janeiro, Brazil; [de Oliveira, Rodrigo Ribeiro] Univ Fed Ceara, Dept Phys Therapy, Fortaleza, Ceara, Brazil; [de Oliveira, Rodrigo Ribeiro] Tendon Res Grp, Fortaleza, Ceara, Brazil; [de Mattos, Romulo Medina; Nasciutti, Luiz Eurico] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil; [Rebelo, Luciana Magalhaes] Univ Fed Ceara, Fac Phys, Dept Phys, Fortaleza, Ceara, Brazil; [Meireles Ferreira, Fernanda Guimaraes; Tovar-Moll, Fernanda] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil; [Meireles Ferreira, Fernanda Guimaraes; Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Ceara; Universidade Federal do Rio de Janeiro; Universidade Federal do Ceara; IDOR - Instituto D'Or de Ensino e Pesquisa; Universidade Federal do Rio de Janeiro	de Oliveira, RR (corresponding author), Univ Fed Rio de Janeiro, Fed Univ Ceara, Interinst Doctorate Program Morphol Sci, Rio De Janeiro, Brazil.; de Oliveira, RR (corresponding author), Univ Fed Ceara, Dept Phys Therapy, Fortaleza, Ceara, Brazil.; de Oliveira, RR (corresponding author), Tendon Res Grp, Fortaleza, Ceara, Brazil.	rodrigo@ufc.br	Moll, Fernanda Tovar/AAF-8477-2021; Moll, Fernanda Tovar/N-3320-2018; de Castro Brito, Gerly Anne/C-8597-2013; Alencar, Luciana Magalhães Rebelo/O-6736-2018; Brito, Gerly/AHB-3965-2022; de Oliveira, Rodrigo Ribeiro/N-9892-2013	Moll, Fernanda Tovar/0000-0002-0292-5985; Moll, Fernanda Tovar/0000-0002-0292-5985; de Castro Brito, Gerly Anne/0000-0002-8214-4379; Alencar, Luciana Magalhães Rebelo/0000-0001-8210-2016; Brito, Gerly/0000-0002-8214-4379; de Oliveira, Rodrigo Ribeiro/0000-0002-5810-3737	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [477692/2011-7]; CAPES [23038044935/2009-12]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Universal nu 477692/2011-7) and by a fellowship from the CAPES for Inter-institutional Doctorate Program in Morphological Sciences-Federal University of Ceara-UFC/Federal University of Rio de Janeiro-UFRJ-Brazil (Nu23038044935/2009-12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akturk M, 2007, EXP CLIN ENDOCR DIAB, V115, P92, DOI 10.1055/s-2007-955097; Akturk M, 2002, DIABETES CARE, V25, P408, DOI 10.2337/diacare.25.2.408; Alfredson H, 1999, KNEE SURG SPORT TR A, V7, P378, DOI 10.1007/s001670050184; Batista F, 2008, FOOT ANKLE INT, V29, P498, DOI 10.3113/FAI.2008.0498; Bohm S, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-015-0009-9; Bolton NRM, 2005, CLIN BIOMECH, V20, P540; Dall'Ago P, 2002, BRAZ J MED BIOL RES, V35, P843, DOI 10.1590/S0100-879X2002000700013; de Oliveira RR, 2011, DIABETIC MED, V28, P886, DOI 10.1111/j.1464-5491.2010.03197.x; de Oliveira RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074942; de Oliveira RR, 2012, J DIABETES COMPLICAT, V26, P163, DOI 10.1016/j.jdiacomp.2012.03.017; de Oliveira RR, 2011, ANN BIOMED ENG, V39, P1528, DOI 10.1007/s10439-011-0247-z; Fox AJS, 2011, J ORTHOPAEDIC RES; Giacomozzi C, 2005, CLIN BIOMECH, V20, P532, DOI 10.1016/j.clinbiomech.2005.01.011; Glazebrook MA, 2008, J ORTHOP RES, V26, P840, DOI 10.1002/jor.20546; Gonzalez AD, 2014, J BIOMECH, V47, P681, DOI 10.1016/j.jbiomech.2013.11.045; Kannus P, 1997, SCAND J MED SCI SPOR, V7, P107; Karjalainen PT, 2000, AM J ROENTGENOL, V175, P251, DOI 10.2214/ajr.175.1.1750251; LE JM, 1987, J IMMUNOL, V138, P2137; Lichtwark GA, 2010, J EXP BIOL, V213, P707, DOI 10.1242/jeb.038026; Maffulli N, 2002, J BONE JOINT SURG BR, V84B, P1, DOI 10.1302/0301-620X.84B1.12792; Maffulli N., 2005, TENDON INJURIES; Nakama LH, 2005, J ORTHOP RES, V23, P1199, DOI 10.1016/j.orthres.2005.03.006; Odetti P, 2000, DIABETES-METAB RES, V16, P74, DOI 10.1002/(SICI)1520-7560(200003/04)16:2<74::AID-DMRR80>3.3.CO;2-T; Paavola M, 2002, J BONE JOINT SURG AM, V84A, P2062, DOI 10.2106/00004623-200211000-00024; Papanas N, 2009, EXP CLIN ENDOCR DIAB, V117, P645, DOI 10.1055/s-0029-1224121; Ranger TA, 2015, BRIT J SPORTS MED; Riley G, 2004, RHEUMATOLOGY, V43, P131, DOI 10.1093/rheumatology/keg448; Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850; Szkudelski T, 2001, PHYSIOL RES, V50, P537; Yoo SD, 2012, LASER MED SCI, V27, P1195, DOI 10.1007/s10103-011-1049-0; Zhang ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108337	31	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0169513	10.1371/journal.pone.0169513	http://dx.doi.org/10.1371/journal.pone.0169513			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095484	Green Published, gold			2022-12-26	WOS:000392372300021
J	Gartner, F; Abraham, G; Kassner, A; Baurichter, D; Milting, H				Gaertner, Florian; Abraham, Getu; Kassner, Astrid; Baurichter, Daniela; Milting, Hendrik			Influence of Mechanical Circulatory Support on Endothelin Receptor Expression in Human Left Ventricular Myocardium from Patients with Dilated Cardiomyopathy (DCM)	PLOS ONE			English	Article							HEART-FAILURE PATIENTS; SELECTIVE UP-REGULATION; MESSENGER-RNA; INHIBITION; SECRETION	Background In terminal failing hearts ventricular assist devices (VAD) are implanted as a bridge to transplantation. Endothelin receptor (ETR) antagonists are used for treatment of secondary pulmonary hypertension in VAD patients. However, the cardiac ETR regulation in human heart failure and during VAD support is incompletely understood. Methods In paired left ventricular samples of 12 dilated cardiomyopathy patients we investigated the density of endothelin A (ETA) and B (ETB) receptors before VAD implantation and after device removal. Left ventricular samples of 12 non-failing donor hearts served as control. Receptor quantification was performed by binding of [1251]-ET-1 in the presence of nonselective and ETA selective ETR ligands as competitors. Additionally, the ETR mRNA expression was analyzed using quantitative real-time-PCR. Results The mRNA of ETA but not ETB receptors was significantly elevated in heart failure, whereas total ETR density analyzed by radioligand binding was significantly reduced due to ETB receptor down regulation. ETA and ETB receptor density showed poor correlation to mRNA data (spearman correlation factor: 0.43 and 0.31, respectively). VAD support had no significant impact on the density of both receptors and on mRNA expression of ETA whereas ETB mRNA increased during VAD. A meta-analysis reveals that the ETA receptor regulation in human heart failure appears to depend on non-failing hearts. Conclusions In deteriorating hearts of patients suffering from dilated cardiomyopathy the ETA receptor density is not changed whereas the ETB receptor is down regulated. The mRNA and the proteins of ETA and ETB show a weak correlation. Non-failing hearts might influence the interpretation of ETA receptor regulation. Mechanical unloading of the failing hearts has no impact on the myocardial ETR density.	[Gaertner, Florian; Kassner, Astrid; Baurichter, Daniela; Milting, Hendrik] Heart & Diabetesctr NRW, Erich & Hanna Klessmann Inst Cardiovasc Res & Dev, Clin Thorac & Cardiovasc Surg, Bad Oeynhausen, Germany; [Abraham, Getu] Univ Leipzig, Inst Pharmacol Pharm & Toxicol, Leipzig, Germany	Ruhr University Bochum; Leipzig University	Milting, H (corresponding author), Heart & Diabetesctr NRW, Erich & Hanna Klessmann Inst Cardiovasc Res & Dev, Clin Thorac & Cardiovasc Surg, Bad Oeynhausen, Germany.	hmilting@hdz-nrw.de			Actelion	Actelion	This work was supported by Actelion (CH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano K, 2002, J MOL CELL CARDIOL, V34, P833, DOI 10.1006/jmcc.2002.2022; DEBLASI A, 1989, TRENDS PHARMACOL SCI, V10, P227, DOI 10.1016/0165-6147(89)90266-6; Del Ry S, 2001, LIFE SCI, V68, P2715, DOI 10.1016/S0024-3205(01)01076-1; Dipla K, 1998, CIRCULATION, V97, P2316, DOI 10.1161/01.CIR.97.23.2316; Hafizi S, 2004, CELL PHYSIOL BIOCHEM, V14, P285, DOI 10.1159/000080338; Hasegawa K, 1996, HYPERTENSION, V27, P259, DOI 10.1161/01.HYP.27.2.259; Hefke T, 2012, THORAC CARDIOV SURG, V60, P26, DOI 10.1055/s-0030-1250726; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; ISHIKAWA T, 1988, PFLUG ARCH EUR J PHY, V413, P108, DOI 10.1007/BF00581239; ISHIKAWA T, 1988, AM J PHYSIOL, V255, pH970, DOI 10.1152/ajpheart.1988.255.4.H970; Krum H, 2001, Heart Fail Rev, V6, P341; LaRue SJ, 2015, CARDIOVASC THER; MACCUMBER MW, 1989, P NATL ACAD SCI USA, V86, P7285, DOI 10.1073/pnas.86.18.7285; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Maybaum S, 2007, CIRCULATION, V115, P2497, DOI 10.1161/CIRCULATIONAHA.106.633180; Milting H, 2008, J HEART LUNG TRANSPL, V27, P589, DOI 10.1016/j.healun.2008.02.018; Milting H, 2006, J MOL CELL CARDIOL, V41, P441, DOI 10.1016/j.yjmcc.2006.04.010; Morawietz H, 2000, CIRCULATION, V102, P188; NUNEZ DJR, 1990, J CLIN INVEST, V85, P1537, DOI 10.1172/JCI114601; Pieske B, 1999, CIRCULATION, V99, P1802, DOI 10.1161/01.CIR.99.14.1802; Ponicke K, 1998, CIRCULATION, V97, P744, DOI 10.1161/01.CIR.97.8.744; RESINK TJ, 1990, BIOCHEM BIOPH RES CO, V168, P1303, DOI 10.1016/0006-291X(90)91171-N; Sakai S, 1996, NATURE, V384, P353, DOI 10.1038/384353a0; Schafer S, 2009, CARDIOVASC RES, V82, P30, DOI 10.1093/cvr/cvp002; SCHWIENTEK P, 2010, PHYSIOL GENOMICS, V42, P397, DOI DOI 10.1152/PHYSI0LGEN0MICS.00030.2010; SEO B, 1994, CIRCULATION, V89, P1203, DOI 10.1161/01.CIR.89.3.1203; Serneri GGN, 2000, CIRC RES, V86, P377, DOI 10.1161/01.RES.86.4.377; STEGEMANN H, 1958, H-S Z PHYSIOL CHEM, V311, P41, DOI 10.1515/bchm2.1958.311.1.41; Touyz RM, 2003, CAN J PHYSIOL PHARM, V81, P533, DOI 10.1139/Y03-009; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WAGNER OF, 1992, J BIOL CHEM, V267, P16066; Walker CA, 2001, J CARD FAIL, V7, P129, DOI 10.1054/jcaf.2001.24125; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Zolk O, 1999, CIRCULATION, V99, P2118, DOI 10.1161/01.CIR.99.16.2118	34	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0169896	10.1371/journal.pone.0169896	http://dx.doi.org/10.1371/journal.pone.0169896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095452	Green Published, Green Submitted, gold			2022-12-26	WOS:000392372300041
J	Maggia, ME; Vigouroux, Y; Renno, JF; Duponchelle, F; Desmarais, E; Nunez, J; Garcia-Davila, C; Carvajal-Vallejos, FM; Paradis, E; Martin, JF; Mariac, C				Maggia, M. E.; Vigouroux, Y.; Renno, J. F.; Duponchelle, F.; Desmarais, E.; Nunez, J.; Garcia-Davila, C.; Carvajal-Vallejos, F. M.; Paradis, E.; Martin, J. F.; Mariac, C.			DNA Metabarcoding of Amazonian Ichthyoplankton Swarms	PLOS ONE			English	Article							BRACHYPLATYSTOMA-ROUSSEAUXII; RIVER; BIAS; AMPLIFICATION; CONSERVATION; PIMELODIDAE; ENRICHMENT; ALIGNMENT; CAPTURE; FISHES	Tropical rainforests harbor extraordinary biodiversity. The Amazon basin is thought to hold 30% of all river fish species in the world. Information about the ecology, reproduction, and recruitment of most species is still lacking, thus hampering fisheries management and successful conservation strategies. One of the key understudied issues in the study of population dynamics is recruitment. Fish larval ecology in tropical biomes is still in its infancy owing to identification difficulties. Molecular techniques are very promising tools for the identification of larvae at the species level. However, one of their limits is obtaining individual sequences with large samples of larvae. To facilitate this task, we developed a new method based on the massive parallel sequencing capability of next generation sequencing (NGS) coupled with hybridization capture. We focused on the mitochondrial marker cytochrome oxidase I (COI). The results obtained using the new method were compared with individual larval sequencing. We validated the ability of the method to identify Amazonian catfish larvae at the species level and to estimate the relative abundance of species in batches of larvae. Finally, we applied the method and provided evidence for strong temporal variation in reproductive activity of catfish species in the Ucayali River in the Peruvian Amazon. This new time and cost effective method enables the acquisition of large datasets, paving the way for a finer understanding of reproductive dynamics and recruitment patterns of tropical fish species, with major implications for fisheries management and conservation.	[Maggia, M. E.; Vigouroux, Y.; Mariac, C.] Univ Montpellier, Inst Rech Dev, Montpellier, France; [Renno, J. F.; Duponchelle, F.; Nunez, J.] UPMC, Unite Mixte Rech Biol Organismes & Ecosyst Aquat, Inst Rech Dev, MNHN,CNRS 7208,UCBN,IRD 207, Montpellier, France; [Renno, J. F.; Duponchelle, F.; Nunez, J.; Garcia-Davila, C.] UMR BOREA, IIAP UAGRM IRD, LMI EDIA, 7 Rue Cuvier,CP 32, Paris, France; [Desmarais, E.; Paradis, E.] Univ Montpellier, Inst Sci Evolut, UMR ISEM, CNRS,IRD,EPHE, Pl Eugene Bataillon CC 065, Montpellier, France; [Garcia-Davila, C.] IIAP, LBGM, Iquitos, Peru; [Carvajal-Vallejos, F. M.] ECOSINTEGRALES SRL, ULRA UMSS, FAUNAGUA, Cochabamba, Plurinational S, Bolivia; [Martin, J. F.] Montpellier SupAgro, Ctr Biol Gest Populat, UMR CBGP, Montferrier Sur Lez, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD)	Mariac, C (corresponding author), Univ Montpellier, Inst Rech Dev, Montpellier, France.	cedric.mariac@ird.fr	Martin, Jean-Francois/M-9426-2017; mariac, cedric/H-9868-2017; Duponchelle, Fabrice/K-1998-2016; Carvajal-Vallejos, Fernando M./AGO-7079-2022; vigouroux, Yves/A-9056-2011; Martin, Jean-Francois/AAD-3883-2019; Renno, Jean-François/L-1082-2017; Carvajal-Vallejos, Fernando M./R-7302-2019; Nunez, Jesus/J-4015-2016	Martin, Jean-Francois/0000-0001-9176-4476; mariac, cedric/0000-0001-6439-115X; Duponchelle, Fabrice/0000-0003-0497-2264; Carvajal-Vallejos, Fernando M./0000-0002-9110-490X; vigouroux, Yves/0000-0002-8361-6040; Martin, Jean-Francois/0000-0001-9176-4476; Nunez, Jesus/0000-0003-3668-5446; Garcia-Davila, Carmen/0000-0003-4125-5563; Renno, Jean-Francois/0000-0002-9071-0086	LMI EDIA; Institut de Recherche pour le Developpement	LMI EDIA; Institut de Recherche pour le Developpement	This project was funded by LMI EDIA and the Institut de Recherche pour le Developpement.	Cordoba EA, 2013, NEOTROP ICHTHYOL, V11, P637, DOI 10.1590/S1679-62252013000300017; Alonso JC, 2005, MANEJO PESCA GRANDES, P21; Araujo-Lima C. A. R. M., 2001, Brazilian Journal of Biology, V61, P357; Ardura A, 2010, FOOD RES INT, V43, P2295, DOI 10.1016/j.foodres.2010.08.004; Ardura A, 2010, FOOD RES INT, V43, P1549, DOI 10.1016/j.foodres.2010.03.016; Ardura A, 2010, BIOL CONSERV, V143, P1438, DOI 10.1016/j.biocon.2010.03.019; Barthem R., 1997, CATFISH CONNECTION E; Barthem R, 2007, ECOSISTEMA ESPERADO; Barthem R, 2014, BIODIVERSITY DYNAMIC, P137, DOI DOI 10.5772/57404; Barthem Ronaldo Borges, 1995, P329; Bye V.J., 1984, P187; Canas CM, 2011, RIVER RES APPL, V27, P602, DOI 10.1002/rra.1377; Carolsfeld J, 2003, MIGRATORY FISHES S A, V380; Carpenter ML, 2013, AM J HUM GENET, V93, P852, DOI 10.1016/j.ajhg.2013.10.002; Carvajal-Vallejos FM, 2013, THESIS; Castello L, 2013, CONSERV LETT, V6, P217, DOI 10.1111/conl.12008; Cella-Ribeiro A, 2015, J FISH BIOL, V86, P1429, DOI 10.1111/jfb.12630; Cordoba EA, 2000, BAGRES AMAZONIA COLO; Dawnay N, 2007, FORENSIC SCI INT, V173, P1, DOI 10.1016/j.forsciint.2006.09.013; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035126; Vasquez AG, 2009, J FISH BIOL, V75, P2527, DOI 10.1111/j.1095-8649.2009.02444.x; Garcia-Davila C, 2015, J APPL ICHTHYOL, V31; Garcia-Davila Carmen Rosa, 2014, Folia Amazonica, V23, P67; Goulding M., 1980, P1; Hawkins MTR, 2015, MOL ECOL RESOUR; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Junk W. J., 1997, CENTRAL AMAZON FLOOD; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kullander S.O., 2003, CHECK LIST FRESHWATE, P605; Leite RG, 2007, LARVAS GRANDES BAGRE; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu SL, 2016, MOL ECOL RESOUR, V16, P470, DOI 10.1111/1755-0998.12472; Mandel JR, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1300085; Mariac C, 2014, MOL ECOL RESOUR, V14, P1103, DOI 10.1111/1755-0998.12258; McConnell R, 1987, ECOLOGICAL STUDIES T; Pawluczyk M, 2015, ANAL BIOANAL CHEM, V407, P1841, DOI 10.1007/s00216-014-8435-y; Petrere M, 2004, REV FISH BIOL FISHER, V14, P403, DOI 10.1007/s11160-004-8362-7; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; R Core Team, 2021, R LANGUAGE ENV STAT; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Templeton Jennifer E L, 2013, Investig Genet, V4, P26, DOI 10.1186/2041-2223-4-26; Tollefson J, 2011, NATURE, V479, P160, DOI 10.1038/479160a; Turner TF, 2004, J FISH BIOL, V64, P186, DOI 10.1111/j.1095-8649.2004.00299.x; Van Damme PA, 2011, INIA COCHABAMBA BOLI, P327; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716	50	11	16	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0170009	10.1371/journal.pone.0170009	http://dx.doi.org/10.1371/journal.pone.0170009			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095487	Green Submitted, Green Published, gold			2022-12-26	WOS:000392372300049
J	Zmyslowski, W; Cabaj, AM; Slawinska, U				Zmyslowski, Wojciech; Cabaj, Anna M.; Slawinska, Urszula			Treatment with Riluzole Restores Normal Control of Soleus and Extensor Digitorum Longus Muscles during Locomotion in Adult Rats after Sciatic Nerve Crush at Birth	PLOS ONE			English	Article							FUNCTIONAL RECOVERY; GROWTH-FACTOR; HINDLIMB KINEMATICS; NEUROTROPHIC FACTOR; PARTIAL DENERVATION; SENSORY NEURONS; MOTOR FUNCTIONS; STANCE-PHASE; INJURY; MOTONEURONS	The effects of sciatic nerve crush (SNC) and treatment with Riluzole on muscle activity during unrestrained locomotion were identified in an animal model by analysis of the EMG activity recorded from soleus (Sol) and extensor digitorum longus (EDL) muscles of both hindlimbs; in intact rats (IN) and in groups of rats treated for 14 days with saline (S) or Riluzole (R) after right limb nerve crush at the 1st (1S and 1R) or 2nd (2S and 2R) day after birth. Changes in the locomotor pattern of EMG activity were correlated with the numbers of survived motor units (MUs) identified in investigated muscles. S rats with 2-8 and 10-28 MUs that survived in Sol and EDL muscles respectively showed increases in the duration and duty factor of muscle EMG activity and a loss of correlation between the duty factors of muscle activity, and abnormal flexor-extensor co-activation 3 months after SNC. R rats with 5, 6 (Sol) and 15-29 MUs (EDL) developed almost normal EMG activity of both Sol and control EDL muscles, whereas EDL muscles with SNC showed a lack of recovery. R rats with 8 (Sol) and 23-33 (EDL) MUs developed almost normal EMG activities of all four muscles. A subgroup of S rats with a lack of recovery and R rats with almost complete recovery that had similar number of MUs (8 and 24-28 vs 8 and 23-26), showed that the number of MUs was not the only determinant of treatment effectiveness. The results demonstrated that rats with SNC failed to develop normal muscle activity due to malfunction of neuronal circuits attenuating EDL muscle activity during the stance phase, whereas treatment with Riluzole enabled almost normal EMG activity of Sol and EDL muscles during locomotor movement.	[Zmyslowski, Wojciech; Cabaj, Anna M.] PAS, Nalecz Inst Biocybernet & Biomed Engn, Dept Engn Nervous & Muscular Syst, Warsaw, Poland; [Cabaj, Anna M.; Slawinska, Urszula] PAS, Nencki Inst Expt Biol, Dept Neurophysiol, Warsaw, Poland	Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Zmyslowski, W (corresponding author), PAS, Nalecz Inst Biocybernet & Biomed Engn, Dept Engn Nervous & Muscular Syst, Warsaw, Poland.	wzmyslowski@ibib.waw.pl	Slawinska, Urszula/R-4085-2016; Slawinska, Urszula/AAV-9919-2021	Slawinska, Urszula/0000-0003-2856-2729; Slawinska, Urszula/0000-0003-2856-2729; Zmyslowski, Wojciech/0000-0002-2435-0078	Polish Ministry of Science and High Education [1527/PO1/2006/31]	Polish Ministry of Science and High Education(Ministry of Science and Higher Education, Poland)	This work was supported by grants from the Polish Ministry of Science and High Education 1527/PO1/2006/31 and statutory donation from the Nencki Institute as well as the Nalecz Institute.; This work was supported by grants from the Polish Ministry of Science and High Education 1527/PO1/2006/31 (AMC) and statutory donation from the Nencki Institute (US) as well as the Nalecz Institute (WZ).	Abelew TA, 2000, J NEUROPHYSIOL, V84, P2709, DOI 10.1152/jn.2000.84.5.2709; Alvarez FJ, 2011, J NEUROPHYSIOL, V106, P2450, DOI 10.1152/jn.01095.2010; Alvarez FJ, 2010, ANN NY ACAD SCI, V1198, P231, DOI 10.1111/j.1749-6632.2010.05459.x; Amado S, 2011, BEHAV BRAIN RES, V225, P562, DOI 10.1016/j.bbr.2011.08.021; Bergerot A, 2004, EXP NEUROL, V187, P359, DOI 10.1016/j.expneurol.2004.02.003; BONDOK AA, 1984, EXP NEUROL, V86, P322, DOI 10.1016/0014-4886(84)90190-0; Bozkurt A, 2008, J NEUROSCI METH, V173, P91, DOI 10.1016/j.jneumeth.2008.05.020; Bozkurt A, 2011, BEHAV BRAIN RES, V219, P55, DOI 10.1016/j.bbr.2010.12.018; Cabaj A, 2015, 19 NAT C BIOC BIOM E, V85; Cabaj AM, 2012, J NEUROTRAUM, V29, P1506, DOI 10.1089/neu.2011.2090; Caumont AS, 2006, J NEUROCHEM, V97, P128, DOI 10.1111/j.1471-4159.2006.03711.x; Copray JCVM, 1997, NEUROSCI LETT, V236, P41, DOI 10.1016/S0304-3940(97)00747-7; de Ruiter GCW, 2008, EXP NEUROL, V211, P339, DOI 10.1016/j.expneurol.2007.12.023; Donelan JM, 2004, CAN J PHYSIOL PHARM, V82, P589, DOI 10.1139/Y04-043; Gorska T, 2009, BEHAV BRAIN RES, V196, P286, DOI 10.1016/j.bbr.2008.09.019; Gramsbergen A, 2000, EXP NEUROL, V161, P183, DOI 10.1006/exnr.1999.7233; Hayes HB, 2012, J NEUROPHYSIOL, V107, P3168, DOI 10.1152/jn.01134.2011; HNIK P, 1961, J EMBRYOL EXP MORPH, V9, P456; Kemp SWP, 2015, NEUROSCIENCE, V284, P202, DOI 10.1016/j.neuroscience.2014.10.005; Kemp SWP, 2015, DEV NEUROSCI-BASEL, V37, P66, DOI 10.1159/000368769; Kemp SWP, 2011, EXP NEUROL, V229, P460, DOI 10.1016/j.expneurol.2011.03.017; Khoo M, 2000, J PHYSIOL-LONDON, V525, p45P; Leinster VHL, 2010, NEUROSCIENCE, V166, P942, DOI 10.1016/j.neuroscience.2009.12.058; LOWRIE MB, 1992, TRENDS NEUROSCI, V15, P80, DOI 10.1016/0166-2236(92)90014-Y; Maas H, 2007, EXP BRAIN RES, V181, P377, DOI 10.1007/s00221-007-0938-8; McCrea DA, 2001, J PHYSIOL-LONDON, V533, P41, DOI 10.1111/j.1469-7793.2001.0041b.x; McCrea DA, 2008, BRAIN RES REV, V57, P134, DOI 10.1016/j.brainresrev.2007.08.006; Mizuta I, 2001, NEUROSCI LETT, V310, P117, DOI 10.1016/S0304-3940(01)02098-5; NAVARRETE R, 1984, J PHYSIOL-LONDON, V351, P675, DOI 10.1113/jphysiol.1984.sp015270; Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005; Nogradi A, 2001, EUR J NEUROSCI, V13, P113, DOI 10.1046/j.0953-816X.2000.01362.x; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Sabatier MJ, 2011, J EXP BIOL, V214, P1007, DOI 10.1242/jeb.051508; Sanusi J, 1998, DEV NEUROSCI-BASEL, V20, P546, DOI 10.1159/000017356; Shortland PJ, 2006, EUR J NEUROSCI, V24, P3343, DOI 10.1111/j.1460-9568.2006.05218.x; SLAWINSKA U, 1995, NEUROMUSCULAR DISORD, V5, P179, DOI 10.1016/0960-8966(94)00053-C; Slawinska U, 1998, EXP BRAIN RES, V120, P193, DOI 10.1007/s002210050393; Slawinska U, 2000, EXP BRAIN RES, V132, P27, DOI 10.1007/s002219900323; Slawinska U, 2012, J PHYSIOL-LONDON, V590, P1721, DOI 10.1113/jphysiol.2011.224931; Tyc F, 1999, ACTA NEUROBIOL EXP, V59, P105; VEJSADA R, 1991, NEUROSCIENCE, V40, P267, DOI 10.1016/0306-4522(91)90189-U; WALKER JL, 1994, J NEUROSCI METH, V52, P47, DOI 10.1016/0165-0270(94)90054-X; Wood MD, 2011, ANN ANAT, V193, P321, DOI 10.1016/j.aanat.2011.04.008; YIP HK, 1984, J NEUROSCI, V4, P2986; Zar JH, 1999, BIOSTATISTICAL ANAL; ZELENA J, 1963, PHYSIOL BOHEMOSLOV, V12, P277; Zelena J, 1994, NERVES MECHANORECEPT	47	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0170235	10.1371/journal.pone.0170235	http://dx.doi.org/10.1371/journal.pone.0170235			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095499	gold, Green Published, Green Submitted			2022-12-26	WOS:000392372300073
J	Araniti, F; Lupini, A; Sunseri, F; Abenavoli, MR				Araniti, Fabrizio; Lupini, Antonio; Sunseri, Francesco; Abenavoli, Maria Rosa			Allelopatic Potential of Dittrichia viscosa (L.) W. Greuter Mediated by VOCs: A Physiological and Metabolomic Approach	PLOS ONE			English	Article							PHYTOTOXIC ACTIVITY; INULA-VISCOSA; AMINO-ACID; OXIDATIVE STRESS; FOLIAR VOLATILES; PLANT-RESPONSES; ROOT-GROWTH; GERMINATION; PROLINE; ACCUMULATION	Dittrichia viscosa (L.) W. Greuter is a pioneer species belonging to the Compositae family. It is widespread in the Mediterranean basin, where it is considered invasive. It is a source of secondary metabolites, playing an important ecological role. D. viscosa plant extracts showed a phytotoxic activity on several physiological processes of different species. In the current study, the allelopathic potential of D. viscosa VOCs, released by its foliage, was evaluated on seed germination and root growth of lettuce. The VOCs effect was also studied on lettuce adult plants in microcosm systems, which better mimicked the open field conditions. D. viscosa VOCs inhibited both seed germination and root growth of lettuce. The VOCs composition revealed a large presence of terpenoids, responsible of the effects observed. Moreover, D. viscosa VOCs caused an alteration on plant water status accompanied by oxidative damages and photoinhibition on lettuce adult plants.	[Araniti, Fabrizio; Lupini, Antonio; Sunseri, Francesco; Abenavoli, Maria Rosa] Univ Mediterranea Reggio Calabria, Dipartimento AGR, Reggio Di Calabria, Italy	Universita Mediterranea di Reggio Calabria	Araniti, F; Abenavoli, MR (corresponding author), Univ Mediterranea Reggio Calabria, Dipartimento AGR, Reggio Di Calabria, Italy.	fabrizio.araniti@unirc.it; mrabenavoli@unirc.it	Lupini, Antonio/D-9126-2012; ENSA - NHSA, Algiers/AAF-1768-2019; Araniti, Fabrizio/F-9925-2016; Sunseri, Francesco/O-8013-2015	Lupini, Antonio/0000-0003-0321-3151; Araniti, Fabrizio/0000-0002-4983-4116; Abenavoli, Maria Rosa/0000-0001-5926-9985; Sunseri, Francesco/0000-0001-5201-5413	Italian Ministry of Education, University and Research (MIUR) [SIR-2014, RBSI14L9CE]	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This research was supported by the Italian Ministry of Education, University and Research (MIUR), project SIR-2014 cod. RBSI14L9CE (MEDANAT) - Principal Investigator Fabrizio Araniti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Italian Ministry of Education, University and Research (MIUR), project SIR-2014 cod. RBSI14L9CE (MEDANAT).	Abrahim D, 2000, J CHEM ECOL, V26, P611, DOI 10.1023/A:1005467903297; Abrahim D, 2003, PLANT PHYSL BIOCH, V41; Akcay N, 2012, J PLANT PHYSIOL, V169, P452, DOI 10.1016/j.jplph.2011.11.006; Al Harun MAY, 2014, S AFR J BOT, V93, P157, DOI 10.1016/j.sajb.2014.04.008; Alexenizer M, 2007, J PEST SCI, V80, P205, DOI 10.1007/s10340-007-0173-x; Antikainen M, 1997, PHYSIOL PLANTARUM, V99, P423, DOI 10.1034/j.1399-3054.1997.990310.x; Araniti F, 2012, ALLELOPATHY J, V29, P107; Araniti F, 2016, ACTA PHYSIOL PLANT, V38, P1; Araniti F, 2016, PLANT BIOL; Araniti F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160202; Araniti F, 2014, PHYTOCHEM LETT, V8, P179, DOI 10.1016/j.phytol.2013.08.019; Araniti F, 2014, ACTA PHYSIOL PLANT, V36, P1071, DOI 10.1007/s11738-013-1482-8; Araniti F, 2013, NAT PROD RES, V27, P2297, DOI 10.1080/14786419.2013.827193; Araniti F, 2013, NAT PROD RES, V27, P1651, DOI 10.1080/14786419.2012.746337; Araniti F, 2013, ACTA PHYSIOL PLANT, V35, P1979, DOI 10.1007/s11738-013-1236-7; Araniti F, 2013, NAT PROD RES, V27, P880, DOI 10.1080/14786419.2012.691491; Arminante F, 2006, ALLELOPATHIC ACTIVIT, V723; Barbafieri M, 2011, INT J PHYTOREMEDIAT, V13, P985, DOI 10.1080/15226514.2010.549858; BARNETT NM, 1966, PLANT PHYSIOL, V41, P1222, DOI 10.1104/pp.41.7.1222; Barney JN, 2005, J CHEM ECOL, V31, P247, DOI 10.1007/s10886-005-1339-8; Baxter CJ, 2007, PLANT PHYSIOL, V143, P312, DOI 10.1104/pp.106.090431; Boothe JG, 1997, PLANT PHYSIOL, V113, P367, DOI 10.1104/pp.113.2.367; Boscaiu M., 2016, OSMOLYTES PLANTS ACC; Bourguignon J, 1999, BOOK SOIL P, P111; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADOW JM, 1990, J CHEM ECOL, V16, P645, DOI 10.1007/BF01016477; Camacho A., 2000, Rivista Italiana EPPOS, P3; Celik TA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/189252; Chaimovitsh D, 2010, PLANT J, V61, P399, DOI 10.1111/j.1365-313X.2009.04063.x; Chon SU, 2002, CROP PROT, V21, P1077, DOI 10.1016/S0261-2194(02)00092-3; D'Abrosca B, 2013, PHYTOCHEMISTRY, V93, P27, DOI 10.1016/j.phytochem.2013.03.016; Duke S, 2004, MODE ACTION PHYTOTOX; Eom SH, 2006, J CHEM ECOL, V32, P1835, DOI 10.1007/s10886-006-9112-1; Galili G, 2016, ANNU REV PLANT BIOL, V67, P153, DOI 10.1146/annurev-arplant-043015-112213; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Gibson KD, 2002, WEED RES, V42, P351, DOI 10.1046/j.1365-3180.2002.00295.x; Grana E, 2015, PLANT BIOL; GRANDE M, 1992, J NAT PROD, V55, P1074, DOI 10.1021/np50086a007; GRANDE M, 1992, PHYTOCHEMISTRY, V31, P1826, DOI 10.1016/0031-9422(92)83159-V; GRANDE M, 1985, PLANTA MED, V51, P414, DOI 10.1055/s-2007-969536; HANSON AD, 1982, ANNU REV PLANT PHYS, V33, P163, DOI 10.1146/annurev.pp.33.060182.001115; Havaux M, 2001, PLANTA, V213, P953, DOI 10.1007/s004250100572; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hortensteiner S, 2011, BBA-BIOENERGETICS, V1807, P977, DOI 10.1016/j.bbabio.2010.12.007; Hulme PE, 2010, ATLAS BIODIVERSITY R; Hussain MI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114826; Jones R. G. W., 1983, Genetic engineering of plants. An agricultural perspective, P355; Kinnersley AM, 2000, CRIT REV PLANT SCI, V19, P479, DOI 10.1016/S0735-2689(01)80006-X; Kishor PBK, 2014, PLANT CELL ENVIRON, V37, P300, DOI 10.1111/pce.12157; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Levizou E, 2002, FLORA, V197, P152, DOI 10.1078/0367-2530-00025; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; LORBER P, 1976, AM J BOT, V63, P196, DOI 10.2307/2441700; Mamoci E, 2011, MOLECULES, V16, P2609, DOI 10.3390/molecules16032609; Mansour F, 2004, PHYTOPARASITICA, V32, P66, DOI 10.1007/BF02980862; Maoz M, 2000, J ETHNOPHARMACOL, V71, P479, DOI 10.1016/S0378-8741(00)00187-2; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; McCalla Fred T M, 1974, AGR ENVIRON, V1, P153, DOI DOI 10.1016/0304-1131(74)90050-2; MERSIE W, 1993, J CHEM ECOL, V19, P1293, DOI 10.1007/BF00984876; MULLER CH, 1966, B TORREY BOT CLUB, V93, P332, DOI 10.2307/2483447; MULLER WALTER H., 1964, BULL TORREY BOT CLUB, V91, P327, DOI 10.2307/2483297; MULLER WH, 1965, BOT GAZ, V126, P195, DOI 10.1086/336319; Murciego AM, 2007, ENVIRON POLLUT, V145, P15, DOI 10.1016/j.envpol.2006.04.004; Nishida N, 2005, J CHEM ECOL, V31, P1187, DOI 10.1007/s10886-005-4256-y; Oka Y, 2001, NEMATOLOGY, V3, P735, DOI 10.1163/156854101753625245; Oka Y, 2006, J NEMATOL, V38, P46; Omezzine F, 2011, INT J AGRIC BIOL, V13, P841; Ort DR, 2002, CURR OPIN PLANT BIOL, V5, P193, DOI 10.1016/S1369-5266(02)00259-5; Parolin P, 2014, PHYTON-INT J EXP BOT, V83, P251; Perez-Alonso Maria Jose, 1996, Flavour and Fragrance Journal, V11, P349, DOI 10.1002/(SICI)1099-1026(199611)11:6&lt;349::AID-FFJ593&gt;3.0.CO;2-1; Pietragalla J., 2012, PHYSIOLOGICAL BREEDI, P25; Poonpaiboonpipat T, 2013, IND CROP PROD, V41, P403, DOI 10.1016/j.indcrop.2012.04.057; Reigosa MJ, 2007, J CHEM ECOL, V33, P1456, DOI 10.1007/s10886-007-9318-x; Rice E. L., 1984, Allelopathy.; ROBINSON SA, 1992, PLANT PHYSIOL, V98, P1190, DOI 10.1104/pp.98.3.1190; Romagni JG, 2000, J CHEM ECOL, V26, P303, DOI 10.1023/A:1005414216848; Sairam RK, 2002, PLANT SCI, V163, P1037, DOI 10.1016/S0168-9452(02)00278-9; Schulz M, 2007, PLANT SIGNAL BEHAV, V2, P231, DOI 10.4161/psb.2.4.4469; Sharma SS, 2006, J EXP BOT, V57, P711, DOI 10.1093/jxb/erj073; Shelp BJ, 1999, TRENDS PLANT SCI, V4, P446, DOI 10.1016/S1360-1385(99)01486-7; SHI HT, 2014, J INTEGR PLANT BIOL, V56, P1064, DOI DOI 10.1111/jipb.12167; Shiraishi Sayaka, 2002, Weed Biology and Management, V2, P133, DOI 10.1046/j.1445-6664.2002.00063.x; SIMOES F, 1990, Fitoterapia, V61, P553; Singh HP, 2006, ANN BOT-LONDON, V98, P1261, DOI 10.1093/aob/mcl213; Skopelitis DS, 2006, PLANT CELL, V18, P2767, DOI 10.1105/tpc.105.038323; Slama I, 2015, ANN BOT; Stamatakis K., 2001, PHOTOSYNTH RES, V69, P119; Stavrianakou S, 2006, ENVIRON EXP BOT, V56, P293, DOI 10.1016/j.envexpbot.2005.03.007; Stewart G. R., 1980, The biochemistry of plants. A comprehensive treatise. Volume 5. Amino acids and derivatives., P609; Sunmonu TO, 2014, S AFR J BOT, V90, P101, DOI 10.1016/j.sajb.2013.10.010; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; SZABO L.G., 2000, ACTA BOT HUNGARICA, V42, P295; Verslues PE, 2006, J EXP BOT, V57, P201, DOI 10.1093/jxb/erj026; Warlop F., 2010, POURQUOI COMMENT PRO, P1; Watanabe S, 2000, PLANT CELL TISS ORG, V63, P199, DOI 10.1023/A:1010619503680; Waters ER, 1996, J EXP BOT, V47, P325, DOI 10.1093/jxb/47.3.325; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Wu-xing L, 2010, FUJIAN J AGR SCI, V1; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Zeng RS, 2001, AGRON J, V93, P72, DOI 10.2134/agronj2001.93172x	100	27	27	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0170161	10.1371/journal.pone.0170161	http://dx.doi.org/10.1371/journal.pone.0170161			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085959	Green Published, gold, Green Submitted			2022-12-26	WOS:000391972600071
J	Plotka, M; Wozniak, M; Kaczorowski, T				Plotka, Magdalena; Wozniak, Mateusz; Kaczorowski, Tadeusz			Quantification of Plasmid Copy Number with Single Colour Droplet Digital PCR	PLOS ONE			English	Article							REAL-TIME PCR; ESCHERICHIA-COLI; DNA EXTRACTION; GENE-THERAPY; BACTERIAL; SYSTEM; QUANTITATION; RECOVERY; CELLS; SPECIFICITY	Bacteria can be considered as biological nanofactories that manufacture a cornucopia of bioproducts most notably recombinant proteins. As such, they must perfectly match with appropriate plasmid vectors to ensure successful overexpression of target genes. Among many parameters that correlate positively with protein productivity plasmid copy number plays pivotal role. Therefore, development of new and more accurate methods to assess this critical parameter will result in optimization of expression of plasmid-encoded genes. In this study, we present a simple and highly accurate method for quantifying plasmid copy number utilizing an EvaGreen single colour, droplet digital PCR. We demonstrate the effectiveness of this method by examining the copy number of the pBR322 vector within Escherichia coli DH5 alpha cells. The obtained results were successfully validated by real-time PCR. However, we observed a strong dependency of the plasmid copy number on the method chosen for isolation of the total DNA. We found that application of silica-membrane-based columns for DNA purification or DNA isolation with use of bead-beating, a mechanical cell disruption lead to determination of an average of 20.5 or 7.3 plasmid copies per chromosome, respectively. We found that recovery of the chromosomal DNA from purification columns was less efficient than plasmid DNA (46.5 +/- 1.9% and 87.4 +/- 5.5%, respectively) which may lead to observed differences in plasmid copy number. Besides, the plasmid copy number variations dependent on DNA template isolation method, we found that droplet digital PCR is a very convenient method for measuring bacterial plasmid content. Careful determination of plasmid copy number is essential for better understanding and optimization of recombinant proteins production process. Droplet digital PCR is a very precise method that allows performing thousands of individual PCR reactions in a single tube. The ddPCR does not depend on running standard curves and is a straightforward and reliable method to quantify the plasmid copy number. Therefore we believe that the ddPCR designed in this study will be widely used for any plasmid copy number calculation in the future.	[Plotka, Magdalena; Wozniak, Mateusz; Kaczorowski, Tadeusz] Univ Gdansk, Dept Microbiol, Lab Extremophiles Biol, Gdansk, Poland	Fahrenheit Universities; University of Gdansk	Kaczorowski, T (corresponding author), Univ Gdansk, Dept Microbiol, Lab Extremophiles Biol, Gdansk, Poland.	tadeusz.kaczorowski@biol.ug.edu.pl	Kaczorowski, Tadeusz/AAX-2027-2020; Plotka, Magdalena/AAY-3997-2020	Plotka, Magdalena/0000-0002-2871-8060	Narodowe Centrum Nauki grant [N302 654240]	Narodowe Centrum Nauki grant(National Science Centre, Poland)	This work was supported by Narodowe Centrum Nauki grant no. N302 654240.	ADAMS CW, 1984, J BIOL CHEM, V259, P7399; Akasaka N, 2015, J BIOSCI BIOENG, V119, P661, DOI 10.1016/j.jbiosc.2014.11.003; Beuselinck K, 2005, J CLIN MICROBIOL, V43, P5541, DOI 10.1128/JCM.43.11.5541-5546.2005; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; Carapuca E, 2007, MOL BIOTECHNOL, V37, P120, DOI 10.1007/s12033-007-0007-3; CARLSON A, 1995, BIOTECHNOL BIOENG, V48, P303, DOI 10.1002/bit.260480403; COPPELLA SJ, 1987, J CHROMATOGR, V402, P189, DOI 10.1016/0021-9673(87)80017-1; Corbisier P, 2015, ANAL BIOANAL CHEM, V407, P1831, DOI 10.1007/s00216-015-8458-z; CORONADO C, 1994, PLASMID, V32, P336, DOI 10.1006/plas.1994.1074; de Boer RF, 2010, J CLIN MICROBIOL, V48, P4140, DOI 10.1128/JCM.01124-10; Dobnik D, 2016, SCI REP-UK, V6, DOI 10.1038/srep35451; Francesconi A, 2008, J CLIN MICROBIOL, V46, P1978, DOI 10.1128/JCM.02246-07; Friehs K, 2004, ADV BIOCHEM ENG BIOT, V86, P47; Herweijer H, 2003, GENE THER, V10, P453, DOI 10.1038/sj.gt.3301983; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Jahn M, 2014, ANAL CHEM, V86, P5969, DOI 10.1021/ac501118v; Klein D, 2002, TRENDS MOL MED, V8, P257, DOI 10.1016/S1471-4914(02)02355-9; Kolisnychenko V, 2002, GENOME RES, V12, P640, DOI 10.1101/gr.217202; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kuske CR, 1998, APPL ENVIRON MICROB, V64, P2463; Lee CL, 2006, J MICROBIOL METH, V65, P258, DOI 10.1016/j.mimet.2005.07.019; Lee C, 2006, J BIOTECHNOL, V123, P273, DOI 10.1016/j.jbiotec.2005.11.014; LINCHAO S, 1986, MOL GEN GENET, V203, P143, DOI 10.1007/BF00330395; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McDermott GP, 2013, ANAL CHEM, V85, P11619, DOI 10.1021/ac403061n; MILLER CA, 1993, MOL MICROBIOL, V9, P695, DOI 10.1111/j.1365-2958.1993.tb01730.x; Miotke L, 2014, ANAL CHEM, V86, P2618, DOI 10.1021/ac403843j; Morisset D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062583; Mumy KL, 2004, J MICROBIOL METH, V57, P259, DOI 10.1016/j.mimet.2004.01.013; Pfaffl M.W., 2004, A Z QUANT PCR, P87; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Prazeres DMF, 1999, TRENDS BIOTECHNOL, V17, P169, DOI 10.1016/S0167-7799(98)01291-8; PROJAN SJ, 1983, PLASMID, V9, P182, DOI 10.1016/0147-619X(83)90019-7; Pushnova EA, 2000, ANAL BIOCHEM, V284, P70, DOI 10.1006/abio.2000.4668; Rocha EPC, 2004, MICROBIOL-SGM, V150, P1609, DOI 10.1099/mic.0.26974-0; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schmidt T, 1996, J BIOTECHNOL, V49, P219, DOI 10.1016/0168-1656(96)01519-2; Skulj M, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-6; Smith MA, 1998, CAN J MICROBIOL, V44, P351, DOI 10.1139/cjm-44-4-351; Stefanska A, 2016, J APPL GENET, V57, P239, DOI 10.1007/s13353-015-0314-5; Stefanska A, 2014, J BIOTECHNOL, V182, P1, DOI 10.1016/j.jbiotec.2014.04.015; TAYLOR RG, 1993, NUCLEIC ACIDS RES, V21, P1677, DOI 10.1093/nar/21.7.1677; Vogel M, 1998, BIOTECHNIQUES, V24, P540; Vogel M, 1988, BIOTECHNIQUES, V24, P544; Werbowy O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148355; Werbowy O, 2015, PLASMID, V77, P39, DOI 10.1016/j.plasmid.2014.12.002; Williams PD, 2011, CARDIOVASC RES, V91, P565, DOI 10.1093/cvr/cvr197; WOMBLE DD, 1977, J BACTERIOL, V130, P148, DOI 10.1128/JB.130.1.148-153.1977; Wrobel B, 1998, PLASMID, V39, P48, DOI 10.1006/plas.1997.1319	52	14	15	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0169846	10.1371/journal.pone.0169846	http://dx.doi.org/10.1371/journal.pone.0169846			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085908	Green Published, Green Submitted, gold			2022-12-26	WOS:000391972600040
J	Sinha, AK; Patel, JR; Shen, Y; Ueno, NT; Giordano, SH; Tripathy, D; Lopez, DS; Barcenas, CH				Sinha, Arup K.; Patel, Jenil R.; Shen, Yu; Ueno, Naoto T.; Giordano, Sharon H.; Tripathy, Debu; Lopez, David S.; Barcenas, Carlos H.			Location of Receipt of Initial Treatment and Outcomes in Long-Term Breast Cancer Survivors	PLOS ONE			English	Article							REFERRAL BIAS; IMPACT; VOLUME; CENTERS; RISK	Purpose Cancer outcomes differ depending on where treatment is received. We assessed differences in outcomes in long-term breast cancer survivors at a specialty care hospital by location of their initial treatment. Methods We retrospectively examined a cohort of women diagnosed with invasive early-stage breast cancer who did not experience recurrence for at least 5 years after the date of diagnosis and were evaluated at The University of Texas MD Anderson Cancer Center between January 1997 and August 2008. The location of initial treatment was categorized as MD Anderson (MDA-treated) or other (OTH-treated). Outcomes analyzed included recurrence-free survival (RFS), distant relapse-free survival (DRFS), and overall survival (OS). The Kaplan-Meier product-limit method was used to compare outcomes between the two groups. Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI). Results We identified 5,091 breast cancer survivors (median follow-up 8.6 years), of whom 89.1% were MDA-treated. The 10-year OS, RFS, and DRFS rates were 90.9%, 88.4%, and 89.0% in the MDA-treated group and 74.3%, 49.8%, and 52.7% in the OTH-treated group, respectively. We observed worse outcomes in the OTH-group in both the univariate analysis and the multivariable analysis (OS: HR = 4.8, 95% CI = 3.9-6.0; RFS: HR = 5.8, 95% CI = 4.8-7.0; DRFS: HR = 5.4, 95% CI = 4.5-6.6). Conclusion Long-term breast cancer survivors who initiated their treatment at MD Anderson had better outcomes. Location of initial treatment could be an independent risk factor for survival outcomes at specialty care hospitals. This analysis has limitations inherent to retrospective observational studies such as other unmeasured variables may be associated with worse prognosis.	[Sinha, Arup K.; Ueno, Naoto T.; Giordano, Sharon H.; Tripathy, Debu; Barcenas, Carlos H.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Sinha, Arup K.] Univ Texas Houston, Sch Publ Hlth, Dept Biostat, Houston, TX USA; [Patel, Jenil R.; Lopez, David S.] Univ Texas Houston, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Houston, TX USA; [Shen, Yu] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Giordano, Sharon H.] Univ Texas MD Anderson Canc Ctr, Dept Hlth Serv Res, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Barcenas, CH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA.	chbarcenas@mdanderson.org	Patel, Jenil/K-7703-2019	Giordano, Sharon H./0000-0002-8700-2767; Patel, Jenil/0000-0002-4875-7390; Lopez, David S./0000-0002-2321-0372	MD Anderson Young Breast Cancer Survivors Program Fund [104029]; NATIONAL CANCER INSTITUTE [K12CA088084, P30CA016672] Funding Source: NIH RePORTER	MD Anderson Young Breast Cancer Survivors Program Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors received research support from the MD Anderson Young Breast Cancer Survivors Program Fund 104029 for this project.	Alderman AK, 2010, CANCER-AM CANCER SOC, V116, P1791, DOI 10.1002/cncr.24891; Birkmeyer NJO, 2005, CANCER-AM CANCER SOC, V103, P435, DOI 10.1002/cncr.20785; Brewster AM, 2008, JNCI-J NATL CANCER I, V100, P1179, DOI 10.1093/jnci/djn233; Cheung MC, 2009, ANN SURG ONCOL, V16, P3, DOI 10.1245/s10434-008-0025-9; Colditz GA, 2014, CA-CANCER J CLIN, V64, P186, DOI 10.3322/caac.21225; Farias AJ, 2016, J CLIN ONCOLOGY; Harirchi I, 2015, ARCH BREAST CANC, V2, P52, DOI DOI 10.19187/abc.20152252-57; Hewitt, 2001, INTERPRETING VOLUME; Hillner BE, 2000, J CLIN ONCOL, V18, P2327, DOI 10.1200/JCO.2000.18.11.2327; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; Kokmen E, 1996, J CLIN EPIDEMIOL, V49, P79, DOI 10.1016/0895-4356(95)00031-3; Kwan ML, 2014, AM J EPIDEMIOL, V179, P95, DOI 10.1093/aje/kwt233; NELSON LM, 1988, J CLIN EPIDEMIOL, V41, P187, DOI 10.1016/0895-4356(88)90093-5; Pfister DG, 2015, JAMA ONCOL, V1, P1303, DOI 10.1001/jamaoncol.2015.3151; Richards MA, 1999, LANCET, V353, P1119, DOI 10.1016/S0140-6736(99)02143-1; Riggs JE, 2005, J RURAL HEALTH, V21, P269, DOI 10.1111/j.1748-0361.2005.tb00094.x; Vrijens F, 2012, BREAST, V21, P261, DOI 10.1016/j.breast.2011.12.002; Wheeler SB, 2013, ONCOLOGIST, V18, P986, DOI 10.1634/theoncologist.2013-0243; Wong SL, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.6004	19	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0170081	10.1371/journal.pone.0170081	http://dx.doi.org/10.1371/journal.pone.0170081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085940	Green Submitted, Green Published, gold			2022-12-26	WOS:000391972600058
J	Strauss, T; von Maltitz, MJ				Strauss, Trudie; von Maltitz, Michael Johan			Generalising Ward's Method for Use with Manhattan Distances	PLOS ONE			English	Article								The claim that Ward's linkage algorithm in hierarchical clustering is limited to use with Euclidean distances is investigated. In this paper, Ward's clustering algorithm is generalised to use with l(1) norm or Manhattan distances. We argue that the generalisation of Ward's linkage method to incorporate Manhattan distances is theoretically sound and provide an example of where this method outperforms the method using Euclidean distances. As an application, we perform statistical analyses on languages using methods normally applied to biology and genetic classification. We aim to quantify differences in character traits between languages and use a statistical language signature based on relative bi-gram ( sequence of two letters) frequencies to calculate a distance matrix between 32 Indo-European languages. We then use Ward's method of hierarchical clustering to classify the languages, using the Euclidean distance and the Manhattan distance. Results obtained from using the different distance metrics are compared to show that the Ward's algorithm characteristic of minimising intra-cluster variation and maximising inter-cluster variation is not violated when using the Manhattan metric.	[Strauss, Trudie; von Maltitz, Michael Johan] Univ Free State, Dept Math Stat & Actuarial Sci, Bloemfontein, South Africa	University of the Free State	Strauss, T (corresponding author), Univ Free State, Dept Math Stat & Actuarial Sci, Bloemfontein, South Africa.	strauss.trudie@gmail.com	von Maltitz, Michael J/H-1366-2015	von Maltitz, Michael J/0000-0001-7308-651X				AbuJamous B, 2015, INTEGRATIVE CLUSTER ANALYSIS IN BIOINFORMATICS, P1, DOI 10.1002/9781118906545; Algeo John, 2004, ORIGINS DEV ENGLISH; [Anonymous], 2010, MATLAB VERS 7 10 0; Barber Charles, 2009, ENGLISH LANGUAGE HIS, V2nd; Benedetto D, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.048702; Boeva V, 2014, SPRINGER HANDBOOK OF BIO-/NEUROINFORMATICS, P223; Brock G, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i04; Chen ZM, 1996, J CLASSIF, V13, P157, DOI 10.1007/BF01202586; Christensen H., 2014, HC CORPORA; CORMACK RM, 1971, J R STAT SOC SER A-G, V134, P321, DOI 10.2307/2344237; FARRIS JS, 1972, AM NAT, V106, P645, DOI 10.1086/282802; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; Gagolewski Marek, 2016, R PACKAGE STRINGI CH; Goldhahn D, 2012, LREC 2012 - EIGHTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION, P759; Hammarstrom H, 2015, GLOTTOLOG 2 6; Handl J, 2005, BIOINFORMATICS, V21, P3201, DOI 10.1093/bioinformatics/bti517; Hogg R, 2006, HISTORY OF THE ENGLISH LANGUAGE, P1, DOI 10.1017/CBO9780511791154; Kastovsky D, 2006, HISTORY OF THE ENGLISH LANGUAGE, P199, DOI 10.1017/CBO9780511791154.005; LANCE GN, 1967, COMPUT J, V9, P373, DOI 10.1093/comjnl/9.4.373; Maechler, 2016, CLUSTER ANAL BASICS; Mayer T, 2014, OCEANIA, V135, P40; MILLIGAN GW, 1979, PSYCHOMETRIKA, V44, P343, DOI 10.1007/BF02294699; Miyamoto S., 2012, P IEEE INT C FUZZ SY, P1, DOI [10.1109/FUZZ-IEEE.2012.6250800, DOI 10.1109/FUZZ-IEEE.2012.6250800]; Mullner D, 2013, J STAT SOFTW, V53, P1; Nerbonne John, 1997, COMPUTATIONAL PHONOL; R Core Team, 2013, R LANG ENV STAT COMP; Rencher AC, 2002, METHODS MULTIVARIATE; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Romero A, 2015, ENVIRON GEOCHEM HLTH, V37, P273, DOI 10.1007/s10653-014-9645-0; Ross NCM, 2000, J AM SOC INFORM SCI, V51, P949, DOI 10.1002/1097-4571(2000)51:10<949::AID-ASI70>3.0.CO;2-5; Schleicher A., 1863, DARWINSCHE THEORIE S; Schleicher August, 1848, VERGLEICHENDEN SPRAC; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; SHANNON CE, 1951, BELL SYST TECH J, V30, P50, DOI 10.1002/j.1538-7305.1951.tb01366.x; SOKAL RR, 1986, ANNU REV ECOL SYST, V17, P423; Sokal RR, 1963, PRINCIPLES NUMERICAL; Szekely GJ, 2005, J CLASSIF, V22, P151, DOI 10.1007/s00357-005-0012-9; Theodoridis S., 2003, PATTERN RECOGNITION; Tohsato Y, 2008, GENOME INFORM SER, V21, P42; Turchi M., 2006, EV LANG P 6 INT C EV, P348; VOGT W, 1992, CLIN CHEM, V38, P182; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Warnow T, 1997, P NATL ACAD SCI USA, V94, P6585, DOI 10.1073/pnas.94.13.6585	43	88	88	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0168288	10.1371/journal.pone.0168288	http://dx.doi.org/10.1371/journal.pone.0168288			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH7SJ	28085891	Green Published, Green Submitted, gold			2022-12-26	WOS:000391972600006
J	Lu, DG; Qiao, YR; Brown, NE; Wang, JL				Lu, Degan; Qiao, Yanru; Brown, Natalie E.; Wang, Junling			Racial and Ethnic Disparities in Influenza Vaccination among Adults with Chronic Medical Conditions Vary by Age in the United States	PLOS ONE			English	Article							HEALTH-CARE; RACIAL/ETHNIC DISPARITIES; SELF-REPORT; IMPACT; POPULATIONS; MORTALITY; COVERAGE; HOSPITALIZATIONS; IMMUNIZATION; PREVENTION	Background People living with chronic health conditions exhibit higher risk for developing severe complications from influenza according to the Centers for Diseases Control and Prevention. Although racial and ethnic disparities in influenza vaccination have been documented, it has not been comprehensively determined whether similar disparities are present among the adult population with at least one such condition. Objective To study if racial and ethnic disparities in relation to influenza vaccination are present in adults suffering from at least one chronic condition and if such inequalities differ between age groups. Methods The Medical Expenditure Panel Survey (2011-2012) was used to study the adult population (age >= 18) who had at least one chronic health condition. Baseline differences in population traits across racial and ethnic groups were identified using a chi-square test. This was conducted among various age groups. In addition, survey logistic regression was utilized to produce odds ratios of receiving influenza vaccination annually between racial and ethnic groups. Results The total sample consisted of 15,499 adults living with at least one chronic health condition. The numbers of non-Hispanic whites (whites), non-Hispanic blacks (blacks), and Hispanics were 8,658, 3,585, and 3,256, respectively. Whites (59.93%) were found to have a higher likelihood of self-reporting their receipt of the influenza vaccine in comparison to the black (48.54%) and Hispanic (48.65%) groups (P<0.001). When examining persons aged 50-64 years and >= 65 years, it was noted that the black (54.99%, 62.72%) and Hispanic (53.54%, 64.48%) population had lower rates of influenza vaccine coverage than the white population (59.22%, 77.89) (both P<0.0001). No significant differences between whites and the blacks or Hispanics were found among the groups among adults between 18 and 49 inclusive (P>0.05). After controlling for patient characteristics, the difference in influenza vaccine coverage between whites and the minority groups were no longer significant for adults aged 50-64 years. However, the difference were still statistically significant for those aged >= 65 years. Conclusions In the United States, there are significant disparities in influenza vaccination by race and ethnicity for adults over 65 years with at least one chronic health condition. Future research is needed to help develop more targeted interventions to address these issues and improve influenza vaccination rates.	[Lu, Degan] Shandong Univ, Shandong Prov Qianfoshan Hosp, Dept Resp Med, Jinan, Shandong, Peoples R China; [Qiao, Yanru; Wang, Junling] Univ Tennessee, Coll Pharm, Memphis, TN USA; [Brown, Natalie E.] Univ Tennessee, Coll Pharm, Hlth Sci Ctr, Memphis, TN USA	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Lu, DG (corresponding author), Shandong Univ, Shandong Prov Qianfoshan Hosp, Dept Resp Med, Jinan, Shandong, Peoples R China.	deganlu@126.com						Aday L A, 1974, Health Serv Res, V9, P208; Agency for Healthcare Research and Quality, 2009, MED EXP PAN SURV; Centers for Disease Control and Prevention, 2012, CHRON DIS OV; Chen JY, 2007, J COMMUN HEALTH, V32, P5, DOI 10.1007/s10900-006-9031-7; Cohen B, 2012, J EPIDEMIOL COMMUN H, V66, P204, DOI 10.1136/jech.2009.099879; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Egede LE, 2003, AM J PUBLIC HEALTH, V93, P2074, DOI 10.2105/AJPH.93.12.2074; Egede LE, 2003, AM J PUBLIC HEALTH, V93, P324, DOI 10.2105/AJPH.93.2.324; Eiser AR, 2007, ACAD MED, V82, P176, DOI 10.1097/ACM.0b013e31802d92ea; Fiscella K, 2007, PREV MED, V45, P83, DOI 10.1016/j.ypmed.2007.03.007; Groom HC, 2014, J PUBLIC HEALTH MAN, V20, P246, DOI 10.1097/PHH.0b013e318298bd88; Hebert PL, 2005, HEALTH SERV RES, V40, P517, DOI 10.1111/j.1475-6773.2005.0e371.x; Howard DH, 2006, J GEN INTERN MED, V21, P857, DOI 10.1111/j.1525-1497.2006.00530.x; Hutchins SS, 2009, AM J PUBLIC HEALTH, V99, pS261, DOI 10.2105/AJPH.2009.161505; Ison MG, 2009, J INFECT DIS, V200, P485, DOI 10.1086/600384; Kennedy Bernice Roberts, 2007, J Cult Divers, V14, P56; La Torre G, 2010, PUBLIC HEALTH, V124, P690, DOI 10.1016/j.puhe.2010.06.006; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; Li Yanrui, 2010, J Biomed Biotechnol, V2010, P716515, DOI 10.1155/2010/716515; Lindley MC, 2006, AM J PREV MED, V31, P281, DOI 10.1016/j.amepre.2006.06.025; Linn ST, 2010, J AM GERIATR SOC, V58, P1333, DOI 10.1111/j.1532-5415.2010.02904.x; Logan JL, 2009, J NATL MED ASSOC, V101, P161, DOI 10.1016/S0027-9684(15)30830-0; Lu PJ, 2014, AM J INFECT CONTROL, V42, P763, DOI 10.1016/j.ajic.2014.03.021; Lu PJ, 2013, AM J EPIDEMIOL, V178, P1478, DOI 10.1093/aje/kwt158; Lu PJ, 2008, VACCINE, V26, P1786, DOI 10.1016/j.vaccine.2008.01.040; Lu PJ, 2005, ARCH INTERN MED, V165, P1849, DOI 10.1001/archinte.165.16.1849; Maciosek MV, 2006, AM J PREV MED, V31, P72, DOI 10.1016/j.amepre.2006.03.008; Mangtani P, 2007, EPIDEMIOL INFECT, V135, P139, DOI 10.1017/S0950268806006479; Marcus P, 2010, CHEST, V138, P188, DOI 10.1378/chest.09-1342; Marder E, 2013, MMWR-MORBID MORTAL W, V62, P1; Matias G, 2014, INFLUENZA OTHER RESP, V8, P507, DOI 10.1111/irv.12258; Maurer J, 2014, J GEN INTERN MED, V29, P1624, DOI 10.1007/s11606-014-2965-z; Maurer J, 2009, J HEALTH ECON, V28, P704, DOI 10.1016/j.jhealeco.2009.01.005; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Mullooly JP, 2007, VACCINE, V25, P846, DOI 10.1016/j.vaccine.2006.09.041; Nichol KL, 2005, DRUG AGING, V22, P495, DOI 10.2165/00002512-200522060-00004; Ojha RP, 2015, AM J PUBLIC HEALTH, V105, pE35, DOI 10.2105/AJPH.2015.302736; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Ompad DC, 2006, EPIDEMIOL REV, V28, P54, DOI 10.1093/epirev/mxj004; Palmer NRA, 2013, AM J PUBLIC HEALTH, V103, P1306, DOI 10.2105/AJPH.2012.301096; Rangel MC, 2005, J GEN INTERN MED, V20, P426, DOI 10.1111/j.1525-1497.2005.0097.x; Schneider EC, 2001, JAMA-J AM MED ASSOC, V286, P1455, DOI 10.1001/jama.286.12.1455; Singleton JA, 2005, AM J PREV MED, V29, P412, DOI 10.1016/j.amepre.2005.08.012; Takayama M, 2012, PREV MED, V54, P358, DOI 10.1016/j.ypmed.2012.03.008; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; US Department of Health and Human Services, 2011, HLTH PEOPL 2020; Walker FJ, 2006, INFECT CONT HOSP EP, V27, P257, DOI 10.1086/501538; Wooten KG, 2012, VACCINE, V30, P6927, DOI 10.1016/j.vaccine.2012.08.036; Yoo BK, 2011, AM J PREV MED, V40, P1, DOI 10.1016/j.amepre.2010.09.028; Zimmerman RK, 2003, VACCINE, V21, P1486, DOI 10.1016/S0264-410X(02)00700-4; [No title captured], DOI DOI 10.5888/PCD11.130389	53	25	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169679	10.1371/journal.pone.0169679	http://dx.doi.org/10.1371/journal.pone.0169679			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH7JQ	28081234	Green Submitted, gold, Green Published			2022-12-26	WOS:000391949500061
J	Oben, KZ; Gachuki, BW; Alhakeem, SS; McKenna, MK; Liang, Y; St Claire, DK; Rangnekar, VM; Bondada, S				Oben, Karine Z.; Gachuki, Beth W.; Alhakeem, Sara S.; McKenna, Mary K.; Liang, Ying; St. Claire, Daret K.; Rangnekar, Vivek M.; Bondada, Subbarao			Radiation Induced Apoptosis of Murine Bone Marrow Cells Is Independent of Early Growth Response 1 (EGR1)	PLOS ONE			English	Article							TRANSCRIPTION FACTOR EGR-1; COMMONLY DELETED REGION; MALIGNANT MYELOID DISEASES; MYELODYSPLASTIC SYNDROME; MOLECULAR DELINEATION; CANCER-CELLS; IN-VITRO; GENE; EXPRESSION; TRANSFORMATION	An understanding of how each individual 5q chromosome critical deleted region (CDR) gene contributes to malignant transformation would foster the development of much needed targeted therapies for the treatment of therapy related myeloid neoplasms (t-MNs). Early Growth Response 1 (EGR1) is a key transcriptional regulator of myeloid differentiation located within the 5q chromosome CDR that has been shown to regulate HSC (hematopoietic stem cell) quiescence as well as the master regulator of apoptosis D p53. Since resistance to apoptosis is a hallmark of malignant transformation, we investigated the role of EGR1 in apoptosis of bone marrow cells; a cell population from which myeloid malignancies arise. We evaluated radiation induced apoptosis of Egr1(+/+) and Egr1(-/-) bone marrow cells in vitro and in vivo. EGR1 is not required for radiation induced apoptosis of murine bone marrow cells. Neither p53 mRNA (messenger RNA) nor protein expression is regulated by EGR1 in these cells. Radiation induced apoptosis of bone marrow cells by double strand DNA breaks induced p53 activation. These results suggest EGR1 dependent signaling mechanisms do not contribute to aberrant apoptosis of malignant cells in myeloid malignancies.	[Oben, Karine Z.; Gachuki, Beth W.; Alhakeem, Sara S.; McKenna, Mary K.; Rangnekar, Vivek M.; Bondada, Subbarao] Univ Kentucky, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40506 USA; [Liang, Ying; St. Claire, Daret K.] Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY USA; [Liang, Ying] Univ Kentucky, Dept Internal Med, Lexington, KY USA; [Rangnekar, Vivek M.] Univ Kentucky, Dept Radiat Med, Lexington, KY USA; [Rangnekar, Vivek M.; Bondada, Subbarao] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40506 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Bondada, S (corresponding author), Univ Kentucky, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40506 USA.; Bondada, S (corresponding author), Univ Kentucky, Markey Canc Ctr, Lexington, KY 40506 USA.	bandada@email.uky.edu		Alhakeem, Sara/0000-0002-1644-1164; Oben, Karine/0000-0003-0195-7253	Edward P. Evan's Foundation; National Institutes of Health [CA 165469]; University of Kentucky Markey Cancer Center [P30CA177558]; NATIONAL CANCER INSTITUTE [R01CA165469, P30CA177558] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124015] Funding Source: NIH RePORTER	Edward P. Evan's Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Kentucky Markey Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the Edward P. Evan's Foundation, the National Institutes of Health (CA 165469), and the University of Kentucky Markey Cancer Center (P30CA177558). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2016, EST NUMB NEW CAS DEA; Amin HM, 2005, LEUKEMIA, V19, P1567, DOI 10.1038/sj.leu.2403876; Baron V, 2006, CANCER GENE THER, V13, P115, DOI 10.1038/sj.cgt.7700896; Baron V, 2003, ANN NY ACAD SCI, V1002, P197, DOI 10.1196/annals.1281.024; Baron V, 2003, ONCOGENE, V22, P4194, DOI 10.1038/sj.onc.1206560; BOULTWOOD J, 1994, GENOMICS, V19, P425, DOI 10.1006/geno.1994.1090; Boultwood J, 2002, BLOOD, V99, P4638, DOI 10.1182/blood.V99.12.4638; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Calogero A, 2001, CLIN CANCER RES, V7, P2788; Calogero A, 2004, CANCER CELL INT, V4, DOI 10.1186/1475-2867-4-1; Cheong MW, 2015, J MOL MED, V93, P807, DOI 10.1007/s00109-015-1272-4; CHRISTY B, 1989, P NATL ACAD SCI USA, V86, P8737, DOI 10.1073/pnas.86.22.8737; Das A, 2001, J BIOL CHEM, V276, P3279, DOI 10.1074/jbc.M008454200; de Belle I, 1999, ONCOGENE, V18, P3633, DOI 10.1038/sj.onc.1202696; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Ebert BL, 2009, LEUKEMIA, V23, P1252, DOI 10.1038/leu.2009.53; Fodde R, 2002, SCIENCE, V298, P761, DOI 10.1126/science.1077707; Godley LA, 2008, SEMIN ONCOL, V35, P418, DOI 10.1053/j.seminoncol.2008.04.012; GOGUEL AF, 1995, CANCER GENET CYTOGEN, V80, P47, DOI 10.1016/0165-4608(94)00154-4; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Gururajan M, 2008, J IMMUNOL, V181, P4590, DOI 10.4049/jimmunol.181.7.4590; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang RP, 1997, INT J CANCER, V72, P102, DOI 10.1002/(SICI)1097-0215(19970703)72:1<102::AID-IJC15>3.0.CO;2-L; Joslin JM, 2007, BLOOD, V110, P719, DOI 10.1182/blood-2007-01-068809; Karlsson C, 1996, CANCER RES, V56, P241; Ke JY, 2006, J BIOL CHEM, V281, P39806, DOI 10.1074/jbc.M604671200; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Krones-Herzig A, 2005, CANCER RES, V65, P5133, DOI 10.1158/0008-5472.CAN-04-3742; Lai F, 2001, GENOMICS, V71, P235, DOI 10.1006/geno.2000.6414; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; LEBEAU MM, 1993, P NATL ACAD SCI USA, V90, P5484, DOI 10.1073/pnas.90.12.5484; LEBEAU MM, 1986, J CLIN ONCOL, V4, P325, DOI 10.1200/JCO.1986.4.3.325; LEVIN WJ, 1995, ONCOGENE, V11, P1261; LEVINE AJ, 1993, ANNU REV BIOCHEM, V62, P623, DOI 10.1146/annurev.bi.62.070193.003203; Liu CT, 2000, J BIOL CHEM, V275, P20315, DOI 10.1074/jbc.M909046199; Liu CT, 1998, CANCER GENE THER, V5, P3; Liu CT, 1999, J BIOL CHEM, V274, P4400, DOI 10.1074/jbc.274.7.4400; Mariotti LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079541; Matt S, 2016, CELLULAR MOL LIFE SC; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Murati A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-304; Muthukkumar S, 1997, J BIOL CHEM, V272, P27987, DOI 10.1074/jbc.272.44.27987; MUTHUSAMY N, 1991, J IMMUNOL, V147, P2483; Nair P, 1997, J BIOL CHEM, V272, P20131, DOI 10.1074/jbc.272.32.20131; NGUYEN HQ, 1993, CELL, V72, P197, DOI 10.1016/0092-8674(93)90660-I; Nunamaker EA, 2013, COMPARATIVE MED, V63, P22; OSHIMURA M, 1988, CANCER RES, V48, P1623; Scholz V, 1997, Z NATURFORSCH C, V52, P364; Stoddart A, 2014, BLOOD, V123, P1069, DOI 10.1182/blood-2013-07-517953; Stoddart A, 2011, MEDITERR J HEMATOL I, V3, DOI 10.4084/MJHID.2011.019; Takeyama K, 2000, INT J HEMATOL, V71, P144; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; Yoon TM, 2015, ONCOL REP, V33, P1717, DOI 10.3892/or.2015.3747; Yu JX, 2004, MOL CELL, V15, P83, DOI 10.1016/j.molcel.2004.06.030; Zhao DNY, 2015, MOL CANCER THER, V14, P2343, DOI 10.1158/1535-7163.MCT-14-1051; Zhao ND, 1997, P NATL ACAD SCI USA, V94, P6948, DOI 10.1073/pnas.94.13.6948	58	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169767	10.1371/journal.pone.0169767	http://dx.doi.org/10.1371/journal.pone.0169767			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081176	Green Published, Green Submitted, gold			2022-12-26	WOS:000391949500073
J	Park, CH; Kim, JH; Lee, EB; Hur, W; Kwon, OJ; Park, HJ; Yoon, SK				Park, Chung-Hwa; Kim, Jung-Hee; Lee, Eun Byul; Hur, Wonhee; Kwon, Oh-Joo; Park, Hyoung-Jin; Yoon, Seung Kew			Aronia melanocarpa Extract Ameliorates Hepatic Lipid Metabolism through PPAR gamma 2 Downregulation	PLOS ONE			English	Article							FATTY LIVER-DISEASE; PPAR-GAMMA; NONALCOHOLIC STEATOHEPATITIS; DIABETES-MELLITUS; OXIDATIVE STRESS; OBESE MICE; LEPTIN; JUICE; ACCUMULATION; LIPOGENESIS	Nonalcoholic fatty liver disease (NAFLD) is a hepatic manifestation of metabolic syndrome. Studies have demonstrated that anthocyanin-rich foods may improve hyperlipidemia and ameliorate hepatic steatosis. Here, effects of Aronia melanocarpa (AM), known to be rich of anthocyanins, on hepatic lipid metabolism and adipogenic genes were determined. AM was treated to C57BL/6N mice fed with high fat diet (HFD) or to FL83B cells treated with free fatty acid (FFA). Changes in levels of lipids, enzymes and hormones were observed, and expressions of adipogenic genes involved in hepatic lipid metabolism were detected by PCR, Western blotting and luciferase assay. In mice, AM significantly reduced the body and liver weight, lipid accumulation in the liver, and levels of biochemical markers such as fatty acid synthase, hepatic triglyceride and leptin. Serum transaminases, indicators for hepatocyte injury, were also suppressed, while superoxide dismutase activity and liver antioxidant capacity were significantly increased. In FL83B cells, AM significantly reduced FFA-induced lipid droplet accumulation. Protein synthesis of an adipogenic transcription factor, peroxisome proliferator-activated receptor gamma 2 (PPAR gamma 2) was inhibited in vivo. Furthermore, transcriptional activity of PPAR gamma 2 was down-regulated in vitro, and mRNA expression of PPAR gamma 2 and its downstream target genes, adipocyte protein 2 and lipoprotein lipase were down-regulated by AM both in vitro and in vivo. These results show beneficial effects of AM against hepatic lipid accumulation through the inhibition of PPAR gamma 2 expression along with improvements in body weight, liver functions, lipid profiles and antioxidant capacity suggesting the potential therapeutic efficacy of AM on NAFLD.	[Park, Chung-Hwa; Yoon, Seung Kew] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Gastroenterol & Hepatol, Seoul, South Korea; [Park, Chung-Hwa; Kim, Jung-Hee; Lee, Eun Byul; Hur, Wonhee; Yoon, Seung Kew] Catholic Univ Korea, CULRC, Seoul, South Korea; [Kim, Jung-Hee; Lee, Eun Byul; Hur, Wonhee; Yoon, Seung Kew] Catholic Univ Korea, WHO Collaborating Ctr Viral Hepatitis, Seoul, South Korea; [Kwon, Oh-Joo] Catholic Univ Korea, Coll Med, Dept Med Biochem, Seoul, South Korea; [Park, Hyoung-Jin] MushMed Co LTD, Chuncheon Si, Gangwon Do, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Yoon, SK (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Gastroenterol & Hepatol, Seoul, South Korea.	yoonsk@catholic.ac.kr		Park, Chung-Hwa/0000-0001-5992-6156	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2015R1A2A1A15052783]; MushMed Co., LTD	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; MushMed Co., LTD	This study was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2015R1A2A1A15052783). There was no additional external funding received for this study. MushMed Co., LTD. provided support in the form of salaries for HJP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section, and this does not alter our adherence to PLOS ONE policies on sharing data and materials.	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Almonacid-Urrego CC, 2012, CURR MED CHEM, V19, P1389, DOI 10.2174/092986712799462586; Badescu M, 2015, PHARM BIOL, V53, P533, DOI 10.3109/13880209.2014.931441; Berlanga A, 2014, CLIN EXP GASTROENTER, V7, P221, DOI 10.2147/CEG.S62831; Broncel M, 2010, MED SCI MONITOR, V16, pCR28; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chang JJ, 2013, J AGR FOOD CHEM, V61, P6069, DOI 10.1021/jf401171k; Chrubasik C, 2010, PHYTOTHER RES, V24, P1107, DOI 10.1002/ptr.3226; den Besten G, 2015, DIABETES, V64, P2398, DOI 10.2337/db14-1213; Fuchs M, 2012, J HEPATOL, V56, P291, DOI 10.1016/j.jhep.2011.05.019; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Geliebter Allan, 2014, J Diabetes Obes, V1, P1; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Guo HH, 2011, J LIPID RES, V52, P908, DOI 10.1194/jlr.M013375; Hsu YW, 2010, FOOD CHEM TOXICOL, V48, P1644, DOI 10.1016/j.fct.2010.03.039; Hur W, 2012, NUTR RES, V32, P778, DOI 10.1016/j.nutres.2012.06.017; Hwang YP, 2011, NUTR RES, V31, P896, DOI 10.1016/j.nutres.2011.09.026; Ikejima K, 2005, HEPATOL RES, V33, P151, DOI 10.1016/j.hepres.2005.09.024; Kardum N, 2014, EFFECTS GLUCOMANNAN, V2014, DOI [10.1155/2014/869250, DOI 10.1155/2014/869250]; Kim B, 2013, NUTR RES, V33, P406, DOI 10.1016/j.nutres.2013.03.001; Kohjima M, 2007, INT J MOL MED, V20, P351; Lefterova MI, 2014, TRENDS ENDOCRIN MET, V25, P293, DOI 10.1016/j.tem.2014.04.001; Lomonaco R, 2013, DRUGS, V73, P1, DOI 10.1007/s40265-012-0004-0; Madhujith T, 2006, J AGR FOOD CHEM, V54, P3283, DOI 10.1021/jf0527504; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Mantzaris MD, 2011, FEBS J, V278, P519, DOI 10.1111/j.1742-4658.2010.07972.x; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Matsusue K, 2014, FEBS LETT, V588, P2277, DOI 10.1016/j.febslet.2014.05.012; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; Mulero J, 2012, CLIN NUTR, V31, P372, DOI 10.1016/j.clnu.2011.11.014; Neuman MG, 2014, CAN J GASTROENTEROL, V28, P607, DOI 10.1155/2014/757929; Nikolopoulou E, 2014, J LIPID RES, V55, P2479, DOI 10.1194/jlr.M049551; Park S, 2011, J HEPATOL, V54, P984, DOI 10.1016/j.jhep.2010.08.019; Pettinelli P, 2011, J CLIN ENDOCR METAB, V96, P1424, DOI 10.1210/jc.2010-2129; Polyzos SA, 2015, METABOLISM, V64, P60, DOI 10.1016/j.metabol.2014.10.012; Qin BL, 2012, BRIT J NUTR, V108, P581, DOI 10.1017/S000711451100599X; Rahimian R, 2001, MOL CELL BIOCHEM, V224, P29, DOI 10.1023/A:1011927113563; Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Salamone F, 2012, WORLD J GASTROENTERO, V18, P3862, DOI 10.3748/wjg.v18.i29.3862; Serviddio G, 2013, FREE RADICAL BIO MED, V65, P952, DOI 10.1016/j.freeradbiomed.2013.08.174; Skarpanska-Stejnborn A, 2014, J INT SOC SPORT NUTR, V11, DOI 10.1186/s12970-014-0048-5; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004; Tessari P, 2009, NUTR METAB CARDIOVAS, V19, P291, DOI 10.1016/j.numecd.2008.12.015; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Tsuda T, 2003, J NUTR, V133, P2125, DOI 10.1093/jn/133.7.2125; Upadhyay G, 2007, EUR J PHARMACOL, V565, P190, DOI 10.1016/j.ejphar.2007.03.004; Valcheva-Kuzmanova S, 2004, EXP TOXICOL PATHOL, V56, P195, DOI 10.1016/j.etp.2004.04.012; Valcheva-Kuzmanova SV, 2014, FOLIA MED, V56, P199; Valenti L, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/145421; Yamazaki T, 2011, J NUTR BIOCHEM, V22, P543, DOI 10.1016/j.jnutbio.2010.04.009; Zhai XG, 2013, BRIT J PHARMACOL, V169, P197, DOI 10.1111/bph.12114	53	27	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169685	10.1371/journal.pone.0169685	http://dx.doi.org/10.1371/journal.pone.0169685			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081181	Green Published, Green Submitted, gold			2022-12-26	WOS:000391949500064
J	Shu, R; Bai, D; Sheu, T; He, Y; Yang, XR; Xue, CR; He, YR; Zhao, MY; Han, XL				Shu, Rui; Bai, Ding; Sheu, Tzongjen; He, Yao; Yang, Xianrui; Xue, Chaoran; He, Yiruo; Zhao, Mengyuan; Han, Xianglong			Sclerostin Promotes Bone Remodeling in the Process of Tooth Movement	PLOS ONE			English	Article							OSTEOGENIC RESPONSE; IN-VIVO; OSTEOCLASTS; EXPRESSION; RESORPTION; CELLS; MICE; STIMULATION; OSTEOCYTES; DENSITY	Tooth movement is a biological process of bone remodeling induced by mechanical force. Sclerostin secreted by osteocytes is mechanosensory and important in bone remodeling. However, little is known regarding the role of sclerostin in tooth movement. In this study, models of experimental tooth movement were established in rats and mice. Sclerostin expression was investigated with immunohistochemistry staining, and osteoclastic activity was analyzed with tartrate-resistant acid phosphatase (TRAP) staining. MLO-Y4 osteocytelike cells underwent uniaxial compression and tension stress or were cultured in hypoxia conditions. Expression of sclerostin was assessed by RT-qPCR and ELISA. MLO-Y4 cells were cultured with recombinant human sclerostin (rhSCL) interference and then co-cultured with RAW264.7 osteoclast precursor cells. Expressions of RANKL and OPG were analyzed by RT-qPCR, and osteoclastic activity was assessed by TRAP staining. During tooth movement, sclerostin was expressed differently in compression and tension sites. In SOST knock-out mice, there were significantly fewer TRAP-positive cells than in WT mice during tooth movement in compression sites. In-vitro studies showed that the expression of sclerostin in MLO-Y4 osteocyte-like cells was not different under a uniaxial compression and tension force, whereas hypoxia conditions significantly increased sclerostin expression in MLO-Y4 cells. rhSCL interference increased the expression of RANKL and the RANKL/OPG ratio in MLO-Y4 cells and the osteoclastic induction ability of MLO-Y4 cells in experimental osteocyte-osteoclast co-culture. These data suggest that sclerostin plays an important role in the bone remodeling of tooth movement.	[Shu, Rui; Bai, Ding; He, Yao; Yang, Xianrui; Xue, Chaoran; He, Yiruo; Zhao, Mengyuan; Han, Xianglong] Sichuan Univ, Dept Orthodont, State Key Lab Oral Dis, West China Sch Stomatol, Chengdu, Sichuan, Peoples R China; [Sheu, Tzongjen] Univ Rochester, Med Ctr, Sch Med & Dent, Rochester, NY 14642 USA	Sichuan University; University of Rochester	Han, XL (corresponding author), Sichuan Univ, Dept Orthodont, State Key Lab Oral Dis, West China Sch Stomatol, Chengdu, Sichuan, Peoples R China.	xhan@vip.163.com	Yang, Xianrui/E-3584-2018	Bai, Ding/0000-0002-5058-4329	National Natural Science Foundation of China [11172190, 81371171, 81371172, 81500885]; Research Fund for the Doctoral Program of Higher Education of China [20130181110013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported by National Natural Science Foundation of China (Grant No. 11172190 (received by Ding), 81371171 (received by Ding), 81371172 (received by Xianglong) and 81500885 (received by Rui)) and Research Fund for the Doctoral Program of Higher Education of China, Grant No. 20130181110013 (received by Ding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balemans W., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P139; Bonewald Lynda F, 2006, Bonekey Osteovision, V3, P7; Brooks PJ, 2009, ANGLE ORTHOD, V79, P1108, DOI 10.2319/121508-638R.1; Bumann A, 1997, EUR J ORTHODONT, V19, P29, DOI 10.1093/ejo/19.1.29; Chen DX, 2013, ADV DIFFER EQU-NY, DOI 10.1186/1687-1847-2013-125; Clinkenbeard Erica L, 2016, Curr Mol Biol Rep, V2, P62; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Genetos DC, 2010, J CELL BIOCHEM, V110, P457, DOI 10.1002/jcb.22559; Hou JH, 2014, KOREAN J ORTHOD, V44, P320, DOI 10.4041/kjod.2014.44.6.320; Ikeda Kyoji, 2007, Clin Calcium, V17, P1554; KHOUW F E, 1970, Archives of Oral Biology, V15, P1125, DOI 10.1016/0003-9969(70)90003-8; Klein-Nulend J, 2013, BONE, V54, P182, DOI 10.1016/j.bone.2012.10.013; KUITERT RB, 1989, ACTA MORPHOL NEER SC, V26, P191; Lai XH, 2015, BONE RES, V3, DOI 10.1038/boneres.2015.9; Le Li M, 2015, ANGLE ORTHODONTIST; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Liu SG, 2007, AM J PHYSIOL-ENDOC M, V293, pE1636, DOI 10.1152/ajpendo.00396.2007; Masella RS, 2006, AM J ORTHOD DENTOFAC, V129, P458, DOI 10.1016/j.ajodo.2005.12.013; Matsumoto T, 2013, J DENT RES, V92, P340, DOI 10.1177/0022034513476037; McGee-Lawrence ME, 2013, BIOCHEM BIOPH RES CO, V441, P886, DOI 10.1016/j.bbrc.2013.10.155; Moustafa A, 2012, OSTEOPOROSIS INT, V23, P1225, DOI 10.1007/s00198-011-1656-4; Niklas A, 2013, INT J DENT, V2013, DOI 10.1155/2013/841840; Noble BS, 2003, AM J PHYSIOL-CELL PH, V284, pC934, DOI 10.1152/ajpcell.00234.2002; Ota K, 2013, J CELL BIOCHEM, V114, P1901, DOI 10.1002/jcb.24537; Ott SM, 2005, J CLIN ENDOCR METAB, V90, P6741, DOI 10.1210/jc.2005-2370; Quarles LD, 2012, NAT REV ENDOCRINOL, V8, P276, DOI 10.1038/nrendo.2011.218; Rangiani A, 2015, EUROPEAN J ORTHODONT; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Tu XL, 2012, BONE, V50, P209, DOI 10.1016/j.bone.2011.10.025; Turner CH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268pt3; Wergedal JE, 2003, J CLIN ENDOCR METAB, V88, P5778, DOI 10.1210/jc.2003-030201; Wijenayaka AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025900; Xu H, 2015, INT J ORAL SCI, V7, P232, DOI 10.1038/ijos.2015.26; Xu YM, 2016, EXP THER MED, V12, P2741, DOI 10.3892/etm.2016.3674; Yadav S, 2015, AM J ORTHOD DENTOFAC, V148, P440, DOI 10.1016/j.ajodo.2015.03.031; Yang XR, 2016, J ORAL SCI, V58, P271, DOI 10.2334/josnusd.15-0690; Yoshiko Y, 2007, BONE, V40, P1565, DOI 10.1016/j.bone.2007.01.017; You LD, 2008, BONE, V42, P172, DOI 10.1016/j.bone.2007.09.047; Zhang P, 2012, INT J MOL MED, V29, P1083, DOI 10.3892/ijmm.2012.934	40	20	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0167312	10.1371/journal.pone.0167312	http://dx.doi.org/10.1371/journal.pone.0167312			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081119	gold, Green Published, Green Submitted			2022-12-26	WOS:000391949500002
J	Tarrio-Saavedra, J; Gonzalez, CG; Naya, S; Lopez-Beceiro, J; Ponton, A				Tarrio-Saavedra, Javier; Gonzalez, Cecilia Galindo; Naya, Salvador; Lopez-Beceiro, Jorge; Ponton, Alain			Statistical Modeling Applied to Deformation-Relaxation Processes in a Composite Biopolymer Network Induced by Magnetic Field	PLOS ONE			English	Article							THERMAL-STABILITY; SILICA	This study investigated a methodology based on image processing and statistics to characterize and model the deformation upon controlled and uniform magnetic field and the relaxation under zero field of droplets observed in aqueous solutions of sodium alginate incorporating magnetic maghemite nanoparticles stabilized by adsorption of citrate ions. The changes of droplet geometry were statistically analyzed using a new approach based on the data obtained from optical microscopy, image processing, nonlinear regression, evolutionary optimization, analysis of variance and resampling. Image enhancement and then image segmentation (Gaussian mixture modeling) processes were applied to extract features with reliable information of droplets dimensions from optical micrographs. The droplets deformation and relaxation trends were accurately adjusted by the Kohlrausch-Williams-Watts (KWW) function and a mean relaxation time was obtained by fitting the time evolution of geometry parameters. It was found to be proportional to the initial radius of the spherical droplets and was associated to interfacial tension.	[Tarrio-Saavedra, Javier; Naya, Salvador] Univ A Coruna, EPS, Dept Math, Avda Mendizabal S-N, Ferrol, Spain; [Gonzalez, Cecilia Galindo; Ponton, Alain] Univ Paris 07, CNRS, UMR 7057, Matiere & Syst Complexes, Batiment Condorcet Case 7056, Paris, France; [Lopez-Beceiro, Jorge] Univ A Coruna, EPS, Dept Ind Engn 2, Avda Mendizabal S-N, Ferrol, Spain	Universidade da Coruna; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; Universidade da Coruna	Ponton, A (corresponding author), Univ Paris 07, CNRS, UMR 7057, Matiere & Syst Complexes, Batiment Condorcet Case 7056, Paris, France.	alain.ponton@univ-paris-diderot.fr	López-Beceiro, Jorge/AAC-6246-2019; Naya, Salvador/F-7405-2014; Tarrío-Saavedra, Javier/K-9077-2017	Naya, Salvador/0000-0003-4931-9859; Tarrío-Saavedra, Javier/0000-0002-9584-127X; Lopez-Beceiro, Jorge/0000-0001-6438-3520; Ponton, Alain/0000-0003-4743-2161	Spanish Ministry of Science and Innovation [MTM2014-52876-R]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research has been supported by the Spanish Ministry of Science and Innovation Grant MTM2014-52876-R (ERDF included).	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Anderson TW, 1994, INTRO MULTIVARIATE S; Artiaga R, 2011, OXIDATION STABILITY, V1477, P29; Assighaou S, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036305; BACRI JC, 1983, J PHYS LETT-PARIS, V44, pL415, DOI 10.1051/jphyslet:019830044011041500; Bacrin J-C, 1982, J PHYSIQUE LETT, V43, P649; BOX G.E.P., 2005, STAT EXPT DESIGN INN; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Gracia-Fernandez C, 2011, J THERM ANAL CALORIM, V106, P101, DOI 10.1007/s10973-011-1361-8; Hand DJ, 1987, MULTIVARIATE ANAL VA, DOI [10.1007/978-94-009-3143-5, DOI 10.1007/978-94-009-3143-5]; Lopez-Beceiro J, 2011, J THERM ANAL CALORIM, V104, P169, DOI 10.1007/s10973-010-1165-2; Mallik A, 2011, CHEMOMETR INTELL LAB, V107, P351, DOI 10.1016/j.chemolab.2011.05.005; MASSART R, 1981, IEEE T MAGN, V17, P1247, DOI 10.1109/TMAG.1981.1061188; Matsuoka S, 1992, RELAXATION PHENOMENA; Maxwell S. E., 2004, DESIGNING EXPT ANAL; Permuter H, 2006, PATTERN RECOGN, V39, P695, DOI 10.1016/j.patcog.2005.10.028; R Development Core Team, 2014, R LANG ENV STAT COMP; Rios-Fachal M, 2013, J THERM ANAL CALORIM, V113, P481, DOI 10.1007/s10973-013-3160-x; Schexnailder P, 2009, COLLOID POLYM SCI, V287, P1, DOI 10.1007/s00396-008-1949-0; Schmidt AM, 2007, COLLOID POLYM SCI, V285, P953, DOI 10.1007/S00396-007-1667-z; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Storn RM, 2006, DIFFERENTIAL EVOLUTI; Tarrio-Saaavedra J, 2008, POLYM DEGRAD STABIL, V93, P2133, DOI 10.1016/j.polymdegradstab.2008.08.006; Tarrio-Saavedra J, 2010, EXPRESS POLYM LETT, V4, P382, DOI 10.3144/expresspolymlett.2010.48; Tarrio-Saavedra J, 2005, DYNA, V85, P341; Tarrio-Saavedra J, 2012, J THERM ANAL CALORIM, V109, P1277, DOI 10.1007/s10973-012-2568-z; Tarrio-Saavedra J, 2011, CHEMOMETR INTELL LAB, V105, P114, DOI 10.1016/j.chemolab.2010.11.006; Tukey J. W., 1971, EXPLORATORY DATA ANA; WILLIAMS G, 1970, T FARADAY SOC, V66, P80, DOI 10.1039/tf9706600080	29	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169866	10.1371/journal.pone.0169866	http://dx.doi.org/10.1371/journal.pone.0169866			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081239	gold, Green Published, Green Submitted			2022-12-26	WOS:000391949500093
J	Lin, H; Shin, WY				Lin, Huifa; Shin, Won-Yong			Non-Orthogonal Random Access in MIMO Cognitive Radio Networks: Beamforming, Power Allocation, and Opportunistic Transmission	PLOS ONE			English	Article							MULTIPLE-ACCESS; WIRELESS COMMUNICATIONS; BROADCAST CHANNELS; SCHEME; THROUGHPUT; CAPACITY; DESIGN; UPLINK	We study secondary random access in multi-input multi-output cognitive radio networks, where a slotted ALOHA-type protocol and successive interference cancellation are used. We first introduce three types of transmit beamforming performed by secondary users, where multiple antennas are used to suppress the interference at the primary base station and/or to increase the received signal power at the secondary base station. Then, we show a simple decentralized power allocation along with the equivalent single-antenna conversion. To exploit the multiuser diversity gain, an opportunistic transmission protocol is proposed, where the secondary users generating less interference are opportunistically selected, resulting in a further reduction of the interference temperature. The proposed methods are validated via computer simulations. Numerical results show that increasing the number of transmit antennas can greatly reduce the interference temperature, while increasing the number of receive antennas leads to a reduction of the total transmit power. Optimal parameter values of the opportunistic transmission protocol are examined according to three types of beamforming and different antenna configurations, in terms of maximizing the cognitive transmission capacity. All the beamforming, decentralized power allocation, and opportunistic transmission protocol are performed by the secondary users in a decentralized manner, thus resulting in an easy implementation in practice.	[Lin, Huifa] Dankook Univ, Commun & Networking Lab, Yongin 448701, South Korea; [Shin, Won-Yong] Dankook Univ, Dept Comp Sci & Engn, Yongin 448701, South Korea	Dankook University; Dankook University	Shin, WY (corresponding author), Dankook Univ, Dept Comp Sci & Engn, Yongin 448701, South Korea.	wyshin@dankook.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A1A2054577]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT AMP; Future Planning (MSIP) [2015R1A2A1A15054248]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A1A2054577]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT AMP; Future Planning (MSIP) [2015R1A2A1A15054248]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT AMP; Future Planning (MSIP); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT AMP; Future Planning (MSIP)	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2014R1A1A2054577): http://www.nrf.re.kr, and by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (MSIP) (2015R1A2A1A15054248): http://www.nrf.re.kr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Gumaei YA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135137; Boccardi F, 2014, IEEE COMMUN MAG, V52, P74, DOI 10.1109/MCOM.2014.6736746; Caire G, 1998, IEEE T INFORM THEORY, V44, P927, DOI 10.1109/18.669123; Cordeschi N, 2015, VEH COMMUN, V2, P1, DOI 10.1016/j.vehcom.2014.08.004; COVER TM, 1972, IEEE T INFORM THEORY, V18, P2, DOI 10.1109/TIT.1972.1054727; Cui XR, 2016, IEEE ACCESS, V4, P5520, DOI 10.1109/ACCESS.2016.2604360; Dong Q, 2015, IET COMMUN, V9, P1306, DOI 10.1049/iet-com.2014.0859; Du HQ, 2012, IEEE T SIGNAL PROCES, V60, P781, DOI 10.1109/TSP.2011.2174790; Du QH, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0506-5; Foschini G. J., 1996, Bell Labs Technical Journal, V1, P41, DOI 10.1002/bltj.2015; Ghasemi A, 2007, IEEE T WIREL COMMUN, V6, P649, DOI 10.1109/TWC.2007.05447; Goldsmith A, 2009, P IEEE, V97, P894, DOI 10.1109/JPROC.2009.2015717; Haykin S, 2005, IEEE J SEL AREA COMM, V23, P201, DOI 10.1109/JSAC.2004.839380; He HL, 2015, IEEE ICC, P617, DOI 10.1109/ICC.2015.7248390; Houbing Song CB., 2016, CYBER PHYS SYSTEMS F; Kang X, 2010, IEEE T WIREL COMMUN, V9, P2382, DOI 10.1109/TWC.2010.07.091743; Kim YJ, 2013, IEEE T WIREL COMMUN, V12, P4142, DOI 10.1109/TWC.2013.071913.121996; Ku ML, 2015, IEEE J SEL AREA COMM, V33, P896, DOI 10.1109/JSAC.2014.2361083; LaMaire RO, 1998, WIREL NETW, V4, P263, DOI 10.1023/A:1019164308540; Lee BO, 2009, IEEE T WIREL COMMUN, V8, P4981, DOI 10.1109/TWC.2009.081690; Lee J, 2011, IEEE T WIREL COMMUN, V10, P3053, DOI 10.1109/TWC.2011.070511.101941; Leung YW, 1997, IEEE T COMMUN, V45, P957, DOI 10.1109/26.618300; Li GY, 2011, IEEE WIREL COMMUN, V18, P28, DOI 10.1109/MWC.2011.6108331; Lin H, 2016, P IEEE INT C COMM IC; Lin HF, 2015, IEEE COMMUN LETT, V19, P2118, DOI 10.1109/LCOMM.2015.2489650; METZNER JJ, 1976, IEEE T COMMUN, V24, P447, DOI 10.1109/TCOM.1976.1093317; Mitola J, 1999, IEEE PERS COMMUN, V6, P13, DOI 10.1109/98.788210; Nekouei E, 2014, IEEE T COMMUN, V62, P41, DOI 10.1109/TCOMM.2013.112413.130510; Perahia E., 2013, NEXT GENERATION WIRE; Shapiro J, 2007, P IEEE WORKSH SIG PR; Sheng G, 2016, COMPUTERS ELECT ENG; Shin WY, 2013, 2013 IEEE CONSUMER COMMUNICATIONS AND NETWORKING CONFERENCE (CCNC), P91, DOI 10.1109/CCNC.2013.6488431; Shojafar M, 2015, WIRELESS PERS COMMUN, V82, P61, DOI 10.1007/s11277-014-2194-0; Tse D., 2005, FUNDAMENTALS WIRELES, P290, DOI [10.1017/CBO9780511807213.008, DOI 10.1017/CBO9780511807213.008]; Verdu S., 1998, MULTIUSER DETECTION; Wang JH, 2011, IEEE T SIGNAL PROCES, V59, P1183, DOI 10.1109/TSP.2010.2092773; Wei W, 2018, IEEE T SERV COMPUT, V11, P78, DOI 10.1109/TSC.2016.2528246; Xu CB, 2013, IEEE J SEL AREA COMM, V31, P2387, DOI 10.1109/JSAC.2013.131113; Xu Q, 2016, IEEE ACCESS, V4, P2840, DOI 10.1109/ACCESS.2016.2575863; Yang HJ, 2013, IEEE T WIREL COMMUN, V12, P2180, DOI 10.1109/TWC.2013.032113.120673; Zhai LB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155074; Zhang R, 2015, IEEE WIREL COMMUN, V22, P150, DOI 10.1109/MWC.2015.7143339; Zhang R, 2008, IEEE J-STSP, V2, P88, DOI 10.1109/JSTSP.2007.914894; Zhang R, 2009, IEEE T INFORM THEORY, V55, P5161, DOI 10.1109/TIT.2009.2030449; Zhang ZH, 2015, IEEE WIREL COMMUN LE, V4, P117, DOI 10.1109/LWC.2014.2381663; Zhu J, 2016, IEEE ACCESS, V4, P4609, DOI 10.1109/ACCESS.2016.2600633	47	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169902	10.1371/journal.pone.0169902	http://dx.doi.org/10.1371/journal.pone.0169902			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076402	Green Submitted, Green Published, gold			2022-12-26	WOS:000391857100066
J	Nazir, S; Newey, S; Irvine, RJ; Verdicchio, F; Davidson, P; Fairhurst, G; van der Wal, R				Nazir, Sajid; Newey, Scott; Irvine, R. Justin; Verdicchio, Fabio; Davidson, Paul; Fairhurst, Gorry; van der Wal, Rene			WiseEye: Next Generation Expandable and Programmable Camera Trap Platform for Wildlife Research	PLOS ONE			English	Article							WIRELESS SENSOR NETWORKS; DIVERSITY; DENSITY; ECOLOGY; MAMMALS; DESIGN; IMAGES; NEED	The widespread availability of relatively cheap, reliable and easy to use digital camera traps has led to their extensive use for wildlife research, monitoring and public outreach. Users of these units are, however, often frustrated by the limited options for controlling camera functions, the generation of large numbers of images, and the lack of flexibility to suit different research environments and questions. We describe the development of a user-customisable open source camera trap platform named 'WiseEye', designed to provide flexible camera trap technology for wildlife researchers. The novel platform is based on a Raspberry Pi single-board computer and compatible peripherals that allow the user to control its functions and performance. We introduce the concept of confirmatory sensing, in which the Passive Infrared triggering is confirmed through other modalities (i.e. radar, pixel change) to reduce the occurrence of false positives images. This concept, together with user-definable meta-data, aided identification of spurious images and greatly reduced post-collection processing time. When tested against a commercial camera trap, WiseEye was found to reduce the incidence of false positive images and false negatives across a range of test conditions. WiseEye represents a step-change in camera trap functionality, greatly increasing the value of this technology for wildlife research and conservation management.	[Nazir, Sajid; Verdicchio, Fabio; Fairhurst, Gorry] Univ Aberdeen, Sch Engn, Aberdeen, Scotland; [Newey, Scott; Irvine, R. Justin; Davidson, Paul] James Hutton Inst, Aberdeen, Scotland; [Newey, Scott] Hedmark Univ Coll, Campus Evanstad, Evanstad, Norway; [Davidson, Paul; van der Wal, Rene] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland; [Nazir, Sajid] London South Bank Univ, Sch Engn, London, England	University of Aberdeen; James Hutton Institute; Inland Norway University of Applied Sciences; University of Aberdeen; London South Bank University	Nazir, S (corresponding author), Univ Aberdeen, Sch Engn, Aberdeen, Scotland.; Nazir, S (corresponding author), London South Bank Univ, Sch Engn, London, England.	sajid@erg.abdn.ac.uk	Newey, Scott/A-5079-2010; Irvine, Robert J/G-5074-2012	Newey, Scott/0000-0002-2264-964X; Irvine, Robert J/0000-0002-0411-6217	RCUK Digital Economy programme [EP/G066051/1]; Scottish Government's Rural and Environment Science and Analytical Services (RESAS); Engineering and Physical Sciences Research Council [EP/G066051/1] Funding Source: researchfish; EPSRC [EP/G066051/1] Funding Source: UKRI	RCUK Digital Economy programme; Scottish Government's Rural and Environment Science and Analytical Services (RESAS); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The work was supported by the RCUK Digital Economy programme to the dot.rural Digital Economy Hub; award reference: EP/G066051/1. The work of S. Newey and RJI was part funded by the Scottish Government's Rural and Environment Science and Analytical Services (RESAS).	Abi-Said M, 2012, VERTEBR ZOOL, V62, P145; Ahmadi A, 2014, J SUPERCOMPUT, V68, P599, DOI 10.1007/s11227-013-1054-0; Ahumada JA, 2011, PHILOS T R SOC B, V366, P2703, DOI 10.1098/rstb.2011.0115; Burton AC, 2015, J APPL ECOL, V52, P675, DOI 10.1111/1365-2664.12432; Fegraus EH, 2011, ECOL INFORM, V6, P345, DOI 10.1016/j.ecoinf.2011.06.003; Glen AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067940; Hamel S, 2013, METHODS ECOL EVOL, V4, P105, DOI 10.1111/j.2041-210x.2012.00262.x; Harris G., 2010, B ECOL SOC AM, V91, P352, DOI DOI 10.1890/0012-9623-91.3.352; Karanth KU, 2006, ECOLOGY, V87, P2925, DOI 10.1890/0012-9658(2006)87[2925:ATPDUP]2.0.CO;2; Kays Roland, 2011, International Journal of Research and Reviews in Wireless Sensor Networks, V1, P19; Kays Roland W., 2008, P110; Kucera TE, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P9, DOI 10.1007/978-4-431-99495-4_2; Meek PD, 2012, WILDLIFE RES, V39, P649, DOI 10.1071/WR12138; Meek PD, 2015, AUST MAMMAL, V37, P13, DOI 10.1071/AM14023; Nazir S, 2016, INT J SATELL COMM NE; Newey S, 2015, AMBIO, V44, pS624, DOI 10.1007/s13280-015-0713-1; Nichols JD, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P253, DOI 10.1007/978-4-431-99495-4_14; OConnell AF, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P1, DOI 10.1007/978-4-431-99495-4; Porter J, 2005, BIOSCIENCE, V55, P561, DOI 10.1641/0006-3568(2005)055[0561:WSNFE]2.0.CO;2; Rovero F, 2013, HYSTRIX, V24, P148, DOI 10.4404/hystrix-24.2-6316; Rovero F, 2009, J APPL ECOL, V46, P1011, DOI 10.1111/j.1365-2664.2009.01705.x; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Rutz C, 2013, METHODS ECOL EVOL, V4, P114, DOI 10.1111/2041-210x.12003; Rutz C, 2009, BIOL LETTERS, V5, P289, DOI 10.1098/rsbl.2009.0089; Sundaresan S.R., 2011, B ECOL SOC AM, V92, P188, DOI DOI 10.1890/0012-9623-92.2.188; Swann DE, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P27, DOI 10.1007/978-4-431-99495-4_3; Swinnen KRR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098881; Tack JLP, 2016, ECOL INFORM, V36, P145, DOI 10.1016/j.ecoinf.2016.11.003; Tan CL, 2013, PRIMATES, V54, P1, DOI 10.1007/s10329-012-0318-2; Tavoli R, 2013, 2013 36TH INTERNATIONAL CONFERENCE ON TELECOMMUNICATIONS AND SIGNAL PROCESSING (TSP), P773, DOI 10.1109/TSP.2013.6614043; Tobler MW, 2009, J TROP ECOL, V25, P261, DOI 10.1017/S0266467409005896; van der Wal R, 2015, AMBIO, V44, pS612, DOI 10.1007/s13280-015-0711-3; van der Wal R, 2015, AMBIO, V44, pS517, DOI 10.1007/s13280-015-0701-5; Welbourne DJ, 2016, REMOTE SENS ECOL CON, V2, P77, DOI 10.1002/rse2.20; Willmott JR, 2015, AMBIO, V44, pS557, DOI 10.1007/s13280-015-0707-z; Xiong JP, 2016, IEEE ACCESS, V4, P3076, DOI 10.1109/ACCESS.2016.2580594; Yang JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145800; Yu XY, 2013, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2013-52; Zarybnicka M, 2016, METHODS ECOL EVOL, V7, P483, DOI 10.1111/2041-210X.12509	39	15	14	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169758	10.1371/journal.pone.0169758	http://dx.doi.org/10.1371/journal.pone.0169758			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076444	Green Published, gold, Green Submitted			2022-12-26	WOS:000391857100054
J	Fukuta, T; Asai, T; Yanagida, Y; Namba, M; Koide, H; Shimizu, K; Oku, N				Fukuta, Tatsuya; Asai, Tomohiro; Yanagida, Yosuke; Namba, Mio; Koide, Hiroyuki; Shimizu, Kosuke; Oku, Naoto			Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke	FASEB JOURNAL			English	Article						blood-brain barrier; drug delivery system; fasudil; photochemically induced thrombosis; liposome	MIDDLE CEREBRAL-ARTERY; RHO-KINASE; HEMORRHAGIC TRANSFORMATION; TIME WINDOW; MATRIX METALLOPROTEINASES; PEGYLATED LIPOSOMES; REPERFUSION THERAPY; THROMBOSIS MODEL; BRAIN; INJURY	For ischemic stroke treatment, extension of the therapeutic time window(TTW) of thrombolytic therapy with tissue plasminogen activator (tPA) and amelioration of secondary ischemia/reperfusion (I/R) injury are most desirable. Our previous studies have indicated that liposomal delivery of neuroprotectants into an ischemic region is effective for stroke treatment. In the present study, for solving the above problems in the clinical setting, the usefulness of combination therapy with tPA and liposomal fasudil (fasudil-Lip) was investigated in ischemic stroke model rats with photochemically induced thrombosis, with clots that were dissolved by tPA. Treatment with tPA3 h after occlusion markedly increased blood-brain barrier permeability and activated matrix metalloproteinase (MMP)-2 and -9, which are involved in cerebralhemorrhage. However, an intravenous administration of fasudil-Lip before tPA markedly suppressed the increase in permeability and the MMP activation stemming from tPA. The combination treatment showed significantly larger neuroprotective effects, even in the case of delayed tPA administration compared with each treatment alone or the tPA/fasudil-treated group. These findings suggest that treatment with fasudil-Lip before tPA could decrease the risk of tPA-derived cerebral hemorrhage and extend the TTW of tPA and that the combination therapy could be a useful therapeutic option for ischemic stroke.-Fukuta, T., Asai, T., Yanagida, Y., Namba, M., Koide, H., Shimizu, K., Oku, N. Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke.	[Fukuta, Tatsuya; Asai, Tomohiro; Yanagida, Yosuke; Namba, Mio; Koide, Hiroyuki; Shimizu, Kosuke; Oku, Naoto] Univ Shizuoka, Sch Pharmaceut Sci, Dept Med Biochem, Shizuoka, Japan; [Fukuta, Tatsuya] Japan Soc Promot Sci, Tokyo, Japan	University of Shizuoka; Japan Society for the Promotion of Science	Oku, N (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Med Biochem, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	oku@u-shizuoka-ken.ac.jp		Fukuta, Tatsuya/0000-0001-8878-8602; Shimizu, Kosuke/0000-0003-3789-2447	Japan Society for the Promotion of Science [14J10730, 16H05081]; Research Grants in the Natural Sciences of the Mitsubishi Foundation; Grants-in-Aid for Scientific Research [15H02569] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Grants in the Natural Sciences of the Mitsubishi Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Asahi Kasei Pharma Corp. (Tokyo, Japan) for the gift of fasudil; Norihiro Harada and Dai Fukumoto (Hamamatsu Photonics PET Center, Minamisoma, Japan) for their technical guidance in preparing MCAO rats by the PIT method. This research was supported by Grants-in-Aid for Scientific Research 14J10730 and 16H05081 from the Japan Society for the Promotion of Science, and by the Research Grants in the Natural Sciences of the Mitsubishi Foundation.	Chamorro A, 2016, LANCET NEUROL, V15, P869, DOI 10.1016/S1474-4422(16)00114-9; Cuadrado E, 2008, J LEUKOCYTE BIOL, V84, P207, DOI 10.1189/jlb.0907606; del Zoppo GJ, 2003, J CEREBR BLOOD F MET, V23, P879, DOI 10.1097/01.WCB.0000078322.96027.78; del Zoppo GJ, 2009, CEREBROVASC DIS, V27, P65, DOI 10.1159/000200442; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Fagan SC, 2004, STROKE, V35, P2220, DOI 10.1161/01.STR.0000138023.60272.9e; Fukuta T, 2016, INT J PHARMACEUT, V506, P129, DOI 10.1016/j.ijpharm.2016.04.046; Fukuta T, 2015, EUR J PHARM BIOPHARM, V97, P1, DOI 10.1016/j.ejpb.2015.09.020; Fukuta T, 2014, ARTIF ORGANS, V38, P662, DOI 10.1111/aor.12350; Gibson CL, 2014, J NEUROCHEM, V129, P816, DOI 10.1111/jnc.12681; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Iadecola C, 2011, NAT NEUROSCI, V14, P1363, DOI 10.1038/nn.2953; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Ishiguro M, 2012, NEUROSCIENCE, V220, P302, DOI 10.1016/j.neuroscience.2012.06.015; Ishii T, 2013, FASEB J, V27, P1362, DOI 10.1096/fj.12-221325; Ishii T, 2012, J CONTROL RELEASE, V160, P81, DOI 10.1016/j.jconrel.2012.02.004; Jickling GC, 2015, J CEREBR BLOOD F MET, V35, P888, DOI 10.1038/jcbfm.2015.45; Jickling GC, 2014, J CEREBR BLOOD F MET, V34, P185, DOI 10.1038/jcbfm.2013.203; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Justicia C, 2003, J CEREBR BLOOD F MET, V23, P1430, DOI 10.1097/01.WCB.0000090680.07515.C8; Lakhan SE, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00032; Lo EH, 2002, J NEUROSCI RES, V69, P1, DOI 10.1002/jnr.10270; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; Maeda M, 2002, J CEREBR BLOOD F MET, V22, P1205, DOI 10.1097/01.wcb.0000037993.34930.72; Mueller BK, 2005, NAT REV DRUG DISCOV, V4, P387, DOI 10.1038/nrd1719; Murata Y, 2008, STROKE, V39, P3372, DOI 10.1161/STROKEAHA.108.514026; NAGASAWA H, 1989, STROKE, V20, P1037, DOI 10.1161/01.STR.20.8.1037; Niego B, 2012, BLOOD, V119, P4752, DOI 10.1182/blood-2011-07-369512; O'Collins VE, 2012, J CEREBR BLOOD F MET, V32, P585, DOI 10.1038/jcbfm.2011.203; Rogalewski A, 2006, STROKE, V37, P1129, DOI 10.1161/01.STR.0000209330.73175.34; Satoh SI, 2008, BRAIN RES, V1193, P102, DOI 10.1016/j.brainres.2007.11.050; Shibuya M, 2005, J NEUROL SCI, V238, P31, DOI 10.1016/j.jns.2005.06.003; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; Sutherland BA, 2012, INT J STROKE, V7, P407, DOI 10.1111/j.1747-4949.2012.00770.x; Tsukada H, 2014, J NUCL MED, V55, P473, DOI 10.2967/jnumed.113.125328; UMEMURA K, 1993, STROKE, V24, P1077, DOI 10.1161/01.STR.24.7.1077; Umemura K, 2007, PATHOPHYSIOL HAEMO T, V36, P245, DOI 10.1159/000252820; Vivien D, 2011, J CEREBR BLOOD F MET, V31, P2119, DOI 10.1038/jcbfm.2011.127; Wang W, 2015, MOL NEUROBIOL, V52, P1572, DOI 10.1007/s12035-014-8952-x; Wang XY, 2004, STROKE, V35, P2726, DOI 10.1161/01.STR.0000143219.16695.af; Yagita Y, 2007, J NEUROSCI RES, V85, P2460, DOI 10.1002/jnr.21375; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022	44	57	57	2	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1879	1890		10.1096/fj.201601209R	http://dx.doi.org/10.1096/fj.201601209R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28082354				2022-12-26	WOS:000399195500011
J	Jung, HJ; Byun, HO; Jee, BA; Min, S; Jeoun, UW; Lee, YK; Seo, Y; Woo, HG; Yoon, G				Jung, Hyun-Jung; Byun, Hae-Ok; Jee, Byul A.; Min, Seongki; Jeoun, Un-woo; Lee, Young-Kyoung; Seo, Yonghak; Woo, Hyun Goo; Yoon, Gyesoon			The Ubiquitin-like with PHD and Ring Finger Domains 1 (UHRF1)/DNA Methyltransferase 1 (DNMT1) Axis Is a Primary Regulator of Cell Senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cellular senescence; DNA methylation; gene expression; gene regulation; microarray	DNA METHYLATION; GENE-EXPRESSION; CANCER; STABILITY; UHRF1; PHOSPHORYLATION; OVEREXPRESSION; MAINTENANCE; MECHANISM; CARCINOMA	As senescence develops, cells sequentially acquire diverse senescent phenotypes along with simultaneous multistage gene reprogramming. It remains unclear what acts as the key regulator of the collective changes in gene expression at initiation of senescent reprogramming. Here we analyzed time series gene expression profiles obtained in two different senescence models in human diploid fibroblasts: replicative senescence and H2O2-induced senescence. Our results demonstrate that suppression of DNA methyltransferase 1 (DNMT1)-mediated DNA methylation activity was an initial event prior to the display of senescent phenotypes. We identified seven DNMT1-interacting proteins, ubiquitin-like with PHD and ring finger domains 1 (UHRF1), EZH2, CHEK1, SUV39H1, CBX5, PARP1, and HELLS (also known as LSH (lymphoid-specific helicase) 1), as being commonly down-regulated at the same time point as DNMT1 in both senescence models. Knockdown experiments revealed that, among the DNMT1-interacting proteins, only UHRF1 knockdown suppressed DNMT1 transcription. However, UHRF1 overexpression alone did not induce DNMT1 expression, indicating that UHRF1 was essential but not sufficient for DNMT1 transcription. Although UHRF1 knockdown effectively induced senescence, this was significantly attenuated by DNMT1 overexpression, clearly implicating the UHRF1/DNMT1 axis in senescence. Bioinformatics analysis further identified WNT5A as a downstream effector of UHRF1/DNMT1-mediated senescence. Senescence-associated hypomethylation was found at base pairs -1569 to -1363 from the transcription start site of the WNT5A gene in senescent human diploid fibroblasts. As expected, WNT5A overexpression induced senescent phenotypes. Overall, our results indicate that decreased UHRF1 expression is a key initial event in the suppression of DNMT1-mediated DNA methylation and in the consequent induction of senescence via increasing WNT5A expression.	[Jung, Hyun-Jung; Byun, Hae-Ok; Min, Seongki; Jeoun, Un-woo; Lee, Young-Kyoung; Yoon, Gyesoon] Ajou Univ, Grad Sch, Dept Biochem & Mol Biol, Suwon 16499, South Korea; [Jee, Byul A.; Woo, Hyun Goo] Ajou Univ, Grad Sch, Dept Physiol, Suwon 16499, South Korea; [Jung, Hyun-Jung; Jee, Byul A.; Min, Seongki; Jeoun, Un-woo; Lee, Young-Kyoung; Woo, Hyun Goo; Yoon, Gyesoon] Ajou Univ, Grad Sch, Dept Biomed Sci, Suwon 16499, South Korea; [Seo, Yonghak] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA	Ajou University; Ajou University; Ajou University; University of Massachusetts System; University of Massachusetts Worcester	Woo, HG (corresponding author), Ajou Univ, Sch Med, Dept Physiol, Suwon 443721, South Korea.; Yoon, G (corresponding author), Ajou Univ, Sch Med, Dept Biochem, Suwon 443721, South Korea.	hg@ajou.ac.kr; ypeace@ajou.ac.kr	Woo, Hyun Goo | 우현구/I-8954-2019; Woo, Hyun Goo/AEJ-7372-2022	Woo, Hyun Goo | 우현구/0000-0002-0916-893X; Woo, Hyun Goo/0000-0002-0916-893X	National Research Foundation of Korea [2012R1A5A2048183, 2015R1A2A1A10055038]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by National Research Foundation of Korea Grants 2012R1A5A2048183 and 2015R1A2A1A10055038. The authors declare that they have no conflicts of interest with the contents of this article. The raw data from the microarray experiments are available in the GEO database (http://www.ncbi.nlm.nih.gov/geo) under accession number GSE80322.	Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Bitler BG, 2011, CANCER RES, V71, P6184, DOI 10.1158/0008-5472.CAN-11-1341; Campisi J, 2011, SEMIN CANCER BIOL, V21, P354, DOI 10.1016/j.semcancer.2011.09.001; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Esteve PO, 2011, NAT STRUCT MOL BIOL, V18, P42, DOI 10.1038/nsmb.1939; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gonzalo S, 2010, J APPL PHYSIOL, V109, P586, DOI 10.1152/japplphysiol.00238.2010; Hwang ES, 2009, CELL MOL LIFE SCI, V66, P2503, DOI 10.1007/s00018-009-0034-2; Iannetti A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004642; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kim JH, 2011, AUTOPHAGY, V7, P1187, DOI 10.4161/auto.7.10.16643; Kim YM, 2013, AGING CELL, V12, P622, DOI 10.1111/acel.12087; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lin RK, 2010, CANCER RES, V70, P5807, DOI 10.1158/0008-5472.CAN-09-4161; Ma J, 2015, BIOCHEM BIOPH RES CO, V464, P147, DOI 10.1016/j.bbrc.2015.06.104; Maegawa S, 2010, GENOME RES, V20, P332, DOI 10.1101/gr.096826.109; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Mudbhary R, 2014, CANCER CELL, V25, P196, DOI 10.1016/j.ccr.2014.01.003; Myant K, 2008, MOL CELL BIOL, V28, P215, DOI 10.1128/MCB.01073-07; Palii SS, 2008, MOL CELL BIOL, V28, P752, DOI 10.1128/MCB.01799-07; Piskunova Tatiana S, 2008, Curr Gerontol Geriatr Res, P754190, DOI 10.1155/2008/754190; Poehlmann A, 2011, J CELL MOL MED, V15, P1528, DOI 10.1111/j.1582-4934.2010.01143.x; Qin WH, 2011, NUCLEUS-PHILA, V2, P392, DOI 10.4161/nucl.2.5.17928; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Schermelleh L, 2007, NUCLEIC ACIDS RES, V35, P4301, DOI 10.1093/nar/gkm432; Seo YH, 2008, AGING CELL, V7, P894, DOI 10.1111/j.1474-9726.2008.00436.x; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Sidler C, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00411; So AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019503; Sugiyama Y, 2010, BIOCHEM J, V427, P489, DOI 10.1042/BJ20091856; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; WILSON VL, 1983, SCIENCE, V220, P1054; Yoder JA, 1997, J MOL BIOL, V270, P385, DOI 10.1006/jmbi.1997.1125; Zampieri M, 2012, BIOCHEM J, V441, P645, DOI 10.1042/BJ20111417; Zheng QH, 2006, J CELL BIOCHEM, V98, P1230, DOI 10.1002/jcb.20838; Zhou R, 2009, NUCLEIC ACIDS RES, V37, P5183, DOI 10.1093/nar/gkp533	39	23	23	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3729	3739		10.1074/jbc.M116.750539	http://dx.doi.org/10.1074/jbc.M116.750539			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28100769	hybrid, Green Published			2022-12-26	WOS:000395542500016
J	Li, WM; Chan, CM; Miller, AL; Lee, CH				Li, Wai Ming; Chan, Ching-Man; Miller, Andrew L.; Lee, Chow H.			Dual Functional Roles of Molecular Beacon as a MicroRNA Detector and Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene silencing; in vivo imaging; microRNA (miRNA); microscopy; zebrafish; anti-miR; miR-430; molecular beacon	IMAGING-SYSTEM; RNA DECAY; ZEBRAFISH; EXPRESSION; FATE; MIR-430; CELLS; HYBRIDIZATION; ORGANIZATION	MicroRNAs are essential in many cellular processes. The ability to detect microRNAs is important for understanding its function and biogenesis. This study is aimed at using a molecular beacon to detect miR-430 in developing zebrafish embryos as a proof of principle. miR-430 is crucial for the clearance of maternal mRNA during maternal zygotic transition in embryonic development. Despite its known function, the temporal and spatial expression of miR-430 remains unclear. We used various imaging techniques, including laser scanning confocal microscopy, spinning disk, and lightsheet microscopy, to study the localization of miR-430 and any developmental defects possibly caused by the molecular beacon. Our results show that miR-430 is expressed early in development and is localized in distinct cytoplasmic granules where its target mRNA can be detected. We also show that the designed molecular beacon can inhibit the function of miR-430 and cause developmental defect in the brain, notochord, heart, and kidney, depending on the delivery site within the embryo, suggesting that miR-430 plays a diverse role in embryonic morphogenesis. When compared with morpholino, molecular beacon is 2 orders of magnitude more potent in inhibiting miR-430. Thus, our results reveal that in addition to being used as a valuable tool for the detection of microRNAs in vivo, molecular beacons can also be employed to inhibit microRNAs in a specific manner.	[Li, Wai Ming; Lee, Chow H.] Univ Northern British Columbia, Chem Program, 3333 Univ Way, Prince George, BC V2N 4Z9, Canada; [Chan, Ching-Man; Miller, Andrew L.] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Chan, Ching-Man; Miller, Andrew L.] Hong Kong Univ Sci & Technol, Key State Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China	University of Northern British Columbia; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Lee, CH (corresponding author), Univ Northern British Columbia, Chem Program, 3333 Univ Way, Prince George, BC V2N 4Z9, Canada.	chow.lee@unbc.ca			Natural Sciences & Engineering Research Council Discovery Grant [227158]; Hong Kong Research Grant Council (RGC) General Research Fund Awards [662113, 16101714, 16100115]; Hong Kong Innovation and Technology Commission Grant [ITCPD/17-9]	Natural Sciences & Engineering Research Council Discovery Grant; Hong Kong Research Grant Council (RGC) General Research Fund Awards; Hong Kong Innovation and Technology Commission Grant	This work was supported by Natural Sciences & Engineering Research Council Discovery Grant 227158 (to C. H. L.), Hong Kong Research Grant Council (RGC) General Research Fund Awards 662113, 16101714, and 16100115, and Hong Kong Innovation and Technology Commission Grant ITCPD/17-9 (to A. L. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Arribas-Layton M, 2013, BBA-GENE REGUL MECH, V1829, P580, DOI 10.1016/j.bbagrm.2012.12.006; Baker MB, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1016; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Bratu DP, 2011, METHODS MOL BIOL, V714, P141, DOI 10.1007/978-1-61779-005-8_9; Cheng CJ, 2013, CURR MED CHEM, V20, P3582; Chlebowski A, 2013, BBA-GENE REGUL MECH, V1829, P552, DOI 10.1016/j.bbagrm.2013.01.006; Choi WY, 2007, SCIENCE, V318, P271, DOI 10.1126/science.1147535; Choi Y.J., 2014, ARCH PHARM RES, V2014, P1, DOI DOI 10.1016/j.jaccpubpol.2014.06.001; Dhanasiri AKS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065028; Flynt AS, 2007, NAT GENET, V39, P259, DOI 10.1038/ng1953; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Hernandez R, 2013, CURR MED CHEM, V20, P3594; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Jeffries CD, 2011, RNA, V17, P675, DOI 10.1261/rna.2006511; Jo MH, 2012, BIOMATERIALS, V33, P6456, DOI 10.1016/j.biomaterials.2012.05.057; Kang WJ, 2012, BIOMATERIALS, V33, P6430, DOI 10.1016/j.biomaterials.2012.05.056; Kang WJ, 2011, BIOMATERIALS, V32, P1915, DOI 10.1016/j.biomaterials.2010.11.007; Kato Y, 2010, J BIOCHEM, V147, P63, DOI 10.1093/jb/mvp144; Kato Y, 2009, INT J BIOCHEM CELL B, V41, P2225, DOI 10.1016/j.biocel.2009.04.018; Khudayberdiev SA, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00043; KIMMEL CB, 1990, DEVELOPMENT, V108, P581; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Ko HY, 2015, CHEM COMMUN, V51, P2159, DOI 10.1039/c4cc08898k; Ko HY, 2009, NAT PROTOC, V4, P1663, DOI 10.1038/nprot.2009.119; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Lee C. H., 2013, J MOL IMAGING DYNAM, V2, P113; Leucht C, 2008, NAT NEUROSCI, V11, P641, DOI 10.1038/nn.2115; Liao JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010563; Lund E, 2009, RNA, V15, P2351, DOI 10.1261/rna.1882009; Martello G, 2007, NATURE, V449, P183, DOI 10.1038/nature06100; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Politz JCR, 2006, P NATL ACAD SCI USA, V103, P18957, DOI 10.1073/pnas.0609466103; Politz JCR, 2009, RNA, V15, P1705, DOI 10.1261/rna.1470409; Rosa A, 2009, DEV CELL, V16, P517, DOI 10.1016/j.devcel.2009.02.007; Salmanidis M, 2014, INT J BIOCHEM CELL B, V54, P304, DOI 10.1016/j.biocel.2014.03.010; Sleep E, 2010, J CARDIOVASC MED, V11, P369, DOI 10.2459/JCM.0b013e3283375900; Staton AA, 2011, NAT GENET, V43, P204, DOI 10.1038/ng.758; Stenvang Jan, 2012, Silence, V3, P1, DOI 10.1186/1758-907X-3-1; Thatcher EJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-253; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Urbanek MO, 2015, INT J MOL SCI, V16, P13259, DOI 10.3390/ijms160613259; Wei CY, 2012, RNA, V18, P915, DOI 10.1261/rna.029090.111; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WOO K, 1995, CURR OPIN GENET DEV, V5, P439, DOI 10.1016/0959-437X(95)90046-J; Zeng L, 2009, P NATL ACAD SCI USA, V106, P17793, DOI 10.1073/pnas.0903693106; Zhao ZX, 2001, DEV BIOL, V229, P215, DOI 10.1006/dbio.2000.9982	48	9	10	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3568	3580		10.1074/jbc.M116.765776	http://dx.doi.org/10.1074/jbc.M116.765776			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28100783	Green Published, hybrid			2022-12-26	WOS:000395542500003
J	Jiang, C; Kawabe, H; Rotin, D				Jiang, Chong; Kawabe, Hiroshi; Rotin, Daniela			The Ubiquitin Ligase Nedd4L Regulates the Na/K/2Cl Co-transporter NKCC1/SLC12A2 in the Colon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell biology; E3 ubiquitin ligase; epithelial sodium channel (ENaC); gene knockout; intestine; membrane transport; ubiquitin	EPITHELIAL NA+ CHANNEL; CELL-SURFACE EXPRESSION; CL-COTRANSPORTER; LIDDLE-SYNDROME; PY MOTIF; TRANSPORT; SUBUNITS; SODIUM; ENAC; HYPERTENSION	The ubiquitin ligase Nedd4-like (Nedd4L, or Nedd4-2) binds to and regulates stability of the epithelial Na+ channel (ENaC) in salt-absorbing epithelia in the kidney, lung, and other tissues. Its role in the distal colon, which also absorbs salt and fluid and expresses ENaC, is unknown. Using a conditional knock-out approach to knock out Nedd4L in mice intestinal epithelium (Nedd4L(f/f);Vil-Cre(ERT2)) we show here that Nedd4L depletion leads to a higher steady-state short circuit current (Isc) in mouse distal colon tissue relative to controls. This higher Isc was partially reduced by the addition of apical amiloride and strongly reduced by basolateral bumetanide as well as by depletion of basolateral Cl-, suggesting that Na+/K+/2Cl(-) (NKCC1/SLC12A2) co-transporter and ENaC are targets of Nedd4L in the colon. In accordance, NKCC1 (and ENaC) protein abundance in the colon of the Nedd4L knock-out animals was increased, indicating that Nedd4L normally suppresses these proteins. However, we did not observe co-immunoprecipitation between Nedd4L and NKCC1, suggesting that Nedd4L indirectly suppresses NKCC1 expression. Low salt diet resulted in a strong increase in and (but not ) ENaC mRNA and protein expression and ENaC activity. Although salt restriction also increased NKCC1 protein and mRNA abundance, it did not lead to its elevated activity (Isc). These results identify NKCC1 as a novel target for Nedd4L-mediated down-regulation in vivo, which modulates ion and fluid transport in the distal colon together with ENaC.	[Jiang, Chong; Rotin, Daniela] Hosp Sick Children, PGCRL 19-9715,686 Bay St, Toronto, ON M5G 0A4, Canada; [Jiang, Chong; Rotin, Daniela] Univ Toronto, Toronto, ON M5G 0A4, Canada; [Kawabe, Hiroshi] Max Planck Inst Expt Med, Dept Mol Neurobiol, Hermann Rein Str 3D, D-37075 Gottingen, Germany	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Max Planck Society	Rotin, D (corresponding author), Hosp Sick Children, PGCRL 19-9715,686 Bay St, Toronto, ON M5G 0A4, Canada.	drotin@sickkids.ca	Kawabe, Hiroshi/U-7325-2018	Kawabe, Hiroshi/0000-0001-5650-8696	Canadian Institute of Health Research [CIHR MOP-130422]; Cystic Fibrosis Canada	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada	This work was supported by the Canadian Institute of Health Research (CIHR MOP-130422) and by Cystic Fibrosis Canada (to D. R.). The authors declare that they have no conflict of interests with the content of this article.	Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Boase NA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1284; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; DUC C, 1994, J CELL BIOL, V127, P1907, DOI 10.1083/jcb.127.6.1907; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Flemmer AW, 2002, J BIOL CHEM, V277, P37551, DOI 10.1074/jbc.M206294200; Frindt G, 2008, J GEN PHYSIOL, V131, P617, DOI 10.1085/jgp.200809989; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kahle KT, 2005, P NATL ACAD SCI USA, V102, P16783, DOI 10.1073/pnas.0508307102; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Kimura T, 2011, P NATL ACAD SCI USA, V108, P3216, DOI 10.1073/pnas.1010334108; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Lagnaz D, 2014, AM J PHYSIOL-RENAL, V307, pF275, DOI 10.1152/ajprenal.00574.2013; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Loffing J, 2000, AM J PHYSIOL-RENAL, V279, pF252, DOI 10.1152/ajprenal.2000.279.2.F252; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Malsure S, 2014, J AM SOC NEPHROL, V25, P1453, DOI 10.1681/ASN.2013090936; Markadieu N, 2014, PFLUG ARCH EUR J PHY, V466, P91, DOI 10.1007/s00424-013-1370-5; No YR, 2014, J BIOL CHEM, V289, P18360, DOI 10.1074/jbc.M113.541706; Arroyo JP, 2011, J AM SOC NEPHROL, V22, P1707, DOI 10.1681/ASN.2011020132; Ronzaud C, 2013, J CLIN INVEST, V123, P657, DOI 10.1172/JCI61110; Rossier BC, 2013, FEBS LETT, V587, P1929, DOI 10.1016/j.febslet.2013.05.013; Rotin D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00212; Roy A, 2015, J CLIN INVEST, V125, P3433, DOI 10.1172/JCI75245; Rozansky DJ, 2002, AM J PHYSIOL-RENAL, V283, pF105, DOI 10.1152/ajprenal.00176.2001; Schild L, 1996, EMBO J, V15, P2381, DOI 10.1002/j.1460-2075.1996.tb00594.x; Shi PP, 2008, AM J PHYSIOL-RENAL, V295, pF462, DOI 10.1152/ajprenal.90300.2008; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Susa K, 2012, CLIN EXP NEPHROL, V16, P530, DOI 10.1007/s10157-012-0590-x; Wang CJ, 2012, BIOCHEM J, V444, P279, DOI 10.1042/BJ20111983; Wu JJ, 2013, HUM GENET, V132, P179, DOI 10.1007/s00439-012-1238-3; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	36	18	18	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3137	3145		10.1074/jbc.M116.770065	http://dx.doi.org/10.1074/jbc.M116.770065			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28087701	hybrid, Green Published			2022-12-26	WOS:000395538800007
J	Nsor, CA; Chapman, HM; Godsoe, W				Nsor, Charles A.; Chapman, Hazel M.; Godsoe, William			Does a Species' Extinction-Proneness Predict Its Contribution to Nestedness? A Test Using a Sunbird-Tree Visitation Network	PLOS ONE			English	Article							DISENTANGLING NESTEDNESS; HUMMINGBIRDS; STABILITY; ARCHITECTURE	Animal pollinators and the plants they pollinate depend on networks of mutualistic partnerships and more broadly on the stability of such networks. Based mainly on insect-plant visitation networks, theory predicts that species that are most prone to extinction contribute the most to nestedness, however empirical tests are rare. We used a sunbird-tree visitation network within which were both extinction prone vs non extinction prone sunbird species to test the idea. We predicted that the extinction prone species would contribute the most to nestedness. Using local abundance as a proxy for extinction risk we considered that locally rare sunbird species, by virtue of their small population size and associated demographic stochasticity to be more at risk of extinction than the common species. Our network was not strongly nested and all sunbird species made similar contributions to nestedness, so that in our empirical test, extinction proneness did not predict contribution to nestedness. The consequences of this finding remain unclear. It may be that network theory based on plant insect mutualisms is not widely applicable and does not work for tree-sunbird mutualistic networks. Alternatively it may be that our network was too small to provide results with any statistical power. Without doubt our study highlights the problems faced when testing network theory in the field; a plethora of ecological considerations can variously impact on results.	[Nsor, Charles A.; Chapman, Hazel M.] Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand; [Nsor, Charles A.] Gombe State Univ, Dept Biol Sci, Gombe, Nigeria; [Godsoe, William] Lincoln Univ, Dept Biol Sci, Lincoln, New Zealand	University of Canterbury; Lincoln University - New Zealand	Chapman, HM (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand.	hazel.chapman@canterbury.ac.nz	Godsoe, William/L-7987-2013	Godsoe, William/0000-0003-1697-6916; Chapman, Hazel/0000-0001-8509-703X	Tertiary Education trust fund Nigeria CN; A.G. Leventis Foundation; Chester Zoo; Nexen Nigeria	Tertiary Education trust fund Nigeria CN; A.G. Leventis Foundation; Chester Zoo; Nexen Nigeria	This study was supported by the Tertiary Education trust fund Nigeria CN; A.G. Leventis Foundation; Chester Zoo; and Nexen Nigeria.	Allen-Wardell G, 1998, CONSERV BIOL, V12, P8; Allesina S, 2012, NATURE, V483, P205, DOI 10.1038/nature10832; Almeida-Neto M, 2008, ENVIRON MODELL SOFTW, V26, P173; Armbruster S., 2000, SCANDINAVIAN ASS POL, V39, P179; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Beavon MA, 2011, PLANT SYST EVOL, V296, P217, DOI 10.1007/s00606-011-0488-1; Bewick S, 2013, OIKOS, V122, P1710, DOI 10.1111/j.1600-0706.2013.00016.x; Bezerra ELS, 2009, J ANIM ECOL, V78, P1096, DOI 10.1111/j.1365-2656.2009.01567.x; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Borgella R, 2001, BIOTROPICA, V33, P90, DOI 10.1111/j.1744-7429.2001.tb00160.x; Borrow N., 2001, GUIDE BIRDS W AFRICA; Burkle LA, 2013, SCIENCE, V339, P1611, DOI 10.1126/science.1232728; Chapman J.D., 2001, FORESTS TARABA ADAMA; Cheke RA., 2001, SUNBIRDS GUIDE SUNBI; Courter JR, 2013, AUK, V130, P107, DOI 10.1525/auk.2012.12058; Dominguez-Garcia V, 2015, SCI REP-UK, V5, DOI 10.1038/srep08182; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Ezealor A., 2001, BIRDLIFE CONSERVATIO, V11, P673; Geerts S, 2012, S AFR J BOT, V78, P159, DOI 10.1016/j.sajb.2011.06.007; Geerts S, 2009, S AFR J BOT, V75, P699, DOI 10.1016/j.sajb.2009.08.001; Genini J, 2010, BIOL LETTERS, V6, P494, DOI 10.1098/rsbl.2009.1021; Horak D, 2010, AFR J ECOL, V48, P822, DOI 10.1111/j.1365-2028.2009.01155.x; James A, 2013, NATURE, V500, pE2, DOI 10.1038/nature12381; James A, 2012, NATURE, V487, P227, DOI 10.1038/nature11214; Janecek S, 2012, BIOL J LINN SOC, V107, P355, DOI 10.1111/j.1095-8312.2012.01943.x; Kaiser-Bunbury CN, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv076; Kaiser-Bunbury CN, 2010, PERSPECT PLANT ECOL, V12, P131, DOI 10.1016/j.ppees.2009.10.002; King C, 2013, METHODS ECOL EVOL, V4, P811, DOI 10.1111/2041-210X.12074; McKinney AM, 2012, ECOLOGY, V93, P1987, DOI 10.1890/12-0255.1; Memmott J, 1999, ECOL LETT, V2, P276, DOI 10.1046/j.1461-0248.1999.00087.x; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Nsor CA, 2015, THESIS; Nsor Charles, 2013, Malimbus, V35, P37; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Padysakova E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059299; Pauw A, 2012, ECOL SOC, V17, DOI 10.5751/ES-04758-170227; R Core Team, 2021, R LANGUAGE ENV STAT; Regan EC, 2015, CONSERV LETT, V8, P397, DOI 10.1111/conl.12162; Saavedra S, 2013, NATURE, V500, pE1, DOI 10.1038/nature12380; Saavedra S, 2011, NATURE, V478, P233, DOI 10.1038/nature10433; Strona G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5114; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Tylianakis JM, 2010, BIOL CONSERV, V143, P2270, DOI 10.1016/j.biocon.2009.12.004; Vazquez DP, 2009, UNITING PATTERN PROC; Vidal MM, 2014, ECOLOGY, V95, P3440, DOI 10.1890/13-1584.1; Vieira MC, 2015, ECOL LETT, V18, P144, DOI 10.1111/ele.12394	49	1	1	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170223	10.1371/journal.pone.0170223	http://dx.doi.org/10.1371/journal.pone.0170223			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103287	Green Submitted, Green Published, gold			2022-12-26	WOS:000392381100044
J	Wang, QY; Xie, NZ; Du, QS; Qin, Y; Li, JX; Meng, JZ; Huang, RB				Wang, Qing-Yan; Xie, Neng-Zhong; Du, Qi-Shi; Qin, Yan; Li, Jian-Xiu; Meng, Jian-Zong; Huang, Ri-Bo			Active Hydrogen Bond Network (AHBN) and Applications for Improvement of Thermal Stability and pH-Sensitivity of Pullulanase from Bacillus naganoensis	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; CASSAVA MANIHOT-ESCULENTA; ETHANOL; ENZYME; YEAST; THERMOSTABILIZATION; OLIGONUCLEOTIDES; FERMENTATION; GLUCOAMYLASE; EVOLUTION	A method, so called "active hydrogen bond network" (AHBN), is proposed for site-directed mutations of hydrolytic enzymes. In an enzyme the AHBN consists of the active residues, functional residues, and conservative water molecules, which are connected by hydrogen bonds, forming a three dimensional network. In the catalysis hydrolytic reactions of hydrolytic enzymes AHBN is responsible for the transportation of protons and water molecules, and maintaining the active and dynamic structures of enzymes. The AHBN of pullulanase BNPulA324 from Bacillus naganoensis was constructed based on a homologous model structure using Swiss Model Protein-modeling Server according to the template structure of pullulanase BAPulA (2WAN). The pullulanase BNPulA324 are mutated at the mutation sites selected by means of the AHBN method. Both thermal stability and pH-sensitivity of pullulanase BNPulA324 were successfully improved. The mutations at the residues located at the out edge of AHBN may yield positive effects. On the other hand the mutations at the residues inside the AHBN may deprive the bioactivity of enzymes. The AHBN method, proposed in this study, may provide an assistant and alternate tool for protein rational design and protein engineering.	[Wang, Qing-Yan; Xie, Neng-Zhong; Du, Qi-Shi; Qin, Yan; Li, Jian-Xiu; Huang, Ri-Bo] Guangxi Acad Sci, State Key Lab Biomass Enzyme Technol, Natl Engn Res Ctr Nonfood Biorefinery, Nanning, Guangxi, Peoples R China; [Du, Qi-Shi] Gordon Life Sci Inst, Belmont, MA USA; [Li, Jian-Xiu; Meng, Jian-Zong; Huang, Ri-Bo] Guangxi Univ, Life Sci & Technol Coll, Nanning, Peoples R China	Gordon Life Science Institute; Guangxi University		duqishi@foxmail.com			National Science Foundation of China (NSFC) [31360207, 31400079, 31370716]; Guangxi Science and Technology Development Project [14123001-19, 14125008-2-22, 15104001-1]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Guangxi Science and Technology Development Project	This work was supported by a grant from the National Science Foundation of China (NSFC; http://www.nsfc.gov.cn/) under the contract numbers 31360207, 31400079 and 31370716, and supported by the Guangxi Science and Technology Development Project (no. 14123001-19, 14125008-2-22 and 15104001-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grant from the National Science Foundation of China (NSFC; http://www.nsfc.gov.cn/) under the contract numbers31360207, 31400079 and 31370716, and supported by the Guangxi Science and Technology Development Project (no. 14123001-19, 14125008-2-22 and 15104001-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank the National Supper Computing Center (NSCC www.nscc-tj.gov.cn) in Tianjin for the valuable help in the modeling calculations using TH-1A super computer.	Bender H, 1966, METHODS ENZYMOL, V8, P555, DOI [10.1016/0076-6879(66)08100-x, DOI 10.1016/0076-6879(66)08100-X]; Bershtein S, 2008, CURR OPIN CHEM BIOL, V12, P151, DOI 10.1016/j.cbpa.2008.01.027; Branden C., 1999, INTRO PROTEIN STRUCT, P47; Chica RA, 2005, CURR OPIN BIOTECH, V16, P378, DOI 10.1016/j.copbio.2005.06.004; Coyne DL, 2006, INT J PEST MANAGE, V52, P215, DOI 10.1080/09670870600722959; Crabb WD, 1999, CURR OPIN MICROBIOL, V2, P252, DOI 10.1016/S1369-5274(99)80044-7; Duan XG, 2013, APPL ENVIRON MICROB, V79, P4072, DOI 10.1128/AEM.00457-13; Edelheit O, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-61; Hii Siew Ling, 2012, Enzyme Res, V2012, P921362; Joo JC, 2011, J BIOTECHNOL, V151, P56, DOI 10.1016/j.jbiotec.2010.10.002; Korkegian A, 2005, SCIENCE, V308, P857, DOI 10.1126/science.1107387; Kosugi A, 2009, RENEW ENERG, V34, P1354, DOI 10.1016/j.renene.2008.09.002; Kunamneni A, 2006, ENZYME MICROB TECH, V39, P1399, DOI 10.1016/j.enzmictec.2006.03.023; Kuriki T, 1999, J BIOSCI BIOENG, V87, P557, DOI 10.1016/S1389-1723(99)80114-5; Lee E. Y. C., 1971, ENZYMES, V5, P191; Liao SM, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-44; Madihah MS, 2001, WORLD J MICROB BIOT, V17, P567, DOI 10.1023/A:1012351112351; Makumbi-Kidza NN, 2000, J NEMATOL, V32, P475; Manners D. J., 1997, Journal of Applied Glycoscience, V44, P83; Nuwamanya E, 2012, AMBIO, V41, P262, DOI 10.1007/s13280-011-0183-z; Ochoa-Leyva A, 2011, J MOL BIOL, V411, P143, DOI 10.1016/j.jmb.2011.05.027; Ochoa-Leyva A, 2009, J MOL BIOL, V387, P949, DOI 10.1016/j.jmb.2009.02.022; Philippe D, 1993, Europe patent, Patent No. [0,605,040 A1, 0605040]; PLANT AR, 1987, BIOCHEM J, V246, P537, DOI 10.1042/bj2460537; Reddy BVB, 1999, PROTEIN SCI, V8, P573; Roy I, 2004, ENZYME MICROB TECH, V34, P26, DOI 10.1016/j.enzmictec.2003.07.001; Spadiut O, 2009, FEBS J, V276, P776, DOI 10.1111/j.1742-4658.2008.06823.x; Storici F, 2003, GENET ENG P, V25, P189; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Turkenburg JP, 2009, PROTEINS, V76, P516, DOI 10.1002/prot.22416; Vazquez-Figueroa E, 2007, CHEMBIOCHEM, V8, P2295, DOI 10.1002/cbic.200700500; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0; Xie NZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137113; Zidenga T, 2012, PLANT PHYSIOL, V159, P1396, DOI 10.1104/pp.112.200345	34	9	10	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0169080	10.1371/journal.pone.0169080	http://dx.doi.org/10.1371/journal.pone.0169080			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103251	gold, Green Submitted, Green Published			2022-12-26	WOS:000392381100008
J	Khanal, S; Elsey, H; King, R; Baral, SC; Bhatta, BR; Newell, JN				Khanal, Sudeepa; Elsey, Helen; King, Rebecca; Baral, Sushil C.; Bhatta, Bharat Raj; Newell, James N.			Development of a Patient-Centred, Psychosocial Support Intervention for Multi-Drug-Resistant Tuberculosis (MDR-TB) Care in Nepal	PLOS ONE			English	Article								Multi-drug-resistant tuberculosis (MDR-TB) poses a major threat to public health worldwide, particularly in low-income countries. The current long (20 month) and arduous treatment regime uses powerful drugs with side-effects that include mental ill-health. It has a high loss to-follow-up (25%) and higher case fatality and lower cure-rates than those with drug sensitive tuberculosis (TB). While some national TB programmes provide small financial allowances to patients, other aspects of psychosocial ill-health, including iatrogenic ones, are not routinely assessed or addressed. We aimed to develop an intervention to improve psycho social well-being for MDR-TB patients in Nepal. To do this we conducted qualitative work with MDR-TB patients, health professionals and the National TB programme (NTP) in Nepal. We conducted semi-structured interviews (SSIs) with 15 patients (10 men and 5 women, aged 21 to 68), four family members and three frontline health workers. In addition, three focus groups were held with MDR-TB patients and three with their family members. We conducted a series of meetings and workshops with key stakeholders to design the intervention, working closely with the NTP to enable government ownership. Our findings highlight the negative impacts of MDR-TB treatment on mental health, with greater impacts felt among those with limited social and financial support, predominantly married women. Michie et al's (2011) framework for behaviour change proved helpful in identifying corresponding practice- and policy-level changes. The findings from this study emphasise the need for tailored psycho-social support. Recent work on simple psychological support packages for the general population can usefully be adapted for use with people with MDR-TB.	[Khanal, Sudeepa; Baral, Sushil C.; Bhatta, Bharat Raj] Hlth Res & Social Dev Forum HERD Nepal, Kathmandu, Nepal; [Elsey, Helen; King, Rebecca; Newell, James N.] Univ Leeds, Nuffield Ctr Int Hlth & Dev, Charles Thackrah Bldg, Leeds, W Yorkshire, England	University of Leeds	King, R (corresponding author), Univ Leeds, Nuffield Ctr Int Hlth & Dev, Charles Thackrah Bldg, Leeds, W Yorkshire, England.	r.king@leeds.ac.uk	Bhatta, Bharat Raj/HDM-7544-2022; Elsey, Helen/AAZ-1121-2020	Elsey, Helen/0000-0003-4724-0581; Bhatta, Bharat Raj/0000-0003-2405-3628	UK Aid from the UK government; Department for International Development (DFID) [201025] Funding Source: researchfish	UK Aid from the UK government(CGIAR); Department for International Development (DFID)	This study was conducted as part of the research programme consortium Comdis-HSD, which is funded by UK Aid from the UK government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation or the manuscript.	Acha J, 2010, GLOB PUBLIC HEALTH, V2, P404; Atif M, 2013, QUAL LIFE RES, V22, P1955, DOI 10.1007/s11136-012-0337-x; Baghaei P, 2011, AM J THER, V18, pE29, DOI 10.1097/MJT.0b013e3181c0806d; Baral SC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-211; Baral SC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-46; Chalco K, 2006, INT NURS REV, V53, P253, DOI 10.1111/j.1466-7657.2006.00490.x; Furin JJ, 2001, INT J TUBERC LUNG D, V5, P648; Isaakidis P, 2013, TROP MED INT HEALTH, V18, P1128, DOI 10.1111/tmi.12146; Lewis CP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-190; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Newell JN, 2006, LANCET, V367, P903, DOI 10.1016/S0140-6736(06)68380-3; Norra C, 2003, EUR PSYCHIAT, V18, P262, DOI 10.1016/S0924-9338(03)00091-9; Rajeswari R, 2005, SOC SCI MED, V60, P1845, DOI 10.1016/j.socscimed.2004.08.024; Ritchie J, 2002, ANAL QUALITATIVE DAT, P187; Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537; Torun T, 2005, INT J TUBERC LUNG D, V9, P1373; Walley J, 2007, B WORLD HEALTH ORGAN, V85, P424, DOI 10.2471/BLT.07.042531; WHO, 2014, NEP TB COUNTR PROF; World Health Organization, 2011, GUID PROGR MAN DRUG; World Health Organization, 2014, TB CARE INT STAND TU, V3rd; World Health Organization, 2015, GLOB TUB REP 2015; World Health Organization, 2006, STOP TB STRAT BUILD; World Health Organization, 2014, GLOB STRAT TARG TUB	23	22	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0167559	10.1371/journal.pone.0167559	http://dx.doi.org/10.1371/journal.pone.0167559			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI3HH	28099475	gold, Green Accepted, Green Published			2022-12-26	WOS:000392380100004
J	Skoracka, A; Lewandowski, M; Rector, BG; Szydlo, W; Kuczynski, L				Skoracka, Anna; Lewandowski, Mariusz; Rector, Brian G.; Szydlo, Wiktoria; Kuczynski, Lechoslaw			Spatial and Host-Related Variation in Prevalence and Population Density of Wheat Curl Mite (Aceria tosichella) Cryptic Genotypes in Agricultural Landscapes	PLOS ONE			English	Article							STREAK-MOSAIC-VIRUS; DIFFERENTIAL TRANSMISSION; REPRODUCTIVE ISOLATION; SPECIATION; DYNAMICS; RANGE; IDENTIFICATION; DISTRIBUTIONS; CONSERVATION; ECOLOGY	The wheat curl mite (WCM), Aceria tosichella Keifer, is a major pest of cereals worldwide that also comprises a complex of at least 16 genetic lineages with divergent physiological traits, including host associations and specificity. The goal of this study was to test the extent to which host-plant species and landscape spatial variation influence WCM presence and population density across the entire area of Poland (>311,000 km(2)). Three important findings arose from the results of the study. (1) The majority of WCM lineages analyzed exhibited variation in patterns of prevalence and/or population density on both spatial and host associated scales. (2) Areas of occurrence and local abundance were delineated for specific WCM lineages and it was determined that the most pestiferous lineages are much less widespread than was expected, suggesting relatively recent introductions into Poland and the potential for further spread. (3) The 16 WCM lineages under study assorted within four discrete host assemblages, within which similar host preferences and host infestation patterns were detected. Of these four groups, one consists of lineages associated with cereals. In addition to improving basic ecological knowledge of a widespread arthropod herbivore, the results of this research identify high-risk areas for the presence of the most pestiferous WCM lineages in the study area (viz, the entirety of Poland). They also provide insight into the evolution of pest species of domesticated crops and facilitate testing of fundamental hypotheses about the ecological factors that shape this pest community.	[Skoracka, Anna; Szydlo, Wiktoria; Kuczynski, Lechoslaw] Adam Mickiewicz Univ, Fac Biol, Inst Environm Biol, Populat Ecol Lab, Poznan, Poland; [Lewandowski, Mariusz] Warsaw Univ Life Sci SGGW, Fac Hort Biotechnol & Landscape Architecture, Dept Appl Entomol, Warsaw, Poland; [Rector, Brian G.] USDA ARS, Great Basin Rangelands Res Unit, Reno, NV USA	Adam Mickiewicz University; Warsaw University of Life Sciences; United States Department of Agriculture (USDA)	Skoracka, A (corresponding author), Adam Mickiewicz Univ, Fac Biol, Inst Environm Biol, Populat Ecol Lab, Poznan, Poland.	skoracka@amu.edu.pl	Kuczyński, Lechosław/E-5525-2011; Skoracka, Anna/E-6002-2011; Lewandowski, Mariusz/H-2184-2011; Szydło, Wiktoria/GPX-7846-2022; Lewandowski, Mariusz/N-1142-2019; Szydło, Wiktoria/ABF-7041-2020	Kuczyński, Lechosław/0000-0003-3498-5445; Skoracka, Anna/0000-0002-9485-532X; Lewandowski, Mariusz/0000-0001-5360-0382; Lewandowski, Mariusz/0000-0001-5360-0382; Rector, Brian/0000-0001-5356-8714; Szydlo, Wiktoria/0000-0001-5990-5611	National Science Centre in Poland [2011/03/B/NZ8/00129]	National Science Centre in Poland(National Science Centre, Poland)	The study was funded by the National Science Centre in Poland, grant no. 2011/03/B/NZ8/00129, https://www.ncn.gov.pl/?language=en. AS received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amor MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098982; Balestrieri A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158203; Bateman BL, 2016, GLOBAL CHANGE BIOL, V22, P1130, DOI 10.1111/gcb.13154; Beeton NJ, 2015, METHODS ECOL EVOL, V6, P1407, DOI 10.1111/2041-210X.12434; Berlocher SH, 2002, ANNU REV ENTOMOL, V47, P773, DOI 10.1146/annurev.ento.47.091201.145312; Biber-Freudenberger L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153237; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Braschler B, 2007, J ANIM ECOL, V76, P415, DOI 10.1111/j.1365-2656.2007.01217.x; Carew M, 2009, B ENTOMOL RES, V99, P479, DOI 10.1017/S0007485308006512; Coutts BA, 2014, PLANT DIS, V98, P285, DOI 10.1094/PDIS-03-13-0288-PDN; Coutts BA, 2014, EUR J PLANT PATHOL, V140, P797, DOI 10.1007/s10658-014-0510-x; Crawford PHC, 2010, J INSECT CONSERV, V14, P511, DOI 10.1007/s10841-010-9280-8; Dabert Jacek, 2008, Zootaxa, V1719, P41; Delatte H, 2009, BIOL INVASIONS, V11, P1059, DOI 10.1007/s10530-008-9328-9; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; European Environment Agency, 2007, 172007 EEA; Ge XZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141111; Gilioli G, 2016, ECOL MODEL, V320, P348, DOI 10.1016/j.ecolmodel.2015.10.018; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hill NJ, 2016, GLOBAL CHANGE BIOL, V22, P1086, DOI 10.1111/gcb.13129; Kolde R., 2015, PHEATMAP PRETTY HEAT, DOI DOI 10.1093/nar/gkv007; Kuczynski L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154600; Leal AI, 2016, J NAT CONSERV, V30, P103, DOI 10.1016/j.jnc.2016.02.001; Luscher G, 2015, BASIC APPL ECOL, V16, P281, DOI 10.1016/j.baae.2015.04.003; McMechan AJ, 2014, PLANT DIS, V98, P806, DOI 10.1094/PDIS-06-13-0582-RE; Miller AD, 2013, MOL PHYLOGENET EVOL, V66, P928, DOI 10.1016/j.ympev.2012.11.021; Navia D, 2013, EXP APPL ACAROL, V59, P95, DOI 10.1007/s10493-012-9633-y; Navia D, 2010, EXP APPL ACAROL, V51, P225, DOI 10.1007/s10493-009-9327-2; Nielsen RO, 2016, PALGRAVE PIVOT, P1, DOI [10.1371/journal.pone.0159271, 10.1057/9781137561725.0007]; Nosil P, 2007, AM NAT, V169, P151, DOI 10.1086/510634; Penczykowski RM, 2016, EVOL APPL, V9, P37, DOI 10.1111/eva.12294; R Core Team, 2021, R LANGUAGE ENV STAT; RIVAS LR, 1964, SYST ZOOL, V13, P42, DOI 10.2307/2411436; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Seehausen O, 2008, MOL ECOL, V17, P30, DOI 10.1111/j.1365-294X.2007.03529.x; Seifers DL, 2009, PLANT DIS, V93, P25, DOI 10.1094/PDIS-93-1-0025; Skoracka A, 2014, ANN APPL BIOL, V165, P222, DOI 10.1111/aab.12130; Skoracka A, 2010, B ENTOMOL RES, V100, P263, DOI 10.1017/S0007485309990216; Skoracka A, 2008, EVOL ECOL, V22, P607, DOI 10.1007/s10682-007-9185-5; Skoracka A, 2013, BIOL J LINN SOC, V109, P165, DOI 10.1111/bij.12024; Skoracka A, 2012, INVERTEBR SYST, V26, P417, DOI 10.1071/IS11037; Stephan D, 2008, ARCH VIROL, V153, P181, DOI 10.1007/s00705-007-1065-3; Szydlo W, 2015, J ECON ENTOMOL, V108, P2030, DOI 10.1093/jee/tov180; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Via S, 1999, EVOLUTION, V53, P1446, DOI 10.1111/j.1558-5646.1999.tb05409.x; Lantschner MV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127099; Wegulo SN, 2008, MANAGING WHEAT STREA; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Wood SN, 2006, GEN ADDITIVE MODELS; Wosula EN, 2016, PLANT DIS, V100, P154, DOI 10.1094/PDIS-03-15-0342-RE; Wosula EN, 2015, J ECON ENTOMOL, V108, P1545, DOI 10.1093/jee/tov185; WU CI, 1983, GENETICS, V105, P71; Zajac A., 2019, DISTRIBUTION ATLAS V	55	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0169874	10.1371/journal.pone.0169874	http://dx.doi.org/10.1371/journal.pone.0169874			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099506	Green Published, Green Submitted, gold			2022-12-26	WOS:000392380100039
J	Thirukkumaran, C; Shi, ZQ; Thirukkumaran, P; Luider, J; Kopciuk, K; Spurrell, J; Elzinga, K; Morris, D				Thirukkumaran, Chandini; Shi, Zhong-Qiao; Thirukkumaran, Ponnampalam; Luider, Joanne; Kopciuk, Karen; Spurrell, Jason; Elzinga, Kate; Morris, Don			PUMA and NF-kappa B Are Cell Signaling Predictors of Reovirus Oncolysis of Breast Cancer	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; INDUCED APOPTOSIS; EXPRESSION; ACTIVATION; PARTICLE; THERAPY; PATHWAY; POTENT; DEATH	Background and purpose Reovirus is a ubiquitous RNA virus that exploits aberrant signaling pathways for its replication. The oncolytic potential of reovirus against numerous cancers under pre-clinical/clinical conditions has been documented by us and others. Despite its proven clinical activity, the underlying mechanisms of reovirus oncolysis is still not well elucidated. If reovirus therapy is to be optimized for cancer, including breast cancer patients, it is imperative to understand the mechanisms of reovirus oncolysis, especially in treatment of resistant tumour. Experimental approach and results In the present study global gene expression profiling was utilized as a preliminary roadmap to tease-out pivotal molecules involved in reovirus induced apoptosis in breast cancer. Reovirus treated HTB133 and MCF7 breast cancer cells revealed transcriptional alteration of a defined subset of apoptotic genes and members of the nuclear factor-kappa B (NF-kappa B) family and p53 upregulated modulator of apoptosis (PUMA) were prominent. Since NF-kappa B can paradoxically suppress or promote apoptosis in cancer, the significance of NF-kappa B in reovirus oncolysis of breast cancer was investigated. Real time PCR analysis indicated a 2.9-4.3 fold increase in NF-kappa B p65 message levels following reovirus infection of MCF7 and HTB133, respectively. Nuclear translocation of NF-kappa B p65 protein was also dramatically augmented post reovirus treatment and correlated with enhanced DNA binding. Pharmacologic inhibition of NF-kappa B lead to oncolytic protection and significant down regulation of PUMA message levels. PUMA down regulation using siRNA suppressed reovirus oncolysis via significantly repressed apoptosis in p53 mutant HTB133 cells. Conclusions This study demonstrates for the first time that a prominent pathway of reovirus oncolysis of breast cancer is mediated through NF-kappa B and that PUMA upregulation is dependent on NF-kappa B activation. These findings represent potential therapeutic indicators of reovirus treatment in future clinical trials.	[Thirukkumaran, Chandini; Shi, Zhong-Qiao; Spurrell, Jason; Elzinga, Kate; Morris, Don] Tom Baker Canc Clin, Translat Res Labs, Calgary, AB, Canada; [Thirukkumaran, Ponnampalam] Hosp Dr NW, Alberta Prov Labs, Calgary, AB, Canada; [Luider, Joanne] Foothills Med Ctr, Calgary Lab Serv, Calgary, AB, Canada; [Kopciuk, Karen] Holy Cross Ctr SW, AHS, Canc Control Alberta, Dept Canc Epidemiol & Prevent Res, Calgary, AB, Canada; [Morris, Don] Univ Calgary, Tom Baker Canc Ctr, Dept Med & Oncol, Calgary, AB, Canada	Tom Baker Cancer Clinic; University of Calgary; University of Calgary; Tom Baker Cancer Clinic; University of Calgary	Morris, D (corresponding author), Tom Baker Canc Clin, Translat Res Labs, Calgary, AB, Canada.; Morris, D (corresponding author), Univ Calgary, Tom Baker Canc Ctr, Dept Med & Oncol, Calgary, AB, Canada.	Don.Morris@albertahealthservices.ca			Canadian Breast Cancer Foundation [10000599]	Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS))	This work was supported by grants awarded to DM and CT through the Canadian Breast Cancer Foundation (Project number 10000599). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain T, 2007, MOL THER, V15, P1512, DOI 10.1038/sj.mt.6300207; [Anonymous], 2012, R STATS PROGR R LANG; Cao Z, 1999, COLD SPRING HARB SYM, V64, P473, DOI 10.1101/sqb.1999.64.473; Cejkova S, 2009, EUR J HAEMATOL, V82, P133, DOI 10.1111/j.1600-0609.2008.01177.x; Chen F, 2007, CANCER RES, V67, P11093, DOI 10.1158/0008-5472.CAN-07-1576; Clarke P, 2001, ONCOGENE, V20, P6910, DOI 10.1038/sj.onc.1204842; Clarke P, 2003, J BIOL CHEM, V278, P18092, DOI 10.1074/jbc.M300265200; Coffey MC, 1998, SCIENCE, V282, P1332, DOI 10.1126/science.282.5392.1332; Connolly JL, 2000, J VIROL, V74, P2981, DOI 10.1128/JVI.74.7.2981-2989.2000; DeBiasi RL, 2003, J VIROL, V77, P8934, DOI 10.1128/JVI.77.16.8934-8947.2003; Donepudi MS, 2014, J CANCER RES THER, V10, P506, DOI 10.4103/0973-1482.137927; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Groll M, 2004, BBA-MOL CELL RES, V1695, P33, DOI 10.1016/j.bbamcr.2004.09.025; Han JW, 2001, P NATL ACAD SCI USA, V98, P11318, DOI 10.1073/pnas.201208798; Hirasawa K, 2002, CANCER RES, V62, P1696; Katayama Y, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/468457; Kelly KR, 2015, ONCOTARGET, V6, P41275, DOI 10.18632/oncotarget.5753; Marcato P, 2007, MOL THER, V15, P1522, DOI 10.1038/sj.mt.6300179; Middelburg R, 2005, CLIN CANCER RES, V11, P1863, DOI 10.1158/1078-0432.CCR-04-1372; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Norman KL, 2002, HUM GENE THER, V13, P641, DOI 10.1089/10430340252837233; Norman KL, 2004, P NATL ACAD SCI USA, V101, P11099, DOI 10.1073/pnas.0404310101; Pan D, 2011, BRIT J CANCER, V105, P1012, DOI 10.1038/bjc.2011.325; PETERS CA, 2001, ENV ENG PROCESSES LA, P1; Shetty S, 2005, MOL CELL BIOL, V25, P5404, DOI 10.1128/MCB.25.13.5404-5416.2005; Sinicrope FA, 2008, CLIN CANCER RES, V14, P5810, DOI 10.1158/1078-0432.CCR-07-5202; Smakman N, 2006, CANCER RES, V66, P5403, DOI 10.1158/0008-5472.CAN-05-4108; SMITH RE, 1969, VIROLOGY, V39, P791, DOI 10.1016/0042-6822(69)90017-8; Smith RA, 2012, ONCOLOGY-NY, V26, P471; Strong JE, 1998, EMBO J, V17, P3351, DOI 10.1093/emboj/17.12.3351; Thirukkumaran C, 2005, P 96 ANN M AM ASS CA, P46; Thirukkumaran C, 2007, P 98 ANN M AM ASS CA, P48; Thirukkumaran C, 2011, P 102 ANN M AM ASS C; Thirukkumaran CM, 2012, CLIN CANCER RES, V18, P4962, DOI 10.1158/1078-0432.CCR-11-3085; Thirukkumaran CM, 2010, CANCER RES, V70, P2435, DOI 10.1158/0008-5472.CAN-09-2408; Thirukkumaran CM, 2003, BLOOD, V102, P377, DOI 10.1182/blood-2002-08-2508; Toss A, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0560-9; TYLER KL, 1996, FIELDS VIROLOGY, P1597; Wang P, 2009, CELL DEATH DIFFER, V16, P1192, DOI 10.1038/cdd.2009.51; Wilcox ME, 2001, J NATL CANCER I, V93, P903, DOI 10.1093/jnci/93.12.903; Xu Bo, 2006, Zhongguo Dang Dai Er Ke Za Zhi, V8, P151; Yang WQ, 2004, GENE THER, V11, P1579, DOI 10.1038/sj.gt.3302319; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45	47	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0168233	10.1371/journal.pone.0168233	http://dx.doi.org/10.1371/journal.pone.0168233			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099441	gold, Green Published, Green Submitted			2022-12-26	WOS:000392380100008
J	Hu, LH; Huang, X; You, CJ; Li, JX; Hong, K; Li, P; Wu, YQ; Wu, QH; Bao, HH; Cheng, XS				Hu, Lihua; Huang, Xiao; You, Chunjiao; Li, Juxiang; Hong, Kui; Li, Ping; Wu, Yanqing; Wu, Qinhua; Bao, Huihui; Cheng, Xiaoshu			Prevalence and Risk Factors of Prehypertension and Hypertension in Southern China	PLOS ONE			English	Article							JOINT-NATIONAL-COMMITTEE; HIGH BLOOD-PRESSURE; 7TH REPORT; HEART-RATE; BODY-MASS; EPIDEMIOLOGY; INFLAMMATION; ASSOCIATION; POPULATION; PREVENTION	Background This study aimed to describe the prevalence and risk factors of prehypertension and hypertension in Jiangxi Province, China. Individuals with prehypertension frequently progress into hypertension and are at high risk of developing cardiovascular disease and stroke. Methods A cross-sectional survey of 15,296 participants (15 years or older) was conducted in Jiangxi Province, China, in 2013, using questionnaire forms and physical measurements. Results The prevalence of prehypertension and hypertension was 32.3% (39.2% in men and 27.6% in women) and 29.0% (30.1% in men and 28.2% in women), respectively. The awareness, treatment, and control rates among all hypertensive participants were 64.8%, 27.1%, and 12.6%, respectively. The prevalence of prehypertension in males declined with age, but the prevalence of hypertension increased in different genders. The prevalence of prehypertension and hypertension increased with increasing body mass index (BMI). The prevalence of prehypertension decreased, in parallel to an increase in the prevalence of hypertension, with increasing waist circumference (WC). A combination of WC and BMI was superior to individual indices in identifying hypertension. A multivariate logistic regression analysis indicated that increasing age, high BMI, high visceral adipose index, and high heart rate were risk factors for prehypertension and hypertension. The high body fat percentage was significantly associated with prehypertension. Living in an urban area, male sex, abdominal obesity, and menopause were correlated with hypertension. Conclusions Prehypertension and hypertension are epidemic in southern China. Further studies are needed to explore an indicator that can represent the visceral fat accurately and has a close relationship with cardiovascular disease.	[Hu, Lihua; Huang, Xiao; You, Chunjiao; Li, Juxiang; Hong, Kui; Li, Ping; Wu, Yanqing; Wu, Qinhua; Bao, Huihui; Cheng, Xiaoshu] Nanchang Univ, Affiliated Hosp 2, Dept Cardiovasc Med, Nanchang, Jiangxi, Peoples R China	Nanchang University	Bao, HH; Cheng, XS (corresponding author), Nanchang Univ, Affiliated Hosp 2, Dept Cardiovasc Med, Nanchang, Jiangxi, Peoples R China.	huihui_bao77@126.com; xiaoshumenfan126@163.com	Huang, Xiao/ABB-9211-2020		National Key R&D Program in the Twelfth Five-year Plan from the Chinese Ministry of Science and Technology [2011BAI11B01]; National Natural Science Foundation of China [81260023, 81560051, 81500233]; Science and Technology project of Jiangxi Province [20151BDH80038, 20161BAB215239, 20161BBH80073]	National Key R&D Program in the Twelfth Five-year Plan from the Chinese Ministry of Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology project of Jiangxi Province	This research was supported by the National Key R&D Program in the Twelfth Five-year Plan (No. 2011BAI11B01) from the Chinese Ministry of Science and Technology and National Natural Science Foundation of China (No. 81260023, 81560051 and 81500233). This research was also supported by Science and Technology project of Jiangxi Province (No. 20151BDH80038, 20161BAB215239 and 20161BBH80073).	Amato MC, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/730827; Bajpai JK, 2014, J CLIN DIAGN RES, V8, pBC7, DOI 10.7860/JCDR/2014/8023.4277; Casiglia E, 1996, J HYPERTENS, V14, P729; Celik T, 2013, BLOOD PRESSURE, V22, P94, DOI 10.3109/08037051.2012.716580; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chandra A, 2014, J AM COLL CARDIOL, V64, P997, DOI 10.1016/j.jacc.2014.05.057; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Diederichs C, 2014, J HYPERTENS, V32, P1405, DOI 10.1097/HJH.0000000000000211; Ding Y, 2015, PLOS ONE, V10; Dong GH, 2012, J HYPERTENS, V30, P485, DOI 10.1097/HJH.0b013e32834f9dd3; Guo FJ, 2012, J AM COLL CARDIOL, V60, P599, DOI 10.1016/j.jacc.2012.04.026; Guo XF, 2013, EUR J PEDIATR, V172, P223, DOI 10.1007/s00431-012-1873-7; Hou XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057319; Huang YL, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-177; Huang YL, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006551; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Lenfant C, 2003, HYPERTENSION, V41, P1178, DOI 10.1161/01.HYP.0000075790.33892.AE; Li GJ, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2965-5; Li Li-ming, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P478; Lin YHL, 2012, KIDNEY BLOOD PRESS R, V35, P305, DOI 10.1159/000336085; Musa BM, 2016, ANN HEMATOLOGY; Navarro-Gonzalez JF, 2013, J HUM HYPERTENS, V27, P119, DOI 10.1038/jhh.2011.118; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Palatini P, 2011, HYPERTENSION, V58, P745, DOI 10.1161/HYPERTENSIONAHA.111.173104; Portaluppi F, 1997, HYPERTENSION, V29, P976, DOI 10.1161/01.HYP.29.4.976; Rahmanian Karamatollah, 2012, BMC Res Notes, V5, P386, DOI 10.1186/1756-0500-5-386; Recio-Rodriguez JI, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-3; Reule S, 2012, CURR HYPERTENS REP, V14, P478, DOI 10.1007/s11906-012-0306-3; Silva DAS, 2012, REV SAUDE PUBL, V46, P988, DOI 10.1590/S0034-89102012000600008; Staessen JA, 1998, J HUM HYPERTENS, V12, P587, DOI 10.1038/sj.jhh.1000670; Sun ZQ, 2007, CIRC J, V71, P550, DOI 10.1253/circj.71.550; Suri MFK, 2006, J CARDIOVASC NURS, V21, P478, DOI 10.1097/00005082-200611000-00012; Tsai PS, 2005, J HYPERTENS, V23, P1355, DOI 10.1097/01.hjh.0000173517.68234.c3; Tyson CC, 2013, J CLIN HYPERTENS, V15, P458, DOI 10.1111/jch.12108; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Vasan RS, 2001, LANCET, V358, P1682, DOI 10.1016/S0140-6736(01)06710-1; Wang J, 2014, PREVALENCE AWARENESS; Wang R, 2015, INT J CLIN EXP MED, V8, P16424; Wang ZW, 2014, INT J CARDIOL, V174, P721, DOI 10.1016/j.ijcard.2014.03.117; Xue H, 2015, PLOS ONE, V10; Yang G, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13010082; Yang L, 2016, PLOS ONE, V11	43	103	119	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0170238	10.1371/journal.pone.0170238	http://dx.doi.org/10.1371/journal.pone.0170238			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095471	gold, Green Published, Green Submitted			2022-12-26	WOS:000392372300074
J	Sagong, HY; Kim, KJ				Sagong, Hye-Young; Kim, Kyung-Jin			Lysine Decarboxylase with an Enhanced Affinity for Pyridoxal 5-Phosphate by Disulfide Bond-Mediated Spatial Reconstitution	PLOS ONE			English	Article							ESCHERICHIA-COLI; CORYNEBACTERIUM-GLUTAMICUM; CADAVERINE; AMINOTRANSFERASE; STABILITY; MECHANISM; PROTEIN; PH	Lysine decarboxylase (LDC) catalyzes the decarboxylation of L-lysine to produce cadaverine, an important industrial platform chemical for bio-based polyamides. However, due to high flexibility at the pyridoxal 5-phosphate (PLP) binding site, use of the enzyme for cadaverine production requires continuous supplement of large amounts of PLP. In order to develop an LDC enzyme from Selenomonas ruminantium (SrLDC) with an enhanced affinity for PLP, we introduced an internal disulfide bond between A1a225 and Thr302 residues with a desire to retain the PLP binding site in a closed conformation. The SrLDCA225Cf1-302C mutant showed a yellow color and the characteristic UVNis absorption peaks for enzymes with bound PLP, and exhibited three-fold enhanced PLP affinity compared with the wild-type SrLDC. The mutant also exhibited a dramatically enhanced LDC activity and cadaverine conversion particularly under no or low PLP concentrations. Moreover, introduction of the disulfide bond rendered SrLDC more resistant to high pH and temperature. The formation of the introduced disulfide bond and the maintenance of the PLP binding site in the closed conformation were confirmed by determination of the crystal structure of the mutant. This study shows that disulfide bond-mediated spatial reconstitution can be a platform technology for development of enzymes with enhanced PLP affinity.	[Sagong, Hye-Young; Kim, Kyung-Jin] Kyungpook Natl Univ, Sch Life Sci, KNU Creat BioRes Grp, Daegu, South Korea	Kyungpook National University	Kim, KJ (corresponding author), Kyungpook Natl Univ, Sch Life Sci, KNU Creat BioRes Grp, Daegu, South Korea.	kkim@knu.ac.kr		Sagong, Hye-Young/0000-0003-1823-4991	National Research Foundation of Korea (NRF) grant by C1 Gas Refinery Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2016M3D3A1A01913269]; Advanced Biomass R&D Center (ABC) of Global Frontier Project - MEST [NRF-2015M3A6A2053895]	National Research Foundation of Korea (NRF) grant by C1 Gas Refinery Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Advanced Biomass R&D Center (ABC) of Global Frontier Project - MEST	This work was supported by a National Research Foundation of Korea (NRF) grant by C1 Gas Refinery Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2016M3D3A1A01913269), and by the Advanced Biomass R&D Center (ABC) of Global Frontier Project funded by the MEST (NRF-2015M3A6A2053895).	BALK H, 1981, BIOCHEMISTRY-US, V20, P6391, DOI 10.1021/bi00525a017; Bearson S, 1997, FEMS MICROBIOL LETT, V147, P173, DOI 10.1016/S0378-1097(96)00503-4; Dogovski C., 2012, ENZYMOLOGY BACTERIAL; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flieger M, 2003, FOLIA MICROBIOL, V48, P27, DOI 10.1007/BF02931273; Imani M, 2010, PHOTOCH PHOTOBIO SCI, V9, P1167, DOI 10.1039/c0pp00105h; Jenkins W, 1985, TRANSAMINASES, V2, P216; Kind S, 2010, METAB ENG, V12, P341, DOI 10.1016/j.ymben.2010.03.005; Kulik V, 2002, J MOL BIOL, V324, P677, DOI 10.1016/S0022-2836(02)01109-9; Lee JW, 2011, CURR OPIN BIOTECH, V22, P758, DOI 10.1016/j.copbio.2011.02.011; Lee SG, 2006, FEBS J, V273, P5564, DOI 10.1111/j.1742-4658.2006.05546.x; Ma W, 2015, SCI REPORTS, V5; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2006, P NATL ACAD SCI USA, V103, P17909, DOI 10.1073/pnas.0608643103; Meister A., 2009, ADV ENZYMOLOGY RELAT; Mimitsuka T, 2007, BIOSCI BIOTECH BIOCH, V71, P2130, DOI 10.1271/bbb.60699; Mimizuka T, 2002, HOST METHOD PRODUCIN; MORINO Y, 1984, METHOD ENZYMOL, V106, P116; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nazari M, 2011, PHOTOCH PHOTOBIO SCI, V10, P1203, DOI 10.1039/c1pp05012e; Neely MN, 1996, J BACTERIOL, V178, P5522, DOI 10.1128/jb.178.18.5522-5528.1996; Nishi K., 2006, Eur. Pat, Patent No. [EP1482055 (B1), 1482055]; OKAMOTO A, 1994, J BIOCHEM, V116, P95, DOI 10.1093/oxfordjournals.jbchem.a124509; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park YK, 1996, MOL MICROBIOL, V20, P605, DOI 10.1046/j.1365-2958.1996.5441070.x; Percudani R, 2003, EMBO REP, V4, P850, DOI 10.1038/sj.embor.embor914; PERRY LJ, 1984, SCIENCE, V226, P555, DOI 10.1126/science.6387910; PETERSON EA, 1954, J AM CHEM SOC, V76, P169, DOI 10.1021/ja01630a045; Qian ZG, 2011, BIOTECHNOL BIOENG, V108, P93, DOI 10.1002/bit.22918; Rath VL, 2000, MOL CELL, V6, P139, DOI 10.1016/S1097-2765(00)00015-0; Sagong H-Y S H, 2016, PLOS ONE IN PRESS; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; SAUER RT, 1986, BIOCHEMISTRY-US, V25, P5992, DOI 10.1021/bi00368a024; Schneider J, 2011, APPL MICROBIOL BIOT, V91, P17, DOI 10.1007/s00253-011-3252-0; Sugio S, 1998, PROTEIN ENG, V11, P613, DOI 10.1093/protein/11.8.613; TAKAGI H, 1990, J BIOL CHEM, V265, P6874; Tateno T, 2009, APPL MICROBIOL BIOT, V82, P115, DOI 10.1007/s00253-008-1751-4; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; WAKARCHUK WW, 1994, PROTEIN ENG, V7, P1379, DOI 10.1093/protein/7.11.1379; WETZEL R, 1988, P NATL ACAD SCI USA, V85, P401, DOI 10.1073/pnas.85.2.401; Willke T, 2004, APPL MICROBIOL BIOT, V66, P131, DOI 10.1007/s00253-004-1733-0; YEH P, 1988, MOL GEN GENET, V212, P105, DOI 10.1007/BF00322451	42	8	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0170163	10.1371/journal.pone.0170163	http://dx.doi.org/10.1371/journal.pone.0170163			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095457	gold, Green Published, Green Submitted			2022-12-26	WOS:000392372300065
J	Souza, LV; Oliveira, V; De Meneck, F; Clemente, APG; Strufaldi, MWL; Franco, MD				Souza, Livia Victorino; Oliveira, Vanessa; De Meneck, Franciele; Grotti Clemente, Ana Paula; Louzada Strufaldi, Maria Wany; Franco, Maria do Carmo			Birth Weight and Its Relationship with the Cardiac Autonomic Balance in Healthy Children	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; PRENATAL ZINC SUPPLEMENTATION; GESTATIONAL-AGE; YOUNG-ADULTS; BIOELECTRICAL-IMPEDANCE; ENDOTHELIAL FUNCTION; FETAL; SIZE; STIFFNESS; GROWTH	Several studies indicate that the fetal environment plays a significant role in the development of cardiometabolic disease later in life. However, a few studies present conflicting data about the correlation between birth weight and the impairment of cardiac autonomic modulation. The purpose of the present study was to provide further knowledge to elucidate this contradictory relationship. One hundred children aged 5 and 14 years had anthropometric parameters, body composition and blood pressure levels determined. Heart rate variability (HRV) was evaluated by heart rate monitoring, including measurements of both the time and frequency domains. The results showed inverse correlation between the HRV parameters with BMI (RMSSD: P = 0.047; PNN50: P = 0.021; HF: P = 0.041), systolic (RMSSD: P = 0.023; PNN50: P = 0.032) and diastolic (PNN50: P = 0.030) blood pressure levels. On the other hand, there were consistent positive correlations between the HRV parameters and birth weight (RMSSD: P = 0.001; PNN50: P = 0.001; HF: P = 0.002). To determine the effect of birth weight on HRV parameters, we perform multivariate linear regression analysis adjusted for potentially confounding factors (prematurity, gender, age, BMI, physical activity index and SBP levels). These findings were preserved even after adjusting for these confounders. Our results suggested that impaired cardiac autonomic modulation characterized by a reduction in the parasympathetic activity occurs in children with low birth weight. One possible interpretation for these data is that a vagal withdrawal, rather than a sympathetic overactivity, could precede the development of hypertension and other cardiometabolic diseases in children with low birth weight. However, long-term studies should be performed to investigate this possibility.	[Souza, Livia Victorino; Oliveira, Vanessa; De Meneck, Franciele; Franco, Maria do Carmo] Univ Fed Sao Paulo, Div Nephrol, Sao Paulo, Brazil; [Grotti Clemente, Ana Paula] Univ Fed Alagoas, Dept Nutr, Alagoas, Brazil; [Louzada Strufaldi, Maria Wany] Univ Fed Sao Paulo, Dept Pediat, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Alagoas; Universidade Federal de Sao Paulo (UNIFESP)	Franco, MD (corresponding author), Univ Fed Sao Paulo, Div Nephrol, Sao Paulo, Brazil.	maria.franco@unifesp.br	Strufaldi, Maria Wany L/C-6663-2016; Franco, Maria CP/F-9421-2012; Oliveira, Vanessa/AAA-4748-2021; do Carmo P Franco, Maria/F-7771-2015; CLEMENTE, ANA PAULA/N-6720-2019; Louzada Strufaldi, Maria Wany/GVU-7692-2022	Strufaldi, Maria Wany L/0000-0003-0335-5344; Franco, Maria CP/0000-0003-0604-7689; Oliveira, Vanessa/0000-0003-3268-1384	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil) [2013/03139-0]	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by a project grant from the FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil) (Project Number: 2013/03139-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajala AR, 2012, AM J HYPERTENS, V25, P827, DOI 10.1038/ajh.2012.50; Akira M, 2006, J PEDIATR-US, V148, P49, DOI 10.1016/j.jpeds.2005.06.044; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Boguszewski MCS, 2004, J HYPERTENS, V22, P1157, DOI 10.1097/00004872-200406000-00017; Caulfield LE, 2011, J NUTR, V141, P327, DOI 10.3945/jn.110.128843; DAWES GS, 1982, BRIT J OBSTET GYNAEC, V89, P276, DOI 10.1111/j.1471-0528.1982.tb04696.x; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; DiPietro JA, 2004, DEV PSYCHOL, V40, P445, DOI 10.1037/0012-1649.40.3.445; DiPietro JA, 2000, DEV PSYCHOBIOL, V37, P221, DOI 10.1002/1098-2302(2000)37:4<221::AID-DEV2>3.0.CO;2-A; DiPietro JA, 2007, CHILD DEV, V78, P1788, DOI 10.1111/j.1467-8624.2007.01099.x; Espineira AR, 2011, CLIN ENDOCRINOL, V75, P335, DOI 10.1111/j.1365-2265.2011.04054.x; Franco MCP, 2008, CLIN SCI, V114, P375, DOI 10.1042/CS20070284; Franco MCP, 2006, HYPERTENSION, V48, P45, DOI 10.1161/01.HYP.0000223446.49596.3a; Franz AR, 2004, PEDIATRICS, V114, P1, DOI 10.1542/peds.114.1.1; GAGNON R, 1987, AM J OBSTET GYNECOL, V157, P743, DOI 10.1016/S0002-9378(87)80042-X; Galland BC, 2006, J APPL PHYSIOL, V100, P933, DOI 10.1152/japplphysiol.01275.2005; Gamelin FX, 2008, INT J SPORTS MED, V29, P134, DOI 10.1055/s-2007-964995; Hung GCL, 2015, INT J EPIDEMIOL, V44, P1889, DOI 10.1093/ije/dyv303; IJzerman RG, 2003, CIRCULATION, V108, P566, DOI 10.1161/01.CIR.0000081778.35370.1B; Johansson S, 2007, J INTERN MED, V261, P480, DOI 10.1111/j.1365-2796.2007.01776.x; Jones A, 2007, HYPERTENSION, V49, P548, DOI 10.1161/01.HYP.0000257196.13485.9b; Kajantie E, 2005, INT J EPIDEMIOL, V34, P655, DOI 10.1093/ije/dyi048; Koklu E, 2007, EUR J PEDIATR, V166, P333, DOI 10.1007/s00431-006-0243-8; Kumar V, 1984, Indian Pediatr, V21, P113; Lahiri MK, 2008, J AM COLL CARDIOL, V51, P1725, DOI 10.1016/j.jacc.2008.01.038; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; LUKASKI HC, 1986, J APPL PHYSIOL, V60, P1327, DOI 10.1152/jappl.1986.60.4.1327; Martin H, 2000, CIRCULATION, V102, P2739, DOI 10.1161/01.CIR.102.22.2739; Martyn CN, 1997, LANCET, V350, P953, DOI 10.1016/S0140-6736(96)10508-0; Massin MM, 2001, CARDIOLOGY, V95, P80, DOI 10.1159/000047350; Mathewson KJ, 2014, INT J PSYCHOPHYSIOL, V93, P198, DOI 10.1016/j.ijpsycho.2014.04.005; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; Merialdi M, 2004, AM J OBSTET GYNECOL, V190, P1106, DOI 10.1016/j.ajog.2003.09.072; Merialdi M, 1999, AM J OBSTET GYNECOL, V180, P483, DOI 10.1016/S0002-9378(99)70236-X; Miyawaki M, 2006, ARCH DIS CHILD-FETAL, V91, P359, DOI 10.1136/adc.2005.089573; Nagai N, 2003, OBES RES, V11, P25, DOI 10.1038/oby.2003.6; Oldroyd J, 2011, EUR J PEDIATR, V170, P899, DOI 10.1007/s00431-010-1375-4; Oren A, 2003, AM J HYPERTENS, V16, P76, DOI 10.1016/S0895-7061(02)03151-5; Rakow A, 2013, PEDIATR RES, V74, P339, DOI 10.1038/pr.2013.97; Rush EC, 2003, EUR J CLIN NUTR, V57, P1394, DOI 10.1038/sj.ejcn.1601701; Saaka M, 2009, J HEALTH POPUL NUTR, V27, P619, DOI 10.3329/jhpn.v27i5.3638; Schaffer L, 2008, AM J PHYSIOL-HEART C, V294, pH884, DOI 10.1152/ajpheart.00318.2007; Skilton MR, 2014, ARTERIOSCL THROM VAS, V34, P1064, DOI 10.1161/ATVBAHA.113.302934; SPASSOV L, 1994, PEDIATR RES, V35, P500, DOI 10.1203/00006450-199404000-00022; Stanganelli LC., 2006, REV PORT CIENC DESPO, V6, P265, DOI [10.5628/rpcd.06.03.265, DOI 10.5628/RPCD.06.03.265]; Tarvainen MP, 2002, IEEE T BIO-MED ENG, V49, P172, DOI 10.1109/10.979357; Thayer JF, 2007, BIOL PSYCHOL, V74, P224, DOI 10.1016/j.biopsycho.2005.11.013; TOWNEND JN, 1995, HYPERTENSION, V25, P1270, DOI 10.1161/01.HYP.25.6.1270; Vanderlei LCM, 2008, BRAZ J MED BIOL RES, V41, P854, DOI 10.1590/S0100-879X2008005000039; Wadhwa P D, 2001, Prog Brain Res, V133, P131; Ward AMV, 2004, J HYPERTENS, V22, P2295, DOI 10.1097/00004872-200412000-00011; Weitz G, 2013, AM J CARDIOVASC DIS, V3, P239; Young JB, 2002, TRENDS ENDOCRIN MET, V13, P381, DOI 10.1016/S1043-2760(02)00661-6	54	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0167328	10.1371/journal.pone.0167328	http://dx.doi.org/10.1371/journal.pone.0167328			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI3EK	28095501	Green Submitted, Green Published, gold			2022-12-26	WOS:000392372300004
J	Zhang, QY; Shao, MA; Jia, XX; Wei, XR				Zhang, Qingyin; Shao, Ming'an; Jia, Xiaoxu; Wei, Xiaorong			Relationship of Climatic and Forest Factors to Drought- and Heat-Induced Tree Mortality	PLOS ONE			English	Article							PINYON-JUNIPER WOODLAND; CARBON METABOLISM; HYDRAULIC LIMITS; PONDEROSA PINE; MIXED-CONIFER; DIE-OFF; GROWTH; DENSITY; RECRUITMENT; SENSITIVITY	Tree mortality due to warming and drought is a critical aspect of forest ecosystem in responding to climate change. Spatial patterns of tree mortality induced by drought and its influencing factors, however, have yet to be documented at the global scale. We collected observations from 248 sites globally where trees have died due to drought and then assessed the effects of climatic and forest factors on the rate of tree mortality. The global mean annual mortality rate was 5.5%. The rate of tree mortality was significantly and negatively correlated with mean annual precipitation (P<0.01). Tree mortality was lowest in tropical rainforests with mean annual precipitation >2000 mm and was severe in regions with mean annual precipitation <1000 mm. Mortality rates varied amongst species. The global annual rate of mortality was much higher for gymnosperms (7.1%) than angiosperms (4.8%) but did not differ significantly between evergreen (6.2%) and deciduous (6.1%) species. Stand age and wood density affected the mortality rate. Saplings (4.6%) had a higher mortality rate than mature trees (3.2%), and mortality rates significantly decreased with increasing wood density for all species (P < 0.01). We therefore concluded that the tree mortality around the globe varied with climatic and forest factors. The differences between tree species, wood density, stand density, and stand age should be considered when evaluating tree mortality at a large spatial scale during future climatic extremes.	[Zhang, Qingyin; Shao, Ming'an] Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Shaanxi, Peoples R China; [Shao, Ming'an; Jia, Xiaoxu] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China; [Shao, Ming'an; Wei, Xiaorong] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China; [Shao, Ming'an; Jia, Xiaoxu] Univ Chinese Acad Sci, Coll Resources & Environm, Beijing, Peoples R China	Northwest A&F University - China; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Northwest A&F University - China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Shao, MA (corresponding author), Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Shaanxi, Peoples R China.; Shao, MA; Jia, XX (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China.; Shao, MA (corresponding author), Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China.; Shao, MA; Jia, XX (corresponding author), Univ Chinese Acad Sci, Coll Resources & Environm, Beijing, Peoples R China.	shaoma@igsnrr.ac.cn; jiaxx@igsnrr.ac.cn			National Natural Science Foundation of China [41390461, 41501233, 41530854]; National Key Project for Research and Development [2016YFC0501605]; Program for Bingwei Excellent Talents from Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Sciences [2015RC204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Project for Research and Development; Program for Bingwei Excellent Talents from Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Sciences	This work was supported by the National Natural Science Foundation of China (41390461, 41501233) to Xiaoxu Jia (http://www.nsfc.gov.cn/); the National Natural Science Foundation of China (41530854) (http://www.nsfc.gov.cn/); the National Key Project for Research and Development (2016YFC0501605) to Mingan Shao (http://www.most.gov.cn/); the Program for Bingwei Excellent Talents from Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Sciences (2015RC204) to Xiaoxu Jia (http://www.cas.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker SA, 2015, FOREST ECOL MANAG, V336, P109, DOI 10.1016/j.foreco.2014.10.008; Adams HD, 2013, NEW PHYTOL, V197, P1142, DOI 10.1111/nph.12102; Adams HD, 2009, P NATL ACAD SCI USA, V106, P7063, DOI 10.1073/pnas.0901438106; Allen CD, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00203.1; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderegg WRL, 2016, P NATL ACAD SCI USA, V113, P5024, DOI 10.1073/pnas.1525678113; Anderegg WRL, 2013, TREE PHYSIOL, V33, P252, DOI 10.1093/treephys/tpt016; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Brodribb TJ, 2003, PLANT CELL ENVIRON, V26, P443, DOI 10.1046/j.1365-3040.2003.00975.x; Campos GEP, 2013, NATURE, V494, P349, DOI 10.1038/nature11836; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Choat B, 2012, NATURE, V491, P752, DOI 10.1038/nature11688; Clifford MJ, 2013, NEW PHYTOL, V200, P413, DOI 10.1111/nph.12362; Clifford MJ, 2011, ECOSYSTEMS, V14, P949, DOI 10.1007/s10021-011-9458-2; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Fensham RJ, 2009, GLOBAL CHANGE BIOL, V15, P380, DOI 10.1111/j.1365-2486.2008.01718.x; Floyd ML, 2015, FOREST ECOL MANAG, V341, P18, DOI 10.1016/j.foreco.2014.12.033; Floyd ML, 2009, ECOL APPL, V19, P1223, DOI 10.1890/08-1265.1; Fraver S, 2008, J VEG SCI, V19, P789, DOI 10.3170/2008-8-18449; Ganey JL, 2011, FOREST ECOL MANAG, V261, P162, DOI 10.1016/j.foreco.2010.09.048; Greenwood DL, 2008, FOREST ECOL MANAG, V255, P2129, DOI 10.1016/j.foreco.2007.12.048; Guarin A, 2005, FOREST ECOL MANAG, V218, P229, DOI 10.1016/j.foreco.2005.07.014; He JS, 2005, TREES-STRUCT FUNCT, V19, P442, DOI 10.1007/s00468-004-0403-2; Hoch G, 2003, PLANT CELL ENVIRON, V26, P1067, DOI 10.1046/j.0016-8025.2003.01032.x; Johnson DM, 2012, PLANT SCI, V195, P48, DOI 10.1016/j.plantsci.2012.06.010; Keeling HC, 2008, OECOLOGIA, V158, P521, DOI 10.1007/s00442-008-1161-4; Kim YX, 2007, J EXP BOT, V58, P4119, DOI 10.1093/jxb/erm270; Kraft NJB, 2010, NEW PHYTOL, V188, P1124, DOI 10.1111/j.1469-8137.2010.03444.x; Laarmann D, 2009, FOREST ECOL MANAG, V258, pS187, DOI 10.1016/j.foreco.2009.07.014; Law BE, 2014, GLOBAL CHANGE BIOL, V20, P3595, DOI 10.1111/gcb.12651; Lewis SL, 2004, J ECOL, V92, P929, DOI 10.1111/j.0022-0477.2004.00923.x; Liu HY, 2013, GLOBAL CHANGE BIOL, V19, P2500, DOI 10.1111/gcb.12217; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; McDowell NG, 2011, PLANT PHYSIOL, V155, P1051, DOI 10.1104/pp.110.170704; McKee TB, 1993, 8 C APPL CLIM 17 JA, V17, P179, DOI DOI 10.1111/J.1467-7717.1988.TB00685; Michaelian M, 2011, GLOBAL CHANGE BIOL, V17, P2084, DOI 10.1111/j.1365-2486.2010.02357.x; Mueller RC, 2005, J ECOL, V93, P1085, DOI 10.1111/j.1365-2745.2005.01042.x; Nardini A, 2013, NEW PHYTOL, V200, P322, DOI 10.1111/nph.12288; Negron JF, 2003, WEST N AM NATURALIST, V63, P440; Niinemets U, 2010, FOREST ECOL MANAG, V260, P1623, DOI 10.1016/j.foreco.2010.07.054; Niklas KJ, 2004, P NATL ACAD SCI USA, V101, P15661, DOI 10.1073/pnas.0405857101; Niu SL, 2014, ENVIRON EXP BOT, V98, P13, DOI 10.1016/j.envexpbot.2013.10.004; Patino S, 2009, BIOGEOSCIENCES, V6, P545, DOI 10.5194/bg-6-545-2009; Peng CH, 2011, NAT CLIM CHANGE, V1, P467, DOI 10.1038/NCLIMATE1293; Peterman W, 2012, ECOHYDROLOGY, DOI 10.1002/eco.1284; Phillips OL, 2010, NEW PHYTOL, V187, P631, DOI 10.1111/j.1469-8137.2010.03359.x; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Plaut JA, 2012, PLANT CELL ENVIRON, V35, P1601, DOI 10.1111/j.1365-3040.2012.02512.x; Powers MD, 2010, FOREST ECOL MANAG, V260, P1138, DOI 10.1016/j.foreco.2010.07.002; Reichstein M, 2013, NATURE, V500, P287, DOI 10.1038/nature12350; Sala A, 2009, PLANT CELL ENVIRON, V32, P22, DOI 10.1111/j.1365-3040.2008.01896.x; Santos MJ, 2010, ENVIRON MANAGE, V45, P239, DOI 10.1007/s00267-009-9413-6; Sheil D, 1996, J ECOL, V84, P91, DOI 10.2307/2261703; Smith JB, 2009, P NATL ACAD SCI USA, V106, P4133, DOI 10.1073/pnas.0812355106; Song QH, 2013, ECOL MODEL, V265, P136, DOI 10.1016/j.ecolmodel.2013.06.010; Sperry JS, 2002, PLANT CELL ENVIRON, V25, P251, DOI 10.1046/j.0016-8025.2001.00799.x; Stegen JC, 2011, GLOBAL ECOL BIOGEOGR, V20, P744, DOI 10.1111/j.1466-8238.2010.00645.x; Van Gunst KJ, 2016, FOREST ECOL MANAG, V359, P19, DOI 10.1016/j.foreco.2015.09.032; van Mantgem PJ, 2007, ECOL LETT, V10, P909, DOI 10.1111/j.1461-0248.2007.01080.x; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Vicente-Serrano SM, 2013, P NATL ACAD SCI USA, V110, P52, DOI 10.1073/pnas.1207068110; West AG, 2008, ECOL APPL, V18, P911, DOI 10.1890/06-2094.1; Zanne A. E., 2009, DATA WORLDWIDE WOOD	64	37	37	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0169770	10.1371/journal.pone.0169770	http://dx.doi.org/10.1371/journal.pone.0169770			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095437	Green Submitted, gold, Green Published			2022-12-26	WOS:000392372300032
J	Federman, S; Sinnott-Armstrong, M; Baden, AL; Chapman, CA; Daly, DC; Richard, AR; Valenta, K; Donoghue, MJ				Federman, Sarah; Sinnott-Armstrong, Miranda; Baden, Andrea L.; Chapman, Colin A.; Daly, Douglas C.; Richard, Alison R.; Valenta, Kim; Donoghue, Michael J.			The Paucity of Frugivores in Madagascar May Not Be Due to Unpredictable Temperatures or Fruit Resources	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; VARECIA-VARIEGATA; PHENOLOGY; DISPERSAL; PRIMATE; TREES; COMMUNITIES; CONTINGENCY; EVOLUTION; DOMINANCE	The evolution of ecological idiosyncrasies in Madagascar has often been attributed to selective pressures stemming from extreme unpredictability in climate and resource availability compared to other tropical areas. With the exception of rainfall, few studies have investigated these assumptions. To assess the hypothesis that Madagascar's paucity of frugivores is due to unreliability in fruiting resources, we use statistical modeling to analyze phenology datasets and their environmental correlates from two tropical wet forests, the Re A serve Naturelle Integrale Betampona in Madagascar, and Kibale National Park in Uganda. At each site we found that temperature is a good environmental predictor of fruit availability. We found no evidence of a significant difference in the predictability of fruit availability between the two sites, although the shorter duration of phenological monitoring at Betampona (two years, versus 15 years at Kibale) limits our ability to infer long-term patterns. Comparisons of long-term temperature data from each site (15 years from Kibale and 14 from Betampona) indicate that temperature is more predictable at Betampona than at Kibale. However, there does appear to be a difference between the two sites in the total fruit availability at any given time, with fruit being generally less abundant at Betampona. Our results appear contrary to the prevailing hypothesis of a selective force imposed by unpredictable resource availability or temperature, and we suggest other possible explanations for Madagascar's unique biota.	[Federman, Sarah; Sinnott-Armstrong, Miranda; Donoghue, Michael J.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Baden, Andrea L.] CUNY Hunter Coll, Dept Anthropol, New York, NY 10021 USA; [Baden, Andrea L.] CUNY, Grad Ctr, Dept Anthropol, New York, NY USA; [Baden, Andrea L.] CUNY, Grad Ctr, Dept Biol, New York, NY USA; [Baden, Andrea L.] NYCEP, New York, NY USA; [Chapman, Colin A.; Valenta, Kim] McGill Univ, Dept Anthropol, Montreal, PQ, Canada; [Chapman, Colin A.; Valenta, Kim] McGill Univ, McGill Sch Environm, Montreal, PQ, Canada; [Chapman, Colin A.] Wildlife Conservat Soc, Bronx, NY USA; [Daly, Douglas C.] New York Bot Garden, Inst Systemat Bot, Bronx, NY 10458 USA; [Richard, Alison R.] Yale Univ, Dept Anthropol, New Haven, CT 06520 USA	Yale University; City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; McGill University; McGill University; Wildlife Conservation Society; New York Botanical Garden; Yale University	Federman, S (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	sarah.federman@yale.edu	Chapman, Colin/S-1911-2019	Chapman, Colin/0000-0002-8827-8140; Baden, Andrea/0000-0002-4722-0532	National Science Foundation Graduate Research Fellowships [DGE-1122492]; Yale Herbarium; New York Botanical Garden; Conservation International's Primate Action Fund [PAF 14-15]; Canada Research Chairs Program; Wildlife Conservation Society; Natural Science and Engineering Research Council of Canada; US National Science Foundation; National Geographic; Quebecois de la Recherche sur la Nature et les Technologies	National Science Foundation Graduate Research Fellowships(National Science Foundation (NSF)); Yale Herbarium; New York Botanical Garden; Conservation International's Primate Action Fund; Canada Research Chairs Program(Canada Research Chairs); Wildlife Conservation Society; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); US National Science Foundation(National Science Foundation (NSF)); National Geographic(National Geographic Society); Quebecois de la Recherche sur la Nature et les Technologies	Funding for the Betampona research was supported by National Science Foundation Graduate Research Fellowships (www.nsfgrfp.org) to SF (DGE-1122492) and MSA (DGE-1122492), the Yale Herbarium, the New York Botanical Garden (www.nybg.org), and Conservation International's Primate Action Fund (PAF 14-15) to SF (www.conservation.org/Pages/default.aspx). Funding for the Kibale research to CAC and KV was provided by the Canada Research Chairs Program (www.chairs-chaires.gc.catome-accueil-eng.aspx), the Wildlife Conservation Society (www.wcs.org), the Natural Science and Engineering Research Council of Canada (wm.nserc-crsrig.gc.calindexeng.asp), the US National Science Foundation (www.nsf.gov), National Geographic (www.nationalgeographic.com), and the Quebecois de la Recherche sur la Nature et les Technologies (www.frqnt.gouv.qc.ca/en/accueil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baden AL, 2008, AM J PRIMATOL, V70, P913, DOI 10.1002/ajp.20583; Balko E. A., 1998, THESIS; Bollen A, 2005, BIOTROPICA, V37, P32, DOI 10.1111/j.1744-7429.2005.04094.x; Britt A, 2000, FOLIA PRIMATOL, V71, P133, DOI 10.1159/000021741; Britt A, 1996, THESIS; BULLOCK SH, 1990, BIOTROPICA, V22, P22, DOI 10.2307/2388716; CHAPMAN CA, 1994, BIOTROPICA, V26, P160, DOI 10.2307/2388805; Chapman CA, 2000, AM J PRIMATOL, V50, P169, DOI 10.1002/(SICI)1098-2345(200003)50:3&lt;169::AID-AJP1&gt;3.0.CO;2-P; COLWELL RK, 1974, ECOLOGY, V55, P1148, DOI 10.2307/1940366; Crowley BE, 2011, AM J PRIMATOL, V73, P25, DOI 10.1002/ajp.20817; Dewar RE, 2007, P NATL ACAD SCI USA, V104, P13723, DOI 10.1073/pnas.0704346104; Federman S, 2016, P NATL ACAD SCI USA, V113, P5041, DOI 10.1073/pnas.1523825113; Fleagle JG, 1996, J HUM EVOL, V30, P489, DOI 10.1006/jhev.1996.0039; Fukami T, 2007, NATURE, V446, P436, DOI 10.1038/nature05629; Godfrey LR, 2008, DEV PRIMATOL-PROG PR, P361, DOI 10.1007/978-0-387-73896-3_24; Goodman SM, 1997, REV ECOL-TERRE VIE, V52, P321; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Hansen DM, 2009, SCIENCE, V324, P42, DOI 10.1126/science.1172393; Hemingway CA, 1995, THESIS; Hudson IL, 2010, PHENOLOGICAL RESEARCH: METHODS FOR ENVIRONMENTAL AND CLIMATE CHANGE ANALYSIS, P1, DOI 10.1007/978-90-481-3335-2; Jolly A., 1984, Monographs in Primatology, V4, P197; KIELLAND P, 1992, INT HYDROGR REV, V69, P72; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; MANSFIELD ER, 1982, AM STAT, V36, P158, DOI 10.2307/2683167; Morellato LPC, 2000, BIOTROPICA, V32, P811, DOI 10.1111/j.1744-7429.2000.tb00620.x; Morris S. C, 2008, DEEP STRUCTURE BIOL; NEWSTROM LE, 1994, BIOTROPICA, V26, P141, DOI 10.2307/2388804; Overdorff DJ, 1996, AM J PRIMATOL, V40, P327, DOI 10.1002/(SICI)1098-2345(1996)40:4<327::AID-AJP3>3.0.CO;2-#; Overdorff DJ, 1996, AM J PHYS ANTHROPOL, V100, P487; Pau S, 2011, GLOBAL CHANGE BIOL, V17, P3633, DOI 10.1111/j.1365-2486.2011.02515.x; PERES CA, 1994, BIOTROPICA, V26, P98, DOI 10.2307/2389114; Polansky L, 2013, BIOTROPICA, V45, P434, DOI 10.1111/btp.12033; R Development Core Team, 2015, LANG ENV STAT COMP; Rasamimanana N., 2012, MALAGASY NATURE, V6, P67; RATSIMBAZAFY J, 2002, THESIS; RICHARD AF, 1987, AM J PRIMATOL, V12, P309, DOI 10.1002/ajp.1350120308; Schulz J, 2009, ATMOS CHEM PHYS, V9, P1687, DOI 10.5194/acp-9-1687-2009; Sorg JP, 1996, PRIMATE REPORT, P57; Stampone M. D., 2011, Research Journal of Environmental and Earth Sciences, V3, P14; Struhsaker T.T., 1975, RED COLOBUS MONKEY; STRUHSAKER T. T., 1997, ECOLOGY AFRICAN RAIN; Terborgh J., 1986, Tasks for Vegetation Science, V15, P371; Valenta K., 2013, SCI REPORTS, V3, P1, DOI DOI 10.1038/SREP02424; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Voigt FA, 2004, OECOLOGIA, V141, P94, DOI 10.1007/s00442-004-1654-8; WILLSON MF, 1989, BIOTROPICA, V21, P133, DOI 10.2307/2388704; Wright PC, 1999, YEARB PHYS ANTHROPOL, V42, P31; Wright PC, 2005, TROPICAL FRUITS AND FRUGIVORES: THE SEARCH FOR STRONG INTERACTORS, P121, DOI 10.1007/1-4020-3833-X_7; Yoder AD, 2006, ANNU REV ECOL EVOL S, V37, P405, DOI 10.1146/annurev.ecolsys.37.091305.110239; YOUNG AL, 1990, AM NAT, V135, P473, DOI 10.1086/285057	50	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0168943	10.1371/journal.pone.0168943	http://dx.doi.org/10.1371/journal.pone.0168943			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH7SJ	28085890	Green Published, gold			2022-12-26	WOS:000391972600009
J	MacDonald, HJ; McMorland, AJC; Stinear, CM; Coxon, JP; Byblow, WD				MacDonald, Hayley J.; McMorland, Angus J. C.; Stinear, Cathy M.; Coxon, James P.; Byblow, Winston D.			An Activation Threshold Model for Response Inhibition	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MEDIAL FRONTAL-CORTEX; INDUCED BEHAVIORAL-ADJUSTMENT; SUPPLEMENTARY MOTOR AREA; PREFRONTAL CORTEX; SELECTIVE-INHIBITION; SUBTHALAMIC NUCLEUS; BIMANUAL MOVEMENTS; PREPARED ACTION; STOP	Reactive response inhibition (RI) is the cancellation of a prepared response when it is no longer appropriate. Selectivity of RI can be examined by cueing the cancellation of one component of a prepared multi-component response. This substantially delays execution of other components. There is debate regarding whether this response delay is due to a selective neural mechanism. Here we propose a computational activation threshold model (ATM) and test it against a classical "horse-race" model using behavioural and neurophysiological data from partial RI experiments. The models comprise both facilitatory and inhibitory processes that compete upstream of motor output regions. Summary statistics (means and standard deviations) of predicted muscular and neurophysiological data were fit in both models to equivalent experimental measures by minimizing a Pearson Chi-square statistic. The ATM best captured behavioural and neurophysiological dynamics of partial RI. The ATM demonstrated that the observed modulation of corticomotor excitability during partial RI can be explained by nonselective inhibition of the prepared response. The inhibition raised the activation threshold to a level that could not be reached by the original response. This was necessarily followed by an additional phase of facilitation representing a secondary activation process in order to reach the new inhibition threshold and initiate the executed component of the response. The ATM offers a mechanistic description of the neural events underlying RI, in which partial movement cancellation results from a nonselective inhibitory event followed by subsequent initiation of a new response. The ATM provides a framework for considering and exploring the neuroanatomical constraints that underlie RI.	[MacDonald, Hayley J.; McMorland, Angus J. C.; Byblow, Winston D.] Univ Auckland, Dept Sport & Exercise Sci, Movement Neurosci Lab, Auckland 1142, New Zealand; [MacDonald, Hayley J.; McMorland, Angus J. C.; Stinear, Cathy M.; Byblow, Winston D.] Univ Auckland, Ctr Brain Res, Auckland 1142, New Zealand; [Stinear, Cathy M.] Univ Auckland, Dept Med, Clin Neurosci Lab, Auckland 1142, New Zealand; [Coxon, James P.] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3800, Australia; [Coxon, James P.] Monash Univ, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic 3800, Australia	University of Auckland; University of Auckland; University of Auckland; Monash University; Monash University	Byblow, WD (corresponding author), Univ Auckland, Dept Sport & Exercise Sci, Movement Neurosci Lab, Auckland 1142, New Zealand.; Byblow, WD (corresponding author), Univ Auckland, Ctr Brain Res, Auckland 1142, New Zealand.	w.byblow@auckland.ac.nz	Coxon, James/S-1286-2019	Coxon, James/0000-0003-2351-8489; MacDonald, Hayley Jessica/0000-0002-3350-7874	Neurological Foundation of New Zealand W&B Miller Scholarship; Kate Edger Educational Charitable Trust; NeSI; Ministry of Business, Innovation & Employment's Research Infrastructure programme	Neurological Foundation of New Zealand W&B Miller Scholarship; Kate Edger Educational Charitable Trust; NeSI; Ministry of Business, Innovation & Employment's Research Infrastructure programme	HM was supported by a Neurological Foundation of New Zealand W&B Miller Scholarship (http://www.neurological.org.nz/) and the Kate Edger Educational Charitable Trust (http://www.academicdresshire.co.nz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; H.M. was supported by a Neurological Foundation of New Zealand W&B Miller scholarship and the Kate Edger Educational Charitable Trust. The authors wish to thank Sina Masoud-Ansari for assistance with running the code on the computer cluster and acknowledge the contribution of NeSI high-performance computing facilities to the results of this research. NZ's national facilities are provided by the NZ eScience Infrastructure and funded jointly by NeSI's collaborator institutions and through the Ministry of Business, Innovation & Employment's Research Infrastructure programme. haps://www.nesi.org.nz.	Aron AR, 2008, PSYCHOL SCI, V19, P1146, DOI 10.1111/j.1467-9280.2008.02216.x; Boucher L, 2007, PSYCHOL REV, V114, P376, DOI 10.1037/0033-295X.114.2.376; Cai WD, 2012, BRAIN LANG, V120, P412, DOI 10.1016/j.bandl.2011.11.006; Cai WD, 2011, J NEUROSCI, V31, P5965, DOI 10.1523/JNEUROSCI.6292-10.2011; Claffey MP, 2010, NEUROPSYCHOLOGIA, V48, P541, DOI 10.1016/j.neuropsychologia.2009.10.015; Coxon J.P., 2014, CEREB CORTEX; Coxon JP, 2007, J NEUROPHYSIOL, V97, P2480, DOI 10.1152/jn.01284.2006; Coxon JP, 2006, J NEUROPHYSIOL, V95, P3371, DOI 10.1152/jn.01334.2005; Coxon JP, 2012, J NEUROSCI, V32, P8401, DOI 10.1523/JNEUROSCI.6360-11.2012; Coxon JP, 2009, J COGNITIVE NEUROSCI, V21, P1193, DOI 10.1162/jocn.2009.21081; Dacks AM, 2012, J NEUROSCI, V32, P17740, DOI 10.1523/JNEUROSCI.4137-12.2012; Devanne H, 1997, EXP BRAIN RES, V114, P329, DOI 10.1007/PL00005641; Dorris MC, 1998, J NEUROSCI, V18, P7015; Duque J, 2014, NEUROPSYCHOLOGIA, V65, P287, DOI 10.1016/j.neuropsychologia.2014.08.006; Duque J, 2010, J NEUROSCI, V30, P3793, DOI 10.1523/JNEUROSCI.5722-09.2010; Frank MJ, 2006, NEURAL NETWORKS, V19, P1120, DOI 10.1016/j.neunet.2006.03.006; Greenhouse I, 2015, J NEUROSCI, V35, P10675, DOI 10.1523/JNEUROSCI.1436-15.2015; Greenhouse I, 2015, J NEUROPHYSIOL, V113, P2792, DOI 10.1152/jn.00999.2014; HEUER H, 1993, PSYCHOL RES-PSYCH FO, V55, P83, DOI 10.1007/BF00419639; Hoshiyama M, 1997, ELECTROMYOGR MOTOR C, V105, P255, DOI 10.1016/S0924-980X(97)00019-2; Hu SE, 2014, HUM BRAIN MAPP, V35, P2531, DOI 10.1002/hbm.22347; Isoda M, 2008, J NEUROSCI, V28, P7209, DOI 10.1523/JNEUROSCI.0487-08.2008; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Jaffard M, 2008, NEUROIMAGE, V42, P1196, DOI 10.1016/j.neuroimage.2008.05.041; Kelso J, 1984, AM J PHYSIOL-REG I, V15, pR1000, DOI DOI 10.1152/ajpregu.1984.246.6.R1000; Klein PA, 2016, NEUROIMAGE, V125, P220, DOI 10.1016/j.neuroimage.2015.10.007; Ko YT, 2012, J EXP PSYCHOL HUMAN, V38, P465, DOI 10.1037/a0027034; Ko YT, 2011, PSYCHON B REV, V18, P813, DOI 10.3758/s13423-011-0090-0; Koval MJ, 2011, J NEUROSCI, V31, P8659, DOI 10.1523/JNEUROSCI.1258-11.2011; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; MacDonald HJ, 2014, J NEUROPHYSIOL, V112, P2707, DOI 10.1152/jn.00366.2014; MacDonald HJ, 2012, J NEUROPHYSIOL, V108, P1492, DOI 10.1152/jn.01184.2011; Majid DSA, 2012, CEREB CORTEX, V22, P363, DOI 10.1093/cercor/bhr112; Mansouri FA, 2007, SCIENCE, V318, P987, DOI 10.1126/science.1146384; Mansouri FA, 2009, NAT REV NEUROSCI, V10, P141, DOI 10.1038/nrn2538; Meyer-Lindenberg A, 2002, P NATL ACAD SCI USA, V99, P10948, DOI 10.1073/pnas.162114799; Nachev P, 2005, CURR BIOL, V15, P122, DOI 10.1016/j.cub.2005.01.006; Nachev P, 2007, NEUROIMAGE, V36, pT155, DOI 10.1016/j.neuroimage.2007.03.034; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; RATCLIFF R, 1979, PSYCHOL BULL, V86, P446, DOI 10.1037/0033-2909.86.3.446; Rushworth MFS, 2002, J NEUROPHYSIOL, V87, P2577, DOI 10.1152/jn.2002.87.5.2577; Serrien DJ, 2002, NEUROSCI LETT, V328, P89, DOI 10.1016/S0304-3940(02)00499-8; Smittenaar P, 2013, J NEUROSCI, V33, P18087, DOI 10.1523/JNEUROSCI.2167-13.2013; Verbruggen F, 2013, PSYCHOL SCI, V24, P352, DOI 10.1177/0956797612457390; Wenderoth N, 2009, J NEUROPHYSIOL, V102, P302, DOI 10.1152/jn.91090.2008; Wiecki TV, 2013, PSYCHOL REV, V120, P329, DOI 10.1037/a0031542; Xu J, 2014, J NEUROPHYSIOL; Yamanaka K., 2014, NEUROSCIENCE; Yamanaka K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082272; Zandbelt BB, 2013, J COGNITIVE NEUROSCI, V25, P157, DOI 10.1162/jocn_a_00309; Zandbelt BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013848	52	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0169320	10.1371/journal.pone.0169320	http://dx.doi.org/10.1371/journal.pone.0169320			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH7SJ	28085907	Green Published, gold, Green Submitted			2022-12-26	WOS:000391972600019
J	McCloskey, MA; Mosher, CL; Henderson, ER				McCloskey, Michael A.; Mosher, Curtis L.; Henderson, Eric R.			Wind Energy Conversion by Plant-Inspired Designs	PLOS ONE			English	Article							LIGHT ENVIRONMENT; VIBRATION; BEHAVIOR; TREES; POPLARS; SYSTEM; LOADS	In 2008 the U.S. Department of Energy set a target of 20% wind energy by 2030. To date, induction-based turbines form the mainstay of this effort, but turbines are noisy, perceived as unattractive, a potential hazard to bats and birds, and their height hampers deployment in residential settings. Several groups have proposed that artificial plants containing piezoelectric elements may harvest wind energy sufficient to contribute to a carbon-neutral energy economy. Here we measured energy conversion by cottonwood-inspired piezoelectric leaves, and by a "vertical flapping stalk"-the most efficient piezo-leaf previously reported. We emulated cottonwood for its unusually ordered, periodic flutter, properties conducive to piezo excitation. Integrated over 0 degrees-90 degrees (azimuthal) of incident airflow, cottonwood mimics outperformed the vertical flapping stalk, but they produced << daW per conceptualized tree. In contrast, a modest-sized cottonwood tree may dissipate similar to 80 W via leaf motion alone. A major limitation of piezo-transduction is charge generation, which scales with capacitance (area). We thus tested a rudimentary, cattail-inspired leaf with stacked elements wired in parallel. Power increased systematically with capacitance as expected, but extrapolation to acre-sized assemblages predicts << daW. Although our results suggest that present piezoelectric materials will not harvest mid-range power from botanic mimics of convenient size, recent developments in electrostriction and triboelectric systems may offer more fertile ground to further explore this concept.	[McCloskey, Michael A.; Mosher, Curtis L.; Henderson, Eric R.] Iowa State Univ, Dept GDCB, Ames, IA 50011 USA; [McCloskey, Michael A.; Henderson, Eric R.] Creodyne LLC, 2410 NE 13th Ct, Ankeny, IA 50014 USA	Iowa State University	McCloskey, MA (corresponding author), Iowa State Univ, Dept GDCB, Ames, IA 50011 USA.; McCloskey, MA (corresponding author), Creodyne LLC, 2410 NE 13th Ct, Ankeny, IA 50014 USA.	drmike@iastate.edu			Creodyne through an NSF SBIR award [1013963]; Creodyne; NSF-SBIR contract [1013963]	Creodyne through an NSF SBIR award; Creodyne; NSF-SBIR contract(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Creodyne provided funds through an NSF SBIR award (# 1013963) for this study to authors McCloskey and Henderson. Funds from Creodyne were provided in the form of salary for McCloskey during the course of the Phase I SBIR award, and were also used to obtain supplies for the study. The funder did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work was supported by an NSF-SBIR contract (# 1013963) to McCloskey and Henderson. Several types of PVDF elements were gifted by Don Halvorsen of Measurement Specialties, Inc. (Hampton, VA).	[Anonymous], 2008, 20 WIND EN 2030; Castro-Garcia S, 2008, TREES-STRUCT FUNCT, V22, P795, DOI 10.1007/s00468-008-0240-9; Curry A, 2009, SCIENCE, V325, P386, DOI 10.1126/science.325_386; Doare O, 2004, J BIOMECH ENG-T ASME, V126, P146, DOI 10.1115/1.1688773; Dong XX, 2002, BIOPHYS J, V82, P1254, DOI 10.1016/S0006-3495(02)75481-7; Hadhazy A., 2009, SCI AM; Harne RL, 2016, J SOUND VIB, V363, P517, DOI 10.1016/j.jsv.2015.11.017; Hernandez LF, 2009, 6 PLANT BIOM C; James KR, 2008, AGR FOREST METEOROL, V148, P1055, DOI 10.1016/j.agrformet.2008.02.003; Kim J, 2008, J INTEL MAT SYST STR, V19, P417, DOI 10.1177/1045389X07083140; Li SG, 2011, J APPL PHYS, V109, DOI 10.1063/1.3525045; Measurement Specialties Inc, 1999, PIEZ FILM SENS TECHN; Moore JR, 2008, TREE PHYSIOL, V28, P75, DOI 10.1093/treephys/28.1.75; Myers R, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2435346; Nechibvute A., 2012, INT J ENG TECHNOL, V2, P936; Oh SJ, 2010, INT J ENERG RES, V34, P431, DOI 10.1002/er.1644; Ovejas VJ, 2011, SMART MATER STRUCT, V20, DOI 10.1088/0964-1726/20/8/085030; Park SE, 1997, J APPL PHYS, V82, P1804, DOI 10.1063/1.365983; RODEN JS, 1993, OECOLOGIA, V93, P208, DOI 10.1007/BF00317673; RODEN JS, 1993, OECOLOGIA, V93, P201, DOI 10.1007/BF00317672; Saito T, 2004, PLANT CELL ENVIRON, V27, P863, DOI 10.1111/j.1365-3040.2004.01192.x; Tong HL, 1996, AGR FOREST METEOROL, V80, P249, DOI 10.1016/0168-1923(95)02293-7; TREITEL OTTO, 1949, TRANS KANSAS ACAD SCI, V52, P219, DOI 10.2307/3626173; VTT Technical Research Center (Finland), 2015, 3D PRINT SOL EN TREE; Wang LQ, 2015, J INTEL MAT SYST STR, V26, P2123, DOI 10.1177/1045389X14549866; Wang SH, 2012, NANO LETT, V12, P6339, DOI 10.1021/nl303573d; Williams RB, 2004, J COMPOS MATER, V38, P855, DOI 10.1177/0021998304040555; Zhang G, 2014, ASME P; Zuo L, 2013, J INTEL MAT SYST STR, V24, P1405, DOI 10.1177/1045389X13486707	29	7	7	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0170022	10.1371/journal.pone.0170022	http://dx.doi.org/10.1371/journal.pone.0170022			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085933	Green Submitted, Green Published, gold			2022-12-26	WOS:000391972600053
J	Torok, A; Ferre, ER; Kokkinara, E; Csepe, V; Swapp, D; Haggard, P				Torok, Agoston; Ferre, Elisa Raffaella; Kokkinara, Elena; Csepe, Valeria; Swapp, David; Haggard, Patrick			Up, Down, Near, Far: An Online Vestibular Contribution to Distance Judgement	PLOS ONE			English	Article							PERCEPTION; SYSTEM; DEPTH; MICROGRAVITY; ASTRONAUTS; ILLUSIONS	Whether a visual stimulus seems near or far away depends partly on its vertical elevation. Contrasting theories suggest either that perception of distance could vary with elevation, because of memory of previous upwards efforts in climbing to overcome gravity, or because of fear of falling associated with the downwards direction. The vestibular system provides a fundamental signal for the downward direction of gravity, but the relation between this signal and depth perception remains unexplored. Here we report an experiment on vestibular contributions to depth perception, using Virtual Reality. We asked participants to judge the absolute distance of an object presented on a plane at different elevations during brief artificial vestibular inputs. Relative to distance estimates collected with the object at the level of horizon, participants tended to overestimate distances when the object was presented above the level of horizon and the head was tilted upward and underestimate them when the object was presented below the level of horizon. Interestingly, adding artificial vestibular inputs strengthened these distance biases, showing that online multisensory signals, and not only stored information, contribute to such distance illusions. Our results support the gravity theory of depth perception, and show that vestibular signals make an on-line contribution to the perception of effort, and thus of distance.	[Torok, Agoston; Csepe, Valeria] Hungarian Acad Sci, Brain Imaging Ctr, Res Ctr Nat Sci, Budapest, Hungary; [Ferre, Elisa Raffaella; Haggard, Patrick] UCL, Inst Cognit Neurosci, London, England; [Ferre, Elisa Raffaella] Royal Holloway Univ London, Dept Psychol, Egham, Surrey, England; [Kokkinara, Elena] Univ Barcelona, Dept Personal Assessment & Psychol Treatments, Barcelona, Spain; [Swapp, David] UCL, Dept Comp Sci, London, England	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of London; University College London; University of London; Royal Holloway University London; University of Barcelona; University of London; University College London	Haggard, P (corresponding author), UCL, Inst Cognit Neurosci, London, England.	p.haggard@ucl.ac.uk	Csépe, Valéria/P-6571-2018	Csépe, Valéria/0000-0002-5021-6024; Haggard, Patrick/0000-0001-7798-793X; Swapp, David/0000-0002-9335-8663; Ferre, Elisa Raffaella/0000-0002-0643-848X	European Community's Research Infrastructure Action [262044]; Magyar Tudomanyos Akademia (HU) Young Researcher Fellowship; European Union Seventh Framework Programme (EU FP7) vere wp1; BIAL [269/14]; Economic and Social Research Council Professorial Fellowship; European Research Council Advanced Grant HUMVOL	European Community's Research Infrastructure Action; Magyar Tudomanyos Akademia (HU) Young Researcher Fellowship; European Union Seventh Framework Programme (EU FP7) vere wp1; BIAL(Bial Group); Economic and Social Research Council Professorial Fellowship(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); European Research Council Advanced Grant HUMVOL	This work was supported by European Community's Research Infrastructure Action 262044 Mr. Agoston Torok and Elena Kokkinara; Magyar Tudomanyos Akademia (HU) Young Researcher Fellowship Mr. Agoston Torok; European Union Seventh Framework Programme (EU FP7) vere wp1 Dr. Elisa Raffaella Ferre and Prof. Patrick Haggard; BIAL 269/14 Dr. Elisa Raffaella Ferre and Prof. Patrick Haggard; Economic and Social Research Council Professorial Fellowship Prof. Patrick Haggard; European Research Council Advanced Grant HUMVOL Prof. Patrick Haggard.	Andre J, 2006, PERCEPT PSYCHOPHYS, V68, P353, DOI 10.3758/BF03193682; Barany R., 1906, UNTERSUCHUNGEN VESTI; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates DM, 2008, INTERNATIONAL MEETIN; Bense S, 2001, J NEUROPHYSIOL, V85, P886, DOI 10.1152/jn.2001.85.2.886; Bhalla M, 1999, J EXP PSYCHOL HUMAN, V25, P1076, DOI 10.1037/0096-1523.25.4.1076; Bohmer A, 1999, ANN NY ACAD SCI, V871, P221, DOI 10.1111/j.1749-6632.1999.tb09187.x; Bucher SF, 1998, ANN NEUROL, V44, P120, DOI 10.1002/ana.410440118; Clement G, 2008, ACTA ASTRONAUT, V63, P828, DOI 10.1016/j.actaastro.2008.01.002; Clement Gilles, 2013, Life-Basel, V3, P524, DOI 10.3390/life3040524; Clement G, 2012, NEUROREPORT, V23, P894, DOI 10.1097/WNR.0b013e3283594705; Clement G, 2009, NEUROREPORT, V20, P457, DOI 10.1097/WNR.0b013e328326f815; Cruz-Neira C., 1993, Computer Graphics Proceedings, P135, DOI 10.1145/166117.166134; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; Curthoys Ian S, 2012, Front Neurol, V3, P117, DOI 10.3389/fneur.2012.00117; Di Cesare CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099866; Ferre ER, 2013, NEUROSCI LETT, V550, P35, DOI 10.1016/j.neulet.2013.06.046; Ferre ER, 2013, NEUROPSYCHOLOGIA, V51, P1445, DOI 10.1016/j.neuropsychologia.2013.04.006; Fitzpatrick RC, 2004, J APPL PHYSIOL, V96, P2301, DOI 10.1152/japplphysiol.00008.2004; Gajewski DA, 2014, J VISION, V14, DOI 10.1167/14.1.20; Gibson EJ, 1960, THE VISUAL CLIFF; GOLDBERG JM, 1984, J NEUROPHYSIOL, V51, P1236, DOI 10.1152/jn.1984.51.6.1236; Guldin WO, 1998, TRENDS NEUROSCI, V21, P254, DOI 10.1016/S0166-2236(97)01211-3; Harris LR, 2014, J VISION, V14, DOI 10.1167/14.12.17; Howard I. P., 1966, HUMAN SPATIAL ORIENT; Jackson RE, 2007, PERCEPT PSYCHOPHYS, V69, P353, DOI 10.3758/BF03193756; Jackson RE, 2010, J VISION, V10, DOI 10.1167/10.5.9; Kenward MG, 1997, JSTOR, P983; Kerkhoff G, 2011, NEUROPSYCHOLOGIA, V49, P186, DOI 10.1016/j.neuropsychologia.2010.11.014; Klein E, 2009, IEEE VIRTUAL REALITY 2009, PROCEEDINGS, P107, DOI 10.1109/VR.2009.4811007; Leyrer Markus, 2011, P ACM SIGGRAPH S APP, P67, DOI [DOI 10.1145/2077451.2077464, DOI 10.1145/2077451]; Loomis JM, 2003, VIRTUAL AND ADAPTIVE ENVIRONMENTS: APPLICATIONS, IMPLICATIONS, AND HUMAN PERFORMANCE ISSUES, P21; Lopez C, 2010, CONSCIOUS COGN, V19, P33, DOI 10.1016/j.concog.2009.12.003; MAYHEW JEW, 1982, NATURE, V297, P376, DOI 10.1038/297376a0; Mohler B. J, 2010, P 7 S APPL PERC GRAP, P57, DOI [DOI 10.1145/1836248.1836258, 10.1145/1836248.1836258]; Mon-Williams M, 1999, PERCEPTION, V28, P167, DOI 10.1068/p2737; Mon-Williams M, 2000, EXP BRAIN RES, V133, P407, DOI 10.1007/s002210000410; Nakamizo Sachio, 2004, J Physiol Anthropol Appl Human Sci, V23, P325, DOI 10.2114/jpa.23.325; Ooi TL, 2001, NATURE, V414, P197, DOI 10.1038/35102562; Proffitt DR, 2003, PSYCHOL SCI, V14, P106, DOI 10.1111/1467-9280.t01-1-01427; Proffitt DR, 1995, PSYCHON B REV, V2, P409, DOI 10.3758/BF03210980; Quene H, 2008, J MEM LANG, V59, P413, DOI 10.1016/j.jml.2008.02.002; Reschke M.F., 2010, NEUROSCIENCE SPACE; Schmidt L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00090; Servos P, 2000, EXP BRAIN RES, V130, P35, DOI 10.1007/s002210050004; Sugovic M, 2013, EXP BRAIN RES, V226, P383, DOI 10.1007/s00221-013-3447-y; Sun HJ, 2004, PERCEPTION, V33, P49, DOI 10.1068/p5145; Team RC, 2014, R LANG ENV STAT COMP; van der Hoort B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020195; Villard E, 2005, NEUROREPORT, V16, P1395, DOI 10.1097/01.wnr.0000174060.34274.3e; Wickham H., 2008, GGPLOT2 IMPLEMENTATI; Wilkinson D, 2010, J NEUROPSYCHOL, V4, P107, DOI 10.1348/174866409X468205; Willey CR, 2014, ATTEN PERCEPT PSYCHO, V76, P1036, DOI 10.3758/s13414-014-0639-x; Wu B, 2004, NATURE, V428, P73, DOI 10.1038/nature02350	54	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0169990	10.1371/journal.pone.0169990	http://dx.doi.org/10.1371/journal.pone.0169990			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH7SJ	28085939	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000391972600049
J	Chen, HB; Mo, SF				Chen, Hongbo; Mo, Shaofeng			Regional Homogeneity Changes in Nicotine Addicts by Resting-State fMRI	PLOS ONE			English	Article							BRAIN ABNORMALITIES; CIGARETTE-SMOKING; PRECUNEUS; CONNECTIVITY; FREQUENCY	Objective To reveal the brain functional changes of nicotine addicts compared with those of non-smokers and explore the objective biomarker for nicotine dependence evaluation. Methods A total of 14 smokers and 11 non-smoking controls were recruited for this study. Resting state functional magnetic resonance imaging and regional homogeneity (ReHo) were applied in the neural activity analysis. Two-sample t-test was performed to examine the voxel-wise difference between the smokers and the controls. Correlation analysis between the ReHo values and the Fagerstrom Test for Nicotine Dependence (FTND) scores were performed to explore the biomarkers for the clinical characteristics of smokers. Results The ReHo values from the right superior frontal gyrus of the Brodmann's area (BA) 9 to the right middle frontal gyrus and the ReHo value from the left and right precuneus (BA 23) to the left and right middle cingulum gyrus were lower in the smokers than in the non-smokers. The ReHo value in the precuneus (BA 23) was significantly and positively correlated with the FTND score of smokers. Conclusion The ReHo values in the right superior frontal gyrus and left precuneus can be used to separate the smokers from the non-smokers. In particular, the left precuneus is a potential neuroimaging biomarker for nicotine addicts.	[Chen, Hongbo] Guilin Univ Elect Technol, Sch Life & Environm Sci, Guilin, Guangxi, Peoples R China; [Mo, Shaofeng] Cent S Univ, Sch Geosci & Infophys, Changsha, Hunan, Peoples R China	Guilin University of Electronic Technology; Central South University	Chen, HB (corresponding author), Guilin Univ Elect Technol, Sch Life & Environm Sci, Guilin, Guangxi, Peoples R China.; Mo, SF (corresponding author), Cent S Univ, Sch Geosci & Infophys, Changsha, Hunan, Peoples R China.	hangbochen@163.com; nactiluceut@163.com			National Natural Science Foundation of China [81460273]; Guangxi Natural Science Foundation [2013GXNSFAA019325]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	This study is supported by the project grants from the National Natural Science Foundation of China to Hongbo (81460273) and Guangxi Natural Science Foundation to Hongbo (2013GXNSFAA019325). The study design and resting state fMRI data collection have received the support from the two grants.	Andrew JG, 2016, MAGNETIC RESONANCE I, V34, P209, DOI [10.1016/j.mri.2015.10.036, DOI 10.1016/J.MRI.2015.10.036]; Pineda-Pardo JA, 2016, INTELLIGENCE, V54, P105, DOI 10.1016/j.intell.2015.12.002; Bowyer S.M., 2015, J BEHAV BRAIN SCI, V5, P52984, DOI [10.4236/jbbs.2015.51001, DOI 10.4236/JBBS.2015.51001]; Chao W, 2016, BRAIN IMAGING BEHAV, V1-8; Chen C, 2015, J NEUROPSYCH CLIN N, V27, P27, DOI 10.1176/appi.neuropsych.13030044; Chen HB, 2016, NEUROIMAGE-CLIN, V11, P339, DOI 10.1016/j.nicl.2016.02.010; Chen QF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151263; Do KT, 2016, J ADOLESCENT HEALTH, V58, P186, DOI 10.1016/j.jadohealth.2015.10.004; Fagerstrom K, 2012, NICOTINE TOB RES, V14, P1467, DOI 10.1093/ntr/nts018; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; General OO, 2004, USDHEW PUBLIC HLTH S, V28, P379; Kanteti R, 2016, CANCER BIOL THER, V17, P91, DOI 10.1080/15384047.2015.1108495; Kraft A, 2015, BRAIN STIMUL, V8, P216, DOI 10.1016/j.brs.2014.11.004; Leutgeb V, 2016, NEUROSCI LETT, V610, P160, DOI 10.1016/j.neulet.2015.10.063; Li Y, 2016, CLIN RADIOL, V71, pE28, DOI 10.1016/j.crad.2015.10.006; Liu CH, 2013, PROG NEURO-PSYCHOPH, V41, P52, DOI 10.1016/j.pnpbp.2012.11.010; Luber B, 2007, BRAIN RES, V1128, P120, DOI 10.1016/j.brainres.2006.10.011; Mcclernon FJ, 2015, ADDICT BIOL, V3, P108; McClernon FJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2148, DOI 10.1038/sj.npp.1301618; Miller RL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149849; Oh DH, 2011, LUPUS, V20, P855, DOI 10.1177/0961203310394895; Smolka MN, 2006, PSYCHOPHARMACOLOGY, V184, P577, DOI 10.1007/s00213-005-0080-x; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sutherland MT, 2016, BEHAV BRAIN FUNCT, V12, DOI 10.1186/s12993-016-0100-5; Tanriover O, 2013, ASIAN PAC J CANCER P, V14, P579, DOI 10.7314/APJCP.2013.14.1.579; Wang KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102828; Xu X, 2013, PLOS ONE, V9; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yu RJ, 2013, ADDICT BIOL, V18, P729, DOI 10.1111/j.1369-1600.2011.00359.x; Yuan X, 2016, NEUROSCIENCE LETT; Zanchi D, 2015, ADDICT BIOL, V20, P1033, DOI 10.1111/adb.12292; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhan J, 2015, J NERV MENT DIS, V203, P786, DOI 10.1097/NMD.0000000000000368; Zhou IY, 2014, NEUROIMAGE, V84, P1, DOI 10.1016/j.neuroimage.2013.08.037	35	9	10	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0170143	10.1371/journal.pone.0170143	http://dx.doi.org/10.1371/journal.pone.0170143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081226	Green Published, gold, Green Submitted			2022-12-26	WOS:000391949500135
J	Guo, HC; Huang, M; Yuan, Q; Wei, YQ; Gao, Y; Mao, LJ; Gu, LJ; Tang, YW; Zhong, YX; Liu, DX; Sun, SQ				Guo, Huichen; Huang, Mei; Yuan, Quan; Wei, Yanquan; Gao, Yuan; Mao, Lejiao; Gu, Lingjun; Tang, Yong Wah; Zhong, Yanxin; Liu, Dingxiang; Sun, Shiqi			The Important Role of Lipid Raft-Mediated Attachment in the Infection of Cultured Cells by Coronavirus Infectious Bronchitis Virus Beaudette Strain	PLOS ONE			English	Article							AVIAN CORONAVIRUS; AMINO-ACIDS; VERO CELLS; ENTRY; CHOLESTEROL; REPLICATION; CAVEOLAE; KINASE; MORPHOGENESIS; ENDOCYTOSIS	Lipid raft is an important element for the cellular entry of some viruses, including coronavirus infectious bronchitis virus (IBV). However, the exact role of lipid rafts in the cellular membrane during the entry of IBV into host cells is still unknown. In this study, we biochemically fractionated IBV-infected cells via sucrose density gradient centrifugation after depleting plasma membrane cholesterol with methyl-beta-cyclodextrin or Mevastatin. Our results demonstrated that unlike IBV non-structural proteins, IBV structural proteins co-localized with lipid raft marker caveolin-1. Infectivity assay results of Vero cells illustrated that the drug-induced disruption of lipid rafts significantly suppressed IBV infection. Further studies revealed that lipid rafts were not required for IBV genome replication or virion release at later stages. However, the drug-mediated depletion of lipid rafts in Vero cells before IBV attachment significantly reduced the expression of viral structural proteins, suggesting that drug treatment impaired the attachment of IBV to the cell surface. Our results indicated that lipid rafts serve as attachment factors during the early stages of IBV infection, especially during the attachment stage.	[Guo, Huichen; Huang, Mei; Wei, Yanquan; Gao, Yuan; Mao, Lejiao; Gu, Lingjun; Liu, Dingxiang; Sun, Shiqi] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China; [Huang, Mei; Yuan, Quan; Tang, Yong Wah; Zhong, Yanxin; Liu, Dingxiang] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Gu, Lingjun] Yangtze Univ, Coll Anim Sci, Jingzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Yangtze University	Liu, DX; Sun, SQ (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China.; Liu, DX (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	dxliu0001@163.com; sunshiqi@caas.cn	Gao, Yuan/J-1442-2019	Gao, Yuan/0000-0002-6149-5487	International Science & Technology Cooperation Program of China [2014DFA31890]; National Natural Science Foundation of China [31672592, 31602038, 31602083]; Elite Youth Program of Chinese Academy of Agricultural Sciences, China; National Science and Technology Support Program [2013BAD12B00]	International Science & Technology Cooperation Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Elite Youth Program of Chinese Academy of Agricultural Sciences, China; National Science and Technology Support Program	This research was supported by grants from International Science & Technology Cooperation Program of China (2014DFA31890), the National Natural Science Foundation of China (31672592, 31602038, 31602083), Elite Youth Program of Chinese Academy of Agricultural Sciences, China, and the National Science and Technology Support Program (2013BAD12B00).	Adams MJ, 2012, ARCH VIROL, V157, P1411, DOI 10.1007/s00705-012-1299-6; Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; ALONSOCAPLEN FV, 1984, VIRUS RES, V1, P153, DOI 10.1016/0168-1702(84)90070-4; Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003; Danthi P, 2004, J VIROL, V78, P33, DOI 10.1128/JVI.78.1.33-41.2004; Emmott E, 2010, MOL CELL PROTEOMICS, V9, P1920, DOI 10.1074/mcp.M900345-MCP200; Fang SG, 2005, BIOCHEM BIOPH RES CO, V336, P417, DOI 10.1016/j.bbrc.2005.08.105; Fivaz M, 1999, TRENDS CELL BIOL, V9, P212, DOI 10.1016/S0962-8924(99)01567-6; Huang HL, 2006, J GEN VIROL, V87, P277, DOI 10.1099/vir.0.81551-0; Jackwood MW, 2012, AVIAN DIS, V56, P634, DOI 10.1637/10227-043012-Review.1; Kerviel A, 2013, VIRUS RES, V171, P332, DOI 10.1016/j.virusres.2012.08.014; Liao Y, 2013, J VIROL, V87, P8124, DOI 10.1128/JVI.00626-13; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu C, 2001, J VIROL, V75, P6402, DOI 10.1128/JVI.75.14.6402-6409.2001; Lorizate M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004820; Lu YN, 2008, BIOCHEM BIOPH RES CO, V369, P344, DOI 10.1016/j.bbrc.2008.02.023; Manes S, 2003, NAT REV IMMUNOL, V3, P557, DOI 10.1038/nri1129; Manes S, 1999, MOL CELL BIOL, V19, P3125; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Martin-Acebes MA, 2007, VIROLOGY, V369, P105, DOI 10.1016/j.virol.2007.07.021; Medigeshi GR, 2008, J VIROL, V82, P5212, DOI 10.1128/JVI.00008-08; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Ng LFP, 2000, VIROLOGY, V272, P27, DOI 10.1006/viro.2000.0330; Nomura R, 2004, J VIROL, V78, P8701, DOI 10.1128/JVI.78.16.8701-8708.2004; Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058; Ono A, 2005, ADV VIRUS RES, V64, P311, DOI 10.1016/S0065-3527(05)64010-9; OTSUKI K, 1979, ARCH VIROL, V60, P115, DOI 10.1007/BF01348027; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Parton RG, 1999, IMMUNOLOGICAL REV, V168; Pelkmans L, 2005, BBA-MOL CELL RES, V1746, P295, DOI 10.1016/j.bbamcr.2005.06.009; Pierini LM, 2003, J BIOL CHEM, V278, P10831, DOI 10.1074/jbc.M212386200; Plociennikowska A, 2015, CELL MOL LIFE SCI, V72, P557, DOI 10.1007/s00018-014-1762-5; Promkuntod N, 2014, VIROLOGY, V448, P26, DOI 10.1016/j.virol.2013.09.018; Simons K, 1997, CELL, V387, P569, DOI DOI 10.1038/42408; Stapleford KA, 2010, VIRUSES-BASEL, V2, P1055, DOI 10.3390/v2051055; Tay FPL, 2012, VIROLOGY, V433, P421, DOI 10.1016/j.virol.2012.08.037; Thorp EB, 2004, J VIROL, V78, P2682, DOI 10.1128/JVI.78.6.2682-2692.2004; Veit M, 2013, CELL MICROBIOL, V15, P179, DOI 10.1111/cmi.12045; Viard M, 2002, J VIROL, V76, P11584, DOI 10.1128/JVI.76.22.11584-11595.2002; Wei YQ, 2014, APPL MICROBIOL BIOT, V98, P1727, DOI 10.1007/s00253-013-5352-5; Young RM, 2003, J BIOL CHEM, V278, P20746, DOI 10.1074/jbc.M211402200	42	55	55	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0170123	10.1371/journal.pone.0170123	http://dx.doi.org/10.1371/journal.pone.0170123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081264	Green Published, gold			2022-12-26	WOS:000391949500133
J	Mattel, V; Martellucci, S; Santilli, F; Manganelli, V; Garofalo, T; Candelise, N; Caruso, A; Sorice, M; Scaccianoce, S; Misasi, R				Mattel, Vincenzo; Martellucci, Stefano; Santilli, Francesca; Manganelli, Valeria; Garofalo, Tina; Candelise, Niccolo; Caruso, Alessandra; Sorice, Maurizio; Scaccianoce, Sergio; Misasi, Roberta			Morphine Withdrawal Modifies Prion Protein Expression in Rat Hippocampus	PLOS ONE			English	Article							TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES; STRESS-INDUCIBLE PROTEIN-1; RAFT-LIKE MICRODOMAINS; CELLULAR PRION; OXIDATIVE STRESS; IN-VIVO; SUPEROXIDE-DISMUTASE; NEURONAL CELLS; ALPHA-CLEAVAGE; BETA-CLEAVAGE	The hippocampus is a vulnerable brain structure susceptible to damage during aging and chronic stress. Repeated exposure to opioids may alter the brain so that it functions normally when the drugs are present, thus, a prolonged withdrawal might lead to homeostatic changes headed for the restoration of the physiological state. Abuse of morphine may lead to Reacting Oxygen Species-induced neurodegeneration and apoptosis. It has been proposed that during morphine withdrawal, stress responses might be responsible, at least in part, for long-term changes of hippocampal plasticity. Since prion protein is involved in both, Reacting Oxygen Species mediated stress responses and synaptic plasticity, in this work we investigate the effect of opiate withdrawal in rats after morphine treatment. We hypothesize that stressful stimuli induced by opiate withdrawal, and the subsequent long-term homeostatic changes in hippocampal plasticity, might modulate the Prion protein expression. Our results indicate that abstinence from the opiate induced a time-dependent and region-specific modification in Prion protein content, indeed during morphine withdrawal a selective unbalance of hippocampal Prion Protein is observable. Moreover, Prion protein overexpression in hippocampal tissue seems to generate a dimeric structure of Prion protein and a-cleavage at the hydrophobic domain. Stress factors or toxic insults can induce cytosolic dimerization of Prion Protein through the hydrophobic domain, which in turn, it stimulates the a-cleavage and the production of neuroprotective Prion protein fragments. We speculate that this might be the mechanism by which stressful stimuli induced by opiate withdrawal and the subsequent long-term homeostatic changes in hippocampal plasticity, modulate the expression and the dynamics of Prion protein.	[Mattel, Vincenzo; Martellucci, Stefano; Santilli, Francesca] Sabina Univ, Polo Univ Rieti, Lab Med Sperimentale & Patol Ambientale, Rieti, Italy; [Manganelli, Valeria; Garofalo, Tina; Candelise, Niccolo; Sorice, Maurizio; Misasi, Roberta] Univ Roma La Sapienza, Dipartimento Med Sperimentale, Rome, Italy; [Caruso, Alessandra; Scaccianoce, Sergio] Univ Roma La Sapienza, Dipartimento Fisiol & Farmacol Vittorio Erspamer, Rome, Italy	Sapienza University Rome; Sapienza University Rome	Misasi, R (corresponding author), Univ Roma La Sapienza, Dipartimento Med Sperimentale, Rome, Italy.	roberta.misasi@uniroma1.it	Mattei, Vincenzo/AAQ-3667-2020; Martellucci, Stefano/O-8129-2019; Candelise, Niccolò/AAB-7421-2022; Sorice, Maurizio/Q-5079-2019; Sousa, Maria/HCI-9642-2022	Mattei, Vincenzo/0000-0003-4677-088X; Martellucci, Stefano/0000-0002-3952-3162; Candelise, Niccolò/0000-0001-5086-3996; misasi, roberta/0000-0002-1181-6190; Sorice, Maurizio/0000-0003-3534-1502; Garofalo, Tina/0000-0003-0645-2510; Santilli, Francesca/0000-0003-0863-2996	University La Sapienza School of Medicine	University La Sapienza School of Medicine	This work has been supported by grants from the University La Sapienza School of Medicine (to SS and RM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has been supported by grants from the University La Sapienza, School of Medicine (to S.S. and R.M.). We thank Dr Anna Rita Casella for her helpful technical support.	ACQUAS E, 1992, J NEUROCHEM, V58, P1620, DOI 10.1111/j.1471-4159.1992.tb10033.x; Altmeppen HC, 2013, FEBS J, V280, P4338, DOI 10.1111/febs.12196; Anantharam V, 2008, FREE RADICAL BIO MED, V45, P1530, DOI 10.1016/j.freeradbiomed.2008.08.028; Beland M, 2013, PRION, V7, P170, DOI 10.4161/pri.23583; Beland M, 2012, J NEUROSCI, V32, P13255, DOI 10.1523/JNEUROSCI.2236-12.2012; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown DR, 2001, J NEUROCHEM, V76, P69, DOI 10.1046/j.1471-4159.2001.00009.x; Brown DR, 1999, BIOCHEM J, V344, P1, DOI 10.1042/0264-6021:3440001; Brown DR, 1997, EXP NEUROL, V146, P104, DOI 10.1006/exnr.1997.6505; Buttner A, 2011, NEUROPATH APPL NEURO, V37, P118, DOI 10.1111/j.1365-2990.2010.01131.x; Caetano FA, 2008, J NEUROSCI, V28, P6691, DOI 10.1523/JNEUROSCI.1701-08.2008; Checler F, 2002, TRENDS NEUROSCI, V25, P616, DOI 10.1016/S0166-2236(02)02263-4; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Coltinho AS, 2007, NEUROBIOL DIS, V26, P282, DOI 10.1016/j.nbd.2007.01.005; Das D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011420; Ding QX, 2001, J NEUROCHEM, V77, P1010, DOI 10.1046/j.1471-4159.2001.00302.x; Dong ZF, 2006, HIPPOCAMPUS, V16, P1017, DOI 10.1002/hipo.20234; Gasperini L, 2015, ANTIOXID REDOX SIGN, V22, P772, DOI 10.1089/ars.2014.6032; Hamilton KL, 2013, BRAIN RES, V1538, P73, DOI 10.1016/j.brainres.2013.09.026; Hernandez-Rapp J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04881; Hernandez-Rapp J, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00025; Hirsch TZ, 2014, BIOCHIMIE, V104, P2, DOI 10.1016/j.biochi.2014.06.009; HUANG YY, 1992, SCIENCE, V255, P730, DOI 10.1126/science.1346729; Jimenez-Huete A, 1998, AM J PATHOL, V153, P1561, DOI 10.1016/S0002-9440(10)65744-6; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Lewis V, 2011, FRONT BIOSCI-LANDMRK, V16, P151, DOI 10.2741/3681; Li RL, 2001, CELL IMMUNOL, V207, P49, DOI 10.1006/cimm.2000.1751; Linden R., 2008, PHYSIOL REV; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; Mattei V, 2004, FEBS LETT, V560, P14, DOI 10.1016/S0014-5793(04)00029-8; Mattei V, 2011, MOL BIOL CELL, V22, P4842, DOI 10.1091/mbc.E11-04-0348; McDonald AJ, 2014, J BIOL CHEM, V289, P803, DOI 10.1074/jbc.M113.502351; Meyer RK, 2000, J BIOL CHEM, V275, P38081, DOI 10.1074/jbc.M007114200; Milhavet O, 2002, BRAIN RES REV, V38, P328, DOI 10.1016/S0165-0173(01)00150-3; Modafferi AME, 2008, NEUROREPORT, V19, P911, DOI 10.1097/WNR.0b013e3283021cc0; Monnet C, 2004, FEBS LETT, V576, P114, DOI 10.1016/j.febslet.2004.08.076; Nunez C, 2008, N-S ARCH PHARMACOL, V378, P407, DOI 10.1007/s00210-008-0304-9; Pradines E, 2009, J NEUROCHEM, V110, P912, DOI 10.1111/j.1471-4159.2009.06176.x; Prcina M, 2015, ACTA VIROL, V59, P179, DOI 10.4149/av_2015_02_179; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Puig B, 2014, PRION, V8, P11, DOI 10.4161/pri.27892; Rambold AS, 2008, EMBO J, V27, P1974, DOI 10.1038/emboj.2008.122; Ramljak S, 2015, EXP NEUROL, V271, P155, DOI 10.1016/j.expneurol.2015.04.025; Rigter A, 2010, VACCINE, V28, P7810, DOI 10.1016/j.vaccine.2010.09.012; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Sasaki K, 2009, J PATHOL, V219, P123, DOI 10.1002/path.2576; Sauer H, 2003, FREE RADICAL BIO MED, V35, P586, DOI 10.1016/S0891-5849(03)00360-5; Schmitz M, 2014, PRION, V8, P381, DOI 10.4161/19336896.2014.983746; Schneider B, 2003, P NATL ACAD SCI USA, V100, P13326, DOI 10.1073/pnas.2235648100; Schneider K, 2008, BRAIN RES BULL, V77, P343, DOI 10.1016/j.brainresbull.2008.09.012; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sorice M, 2012, PRION, V6, P354, DOI 10.4161/pri.20479; Sun K, 2007, NEUROBIOL AGING, V28, P1840, DOI 10.1016/j.neurobiolaging.2007.07.012; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Urso E, 2012, CELL MOL NEUROBIOL, V32, P989, DOI 10.1007/s10571-012-9815-5; Watt NT, 2005, J BIOL CHEM, V280, P35914, DOI 10.1074/jbc.M507327200; White AR, 1999, AM J PATHOL, V155, P1723, DOI 10.1016/S0002-9440(10)65487-9; Wong BS, 2000, BIOCHEM BIOPH RES CO, V273, P136, DOI 10.1006/bbrc.2000.2911; Xu B, 2006, BASIC CLIN PHARMACOL, V99, P153, DOI 10.1111/j.1742-7843.2006.pto_461.x; Yuan FZ, 2013, J MOL NEUROSCI, V51, P219, DOI 10.1007/s12031-013-0008-6; Zeng L, 2015, INT J CLIN EXP MED, V8, P8042; Zhong WX, 2006, LIFE SCI, V79, P861, DOI 10.1016/j.lfs.2006.02.040	64	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169571	10.1371/journal.pone.0169571	http://dx.doi.org/10.1371/journal.pone.0169571			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081197	Green Submitted, Green Published, gold			2022-12-26	WOS:000391949500056
J	Mombo, IM; Lukashev, AN; Bleicker, T; Brunink, S; Berthet, N; Maganga, GD; Durand, P; Arnathau, C; Boundenga, L; Ngoubangoye, B; Boue, V; Liegeois, F; Ollomo, B; Prugnolle, F; Drexler, JF; Drosten, C; Renaud, F; Rougeron, V; Leroy, E				Mombo, Illich Manfred; Lukashev, Alexander N.; Bleicker, Tobias; Bruenink, Sebastian; Berthet, Nicolas; Maganga, Gael D.; Durand, Patrick; Arnathau, Celine; Boundenga, Larson; Ngoubangoye, Barthelemy; Boue, Vanina; Liegeois, Florian; Ollomo, Benjamin; Prugnolle, Franck; Drexler, Jan Felix; Drosten, Christian; Renaud, Francois; Rougeron, Virginie; Leroy, Eric			African Non-Human Primates Host Diverse Enteroviruses	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCES; MOLECULAR-IDENTIFICATION; PLASMODIUM-FALCIPARUM; VIRUS TYPE-1; EBOLA-VIRUS; EVOLUTION; RNA; RECOMBINATION; AMPLIFICATION; EPIDEMIOLOGY	Enteroviruses (EVs) belong to the family Picornaviridae and are responsible for mild to severe diseases in mammals including humans and non-human primates (NHP). Simian EVs were first discovered in the 1950s in the Old World Monkeys and recently in wild chimpanzee, gorilla and mandrill in Cameroon. In the present study, we screened by PCR EVs in 600 fecal samples of wild apes and monkeys that were collected at four sites in Gabon. A total of 32 samples were positive for EVs (25 from mandrills, 7 from chimpanzees, none from gorillas). The phylogenetic analysis of VP1 and VP2 genes showed that EVs identified in chimpanzees were members of two human EV species, EV-A and EV-B, and those identified in mandrills were members of the human species EV-B and the simian species EV-J. The identification of two novel enterovirus types, EV-B112 in a chimpanzee and EV-B113 in a mandrill, suggests these NHPs could be potential sources of new EV types. The identification of EV-B107 and EV90 that were previously found in humans indicates cross-species transfers. Also the identification of chimpanzee-derived EV110 in a mandrill demonstrated a wide host range of this EV. Further research of EVs in NHPs would help understanding emergence of new types or variants, and evaluating the real risk of cross-species transmission for humans as well for NHPs populations.	[Mombo, Illich Manfred; Berthet, Nicolas; Maganga, Gael D.; Boundenga, Larson; Ngoubangoye, Barthelemy; Ollomo, Benjamin; Prugnolle, Franck; Rougeron, Virginie; Leroy, Eric] Int Ctr Med Res Franceville, BP769, Franceville, Gabon; [Mombo, Illich Manfred; Berthet, Nicolas; Durand, Patrick; Arnathau, Celine; Prugnolle, Franck; Renaud, Francois; Rougeron, Virginie; Leroy, Eric] Univ Montpellier, CNRS 5290, IRD 224, Lab MIVEGEC,UMR, Montpellier, France; [Lukashev, Alexander N.] Chumakov Inst Poliomyelitis & Viral Encephalitide, Moscow, Russia; [Lukashev, Alexander N.] Sechenov First Moscow State Med Univ, Inst Mol Med, Moscow, Russia; [Bleicker, Tobias; Bruenink, Sebastian; Drexler, Jan Felix; Drosten, Christian] Univ Bonn, Inst Virol, Med Ctr, Bonn, Germany; [Durand, Patrick; Arnathau, Celine] CHRU Montpellier, Montpellier, France; [Boue, Vanina; Liegeois, Florian; Renaud, Francois] Univ Montpellier I, IRD, UMI 233, Lab Retrovirus, Montpellier, France; [Drexler, Jan Felix; Drosten, Christian] German Ctr Infect Res, Partner Bonn, Cologne, Germany	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Chumakov Federal Scientific Center for Research & Development of Immune & Biological Products of Russian Academy of Sciences; Sechenov First Moscow State Medical University; University of Bonn; Universite de Montpellier; CHU de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; German Center for Infection Research; University of Cologne	Mombo, IM (corresponding author), Int Ctr Med Res Franceville, BP769, Franceville, Gabon.; Mombo, IM (corresponding author), Univ Montpellier, CNRS 5290, IRD 224, Lab MIVEGEC,UMR, Montpellier, France.	mombo.illich@gmail.com	Berthet, Nicolas/J-9373-2012; larson, Boundenga/AAK-5003-2020; LEROY, Eric M/I-4347-2016; Rougeron, Virginie/AAH-7447-2020; Florian, Liegeois/D-3798-2013; Lukashev, Alexander/G-2777-2013; Drexler, Jan Felix/GMW-5098-2022	larson, Boundenga/0000-0001-9551-3017; LEROY, Eric M/0000-0003-0022-0890; Florian, Liegeois/0000-0003-1048-0661; Lukashev, Alexander/0000-0001-7365-0352; MOMBO, Illich Manfred/0000-0001-9292-7943; Rougeron, Virginie/0000-0001-5873-5681; Drexler, Jan Felix/0000-0002-3509-0232; Prugnolle, Franck/0000-0001-8519-1253	Gabonese Government; Total Gabon; fellowship BSTD of IRD France [743296H]; ANR JCJC ORIGIN	Gabonese Government; Total Gabon(Total SA); fellowship BSTD of IRD France; ANR JCJC ORIGIN(French National Research Agency (ANR))	We thank the Gabonese Government and Total Gabon for their financial supports. The work was also supported by the fellowship BSTD 743296H of IRD France as well as the ANR JCJC 2012 ORIGIN.	Alidjinou EK, 2014, DISCOV MED, V18, P273; Berthet N, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-77; Blomqvist S, 2008, J CLIN MICROBIOL, V46, P2410, DOI 10.1128/JCM.00313-08; Brown DWG, 1997, REV MED VIROL, V7, P239, DOI 10.1002/(SICI)1099-1654(199712)7:4&lt;239::AID-RMV210&gt;3.0.CO;2-Q; Buchan JC, 2005, MOL ECOL NOTES, V5, P680, DOI 10.1111/j.1471-8286.2005.01002.x; Cammock CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074569; Charpentier MJE, 2012, MOL ECOL, V21, P715, DOI 10.1111/j.1365-294X.2011.05302.x; Deng XT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv002; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dierssen U, 2008, J CLIN VIROL, V42, P58, DOI 10.1016/j.jcv.2007.11.016; Drexler JF, 2011, J GEN VIROL, V92, P564, DOI 10.1099/vir.0.022525-0; Formenty P, 1999, J INFECT DIS, V179, pS48, DOI 10.1086/514285; FUENTESMARINS RA, 1963, J BACTERIOL, V85, P1045, DOI 10.1128/JB.85.5.1045-1050.1963; Gilardi KVK, 2014, EMERG INFECT DIS, V20, P1883, DOI 10.3201/eid2011.140075; Gonzalez JP, 2013, CURR TOP MICROBIOL, V365, P337, DOI 10.1007/82_2012_304; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harvala H, 2014, J GEN VIROL, V95, P403, DOI 10.1099/vir.0.059048-0; Harvala H, 2011, J VIROL, V85, P4480, DOI 10.1128/JVI.02285-10; HOFFERT WR, 1958, AM J HYG, V68, P15, DOI 10.1093/oxfordjournals.aje.a119946; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jacques J, 2008, J CLIN MICROBIOL, V46, P206, DOI 10.1128/JCM.01414-07; Jiang P, 2014, MICROBIOL MOL BIOL R, V78, P418, DOI 10.1128/MMBR.00012-14; Jorba J, 2008, J VIROL, V82, P4429, DOI 10.1128/JVI.02354-07; KALTER S S, 1960, Bull World Health Organ, V22, P319; KALTER SS, 1982, VET PATHOL, V19, P33, DOI 10.1177/030098588201907s05; Kaur T, 2008, AM J PRIMATOL, V70, P755, DOI 10.1002/ajp.20565; Knowles NJ, 2012, VIRUS TAXONOMY CLASS, P855, DOI DOI 10.1016/B978-0-12-384684-6.00074-4; Kondgen S, 2010, ECOHEALTH, V7, P332, DOI 10.1007/s10393-010-0340-z; Leendertz FH, 2006, AM J PRIMATOL, V68, P928, DOI 10.1002/ajp.20298; Leitch ECM, 2010, J VIROL, V84, P9292, DOI 10.1128/JVI.00783-10; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lukashev AN, 2014, J GEN VIROL, V95, P868, DOI 10.1099/vir.0.060004-0; Lukashev AN, 2012, J GEN VIROL, V93, P2357, DOI 10.1099/vir.0.043216-0; Lukashev AN, 2005, REV MED VIROL, V15, P157, DOI 10.1002/rmv.457; MALHERBE H., 1963, S AFRICAN MED JOUR, V37, P407; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Mombo IM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136700; Nasri D, 2007, J CLIN MICROBIOL, V45, P2370, DOI 10.1128/JCM.00093-07; Neel C, 2010, J VIROL, V84, P1464, DOI 10.1128/JVI.02129-09; Nix WA, 2008, J CLIN MICROBIOL, V46, P2874, DOI 10.1128/JCM.00074-08; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Oberste MS, 2008, ARCH VIROL, V153, P2117, DOI 10.1007/s00705-008-0225-4; Oberste MS, 2007, J GEN VIROL, V88, P3360, DOI 10.1099/vir.0.83124-0; Oberste MS, 2005, J GEN VIROL, V86, P445, DOI 10.1099/vir.0.80475-0; Oberste MS, 2004, J GEN VIROL, V85, P1597, DOI 10.1099/vir.0.79789-0; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Oberste MS, 2000, J CLIN MICROBIOL, V38, P1170, DOI 10.1128/JCM.38.3.1170-1174.2000; Ollomo B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000446; Palacios G, 2005, J NEUROVIROL, V11, P424, DOI 10.1080/13550280591002531; Pinkert S, 2011, J VIROL, V85, P13409, DOI 10.1128/JVI.00621-11; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prugnolle F, 2013, P NATL ACAD SCI USA, V110, P8123, DOI 10.1073/pnas.1306004110; Prugnolle F, 2011, P NATL ACAD SCI USA, V108, P11948, DOI 10.1073/pnas.1109368108; Prugnolle F, 2010, P NATL ACAD SCI USA, V107, P1458, DOI 10.1073/pnas.0914440107; Rajtar B, 2008, ANN AGR ENV MED, V15, P199; Sadeuh-Mba SA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003052; Shaukat S, 2012, VIRUS RES, V170, P164, DOI 10.1016/j.virusres.2012.09.010; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; SULLIVAN KM, 1993, BIOTECHNIQUES, V15, P636; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tao ZX, 2013, ARCH VIROL, V158, P479, DOI 10.1007/s00705-012-1517-2; Van Nguyen D, 2014, J VIROL; VANDERKUYL AC, 1995, J MOL EVOL, V40, P173, DOI 10.1007/BF00167111; Yamashita T, 2010, J GEN VIROL, V91, P1063, DOI 10.1099/vir.0.016014-0	68	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169067	10.1371/journal.pone.0169067	http://dx.doi.org/10.1371/journal.pone.0169067			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081564	Green Published, gold			2022-12-26	WOS:000391949500024
J	Rajabi, F; Heene, E; Maisch, J; Nick, P				Rajabi, Fatemeh; Heene, Ernst; Maisch, Jan; Nick, Peter			Combination of Plant Metabolic Modules Yields Synthetic Synergies	PLOS ONE			English	Article							N-METHYLPUTRESCINE OXIDASE; TOBACCO NICOTIANA-TABACUM; ALKALOID BIOSYNTHESIS; CELL-CULTURES; BY-2 CELLS; NORNICOTINE; TOMENTOSIFORMIS; TRANSFORMATION; DEMETHYLATION; CONVERSION	The great potential of pharmacologically active secondary plant metabolites is often limited by low yield and availability of the producing plant. Chemical synthesis of these complex compounds is often too expensive. Plant cell fermentation offers an alternative strategy to overcome these limitations. However, production in batch cell cultures remains often inefficient. One reason might be the fact that different cell types have to interact for metabolite maturation, which is poorly mimicked in suspension cell lines. Using alkaloid metabolism of tobacco, we explore an alternative strategy, where the metabolic interactions of different cell types in a plant tissue are technically mimicked based on different plant-cell based metabolic modules. In this study, we simulate the interaction found between the nicotine secreting cells of the root and the nicotine-converting cells of the senescent leaf, generating the target compound nornicotine in the model cell line tobacco BY-2. When the nicotine demethylase NtomCYP82E4 was overexpressed in tobacco BY-2 cells, nornicotine synthesis was triggered, but only to a minor extent. However, we show here that we can improve the production of nornicotine in this cell line by feeding the precursor, nicotine. Engineering of another cell line overexpressing the key enzyme NtabMPO1 allows to stimulate accumulation and secretion of this precursor. We show that the nornicotine production of NtomCYP82E4 cells can be significantly stimulated by feeding conditioned medium from NtabMPO1 overexpressors without any negative effect on the physiology of the cells. Co-cultivation of NtomCYP82E4 with NtabMPO1 stimulated nornicotine accumulation even further, demonstrating that the physical presence of cells was superior to just feeding the conditioned medium collected from the same cells. These results provide a proof of concept that combination of different metabolic modules can improve the productivity for target compounds in plant cell fermentation.	[Rajabi, Fatemeh; Heene, Ernst; Maisch, Jan; Nick, Peter] Karlsruhe Inst Technol, Inst Bot, Mol Cell Biol, D-76021 Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Rajabi, F (corresponding author), Karlsruhe Inst Technol, Inst Bot, Mol Cell Biol, D-76021 Karlsruhe, Germany.	Fatemeh.rajabi@student.kit.edu			German Academic Exchange Service (DAAD); German Federal Ministry of Education and Research (BMBF, Bioeconomy Initiative) [031B0065A]	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); German Federal Ministry of Education and Research (BMBF, Bioeconomy Initiative)	This work was supported by a Ph.D. fellowship to Fatemeh Rajabi by the German Academic Exchange Service (DAAD), and by funds from the German Federal Ministry of Education and Research (BMBF, Bioeconomy Initiative, 031B0065A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anarat-Cappillino G, 2014, CURR OPIN PLANT BIOL, V19, P51, DOI 10.1016/j.pbi.2014.03.007; Baldwin IT, 2001, PLANT PHYSIOL, V127, P1449, DOI 10.1104/pp.010762; Barbulova A., 2014, COSMETICS-BASEL, V1, P94, DOI [10.3390/cosmetics1020094, DOI 10.3390/COSMETICS1020094]; Buschmann H, 2011, NEW PHYTOL, V190, P258, DOI 10.1111/j.1469-8137.2010.03587.x; Cai B, 2016, J NAT PROD, V79, P754, DOI 10.1021/acs.jnatprod.5b00678; Cai B, 2012, J BIOL CHEM, V287, P42804, DOI 10.1074/jbc.M112.413807; Capell T, 2004, CURR OPIN BIOTECH, V15, P148, DOI 10.1016/j.copbio.2004.01.009; Ching SLK, 2012, J INTEGR PLANT BIOL, V54, P152, DOI 10.1111/j.1744-7909.2012.01103.x; DeBoer KD, 2009, PLANT MOL BIOL, V69, P299, DOI 10.1007/s11103-008-9425-2; Dewey RE, 2013, PHYTOCHEMISTRY, V94, P10, DOI 10.1016/j.phytochem.2013.06.002; Dickerson TJ, 2003, P NATL ACAD SCI USA, V100, P8182, DOI 10.1073/pnas.1332847100; GAFF DF, 1971, J EXP BOT, V22, P756, DOI 10.1093/jxb/22.3.756; Gaosheng H., 2012, RECENT ADV PLANT IN, V11, P197; Gavilano LB, 2007, PLANT CELL PHYSIOL, V48, P1567, DOI 10.1093/pcp/pcm128; Gavilano LB, 2007, J BIOL CHEM, V282, P249, DOI 10.1074/jbc.M609512200; Georgiev MI, 2009, APPL MICROBIOL BIOT, V83, P809, DOI 10.1007/s00253-009-2049-x; Goossens A, 2003, P NATL ACAD SCI USA, V100, P8595, DOI 10.1073/pnas.1032967100; Gutjahr C, 2008, PLANT CELL, V20, P2989, DOI 10.1105/tpc.108.062414; Hakkinen S, 2004, PLANTA MED, V70, P936, DOI 10.1055/s-2004-832620; Han JP, 2016, SCI REP-UK, V6, DOI 10.1038/srep18723; Hao DY, 1998, J PLANT PHYSIOL, V152, P420, DOI 10.1016/S0176-1617(98)80258-7; HASHIMOTO T, 1994, ANNU REV PLANT PHYS, V45, P257, DOI 10.1146/annurev.pp.45.060194.001353; Heim WG, 2007, PHYTOCHEMISTRY, V68, P454, DOI 10.1016/j.phytochem.2006.11.003; Jimenez-Garcia SN, 2013, POL J FOOD NUTR SCI, V63, P67, DOI 10.2478/v10222-012-0072-6; Kajikawa M, 2011, PLANT PHYSIOL, V155, P2010, DOI 10.1104/pp.110.170878; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Katoh A, 2007, PLANT CELL PHYSIOL, V48, P550, DOI 10.1093/pcp/pcm018; Katoh A, 2006, PLANT PHYSIOL, V141, P851, DOI 10.1104/pp.106.081091; Lewis RS, 2008, PLANT BIOTECHNOL J, V6, P346, DOI 10.1111/j.1467-7652.2008.00324.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maisch J, 2007, PLANT PHYSIOL, V143, P1695, DOI 10.1104/pp.106.094052; Maisch J, 2016, J PLANT PHYSIOL, V200, P28, DOI 10.1016/j.jplph.2016.06.004; Maisch J, 2009, J EXP BOT, V60, P603, DOI 10.1093/jxb/ern307; Mehrotra S, 2015, PROTOPLASMA, V252, P1189, DOI 10.1007/s00709-015-0761-1; Murad L, 2002, AM J BOT, V89, P921, DOI 10.3732/ajb.89.6.921; Naconsie M, 2014, PLANT CELL PHYSIOL, V55, P436, DOI 10.1093/pcp/pct179; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; Nick P, 2000, PROTOPLASMA, V211, P234, DOI 10.1007/BF01304491; Noctor G, 2006, J EXP BOT, V57, P1603, DOI 10.1093/jxb/erj202; Roberts SC, 2007, NAT CHEM BIOL, V3, P387, DOI 10.1038/nchembio.2007.8; Sato F, 2001, P NATL ACAD SCI USA, V98, P367, DOI 10.1073/pnas.011526398; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Shoji T, 2008, PLANT CELL PHYSIOL, V49, P1209, DOI 10.1093/pcp/pcn096; Shoji T, 2009, PLANT PHYSIOL, V149, P708, DOI 10.1104/pp.108.132811; Siminszky B, 2005, P NATL ACAD SCI USA, V102, P14919, DOI 10.1073/pnas.0506581102; Sinclair SJ, 2000, PLANT MOL BIOL, V44, P603, DOI 10.1023/A:1026590521318; Steppuhn A, 2004, PLOS BIOL, V2, P1074, DOI 10.1371/journal.pbio.0020217; Subroto MA, 1996, BIOTECHNOL BIOENG, V49, P481, DOI 10.1002/(SICI)1097-0290(19960305)49:5&lt;481::AID-BIT1&gt;3.0.CO;2-F; Trehy ML, 2011, J LIQ CHROMATOGR R T, V34, P1442, DOI 10.1080/10826076.2011.572213; Verpoorte R, 1999, BIOTECHNOL LETT, V21, P467, DOI 10.1023/A:1005502632053; Wilson SA, 2012, PLANT BIOTECHNOL J, V10, P249, DOI 10.1111/j.1467-7652.2011.00664.x; Yukawa M, 2006, MOL GENET GENOMICS, V275, P367, DOI 10.1007/s00438-005-0092-6	52	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169778	10.1371/journal.pone.0169778	http://dx.doi.org/10.1371/journal.pone.0169778			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081182	Green Published, Green Submitted, gold			2022-12-26	WOS:000391949500077
J	Sakakibara, A; Sakakibara, S; Kusumoto, J; Takeda, D; Hasegawa, T; Akashi, M; Minamikawa, T; Hashikawa, K; Terashi, H; Komori, T				Sakakibara, Akiko; Sakakibara, Shunsuke; Kusumoto, Junya; Takeda, Daisuke; Hasegawa, Takumi; Akashi, Masaya; Minamikawa, Tsutomu; Hashikawa, Kazunobu; Terashi, Hiroto; Komori, Takahide			Upregulated Expression of Transient Receptor Potential Cation Channel Subfamily V Receptors in Mucosae of Patients with Oral Squamous Cell Carcinoma and Patients with a History of Alcohol Consumption or Smoking	PLOS ONE			English	Article							VANILLOID RECEPTOR-1; PHARYNGEAL CANCER; TRPV1; CAPSAICIN; ACTIVATION; DRINKING; KERATINOCYTES; SENSITIVITY; PREVENTION; APOPTOSIS	Objectives Transient receptor potential cation channel (subfamily V, members 1-4) (TRPV1-4) are expressed in skin and neurons and activated by external stimuli in normal mucosae of all oral cavity sites. The oral cavity is exposed to various stimuli, including temperature, mechanical stimuli, chemical substances, and changes in pH, and, notably, the risk factors for oncogenic transformation in oral squamous epithelium are the same as the external stimuli received by TRPV1-4 receptors. Hence, we examined the relationship between oral squamous cell carcinoma (SCC) and TRPV1-4 expression. Materials and Methods Oral SCC patients (n = 37) who underwent surgical resection were included in this study. We investigated the expression of TRPV1-4 by immunohistochemical staining and quantification of TRPV1-4 mRNA in human oral mucosa. In addition, we compared the TRPV1-4 levels in mucosa from patients with SCC to those in normal oral mucosa. Results The receptors were expressed in oral mucosa at all sites (tongue, buccal mucosa, gingiva, and oral floor) and the expression was stronger in epithelia from patients with SCC than in normal epithelia. Furthermore, alcohol consumption and tobacco use were strongly associated with the occurrence of oral cancer and were found to have a remarkable influence on TRPV1-4 receptor expression in normal oral mucosa. In particular, patients with a history of alcohol consumption demonstrated significantly higher expression levels. Conclusion Various external stimuli may influence the behavior of cancer cells. Overexpression of TRPV1-4 is likely to be a factor in enhanced sensitivity to external stimuli. These findings could contribute to the establishment of novel strategies for cancer therapy or prevention.	[Sakakibara, Akiko; Kusumoto, Junya; Takeda, Daisuke; Hasegawa, Takumi; Akashi, Masaya; Minamikawa, Tsutomu; Komori, Takahide] Kobe Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kobe, Hyogo, Japan; [Sakakibara, Shunsuke; Hashikawa, Kazunobu; Terashi, Hiroto] Kobe Univ, Grad Sch Med, Dept Plast Surg, Kobe, Hyogo, Japan	Kobe University; Kobe University	Sakakibara, A (corresponding author), Kobe Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kobe, Hyogo, Japan.	ogni@med.kobe-u.ac.jp	Akashi, Masaya/X-9847-2019; Kusumoto, Junya/AAR-4910-2021	Kusumoto, Junya/0000-0003-4289-1852	JSPS KAKENHI [24792210]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 24792210.	Aijima R, 2015, FASEB J, V29, P182, DOI 10.1096/fj.14-251314; Amantini C, 2007, J NEUROCHEM, V102, P977, DOI 10.1111/j.1471-4159.2007.04582.x; BLOT WJ, 1988, CANCER RES, V48, P3282; Bode AM, 2011, CANCER RES, V71, P2809, DOI 10.1158/0008-5472.CAN-10-3756; Caprodossi S, 2011, CARCINOGENESIS, V32, P686, DOI 10.1093/carcin/bgr025; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Denda S, 2010, J DERMATOL SCI, V57, P108, DOI 10.1016/j.jdermsci.2009.11.007; drinking Alcohol, 1988, IARC MON EV CARC RIS, V44, P153; Everaerts W, 2010, PROG BIOPHYS MOL BIO, V103, P2, DOI 10.1016/j.pbiomolbio.2009.10.002; Gajendra S, 2006, J CANCER EDUC, V21, P157, DOI 10.1207/s15430154jce2103_14; Gonzales CB, 2014, ORAL ONCOL, V50, P437, DOI 10.1016/j.oraloncology.2013.12.023; GUPTA PC, 1980, COMMUNITY DENT ORAL, V8, P287, DOI 10.1111/j.1600-0528.1980.tb01302.x; Homma Y, 2013, J UROLOGY, V190, P1925, DOI 10.1016/j.juro.2013.05.049; Huang SM, 2008, J NEUROSCI, V28, P13727, DOI 10.1523/JNEUROSCI.5741-07.2008; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; Kim HY, 2006, ORAL SURG ORAL MED O, V102, P625, DOI 10.1016/j.tripleo.2005.10.036; KROLLS SO, 1976, J AM DENT ASSOC, V92, P571, DOI 10.14219/jada.archive.1976.0556; Lapointe TK, 2015, AM J PHYSIOL-GASTR L, V309, pG87, DOI 10.1152/ajpgi.00421.2014; Marincsak R, 2009, ORAL DIS, V15, P328, DOI 10.1111/j.1601-0825.2009.01526.x; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Petti S, 2005, ORAL ONCOL, V41, P828, DOI 10.1016/j.oraloncology.2005.04.004; Ramer R, 2008, J NATL CANCER I, V100, P59, DOI 10.1093/jnci/djm268; Ramer R, 2010, BIOCHEM PHARMACOL, V79, P955, DOI 10.1016/j.bcp.2009.11.007; Shapovalov G, 2011, CELL CALCIUM, V50, P295, DOI 10.1016/j.ceca.2011.05.006; Southall MD, 2003, J PHARMACOL EXP THER, V304, P217, DOI 10.1124/jpet.102.040675; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suzuki T, 2006, CANCER SCI, V97, P760, DOI 10.1111/j.1349-7006.2006.00232.x; Takahashi N, 2014, J DENT RES, V93, P1141, DOI 10.1177/0022034514552826; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Wang B, 2011, J DENT RES, V90, P163, DOI 10.1177/0022034510385459; Waning J, 2007, CELL CALCIUM, V42, P17, DOI 10.1016/j.ceca.2006.11.005; Ziglioli Francesco, 2009, Acta Biomed, V80, P13	33	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169723	10.1371/journal.pone.0169723	http://dx.doi.org/10.1371/journal.pone.0169723			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081185	Green Published, Green Submitted, gold			2022-12-26	WOS:000391949500067
J	Weiss, D; Avraham, S; Guttlieb, R; Gasner, L; Lotman, A; Rotman, OM; Einav, S				Weiss, Dar; Avraham, Sharon; Guttlieb, Ruth; Gasner, Lee; Lotman, Aline; Rotman, Oren M.; Einav, Shmuel			Mechanical Compression Effects on the Secretion of vWF and IL-8 by Cultured Human Vein Endothelium	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; WEIBEL-PALADE BODIES; SHEAR-STRESS; CELLS; INTERLEUKIN-8; PROTEIN; EXOCYTOSIS; PLATELETS; PRESSURE	Short peripheral catheters are ubiquitous in today's healthcare environment enabling effective delivery of fluids and medications directly into a patient's vasculature. However, complications related to their use, such as short peripheral catheter thrombophlebitis (SPCT), affect up to 80% of hospitalized patients. While indwelling within the vein, the catheters exert prolonged constant pressure upon the endothelium which can trigger inflammation processes. We have developed and studied an in-vitro model of cultured endothelial cells subjected to mechanical compression of modular self-designed weights, and explored their inflammatory response by quantification of two key biomarkers-vWF and IL-8. Evaluation was performed by ELISA immunoassay and processing of vWF-labeled immunofluorescence images. We found that application of weights correspond to 272 Pa yielded increased release of vWF and IL-8 up to 150% and 250% respectively, comparing to the exertion of 136 Pa. Analyses of the immunofluorescence images revealed significantly longer and more extracellular vWF-strings as well as higher intensity stained-pixels in cells exposed to elevated pressures. The release of both factors found to be significantly dependent on the extent of the exerted pressure. The research shed a light on the relationship between induced mechanical compression and the pathogenesis of SPCT. Minimizing, let alone eliminating the contact between the catheter and the vein wall will mitigate the pressure acting on the endothelium, thereby reducing the secretion of inflammatory factors and lessen the incidence of SPCT.	[Weiss, Dar; Avraham, Sharon; Guttlieb, Ruth; Gasner, Lee; Lotman, Aline; Einav, Shmuel] Tel Aviv Univ, Fac Engn, Dept Biomed Engn, Tel Aviv, Israel; [Rotman, Oren M.; Einav, Shmuel] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA	Tel Aviv University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Weiss, D (corresponding author), Tel Aviv Univ, Fac Engn, Dept Biomed Engn, Tel Aviv, Israel.	darweiss@gmail.com			Joseph Drown Foundation [0605411342]; Herbert Berman Fund [0605534561]	Joseph Drown Foundation; Herbert Berman Fund	This research was partially supported by Joseph Drown Foundation (Grant Number 0605411342)and Herbert Berman Fund (Grant Number 0605534561).	ACEVEDO AD, 1993, J CELL PHYSIOL, V157, P603, DOI 10.1002/jcp.1041570321; BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; Bernardo A, 2005, J THROMB HAEMOST, V3, P562, DOI 10.1111/j.1538-7836.2005.01122.x; Brill A, 2011, BLOOD, V117, P1400, DOI 10.1182/blood-2010-05-287623; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; COLLINS PD, 1993, IMMUNOLOGY, V79, P312; De Ceunynck K, 2013, BLOOD, V121, P270, DOI 10.1182/blood-2012-07-442285; De Meyer Simon F., 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P9; Dougherty L., 2008, OBTAINING PERIPHERAL; Galbusera M, 1997, BLOOD, V90, P1558, DOI 10.1182/blood.V90.4.1558.1558_1558_1564; JEANNIN P, 1994, BLOOD, V84, P2229; LARSEN CG, 1989, SCIENCE, V243, P1464, DOI 10.1126/science.2648569; LEONARD EJ, 1990, J IMMUNOL, V144, P1323; Matsushita K, 2005, J CELL BIOL, V170, P73, DOI 10.1083/jcb.200502031; MCEVER RP, 1989, J CLIN INVEST, V84, P92, DOI 10.1172/JCI114175; Otsuka F, 2012, NAT REV CARDIOL, V9, P439, DOI 10.1038/nrcardio.2012.64; Panadero A, 2002, ANAESTHESIA, V57, P921, DOI 10.1046/j.1365-2044.2002.02786.x; Rotman OM, 2013, J BIOMED SCI ENG, V6, P6, DOI [10.4236/jbise.2013.612A002, DOI 10.4236/JBISE.2013.612A002]; Schluter T, 1999, BIOCHEM PHARMACOL, V57, P1191, DOI 10.1016/S0006-2952(99)00011-8; Shin HY, 2002, ANN BIOMED ENG, V30, P297, DOI 10.1114/1.1458595; Tagalakis V, 2002, AM J MED, V113, P146, DOI 10.1016/S0002-9343(02)01163-4; Tsai HM, 2010, INT J HEMATOL, V91, P1, DOI 10.1007/s12185-009-0476-1; Turner N, 2009, J THROMB HAEMOST, V7, P229, DOI 10.1111/j.1538-7836.2008.03209.x; Turner NA, 2009, BLOOD, V114, P5102, DOI 10.1182/blood-2009-07-231597; van Mourik JA, 2002, HISTOCHEM CELL BIOL, V117, P113, DOI 10.1007/s00418-001-0368-9; WAGNER DD, 1982, J CELL BIOL, V95, P355, DOI 10.1083/jcb.95.1.355; Wagner DD, 2008, BLOOD, V111, P5271, DOI 10.1182/blood-2008-01-078204; Weiss D, 2016, COMPUT METHOD BIOMEC, V19, P330, DOI 10.1080/10255842.2015.1024667	28	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169752	10.1371/journal.pone.0169752	http://dx.doi.org/10.1371/journal.pone.0169752			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081186	Green Submitted, gold, Green Published			2022-12-26	WOS:000391949500070
J	Fujimori, S; Abe, M; Kinoshita, T; Hasegawa, T; Kawase, H; Kushida, K; Masui, T; Oka, K; Shiogama, H; Takahashi, K; Tatebe, H; Yoshikawa, M				Fujimori, Shinichiro; Abe, Manabu; Kinoshita, Tsuguki; Hasegawa, Tomoko; Kawase, Hiroaki; Kushida, Kazuhide; Masui, Toshihiko; Oka, Kazutaka; Shiogama, Hideo; Takahashi, Kiyoshi; Tatebe, Hiroaki; Yoshikawa, Minoru			Downscaling Global Emissions and Its Implications Derived from Climate Model Experiments	PLOS ONE			English	Article							ENVIRONMENTAL-CHANGE; SIMULATION; SCENARIOS	In climate change research, future scenarios of greenhouse gas and air pollutant emissions generated by integrated assessment models (IAMs) are used in climate models (CMs) and earth system models to analyze future interactions and feedback between human activities and climate. However, the spatial resolutions of IAMs and CMs differ. IAMs usually disaggregate the world into 10-30 aggregated regions, whereas CMs require a grid-based spatial resolution. Therefore, downscaling emissions data from IAMs into a finer scale is necessary to input the emissions into CMs. In this study, we examined whether differences in downscaling methods significantly affect climate variables such as temperature and precipitation. We tested two downscaling methods using the same regionally aggregated sulfur emissions scenario obtained from the Asian-Pacific Integrated Model/Computable General Equilibrium (AIM/CGE) model. The downscaled emissions were fed into the Model for Interdisciplinary Research on Climate (MIROC). One of the methods assumed a strong convergence of national emissions intensity (e.g., emissions per gross domestic product), while the other was based on inertia (i.e., the base-year remained unchanged). The emissions intensities in the downscaled spatial emissions generated from the two methods markedly differed, whereas the emissions densities (emissions per area) were similar. We investigated whether the climate change projections of temperature and precipitation would significantly differ between the two methods by applying a field significance test, and found little evidence of a significant difference between the two methods. Moreover, there was no clear evidence of a difference between the climate simulations based on these two downscaling methods.	[Fujimori, Shinichiro; Hasegawa, Tomoko; Masui, Toshihiko; Takahashi, Kiyoshi] NIES, Ctr Social & Environm Syst Res, 16-2 Onogawa, Tsukuba, Ibaraki, Japan; [Abe, Manabu; Tatebe, Hiroaki] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Dept Integrated Climate Change Project Res, Kanazawa Ku, 3173-25 Showa Machi, Yokohama, Kanagawa, Japan; [Kinoshita, Tsuguki] Ibaraki Univ, Coll Agr, 3-21-1 Chuo, Ami, Ibaraki, Japan; [Kawase, Hiroaki] Meteorol Res Inst, 1-1 Nagamine, Tsukuba, Ibaraki, Japan; [Kushida, Kazuhide; Oka, Kazutaka; Yoshikawa, Minoru] Mizuho Informat & Res Inst Inc, Chiyoda Ku, 2-3 Kanda Nishikicho, Tokyo, Japan; [Shiogama, Hideo] NIES, Ctr Global Environm Res, 16-2 Onogawa, Tsukuba, Ibaraki, Japan	National Institute for Environmental Studies - Japan; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Ibaraki University; Meteorological Research Institute - Japan; Mizuho Research & Technologies, Ltd.; National Institute for Environmental Studies - Japan	Fujimori, S (corresponding author), NIES, Ctr Social & Environm Syst Res, 16-2 Onogawa, Tsukuba, Ibaraki, Japan.	fujimori.shinichiro@nies.go.jp	Abe, Manabu/A-9221-2008; Shiogama, Hideo/B-9598-2012; TAKAHASHI, KIYOSHI/AAD-5992-2019; Hasegawa, Tomoko/AAB-2616-2019; Fujimori, Shinichiro/A-1288-2015	Shiogama, Hideo/0000-0001-5476-2148; TAKAHASHI, KIYOSHI/0000-0002-0163-545X; Hasegawa, Tomoko/0000-0003-2456-5789; Fujimori, Shinichiro/0000-0001-7897-1796; tatebe, hiroaki/0000-0002-2265-5847	Ministry of Environment of Japan [2-1402, S10-4, S14-5]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Mizuho Information & Research Institute, Inc.; Grants-in-Aid for Scientific Research [15K16164] Funding Source: KAKEN	Ministry of Environment of Japan(Ministry of the Environment, Japan); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mizuho Information & Research Institute, Inc.(Mukai Science and Technology Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Global Environmental Research Fund grants 2-1402, S10-4, and S14-5 from the Ministry of Environment of Japan and the Program for Risk Information on Climate Change (SOUSEI program) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The authors are most grateful for the generous support provided by these funds. Mizuho Information & Research Institute, Inc. provided support in the form of salaries for authors [K.K., K.O., and M.Y.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This study was supported by Global Environmental Research Fund grants 2-1402, S10-4, and S14-5 from the Ministry of Environment of Japan and the Program for Risk Information on Climate Change (SOUSEI program) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The authors are most grateful for the generous support provided by these funds.	Bauer N., 2013, CLIMATIC CHANGE, DOI [10.1007/s10584-013-0901-6, DOI 10.1007/S10584-013-0901-6]; Center for International Earth Science Information Network (CIESIN) Columbia University, 2005, GRIDDED POPULATION W; Collins WD, 2015, GEOSCI MODEL DEV, V8, P2203, DOI 10.5194/gmd-8-2203-2015; Ebi KL, 2014, CLIMATIC CHANGE, V122, P363, DOI 10.1007/s10584-013-0912-3; Fujimori S, 2014, ENERG POLICY, V75, P379, DOI 10.1016/j.enpol.2014.09.015; Fujimori S., 2013, GLOB ENVIRON RES, V17, P79; Fujimori S, 2012, AIM CGE BASIC MANUA; Fujimori S, 2015, ENERG ECON, V48, P306, DOI 10.1016/j.eneco.2014.12.011; Fujimori S, 2014, FOOD SECUR, V6, P685, DOI 10.1007/s12571-014-0375-z; Fujimori S, 2014, APPL ENERG, V128, P296, DOI 10.1016/j.apenergy.2014.04.074; Grubler A, 2007, TECHNOL FORECAST SOC, V74, P980, DOI 10.1016/j.techfore.2006.05.023; Hasegawa T, 2015, ENVIRON SCI TECHNOL, V49, P7245, DOI 10.1021/es5051748; Hasegawa T, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/1/014010; Hasumi H., 2000, CCSR REP, V13, P68; Hoehne N, 2005, EMISSION ALLOWANCES; IIASA, 2012, SHAR SOC PATHW SSP D; Jones AD, 2015, CLIMATIC CHANGE, V131, P691, DOI 10.1007/s10584-015-1411-5; Jones AD, 2013, J CLIMATE, V26, P3657, DOI 10.1175/JCLI-D-12-00377.1; Karoly DJ, 2005, J CLIMATE, V18, P4337, DOI 10.1175/JCLI3565.1; Komuro Y, 2014, J CLIMATE, V27, P4359, DOI 10.1175/JCLI-D-13-00090.1; Liston GE, 2004, J CLIMATE, V17, P1381, DOI 10.1175/1520-0442(2004)017<1381:RSSCHI>2.0.CO;2; LIVEZEY RE, 1983, MON WEATHER REV, V111, P46, DOI 10.1175/1520-0493(1983)111<0046:SFSAID>2.0.CO;2; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Murray RJ, 1996, J COMPUT PHYS, V126, P251, DOI 10.1006/jcph.1996.0136; Nakicenovic N., 2000, INTERGOVERNMENTAL PA, P599; Nitta T, 2015, J JAPAN SOC CIVIL B1, V71, pI_ 955; O'Neill BC, 2017, GLOBAL ENVIRON CHANG, V42, P169, DOI 10.1016/j.gloenvcha.2015.01.004; Riahi K., 2015, INTEGRATED ASSESSMEN; Riahi K, 2017, GLOBAL ENVIRON CHANG, V42, P153, DOI 10.1016/j.gloenvcha.2016.05.009; Riahi K, 2011, CLIMATIC CHANGE, V109, P33, DOI 10.1007/s10584-011-0149-y; Schaeffer M, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002581; Shiogama H, 2013, INT J CLIMATOL, V33, P2542, DOI 10.1002/joc.3607; Shiogama H, 2012, CLIM DYNAM, V39, P3041, DOI 10.1007/s00382-012-1441-x; Sitch S, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002311; Sudo K, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001113; Taikan, 2012, J JAPAN SOC CIVIL EN, V68, P325, DOI [10.2208/jscejhe.68.i_325, DOI 10.2208/JSCEJHE.68.I_325]; Takata K, 2003, GLOBAL PLANET CHANGE, V38, P209, DOI 10.1016/S0921-8181(03)00030-4; Takemura T, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005029; Takemura T, 2009, ATMOS CHEM PHYS, V9, P3061, DOI 10.5194/acp-9-3061-2009; TANG IN, 1994, J GEOPHYS RES-ATMOS, V99, P18801, DOI 10.1029/94JD01345; Thomson AM, 2011, CLIMATIC CHANGE, V109, P77, DOI 10.1007/s10584-011-0151-4; Tsujino H, 2000, J PHYS OCEANOGR, V30, P2853, DOI 10.1175/1520-0485(2001)031<2853:DPCCBV>2.0.CO;2; van Vuuren DP, 2007, GLOBAL ENVIRON CHANG, V17, P114, DOI 10.1016/j.gloenvcha.2006.04.004; van Vuuren DP, 2014, CLIMATIC CHANGE, V122, P373, DOI 10.1007/s10584-013-0906-1; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; van Vuuren DP, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/024012; van Vuuren DP, 2010, WIRES CLIM CHANGE, V1, P393, DOI 10.1002/wcc.50; Watanabe M, 2010, J CLIMATE, V23, P6312, DOI 10.1175/2010JCLI3679.1; Wilks D.S, 2011, INT GEOPHYS; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	50	14	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169733	10.1371/journal.pone.0169733	http://dx.doi.org/10.1371/journal.pone.0169733			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH6BJ	28076446	gold, Green Published, Green Submitted			2022-12-26	WOS:000391857100050
J	Juskiewicz, J; Jankowski, J; Zielinski, H; Zdunczyk, Z; Mikulski, D; Antoszkiewicz, Z; Kosmala, M; Zdunczyk, P				Juskiewicz, Jerzy; Jankowski, Jan; Zielinski, Henryk; Zdunczyk, Zenon; Mikulski, Dariusz; Antoszkiewicz, Zofia; Kosmala, Monika; Zdunczyk, Przemyslaw			The Fatty Acid Profile and Oxidative Stability of Meat from Turkeys Fed Diets Enriched with n-3 Polyunsaturated Fatty Acids and Dried Fruit Pomaces as a Source of Polyphenols	PLOS ONE			English	Article							GRAPE SEED EXTRACT; VIRGIN OLIVE OIL; VITAMIN-E; GROWTH-PERFORMANCE; ANTIOXIDANT ACTIVITY; LIPID OXIDATION; POULTRY MEAT; CHEMICAL-COMPOSITION; BROILER CHICKS; LINOLEIC-ACID	The aim of this study was to determine the efficacy of different dietary fruit pomaces in reducing lipid oxidation in the meat of turkeys fed diets with a high content of n-3 polyunsaturated fatty acids (PUFAs). Over a period of 4 weeks before slaughter, turkeys were fed diets with the addition of 5% dried apple, blackcurrant, strawberry and seedless strawberry pomaces (groups AP, BP, SP and SSP, respectively) and 2.5% linseed oil. Pomaces differed in the content (from 5.5 in AP to 43.1 mg/g in SSP) and composition of polyphenols Proanthocyanidins were the main polyphenolic fraction in all pomaces, AP contained flavone glycosides and dihy-drochalcones, BP contained anthocyanins, and SP and SSP ellagitannins. The n-6/n-3 PUFA ratio in all diets was comparable and lower than 2:1. In comparison with groups C and AP, the percentage of n-3 PUFAs in the total fatty acid pool of white meat from the breast muscles of turkeys in groups BP, SP and SSP was significantly higher, proportionally to the higher content of alpha-linolenic acid in berry pomaces. The fatty acid profile of dark meat from thigh muscles, including the n-6/n-3 PUFA ratio, was similar and lower than 3:1 in all groups. Vitamin A levels in raw breast muscles were higher in group AP than in groups C and BP (P<0.05). The addition of fruit pomaces to turkey diets lowered vitamin E concentrations (P=0.001) in raw breast muscles relative to group C. Diets supplemented with fruit pomaces significantly lowered the concentration of thiobarbituric acid reactive substances (TBARS) in raw, frozen and cooked meat. Our results indicate that the dietary application of dried fruit pomaces increases the oxidative stability of meat from turkeys fed linseed oil, and strawberry pomace exerted the most desirable effects due to its highest polyphenol content and antioxidant potential.	[Juskiewicz, Jerzy; Zielinski, Henryk; Zdunczyk, Zenon; Zdunczyk, Przemyslaw] Polish Acad Sci, Inst Anim Reprod & Food Res, Olsztyn, Poland; [Jankowski, Jan; Mikulski, Dariusz] Univ Warmia & Mazury, Dept Poultry Sci, Olsztyn, Poland; [Antoszkiewicz, Zofia] Univ Warmia & Mazury, Dept Anim Nutr & Food Management, Olsztyn, Poland; [Kosmala, Monika] Lodz Univ Technol, Inst Food Technol & Anal, Lodz, Poland	Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences; University of Warmia & Mazury; University of Warmia & Mazury; Lodz University of Technology	Juskiewicz, J (corresponding author), Polish Acad Sci, Inst Anim Reprod & Food Res, Olsztyn, Poland.	j.juskiewicz@pan.olsztyn.pl	Juśkiewicz, Jerzy/H-7193-2017; Mikulski, Dariusz/AAA-4897-2022; Mikulski, Dariusz/AFN-4982-2022; Kosmala, Monika/AAB-3395-2019; Jankowski, Jan/AAA-1623-2021; Zieliński, Henryk/F-2907-2017; Zduńczyk, Przemysław/H-7271-2017; Zduńczyk, Zenon/H-7272-2017; Mikulski, Dariusz/AAC-8868-2020	Juśkiewicz, Jerzy/0000-0003-0068-5970; Mikulski, Dariusz/0000-0002-6668-9977; Mikulski, Dariusz/0000-0002-6668-9977; Kosmala, Monika/0000-0002-9018-3028; Jankowski, Jan/0000-0002-6250-4031; Zieliński, Henryk/0000-0002-4333-6677; Zduńczyk, Przemysław/0000-0003-4815-1716; Zduńczyk, Zenon/0000-0002-0640-7552; 	"BIOFOOD - innovative, functional products of animal origin" - European Regional Development Fund, Innovative Economy Operational Program [POIG.01.01.02-014-090/09]	"BIOFOOD - innovative, functional products of animal origin" - European Regional Development Fund, Innovative Economy Operational Program	Funding for this study was provided by the "BIOFOOD - innovative, functional products of animal origin" project no. POIG.01.01.02-014-090/09 co-financed by the European Regional Development Fund as part of the Innovative Economy Operational Program 2007-2013 (www.biozywnosc.edu.pl).	Ahmed ST, 2015, FOOD CHEM, V188, P481, DOI 10.1016/j.foodchem.2015.04.140; Barroeta AC, 2007, WORLD POULTRY SCI J, V63, P277, DOI 10.1017/S0043933907001468; Bieger J, 2008, J NUTR, V138, P1417, DOI 10.1093/jn/138.8.1417; Brenes A, 2008, POULTRY SCI, V87, P307, DOI 10.3382/ps.2007-00297; Brenes A, 2010, SPAN J AGRIC RES, V8, P326, DOI 10.5424/sjar/2010082-1199; Buendia B, 2010, J AGR FOOD CHEM, V58, P3916, DOI 10.1021/jf9030597; Chamorro S, 2015, FOOD RES INT, V73, P197, DOI 10.1016/j.foodres.2014.11.054; Chamorro S, 2013, ANIMAL, V7, P555, DOI 10.1017/S1751731112001851; de Boer VCJ, 2005, J NUTR, V135, P1718, DOI 10.1093/jn/135.7.1718; Dinkova-Kostova AT, 2008, MOL NUTR FOOD RES, V52, pS128, DOI 10.1002/mnfr.200700195; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Duester G, 2003, CHEM-BIOL INTERACT, V143, P201, DOI 10.1016/S0009-2797(02)00204-1; Estevez M, 2015, POULTRY SCI, V94, P1368, DOI 10.3382/ps/pev094; Fellenberg MA, 2006, WORLD POULTRY SCI J, V62, P53, DOI 10.1079/WPS200584; Fotschki B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149081; Giomaro G, 2014, CHEM CENT J, V8, DOI 10.1186/1752-153X-8-45; Goni I, 2007, POULTRY SCI, V86, P508, DOI 10.1093/ps/86.3.508; Gonzalez E, 2007, ANIMAL, V1, P1060, DOI 10.1017/S1751731107000195; Gonzalez-Esquerra R, 2000, BRIT POULTRY SCI, V41, P481, DOI 10.1080/713654967; Gow-Chin Yen, 1995, Journal of Agricultural and Food Chemistry, V43, P27, DOI 10.1021/jf00049a007; Halliwell B, 2007, CARDIOVASC RES, V73, P341, DOI 10.1016/j.cardiores.2006.10.004; Helbig D, 2008, FOOD CHEM, V111, P1043, DOI 10.1016/j.foodchem.2008.05.017; Hibbeln JR, 2006, AM J CLIN NUTR, V83, p1483S, DOI 10.1093/ajcn/83.6.1483S; Howe P, 2006, NUTRITION, V22, P47, DOI 10.1016/j.nut.2005.05.009; Iqbal Z, 2015, J APPL POULTRY RES, V24, P127, DOI 10.3382/japr/pfv009; Jang A, 2008, POULTRY SCI, V87, P2382, DOI 10.3382/ps.2007-00506; Jankowski J, 2012, ANIM FEED SCI TECH, V178, P74, DOI 10.1016/j.anifeedsci.2012.09.012; Jankowski J, 2012, EUR J LIPID SCI TECH, V114, P1025, DOI 10.1002/ejlt.201200003; Jaroslawska J, 2011, J NUTR, V141, P1777, DOI 10.3945/jn.111.143677; Jia W, 2010, CAN J ANIM SCI, V90, P203, DOI 10.4141/CJAS09106; Jung KA, 2010, MOLECULES, V15, P7266, DOI 10.3390/molecules15107266; Jung MY, 2011, FOOD SCI BIOTECHNOL, V20, P725, DOI 10.1007/s10068-011-0102-x; Jurgonski A, 2015, EUR J NUTR; Jurgonski A, 2014, EUR J NUTR, V53, P1603, DOI 10.1007/s00394-014-0665-4; Juskiewicz J, 2016, J ANIM PHYSIOL AN N, V100, P967, DOI 10.1111/jpn.12415; Juskiewicz J, 2015, J ANIM FEED SCI, V24, P53, DOI 10.22358/jafs/65653/2015; Juskiewicz J, 2015, POL J FOOD NUTR SCI, V65, P199, DOI 10.1515/pjfns-2015-0007; Kahkonen M, 2012, J AGR FOOD CHEM, V60, P1167, DOI 10.1021/jf203431g; Kamboh AA, 2013, POULTRY SCI, V92, P454, DOI 10.3382/ps.2012-02584; Kennedy JA, 2001, J AGR FOOD CHEM, V49, P1740, DOI 10.1021/jf001030o; Kosmala M, 2011, J AGR FOOD CHEM, V59, P9177, DOI 10.1021/jf201950y; Landes N, 2003, BIOCHEM PHARMACOL, V65, P269, DOI 10.1016/S0006-2952(02)01520-4; Lands WEM, 2005, ANN NY ACAD SCI, V1055, P179, DOI 10.1196/annals.1323.028; Laudadio V, 2009, POULTRY SCI, V88, P805, DOI 10.3382/ps.2008-00082; Laudadio V, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0001-x; Le Bourvellec C, 2009, CARBOHYD POLYM, V75, P251, DOI 10.1016/j.carbpol.2008.07.010; Luehring M, 2011, ANIM FEED SCI TECH, V169, P199, DOI 10.1016/j.anifeedsci.2011.06.006; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Miller Nicholas J., 2002, Journal of Nutritional and Environmental Medicine (Abingdon), V12, P39, DOI 10.1080/13590840220123352; NRC National Research Council, 2014, NUTR REQ POULTR, P35; Palacios A, 2003, MOL CELL BIOCHEM, V250, P107, DOI 10.1023/A:1024977613141; Patras A, 2010, TRENDS FOOD SCI TECH, V21, P3, DOI 10.1016/j.tifs.2009.07.004; PEISKER KV, 1964, J AM OIL CHEM SOC, V41, P87, DOI 10.1007/BF02661915; Perez-Jimenez J, 2010, EUR J CLIN NUTR, V64, pS112, DOI 10.1038/ejcn.2010.221; Pinto MDS, 2008, FOOD CHEM, V107, P1629, DOI 10.1016/j.foodchem.2007.10.038; Popov I., 1999, OXIDANTS ANTIOXIDA B, V300, P96; Puiggros F, 2005, J AGR FOOD CHEM, V53, P6080, DOI 10.1021/jf050343m; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; RETTENMAIER R, 1992, INT J VITAM NUTR RES, V62, P312; Rothwell JA, 2005, J AGR FOOD CHEM, V53, P4355, DOI 10.1021/jf0483669; Saha P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156811; Sahin K, 2010, POULTRY SCI, V89, P2251, DOI 10.3382/ps.2010-00749; Sehm J., 2011, Food and Nutrition Sciences, V2, P366; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Sojka M, 2013, EUR FOOD RES TECHNOL, V237, P995, DOI 10.1007/s00217-013-2070-2; Suarez B, 2010, FOOD CHEM, V120, P339, DOI 10.1016/j.foodchem.2009.09.073; Tang S, 2001, FOOD RES INT, V34, P651, DOI 10.1016/S0963-9969(00)00190-3; Traber MG, 2004, ARCH BIOCHEM BIOPHYS, V423, P6, DOI 10.1016/j.abb.2003.10.009; Tufarelli V, 2016, ENVIRON SCI POLLUT R, V23, P6197, DOI 10.1007/s11356-015-5852-1; Vossen E, 2011, J ANIM PHYSIOL AN N, V95, P198, DOI 10.1111/j.1439-0396.2010.01041.x; Wiegand H, 2010, J ANIM PHYSIOL AN N, V94, P307, DOI 10.1111/j.1439-0396.2008.00910.x; Wojdylo A., 2007, POLISH J FOOD NUTR S, V57, P601; Zdunczyk Z, 2013, POL J VET SCI, V16, P333, DOI 10.2478/pjvs-2013-0045; Zdunczyk Z, 2013, ANN ANIM SCI, V13, P463, DOI 10.2478/aoas-2013-0039; Zielinska D, 2007, J AGR FOOD CHEM, V55, P6124, DOI 10.1021/jf071046f	75	21	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0170074	10.1371/journal.pone.0170074	http://dx.doi.org/10.1371/journal.pone.0170074			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076425	Green Submitted, gold, Green Published			2022-12-26	WOS:000391857100084
J	Tonelli, C; Morelli, MJ; Sabo, A; Verrecchia, A; Rotta, L; Capra, T; Bianchi, S; Campaner, S; Amati, B				Tonelli, C.; Morelli, M. J.; Sabo, A.; Verrecchia, A.; Rotta, L.; Capra, T.; Bianchi, S.; Campaner, S.; Amati, B.			Genome-wide analysis of p53-regulated transcription in Myc-driven lymphomas	ONCOGENE			English	Article							DNA-DAMAGE RESPONSE; TUMOR SUPPRESSION; P53 RESTORATION; GENE; CHEMORESISTANCE; PATHWAY; BINDING; MECHANISMS; ALIGNMENT	The tumour suppressor p53 is a transcription factor that controls cellular stress responses. Here, we dissected the transcriptional programmes triggered upon restoration of p53 in Myc-driven lymphomas, based on the integrated analysis of p53 genomic occupancy and gene regulation. p53 binding sites were identified at promoters and enhancers, both characterized by the preexistence of active chromatin marks. Only a small fraction of these sites showed the 20 base-pair p53 consensus motif, suggesting that p53 recruitment to genomic DNA was primarily mediated through protein-protein interactions in a chromatin context. p53 also targeted distal sites devoid of activation marks, at which binding was prevalently driven by sequence recognition. In all instances, the relevant motif was the canonical unsplit consensus element, with no clear evidence for p53 recruitment by split motifs. At promoters, p53 binding to the consensus motif was associated with gene induction, but not repression, indicating that the latter was most likely indirect. Altogether, our data highlight key features of genome recognition by p53 and provide unprecedented insight into the pathways associated with p53 reactivation and tumour regression, paving the way for their therapeutic application.	[Tonelli, C.; Verrecchia, A.; Rotta, L.; Capra, T.; Amati, B.] European Inst Oncol IEO, Dept Expt Oncol, Via Adamello 16, I-20139 Milan, Italy; [Morelli, M. J.; Sabo, A.; Bianchi, S.; Campaner, S.; Amati, B.] Fdn Ist Italiano Tecnol IIT, Ctr Genom Sci IIT SEMM, Milan, Italy	IRCCS European Institute of Oncology (IEO); Istituto Italiano di Tecnologia - IIT	Amati, B (corresponding author), European Inst Oncol IEO, Dept Expt Oncol, Via Adamello 16, I-20139 Milan, Italy.	bruno.amati@ieo.it	Capra, Thelma/AAN-4064-2020; Verrecchia, Alessandro/AAQ-6454-2020; Morelli, Marco/AAN-1879-2020; Rotta, Luca/AAB-9751-2019; Sabò, Arianna/J-9531-2018; Amati, Bruno/AAM-3418-2020	Verrecchia, Alessandro/0000-0002-8596-6650; Morelli, Marco/0000-0003-1862-667X; Rotta, Luca/0000-0001-6915-1120; Sabò, Arianna/0000-0002-9542-0045; CAMPANER, Stefano/0000-0003-4547-6849; Amati, Bruno/0000-0002-2958-1799; Tonelli, Claudia/0000-0002-5626-3403	European Research Council (ERC); Italian Health Ministry; Italian Association for Cancer Research (AIRC); Fondazione Cariplo	European Research Council (ERC)(European Research Council (ERC)European Commission); Italian Health Ministry(Ministry of Health, Italy); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Cariplo(Fondazione Cariplo)	This work was supported by grants from the European Research Council (ERC), the Italian Health Ministry, Fondazione Cariplo and the Italian Association for Cancer Research (AIRC) to Bruno Amati.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Broz DK, 2013, GENE DEV, V27, P1016, DOI 10.1101/gad.212282.112; Campaner S, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-6; Chang GS, 2014, CELL REP, V8, P513, DOI 10.1016/j.celrep.2014.06.030; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; FRITSCHE M, 1993, ONCOGENE, V8, P307; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; He HSHS, 2012, GENOME RES, V22, P1015, DOI 10.1101/gr.133280.111; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li MM, 2012, MOL CELL, V46, P30, DOI 10.1016/j.molcel.2012.01.020; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Macias E, 2010, CANCER CELL, V18, P231, DOI 10.1016/j.ccr.2010.08.007; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Menendez D, 2013, NUCLEIC ACIDS RES, V41, P7286, DOI 10.1093/nar/gkt504; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nikulenkov F, 2012, CELL DEATH DIFFER, V19, P1992, DOI 10.1038/cdd.2012.89; Okamura S, 2001, MOL CELL, V8, P85, DOI 10.1016/S1097-2765(01)00284-2; Renault VM, 2011, ONCOGENE, V30, P3207, DOI 10.1038/onc.2011.35; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Ringshausen I, 2006, CANCER CELL, V10, P501, DOI 10.1016/j.ccr.2006.10.010; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Sammons MA, 2015, GENOME RES, V25, P179, DOI 10.1101/gr.181883.114; Schlereth K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003726; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Schmitt CA, 2001, BLOOD CELL MOL DIS, V27, P206, DOI 10.1006/bcmd.2000.0372; Schmitt CA, 2000, NAT MED, V6, P1029, DOI 10.1038/79542; Smeenk L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017574; Su D, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004885; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tonelli C, 2015, ONCOTARGET, V6, P24611, DOI 10.18632/oncotarget.5232; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang YX, 2011, J CLIN INVEST, V121, P893, DOI 10.1172/JCI44504; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	48	10	10	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 25	2017	36	21					2921	2929		10.1038/onc.2016.443	http://dx.doi.org/10.1038/onc.2016.443			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EV7ZP	28092679	Green Published, hybrid			2022-12-26	WOS:000402000400001
J	Thai, V; Dephoure, N; Weiss, A; Ferguson, J; Leitao, R; Gygi, SP; Kellogg, DR				Thai, Vu; Dephoure, Noah; Weiss, Amit; Ferguson, Jacqueline; Leitao, Ricardo; Gygi, Steven P.; Kellogg, Douglas R.			Protein Kinase C Controls Binding of Igo/ENSA Proteins to Protein Phosphatase 2A in Budding Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SIZE CONTROL; SACCHAROMYCES-CEREVISIAE; SITE LOCALIZATION; MITOTIC ENTRY; GROWTH; MITOSIS; SECRETION; DIVISION; CYCLE; PHOSPHORYLATION	Protein phosphatase 2A (PP2A) plays important roles in controlling mitosis in all eukaryotic cells. The form of PP2A that controls mitosis is associated with a conserved regulatory subunit that is called B55 in vertebrates and Cdc55 in budding yeast. The activity of this form of PP2A can be inhibited by binding of conserved Igo/ ENSA proteins. Although the mechanisms that activate Igo/ ENSA to bind and inhibit PP2A are well understood, little is known about how Igo/ Ensa are inactivated. Here, we have analyzed regulation of Igo/ ENSA in the context of a checkpoint pathway that links mitotic entry to membrane growth in budding yeast. Protein kinase C (Pkc1) relays signals in the pathway by activating PP2A(Cdc55). We discovered that constitutively active Pkc1 can drive cells through a mitotic checkpoint arrest, which suggests that Pkc1-dependent activation of PP2A(Cdc55) plays a critical role in checkpoint signaling. We therefore used mass spectrometry to determine how Pkc1 modifies the PP2A(Cdc55) complex. This revealed that Pkc1 induces changes in the phosphorylation of multiple subunits of the complex, as well as dissociation of Igo/ ENSA. Pkc1 directly phosphorylates Cdc55 and Igo/ ENSA, and phosphorylation site mapping and mutagenesis indicate that phosphorylation of Cdc55 contributes to Igo/ ENSA dissociation. Association of Igo2 with PP2A(Cdc55) is regulated during the cell cycle, yet mutation of Pkc1-dependent phosphorylation sites on Cdc55 and Igo2 did not cause defects in mitotic progression. Together, the data suggest that Pkc1 controls PP2A(Cdc55) by multiple overlapping mechanisms.	[Thai, Vu; Weiss, Amit; Ferguson, Jacqueline; Leitao, Ricardo; Kellogg, Douglas R.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Dephoure, Noah] Weill Cornell Med Coll, Dept Biochem, New York, NY 10021 USA; [Gygi, Steven P.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA	University of California System; University of California Santa Cruz; Cornell University; Harvard University; Harvard Medical School	Kellogg, DR (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	dkellogg@ucsc.edu	Dephoure, Noah/N-7818-2014	Dephoure, Noah/0000-0001-5802-2657	University of California Cancer Research; National Institutes of Health [GM069602]; National Institutes of Health Postdoctoral Fellowship Grant [F32GM087103-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069602] Funding Source: NIH RePORTER	University of California Cancer Research(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Postdoctoral Fellowship Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the University of California Cancer Research Coordinating Committee and National Institutes of Health Grant GM069602. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Postdoctoral Fellowship Grant F32GM087103-02.	Abe M, 2003, J CELL BIOL, V162, P85, DOI 10.1083/jcb.200301022; Altman R, 1997, J CELL BIOL, V138, P119, DOI 10.1083/jcb.138.1.119; Anastasia SD, 2012, J CELL BIOL, V197, P89, DOI 10.1083/jcb.201108108; ANDERSON CW, 1973, J VIROL, V12, P241, DOI 10.1128/JVI.12.2.241-252.1973; Andrews PD, 2000, J CELL SCI, V113, P2685; Artiles K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000727; Bakalarski CE, 2008, J PROTEOME RES, V7, P4756, DOI 10.1021/pr800333e; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Bontron S, 2013, CELL REP, V3, P16, DOI 10.1016/j.celrep.2012.11.025; Chica N, 2016, CURR BIOL, V26, P319, DOI 10.1016/j.cub.2015.12.035; Drees BL, 2001, J CELL BIOL, V154, P549, DOI 10.1083/jcb.200104057; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Gentry MS, 2002, MOL BIOL CELL, V13, P3477, DOI 10.1091/mbc.02-05-0065; Gharbi-Ayachi A, 2010, SCIENCE, V330, P1673, DOI 10.1126/science.1197048; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HARTWELL LH, 1977, J CELL BIOL, V75, P422, DOI 10.1083/jcb.75.2.422; Harvey SL, 2011, MOL BIOL CELL, V22, P3595, DOI 10.1091/mbc.E11-04-0340; Hombauer H, 2007, PLOS BIOL, V5, P1355, DOI 10.1371/journal.pbio.0050155; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Juanes MA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003575; Kamada Y, 1996, J BIOL CHEM, V271, P9193, DOI 10.1074/jbc.271.16.9193; KELLOGG DR, 1995, J CELL BIOL, V130, P675, DOI 10.1083/jcb.130.3.675; LEW DJ, 1993, J CELL BIOL, V120, P1305, DOI 10.1083/jcb.120.6.1305; Li Y, 2000, MOL CELL BIOL, V20, P3843, DOI 10.1128/MCB.20.11.3843-3851.2000; LIN FC, 1995, EMBO J, V14, P2745, DOI 10.1002/j.1460-2075.1995.tb07275.x; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Minshull J, 1996, CURR BIOL, V6, P1609, DOI 10.1016/S0960-9822(02)70784-7; Mochida S, 2010, SCIENCE, V330, P1670, DOI 10.1126/science.1195689; Mortensen EM, 2002, MOL BIOL CELL, V13, P2091, DOI 10.1091/mbc.01-10-0500; Nanduri J, 2001, MOL CELL, V8, P281, DOI 10.1016/S1097-2765(01)00312-4; NOVICK P, 1979, P NATL ACAD SCI USA, V76, P1858, DOI 10.1073/pnas.76.4.1858; Pal G, 2008, J CELL BIOL, V180, P931, DOI 10.1083/jcb.200711014; Queralt E, 2008, J CELL BIOL, V182, P873, DOI 10.1083/jcb.200801054; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rossio V, 2011, J CELL BIOL, V193, P445, DOI 10.1083/jcb.201101134; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Torres EM, 2010, CELL, V143, P71, DOI 10.1016/j.cell.2010.08.038; Turner JJ, 2012, CURR BIOL, V22, pR350, DOI 10.1016/j.cub.2012.02.041; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wicky S, 2011, MOL BIOL CELL, V22, P20, DOI 10.1091/mbc.E10-06-0487; Williams BC, 2014, ELIFE, V3, DOI 10.7554/eLife.01695; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; YAMOCHI W, 1994, J CELL BIOL, V125, P1077, DOI 10.1083/jcb.125.5.1077; Yang HF, 2000, MOL CELL BIOL, V20, P8143, DOI 10.1128/MCB.20.21.8143-8156.2000; Yasutis K, 2010, MOL BIOL CELL, V21, P4373, DOI 10.1091/mbc.E10-04-0326; Zimmerman ZA, 2001, MOL BIOL CELL, V12, P201, DOI 10.1091/mbc.12.1.201	50	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4925	4941		10.1074/jbc.M116.753004	http://dx.doi.org/10.1074/jbc.M116.753004			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28100785	hybrid, Green Published			2022-12-26	WOS:000397590400015
J	Guerra, D; Chapiro, SM; Pratelli, R; Yu, S; Jia, WT; Leary, J; Pilot, G; Callis, J				Guerra, Damian; Chapiro, Sonia M.; Pratelli, Rejane; Yu, Shi; Jia, Weitao; Leary, Julie; Pilot, Guillaume; Callis, Judy			Control of Amino Acid Homeostasis by a Ubiquitin Ligase-Coactivator Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amino acid transport; E3 ubiquitin ligase; protein degradation; ubiquitin; ubiquitin ligase; ubiquitylation (ubiquitination); glutamine dumper; Loss of GDU1 2; amino acid resistance	ENDOPLASMIC-RETICULUM; GLUTAMINE; SYSTEM; DOMAIN; MONOUBIQUITINATION; TRANSFORMATION; DEGRADATION; INHIBITORS; TRANSPORT; BINDING	Intercellular amino acid transport is essential for the growth of all multicellular organisms, and its dysregulation is implicated in developmental disorders. By an unknown mechanism, amino acid efflux is stimulated in plants by overexpression of a membrane-localized protein (GLUTAMINE DUMPER 1 (GDU1)) that requires a ubiquitin ligase (LOSS OF GDU 2 (LOG2). Here we further explore the physiological consequences of the interaction between these two proteins. LOG2 ubiquitin ligase activity is necessary for GDU1-dependent tolerance to exogenous amino acids, and LOG2 self-ubiquitination was markedly stimulated by the GDU1 cytosolic domain, suggesting that GDU1 functions as an adaptor or coactivator of amino acid exporter(s). However, other consequences more typical of a ligase-substrate relationship are observed: disruption of the LOG2 gene increased the in vivo half-life of GDU1, mass spectrometry confirmed that LOG2 ubiquitinates GDU1 at cytosolic lysines, and GDU1 protein levels decreased upon co-expression with active, but not enzymatically inactive LOG2. Altogether these data indicate LOG2 negatively regulates GDU1 protein accumulation by a mechanism dependent upon cytosolic GDU1 lysines. Although GDU1-lysine substituted protein exhibited diminished in vivo ubiquitination, overexpression of GDU1 lysine mutants still conferred amino acid tolerance in a LOG2-dependent manner, consistent with GDU1 being both a substrate and facilitator of LOG2 function. From these data, we offer a model in which GDU1 activates LOG2 to stimulate amino acid export, a process that could be negatively regulated by GDU1 ubiquitination and LOG2 self-ubiquitination.	[Guerra, Damian; Chapiro, Sonia M.; Jia, Weitao; Leary, Julie; Callis, Judy] Univ Calif Davis, Dept Mol & Cellular Biol, 1 Shields Ave, Davis, CA 95616 USA; [Pratelli, Rejane; Yu, Shi; Pilot, Guillaume] Virginia Polytech Inst & State Univ, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA; [Guerra, Damian] Univ Colorado, Dept Obstet & Gynecol, Aurora, CO 80045 USA; [Chapiro, Sonia M.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Chapiro, Sonia M.] Joint Bioenergy Inst, Emeryville, CA 94608 USA; [Yu, Shi] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Jia, Weitao] Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA	University of California System; University of California Davis; Virginia Polytechnic Institute & State University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Scripps Research Institute; Roche Holding; Genentech	Callis, J (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, 1 Shields Ave, Davis, CA 95616 USA.	jcallis@ucdavis.edu	Yu, Shi/R-2287-2018	Callis, Judy/0000-0002-0622-078X; Pilot, Guillaume/0000-0001-7520-1059; Guerra, Damian/0000-0002-6621-4656; Yu, Shi/0000-0003-0735-9713	National Science Foundation [MCB-0929100, IOS-1557760, MCB-1052048]; National Institutes of Health [GM0007377l, 1S10RR023558-01]; Hatch Program of the National Institute of Food and Agriculture [VA-135908, CA-D-MCB-5554-H]; Virginia Agricultural Experiment Station; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007377] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hatch Program of the National Institute of Food and Agriculture; Virginia Agricultural Experiment Station; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation (MCB-0929100 and IOS-1557760 (to J. C.) and MCB-1052048 (to G. P.)). This work was also supported, in whole or in part, by the National Institutes of Health (Predoctoral Training Grant fellowship GM0007377l to J. Trimmer (principal investigator) (to D. G.). and Grant 1S10RR023558-01 (to J. L.)), the Hatch Program of the National Institute of Food and Agriculture (VA-135908 (to G. P.) and CA-D-MCB-5554-H (to J. C.)), and the Virginia Agricultural Experiment Station (to G. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amanso AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014591; Amemiya Y, 2008, MOL CANCER RES, V6, P1385, DOI 10.1158/1541-7786.MCR-08-0094; Batoko H, 2000, PLANT CELL, V12, P2201, DOI 10.1105/tpc.12.11.2201; BONNER CA, 1992, PHYSIOL PLANTARUM, V84, P319; Bourgeois-Daigneault MC, 2012, J IMMUNOL, V188, P4959, DOI 10.4049/jimmunol.1102708; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; Chen X, 2011, VET PATHOL, V48, P245, DOI 10.1177/0300985810385154; Chen YT, 2013, PLANT J, V75, P965, DOI 10.1111/tpj.12259; Chhangani D, 2014, BBA-MOL BASIS DIS, V1842, P1472, DOI 10.1016/j.bbadis.2014.04.014; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; de Bie P, 2011, CELL DEATH DIFFER, V18, P1393, DOI 10.1038/cdd.2011.16; Dreher KA, 2006, PLANT CELL, V18, P699, DOI 10.1105/tpc.105.039172; Guerra DD, 2013, FEBS LETT, V587, P3400, DOI 10.1016/j.febslet.2013.08.045; Guerra DD, 2012, PLANT PHYSIOL, V160, P56, DOI 10.1104/pp.112.199869; HANSEN SH, 1995, J BIOL CHEM, V270, P28425; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hommema E., 2013, 1602635 THERM FISH S; Hooper C, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-72; Hsia MM, 2010, J BIOL CHEM, V285, P37070, DOI 10.1074/jbc.M110.168021; Ihara Yasuo, 2012, Cold Spring Harb Perspect Med, V2, DOI 10.1101/cshperspect.a006361; Jacobson AD, 2009, J BIOL CHEM, V284, P35485, DOI 10.1074/jbc.M109.052928; Jia WT, 2010, J PROTEOME RES, V9, P1843, DOI 10.1021/pr901006h; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lakatos L, 2004, EMBO J, V23, P876, DOI 10.1038/sj.emboj.7600096; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; Leon S, 2009, EXP CELL RES, V315, P1574, DOI 10.1016/j.yexcr.2008.11.014; Loebke C, 2007, PROTEOMICS, V7, P558, DOI 10.1002/pmic.200600757; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Lucero P, 2000, J BACTERIOL, V182, P241, DOI 10.1128/JB.182.1.241-243.2000; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Mimnaugh Edward G., 2005, V301, P223; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; Nishikawa H, 2004, J BIOL CHEM, V279, P3916, DOI 10.1074/jbc.M308540200; NORRIS SR, 1993, PLANT MOL BIOL, V21, P895, DOI 10.1007/BF00027120; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pilot G, 2004, PLANT CELL, V16, P1827, DOI 10.1105/tpc.021642; Pratelli R, 2006, FEBS LETT, V580, P6961, DOI 10.1016/j.febslet.2006.11.064; Pratelli R, 2014, J EXP BOT, V65, P5535, DOI 10.1093/jxb/eru320; Pratelli R, 2012, PLANT PHYSIOL, V158, P1628, DOI 10.1104/pp.111.191965; Pratelli R, 2007, PLANT SIGNAL BEHAV, V2, P182, DOI 10.4161/psb.2.3.3972; Pratelli R, 2010, PLANT PHYSIOL, V152, P762, DOI 10.1104/pp.109.151746; Ramos JA, 2001, PLANT CELL, V13, P2349, DOI 10.1105/tpc.13.10.2349; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Uhrig RG, 2008, J BIOL CHEM, V283, P29650, DOI 10.1074/jbc.M806102200; Upadhyay A, 2016, MOL NEUROBIOL, V53, P4484, DOI 10.1007/s12035-015-9379-8; Verdaguer B, 1998, PLANT MOL BIOL, V37, P1055, DOI 10.1023/A:1006004819398; Weissman AM, 2011, NAT REV MOL CELL BIO, V12, P605, DOI 10.1038/nrm3173; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; WOO JT, 1992, J ANTIBIOT, V45, P1108, DOI 10.7164/antibiotics.45.1108; Yu S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00593; Zhadina M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001153	54	6	6	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3827	3840		10.1074/jbc.M116.766469	http://dx.doi.org/10.1074/jbc.M116.766469			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28100770	Green Published, hybrid			2022-12-26	WOS:000395542500024
J	Mergner, J; Kuster, B; Schwechheimer, C				Mergner, Julia; Kuster, Bernhard; Schwechheimer, Claus			DENEDDYLASE1 Protein Counters Automodification of Neddylating Enzymes to Maintain NEDD8 Protein Homeostasis in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis; Arabidopsis thaliana; deubiquitylation (deubiquitination); ubiquitin; ubiquitin-dependent protease; ubiquitylation (ubiquitination)	COP9 SIGNALOSOME; UBIQUITIN-LIGASE; DEUBIQUITINATING ENZYME; AUXIN RESPONSE; IN-VIVO; CULLIN; CONJUGATION; YEAST; SCF; SYSTEM	In eukaryotes, the conjugation of the ubiquitin-like protein NEDD8 onto protein targets is an important post-translational modification. The best understood neddylation targets are the cullins, scaffold subunits of E3 ubiquitin ligases, where neddylation as well as deneddylation, facilitated by the protease activity of the CSN (COP9 signalosome), are required to control ubiquitin ligase assembly, function, and ultimately substrate degradation. Little is known about the role of other deneddylating enzymes besides CSN and the role of neddylation and deneddylation of their substrates. We previously characterized Arabidopsis thaliana mutants with defects in the conserved NEDD8-specific protease DEN1 (DENEDDYLASE1). These mutants display only subtle growth phenotypes despite the strong accumulation of a broad range of neddylated proteins. Specifically, we identified AXR1 (AUXIN-RESISTANT1), a subunit of the heterodimeric NAE (E1 NEDD8-ACTIVATING ENZYME), as highly neddylated in den1 mutants. Here, we examined the mechanism and consequences of AXR1 neddylation in more detail. We find that AXR1 as well as other neddylation enzymes are autoneddylated at multiple lysines. NAE autoneddylation can be linked to reduced NCE (E2 NEDD8-CONJUGATING ENZYME) NEDD8 thioester levels, either by critically reducing the pool of free NEDD8 or by reducing NAE activity. In planta, increasing NEDD8 gene dosage is sufficient to suppress den1 mutant phenotypes. We therefore suggest that DEN1 serves to recover diverted NEDD8 moieties from autoneddylated NAE subunits, and possibly also other neddylated proteins, to maintain NEDD8 pathway activity toward other NEDD8-dependent processes such as cullin E3 ligase regulation.	[Mergner, Julia; Schwechheimer, Claus] Tech Univ Munich, Chair Plant Syst Biol, Emil Ramann Str 8, D-85354 Freising Weihenstephan, Germany; [Mergner, Julia; Kuster, Bernhard] Tech Univ Munich, Chair Prote & Bioanalyt, Emil Erlenmeyer Forum 5, D-85354 Freising Weihenstephan, Germany	Technical University of Munich; Technical University of Munich	Schwechheimer, C (corresponding author), Tech Univ Munich, Chair Plant Syst Biol, Emil Ramann Str 8, D-85354 Freising Weihenstephan, Germany.	claus.schwechheimer@wzw.tum.de	; Kuster, Bernhard/Q-6031-2016; Schwechheimer, Claus/Q-7907-2016	Mergner, Julia/0000-0002-4332-1280; Kuster, Bernhard/0000-0002-9094-1677; Schwechheimer, Claus/0000-0003-0269-2330	Deutsche Forschungsgemeinschaft as part of the Schwerpunktprogramm SPP1365 [SCHW751/11-1]; Deutsche Forschungsgemeinschaft as part of Sonderforschungsbereich Grant [924]; COST ACTION in the European Union [BM1307 PROTEOSTASIS]	Deutsche Forschungsgemeinschaft as part of the Schwerpunktprogramm SPP1365(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft as part of Sonderforschungsbereich Grant(German Research Foundation (DFG)); COST ACTION in the European Union	This work was supported by Deutsche Forschungsgemeinschaft Grant SCHW751/11-1 (to C. S.) as part of the Schwerpunktprogramm SPP1365 "Ubiquitin Family Proteins" and as part of Sonderforschungsbereich Grant 924 (to C. S. and B. K.). This work was also supported by the COST ACTION BM1307 PROTEOSTASIS in the European Union Framework Programme Horizon 2020. The authors declare that they have no conflicts of interest with the contents of this article.	ARNOLD JE, 1990, BIOCHEM J, V267, P751, DOI 10.1042/bj2670751; BANERJEE A, 1993, J BIOL CHEM, V268, P5668; Banka PA, 2015, J MOL BIOL, V427, P2290, DOI 10.1016/j.jmb.2015.04.011; Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Bostick M, 2004, PLANT CELL, V16, P2418, DOI 10.1105/tpc.104.024943; Chan Y, 2008, J CELL SCI, V121, P3218, DOI 10.1242/jcs.030445; Christmann M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003275; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; del Pozo JC, 2002, PLANT CELL, V14, P421, DOI 10.1105/tpc.010282; del Pozo JC, 1998, SCIENCE, V280, P1760, DOI 10.1126/science.280.5370.1760; Dharmasiri N, 2007, PLANT J, V52, P114, DOI 10.1111/j.1365-313X.2007.03211.x; Dharmasiri S, 2003, EMBO J, V22, P1762, DOI 10.1093/emboj/cdg190; Dohmann EMN, 2005, PLANT CELL, V17, P1967, DOI 10.1105/tpc.105.032870; Enchev RI, 2015, NAT REV MOL CELL BIO, V16, P30, DOI 10.1038/nrm3919; Gan-Erdene T, 2003, J BIOL CHEM, V278, P28892, DOI 10.1074/jbc.M302890200; Gusmaroli G, 2004, PLANT CELL, V16, P2984, DOI 10.1105/tpc.104.025999; Hjerpe R, 2012, J MOL BIOL, V421, P27, DOI 10.1016/j.jmb.2012.05.013; Hjerpe R, 2012, BIOCHEM J, V441, P927, DOI 10.1042/BJ20111671; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hotton SK, 2011, PLANT MOL BIOL, V75, P515, DOI 10.1007/s11103-011-9750-8; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Jones D, 2000, DEV BIOL, V226, P152, DOI 10.1006/dbio.2000.9847; Truong K, 2012, J BIOL CHEM, V287, P42611, DOI 10.1074/jbc.M112.420877; Truong K, 2012, J BIOL CHEM, V287, P15154, DOI 10.1074/jbc.M112.353789; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; LEYSER HMO, 1993, NATURE, V364, P161, DOI 10.1038/364161a0; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; Lu XL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12580; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Mendoza HM, 2003, J BIOL CHEM, V278, P25637, DOI 10.1074/jbc.M212948200; Mergner J, 2015, PLANT CELL, V27, P741, DOI 10.1105/tpc.114.135996; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; Ou CY, 2002, GENE DEV, V16, P2403, DOI 10.1101/gad.1011402; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierce NW, 2013, CELL, V153, P206, DOI 10.1016/j.cell.2013.02.024; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Schwechheimer C, 2002, PLANT CELL, V14, P2553, DOI 10.1105/tpc.003434; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; Tateishi K, 2001, J CELL BIOL, V155, P571, DOI 10.1083/jcb.200104035; Vierstra RD, 2012, PLANT PHYSIOL, V160, P2, DOI 10.1104/pp.112.200667; Vogl AM, 2015, NAT NEUROSCI, V18, P239, DOI 10.1038/nn.3912; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Willige BC, 2007, PLANT CELL, V19, P1209, DOI 10.1105/tpc.107.051441; Wu SD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2636; Zemla A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2628; Zhou LH, 2005, BIOCHEM J, V389, P307, DOI 10.1042/BJ20041991	58	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3854	3865		10.1074/jbc.M116.767103	http://dx.doi.org/10.1074/jbc.M116.767103			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28096463	Green Published, hybrid			2022-12-26	WOS:000395542500026
J	Takeuchi, T; Harada, Y; Moriyama, S; Furuta, K; Tanaka, S; Miyaji, T; Omote, H; Moriyama, Y; Hiasa, M				Takeuchi, Tomoya; Harada, Yuika; Moriyama, Satomi; Furuta, Kazuyuki; Tanaka, Satoshi; Miyaji, Takaaki; Omote, Hiroshi; Moriyama, Yoshinori; Hiasa, Miki			Vesicular Polyamine Transporter Mediates Vesicular Storage and Release of Polyamine from Mast Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						histamine; mast cell; polyamine; transporter; vesicles; secretory granules; spermine; vesicular polyamine transporter	INDUCED HISTAMINE-RELEASE; MEMBRANE-PROTEIN; NEUROTRANSMITTER TRANSPORTERS; L-GLUTAMATE; EXOCYTOSIS; SECRETION; RECEPTOR; ACTIVATION; IDENTIFICATION; CHROMATOGRAPHY	Mast cells are secretory cells that play an important role in host defense by discharging various intragranular contents, such as histamine and serotonin, upon stimulation of Fc receptors. The granules also contain spermine and spermidine, which can act as modulators of mast cell function, although the mechanism underlying vesicular storage remains unknown. Vesicular polyamine transporter (VPAT), the fourth member of the SLC18 transporter family, is an active transporter responsible for vesicular storage of spermine and spermidine in neurons. In the present study, we investigated whether VPAT functions in mast cells. RT-PCR and Western blotting indicated VPAT expression in murine bone marrow-derived mast cells (BMMCs). Immunohistochemical analysis indicated that VPAT is colocalized with VAMP3 but not with histamine, serotonin, cathepsin D, VAMP2, or VAMP7. Membrane vesicles from BMMCs accumulated spermidine upon the addition of ATP in a reserpine- and bafilomycin A(1)-sensitive manner. BMMCs secreted spermine and spermidine upon the addition of either antigen or A23187 in the presence of Ca2+, and the antigen-mediated release, which was shown to be temperature-dependent and sensitive to bafilomycin A(1) and tetanus toxin, was significantly suppressed by VPAT gene RNA interference. Under these conditions, expression of vesicular monoamine transporter 2 was unaffected, but antigen-dependent histamine release was significantly suppressed, which was recovered by the addition of 1 mm spermine. These results strongly suggest that VPAT is expressed and is responsible for vesicular storage of spermine and spermidine in novel secretory granules that differ from histamine- and serotonin-containing granules and is involved in vesicular release of these polyamines from mast cells.	[Takeuchi, Tomoya; Harada, Yuika; Moriyama, Satomi; Omote, Hiroshi; Moriyama, Yoshinori; Hiasa, Miki] Okayama Univ, Dept Membrane Biochem, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Furuta, Kazuyuki; Tanaka, Satoshi] Okayama Univ, Grad Sch Med Dent, Dept Immunobiol, Okayama 7008530, Japan; [Miyaji, Takaaki] Okayama Univ, Adv Sci Res Ctr, Okayama 7008530, Japan	Okayama University; Okayama University; Okayama University	Moriyama, Y; Hiasa, M (corresponding author), Okayama Univ, Dept Membrane Biochem, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan.	moriyama@pharm.okayama-u.ac.jp; hiasa@okayama-u.ac.jp	Tanaka, Satoshi/H-6800-2019; TANAKA, Satoshi/B-1624-2011	Tanaka, Satoshi/0000-0002-3468-7694; TANAKA, Satoshi/0000-0002-3468-7694; Miyaji, Takaaki/0000-0002-7257-7621	Japanese Ministry of Education, Culture, Sports, Science, and Technology of Japan [22790067, 25253008, 16K08230]; Uehara Memorial Foundation; Smoking Research Foundation; Takeda Science Foundation; Astellas Foundation for Research on Metabolic Disorders	Japanese Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Smoking Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Astellas Foundation for Research on Metabolic Disorders	This work was supported in part by Grants-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology of Japan 22790067 (to T. M.), 25253008 (to H. O. and Y. M.), and 16K08230 (to M. H.); by the Uehara Memorial Foundation and the Smoking Research Foundation (to T. M.); and by the Takeda Science Foundation and the Astellas Foundation for Research on Metabolic Disorders (to T. M. and M. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Anlauf M, 2004, J HISTOCHEM CYTOCHEM, V52, P779, DOI 10.1369/jhc.4A6264.2004; BUEB JL, 1991, AGENTS ACTIONS, V33, P84, DOI 10.1007/BF01993133; Galli T, 1998, MOL BIOL CELL, V9, P1437, DOI 10.1091/mbc.9.6.1437; Garcia-Faroldi G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015071; Garcia-Faroldi G, 2009, J CELL BIOCHEM, V108, P261, DOI 10.1002/jcb.22246; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Hayashi M, 2003, J BIOL CHEM, V278, P1966, DOI 10.1074/jbc.M206758200; Hiasa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep06836; INAGAKI N, 1994, LIFE SCI, V54, P1403, DOI 10.1016/0024-3205(94)00595-8; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kanerva K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006858; KUROSAWA M, 1991, ALLERGY, V46, P349, DOI 10.1111/j.1398-9995.1991.tb00597.x; LAGUNOFF D, 1983, ANNU REV PHARMACOL, V23, P331, DOI 10.1146/annurev.pa.23.040183.001555; Lorentz A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00143; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022; Medina MA, 2003, CRIT REV BIOCHEM MOL, V38, P23, DOI 10.1080/713609209; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; MORIYAMA Y, 1995, J BIOL CHEM, V270, P22314, DOI 10.1074/jbc.270.38.22314; Niemann Heiner, 1994, Trends in Cell Biology, V4, P179, DOI 10.1016/0962-8924(94)90203-8; Ogden KK, 2011, TRENDS PHARMACOL SCI, V32, P726, DOI 10.1016/j.tips.2011.08.003; Omote H, 2016, ANNU REV PHARMACOL, V56, P385, DOI 10.1146/annurev-pharmtox-010814-124816; Omote H, 2013, PHYSIOLOGY, V28, P39, DOI 10.1152/physiol.00033.2012; Omote H, 2011, BIOCHEMISTRY-US, V50, P5558, DOI 10.1021/bi200567k; Paumet F, 2000, J IMMUNOL, V164, P5850, DOI 10.4049/jimmunol.164.11.5850; PURCELL WM, 1994, BIOCHEM SOC T, V22, pS398, DOI 10.1042/bst022398s; Purcell WM, 1996, J NEUROIMMUNOL, V65, P49, DOI 10.1016/0165-5728(95)00182-4; Puri N, 2008, P NATL ACAD SCI USA, V105, P2580, DOI 10.1073/pnas.0707854105; READ GW, 1982, J PHARMACOL EXP THER, V222, P652; ROTTEM M, 1993, J IMMUNOL, V151, P4950; Sander LE, 2008, EUR J IMMUNOL, V38, P855, DOI 10.1002/eji.200737634; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SJOERDSMA A, 1957, SCIENCE, V125, P1201; SMITH MA, 1985, PLANT PHYSIOL, V78, P89, DOI 10.1104/pp.78.1.89; Tatemoto K, 2006, BIOCHEM BIOPH RES CO, V349, P1322, DOI 10.1016/j.bbrc.2006.08.177; THEOHARIDES TC, 1982, NATURE, V297, P229, DOI 10.1038/297229a0; Tiwari N, 2008, BLOOD, V111, P3665, DOI 10.1182/blood-2007-07-103309; Vliagoftis H, 1999, INT J IMMUNOPHARMACO, V21, P547, DOI 10.1016/S0192-0561(99)00031-4; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Williams K, 1997, CELL SIGNAL, V9, P1, DOI 10.1016/S0898-6568(96)00089-7; YAMATODANI A, 1985, J CHROMATOGR, V344, P115, DOI 10.1016/S0378-4347(00)82012-5	41	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3909	3918		10.1074/jbc.M116.756197	http://dx.doi.org/10.1074/jbc.M116.756197			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28082679	Green Published, hybrid			2022-12-26	WOS:000395542500031
J	Bruck, I; Dhingra, N; Kaplan, DL				Bruck, Irina; Dhingra, Nalini; Kaplan, Daniel L.			A Positive Amplification Mechanism Involving a Kinase and Replication Initiation Factor Helps Assemble the Replication Fork Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; DNA helicase; DNA replication; DNA-protein interaction; phosphorylation	EUKARYOTIC DNA-REPLICATION; SINGLE-STRANDED-DNA; CELL-CYCLE CHECKPOINT; S-PHASE PROGRESSION; BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; MCM2-7 HELICASE; PROTEIN; GINS; PHOSPHORYLATION	The assembly of the replication fork helicase during S phase is key to the initiation of DNA replication in eukaryotic cells. One step in this assembly in budding yeast is the association of Cdc45 with the Mcm2-7 heterohexameric ATPase, and a second step is the assembly of the tetrameric GINS (GG-Ichi-Nii-San) complex with Mcm2-7. Dbf4-dependent kinase (DDK) and S-phase cyclin-dependent kinase (S-CDK) are two S phase-specific kinases that phosphorylate replication proteins during S phase, and Dpb11, Sld2, Sld3, Pol E, and Mcm10 are factors that are also required for replication initiation. However, the exact roles of these initiation factors in assembly of the replication fork helicase remain unclear. We show here that Dpb11 stimulates DDK phosphorylation of the minichromosome maintenance complex protein Mcm4 alone and also of the Mcm2-7 complex and the dsDNA-loaded Mcm2-7 complex. We further demonstrate that Dpb11 can directly recruit DDK to Mcm4. A DDK phosphomimetic mutant of Mcm4 bound Dpb11 with substantially higher affinity than wild-type Mcm4, suggesting a mechanism to recruit Dpb11 to DDK-phosphorylated Mcm2-7. Furthermore, dsDNA-loaded Mcm2-7 harboring the DDK phosphomimetic Mcm4 mutant bound GINS in the presence of Dpb11, suggesting a mechanism for how GINS is recruited to Mcm2-7. We isolated a mutant of Dpb11 that is specifically defective for binding to Mcm4. This mutant, when expressed in budding yeast, diminished cell growth and DNA replication, substantially decreased Mcm4 phosphorylation, and decreased association of GINS with replication origins. We conclude that Dpb11 functions with DDK and Mcm4 in a positive amplification mechanism to trigger the assembly of the replication fork helicase.	[Bruck, Irina; Dhingra, Nalini; Kaplan, Daniel L.] Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA; [Bruck, Irina] Sloan Kettering Mem Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA	State University System of Florida; Florida State University; Memorial Sloan Kettering Cancer Center	Kaplan, DL (corresponding author), Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA.	Daniel.Kaplan@med.fsu.edu		Kaplan, Daniel/0000-0003-2760-7745; Dhingra, Nalini/0000-0003-0949-883X	NIGMS, National Institutes of Health [R15GM113167]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM113167] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant R15GM113167 (to D.L.K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; Bagowski CP, 2001, CURR BIOL, V11, P1176, DOI 10.1016/S0960-9822(01)00330-X; Boos D, 2011, CURR BIOL, V21, P1152, DOI 10.1016/j.cub.2011.05.057; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Bruck I, 2015, J BIOL CHEM, V290, P27414, DOI 10.1074/jbc.M115.688424; Bruck I, 2015, P NATL ACAD SCI USA, V112, P11223, DOI 10.1073/pnas.1509608112; Bruck I, 2015, J BIOL CHEM, V290, P1210, DOI 10.1074/jbc.M114.608232; Bruck I, 2014, J BIOL CHEM, V289, P1948, DOI 10.1074/jbc.M113.532085; Bruck I, 2013, J BIOL CHEM, V288, P7550, DOI 10.1074/jbc.M112.440941; Bruck I, 2011, J BIOL CHEM, V286, P36414, DOI 10.1074/jbc.M111.282822; Bruck I, 2011, J BIOL CHEM, V286, P18602, DOI 10.1074/jbc.M111.226332; Bruck I, 2011, J BIOL CHEM, V286, P14157, DOI 10.1074/jbc.M111.218305; Bruck I, 2009, J BIOL CHEM, V284, P28823, DOI 10.1074/jbc.M109.039123; Costa A, 2014, ELIFE, V3, DOI 10.7554/eLife.03273; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Coster G, 2014, MOL CELL, V55, P666, DOI 10.1016/j.molcel.2014.06.034; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Deegan TD, 2016, EMBO J, V35, P961, DOI 10.15252/embj.201593552; Dhingra N, 2015, J BIOL CHEM, V290, P7586, DOI 10.1074/jbc.M115.640383; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Homesley L, 2000, GENE DEV, V14, P913; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Kamimura Y, 1998, MOL CELL BIOL, V18, P6102, DOI 10.1128/MCB.18.10.6102; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kanemaki M, 2006, EMBO J, V25, P1753, DOI 10.1038/sj.emboj.7601063; Kanter DM, 2011, NUCLEIC ACIDS RES, V39, P2580, DOI 10.1093/nar/gkq1222; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Lee JK, 2003, P NATL ACAD SCI USA, V100, P2334, DOI 10.1073/pnas.0237384100; Lindsey-Boltz LA, 2011, J BIOL CHEM, V286, P19229, DOI 10.1074/jbc.M111.237958; Mantiero D, 2011, EMBO J, V30, P4805, DOI 10.1038/emboj.2011.404; Masumoto H, 2000, MOL CELL BIOL, V20, P2809, DOI 10.1128/MCB.20.8.2809-2817.2000; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; Navadgi-Patil VM, 2008, J BIOL CHEM, V283, P35853, DOI 10.1074/jbc.M807435200; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Perez-Arnaiz P, 2016, NUCLEIC ACIDS RES, V44, P315, DOI 10.1093/nar/gkv1260; Ramer MD, 2013, J BIOL CHEM, V288, P14926, DOI 10.1074/jbc.M112.392910; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sun JC, 2015, NAT STRUCT MOL BIOL, V22, P976, DOI 10.1038/nsmb.3113; Sun JC, 2014, GENE DEV, V28, P2291, DOI 10.1101/gad.242313.114; Tak YS, 2006, EMBO J, V25, P1987, DOI 10.1038/sj.emboj.7601075; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; Tanaka S, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-16; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tanaka S, 2013, MOL CELL BIOL, V33, P2614, DOI 10.1128/MCB.00431-13; Tognetti S, 2015, CHROMOSOMA, V124, P13, DOI 10.1007/s00412-014-0489-2; van Deursen F, 2012, EMBO J, V31, P2195, DOI 10.1038/emboj.2012.69; Yardimci H, 2010, MOL CELL, V40, P834, DOI 10.1016/j.molcel.2010.11.027; Yeeles JTP, 2015, NATURE, V519, P431, DOI 10.1038/nature14285; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	54	4	4	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3062	3073		10.1074/jbc.M116.772368	http://dx.doi.org/10.1074/jbc.M116.772368			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28082681	hybrid, Green Published			2022-12-26	WOS:000395538800001
J	Mildner, S; Roces, F				Mildner, Stephanie; Roces, Flavio			Plasticity of Daily Behavioral Rhythms in Foragers and Nurses of the Ant Camponotus rufipes: Influence of Social Context and Feeding Times	PLOS ONE			English	Article							LEPTOTHORAX-ALLARDYCEI HYMENOPTERA; CIRCADIAN-RHYTHMS; LOCOMOTOR-ACTIVITY; HONEY-BEES; THERMAL SENSITIVITY; INDIVIDUAL WORKERS; ACTIVITY CYCLES; HARVESTER ANTS; FOREST ANT; TEMPERATURE	Daily activities within an ant colony need precise temporal organization, and an endogenous clock appears to be essential for such timing processes. A clock drives locomotor rhythms in isolated workers in a number of ant species, but its involvement in activities displayed in the social context is unknown. We compared locomotor rhythms in isolated individuals and behavioral rhythms in the social context of workers of the ant Camponotus rufipes. Both forager and nurse workers exhibited circadian rhythms in locomotor activity under constant conditions, indicating the involvement of an endogenous clock. Activity was mostly nocturnal and synchronized with the 12: 12h light-dark-cycle. To evaluate whether rhythmicity was maintained in the social context and could be synchronized with non-photic zeitgebers such as feeding times, daily behavioral activities of single workers inside and outside the nest were quantified continuously over 24 hours in 1656 hours of video recordings. Food availability was limited to a short time window either at day or at night, thus mimicking natural conditions of temporally restricted food access. Most foragers showed circadian foraging behavior synchronized with food availability, either at day or nighttime. When isolated thereafter in single locomotor activity monitors, foragers mainly displayed arrhythmicity. Here, high mortality suggested potential stressful effects of the former restriction of food availability. In contrast, nurse workers showed high overall activity levels in the social context and performed their tasks all around the clock with no circadian pattern, likely to meet the needs of the brood. In isolation, the same individuals exhibited in turn strong rhythmic activity and nocturnality. Thus, endogenous activity rhythms were inhibited in the social context, and timing of daily behaviors was flexibly adapted to cope with task demands. As a similar socially-mediated plasticity in circadian rhythms was already shown in honey bees, the temporal organization in C. rufipes and honey bees appear to share similar basic features.	[Mildner, Stephanie; Roces, Flavio] Univ Wurzburg, Bioctr, Dept Behav Biol & Sociobiol Zool 2, Wurzburg, Germany	University of Wurzburg	Mildner, S (corresponding author), Univ Wurzburg, Bioctr, Dept Behav Biol & Sociobiol Zool 2, Wurzburg, Germany.	steffi.mildner@uni-wuerzburg.de		Roces, Flavio/0000-0001-9258-3079	German Research Foundation (DFG) [SFB 1047, C1]; University of Wurzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wurzburg	The study was funded by the German Research Foundation (DFG), SFB 1047 "Insect Timing", Project C1 to FR. This publication was funded by the German Research Foundation (DFG) and the University of Wurzburg in the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azcarate FM, 2007, J INSECT BEHAV, V20, P315, DOI 10.1007/s10905-007-9074-3; Barbieri RF, 2015, AUSTRAL ECOL, V40, P90, DOI 10.1111/aec.12176; Beer K, 2016, J COMP PHYSIOL A, V202, P555, DOI 10.1007/s00359-016-1103-2; BERTON F, 1992, SOCIOBIOLOGY, V20, P301; Bestelmeyer BT, 2000, J ANIM ECOL, V69, P998, DOI 10.1046/j.1365-2656.2000.00455.x; Bloch G, 2010, J BIOL RHYTHM, V25, P307, DOI 10.1177/0748730410380149; Bluthgen N, 2004, OIKOS, V106, P344, DOI 10.1111/j.0030-1299.2004.12687.x; Boi S, 1999, P ROY SOC B-BIOL SCI, V266, P371, DOI 10.1098/rspb.1999.0647; Brling, 1929, Z VERGL PHYSIOL, V9, P259; Cammaerts MC, 2004, BIOLOGIA, V59, P243; CASSILL DL, 1995, ANIM BEHAV, V50, P801, DOI 10.1016/0003-3472(95)80140-5; Charbonneau D, 2015, INSECT SOC, V62, P31, DOI 10.1007/s00040-014-0370-6; Charbonneau D, 2015, BEHAV ECOL SOCIOBIOL, V69, P1459, DOI 10.1007/s00265-015-1958-1; Chiu JC., 2010, JOVE-J VIS EXP, V43, pE2157; Chong KF, 2009, SOCIOBIOLOGY, V54, P531; COLE BJ, 1986, BEHAV ECOL SOCIOBIOL, V18, P165, DOI 10.1007/BF00290820; Cole BJ, 1996, AM NAT, V148, P1, DOI 10.1086/285908; Cole BJ, 1996, J INSECT BEHAV, V9, P539, DOI 10.1007/BF02213878; COLE BJ, 1991, AM NAT, V137, P244, DOI 10.1086/285156; Crailsheim K, 1996, APIDOLOGIE, V27, P235, DOI 10.1051/apido:19960406; Cros S, 1997, ECOSCIENCE, V4, P269, DOI 10.1080/11956860.1997.11682405; Dattilo W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099838; Del-Claro K, 1999, BIOTROPICA, V31, P135, DOI 10.2307/2663967; Fagundes M, 2005, ECOL ENTOMOL, V30, P28, DOI 10.1111/j.0307-6946.2005.00668.x; Falibene A, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00073; Fourcassie VI, 1999, TEMPORAL INFORM SOCI; FRANKS NR, 1990, B MATH BIOL, V52, P597, DOI 10.1016/S0092-8240(05)80368-4; FRISCH B, 1987, PHYSIOL ENTOMOL, V12, P41, DOI 10.1111/j.1365-3032.1987.tb00722.x; Fuchikawa T, 2014, BEHAV ECOL SOCIOBIOL, V68, P1843, DOI 10.1007/s00265-014-1793-9; Giannoni-Guzman MA, 2014, J EXP BIOL, V217, P1307, DOI 10.1242/jeb.096180; GORDON DM, 1989, ANIM BEHAV, V38, P194, DOI 10.1016/S0003-3472(89)80082-X; GRABENSBERGER WILHELM, 1933, ZEITSCHR WISS BIOL ABT C ZEITSCHR VERGLEICH PHYSIOL, V20, P1, DOI 10.1007/BF00340753; HARRISON JM, 1987, PHYSIOL ENTOMOL, V12, P317, DOI 10.1111/j.1365-3032.1987.tb00756.x; HATCHER MJ, 1992, NATURWISSENSCHAFTEN, V79, P32, DOI 10.1007/BF01132279; Heil M, 2000, FUNCT ECOL, V14, P749, DOI 10.1046/j.1365-2435.2000.00480.x; Herbers J.M., 1983, Psyche (Cambridge), V90, P361, DOI 10.1155/1983/52489; HERBERS JM, 1983, ANIM BEHAV, V31, P759, DOI 10.1016/S0003-3472(83)80233-4; Holldobler B., 1990, pi; Ingram KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045715; Ingram Krista K., 2009, BMC Ecology, V9, P7, DOI 10.1186/1472-6785-9-7; JAFFE K, 1984, Acta Cientifica Venezolana, V35, P270; Kaschef AH, 1963, Z MORPH OKOL TIERE; Koh K, 2006, P NATL ACAD SCI USA, V103, P13843, DOI 10.1073/pnas.0605903103; Koto A, 2015, BEHAV ECOL SOCIOBIOL, V69, P583, DOI 10.1007/s00265-014-1869-6; Lessard JP, 2009, INSECT SOC, V56, P149, DOI 10.1007/s00040-009-0006-4; LINDAUER M, 1952, Z VERGL PHYSIOL, V34, P299, DOI 10.1007/BF00298048; Lone SR, 2011, CHRONOBIOL INT, V28, P862, DOI 10.3109/07420528.2011.622676; Luo WY, 2012, AGING CELL, V11, P428, DOI 10.1111/j.1474-9726.2012.00800.x; MCCLUSKEY ES, 1965, SCIENCE, V150, P1037, DOI 10.1126/science.150.3699.1037; Mersch DP, 2013, SCIENCE, V340, P1090, DOI 10.1126/science.1234316; Moore D, 2001, J INSECT PHYSIOL, V47, P843, DOI 10.1016/S0022-1910(01)00057-9; Moore D, 1998, BEHAV ECOL SOCIOBIOL, V43, P147, DOI 10.1007/s002650050476; NORTH RD, 1987, PHYSIOL ENTOMOL, V12, P445, DOI 10.1111/j.1365-3032.1987.tb00771.x; Oliveira Paulo S., 1995, Entomologist's Monthly Magazine, V131, P77; Soares PAO, 2008, SOCIOBIOLOGY, V51, P705; ORR AG, 1994, J NAT HIST, V28, P861, DOI 10.1080/00222939400770461; PASSERA L, 1994, ETHOL ECOL EVOL, V6, P13, DOI 10.1080/08927014.1994.9523004; RETANA J, 1988, ACTA OECOL-OEC GEN, V9, P101; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; ROCES F, 1995, J COMP PHYSIOL A, V177, P637, DOI 10.1007/BF00207192; Roces F, 1996, PHYSIOL ENTOMOL, V21, P138, DOI 10.1111/j.1365-3032.1996.tb00846.x; ROCES F, 1989, OECOLOGIA, V81, P33, DOI 10.1007/BF00377006; ROCES F, 1995, J INSECT PHYSIOL, V41, P659, DOI 10.1016/0022-1910(95)00019-Q; Rosengren R., 1977, ACTA ZOOL FENN, V149, P1; SCHATZ B, 1994, ANIM BEHAV, V48, P236, DOI 10.1006/anbe.1994.1232; Schatz B, 1999, J EXP BIOL, V202, P1897; Schilman PE, 2003, ANIM BEHAV, V66, P687, DOI 10.1006/anbe.2003.2242; Schlichting M, 2015, METHOD ENZYMOL, V552, P105, DOI 10.1016/bs.mie.2014.10.017; Schmid B, 2011, J BIOL RHYTHM, V26, P464, DOI 10.1177/0748730411414264; Sharma VK, 2004, NATURWISSENSCHAFTEN, V91, P386, DOI 10.1007/s00114-004-0544-6; Sharma VK, 2004, CHRONOBIOL INT, V21, P297, DOI 10.1081/CBI-120037817; Shemesh Y, 2007, FASEB J, V21, P2304, DOI 10.1096/fj.06-8032com; Shemesh Y, 2010, J NEUROSCI, V30, P12517, DOI 10.1523/JNEUROSCI.1490-10.2010; SOUTHWICK EE, 1987, PHYSIOL ENTOMOL, V12, P209, DOI 10.1111/j.1365-3032.1987.tb00743.x; Vienne C, 1998, ETHOLOGY, V104, P431, DOI 10.1111/j.1439-0310.1998.tb00081.x; Wahl O., 1932, Zeitschrift fuer Vergleichende Physiologie Berlin, V16, P529; Weidenmuller A, 2009, CURR BIOL, V19, P1897, DOI 10.1016/j.cub.2009.08.059	77	15	16	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0169244	10.1371/journal.pone.0169244	http://dx.doi.org/10.1371/journal.pone.0169244			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099496	Green Submitted, gold, Green Published			2022-12-26	WOS:000392380100016
J	Rees, CA; Flick, RJ; Sullivan, D; Bvumbwe, M; Mhango, J; Hosseinipour, MC; Kazembe, PN				Rees, Chris A.; Flick, Robert J.; Sullivan, David; Bvumbwe, Menard; Mhango, Joseph; Hosseinipour, Mina C.; Kazembe, Peter N.			An Analysis of the Last Clinical Encounter before Outpatient Mortality among Children with HIV Infection and Exposure in Lilongwe, Malawi	PLOS ONE			English	Article							RECEIVING ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; SUB-SAHARAN AFRICA; CARE; TUBERCULOSIS; MALNUTRITION; PNEUMONIA; DIAGNOSIS; QUALITY; RISK	Background Human immunodeficiency virus (HIV) contributes to nearly 20% of all deaths in children under five years of age in Malawi. Expanded coverage of antiretroviral therapy has allowed children to access treatment on an outpatient basis. Little is known about characteristics of the final outpatient encounter prior to mortality in the outpatient setting. Methods This retrospective cohort study assessed clinical factors associated with mortality among HIV-exposed infants and HIV-infected children less than 18 years of age at the Baylor College of Medicine Abbott Fund Children's Center of Excellence in Lilongwe, Malawi. We compared clinical indicators documented from the final outpatient encounter for patients who died in the outpatient setting versus those who were alive after their penultimate clinical encounter. Results Of the 8,546 patients who were attended to over a 10-year period at the Baylor Center of Excellence, 851 had died (10%). Of children who died, 392 (46%) were directly admitted to the hospital after their last clinical encounter and died as inpatients. Of the remaining 459 who died as outpatients after their last visit, 53.5% had a World Health Organization (WHO) stage IV condition at their last visit, and 25% had a WHO stage III condition. Multivariate regression analysis demonstrated that poor nutritional status, female gender, shorter time as a patient, more clinical encounters in the prior month, if last visit was an unscheduled sick visit, and if the patient had lost weight since their prior visit independently predicted increased mortality in the outpatient setting after the final clinical encounter. Conclusion Clinical indicators may assist in identifying children with HIV who have increased risk of mortality in the outpatient setting. Recognizing these indicators may aid in identifying HIV-infected children who require a higher level of care or closer follow-up.	[Rees, Chris A.; Flick, Robert J.; Sullivan, David; Bvumbwe, Menard; Mhango, Joseph; Kazembe, Peter N.] Childrens Fdn Malawi, Baylor Coll Med, Lilongwe, Malawi; [Rees, Chris A.] Baylor Coll Med, Houston, TX 77030 USA; [Flick, Robert J.; Hosseinipour, Mina C.] Univ Colorado, Sch Med, Denver, CO USA; [Flick, Robert J.] Univ North Carolina Project Malawi, Lilongwe, Malawi; [Kazembe, Peter N.] Texas Childrens Hosp, Baylor Int Pediat AIDS Initiat, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Baylor College of Medicine	Rees, CA (corresponding author), Childrens Fdn Malawi, Baylor Coll Med, Lilongwe, Malawi.; Rees, CA (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.	chris.rees@bcm.edu		Rees, Chris/0000-0001-6449-0377; Flick, Robert/0000-0002-8155-6398				Amthor RE, 2009, J AM DIET ASSOC, V109, P464, DOI 10.1016/j.jada.2008.11.028; Bell F, 2007, T ROY SOC TROP MED H, V101, P511, DOI 10.1016/j.trstmh.2006.10.004; Bjornstad E, 2014, PAEDIATR INT CHILD H, V34, P29, DOI 10.1179/2046905513Y.0000000070; Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Brophy JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165772; Buck WC, 2013, INT J TUBERC LUNG D, V17, P1389, DOI 10.5588/ijtld.13.0030; Burkey MD, 2014, JAIDS-J ACQ IMM DEF, V66, P41, DOI 10.1097/QAI.0000000000000094; Chinkhumba J, 2008, T ROY SOC TROP MED H, V102, P639, DOI 10.1016/j.trstmh.2008.04.028; Cox JA, 2010, AIDS REV, V12, P183; Fergusson P, 2009, ARCH DIS CHILD, V94, P512, DOI 10.1136/adc.2008.142646; Fetzer BC, 2009, TROP MED INT HEALTH, V14, P862, DOI 10.1111/j.1365-3156.2009.02315.x; Government of Malawi Ministry of Health, 2006, GUID MAN SEV AC MALN; Gupta RK, 2015, AIDS, V29, P1987, DOI 10.1097/QAD.0000000000000802; Kerac M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096030; Kline MW, 2006, PEDIATRICS, V117, P1388, DOI 10.1542/peds.2005-1348; LaCourse SM, 2015, J TROP PEDIATRICS, V61, P44, DOI 10.1093/tropej/fmu065; LaCourse SM, 2014, PEDIATR INFECT DIS J, V33, P1200, DOI 10.1097/INF.0000000000000384; Leyenaar JK, 2010, PEDIATR INFECT DIS J, V29, P340, DOI 10.1097/INF.0b013e3181bf8ecb; Ministry of Health Malawi, 2014, CLIN MAN HIV CHILDR; Molyneux E, 2006, B WORLD HEALTH ORGAN, V84, P314, DOI 10.2471/BLT.04.019505; Olson D, 2013, TROP MED INT HEALTH, V18, P879, DOI 10.1111/tmi.12114; Preidis GA, 2013, JAIDS-J ACQ IMM DEF, V63, pE16, DOI 10.1097/QAI.0b013e318288aad6; Preidis GA, 2011, J PEDIATR-US, V159, P484, DOI 10.1016/j.jpeds.2011.02.033; Rees CA, 2016, PEDIATR BLOOD CANCER, V63, P1325, DOI 10.1002/pbc.26021; Robison JA, 2012, PEDIATRICS, V130, pE676, DOI 10.1542/peds.2012-0026; UNICEF, 2013, MAL STAT; Wamalwa D, 2012, PEDIATR INFECT DIS J, V31, P729, DOI 10.1097/INF.0b013e3182587796; WHO, 2014, NEON CHILD HLTH PROF; WHO, 2013, GUID UPD MAN SEV AC; World Health Organization, 2011, GLOB HIV AIDS RESP P; World Health Organization (WHO), 2015, WHO GLOB TB REP	31	7	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0169057	10.1371/journal.pone.0169057	http://dx.doi.org/10.1371/journal.pone.0169057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099432	Green Published, gold, Green Submitted			2022-12-26	WOS:000392380100014
J	Sabri, B; McFall, AM; Solomon, SS; Srikrishnan, AK; Vasudevan, CK; Anand, S; Celentano, DD; Mehta, SH; Kumar, S; Lucas, GM				Sabri, Bushra; McFall, Allison M.; Solomon, Sunil S.; Srikrishnan, Aylur K.; Vasudevan, Canjeevaram K.; Anand, Santhanam; Celentano, David D.; Mehta, Shruti H.; Kumar, Suresh; Lucas, Gregory M.			Gender Differences in Factors Related to HIV Risk Behaviors among People Who Inject Drugs in North-East India	PLOS ONE			English	Article							USERS; DEPRESSION; PREVALENCE; WOMEN; EXPLORATION; NETWORKS; STIGMA; IMPACT; DELHI; MEN	People who inject drugs (PWID) in India are at high risk for HIV, with women being at elevated risk. Using a socio-ecological framework, this study assessed whether factors associated with HIV transmission risk behaviors differed across men and women PWID. Data for this cross-sectional study were collected from 6449 PWID in 7 cities in Northeast India. Men (n = 5653) and women (n = 796) PWID were recruited using respondent-driven sampling (RDS). We assessed sex differences in two recent HIV transmission risk behaviors: multiple sex partners and needle/syringe sharing. We used multi-level logistic regression models, which incorporated sampling weights and random intercepts for city, to assess factors associated with these HIV risks, separately among men and women. The prevalence of HIV was significantly higher among women than men (53% vs 18.4%, p<0.01). Nearly 13% of men and 8% of women (p = .30) had multiple partners. Employment in men and relationship status and stigma in women were significantly associated with multiple partners. Approximately 25% of men and 19% of women engaged in needle sharing (p = .16). Younger age in women and depression symptoms in men were significantly associated with increased risk for sharing needles. We found that sexual and drug related risk behaviors were common among PWID in Northeast India, and there were differences between men and women in the socio-ecologic correlates of these behaviors. Contextually-integrated and gender-specific HIV prevention and intervention efforts are needed that consider factors at individual, interpersonal- and community-levels that uniquely impact HIV risks among PWID.	[Sabri, Bushra] Johns Hopkins Univ, Sch Nursing, Dept Community & Publ Hlth Nursing, Baltimore, MD 21218 USA; [McFall, Allison M.; Celentano, David D.; Mehta, Shruti H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Solomon, Sunil S.; Lucas, Gregory M.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Solomon, Sunil S.; Srikrishnan, Aylur K.; Vasudevan, Canjeevaram K.; Anand, Santhanam; Kumar, Suresh] YR Gaitonde Ctr AIDS Res & Educ, Madras, Tamil Nadu, India	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Sabri, B (corresponding author), Johns Hopkins Univ, Sch Nursing, Dept Community & Publ Hlth Nursing, Baltimore, MD 21218 USA.	bsabri1@jhu.edu	Solomon, Sunil Suhas/P-6907-2019; Sabri, Bushra/P-1366-2018	Sabri, Bushra/0000-0002-3258-523X; McFall, Allison/0000-0002-1157-2931	National Institute on Drug Abuse [R01 DA032059, R01 DA041034, K24 DA035684]; Eunice Kennedy Shriver National Institute for Child Health & Human Development [K99HD082350]; Johns Hopkins University Center for AIDS Research [P30 AI094189]; Elton John AIDS Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K99HD082350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189, T32AI102623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA032059, K24DA035684, R01DA041034] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Eunice Kennedy Shriver National Institute for Child Health & Human Development; Johns Hopkins University Center for AIDS Research; Elton John AIDS Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute on Drug Abuse (R01 DA032059, R01 DA041034, and K24 DA035684), Eunice Kennedy Shriver National Institute for Child Health & Human Development (K99HD082350), by the Johns Hopkins University Center for AIDS Research (P30 AI094189), and by the Elton John AIDS Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceijas C, 2006, SEX TRANSM INFECT, V82, pIII10, DOI 10.1136/sti.2005.019471; Ahern J, 2007, DRUG ALCOHOL DEPEN, V88, P188, DOI 10.1016/j.drugalcdep.2006.10.014; Armstrong G, 2014, HARM REDUCT J, V11, DOI 10.1186/1477-7517-11-27; Armstrong G, 2013, JAIDS-J ACQ IMM DEF, V64, P502, DOI 10.1097/QAI.0b013e3182a7ef21; Armstrong G, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S9; Baldwin Patrick, 2013, ISRN AIDS, V2013, P976035, DOI 10.1155/2013/976035; Baral S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-482; Beck A. T, 1976, DEPRESSION CLIN EXPT; Booth RE, 2007, JAIDS-J ACQ IMM DEF, V46, P112; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066x.32.7.513; Bronfenbrenner U., 1994, INT ENCY ED, V3, P37; Burack JH, 1998, EPIDEMIOLOGY HIV TRA; Burns PA, 2012, HEALTH PLACE, V18, P1088, DOI 10.1016/j.healthplace.2012.04.013; Campbell JC, 2013, AM J REPROD IMMUNOL, V69, P41, DOI 10.1111/aji.12026; Centers for Disease Control and Prevention, HIV YOUTH 2015; Chakrapani V, 2010, AIDS PATIENT CARE ST, V24, P49, DOI 10.1089/apc.2009.0214; Cooperman NA, 2014, HEALTH CARE WOMEN IN, V35, P1133, DOI 10.1080/07399332.2013.770004; Erausquin JT, 2008, HIV KNOWLEDGE BEHAV; Goswami P, 2014, INT J DRUG POLICY, V25, P853, DOI 10.1016/j.drugpo.2014.04.016; Heise L L, 1998, Violence Against Women, V4, P262, DOI 10.1177/1077801298004003002; Kennedy SH, 2009, J CLIN PSYCHOPHARM, V29, P157, DOI 10.1097/JCP.0b013e31819c76e9; Kermode M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-825; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Larios SE, 2009, AIDS CARE, V21, P1335, DOI 10.1080/09540120902803190; Latkin C, 2010, DRUG ALCOHOL DEPEN, V110, P221, DOI 10.1016/j.drugalcdep.2010.03.004; Latkin CA, 2013, INT J DRUG POLICY, V24, P135, DOI 10.1016/j.drugpo.2012.07.007; Lucas GM, 2016, AIDS, V30, P619, DOI [10.1097/QAD.0000000000000949, 10.1097/QAD.0000000000000592]; Magnus M, 2013, J URBAN HEALTH, V90, P157, DOI 10.1007/s11524-012-9687-5; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Ministry of Health and Social Welfare, 2012, 2012 SERV STAT REP F; National Institute of Medical Statistics and National Aids Control Organisation, 2010, IND HIV EST 2010; Sarna A, 2007, SEXUAL BEHAV SEXUAL; Semple SJ, 2012, DRUG ALCOHOL DEPEN, V125, P154, DOI 10.1016/j.drugalcdep.2012.04.007; Solomon SS, 2008, JAIDS-J ACQ IMM DEF, V49, P327, DOI 10.1097/QAI.0b013e3181831e85; Steward WT, 2008, SOC SCI MED, V67, P1225, DOI 10.1016/j.socscimed.2008.05.032; Tun W, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-16; UNAIDS, 2003, UNAIDS EP UPD; Wagner KD, 2010, PSYCHOL HEALTH MED, V15, P560, DOI 10.1080/13548506.2010.498890; White RG, 2015, J CLIN EPIDEMIOL, V68, P1463, DOI 10.1016/j.jclinepi.2015.04.002; Wohlfeiler D, 2005, SEX TRANSM DIS, V32, pS48, DOI 10.1097/01.olq.0000175394.81945.68	40	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0169482	10.1371/journal.pone.0169482	http://dx.doi.org/10.1371/journal.pone.0169482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI3HH	28099458	gold, Green Published, Green Submitted			2022-12-26	WOS:000392380100025
J	Early, AM; Shanmugarajah, N; Buchon, N; Clark, AG				Early, Angela M.; Shanmugarajah, Niroshan; Buchon, Nicolas; Clark, Andrew G.			Drosophila Genotype Influences Commensal Bacterial Levels	PLOS ONE			English	Article							MICROBIOME INFLUENCES; IMMUNE HOMEOSTASIS; NATURAL VARIATION; DIGESTIVE-TRACT; GUT MICROBIOTA; DUAL OXIDASE; MELANOGASTER; INFECTION; ASSOCIATION; DYSBIOSIS	Host genotype can influence the composition of the commensal bacterial community in some organisms. Composition, however, is only one parameter describing a microbial community. Here, we test whether a second parameter-abundance of bacteria-is a heritable trait by quantifying the presence of four commensal bacterial strains within 36 gnotobiotic inbred lines of Drosophila melanogaster. We find that D. melanogaster genotype exerts a significant effect on microbial levels within the fly. When introduced as monocultures into axenic flies, three of the four bacterial strains were reliably detected within the fly. The amounts of these different strains are strongly correlated, suggesting that the host regulates commensal bacteria through general, not bacteria-specific, means. While the correlation does not appear to be driven by simple variation in overall gut dimensions, a genetic association study suggests that variation in commensal bacterial load may largely be attributed to physical aspects of host cell growth and development.	[Early, Angela M.; Clark, Andrew G.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA; [Early, Angela M.; Shanmugarajah, Niroshan; Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA; [Buchon, Nicolas] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Early, Angela M.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Cornell University; Cornell University; Cornell University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Early, AM (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA.; Early, AM (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.; Early, AM (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	ame54@cornell.edu	Buchon, Nicolas/AAE-9323-2019	Buchon, Nicolas/0000-0003-3636-8387; Clark, Andrew/0000-0001-7159-8511; Early, Angela/0000-0002-3169-2324	National Institutes of Health [R01 AI064950]; National Science Foundation [1354421]; Empire State Stem Cell Fund through the New York State Department of Health NYSTEM contract [C029542]; National Science Foundation Graduate Research Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064950] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Empire State Stem Cell Fund through the New York State Department of Health NYSTEM contract; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant R01 AI064950 to AGC, National Science Foundation grant 1354421 and Empire State Stem Cell Fund through the New York State Department of Health NYSTEM contract C029542 to NB, and a National Science Foundation Graduate Research Fellowship to AME. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Blum JE, 2013, MBIO, V4, DOI 10.1128/mBio.00860-13; Bonfini A, 2016, DEV COMP IMMUNOL, V64, P22, DOI 10.1016/j.dci.2016.02.008; Broderick NA, 2014, MBIO, V5, DOI 10.1128/mBio.01117-14; Broderick NA, 2012, GUT MICROBES, V3, P307, DOI 10.4161/gmic.19896; Brummel T, 2004, P NATL ACAD SCI USA, V101, P12974, DOI 10.1073/pnas.0405207101; Buchon N, 2013, NAT REV MICROBIOL, V11, P615, DOI 10.1038/nrmicro3074; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Chaston JM, 2016, APPL ENVIRON MICROB, V82, P671, DOI 10.1128/AEM.03301-15; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Clark RI, 2015, CELL REP, V12, P1656, DOI 10.1016/j.celrep.2015.08.004; Cognigni P, 2011, CELL METAB, V13, P92, DOI 10.1016/j.cmet.2010.12.010; Coluccio AE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002873; Corby-Harris V, 2007, APPL ENVIRON MICROB, V73, P3470, DOI 10.1128/AEM.02120-06; Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dutta D, 2015, CELL REP, V12, P346, DOI 10.1016/j.celrep.2015.06.009; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Foster JA, 2013, TRENDS NEUROSCI, V36, P305, DOI 10.1016/j.tins.2013.01.005; Garlapow ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138129; Gay C, 2000, ANAL BIOCHEM, V284, P217, DOI 10.1006/abio.2000.4696; Glittenberg MT, 2011, DIS MODEL MECH, V4, P515, DOI 10.1242/dmm.006627; Gregory SL, 2007, FLY, V1, P13, DOI 10.4161/fly.3806; Guo LL, 2014, CELL, V156, P109, DOI 10.1016/j.cell.2013.12.018; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; Ha EM, 2009, DEV CELL, V16, P386, DOI 10.1016/j.devcel.2008.12.015; Hergarden AC, 2012, P NATL ACAD SCI USA, V109, P3967, DOI 10.1073/pnas.1200778109; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kinross JM, 2011, GENOME MED, V3, DOI 10.1186/gm228; Kuraishi T, 2011, P NATL ACAD SCI USA, V108, P15966, DOI 10.1073/pnas.1105994108; Lazzaro BP, 2004, SCIENCE, V303, P1873, DOI 10.1126/science.1092447; Lee WJ, 2013, ANNU REV CELL DEV BI, V29, P571, DOI 10.1146/annurev-cellbio-101512-122333; Lemaitre B, 2013, ANNU REV GENET, V47, P377, DOI 10.1146/annurev-genet-111212-133343; Li HJ, 2016, CELL HOST MICROBE, V19, P240, DOI 10.1016/j.chom.2016.01.008; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Morozova TV, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2064-5; Newell PD, 2014, APPL ENVIRON MICROB, V80, P788, DOI 10.1128/AEM.02742-13; Overend G, 2016, SCI REP-UK, V6, DOI 10.1038/srep27242; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Ryu JH, 2006, EMBO J, V25, P3693, DOI 10.1038/sj.emboj.7601233; Ryu JH, 2010, DEV COMP IMMUNOL, V34, P369, DOI 10.1016/j.dci.2009.11.010; Sachs JL, 2011, TRENDS ECOL EVOL, V26, P202, DOI 10.1016/j.tree.2011.01.010; Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Sleiman MSB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8829; Staubach F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070749; Stofanko M, 2008, GENETICS, V180, P253, DOI 10.1534/genetics.108.089094; Storelli G, 2011, CELL METAB, V14, P403, DOI 10.1016/j.cmet.2011.07.012; Unckless RL, 2015, G3-GENES GENOM GENET, V5, P417, DOI 10.1534/g3.114.016477; Weber AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034745; Weiss B, 2011, TRENDS PARASITOL, V27, P514, DOI 10.1016/j.pt.2011.05.001; Wong ACN, 2013, ISME J, V7, P1922, DOI 10.1038/ismej.2013.86; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324; Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x	62	20	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0170332	10.1371/journal.pone.0170332	http://dx.doi.org/10.1371/journal.pone.0170332			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095502	Green Published, Green Submitted, gold			2022-12-26	WOS:000392372300079
J	Guerin, GR; Sparrow, B; Tokmakoff, A; Smyth, A; Leitch, E; Baruch, Z; Lowe, AJ				Guerin, Greg R.; Sparrow, Ben; Tokmakoff, Andrew; Smyth, Anita; Leitch, Emrys; Baruch, Zdravko; Lowe, Andrew J.			Opportunities for Integrated Ecological Analysis across Inland Australia with Standardised Data from Ausplots Rangelands	PLOS ONE			English	Article							SPECIES-ABUNDANCE DISTRIBUTIONS; COMMUNITY EVENNESS; CLIMATE; BIODIVERSITY; VEGETATION; SHAPE	Australian rangelands ecosystems cover 81% of the continent but are understudied and continental-scale research has been limited in part by a lack of precise data that are standardised between jurisdictions. We present a new dataset from AusPlots Rangelands that enables integrative rangelands analysis due to its geographic scope and standardised methodology. The method provides data on vegetation and soils, enabling comparison of a suite of metrics including fractional vegetation cover, basal area, and species richness, diversity, and composition. Cover estimates are robust and repeatable, allowing comparisons among environments and detection of modest change. The 442 field plots presented here span a rainfall gradient of 129-1437 mm Mean annual precipitation with varying seasonality. Vegetation measurements include vouchered vascular plant species, growth form, basal area, height, cover and substrate type from 1010 point intercepts as well as systematically recorded absences, which are useful for predictive modelling and validation of remote sensing applications. Leaf and soil samples are sampled for downstream chemical and genomic analysis. We overview the sampling of vegetation parameters and environments, applying the data to the question of how species abundance distributions (SADs) vary over climatic gradients, a key question for the influence of environmental change on ecosystem processes. We found linear relationships between SAD shape and rainfall within grassland and shrubland communities, indicating more uneven abundance in deserts and suggesting relative abundance may shift as a consequence of climate change, resulting in altered diversity and ecosystem function. The standardised data of AusPlots enables such analyses at large spatial scales, and the testing of predictions through time with longitudinal sampling. In future, the AusPlots field program will be directed towards improving coverage of space, under-represented environments, vegetation types and fauna and, increasingly, re-sampling of established plots. Providing up-to-date data access methods to enhance re-use is also a priority.	[Guerin, Greg R.; Sparrow, Ben; Tokmakoff, Andrew; Smyth, Anita; Leitch, Emrys; Baruch, Zdravko; Lowe, Andrew J.] Univ Adelaide, Sch Biol Sci, Terr Ecosyst Res Network, Adelaide Node, North Terrace, Adelaide, SA, Australia	University of Adelaide	Guerin, GR (corresponding author), Univ Adelaide, Sch Biol Sci, Terr Ecosyst Res Network, Adelaide Node, North Terrace, Adelaide, SA, Australia.	greg.guerin@adelaide.edu.au	Sparrow, Ben/O-9308-2016; Guerin, Greg R./R-8955-2019	Sparrow, Ben/0000-0003-2566-1895; Lowe, Andrew/0000-0003-1139-2516; Guerin, Greg/0000-0002-2104-6695	Australian Government; Terrestrial Ecosystem Research Network, a facility of the National Collaborative Research Infrastructure Strategy - Australian Government	Australian Government(Australian GovernmentCGIAR); Terrestrial Ecosystem Research Network, a facility of the National Collaborative Research Infrastructure Strategy - Australian Government	This work was funded by the Terrestrial Ecosystem Research Network, a facility of the National Collaborative Research Infrastructure Strategy funded by the Australian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Terrestrial Ecosystem Research Network, a facility of the National Collaborative Research Infrastructure Strategy funded by the Australian Government.	Armstrong G, 2011, AUSTRAL ECOL, V36, P849, DOI 10.1111/j.1442-9993.2010.02228.x; Bastin G., 2008, RANGELANDS 2008 TAKI; Bastin GN, 2009, RANGELAND J, V31, P111, DOI 10.1071/RJ08072; Conway J., 2016, RPOSTGRESQL R INTERF; Department of the Environment, 2012, AUSTR PRES MAJ VEG G; Eyre TJ, 2011, RANGELAND J, V33, P239, DOI 10.1071/RJ10071; Gallant J, CSIRO DATA COLLECTIO; Garnett Stephen T., 2010, P191; Gill A. Malcolm, 2009, P113, DOI 10.1007/978-3-540-77381-8_5; Guerin G. R., 2016, AUSPLOTS RANGELANDS; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ., 2015, PACKAGE RASTER R PAC; Holmes J. H., 1997, Rangeland Journal, V19, P3, DOI 10.1071/RJ9970003; Holmgren M, 2006, FRONT ECOL ENVIRON, V4, P87, DOI 10.1890/1540-9295(2006)004[0087:ECESAA]2.0.CO;2; HUBBELL SP, 1979, SCIENCE, V203, P1299, DOI 10.1126/science.203.4387.1299; Kardol P, 2010, GLOBAL CHANGE BIOL, V16, P2676, DOI 10.1111/j.1365-2486.2010.02162.x; Landsberg J, 2003, J APPL ECOL, V40, P1008, DOI 10.1111/j.1365-2664.2003.00862.x; Magurran AE, 2003, NATURE, V422, P714, DOI 10.1038/nature01547; Matthews T.J., 2014, FRONT BIOGEOGR, V6, P67, DOI [DOI 10.21425/F56220607, 10.21425/F56220607]; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; Meissner RA, 1999, J ARID ENVIRON, V42, P117, DOI 10.1006/jare.1999.0515; Morton SR, 2011, J ARID ENVIRON, V75, P313, DOI 10.1016/j.jaridenv.2010.11.001; Morton SR, 2009, AUSTRAL ECOL, V34, P1, DOI 10.1111/j.1442-9993.2008.01938.x; Oksanen J, 2022, R PACKAGE VERSION; Orians GH, 2007, BIOL REV, V82, P393, DOI 10.1111/j.1469-185X.2007.00017.x; Paul KI, 2016, GLOBAL CHANGE BIOL, V22, P2106, DOI 10.1111/gcb.13201; Prado P., 2016, SADS MAXIMUM LIKELIH; R Core Team, 2013, R LANG ENV STAT COMP; Sparrow B, 2014, BIODIVERSITY ENV CHA, P51; STAFFORD SMITH DM, 1990, J ARID ENVIRON, V18, P255, DOI 10.1016/S0140-1963(18)30837-1; TERN AusPlots, 2013, AUSPLOTS RANG VERS 1; Thompson GG, 2003, AUSTRAL ECOL, V28, P355, DOI 10.1046/j.1442-9993.2003.01294.x; Tokmakoff A, 2016, FUTURE GENER COMP SY, V56, P537, DOI 10.1016/j.future.2015.08.016; Ulrich W, 2016, J VEG SCI, V27, P295, DOI 10.1111/jvs.12346; Ulrich W, 2010, OIKOS, V119, P1149, DOI 10.1111/j.1600-0706.2009.18236.x; Venables WN., 2002, MODERN APPL STAT S 4; Viscarra Rossel R, CSIRO DATA COLLECTIO; Wardle GM, 2013, AUSTRAL ECOL, V38, P731, DOI 10.1111/aec.12073; White A., 2012, AUSPLOTS RANGELANDS; WHITTAKER RH, 1956, ECOL MONOGR, V26, P1, DOI 10.2307/1943577; WILLETT JB, 1988, AM STAT, V42, P236, DOI 10.2307/2685031; Williams RJ, 1996, J BIOGEOGR, V23, P747, DOI 10.1111/j.1365-2699.1996.tb00036.x; Williamson M, 2005, J ANIM ECOL, V74, P409, DOI 10.1111/j.1365-2656.2005.00936.x; Wilsey BJ, 2000, ECOLOGY, V81, P887, DOI 10.1890/0012-9658(2000)081[0887:BAEFIO]2.0.CO;2; Wilsey BJ, 2002, ECOL LETT, V5, P676, DOI 10.1046/j.1461-0248.2002.00372.x; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840; Wood SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137811	47	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0170137	10.1371/journal.pone.0170137	http://dx.doi.org/10.1371/journal.pone.0170137			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095496	Green Published, gold, Green Submitted			2022-12-26	WOS:000392372300059
J	Kong, HK; Law, HW; Liu, X; Law, COK; Pan, Q; Gao, L; Xiong, LF; Lau, SKP; Woo, PCY; Lau, TCK				Kong, Hoi-Kuan; Law, Hon-Wai; Liu, Xuan; Law, Carmen O. K.; Pan, Qing; Gao, Lin; Xiong, Lifeng; Lau, Susanna K. P.; Woo, Patrick C. Y.; Lau, Terrence Chi Kong			Transcriptomic Analysis of Laribacter hongkongensis Reveals Adaptive Response Coupled with Temperature	PLOS ONE			English	Article							UNIVERSAL STRESS-PROTEIN; GENOME-WIDE ANALYSIS; ARGININE DEIMINASE PATHWAY; BURROWS-WHEELER TRANSFORM; GRAM-NEGATIVE BACTERIA; FRESH-WATER FISH; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; MOLECULAR CHARACTERIZATION; ANTIMICROBIAL RESISTANCE	Bacterial adaptation to different hosts requires transcriptomic alteration in response to the environmental conditions. Laribacter hongkongensis is a gram-negative, facultative anaerobic, urease-positive bacillus caused infections in liver cirrhosis patients and community-acquired gastroenteritis. It was also found in intestine from commonly consumed freshwater fishes and drinking water reservoirs. Since L. hongkongensis could survive as either fish or human pathogens, their survival mechanisms in two different habitats should be temperature-regulated and highly complex. Therefore, we performed transcriptomic analysis of L. hongkongensis at body temperatures of fish and human in order to elucidate the versatile adaptation mechanisms coupled with the temperatures. We identified numerous novel temperature-induced pathways involved in host pathogenesis, in addition to the shift of metabolic equilibriums and overexpression of stress-related proteins. Moreover, these pathways form a network that can be activated at a particular temperature, and change the physiology of the bacteria to adapt to the environments. In summary, the dynamic of transcriptomes in L. hongkongensis provides versatile strategies for the bacterial survival at different habitats and this alteration prepares the bacterium for the challenge of host immunity.	[Kong, Hoi-Kuan; Law, Hon-Wai; Liu, Xuan; Law, Carmen O. K.; Pan, Qing; Gao, Lin; Lau, Terrence Chi Kong] City Univ Hong Kong, Dept Biomed Sci, Kowloon, Hong Kong, Peoples R China; [Xiong, Lifeng; Lau, Susanna K. P.; Woo, Patrick C. Y.] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Xiong, Lifeng; Lau, Susanna K. P.; Woo, Patrick C. Y.] Univ Hong Kong, Carol Yu Ctr Infect, Hong Kong, Hong Kong, Peoples R China	City University of Hong Kong; University of Hong Kong; University of Hong Kong	Lau, TCK (corresponding author), City Univ Hong Kong, Dept Biomed Sci, Kowloon, Hong Kong, Peoples R China.	chiklau@cityu.edu.hk	Pan, Qing/O-1168-2015; Lau, Terrence/ABB-7900-2021; Woo, Patrick Chiu Yat/AAJ-6112-2020; Lau, Susanna Kar Pui/AAJ-6848-2020; Liu, Xuan/ABB-5772-2020	Pan, Qing/0000-0002-4372-5349; Lau, Terrence/0000-0002-7505-7306; Woo, Patrick Chiu Yat/0000-0001-9401-1832; Lau, Susanna Kar Pui/0000-0002-1383-7374; 	ECS [CityU 189813]; HMRF [13121502]; Strategic Research Theme Fund; Croucher Senior Medical Research Fellowships; Strategic Research Theme Fund, The University of Hong Kong	ECS; HMRF; Strategic Research Theme Fund; Croucher Senior Medical Research Fellowships; Strategic Research Theme Fund, The University of Hong Kong	This study was supported by ECS (CityU 189813) and HMRF (13121502), to Terrence C. K. Lau, and Strategic Research Theme Fund and Croucher Senior Medical Research Fellowships, to Susanna K. P. Lau and Patrick C. Y. Woo.; This work is supported by ECS (CityU 189813) and HMRF (13121502), and is partly supported by the Strategic Research Theme Fund, The University of Hong Kong and Croucher Senior Medical Research Fellowships.	Adebusuyi Abigail A F JM, 2011, BMC MICROBIOLOGY, V11; Aguado-Urda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079692; Aguilar PS, 2001, EMBO J, V20, P1681, DOI 10.1093/emboj/20.7.1681; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Bajaj JS, 2012, AM J GASTROENTEROL S, V1, P9, DOI DOI 10.1038/ajgsup.2012.3; Basile AS, 1997, HEPATOLOGY, V25, P1303, DOI 10.1002/hep.510250636; Benitez-Nelson CR, 2000, EARTH-SCI REV, V51, P109, DOI 10.1016/S0012-8252(00)00018-0; Braun V, 2001, INT J MED MICROBIOL, V291, P67, DOI 10.1078/1438-4221-00103; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Cotter PAC V, 1990, J BACTERIOLOGY, V172; Crepin S, 2011, VET MICROBIOL, V153, P82, DOI 10.1016/j.vetmic.2011.05.043; Croucher NJ, 2010, CURR OPIN MICROBIOL, V13, P619, DOI 10.1016/j.mib.2010.09.009; Curreem SO, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-16; Denich TJ, 2003, J MICROBIOL METH, V52, P149, DOI 10.1016/S0167-7012(02)00155-0; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; Feng JL, 2012, FOOD MICROBIOL, V32, P118, DOI 10.1016/j.fm.2012.04.018; Fonseca P, 2011, ENV MICROBIOL REP, V3, P329, DOI 10.1111/j.1758-2229.2010.00229.x; Fraud S, 2008, ANTIMICROB AGENTS CH, V52, P4478, DOI 10.1128/AAC.01072-08; Ganz T, 2015, NAT REV IMMUNOL, V15, P500, DOI 10.1038/nri3863; Guijarro JA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00700; Hebraud Michel, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P211; Hengge R, 2009, RES MICROBIOL, V160, P667, DOI 10.1016/j.resmic.2009.08.014; Kaiser JC, 2015, INFECT IMMUN, V83, P1019, DOI 10.1128/IAI.02542-14; Kim DS, 2011, J KOREAN MED SCI, V26, P679, DOI 10.3346/jkms.2011.26.5.679; Kim SK, 2012, LETT APPL MICROBIOL, V54, P306, DOI 10.1111/j.1472-765X.2012.03209.x; Krell T, 2010, ANNU REV MICROBIOL, V64, P539, DOI 10.1146/annurev.micro.112408.134054; Krewulak KD, 2008, BBA-BIOMEMBRANES, V1778, P1781, DOI 10.1016/j.bbamem.2007.07.026; Kvint K, 2003, CURR OPIN MICROBIOL, V6, P140, DOI 10.1016/S1369-5274(03)00025-0; Lamarche MG, 2008, J BACTERIOL, V190, P5256, DOI 10.1128/JB.01536-07; Lau SKP, 2008, J ANTIMICROB CHEMOTH, V61, P488, DOI 10.1093/jac/dkm539; Lau SKP, 2007, INT J FOOD MICROBIOL, V113, P62, DOI 10.1016/j.ijfoodmicro.2006.07.017; Lau SKP, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-28; Lau SKP, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-22; Lau SKP, 2009, J ANTIMICROB CHEMOTH, V63, P704, DOI 10.1093/jac/dkp010; Lau SKP, 2009, INT J FOOD MICROBIOL, V129, P78, DOI 10.1016/j.ijfoodmicro.2008.10.021; Li H, 2012, BIOINFORMATICS, V28, P1838, DOI 10.1093/bioinformatics/bts280; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093289; Llanes C, 2004, ANTIMICROB AGENTS CH, V48, P1797, DOI 10.1128/AAC.48.5.1797-1802.2004; MA D, 1995, MOL MICROBIOL, V16, P45, DOI 10.1111/j.1365-2958.1995.tb02390.x; Mettert EL, 2015, ANNU REV MICROBIOL, V69, P505, DOI 10.1146/annurev-micro-091014-104457; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Minoru K, 2000, NUCLEIC ACIDS RES, V28, P27, DOI DOI 10.1093/nar/28.1.27; MOBLEY HLT, 1989, MICROBIOL REV, V53, P85, DOI 10.1128/MMBR.53.1.85-108.1989; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Nystrom T, 1996, J BACTERIOL, V178, P927, DOI 10.1128/jb.178.3.927-930.1996; NYSTROM T, 1994, MOL MICROBIOL, V11, P537, DOI 10.1111/j.1365-2958.1994.tb00334.x; O'Toole R, 2003, RES MICROBIOL, V154, P387, DOI 10.1016/S0923-2508(03)00081-0; Pal C, 2005, NAT GENET, V37, P1372, DOI 10.1038/ng1686; Poole K, 2004, CLIN MICROBIOL INFEC, V10, P12, DOI 10.1111/j.1469-0691.2004.00763.x; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Spaniol V, 2015, ANTIMICROB AGENTS CH, V59, P1886, DOI 10.1128/AAC.03727-14; Steele KH, 2012, J BACTERIOL, V194, P6162, DOI 10.1128/JB.01465-12; Stickland HG, 2010, J PROTEOME RES, V9, P2957, DOI 10.1021/pr9011415; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Teng JLL, 2005, J CLIN MICROBIOL, V43, P919, DOI 10.1128/JCM.43.2.919-922.2005; Thorvaldsdottir H, 2012, BRIEF BIOINFORM; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang F, 2009, J BACTERIOL, V191, P2574, DOI 10.1128/JB.00498-08; Woo PCY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000416; Woo PCY, 2005, CURR OPIN INFECT DIS, V18, P413, DOI 10.1097/01.qco.0000180162.76648.c9; Woo PCY, 2004, LANCET, V363, P1941, DOI 10.1016/S0140-6736(04)16407-6; Wurtzel O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002945; Xie J, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.73; Xiong LF, 2015, ENVIRON MICROBIOL, V17, P4469, DOI 10.1111/1462-2920.12897; Xiong LF, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-42; Yamanaka Kunitoshi, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P193; Yuen KY, 2001, J CLIN MICROBIOL, V39, P4227, DOI 10.1128/JCM.39.12.4227-4232.2001	71	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0169998	10.1371/journal.pone.0169998	http://dx.doi.org/10.1371/journal.pone.0169998			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085929	Green Submitted, Green Published, gold			2022-12-26	WOS:000391972600052
J	Lai, HH; Lai, YJ; Yen, YF				Lai, Hsin-Hao; Lai, Yun-Ju; Yen, Yung-Feng			Association of Body Mass Index with Timing of Death during Tuberculosis Treatment	PLOS ONE			English	Article							IN-HOSPITAL DEATHS; PULMONARY TUBERCULOSIS; RISK-FACTORS; MORTALITY; ADULTS; MALNUTRITION; PREDICTORS	Background The association between body mass index and mortality in patients with tuberculosis has not been extensively studied, and the existing evidence is inconsistent. This study aimed to investigate the impact of body mass index on timing of death in patients with tuberculosis. Methods All Taiwanese adults with tuberculosis in Taipei, Taiwan, were included in a retrospective cohort study in 2011-2012. Multinomial logistic regression was used to evaluate the association between body mass index and timing of death in patients with tuberculosis. Results Among 1557 eligible patients, 84.1% (1310), 8.2% (128), and 7.6% (119) underwent successful treatment, early death, and late death, respectively. The mean age of the patients with tuberculosis was 64.2 years old, and 67.7% were male. After controlling for potential confounding variables, underweight with body mass index less than 18.5 kg/m(2) was significantly associated with elevated risk of all-cause mortality [Adjusted odds ratio (AOR), 1.64; 95% confidence interval (CI), 1.17-2.30]. Considering timing of death, underweight with body mass index less than 18.5 was significantly associated only with elevated risk of early mortality within the first 8 weeks of treatment onset (AOR, 2.22; 95% CI, 1.45-3.40) Conclusions For patients with tuberculosis infection, underweight with body mass index less than 18.5 kg/m(2) is an independent predictor for early mortality within the first 8 weeks of treatment.	[Lai, Hsin-Hao; Yen, Yung-Feng] Taipei City Hosp, Taipei City Govt, Infect Dis Sect, Taipei, Taiwan; [Lai, Yun-Ju] Taichung Vet Gen Hosp, Div Endocrinol & Metab, Dept Internal Med, Puli Branch, Nantou, Taiwan; [Lai, Yun-Ju; Yen, Yung-Feng] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan	Taipei City Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University	Yen, YF (corresponding author), Taipei City Hosp, Taipei City Govt, Infect Dis Sect, Taipei, Taiwan.; Yen, YF (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.	dam37@tpech.gov.tw	Lai, Yun-Ju/AAX-4990-2020					Bhargava A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077979; ELLIOTT AM, 1995, T ROY SOC TROP MED H, V89, P78, DOI 10.1016/0035-9203(95)90668-1; Fagundez G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161995; Glaziou P, 2015, CSH PERSPECT MED, V5, DOI [10.1101/cshperspect.a017798, 10.1055/s-0038-1651492]; Gustafson P, 2007, INFECTION, V35, P69, DOI 10.1007/s15010-007-6090-3; Hanrahan CF, 2010, AIDS, V24, P1501, DOI 10.1097/QAD.0b013e32833a2a4a; Kliiman K, 2010, INT J TUBERC LUNG D, V14, P454; Kwon YS, 2014, J KOREAN MED SCI, V29, P1226, DOI 10.3346/jkms.2014.29.9.1226; LEE PR, 1995, PUBLIC HEALTH REP, V110, P302; Lu SH, 2009, INT J TUBERC LUNG D, V13, P1493; Matos ED, 2006, INT J TUBERC LUNG D, V10, P1360; Mfinanga SG, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-158; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Nguyen LT, 2011, INT J TUBERC LUNG D, V15, P257; Sacks LV, 1998, ARCH INTERN MED, V158, P1916, DOI 10.1001/archinte.158.17.1916; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; Schaible UE, 2007, PLOS MED, V4, P806, DOI 10.1371/journal.pmed.0040115; Van Lettow M, 2004, INT J TUBERC LUNG D, V8, P211; Waitt CJ, 2011, INT J TUBERC LUNG D, V15, P871, DOI 10.5588/ijtld.10.0352; Wang FD, 2006, INFECT CONT HOSP EP, V27, P510, DOI 10.1086/503639; Wang JY, 2007, INT J TUBERC LUNG D, V11, P143; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; World Health Organization, 1995, PHYS STAT US INT ANT; Yang SL, 2013, TUBERCULOSIS CONTROL; Yen YF, 2013, INT J TUBERC LUNG D, V17, P1310, DOI [10.5588/ijtld.12.0888, 10.5588/ijtid.12.0888]; Yen YF, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002300; Zachariah R, 2002, T ROY SOC TROP MED H, V96, P291, DOI 10.1016/S0035-9203(02)90103-3; Zahar JR, 2001, INTENS CARE MED, V27, P513, DOI 10.1007/s001340000849	28	21	21	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0170104	10.1371/journal.pone.0170104	http://dx.doi.org/10.1371/journal.pone.0170104			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085951	Green Published, gold, Green Submitted			2022-12-26	WOS:000391972600061
J	Kim, YK; Na, KI; Jeoung, JW; Park, KH				Kim, Young Kook; Na, Kyeong Ik; Jeoung, Jin Wook; Park, Ki Ho			Intraocular Pressure-Lowering Effect of Latanoprost Is Hampered by Defective Cervical Lymphatic Drainage	PLOS ONE			English	Article							MANIFEST GLAUCOMA TRIAL; AQUEOUS-HUMOR OUTFLOW; CAPILLARY-PRESSURE; CANCER METASTASIS; PROSTAGLANDIN-F2-ALPHA; EYE; LYMPHEDEMA; CONTRACTILITY; CONSEQUENCE; PROGRESSION	Purpose To evaluate whether defects in cervical lymphatic drainage influence the intraocular pressure (IOP)-lowering effect of latanoprost in patients with primary open-angle glaucoma (POAG) who have undergone unilateral radical neck dissection (uRND). Methods We enrolled (1) bilateral POAG patients who had started (bilateral) latanoprost (0.005%) monotherapy prior to their uRND and (2) treatment-naive, bilateral glaucoma suspects (GSs) who had undergone the same surgery. We compared the eyes ipsilateral to the uRND with their fellow eyes in terms of the changes in IOP between the baseline (prior to the uRND) and the follow-up visits (1, 3, and 6 months after the uRND). Results The study involved 22 eyes of 11 POAG patients and 14 eyes of 7 GSs. In the POAG patients, IOP had increased significantly after surgery in the eyes ipsilateral to the uRND (from 14.7 +/- 1.4mmHg to 17.1 +/- 2.2mmHg; P = 0.007). Interestingly, in the eyes contralateral to the uRND, IOP had not changed significantly after surgery (from 14.2 +/- 1.8mmHg to 14.4 +/- 2.0mmHg; P = 0.826). In GSs, the eyes ipsilateral to the uRND did not differ significantly from their fellow eyes in terms of post-operative IOP change (ipsilateral value: 0.3 +/- 0.5 mmHg, fellow eyes: -0.1 +/- 0.7mmHg; P = 0.242). Conclusion In the POAG patients, IOP had increased significantly in the eyes ipsilateral to the uRND. However, it had not changed significantly in the eyes contralateral to the surgery or in the eyes of the GSs. These findings suggest that, latanoprost works, at least in part, by enhancing outflow from the aqueous humor via the uveolymphatic pathway.	[Kim, Young Kook; Na, Kyeong Ik; Jeoung, Jin Wook; Park, Ki Ho] Seoul Natl Univ Hosp, Dept Ophthalmol, Seoul, South Korea; [Kim, Young Kook; Jeoung, Jin Wook; Park, Ki Ho] Seoul Natl Univ, Dept Ophthalmol, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Park, KH (corresponding author), Seoul Natl Univ Hosp, Dept Ophthalmol, Seoul, South Korea.; Park, KH (corresponding author), Seoul Natl Univ, Dept Ophthalmol, Coll Med, Seoul, South Korea.	kihopark@snu.ac.kr		Na, Kyeong Ik/0000-0002-0951-9162; Kim, Young Kook/0000-0002-6037-8449				Alm A, 1995, OPHTHALMOLOGY, V102, P1743, DOI 10.1016/S0161-6420(95)30798-1; Amann-Vesti BR, 2003, J VASC RES, V40, P77, DOI 10.1159/000068942; BRADBURY MWB, 1980, J PHYSIOL-LONDON, V299, P353, DOI 10.1113/jphysiol.1980.sp013129; Camras CB, 1996, OPHTHALMOLOGY, V103, P138, DOI 10.1016/S0161-6420(96)30749-5; CASLEYSMITH JR, 1978, J PATHOL, V124, P13, DOI 10.1002/path.1711240104; CRAWFORD K, 1987, ARCH OPHTHALMOL-CHIC, V105, P1112, DOI 10.1001/archopht.1987.01060080114039; Cross JM, 2008, BRIT J OPHTHALMOL, V92, P1503, DOI 10.1136/bjo.2008.147165; FOLDI M, 1968, ANGIOLOGICA, V5, P250; FOLDI M, 1967, ANGIOLOGICA, V4, P341; Franzeck UK, 1997, J VASC RES, V34, P306, DOI 10.1159/000159238; Goel M, 2010, OPEN OPHTHALMOL J, V4, P52, DOI 10.2174/1874364101004010052; Harisinghani MG, 2013, ATLAS LYMPH NODE ANA; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; HOLLO G, 1991, ACTA OPHTHALMOL, V69, P527; HOLLO G, 1993, ACTA OPHTHALMOL, V71, P415; JOHNSTON MG, 1981, NATURE, V293, P294, DOI 10.1038/293294a0; Krohn J, 2002, ACTA OPHTHALMOL SCAN, V80, P642, DOI 10.1034/j.1600-0420.2002.800616.x; KRUPIN T, 1977, AM J OPHTHALMOL, V83, P643, DOI 10.1016/0002-9394(77)90129-5; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; LUTJENDRECOLL E, 1988, EXP EYE RES, V47, P761, DOI 10.1016/0014-4835(88)90043-7; Nilsson S F, 1989, Prog Clin Biol Res, V312, P429; Ohhashi T, 2005, PHARMACOL THERAPEUT, V105, P165, DOI 10.1016/j.pharmthera.2004.10.009; OHHASHI T, 1983, CIRC RES, V53, P535, DOI 10.1161/01.RES.53.4.535; Parekh AS, 2015, CLIN EXP OPHTHALMOL, V43, P108, DOI 10.1111/ceo.12400; POYER JF, 1995, INVEST OPHTH VIS SCI, V36, P2461; Richter M, 2003, INVEST OPHTH VIS SCI, V44, P4419, DOI 10.1167/iovs.02-1281; Scherer WJ, 2002, J OCUL PHARMACOL TH, V18, P287, DOI 10.1089/108076802760116205; Shayan R, 2006, CARCINOGENESIS, V27, P1729, DOI 10.1093/carcin/bgl031; Swartz MA, 2001, MICROSC RES TECHNIQ, V55, P92, DOI 10.1002/jemt.1160; Swartz MA, 2001, ADV DRUG DELIVER REV, V50, P3, DOI 10.1016/S0169-409X(01)00150-8; Swartz MA, 2008, SEMIN IMMUNOL, V20, P147, DOI 10.1016/j.smim.2007.11.007; Tam ALC, 2013, TRANSL VIS SCI TECHN, V2, DOI 10.1167/tvst.2.5.3; Tam ALC, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/42/425101; Thieme H, 2006, INVEST OPHTH VIS SCI, V47, P938, DOI 10.1167/iovs.05-0527; UNTHANK JL, 1987, BLOOD VESSELS, V24, P31; Wiig H, 2012, PHYSIOL REV, V92, P1005, DOI 10.1152/physrev.00037.2011; Yucel Y, 2015, PROG BRAIN RES, V220, P185, DOI 10.1016/bs.pbr.2015.07.028; Yuecel YH, 2010, CAN J OPHTHALMOL, V45, P115, DOI 10.3129/i10-005; Yucel YH, 2009, EXP EYE RES, V89, P810, DOI 10.1016/j.exer.2009.08.010	39	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169683	10.1371/journal.pone.0169683	http://dx.doi.org/10.1371/journal.pone.0169683			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081184	Green Published, gold, Green Submitted			2022-12-26	WOS:000391949500063
J	Adams, KW; Kletsov, S; Lamm, RJ; Elman, JS; Mullenbrock, S; Cooper, GM				Adams, Kenneth W.; Kletsov, Sergey; Lamm, Ryan J.; Elman, Jessica S.; Mullenbrock, Steven; Cooper, Geoffrey M.			Role for Egr1 in the Transcriptional Program Associated with Neuronal Differentiation of PC12 Cells	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; ZINC-FINGER PROTEIN; TUMOR GENE-PRODUCT; TISSUE FACTOR GENE; MAP KINASE KINASE; FACTOR-A-CHAIN; NGFI-A; TRYPTOPHAN-HYDROXYLASE; PHEOCHROMOCYTOMA CELLS; ENDOTHELIAL-CELLS	PC12 cells are a well-established model to study how differences in signal transduction duration can elicit distinct cell behaviors. Epidermal growth factor (EGF) activates transient ERK signaling in PC12 cells that lasts 30-60 min, which in turn promotes proliferation; nerve growth factor (NGF) activates more sustained ERK signaling that lasts 4-6 h, which in turns induces neuronal differentiation. Data presented here extend a previous study by Mullen-brock et al. (2011) that demonstrated that sustained ERK signaling in response to NGF induces preferential expression of a 69-member gene set compared to transient ERK signaling in response to EGF and that the transcription factors AP-1 and CREB play a major role in the preferential expression of several genes within the set. Here, we examined whether the Egr family of transcription factors also contributes to the preferential expression of the gene set in response to NGF. Our data demonstrate that NGF causes transient induction of all Egr family member transcripts, but a corresponding induction of protein was detected for only Egr1 and 2. Chromatin immunoprecipitation experiments provided clearest evidence that, after induction, Egr1 binds 12 of the 69 genes that are preferentially expressed during sustained ERK signaling. In addition, Egr1 expression and binding upstream of its target genes were both sustained in response to NGF versus EGF within the same timeframe that its targets are preferentially expressed. These data thus provide evidence that Egr1 contributes to the transcriptional program activated by sustained ERK signaling in response to NGF, specifically by contributing to the preferential expression of its target genes identified here.	[Adams, Kenneth W.; Kletsov, Sergey] Bridgewater State Univ, Dept Biol Sci, Bridgewater, MA 02324 USA; [Lamm, Ryan J.; Elman, Jessica S.; Mullenbrock, Steven; Cooper, Geoffrey M.] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA; [Lamm, Ryan J.] SUNY Stony Brook, Sch Med, Stony Brook, NY USA; [Elman, Jessica S.] Tufts Univ, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA; [Mullenbrock, Steven] Cell Signaling Technol, Danvers, MA USA	Massachusetts System of Public Higher Education; Bridgewater State College; Boston University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Tufts University	Adams, KW (corresponding author), Bridgewater State Univ, Dept Biol Sci, Bridgewater, MA 02324 USA.	kenneth.adams@bridgew.edu		Lamm, Ryan/0000-0002-9158-654X	National Institutes of Health [R01 CA18689]; Adrian Tinsley Program for Undergraduate Research at Brigewater State University; NATIONAL CANCER INSTITUTE [R01CA018689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Adrian Tinsley Program for Undergraduate Research at Brigewater State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The majority of funding for this program was provided by grant R01 CA18689 from the National Institutes of Health (https://grants.nih.gov/grants/oer.htm). Additional funding was provided through several undergraduate research grants provided by the Adrian Tinsley Program for Undergraduate Research at Brigewater State University (https://my.bridgew.edu/departments/OUR/SitePages/Funding%20and%20Presentation %200pportunities.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Burgold T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003034; Canettieri G, 2010, NAT CELL BIOL, V12, P132, DOI 10.1038/ncb2013; CAO XM, 1990, MOL CELL BIOL, V10, P1931, DOI 10.1128/MCB.10.5.1931; Chandra A, 2013, J BIOL CHEM, V288, P20488, DOI 10.1074/jbc.M112.447250; Cheval H, 2012, HIPPOCAMPUS, V22, P631, DOI 10.1002/hipo.20926; CHRISTY B, 1989, P NATL ACAD SCI USA, V86, P8737, DOI 10.1073/pnas.86.22.8737; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; CROSBY SD, 1991, MOL CELL BIOL, V11, P3835, DOI 10.1128/MCB.11.8.3835; Cui MZ, 1996, J BIOL CHEM, V271, P2731, DOI 10.1074/jbc.271.5.2731; DArcangelo G, 1996, MOL CELL BIOL, V16, P4621; Decker L, 2006, J NEUROSCI, V26, P9771, DOI 10.1523/JNEUROSCI.0716-06.2006; Drummond IA, 1992, SCIENCE, P257; Fang F, 2011, AM J PATHOL, V178, P2077, DOI 10.1016/j.ajpath.2011.01.035; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gallitano-Mendel A, 2007, NEUROSCIENCE, V148, P633, DOI 10.1016/j.neuroscience.2007.05.050; Gallo R, 2002, J CELL BIOL, V158, P731, DOI 10.1083/jcb.200202024; GASHLER AL, 1993, MOL CELL BIOL, V13, P4556, DOI 10.1128/MCB.13.8.4556; GASHLER AL, 1992, P NATL ACAD SCI USA, V89, P10984, DOI 10.1073/pnas.89.22.10984; Grasberger H, 2013, AM J GASTROENTEROL, V108, P1766, DOI 10.1038/ajg.2013.304; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hamilton TB, 1998, BIOCHEMISTRY-US, V37, P2051, DOI 10.1021/bi9717993; Han S, 2014, MOL CELLS, V37, P24, DOI 10.14348/molcells.2014.2206; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; HUFF K, 1981, J CELL BIOL, V88, P189, DOI 10.1083/jcb.88.1.189; James AB, 2006, J NEUROSCI, V26, P1624, DOI 10.1523/JNEUROSCI.4199-05.2006; Jang SW, 2006, J NEUROCHEM, V98, P1678, DOI 10.1111/j.1471-4159.2006.04069.x; Jang SW, 2010, J NEUROCHEM, V115, P1409, DOI 10.1111/j.1471-4159.2010.07045.x; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Jin KL, 2002, J NEUROSCI, V22, P5365; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; JOSEPH LJ, 1988, P NATL ACAD SCI USA, V85, P7164, DOI 10.1073/pnas.85.19.7164; Khachigian LM, 1997, ARTERIOSCL THROM VAS, V17, P2280, DOI 10.1161/01.ATV.17.10.2280; Klesse LJ, 1999, ONCOGENE, V18, P2055, DOI 10.1038/sj.onc.1202524; LeBlanc SE, 2006, J BIOL CHEM, V281, P5453, DOI 10.1074/jbc.M512159200; Lee CG, 2004, J EXP MED, V200, P377, DOI 10.1084/jem.20040104; Lee S, 2010, CURR OPIN NEUROBIOL, V20, P29, DOI 10.1016/j.conb.2010.01.003; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; LEMAIRE P, 1990, MOL CELL BIOL, V10, P3456, DOI 10.1128/MCB.10.7.3456; Levi A, 2004, CELL MOL NEUROBIOL, V24, P517, DOI 10.1023/B:CEMN.0000023627.79947.22; Levkovitz Y, 2001, J NEUROSCI, V21, P45, DOI 10.1523/JNEUROSCI.21-01-00045.2001; Lewis JE, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00003; Li L, 2005, MOL CELL BIOL, V25, P10286, DOI 10.1128/MCB.25.23.10286-10300.2005; Li L, 2007, MOL CELL NEUROSCI, V35, P76, DOI 10.1016/j.mcn.2007.02.004; Lonergan ME, 2010, NEURAL PLAST, V2010, P1, DOI 10.1155/2010/139891; Lonn P, 2005, NEUROCHEM RES, V30, P753, DOI 10.1007/s11064-005-6868-6; MADDEN SL, 1991, SCIENCE, V253, P1550, DOI 10.1126/science.1654597; Maddox SA, 2011, LEARN MEMORY, V18, P24, DOI 10.1101/lm.1980211; MAHESWARAN S, 1993, P NATL ACAD SCI USA, V90, P5100, DOI 10.1073/pnas.90.11.5100; Malek ZS, 2005, EUR J NEUROSCI, V22, P895, DOI 10.1111/j.1460-9568.2005.04264.x; Manzanares M, 1999, DEVELOPMENT, V126, P759; Manzanares M, 1997, NATURE, V387, P191, DOI 10.1038/387191a0; Manzanares M, 1999, DEV BIOL, V211, P220, DOI 10.1006/dbio.1999.9318; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; Mokin M, 2005, LEARN MEMORY, V12, P144, DOI 10.1101/lm.87305; Morin JP, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/184083; Mullenbrock S, 2011, J BIOL CHEM, V286, P45131, DOI 10.1074/jbc.M111.274076; Nakamura K, 2006, J NEUROSCI, V26, P530, DOI 10.1523/JNEUROSCI.1835-05.2006; Nakamura K, 2007, MOL NEUROBIOL, V35, P45, DOI 10.1007/BF02700623; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Oyagi A, 2012, CNS NEUROSCI THER, V18, P803, DOI 10.1111/j.1755-5949.2012.00371.x; Pagel JI, 2012, INT J MOL SCI, V13, P13104, DOI 10.3390/ijms131013104; Pagel JI, 2012, THROMB HAEMOSTASIS, V107, P562, DOI 10.1160/TH11-07-0490; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; PATWARDHAN S, 1991, ONCOGENE, V6, P917; Qin XK, 2015, J BIOL CHEM, V290, P29603, DOI 10.1074/jbc.M115.668889; RAUSCHER FJ, 1990, SCIENCE, V250, P1259, DOI 10.1126/science.2244209; Ravni A, 2008, MOL PHARMACOL, V73, P1688, DOI 10.1124/mol.107.044792; Roberts DS, 2006, J BIOL CHEM, V281, P29431, DOI 10.1074/jbc.C600167200; RUSSO MW, 1993, MOL CELL BIOL, V13, P6858, DOI 10.1128/MCB.13.11.6858; RUSSO MW, 1995, P NATL ACAD SCI USA, V92, P6873, DOI 10.1073/pnas.92.15.6873; Sarfstein R, 2006, J NEUROCHEM, V99, P818, DOI 10.1111/j.1471-4159.2006.04119.x; Schabbauer G, 2007, THROMB HAEMOSTASIS, V97, P988, DOI 10.1160/TH07-01-0037; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Sevetson BR, 2000, J BIOL CHEM, V275, P9749, DOI 10.1074/jbc.275.13.9749; Suehiro J, 2010, BLOOD, V115, P2520, DOI 10.1182/blood-2009-07-233478; Suto F, 2007, NEURON, V53, P535, DOI 10.1016/j.neuron.2007.01.028; Svaren J, 1996, MOL CELL BIOL, V16, P3545; SWIRNOFF AH, 1995, MOL CELL BIOL, V15, P2275; Swirnoff AH, 1998, MOL CELL BIOL, V18, P512, DOI 10.1128/MCB.18.1.512; SZEBERENYI J, 1990, MOL CELL BIOL, V10, P5324, DOI 10.1128/MCB.10.10.5324; Thiel G, 2014, MOL CELL ENDOCRINOL, V388, P10, DOI 10.1016/j.mce.2014.03.001; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Tullai JW, 2004, J BIOL CHEM, V279, P20167, DOI 10.1074/jbc.M309260200; VESQUE C, 1992, NUCLEIC ACIDS RES, V20, P2485, DOI 10.1093/nar/20.10.2485; WANG ZY, 1993, J BIOL CHEM, V268, P9172; WANG ZY, 1992, J BIOL CHEM, V267, P21999; Wei F, 2000, J CELL BIOL, V149, P1325, DOI 10.1083/jcb.149.7.1325; Williams JM, 2000, MOL BRAIN RES, V77, P258, DOI 10.1016/S0169-328X(00)00061-9; WISDEN W, 1990, NEURON, V4, P603, DOI 10.1016/0896-6273(90)90118-Y; WORLEY PF, 1991, P NATL ACAD SCI USA, V88, P5106, DOI 10.1073/pnas.88.12.5106; Yamagata K, 1994, Learn Mem, V1, P140; Zeitlinger J, 2003, CELL, V113, P395, DOI 10.1016/S0092-8674(03)00301-5; Zhuang BQ, 2009, NEURON, V61, P359, DOI 10.1016/j.neuron.2008.12.022; Zorick TS, 1996, MOL CELL NEUROSCI, V8, P129, DOI 10.1006/mcne.1996.0052	97	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0170076	10.1371/journal.pone.0170076	http://dx.doi.org/10.1371/journal.pone.0170076			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076410	gold, Green Published, Green Submitted			2022-12-26	WOS:000391857100085
J	Boe, LJ; Berthommier, F; Legou, T; Captier, G; Kemp, C; Sawallis, TR; Becker, Y; Rey, A; Fagot, J				Boe, Louis-Jean; Berthommier, Frederic; Legou, Thierry; Captier, Guillaume; Kemp, Caralyn; Sawallis, Thomas R.; Becker, Yannick; Rey, Arnaud; Fagot, Joel			Evidence of a Vocalic Proto-System in the Baboon (Papio papio) Suggests Pre-Hominin Speech Precursors	PLOS ONE			English	Article							ARTICULATORY MODEL; ACOUSTIC STRUCTURE; EVOLUTION; VOWELS; TRACT; LANGUAGE; VOCALIZATIONS; IMITATION; FORMANTS; FEATURES	Language is a distinguishing characteristic of our species, and the course of its evolution is one of the hardest problems in science. It has long been generally considered that human speech requires a low larynx, and that the high larynx of nonhuman primates should preclude their producing the vowel systems universally found in human language. Examining the vocalizations through acoustic analyses, tongue anatomy, and modeling of acoustic potential, we found that baboons (Papio papio) produce sounds sharing the F1/F2 formant structure of the human [i o a e u] vowels, and that similarly with humans those vocalic qualities are organized as a system on two acoustic-anatomic axes. This confirms that hominoids can produce contrasting vowel qualities despite a high larynx. It suggests that spoken languages evolved from ancient articulatory skills already present in our last common ancestor with Cercopithecoidea, about 25 MYA.	[Boe, Louis-Jean; Berthommier, Frederic] CNRS, GIPSA Lab, St Martin Dheres, France; [Boe, Louis-Jean; Berthommier, Frederic] Grenoble Alpes Univ, St Martin Dheres, France; [Legou, Thierry] CNRS, Speech & Language Lab, Aix En Provence, France; [Legou, Thierry] Aix Marseille Univ, Aix En Provence, France; [Kemp, Caralyn; Rey, Arnaud; Fagot, Joel] Aix Marseille Univ, Brain & Language Res Inst, Aix En Provence, France; [Captier, Guillaume] Univ Montpellier, Anat Lab, Montpellier, France; [Kemp, Caralyn; Becker, Yannick; Rey, Arnaud; Fagot, Joel] CNRS, Cognit Psychol Lab, Marseille, France; [Kemp, Caralyn; Becker, Yannick; Rey, Arnaud; Fagot, Joel] Aix Marseille Univ, Marseille, France; [Sawallis, Thomas R.] Univ Alabama, New Coll, Tuscaloosa, AL USA	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Alabama System; University of Alabama Tuscaloosa	Fagot, J (corresponding author), Aix Marseille Univ, Brain & Language Res Inst, Aix En Provence, France.; Fagot, J (corresponding author), CNRS, Cognit Psychol Lab, Marseille, France.; Fagot, J (corresponding author), Aix Marseille Univ, Marseille, France.	joel.fagot@univ-amu.fr	BECKER, Yannick/AHB-9379-2022; Rey, Arnaud/F-1680-2010; Rey, Arnaud/GMW-5825-2022	BECKER, Yannick/0000-0002-9728-8316; Rey, Arnaud/0000-0001-8204-483X; Rey, Arnaud/0000-0001-8204-483X; Captier, Guillaume/0000-0002-1705-2339	BLRI [ANR-11-LABX-0036]; A*MIDEX [ANR-11-IDEX-0001-02]; BLRI research post-doctoral grant	BLRI; A*MIDEX(French National Research Agency (ANR)); BLRI research post-doctoral grant	Research was supported by grants ANR-11-LABX-0036 (BLRI) and ANR-11-IDEX-0001-02 (A*MIDEX). CK was supported by a BLRI research post-doctoral grant.	Andrew RJ, 1976, ORIGINS EVOLUTION LA, P673; Arbib MA, 2011, ANNU REV ANTHROPOL, V40, P257, DOI 10.1146/annurev-anthro-081309-145722; ATAL BS, 1971, J ACOUST SOC AM, V50, P637, DOI 10.1121/1.1912679; Badin P., 1984, Q PROGR STATUS REPOR, V25, P53; Boe LJ, 2002, J PHONETICS, V30, P465, DOI 10.1006/jpho.2002.0170; Boe LJ, 2013, J PHONETICS, V41, P379, DOI 10.1016/j.wocn.2013.04.001; Bolhuis JJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001934; Buchaillard S, 2009, J ACOUST SOC AM, V126, P2033, DOI 10.1121/1.3204306; Corballis MC, 2003, BEHAV BRAIN SCI, V26, P199, DOI 10.1017/S0140525X03000062; Dang JW, 2004, J ACOUST SOC AM, V115, P853, DOI 10.1121/1.1639325; DEBOYSSONBARDIES B, 1989, J CHILD LANG, V16, P1, DOI 10.1017/S0305000900013404; Fagot J, 2010, BEHAV RES METHODS, V42, P507, DOI 10.3758/BRM.42.2.507; Fant G., 1960, ACOUSTIC THEORY SPEE; Fischer J, 2002, J ACOUST SOC AM, V111, P1465, DOI 10.1121/1.1433807; Fitch WT, 2006, J ACOUST SOC AM, V120, P2132, DOI 10.1121/1.2258499; Fitch WT, 2000, TRENDS COGN SCI, V4, P258, DOI 10.1016/S1364-6613(00)01494-7; Fitch WT, 2001, P ROY SOC B-BIOL SCI, V268, P1669, DOI 10.1098/rspb.2001.1704; Gamba M, 2006, ACTA ACUST UNITED AC, V92, P749; Gamba M, 2012, INT J PRIMATOL, V33, P1453, DOI 10.1007/s10764-012-9635-y; Goldstein Ursula, 1980, THESIS; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Honda K, 1996, J PHONETICS, V24, P39, DOI 10.1006/jpho.1996.0004; International Phonetic Association, 1999, HDB INT PHON ASS GUI; ITAKURA F, 1970, ELECTRON COMMUN JPN, V53, P36; Kuhl PK, 1996, J ACOUST SOC AM, V100, P2425, DOI 10.1121/1.417951; Lee S, 1999, J ACOUST SOC AM, V105, P1455, DOI 10.1121/1.426686; LIEBERMAN PH, 1969, SCIENCE, V164, P1185, DOI 10.1126/science.164.3884.1185; Lieberman P, 2007, CURR ANTHROPOL, V48, P39, DOI 10.1086/509092; Maciej P, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-58; Maddieson I, 2009, PATTERNS SOUNDS; Marcus GF, 2003, TRENDS COGN SCI, V7, P257, DOI 10.1016/S1364-6613(03)00104-9; Markel J., 1976, LINEAR PREDICTION SP; Menard L, 2007, J PHONETICS, V35, P1, DOI 10.1016/j.wocn.2006.01.003; Nishimura T, 2006, J HUM EVOL, V51, P244, DOI 10.1016/j.jhevol.2006.03.005; Owren MJ, 1997, J ACOUST SOC AM, V101, P2951, DOI 10.1121/1.418523; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; Rendall D, 2005, J ACOUST SOC AM, V117, P944, DOI 10.1121/1.1848011; Riede T, 2005, J HUM EVOL, V48, P85, DOI 10.1016/j.jhevol.2004.10.002; Riede T, 2003, J ACOUST SOC AM, V114, P1132, DOI 10.1121/1.1580812; Roers F, 2009, J VOICE, V23, P408, DOI 10.1016/j.jvoice.2007.12.003; Schwartz JL, 1997, J PHONETICS, V25, P255, DOI 10.1006/jpho.1997.0043; SONDHI MM, 1986, J ACOUST SOC AM, V79, P1113, DOI 10.1121/1.393383; Waltl S., 2008, 8 INT SEM SPEECH PRO, P445	43	52	52	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169321	10.1371/journal.pone.0169321	http://dx.doi.org/10.1371/journal.pone.0169321			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH6BJ	28076426	Green Published, gold, Green Submitted			2022-12-26	WOS:000391857100032
J	Delyon, J; Servy, A; Laugier, F; Andre, J; Ortonne, N; Battistella, M; Mourah, S; Bensussan, A; Lebbe, C; Dumaz, N				Delyon, J.; Servy, A.; Laugier, F.; Andre, J.; Ortonne, N.; Battistella, M.; Mourah, S.; Bensussan, A.; Lebbe, C.; Dumaz, N.			PDE4D promotes FAK-mediated cell invasion in BRAF-mutated melanoma	ONCOGENE			English	Article							IMPROVED SURVIVAL; MEK INHIBITION; CANCER; PHOSPHODIESTERASE-4; GROWTH; DIFFERENTIATION; IDENTIFICATION; PROLIFERATION; PATHWAY; RISK	The cyclic AMP (cAMP) signaling pathway is critical in melanocyte biology for regulating differentiation. It is downregulated by phosphodiesterase (PDE) enzymes, which degrade cAMP itself. In melanoma evidence suggests that inhibition of the cAMP pathway by PDE type 4 (PDE4) favors tumor progression. For example, in melanomas harboring RAS mutations, the overexpression of PDE4 is crucial for MAPK pathway activation and proliferation induced by oncogenic RAS. Here we showed that PDE4D is overexpressed in BRAF-mutated melanoma cell lines, constitutively disrupting the cAMP pathway activation. PDE4D promoted melanoma invasion by interacting with focal adhesion kinase (FAK) through the scaffolding protein RACK1. Inhibition of PDE4 activity or inhibition of PDE4D interaction with FAK reduced invasion. PDE4D expression is increased in patients with advanced melanoma and PDE4D-FAK interaction is detectable in situ in metastatic melanoma. Our study establishes the role of PDE4D in BRAF-mutated melanoma as regulator of cell invasion, and suggests its potential as a target for preventing metastatic	[Delyon, J.; Servy, A.; Laugier, F.; Andre, J.; Mourah, S.; Bensussan, A.; Lebbe, C.; Dumaz, N.] INSERM, Ctr Rech Peau, U976, F-75010 Paris, France; [Delyon, J.; Servy, A.; Laugier, F.; Andre, J.; Mourah, S.; Bensussan, A.; Lebbe, C.; Dumaz, N.] Univ Paris Diderot, Sorbonne Paris Cite, UMR 976, F-75010 Paris, France; [Delyon, J.; Lebbe, C.] Hop St Louis, AP HP, Dept Dermatol, Paris, France; [Ortonne, N.] Hop Henri Mondor, AP HP, Dept Pathol, Creteil, France; [Ortonne, N.] Hop Henri Mondor, AP HP, INSERM, U955,Equipe 9, Creteil, France; [Ortonne, N.] Univ Paris Est Creteil Val de Marne, Fac Med, Creteil, France; [Battistella, M.] Hop St Louis, AP HP, Dept Pathol, Paris, France; [Battistella, M.] Univ Paris Diderot, Sorbonne Paris Cite, INSERM, U1165, Paris, France; [Mourah, S.] Hop St Louis, AP HP, Lab Pharmacol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Dumaz, N (corresponding author), Hop St Louis, INSERM, Ctr Rech Peau, U976, 1 Ave Claude Vellefaux, F-75475 Paris 10, France.	nicolas.dumaz@inserm.fr	Dumaz, Nicolas/B-5907-2008; Bensussan, Armand/E-5434-2017; Battistella, Maxime/K-2949-2012; Delyon, Julie/O-5147-2019	Dumaz, Nicolas/0000-0003-3511-2160; Battistella, Maxime/0000-0002-7053-7431; Delyon, Julie/0000-0002-4557-3377; Bensussan, Armand/0000-0002-0409-2497; Ortonne, Nicolas/0000-0003-0111-7422	INSERM; fondation ARC pour la recherche sur le cancer (Poste Accueil); Ligue Contre le Cancer Comite de Paris; GEFLUC Paris-Ile-de-France; fondation ARC pour la recherche sur le cancer; Universite Paris Diderot	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); fondation ARC pour la recherche sur le cancer (Poste Accueil)(Fondation ARC pour la Recherche sur le Cancer); Ligue Contre le Cancer Comite de Paris(Ligue nationale contre le cancer); GEFLUC Paris-Ile-de-France; fondation ARC pour la recherche sur le cancer(Fondation ARC pour la Recherche sur le Cancer); Universite Paris Diderot	Julie Delyon was supported by INSERM and the fondation ARC pour la recherche sur le cancer (Poste Accueil). This research was supported by grants from the Ligue Contre le Cancer Comite de Paris, the GEFLUC Paris-Ile-de-France, the fondation ARC pour la recherche sur le cancer, INSERM and Universite Paris Diderot.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Arozarena I, 2011, CANCER CELL, V19, P45, DOI 10.1016/j.ccr.2010.10.029; Bastiaens MT, 2001, AM J HUM GENET, V68, P884, DOI 10.1086/319500; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Conti M, 2003, J BIOL CHEM, V278, P5493, DOI 10.1074/jbc.R200029200; Dumaz N, 2002, MOL CELL BIOL, V22, P3717, DOI 10.1128/MCB.22.11.3717-3728.2002; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Goldhoff P, 2008, CLIN CANCER RES, V14, P7717, DOI 10.1158/1078-0432.CCR-08-0827; Hess AR, 2005, CANCER RES, V65, P9851, DOI 10.1158/0008-5472.CAN-05-2172; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Hu HH, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv340; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Khaled M, 2010, GENE DEV, V24, P2276, DOI 10.1101/gad.1937710; Krayem M, 2014, EUR J CANCER, V50, P1310, DOI 10.1016/j.ejca.2014.01.021; Landi MT, 2006, SCIENCE, V313, P521, DOI 10.1126/science.1127515; Liang SL, 2007, CANCER RES, V67, P5814, DOI 10.1158/0008-5472.CAN-06-4233; Lin DC, 2013, P NATL ACAD SCI USA, V110, P6109, DOI 10.1073/pnas.1218206110; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Lyons J, 2013, P NATL ACAD SCI USA, V110, P13845, DOI 10.1073/pnas.1201917110; Marquette A, 2011, NAT STRUCT MOL BIOL, V18, P584, DOI 10.1038/nsmb.2022; Mayer JE, 2014, J AM ACAD DERMATOL, V71, DOI [10.1016/j.jaad.2014.05.045, 10.1016/j.jaad.2014.05.046]; Murata K, 2001, CLIN EXP METASTAS, V18, P599, DOI 10.1023/A:1011926116777; Narita M, 2007, ONCOL REP, V17, P1133; Perego M, 2010, J INVEST DERMATOL, V130, P1877, DOI 10.1038/jid.2010.69; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Poulikakos PI, 2011, CANCER CELL, V19, P11, DOI 10.1016/j.ccr.2011.01.008; Powers GL, 2015, MOL CANCER RES, V13, P149, DOI 10.1158/1541-7786.MCR-14-0110; Pullamsetti SS, 2013, ONCOGENE, V32, P1121, DOI 10.1038/onc.2012.136; Rahrmann EP, 2009, CANCER RES, V69, P4388, DOI 10.1158/0008-5472.CAN-08-3901; Rodriguez CI, 2014, ARCH BIOCHEM BIOPHYS, V563, P22, DOI 10.1016/j.abb.2014.07.003; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Serrels B, 2010, CURR BIOL, V20, P1086, DOI 10.1016/j.cub.2010.04.042; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Takeuchi H, 2003, CANCER RES, V63, P441; Yarwood SJ, 1999, J BIOL CHEM, V274, P14909, DOI 10.1074/jbc.274.21.14909	38	18	19	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 8	2017	36	23					3252	3262		10.1038/onc.2016.469	http://dx.doi.org/10.1038/onc.2016.469			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EW9WJ	28092671				2022-12-26	WOS:000402869800005
J	Hsieh, CH; Chou, YT; Kuo, MH; Tsai, HP; Chang, JL; Wu, CW				Hsieh, C-H; Chou, Y-T; Kuo, M-H; Tsai, H-P; Chang, J-L; Wu, C-W			A targetable HB-EGF-CITED4 axis controls oncogenesis in lung cancer	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; NONSMALL CELL LUNG; OVARIAN-CANCER; HB-EGF; CLINICAL-SIGNIFICANCE; TRANSCRIPTION FACTOR; CITED FAMILY; EXPRESSION; MUTATIONS; LIGANDS	Aberrant epidermal growth factor (EGF) receptor (EGFR) signaling contributes to neoplastic initiation and progression in lung. Mutated EGFR has become as an important therapeutic target in lung cancer, whereas targeted treatment is not available for wildtype EGFR or its ligands. In this study, we found that heparin-binding (HB)-EGF, a member of the EGF family, was highly expressed in a subset of lung cancer, proliferation of which was dependent on HB-EGF signaling. Silencing of HB-EGF with RNA interference inhibited cell cycle progression in lung cancer cells. We observed that, upon HB-EGF induction, CITED4 was induced through a signal transducer and activator of transcription 3 (STAT3)-dependent pathway, regulating cell proliferation. CITED4 interacted with MYC and potentiated MYC-mediated transactivation of the CCND1 promoter, leading to cell cycle progression. Correlation analysis revealed that HB-EGF and CITED4 were significantly positively associated in primary lung tumors, and expression of HB-EGF predicted a poor survival outcome in patients. In vitro and in vivo experiments revealed that pharmacological inhibition of HB-EGF with CRM197 significantly attenuated tumor cell growth. Thus, CITED4 functions as a molecular switch in HB-EGF-induced growth control, and HB-EGF provides a novel therapeutic target for lung cancer intervention.	[Hsieh, C-H; Wu, C-W] Natl Yang Ming Univ, Inst Microbiol & Immunol, 155,Sect 2,Linong St, Taipei 112, Taiwan; [Chou, Y-T; Kuo, M-H; Wu, C-W] Natl Tsing Hua Univ, Inst Biotechnol, 101,Sect 2,Kuang Fu Rd, Hsinchu 300, Taiwan; [Tsai, H-P] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Chang, J-L] Taoyuan Armed Forces Gen Hosp, Dept Pathol & Lab Med, Taoyuan, Taiwan; [Chang, J-L] Ming Chuan Univ, Dept Biomed Engn, Taoyuan, Taiwan	National Yang Ming Chiao Tung University; National Tsing Hua University; Kaohsiung Medical University; Ming Chuan University	Wu, CW (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, 155,Sect 2,Linong St, Taipei 112, Taiwan.; Chou, YT (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, 101,Sect 2,Kuang Fu Rd, Hsinchu 300, Taiwan.	ytchou@life.nthu.edu.tw; cwwu@ym.edu.tw		Chou, Yu-Ting/0000-0001-9274-8603	National Yang-Ming University; National Tsing Hua University; Institute of Biomedical Sciences, Academia Sinica; Ministry of Science and Technology, Executive Yuan, Taiwan, ROC [MOST104-2321-B-010-007, MOST103-2320-B-007-006-MY3]	National Yang-Ming University; National Tsing Hua University; Institute of Biomedical Sciences, Academia Sinica(Academia Sinica - Taiwan); Ministry of Science and Technology, Executive Yuan, Taiwan, ROC	This research was supported by National Yang-Ming University, National Tsing Hua University, the Institute of Biomedical Sciences, Academia Sinica and the Ministry of Science and Technology (MOST104-2321-B-010-007 and MOST103-2320-B-007-006-MY3), Executive Yuan, Taiwan, ROC.	Bostrom P, 2010, CELL, V143, P1072, DOI 10.1016/j.cell.2010.11.036; Boyle S, 2007, DEV DYNAM, V236, P2321, DOI 10.1002/dvdy.21242; Braganca J, 2002, J BIOL CHEM, V277, P8559, DOI 10.1074/jbc.M110850200; Chou YT, 2006, ONCOGENE, V25, P5547, DOI 10.1038/sj.onc.1209552; Chou YT, 2012, CELL DEATH DIFFER, V19, P2015, DOI 10.1038/cdd.2012.91; Chou YT, 2006, J BIOL CHEM, V281, P18451, DOI 10.1074/jbc.M601720200; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; DAKSIS JI, 1994, ONCOGENE, V9, P3635; Dunwoodie SL, 1998, MECH DEVELOP, V72, P27, DOI 10.1016/S0925-4773(98)00011-2; Fox SB, 2004, CANCER RES, V64, P6075, DOI 10.1158/0008-5472.CAN-04-0708; Fujimoto N, 2005, CANCER RES, V65, P11478, DOI 10.1158/0008-5472.CAN-05-1977; Garassino MC, 2013, LANCET ONCOL, V14, P981, DOI 10.1016/S1470-2045(13)70310-3; Gazdar AF, 2008, CANCER PREV RES, V1, P156, DOI 10.1158/1940-6207.CAPR-08-0080; GOISHI K, 1995, MOL BIOL CELL, V6, P967, DOI 10.1091/mbc.6.8.967; Harada D, 2014, CANCERS, V6, P708, DOI 10.3390/cancers6020708; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; Kageyama T, 2007, J BIOCHEM, V142, P95, DOI 10.1093/jb/mvm116; KOBRIN MS, 1994, BIOCHEM BIOPH RES CO, V202, P1705, DOI 10.1006/bbrc.1994.2131; Laurie SA, 2013, J CLIN ONCOL, V31, P1061, DOI 10.1200/JCO.2012.43.4522; Leslie CC, 1997, AM J RESP CELL MOL, V16, P379, DOI 10.1165/ajrcmb.16.4.9115748; Li HC, 1998, EXP CELL RES, V242, P478, DOI 10.1006/excr.1998.4123; Mishima K, 1998, ACTA NEUROPATHOL, V96, P322, DOI 10.1007/s004010050901; Miyamoto S, 2004, CANCER RES, V64, P5720, DOI 10.1158/0008-5472.CAN-04-0811; Naef M, 1996, INT J CANCER, V66, P315; Ongusaha PP, 2004, CANCER RES, V64, P5283, DOI 10.1158/0008-5472.CAN-04-0925; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Qu X, 2007, EMBO J, V26, P4445, DOI 10.1038/sj.emboj.7601883; RUSCH V, 1993, CANCER RES, V53, P2379; Ryall KA, 2014, J MOL CELL CARDIOL, V72, P74, DOI 10.1016/j.yjmcc.2014.02.013; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Sun HB, 1998, P NATL ACAD SCI USA, V95, P13555, DOI 10.1073/pnas.95.23.13555; Tanaka Y, 2005, CLIN CANCER RES, V11, P4783, DOI 10.1158/1078-0432.CCR-04-1426; Thogersen VB, 2001, CANCER RES, V61, P6227; Vinante F, 2013, TOXINS, V5, P1180, DOI 10.3390/toxins5061180; Volante M, 2007, CANCER, V110, P1321, DOI 10.1002/cncr.22903; Wang YL, 2009, J PHYSIOL-LONDON, V587, P1739, DOI 10.1113/jphysiol.2008.163899; Wei X, 2015, TRENDS CARDIOVAS MED, V25, P529, DOI 10.1016/j.tcm.2014.12.014; Weninger WJ, 2005, DEVELOPMENT, V132, P1337, DOI 10.1242/dev.01696; Wu WJ, 2007, MOL CANCER THER, V6, P2652, DOI 10.1158/1535-7163.MCT-06-0759; Yagi H, 2005, BRIT J CANCER, V92, P1737, DOI 10.1038/sj.bjc.6602536; Yahata T, 2002, GENOMICS, V80, P601, DOI 10.1006/geno.2002.7005	42	12	12	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 25	2017	36	21					2946	2956		10.1038/onc.2016.465	http://dx.doi.org/10.1038/onc.2016.465			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EV7ZP	28092674				2022-12-26	WOS:000402000400003
J	Maeda, R; Tamashiro, H; Takano, K; Takahashi, H; Suzuki, H; Saito, S; Kojima, W; Adachi, N; Ura, K; Endo, T; Tamura, T				Maeda, Ryo; Tamashiro, Hiroyuki; Takano, Kazunori; Takahashi, Hiro; Suzuki, Hidefumi; Saito, Shinta; Kojima, Waka; Adachi, Noritaka; Ura, Kiyoe; Endo, Takeshi; Tamura, Taka-aki			TBP-like Protein (TLP) Disrupts the p53-MDM2 Interaction and Induces Long-lasting p53 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; cell growth; p53; protein stability; transcription factor	TATA-BINDING PROTEIN; TRANSCRIPTION-FACTOR; NUCLEAR EXPORT; CANCER GENOMICS; MDM2 PROTEIN; DNA-BINDING; PHOSPHORYLATION; DEGRADATION; REPRESSION; DOMAINS	Stress-induced activation of p53 is an essential cellular response to prevent aberrant cell proliferation and cancer development. The ubiquitin ligase MDM2 promotes p53 degradation and limits the duration of p53 activation. It remains unclear, however, how p53 persistently escapes MDM2-mediated negative control for making appropriate cell fate decisions. Here we report that TBP-like protein (TLP), a member of the TBP family, is a new regulatory factor for the p53-MDM2 interplay and thus for p53 activation. We found that TLP acts to stabilize p53 protein to ensure long-lasting p53 activation, leading to potentiation of p53-induced apoptosis and senescence after genotoxic stress. Mechanistically, TLP interferes with MDM2 binding and ubiquitination of p53. Moreover, single cell imaging analysis shows that TLP depletion accelerates MDM2-mediated nuclear export of p53. We further show that a cervical cancer-derived TLP mutant has less p53 binding ability and lacks a proliferation-repressive function. Our findings uncover a role of TLP as a competitive MDM2 blocker, proposing a novel mechanism by which p53 escapes the p53-MDM2 negative feedback loop to modulate cell fate decisions.	[Maeda, Ryo; Tamashiro, Hiroyuki; Takano, Kazunori; Suzuki, Hidefumi; Kojima, Waka; Ura, Kiyoe; Endo, Takeshi; Tamura, Taka-aki] Chiba Univ, Grad Sch Sci, Dept Biol, Chiba 2638522, Japan; [Takahashi, Hiro] Chiba Univ, Grad Sch Hort, Chiba 2718510, Japan; [Saito, Shinta; Adachi, Noritaka] Yokohama City Univ, Grad Sch Nanobiosci, Yokohama, Kanagawa 2360027, Japan; [Adachi, Noritaka] Yokohama City Univ, Adv Med Res Ctr, Yokohama, Kanagawa 2360004, Japan; [Kojima, Waka] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Tokyo 2770882, Japan	Chiba University; Chiba University; Yokohama City University; Yokohama City University; University of Tokyo	Maeda, R (corresponding author), Chiba Univ, Grad Sch Sci, Dept Biol, Chiba 2638522, Japan.	rmaeda@chiba-u.jp	Suzuki, Hidefumi/GRR-9474-2022; Takahashi, Hiro/E-6746-2013	Takahashi, Hiro/0000-0002-8230-9524	Japan Society for the Promotion of Science [272670, 26114703, 254583, 24570193]; Grants-in-Aid for Scientific Research [15J02670, 15H04323, 15H04348] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (272670 (to R. M.), 26114703 (to H. Tamashiro), 254583 (to H. S.), and 24570193 (to T. T.)). The authors declare that they have no conflicts of interest with the contents of this article.	Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Barsotti AM, 2009, ONCOGENE, V28, P4295, DOI 10.1038/onc.2009.282; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; CHEN XB, 1993, GENE DEV, V7, P1837, DOI 10.1101/gad.7.10.1837; Cross B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.228981; Fischer M, 2014, CELL CYCLE, V13, P3037, DOI 10.4161/15384101.2014.949083; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Freedman DA, 1997, MOL MED, V3, P248, DOI 10.1007/BF03401678; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Goldman SC, 1996, AM J PATHOL, V148, P1381; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; HORIKOSHI N, 1995, MOL CELL BIOL, V15, P227, DOI 10.1128/MCB.15.1.227; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Kracikova M, 2013, CELL DEATH DIFFER, V20, P576, DOI 10.1038/cdd.2012.155; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Leontieva OV, 2010, CELL CYCLE, V9, P4323, DOI 10.4161/cc.9.21.13584; Li HH, 2004, MOL CELL, V13, P867, DOI 10.1016/S1097-2765(04)00123-6; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Maeda R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090190; Mizuno S, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-17; MOLL UM, 1992, P NATL ACAD SCI USA, V89, P7262, DOI 10.1073/pnas.89.15.7262; Nie LH, 2007, J BIOL CHEM, V282, P14616, DOI 10.1074/jbc.M610515200; Ohbayashi T, 1999, NUCLEIC ACIDS RES, V27, P750, DOI 10.1093/nar/27.3.750; Rabenstein MD, 1999, P NATL ACAD SCI USA, V96, P4791, DOI 10.1073/pnas.96.9.4791; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; Shi DD, 2009, P NATL ACAD SCI USA, V106, P16275, DOI 10.1073/pnas.0904305106; Suenaga Y, 2009, J BIOL CHEM, V284, P35433, DOI 10.1074/jbc.M109.050047; Suzuki H, 2015, NUCLEIC ACIDS RES, V43, P6285, DOI 10.1093/nar/gkv576; Suzuki H, 2012, J BIOL CHEM, V287, P19792, DOI 10.1074/jbc.M112.369629; Tanaka Y, 2007, BIOCHEM BIOPH RES CO, V352, P21, DOI 10.1016/j.bbrc.2006.10.175; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Teufel DP, 2009, ONCOGENE, V28, P2112, DOI 10.1038/onc.2009.71; Towers CG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10077; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Unger T, 1999, EMBO J, V18, P1805, DOI 10.1093/emboj/18.7.1805; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang YL, 2014, GENE DEV, V28, P1550, DOI 10.1101/gad.245662.114; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wu Y, 2014, MOL CELL, V53, P63, DOI 10.1016/j.molcel.2013.10.031; XIAO H, 1994, MOL CELL BIOL, V14, P7013, DOI 10.1128/MCB.14.10.7013; Zehavi Y, 2015, TRANSCR-AUSTIN, V6, P1, DOI 10.1080/21541264.2015.1004980	48	6	8	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3201	3212		10.1074/jbc.M116.763318	http://dx.doi.org/10.1074/jbc.M116.763318			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28082682	Green Published, hybrid			2022-12-26	WOS:000395538800013
J	Hruby, A; Bulathsinhala, L; McKinnon, CJ; Hill, OT; Montain, SJ; Young, AJ; Smith, TJ				Hruby, Adela; Bulathsinhala, Lakmini; McKinnon, Craig J.; Hill, Owen T.; Montain, Scott J.; Young, Andrew J.; Smith, Tracey J.			Body Mass Index at Accession and Incident Cardiometabolic Risk Factors in US Army Soldiers, 2001-2011	PLOS ONE			English	Article							YOUNG-ADULTS CARDIA; 20-YEAR FOLLOW-UP; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR-DISEASE; PHYSICAL-FITNESS; HEALTHY OBESE; OVERWEIGHT; ASSOCIATION; PREVALENCE; DEPLOYMENT	Individuals entering US Army service are generally young and healthy, but many are overweight, which may impact cardiometabolic risk despite physical activity and fitness requirements. This analysis examines the association between Soldiers' BMI at accession and incident cardiometabolic risk factors (CRF) using longitudinal data from 731,014 Soldiers (17.0% female; age: 21.6 [3.9] years; BMI: 24.7 [3.8] kg/m2) who were assessed at Army accession, 2001-2011. CRF were defined as incident diagnoses through 2011, by ICD-9 code, of metabolic syndrome, glucose/insulin disorder, hypertension, dyslipidemia, or overweight/obesity (in those not initially overweight/obese). Multivariable-adjusted proportional hazards models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) between BMI categories at accession and CRF. Initially underweight (BMI<18.5 kg/m(2)) were 2.4% of Soldiers, 53.5% were normal weight (18.5-<25), 34.2% were overweight (25 -<30), and 10.0% were obese (>= 30). Mean age range at CRF diagnosis was 24-29 years old, with generally low CRF incidence: 228 with metabolic syndrome, 3,880 with a glucose/insulin disorder, 26,373 with hypertension, and 13,404 with dyslipidemia. Of the Soldiers who were not overweight or obese at accession, 5,361 were eventually diagnosed as overweight or obese. Relative to Soldiers who were normal weight at accession, those who were overweight or obese, respectively, had significantly higher risk of developing each CRF after multivariable adjustment (HR [95% CI]: metabolic syndrome: 4.13 [2.87-5.94], 13.36 [9.00-19.83]; glucose/insulin disorder: 1.39 [1.30-1.50], 2.76 [2.52-3.04]; hypertension: 1.85 [1.80-1.90], 3.31 [3.20-3.42]; dyslipidemia: 1.81 [1.75-1.89], 3.19 [3.04-3.35]). Risk of hypertension, dyslipidemia, and overweight/obesity in initially underweight Soldiers was 40%, 31%, and 79% lower, respectively, versus normal-weight Soldiers. BMI in early adulthood has important implications for cardiometabolic health, even within young, physically active populations.	[Hruby, Adela; Montain, Scott J.; Young, Andrew J.; Smith, Tracey J.] US Army, Mil Nutr Div, Environm Med Res Inst, Natick, MA 01760 USA; [Hruby, Adela] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Nutr Epidemiol Program, Boston, MA 02111 USA; [Bulathsinhala, Lakmini; McKinnon, Craig J.; Hill, Owen T.] US Army, Mil Performance Div, Environm Med Res Inst, Natick, MA 01760 USA; [Bulathsinhala, Lakmini; Hill, Owen T.] US Army, Med Dept Ctr & Sch, Hlth Readiness Ctr Excellence, Ft Sam Houston, TX USA	Tufts University; United States Department of Agriculture (USDA)	Smith, TJ (corresponding author), US Army, Mil Nutr Div, Environm Med Res Inst, Natick, MA 01760 USA.	tracey.smith10.civ@mail.mil	Smith, Tracey/ABF-1641-2021		United States Army Medical Research and Materiel Command	United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This work was funded in part by the United States Army Medical Research and Materiel Command. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt JP, 2016, MIL MED, V181, P173, DOI 10.7205/MILMED-D-15-00036; Allison Katelyn F, 2015, US Army Med Dep J, P22; Amoroso P J, 1999, Mil Med, V164, P1; Armed Forces Health Surveillance Center (AFHSC), 2011, MSMR, V18, P2; Armed Forces Health Surveillance Center (AFHSC), 2011, MSMR, V18, P7; Aune D, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2156; Barry VW, 2014, PROG CARDIOVASC DIS, V56, P382, DOI 10.1016/j.pcad.2013.09.002; Bell JA, 2015, J AM COLL CARDIOL, V66, P871, DOI 10.1016/j.jacc.2015.06.014; Carnethon MR, 2009, DIABETES CARE, V32, P1284, DOI 10.2337/dc08-1971; Carnethon MR, 2003, JAMA-J AM MED ASSOC, V290, P3092, DOI 10.1001/jama.290.23.3092; DeKoning BL, 2006, RECRUIT MED; Farrell SW, 2013, CIRC-HEART FAIL, V6, P898, DOI 10.1161/CIRCHEARTFAILURE.112.000088; Ford ES, 2005, DIABETES CARE, V28, P1808, DOI 10.2337/diacare.28.7.1808; Friedl Karl E, 2004, Diabetes Technol Ther, V6, P732, DOI 10.1089/dia.2004.6.732; Friedl Karl E, 2012, J Strength Cond Res, V26 Suppl 2, pS87, DOI 10.1519/JSC.0b013e31825ced6c; Funderburk LK, 2013, MIL MED, V178, P1137, DOI 10.7205/MILMED-D-13-00096; Fung MDT, 2015, OBESITY, V23, P1320, DOI 10.1002/oby.21087; Guo FJ, 2014, OBESITY, V22, P110, DOI 10.1002/oby.20585; Hruby A, 2014, PHARMACOECONOMICS; Hruby A, 2016, AM J PREV MED, V50, pE163, DOI 10.1016/j.amepre.2015.10.015; Hruby A, 2015, OBESITY, V23, P662, DOI 10.1002/oby.20978; Lavie CJ, 2015, NAT REV ENDOCRINOL, V11, P55, DOI 10.1038/nrendo.2014.165; Lester ME, 2010, MIL MED, V175, P417, DOI 10.7205/MILMED-D-09-00192; Lin XC, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002014; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Martin BJ, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-70; National Institutes of Health National Heart Lung and Blood Institute, 1998, EXP PAN ID EV TREATM; Ortega FB, 2015, PROG CARDIOVASC DIS, V58, P76, DOI 10.1016/j.pcad.2015.05.001; Packnett ER, 2011, AM J CLIN NUTR, V93, P608, DOI 10.3945/ajcn.110.007070; Pasiakos SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031222; Quan H, 2008, HEALTH SERV RES, V43, P1424, DOI 10.1111/j.1475-6773.2007.00822.x; Nguyen QM, 2012, DIABETES CARE, V35, P1341, DOI 10.2337/dc11-1818; Reis JP, 2015, OBESITY, V23, P879, DOI 10.1002/oby.21023; Reyes-Guzman CM, 2015, AM J PREV MED, V48, P145, DOI 10.1016/j.amepre.2014.08.033; Shah RV, 2016, JAMA INTERN MED, V176, P87, DOI 10.1001/jamainternmed.2015.6309; Sharp MA, 2008, MED SCI SPORT EXER, V40, P1687, DOI 10.1249/MSS.0b013e318176b978; Skinner AC, 2015, NEW ENGL J MED, V373, P1307, DOI 10.1056/NEJMoa1502821; U. S. Department of Health and Human Services and U. S. Department of the Army, 2012, FIELD MAN; Webber BJ, 2012, JAMA-J AM MED ASSOC, V308, P2577, DOI 10.1001/jama.2012.70830; Zgibor JC, 2007, DIABETES RES CLIN PR, V75, P313, DOI 10.1016/j.diabres.2006.07.007	40	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0170144	10.1371/journal.pone.0170144	http://dx.doi.org/10.1371/journal.pone.0170144			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095509	Green Submitted, gold, Green Published			2022-12-26	WOS:000392372300061
J	Mei, GY; Sun, YJ; Saeed, S				Mei Guangyi; Sun Yujun; Saeed, Sajjad			Models for Predicting the Biomass of Cunninghamialanceolata Trees and Stands in Southeastern China	PLOS ONE			English	Article							CARBON STORAGE; FOREST; FIR; CONVERSION; EQUATIONS; STOCKS	Using existing equations to estimate the biomass of a single tree or a forest stand still involves large uncertainties. In this study, we developed individual-tree biomass models for Chinese Fir (Cunninghamia lanceolate.) stands in Fujian Province, southeast China, by using 74 previously established models that have been most commonly used to estimate tree biomass. We selected the best fit models and modified them. The results showed that the published model In(B(Biomass)) = a + b* In(D) + c* (In(1-1))(2) + d* (In(1-1))(3) + e* In(WD) had the best fit for estimating the tree biomass of Chinese Fir stands. Furthermore, we observed that variables D(diameter at breast height), H (height), and WD(wood density)were significantly correlated with the total tree biomass estimation model. As a result, a natural logarithm structure gave the best estimates for the tree biomass structure. Finally, when a multistep improvement on tree biomass model was performed, the tree biomass model with Tree volume(TV), WD and biomass wood density conversion factor (BECF),achieved the highest simulation accuracy, expressed as In(TB) = -0.0703 + 0.9780 * In(TV) + 0.0213 * In(WD) + 1.0166 * In(BECF). Therefore, when TV, WD and BECF were combined with tree biomass volume coefficient bi for Chinese Fir, the stand biomass (SB)model included both volume (SV) and coefficient bi variables of the stand as follows: bi = Exp(-0.0703+0.9780*/n(TV)+ 0.0213 * In( WD)+1.0166*In(BECF)). The stand biomass model is SB= SV/TV*bi.	[Mei Guangyi; Sun Yujun; Saeed, Sajjad] Beijing Forestry Univ, Lab Silviculture & Conservat, Beijing, Peoples R China	Beijing Forestry University	Sun, YJ (corresponding author), Beijing Forestry Univ, Lab Silviculture & Conservat, Beijing, Peoples R China.	sunyj@bjfu.edu.cn	saeed, sajjad/G-3056-2017	saeed, sajjad/0000-0001-9182-5785	Introduce Project of Forest Multifunction Management Science and Technology of Forplan System [2015-4-31]; National Technology Extension Fund of Forestry [[2014]26]	Introduce Project of Forest Multifunction Management Science and Technology of Forplan System; National Technology Extension Fund of Forestry	This study was supported by the Introduce Project of Forest Multifunction Management Science and Technology of Forplan System (No.2015-4-31) and the National Technology Extension Fund of Forestry ([2014]26). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker TR, 2004, GLOBAL CHANGE BIOL, V10, P545, DOI 10.1111/j.1365-2486.2004.00751.x; Colgan MS, 2014, TREES-STRUCT FUNCT, V28, P91, DOI 10.1007/s00468-013-0932-7; Crecente-Campo F, 2010, FOREST ECOL MANAG, V259, P943, DOI 10.1016/j.foreco.2009.11.036; Enes TD, 2014, FOREST SYST, V23, P438, DOI 10.5424/fs/2014233-05128; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Gomez-Garcia E, 2015, EUR J FOREST RES, V134, P569, DOI 10.1007/s10342-015-0873-3; Guan FY, 2015, CATENA, V133, P455, DOI 10.1016/j.catena.2015.03.002; Gurdak DJ, 2014, PLANT ECOL DIVERS, V7, P143, DOI 10.1080/17550874.2013.818073; Hounzandji API, 2015, ANN FOREST SCI, V72, P795, DOI 10.1007/s13595-014-0423-z; Jenkins JC, 2003, FOREST SCI, V49, P12; Jose A N, 2015, FOREST ECOL MANAG; Li Yan, 2010, Yingyong Shengtai Xuebao, V21, P3036; Litton CM, 2008, BIOTROPICA, V40, P313, DOI 10.1111/j.1744-7429.2007.00383.x; Liu ZW, 2015, ENVIRON EARTH SCI, V73, P5513, DOI 10.1007/s12665-014-3805-5; Luo YB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098306; Malhi Y, 2006, GLOBAL CHANGE BIOL, V12, P1107, DOI 10.1111/j.1365-2486.2006.01120.x; Mei GY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140095; Menendez-Miguelez M, 2013, FOREST ECOL MANAG, V291, P417, DOI 10.1016/j.foreco.2012.11.040; Ostadhashemi R., 2014, Journal of Forest Science (Prague), V60, P363, DOI 10.17221/55/2014-JFS; Pasalodos-Tato M, 2015, EUR J FOREST RES, V134, P537, DOI 10.1007/s10342-015-0870-6; Punt AE, 2015, FISH RES, V166, P103, DOI 10.1016/j.fishres.2014.07.016; Ribeiro SC, 2011, FOREST ECOL MANAG, V262, P491, DOI 10.1016/j.foreco.2011.04.017; Sitoe AA, 2014, FORESTS, V5, P1967, DOI 10.3390/f5081967; Taeroe A, 2015, BIOENERG RES, V8, P1332, DOI 10.1007/s12155-015-9592-3; Temesgen H, 2015, SCAND J FOREST RES, V30, P326, DOI 10.1080/02827581.2015.1012114; Zeng WS, 2015, SCAND J FOREST RES, V30, P594, DOI 10.1080/02827581.2015.1046481; Zhang J.G., 2011, SELF THINNING GROWTH; Zhang XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079868; Zhao MF, 2009, FOREST ECOL MANAG, V257, P1520, DOI 10.1016/j.foreco.2008.12.025; Zheng CH, 2015, TREES-STRUCT FUNCT, V29, P705, DOI 10.1007/s00468-014-1148-1; Zianis D., 2005, Silva Fennica Monographs, P1; Zianis D, 2004, FOREST ECOL MANAG, V187, P311, DOI 10.1016/j.foreco.2003.07.007; Zianis D, 2011, EUR J FOREST RES, V130, P145, DOI 10.1007/s10342-010-0417-9; Zou WT, 2015, FORESTS, V6, P433, DOI 10.3390/f6020433; Zuo Shu-di, 2015, Yingyong Shengtai Xuebao, V26, P356; Zuo ShuDi, 2014, Scientia Silvae Sinicae, V50, P1	36	10	12	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0169747	10.1371/journal.pone.0169747	http://dx.doi.org/10.1371/journal.pone.0169747			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095512	Green Published, gold, Green Submitted			2022-12-26	WOS:000392372300030
J	Mruthyunjaya, MD; Chapla, A; Shyamasunder, AH; Varghese, D; Varshney, M; Paul, J; Inbakumari, M; Christina, F; Varghese, RT; Kuruvilla, KA; Paul, TV; Jose, R; Regi, A; Lionel, J; Jeyaseelan, L; Mathew, J; Thomas, N				Mruthyunjaya, Mahesh Doddabelavangala; Chapla, Aaron; Shyamasunder, Asha Hesarghatta; Varghese, Deny; Varshney, Manika; Paul, Johan; Inbakumari, Mercy; Christina, Flory; Varghese, Ron Thomas; Kuruvilla, Kurien Anil; Paul, Thomas V.; Jose, Ruby; Regi, Annie; Lionel, Jessie; Jeyaseelan, L.; Mathew, Jiji; Thomas, Nihal			Comprehensive Maturity Onset Diabetes of the Young (MODY) Gene Screening in Pregnant Women with Diabetes in India	PLOS ONE			English	Article							MUTATIONS; MELLITUS; DIAGNOSIS; TYPE-2; NEUROD1; FAMILY; PATHOPHYSIOLOGY; IDENTIFICATION; DISEASES; LOCUS	Pregnant women with diabetes may have underlying beta cell dysfunction due to mutations/rare variants in genes associated with Maturity Onset Diabetes of the Young (MODY). MODY gene screening would reveal those women genetically predisposed and previously unrecognized with a monogenic form of diabetes for further clinical management, family screening and genetic counselling. However, there are minimal data available on MODY gene variants in pregnant women with diabetes from India. In this study, utilizing the Next generation sequencing (NGS) based protocol fifty subjects were screened for variants in a panel of thirteen MODY genes. Of these subjects 18% (9/50) were positive for definite or likely pathogenic or uncertain MODY variants. The majority of these variants was identified in subjects with autosomal dominant family history, of whom five were in women with preGDM and four with overt-GDM. The identified variants included one patient with HNF1A Ser3Cys, two PDX1 Glu224Lys, His94Gln, two NEUROD1 Glu59Gln, Phe318Ser, one INS Gly44Arg, one GCK, one ABCC8 Arg620Cys and one BLK Val418Met variants. In addition, three of the seven offspring screened were positive for the identified variant. These identified variants were further confirmed by Sanger sequencing. In conclusion, these findings in pregnant women with diabetes, imply that a proportion of GDM patients with autosomal dominant family history may have MODY. Further NGS based comprehensive studies with larger samples are required to confirm these finding	[Mruthyunjaya, Mahesh Doddabelavangala; Chapla, Aaron; Shyamasunder, Asha Hesarghatta; Varghese, Deny; Varshney, Manika; Paul, Johan; Inbakumari, Mercy; Christina, Flory; Varghese, Ron Thomas; Paul, Thomas V.; Thomas, Nihal] Christian Med Coll & Hosp, Dept Endocrinol Diabet & Metab, Vellore, Tamil Nadu, India; [Kuruvilla, Kurien Anil] Christian Med Coll & Hosp, Dept Neonatol, Vellore, Tamil Nadu, India; [Jose, Ruby; Regi, Annie; Lionel, Jessie; Mathew, Jiji] Christian Med Coll & Hosp, Dept Obstet & Gynaecol, Vellore, Tamil Nadu, India; [Jeyaseelan, L.] Christian Med Coll & Hosp, Dept Biostat, Vellore, Tamil Nadu, India	Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore	Thomas, N (corresponding author), Christian Med Coll & Hosp, Dept Endocrinol Diabet & Metab, Vellore, Tamil Nadu, India.	nihal_thomas@cmcvellore.ac.in			Ministry of Science and Technology, Department of Biotechnology, Government of India [BT/PR6461/MED/12/576/2012]	Ministry of Science and Technology, Department of Biotechnology, Government of India	Funded by Ministry of Science and Technology, Department of Biotechnology, Government of India. NO.BT/PR6461/MED/12/576/2012.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Blumer I, 2013, J CLIN ENDOCR METAB, V98, P4227, DOI 10.1210/jc.2013-2465; Boesgaard TW, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-42; Borowiec M, 2009, P NATL ACAD SCI USA, V106, P14460, DOI 10.1073/pnas.0906474106; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chapla A, 2015, CLIN ENDOCRINOL, V82, P533, DOI 10.1111/cen.12541; Cockburn BN, 2004, J CLIN ENDOCR METAB, V89, P971, DOI 10.1210/jc.2003-031282; Colclough K, 2014, EUR J HUM GENET, V22, pE1, DOI 10.1038/ejhg.2014.14; Colom C, 2010, BEST PRACT RES CL EN, V24, P605, DOI 10.1016/j.beem.2010.05.008; Cooper GM, 2010, NAT METHODS, V7, P250, DOI 10.1038/nmeth0410-250; Cuesta-Munoz AL, 2010, DIABETES CARE, V33, P290, DOI 10.2337/dc09-0681; Fajans SS, 2011, DIABETES CARE, V34, P1878, DOI 10.2337/dc11-0035; Flannick J, 2013, NAT GENET, V45, P1380, DOI 10.1038/ng.2794; Gazzo AM, 2016, NUCLEIC ACIDS RES, V44, pD900, DOI 10.1093/nar/gkv1068; Gonsorcikova L, 2008, PEDIATR DIABETES, V9, P367, DOI 10.1111/j.1399-5448.2008.00379.x; Gragnoli C, 2005, METABOLISM, V54, P983, DOI 10.1016/j.metabol.2005.01.037; Huopio H, 2003, LANCET, V361, P301, DOI 10.1016/S0140-6736(03)12325-2; James C, 2009, J MED GENET, V46, P289, DOI 10.1136/jmg.2008.064337; Kavvoura FK, 2012, PEDIATR ENDOCR REV P, V10, P234; Kim C, 2007, DIABETES CARE, V30, P1314, DOI 10.2337/dc06-2517; Kim SH, 2004, DIABETES, V53, P1375, DOI 10.2337/diabetes.53.5.1375; Kristinsson SY, 2001, DIABETOLOGIA, V44, P2098, DOI 10.1007/s001250100016; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liu AH, 2006, FEBS LETT, V580, P6701, DOI 10.1016/j.febslet.2006.11.021; Liu LM, 2007, MOL CELL BIOCHEM, V303, P115, DOI 10.1007/s11010-007-9463-0; Malecki MT, 1999, NAT GENET, V23, P323, DOI 10.1038/15500; Metzger BE, 1998, DIABETES CARE, V21, pB161; Molven A, 2011, EXPERT REV MOL DIAGN, V11, P313, DOI [10.1586/ERM.10.123, 10.1586/erm.10.123]; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Noctor E, 2015, WORLD J DIABETES, V6, P234, DOI 10.4239/wjd.v6.i2.234; Owen KR, 2013, CLIN MED, V13, P278, DOI 10.7861/clinmedicine.13-3-278; Pulst SM, 2015, NEUROL GENET, V1; Sagen JV, 2005, DIABETIC MED, V22, P1012, DOI 10.1111/j.1464-5491.2005.01565.x; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Seshiah V, 2008, J Assoc Physicians India, V56, P329; Seshiah V, 2009, INT J GYNECOL OBSTET, V104, pS35, DOI 10.1016/j.ijgo.2008.11.035; Shepherd M, 2009, DIABETIC MED, V26, P437, DOI 10.1111/j.1464-5491.2009.02690.x; Thanabalasingham G, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6044; Vaxillaire M, 2008, ENDOCR REV, V29, P254, DOI 10.1210/er.2007-0024; Weng JP, 2002, DIABETES CARE, V25, P68, DOI 10.2337/diacare.25.1.68; Wong T, 2013, DIABETIC MED, V30, P468, DOI 10.1111/dme.12110; Woodhouse Nicholas Jy, 2010, Sultan Qaboos Univ Med J, V10, P80; Zhang W, 2014, TOP CURR CHEM, V336, P19, DOI 10.1007/128_2012_325	43	19	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0168656	10.1371/journal.pone.0168656	http://dx.doi.org/10.1371/journal.pone.0168656			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095440	Green Published, gold, Green Submitted			2022-12-26	WOS:000392372300011
J	Rajoo, Y; Ambu, S; Lim, YAL; Rajoo, K; Tey, SC; Lu, CW; Ngui, R				Rajoo, Yamuna; Ambu, Stephen; Lim, Yvonne Ai Lian; Rajoo, Komalaveni; Tey, Siew Chang; Lu, Chan Woon; Ngui, Romano			Neglected Intestinal Parasites, Malnutrition and Associated Key Factors: A Population Based Cross-Sectional Study among Indigenous Communities in Sarawak, Malaysia	PLOS ONE			English	Article							TRANSMITTED HELMINTH INFECTIONS; IRON-DEFICIENCY ANEMIA; RISK-FACTORS; ASCARIS-LUMBRICOIDES; TRICHURIS-TRICHIURA; HOOKWORM INFECTION; TROPICAL DISEASES; CHILDREN; PREVALENCE; PATTERNS	Intestinal parasitic infections (IPIs) have been recognized as one of the most significant causes of illness among disadvantaged communities. Many studies have been conducted on the prevalence of IPIs in Malaysia. However, these studies mostly focused on the indigenous groups in Peninsular Malaysia. The present study was conducted to provide the current baseline data on prevalence of IPIs, anaemia, malnutrition and associated risk factors among the indigenous communities in Sarawak, situation at northwest Borneo island of Malaysia. A cross sectional study was conducted among the longhouses communities. Stool samples were obtained and examined for the presence of IPIs using microscopy technique. Haemoglobin measurement was done using a portable haemoglobin analyzer. Malnutrition (i.e., stunting, underweight and wasting) was assessed using the WHO Anthro software. Statistical analysis was carried out using SPSS software. A total of 341-participants took part in this study. The overall prevalence of IPIs was 57.5%. Multivariate analysis indicated that the absence of toilets (OR = 1.6; 95% CI = 1.1-2.7; p=0.002) and close contact with animals (OR = 1.8; 95% CI = 1.3-2.9; p = 0.027) as significant predictors for IPIs. The incidence of anaemia was 36.4%. The incidence of underweight, wasting and stunting were 22.2%, 5.6% and 35.4%, respectively. Multivariate analysis demonstrated that low level of parental education attainment (OR = 1.9; 95% CI = 1.2-3.0; p = 0.006) was identified as significant predictor for anaemia. The incidence of wasting was significantly associated with mild anaemia (OR = 1.2; 95% CI = 0.9-1.7; p= 0.024). Low household income was identified as significant predictor for stunting (OR = 2.1; 95% CI = 9.8-22.2; p = 0.001) and underweight (OR = 1.9; 95% CI = 5.6-18.7; p= 0.037), respectively. Essentially, the present study highlighted that intestinal parasitic infections, anaemia and malnutrition are still prevalent among rural indigenous community in Sarawak. Improvement of socioeconomic status, periodic mass deworming, iron supplementation and health education program should be included in the control and prevention of public health strategies.	[Rajoo, Yamuna; Ambu, Stephen] Int Med Univ, Kuala Lumpur, Malaysia; [Rajoo, Yamuna; Lim, Yvonne Ai Lian; Ngui, Romano] Univ Malaya, Dept Parasitol, Fac Med, Kuala Lumpur, Malaysia; [Rajoo, Komalaveni; Tey, Siew Chang; Lu, Chan Woon] Hosp Sarikei, Jalan Rentap, Sarikei, Sarawak, Malaysia	International Medical University Malaysia; Universiti Malaya	Lim, YAL; Ngui, R (corresponding author), Univ Malaya, Dept Parasitol, Fac Med, Kuala Lumpur, Malaysia.	limailian@um.edu.my; romano@um.edu.my	LIM, YVONNE AL/B-5276-2010; Ngui, Romano/H-9645-2015; Ambu, Stephen/A-7204-2013	LIM, YVONNE AL/0000-0003-4050-6332; Ngui, Romano/0000-0002-3520-579X; Ambu, Stephen/0000-0001-7840-6113	University of Malaya [BKP007-2014]	University of Malaya(Universiti Malaya)	This study was funded by University of Malaya (BKP007-2014).	Abraar K., 2012, J PARASITOL RES, V2012, P1; Ahmed A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-119; Ahmed A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-242; Aini UN, 2007, ASIA PAC J CLIN NUTR, V16, P724; Al-Delaimy AK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003074; Al-Mekhlafi MH, 2008, T ROY SOC TROP MED H, V102, P1046, DOI 10.1016/j.trstmh.2008.05.012; Alelign T, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0084-x; ALLEN AVH, 1970, J CLIN PATHOL, V23, P545, DOI 10.1136/jcp.23.6.545; ANDERSON R M, 1991; Belizario VY, 2011, ACTA TROP, V120, pS12, DOI 10.1016/j.actatropica.2011.02.010; Bethony J, 2002, CLIN INFECT DIS, V35, P1336, DOI 10.1086/344268; Brooker S, 2007, T ROY SOC TROP MED H, V101, P146, DOI 10.1016/j.trstmh.2006.05.012; CHAN L, 1994, T ROY SOC TROP MED H, V88, P46, DOI 10.1016/0035-9203(94)90492-8; Choy SH, 2014, SCI REP-UK, V4, DOI 10.1038/srep06909; Crompton DWT, 1990, HOOKWORM DIS CURRENT; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; Dzwairo B, 2006, PHYS CHEM EARTH, V31, P779, DOI 10.1016/j.pce.2006.08.031; Foo LH, 2004, ASIA PAC J CLIN NUTR, V13, P48; FOY H, 1963, EXP PARASITOL, V14, P240, DOI 10.1016/0014-4894(63)90029-8; Galvani AP, 2005, J PARASITOL, V91, P24, DOI 10.1645/GE-191R1; Gelaw A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-304; Gilles H., 1996, MANSONS TROPICAL DIS; Harpham T, 2002, J TROP PEDIATRICS, V48, P128, DOI 10.1093/tropej/48.3.128; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000405; Jinabhai CC, 2001, ANN TROP PAEDIATR, V21, P50, DOI 10.1080/02724930020028920; Khor G L, 1988, Med J Malaysia, V43, P318; Larocque R, 2005, AM J TROP MED HYG, V73, P783, DOI 10.4269/ajtmh.2005.73.783; Lee D L, 1999, Med J Malaysia, V54, P96; Leedy PD., 1993, PRACTICAL RES PLANNI; Liese B, 2010, LANCET, V375, P67, DOI 10.1016/S0140-6736(09)61749-9; Mehraj V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003680; Mineno T, 2003, CURR PHARM DESIGN, V9, P841, DOI 10.2174/1381612033455260; MOH/UNICEF, 2000, NUTR STAT CHILDR 5 Y; Neo C B, 1987, Med J Malaysia, V42, P294; Ngui R, 2015, AM J TROP MED HYG, V93, P361, DOI 10.4269/ajtmh.13-0677; Ngui R, 2013, ACTA TROP, V128, P154, DOI 10.1016/j.actatropica.2013.06.003; Ngui R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001550; Ngui R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000974; Norhayati M, 1997, Asia Pac J Clin Nutr, V6, P260; Olivares M, 1999, BRIT MED BULL, V55, P534, DOI 10.1258/0007142991902600; ROBERTSON LJ, 1992, T ROY SOC TROP MED H, V86, P654, DOI 10.1016/0035-9203(92)90176-D; Sagin D. D., 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P373; Sagin D. D., 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P18; SESHADRI S, 1989, AM J CLIN NUTR, V50, P675, DOI 10.1093/ajcn/50.3.675; Shalaby HA, 2010, PARASITOL RES, V106, P1021, DOI 10.1007/s00436-010-1755-8; Traub RJ, 2003, PARASITOL RES, V90, pS156, DOI 10.1007/s00436-003-0925-3; WHO, 2000, NUTR HLTH DEV GLOB A; WHO, 2001, IRON DEFICIENCY ANAE; Woolhouse MEJ, 1998, PARASITOL TODAY, V14, P428, DOI 10.1016/S0169-4758(98)01318-0; World Health Organization, 2008, WHO GLOBAL DATABASE	52	24	24	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0170174	10.1371/journal.pone.0170174	http://dx.doi.org/10.1371/journal.pone.0170174			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095446	Green Submitted, Green Published, gold			2022-12-26	WOS:000392372300066
J	Jansen, J; McKinn, S; Bonner, C; Irwig, L; Doust, J; Glasziou, P; Bell, K; Naganathan, V; McCaffery, K				Jansen, Jesse; McKinn, Shannon; Bonner, Carissa; Irwig, Les; Doust, Jenny; Glasziou, Paul; Bell, Katy; Naganathan, Vasi; McCaffery, Kirsten			General Practitioners' Decision Making about Primary Prevention of Cardiovascular Disease in Older Adults: A Qualitative Study	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; UNRECOGNIZED MYOCARDIAL-INFARCTION; PRIMARY-CARE; ELDERLY-PATIENTS; RISK; RECOMMENDATIONS; MULTIMORBIDITY; PREVALENCE; FRAILTY; PERSPECTIVES	Background Primary cardiovascular disease (CVD) prevention in older people is challenging as they are a diverse group with varying needs, frequent presence of comorbidities, and are more susceptible to treatment harms. Moreover the potential benefits and harms of preventive medication for older people are uncertain. We explored GPs' decision making about primary CVD prevention in patients aged 75 years and older. Method 25 GPs participated in semi-structured interviews in New South Wales, Australia. Transcribed audio-recordings were thematically coded and Framework Analysis was used. Results Analysis identified factors that are likely to contribute to variation in the management of CVD risk in older people. Some GPs based CVD prevention on guidelines regardless of patient age. Others tailored management based on factors such as perceptions of prevention in older age, knowledge of limited evidence, comorbidities, polypharmacy, frailty, and life expectancy. GPs were more confident about: 1) medication and lifestyle change for fit/ healthy older patients, and 2) stopping or avoiding medication for frail/nursing home patients. Decision making for older patients outside of these categories was less clear. Conclusion Older patients receive different care depending on their GP's perceptions of ageing and CVD prevention, and their knowledge of available evidence. GPs consider CVD prevention for older patients challenging and would welcome more guidance in this area.	[Jansen, Jesse; McKinn, Shannon; Bonner, Carissa; Irwig, Les; Doust, Jenny; Glasziou, Paul; Bell, Katy; McCaffery, Kirsten] Univ Sydney, Sydney Sch Publ Hlth, STEP, Sydney, NSW, Australia; [Jansen, Jesse; McKinn, Shannon; Bonner, Carissa; McCaffery, Kirsten] Univ Sydney, Ctr Med Psychol & Evidence Based Decis Making CeM, Sydney, NSW, Australia; [Doust, Jenny; Glasziou, Paul] Bond Univ, Fac Hlth Sci & Med, Robina, Qld, Australia; [Naganathan, Vasi] Univ Sydney, Concord Hosp, Ageing & Alzheimers Inst, Ctr Educ & Res Ageing, Sydney, NSW, Australia	University of Sydney; University of Sydney; Bond University; Concord Repatriation General Hospital; University of Sydney	Jansen, J (corresponding author), Univ Sydney, Sydney Sch Publ Hlth, STEP, Sydney, NSW, Australia.; Jansen, J (corresponding author), Univ Sydney, Ctr Med Psychol & Evidence Based Decis Making CeM, Sydney, NSW, Australia.	jesse.jansen@sydney.edu.au	Doust, Jenny/AGI-8773-2022; McKinn, Shannon/AAW-7934-2020; Bell, Katy/B-9650-2013; Glasziou, Paul/A-7832-2008; McCaffery, Kirsten/K-7945-2019	Doust, Jenny/0000-0002-4024-9308; McKinn, Shannon/0000-0001-6384-1745; Bell, Katy/0000-0002-0137-3218; Glasziou, Paul/0000-0001-7564-073X; McCaffery, Kirsten/0000-0003-2696-5006; Bonner, Carissa/0000-0002-4797-6460; Naganathan, Vasikaran/0000-0001-7243-0796	National Health and Medical Research Council (NHMRC) [633003]; Bond University [511217]; Australian Postgraduate Award; NHMRC fellowships	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Bond University; Australian Postgraduate Award(Australian Government); NHMRC fellowships(National Health and Medical Research Council (NHMRC) of Australia)	The study was funded by the National Health and Medical Research Council (NHMRC), through grants awarded to the Screening and Test Evaluation Program (no. 633003) and Bond University (no. 511217). CB was supported by an Australian Postgraduate Award. JJ and KM were supported by NHMRC fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity, 2012, J Am Geriatr Soc, V60, P1957, DOI 10.1111/j.1532-5415.2012.04187.x; Anthierens S, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-65; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Benetos A, 2015, JAMA-J AM MED ASSOC, V314, P170, DOI 10.1001/jama.2015.7517; Bonner C, 2015, HEALTH PSYCHOL, V34, P253, DOI 10.1037/hea0000122; Bonner C, 2013, MED J AUSTRALIA, V199, P485, DOI 10.5694/mja13.10133; Bowen GA, 2008, QUAL RES, V8, P137, DOI 10.1177/1468794107085301; Christian AH, 2006, J GEN INTERN MED, V21, P231, DOI 10.1111/j.1525-1497.2006.00331.x; Collard RM, 2012, J AM GERIATR SOC, V60, P1487, DOI 10.1111/j.1532-5415.2012.04054.x; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Dalton AF, 2015, MED DECIS MAKING, V35, P458, DOI 10.1177/0272989X15572828; Doroodchi H, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-42; Ferket BS, 2010, ARCH INTERN MED, V170, P27, DOI 10.1001/archinternmed.2009.434; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried TR, 2008, J AM GERIATR SOC, V56, P1839, DOI 10.1111/j.1532-5415.2008.01923.x; Fried TR, 2011, ARCH INTERN MED, V171, P1854, DOI 10.1001/archinternmed.2011.424; Gnjidic D, 2012, J CLIN EPIDEMIOL, V65, P989, DOI 10.1016/j.jclinepi.2012.02.018; Gu QP, 2012, CIRCULATION, V126, P2105, DOI 10.1161/CIRCULATIONAHA.112.096156; Holmes HM, 2015, JAMA INTERN MED, V175, P701, DOI 10.1001/jamainternmed.2015.0328; Jackson R, 2008, HEART, V94, P1, DOI 10.1136/hrt.2007.138040; Jansen J, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2893; Jansen J, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0310-1; Kutner JS, 2015, JAMA INTERN MED, V175, P691, DOI 10.1001/jamainternmed.2015.0289; Leppin AL, 2015, HEALTHCARE-BASEL, V3, P50, DOI 10.3390/healthcare3010050; Liew SM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000728; Mitnitski Arnold B, 2002, BMC Geriatr, V2, P1; Mutasingwa DR, 2011, CAN FAM PHYSICIAN, V57, pE253; Muth C, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0223-1; Petersen LK, 2010, AGE AGEING, V39, P674, DOI 10.1093/ageing/afq129; Pound P, 2005, SOC SCI MED, V61, P133, DOI 10.1016/j.socscimed.2004.11.063; Ramos R, 2016, INT J CARDIOL, V225, P300, DOI 10.1016/j.ijcard.2016.10.005; Ritchie J, 2003, QUALITATIVE RES PRAC, P219, DOI DOI 10.1186/1471-2288-13-117; Rodriguez-Manas L, 2015, LANCET, V385, pE7, DOI 10.1016/S0140-6736(14)61595-6; Rossello X, 2015, J AM COLL CARDIOL, V66, P1273, DOI 10.1016/j.jacc.2015.07.018; Russell BJ, 2014, INTERN MED J, V44, P177, DOI 10.1111/imj.12340; Savarese G, 2013, J AM COLL CARDIOL, V62, P2090, DOI 10.1016/j.jacc.2013.07.069; Schelbert EB, 2012, JAMA-J AM MED ASSOC, V308, P890, DOI 10.1001/2012.jama.11089; Schmittdiel JA, 2009, J WOMENS HEALTH, V18, P2065, DOI 10.1089/jwh.2009.1406; Schuling J, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-56; Scott IA, 2010, ARCH INTERN MED, V170, P387; Tinetti ME, 2008, J AM GERIATR SOC, V56, P730, DOI 10.1111/j.1532-5415.2007.01627.x; Tinetti ME, 2004, NEW ENGL J MED, V351, P2870, DOI 10.1056/NEJMsb042458; van Peet PG, 2015, BRIT J GEN PRACT, V65, pE739, DOI 10.3399/bjgp15X687373; Vitry AI, 2008, MED J AUSTRALIA, V189, P360, DOI 10.5694/j.1326-5377.2008.tb02079.x; Vollrath Annette M, 2005, J Palliat Med, V8, P876, DOI 10.1089/jpm.2005.8.876; Weiner M, 2009, J PRIM HEALTH CARE, V1, P198, DOI 10.1071/HC09198; Wyatt KD, 2014, MED CARE, V52, pS92, DOI 10.1097/MLR.0b013e3182a51b3d	48	30	30	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0170228	10.1371/journal.pone.0170228	http://dx.doi.org/10.1371/journal.pone.0170228			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH7SJ	28085944	Green Published, Green Submitted, gold			2022-12-26	WOS:000391972600077
J	Lee, JS; Cho, SH; Lim, CM; Chang, MI; Joo, HJ; Bae, H; Park, HJ				Lee, Ji Sun; Cho, Soo Hee; Lim, Chae Mi; Chang, Moon Ik; Joo, Hyun Jin; Bae, Hojae; Park, Hyun Jin			A Liquid Chromatography - Tandem Mass Spectrometry Approach for the Identification of Mebendazole Residue in Pork, Chicken, and Horse	PLOS ONE			English	Article							METABOLITES; BENZIMIDAZOLES; VALIDATION; EXTRACTION; ARRAY	A confirmatory and quantitative method of liquid chromatography-tandem mass spectrometry (LC-MS/MS) for the determination of mebendazole and its hydrolyzed and reduced metabo-lites in pork, chicken, and horse muscles was developed and validated in this study. Anthelmintic compounds were extracted with ethyl acetate after sample mixture was made alkaline followed by liquid chromatographic separation using a reversed phase C-18 column. Gradient elution was performed with a mobile phase consisting of water containing 10 mM ammonium formate and methanol. This confirmatory method was validated according to EU requirements. Evaluated validation parameters included specificity, accuracy, precision (repeatability and within-laboratory reproducibility), analytical limits (decision limit and detection limit), and applicability. Most parameters were proved to be conforming to the EU requirements. The decision limit (CC alpha) and detection capability (CC beta) for all analytes ranged from 15.84 to 17.96 mu gkg(-1). The limit of detection (LOD) and the limit of quantification (LOQ) for all analytes were 0.07 mu gkg(-1) and 0.2 mu gkg(-1), respectively. The developed method was successfully applied to monitoring samples collected from the markets in major cities and proven great potential to be used as a regulatory tool to determine mebendazole residues in animal based foods.	[Lee, Ji Sun] Seoul Reg Food & Drug Adm, Imported Food Anal Div, 212 Mokdongjungang Ro, Seoul, South Korea; [Lee, Ji Sun; Park, Hyun Jin] Korea Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, 5 Ka, Seoul, South Korea; [Cho, Soo Hee] Korea Hlth Supplements Inst, Korea Hlth Supplements Assoc Sub, B Dong 101,700 Daewangpangyo Ro, Seongnam Si, Gyeonggi Do, South Korea; [Lim, Chae Mi; Joo, Hyun Jin] Minist Food & Drug Safety, 187 Osongsaengmyeong2 I Ro, Chungju Si, Chungcheonbuk D, South Korea; [Chang, Moon Ik] Minist Food & Drug Safety, Pesticide & Vet Drug Residues Div, Food Safety Evaluat Dept, Natl Inst Food & Drug Safety Evaluat, 187 Osongsaengmyeong2 I Ro, Chungju Si, Chungcheonbuk D, South Korea; [Bae, Hojae] Konkuk Univ, Dept Bioind Technol, Coll Anim Biosci & Technol, Seoul, South Korea; [Park, Hyun Jin] Clemson Univ, Dept Packaging Sci, Clemson, SC USA	Korea University; Ministry of Food & Drug Safety (MFDS), Republic of Korea; Ministry of Food & Drug Safety (MFDS), Republic of Korea; National Institute of Food & Drug Safety Evaluation; Konkuk University; Clemson University	Park, HJ (corresponding author), Korea Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, 5 Ka, Seoul, South Korea.; Bae, H (corresponding author), Konkuk Univ, Dept Bioind Technol, Coll Anim Biosci & Technol, Seoul, South Korea.; Park, HJ (corresponding author), Clemson Univ, Dept Packaging Sci, Clemson, SC USA.	hajaebae@konkuk.ac.kr; hjpark@korea.ac.kr		bae, hojae/0000-0003-3057-4999	Ministry of Food and Drug Safety, Republic of Korea [13161foodsafety002]	Ministry of Food and Drug Safety, Republic of Korea(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	This work was supported by a Project (No.13161foodsafety002) for Method development and monitoring on Residues of Veterinary Drugs in foods funded by the Ministry of Food and Drug Safety, Republic of Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera-Luiz MM, 2008, J CHROMATOGR A, V1205, P10, DOI 10.1016/j.chroma.2008.07.066; Caprioli G, 2010, J CHROMATOGR A, V1217, P1779, DOI 10.1016/j.chroma.2010.01.056; Chen D, J CHROMATOGRAPHY B, V878, P2928; Chen DM, 2011, J CHROMATOGR B, V879, P1659, DOI 10.1016/j.jchromb.2011.04.004; Crawdord LM, 1994, ANIMAL DRUGS HUMAN H; De Ruyck H, 2003, ANAL CHIM ACTA, V483, P111, DOI 10.1016/S0003-2670(02)01018-8; De Ruyck H, 2001, ANALYST, V126, P2144, DOI 10.1039/b105767g; Hadad GM, 2009, TALANTA, V79, P1360, DOI 10.1016/j.talanta.2009.06.003; Jedziniak P, 2009, J CHROMATOGR A, V1216, P8165, DOI 10.1016/j.chroma.2009.07.036; Korean Food Standards Codex, GEN AN METH 5 3 95 M; Li B, 2012, PARASITOL RES, V111, P935, DOI 10.1007/s00436-012-2838-5; Liu HA, 2010, CHROMATOGRAPHIA, V72, P1083, DOI 10.1365/s10337-010-1768-6; LONG A R, 1990, Journal of Food Composition and Analysis, V3, P20, DOI 10.1016/0889-1575(90)90005-7; Nobilis M, 2008, J CHROMATOGR B, V876, P89, DOI 10.1016/j.jchromb.2008.10.032; Su SC, 2003, J FOOD DRUG ANAL, V11, P307; Whelan M, J CHROMATOGR A, V1217, P4612, DOI DOI 10.1016/J.003; Xia X, 2013, J CHROMATOGR A, V1292, P96, DOI 10.1016/j.chroma.2012.09.006; Zhu XL, 2011, J AOAC INT, V94, P839	18	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0169597	10.1371/journal.pone.0169597	http://dx.doi.org/10.1371/journal.pone.0169597			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085912	Green Published, Green Submitted, gold			2022-12-26	WOS:000391972600026
J	Montgomery, MD; Chan, T; Swigart, PM; Myagmar, BE; Dash, R; Simpson, PC				Montgomery, Megan D.; Chan, Trevor; Swigart, Philip M.; Myagmar, Bat-erdene; Dash, Rajesh; Simpson, Paul C.			An Alpha-1A Adrenergic Receptor Agonist Prevents Acute Doxorubicin Cardiomyopathy in Male Mice	PLOS ONE			English	Article							HEART-FAILURE; ANTHRACYCLINE CARDIOTOXICITY; ALPHA-1-ADRENERGIC RECEPTORS; CARDIAC DYSFUNCTION; PROTECTS; HYPERTROPHY; ACTIVATION; SUBTYPE; HEPATOTOXICITY; PRESSURE	Alpha-1 adrenergic receptors mediate adaptive effects in the heart and cardiac myocytes, and a myocyte survival pathway involving the alpha-1A receptor subtype and ERK activation exists in vitro. However, data in vivo are limited. Here we tested A61603 (N-[5-(4,5-dihydro-1H- imidazol-2-yl)-2-hydroxy- 5,6,7,8-tetrahydronaphthalen-1-yl] methanesulfonamide), a selective imidazoline agonist for the alpha-1A. A61603 was the most potent alpha-1-agonist in activating ERK in neonatal rat ventricular myocytes. A61603 activated ERK in adult mouse ventricular myocytes and protected the cells from death caused by the anthracycline doxorubicin. A low dose of A61603 (10 ng/kg/d) activated ERK in the mouse heart in vivo, but did not change blood pressure. In male mice, concurrent subcutaneous A61603 infusion at 10 ng/kg/d for 7 days after a single intraperitoneal dose of doxorubicin (25 mg/kg) increased survival, improved cardiac function, heart rate, and cardiac output by echocardiography, and reduced cardiac cell necrosis and apoptosis and myocardial fibrosis. All protective effects were lost in alpha-1A-knockout mice. In female mice, doxorubicin at doses higher than in males (35-40 mg/kg) caused less cardiac toxicity than in males. We conclude that the alpha-1A-selective agonist A61603, via the alpha-1A adrenergic receptor, prevents doxorubicin cardiomyopathy in male mice, supporting the theory that alpha-1A adrenergic receptor agonists have potential as novel heart failure therapies.	[Montgomery, Megan D.; Chan, Trevor; Swigart, Philip M.; Myagmar, Bat-erdene; Dash, Rajesh; Simpson, Paul C.] VA Med Ctr, Dept Med, Div Cardiol, San Francisco, CA 94121 USA; [Montgomery, Megan D.; Chan, Trevor; Swigart, Philip M.; Myagmar, Bat-erdene; Dash, Rajesh; Simpson, Paul C.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Montgomery, Megan D.; Chan, Trevor; Swigart, Philip M.; Myagmar, Bat-erdene; Dash, Rajesh; Simpson, Paul C.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Chan, Trevor; Dash, Rajesh] Stanford Univ, Stanford, CA 94305 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University	Simpson, PC (corresponding author), VA Med Ctr, Dept Med, Div Cardiol, San Francisco, CA 94121 USA.; Simpson, PC (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Simpson, PC (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	paul.simpson@ucsf.edu			National Institutes of Health [HL31113]; Department of Veterans Affairs [BX001970]; Western States Affiliate of the American Heart Association; Sarnoff Foundation for Cardiovascular Research; PhRMA Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Western States Affiliate of the American Heart Association(American Heart Association); Sarnoff Foundation for Cardiovascular Research; PhRMA Foundation	This work was supported by National Institutes of Health (PCS, HL31113), the Department of Veterans Affairs (PCS, BX001970), the Western States Affiliate of the American Heart Association (RD), the Sarnoff Foundation for Cardiovascular Research (TC), and the PhRMA Foundation (MDM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLQUIST RP, 1948, AM J PHYSIOL, V153, P586, DOI 10.1152/ajplegacy.1948.153.3.586; Altenbach RJ, 2004, J MED CHEM, V47, P3220, DOI 10.1021/jm030551a; BAGCHI D, 1995, TOXICOLOGY, V95, P1, DOI 10.1016/0300-483X(94)02867-T; Bai P, 2004, ONCOL REP, V11, P505; Baker AJ, 2014, PFLUG ARCH EUR J PHY, V466, P1139, DOI 10.1007/s00424-014-1491-5; Beak JY, 2016, JACC BASIC IN PRESS; Belmonte F, 2015, AM J PHYSIOL-HEART C, V309, pH271, DOI 10.1152/ajpheart.00517.2014; Blenck CL, 2016, CIRC RES, V118, P1294, DOI 10.1161/CIRCRESAHA.116.307509; Bueno OF, 2002, CIRC RES, V91, P776, DOI 10.1161/01.RES.0000038488.38975.1A; Cardinale D, 2000, J AM COLL CARDIOL, V36, P517, DOI 10.1016/S0735-1097(00)00748-8; Cardinale D, 2015, CIRCULATION, V131, P1981, DOI 10.1161/CIRCULATIONAHA.114.013777; Center for Drug Evaluation and Research, 2005, GUID IND EST MAX SAF; Chen YL, 2015, J PHARMACOL EXP THER, V355, P516, DOI 10.1124/jpet.115.225375; COHN JN, 1993, CIRCULATION, V87, P1; Cowley PM, 2015, AM J PHYSIOL-HEART C, V309, pH888, DOI 10.1152/ajpheart.00042.2015; Danesi R, 2002, CLIN PHARMACOKINET, V41, P431, DOI 10.2165/00003088-200241060-00004; Dash R, 2011, MAGN RESON MED, V66, P1152, DOI 10.1002/mrm.22876; Deng XF, 2000, CIRC RES, V87, P781, DOI 10.1161/01.RES.87.9.781; Du XJ, 2006, CARDIOVASC RES, V71, P735, DOI 10.1016/j.cardiores.2006.06.015; Du XJ, 2004, J MOL CELL CARDIOL, V37, P979, DOI 10.1016/j.yjmcc.2004.07.010; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Gianni L, 2008, J CLIN ONCOL, V26, P3777, DOI 10.1200/JCO.2007.14.9401; Huang Y, 2007, CIRCULATION, V115, P763, DOI 10.1161/CIRCULATIONAHA.106.664862; Ishizaka S, 2004, AM J PHYSIOL-HEART C, V286, pH1208, DOI 10.1152/ajpheart.00011.2003; Jensen BC, 2014, J CARDIOVASC PHARM, V63, P291, DOI 10.1097/FJC.0000000000000032; Jensen BC, 2011, J MOL CELL CARDIOL, V51, P518, DOI 10.1016/j.yjmcc.2010.11.014; Jensen BC, 2009, CIRC-HEART FAIL, V2, P654, DOI 10.1161/CIRCHEARTFAILURE.108.846212; Jensen BC, 2009, J AM COLL CARDIOL, V54, P1137, DOI 10.1016/j.jacc.2009.05.056; Kalender Y, 2005, TOXICOLOGY, V209, P39, DOI 10.1016/j.tox.2004.12.003; Ky B, 2013, CIRC RES, V113, P754, DOI 10.1161/CIRCRESAHA.113.300218; Li DZ, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003172; Li K, 2006, CIRCULATION, V113, P2211, DOI 10.1161/CIRCULATIONAHA.105.560250; Li LH, 2006, CIRCULATION, V113, P535, DOI 10.1161/CIRCULATIONAHA.105.568402; Li LH, 2007, LAB INVEST, V87, P440, DOI 10.1038/labinvest.3700530; Li SY, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/748524; Lin G, 2001, CIRC RES, V89, P343, DOI 10.1161/hh1601.095912; Liu XW, 2002, AM J PHYSIOL-HEART C, V283, pH254, DOI 10.1152/ajpheart.01023.2001; Luminari S, 2010, ANN ONCOL, V21, P1492, DOI 10.1093/annonc/mdp544; Mukhopadhyay P, 2007, J AM COLL CARDIOL, V50, P528, DOI 10.1016/j.jacc.2007.03.057; Neilan TG, 2012, AM J CARDIOL, V110, P1679, DOI 10.1016/j.amjcard.2012.07.040; O'Connell TD, 2006, METHOD MOL BIOL, V357; O'Connell TD, 2014, PHARMACOL REV, V66, P308, DOI 10.1124/pr.112.007203; Pacher P, 2003, CIRCULATION, V107, P896, DOI 10.1161/01.CIR.0000048192.52098.DD; Pacher P, 2002, J PHARMACOL EXP THER, V300, P862, DOI 10.1124/jpet.300.3.862; Robert J, 2007, CARDIOVASC TOXICOL, V7, P135, DOI 10.1007/s12012-007-0022-4; Rokosh DG, 2002, P NATL ACAD SCI USA, V99, P9474, DOI 10.1073/pnas.132552699; Sawyer DB, 2010, PROG CARDIOVASC DIS, V53, P105, DOI 10.1016/j.pcad.2010.06.007; Shindler D, 2015, E CHOCARDIOGRAPHY J; SILBER JH, 1993, MED PEDIATR ONCOL, V21, P477, DOI 10.1002/mpo.2950210704; SIMPSON P, 1985, CIRC RES, V56, P884, DOI 10.1161/01.RES.56.6.884; Skomedal T, 1997, J PHARMACOL EXP THER, V280, P721; Sterba M, 2011, J MOL CELL CARDIOL, V50, P849, DOI 10.1016/j.yjmcc.2011.01.018; Thomas R Croft, 2016, JACC Basic Transl Sci, V1, P155; Tirelli U, 1998, J CLIN ONCOL, V16, P27, DOI 10.1200/JCO.1998.16.1.27; Yeh CC, 2010, J CELL BIOCHEM, V109, P1185, DOI 10.1002/jcb.22498; Zhao XY, 2012, BIOL PHARM BULL, V35, P796, DOI 10.1248/bpb.35.796	56	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0168409	10.1371/journal.pone.0168409	http://dx.doi.org/10.1371/journal.pone.0168409			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081170	gold, Green Published, Green Submitted			2022-12-26	WOS:000391949500011
J	Nieuwenhuys, A; Papageorgiou, E; Desloovere, K; Molenaers, G; De Laet, T				Nieuwenhuys, Angela; Papageorgiou, Eirini; Desloovere, Kaat; Molenaers, Guy; De Laet, Tinne			Statistical Parametric Mapping to Identify Differences between Consensus-Based Joint Patterns during Gait in Children with Cerebral Palsy	PLOS ONE			English	Article							BAYESIAN-APPROACH; CLASSIFICATION; IDENTIFICATION; INDIVIDUALS; DIPLEGIA	Experts recently identified 49 joint motion patterns in children with cerebral palsy during a Delphi consensus study. Pattern definitions were therefore the result of subjective expert opinion. The present study aims to provide objective, quantitative data supporting the identification of these consensus-based patterns. To do so, statistical parametric mapping was used to compare the mean kinematic waveforms of 154 trials of typically developing children (n = 56) to the mean kinematic waveforms of 1719 trials of children with cerebral palsy (n = 356), which were classified following the classification rules of the Delphi study. Three hypotheses stated that: (a) joint motion patterns with 'no or minor gait deviations' (n = 11 patterns) do not differ significantly from the gait pattern of typically developing children; (b) all other pathological joint motion patterns (n = 38 patterns) differ from typically developing gait and the locations of difference within the gait cycle, highlighted by statistical parametric mapping, concur with the consensus-based classification rules. (c) all joint motion patterns at the level of each joint (n = 49 patterns) differ from each other during at least one phase of the gait cycle. Results showed that: (a) ten patterns with 'no or minor gait deviations' differed somewhat unexpectedly from typically developing gait, but these differences were generally small (<= 3(*)); (b) all other joint motion patterns (n = 38) differed from typically developing gait and the significant locations within the gait cycle that were indicated by the statistical analyses, coincided well with the classification rules; (c) joint motion patterns at the level of each joint significantly differed from each other, apart from two sagittal plane pelvic patterns. In addition to these results, for several joints, statistical analyses indicated other significant areas during the gait cycle that were not included in the pattern definitions of the consensus study. Based on these findings, suggestions to improve pattern definitions were made.	[Nieuwenhuys, Angela; Papageorgiou, Eirini; Desloovere, Kaat] Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium; [Nieuwenhuys, Angela; Papageorgiou, Eirini; Desloovere, Kaat] Univ Hosp Leuven, Clin Mot Anal Lab, Leuven, Belgium; [Molenaers, Guy] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium; [Molenaers, Guy] Univ Hosp Leuven, Dept Orthoped, Leuven, Belgium; [De Laet, Tinne] Katholieke Univ Leuven, Fac Engn Sci, Leuven, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven	Nieuwenhuys, A (corresponding author), Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium.; Nieuwenhuys, A (corresponding author), Univ Hosp Leuven, Clin Mot Anal Lab, Leuven, Belgium.	angelanieuwenhuys@gmail.com	Desloovere, Kaat/F-3240-2014; De Laet, Tinne/AAK-8612-2020	Desloovere, Kaat/0000-0002-8507-5276; De Laet, Tinne/0000-0003-0624-3305	OT project of KU Leuven University [OT/12/100]; MD Paedigree project, a Model-Driven Paediatric European Digital Repository - European Commission under FP7 - ICT Programme [600932]; SIMCP IWT-project (Agentschap voor Innovatie door Wetenschap en Technologie) [IWT 140184]	OT project of KU Leuven University; MD Paedigree project, a Model-Driven Paediatric European Digital Repository - European Commission under FP7 - ICT Programme; SIMCP IWT-project (Agentschap voor Innovatie door Wetenschap en Technologie)	AN is supported by an OT project of KU Leuven University (OT/12/100). EP is supported by the MD Paedigree project, a Model-Driven Paediatric European Digital Repository, partially funded by the European Commission under FP7 - ICT Programme (grant agreement no: 600932, http://www.md-paedigree.eu) and by the SIMCP IWT-project (Agentschap voor Innovatie door Wetenschap en Technologie), a simulation platform to predict gait performance following orthopedic intervention in children with cerebral palsy (IWT 140184). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler R., 2007, RANDOM FIELDS GEOMET; Bonnefoy-Mazure A, 2013, RES DEV DISABIL, V34, P2684, DOI 10.1016/j.ridd.2013.05.002; Carriero A, 2009, GAIT POSTURE, V29, P71, DOI 10.1016/j.gaitpost.2008.06.011; Cook RE, 2003, J PEDIATR ORTHOPED, V23, P292, DOI 10.1097/00004694-200305000-00004; Davids JR, 2014, J AM ACAD ORTHOP SUR, V22, P782, DOI 10.5435/JAAOS-22-12-782; DeLuca PA, 1997, J PEDIATR ORTHOPED, V17, P608, DOI 10.1097/00004694-199709000-00007; Dobson F, 2007, GAIT POSTURE, V25, P140, DOI 10.1016/j.gaitpost.2006.01.003; Ferrari A, 2008, EUR J PHYS REHAB MED, V44, P195; Nieuwenhuys A, 2015, GAIT POSTURE S1, V42, pS46; Nieuwenhuys A, 2016, DEV MED CHILD NEUROL, V58, P306, DOI 10.1111/dmcn.12892; Pataky TC, 2010, J BIOMECH, V43, P1976, DOI 10.1016/j.jbiomech.2010.03.008; Rha DW, 2015, ARCH PHYS MED REHAB, V96, P511, DOI 10.1016/j.apmr.2014.09.039; Rodda JM, 2004, J BONE JOINT SURG BR, V86B, P251, DOI 10.1302/0301-620X.86B2.13878; Schwartz MH, 2004, GAIT POSTURE, V20, P196, DOI 10.1016/j.gaitpost.2003.09.011; Skaggs DL, 2000, J PEDIATR ORTHOPED, V20, P759, DOI 10.1097/01241398-200011000-00012; Sutherland DH, 1999, GAIT POSTURE, V10, P1, DOI 10.1016/S0966-6362(99)00012-0; SUTHERLAND DH, 1993, CLIN ORTHOP RELAT R, V288, P139; Toro B, 2007, GAIT POSTURE, V25, P157, DOI 10.1016/j.gaitpost.2006.02.004; Van Gestel L, 2011, RES DEV DISABIL, V32, P2542, DOI 10.1016/j.ridd.2011.07.004; Wren TAL, 2013, GAIT POSTURE, V38, P236, DOI 10.1016/j.gaitpost.2012.11.018; Wren TAL, 2011, GAIT POSTURE, V34, P149, DOI 10.1016/j.gaitpost.2011.03.027; Zhang BL, 2009, PATTERN RECOGN, V42, P581, DOI 10.1016/j.patcog.2008.09.025	22	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169834	10.1371/journal.pone.0169834	http://dx.doi.org/10.1371/journal.pone.0169834			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081229	Green Submitted, Green Published, gold			2022-12-26	WOS:000391949500087
J	Song, JY; Song, QY; Wang, S; Ma, J; Wang, HJ				Song, Jie-Yun; Song, Qi-Ying; Wang, Shuo; Ma, Jun; Wang, Hai-Jun			Physical Activity and Sedentary Behaviors Modify the Association between Melanocortin 4 Receptor Gene Variant and Obesity in Chinese Children and Adolescents	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SINGLE NUCLEOTIDE POLYMORPHISMS; COMMON VARIANTS; MC4R; RISK; LOCI; OVERWEIGHT; INSIG2; MASS; FTO	Effects of MC4R variants in previous Chinese population studies were inconsistent. Gene environment interactions might influence the effect of MC4R variants on obesity, which was still unclear. We performed the study to clarify the association of variants near MC4R gene with obesity-related phenotypes and gene-environment interactions in Chinese children and adolescents. Two common variants (rs12970134 and rs17782313) near MC4R were geno-typed in 2179 children and adolescents aged 7-18 years in Beijing of China. Associations between the variants and obesity-related phenotypes together with gene-environment interactions were analyzed. The A-alleles of rs12970134 were nominally associated with risk of overweight/obesity (Odds Ratios (OR) = 1.21, 95%Cl: 1.03-1.44, P= 0.025) and BMI ((3 = 0.33 kg/m2, 95`)/X1: 0.02-0.63, P= 0.025), respectively. The rs12970134 was also associated with HDL-C ((3 =-0.03mmol/L per A-allele, 95%Cl:-0.05,-0.01, P= 0.013) independent of BMI. In the further analysis, we found the significant interaction of rs12970134 and physical activity/sedentary behaviors on BMI (P-interaction = 0.043). The rs12970134 was found to be associated with BMI only in children with physical activity<1 h/d and sedentary behaviors >= 2h/d (BMI: beta = 1.27 kg/m(2), 95%Cl: 0.10-2.45, P= 0.034). The association was not detected in their counterparts with physical activity >= 1 h/d or sedentary behaviors <2h/d. We identified the effect of MC4R rs12970134 on overweight/obesity and BMI, and we also found physical activity and sedentary behaviors modified the association between the rs12970134 and BMI in Chinese children and adolescents.	[Song, Jie-Yun; Song, Qi-Ying; Wang, Shuo; Ma, Jun; Wang, Hai-Jun] Peking Univ, Inst Child & Adolescent Hlth, Sch Publ Hlth, Beijing, Peoples R China	Peking University	Wang, HJ (corresponding author), Peking Univ, Inst Child & Adolescent Hlth, Sch Publ Hlth, Beijing, Peoples R China.	whjun1@bjmu.edu.cn	Song, Qiying/AAV-6247-2021; Wang, Haijun/AAD-1302-2021	Wang, Haijun/0000-0003-0849-2903	National Natural Science Foundation of China [81573170]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by grants from National Natural Science Foundation of China 81573170 (http://www.nsfc.gov.cn/).	[Anonymous], 4562014 WST NAT HLTH; Cauchi S, 2009, J MOL MED, V87, P537, DOI 10.1007/s00109-009-0451-6; Cha S, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/nep162; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Chen CM, 2007, PREVENTION CONTROL G, P36; Cheung CYY, 2010, J CLIN ENDOCR METAB, V95, P1395, DOI 10.1210/jc.2009-1465; Corella D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052344; Fiebig R, 1999, J APPL PHYSIOL, V87, P1009, DOI 10.1152/jappl.1999.87.3.1009; GOODRIDGE AG, 1987, ANNU REV NUTR, V7, P157, DOI 10.1146/annurev.nu.07.070187.001105; Hebebrand J, 2010, OBESITY FACTS, V3, P294, DOI 10.1159/000321537; Hong J, 2013, INT J OBESITY, V37, P673, DOI 10.1038/ijo.2012.87; Huang W, 2011, ENDOCRINE, V39, P69, DOI 10.1007/s12020-010-9413-6; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Ji CY, 2005, BIOMED ENVIRON SCI, V18, P390; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Li SX, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000332; Li XH, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1282; Liem ET, 2010, AM J CLIN NUTR, V91, P321, DOI 10.3945/ajcn.2009.28186; Liu GF, 2010, J PEDIATR-US, V156, P598, DOI 10.1016/j.jpeds.2009.10.037; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Ma J., 2009, CHIN J SCH HLTH, V30, P214; Ma J, 2009, CHINESE J SCH HLTH, V30, P201; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Nogueiras R, 2007, J CLIN INVEST, V117, P3475, DOI 10.1172/JCI31743; Qi QB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1610; Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039; Shi JJ, 2010, AM J EPIDEMIOL, V172, P244, DOI 10.1093/aje/kwq129; Tao LM, 2012, MOL BIOL REP, V39, P6487, DOI 10.1007/s11033-012-1476-4; Tao YX, 2010, ENDOCR REV, V31, P506, DOI 10.1210/er.2009-0037; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Walker WA, 2004, J NUTR, V134, p2434S, DOI 10.1093/jn/134.9.2434S; Wang D, 2010, OBESITY, V18, P573, DOI 10.1038/oby.2009.268; Wang HJ, 2008, BIOMED ENVIRON SCI, V21, P528, DOI 10.1016/S0895-3988(09)60013-1; Wang J, 2012, INT J OBESITY, V36, P542, DOI 10.1038/ijo.2011.218; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; World Health Organization, GROWTH REF DAT 5 19; Wu LJ, 2010, DIABETES, V59, P3085, DOI 10.2337/db10-0273; Xi Bo, 2012, PLoS One, V7, pe45731, DOI 10.1371/journal.pone.0045731; Xi B, 2011, AM J EPIDEMIOL, V173, P1256, DOI 10.1093/aje/kwr008; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88; Zobel DP, 2009, DIABETES, V58, P757, DOI 10.2337/db08-0620	41	60	65	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0170062	10.1371/journal.pone.0170062	http://dx.doi.org/10.1371/journal.pone.0170062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081251	Green Published, Green Submitted, gold			2022-12-26	WOS:000391949500125
J	Flint, M; Mills, PC; Loban, F; Simpson, T; Lui, S; Fujii, R; Whap, D; Flint, JB; Owen, H				Flint, Mark; Mills, Paul C.; Loban, Frank; Simpson, Tristan; Lui, Stan; Fujii, Ronald; Whap, Don; Flint, Jaylene B.; Owen, Helen			Development of a Humane Slaughter Device for Green Turtles for Use by Traditional Owners in the Torres Strait Islands, Australia	PLOS ONE			English	Article								Marine turtles are caught and slaughtered for consumption as part of traditional indigenous community harvest in Australia as well as in many countries in which marine turtles can be found. However, changes to the Animal Care and Protection Act 2001 in 2012 resulted in Australian indigenous hunters becoming potentially liable to prosecution for using traditional practices to slaughter marine turtles. To provide indigenous hunters with an alternative scientifically tested method to hunt, we developed and tested a humane method as an option to use in indigenous communities. Between 2012 and 2015, a device was developed, tested on 11 carcasses to determine effectiveness and repeatability, used on 5 anaesthetised animals independently diagnosed as candidates for euthanasia, and ultimately used on 2 healthy, conscious animals as part of normal indigenous community subsistence harvesting under observation before being left with the communities for use. Feedback was sought from the communities on the suitability and potential adoption of the device. The device effectively ablated the hind brain and severed the spinal cord when deployed in 81% (9/11) of the tested carcasses, with death in 100% (5/5) of turtles, on average, within 78 seconds of deployment on anaesthetised turtles and death in 100% (2/2) of turtles, on average, within 144 seconds when deployed on healthy turtles within community. Failure to ablate the hind brain and sever the spinal cord in the cadaver cases was due to incorrect deployment of the device. This device showed promise as an alternative euthanasia method available to indigenous communities of the Torres Straits. Further work is required to encourage acceptance by hunters.	[Flint, Mark; Mills, Paul C.; Flint, Jaylene B.; Owen, Helen] Univ Queensland, Sch Vet Sci, Vet Marine Anim Res Teaching & Invest Unit, Gatton Campus, Brisbane, Qld 4072, Australia; [Flint, Mark] Univ Florida, Sch Forest Resources & Conservat, Florida Aquariums Ctr Conservat, Apollo Beach, FL 33572 USA; [Loban, Frank; Simpson, Tristan; Lui, Stan; Fujii, Ronald; Whap, Don] Torres Strait Reg Author, Environm Management Program, Land & Sea Management Unit, Thursday Isl, Qld, Australia; [Flint, Jaylene B.] Florida Aquariums Ctr Conservat, Apollo Beach, FL USA	University of Queensland; State University System of Florida; University of Florida	Flint, M (corresponding author), Univ Queensland, Sch Vet Sci, Vet Marine Anim Res Teaching & Invest Unit, Gatton Campus, Brisbane, Qld 4072, Australia.; Flint, M (corresponding author), Univ Florida, Sch Forest Resources & Conservat, Florida Aquariums Ctr Conservat, Apollo Beach, FL 33572 USA.	flintm@ufl.edu			Torres Strait Regional Authority [CA-2012-00037]	Torres Strait Regional Authority	This research was funded by the Torres Strait Regional Authority through contract CA-2012-00037.	Appelt M, 2007, CAN VET J, V48, P529; BLOOD DC, 2000, SAUNDERS COMPREHENSI; Flint M, 2010, VET J, V185, P299, DOI 10.1016/j.tvjl.2009.06.011; Flint M, 2009, J VET DIAGN INVEST, V21, P733, DOI 10.1177/104063870902100601; GRANDIN T, 1994, J AM VET MED ASSOC, V204, P1354; Leary S, 2013, AVMA GUIDELINES EUTH; Leary S, 2016, AVMA GUIDELINES HUMA, P64; Scheelings T. Franciscus, 2013, Journal of Herpetological Medicine and Surgery, V23, P91, DOI 10.5818/1529-9651-23.3.91; Work Thierry M., 2013, Marine Turtle Newsletter, P5	9	2	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0167849	10.1371/journal.pone.0167849	http://dx.doi.org/10.1371/journal.pone.0167849			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076432	Green Published, Green Submitted, gold			2022-12-26	WOS:000391857100007
J	Marko, MD; Shevach, G				Marko, Matthew David; Shevach, Glenn			Sensorless Modeling of Varying Pulse Width Modulator Resolutions in Three-Phase Induction Motors	PLOS ONE			English	Article							DIRECT TORQUE CONTROL; SPEED CONTROL; OBSERVERS; ZERO	A sensorless algorithm was developed to predict rotor speeds in an electric three-phase induction motor. This sensorless model requires a measurement of the stator currents and voltages, and the rotor speed is predicted accurately without any mechanical measurement of the rotor speed. A model of an electric vehicle undergoing acceleration was built, and the sensorless prediction of the simulation rotor speed was determined to be robust even in the presence of fluctuating motor parameters and significant sensor errors. Studies were conducted for varying pulse width modulator resolutions, and the sensorless model was accurate for all resolutions of sinusoidal voltage functions.	[Marko, Matthew David; Shevach, Glenn] Joint Base McGuire Dix Lakehurst, Naval Air Warfare Ctr Aircraft Div, Lakehurst, NJ 08733 USA		Marko, MD (corresponding author), Joint Base McGuire Dix Lakehurst, Naval Air Warfare Ctr Aircraft Div, Lakehurst, NJ 08733 USA.	matthew.marko@navy.mil			In-house Laboratory Independent Research (ILIR) project "Sensorless Failover Design in High Criticality / High Performance Applications"	In-house Laboratory Independent Research (ILIR) project "Sensorless Failover Design in High Criticality / High Performance Applications"	This effort is funded by the In-house Laboratory Independent Research (ILIR) project "Sensorless Failover Design in High Criticality / High Performance Applications." The funder had no role in study design, data collection and analysis, or preparation of the manuscript.	Areed FG, 2010, AIN SHAMS ENG J, V1, P71, DOI 10.1016/j.asej.2010.09.008; Chen ZQ, 2000, IEEE T IND ELECTRON, V47, P582, DOI 10.1109/41.847899; CONSOLI A, 1994, IEEE T IND ELECTRON, V41, P91, DOI 10.1109/41.281613; Damodharan P, 2010, IEEE T ENERGY CONVER, V25, P661, DOI 10.1109/TEC.2010.2041781; FURUHASHI T, 1992, IEEE T IND ELECTRON, V39, P89, DOI 10.1109/41.166729; JANSEN PL, 1994, IEEE T IND APPL, V30, P101, DOI 10.1109/28.273627; Johnson J. P., 1999, Conference Record of the 1999 IEEE Industry Applications Conference. Thirty-Forth IAS Annual Meeting (Cat. No.99CH36370), P143, DOI 10.1109/IAS.1999.799944; Kim TH, 2004, IEEE T POWER ELECTR, V19, P1635, DOI 10.1109/TPEL.2004.836625; Lascu C, 2000, IEEE T IND APPL, V36, P122, DOI 10.1109/28.821806; Lyshevski SE, 1999, ELECTROMAGNETIC SYST; Makiela D., 2011, 2011 IEEE 20th International Symposium on Industrial Electronics (ISIE 2011), P722, DOI 10.1109/ISIE.2011.5984246; Matsui N, 1996, IEEE T IND ELECTRON, V43, P300, DOI 10.1109/41.491354; Noroozi MA, 2013, 4TH ANNUAL INTERNATIONAL POWER ELECTRONICS, DRIVE SYSTEMS & TECHNOLOGIES CONFERENCE (PEDSTC 2013), P26, DOI 10.1109/PEDSTC.2013.6506667; Rashed M, 2007, IEEE T IND ELECTRON, V54, P1664, DOI 10.1109/TIE.2007.895136; Senjyu T., 1995, 1995 International IEEE/IAS Conference on Industrial Automation and Control: Emerging Technologies (Cat. No.95TH8070), P160, DOI 10.1109/IACET.1995.527556; TAJIMA H, 1993, IEEE T IND APPL, V29, P175, DOI 10.1109/28.195904; TAKAHASHI I, 1986, IEEE T IND APPL, V22, P820, DOI 10.1109/TIA.1986.4504799; Tzuen-Lih Chern, 2010, 2010 5th IEEE Conference on Industrial Electronics and Applications (ICIEA 2010), P1358, DOI 10.1109/ICIEA.2010.5514901; Ying M, 2010, INT C EL CONTR ENG I, P3212; Zhang YC, 2012, IEEE T POWER ELECTR, V27, P1502, DOI 10.1109/TPEL.2010.2043543	20	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0168149	10.1371/journal.pone.0168149	http://dx.doi.org/10.1371/journal.pone.0168149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076418	Green Submitted, gold, Green Published			2022-12-26	WOS:000391857100009
J	Zhao, K; Wu, YY				Zhao, Kuan; Wu, Yanyou			Effects of Zn Deficiency and Bicarbonate on the Growth and Photosynthetic Characteristics of Four Plant Species	PLOS ONE			English	Article							STRESS; ROOTS; SOIL; MN; FE	Calcareous soils are characterized by low nutrient contents, high bicarbonate (HCO3-) content, and high alkalinity. The effects of HCO3- addition under zinc-sufficient (+Zn) and zinc-deficient (-Zn) conditions on the growth and photosynthetic characteristics of seedlings of two Moraceae species (Broussonetia papyrifera and Morus alba) and two Brassicaceae species (Orychophragmus violaceus and Brassica napus) were investigated. These four species were hydroponically grown in nutrient solution with 0 mM Zn (-Zn) or 0.02 mM Zn (+Zn) and 0 mM or 10 mM HCO3-. The photosynthetic response to HCO3- treatment, Zn deficiency, or both varied according to plant species. Of the four species, Broussonetia papyrifera showed the best adaptability to Zn deficiency for both the 0 mM and 10 mM HCO3- treatments due to its strong growth and minimal inhibition of photosynthesis and photosystem II (PS II). Brassica napus was sensitive to Zn deficiency, HCO3- treatment, or both as evidenced by the considerable inhibition of photosynthesis and high PS II activity. The results indicated different responses of various plant species to Zn deficiency and excess HCO3-. Broussonetia papyrifera was shown to have potential as a pioneer species in karst regions.	[Zhao, Kuan] Anqing Normal Univ, Sch Environm & Resources, Anqing, Peoples R China; [Zhao, Kuan; Wu, Yanyou] Jiangsu Univ, Minist Educ, Key Lab Modern Agr Equipment & Technol, Zhenjiang, Peoples R China; [Wu, Yanyou] Chinese Acad Sci, Inst Geochem, State Key Lab Environm Geochem, Guiyang, Peoples R China	Anqing Normal University; Jiangsu University; Chinese Academy of Sciences; Guiyang Institute of Geochemistry, CAS	Wu, YY (corresponding author), Jiangsu Univ, Minist Educ, Key Lab Modern Agr Equipment & Technol, Zhenjiang, Peoples R China.; Wu, YY (corresponding author), Chinese Acad Sci, Inst Geochem, State Key Lab Environm Geochem, Guiyang, Peoples R China.	wuyanyou@mail.gyig.ac.cn			National Key Basic Research Program of China [2013CB956701]; National Key Research and Development Program of China [2016YFC0502602]; National Natural Science Foundation of China [31070365]; Project on Social Development of Guizhou Province [SY[2010]3043]; Research Foundation for Advanced Talents of Anqing Normal University [044-140001000032]	National Key Basic Research Program of China(National Basic Research Program of China); National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project on Social Development of Guizhou Province; Research Foundation for Advanced Talents of Anqing Normal University	The study was supported by National Key Basic Research Program of China (grant no. 2013CB956701), by the National Key Research and Development Program of China (2016YFC0502602), by the National Natural Science Foundation of China (grant no. 31070365), and by the Project on Social Development of Guizhou Province (SY[2010]3043), and by the Research Foundation for Advanced Talents of Anqing Normal University (044-140001000032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhendawi RA, 1997, J PLANT NUTR, V20, P1731, DOI 10.1080/01904169709365371; Bae YS, 2011, MOL CELLS, V32, P491, DOI 10.1007/s10059-011-0276-3; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; Fu WG, 2012, SCI HORTIC-AMSTERDAM, V135, P45, DOI 10.1016/j.scienta.2011.12.004; Hafeez B., 2013, American Journal of Experimental Agriculture, V3, P374; Hopkinson BM, 2011, P NATL ACAD SCI USA, V108, P3830, DOI 10.1073/pnas.1018062108; Liu CC, 2010, PHYSIOL PLANTARUM, V139, P39, DOI 10.1111/j.1399-3054.2009.01341.x; Liu CC, 2011, ENVIRON EXP BOT, V71, P174, DOI 10.1016/j.envexpbot.2010.11.012; McConnell IL, 2012, ADV PHOTOSYNTH RESP, V34, P475, DOI 10.1007/978-94-007-1579-0_20; MCCRAY JM, 1992, J PLANT NUTR, V15, P1877, DOI 10.1080/01904169209364445; Misra A, 2005, PHOTOSYNTHETICA, V43, P153, DOI 10.1007/s11099-005-3155-3; Ollat N, 2003, J PLANT NUTR, V26, P2165, DOI 10.1081/PLN-120024272; Rehman HU, 2012, PLANT SOIL, V361, P203, DOI 10.1007/s11104-012-1346-9; Rengel Z, 2015, J SOIL SCI PLANT NUT, V15, P397; Roosta HR, 2012, J PLANT NUTR, V35, P1843, DOI 10.1080/01904167.2012.706680; Rose MT, 2011, FUNCT PLANT BIOL, V38, P493, DOI 10.1071/FP11008; STROM L, 1994, PLANT SOIL, V167, P239, DOI 10.1007/BF00007950; Tavallali V, 2009, SCI HORTIC-AMSTERDAM, V123, P272, DOI 10.1016/j.scienta.2009.09.006; van Rensen JJS, 2002, PHOTOSYNTH RES, V73, P185, DOI 10.1023/A:1020451114262; Wang H, 2005, PHOTOSYNTHETICA, V43, P591, DOI 10.1007/s11099-005-0092-0; Widodo, 2010, NEW PHYTOL, V186, P400, DOI 10.1111/j.1469-8137.2009.03177.x; Wu YY, 2012, PHOTOSYNTHETICA, V50, P587, DOI 10.1007/s11099-012-0065-z; Wu YY, 2009, PHOTOSYNTHETICA, V47, P155, DOI 10.1007/s11099-009-0026-3; [吴沿友 WU Yanyou], 2011, [地球与环境, Earth and Environment], V39, P273; Wu YY, 2010, GEOCHIM COSMOCHIM AC, V74, pA1148; Wu YY, 1997, J OIL CROP SCI CHINA, V19, P47; Xing DK, 2016, ACTA GEOCHIM, V35, P309, DOI 10.1007/s11631-016-0099-1; Yan JH, 2012, CHEM GEOL, V304, P1, DOI 10.1016/j.chemgeo.2012.02.003; Zhang QA, 2010, THEOR APPL CLIMATOL, V101, P53, DOI 10.1007/s00704-009-0203-0	30	28	34	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169812	10.1371/journal.pone.0169812	http://dx.doi.org/10.1371/journal.pone.0169812			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076430	Green Published, Green Submitted, gold			2022-12-26	WOS:000391857100059
J	Luo, C; Shu, Y; Luo, J; Liu, D; Huang, DS; Han, Y; Chen, C; Li, YC; Zou, JM; Qin, J; Wang, Y; Li, D; Wang, SS; Zhang, GM; Chen, J; Feng, ZH				Luo, C.; Shu, Y.; Luo, J.; Liu, D.; Huang, D-S; Han, Y.; Chen, C.; Li, Y-C; Zou, J-M; Qin, J.; Wang, Y.; Li, D.; Wang, S-S; Zhang, G-M; Chen, J.; Feng, Z-H			Intracellular IL-37b interacts with Smad3 to suppress multiple signaling pathways and the metastatic phenotype of tumor cells	ONCOGENE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; TGF-BETA; CANCER-CELLS; INNATE INFLAMMATION; GENE-EXPRESSION; IN-VITRO; IL-1; RECEPTOR; ACTIVATION; INHIBITION	Multiple signaling pathways that promote tumor cell metastasis are differentially activated in low/non-metastatic and metastatic tumor cells, resulting in the differential expression of metastasis-related genes. The underlying mechanism may involve the alterations of the intrinsic negative regulation in tumor cells. Here we report that the differential expression of interleukin-37b (IL-37b) in tumor cells alters the intrinsic negative regulation of signaling pathways, resulting in the difference of metastatic capacity. IL-37b could bind Smad3 and suppress Smad pathway by interfering with the formation and nuclear translocation of Smad2/3/4 complex. In turn, Smad3 could function as a co-regulator, enabling IL-37b to suppress multiple non-Smad pathways. IL-37b-Smad3 translocated into nucleus to upregulate the expression of non-receptor protein tyrosine phosphatases (PTPNs), thus promoting dephosphorylation to suppress the activation of tyrosine phosphorylation-dependent signaling pathways such as ERK, p38 MAPK, JNK, PI3K, NF-kappa B, and STAT3 pathways. Intriguingly, 13 of 17 PTPNs, most of which are metastasis suppressors, were downregulated in metastatic tumor cells because of the low expression of IL-37b. The marked decrease of intracellular IL-37b attenuated the intrinsic negative regulation in tumor cells, resulting in the enhanced activation of multiple signaling pathways and the increased capacity of invasiveness and metastatic colonization. Consistently, low expression of IL-37b in tumors was significantly associated with poor prognosis of cancer patients. Taken together, these findings reveal that intracellular IL-37b is a critical factor in the negative regulation of multiple signaling pathways that modulate the expression of metastasis-related genes, and suggest that IL-37b expression in tumor cells can potentially be a histopathological prognostic parameter for cancer patients and a therapeutic target for preventing tumor metastasis.	[Luo, C.; Shu, Y.; Luo, J.; Li, Y-C; Zou, J-M; Qin, J.; Wang, Y.; Li, D.; Wang, S-S; Zhang, G-M; Chen, J.; Feng, Z-H] Huazhong Univ Sci & Technol, Sch Basic Med, Dept Biochem & Mol Biol, Tongji Med Coll, Wuhan 430030, Peoples R China; [Liu, D.] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Canc Biol Res Ctr, Wuhan, Peoples R China; [Huang, D-S; Han, Y.] Zhejiang Prov Peoples Hosp, Clin Res Inst, Hangzhou, Zhejiang, Peoples R China; [Chen, C.] Wuhan Univ, Renmin Hosp, Res Inst Otolaryngol Head & Neck Surg, Wuhan 430060, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Zhejiang Provincial People's Hospital; Wuhan University	Chen, J (corresponding author), Huazhong Univ Sci & Technol, Sch Basic Med, Dept Biochem & Mol Biol, Tongji Med Coll, Wuhan 430030, Peoples R China.	chenjuanlinda69@163.com; fengzhg_tj@163.com			National Natural Science Foundation of China [81472704, 30830095, 81272314]; National Development Program (973) For Key Basic Research of China [2009CB521806]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Development Program (973) For Key Basic Research of China(National Basic Research Program of China)	We thank Zhi-Hui Liang, Hui-Fen Zhu, Sheng-Hong Liu for technical assistance; Professor Guan-Xin Shen, Xiong-Wen Wu, Xin-Xing Wu, Zhan-Qiu Yang for their valuable comments and critical review of the manuscript. This work was supported by National Natural Science Foundation of China (no. 81472704 and 30830095 to Z-HF, and 81272314 to G-MZ), and National Development Program (973) For Key Basic Research of China (no. 2009CB521806 to Z-HF).	Abdel-Ghany M, 2002, J BIOL CHEM, V277, P34391, DOI 10.1074/jbc.M205307200; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Bettaieb A, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-13; Boraschi D, 2011, EUR CYTOKINE NETW, V22, P127, DOI 10.1684/ecn.2011.0288; Brown KA, 2004, BREAST CANCER RES, V6, pR215, DOI 10.1186/bcr778; Bulau AM, 2014, P NATL ACAD SCI USA, V111, P2650, DOI 10.1073/pnas.1324140111; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dinarello CA, 2016, EUR J IMMUNOL, V46, P1067, DOI 10.1002/eji.201545828; Fekete T, 2012, INT J CANCER, V131, P95, DOI 10.1002/ijc.26364; Feng XX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079857; Gallego MI, 2003, ONCOGENE, V22, P8498, DOI 10.1038/sj.onc.1207063; Gao ZH, 2014, NATURE, V516, P349, DOI 10.1038/nature13921; Gong W, 2008, INT J CANCER, V123, P702, DOI 10.1002/ijc.23553; Ida M, 1996, BIOCHEM PHARMACOL, V51, P1061, DOI 10.1016/0006-2952(95)02438-7; Jiang YZ, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0695-7; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Krueger JS, 2001, ONCOGENE, V20, P4209, DOI 10.1038/sj.onc.1204541; Kumar S, 2002, CYTOKINE, V18, P61, DOI 10.1006/cyto.2002.0873; Kuwada Y, 2003, INT J ONCOL, V22, P765; Lane AE, 2010, BIOCHEM J, V430, P161, DOI 10.1042/BJ20100082; Lee K, 2002, FREE RADICAL BIO MED, V33, P1121, DOI 10.1016/S0891-5849(02)01000-6; Li S, 2012, CANCER RES, V72, P865, DOI 10.1158/0008-5472.CAN-11-1357; Li SZ, 2015, P NATL ACAD SCI USA, V112, P2497, DOI 10.1073/pnas.1424626112; Li Y, 2010, ENDOCRINOLOGY, V151, P5146, DOI 10.1210/en.2009-1506; Liao SJ, 2012, BREAST CANCER RES TR, V133, P853, DOI 10.1007/s10549-011-1844-0; Liu D, 2014, CANCER RES, V74, P5597, DOI 10.1158/0008-5472.CAN-13-3598; Liu DW, 2012, INT J MOL SCI, V13, P828, DOI 10.3390/ijms13010828; Ludyga N, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-28; Marshall JC, 2009, MOL CELL BIOCHEM, V329, P115, DOI 10.1007/s11010-009-0116-3; Marshall JCA, 2012, JNCI-J NATL CANCER I, V104, P1306, DOI 10.1093/jnci/djs319; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; McCarty Mark F, 2004, Integr Cancer Ther, V3, P349, DOI 10.1177/1534735404270757; Meulmeester E, 2011, J PATHOL, V223, P205, DOI 10.1002/path.2785; Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944; Nold-Petry CA, 2015, NAT IMMUNOL, V16, P354, DOI 10.1038/ni.3103; Ozaki I, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00078; Palmieri D, 2006, J BIOENERG BIOMEMBR, V38, P151, DOI 10.1007/s10863-006-9039-9; Paoli P, 2013, BBA-MOL CELL RES, V1833, P3481, DOI 10.1016/j.bbamcr.2013.06.026; Pickup M, 2013, NAT REV CANCER, V13, P788, DOI 10.1038/nrc3603; Sastry SK, 2011, BIOCHEM PHARMACOL, V82, P435, DOI 10.1016/j.bcp.2011.06.016; Schneider MA, 2015, CLIN CANCER RES, V21, P3529, DOI 10.1158/1078-0432.CCR-14-2464; Sharma S, 2008, J IMMUNOL, V180, P5477, DOI 10.4049/jimmunol.180.8.5477; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Wang ZH, 2013, J IMMUNOL, V190, P2415, DOI 10.4049/jimmunol.1202535; Wu WS, 2008, CANCER METAST REV, V27, P303, DOI 10.1007/s10555-008-9112-4; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; You M, 2001, J EXP MED, V193, P101, DOI 10.1084/jem.193.1.101; Zhang P, 2013, J IMMUNOL, V190, P1685, DOI 10.4049/jimmunol.1202384; Zhou YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065906	54	23	25	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 18	2017	36	20					2889	2899		10.1038/onc.2016.444	http://dx.doi.org/10.1038/onc.2016.444			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EV3ZM	28092676				2022-12-26	WOS:000401697800011
J	Liu, HJ; Wan, CX; Ding, YA; Han, RR; He, YT; Xiao, JT; Hao, JW				Liu, Haijie; Wan, Chunxiao; Ding, Yanan; Han, Ranran; He, Yating; Xiao, Jinting; Hao, Junwei			PR-957, a selective inhibitor of immunoproteasome subunit low-MW polypeptide 7, attenuates experimental autoimmune neuritis by suppressing T(h)17-cell differentiation and regulating cytokine production	FASEB JOURNAL			English	Article						ONX-0914; inflammation; Guillain-Barre syndrome	GUILLAIN-BARRE-SYNDROME; PROTEASOME INHIBITORS; TH17 CELLS; T-CELLS; IMMUNOGLOBULIN; DISORDERS; MODELS	Experimental autoimmune neuritis (EAN) is a CD4+T-cell-mediated autoimmune inflammatory demyelinating disease of the peripheral nervous system. It has been replicated in an animal model of human inflammatory demyelinating polyradiculoneuropathy, Guillain-Barre syndrome. In this study, we evaluated the therapeutic efficacy of a selective inhibitor of the immunoproteasome subunit, low-MWpolypeptide 7 (PR-957) in rats with EAN. Our results showed that PR-957 significantly delayed onset day, reduced severity and shortened duration of EAN, and alleviated demyelination and inflammatory infiltration in sciatic nerves. In addition to significantly regulating expression of the cytokine profile, PR-957 treatment down-regulated the proportion of proinflammatory T-helper (T-h)17 cells in sciatic nerves and spleens of rats with EAN. Data presented showthe role of PR-957 in the signal transducer and activator of transcription 3(STAT3) pathway. PR-957 not only decreased expression of IL-6 and IL-23 but also led to down- regulation of STAT3 phosphorylation inCD4+T cells. Regulation of the STAT3 pathway led to a reduction in retinoid-related orphan nuclear receptor g t and IL-17 production. Furthermore, reduction of STAT3 phosphorylationmay have directly suppressed Th17-cell differentiation. Therefore, our study demonstrates that PR-957 couldpotently alleviate inflammationin rats withEANandthat itmaybe a likely candidate for treating Guillain-Barr ' e syndrome.-Liu, H., Wan, C., Ding, Y., Han, R., He, Y., Xiao, J., Hao, J. PR-957, a selective inhibitor of immunoproteasome subunit low- MW polypeptide 7, attenuates experimental autoimmune neuritis by suppressing Th17-cell differentiation and regulating cytokine production. FASEBJ. 31, 1756-1766 (2017). www. fasebj. org	[Liu, Haijie; Ding, Yanan; Han, Ranran; He, Yating; Xiao, Jinting; Hao, Junwei] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Anshan Rd, Tianjin 300052, Peoples R China; [Liu, Haijie; Wan, Chunxiao] Tianjin Med Univ, Gen Hosp, Dept Phys Med & Rehabil, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Hao, JW (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Anshan Rd, Tianjin 300052, Peoples R China.	hjw@tmu.edu.cn		Hao, Junwei/0000-0002-3075-5434	National Natural Science Foundation of China [81322018, 81273287, 81100887]; Program for New Century Excellent Talents in University of China [NCET 111067]; Key Project of Natural Science Foundation of Tianjin Province [12JCZDJC24200]; Key Project of Chinese Ministry of Education [212005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET)); Key Project of Natural Science Foundation of Tianjin Province; Key Project of Chinese Ministry of Education(Ministry of Education, China)	This work was funded by the National Natural Science Foundation of China (81322018, 81273287, and 81100887 to J.W.H), the Program for New Century Excellent Talents in University of China (NCET 111067 to J.W.H), the Key Project of Natural Science Foundation of Tianjin Province (12JCZDJC24200 to J.W.H), and the Key Project of Chinese Ministry of Education (212005 to J.W.H). The authors declare no conflicts of interest.	Basler M, 2015, CLIN EXP RHEUMATOL, V33, pS74; Basler M, 2004, J IMMUNOL, V173, P3925, DOI 10.4049/jimmunol.173.6.3925; Basler M, 2006, J IMMUNOL, V176, P6665, DOI 10.4049/jimmunol.176.11.6665; Basler M, 2014, EMBO MOL MED, V6, P226, DOI 10.1002/emmm.201303543; Basler M, 2013, CURR OPIN IMMUNOL, V25, P74, DOI 10.1016/j.coi.2012.11.004; Basler M, 2010, J IMMUNOL, V185, P634, DOI 10.4049/jimmunol.0903182; Bennett MK, 2008, CURR OPIN DRUG DISC, V11, P616; Burke MK, 2012, P ROY SOC B-BIOL SCI, V279, P5029, DOI 10.1098/rspb.2012.0799; De La Cour CD, 2005, MUSCLE NERVE, V31, P70, DOI 10.1002/mus.20240; Gold R, 2000, MOL MED TODAY, V6, P88, DOI 10.1016/S1357-4310(99)01639-1; Groettrup M, 2010, NAT REV IMMUNOL, V10, P72, DOI 10.1038/nri2687; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hasinoff BB, 2016, CARDIOVASC TOXICOL; Huber EM, 2012, CELL, V148, P727, DOI 10.1016/j.cell.2011.12.030; Hughes RAC, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002063.pub3; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Hughes RAC, 1999, J NEUROIMMUNOL, V100, P74, DOI 10.1016/S0165-5728(99)00195-2; Hughes RAC, 2007, BRAIN, V130, P2245, DOI 10.1093/brain/awm004; Ichikawa HT, 2012, ARTHRITIS RHEUM-US, V64, P493, DOI 10.1002/art.33333; Jaganathan A, 2014, MOL ENDOCRINOL, V28, P872, DOI 10.1210/me.2014-1055; Kalim KW, 2012, J IMMUNOL, V189, P4182, DOI 10.4049/jimmunol.1201183; Kieseier BC, 2004, MUSCLE NERVE, V30, P131, DOI 10.1002/mus.20076; Kimura H, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/541984; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; Kuhn DJ, 2009, BLOOD, V113, P4667, DOI 10.1182/blood-2008-07-171637; Kunjappu MJ, 2014, BBA-MOL CELL RES, V1843, P2, DOI 10.1016/j.bbamcr.2013.03.008; Liang SL, 2012, IMMUNOPHARM IMMUNOT, V34, P1039, DOI 10.3109/08923973.2012.697469; Lu MO, 2011, J NEUROL, V258, P533, DOI 10.1007/s00415-010-5836-5; Moebius J, 2010, EUR J IMMUNOL, V40, P3439, DOI 10.1002/eji.201040620; Muchamuel T, 2009, NAT MED, V15, P781, DOI 10.1038/nm.1978; Nagayama Y, 2012, CLIN EXP IMMUNOL, V168, P268, DOI 10.1111/j.1365-2249.2012.04578.x; Nandi D, 1997, EMBO J, V16, P5363, DOI 10.1093/emboj/16.17.5363; Orlowski RZ, 1998, CANCER RES, V58, P4342; Raphael JC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001798.pub2; Richardson PG, 2008, EXPERT REV ANTICANC, V8, P1053, DOI 10.1586/14737140.8.7.1053; ROPPER AH, 1992, NEW ENGL J MED, V326, P1130, DOI 10.1056/NEJM199204233261706; Stephanou A, 1998, BIOCHEM J, V330, P189, DOI 10.1042/bj3300189; Taylor JM, 2003, MUSCLE NERVE, V28, P344, DOI 10.1002/mus.10432; van Doorn Pieter A, 2013, Presse Med, V42, pe193, DOI 10.1016/j.lpm.2013.02.328; van Swieten PF, 2007, BIOORG MED CHEM LETT, V17, P3402, DOI 10.1016/j.bmcl.2007.03.092; Wang X, 2014, SCAND J IMMUNOL, V80, P180, DOI 10.1111/sji.12201; Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1; Wu XJ, 2016, EXPERT OPIN THER TAR, V20, P209, DOI 10.1517/14728222.2016.1086751; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zhang CJ, 2014, IMMUNOL CELL BIOL, V92, P164, DOI 10.1038/icb.2013.81; Zhang HL, 2013, CYTOKINE GROWTH F R, V24, P443, DOI 10.1016/j.cytogfr.2013.05.005; Zhang ZY, 2009, NEUROPATH APPL NEURO, V35, P487, DOI 10.1111/j.1365-2990.2009.01016.x	49	27	30	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1756	1766		10.1096/fj.201601147R	http://dx.doi.org/10.1096/fj.201601147R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28096232				2022-12-26	WOS:000398504300039
J	Chawla, B; Hedman, AC; Sayedyahossein, S; Erdemir, HH; Li, ZG; Sacks, DB				Chawla, Bhavna; Hedman, Andrew C.; Sayedyahossein, Samar; Erdemir, Huseyin H.; Li, Zhigang; Sacks, David B.			Absence of IQGAP1 Protein Leads to Insulin Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; insulin; insulin receptor; insulin receptor substrate 1 (IRS-1); insulin resistance; mitogen-activated protein kinase (MAPK); phosphatidylinositide 3-kinase (PI 3-kinase); IQGAP1	PLECKSTRIN-HOMOLOGY DOMAIN; HEPATOCELLULAR-CARCINOMA; MICE LACKING; PTB DOMAIN; IQ MOTIFS; RECEPTOR; IRS-1; SCAFFOLD; BINDING; ACTIVATION	Insulin binds to the insulin receptor (IR) and induces tyrosine phosphorylation of the receptor and insulin receptor substrate-1 (IRS-1), leading to activation of the PKB/Akt and MAPK/ERK pathways. IQGAP1 is a scaffold protein that interacts with multiple binding partners and integrates diverse signaling cascades. Here we show that IQGAP1 associates with both IR and IRS-1 and influences insulin action. In vitro analysis with pure proteins revealed that the IQ region of IQGAP1 binds directly to the intracellular domain of IR. Similarly, the phosphotyrosine-binding domain of IRS-1 mediates a direct interaction with the C-terminal tail of IQGAP1. Consistent with these observations, both IR and IRS-1 co-immunoprecipitated with IQGAP1 from cells. Investigation of the functional effects of the interactions revealed that in the absence of IQGAP1, insulin-stimulated phosphorylation of Akt and ERK, as well as the association of phosphatidylinositol 3-kinase with IRS-1, were significantly decreased. Importantly, loss of IQGAP1 results in impaired insulin signaling and glucose homeostasis in vivo. Collectively, these data reveal that IQGAP1 is a scaffold for IR and IRS-1 and implicate IQGAP1 as a participant in insulin signaling.	[Chawla, Bhavna; Hedman, Andrew C.; Sayedyahossein, Samar; Erdemir, Huseyin H.; Li, Zhigang; Sacks, David B.] NIH, Dept Lab Med, 10 Ctr Dr,10-2C306, Bethesda, MD 20892 USA; [Chawla, Bhavna] US FDA, Ctr Biol Evaluat & Res, Div Emerging & Transfus Transmitted Dis, Silver Spring, MD 20993 USA; [Erdemir, Huseyin H.] Cleveland Clin, Dept Pediat Hematol Oncol, Cleveland, OH 44195 USA; [Erdemir, Huseyin H.] Cleveland Clin, BMT, Cleveland, OH 44195 USA	National Institutes of Health (NIH) - USA; US Food & Drug Administration (FDA); Cleveland Clinic Foundation; Cleveland Clinic Foundation	Sacks, DB (corresponding author), NIH, Dept Lab Med, 10 Ctr Dr,10-2C306, Bethesda, MD 20892 USA.	david.sacks2@nih.gov		Sayedyahossein, Samar/0000-0003-1773-4740; Sacks, David/0000-0003-3100-0735	National Institutes of Health Intramural Research Program; CLINICAL CENTER [ZIACL080017] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CLINICAL CENTER	This work was supported by the National Institutes of Health Intramural Research Program. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Algenstaedt PM, 1997, J BIOL CHEM, V272, P23696, DOI 10.1074/jbc.272.38.23696; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Backer JM, 1997, EUR J BIOCHEM, V245, P91, DOI 10.1111/j.1432-1033.1997.t01-1-00091.x; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Brown MD, 2007, J BIOL CHEM, V282, P30265, DOI 10.1074/jbc.M702537200; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; Chen F, 2010, EXP MOL MED, V42, P477, DOI 10.3858/emm.2010.42.7.049; Chiariello CS, 2012, REGUL PEPTIDES, V173, P36, DOI 10.1016/j.regpep.2011.09.003; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Dinchuk JE, 2010, ENDOCRINOLOGY, V151, P4123, DOI 10.1210/en.2010-0032; Dugani CB, 2005, EMBO REP, V6, P1137, DOI 10.1038/sj.embor.7400584; Dummler B, 2006, MOL CELL BIOL, V26, P8042, DOI 10.1128/MCB.00722-06; Eck MJ, 1996, CELL, V85, P695, DOI 10.1016/S0092-8674(00)81236-2; Erdemir HH, 2014, J BIOL CHEM, V289, P9100, DOI 10.1074/jbc.M114.553511; Geetha T, 2012, J BIOL CHEM, V287, P29672, DOI 10.1074/jbc.M111.322404; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Hedman AC, 2015, EMBO REP, V16, P427, DOI 10.15252/embr.201439834; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Jadeski L, 2008, J BIOL CHEM, V283, P1008, DOI 10.1074/jbc.M708466200; Kim H, 2011, BIOCHEM J, V440, P309, DOI 10.1042/BJ20110419; Kohno T, 2013, AM J PHYSIOL-CELL PH, V305, pC591, DOI 10.1152/ajpcell.00011.2013; Komander D, 2004, EMBO J, V23, P3918, DOI 10.1038/sj.emboj.7600379; Kriauciunas KM, 2000, MOL CELL BIOL, V20, P6849, DOI 10.1128/MCB.20.18.6849-6859.2000; Li SH, 2000, MOL CELL BIOL, V20, P697, DOI 10.1128/MCB.20.2.697-701.2000; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Lim J, 2010, GENE DEV, V24, P1496, DOI 10.1101/gad.1904610; Luan B, 2009, NATURE, V457, P1146, DOI 10.1038/nature07617; McNulty DE, 2011, J BIOL CHEM, V286, P15010, DOI 10.1074/jbc.M111.227694; Munshi HG, 1996, BIOCHEMISTRY-US, V35, P15883, DOI 10.1021/bi962107y; Ramos RR, 2007, P NATL ACAD SCI USA, V104, P10470, DOI 10.1073/pnas.0701114104; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Ren JG, 2005, J BIOL CHEM, V280, P34548, DOI 10.1074/jbc.M507321200; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Sbroggio M, 2011, CARDIOVASC RES, V91, P456, DOI 10.1093/cvr/cvr103; Schmidt VA, 2008, MOL CELL BIOL, V28, P1489, DOI 10.1128/MCB.01090-07; Smith JM, 2015, TRENDS CELL BIOL, V25, P171, DOI 10.1016/j.tcb.2014.12.005; Smith MJ, 2010, EMBO J, V29, P884, DOI 10.1038/emboj.2009.399; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Ueki K, 2000, J CLIN INVEST, V105, P1437, DOI 10.1172/JCI7656; VANOBBERGHEN E, 1994, DIABETOLOGIA, V37, pS125, DOI 10.1007/BF00400836; VanRenterghem B, 1998, J BIOL CHEM, V273, P29942, DOI 10.1074/jbc.273.45.29942; Wagner MJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008987; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; White CD, 2011, J BIOL CHEM, V286, P29734, DOI 10.1074/jbc.M111.220939; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; WOLF G, 1995, J BIOL CHEM, V270, P27407, DOI 10.1074/jbc.270.46.27407; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60; Yenush L, 1996, J BIOL CHEM, V271, P24300, DOI 10.1074/jbc.271.39.24300	53	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3273	3289		10.1074/jbc.M116.752642	http://dx.doi.org/10.1074/jbc.M116.752642			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28082684	Green Published, hybrid			2022-12-26	WOS:000395538800019
J	Du, CY; Cao, SY; Shi, XY; Nie, XT; Zheng, JS; Deng, Y; Ruan, LF; Peng, DH; Sun, M				Du, Cuiying; Cao, Shiyun; Shi, Xiangyu; Nie, Xiangtao; Zheng, Jinshui; Deng, Yun; Ruan, Lifang; Peng, Donghai; Sun, Ming			Genetic and Biochemical Characterization of a Gene Operon for trans-Aconitic Acid, a Novel Nematicide from Bacillus thuringiensis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial genetics; bacterial toxin; biosynthesis; small molecule; tricarboxylic acid cycle (TCA cycle) (Krebs cycle); Bacillus thuringiensis; aconitate isomerase; membrane transporter; nematicidal factor; trans-aconitic acid	ROOT-KNOT NEMATODE; COMPLETE GENOME SEQUENCE; CAENORHABDITIS-ELEGANS; ESCHERICHIA-COLI; SECONDARY METABOLITE; VIRULENCE FACTORS; ISOCITRATE LYASE; PROTEIN; ISOMERASE; PLANT	trans-Aconitic acid (TAA) is an isomer of cis-aconitic acid (CAA), an intermediate of the tricarboxylic acid cycle that is synthesized by aconitase. Although TAA production has been detected in bacteria and plants for many years and is known to be a potent inhibitor of aconitase, its biosynthetic origins and the physiological relevance of its activity have remained unclear. We have serendipitously uncovered key information relevant to both of these questions. Specifically, in a search for novel nematicidal factors from Bacillus thuringiensis, a significant nematode pathogen harboring many protein virulence factors, we discovered a high yielding component that showed activity against the plant-parasitic nematode Meloidogyne incognita and surprisingly identified it as TAA. Comparison with CAA, which displayed a much weaker nematicidal effect, suggested that TAA is specifically synthesized by B. thuringiensis as a virulence factor. Analysis of mutants deficient in plasmids that were anticipated to encode virulence factors allowed us to isolate a TAA biosynthesis-related (tbr) operon consisting of two genes, tbrA and tbrB. We expressed the corresponding proteins, TbrA and TbrB, and characterized them as an aconitate isomerase and TAA transporter, respectively. Bioinformatics analysis of the TAA biosynthetic gene cluster revealed the association of the TAA genes with transposable elements relevant for horizontal gene transfer as well as a distribution across B. cereus bacteria and other B. thuringiensis strains, suggesting a general role for TAA in the interactions of B. cereus group bacteria with nematode hosts in the soil environment. This study reveals new bioactivity for TAA and the TAA biosynthetic pathway, improving our understanding of virulence factors employed by B. thuringiensis pathogenesis and providing potential implications for nematode management applications.	[Du, Cuiying; Cao, Shiyun; Shi, Xiangyu; Nie, Xiangtao; Zheng, Jinshui; Deng, Yun; Ruan, Lifang; Peng, Donghai; Sun, Ming] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China; [Cao, Shiyun] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA	Huazhong Agricultural University; State University System of Florida; University of Florida	Sun, M (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.	m98sun@mail.hzau.edu.cn	Ming, Sun/Q-1497-2015	Ming, Sun/0000-0001-5465-5983	China 948 Program of the Ministry of Agriculture [2016-X21]; National Natural Science Foundation of China [31670085, 31171901]; National Key Research and Development Program of China [2017YFC204521201]	China 948 Program of the Ministry of Agriculture; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work was supported by the China 948 Program of the Ministry of Agriculture (Grant 2016-X21), National Natural Science Foundation of China Grants 31670085 and 31171901, and National Key Research and Development Program of China Grant 2017YFC204521201. The authors declare that they have no conflicts of interest with the contents of this article.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; ALTEKAR WW, 1963, J BACTERIOL, V85, P604, DOI 10.1128/JB.85.3.604-613.1963; ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; Bernheim F, 1928, BIOCHEM J, V22, P1178, DOI 10.1042/bj0221178; Blin K, 2017, NUCLEIC ACIDS RES, V45, pD555, DOI 10.1093/nar/gkw960; BRAUER D, 1981, PLANT PHYSIOL, V68, P1406, DOI 10.1104/pp.68.6.1406; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Cai H, 1999, J BIOL CHEM, V274, P13470, DOI 10.1074/jbc.274.19.13470; Chen S. T., 2015, U. S. Patent, Patent No. 20150104531; Cordes T, 2015, ANNU REV NUTR, V35, P451, DOI 10.1146/annurev-nutr-071714-034243; Garcia ED, 2010, PHYTOMEDICINE, V18, P80, DOI 10.1016/j.phymed.2010.05.008; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Garvey GS, 2007, PROTEIN SCI, V16, P1274, DOI 10.1110/ps.072801907; Grimek TL, 2004, J BACTERIOL, V186, P454, DOI 10.1128/JB.186.2.454-462.2004; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; He J, 2011, J BACTERIOL, V193, P3407, DOI 10.1128/JB.05085-11; He J, 2010, J BACTERIOL, V192, P4074, DOI 10.1128/JB.00562-10; Hu Y, 2010, P NATL ACAD SCI USA, V107, P5955, DOI 10.1073/pnas.0912327107; Iatsenko I, 2014, TOXINS, V6, P2050, DOI 10.3390/toxins6072050; Iatsenko I, 2014, APPL ENVIRON MICROB, V80, P3266, DOI 10.1128/AEM.00464-14; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Jones JT, 2013, MOL PLANT PATHOL, V14, P946, DOI 10.1111/mpp.12057; Jouzani GS, 2008, CAN J MICROBIOL, V54, P812, DOI [10.1139/W08-074, 10.1139/w08-074]; KAR S, 1993, ANTIMICROB AGENTS CH, V37, P2459, DOI 10.1128/AAC.37.11.2459; KIM M, 1976, Applied Entomology and Zoology, V11, P53; KLINMAN JP, 1971, BIOCHEMISTRY-US, V10, P2259, DOI 10.1021/bi00788a012; KLINMAN JP, 1971, BIOCHEMISTRY-US, V10, P2253, DOI 10.1021/bi00788a011; Lenane IJ, 2008, FEMS MICROBIOL LETT, V278, P115, DOI 10.1111/j.1574-6968.2007.00987.x; Li XQ, 2008, BIOL CONTROL, V47, P97, DOI 10.1016/j.biocontrol.2008.06.007; Li XQ, 2007, PLANT BIOTECHNOL J, V5, P455, DOI 10.1111/j.1467-7652.2007.00257.x; Liu XY, 2010, J BIOL CHEM, V285, P39191, DOI 10.1074/jbc.M110.148387; Liu XY, 2014, TOXINS, V6, P2229, DOI 10.3390/toxins6082229; Liu YY, 2014, STAND GENOMIC SCI, V9, DOI 10.4056/sigs.4738557; Lourenco-Tessutti IT, 2015, PHYTOPATHOLOGY, V105, P628, DOI 10.1094/PHYTO-09-14-0237-R; Luo H, 2013, APPL MICROBIOL BIOT, V97, P10135, DOI 10.1007/s00253-013-5249-3; Luo XX, 2013, APPL ENVIRON MICROB, V79, P460, DOI 10.1128/AEM.02551-12; Luo Y, 2011, ANTIMICROB AGENTS CH, V55, P4161, DOI 10.1128/AAC.00111-11; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; MIDDENDORF PJ, 1993, J NEMATOL, V25, P573; MILLER RE, 1951, ADV CARBOHYD CHEM, V6, P231; MISRA S, 1989, BIOCHEM MED METAB B, V42, P171, DOI 10.1016/0885-4505(89)90052-2; NOEL GR, 1990, J NEMATOL, V22, P763; Peng DH, 2016, ENVIRON MICROBIOL, V18, P846, DOI 10.1111/1462-2920.13069; RAGHAVEN.M, 1961, BIOCHEM BIOPH RES CO, V4, P101, DOI 10.1016/0006-291X(61)90355-2; Raymond B, 2010, TRENDS MICROBIOL, V18, P189, DOI 10.1016/j.tim.2010.02.006; Ruan LF, 2015, ENVIRON MICROBIOL, V17, P4547, DOI 10.1111/1462-2920.12968; Ruan LF, 2015, TRENDS MICROBIOL, V23, P341, DOI 10.1016/j.tim.2015.02.011; SAFFRAN M, 1949, J BIOL CHEM, V180, P1301; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Sugimoto T, 2014, J BIOSCI BIOENG, V117, P563, DOI 10.1016/j.jbiosc.2013.10.020; Sun M, 1996, Wei Sheng Wu Xue Bao, V36, P303; TATE CG, 1993, J BIOL CHEM, V268, P26850; TATE CG, 1992, J BIOL CHEM, V267, P6923; THOMPSON JF, 1990, ANAL BIOCHEM, V184, P39, DOI 10.1016/0003-2697(90)90008-W; Thompson JF, 1997, J AGR FOOD CHEM, V45, P3684, DOI 10.1021/jf970131s; Wei JZ, 2003, P NATL ACAD SCI USA, V100, P2760, DOI 10.1073/pnas.0538072100; Zhang LL, 2014, J ECON ENTOMOL, V107, P551, DOI 10.1603/EC13201; Zheng JS, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0942; Zheng ZQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep31341; Zhou JH, 2011, J HAZARD MATER, V192, P1243, DOI 10.1016/j.jhazmat.2011.06.035; Zhu L, 2015, SCI REP-UK, V5, DOI 10.1038/srep14129	63	22	26	1	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3517	3530		10.1074/jbc.M116.762666	http://dx.doi.org/10.1074/jbc.M116.762666			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28087696	Green Published, hybrid			2022-12-26	WOS:000395538800039
J	Mardo, K; Visnapuu, T; Vija, H; Aasamets, A; Viigand, K; Alamae, T				Mardo, Karin; Visnapuu, Triinu; Vija, Heiki; Aasamets, Anneli; Viigand, Katrin; Alamae, Tiina			A Highly Active Endo-Levanase BT1760 of a Dominant Mammalian Gut Commensal Bacteroides thetaiotaomicron Cleaves Not Only Various Bacterial Levans, but Also Levan of Timothy Grass	PLOS ONE			English	Article							SYRINGAE PV. TOMATO; HANSENULA-POLYMORPHA; HALOMONAS-SMYRNENSIS; MICROBIOTA; FRUCTAN; GENE; OLIGOSACCHARIDES; METABOLISM; EXPRESSION; BUTYRATE	Bacteroides thetaiotaomicron, an abundant commensal of the human gut, degrades numerous complex carbohydrates. Recently, it was reported to grow on a beta-2,6-linked polyfructan levan produced by Zymomonas mobilis degrading the polymer into fructooligosaccharides (FOS) with a cell surface bound endo-levanase BT1760. The FOS are consumed by B. thetaiotaomicron, but also by other gut bacteria, including health-promoting bifidobacteria and lactobacilli. Here we characterize biochemical properties of BT1760, including the activity of BT1760 on six bacterial levans synthesized by the levansucrase Lsc3 of Pseudomonas syringae pv. tomato, its mutant Asp300Asn, levansucrases of Zymomonas mobilis, Erwinia herbicola, Halomonas smyrnensis as well as on levan isolated from timothy grass. For the first time a plant levan is shown as a perfect substrate for an endo-fructanase of a human gut bacterium. BT1760 degraded levans to FOS with degree of polymerization from 2 to 13. At optimal reaction conditions up to 1 g of FOS were produced per 1 mg of BT1760 protein. Low molecular weight (<60 kDa) levans, including timothy grass levan and levan synthesized from sucrose by the Lsc3Asp300Asn, were degraded most rapidly whilst levan produced by Lsc3 from raffinose least rapidly. BT1760 catalyzed finely at human body temperature (37 degrees C) and in moderately acidic environment (pH 5-6) that is typical for the gut lumen. According to differential scanning fluorimetry, the T-m of the endo-levanase was 51.5 degrees C. All tested levans were sufficiently stable in acidic conditions (pH 2.0) simulating the gastric environment. Therefore, levans of both bacterial and plant origin may serve as a pre biotic fiber for B. thetaiotaomicron and contribute to short-chain fatty acids synthesis by gut microbiota. In the genome of Bacteroides xylanisolvens of human origin a putative levan degradation locus was disclosed.	[Mardo, Karin; Visnapuu, Triinu; Aasamets, Anneli; Viigand, Katrin; Alamae, Tiina] Univ Tartu, Inst Mol & Cell Biol, Dept Genet, Tartu, Estonia; [Vija, Heiki] NICPB, Lab Environm Toxicol, Tallinn, Estonia; [Visnapuu, Triinu] Tech Univ Denmark, Dept Biotechnol & Biomed, Lyngby, Denmark	University of Tartu; National Institute of Chemical Physics & Biophysics (NICPB); Technical University of Denmark	Alamae, T (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Dept Genet, Tartu, Estonia.	talamae@ebc.ee	Ernits, Karin/F-5511-2019; Visnapuu, Triinu/G-3208-2016; Ernits, Karin/X-4427-2019	Ernits, Karin/0000-0003-1072-4945; Visnapuu, Triinu/0000-0003-1778-7949; Ernits, Karin/0000-0003-1072-4945	Estonian Research Council [GLOMR9072, GLTMR1050P, IUT23-5]; European Regional Development Fund [3.2.0701.12-0041 (SLOMR12215T)]; Archimedes Foundation [16-3.4/52]	Estonian Research Council(Estonian Research Council); European Regional Development Fund(European Commission); Archimedes Foundation	This work was financed by Estonian Research Council grants GLOMR9072 (TA) and GLTMR1050P (TA), partly by IUT23-5 (experiments conducted by HV) from Estonian Research Council and 3.2.0701.12-0041 (SLOMR12215T) (TA) from European Regional Development Fund. Kristjan Jaak Scholarship 16-3.4/52 from Archimedes Foundation to AA for research visit at National University of Mexico (UNAM) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamberg K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144042; Adamberg Signe, 2014, Front Nutr, V1, P21, DOI 10.3389/fnut.2014.00021; Alamae T, 2012, SPR CARB CH, V38, P176, DOI 10.1039/9781849734769-00176; Andersone I, 2004, ENG LIFE SCI, V4, P56, DOI 10.1002/elsc.200400006; Curiel JA, 2011, PROTEIN EXPRES PURIF, V76, P44, DOI 10.1016/j.pep.2010.10.013; AVIGAD G, 1966, METHOD ENZYMOL, V8, P621; Avila-Fernandez A, 2016, J APPL MICROBIOL, V121, P263, DOI 10.1111/jam.13154; Avila-Fernandez A, 2011, FOOD CHEM, V129, P380, DOI 10.1016/j.foodchem.2011.04.088; Benigar E, 2014, LANGMUIR, V30, P4172, DOI 10.1021/la500830j; Bondarenko OM, 2016, CARBOHYD POLYM, V136, P710, DOI 10.1016/j.carbpol.2015.09.093; Bultman SJ, 2014, CLIN CANCER RES, V20, P799, DOI 10.1158/1078-0432.CCR-13-2483; Cairns AJ, 1999, NEW PHYTOL, V142, P79, DOI 10.1046/j.1469-8137.1999.00378.x; Cummings JH, 2001, AM J CLIN NUTR, V73, p415S, DOI 10.1093/ajcn/73.2.415s; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Erginer M, 2016, CARBOHYD POLYM, V149, P289, DOI 10.1016/j.carbpol.2016.04.092; Fischbach MA, 2011, CELL HOST MICROBE, V10, P336, DOI 10.1016/j.chom.2011.10.002; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Gibson G. R., 2010, Food Science and Technology Bulletin: Functional Foods, V7, P1; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hamaker BR, 2014, J MOL BIOL, V426, P3838, DOI 10.1016/j.jmb.2014.07.028; Hayashi H, 2002, MICROBIOL IMMUNOL, V46, P535, DOI 10.1111/j.1348-0421.2002.tb02731.x; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Jenkins CLD, 2011, J CEREAL SCI, V53, P188, DOI 10.1016/j.jcs.2010.12.001; Jensen SL, 2016, INT J BIOL MACROMOL, V85, P514, DOI 10.1016/j.ijbiomac.2016.01.008; Jogi E, 2015, INT C POLYSACCH GLYC, P5; Kang Soon Ah, 2009, P145; Kasperowicz A, 2016, J APPL MICROBIOL, V120, P29, DOI 10.1111/jam.12976; KEITH J, 1991, BIOTECHNOL BIOENG, V38, P557, DOI 10.1002/bit.260380515; Khan MT, 2012, ISME J, V6, P1578, DOI 10.1038/ismej.2012.5; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; KRASINSKI SD, 1986, J AM GERIATR SOC, V34, P800, DOI 10.1111/j.1532-5415.1986.tb03985.x; Lahtchev KL, 2002, ARCH MICROBIOL, V177, P150, DOI 10.1007/s00203-001-0370-6; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990; Mardo K, 2014, MOLECULES, V19, P8434, DOI 10.3390/molecules19068434; Mardo K, 2014, BIOTECHNOL APPL BIOC, V61, P11, DOI 10.1002/bab.1129; Marieb EN, 2010, HUMAN ANATOMY PHYSL; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Marx SP, 2000, FEMS MICROBIOL LETT, V182, P163, DOI 10.1016/S0378-1097(99)00584-4; Matsuhira H, 2014, J BIOTECHNOL, V192, P215, DOI 10.1016/j.jbiotec.2014.09.025; Miasnikov AN, 1997, FEMS MICROBIOL LETT, V154, P23, DOI 10.1016/S0378-1097(97)00295-4; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; NELSON CJ, 1987, PHYSIOL PLANTARUM, V71, P512, DOI 10.1111/j.1399-3054.1987.tb02892.x; Oner ET, 2016, BIOTECHNOL ADV, V34, P827, DOI 10.1016/j.biotechadv.2016.05.002; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Poli A, 2009, CARBOHYD POLYM, V78, P651, DOI 10.1016/j.carbpol.2009.05.031; Porras-Dominguez JR, 2015, CARBOHYD POLYM, V132, P338, DOI 10.1016/j.carbpol.2015.06.056; Porras-Dominguez JR, 2014, PROCESS BIOCHEM, V49, P783, DOI 10.1016/j.procbio.2014.02.005; Pouyez J, 2012, BIOCHIMIE, V94, P2423, DOI 10.1016/j.biochi.2012.06.020; Rakoff-Nahoum S, 2014, CURR BIOL, V24, P40, DOI 10.1016/j.cub.2013.10.077; Ramsay AG, 2006, MICROBIOL-SGM, V152, P3281, DOI 10.1099/mic.0.29233-0; Velazquez-Martinez JR, 2014, MOLECULES, V19, P12660, DOI 10.3390/molecules190812660; RUMNEY CJ, 1995, LETT APPL MICROBIOL, V20, P232, DOI 10.1111/j.1472-765X.1995.tb00435.x; Sarilmiser HK, 2015, J BIOSCI BIOENG, V119, P455, DOI 10.1016/j.jbiosc.2014.09.019; Saulnier DMA, 2009, CURR OPIN BIOTECH, V20, P135, DOI 10.1016/j.copbio.2009.01.002; Sebastian C, 2014, CANCER DISCOV, V4, P1368, DOI 10.1158/2159-8290.CD-14-1231; Shenderov Boris A., 2014, Microbial Ecology in Health and Disease, V25, P24145, DOI 10.3402/mehd.v25.24145; Shih IL, 2005, BIOTECHNOL LETT, V27, P103, DOI 10.1007/s10529-004-6936-z; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sonnenburg ED, 2014, CELL METAB, V20, P779, DOI 10.1016/j.cmet.2014.07.003; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Srikanth R, 2015, CARBOHYD POLYM, V120, P102, DOI 10.1016/j.carbpol.2014.12.003; Stingele F, 1999, J BACTERIOL, V181, P6354, DOI 10.1128/JB.181.20.6354-6360.1999; StJohn JA, 1996, NEW PHYTOL, V134, P197, DOI 10.1111/j.1469-8137.1996.tb04624.x; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TANAKA T, 1980, J BIOCHEM, V87, P297, DOI 10.1093/oxfordjournals.jbchem.a132737; Ulsemer P, 2012, APPL ENVIRON MICROB, V78, P528, DOI 10.1128/AEM.06641-11; van Bueren AL, 2015, APPL ENVIRON MICROB, V81, P3973, DOI 10.1128/AEM.00149-15; Verspreet J, 2015, TRENDS FOOD SCI TECH, V43, P32, DOI 10.1016/j.tifs.2015.01.006; Viigand K, 2016, YEAST, V33, P415, DOI 10.1002/yea.3157; Vijn I, 1999, PLANT PHYSIOL, V120, P351, DOI 10.1104/pp.120.2.351; Visnapuu T, 2008, PROCESS BIOCHEM, V43, P414, DOI 10.1016/j.procbio.2008.01.002; Visnapuu T, 2015, NEW BIOTECHNOL, V32, P597, DOI 10.1016/j.nbt.2015.01.009; Visnapuu T, 2011, J BIOTECHNOL, V155, P338, DOI 10.1016/j.jbiotec.2011.07.026; Visnapuu T, 2009, RAPID COMMUN MASS SP, V23, P1337, DOI 10.1002/rcm.4007; Voragen AGJ, 1998, TRENDS FOOD SCI TECH, V9, P328, DOI 10.1016/S0924-2244(98)00059-4; Vrieze A, 2010, DIABETOLOGIA, V53, P606, DOI 10.1007/s00125-010-1662-7; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Yamamoto S, 2010, GRASSL SCI, V56, P194, DOI 10.1111/j.1744-697X.2010.00194.x; Yamamoto Y, 1999, J NUTR BIOCHEM, V10, P13, DOI 10.1016/S0955-2863(98)00077-1; Yanase H, 2002, J BIOCHEM, V132, P565, DOI 10.1093/oxfordjournals.jbchem.a003258; Young DG, 2001, BIOTECH HISTOCHEM, V76, P31, DOI 10.1080/714028121; ZIOLECKI A, 1992, LETT APPL MICROBIOL, V15, P244, DOI 10.1111/j.1472-765X.1992.tb00774.x	84	27	27	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0169989	10.1371/journal.pone.0169989	http://dx.doi.org/10.1371/journal.pone.0169989			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103254	gold, Green Submitted, Green Published			2022-12-26	WOS:000392381100031
J	Qin, HM; Janowski, M; Pearl, MS; Malysz-Cymborska, I; Li, S; Eberhart, CG; Walczak, P				Qin, Huamin; Janowski, Miroslaw; Pearl, Monica S.; Malysz-Cymborska, Izabela; Li, Shen; Eberhart, Charles G.; Walczak, Piotr			Rabbit Model of Human Gliomas: Implications for Intra-Arterial Drug Delivery	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; RADIOFREQUENCY ABLATION; TUMOR-MODEL; CEST MRI; CHEMOTHERAPY; DISRUPTION; INOCULATION; CARCINOMA; GROWTH; VIRUS	The prognosis for malignant brain tumors remains poor despite a combination of surgery, radiotherapy, and chemotherapy. This is partly due to the blood-brain barrier, a major obstacle that prevents therapeutic agents from effectively reaching the tumor. We have recently developed a method for precise and predictable opening of the blood-brain barrier via the intra-arterial administration of mannitol, a hyperosmolar agent, in a rabbit model, whose vascular anatomy facilitates the use of standard interventional neuroradiology techniques and devices. To date, however, no protocols are available that enable human glioma modeling in rabbits. In this article, we report on the xenotransplantation of a human glioblastoma (GBM-1) in adult New Zealand rabbits. We induced multi-drug immunosuppression (Mycophenolate Mofetil, Dexamethasone, Tacrolimus) and stereotactically implanted GBM-1 tumor cells into rabbit brains. The rabbits were followed for 42 days, monitored by MRI and body weight measurements, and underwent postmortem histopathological analysis. On MRI, brain tumors were identified on T2-weighted scans. On histopathology, tumors were detected with hematoxylin/eosin and their human origin was confirmed with immunohistochemistry against human-specific antigens. Our method for human glioma modeling in rabbits provides the foundation to test novel treatment strategies, including intra-arterial therapeutic agent delivery.	[Qin, Huamin; Janowski, Miroslaw; Li, Shen; Walczak, Piotr] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Div MR Res,Cellular Imaging Sect, Baltimore, MD 21218 USA; [Qin, Huamin; Janowski, Miroslaw; Li, Shen; Walczak, Piotr] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA; [Qin, Huamin] Dalian Med Univ, Affiliated Hosp 2, Dept Pathol, Dalian, Liaoning, Peoples R China; [Janowski, Miroslaw] Polish Acad Sci, NeuroRepair Dept, Mossakowski Med Res Ctr, Warsaw, Poland; [Pearl, Monica S.] Johns Hopkins Univ, Sch Med, Div Intervent Neu roradiol, Baltimore, MD USA; [Malysz-Cymborska, Izabela; Walczak, Piotr] Univ Warmia & Mazury, Fac Med Sci, Dept Neurol & Neurosurg, Olsztyn, Poland; [Eberhart, Charles G.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Dalian Medical University; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Johns Hopkins University; University of Warmia & Mazury; Johns Hopkins University		pwalczak@mri.jhu.edu		Walczak, Piotr/0000-0002-3733-3322; Janowski, Miroslaw/0000-0001-5261-7975; Malysz-Cymborska, Izabela/0000-0003-4192-6726	Strategmed [1/233209/12/NCBIR/2015];  [R01 NS076573];  [R01 NS091110];  [R01NS091100];  [R21NS091599]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076573, R01NS091110, R01NS091100, R21NS091599] Funding Source: NIH RePORTER	Strategmed; ; ; ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was supported by R01 NS076573, R01 NS091110, R01NS091100, R21NS091599, and Strategmed 1/233209/12/NCBIR/2015.	Anayama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067355; CARSON BS, 1982, NEUROSURGERY, V11, P603, DOI 10.1227/00006123-198211000-00003; Chen L, 2015, AM J NEURORADIOL, V36, P153, DOI 10.3174/ajnr.A3956; Doolittle N D, 1998, J Neurosci Nurs, V30, P81; FRANK JA, 1987, J NEUROSURG, V67, P106, DOI 10.3171/jns.1987.67.1.0106; Hall WA, 2006, J NEURO-ONCOL, V77, P279, DOI 10.1007/s11060-005-9038-4; Janowski M, 2016, J CEREBR BLOOD F MET, V36, P569, DOI 10.1177/0271678X15615875; Kidd JG, 1940, J EXP MED, V71, P813, DOI 10.1084/jem.71.6.813; Lim KJ, 2011, CANCER BIOL THER, V11, P464, DOI 10.4161/cbt.11.5.14410; Liu HL, 2016, THERANOSTICS, V6, P1588, DOI 10.7150/thno.15492; Miao Y, 2000, EUR RADIOL, V10, P188, DOI 10.1007/s003300050031; Miao Y, 2001, ANN SURG ONCOL, V8, P651, DOI 10.1245/aso.2001.8.8.651; NEUWELT EA, 1980, NEUROSURGERY, V7, P44, DOI 10.1227/00006123-198007000-00007; Ngen EJ, 2016, MOL PHARMACEUT, V13, P3043, DOI 10.1021/acs.molpharmaceut.6b00130; Parvinian A, 2014, DIAGN INTERV RADIOL, V20, P335, DOI 10.5152/dir.2014.13415; RAPOPORT SI, 1970, AM J PHYSIOL, V219, P270, DOI 10.1152/ajplegacy.1970.219.1.270; ROMANGOLDSTEIN S, 1995, AM J NEURORADIOL, V16, P543; Rous P, 1935, J EXP MED, V62, P523, DOI 10.1084/jem.62.4.523; Selek L, 2014, J NEUROSCI METH, V221, P159, DOI 10.1016/j.jneumeth.2013.10.002; Song XL, 2016, J CEREBR BLOOD F MET, V36, P1186, DOI 10.1177/0271678X16637882	20	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0169656	10.1371/journal.pone.0169656	http://dx.doi.org/10.1371/journal.pone.0169656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103265	Green Published, gold, Green Submitted			2022-12-26	WOS:000392381100017
J	Bonacci, T; Audebert, S; Camoin, L; Baudelet, E; Iovanna, JL; Soubeyran, P				Bonacci, Thomas; Audebert, Stephane; Camoin, Luc; Baudelet, Emilie; Iovanna, Juan-Lucio; Soubeyran, Philippe			Regulation of NUB1 Activity through Non-Proteolytic Mdm2-Mediated Ubiquitination	PLOS ONE			English	Article							PROTEASOMAL DEGRADATION; NEDD8; P53; PROTEIN; IDENTIFICATION; SYSTEM	NUB1 (Nedd8 ultimate buster 1) is an adaptor protein which negatively regulates the ubiquitin-like protein Nedd8 as well as neddylated proteins levels through proteasomal degradation. However, molecular mechanisms underlying this function are not completely understood. Here, we report that the oncogenic E3 ubiquitin ligase Mdm2 is a new NUB1 interacting protein which induces its ubiquitination. Interestingly, we found that Mdm2-mediated ubiquitination of NUB1 is not a proteolytic signal. Instead of promoting the conjugation of polyubiquitin chains and the subsequent proteasomal degradation of NUB1, Mdm2 rather induces its di-ubiquitination on lysine 159. Importantly, mutation of lysine 159 into arginine inhibits NUB1 activity by impairing its negative regulation of Nedd8 and of neddylated proteins. We conclude that Mdm2 acts as a positive regulator of NUB1 function, by modulating NUB1 ubiquitination on lysine 159.	[Soubeyran, Philippe] Aix Marseille Univ, CNRS, UMR 7258, CRCM,INSERM,U1068, Parc Sci & Technol Luminy, Marseille, France; Inst Paoli Calmettes, Parc Sci & Technol Luminy, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Soubeyran, P (corresponding author), Aix Marseille Univ, CNRS, UMR 7258, CRCM,INSERM,U1068, Parc Sci & Technol Luminy, Marseille, France.	philippe.soubeyran@inserm.fr	Soubeyran, Philippe/P-1758-2018; Iovanna, Juan/M-9805-2017; Camoin, Luc/AAB-3856-2019	Iovanna, Juan/0000-0003-1822-2237; Camoin, Luc/0000-0002-1230-4787; Soubeyran, Philippe/0000-0002-5876-3217; Audebert, Stephane/0000-0002-9409-2588	INSERM; INCA; La Ligue Contre le Cancer; Canceropole PACA; IBiSA (Infrastructures Biologie Sante et Agronomie); Region PACA; Institut Paoli-Calmettes	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); INCA(Institut National du Cancer (INCA) France); La Ligue Contre le Cancer(Ligue nationale contre le cancer); Canceropole PACA(Region Grand-Est); IBiSA (Infrastructures Biologie Sante et Agronomie); Region PACA(Region Provence-Alpes-Cote d'Azur); Institut Paoli-Calmettes	This work was supported by grants from INSERM, INCA, and La Ligue Contre le Cancer. TB was supported by a fellowship from La Ligue contre le Cancer and INSERM. EB was supported by Canceropole PACA. The Marseille Proteomic facility (MaP; http://map.univmed.fr/) is supported by IBiSA (Infrastructures Biologie Sante et Agronomie), Canceropole PACA, Region PACA and Institut Paoli-Calmettes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonacci T, 2014, J PROTEOME RES, V13, P2478, DOI 10.1021/pr401258d; David Y, 2011, J BIOL CHEM, V286, P44104, DOI 10.1074/jbc.M111.234559; Fuchs SY, 1998, ONCOGENE, V17, P2543, DOI 10.1038/sj.onc.1202200; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Hipp MS, 2004, J BIOL CHEM, V279, P16503, DOI 10.1074/jbc.M310114200; Hjerpe R, 2012, J MOL BIOL, V421, P27, DOI 10.1016/j.jmb.2012.05.013; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Kamitani T, 2001, J BIOL CHEM, V276, P46655, DOI 10.1074/jbc.M108636200; Kanaya K, 2004, BIOCHEM BIOPH RES CO, V317, P768, DOI 10.1016/j.bbrc.2004.03.108; Kito K, 2001, J BIOL CHEM, V276, P20603, DOI 10.1074/jbc.M100920200; Leidecker O, 2012, CELL CYCLE, V11, P1142, DOI 10.4161/cc.11.6.19559; Li J, 2015, BOUND VALUE PROBL, DOI 10.1186/s13661-014-0269-1; Liu G, 2010, ONCOGENE, V29, P2252, DOI 10.1038/onc.2009.494; Lu BX, 2013, NAT NEUROSCI, V16, P562, DOI 10.1038/nn.3367; Matsumoto M, 2005, PROTEOMICS, V5, P4145, DOI 10.1002/pmic.200401280; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; Ryu KY, 2007, EMBO J, V26, P2693, DOI 10.1038/sj.emboj.7601722; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Tanji K, 2006, AM J PATHOL, V169, P553, DOI 10.2353/ajpath.2006.051067; Vertegaal ACO, 2011, CHEM REV, V111, P7923, DOI 10.1021/cr200187e; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Zheng NN, 2016, BBA-REV CANCER, V1866, P12, DOI 10.1016/j.bbcan.2016.05.001	22	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0169988	10.1371/journal.pone.0169988	http://dx.doi.org/10.1371/journal.pone.0169988			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099510	Green Published, gold, Green Submitted			2022-12-26	WOS:000392380100048
J	Chedik, L; Bruyere, A; Le Vee, M; Stieger, B; Denizot, C; Parmentier, Y; Potin, S; Fardel, O				Chedik, Lisa; Bruyere, Arnaud; Le Vee, Marc; Stieger, Bruno; Denizot, Claire; Parmentier, Yannick; Potin, Sophie; Fardel, Olivier			Inhibition of Human Drug Transporter Activities by the Pyrethroid Pesticides Allethrin and Tetramethrin	PLOS ONE			English	Article							PREGNANE-X-RECEPTOR; ORGANIC CATION TRANSPORTER-2; RESISTANCE PROTEIN ABCG2; P-GLYCOPROTEIN; SODIUM-CHANNELS; HEPATIC DRUG; RISK-ASSESSMENT; RAT NA(V)1.6; HUMAN MDR1; INSECTICIDES	Pyrethroids are widely-used chemical insecticides, to which humans are commonly exposed, and known to alter functional expression of drug metabolizing enzymes. Limited data have additionally suggested that drug transporters, that constitute key-actors of the drug detoxification system, may also be targeted by pyrethroids. The present study was therefore designed to analyze the potential regulatory effects of these pesticides towards activities of main ATP-binding cassette (ABC) and solute carrier (SLC) drug transporters, using transporter-overexpressing cells. The pyrethroids allethrin and tetramethrin were found to inhibit various ABC and SLC drug transporters, including multidrug resistance-associated protein (MRP) 2, breast cancer resistance protein (BCRP), organic anion transporter polypeptide (OATP) 1B1, organic anion transporter (OAT) 3, multidrug and toxin extrusion transporter (MATE) 1, organic cation transporter (OCT) 1 and OCT2, with IC50 values however ranging from 2.6 mu M (OCT1 inhibition by allethrin) to 77.6 mu M (OAT3 inhibition by tetramethrin) and thus much higher than pyrethroid concentrations (in the nM range) reached in environmentally pyrethroid-exposed humans. By contrast, allethrin and tetramethrin cis-stimulated OATP2B1 activity and failed to alter activities of OATP1B3, OAT1 and MATE2-K, whereas P-glycoprotein activity was additionally moderately inhibited. Twelve other pyrethoids used at 100 mu M did not block activities of the various investigated transporters, or only moderately inhibited some of them (inhibition by less than 50%). In silico analysis of structure-activity relationships next revealed that molecular parameters, including molecular weight and lipophilicity, are associated with transporter inhibition by allethrin/tetramethrin and successfully predicted transporter inhibition by the pyrethroids imiprothrin and prallethrin. Taken together, these data fully demonstrated that two pyrethoids, i.e., allethrin and tetramethrin, can act as regulators of the activity of various ABC and SLC drug transporters, but only when used at high and non-relevant concentrations, making unlikely any contribution of these transporter activity alterations to pyrethroid toxicity in environmentally exposed humans.	[Chedik, Lisa; Bruyere, Arnaud; Le Vee, Marc; Potin, Sophie; Fardel, Olivier] Fac Pharm, IRSET, UMR INSERM U1085, 2 Ave Pr Leon Bernard, Rennes, France; [Chedik, Lisa; Potin, Sophie] Ctr Hosp Univ, Pole Pharm, 2 Rue Henri Le Guilloux, Rennes, France; [Stieger, Bruno] Univ Zurich, Univ Zurich Hosp, Dept Clin Pharmacol & Toxicol, Ramistr 100, Zurich, Switzerland; [Denizot, Claire; Parmentier, Yannick] Ctr Pharmacocinet, Technol Servier, 25-27 Rue Eugene Vignat, Orleans, France; [Fardel, Olivier] Ctr Hosp Univ, Pole Biol, 2 Rue Henri Le Guilloux, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU Rennes; University of Zurich; University Zurich Hospital; Servier; CHU Rennes	Fardel, O (corresponding author), Fac Pharm, IRSET, UMR INSERM U1085, 2 Ave Pr Leon Bernard, Rennes, France.; Fardel, O (corresponding author), Ctr Hosp Univ, Pole Biol, 2 Rue Henri Le Guilloux, Rennes, France.	olivier.fardel@univ-rennes1.fr	Bruyere, Arnaud/J-8577-2015; Le Vee, Marc/U-8843-2019; Stieger, Bruno/U-6323-2017; LE VÉE, Marc/AAP-6961-2020	Bruyere, Arnaud/0000-0003-1158-1413; Stieger, Bruno/0000-0002-7190-5785; 				Abass K, 2012, TOXICOLOGY, V294, P17, DOI 10.1016/j.tox.2012.01.010; Ahlin G, 2008, J MED CHEM, V51, P5932, DOI 10.1021/jm8003152; Amaraneni M, 2016, TOXICOL LETT, V250, P21, DOI 10.1016/j.toxlet.2016.03.006; Bain LJ, 1996, TOXICOL APPL PHARM, V141, P288, DOI 10.1016/S0041-008X(96)80035-4; Baltazar MT, 2014, TOXICOL LETT, V230, P85, DOI 10.1016/j.toxlet.2014.01.039; Bircsak KM, 2013, J BIOCHEM MOL TOXIC, V27, P157, DOI 10.1002/jbt.21458; Bouvier G, 2005, J TOXICOL ENV HEAL B, V8, P485, DOI 10.1080/10937400591007284; Boxberger KH, 2014, DRUG METAB DISPOS, V42, P990, DOI 10.1124/dmd.113.055095; Bradberry Sally M, 2005, Toxicol Rev, V24, P93, DOI 10.2165/00139709-200524020-00003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bucher S, 2014, J BIOCHEM MOL TOXIC, V28, P119, DOI 10.1002/jbt.21543; Cao ZY, 2011, ENVIRON HEALTH PERSP, V119, P1239, DOI 10.1289/ehp.1003394; Chen HY, 2002, J TOXICOL ENV HEAL A, V65, P1419, DOI 10.1080/00984100290071243; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Choi JS, 2006, TOXICOL APPL PHARM, V211, P233, DOI 10.1016/j.taap.2005.06.022; Clark JM, 2012, TOP CURR CHEM, V314, P49, DOI 10.1007/128_2011_268; CROFTON KM, 1987, J PHARMACOL EXP THER, V243, P946; Das Parikshit C., 2008, Drug Metabolism and Drug Interactions, V23, P211; De Bruyn T, 2013, MOL PHARMACOL, V83, P1257, DOI 10.1124/mol.112.084152; de Winters JCF, 2013, PRACTICAL ASSESSMENT, V18; Du GZ, 2010, TOXICOL SCI, V116, P58, DOI 10.1093/toxsci/kfq120; Duan P, 2012, MOL PHARMACEUT, V9, P3340, DOI 10.1021/mp300365t; Fardel O, 2001, TOXICOLOGY, V167, P37, DOI 10.1016/S0300-483X(01)00456-5; Fardel O, 2015, EXPERT OPIN DRUG MET, V11, P1233, DOI 10.1517/17425255.2015.1053462; Fardel O, 2012, EXPERT OPIN DRUG MET, V8, P29, DOI 10.1517/17425255.2012.637918; Foucaud-Vignault M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023614; Geick A, 2001, J BIOL CHEM, V276, P14581, DOI 10.1074/jbc.M010173200; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Gotoh Y, 1998, J TOXICOL-CLIN TOXIC, V36, P57, DOI 10.3109/15563659809162587; Gui C, 2008, EUR J PHARMACOL, V584, P57, DOI 10.1016/j.ejphar.2008.01.042; Hacker K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136451; Halwachs S, 2016, TOXICOL APPL PHARM, V305, P66, DOI 10.1016/j.taap.2016.06.007; He BJ, 2011, TOXICOL APPL PHARM, V257, P377, DOI 10.1016/j.taap.2011.09.021; Heredi-Szabo K, 2009, CHEM BIODIVERS, V6, P1970, DOI 10.1002/cbdv.200900102; Heudorf U, 2001, ENVIRON HEALTH PERSP, V109, P213, DOI 10.2307/3434687; Janusonis S, 2009, J NEUROSCI METH, V179, P173, DOI 10.1016/j.jneumeth.2009.01.017; Jigorel E, 2005, DRUG METAB DISPOS, V33, P1418, DOI 10.1124/dmd.105.004762; Jouan E, 2014, FUND CLIN PHARMACOL, V28, P65, DOI 10.1111/j.1472-8206.2012.01071.x; Kamel F, 2004, ENVIRON HEALTH PERSP, V112, P950, DOI 10.1289/ehp.7135; Kaneko H, 2011, J AGR FOOD CHEM, V59, P2786, DOI 10.1021/jf102567z; Kast HR, 2002, J BIOL CHEM, V277, P2908, DOI 10.1074/jbc.M109326200; Katsuda Y, 2012, TOP CURR CHEM, V314, P1, DOI 10.1007/128_2011_252; Kido Y, 2011, J MED CHEM, V54, P4548, DOI 10.1021/jm2001629; Klaassen CD, 2005, CURR DRUG METAB, V6, P309, DOI 10.2174/1389200054633826; Knaak JB, 2012, REV ENVIRON CONTAM T, V219, P1, DOI 10.1007/978-1-4614-3281-4_1; Le Vee M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121232; Lecureur V, 2000, TOXICOLOGY, V153, P203, DOI 10.1016/S0300-483X(00)00315-2; Lemaire G, 2004, BIOCHEM PHARMACOL, V68, P2347, DOI 10.1016/j.bcp.2004.07.041; Leng G, 2003, INT J HYG ENVIR HEAL, V206, P85, DOI 10.1078/1438-4639-00199; Martinez-Guerrero LJ, 2013, J PHARMACOL EXP THER, V346, P495, DOI 10.1124/jpet.113.204206; Matsson P, 2007, J PHARMACOL EXP THER, V323, P19, DOI 10.1124/jpet.107.124768; Mayati A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144667; Montanari F, 2015, ADV DRUG DELIVER REV, V86, P17, DOI 10.1016/j.addr.2015.03.001; Morgan MK, 2012, INT J ENV RES PUB HE, V9, P2964, DOI 10.3390/ijerph9082964; Morisseau C, 1999, TOXICOL SCI, V52, P148, DOI 10.1093/toxsci/52.2.148; Morjani H, 2001, INT J CANCER, V94, P157, DOI 10.1002/ijc.1449; Nakagawa H, 2009, BASIC CLIN PHARMACOL, V105, P136, DOI 10.1111/j.1742-7843.2009.00409.x; Nicklisch SCT, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600001; Olsavsky KM, 2007, TOXICOL APPL PHARM, V222, P42, DOI 10.1016/j.taap.2007.03.032; Ose A, 2016, J PHARM SCI-US, V105, P2222, DOI 10.1016/j.xphs.2016.04.023; Pedersen JM, 2008, J MED CHEM, V51, P3275, DOI 10.1021/jm7015683; Peruga A, 2013, J CHROMATOGR A, V1307, P126, DOI 10.1016/j.chroma.2013.07.090; Pivcevic B, 2006, ENVIRON TOXICOL PHAR, V22, P268, DOI 10.1016/j.etap.2006.04.002; Ramos-Chavez LA, 2015, J TOXICOL ENV HEAL A, V78, P7, DOI 10.1080/15287394.2015.956025; Riederer AM, 2010, ENVIRON SCI TECHNOL, V44, P483, DOI 10.1021/es902479h; Rizzati V, 2016, CHEM-BIOL INTERACT, V254, P231, DOI 10.1016/j.cbi.2016.06.003; Romero A, 2015, ENVIRON RES, V138, P58, DOI 10.1016/j.envres.2015.02.008; SODERLUND DM, 1989, ANNU REV ENTOMOL, V34, P77, DOI 10.1146/annurev.en.34.010189.000453; Soderlund DM, 2002, TOXICOLOGY, V171, P3, DOI 10.1016/S0300-483X(01)00569-8; Soderlund DM, 2016, NEUROTOXICOLOGY; Sreeramulu K, 2007, BBA-BIOMEMBRANES, V1768, P1750, DOI 10.1016/j.bbamem.2007.04.001; Staudinger JL, 2013, DRUG METAB REV, V45, P48, DOI 10.3109/03602532.2012.748793; Stieger B, 2011, PHARMACOGENOMICS, V12, P611, DOI [10.2217/pgs.11.53, 10.2217/PGS.11.53]; Tan JG, 2011, PESTIC BIOCHEM PHYS, V101, P256, DOI 10.1016/j.pestbp.2011.10.003; Teng S, 2003, DRUG METAB DISPOS, V31, P1296, DOI 10.1124/dmd.31.11.1296; Thevenod F, 2013, MOL PHARMACEUT, V10, P3045, DOI 10.1021/mp400113d; Thiphom S, 2013, J ENV SCI HLTH B, V49, P15, DOI DOI 10.1080/03601234.2013.836862; Tournier N, 2010, INT J NEUROPSYCHOPH, V13, P905, DOI 10.1017/S1461145709990848; Wittwer MB, 2013, J MED CHEM, V56, P781, DOI 10.1021/jm301302s; Yang DF, 2009, TOXICOL APPL PHARM, V237, P49, DOI 10.1016/j.taap.2009.02.012; Zastre J, 2013, TOXICOL SCI, V136, P284, DOI 10.1093/toxsci/kft193; Zhang L, 1999, J PHARMACOL EXP THER, V288, P1192; Zhou Q, 2014, DRUG METAB REV, V46, P283, DOI 10.3109/03602532.2014.887094	83	22	22	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0169480	10.1371/journal.pone.0169480	http://dx.doi.org/10.1371/journal.pone.0169480			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099443	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000392380100024
J	Pavan, S; Rommel, K; Marquina, MEM; Hohn, S; Lanneau, V; Rath, A				Pavan, Sonia; Rommel, Kathrin; Mateo Marquina, Maria Elena; Hohn, Sophie; Lanneau, Valerie; Rath, Ana			Clinical Practice Guidelines for Rare Diseases: The Orphanet Database	PLOS ONE			English	Article							METHODOLOGICAL QUALITY; GOOGLE SCHOLAR; APPRAISAL; SEARCHES	Clinical practice guidelines (CPGs) for rare diseases (RDs) are scarce, may be difficult to identify through Internet searches and may vary in quality depending on the source and methodology used. In order to contribute to the improvement of the diagnosis, treatment and care of patients, Orphanet (vvwvv.orphanet) has set up a procedure for the selection, quality evaluation and dissemination of CPGs, with the aim to provide easy access to relevant, accurate and specific recommendations for the management of RDs. This article provides an analysis of selected CPGs by medical domain coverage, prevalence of diseases, languages and type of producer, and addresses the variability in CPG quality and availability. CPGs are identified via bibliographic databases, websites of research networks, expert centres or medical societies. They are assessed according to quality criteria derived from the Appraisal of Guidelines, REsearch and Evaluation (AGREE II) Instrument. Only open access CPGs and documents for which permission from the copyright holders has been obtained are disseminated on the Orphanet website. From January 2012 to July 2015, 277 CPGs were disseminated, representing coverage of 1,122 groups of diseases, diseases or subtypes in the Orphanet database. No language restriction is applied, and so far 10 languages are represented, with a predominance of CPGs in English, French and German (92% of all CPGs). A large proportion of diseases with identified CPGs belong to rare oncologic, neurologic, hematologic diseases or developmental anomalies. The Orphanet project on CPG collection, evaluation and dissemination is a continuous process, with regular addition of new guidelines, and updates. CPGs meeting the quality criteria are integrated to the Orphanet database of rare diseases, together with other types of textual information and the appropriate services for patients, researchers and healthcare professionals in 40 countries.	[Pavan, Sonia; Hohn, Sophie; Lanneau, Valerie; Rath, Ana] INSERM, Orphanet US14, Paris, France; [Rommel, Kathrin] Hannover Med Sch, Orphanet Germany, Ctr Rare Dis, Hannover, Germany; [Mateo Marquina, Maria Elena] CIBERER, Orphanet Spain, Valencia, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); Hannover Medical School; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Pavan, S (corresponding author), INSERM, Orphanet US14, Paris, France.	sonia.pavan@inserm.fr		Pavan, Sonia/0000-0002-4394-7291	French Directorate General for Health (DGS); European Commission Directorate-General for Health and Consumers [20102206, 20133305-INSERM_FY2014]	French Directorate General for Health (DGS); European Commission Directorate-General for Health and Consumers(European CommissionEuropean Commission Joint Research Centre)	This work was supported by funds from the French Directorate General for Health (DGS, http://social-sante.gouv.fr/ministere/organisation/directions/article/dgs-direction-generale-de-la-sante) and from the European Commission Directorate-General for Health and Consumers (http://ec.europa.eu/dgs/health_food-safety/index_en.htm) (Orphanet Europe Joint Action grant #20102206 and Orphanet Operating grant #20133305-INSERM_FY2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Coello P, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2010.042077; [Anonymous], 2015, SIGN 50 GUID DEV HDB; Ansari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049864; Beales D. L., 2011, J HOSP LIBRARIANSHIP, V11, P311; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Cassis L, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0376-9; Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18; Cordier JF, 2014, EUR RESPIR J, V44, P853, DOI 10.1183/09031936.00027414; Council of the European Union, 2009, OFFICIAL J EUROPEAN, V151, P7; Dosquet P., 2013, COMITE SUIVI PROSPEC; Field MJ, 1990, CLIN PRACTICE GUIDEL; Griffiths P., 2010, ORPHANET J RARE DIS, V5, pP20, DOI [10.1186/1750-1172-5-S1-P20, DOI 10.1186/1750-1172-5-S1-P20]; HAS, 2012, METH EL PROT NAT DIA; Henter JI, 2014, RARE DIS ORPHAN DRUG, VS1, pOP; Hilton Boon M, 2014, RARE DIS ORPHAN DRUG, V1, P20; Institut national du cancer, 2014, PLAN CANC 2014 2019; Institute for Quality and Efficiency in Health Care, 2011, IQWIG REP WHAT TYP E; Jacobs C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116267; Kirschner J, 2012, ORPHANET J RARE D S2, V7, pA14; Knai C, 2012, HEALTH POLICY, V107, P157, DOI 10.1016/j.healthpol.2012.06.004; Kremp O., 2012, ORPHANET J RARE DIS, V7, pA12, DOI [10.1186/1750-1172-7-S2-A12, DOI 10.1186/1750-1172-7-S2-A12]; Nourbakhsh E, 2012, HEALTH INFO LIBR J, V29, P214, DOI 10.1111/j.1471-1842.2012.00992.x; Orphan Drugs Collection, 2015, LISTS MED PROD RAR D; Orphanet D Linearization rules for rare diseases, 2014, LIN RUL RAR DIS ORPH; Pentheroudakis G, 2008, ANN ONCOL, V19, P2067, DOI 10.1093/annonc/mdn418; Rodwell C, 2014, REPORT STATE ART R 1; Rodwell C, 2014, REPORT STATE ART R 5; Sejersen T, 2014, RARE DIS ORPHAN DRUG, V1, P10; Shariff SZ, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2624; Standing Guideline Commission of the Association of Scientific Medical Societiesin Germany(AWMF), 2012, AWMF GUID MAN RUL GU; Taruscio D, 2014, RARE DIS ORPHAN DRUG, V1, P5; Turner T, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-45; Vlayen J, 2005, INT J QUAL HEALTH C, V17, P235, DOI 10.1093/intqhc/mzi027; Wallerstein N., 2006, WHAT IS EVIDENCE EFF	34	87	90	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170365	10.1371/journal.pone.0170365	http://dx.doi.org/10.1371/journal.pone.0170365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099516	Green Published, gold, Green Submitted			2022-12-26	WOS:000392380100080
J	Shah, SM; Ali, R; Loney, T; Aziz, F; ElBarazi, I; Al Dhaheri, S; Farooqi, MH; Blair, I				Shah, Syed M.; Ali, Raghib; Loney, Tom; Aziz, Faisal; ElBarazi, Iffat; Al Dhaheri, Salma; Farooqi, M. Hamed; Blair, Iain			Prevalence of Diabetes among Migrant Women and Duration of Residence in the United Arab Emirates: A Cross Sectional Study	PLOS ONE			English	Article							RISK-FACTORS; ASIAN SUBGROUPS; ACCULTURATION; IMMIGRANTS; HEALTH; DISPARITIES; DISEASES	Background The prevalence rate of type 2 diabetes mellitus (T2DM) is one of the highest in United Arab Emirates (UAE), however data for the expatriate population is limited. This study aimed to identify the prevalence of T2DM amongst migrant women and test the hypothesis that acculturation (measured by years of residency) is associated with an increased risk of T2DM. Methods This was a cross-sectional study and we recruited a representative sample (n = 599, 75% participation rate) of migrant women aged 18 years and over in Al Ain, UAE. The American Diabetes Association criteria were used to diagnose T2DM. An adapted WHO STEPS questionnaire was used to collect socio-demographic, lifestyle and clinical data. Logistic regression analysis was performed to identify correlates of T2DM including length of UAE residence. Results The mean age of participants was 34.1 (+/-9.5) years. Of the study participants, based on HbA1C levels, 18.6% (95% Cl: 13.9-24.4) had prediabetes and 10.7% (95% Cl: 7.2-15.6) had T2DM. Prevalence of prediabetes was 8.5% for Filipinos, 16.7% for Arabs and 30.3% for South Asians. Similarly the prevalence of T2DM was 1.7% for Filipinos, 12.2% for Arabs and 16.7% for South Asians. Significant correlates of overall T2DM (measured and known diabetes) included length of UAE residence for more than 10 years (Adjusted Odds Ratio [AOR]2.74, 95% Cl: 1.21-6.20), age >= 40 years (AOR = 3.48, 95% Cl: 1.53-7.87) and South Asian nationality (AOR 2.10,95% Cl: 0.94-4.70). Conclusion Diabetes is a significant public health problem among migrant women in the UAE, particularly for South Asians. Longer length of residence in the UAE is associated with a higher prevalence of diabetes. Conclusion Diabetes is a significant public health problem among migrant women in the UAE, particularly for South Asians. Longer length of residence in the UAE is associated with a higher prevalence of diabetes.	[Shah, Syed M.; Ali, Raghib; Loney, Tom; Aziz, Faisal; ElBarazi, Iffat; Blair, Iain] United Arab Emirates Univ, Coll Med & Hlth Sci, Inst Publ Hlth, Al Ain, U Arab Emirates; [Ali, Raghib] New York Univ Abu Dhabi, Publ Hlth Res Ctr, Abu Dhabi, U Arab Emirates; [Al Dhaheri, Salma] SEHA, Ambulatory Hlth Serv, Al Ain, U Arab Emirates; [Farooqi, M. Hamed] Dubai Hlth Author, Dubai Diabet Ctr, Dubai, U Arab Emirates	United Arab Emirates University	Blair, I (corresponding author), United Arab Emirates Univ, Coll Med & Hlth Sci, Inst Publ Hlth, Al Ain, U Arab Emirates.	iain_blair@uaeu.ac.ae	Aziz, Faisal/O-3263-2016	Aziz, Faisal/0000-0002-0109-2969; Loney, Tom/0000-0003-1687-6587; FAROOQI, MUHAMMAD HAMED/0000-0001-6489-3715; Elbarazi, Iffat/0000-0001-7151-2175	United Arab Emirates University [NP09-30]	United Arab Emirates University	This work was supported by the United Arab Emirates University (Grant No. NP09-30) SMS received the funding http.//www.uaeu.ac.ae/art. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afable-Munsuz A, 2014, AM J PUBLIC HEALTH, V104, pS243, DOI 10.2105/AJPH.2012.300969; Alhyas L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040948; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; [Anonymous], 2008, WHO WAIST CIRCUMFERE; [Anonymous], 2000, PREV MAN GLOB EPID R; Araneta MRG, 2006, DIABETES RES CLIN PR, V71, P306, DOI 10.1016/j.diabres.2005.07.012; Azar KMJ, 2013, J IMMIGR MINOR HEALT, V15, P953, DOI 10.1007/s10903-012-9705-4; Cheema A, 2014, J GLOB HEALTH, V4, DOI 10.7189/jogh.04.010404; Chiu M, 2012, CAN J CARDIOL, V28, P20, DOI 10.1016/j.cjca.2011.06.002; Choi SE, 2013, J DIABETES COMPLICAT, V27, P429, DOI 10.1016/j.jdiacomp.2013.01.002; Clark L., 1998, HDB IMMIGRANT HLTH, P37; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Creatore MI, 2010, CAN MED ASSOC J, V182, P781, DOI 10.1503/cmaj.091551; Dekker LH, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-441; Delavari M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-458; Golden SH, 2012, J CLIN ENDOCR METAB, V97, pE1579, DOI 10.1210/jc.2012-2043; Gomez SL, 2004, AM J PUBLIC HEALTH, V94, P1977, DOI 10.2105/AJPH.94.11.1977; Gujral UP, 2013, ANN NY ACAD SCI, V1281, P51, DOI 10.1111/j.1749-6632.2012.06838.x; Hajat C, 2012, AM J PUBLIC HEALTH, V102, P909, DOI 10.2105/AJPH.2011.300290; International Diabetes Federation, 2015, IDF DIABETES ATLAS; Jayawardena R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-380; Kandula NR, 2008, DIABETES CARE, V31, P1621, DOI 10.2337/dc07-2182; Lee JWR, 2011, DIABETES CARE, V34, P353, DOI 10.2337/dc10-0746; Lesser IA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088495; Loney T, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20100; Lopez L, 2014, DIABETES CARE, V37, P2081, DOI 10.2337/dc14-0923; Maneze D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/506269; Montesi L, 2016, WORLD J DIABETES, V7, P34, DOI 10.4239/wjd.v7.i3.34; Odegaard AO, 2012, CIRCULATION, V126, P182, DOI 10.1161/CIRCULATIONAHA.111.084004; Oh CH, 2015, J IMMIGR MINOR HEALT, V17, P467, DOI 10.1007/s10903-014-0024-9; Patel M, 2012, J IMMIGR MINOR HEALT, V14, P774, DOI 10.1007/s10903-011-9550-x; Sanou D, 2014, J IMMIGR MINOR HEALT, V16, P24, DOI 10.1007/s10903-013-9823-7; Shah SM, BMC PUBLIC HEALTH, V15, P1568; Shah SM, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0024-2; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Sy RG, 2012, J EPIDEMIOL, V22, P440, DOI 10.2188/jea.JE20110095; The IPAQ Group, GUIDELINES DATA PROC; Vargas P, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13010016; World Health Organisation, 2012, GLOB STAT REP NONC D; World Health Organization, CHRON DIS HLTH PROM; World Health Organization (WHO), 2014, GLOB HLTH EST DEATH	41	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0169949	10.1371/journal.pone.0169949	http://dx.doi.org/10.1371/journal.pone.0169949			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI3HH	28099445	gold, Green Submitted, Green Published			2022-12-26	WOS:000392380100044
J	Chang, WLW; Gonzalez, DF; Kieu, HT; Castillo, LD; Messaoudi, I; Shen, XY; Tomaras, GD; Shacklett, BL; Barry, PA; Sparger, EE				Chang, W. L. William; Gonzalez, Denise F.; Kieu, Hung T.; Castillo, Luis D.; Messaoudi, Ilhem; Shen, Xiaoying; Tomaras, Georgia D.; Shacklett, Barbara L.; Barry, Peter A.; Sparger, Ellen E.			Changes in Circulating B Cell Subsets Associated with Aging and Acute SIV Infection in Rhesus Macaques	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; RAPID DISEASE PROGRESSION; NONHUMAN PRIMATE MODELS; PERIPHERAL-BLOOD; HIV-INFECTION; MARGINAL ZONE; CYTOMEGALOVIRUS-INFECTION; ANTIRETROVIRAL THERAPY; VIREMIC INDIVIDUALS; HUMAN IMMUNOLOGY	Aging and certain viral infections can negatively impact humoral responses in humans. To further develop the nonhuman primate (NHP) model for investigating B cell dynamics in human aging and infectious disease, a flow cytometric panel was developed to characterize circulating rhesus B cell subsets. Significant differences between human and macaque B cells included the proportions of cells within IgD(+) and switched memory populations and a prominent CD21(-)CD27(+) unswitched memory population detected only in macaques. We then utilized the expanded panel to analyze B cell alterations associated with aging and acute simian immunodeficiency virus (SIV) infection in the NHP model. In the aging study, distinct patterns of B cell subset frequencies were observed for macaques aged one to five years compared to those between ages 5 and 30 years. In the SIV infection study, B cell frequencies and absolute number were dramatically reduced following acute infection, but recovered within four weeks of infection. Thereafter, the frequencies of activated memory B cells progressively increased; these were significantly correlated with the magnitude of SIVspecific IgG responses, and coincided with impaired maturation of anti-SIV antibody avidity, as previously reported for HIV-1 infection. These observations further validate the NHP model for investigation of mechanisms responsible for B cells alterations associated with immunosenescence and infectious disease.	[Chang, W. L. William; Kieu, Hung T.; Castillo, Luis D.; Barry, Peter A.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Gonzalez, Denise F.; Kieu, Hung T.; Sparger, Ellen E.] Univ Calif Davis, Dept Med & Epidemiol, Sch Vet Med, Davis, CA 95616 USA; [Messaoudi, Ilhem] Univ Calif Riverside, Dept Biomed Sci, Sch Med, Riverside, CA 92521 USA; [Shen, Xiaoying; Tomaras, Georgia D.] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC USA; [Shacklett, Barbara L.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Shacklett, Barbara L.] Univ Calif Davis, Div Infect Dis, Dept Med, Sch Med, Davis, CA 95616 USA; [Barry, Peter A.] Univ Calif Davis, Sch Med, Dept Pathol & Lab Med, Davis, CA 95616 USA; [Barry, Peter A.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Riverside; Duke University; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Chang, WLW (corresponding author), Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.	wlchang@ucdavis.edu	Shacklett, Barbara/A-7288-2009; Chang, W. L. William/AAX-1773-2021	Shacklett, Barbara/0000-0002-7067-732X; CHANG, WEN-LAN/0000-0002-1258-7369	National Institutes of Health [AI088471, DE021273, OD011107, OD010990]; NIH-NIAID Primate Central Immunology Laboratory [HHSN27201100016C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021273] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107, U42OD010990] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NIAID Primate Central Immunology Laboratory; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (http://www.nih.gov) grants AI088471 (to EES and PAB), DE021273 (to EES, PAB, and BLS), and in part by National Institutes of Health grants OD011107, OD010990 to California National Primate Research Center (to PAB) and NIH-NIAID Primate Central Immunology Laboratory Contract HHSN27201100016C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ademokun A, 2010, BIOGERONTOLOGY, V11, P125, DOI 10.1007/s10522-009-9256-9; Amu S, 2013, AIDS, V27, P2323, DOI 10.1097/QAD.0b013e328361a427; Asquith M, 2012, PATHOBIOL AGING AGE, V2, DOI 10.3402/pba.v2i0.18052; Barry PA, 2008, COMPARATIVE MED, V58, P43; Bemark M, 2012, CLIN EXP IMMUNOL, V167, P15, DOI 10.1111/j.1365-2249.2011.04469.x; Blomberg BB, 2013, IMMUNOL RES, V57, P354, DOI 10.1007/s12026-013-8440-9; Bolton DL, 2012, MUCOSAL IMMUNOL, V5, P41, DOI 10.1038/mi.2011.45; Boyd SD, 2013, CURR OPIN IMMUNOL, V25, P511, DOI 10.1016/j.coi.2013.07.007; Buckner CM, 2013, J VIROL, V87, P5800, DOI 10.1128/JVI.00094-13; Bulati M, 2011, AGEING RES REV, V10, P274, DOI 10.1016/j.arr.2010.12.002; Cagigi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005427; Chang WLW, 2010, P NATL ACAD SCI USA, V107, P22647, DOI 10.1073/pnas.1013794108; Chang WLW, 2003, J VIROL, V77, P5073, DOI 10.1128/JVI.77.9.5073-5083.2003; Chidrawar S, 2009, CLIN EXP IMMUNOL, V155, P423, DOI 10.1111/j.1365-2249.2008.03785.x; Colonna-Romano G, 2009, MECH AGEING DEV, V130, P681, DOI 10.1016/j.mad.2009.08.003; Das A, 2011, CLIN IMMUNOL, V140, P223, DOI 10.1016/j.clim.2011.04.018; Das A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016524; de Bree GJ, 2016, CURR OPIN INFECT DIS, V29, P23, DOI 10.1097/QCO.0000000000000225; Demberg T, 2015, VIROLOGY, V484, P323, DOI 10.1016/j.virol.2015.06.022; Demberg T, 2014, CLIN IMMUNOL, V153, P264, DOI 10.1016/j.clim.2014.04.017; Demberg T, 2012, J VIROL, V86, P12591, DOI 10.1128/JVI.00298-12; Dubie RA, 2009, VIROLOGY, V386, P109, DOI 10.1016/j.virol.2009.01.007; Dykhuizen M, 1998, J GEN VIROL, V79, P2461, DOI 10.1099/0022-1317-79-10-2461; Fecteau JF, 2006, J IMMUNOL, V177, P3728, DOI 10.4049/jimmunol.177.6.3728; Frasca D, 2008, J IMMUNOL, V180, P5283, DOI 10.4049/jimmunol.180.8.5283; Frasca D, 2011, AGEING RES REV, V10, P330, DOI 10.1016/j.arr.2010.08.004; Garland FC, 1996, ANN EPIDEMIOL, V6, P341, DOI 10.1016/S1047-2797(96)00053-1; Garraud O, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-63; Goldeck D, 2016, GERONTOLOGY, V62, P323, DOI 10.1159/000382076; Hong JJ, 2014, J IMMUNOL, V193, P797, DOI 10.4049/jimmunol.1400749; Hu ZL, 2015, VACCINE, V33, P2524, DOI 10.1016/j.vaccine.2015.04.008; Kaminski DA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00302; Kardava L, 2011, J CLIN INVEST, V121, P2614, DOI 10.1172/JCI45685; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Kogut I, 2012, SEMIN IMMUNOL, V24, P342, DOI 10.1016/j.smim.2012.04.004; Kuhrt D, 2010, J VIROL, V84, P2466, DOI 10.1128/JVI.01966-09; Leutenegger CM, 2001, AIDS RES HUM RETROV, V17, P243, DOI 10.1089/088922201750063160; Marthas ML, 2001, AIDS RES HUM RETROV, V17, P1455, DOI 10.1089/088922201753197123; Messaoudi I, 2011, ANTIOXID REDOX SIGN, V14, P261, DOI 10.1089/ars.2010.3241; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Meyer C, 2015, METHODS MOL BIOL, V1343, P65, DOI 10.1007/978-1-4939-2963-4_6; Michael NL, 1997, J INFECT DIS, V175, P1352, DOI 10.1086/516467; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2010, BLOOD, V116, P5571, DOI 10.1182/blood-2010-05-285528; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Morbach H, 2010, CLIN EXP IMMUNOL, V162, P271, DOI 10.1111/j.1365-2249.2010.04206.x; Neumann B, 2015, J LEUKOCYTE BIOL, V97, P19, DOI 10.1189/jlb.1HI0514-243R; Otsyula MG, 1996, PEDIATR RES, V39, P630, DOI 10.1203/00006450-199604000-00012; Oxford KL, 2015, IMMUN AGEING, V12, DOI 10.1186/s12979-015-0030-3; PANTALEO G, 1994, IMMUNOL REV, V140, P105, DOI 10.1111/j.1600-065X.1994.tb00867.x; Pensieroso S, 2013, AIDS, V27, P1209, DOI 10.1097/QAD.0b013e32835edc47; Peruchon S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005966; Pieper K, 2013, J ALLERGY CLIN IMMUN, V131, P959, DOI 10.1016/j.jaci.2013.01.046; Sanz I, 2008, SEMIN IMMUNOL, V20, P67, DOI 10.1016/j.smim.2007.12.006; Scholz JL, 2013, CURR OPIN IMMUNOL, V25, P504, DOI 10.1016/j.coi.2013.07.006; Steger KK, 1998, J VIROL, V72, P1600, DOI 10.1128/JVI.72.2.1600-1605.1998; Titanji K, 2010, J CLIN INVEST, V120, P3878, DOI 10.1172/JCI43271; Tomaras GD, 2014, VACCINES, V2, P15, DOI 10.3390/vaccines2010015; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Van Rompay KKA, 2012, AIDS RES HUM RETROV, V28, P16, DOI [10.1089/AID.2011.0234, 10.1089/aid.2011.0234]; Veneri D, 2009, BLOOD TRANSFUS-ITALY, V7, P29, DOI 10.2450/2008.0007-08; Wang C, 2014, J IMMUNOL, V192, P603, DOI 10.4049/jimmunol.1301384; Warnatz K, 2008, CYTOM PART B-CLIN CY, V74B, P261, DOI 10.1002/cyto.b.20432; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Zhang ZQ, 2007, VIROLOGY, V361, P455, DOI 10.1016/j.virol.2006.12.006; Zheng Hong-Yi, 2014, Zoological Research, V35, P465, DOI 10.13918/j.issn.2095-8137.2014.6.465; Zheng HY, 2014, EXP GERONTOL, V55, P113, DOI 10.1016/j.exger.2014.04.004	67	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0170154	10.1371/journal.pone.0170154	http://dx.doi.org/10.1371/journal.pone.0170154			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095513	Green Submitted, Green Published, gold			2022-12-26	WOS:000392372300062
J	da Costa, CF; Samesima, N; Pastore, CA				da Costa, Cassia Fre; Samesima, Nelson; Pastore, Carlos Alberto			Cardiac Mean Electrical Axis in Thoroughbreds-Standardization by the Dubois Lead Positioning System	PLOS ONE			English	Article							HEALTHY SHOWJUMPING HORSES; ELECTROCARDIOGRAPHIC PARAMETERS; DIFFERENT AGES; ARRHYTHMIAS; EXERCISE; ENDURANCE; DIPOLE	Background Different methodologies for electrocardiographic acquisition in horses have been used since the first ECG recordings in equines were reported early in the last century. This study aimed to determine the best ECG electrodes positioning method and the most reliable calculation of mean cardiac axis (MEA) in equines. Materials and Methods We evaluated the electrocardiographic profile of 53 clinically healthy Thoroughbreds, 38 males and 15 females, with ages ranging 2-7 years old, all reared at the Sao Paulo Jockey Club, in Brazil. Two ECG tracings were recorded from each animal, one using the Dubois lead positioning system, the second using the base-apex method. QRS complex amplitudes were analyzed to obtain MEA values in the frontal plane for each of the two electrode positioning methods mentioned above, using two calculation approaches, the first by Tilley tables and the second by trigonometric calculation. Results There were compared between the two methods. Results There was significant difference in cardiac axis values: MEA obtained by the Tilley tables was +135.1 degrees +/- 90.9 degrees vs. -81.1 degrees +/- 3.6 degrees (p<0.0001), and by trigonometric calculation it was -15.0 degrees +/- 11.3 degrees vs. -79.9 degrees +/- 7.4 degrees (p<0.0001), base-apex and Dubois, respectively. Furthermore, Dubois method presented small range of variation without statistical or clinical difference by either calculation mode, while there was a wide variation in the base-apex method. Conclusion Dubois improved centralization of the Thoroughbreds' hearts, engendering what seems to be the real frontal plane. By either calculation mode, it was the most reliable methodology to obtain cardiac mean electrical axis in equines.	[da Costa, Cassia Fre; Samesima, Nelson; Pastore, Carlos Alberto] Univ Sao Paulo, Fac Med, Hosp Clin, Clin Unit Electrocardiog,Heart Inst InCor, Sao Paulo, Brazil	Universidade de Sao Paulo	da Costa, CF; Pastore, CA (corresponding author), Univ Sao Paulo, Fac Med, Hosp Clin, Clin Unit Electrocardiog,Heart Inst InCor, Sao Paulo, Brazil.	cassiafre@usp.br; ecg_pastore@incor.usp.br	SAMESIMA, NELSON/D-2149-2013; Pastore, Carlos Alberto/D-8567-2011	SAMESIMA, NELSON/0000-0003-4116-6835; Pastore, Carlos Alberto/0000-0001-6134-629X	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [142321/2013-3]; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [Sao Paulo State Research Foundation] [2013/15320-0]	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [Sao Paulo State Research Foundation](Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Grant No. 142321/2013-3-CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) CFC; Grant No. 2013/15320-0-FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [Sao Paulo State Research Foundation]-CAP. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ansari A, 1999, ANAT REC, V254, P92, DOI 10.1002/(SICI)1097-0185(19990101)254:1<92::AID-AR12>3.0.CO;2-3; Ayala I, 2000, VET RES, V31, P347, DOI 10.1051/vetres:2000124; Bright J.M., 2010, CARDIOLOGY HORSE, V2nd; Buhl R, 2010, EQUINE VET J, V42, P196, DOI 10.1111/j.2042-3306.2010.00185.x; Colahan PT, 1991, EQUINE MED SURG, P187; De Luna AB, 2008, BASIC ELECTROCARDIOG, V1st; Diniz MP, 2011, PESQUI VET BRASIL, V31, P355, DOI 10.1590/S0100-736X2011000400014; Dumont CBS, 2011, ARQ BRAS MED VET ZOO, V63, P20, DOI 10.1590/S0102-09352011000100004; Dumont CBD, 2010, CIENC RURAL, V40, P1966, DOI 10.1590/S0103-84782010000900018; Fernandes WR, 2004, ARQ BRAS MED VET ZOO, V56, P143, DOI 10.1590/S0102-09352004000200002; Grauer K., 1998, PRACTICAL GUIDE ECG; HELM RA, 1966, AM HEART J, V72, P218, DOI 10.1016/0002-8703(66)90446-7; HOLMES JR, 1967, CAN J COMPARAT MED, V31, P92; Melchert A, 2012, ARQ BRAS MED VET ZOO, V64, P547, DOI 10.1590/S0102-09352012000300004; Palma JM, 2013, BIOSCI J, V29, P174; Paslawska U, 2012, B VET I PULAWY, V56, P631, DOI 10.2478/v10213-012-0111-4; Sanchez-Quintana D, 2003, REV ESP CARDIOL, V56, P1085, DOI 10.1157/13054255; Slack J, 2015, EQUINE VET J, V47, P398, DOI 10.1111/evj.12299; Tilley LP, 1992, ESSENTIALS CANINE FE, V3rd, P21; Trachsel DS, 2010, EQUINE VET J, V42, P208, DOI 10.1111/j.2042-3306.2010.00172.x	20	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0169619	10.1371/journal.pone.0169619	http://dx.doi.org/10.1371/journal.pone.0169619			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095442	Green Published, gold, Green Submitted			2022-12-26	WOS:000392372300027
J	Jenkins, HL; Waeschenbach, A; Okamura, B; Hughes, RN; Bishop, JDD				Jenkins, Helen L.; Waeschenbach, Andrea; Okamura, Beth; Hughes, Roger N.; Bishop, John D. D.			Phylogenetically Widespread Polyembryony in Cyclostome Bryozoans and the Protracted Asynchronous Release of Clonal Brood-Mates	PLOS ONE			English	Article							PARADOX; MARKERS; PHYLOGENY; EVOLUTION; PHYLUM; LARVAE	Polyembryony the production of multiple cloned embryos from a single fertilised egg is a seemingly paradoxical combination of reproductive modes that nevertheless persists in diverse taxa. We document features of polyembryony in the Cyclostomata (Bryozoa) an ancient order of modular colonial marine invertebrates that suggest a substantial reduction in the paradoxical nature of this enigmatic reproductive mode. Firstly, we provide molecular evidence for polyembryony in three exemplar species, supporting the widely cited inference that polyembryony characterises the entire order. Secondly, genotyping demonstrates protracted release of cloned offspring from the primary embryo in a given gonozooid (chamber for embryonic incubation), thus exposing the same genotype to changing environmental conditions over time. Finally, we confirm that each gonozooid produces a distinct genotype, with each primary embryo being the result of a separate fertilisation event. We hypothesise that the sustained release of one or a few genotypes against varying environmental conditions achieves levels of risk-spreading similar to those in organisms that release multiple, unique genotypes at a single time. We argue that polyembryony, specifically with the production of a large number of progeny per fertilisation event, has been favoured in the Cyclostomata over long geological periods.	[Jenkins, Helen L.; Bishop, John D. D.] Marine Biol Assoc UK, Plymouth, Devon, England; [Jenkins, Helen L.; Waeschenbach, Andrea; Okamura, Beth] Nat Hist Museum, Dept Life Sci, London, England; [Jenkins, Helen L.; Hughes, Roger N.] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales	Marine Biological Association United Kingdom; Natural History Museum London; Bangor University	Jenkins, HL (corresponding author), Marine Biol Assoc UK, Plymouth, Devon, England.; Jenkins, HL (corresponding author), Nat Hist Museum, Dept Life Sci, London, England.; Jenkins, HL (corresponding author), Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales.	helenjenkins80@hotmail.com		Waeschenbach, Andrea/0000-0001-8571-9345	Natural Environment Research Council studentship [NE/G012644/1]; ASSEMBLE EU FP7 grant [227799]	Natural Environment Research Council studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ASSEMBLE EU FP7 grant	This work was supported by a Natural Environment Research Council studentship (NE/G012644/1) awarded to HLJ. Additional support was funded by an ASSEMBLE EU FP7 grant awarded to JDDB for access to Goteborg University, Sven Loven Centre for Marine Science, Kristineberg (ASSEMBLE grant agreement no. 227799). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulous CJ, 1952, INTRO MYCOLOGY; Boardman R.S., 1992, SMITHSON CONTRIB PAL, V70, P1; Bock PE, 2013, ZOOTAXA, V3703, P67; Borg F, 1933, ZOOL BIDR UPPS, V14, P253; Borg F, 1926, ZOOL BIDR UPPS, V10, P181; Borg Folke, 1944, FURTHER ZOOL RESULTS SWEDISH ANTARCTIC EXPED 1901 1903, V3, P1; Cossu P, 2012, MAR ECOL PROG SER, V452, P171, DOI 10.3354/meps09611; CRAIG SF, 1995, TRENDS ECOL EVOL, V10, P371, DOI 10.1016/S0169-5347(00)89138-7; Craig SF, 2001, MOL ECOL NOTES, V1, P281, DOI 10.1046/j.1471-8278 .2001.00108.x; Craig SF, 1997, EVOL ECOL, V11, P127, DOI 10.1023/A:1018443714917; Galbreath G.J., 1985, P243; Gasmi S, 2014, ESTUAR COAST SHELF S, V145, P22, DOI 10.1016/j.ecss.2014.04.005; Harmer S.F, 1893, Q J MICROSCOP SCI N, V34, P199; Harmer S. F., 1896, Q J MICROSC SCI, V39, P71; Harmer S. F., 1898, Q J MICROSCOPICAL SC, V41, P73; Harmer S. F., 1890, P CAMB PHILOS SOC, V7, P48; Hughes RN, 2005, BIOL LETT-UK, V1, P178, DOI 10.1098/rsbl.2004.0259; Jugran AK, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0241-5; Kluge GA, 1962, BRYOZOANS NO SEA USS; LIDGARD S, 1993, PALEOBIOLOGY, V19, P352, DOI 10.1017/S0094837300000324; Malausa T, 2011, MOL ECOL RESOUR, V11, P638, DOI 10.1111/j.1755-0998.2011.02992.x; MCKINNEY FK, 1993, PALEOBIOLOGY, V19, P335, DOI 10.1017/S0094837300000312; McKinney FK, 1997, PALAEONTOLOGY, V40, P515; Meglecz E, 2010, BIOINFORMATICS, V26, P403, DOI 10.1093/bioinformatics/btp670; Ng WL, 2015, AQUAT BOT, V120, P222, DOI 10.1016/j.aquabot.2014.07.006; Nielsen C, 1998, MAR ECOL PROG SER, V168, P163, DOI 10.3354/meps168163; Ostrovsky AN, 2013, EVOLUTION OF SEXUAL REPRODUCTION IN MARINE INVERTEBRATES: EXAMPLE OF GYMNOLAEMATE BRYOZOANS, DOI 10.1007/978-94-007-7146-8; Ostrovsky AN, 2016, BIOL REV, V91, P673, DOI 10.1111/brv.12189; Ostrovsky AN, 2013, EVOLUTION, V67, P1368, DOI 10.1111/evo.12039; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pemberton AJ, 2007, MAR BIOL, V153, P71, DOI 10.1007/s00227-007-0785-y; Pemberton AJ, 2011, MAR ECOL PROG SER, V430, P113, DOI 10.3354/meps09039; RYLAND JS, 1990, MAR ECOL PROG SER, V61, P125, DOI 10.3354/meps061125; Ryland JS, 1996, TRENDS ECOL EVOL, V11, P26, DOI 10.1016/0169-5347(96)80240-0; Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249; SEARLES RB, 1980, AM NAT, V115, P113, DOI 10.1086/283548; Sepkoski JJ, 2000, PALEOBIOLOGY, V26, P7, DOI 10.1666/0094-8373(2000)026<0007:CDAPPC>2.0.CO;2; Taylor P.D., 1991, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V182, P285; Taylor P.D., 1993, P465; Taylor P.D., 1988, Historical Biology, V1, P45; Taylor PD, 2000, ZOOL J LINN SOC-LOND, V128, P337; Taylor PD, 2000, P 11 INT BRYOZ ASS C, P87; Waeschenbach A, 2009, MOL PHYLOGENET EVOL, V52, P241, DOI 10.1016/j.ympev.2009.02.002; Webster BL, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-50; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi; Wolfe A, 1998, PLANT MOL SYSTEMATIC, DOI [10.1007/978-1-4615-5419-6, DOI 10.1007/978-1-4615-5419-6]; Yang JQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130905; ZIETKIEWICZ E, 1994, GENOMICS, V20, P176, DOI 10.1006/geno.1994.1151	49	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0170010	10.1371/journal.pone.0170010	http://dx.doi.org/10.1371/journal.pone.0170010			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095467	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000392372300050
J	Li, X; Kanakala, S; He, YH; Zhong, XL; Yu, SM; Li, RX; Sun, LX; Ma, J				Li, Xia; Kanakala, Surapathrudu; He, Yehua; Zhong, Xiaolan; Yu, Sanmiao; Li, Ruixue; Sun, Lingxia; Ma, Jun			Physiological Characterization and Comparative Transcriptome Analysis of White and Green Leaves of Ananas comosus var. bracteatus	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; BAMBUSA-EDULIS; ALBINO MUTANT; CHLOROPLAST; IDENTIFICATION; PIGMENTS; ACID	Leaf coloration is one of the most important and attractive characteristics of Ananas comosus var. bracteatus. The chimeric character is not stable during the in vitro tissue culturing. Many regenerated plants lost economic values for the loss of the chimeric character of leaves. In order to reveal the molecular mechanisms involved in the albino phenotype of the leaf cells, the physiological and transcriptional differences between complete white (CWh) and green (CGr) leaf cells of A. comosus var. bracteatus were analyzed. A total of 1,431 differentially expressed unigenes (DEGs) in CGr and CWh leaves were identified using RNA-seq. A comparison to the COG, GO and KEGG annotations revealed DEGs involved in chlorophyll biosynthesis, chloroplast development and photosynthesis. Furthermore, the measurement of main precursors of chlorophyll in the CWh leaves confirmed that the rate limiting step in chlorophyll biosynthesis, and thus the cause of the albino phenotype of the white cells, was the conversion of pyrrole porphobilinogen (PBG) to uroporphyrinogen III (Uro III). The enzyme activity of porphobilinogen deaminase (PBGD) and uroporporphyrinogn III synthase (UROS), which catalyze the transition of PBG to Uro III, was significantly decreased in the CWh leaves. Our data showed the transcriptional differences between the CWh and CGr plants and characterized key steps in chlorophyll biosynthesis of the CWh leaves. These results contribute to our understanding of the mechanisms and regulation of pigment biosynthesis in the CWh leaf cells of A. comosus var. bracteatus.	[Li, Xia; Zhong, Xiaolan; Yu, Sanmiao; Li, Ruixue; Sun, Lingxia; Ma, Jun] Sichuan Agr Univ, Coll Landscape Architecture, Chengdu, Sichuan, Peoples R China; [Kanakala, Surapathrudu] Agr Res Org, Inst Plant Protect, Volcani Ctr, Bet Dagan, Israel; [He, Yehua] South China Agr Univ, Hort Biotechnol Coll, Guangzhou, Guangdong, Peoples R China	Sichuan Agricultural University; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; South China Agricultural University	Ma, J (corresponding author), Sichuan Agr Univ, Coll Landscape Architecture, Chengdu, Sichuan, Peoples R China.	junma365@hotmail.com	Surapathrudu, Kanakala/I-3791-2019	Surapathrudu, Kanakala/0000-0003-4702-3990	Natural Science Foundation of China [31300585, 31570698]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was supported by the Natural Science Foundation of China (31300585; 31570698 (http://www.nsfc.gov.cn/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bartholomew D.P., 2002, PINEAPPLE BOT PRODUC; Beauman F., 2006, PINEAPPLE KING FRUIT, P3674; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOGORAD L, 1962, METHOD ENZYMOL, V5, P885, DOI 10.1016/S0076-6879(62)05334-3; Boussiba S, 1999, BIOTECHNOL LETT, V21, P601, DOI 10.1023/A:1005507514694; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Cao L, 2011, STUDY VITRO CULTURE; Carvalho LC, 2001, PLANT CELL TISS ORG, V67, P271, DOI 10.1023/A:1012722112406; Chen G, 2005, PLANT J, V41, P364, DOI 10.1111/j.1365-313X.2004.02308.x; Chen Tao, 2007, Journal of Genetics and Genomics, V34, P331, DOI 10.1016/S1673-8527(07)60035-6; Chen Y, 2015, PLANT CELL TISS ORG, V123, P283, DOI 10.1007/s11240-015-0831-2; COLLINS J. L, 1960, PINEAPPLE BOT UTILIZ; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Czarnecki O, 2011, METHODS MOL BIOL, V775, P357, DOI 10.1007/978-1-61779-237-3_20; DEI M, 1985, PHYSIOL PLANTARUM, V64, P153, DOI 10.1111/j.1399-3054.1985.tb02329.x; Holm G., 1954, Acta Agriculturae Scandinavica, V4, P457; Hu HH, 2003, BIOTECHNOL LETT, V25, P1881, DOI 10.1023/B:BILE.0000003976.18970.cd; Larkin RM, 2003, SCIENCE, V299, P902, DOI 10.1126/science.1079978; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Lin CS, 2006, PLANT CELL TISS ORG, V86, P169, DOI 10.1007/s11240-006-9105-3; Liu NT, 2007, PLANT CELL TISS ORG, V88, P147, DOI 10.1007/s11240-006-9182-3; Liu YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129148; Ma J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125695; MAUZERALL D, 1956, J BIOL CHEM, V219, P435; Ming R, 2015, NATURE GENETIC; Montinola LR, 1991, PINA; Moyle R, 2005, J EXP BOT, V56, P101, DOI 10.1093/jxb/eri015; Moyle RL, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-21; Neuteboom LW, 2002, PLANT SCI, V163, P1021, DOI 10.1016/S0168-9452(02)00277-7; Ong WD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046937; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RIMINGTON C, 1960, BIOCHEM J, V75, P620, DOI 10.1042/bj0750620; Rivero RM, 2010, PLANT CELL PHYSIOL, V51, P1929, DOI 10.1093/pcp/pcq143; Rocha FD, 2000, AN ACAD BRAS CIENC, V72, P295; Sugimoto H, 2004, PLANT CELL PHYSIOL, V45, P985, DOI 10.1093/pcp/pch111; TAKATA RH, 1976, LLOYDIA, V39, P409; TAUSSIG SJ, 1988, J ETHNOPHARMACOL, V22, P191, DOI 10.1016/0378-8741(88)90127-4; Tomcal M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082569; Walker NS, 2007, NUCLEIC ACIDS RES, V35, pD852, DOI 10.1093/nar/gkl795; Wang F, 2012, CHINESE SCI BULL, V57, P3798, DOI 10.1007/s11434-012-5154-7; Wei Q, 2013, PLANT CELL TISS ORG, V114, P1, DOI 10.1007/s11240-013-0298-y; Wen L, 1999, J AGR FOOD CHEM, V47, P850, DOI 10.1021/jf9808067; Yadav SP, 2010, PLANT CELL TISS ORG, V100, P183, DOI 10.1007/s11240-009-9635-6; Yang YX, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00139	46	16	16	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0169838	10.1371/journal.pone.0169838	http://dx.doi.org/10.1371/journal.pone.0169838			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095462	Green Published, Green Submitted, gold			2022-12-26	WOS:000392372300037
J	Sahu, BB; Baumbach, JL; Singh, P; Srivastava, SK; Yi, XP; Bhattacharyya, MK				Sahu, Binod B.; Baumbach, Jordan L.; Singh, Prashant; Srivastava, Subodh K.; Yi, Xiaoping; Bhattacharyya, Madan K.			Investigation of the Fusarium virguliforme Transcriptomes Induced during Infection of Soybean Roots Suggests that Enzymes with Hydrolytic Activities Could Play a Major Role in Root Necrosis	PLOS ONE			English	Article							SUDDEN-DEATH SYNDROME; F SP. GLYCINES; DIENELACTONE HYDROLASE; POLYKETIDE SYNTHASE; VIRULENCE FACTOR; CAUSAL AGENT; SOLANI; GENE; RESISTANCE; EXPRESSION	Sudden death syndrome (SDS) is caused by the fungal pathogen, Fusarium virguliforme, and is a major threat to soybean production in North America. There are two major components of this disease: (i) root necrosis and (ii) foliar SDS. Root symptoms consist of root necrosis with vascular discoloration. Foliar SDS is characterized by interveinal chlorosis and leaf necrosis, and in severe cases by flower and pod abscission. A major toxin involved in initiating foliar SDS has been identified. Nothing is known about how root necrosis develops. In order to unravel the mechanisms used by the pathogen to cause root necrosis, the transcriptome of the pathogen in infected soybean root tissues of a susceptible cultivar, 'Essex', was investigated. The transcriptomes of the germinating conidia and mycelia were also examined. Of the 14,845 predicted F. virguliforme genes, we observed that 12,017 (81%) were expressed in germinating conidia and 12,208 (82%) in mycelia and 10,626 (72%) in infected soybean roots. Of the 10,626 genes induced in infected roots, 224 were transcribed only following infection. Expression of several infection-induced genes encoding enzymes with oxidation-reduction properties suggests that degradation of antimicrobial compounds such as the phytoalexin, glyceollin, could be important in early stages of the root tissue infection. Enzymes with hydrolytic and catalytic activities could play an important role in establishing the necrotrophic phase. The expression of a large number of genes encoding enzymes with catalytic and hydrolytic activities during the late infection stages suggests that cell wall degradation could be involved in root necrosis and the establishment of the necrotrophic phase in this pathogen.	[Sahu, Binod B.; Baumbach, Jordan L.; Singh, Prashant; Srivastava, Subodh K.; Yi, Xiaoping; Bhattacharyya, Madan K.] Iowa State Univ, Dept Agron, Ames, IA 50011 USA; [Baumbach, Jordan L.; Bhattacharyya, Madan K.] Iowa State Univ, Interdept Genet Program, Ames, IA 50011 USA; [Sahu, Binod B.] NIT Rourkela, Dept Life Sci, Odisha, India; [Singh, Prashant] Univ Lancaster, Lancaster Environm Ctr, Lancaster LA1 4YQ, England; [Srivastava, Subodh K.] Clemson Univ, 317C Biosyst Res Complex, Clemson, SC USA; [Yi, Xiaoping] Southern Univ, Baton Rouge, LA USA; [Yi, Xiaoping] A&M Coll, Baton Rouge, LA USA	Iowa State University; Iowa State University; National Institute of Technology (NIT System); National Institute of Technology Rourkela; Lancaster University; Clemson University; Southern University System; Southern University & A&M College; Louisiana State University System; Louisiana State University	Bhattacharyya, MK (corresponding author), Iowa State Univ, Dept Agron, Ames, IA 50011 USA.; Bhattacharyya, MK (corresponding author), Iowa State Univ, Interdept Genet Program, Ames, IA 50011 USA.	mbhattac@iastate.edu	Sahu, Binod B/O-8394-2017; Sahu, Binod Bihari/S-4290-2019; Sahu, Binod B./C-3369-2009	Sahu, Binod B/0000-0002-2151-0654; Sahu, Binod Bihari/0000-0002-2151-0654; 	Iowa Soybean Association; National Institute of Food and Agriculture (NIFA), United States Department of Agriculture [2013-68004-20374]	Iowa Soybean Association; National Institute of Food and Agriculture (NIFA), United States Department of Agriculture	This work was supported by Iowa Soybean Association and the National Institute of Food and Agriculture (NIFA), United States Department of Agriculture (Grant no. 2013-68004-20374).	Abeysekara NS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093667; Anderson J, 2015, 3 BIOTECH, V5, P203, DOI 10.1007/s13205-014-0211-3; Anderson TR, 1998, PLANT DIS, V82, P448, DOI 10.1094/PDIS.1998.82.4.448D; [Anonymous], 2008, MOL BIOL PLANT PATH; Aoki T, 2003, MYCOLOGIA, V95, P660, DOI 10.2307/3761942; Baker SE, 2006, MOL PLANT MICROBE IN, V19, P139, DOI 10.1094/MPMI-19-0139; Ben-Daniel BH, 2012, MOL PLANT PATHOL, V13, P187, DOI 10.1111/j.1364-3703.2011.00740.x; Brar HK, 2012, MOL PLANT MICROBE IN, V25, P817, DOI 10.1094/MPMI-12-11-0317; Brar HK, 2011, MOL PLANT MICROBE IN, V24, P1179, DOI 10.1094/MPMI-12-10-0285; Chang HX, 2016, MOL PLANT MICROBE IN, V29, P96, DOI 10.1094/MPMI-09-15-0219-R; CHEAH E, 1993, PROTEINS, V16, P64, DOI 10.1002/prot.340160108; Chibucos MC, 2006, APPL ENVIRON MICROB, V72, P3350, DOI 10.1128/AEM.72.5.3350-3356.2006; Coleman JJ, 2011, MOL PLANT MICROBE IN, V24, P1482, DOI 10.1094/MPMI-05-11-0119; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CUNDLIFFE E, 1977, ANTIMICROB AGENTS CH, V11, P491, DOI 10.1128/AAC.11.3.491; Di Pietro A, 2001, MOL PLANT MICROBE IN, V14, P653, DOI 10.1094/MPMI.2001.14.5.653; Dong ZY, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-51; Gomez-Gomez E, 2002, FUNGAL GENET BIOL, V35, P213, DOI 10.1006/fgbi.2001.1318; Guo JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013143; HAHN MG, 1985, PLANT PHYSIOL, V77, P591, DOI 10.1104/pp.77.3.591; Hartman GL, 2015, CROP PROT, V73, P60, DOI 10.1016/j.cropro.2015.01.017; Hirrel MC, 1986, P 16 SOYB SEED C AM, P95; Iqbal MJ, 2001, THEOR APPL GENET, V102, P187, DOI 10.1007/s001220051634; Iqbal MJ, 2005, THEOR APPL GENET, V110, P1429, DOI 10.1007/s00122-005-1969-9; Ji J, 2006, PLANT BIOLOGY, V8, P597, DOI 10.1055/s-2006-924175; Ji Y, 2011, BIOMETRICS, V67, P1215, DOI 10.1111/j.1541-0420.2011.01605.x; Jin H, 1996, PHYTOPATHOLOGY, V86, P277, DOI 10.1094/Phyto-86-277; Kim YK, 2000, J BACTERIOL, V182, P4688, DOI 10.1128/JB.182.17.4688-4695.2000; KOLATTUKUDY PE, 1980, SCIENCE, V208, P990, DOI 10.1126/science.208.4447.990; KOLATTUKUDY PE, 1985, ANNU REV PHYTOPATHOL, V23, P223, DOI 10.1146/annurev.py.23.090185.001255; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leandro LFS, 2013, PLANT HLTH PROGR; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu XG, 2003, CURR GENET, V44, P95, DOI 10.1007/s00294-003-0428-x; Luckew AS, 2013, THEOR APPL GENET, V126, P2391, DOI 10.1007/s00122-013-2143-4; Lun SC, 2007, J BIOL CHEM, V282, P18348, DOI 10.1074/jbc.M700035200; Maceira FIG, 1997, FEMS MICROBIOL LETT, V154, P37, DOI 10.1016/S0378-1097(97)00298-X; MALONEY AP, 1994, MOL GEN GENET, V243, P506, DOI 10.1007/BF00284198; Morrissey JP, 1999, MICROBIOL MOL BIOL R, V63, P708, DOI 10.1128/MMBR.63.3.708-724.1999; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Navi SS, 2008, PLANT HEALTH PROGRES; Neto ALDF, 2006, CROP SCI, V46, P2547, DOI 10.2135/cropsci2006.02.0129; Palma-Guerrero J, 2016, MOL PLANT PATHOL, V17, P845, DOI 10.1111/mpp.12333; PATHAK D, 1991, PROTEINS, V9, P267, DOI 10.1002/prot.340090405; Perfect SE, 2001, MOL PLANT PATHOL, V2, P101, DOI 10.1046/j.1364-3703.2001.00055.x; Pudake RN, 2013, CURR GENET, V59, P107, DOI 10.1007/s00294-013-0392-z; Radwan O, 2013, MOL PLANT PATHOL, V14, P293, DOI 10.1111/mpp.12006; Radwan O, 2011, MOL PLANT MICROBE IN, V24, P958, DOI 10.1094/MPMI-11-10-0271; Rittenour WR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081603; Roy KW, 1997, PLANT DIS, V81, P1100, DOI 10.1094/PDIS.1997.81.10.1100; RUPE JC, 1989, PLANT DIS, V73, P581, DOI 10.1094/PD-73-0581; Scott-Craig JS, 2011, J BIOL CHEM, V286, P42848, DOI 10.1074/jbc.M111.307397; SIRAKOVA TD, 1994, INFECT IMMUN, V62, P4208, DOI 10.1128/IAI.62.10.4208-4218.1994; SNYDER BA, 1990, SCIENCE, V248, P1637, DOI 10.1126/science.248.4963.1637; Srivastava SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081832; Subramoni S., 2010, HDB HYDROCARBON LIPI, P3269, DOI DOI 10.1007/978-3-540-77587-4_248; TAKAHASHI Y, 1975, J BIOCHEM-TOKYO, V77, P823, DOI 10.1093/oxfordjournals.jbchem.a130789; Timothy DHB, 2004, BIOORG CHEM, V32, P367, DOI [10.1016/j.bioorg.2004.05.005, DOI 10.1016/J.BIOORG.2004.05.005]; Tokai T, 2007, BIOCHEM BIOPH RES CO, V353, P412, DOI 10.1016/j.bbrc.2006.12.033; van den Brink HJM, 1998, FUNGAL GENET BIOL, V23, P1, DOI 10.1006/fgbi.1997.1021; Voigt CA, 2005, PLANT J, V42, P364, DOI 10.1111/j.1365-313X.2005.02377.x; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Wen ZX, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-809; Wrather JA, 2011, SOYBEAN DIS LOSS EST; Yang G, 1996, PLANT CELL, V8, P2139, DOI 10.1105/tpc.8.11.2139; Yuan JZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S6; Zhang ZF, 2015, AM J GASTROENTEROL, V110, P596, DOI 10.1038/ajg.2015.35	67	9	9	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0169963	10.1371/journal.pone.0169963	http://dx.doi.org/10.1371/journal.pone.0169963			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095498	Green Submitted, Green Published, gold			2022-12-26	WOS:000392372300047
J	Chopra-Dewasthaly, R; Korb, M; Brunthaler, R; Ertl, R				Chopra-Dewasthaly, Rohini; Korb, Melanie; Brunthaler, Rene; Ertl, Reinhard			Comprehensive RNA-Seq Profiling to Evaluate the Sheep Mammary Gland Transcriptome in Response to Experimental Mycoplasma agalactiae Infection	PLOS ONE			English	Article							FALSE DISCOVERY RATE; CONTAGIOUS AGALACTIA; ESCHERICHIA-COLI; PATHWAY ANALYSES; IMMUNE-RESPONSE; HOST-DEFENSE; BOVINE-MILK; MASTITIS; EXPRESSION; RUMINANTS	Mycoplasma agalactiae is a worldwide serious pathogen of small ruminants that usually spreads through the mammary route causing acute to subacute mastitis progressing to chronic persistent disease that is hard to eradicate. Knowledge of mechanisms of its pathogenesis and persistence in the mammary gland are still insufficient, especially the host-pathogen interplay that enables it to reside in a chronic subclinical state. This study reports transcriptome profiling of mammary tissue from udders of sheep experimentally infected with M. agalactiae type strain PG2 in comparison with uninfected control animals using Illumina RNA-sequencing (RNA-Seq). Several differentially expressed genes (DEGs) were observed in the infected udders and RT-qPCR analyses of selected DEGs showed their expression profiles to be in agreement with results from RNA-Seq. Gene Ontology (GO) analysis revealed majority of the DEGs to be associated with mycoplasma defense responses that are directly or indirectly involved in host innate and adaptive immune responses. Similar RNA-Seq analyses were also performed with spleen cells of the same sheep to know the specific systemic transcriptome responses. Spleen cells exhibited a comparatively lower number of DEGs suggesting a less prominent host response in this organ. To our knowledge this is the first study that describes host transcriptomics of M. agalactiae infection and the related immune-inflammatory responses. The data provides useful information to further dissect the molecular genetic mechanisms underlying mycoplasma mastitis, which is a prerequisite for designing effective intervention strategies.	[Chopra-Dewasthaly, Rohini] Univ Vet Med, Inst Microbiol, Dept Pathobiol, Div Clin Microbiol & Infect Biol, Veterinaerpl 1, Vienna, Austria; [Korb, Melanie; Ertl, Reinhard] Univ Vet Med, VetCore Facil Res, Veterinaerpl 1, Vienna, Austria; [Brunthaler, Rene] Univ Vet Med, Inst Pathol & Forens Vet Med, Dept Pathobiol, Veterinaerpl 1, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Chopra-Dewasthaly, R (corresponding author), Univ Vet Med, Inst Microbiol, Dept Pathobiol, Div Clin Microbiol & Infect Biol, Veterinaerpl 1, Vienna, Austria.	Rohini.Chopra-Dewasthaly@vetmeduni.ac.at	chopra-dewasthaly, rohini/GNH-3258-2022	Ertl, Reinhard/0000-0001-7485-3661	Austrian Science Fund (FWF) [P23595-B20]; University of Veterinary Medicine Vienna [PP0201127201]; Austrian Science Fund (FWF) [P 23595] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); University of Veterinary Medicine Vienna; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF) (P23595-B20 to RCD, Joachim Spergser and Renate Rosengarten) and a supplementary funding by the University of Veterinary Medicine Vienna (PP0201127201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Austrian Science Fund (FWF) (P23595-B20 to RCD, Joachim Spergser and Renate Rosengarten) and a supplementary funding by the University of Veterinary Medicine Vienna (PP0201127201). We wish to thank all the people involved in the sheep infection study, especially Andreas Dagn and Christian Lohinger for helping in the clinical and histopathological analyses.	Addis MF, 2011, INFECT IMMUN, V79, P3833, DOI 10.1128/IAI.00040-11; Baumgartner W, 2002, CLIN PROPAEDEUTICS I; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergonier D, 1997, REV SCI TECH OIE, V16, P848, DOI 10.20506/rst.16.3.1062; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Boehmer JL, 2010, J DAIRY SCI, V93, P593, DOI 10.3168/jds.2009-2526; Boggs I, 2015, EUPA OPEN PROTEOM, V9, P65, DOI DOI 10.1016/J.EUPR0T.2015.09.001; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonnefont CMD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-208; Cacciotto C, 2016, CELL MICROBIOL; Castro-Alonso A, 2009, RES VET SCI, V86, P274, DOI 10.1016/j.rvsc.2008.06.004; Castro-Alonso A, 2010, VET IMMUNOL IMMUNOP, V136, P43, DOI 10.1016/j.vetimm.2010.02.005; Chopra-Dewasthaly R, 2005, INT J MED MICROBIOL, V294, P447, DOI 10.1016/j.ijmm.2004.09.010; Chopra-Dewasthaly R, 2012, FEMS IMMUNOL MED MIC, V66, P307, DOI 10.1111/j.1574-695X.2012.01010.x; Citti C, 2013, TRENDS MICROBIOL, V21, P196, DOI 10.1016/j.tim.2013.01.003; Corrales JC, 2007, SMALL RUMINANT RES, V68, P154, DOI 10.1016/j.smallrumres.2006.09.010; Cudic M, 2009, CURR PROTEIN PEPT SC, V10, P297, DOI 10.2174/138920309788922207; Ertl R, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-52; Gaurivaud P, 2016, APPL ENVIRON MICROB, V82, P3370, DOI 10.1128/AEM.00274-16; Genini S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-225; Gomez-Martin A, 2013, VET J, V198, P48, DOI 10.1016/j.tvjl.2013.04.015; Hegde S, 2016, VET RES, V47, DOI 10.1186/s13567-016-0387-0; Hegde S, 2015, INFECT IMMUN, V83, P2751, DOI 10.1128/IAI.00403-15; Hegde S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119706; Hegde S, 2014, INT J MED MICROBIOL, V304, P1024, DOI 10.1016/j.ijmm.2014.07.011; Hegde S, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv048; Hopfe M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054219; Ibeagha-Awemu EM, 2010, J PROTEOME RES, V9, P4604, DOI 10.1021/pr100336e; Kauf ACW, 2007, J DAIRY SCI, V90, P3336, DOI 10.3168/jds.2007-0058; Klein D, 1999, ELECTROPHORESIS, V20, P291, DOI 10.1002/(SICI)1522-2683(19990201)20:2<291::AID-ELPS291>3.0.CO;2-R; Li B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101968; Li J, 2012, BIOSTATISTICS, V13, P523, DOI 10.1093/biostatistics/kxr031; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lluch-Senar M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137354; Loor JJ, 2011, J MAMMARY GLAND BIOL, V16, P305, DOI 10.1007/s10911-011-9232-2; Loria GR, 2013, VET J, V198, P5, DOI 10.1016/j.tvjl.2013.06.017; Lutzow YCS, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-18; Madsen ML, 2008, INFECT IMMUN, V76, P658, DOI 10.1128/IAI.01291-07; McGowin CL, 2013, J INFECT DIS, V207, P1857, DOI 10.1093/infdis/jit101; Mitterhuemer S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-138; Mohammed J, 2007, VACCINE, V25, P8611, DOI 10.1016/j.vaccine.2007.09.057; Nicholas R, 2016, VET REC, V178, DOI 10.1136/vr.i2521; Pflaum K, 2016, INFECT IMMUN, V84, P351, DOI 10.1128/IAI.01092-15; Plager DA, 1999, J BIOL CHEM, V274, P14464, DOI 10.1074/jbc.274.20.14464; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Rodrigues V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139678; Schiffer L, 2015, CLIN EXP IMMUNOL, V179, P85, DOI 10.1111/cei.12439; SCHLIMGEN AK, 1995, NEURON, V14, P519, DOI 10.1016/0896-6273(95)90308-9; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siqueira FM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110327; Sirand-Pugnet P, 2007, PLOS GENET, V3, P744, DOI 10.1371/journal.pgen.0030075; Smolenski GA, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-19; Solsona M, 1996, VET MICROBIOL, V50, P45, DOI 10.1016/0378-1135(95)00200-6; Szczepanek S.M., 2014, MOLLICUTES MOL BIOL, P273; Tizioto PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131459; World Organization for Animal Health, OIE LIST DIS INF INT; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Zackular JP, 2015, J BIOL CHEM, V290, P18991, DOI 10.1074/jbc.R115.645085	58	12	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0170015	10.1371/journal.pone.0170015	http://dx.doi.org/10.1371/journal.pone.0170015			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081235	gold, Green Published, Green Submitted			2022-12-26	WOS:000391949500117
J	Kim, HI; Kim, TH; Kim, H; Kim, YN; Jang, HW; Chung, JH; Moon, SM; Jhun, BW; Lee, H; Koh, WJ; Kim, SW				Kim, Hye In; Kim, Tae Hyuk; Kim, Hosu; Kim, Young Nam; Jang, Hye Won; Chung, Jae Hoon; Moon, Seong Mi; Jhun, Byung Woo; Lee, Hyun; Koh, Won-Jung; Kim, Sun Wook			Effect of Rifampin on Thyroid Function Test in Patients on Levothyroxine Medication	PLOS ONE			English	Article							DRUG-INTERACTIONS; METABOLISM; HYPOTHYROIDISM; RIFABUTIN; UPDATE; NAT2	Background Levothyroxine (LT4) and rifampin (RIF) are sometimes used together; however, no clinical studies have assessed the effects of these drugs on thyroid function or the need to adjust LT4 dose. Methods We retrospectively reviewed the records of 71 Korean patients who started RIF during LT4 treatment. Clinically relevant cases that required dose adjustment according to the American Thyroid Association (ATA)/American Association of Clinical Endocrinologists (AACE) guidelines were identified, and risk factors of increased LT4 dose were analyzed. Results After administering RIF, median serum thyroid-stimulating hormone (TSH) level (2.58 mIU/L, interquartile range [IQR] 0.21-7.44) was significantly higher than that before RIF (0.25 mIU/L, IQR, 0.03-2.62; P < 0.001). An increased LT4 dose was required for 50% of patients in the TSH suppression group for thyroid cancer and 26% of patients in the replacement group for hypothyroidism. Risk factor analysis showed that remaining thyroid gland (odds ratio [OR] 9.207, P = 0.002), the time interval between starting RIF and TSH measurement (OR 1.043, P = 0.019), and baseline LT4 dose per kg body weight (OR 0.364, P = 0.011) were clinically relevant variables. Conclusions In patients receiving LT4, serum thyroid function test should be performed after starting RIF treatment. For patients with no remnant thyroid gland and those receiving a lower LT4 dose, close observation is needed when starting RIF and TB medication.	[Kim, Hye In; Kim, Tae Hyuk; Kim, Hosu; Kim, Young Nam; Chung, Jae Hoon; Kim, Sun Wook] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Med,Thyroid Ctr, Seoul, South Korea; [Jang, Hye Won] Sungkyunkwan Univ, Sch Med, Dept Med Educ, Seoul, South Korea; [Moon, Seong Mi; Jhun, Byung Woo; Lee, Hyun; Koh, Won-Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, SW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Med,Thyroid Ctr, Seoul, South Korea.; Koh, WJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, Seoul, South Korea.	wjkoh@skku.edu; swkimmd@skku.edu	Koh, Won-Jung/D-9586-2018; KIM, SUN WOOK/I-9389-2017; Koh, Won Jung/C-9595-2011; Lee, Hyun/G-1336-2018	Koh, Won-Jung/0000-0002-4756-3527; Kim, Tae Hyuk/0000-0002-7975-2437; Lee, Hyun/0000-0002-1269-0913				Baciewicz AM, 2008, AM J MED SCI, V335, P126, DOI 10.1097/MAJ.0b013e31814a586a; Baciewicz AM, 2013, CURR MED RES OPIN, V29, P1, DOI 10.1185/03007995.2012.747952; Cho HJ, 2007, TUBERCULOSIS, V87, P551, DOI 10.1016/j.tube.2007.05.012; CHRISTENSEN HR, 1989, ACTA ENDOCRINOL-COP, V121, P406, DOI 10.1530/acta.0.1210406; Desta Z, 2001, ANTIMICROB AGENTS CH, V45, P382, DOI 10.1128/AAC.45.2.382-392.2001; FISH LH, 1987, NEW ENGL J MED, V316, P764, DOI 10.1056/NEJM198703263161302; Garber JR, 2012, ENDOCR PRACT, V18, P989, DOI 10.4158/EP12280.GL; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Hukkanen J, 2012, EXPERT REV CLIN PHAR, V5, P569, DOI [10.1586/ECP.12.39, 10.1586/ecp.12.39]; ISLEY WL, 1987, ANN INTERN MED, V107, P517, DOI 10.7326/0003-4819-107-4-517; Jung JA, 2015, DRUG DES DEV THER, V9, DOI 10.2147/DDDT.S87131; Kim TY, 2014, ENDOCRINOL METAB, V29, P217, DOI 10.3803/EnM.2014.29.3.217; Lee SY, 2002, CLIN CHEM, V48, P775; Nolan SR, 1999, SOUTHERN MED J, V92, P529, DOI 10.1097/00007611-199905000-00018; Reitman ML, 2011, CLIN PHARMACOL THER, V89, P234, DOI 10.1038/clpt.2010.271; RELLING MV, 1989, CLIN PHARMACY, V8, P852; Sabbagh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018507; Takasu N, 2006, J ENDOCRINOL INVEST, V29, P645, DOI 10.1007/BF03344165; Yamashita F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070330	19	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169775	10.1371/journal.pone.0169775	http://dx.doi.org/10.1371/journal.pone.0169775			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081173	Green Submitted, Green Published, gold			2022-12-26	WOS:000391949500074
J	Kindzierski, V; Raschke, S; Knabe, N; Siedler, F; Scheffer, B; Pfluger-Grau, K; Pfeiffer, F; Oesterhelt, D; Marin-Sanguino, A; Kunte, HJ				Kindzierski, Viktoria; Raschke, Silvia; Knabe, Nicole; Siedler, Frank; Scheffer, Beatrix; Pflueger-Grau, Katharina; Pfeiffer, Friedhelm; Oesterhelt, Dieter; Marin-Sanguino, Alberto; Kunte, Hans-Joerg			Osmoregulation in the Halophilic Bacterium Halomonas elongata: A Case Study for Integrative Systems Biology	PLOS ONE			English	Article							ECTOINE TRANSPORTER TEAABC; BINDING-PROTEIN TEAA; ESCHERICHIA-COLI; COMPATIBLE SOLUTE; ALANINE DEHYDROGENASE; GENE-CLUSTER; DSM 2581(T); AMINO-ACID; BIOSYNTHESIS; ACCUMULATION	Halophilic bacteria use a variety of osmoregulatory methods, such as the accumulation of one or more compatible solutes. The wide diversity of compounds that can act as compatible solute complicates the task of understanding the different strategies that halophilic bacteria use to cope with salt. This is specially challenging when attempting to go beyond the pathway that produces a certain compatible solute towards an understanding of how the metabolic network as a whole addresses the problem. Metabolic reconstruction based on genomic data together with Flux Balance Analysis (FBA) is a promising tool to gain insight into this problem. However, as more of these reconstructions become available, it becomes clear that processes predicted by genome annotation may not reflect the processes that are active in vivo. As a case in point, E. coli is unable to grow aerobically on citrate in spite of having all the necessary genes to do it. It has also been shown that the realization of this genetic potential into an actual capability to metabolize citrate is an extremely unlikely event under normal evolutionary conditions. Moreover, many marine bacteria seem to have the same pathways to metabolize glucose but each species uses a different one. In this work, a metabolic network inferred from genomic annotation of the halophilic bacterium Halomonas elongata and proteomic profiling experiments are used as a starting point to motivate targeted experiments in order to find out some of the defining features of the osmoregulatory strategies of this bacterium. This new information is then used to refine the network in order to describe the actual capabilities of H. elongata, rather than its genetic potential.	[Kindzierski, Viktoria; Pflueger-Grau, Katharina; Marin-Sanguino, Alberto] Tech Univ Munich, Specialty Div Syst Biotechnol, Fac Mech Engn, Munich, Germany; [Raschke, Silvia; Knabe, Nicole; Kunte, Hans-Joerg] BAM Fed Inst Mat Res & Testing, Div Biodeteriorat & Reference Organisms 4 1, Berlin, Germany; [Siedler, Frank; Scheffer, Beatrix; Pfeiffer, Friedhelm; Oesterhelt, Dieter] Max Planck Inst Biochem, Dept Membrane Biochem, Martinsried, Germany	Technical University of Munich; Federal Institute for Materials Research & Testing; Max Planck Society	Kunte, HJ (corresponding author), BAM Fed Inst Mat Res & Testing, Div Biodeteriorat & Reference Organisms 4 1, Berlin, Germany.	hans-joerg.kunte@bam.de	Pfeiffer, Friedhelm/K-1757-2019; Marin-Sanguino, Alberto/ABN-4739-2022; Kunte, Hans Jorg/R-7282-2016	Pfeiffer, Friedhelm/0000-0003-4691-3246; Marin-Sanguino, Alberto/0000-0001-8728-7689; Kunte, Hans Jorg/0000-0003-1455-7822	Deutschce Forschungsgemeinschaft [Ku 1112/3-1]; Bundesministerium fur Bildung und Forschung [e:Bio 0316197]	Deutschce Forschungsgemeinschaft; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by Deutschce Forschungsgemeinschaft, http://www.dfg.de, grant number Ku 1112/3-1 (HJK); and Bundesministerium fur Bildung und Forschung, https://www.bmbf.de, grant number e:Bio 0316197 (AMS).	Bethlehem L, 2016, ANN C 2016 ASS GEN A; BROWN AD, 1976, BACTERIOL REV, V40, P803, DOI 10.1128/MMBR.40.4.803-846.1976; Buckel W, 2001, BBA-BIOENERGETICS, V1505, P15, DOI 10.1016/S0005-2728(00)00273-5; Carlson RP, 2016, EXTREMOPHILES, V20, P261, DOI 10.1007/s00792-015-0806-6; Chavarria M, 2012, MBIO, V3, DOI 10.1128/mBio.00028-12; Diken E, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1184-3; DIMROTH P, 1982, EUR J BIOCHEM, V121, P435, DOI 10.1111/j.1432-1033.1982.tb05806.x; DINNIBIER U, 1988, ARCH MICROBIOL, V150, P348, DOI 10.1007/BF00408306; Dulla K, 2010, MOL CELL PROTEOMICS, V9, P1167, DOI 10.1074/mcp.M900335-MCP200; GALINSKI EA, 1991, EUR J BIOCHEM, V198, P593, DOI 10.1111/j.1432-1033.1991.tb16055.x; GALINSKI EA, 1985, EUR J BIOCHEM, V149, P135, DOI 10.1111/j.1432-1033.1985.tb08903.x; GELFAND DH, 1977, J BACTERIOL, V130, P429, DOI 10.1128/JB.130.1.429-440.1977; Goller K, 1998, FEMS MICROBIOL LETT, V161, P293; Goller K., 1999, THESIS; Grammann K, 2002, J BACTERIOL, V184, P3078, DOI 10.1128/JB.184.11.3078-3085.2002; Hoffmann T, 2002, J BACTERIOL, V184, P718, DOI 10.1128/JB.184.3.718-727.2002; Hofs S, 2011, ANN C 2011 ASS GEN A; Hutter B, 1998, FEMS MICROBIOL LETT, V167, P7, DOI 10.1111/j.1574-6968.1998.tb13200.x; Kaguni JM, 2006, ANNU REV MICROBIOL, V60, P351, DOI 10.1146/annurev.micro.60.080805.142111; Kato J, 2001, EMBO J, V20, P4253, DOI 10.1093/emboj/20.15.4253; KENNEDY EP, 1982, P NATL ACAD SCI-BIOL, V79, P1092, DOI 10.1073/pnas.79.4.1092; Klingner A, 2015, APPL ENVIRON MICROB, V81, P2408, DOI 10.1128/AEM.03157-14; Kraegeloh A, 2005, J BACTERIOL, V187, P1036, DOI 10.1128/JB.187.3.1036-1043.2005; Kraegeloh A, 2002, EXTREMOPHILES, V6, P453, DOI 10.1007/s00792-002-0277-4; Kraegeloh A., 2003, THESIS; Kuhlmann SI, 2008, BIOCHEMISTRY-US, V47, P9475, DOI 10.1021/bi8006719; Kunte HJ, 2006, ENVIRON CHEM, V3, P94, DOI 10.1071/EN06016; KUNTE HJ, 2002, Patent No. 1409707; LARSEN PI, 1987, ARCH MICROBIOL, V147, P1, DOI 10.1007/BF00492896; Li YZ, 2002, EMBO J, V21, P5323, DOI 10.1093/emboj/cdf537; Lo CC, 2009, MICROBIOL MOL BIOL R, V73, P594, DOI 10.1128/MMBR.00024-09; MEEKS JC, 1978, J BACTERIOL, V134, P125, DOI 10.1128/JB.134.1.125-130.1978; MILLER KJ, 1986, SCIENCE, V231, P48, DOI 10.1126/science.3941890; Ono H, 1999, J BACTERIOL, V181, P91, DOI 10.1128/JB.181.1.91-99.1999; Oren A., 2002, HALOPHILIC MICROORGA; Oren Aharon, 2008, Saline Syst, V4, P2, DOI 10.1186/1746-1448-4-2; PADAN E, 1993, J BIOENERG BIOMEMBR, V25, P647; Pastor JM, 2013, J BIOL CHEM; PENG ZY, 1992, MOL BIOCHEM PARASIT, V54, P223, DOI 10.1016/0166-6851(92)90114-Y; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PETERS P, 1990, FEMS MICROBIOL LETT, V71, P157; Pfeiffer F, 2008, ARCH MICROBIOL, V190, P281, DOI 10.1007/s00203-008-0389-z; Pramanik J, 1997, BIOTECHNOL BIOENG, V56, P398, DOI 10.1002/(SICI)1097-0290(19971120)56:4<398::AID-BIT6>3.0.CO;2-J; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Reshetnikov AS, 2011, EXTREMOPHILES, V15, P653, DOI 10.1007/s00792-011-0396-x; Reshetnikov AS, 2011, METHOD ENZYMOL, P15, DOI 10.1016/B978-0-12-386905-0.00002-4; Roberts Mary F, 2005, Saline Syst, V1, P5, DOI 10.1186/1746-1448-1-5; ROWELL P, 1976, ARCH MICROBIOL, V107, P115, DOI 10.1007/BF00446830; Sambrook J., 2001, MOL CLONING LAB MANU; Sauer T., 1995, UNTERSUCHUNGEN NUTZU; Schweikhard ES, 2010, BIOCHEMISTRY-US, V49, P2194, DOI 10.1021/bi9017522; Schwibbert K, 2011, ENVIRON MICROBIOL, V13, P1973, DOI 10.1111/j.1462-2920.2010.02336.x; Seip B, 2011, APPL ENVIRON MICROB, V77, P1368, DOI 10.1128/AEM.02124-10; Severin J., 1993, THESIS; SINGH AP, 1986, J ENVIRON PATHOL TOX, V6, P29; Steuber J, 2000, MOL MICROBIOL, V35, P428, DOI 10.1046/j.1365-2958.2000.01712.x; Stoveken N, 2011, J BACTERIOL, V193, P4456, DOI 10.1128/JB.00345-11; TAKASE K, 1994, J BIOL CHEM, V269, P11037; Tebbe A, 2005, PROTEOMICS, V5, P168, DOI 10.1002/pmic.200400910; Tesch M, 1999, APPL ENVIRON MICROB, V65, P1099; Tetsch L, 2002, FEMS MICROBIOL LETT, V211, P213, DOI 10.1111/j.1574-6968.2002.tb11227.x; Trotsenko YA, 2002, ARCH MICROBIOL, V177, P123, DOI 10.1007/s00203-001-0368-0; VanderWerf MJ, 1997, ARCH MICROBIOL, V167, P332; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994; Ventosa A, 1998, MICROBIOL MOL BIOL R, V62, P504, DOI 10.1128/MMBR.62.2.504-544.1998; VREELAND RH, 1980, INT J SYST BACTERIOL, V30, P485, DOI 10.1099/00207713-30-2-485; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WOHLFARTH A, 1990, J GEN MICROBIOL, V136, P705, DOI 10.1099/00221287-136-4-705; ZHAO GS, 1994, P NATL ACAD SCI USA, V91, P1366, DOI 10.1073/pnas.91.4.1366	69	28	30	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0168818	10.1371/journal.pone.0168818	http://dx.doi.org/10.1371/journal.pone.0168818			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081159	Green Published, gold, Green Submitted			2022-12-26	WOS:000391949500019
J	Tao, ZS; Huang, Y; Zhang, LD; Wang, XF; Liu, GH; Wang, HZ				Tao, Zhangsheng; Huang, Yi; Zhang, Lida; Wang, Xinfa; Liu, Guihua; Wang, Hanzhong			BnLATE, a Cys2/His2-Type Zinc-Finger Protein, Enhances Silique Shattering Resistance by Negatively Regulating Lignin Accumulation in the Silique Walls of Brassica napus	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; TRANSGENIC ARABIDOPSIS; CELL-DIFFERENTIATION; TRANSMITTING-TRACT; POD SHATTER; EXPRESSION; FRUIT; GENE; DEHISCENCE; REPRESSOR	Silique shattering resistance is one of the most important agricultural traits in oil crop breeding. Seed shedding from siliques prior to and during harvest causes devastating losses in oilseed yield. Lignin biosynthesis in the silique walls is thought to affect silique-shattering resistance in oil crops. Here, we identified and characterized B. napus LATE FLOWERING (BnLATE), which encodes a Cys2/His2-type zinc-finger protein. Heterologous expression of BnLATE under the double enhanced CaMV 35S promoter (D35S) in wild-type Arabidopsis plants resulted in a marked decrease in lignification in the replum, valve layer (carpel) and dehiscence zone. pBnLATE::GUS activity was strong in the yellowing silique walls of transgenic lines. Furthermore, the expression pattern of BnLATE and the lignin content gradient in the silique walls at 48 days after pollination (DAP) of 73290, a B. napus silique shattering-resistant line, are similar to those in transgenic Arabidopsis lines expressing BnLATE. Transcriptome sequencing of the silique walls revealed that genes encoding peroxidases, which polymerize monolignols and lignin in the phenylpropanoid pathway, were down-regulated at least two-fold change in the D35S::BnLATE transgenic lines. pBnLATE::BnLATE transgenic lines were further used to identify the function of BnLATE, and the results showed that lignification in the carpel and dehiscence zone of yellowing silique also remarkably decreased compared with the wild-type control, the silique shattering-resistance and expression pattern of peroxidase genes are very similar to results with D35S:: BnLATE. These results suggest that BnLATE is a negative regulator of lignin biosynthesis in the yellowing silique walls, and promotes silique-shattering resistance in B. napus through restraining the polymerization of monolignols and lignin.	[Tao, Zhangsheng; Huang, Yi; Wang, Xinfa; Liu, Guihua; Wang, Hanzhong] Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Hubei, Peoples R China; [Tao, Zhangsheng; Huang, Yi; Wang, Xinfa; Liu, Guihua; Wang, Hanzhong] Minist Agr, Key Lab Oil Crop Biol & Genet Improvement, Wuhan, Hubei, Peoples R China; [Zhang, Lida] Shanghai Jiao Tong Univ, Sch Agr & Biol, Plant Biotechnol Res Ctr, Shanghai, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Shanghai Jiao Tong University	Wang, HZ (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Hubei, Peoples R China.; Wang, HZ (corresponding author), Minist Agr, Key Lab Oil Crop Biol & Genet Improvement, Wuhan, Hubei, Peoples R China.	wanghanzhong@caas.cn			National Basic Research Program of China [2015CB150200]; National System of Modern Technology for Rapeseed Industry in China [CARS-13]; Core Research Budget of the Non-profit Governmental Research Institution [161017]	National Basic Research Program of China(National Basic Research Program of China); National System of Modern Technology for Rapeseed Industry in China; Core Research Budget of the Non-profit Governmental Research Institution	This work was financially supported by the National Basic Research Program of China (No.: 2015CB150200), the National System of Modern Technology for Rapeseed Industry in China (No.: CARS-13), and the Core Research Budget of the Non-profit Governmental Research Institution (161017).	Alonso-Cantabrana H, 2007, DEVELOPMENT, V134, P2663, DOI 10.1242/DEV.02864; Asara JM, 2006, NAT PROTOC, V1, P46, DOI 10.1038/nprot.2006.7; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bruce W, 2000, PLANT CELL, V12, P65, DOI 10.1105/tpc.12.1.65; Child RD, 2003, J EXP BOT, V54, P1919, DOI 10.1093/jxb/erg209; Chu Y, 2014, PHYTOCHEMISTRY, V102, P55, DOI 10.1016/j.phytochem.2014.03.003; Chung KS, 2013, MOL CELLS, V35, P519, DOI 10.1007/s10059-013-0030-0; Crawford BCW, 2007, CURR BIOL, V17, P1101, DOI 10.1016/j.cub.2007.05.079; Dinneny JR, 2005, BIOESSAYS, V27, P42, DOI 10.1002/bies.20165; Ferrandiz C, 2000, SCIENCE, V289, P436, DOI 10.1126/science.289.5478.436; Grotewold E, 1998, PLANT CELL, V10, P721, DOI 10.1105/tpc.10.5.721; Gu Q, 1998, DEVELOPMENT, V125, P1509; Herrero J, 2013, PLANTA, V237, P1599, DOI 10.1007/s00425-013-1865-5; Hiratsu K, 2002, FEBS LETT, V514, P351, DOI 10.1016/S0014-5793(02)02435-3; Huang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102024; Jaradat Masrur R, 2014, GM Crops Food, V5, P302, DOI 10.4161/21645698.2014.947827; JEFFERSON RA, 1987, EMBO J, V6, P3901; KADKOL GP, 1984, EUPHYTICA, V33, P63, DOI 10.1007/BF00022751; Kam J, 2008, PLANT MOL BIOL, V67, P305, DOI 10.1007/s11103-008-9319-3; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Khan MS., 2012, INT NANO LETT, V2, P7, DOI [DOI 10.1186/2228-5326-2-7, DOI 10.1186/2228-5326-2-24]; Kim MK, 2002, PLANT CELL REP, V21, P35, DOI 10.1007/s00299-002-0475-7; Lenser T, 2013, PLANT J, V76, P545, DOI 10.1111/tpj.12321; Li XW, 2013, GENE, V532, P72, DOI 10.1016/j.gene.2013.09.015; Liljegren SJ, 2004, CELL, V116, P843, DOI 10.1016/S0092-8674(04)00217-X; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; MEAKIN PJ, 1990, J EXP BOT, V41, P995, DOI 10.1093/jxb/41.8.995; MEAKIN PJ, 1990, J EXP BOT, V41, P1003, DOI 10.1093/jxb/41.8.1003; Mele G, 2003, GENE DEV, V17, P2088, DOI 10.1101/gad.1120003; Miao YC, 2010, P NATL ACAD SCI USA, V107, P22728, DOI 10.1073/pnas.1007747108; Misra P, 2010, PLANT PHYSIOL, V152, P2258, DOI 10.1104/pp.109.150979; Nesi N, 2001, PLANT CELL, V13, P2099, DOI 10.1105/tpc.13.9.2099; Ostergaard L, 2009, CURR OPIN PLANT BIOL, V12, P36, DOI 10.1016/j.pbi.2008.09.011; Pandey A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05018; Payne T, 2004, DEVELOPMENT, V131, P3737, DOI 10.1242/dev.01216; Peng PF, 2015, GENET MOL RES, V14, P871, DOI 10.4238/2015.February.2.11; Price JS, 1996, J AGR ENG RES, V65, P183, DOI 10.1006/jaer.1996.0091; Rajani S, 2001, CURR BIOL, V11, P1914, DOI 10.1016/S0960-9822(01)00593-0; Sakamoto H, 2000, GENE, V248, P23, DOI 10.1016/S0378-1119(00)00133-5; Sasaki S, 2004, FEBS LETT, V562, P197, DOI 10.1016/S0014-5793(04)00224-8; Shigeto J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105332; Shigeto J, 2013, J AGR FOOD CHEM, V61, P3781, DOI 10.1021/jf400426g; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Spence J, 1996, J MICROSC-OXFORD, V181, P195, DOI 10.1046/j.1365-2818.1996.111391.x; Takeda S, 2004, DEVELOPMENT, V131, P425, DOI 10.1242/dev.00938; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Weingartner M, 2011, PLANT J, V68, P681, DOI 10.1111/j.1365-313X.2011.04717.x; Wu ZL, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-183; Xu WJ, 2014, NEW PHYTOL, V202, P132, DOI 10.1111/nph.12620; Ye RJ, 2012, PLANT CELL REP, V31, P1159, DOI 10.1007/s00299-012-1238-8	52	11	12	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0168046	10.1371/journal.pone.0168046	http://dx.doi.org/10.1371/journal.pone.0168046			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081140	Green Submitted, gold, Green Published			2022-12-26	WOS:000391949500006
J	Chiba, T; Hino, H; Akaho, S; Murata, N				Chiba, Tomoaki; Hino, Hideitsu; Akaho, Shotaro; Murata, Noboru			Time-Varying Transition Probability Matrix Estimation and Its Application to Brand Share Analysis	PLOS ONE			English	Article								In a product market or stock market, different products or stocks compete for the same consumers or purchasers. We propose a method to estimate the time-varying transition matrix of the product share using a multivariate time series of the product share. The method is based on the assumption that each of the observed time series of shares is a stationary distribution of the underlying Markov processes characterized by transition probability matrices. We estimate transition probability matrices for every observation under natural assumptions. We demonstrate, on a real-world dataset of the share of automobiles, that the proposed method can find intrinsic transition of shares. The resulting transition matrices reveal interesting phenomena, for example, the change in flows between TOYOTA group and GM group for the fiscal year where TOYOTA group's sales beat GM's sales, which is a reasonable scenario.	[Chiba, Tomoaki; Murata, Noboru] Waseda Univ, Dept Elect Engn & Biosci, Shinjuku Ku, Tokyo, Japan; [Hino, Hideitsu] Univ Tsukuba, Dept Comp Sci, Tsukuba, Ibaraki, Japan; [Akaho, Shotaro] Natl Inst Adv Ind Sci & Technol, Math Neuroinformat Grp, Tsukuba, Ibaraki, Japan	Waseda University; University of Tsukuba; National Institute of Advanced Industrial Science & Technology (AIST)	Hino, H (corresponding author), Univ Tsukuba, Dept Comp Sci, Tsukuba, Ibaraki, Japan.	hinohide@cs.tsukuba.ac.jp	Akaho, Shotaro/N-3401-2016; Murata, Noboru/J-3345-2012	Akaho, Shotaro/0000-0002-4623-2718; Murata, Noboru/0000-0002-4258-6877; Hino, Hideitsu/0000-0002-6405-4361	JSPS KAKENHI Grant [25120009, 25120011, 16K16108]; Grants-in-Aid for Scientific Research [25330276] Funding Source: KAKEN	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers 25120009, 25120011, and 16K16108. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2009, P NATL ACAD SCI USA, V106, P11878, DOI 10.1073/pnas.0901910106; Bailey NTJ, 1990, ELEMENTS STOCHASTIC, V19; Bondy J.A., 2007, GRADUATE TEXTS MATH; Box GEP, 2013, TIME SERIES ANAL FOR, V3; Brown J. H., 1995, MACROECOLOGY; Dantzig GB, 2003, SPRINGER SERIES OPER; Elad M, 2010, SPARSE AND REDUNDANT REPRESENTATIONS, P3, DOI 10.1007/978-1-4419-7011-4_1; Fildes R., 1992, FORECASTING STRUCTUR, V8, DOI [10.1016/0169-2070(92)90072-H, DOI 10.1016/0169-2070(92)90072-H]; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Genon-Catalot V, 2000, BERNOULLI, V6, P1051, DOI 10.2307/3318471; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Gutierrez-Alcaraz G, 2004, 2004 INTERNATIONAL CONFERENCE ON PROBABILISTIC METHODS APPLIED TO POWER SYSTEMS, P14; Haveliwala T H, 2003, 1 STANF U; Ide T, 2009, PROXIMITY BASED ANOM; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Kummerfeld E, 2013, ADV NEURAL INFORM PR, V26, P1; Langville AN., 2004, INTERNET MATH, V1, P335, DOI [10.1080/15427951.2004.10129091, DOI 10.1080/15427951.2004.10129091]; Makhorin A, GLPK GNU LINEAR PROG; Ng A.Y., 2001, P INT JOINT C ART IN; Page L., 1999, PAGERANK CITATION RA; Pearl J, 2001, CAUSALITY MODELS REA; STYAN GPH, 1964, J MARKETING RES, V1, P50, DOI 10.2307/3150320; Tibshirani R, 2005, J R STAT SOC B, V67, P91, DOI 10.1111/j.1467-9868.2005.00490.x; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wright S, 1920, J AGRIC RES, V20, P0557; Wu Y., 2013, INT C MACH LEARN PML; Xuan X., 2007, P 24 INT C MACH LEAR, P1055, DOI DOI 10.1145/1273496.1273629	27	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169981	10.1371/journal.pone.0169981	http://dx.doi.org/10.1371/journal.pone.0169981			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076383	Green Published, gold, Green Submitted			2022-12-26	WOS:000391857100074
J	Meents, JE; Fischer, MJM; McNaughton, PA				Meents, Jannis E.; Fischer, Michael J. M.; McNaughton, Peter A.			Sensitization of TRPA1 by Protein Kinase A	PLOS ONE			English	Article							ION-CHANNEL TRPA1; INFLAMMATORY HYPERALGESIA; SENSORY NEURONS; CALCIUM-IONS; RECEPTOR; ACTIVATION; PHOSPHORYLATION; TRPV1; PAIN; SITE	The TRPA1 ion channel is expressed in nociceptive (pain-sensitive) somatosensory neurons and is activated by a wide variety of chemical irritants, such as acrolein in smoke or isothiocyanates in mustard. Here, we investigate the enhancement of TRPA1 function caused by inflammatory mediators, which is thought to be important in lung conditions such as asthma and COPD. Protein kinase A is an important kinase acting downstream of inflammatory mediators to cause sensitization of TRPA1. By using site-directed mutagenesis, patch clamp electrophysiology and calcium imaging we identify four amino acid residues, S86, S317, S428, and S972, as the principal targets of PKA-mediated phosphorylation and sensitization of TRPA1.	[Meents, Jannis E.; Fischer, Michael J. M.; McNaughton, Peter A.] Univ Cambridge, Dept Pharmacol, Cambridge, England; [Meents, Jannis E.] Uniklin RWTH Aachen, Inst Physiol, Aachen, Germany; [Fischer, Michael J. M.] Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, Erlangen, Germany; [Fischer, Michael J. M.] Med Univ Wien, Ctr Physiol & Pharmacol, Vienna, Austria; [McNaughton, Peter A.] Kings Coll London, Wolfson Ctr Age Related Dis, London, England	University of Cambridge; RWTH Aachen University; RWTH Aachen University Hospital; University of Erlangen Nuremberg; Medical University of Vienna; University of London; King's College London	McNaughton, PA (corresponding author), Univ Cambridge, Dept Pharmacol, Cambridge, England.; McNaughton, PA (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, London, England.	peter.mcnaughton@kcl.co.uk	Meents, Jannis E/F-4134-2017; Fischer, Michael J.M./P-8715-2014	Meents, Jannis E/0000-0001-9423-0453; McNaughton, Peter/0000-0003-1946-9610; Fischer, Michael J.M./0000-0002-3811-7066	Biotechnology and Biological Sciences Research Council, UK (BBSRC); Department of Pharmacology Cambridge; Ernst Schering Foundation; Deutsche Schmerzgesellschaft e.V.; German Academic Exchange Service; Alexander von Humboldt Foundation; BBSRC [BB/L002787/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L002787/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, UK (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department of Pharmacology Cambridge; Ernst Schering Foundation; Deutsche Schmerzgesellschaft e.V.; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funded by grants from the Biotechnology and Biological Sciences Research Council, UK (BBSRC) to PAM, PhD studentship support from the Department of Pharmacology Cambridge, the Ernst Schering Foundation, the Deutsche Schmerzgesellschaft e.V. and the German Academic Exchange Service to JEM and a fellowship from the Alexander von Humboldt Foundation to MJMF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand U, 2008, NEUROSCI LETT, V438, P221, DOI 10.1016/j.neulet.2008.04.007; Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Andre E, 2008, J CLIN INVEST, V118, P2574, DOI 10.1172/JCI34886; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Birrell MA, 2009, AM J RESP CRIT CARE, V180, P1042, DOI 10.1164/rccm.200905-0665OC; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; BORDO D, 1991, J MOL BIOL, V217, P721, DOI 10.1016/0022-2836(91)90528-E; Btesh J, 2013, J NEUROSCI, V33, P9184, DOI 10.1523/JNEUROSCI.4991-12.2013; Dai Y, 2007, J CLIN INVEST, V117, P1979, DOI 10.1172/JCI30951; de la Roche J, 2013, J BIOL CHEM, V288, P20280, DOI 10.1074/jbc.M113.479337; Diogenes A, 2007, J DENT RES, V86, P550, DOI 10.1177/154405910708600612; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; Eberhardt MJ, 2012, J BIOL CHEM, V287, P28291, DOI 10.1074/jbc.M111.328674; Fischer MJM, 2013, J NEUROSCI, V33, P7407, DOI 10.1523/JNEUROSCI.3721-12.2013; Fischer MJM, 2010, J BIOL CHEM, V285, P34781, DOI 10.1074/jbc.M110.143958; Grace MS, 2014, BRIT J PHARMACOL, V171, P2593, DOI 10.1111/bph.12538; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Huang JJ, 2006, SEMIN CELL DEV BIOL, V17, P638, DOI 10.1016/j.semcdb.2006.11.002; Jeske NA, 2008, PAIN, V138, P604, DOI 10.1016/j.pain.2008.02.022; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Lee SP, 2008, BRIT J PHARMACOL, V153, P1739, DOI 10.1038/bjp.2008.85; Leffler A, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-62; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Malin S, 2011, J NEUROSCI, V31, P10516, DOI 10.1523/JNEUROSCI.2992-10.2011; Meents JE, 2016, J PHYSIOL-LONDON, V594, P6643, DOI 10.1113/JP272237; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; Neuberger G, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-1; Nilius B, 2011, J PHYSIOL-LONDON, V589, P1543, DOI 10.1113/jphysiol.2010.200717; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Paulsen C.E., 2015, NATURE; Raisinghani M, 2011, AM J PHYSIOL-CELL PH, V301, pC587, DOI 10.1152/ajpcell.00465.2010; Samad A, 2011, BIOCHEM J, V433, P197, DOI 10.1042/BJ20101256; Schmidt M, 2009, NEURON, V64, P498, DOI 10.1016/j.neuron.2009.09.030; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Talavera K, 2009, NAT NEUROSCI, V12, P1293, DOI 10.1038/nn.2379; Wang S, 2008, BRAIN, V131, P1241, DOI 10.1093/brain/awn060; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Zayats V, 2013, J MOL MODEL, V19, P4689, DOI 10.1007/s00894-012-1505-1; Zhou FF, 2004, BIOCHEM BIOPH RES CO, V325, P1443, DOI 10.1016/j.bbrc.2004.11.001; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	42	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0170097	10.1371/journal.pone.0170097	http://dx.doi.org/10.1371/journal.pone.0170097			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076424	Green Published, Green Submitted, gold			2022-12-26	WOS:000391857100088
J	Mulder, P; van den Hoek, AM; Kleemann, R				Mulder, Petra; van den Hoek, Anita M.; Kleemann, Robert			The CCR2 Inhibitor Propagermanium Attenuates Diet-Induced Insulin Resistance, Adipose Tissue Inflammation and Non-Alcoholic Steatohepatitis	PLOS ONE			English	Article							CHEMOKINE RECEPTOR 2; FATTY LIVER-DISEASE; HEPATIC STEATOSIS; PPAR-GAMMA; OBESITY; RECRUITMENT; ACTIVATION; CELLS; ACCUMULATION; MACROPHAGES	Background and aim Obese patients with chronic inflammation in white adipose tissue (WAT) have an increased risk of developing non-alcoholic steatohepatitis (NASH). The C-C chemokine receptor-2 (CCR2) has a crucial role in the recruitment of immune cells to WAT and liver, thereby promoting the inflammatory component of the disease. Herein, we examined whether intervention with propagermanium, an inhibitor of CCR2, would attenuate tissue inflammation and NASH development. Methods Male C57BL/6J mice received a high-fat diet (HFD) for 0, 6, 12 and 24 weeks to characterize the development of early disease symptoms of NASH, i.e. insulin resistance and WAT inflammation (by hyperinsulinemic-euglycemic clamp and histology, respectively) and to define the optimal time point for intervention. In a separate study, mice were pretreated with HFD followed by propagermanium treatment (0.05% w/w) after 6 weeks (early intervention) or 12 weeks (late intervention). NASH was analyzed after 24 weeks of diet feeding. Results Insulin resistance in WAT developed after 6 weeks of HFD, which was paralleled by modest WAT inflammation. Insulin resistance and inflammation in WAT intensified after 12 weeks of HFD, and preceded NASH development. The subsequent CCR2 intervention experiment showed that early, but not late, propagermanium treatment attenuated insulin resistance. Only the early treatment significantly decreased Mcp-1 and CD11c gene expression in WAT, indicating reduced WAT inflammation. Histopathological analysis of liver demonstrated that propagermanium treatment decreased macrovesicular steatosis and tended to reduce lobular inflammation, with more pronounced effects in the early intervention group. Propagermanium improved the ratio between pro-inflammatory (M1) and anti-inflammatory (M2) macrophages, quantified by CD11c and Arginase-1 gene expression in both intervention groups. Conclusions Overall, early propagermanium administration was more effective to improve insulin resistance, WAT inflammation and NASH compared to late intervention. These data suggest that therapeutic interventions for NASH directed at the MCP-1/CCR2 pathway should be initiated early.	[Mulder, Petra; van den Hoek, Anita M.; Kleemann, Robert] Netherlands Org Appl Sci Res TNO, Dept Metab Hlth Res, Zernikedreef 9, Leiden, Netherlands; [Mulder, Petra; Kleemann, Robert] Leiden Univ, Med Ctr, Dept Vasc Surg, Leiden, Netherlands	Netherlands Organization Applied Science Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Mulder, P (corresponding author), Netherlands Org Appl Sci Res TNO, Dept Metab Hlth Res, Zernikedreef 9, Leiden, Netherlands.; Mulder, P (corresponding author), Leiden Univ, Med Ctr, Dept Vasc Surg, Leiden, Netherlands.	pca.mulder@gmail.com		Mulder, Petra/0000-0002-0982-4466	TNO research program 'Predictive Health Technologies'; TNO research program 'Enabling Technology Systems Biology'	TNO research program 'Predictive Health Technologies'; TNO research program 'Enabling Technology Systems Biology'	This study was supported by the TNO research programs 'Predictive Health Technologies' and 'Enabling Technology Systems Biology'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellentani S, 2010, DIGEST DIS, V28, P155, DOI 10.1159/000282080; Berres ML, 2010, J CLIN INVEST, V120, P4129, DOI 10.1172/JCI41732; Bugianesi E, 2005, HEPATOLOGY, V42, P987, DOI 10.1002/hep.20920; Di Prospero NA, 2014, DIABETES OBES METAB, V16, P1055, DOI 10.1111/dom.12309; Gadd VL, 2014, HEPATOLOGY, V59, P1393, DOI 10.1002/hep.26937; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Hirayama C, 2003, J GASTROENTEROL, V38, P525, DOI 10.1007/s00535-003-1098-7; Ito A, 2008, J BIOL CHEM, V283, P35715, DOI 10.1074/jbc.M804220200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kitade H, 2012, DIABETES, V61, P1680, DOI 10.2337/db11-1506; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; Liang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115922; Lomonaco R, 2012, HEPATOLOGY, V55, P1389, DOI 10.1002/hep.25539; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Maina V, 2012, CLIN SCI, V122, P545, DOI 10.1042/CS20110366; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Marra F, 2013, CURR PHARM DESIGN, V19, P5250, DOI 10.2174/13816128113199990344; Mirza M S, 2011, ISRN Gastroenterol, V2011, P592404, DOI 10.5402/2011/592404; Miura K, 2012, AM J PHYSIOL-GASTR L, V302, pG1310, DOI 10.1152/ajpgi.00365.2011; Mulder P, 2015, INT J OBESITY; Obstfeld AE, 2010, DIABETES, V59, P916, DOI 10.2337/db09-1403; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Shimokawa H, 2003, J CARDIOVASC PHARM, V41, P372, DOI 10.1097/00005344-200303000-00005; Tamura Y, 2008, ARTERIOSCL THROM VAS, V28, P2195, DOI 10.1161/ATVBAHA.108.168633; Tamura Y, 2010, J ATHEROSCLER THROMB, V17, P219, DOI 10.5551/jat.3368; Tilg H, 2006, GASTROENTEROLOGY, V131, P934, DOI 10.1053/j.gastro.2006.05.054; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamashita T, 2002, ARTERIOSCL THROM VAS, V22, P969, DOI 10.1161/01.ATV.0000019051.88366.9C; Yokochi S, 2001, J INTERF CYTOK RES, V21, P389, DOI 10.1089/107999001750277862	37	24	25	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169740	10.1371/journal.pone.0169740	http://dx.doi.org/10.1371/journal.pone.0169740			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076416	Green Published, gold, Green Submitted			2022-12-26	WOS:000391857100052
J	Dokanehiifard, S; Yasari, A; Najafi, H; Jafarzadeh, M; Nikkhah, M; Mowla, SJ; Soltani, BM				Dokanehiifard, Sadat; Yasari, Atena; Najafi, Hadi; Jafarzadeh, Meisam; Nikkhah, Maryam; Mowla, Seyed Javad; Soltani, Bahram M.			A novel microRNA located in the TrkC gene regulates the Wnt signaling pathway and is differentially expressed in colorectal cancer specimens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						annexin; biomarker; cancer; cell cycle; colorectal cancer; TrkC-miR2; Survival; Wnt signaling; Colorectal cancer; Biomarker	COLON-CANCER; NEUROTROPHIN RECEPTORS; TUMOR-SUPPRESSOR; CELL-SURVIVAL; BETA-CATENIN; IDENTIFICATION; PROGRESSION; METASTASIS; ACTIVATION; BIOMARKERS	Tropomyosin receptor kinase C (TrkC) is involved in cell survival, apoptosis, differentiation, and tumorigenesis. TrkC diverse functions might be attributed to the hypothetical non-coding RNAs embedded within the gene. Using bioinformatics approaches, a novel microRNA named TrkC-miR2 was predicted within the TrkC gene capable of regulating the Wnt pathway. For experimental verification of this microRNA, the predicted TrkC-premir2 sequence was overexpressed in SW480 cells, which led to the detection of two mature TrkC-miR2 isomiRs, and their endogenous forms were detected in human cell lines as well. Later, an independent promoter was deduced for TrkC-miR2 after the treatment of HCT116 cells with 5-azacytidine, which resulted in differential expression of TrkC-miR2 and TrkC host gene. RT-quantitative PCR and luciferase assays indicated that the APC2 gene is targeted by TrkC-miR2, and Wnt signaling is up-regulated. Also, Wnt inhibition by using small molecules along with TrkC-miR2 overexpression and TOP/FOP flash assays confirmed the positive effect of TrkC-miR2 on the Wnt pathway. Consistently, TrkC-miR2 overexpression promoted SW480 cell survival, which was detected by flow cytometry, MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assays, and crystal violate analysis. RT-qPCR analysis revealed that TrkC-miR2 is significantly up-regulated (approximate to 70 times) in colorectal tumor tissues compared with their normal pairs. Moreover, the TrkC-miR2 expression level discriminated grades of tumor malignancies, which was consistent with its endogenous levels in HCT116, HT29, and SW480 colorectal cancer cell lines. Finally, an opposite expression pattern was observed for TrkC-miR2 and the APC2 gene in colorectal cancer specimens. In conclusion, here we introduce TrkC-miR2 as a novel regulator of Wnt signaling, which might be a candidate oncogenic colorectal cancer biomarker.	[Dokanehiifard, Sadat; Yasari, Atena; Najafi, Hadi; Jafarzadeh, Meisam; Mowla, Seyed Javad; Soltani, Bahram M.] Tarbiat Modares Univ, Fac Biol Sci, Dept Mol Genet, Tehran 11114115, Iran; [Nikkhah, Maryam] Tarbiat Modares Univ, Fac Biol Sci, Dept Nanobiotechnol, Tehran 11114115, Iran	Tarbiat Modares University; Tarbiat Modares University	Soltani, BM (corresponding author), Tarbiat Modares Univ, Fac Biol Sci, Dept Mol Genet, Tehran 11114115, Iran.	soltanib@modares.ac.ir	Jafarzadeh, Meisam/AAT-9666-2020; Soltani, Bahram/ABH-2649-2021; Dokaneheifard, Sadat/AAE-2871-2020	Soltani, Bahram/0000-0003-2468-901X; Yasari, Atena/0000-0003-1785-0039; Najafi, Hadi/0000-0002-1885-6689; Mowla, Seyed Javad/0000-0002-3300-6332	Tarbiat Modares University; Iran National Science Foundation [91001522]	Tarbiat Modares University; Iran National Science Foundation(Iran National Science Foundation (INSF))	This work was supported by financial aid from Tarbiat Modares University and Iran National Science Foundation Grant 91001522. The authors declare that they have no conflicts of interest with the contents of this article.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Aranha MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021396; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bao RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048670; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Cammarata PR, 2015, MOL VIS, V21, P1024; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Dalmay T, 2008, J INTERN MED, V263, P366, DOI 10.1111/j.1365-2796.2008.01926.x; Demilly A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2915; Dokanehiifard S, 2015, CELL MOL LIFE SCI, V72, P2613, DOI 10.1007/s00018-015-1868-4; Genevois AL, 2013, P NATL ACAD SCI USA, V110, P3017, DOI 10.1073/pnas.1212333110; Gomes Clarissa P. C., 2013, Frontiers in Genetics, V4, P81, DOI 10.3389/fgene.2013.00081; Hapner SJ, 1998, DEV BIOL, V201, P90, DOI 10.1006/dbio.1998.8970; Hartwell L, 2006, NAT BIOTECHNOL, V24, P905, DOI 10.1038/nbt0806-905; Jin W, 2010, CARCINOGENESIS, V31, P1939, DOI 10.1093/carcin/bgq180; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Kalkman HO, 2009, PHARMACOL THERAPEUT, V121, P115, DOI 10.1016/j.pharmthera.2008.11.002; KONDOH N, 1992, CANCER RES, V52, P791; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kumar S, 1998, J NEUROSCI RES, V54, P754, DOI 10.1002/(SICI)1097-4547(19981215)54:6<754::AID-JNR3>3.0.CO;2-K; Kunttas-Tatli E, 2012, GENETICS, V190, P1059, DOI 10.1534/genetics.111.133280; Li BS, 2013, PLANT MOL BIOL, V81, P525, DOI 10.1007/s11103-013-0010-y; Link A, 2010, CANCER EPIDEM BIOMAR, V19, P1766, DOI 10.1158/1055-9965.EPI-10-0027; Liu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027496; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo YX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003552; McGahon MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065809; McGregor LM, 1999, P NATL ACAD SCI USA, V96, P4540, DOI 10.1073/pnas.96.8.4540; McInroy L, 2011, EXP CELL RES, V317, P2468, DOI 10.1016/j.yexcr.2011.07.013; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Minichiello L, 1996, GENE DEV, V10, P2849, DOI 10.1101/gad.10.22.2849; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Mosimann C, 2006, CELL, V125, P327, DOI 10.1016/j.cell.2006.01.053; Neilsen CT, 2012, TRENDS GENET, V28, P544, DOI 10.1016/j.tig.2012.07.005; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Nishita M, 2000, NATURE, V403, P781, DOI 10.1038/35001602; Parsi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035561; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; VERDI JM, 1994, NEURON, V12, P733, DOI 10.1016/0896-6273(94)90327-1; Wang Y, 2009, J CELL MOL MED, V13, P12, DOI 10.1111/j.1582-4934.2008.00510.x; Wang Zhiguo, 2010, World J Biol Chem, V1, P41, DOI 10.4331/wjbc.v1.i4.41; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Xu N, 2012, BIOCHEM BIOPH RES CO, V425, P468, DOI 10.1016/j.bbrc.2012.07.127; Yang LD, 2009, WORLD J SURG, V33, P638, DOI 10.1007/s00268-008-9865-5; Zhang YL, 2012, HEPATOLOGY, V56, P1631, DOI 10.1002/hep.25849; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	53	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7566	7577		10.1074/jbc.M116.760710	http://dx.doi.org/10.1074/jbc.M116.760710			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28100780	Green Published, hybrid			2022-12-26	WOS:000400761300024
J	Newton, J; Hait, NC; Maceyka, M; Colaco, A; Maczis, M; Wassif, CA; Cougnoux, A; Porter, FD; Milstien, S; Platt, N; Platt, FM; Spiegel, S				Newton, Jason; Hait, Nitai C.; Maceyka, Michael; Colaco, Alexandria; Maczis, Melissa; Wassif, Christopher A.; Cougnoux, Antony; Porter, Forbes D.; Milstien, Sheldon; Platt, Nicholas; Platt, Frances M.; Spiegel, Sarah			FTY720/fingolimod increases NPC1 and NPC2 expression and reduces cholesterol and sphingolipid accumulation in Niemann-Pick type C mutant fibroblasts	FASEB JOURNAL			English	Article						histone deacetylase inhibitor; glycosphingolipids; sphingosine kinase; lipid storage disease	HISTONE DEACETYLASE INHIBITORS; ABCA1-DEPENDENT LIPID EFFLUX; CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; DISEASE; TRANSPORT; FTY720; ACID; MICE; 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN	Niemann-Pick type C (NPC) disease is a fatal neurodegenerative disorder caused bymutations in NPC1 or NPC2 with decreased functions leading to lysosomal accumulation of cholesterol and sphingolipids. FTY720/fingolimod, used for treatment ofmultiple sclerosis, is phosphorylatedby nuclear sphingosinekinase 2, andits active phosphorylated form (FTY720-P) is an inhibitor of class I histone deacetylases. In this study, administration of clinically relevant doses of FTY720 to mice increased expression of NPC1 and -2 in brain and liver and decreased cholesterol in an SphK2-dependent manner. FTY720 greatly increased expression of NPC1 and -2 in human NPC1 mutant fibroblasts that correlated with formation of FTY720-P and significantly reduced the accumulation of cholesterol and glycosphingolipids. In agreement with this finding, FTY720 pretreatment of human NPC1 mutant fibroblasts restored transport of the cholera toxin B subunit, which binds ganglioside GM1, to the Golgi apparatus. Together, these findings suggest that FTY720 administration can ameliorate cholesterol and sphingolipid storage and trafficking defects in NPC1 mutant fibroblasts. Because neurodegeneration is the main clinical feature of NPC disease, andFTY720 accumulates in theCNSandhas several advantages over availablehistonedeacetylase inhibitors now in clinical trials, our work provides a potential opportunity for treatment of this incurable disease.-Newton, J., Hait, N. C., Maceyka, M., Colaco, A., Maczis, M., Wassif, C. A., Cougnoux, A., Porter, F. D., Milstien, S., Platt, N., Platt, F. M., Spiegel, S. FTY720/fingolimod increasesNPC1 andNPC2expression and reduces cholesterol and sphingolipid accumulation in Niemann- Pick type C mutant fibroblasts. FASEB J. 31, 1719-1730 (2017). www.fasebj.org	[Newton, Jason; Hait, Nitai C.; Maceyka, Michael; Maczis, Melissa; Milstien, Sheldon; Spiegel, Sarah] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, 2011 Sanger Hall,1101 E Marshall St, Richmond, VA 23298 USA; [Colaco, Alexandria; Platt, Nicholas; Platt, Frances M.] Univ Oxford, Dept Pharmacol, Oxford, England; [Wassif, Christopher A.; Cougnoux, Antony; Porter, Forbes D.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Translat Med, NIH, Bethesda, MD USA; [Hait, Nitai C.] Roswell Pk Canc Inst, Dept Oncol, Buffalo, NY 14263 USA	Virginia Commonwealth University; University of Oxford; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Roswell Park Cancer Institute	Spiegel, S (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, 2011 Sanger Hall,1101 E Marshall St, Richmond, VA 23298 USA.	sarah.spiegel@vcuhealth.org	Maceyka, Michael/B-9277-2008; Newton, Jason/AAN-8428-2020	Platt, Frances/0000-0001-7614-0403; Newton, Jason/0000-0003-2952-2008; Colaco, Alexandria/0000-0001-8612-6357; Cougnoux, Antony/0000-0001-9407-7540	U.S. National Institutes of Health (NIH) National Cancer Institute [P30 CA016059]; University of Virginia, Charlottesville, VA, USA; University of Guelph, Guelph, ON, Canada; NIH; NIH Institute of Neurological Disorders and Stroke [R21NS087273]; NIH Institute of General Medical Science [R01GM043880]; NIH National Heart, Lung, and Blood Institute [T32 HL094290]; intramural research program of the NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development; European Union Seventh Framework Programme [289278]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008824, ZIAHD000139] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS087273] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Virginia, Charlottesville, VA, USA; University of Guelph, Guelph, ON, Canada; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Institute of Neurological Disorders and Stroke; NIH Institute of General Medical Science; NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); intramural research program of the NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development; European Union Seventh Framework Programme(European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Dr. Jeremy Allegood [Virginia Commonwealth University (VCU)] for skillful sphingolipid analyses; the VCU Lipidomics and Microscopy Cores, which are supported, in part, by funding from the U.S. National Institutes of Health (NIH) National Cancer Institute Support Grant P30 CA016059; Drs. J. White (University of Virginia, Charlottesville, VA, USA) and Frances J. Sharom (University of Guelph, Guelph, ON, Canada) for the CHO cell line; and Dr. Richard Proia (NIH) for generously providing the SphK2-knockout mice and SphK2 antibody. This work was supported by NIH Institute of Neurological Disorders and Stroke Grant R21NS087273, NIH Institute of General Medical Science Grant R01GM043880 (to S.S.), NIH National Heart, Lung, and Blood Institute Grant T32 HL094290 (to J. N.), and, in part, by the intramural research program of the NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development (to F.D.P.); and The European Union Seventh Framework Programme (FP7 2007-2013) under Grant Agreement 289278-"Sphingonet" (to A. C. and F. M. P.). F.M.P. is a Royal Society Wolfson Research Merit Award holder and a Wellcome Trust Investigator in Science. The authors declare no conflicts of interest.	Alam MS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9407; Berdyshev EV, 2009, J BIOL CHEM, V284, P5467, DOI 10.1074/jbc.M805186200; Blom T, 2010, CIRC RES, V106, P720, DOI 10.1161/CIRCRESAHA.109.204396; Boadu E, 2006, J MOL MED, V84, P266, DOI 10.1007/s00109-005-0001-9; Briard E, 2011, CHEMMEDCHEM, V6, P667, DOI 10.1002/cmdc.201000477; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Choi HY, 2003, J BIOL CHEM, V278, P32569, DOI 10.1074/jbc.M304553200; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Cologna SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047845; Cougnoux A, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.16; Crumling MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053280; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Efstathopoulos P, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.179; Fan M, 2013, J LIPID RES, V54, P2800, DOI 10.1194/jlr.M040618; Fischer A, 2010, TRENDS PHARMACOL SCI, V31, P605, DOI 10.1016/j.tips.2010.09.003; Foster CA, 2007, J PHARMACOL EXP THER, V323, P469, DOI 10.1124/jpet.107.127183; Garbes L, 2009, HUM MOL GENET, V18, P3645, DOI 10.1093/hmg/ddp313; Gardner NM, 2016, TOXICOL SCI, V150, P161, DOI 10.1093/toxsci/kfv321; Gholamnezhadjafari R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010114; Ginocchio VM, 2013, MOL GENET METAB, V110, P329, DOI 10.1016/j.ymgme.2013.07.019; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hait NC, 2015, ONCOGENESIS, V4, DOI 10.1038/oncsis.2015.16; Hait NC, 2014, NAT NEUROSCI, V17, P971, DOI 10.1038/nn.3728; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hanson JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069964; Higaki K, 2001, J BIOCHEM-TOKYO, V129, P875, DOI 10.1093/oxfordjournals.jbchem.a002932; Hoglinger D, 2015, ELIFE, V4, DOI 10.7554/eLife.10616; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kim SJ, 2007, BIOCHEM BIOPH RES CO, V360, P593, DOI 10.1016/j.bbrc.2007.06.116; Lahiri S, 2009, J BIOL CHEM, V284, P16090, DOI 10.1074/jbc.M807438200; Liu B, 2008, J LIPID RES, V49, P663, DOI 10.1194/jlr.M700525-JLR200; Liu B, 2010, J LIPID RES, V51, P933, DOI 10.1194/jlr.M000257; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Lloyd-Evans E, 2010, TRAFFIC, V11, P419, DOI 10.1111/j.1600-0854.2010.01032.x; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Maarup TJ, 2015, MOL GENET METAB, V116, P75, DOI 10.1016/j.ymgme.2015.07.001; Maceyka M, 2013, FEBS J, V280, P6367, DOI 10.1111/febs.12505; Millat G, 1999, AM J HUM GENET, V65, P1321, DOI 10.1086/302626; Munkacsi AB, 2011, J BIOL CHEM, V286, P23842, DOI 10.1074/jbc.M111.227645; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Neufeld EB, 1999, J BIOL CHEM, V274, P9627, DOI 10.1074/jbc.274.14.9627; Neville DCA, 2004, ANAL BIOCHEM, V331, P275, DOI 10.1016/j.ab.2004.03.051; Ottinger EA, 2014, CURR TOP MED CHEM, V14, P330, DOI 10.2174/1568026613666131127160118; PENTCHEV PG, 1985, P NATL ACAD SCI USA, V82, P8247, DOI 10.1073/pnas.82.23.8247; Pipalia NH, 2011, P NATL ACAD SCI USA, V108, P5620, DOI 10.1073/pnas.1014890108; Platt N, 2016, J NEUROCHEM, V136, P74, DOI 10.1111/jnc.13138; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; Sugimoto Y, 2001, P NATL ACAD SCI USA, V98, P12391, DOI 10.1073/pnas.221181998; Sun YL, 2016, BRIT J PHARMACOL, V173, P2793, DOI 10.1111/bph.13557; Taylor AM, 2012, J LIPID RES, V53, P2331, DOI 10.1194/jlr.M028241; Tint GS, 1998, J INHERIT METAB DIS, V21, P853, DOI 10.1023/A:1005474803278; Van den Bossche J, 2014, BIOCHEM BIOPH RES CO, V455, P396, DOI 10.1016/j.bbrc.2014.11.029; Vanier MT, 2013, HAND CLINIC, V113, P1717, DOI 10.1016/B978-0-444-59565-2.00041-1; Vite CH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010101; Wang ML, 2010, CELL METAB, V12, P166, DOI 10.1016/j.cmet.2010.05.016; Xie XF, 2011, P NATL ACAD SCI USA, V108, P15330, DOI 10.1073/pnas.1112751108; Yanjanin NM, 2010, AM J MED GENET B, V153B, P132, DOI 10.1002/ajmg.b.30969; Yu T, 2012, HUM MOL GENET, V21, P3205, DOI 10.1093/hmg/dds145	61	29	30	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1719	1730		10.1096/fj.201601041R	http://dx.doi.org/10.1096/fj.201601041R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28082351	Green Published			2022-12-26	WOS:000398504300036
J	Peuchant, E; Bats, ML; Moranvillier, I; Lepoivre, M; Guitton, J; Wendum, D; Lacombe, ML; Moreau-Gaudry, F; Boissan, M; Dabernat, S				Peuchant, Evelyne; Bats, Marie-Lise; Moranvillier, Isabelle; Lepoivre, Michel; Guitton, Jerome; Wendum, Dominique; Lacombe, Marie-Lise; Moreau-Gaudry, Francois; Boissan, Mathieu; Dabernat, Sandrine			Metastasis suppressor NM23 limits oxidative stress in mammals by preventing activation of stress-activated protein kinases/JNKs through its nucleoside diphosphate kinase activity	FASEB JOURNAL			English	Article						NDPK; hepatocyte; keratinocyte; MAPK	REACTIVE-OXYGEN; HEPATOCELLULAR-CARCINOMA; SIGNAL-TRANSDUCTION; CELL-PROLIFERATION; ENHANCED TOLERANCE; MASS-SPECTROMETRY; CANCER-CELLS; MOUSE-LIVER; JNK; SENESCENCE	NME1 (nonmetastatic expressed 1) gene, which encodes nucleoside diphosphate kinase (NDPK) A [ also known as nonmetastatic clone 23 (NM23)-H1 in humans and NM23-M1 in mice], is a suppressor of metastasis, but several lines of evidence-mostly from plants-also implicate it in the regulation of the oxidative stress response. Here, our aim was to investigate the physiologic relevance of NDPK A with respect to the oxidative stress response in mammals and to study its molecular basis. NME1-knockout mice died sooner, suffered greater hepatocyte injury, and had lower superoxide dismutase activity than did wild-type (WT) mice in response to paraquat-induced acute oxidative stress. Deletion of NME1 reduced total NDPK activity and exacerbated activation of the stress-related MAPK, JNK, in the liver in response to paraquat. In a mouse transformed hepatocyte cell line and in primary cultures of normal human keratinocytes, MAPK activation in response to H2O2 and UVB, respectively, was dampened by expression of NM23-M1/NM23-H1, dependent on its NDPK catalytic activity. Furthermore, excess or depletion of NM23-M1/NM23-H1NDPK activity did not affect the intracellular bulk concentration of nucleoside di- and triphosphates. NME1-deficient mouse embryo fibroblasts grew poorly in culture, were more sensitive to stress than WT fibroblasts, and did not immortalize, which suggested that they senesce earlier than do WT fibroblasts. Collectively, these results indicate that the NDPK activity of NM23-M1/NM23-H1 protects cells from acute oxidative stress by inhibiting activation of JNK in mammal models.-Peuchant, E., Bats, M.-L., Moranvillier, I., Lepoivre, M., Guitton, J., Wendum, D., Lacombe, M.-L., Moreau-Gaudry, F., Boissan, M., Dabernat, S. Metastasis suppressor NM23 limits oxidative stress in mammals by preventing activation of stress-activated protein kinases/JNKs through its nucleoside diphosphate kinase activity.	[Peuchant, Evelyne; Bats, Marie-Lise; Moranvillier, Isabelle; Moreau-Gaudry, Francois; Dabernat, Sandrine] Univ Bordeaux, Coll Sante, Bordeaux, France; [Peuchant, Evelyne; Moranvillier, Isabelle; Moreau-Gaudry, Francois; Dabernat, Sandrine] INSERM 1035, Bordeaux, France; [Peuchant, Evelyne; Bats, Marie-Lise; Moreau-Gaudry, Francois; Dabernat, Sandrine] Ctr Hosp Univ Bordeaux, Bordeaux, France; [Lepoivre, Michel] Univ Paris 11, Commissariat Energie Atom & Energies, Unit Mixte Rech, CNRS 9198, Orsay, France; [Guitton, Jerome] Hosp Civils Lyon, Pierre Benite, France; [Guitton, Jerome] Univ Lyon, Lyon, France; [Wendum, Dominique; Lacombe, Marie-Lise; Boissan, Mathieu] Univ Paris 06, Univ Paris 06, INSERM, Unite Mixte Rech S938,St Antoine Res Ctr,Sorbonne, 184 Rue Faubourg,St Antoine Kourilsky Bldg, F-75012 Paris, France; [Wendum, Dominique] Hop St Antoine, Lab Anat Pathol, Paris, France; [Boissan, Mathieu] Hop Tenon, AP HP, Serv Biochim & Hormonol, Paris, France	UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Bordeaux; CEA; UDICE-French Research Universities; Universite Paris Saclay; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Boissan, M (corresponding author), Univ Paris 06, Univ Paris 06, INSERM, Unite Mixte Rech S938,St Antoine Res Ctr,Sorbonne, 184 Rue Faubourg,St Antoine Kourilsky Bldg, F-75012 Paris, France.; Dabernat, S (corresponding author), Univ Bordeaux, INSERM U1035, 146 Rue Leo Saignat, F-33000 Bordeaux, France.	mathieu.boissan@inserm.fr; sandrine.dabernat@u-bordeaux.fr		Guitton, Jerome/0000-0001-6180-5708; Bats, Marie-Lise/0000-0002-8359-4662	Ligue Nationale contre le Cancer; Groupement des Entreprises Francaises contre le Cancer (GEFLUC)	Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Groupement des Entreprises Francaises contre le Cancer (GEFLUC)	The authors thank J. Y. Daniel (Universite de Bordeaux) for his enthusiastic commitment to the NM23 field and the enduring support he provided to our group. The authors also thank I. Lascu (Universite de Bordeaux) for his continuous interest in our work and Y. Chretien (Sorbonne Universites, Universite Pierre et Marie Curie) for help with infography. Carol Featherstone (Plume Scientific Communication Services) edited the manuscript. The authors are grateful to Martine Auclair (Sorbonne Universites, Universite Pierre et Marie Curie), who performed senescence markers Western blotting. Core funding for this work was provided by the Ligue Nationale contre le Cancer (to S.D.),and additional support was provided by grants of the Groupement des Entreprises Francaises contre le Cancer (GEFLUC; to M.B.).	Agarwal R P, 1978, Methods Enzymol, V51, P376; An R, 2008, ACTA PHARMACOL SIN, V29, P1451, DOI 10.1111/j.1745-7254.2008.00902.x; Arnaud-Dabernat S, 2003, J BIOENERG BIOMEMBR, V35, P19, DOI 10.1023/A:1023561821551; Arnaud-Dabernat S, 2004, EXP CELL RES, V301, P293, DOI 10.1016/j.yexcr.2004.07.026; Boissan M, 2005, JNCI-J NATL CANCER I, V97, P836, DOI 10.1093/jnci/dji143; Boissan M, 2006, J BIOENERG BIOMEMBR, V38, P169, DOI 10.1007/s10863-006-9031-4; Boissan M, 2014, SCIENCE, V344, P1510, DOI 10.1126/science.1253768; Boissan M, 2010, CANCER RES, V70, P7710, DOI 10.1158/0008-5472.CAN-10-1887; Boissan M, 2009, MOL CELL BIOCHEM, V329, P51, DOI 10.1007/s11010-009-0120-7; Bruneel A, 2011, N-S ARCH PHARMACOL, V384, P407, DOI 10.1007/s00210-011-0639-5; Cho SM, 2004, MOL CELLS, V18, P390; Choi CH, 2013, CELL MICROBIOL, V15, P961, DOI 10.1111/cmi.12089; Creighton T.E., 1992, PROTEINS STRUCTURES; Das M, 2007, P NATL ACAD SCI USA, V104, P15759, DOI 10.1073/pnas.0707782104; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; de Marval PM, 2011, CANCER PREV RES, V4, P851, DOI 10.1158/1940-6207.CAPR-10-0360; Deplagne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018645; Diaz B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000368; Dragin N, 2006, FEBS LETT, V580, P3845, DOI 10.1016/j.febslet.2006.06.006; Eaton P, 2002, J BIOL CHEM, V277, P9806, DOI 10.1074/jbc.M111454200; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Freije JMP, 1997, J BIOL CHEM, V272, P5525, DOI 10.1074/jbc.272.9.5525; Guo YL, 2010, STEM CELLS DEV, V19, P1321, DOI 10.1089/scd.2009.0313; HALEY TJ, 1979, CLIN TOXICOL, V14, P1; Hartsough MT, 2002, J BIOL CHEM, V277, P32389, DOI 10.1074/jbc.M203115200; Jarrett SG, 2013, CLIN EXP METASTAS, V30, P25, DOI 10.1007/s10585-012-9495-z; Kim MS, 2010, ACTA CRYSTALLOGR F, V66, P1490, DOI 10.1107/S1744309110036067; Kim MD, 2010, PHYSIOL PLANTARUM, V140, P153, DOI 10.1111/j.1399-3054.2010.01392.x; Kim YI, 2003, BIOCHEM BIOPH RES CO, V307, P281, DOI 10.1016/S0006-291X(03)01195-1; LASCU I, 1992, J BIOL CHEM, V267, P12775; LEONE A, 1991, CELL, V65, P25, DOI 10.1016/0092-8674(91)90404-M; LEVRAT F, 1993, EXP CELL RES, V209, P307, DOI 10.1006/excr.1993.1315; Machon C, 2014, ANAL BIOANAL CHEM, V406, P2925, DOI 10.1007/s00216-014-7711-1; Macip S, 2003, MOL CELL BIOL, V23, P8576, DOI 10.1128/MCB.23.23.8576-8585.2003; Marionnet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012059; Miyaoka Y, 2013, CELL DIV, V8, DOI 10.1186/1747-1028-8-8; Moon H, 2003, P NATL ACAD SCI USA, V100, P358, DOI 10.1073/pnas.252641899; Pallavi SK, 2012, EMBO J, V31, P2895, DOI 10.1038/emboj.2012.129; Pani G, 2010, CANCER METAST REV, V29, P351, DOI 10.1007/s10555-010-9225-4; Qin ZQ, 2011, J VIROL, V85, P3596, DOI 10.1128/JVI.01596-10; Roy B, 2004, FREE RADICAL BIO MED, V36, P507, DOI 10.1016/j.freeradbiomed.2003.11.028; Salerno M, 2005, MOL CELL BIOL, V25, P1379, DOI 10.1128/MCB.25.4.1379-1388.2005; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; Smith SK, 2004, CYTOGENET GENOME RES, V105, P455, DOI 10.1159/000078219; Song EJ, 2000, BIOCHEMISTRY-US, V39, P10090, DOI 10.1021/bi000267a; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Suntres ZE, 2002, TOXICOLOGY, V180, P65, DOI 10.1016/S0300-483X(02)00382-7; Tang L, 2008, TRANSGENIC RES, V17, P705, DOI 10.1007/s11248-007-9155-2; TODARO GJ, 1963, J CELL COMPAR PHYSL, V62, P257, DOI 10.1002/jcp.1030620305; Wada T, 2008, CELL DEATH DIFFER, V15, P89, DOI 10.1038/sj.cdd.4402222; Wei SJ, 2004, J BIOL CHEM, V279, P5993, DOI 10.1074/jbc.M310820200; Xie KM, 2010, REPRODUCTION, V139, P799, DOI 10.1530/REP-09-0490; Xu J, 1996, DEV BIOL, V177, P544, DOI 10.1006/dbio.1996.0184; Yegutkin GG, 2014, CRIT REV BIOCHEM MOL, V49, P473, DOI 10.3109/10409238.2014.953627; Yegutkin GG, 2003, FASEB J, V17, P1328, DOI 10.1096/fj.02-1136fje; Yokdang N, 2011, BRIT J CANCER, V104, P1628, DOI 10.1038/bjc.2011.134; Yoshida Y, 2006, FEBS LETT, V580, P3282, DOI 10.1016/j.febslet.2006.01.096; Zhang QB, 2011, INT J CANCER, V128, P40, DOI 10.1002/ijc.25307	58	7	7	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1531	1546		10.1096/fj.201600705R	http://dx.doi.org/10.1096/fj.201600705R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28077425				2022-12-26	WOS:000398504300021
J	Sergin, I; Jong, YJI; Harmon, SK; Kumar, V; O'Malley, KL				Sergin, Ismail; Jong, Yuh-Jiin I.; Harmon, Steven K.; Kumar, Vikas; O'Malley, Karen L.			Sequences within the C Terminus of the Metabotropic Glutamate Receptor 5 (mGluR5) Are Responsible for Inner Nuclear Membrane Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; chromatin; G-protein-coupled receptor (GPCR); glutamate; metabotropic glutamate receptor (mGluR); nuclear membrane; nuclear transport	PROTEIN-COUPLED RECEPTORS; SUBCELLULAR-LOCALIZATION; INTRACELLULAR MGLUR5; STRIATAL NEURONS; CELL-NUCLEUS; LAMIN-B; TRAFFICKING; BINDING; TRANSPORT; CA2+	Traditionally, G-protein-coupled receptors (GPCR) are thought to be located on the cell surface where they transmit extracellular signals to the cytoplasm. However, recent studies indicate that some GPCRs are also localized to various subcellular compartments such as the nucleus where they appear required for various biological functions. For example, the metabotropic glutamate receptor 5 (mGluR5) is concentrated at the inner nuclear membrane (INM) where it mediates Ca2+ changes in the nucleoplasm by coupling with G(q/11). Here, we identified a region within the C-terminal domain (amino acids 852-876) that is necessary and sufficient for INM localization of the receptor. Because these sequences do not correspond to known nuclear localization signal motifs, they represent a new motif for INM trafficking. mGluR5 is also trafficked to the plasma membrane where it undergoes re-cycling/degradation in a separate receptor pool, one that does not interact with the nuclear mGluR5 pool. Finally, our data suggest that once at the INM, mGluR5 is stably retained via interactions with chromatin. Thus, mGluR5 is perfectly positioned to regulate nucleoplasmic Ca(2+)in situ.	[Sergin, Ismail; Jong, Yuh-Jiin I.; Harmon, Steven K.; Kumar, Vikas; O'Malley, Karen L.] Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63110 USA	Washington University (WUSTL)	O'Malley, KL (corresponding author), 660 S Euclid Ave,Campus Box 8108, St Louis, MO 63110 USA.	omalleyk@wustl.edu			Washington University School of Medicine; Children's Discovery Institute of Washington University; St. Louis Children's Hospital [CDI-CORE-2015-505]; NINDS, National Institutes of Health [NS086741]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH109019, R01MH057817, R21MH069646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R24NS086741, R21NS081454, R21NS102783] Funding Source: NIH RePORTER	Washington University School of Medicine; Children's Discovery Institute of Washington University; St. Louis Children's Hospital; NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. M. Nathanson (Yale University) for IP<INF>3</INF> sponge constructs. Microscopes and software were provided in part through the use of Washington University Center for Cellular Imaging (WUCCI) supported by Washington University School of Medicine, The Children's Discovery Institute of Washington University and St. Louis Children's Hospital (CDI-CORE-2015-505), and the NINDS, National Institutes of Health (NS086741).	ABE T, 1992, J BIOL CHEM, V267, P13361; Barlow CA, 2010, TRENDS CELL BIOL, V20, P25, DOI 10.1016/j.tcb.2009.09.009; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Benard G, 2012, NAT NEUROSCI, V15, P558, DOI 10.1038/nn.3053; Benyair R, 2015, SEMIN CELL DEV BIOL, V41, P99, DOI 10.1016/j.semcdb.2014.11.006; Bhave G, 2003, J BIOL CHEM, V278, P30294, DOI 10.1074/jbc.M303258200; Boivin B, 2008, J RECEPT SIG TRANSD, V28, P15, DOI [10.1080/10799890801941889, 10.1080/10799890801941889 ]; Branco AF, 2015, J CARDIOVASC PHARM, V65, P101, DOI 10.1097/FJC.0000000000000196; Calebiro D, 2015, METHODS MOL BIOL, V1234, P197, DOI 10.1007/978-1-4939-1755-6_16; Calebiro D, 2010, TRENDS PHARMACOL SCI, V31, P221, DOI 10.1016/j.tips.2010.02.002; Campden R, 2015, J CARDIOVASC PHARM, V65, P110, DOI 10.1097/FJC.0000000000000198; Dores MR, 2014, CURR OPIN CELL BIOL, V27, P44, DOI 10.1016/j.ceb.2013.11.004; Dunn HA, 2015, MOL PHARMACOL, V88, P624, DOI 10.1124/mol.115.098509; Fourgeaud L, 2003, J BIOL CHEM, V278, P12222, DOI 10.1074/jbc.M205663200; Francesconi A, 1998, J BIOL CHEM, V273, P5615, DOI 10.1074/jbc.273.10.5615; Francesconi A, 2009, J NEUROSCI, V29, P3590, DOI 10.1523/JNEUROSCI.5824-08.2009; GERASIMENKO OV, 1995, CELL, V80, P439, DOI 10.1016/0092-8674(95)90494-8; Gobeil F, 2006, CAN J PHYSIOL PHARM, V84, P287, DOI 10.1139/Y05-127; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gomes DA, 2008, J BIOL CHEM, V283, P4344, DOI 10.1074/jbc.M706550200; Goodchild RE, 2015, J CELL SCI, V128, P2854, DOI 10.1242/jcs.167452; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Hermans E, 2001, BIOCHEM J, V359, P465, DOI 10.1042/0264-6021:3590465; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; Holmer L, 2001, CELL MOL LIFE SCI, V58, P1741, DOI 10.1007/PL00000813; HOLZENBURG A, 1992, BIOCHEM SOC T, V20, P591, DOI 10.1042/bst0200591; Hubert GW, 2001, J NEUROSCI, V21, P1838, DOI 10.1523/JNEUROSCI.21-06-01838.2001; Hurt CM, 2013, METHOD ENZYMOL, V521, P171, DOI 10.1016/B978-0-12-391862-8.00009-0; Irannejad R, 2014, CURR OPIN CELL BIOL, V27, P109, DOI 10.1016/j.ceb.2013.10.003; Jong YJI, 2005, J BIOL CHEM, V280, P30469, DOI 10.1074/jbc.M501775200; Jong YJI, 2014, MOL PHARMACOL, V86, P774, DOI 10.1124/mol.114.094763; Jong YJI, 2009, J BIOL CHEM, V284, P35827, DOI 10.1074/jbc.M109.046276; Joyal JS, 2014, NAT MED, V20, P1165, DOI 10.1038/nm.3669; Kang M, 2012, TRAFFIC, V13, P1589, DOI 10.1111/tra.12008; Katta SS, 2014, TRENDS CELL BIOL, V24, P221, DOI 10.1016/j.tcb.2013.10.006; Kniazeff J, 2004, NAT STRUCT MOL BIOL, V11, P706, DOI 10.1038/nsmb794; Ko SJ, 2012, J NEUROSCI, V32, P16391, DOI 10.1523/JNEUROSCI.1964-12.2012; Kumar V, 2008, J BIOL CHEM, V283, P14072, DOI 10.1074/jbc.M708551200; Kumar V, 2012, J BIOL CHEM, V287, P5412, DOI 10.1074/jbc.M111.301366; Lee DK, 2004, J BIOL CHEM, V279, P7901, DOI 10.1074/jbc.M306377200; Lester HA, 2012, BIOL PSYCHIAT, V72, P907, DOI 10.1016/j.biopsych.2012.05.020; Lopez-Bendito G, 2002, CEREB CORTEX, V12, P625, DOI 10.1093/cercor/12.6.625; Lujan R, 1997, J CHEM NEUROANAT, V13, P219, DOI 10.1016/S0891-0618(97)00051-3; Lusk CP, 2007, NAT REV MOL CELL BIO, V8, P414, DOI 10.1038/nrm2165; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Mao LM, 2008, NEUROPHARMACOLOGY, V55, P403, DOI 10.1016/j.neuropharm.2008.05.034; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Meads MB, 2004, J BIOL CHEM, V279, P51793, DOI 10.1074/jbc.M407382200; Morinelli TA, 2007, AM J PHYSIOL-CELL PH, V292, pC1398, DOI 10.1152/ajpcell.00337.2006; O'Malley KL, 2003, J BIOL CHEM, V278, P28210, DOI 10.1074/jbc.M300792200; Oksche A, 2000, MOL PHARMACOL, V57, P1104; Olins AL, 2010, NUCLEUS-PHILA, V1, P53, DOI 10.4161/nucl.1.1.10515; Petralia RS, 1997, J CHEM NEUROANAT, V13, P77, DOI 10.1016/S0891-0618(97)00023-9; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Prokocimer M, 2009, J CELL MOL MED, V13, P1059, DOI [10.1111/j.1582-4934.2009.00676.x, 10.1111/j.1582-4934.2008.00676.x]; Purgert CA, 2014, J NEUROSCI, V34, P4589, DOI 10.1523/JNEUROSCI.3451-13.2014; REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883; Ribeiro FM, 2010, CNS NEUROL DISORD-DR, V9, P574; Rozenfeld R, 2008, FASEB J, V22, P2311, DOI 10.1096/fj.07-102731; Schirmer EC, 2007, EXP CELL RES, V313, P2167, DOI 10.1016/j.yexcr.2007.03.012; Sekine-Aizawa Y, 2004, P NATL ACAD SCI USA, V101, P17114, DOI 10.1073/pnas.0407563101; Shirvani Hamasseh, 2012, Subcell Biochem, V63, P97, DOI 10.1007/978-94-007-4765-4_6; Snapp E.L., 2003, CURR PROTOC CELL BIO; SOULLAM B, 1995, J CELL BIOL, V130, P15, DOI 10.1083/jcb.130.1.15; Tadevosyan A, 2012, J PHYSIOL-LONDON, V590, P1313, DOI 10.1113/jphysiol.2011.222794; Trivedi RR, 2012, BIOCHEM BIOPH RES CO, V427, P185, DOI 10.1016/j.bbrc.2012.09.040; Ulbert S, 2006, J CELL BIOL, V173, P469, DOI 10.1083/jcb.200512078; Vincent K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10604; Walther C, 2013, PROG MOL BIOL TRANSL, V118, P93, DOI 10.1016/B978-0-12-394440-5.00004-8; Wang H, 2009, SCIENCE, V326, P1554, DOI 10.1126/science.1178496; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Wright CD, 2012, CELL SIGNAL, V24, P794, DOI 10.1016/j.cellsig.2011.11.014; YE Q, 1994, J BIOL CHEM, V269, P11306; Zuleger N, 2012, CELL MOL LIFE SCI, V69, P2205, DOI 10.1007/s00018-012-0929-1; Zuleger N, 2011, J CELL BIOL, V193, P109, DOI 10.1083/jcb.201009068; Zuleger N, 2008, BIOCHEM SOC T, V36, P1373, DOI 10.1042/BST0361373	77	24	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3637	3655		10.1074/jbc.M116.757724	http://dx.doi.org/10.1074/jbc.M116.757724			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28096465	hybrid, Green Published			2022-12-26	WOS:000395542500009
J	Yang, XR; Liu, XR; Musser, DM; Moustafa, IM; Arnold, JJ; Cameron, CE; Boehr, DD				Yang, Xiaorong; Liu, Xinran; Musser, Derek M.; Moustafa, Ibrahim M.; Arnold, Jamie J.; Cameron, Craig E.; Boehr, David D.			Triphosphate Reorientation of the Incoming Nucleotide as a Fidelity Checkpoint in Viral RNA-dependent RNA Polymerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; enzyme mechanism; nuclear magnetic resonance (NMR); plus-stranded RNA virus; poliovirus; protein dynamic; RNA polymerase; RNA virus; polymerase fidelity	NUCLEAR-MAGNETIC-RESONANCE; STATE KINETIC-ANALYSIS; DNA-POLYMERASE; STRUCTURAL BASIS; ESCHERICHIA-COLI; BINDING POCKET; LARGE FRAGMENT; RIBONUCLEOTIDE INCORPORATION; CRYSTAL-STRUCTURES; METAL-IONS	The nucleotide incorporation fidelity of the viral RNA-dependent RNA polymerase (RdRp) is important for maintaining functional genetic information but, at the same time, is also important for generating sufficient genetic diversity to escape the bottlenecks of the host's antiviral response. We have previously shown that the structural dynamics of the motif D loop are closely related to nucleotide discrimination. Previous studies have also suggested that there is a reorientation of the triphosphate of the incoming nucleotide, which is essential before nucleophilic attack from the primer RNA 3-hydroxyl. Here, we have used P-31 NMR with poliovirus RdRp to show that the binding environment of the triphosphate is different when correct versus incorrect nucleotide binds. We also show that amino acid substitutions at residues known to interact with the triphosphate can alter the binding orientation/environment of the nucleotide, sometimes lead to protein conformational changes, and lead to substantial changes in RdRp fidelity. The analyses of other fidelity variants also show that changes in the triphosphate binding environment are not always accompanied by changes in the structural dynamics of the motif D loop or other regions known to be important for RdRp fidelity, including motif B. Altogether, our studies suggest that the conformational changes in motifs B and D, and the nucleoside triphosphate reorientation represent separable, tunable fidelity checkpoints.	[Yang, Xiaorong; Liu, Xinran; Musser, Derek M.; Boehr, David D.] Penn State Univ, Dept Chem, 107 Chem Bldg, University Pk, PA 16802 USA; [Moustafa, Ibrahim M.; Arnold, Jamie J.; Cameron, Craig E.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Boehr, DD (corresponding author), Penn State Univ, Dept Chem, 107 Chem Bldg, University Pk, PA 16802 USA.	ddb12@psu.edu	Liu, Xinran/GON-4955-2022	Liu, Xinran/0000-0002-3732-6632	National Institutes of Health [AI104878, AI45818]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104878, R01AI045818] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI104878 (to D. D. B.) and AI45818 (to C. E. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnold JJ, 2006, ANAL BIOCHEM, V350, P214, DOI 10.1016/j.ab.2005.11.001; Arnold JJ, 2005, J BIOL CHEM, V280, P25706, DOI 10.1074/jbc.M503444200; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5126, DOI 10.1021/bi035212y; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5138, DOI 10.1021/bi035213q; Arnold JJ, 2000, J BIOL CHEM, V275, P5329, DOI 10.1074/jbc.275.8.5329; Beard WA, 2003, STRUCTURE, V11, P489, DOI 10.1016/S0969-2126(03)00051-0; BOCK JL, 1980, J INORG BIOCHEM, V12, P119, DOI 10.1016/S0162-0134(00)80123-3; Castro C, 2005, VIRUS RES, V107, P141, DOI 10.1016/j.virusres.2004.11.004; Castro C, 2007, P NATL ACAD SCI USA, V104, P4267, DOI 10.1073/pnas.0608952104; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; COHN M, 1962, J BIOL CHEM, V237, P176; Curti E, 2013, J VIROL, V87, P199, DOI 10.1128/JVI.06968-11; FERRIN LJ, 1986, BIOCHEMISTRY-US, V25, P5131, DOI 10.1021/bi00366a023; FERRIN LJ, 1985, BIOCHEMISTRY-US, V24, P6904, DOI 10.1021/bi00345a024; FERSHT AR, 1987, BIOCHEMISTRY-US, V26, P8031, DOI 10.1021/bi00399a001; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Freudenthal BD, 2013, CELL, V154, P157, DOI 10.1016/j.cell.2013.05.048; Furukawa A, 2016, PROG NUCL MAG RES SP, V96, P47, DOI 10.1016/j.pnmrs.2016.02.002; Garriga D, 2013, J MOL BIOL, V425, P2279, DOI 10.1016/j.jmb.2013.03.034; Gnadig NF, 2012, P NATL ACAD SCI USA, V109, pE2294, DOI 10.1073/pnas.1204022109; Gohara DW, 2000, J BIOL CHEM, V275, P25523, DOI 10.1074/jbc.M002671200; Gohara DW, 2004, BIOCHEMISTRY-US, V43, P5149, DOI 10.1021/bi035429s; Gohara DW, 1999, PROTEIN EXPRES PURIF, V17, P128, DOI 10.1006/prep.1999.1100; Gong P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060272; Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107; Graci JD, 2008, FUTURE VIROL, V3, P553, DOI 10.2217/17460794.3.6.553; GUPTA RK, 1977, J BIOL CHEM, V252, P5967; Johnson SJ, 2004, CELL, V116, P803, DOI 10.1016/S0092-8674(04)00252-1; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kaushik N, 1996, BIOCHEMISTRY-US, V35, P7256, DOI 10.1021/bi960537i; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Kirmizialtin S, 2012, STRUCTURE, V20, P618, DOI 10.1016/j.str.2012.02.018; Korboukh VK, 2014, J BIOL CHEM, V289, P29531, DOI 10.1074/jbc.M114.592303; Korneeva VS, 2007, J BIOL CHEM, V282, P16135, DOI 10.1074/jbc.M610090200; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; Li Y, 1998, PROTEIN SCI, V7, P1116, DOI 10.1002/pro.5560070505; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Liu XR, 2015, VIRUSES-BASEL, V7, P5571, DOI 10.3390/v7102894; Liu XR, 2013, J BIOL CHEM, V288, P32753, DOI 10.1074/jbc.M113.484428; Marcotte LL, 2007, J VIROL, V81, P3583, DOI 10.1128/JVI.02306-06; McDonald S, 2016, J BIOL CHEM, V291, P13999, DOI 10.1074/jbc.M116.726596; MILDVAN AS, 1992, ARCH BIOCHEM BIOPHYS, V294, P327, DOI 10.1016/0003-9861(92)90692-P; Moustafa IM, 2014, J BIOL CHEM, V289, P36229, DOI 10.1074/jbc.M114.616193; Moustafa IM, 2011, J MOL BIOL, V410, P159, DOI 10.1016/j.jmb.2011.04.078; NOMOTO A, 1982, P NATL ACAD SCI-BIOL, V79, P5793, DOI 10.1073/pnas.79.19.5793; Pfeiffer JK, 2005, PLOS PATHOG, V1, P102, DOI 10.1371/journal.ppat.0010011; RAO BDN, 1978, J BIOL CHEM, V253, P8056; SERRANO L, 1990, BIOCHEMISTRY-US, V29, P9343, DOI 10.1021/bi00492a006; Shu B, 2016, P NATL ACAD SCI USA, V113, pE4005, DOI 10.1073/pnas.1602591113; SLOAN DL, 1975, J BIOL CHEM, V250, P8913; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Trakselis MA, 2014, NUCLEIC ACIDS MOL BI, V30, P1, DOI 10.1007/978-3-642-39796-7_1; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Vignuzzi M, 2008, NAT MED, V14, P154, DOI 10.1038/nm1726; Wang WJ, 2011, APPL CATAL B-ENVIRON, V108, P108, DOI 10.1016/j.apcatb.2011.08.015; Wang WN, 2012, J BIOL CHEM, V287, P28215, DOI 10.1074/jbc.M112.366609; Weeks SA, 2012, J BIOL CHEM, V287, P31618, DOI 10.1074/jbc.C112.401471; Wu EY, 2011, J BIOL CHEM, V286, P19758, DOI 10.1074/jbc.M110.191130; Yang XR, 2012, STRUCTURE, V20, P1519, DOI 10.1016/j.str.2012.06.012; Yang XR, 2010, BIOCHEMISTRY-US, V49, P9361, DOI 10.1021/bi100833r; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464	64	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3810	3826		10.1074/jbc.M116.750638	http://dx.doi.org/10.1074/jbc.M116.750638			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28100782	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000395542500023
J	Arkadash, V; Yosef, G; Shirian, J; Cohen, I; Horev, Y; Grossman, M; Sagi, I; Radisky, ES; Shifman, JM; Papo, N				Arkadash, Valeria; Yosef, Gal; Shirian, Jason; Cohen, Itay; Horev, Yuval; Grossman, Moran; Sagi, Irit; Radisky, Evette S.; Shifman, Julia M.; Papo, Niv			Development of High Affinity and High Specificity Inhibitors of Matrix Metalloproteinase 14 through Computational Design and Directed Evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						directed evolution; metastasis; protease inhibitor; protein-protein interaction; proteolysis; binding affinity; computational protein design; matrix metalloproteinases; yeast surface display	HUMAN TISSUE INHIBITOR; CRYSTAL-STRUCTURE; BREAST-CANCER; 1-MATRIX METALLOPROTEINASE; SELECTIVE-INHIBITION; CATALYTIC DOMAIN; TUMOR-GROWTH; BINDING; ANTIBODIES; COMPLEX	Degradation of the extracellular matrices in the human body is controlled by matrix metalloproteinases (MMPs), a family of more than 20 homologous enzymes. Imbalance in MMP activity can result in many diseases, such as arthritis, cardiovascular diseases, neurological disorders, fibrosis, and cancers. Thus, MMPs present attractive targets for drug design and have been a focus for inhibitor design for as long as 3 decades. Yet, to date, all MMP inhibitors have failed in clinical trials because of their broad activity against numerous MMP family members and the serious side effects of the proposed treatment. In this study, we integrated a computational method and a yeast surface display technique to obtain highly specific inhibitors of MMP-14 by modifying the natural non-specific broad MMP inhibitor protein N-TIMP2 to interact optimally with MMP-14. We identified an N-TIMP2 mutant, with five mutations in its interface, that has an MMP-14 inhibition constant (K-i) of 0.9 pm, the strongest MMP-14 inhibitor reported so far. Compared with wild-type N-TIMP2, this variant displays approximate to 900-fold improved affinity toward MMP-14 and up to 16,000-fold greater specificity toward MMP-14 relative to other MMPs. In an in vitro and cell-based model of MMP-dependent breast cancer cellular invasiveness, this N-TIMP2 mutant acted as a functional inhibitor. Thus, our study demonstrates the enormous potential of a combined computational/directed evolution approach to protein engineering. Furthermore, it offers fundamental clues into the molecular basis of MMP regulation by N-TIMP2 and identifies a promising MMP-14 inhibitor as a starting point for the development of protein-based anticancer therapeutics.	[Arkadash, Valeria; Yosef, Gal; Cohen, Itay; Horev, Yuval; Papo, Niv] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel; [Arkadash, Valeria; Yosef, Gal; Cohen, Itay; Horev, Yuval; Papo, Niv] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Shirian, Jason; Shifman, Julia M.] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Grossman, Moran; Sagi, Irit] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Radisky, Evette S.] Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, Jacksonville, FL 32224 USA	Ben Gurion University; Ben Gurion University; Hebrew University of Jerusalem; Weizmann Institute of Science; Mayo Clinic	Papo, N (corresponding author), Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel.; Papo, N (corresponding author), Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel.; Shifman, JM (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	jshifman@mail.huji.ac.il; papo@bgu.ac.il	Radisky, Evette S/C-8526-2012; Papo, Niv/R-3946-2017	Radisky, Evette S/0000-0003-3121-109X; 	European Research Council [ERC-2013-StG, 336041]; NATIONAL CANCER INSTITUTE [R21CA205471, R01CA154387] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by European Research Council "Ideas Program" ERC-2013-StG by Contract Grant 336041 (to N. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson GP, 2013, ANAL CHIM ACTA, V786, P132, DOI 10.1016/j.aca.2013.05.010; Angelini A, 2015, METHODS MOL BIOL, V1319, P3, DOI 10.1007/978-1-4939-2748-7_1; Bahudhanapati H, 2011, J BIOL CHEM, V286, P31761, DOI 10.1074/jbc.M111.253328; Bartolome RA, 2009, AM J PATHOL, V174, P602, DOI 10.2353/ajpath.2009.080636; Batra J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075836; Batra J, 2012, J BIOL CHEM, V287, P15935, DOI 10.1074/jbc.M112.341156; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Butler GS, 1999, J BIOL CHEM, V274, P20391, DOI 10.1074/jbc.274.29.20391; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Decock J, 2011, J CELL MOL MED, V15, P1254, DOI 10.1111/j.1582-4934.2011.01302.x; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; Dollery CM, 2006, CARDIOVASC RES, V69, P625, DOI 10.1016/j.cardiores.2005.11.003; Dufayard JF, 2005, BIOINFORMATICS, V21, P2596, DOI 10.1093/bioinformatics/bti325; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fernandez CA, 2003, J BIOL CHEM, V278, P40989, DOI 10.1074/jbc.M306176200; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; Folgueras AR, 2004, INT J DEV BIOL, V48, P411, DOI 10.1387/ijdb.041811af; Fromer M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000627; Galvez BG, 2001, J BIOL CHEM, V276, P37491, DOI 10.1074/jbc.M104094200; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Graff CP, 2004, PROTEIN ENG DES SEL, V17, P293, DOI 10.1093/protein/gzh038; Greene J, 1996, J BIOL CHEM, V271, P30375, DOI 10.1074/jbc.271.48.30375; Grossman M, 2010, BIOCHEMISTRY-US, V49, P6184, DOI 10.1021/bi902141x; Hegedus L, 2008, J CELL PHYSIOL, V216, P480, DOI 10.1002/jcp.21417; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Huang W, 1996, FEBS LETT, V384, P155, DOI 10.1016/0014-5793(96)00304-3; Iyer S, 2007, J BIOL CHEM, V282, P364, DOI 10.1074/jbc.M607625200; Jiang WG, 2006, INT J MOL MED, V17, P583; Kveiborg M, 2010, BIOCHEM J, V430, P79, DOI 10.1042/BJ20100649; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Maskos K, 2007, J MOL BIOL, V366, P1222, DOI 10.1016/j.jmb.2006.11.072; Mata-Fink J, 2013, J MOL BIOL, V425, P444, DOI 10.1016/j.jmb.2012.11.010; McCamish M, 2011, MABS-AUSTIN, V3, P209, DOI 10.4161/mabs.3.2.15005; Mehner C, 2014, ONCOTARGET, V5, P2736, DOI 10.18632/oncotarget.1932; Moore CS, 2012, AM J PATHOL, V180, P12, DOI 10.1016/j.ajpath.2011.09.008; Morgunova E, 2002, P NATL ACAD SCI USA, V99, P7414, DOI 10.1073/pnas.102185399; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Murphy G, 2008, NAT CLIN PRACT RHEUM, V4, P128, DOI 10.1038/ncprheum0727; Murphy G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-233; Ogata H, 2014, ACTA CRYSTALLOGR F, V70, P232, DOI 10.1107/S2053230X13034857; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Raffetto JD, 2008, BIOCHEM PHARMACOL, V75, P346, DOI 10.1016/j.bcp.2007.07.004; Reddy N Ravindra, 2012, J Indian Soc Periodontol, V16, P549, DOI 10.4103/0972-124X.106907; Reich R, 2005, CLIN CANCER RES, V11, P3925, DOI 10.1158/1078-0432.CCR-04-1985; Romer T, 2011, CURR OPIN BIOTECH, V22, P882, DOI 10.1016/j.copbio.2011.06.007; Roque ACA, 2004, BIOTECHNOL PROGR, V20, P639, DOI 10.1021/bp030070k; Rosenfeld L, 2016, TRENDS BIOCHEM SCI, V41, P421, DOI 10.1016/j.tibs.2016.03.002; Seiki M, 1999, APMIS, V107, P137, DOI 10.1111/j.1699-0463.1999.tb01536.x; Sela-Passwell NA, 2012, NAT MED, V18, P143, DOI 10.1038/nm.2582; Sharabi O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093712; Sharabi O, 2013, BIOCHEM SOC T, V41, P1166, DOI 10.1042/BST20130121; Sharabi O, 2013, METHOD ENZYMOL, V523, P41, DOI 10.1016/B978-0-12-394292-0.00003-5; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Suojanen J, 2009, CANCER BIOL THER, V8, P2362, DOI 10.4161/cbt.8.24.10139; Tam BYY, 2006, NAT MED, V12, P793, DOI 10.1038/nm1428; Tetu B, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1503; Thurber GM, 2008, TRENDS PHARMACOL SCI, V29, P57, DOI 10.1016/j.tips.2007.11.004; Udi Y, 2015, STRUCTURE, V23, P104, DOI 10.1016/j.str.2014.10.012; Vandenbroucke RE, 2014, NAT REV DRUG DISCOV, V13, P904, DOI 10.1038/nrd4390; Vanhoutte D, 2010, J MOL CELL CARDIOL, V48, P445, DOI 10.1016/j.yjmcc.2009.09.013; Wei S, 2003, J BIOL CHEM, V278, P9831, DOI 10.1074/jbc.M211793200; Williamson RA, 1996, EUR J BIOCHEM, V241, P476, DOI 10.1111/j.1432-1033.1996.00476.x; Wisniewska M, 2008, J MOL BIOL, V381, P1307, DOI 10.1016/j.jmb.2008.06.088; Yan TH, 2015, AM J TRANSL RES, V7, P950; Yang JK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15001; Yu Q, 2000, GENE DEV, V14, P163; Zhang HY, 2009, EUR ARCH OTO-RHINO-L, V266, P1427, DOI 10.1007/s00405-009-0943-6; Zhao HR, 2004, J BIOL CHEM, V279, P8592, DOI 10.1074/jbc.M308708200	75	38	40	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3481	3495		10.1074/jbc.M116.756718	http://dx.doi.org/10.1074/jbc.M116.756718			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28087697	hybrid, Green Published			2022-12-26	WOS:000395538800036
J	Gao, F; Chen, B; Jiao, J; Jia, LJ; Liu, CM				Gao, Fei; Chen, Bo; Jiao, Juan; Jia, Lijia; Liu, Cuimin			Two Novel Vesicle-Inducing Proteins in Plastids 1 Genes Cloned and Characterized in Triticum urartu	PLOS ONE			English	Article							THYLAKOID MEMBRANE FORMATION; PHAGE-SHOCK; ARABIDOPSIS-THALIANA; ESCHERICHIA-COLI; VIPP1; CHLAMYDOMONAS; SYNECHOCYSTIS; STRESS; OLIGOMERIZATION; ENVELOPE	Vesicle-inducing protein in plastids 1 (Vipp1) is thought to play an important role both in thylakoid biogenesis and chloroplast envelope maintenance during stress. Vipp1 is conserved in photosynthetic organisms and forms a high homo-oligomer complex structure that may help sustain the membrane integrity of chloroplasts. This study cloned two novel VIPP1 genes from Triticum urartu and named them TuVipp1 and TuVipp2. Both proteins shared high identity with the homologous proteins AtVipp1 and CrVipp1. TuVipp1 and TuVipp2 were expressed in various organs of common wheat, and both genes were induced by light and various stress treatments. Purified TuVipp1 and TuVipp2 proteins showed secondary and advanced structures similar to those of the homologous proteins. Similar to AtVipp1, TuVipp1 is a chloroplast target protein. Additionally, TuVipp1 was able to rescue the phenotypes of pale leaves, lethality, and disordered chloroplast structures of AtVipp1 (-/-) mutant lines. Collectively, our data demonstrate that TuVipp1 and TuVipp2 are functional proteins in chloroplasts in wheat and may be critical for maintaining the chloroplast envelope under stress and membrane biogenesis upon photosynthesis.	[Gao, Fei; Chen, Bo; Jia, Lijia; Liu, Cuimin] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China; [Jiao, Juan] PLA Army Gen Hosp, Dept Clin Lab, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS		feigao@genetics.ac.cn; cmliu@genetics.ac.cn	Gao, Fei/HCH-5479-2022					Aseeva E, 2004, J BIOL CHEM, V279, P35535, DOI 10.1074/jbc.M401750200; Aseeva E, 2007, PLANT PHYSIOL BIOCH, V45, P119, DOI 10.1016/j.plaphy.2007.01.005; Bracha K, 2002, J BIOL CHEM, V277, P29856, DOI 10.1074/jbc.M202916200; Bultema Jelle B, 2010, Commun Integr Biol, V3, P162; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Darwin AJ, 2005, MOL MICROBIOL, V57, P621, DOI 10.1111/j.1365-2958.2005.04694.x; Fuhrmann E, 2009, MOL BIOL CELL, V20, P4620, DOI 10.1091/mbc.E09-04-0319; Gao F, 2015, BIOCHEMISTRY-US, V54, P4877, DOI 10.1021/acs.biochem.5b00050; Huang F, 2006, PROTEOMICS, V6, P910, DOI 10.1002/pmic.200500114; Joly N, 2010, FEMS MICROBIOL REV, V34, P797, DOI 10.1111/j.1574-6976.2010.00240.x; Kota Z, 2002, P NATL ACAD SCI USA, V99, P12149, DOI 10.1073/pnas.192463899; Kroll D, 2001, P NATL ACAD SCI USA, V98, P4238, DOI 10.1073/pnas.061500998; Lavy M, 2002, PLANT CELL, V14, P2431, DOI 10.1105/tpc.005561; Li CCY, 2011, PLOS GENET, V7, DOI [10.1371/journal.pgen.1001380, 10.1371/journal.pgen.1002196]; LI HM, 1994, PLANT MOL BIOL, V25, P619, DOI 10.1007/BF00029601; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Liu CM, 2007, PLANT J, V50, P265, DOI 10.1111/j.1365-313X.2007.03047.x; Lo SM, 2012, PLANT J, V71, P656, DOI 10.1111/j.1365-313X.2012.05020.x; Model P, 1997, MOL MICROBIOL, V24, P255, DOI 10.1046/j.1365-2958.1997.3481712.x; MONERA OD, 1993, J BIOL CHEM, V268, P19218; Nordhues A, 2012, PLANT CELL, V24, P637, DOI 10.1105/tpc.111.092692; Otters S, 2013, PLANTA, V237, P529, DOI 10.1007/s00425-012-1772-1; Standar K, 2008, FEBS LETT, V582, P3585, DOI 10.1016/j.febslet.2008.09.002; TZINAS G, 1987, PHOTOSYNTH RES, V14, P241, DOI 10.1007/BF00032708; Vothknecht UC, 2012, J EXP BOT, V63, P1699, DOI 10.1093/jxb/err357; Westphal S, 2001, P NATL ACAD SCI USA, V98, P4243, DOI 10.1073/pnas.061501198; Zhang LG, 2016, PLANT PHYSIOL, V171, P1983, DOI 10.1104/pp.16.00532; Zhang LG, 2012, PLANT CELL, V24, P3695, DOI 10.1105/tpc.112.103606	28	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170439	10.1371/journal.pone.0170439	http://dx.doi.org/10.1371/journal.pone.0170439			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103282	gold, Green Published, Green Submitted			2022-12-26	WOS:000392381100066
J	Mashruwala, AA; Boyd, JM				Mashruwala, Ameya A.; Boyd, Jeffrey M.			The Staphylococcus aureus SrrAB Regulatory System Modulates Hydrogen Peroxide Resistance Factors, Which Imparts Protection to Aconitase during Aerobic Growth	PLOS ONE			English	Article							OXIDATIVE STRESS RESISTANCE; IRON-SULFUR CLUSTERS; HYDROPEROXIDE REDUCTASE AHPC; OXYGEN-SUPPLY RATES; ESCHERICHIA-COLI; SUPEROXIDE-DISMUTASE; 2-COMPONENT SYSTEM; DNA-DAMAGE; SUCCINATE-DEHYDROGENASE; GENE-EXPRESSION	The SrrAB two-component regulatory system (TCRS) positively influences the transcription of genes involved in aerobic respiration in response to changes in respiratory flux. Hydrogen peroxide (H2O2) can arise as a byproduct of spontaneous interactions between dioxygen and components of respiratory pathways. H2O2 damages cellular factors including protein associated iron-sulfur cluster prosthetic groups. We found that a Staphylococcus aureus strain lacking the SrrAB two-component regulatory system (TCRS) is sensitive to H2O2 intoxication. We tested the hypothesis that SrrAB manages the mutually inclusive expression of genes required for aerobic respiration and H2O2 resistance. Consistent with our hypothesis, a Delta srrAB strain had decreased transcription of genes encoding for H2O2 resistance factors (kat, ahpC, dps). SrrAB was not required for the inducing the transcription of these genes in cells challenged with H2O2. Purified SrrA bound to the promoter region for dps suggesting that SrrA directly influences dps transcription. The H2O2 sensitivity of the Delta srrAB strain was alleviated by iron chelation or deletion of the gene encoding for the peroxide regulon repressor (PerR). The positive influence of SrrAB upon H2O2 metabolism bestowed protection upon the solvent accessible iron-sulfur (FeS) cluster of aconitase from H2O2 poisoning. SrrAB also positively influenced transcription of scdA (ytfE), which encodes for a FeS cluster repair protein. Finally, we found that SrrAB positively influences H2O2 resistance only during periods of high dioxygen-dependent respiratory activity. SrrAB did not influence H2O2 resistance when cellular respiration was diminished as a result of decreased dioxygen availability, and negatively influenced it in the absence of respiration (fermentative growth). We propose a model whereby SrrAB-dependent regulatory patterns facilitate the adaptation of cells to changes in dioxygen concentrations, and thereby aids in the prevention of H2O2 intoxication during respiratory growth upon dixoygen.	[Mashruwala, Ameya A.; Boyd, Jeffrey M.] Rutgers State Univ, Dept Biochem & Microbiol, New Brunswick, NJ USA	Rutgers State University New Brunswick	Boyd, JM (corresponding author), Rutgers State Univ, Dept Biochem & Microbiol, New Brunswick, NJ USA.	jmboyd@AESOP.Rutgers.edu		Boyd, Jeffrey/0000-0001-7721-3926	Rutgers University School of Environmental and Biological Sciences; Busch Biomedical Grant from Rutgers University; United States Department of Agriculture [NE-1028]; Rutgers University; Charles and Johanna Busch foundation; USDA MRF [NE-1028]; Douglas Eveleigh fellowship from the Microbial Biology Graduate Program; Excellence Fellowship from Rutgers University	Rutgers University School of Environmental and Biological Sciences; Busch Biomedical Grant from Rutgers University; United States Department of Agriculture(United States Department of Agriculture (USDA)); Rutgers University; Charles and Johanna Busch foundation; USDA MRF; Douglas Eveleigh fellowship from the Microbial Biology Graduate Program; Excellence Fellowship from Rutgers University	Support was provided by: Rutgers University School of Environmental and Biological Sciences; Busch Biomedical Grant from Rutgers University; United States Department of Agriculture grant NE-1028. The Boyd lab is supported by Rutgers University, the Charles and Johanna Busch foundation and USDA MRF project NE-1028. AAM is supported by the Douglas Eveleigh fellowship from the Microbial Biology Graduate Program and an Excellence Fellowship from Rutgers University.	ARMSTRONGBUISSERET L, 1995, MICROBIOL-SGM, V141, P1655, DOI 10.1099/13500872-141-7-1655; Ballal A, 2009, J BACTERIOL, V191, P3301, DOI 10.1128/JB.01496-08; BEERS RF, 1952, J BIOL CHEM, V195, P133; Benov L, 1998, J BIOL CHEM, V273, P10313, DOI 10.1074/jbc.273.17.10313; Benov L, 1999, J BIOL CHEM, V274, P4202, DOI 10.1074/jbc.274.7.4202; Bhattacharya M, 2011, BIOCHEM BIOPH RES CO, V415, P17, DOI 10.1016/j.bbrc.2011.09.143; Boles BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010146; Bose JL, 2013, APPL ENVIRON MICROB, V79, P2218, DOI 10.1128/AEM.00136-13; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Choby JE, 2016, CELL CHEM BIOL, V23, P1351, DOI 10.1016/j.chembiol.2016.09.012; Clements MO, 1999, TRENDS MICROBIOL, V7, P458, DOI 10.1016/S0966-842X(99)01607-8; Clements MO, 1999, J BACTERIOL, V181, P3898, DOI 10.1128/JB.181.13.3898-3903.1999; Cosgrove K, 2007, J BACTERIOL, V189, P1025, DOI 10.1128/JB.01524-06; de Been M, 2008, ENVIRON MICROBIOL, V10, P2796, DOI 10.1111/j.1462-2920.2008.01700.x; Deng DM, 2007, J DENT RES, V86, P606, DOI 10.1177/154405910708600705; Djaman O, 2004, J BIOL CHEM, V279, P44590, DOI 10.1074/jbc.M406487200; Dukan S, 1996, J BACTERIOL, V178, P6145, DOI 10.1128/jb.178.21.6145-6150.1996; Durand S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004957; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Eraso JM, 2009, J BACTERIOL, V191, P4353, DOI 10.1128/JB.00244-09; Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12; FLINT DH, 1993, J BIOL CHEM, V268, P22369; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; Fuchs S, 2007, J BACTERIOL, V189, P4275, DOI 10.1128/JB.00081-07; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Gaupp R, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00033; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; Glover RT, 2007, J BACTERIOL, V189, P5495, DOI 10.1128/JB.00190-07; Grant RA, 1998, NAT STRUCT BIOL, V5, P294, DOI 10.1038/nsb0498-294; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Horsburgh MJ, 2001, INFECT IMMUN, V69, P3744, DOI 10.1128/IAI.69.6.3744-3754.2001; Horsburgh MJ, 2001, J BACTERIOL, V183, P468, DOI 10.1128/JB.183.2.468-475.2001; Hwang S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022300; Ilari A, 2002, J BIOL CHEM, V277, P37619, DOI 10.1074/jbc.M206186200; IMLAY JA, 1991, FREE RADICAL RES COM, V12-3, P59, DOI 10.3109/10715769109145768; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Imlay JA, 2002, ADV MICROB PHYSIOL, V46, P111, DOI 10.1016/S0065-2911(02)46003-1; Imlay JA, 2006, MOL MICROBIOL, V59, P1073, DOI 10.1111/j.1365-2958.2006.05028.x; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Jang SJ, 2007, J BIOL CHEM, V282, P929, DOI 10.1074/jbc.M607646200; Jang SJ, 2010, MOL MICROBIOL, V78, P1448, DOI 10.1111/j.1365-2958.2010.07418.x; Joska TM, 2014, J MICROBIOL METH, V100, P46, DOI 10.1016/j.mimet.2013.11.013; Justino MC, 2007, J BIOL CHEM, V282, P10352, DOI 10.1074/jbc.M610656200; KENNEDY MC, 1984, J BIOL CHEM, V259, P4463; KENNEDY MC, 1983, J BIOL CHEM, V258, P1098; Kinkel TL, 2013, MBIO, V4, DOI 10.1128/mBio.00696-13; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Ledala N, 2014, J BACTERIOL, V196, P2178, DOI 10.1128/JB.01475-14; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; Loui C, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-183; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Lu S, 2002, INFECT IMMUN, V70, P451, DOI 10.1128/IAI.70.2.451-461.2002; Maalej S, 2006, MICROBIOL-SGM, V152, P855, DOI 10.1099/mic.0.28385-0; Mahawar M, 2011, J BIOL CHEM, V286, P19159, DOI 10.1074/jbc.M111.223677; Malone CL, 2009, J MICROBIOL METH, V77, P251, DOI 10.1016/j.mimet.2009.02.011; Mashruwala AA, MOL MICROBIOLOGY; Mashruwala AA, METHOD MOL BIOL, V1373, P33, DOI [10.1007/7651_2015_275, DOI 10.1007/7651_2015_275]; Mashruwala AA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006233; Mashruwala AA, 2015, MOL MICROBIOL, V95, P383, DOI 10.1111/mmi.12860; McCluskey J, 2004, MOL MICROBIOL, V51, P1661, DOI 10.1111/j.1365-2958.2003.03917.x; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MCDANIEL LE, 1965, APPL MICROBIOL, V13, P115, DOI 10.1128/AEM.13.1.115-119.1965; MCDANIEL LE, 1965, APPL MICROBIOL, V13, P109, DOI 10.1128/AEM.13.1.109-114.1965; Memmi G, 2012, J BACTERIOL, V194, P759, DOI 10.1128/JB.06261-11; Messner KR, 1999, J BIOL CHEM, V274, P10119, DOI 10.1074/jbc.274.15.10119; Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200; Nair D, 2011, J BACTERIOL, V193, P2332, DOI 10.1128/JB.00027-11; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; OLSON BJ, 2007, CURR PROTOC PROTEIN; Oogai Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159768; Overton TW, 2008, J BACTERIOL, V190, P2004, DOI 10.1128/JB.01733-07; Pang YY, 2014, J INNATE IMMUN, V6, P353, DOI 10.1159/000355915; Park S, 2005, P NATL ACAD SCI USA, V102, P9317, DOI 10.1073/pnas.0502051102; Pragman AA, 2004, J BACTERIOL, V186, P2430, DOI 10.1128/JB.186.8.2430-2438.2004; Pragman AA, 2007, BIOCHEMISTRY-US, V46, P314, DOI 10.1021/bi0603266; Richardson AR, 2008, SCIENCE, V319, P1672, DOI 10.1126/science.1155207; Richardson AR, 2006, MOL MICROBIOL, V61, P927, DOI 10.1111/j.1365-2958.2006.05290.x; Sadykov MR, 2010, J BACTERIOL, V192, P1459, DOI 10.1128/JB.01377-09; Seaver LC, 2001, J BACTERIOL, V183, P7182, DOI 10.1128/JB.183.24.7182-7189.2001; Somerville GA, 2003, INFECT IMMUN, V71, P4724, DOI 10.1128/IAI.71.8.4724-4732.2003; Somerville GA, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-9; Song E, 2011, CLIN MOL ALLERGY, V9, P10, DOI [10.1186/1476-7961-9-10, DOI 10.1186/1476-7961-9-10]; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sun F, 2012, P NATL ACAD SCI USA, V109, P9095, DOI 10.1073/pnas.1200603109; Throup JP, 2001, BIOCHEMISTRY-US, V40, P10392, DOI 10.1021/bi0102959; Ulrich M, 2007, MOL MICROBIOL, V65, P1276, DOI 10.1111/j.1365-2958.2007.05863.x; Wilde AD, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005341; Windham IH, J BACTERIOL; Wong SMS, 2007, MOL MICROBIOL, V64, P1375, DOI 10.1111/j.1365-2958.2007.05747.x; Wosten MMSM, 1999, J BIOL CHEM, V274, P27185, DOI 10.1074/jbc.274.38.27185; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605; Yarwood JM, 2001, J BACTERIOL, V183, P1113, DOI 10.1128/JB.183.4.1113-1123.2001	94	31	32	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170283	10.1371/journal.pone.0170283	http://dx.doi.org/10.1371/journal.pone.0170283			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099473	gold, Green Submitted, Green Published			2022-12-26	WOS:000392380100069
J	Shah, AT; Heaster, TM; Skala, MC				Shah, Amy T.; Heaster, Tiffany M.; Skala, Melissa C.			Metabolic Imaging of Head and Neck Cancer Organoids	PLOS ONE			English	Article							CISPLATIN; CETUXIMAB; MICROSCOPY; PHENOTYPES; ONCOLOGY; TISSUE; CELLS; NADH	Head and neck cancer patients suffer from toxicities, morbidities, and mortalities, and these ailments could be minimized through improved therapies. Drug discovery is along, expensive, and complex process, so optimized assays can improve the success rate of drug candidates. This study applies optical imaging of cell metabolism to three-dimensional in vitro cultures of head and neck cancer grown from primary tumor tissue (organoids). This technique is advantageous because it measures cell metabolism using intrinsic fluorescence from NAD(P)H and FAD on a single cell level for a three-dimensional in vitro model. Head and neck cancer organoids are characterized alone and after treatment with standard therapies, including an antibody therapy, a chemotherapy, and combination therapy. Additionally, organoid cellular heterogeneity is analyzed quantitatively and qualitatively. Gold standard measures of treatment response, including cell proliferation, cell death, and in vivo tumor volume, validate therapeutic efficacy for each treatment group in a parallel study. Results indicate that optical metabolic imaging is sensitive to therapeutic response in organoids after 1 day of treatment (p<0.05) and resolves cell subpopulations with distinct metabolic phenotypes. Ultimately, this platform could provide a sensitive high-throughput assay to streamline the drug discovery process for head and neck cancer.	[Shah, Amy T.; Heaster, Tiffany M.; Skala, Melissa C.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Heaster, Tiffany M.; Skala, Melissa C.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA; [Skala, Melissa C.] Morgridge Inst Res, Madison, WI 53715 USA	Vanderbilt University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.	Skala, MC (corresponding author), Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA.; Skala, MC (corresponding author), Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.; Skala, MC (corresponding author), Morgridge Inst Res, Madison, WI 53715 USA.	mcskala@wisc.edu			National Science Foundation Graduate Research Fellowship [DGE-0909667]; National Institutes of Health/National Cancer Institute [R01 CM 85747]; NATIONAL CANCER INSTITUTE [R01CA205101, R01CA185747] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding sources include the National Science Foundation Graduate Research Fellowship (DGE-0909667, ATS and TMH) and National Institutes of Health/National Cancer Institute (R01 CM 85747, MCS). The author(s) received no specific funding for this work.	[Anonymous], [No title captured]; AVIDOR Y, 1962, J BIOL CHEM, V237, P2377; Baselga B J, 2000, PHASE 1 STUDIES ANTI, V18, P904, DOI DOI 10.1200/JCO.2000.18.4.904; BAYREUTHER K, 1988, P NATL ACAD SCI USA, V85, P5112, DOI 10.1073/pnas.85.14.5112; Berndtsson M, 2007, INT J CANCER, V120, P175, DOI 10.1002/ijc.22132; Bernier J, 2009, NAT REV CLIN ONCOL, V6, P266, DOI 10.1038/nrclinonc.2009.40; Bird DK, 2005, CANCER RES, V65, P8766, DOI 10.1158/0008-5472.CAN-04-3922; Bucheler M, 2002, ACTA OTO-LARYNGOL, V122, P541, DOI 10.1080/00016480260092372; Burtness B, 2005, J CLIN ONCOL, V23, P8646, DOI 10.1200/JCO.2005.02.4646; CHANCE B, 1979, J BIOL CHEM, V254, P4764; DAVIES PF, 1986, P NATL ACAD SCI USA, V83, P2114, DOI 10.1073/pnas.83.7.2114; Fung C, 2010, EXPERT OPIN EMERG DR, V15, P355, DOI 10.1517/14728214.2010.497754; Huang SH, 2002, BIOPHYS J, V82, P2811, DOI 10.1016/S0006-3495(02)75621-X; Hughes JP, 2011, BRIT J PHARMACOL, V162, P1239, DOI 10.1111/j.1476-5381.2010.01127.x; Joschko MA, 1997, CANCER CHEMOTH PHARM, V40, P534, DOI 10.1007/s002800050699; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; Kimlin LC, 2013, MOL CARCINOGEN, V52, P167, DOI 10.1002/mc.21844; KLAIDMAN LK, 1995, ANAL BIOCHEM, V228, P312, DOI 10.1006/abio.1995.1356; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Levitt JM, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2401149; Li XQ, 2010, CANCER RES, V70, P5942, DOI 10.1158/0008-5472.CAN-10-0157; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Ramanujam N, 2000, NEOPLASIA, V2, P89, DOI 10.1038/sj.neo.7900077; ROBBINS KT, 1991, ARCH OTOLARYNGOL, V117, P83; Sachs N, 2014, CURR OPIN GENET DEV, V24, P68, DOI 10.1016/j.gde.2013.11.012; Sacks P. G., 1996, CELL TISSUE ORGAN CU, P27; Shah AT, 2015, NEOPLASIA, V17, P862, DOI 10.1016/j.neo.2015.11.006; Shah AT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090746; Skala MC, 2007, P NATL ACAD SCI USA, V104, P19494, DOI 10.1073/pnas.0708425104; Skvortsova I, 2010, RADIOTHER ONCOL, V96, P108, DOI 10.1016/j.radonc.2010.04.017; Tijink BM, 2006, J NUCL MED, V47, P1127; Trotti A, 2000, INT J RADIAT ONCOL, V47, P1, DOI 10.1016/S0360-3016(99)00558-1; Walsh A J, 2014, SPIE P, V89481M; Walsh A. J., 2015, PANCREAS, P1; Walsh A. J., 2014, CANC RES; Walsh AJ, 2015, BIOMED OPT EXPRESS, V6, P559, DOI 10.1364/BOE.6.000559; Walsh AJ, 2013, CANCER RES, V73, P6164, DOI 10.1158/0008-5472.CAN-13-0527	39	46	46	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170415	10.1371/journal.pone.0170415	http://dx.doi.org/10.1371/journal.pone.0170415			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099487	Green Published, Green Submitted, gold			2022-12-26	WOS:000392380100087
J	Wang, H; Zhao, SC; Gao, YC; Yang, JL				Wang, Han; Zhao, Shicheng; Gao, Yuchi; Yang, Jingli			Characterization of Dof Transcription Factors and Their Responses to Osmotic Stress in Poplar (Populus trichocarpa)	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; ABIOTIC STRESS; FACTOR GENES; FAMILY; ARABIDOPSIS; PROTEIN; DOMAIN; PLANTS; IDENTIFICATION; PHYTOCHROME	The DNA-binding One Zinc Finger (Dot) genes are ubiquitous in many plant species and are especial transcription regulators that participate in plant growth, development and various procedures, including biotic and abiotic stress reactions. In this study, we identified 41 PtrDof members from Populus trichocarpa genomes and classified them into four groups. The conserved motifs and gene structures of some PtrDof genes belonging to the same subgroup were almost the same. The 41 PtrDof genes were dispersed on 18 of the 19 Populus chromosomes. Many key stress- or phytohormone-related cis-elements were discovered in the PtrDof gene promoter regions. Consequently, we undertook expression profiling of the PtrDof genes in leaves and roots in response to osmotic stress and abscisic acid. A total of seven genes (PtrDof14, 16, 25, 27, 28, 37and 39) in the Populus Dof gene family were consistently upregulated at point in all time in the leaves and roots under osmotic and abscisic acid (ABA) stress. We observed that 12 PtrDof genes could be targeted by 15 miRNAs. Moreover, we mapped the cleavage site in PtrDof30 using the 5'RLM-RACE. The results showed that PtrDofs may have a role in resistance to abiotic stress in Populus trichocarpa.	[Wang, Han; Yang, Jingli] Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin, Heilongjiang, Peoples R China; [Zhao, Shicheng] Harbin Univ Commerce, Sch Pharm, Harbin, Peoples R China; [Gao, Yuchi] Annoroad Gene Technol Co Ltd, Beijing, Peoples R China	Northeast Forestry University - China; Harbin University of Commerce	Yang, JL (corresponding author), Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin, Heilongjiang, Peoples R China.	yifan85831647@163.com	Zhao, Shicheng/AAA-3632-2019		National Natural Science Foundation of China [31400573]; Science Fund of Heilongjiang Province [QC2015035]; Annoroad Gene Technology Co., Ltd	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Fund of Heilongjiang Province; Annoroad Gene Technology Co., Ltd	This work was supported by the National Natural Science Foundation of China (31400573) and the Science Fund of Heilongjiang Province (QC2015035). Yuchi Gao is employed by Annoroad Gene Technology Co., Ltd. Annoroad Gene Technology Co., Ltd provided support in the form of salary for author YG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-26; Boccara M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003883; Cavalar M, 2003, BIOCHEMISTRY-US, V42, P2149, DOI 10.1021/bi026761r; Chen RM, 2005, DNA SEQUENCE, V16, P358, DOI 10.1080/10425170500272940; Chu YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098334; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; de Lima JC, 2012, GENET MOL BIOL, V35, P1069, DOI 10.1590/S1415-47572012000600023; Dong GQ, 2007, PLANT MOL BIOL, V63, P73, DOI 10.1007/s11103-006-9073-3; Fahlgren N, 2010, PLANT CELL, V22, P1074, DOI 10.1105/tpc.110.073999; Fornara F, 2009, DEV CELL, V17, P75, DOI 10.1016/j.devcel.2009.06.015; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; He L, 2015, BIOCHIMIE, V110, P17, DOI 10.1016/j.biochi.2014.12.017; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Hu RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031149; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Jaakola L, 2001, MOL BIOTECHNOL, V19, P201, DOI 10.1385/MB:19:2:201; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kalluri UC, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-59; Kumar S, 2012, BIOINFORMATICS, V28, P2685, DOI 10.1093/bioinformatics/bts507; Kushwaha H, 2011, MOL BIOL REP, V38, P5037, DOI 10.1007/s11033-010-0650-9; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Li DJ, 2009, PLANTA, V229, P1159, DOI 10.1007/s00425-009-0893-7; Libault M, 2009, PLANT PHYSIOL, V151, P991, DOI 10.1104/pp.109.144105; Lijavetzky D, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-17; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Lu YB, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-123; Ma J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1242-9; Moore RC, 2005, CURR OPIN PLANT BIOL, V8, P122, DOI 10.1016/j.pbi.2004.12.001; Moreno-Risueno MA, 2007, MOL GENET GENOMICS, V277, P379, DOI 10.1007/s00438-006-0186-9; Noguero M, 2013, PLANT SCI, V209, P32, DOI 10.1016/j.plantsci.2013.03.016; Papi M, 2000, GENE DEV, V14, P28; Park DH, 2003, PLANT J, V34, P161, DOI 10.1046/j.1365-313X.2003.01710.x; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Rigal A, 2012, PLANT PHYSIOL, V160, P1996, DOI 10.1104/pp.112.204453; Shaw LM, 2009, FUNCT INTEGR GENOMIC, V9, P485, DOI 10.1007/s10142-009-0130-2; Sjodin A, 2009, NEW PHYTOL, V182, P1013, DOI 10.1111/j.1469-8137.2009.02807.x; Song AP, 2014, INT J MOL SCI, V15, P5063, DOI 10.3390/ijms15035063; Song F, 2002, GENE, V290, P115, DOI 10.1016/S0378-1119(02)00584-X; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Tepperman JM, 2001, P NATL ACAD SCI USA, V98, P9437, DOI 10.1073/pnas.161300998; Umemura Y, 2004, PLANT J, V37, P741, DOI 10.1111/j.1365-313X.2003.01997.x; Wang ZC, 2013, SCI WORLD J, DOI 10.1155/2013/785070; Ward JM, 2005, PLANT CELL, V17, P475, DOI 10.1105/tpc.104.027722; Wen CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep23072; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Yamamoto MP, 2006, PLANT PHYSIOL, V141, P1694, DOI 10.1104/pp.106.082826; Yanagisawa S, 2004, PLANT CELL PHYSIOL, V45, P386, DOI 10.1093/pcp/pch055	51	26	31	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0170210	10.1371/journal.pone.0170210	http://dx.doi.org/10.1371/journal.pone.0170210			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095469	Green Published, Green Submitted, gold			2022-12-26	WOS:000392372300070
J	Manickam, C; Wachtman, L; Martinot, AJ; Giavedoni, LD; Reeves, RK				Manickam, Cordelia; Wachtman, Lynn; Martinot, Amanda J.; Giavedoni, Luis D.; Reeves, R. Keith			Metabolic Dysregulation in Hepacivirus Infection of Common Marmosets (Callithrix jacchus)	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; CHRONIC HCV INFECTION; INSULIN-RESISTANCE; PLUS RIBAVIRIN; HEPATOCELLULAR-CARCINOMA; VIRAL-HEPATITIS; LIVER-DAMAGE; B INFECTIONS; STEATOSIS; MODEL	Chronic hepatitis C has been associated with metabolic syndrome that includes insulin resistance, hepatic steatosis and obesity. These metabolic aberrations are risk factors for disease severity and treatment outcome in infected patients. Experimental infection of marmosets with GBV-B serves as a tangible, small animal model for human HCV infection, and while virology and pathology are well described, a full investigation of clinical disease and the metabolic milieu is lacking. In this study six marmosets were infected intravenously with GBV-B and changes in hematologic, serum biochemical and plasma metabolic measures were investigated over the duration of infection. Infected animals exhibited signs of lymphocytopenia, but platelet and RBC counts were generally stable or even increased. Although most animals showed a transient decline in blood glucose, infection resulted in several fold increases in plasma insulin, glucagon and glucagon-like peptide 1 (GLP-1). All infected animals experienced transient weight loss within the first 28 days of infection, but also became hypertriglyceridemic and had up to 10-fold increases in adipocytokines such as resistin and plasminogen activator inhibitor 1 (PAI-1). In liver, moderate to severe cytoplasmic changes associated with steatotic changes was observed microscopically at 168 days post infection. Collectively, these results suggest that GBV-B infection is accompanied by hematologic, biochemical and metabolic abnormalities that could lead to obesity, diabetes, thrombosis and atherosclerosis, even after virus has been cleared. Our findings mirror those found in HCV patients, suggesting that metabolic syndrome could be conserved among hepaciviruses, and both mechanistic and interventional studies for treating HCV-induced metabolic complications could be evaluated in this animal model.	[Manickam, Cordelia; Martinot, Amanda J.; Reeves, R. Keith] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Wachtman, Lynn; Reeves, R. Keith] Harvard Med Sch, New England Primate Res Ctr, Southborough Campus, Southborough, MA USA; [Giavedoni, Luis D.] Texas Biomed Res Inst, Southwest Natl Primate Res Ctr, San Antonio, TX USA	Harvard University; Beth Israel Deaconess Medical Center; Texas Biomedical Research Institute	Reeves, RK (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.; Reeves, RK (corresponding author), Harvard Med Sch, New England Primate Res Ctr, Southborough Campus, Southborough, MA USA.	rreeves@bidmc.harvard.edu		Reeves, R. Keith/0000-0003-3157-2557	NIH [R21 AI101170]; NIH Office of Research Infrastructure Programs [P51 OD011103, P51 OD011133]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Division of Primate Resources of the New England Primate Research Center for expert animal care. This work was supported by NIH grant R21 AI101170 to RKR, and NIH Office of Research Infrastructure Programs grants supporting the NEPRC (P51 OD011103) and SNPRC (P51 OD011133).	Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; Aisa Y, 2001, INTERNAL MED, V40, P1109, DOI 10.2169/internalmedicine.40.1109; ALTER HJ, 1978, LANCET, V1, P459; Ballestri S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030355; Baranova A, 2011, DIGESTION, V83, P32, DOI 10.1159/000314592; Benci A, 2003, INT J CLIN PRACT, V57, P17; Brack M, 1990, Zentralbl Veterinarmed A, V37, P692; Bright H, 2004, J VIROL, V78, P2062, DOI 10.1128/JVI.78.4.2062-2071.2004; Bukh J, 2004, HEPATOLOGY, V39, P1469, DOI 10.1002/hep.20268; Bukh J, 1999, VIROLOGY, V262, P470, DOI 10.1006/viro.1999.9941; Bukh J, 2001, J MED VIROL, V65, P694, DOI 10.1002/jmv.2092; Calanna S, 2012, EUR J ENDOCRINOL, V166, P917, DOI 10.1530/EJE-11-0765; Chen CL, 2014, CANCER EPIDEM BIOMAR, V23, P1659, DOI 10.1158/1055-9965.EPI-14-0161; Collins MG, 2014, J MED PRIMATOL, V43, P477, DOI 10.1111/jmp.12134; De Gottardi A, 2006, ALIMENT PHARM THER, V23, P107, DOI 10.1111/j.1365-2036.2006.02729.x; DEINHARDT E, 1975, AM J MED SCI, V270, P73, DOI 10.1097/00000441-197507000-00011; Durante-Mangoni E, 2006, ALIMENT PHARM THERAP, V24, P1349, DOI 10.1111/j.1365-2036.2006.03114.x; Dyal HK, 2016, DIGEST DIS SCI, V61, P636, DOI 10.1007/s10620-015-3983-3; Emilia G, 1997, J MED VIROL, V53, P182, DOI 10.1002/(SICI)1096-9071(19971003)53:2<182::AID-JMV12>3.0.CO;2-L; Fabrizi F, 2012, INT J ARTIF ORGANS, V35, P621, DOI [10.5301/ijao.2012.9448, 10.5301/IJAO.2012.9448]; Fartoux L, 2005, GUT, V54, P1003, DOI 10.1136/gut.2004.050302; FEHER J, 1976, ACTA MED HUNG, V33, P217; Fiore G, 1996, Riv Eur Sci Med Farmacol, V18, P197; Furutani M, 2003, LIVER INT, V23, P294, DOI 10.1034/j.1600-0676.2003.00841.x; Garcia-Suarez J, 2000, BRIT J HAEMATOL, V110, P98, DOI 10.1046/j.1365-2141.2000.02132.x; Giavedoni LD, 2005, J IMMUNOL METHODS, V301, P89, DOI 10.1016/j.jim.2005.03.015; GIUSTI G, 1993, HEPATO-GASTROENTEROL, V40, P365; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hanley AJG, 2004, DIABETES, V53, P1773, DOI 10.2337/diabetes.53.7.1773; Harrison SA, 2005, CLIN GASTROENTEROL H, V3, P604, DOI 10.1016/S1542-3565(05)00246-6; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Hotamisligil GS, 2003, INT J OBESITY, V27, pS53, DOI 10.1038/sj.ijo.0802502; Houghton M, 2009, LIVER INT, V29, P82, DOI 10.1111/j.1478-3231.2008.01925.x; Hwang SJ, 2001, J GASTROEN HEPATOL, V16, P190, DOI 10.1046/j.1440-1746.2001.02407.x; Isobe K, 2012, VET PATHOL, V49, P839, DOI 10.1177/0300985811427151; Itou M, 2008, J GASTROEN HEPATOL, V23, P244, DOI 10.1111/j.1440-1746.2007.05183.x; Jamali R, 2016, HEPAT MON, V16, DOI 10.5812/hepatmon.37412; Jinjuvadia R, 2014, AM J MED SCI, V347, P23, DOI 10.1097/MAJ.0b013e31828b25a5; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kawaguchi T, 2011, WORLD J HEPATOL, V3, P99, DOI 10.4254/wjh.v3.i5.99; Kee Kwong-Ming, 2004, Chang Gung Med J, V27, P834; Kohli A, 2014, JAMA-J AM MED ASSOC, V312, P631, DOI 10.1001/jama.2014.7085; Koike K, 2005, HEPATOL RES, V33, P145, DOI 10.1016/j.hepres.2005.09.023; Kolseth IB, 2016, J DIABETES COMPLICAT; Konrad T, 2000, DIGESTION, V62, P52, DOI 10.1159/000007778; Kralj D, 2016, J CLIN TRANSL HEPATO, V4, P66, DOI 10.14218/JCTH.2015.00051; Kramer JA, 2015, VET PATHOL, V52, P404, DOI 10.1177/0300985814537839; Kurtzman G, 1989, Baillieres Clin Haematol, V2, P51, DOI 10.1016/S0950-3536(89)80007-1; Lanford RE, 2003, VIROLOGY, V311, P72, DOI 10.1016/S0042-6822(03)00193-4; Lee HB, 2005, NEPHROLOGY, V10, pS11, DOI 10.1111/j.1440-1797.2005.00449.x; Lee S, 2001, VIROLOGY, V283, P167, DOI 10.1006/viro.2001.0892; Li T, 2013, HEPATOLOGY; Liakina V, 2015, J VIRAL HEPATITIS, V22, P4, DOI 10.1111/jvh.12475; Lonardo A, 2004, GASTROENTEROLOGY, V126, P586, DOI 10.1053/j.gastro.2003.11.020; Lonardo A, 2014, WORLD J GASTROENTERO, V20, P7089, DOI 10.3748/wjg.v20.i23.7089; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Oliveira LPM, 2016, J AM COLL NUTR, V35, P436, DOI 10.1080/07315724.2015.1072756; Maggi G, 1996, ITAL J GASTROENTEROL, V28, P436; Manickam C, 2016, J VIROL; Miki D, 2012, J VIRAL HEPATITIS, V19, pE126, DOI 10.1111/j.1365-2893.2011.01516.x; Molnar MZ, 2015, HEPATOLOGY, V61, P1495, DOI 10.1002/hep.27664; MUERHOFF AS, 1995, J VIROL, V69, P5621, DOI 10.1128/JVI.69.9.5621-5630.1995; Nagamine T, 1996, J HEPATOL, V24, P135, DOI 10.1016/S0168-8278(96)80021-3; Negro F, 2009, LIVER INT, V29, P26, DOI 10.1111/j.1478-3231.2008.01950.x; Oem JK, 2008, J GEN VIROL, V89, P1225, DOI 10.1099/vir.0.83491-0; Parlevliet ET, 2010, AM J PHYSIOL-ENDOC M, V299, pE318, DOI 10.1152/ajpendo.00191.2010; Parvaiz F, 2014, ARCH VIROL, V159, P1017, DOI 10.1007/s00705-013-1892-3; Patton HM, 2004, J HEPATOL, V40, P484, DOI 10.1016/j.jhep.2003.11.004; Perico N, 2009, CLIN J AM SOC NEPHRO, V4, P207, DOI 10.2215/CJN.03710708; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Pittas AG, 2004, J CLIN ENDOCR METAB, V89, P447, DOI 10.1210/jc.2003-031005; Power ML, 2013, OBESITY, V21, pE592, DOI 10.1002/oby.20462; Restivo L, 2012, J VIRAL HEPATITIS, V19, P346, DOI 10.1111/j.1365-2893.2011.01555.x; Rivera-Huizar S, 2006, EXP TOXICOL PATHOL, V58, P185, DOI 10.1016/j.etp.2006.05.001; Romero-Gomez M, 2005, GASTROENTEROLOGY, V128, P636, DOI 10.1053/j.gastro.2004.12.049; Ross CN, 2013, OBESITY, V21, P1891, DOI 10.1002/oby.20432; Saad Y, 2013, EUR J GASTROEN HEPAT, V25, P920, DOI 10.1097/MEG.0b013e32835f2726; Shintani Y, 2004, GASTROENTEROLOGY, V126, P840, DOI 10.1053/j.gastro.2003.11.056; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; SIMONS JN, 1995, P NATL ACAD SCI USA, V92, P3401, DOI 10.1073/pnas.92.8.3401; Stastny J, 2012, DIABETES METAB SYND, V6, P120, DOI 10.1016/j.dsx.2012.08.011; t'Hart BA, 2004, LANCET NEUROL, V3, P588, DOI 10.1016/S1474-4422(04)00879-8; Tardif SD, 2009, OBESITY, V17, P1499, DOI 10.1038/oby.2009.77; Tiftikci A, 2009, ARCH MED RES, V40, P294, DOI 10.1016/j.arcmed.2009.04.008; VERGANI C, 1978, J CLIN PATHOL, V31, P772, DOI 10.1136/jcp.31.8.772; Villanova M, 2000, ACTA NEUROPATHOL, V99, P271, DOI 10.1007/PL00007437; Vollmer K, 2008, DIABETES, V57, P678, DOI 10.2337/db07-1124; Wang CS, 2004, CLIN INFECT DIS, V39, P790, DOI 10.1086/423384; Weatherford T, 2009, J VIROL, V83, P5806, DOI 10.1128/JVI.00033-09; Yaginuma R, 2006, HEPATOL RES, V35, P19, DOI 10.1016/j.hepres.2006.02.001; Yoshida T, 1998, HEPATO-GASTROENTEROL, V45, P468	92	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0170240	10.1371/journal.pone.0170240	http://dx.doi.org/10.1371/journal.pone.0170240			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085952	Green Published, Green Submitted, gold			2022-12-26	WOS:000391972600078
J	Song, M; Mathews, CA; Stewart, SE; Shmelkov, SV; Mezey, JG; Rodriguez-Flores, JL; Rasmussen, SA; Britton, JC; Oh, YS; Walkup, JT; Lee, FS; Glatt, CE				Song, Minseok; Mathews, Carol A.; Stewart, S. Evelyn; Shmelkov, Sergey V.; Mezey, Jason G.; Rodriguez-Flores, Juan L.; Rasmussen, Steven A.; Britton, Jennifer C.; Oh, Yong-Seok; Walkup, John T.; Lee, Francis S.; Glatt, Charles E.			Rare Synaptogenesis-Impairing Mutations in SLITRK5 Are Associated with Obsessive Compulsive Disorder	PLOS ONE			English	Article							VARIANTS; MOUSE; MANAGEMENT; BEHAVIORS; FAMILY; MICE; OCD	Obsessive compulsive disorder (OCD) is substantially heritable, but few molecular genetic risk factors have been identified. Knockout mice lacking SLIT and NTRK-Like Family, Member 5 (SLITRK5) display OCD-like phenotypes including serotonin reuptake inhibitor-sensitive pathologic grooming, and corticostriatal dysfunction. Thus, mutations that impair SLITRK5 function may contribute to the genetic risk for OCD. We re-sequenced the protein-coding sequence of the human SLITRK5 gene (SLITRK5) in three hundred and seventy seven OCD subjects and compared rare non-synonymous mutations (RNMs) in that sample with similar mutations in the 1000 Genomes database. We also performed in silico assessments and in vitro functional synaptogenesis assays on the Slitrk5 mutations identified. We identified four RNM's among these OCD subjects. There were no significant differences in the prevalence or in silico effects of rare non-synonymous mutations in the OCD sample versus controls. Direct functional testing of recombinant SLITRK5 proteins found that all mutations identified in OCD subjects impaired synaptogenic activity whereas none of the pseudo-matched mutations identified in 1000 Genomes controls had significant effects on SLITRK5 function (Fisher's exact test P = 0.028). These results demonstrate that rare functional mutations in SLITRK5 contribute to the genetic risk for OCD in human populations. They also highlight the importance of biological characterization of allelic effects in understanding genotype-phenotype relationships as there were no statistical differences in overall prevalence or bioinformatically predicted effects of OCD case versus control mutations. Finally, these results converge with others to highlight the role of aberrant synaptic function in corticostriatal neurons in the pathophysiology of OCD.	[Song, Minseok] Korea Brain Res Inst, Dept Struct & Funct Neural Network, Synapt Circuit Plast Lab, 61 Cheomdan Ro, Daegu, South Korea; [Mathews, Carol A.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Stewart, S. Evelyn] Univ British Columbia, Dept Psychiat, Fac Med, Vancouver, BC, Canada; [Shmelkov, Sergey V.] NYU, Sch Med, Dept Neurosci & Physiol, New York, NY USA; [Shmelkov, Sergey V.] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Mezey, Jason G.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [Mezey, Jason G.; Rodriguez-Flores, Juan L.] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA; [Rasmussen, Steven A.] Brown Univ, Dept Psychiat & Human Behav, Alpert Med Sch, Providence, RI 02912 USA; [Britton, Jennifer C.] Univ Miami, Dept Psychol, Miami, FL USA; [Oh, Yong-Seok] Daegu Gyeongbuk Inst Sci & Technol, Dept Brain Cognit Sci, Daegu, South Korea; [Walkup, John T.; Lee, Francis S.; Glatt, Charles E.] Weill Cornell Med Coll, Dept Psychiat, New York, NY USA; [Lee, Francis S.] Weill Cornell Med Coll, Sackler Inst Dev Psychobiol, New York, NY USA	Korea Brain Research Institute (KBRI); University of California System; University of California San Francisco; University of British Columbia; New York University; New York University; Cornell University; Cornell University; Brown University; University of Miami; Daegu Gyeongbuk Institute of Science & Technology (DGIST); Cornell University; Cornell University	Song, M (corresponding author), Korea Brain Res Inst, Dept Struct & Funct Neural Network, Synapt Circuit Plast Lab, 61 Cheomdan Ro, Daegu, South Korea.; Glatt, CE (corresponding author), Weill Cornell Med Coll, Dept Psychiat, New York, NY USA.	minseoksci@kbri.re.kr; ceg2004@med.cornell.edu	Mathews, Carol A A/M-8922-2017; Rodriguez-Flores, Juan L/AAJ-7565-2020; Stewart, Evelyn/K-6961-2014	Mathews, Carol A A/0000-0003-2208-7058; Rodriguez-Flores, Juan L/0000-0002-0394-8062; Song, Minseok/0000-0001-9561-8505; Oh, Yong-Seok/0000-0002-9039-2014; Stewart, S. Evelyn/0000-0002-0994-6383	KBRI basic research program - Ministry of Science, ICT & Future Planning [2231-415]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2016R1D1A1B03934438]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry for Health and Welfare, Korea [HI14C1135]; US National Institutes of Health [MH079513, NS052819, RR15533]; Sackler Institute for Developmental Psychobiology; DeWitt-Wallace Fund of the New York Community Trust; Pritzker Consortium; Brain and Behavior Research Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002384] Funding Source: NIH RePORTER	KBRI basic research program - Ministry of Science, ICT & Future Planning; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry for Health and Welfare, Korea; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sackler Institute for Developmental Psychobiology; DeWitt-Wallace Fund of the New York Community Trust; Pritzker Consortium; Brain and Behavior Research Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported from KBRI basic research program funded by the Ministry of Science, ICT & Future Planning (No. 2231-415 to M.S.); the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2016R1D1A1B03934438 to M.S.); the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry for Health and Welfare, Korea (HI14C1135 to M.S.); the US National Institutes of Health (MH079513 to C.E.G, F.S.L., NS052819 to F.S.L., RR15533 to C.A.M.); the Sackler Institute for Developmental Psychobiology to C.E.G. and F.S.L.; the DeWitt-Wallace Fund of the New York Community Trust to C.E.G., F.S.L.; Pritzker Consortium to F.S.L.; Brain and Behavior Research Foundation to F.S.L., S.E.S., and S.V.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; American Psychiatric Association, 2013, DSM 5 TASK FORC DIAG, V5th; Beucke JC, 2014, BRIT J PSYCHIAT, V205, P376, DOI 10.1192/bjp.bp.113.137380; Blier P, 2006, CAN J PSYCHIAT, V51, P417, DOI 10.1177/070674370605100703; Burguiere E, 2015, CURR OPIN NEUROBIOL, V30, P59, DOI 10.1016/j.conb.2014.08.008; Davis LK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003864; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Dincheva I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7395; Ferreira A, 2002, CELL MOL LIFE SCI, V59, P589, DOI 10.1007/s00018-002-8451-5; Glatt C.E., 2015, BIOL PSYCHIAT; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Keen-Kim D, 2006, HUM MOL GENET, V15, P3324, DOI 10.1093/hmg/ddl408; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; KOSIK KS, 1987, J NEUROSCI, V7, P3142; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Mataix-Cols D, 2013, JAMA PSYCHIAT, V70, P709, DOI 10.1001/jamapsychiatry.2013.3; Mathews CA, 2011, J AM ACAD CHILD PSY, V50, P46, DOI 10.1016/j.jaac.2010.10.004; Mattheisen M., 2014, MOL PSYCHIAT, P13; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Proenca CC, 2011, TRENDS NEUROSCI, V34, P143, DOI 10.1016/j.tins.2011.01.001; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Shmelkov SV, 2010, NAT MED, V16, P598, DOI 10.1038/nm.2125; Soliman F, 2010, SCIENCE, V327, P863, DOI 10.1126/science.1181886; Song M, DEV CELL IN PRESS; Stewart SE, 2013, MOL PSYCHIATR, V18, P788, DOI 10.1038/mp.2012.85; Stewart SE, 2012, DRUGS, V72, P881, DOI 10.2165/11632860-000000000-00000; Takahashi H, 2012, NAT NEUROSCI, V15, P389, DOI 10.1038/nn.3040; Um JW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6423; Wan YH, 2014, BIOL PSYCHIAT, V75, P623, DOI 10.1016/j.biopsych.2013.01.008; Wan YH, 2011, J NEUROSCI, V31, P16685, DOI 10.1523/JNEUROSCI.2533-11.2011; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Zuchner S, 2009, MOL PSYCHIATR, V14, P6, DOI 10.1038/mp.2008.83	35	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0169994	10.1371/journal.pone.0169994	http://dx.doi.org/10.1371/journal.pone.0169994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085938	Green Published, gold, Green Submitted			2022-12-26	WOS:000391972600050
J	Cericola, F; Jahoor, A; Orabi, J; Andersen, JR; Janss, LL; Jensen, J				Cericola, Fabio; Jahoor, Ahmed; Orabi, Jihad; Andersen, Jeppe R.; Janss, Luc L.; Jensen, Just			Optimizing Training Population Size and Genotyping Strategy for Genomic Prediction Using Association Study Results and Pedigree Information. A Case of Study in Advanced Wheat Breeding Lines	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; COMPLEX TRAITS; SELECTION; PATTERNS; TIME	Wheat breeding programs generate a large amount of variation which cannot be completely explored because of limited phenotyping throughput. Genomic prediction (GP) has been proposed as a new tool which provides breeding values estimations without the need of phenotyping all the material produced but only a subset of it named training population (TP). However, genotyping of all the accessions under analysis is needed and, therefore, optimizing TP dimension and genotyping strategy is pivotal to implement GP in commercial breeding schemes. Here, we explored the optimum TP size and we integrated pedigree records and genome wide association studies (GWAS) results to optimize the genotyping strategy. A total of 988 advanced wheat breeding lines were genotyped with the Illumina 15K SNPs wheat chip and phenotyped across several years and locations for yield, lodging, and starch content. Cross-validation using the largest possible TP size and all the SNPs available after editing (-11k), yielded predictive abilities (r(GP)) ranging between 0.5-0.6. In order to explore the Training population size, r(GP) were computed using progressively smaller TP. These exercises showed that TP of around 700 lines were enough to yield the highest observed rGP. Moreover, r(GP) were calculated by randomly reducing the SNPs number. This showed that around 1K markers were enough to reach the highest observed rGP. GWAS was used to identify markers associated with the traits analyzed. A GWAS-based selection of SNPs resulted in increased rGP when compared with random selection and few hundreds SNPs were sufficient to obtain the highest observed rGP. For each of these scenarios, advantages of adding the pedigree information were shown. Our results indicate that moderate TP sizes were enough to yield high rGP and that pedigree information and GWAS results can be used to greatly optimize the genotyping strategy.	[Cericola, Fabio; Janss, Luc L.; Jensen, Just] Aarhus Univ, Dept Mol Biol & Genet, Ctr Quantitat Genet & Genom, Tjele, Denmark; [Jahoor, Ahmed] Swedish Univ Agr Sci, Dept Plant Breeding, Uppsala, Sweden; [Jahoor, Ahmed; Orabi, Jihad; Andersen, Jeppe R.] Nordic Seed AS, Odder, Denmark	Aarhus University; Swedish University of Agricultural Sciences	Cericola, F (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Ctr Quantitat Genet & Genom, Tjele, Denmark.	fabio.cercola@mbg.au.dk	Orabi, Jihad/ABB-1020-2020	Andersen, Jeppe Reitan/0000-0003-4666-3400; Orabi, Jihad/0000-0001-9641-6657	Danish Ministry for Food, Agriculture and Fisheries under the "Program for Green Development and Demonstration" (Gront Udviklingsog demonstrations program - GUDP [34009-13-0607]; commercial partner Nordic Seed A/S	Danish Ministry for Food, Agriculture and Fisheries under the "Program for Green Development and Demonstration" (Gront Udviklingsog demonstrations program - GUDP; commercial partner Nordic Seed A/S	Funding: This work has been funded by the Danish Ministry for Food, Agriculture and Fisheries under the "Program for Green Development and Demonstration" (Gront Udviklingsog demonstrations program -GUDP - Award Number: 34009-13-0607). This funder provided support in the form of salaries for authors FC, LLJ, and JJ, and half of the salary of JO, JRA, and AJ. Moreover GUDP financed half of the cost associated with the data production, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of authors are articulated in the 'author contributions' section. Additional funding was provided by the commercial partner Nordic Seed A/S in the form of half of the salaries for JO, JRA, and AJ, as well as for the production of phenotypic and genotypic data. Authors funded by Nordic Seed NS participated in decisions on study design, data collection and analysis, and preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arruda MP, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0508-5; Arruda MP, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.04.0028; Barabaschi D, 2015, PLANT SCI; Bassi FM, 2015, PLANT SCI, P1; Bentley AR, 2014, THEOR APPL GENET, V127, P2619, DOI 10.1007/s00122-014-2403-y; Bernardo R, 2010, QUANTITATIVE TRAITS; Bernardo R, 2008, CROP SCI, V48, P1649, DOI 10.2135/cropsci2008.03.0131; Byrne S, 2013, PLOS ONE, V8; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chao SM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-727; Christensen OF, 2010, GENOMIC PREDICTION S, P1; Crossa J, 2014, HEREDITY, V112, P48, DOI 10.1038/hdy.2013.16; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; de los Campos G, 2009, GENETICS, V182, P375, DOI 10.1534/genetics.109.101501; DUDLEY JW, 1994, CROP SCI, V34, P322, DOI 10.2135/cropsci1994.0011183X003400010094x; Feng S, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-12; GIANOLA D, 1986, J ANIM SCI, V63, P217, DOI 10.2527/jas1986.631217x; Goddard ME, 2011, J ANIM BREED GENET, V128, P409, DOI 10.1111/j.1439-0388.2011.00964.x; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; Habier D, 2009, GENETICS, V182, P343, DOI 10.1534/genetics.108.100289; Heffner EL, 2010, CROP SCI, V50, P1681, DOI 10.2135/cropsci2009.11.0662; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; HENDERSON CR, 1985, J ANIM SCI, V60, P111, DOI 10.2527/jas1985.601111x; Henderson CR, 1984, APPL LINEAR MODELS A, V384; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Isidro J, 2015, THEOR APPL GENET, V128, P145, DOI 10.1007/s00122-014-2418-4; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Jordan KW, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0606-4; Madsen P, 2013, A USERS GUIDE TO DMU, P1; Mangin B, 2012, HEREDITY, V108, P285, DOI 10.1038/hdy.2011.73; Meuwissen THE, 2001, GENETICS, V157, P1819; Misztal I, 2009, J DAIRY SCI, V92, P4648, DOI 10.3168/jds.2009-2064; Riedelsheimer C, 2013, GENETICS, V194, P493, DOI 10.1534/genetics.113.150227; Saint Pierre C, 2016, SCI REP-UK, V6, DOI 10.1038/srep27312; Spindel J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004982; Teri A. Manolio, 2010, NATURE, V461, P747; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Williams PC, 1991, PREDICTION WHEAT KER; Xu YB, 2008, CROP SCI, V48, P391, DOI 10.2135/cropsci2007.04.0191; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao Y, 2014, HEREDITY, V112, P638, DOI 10.1038/hdy.2014.1; Zhong SQ, 2009, GENETICS, V182, P355, DOI 10.1534/genetics.108.098277	46	53	53	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169606	10.1371/journal.pone.0169606	http://dx.doi.org/10.1371/journal.pone.0169606			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081208	Green Submitted, Green Published, gold			2022-12-26	WOS:000391949500058
J	Lee, SJ; Lee, SY; Sung, SA; Chin, HJ; Lee, SW				Lee, Se Jin; Lee, So Young; Sung, Su Ah; Chin, Ho Jun; Lee, Sung Woo			Low Rice Intake Is Associated with Proteinuria in Participants of Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							HYPERTENSIVE VASCULAR-DISEASE; GLOMERULAR-FILTRATION-RATE; BLOOD-PRESSURE; CARDIOVASCULAR MORTALITY; DIPSTICK PROTEINURIA; SOCIOECONOMIC-STATUS; DIAGNOSTIC-ACCURACY; ALL-CAUSE; RISK; CONSUMPTION	Little is known about the risk factors of proteinuria in the Asian population. On the basis of the association between rice intake patterns and chronic diseases, we hypothesized that rice intake patterns are associated with proteinuria in the Asian population. Data, including data regarding rice intake frequency and dipstick urinalysis results, from the Korea National Health and Nutrition Examination Survey in 1998, 2001, 2005, and 2007 were analyzed. The study involved 19,824 participants who were older than 20 years of age. Low rice intake was defined as consumption of rice <= 1 time/day. Proteinuria was defined as dipstick urinalysis protein >= 1 positive. Among the 19,824 participants, the prevalence of low rice intake and proteinuria were 17.3% and 2.9%, respectively. The low rice intake group showed a higher rate of proteinuria than the non-low rice intake group did (3.8% vs. 2.7%, P < 0.001). In multivariate logistic regression analysis, the odds ratio (OR) of low rice intake for proteinuria was 1.54 (95% confidence interval (CI): 1.25-1.89; P< 0.001). Low rice intake was also independently associated with high blood pressure (OR: 1.43, 95% CI: 1.31-1.56; P< 0.001) and diabetes (OR: 1.43, 95% CI: 1.27-1.62; P < 0.001). In conclusion, low rice intake was found to be independently associated with proteinuria in the Asian population, which might have been affected by the associations of low rice intake with high blood pressure and diabetes. Future prospective studies are needed to confirm the results of this study.	[Lee, Se Jin; Lee, So Young; Sung, Su Ah; Lee, Sung Woo] Eulji Univ, Dept Nephrol, Nowon Eulji Med Ctr, Internal Med, Seoul, South Korea; [Chin, Ho Jun] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea; [Lee, Sung Woo] Seoul Natl Univ, Postgrad Sch, Dept Internal Med, Seongnam, South Korea	Eulji University; Seoul National University (SNU); Seoul National University (SNU)	Lee, SW (corresponding author), Eulji Univ, Dept Nephrol, Nowon Eulji Med Ctr, Internal Med, Seoul, South Korea.; Lee, SW (corresponding author), Seoul Natl Univ, Postgrad Sch, Dept Internal Med, Seongnam, South Korea.	neplsw@gmail.com		Lee, Sung Woo/0000-0002-4419-3938; Sung, Su Ah/0000-0001-8434-9944				ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; Bakris GL, 2008, CLIN J AM SOC NEPHRO, V3, pS3, DOI 10.2215/CJN.03250807; Dong F, 2015, ANN NUTR METAB, V66, P209, DOI 10.1159/000430504; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fischbacher CM, 2003, DIABETIC MED, V20, P31, DOI 10.1046/j.1464-5491.2003.00822.x; Grimm RH, 1997, KIDNEY INT, pS10; Hu EA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1454; Iseki K, 2004, AM J KIDNEY DIS, V44, P806, DOI 10.1016/S0272-6386(04)01080-7; Iseki K, 1996, KIDNEY INT, V49, P800, DOI 10.1038/ki.1996.111; Jacobs DR, 2009, AM J KIDNEY DIS, V53, P638, DOI 10.1053/j.ajkd.2008.10.048; Karalliedde J, 2010, J AM SOC NEPHROL, V21, P2020, DOI 10.1681/ASN.2010030250; KEMPNER W, 1974, ARCH INTERN MED, V133, P758, DOI 10.1001/archinte.133.5.758; KEMPNER W, 1949, ANN INTERN MED, V31, P821, DOI 10.7326/0003-4819-31-5-821; KEMPNER W, 1947, N C Med J, V8, P128; KROMHOUT D, 1989, AM J CLIN NUTR, V49, P889, DOI 10.1093/ajcn/49.5.889; Lamb EJ, 2009, ANN CLIN BIOCHEM, V46, P205, DOI 10.1258/acb.2009.009007; Lee J.H., 2015, BIOMED RES INT, V2015, P10, DOI DOI 10.1155/2015/137020; Lenfant C, 2003, HYPERTENSION, V41, P1178, DOI 10.1161/01.HYP.0000075790.33892.AE; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lim D, 2014, KIDNEY RES CLIN PRAC, V33, P199, DOI 10.1016/j.krcp.2014.10.003; LOOFBOUROW DG, 1949, NEW ENGL J MED, V240, P910, DOI 10.1056/NEJM194906092402302; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Matthews KA, 2011, ANNU REV PSYCHOL, V62, P501, DOI 10.1146/annurev.psych.031809.130711; McGill MJ, 1996, DIABETES RES CLIN PR, V33, P173, DOI 10.1016/0168-8227(96)01293-4; Mercado N, 2008, AM J CARDIOL, V102, P1151, DOI 10.1016/j.amjcard.2008.06.035; NEWBORG B, 1955, AM J MED, V19, P33, DOI 10.1016/0002-9343(55)90272-2; Ota H, 2013, J CARDIOL, V62, P277, DOI 10.1016/j.jjcc.2013.05.002; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; Ramirez SPB, 2002, J AM SOC NEPHROL, V13, P1907, DOI 10.1097/01.ASN.0000018406.20282.C8; Raymond NT, 2011, CURR MED RES OPIN, V27, P47, DOI 10.1185/03007995.2011.614937; ROSENBERG B, 1948, AM J MED, V5, P815, DOI 10.1016/0002-9343(48)90160-0; Sato Y, 2012, NEPHROL DIAL TRANSPL, V27, P3862, DOI 10.1093/ndt/gfs324; Shi ZM, 2012, ASIA PAC J CLIN NUTR, V21, P35; Son JT, 2015, J CLIN NURS, V24, P2277, DOI 10.1111/jocn.12864; Soriguer F, 2013, CLIN NUTR, V32, P481, DOI 10.1016/j.clnu.2012.11.008; Tonelli M, 2011, KIDNEY INT, V80, P1306, DOI 10.1038/ki.2011.280; Tucker KL, 2007, NUTR METAB CARDIOVAS, V17, P74, DOI 10.1016/j.numecd.2006.07.010; White SL, 2011, AM J KIDNEY DIS, V58, P19, DOI 10.1053/j.ajkd.2010.12.026; Zambon S, 2012, ATHEROSCLEROSIS, V220, P201, DOI 10.1016/j.atherosclerosis.2011.09.023; Zheng ZhiHao, 2010, Journal of Agricultural and Applied Economics, V42, P337	40	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0170198	10.1371/journal.pone.0170198	http://dx.doi.org/10.1371/journal.pone.0170198			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081248	Green Published, Green Submitted, gold			2022-12-26	WOS:000391949500138
J	Lutzkendorf, J; Wieduwild, E; Nerger, K; Lambrecht, N; Schmoll, HJ; Muller-Tidow, C; Muller, LP				Luetzkendorf, Jana; Wieduwild, Elisabeth; Nerger, Katrin; Lambrecht, Nina; Schmoll, Hans-Joachim; Mueller-Tidow, Carsten; Mueller, Lutz Peter			Resistance for Genotoxic Damage in Mesenchymal Stromal Cells Is Increased by Hypoxia but Not Generally Dependent on p53-Regulated Cell Cycle Arrest	PLOS ONE			English	Article							HUMAN BONE-MARROW; HEMATOPOIETIC STEM-CELLS; DNA-DAMAGE; APOPTOSIS; P53; OXYGEN; QUANTITATION; MECHANISMS; EXPOSURE; THERAPY	Adult stem cells including multipotent mesenchymal stromal cells (MSC) acquire a high amount of DNA-damage due to their prolonged lifespan. MSC may exert specific mechanisms of resistance to avoid loss of functional activity. We have previously shown that resistance of MSC is associated with an induction of p53 and proliferation arrest upon genotoxic damage. Hypoxia may also contribute to resistance in MSC due to the low oxygen tension in the niche. In this study we characterized the role of p53 and contribution of hypoxia in resistance of MSC to genotoxic damage. MSC exhibited increased resistance to cisplatin induced DNA-damage. This resistance was associated with a temporary G2/M cell cycle arrest, induction of p53- and p21-expression and reduced cyclin B / cdk1-levels upon subapoptotic damage. Resistance of MSC to cisplatin was increased at hypoxic conditions i.e. oxygen <0.5%. However, upon hypoxia the cisplatin-induced cell cycle arrest and expression of p53 and p21 were abrogated. MSC with shRNA-mediated p53 knock-down showed a reduced cell cycle arrest and increased cyclin B / cdk1 expression. However, this functional p53 knock down did not alter the resistance to cisplatin. In contrast to cisplatin, functional p53-knock-down increased the resistance of MSC to etoposide. We conclude that resistance of MSC to genotoxic damage is influenced by oxygen tension but is not generally dependent on p53. Thus, p53-dependent and p53-independent mechanisms of resistance are likely to contribute to the life-long functional activity of MSC in vivo. These findings indicate that hypoxia and different resistance pathways contribute to the phenotype that enables the prolonged lifespan of MSC.	[Luetzkendorf, Jana; Wieduwild, Elisabeth; Nerger, Katrin; Lambrecht, Nina; Schmoll, Hans-Joachim; Mueller-Tidow, Carsten; Mueller, Lutz Peter] Martin Luther Univ Halle Wittenberg, Univ Klin & Poliklin Innere Med 4, Hamatol Onkol, Halle, Saale, Germany; [Wieduwild, Elisabeth] Univ Aix Marseille, Ctr Immunol Marseille Luminy, INSERM, CNRS, Marseille, France; [Lambrecht, Nina] Martin Luther Univ Halle Wittenberg, Gastroenterol Pneumol, Univ Klin & Poliklin Innere Med 1, Halle, Saale, Germany	Martin Luther University Halle Wittenberg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Martin Luther University Halle Wittenberg	Lutzkendorf, J (corresponding author), Martin Luther Univ Halle Wittenberg, Univ Klin & Poliklin Innere Med 4, Hamatol Onkol, Halle, Saale, Germany.	jana.luetzkendorf@medizin.uni-halle.de	Müller-Tidow, Carsten/O-7207-2018; Schmoll, Hans-Joachim/AAG-5888-2019; Müller, Lutz/ABE-2941-2020; schmoll, hans-joachim/AAO-5219-2021	Müller-Tidow, Carsten/0000-0002-7166-5232; schmoll, hans-joachim/0000-0001-8705-0593; Lutzkendorf, Jana/0000-0002-5781-9266; Wieduwild, Elisabeth/0000-0002-8550-7665	German Ministry of Education and Research through Wilhelm-Roux-Program at Medical Faculty of the Martin-Luther-University Halle-Wittenberg [FKZ 26/28]	German Ministry of Education and Research through Wilhelm-Roux-Program at Medical Faculty of the Martin-Luther-University Halle-Wittenberg	The study was supported by the German Ministry of Education and Research through the Wilhelm-Roux-Program at the Medical Faculty of the Martin-Luther-University Halle-Wittenberg (FKZ 26/28; LPM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardo ME, 2007, CANCER RES, V67, P9142, DOI 10.1158/0008-5472.CAN-06-4690; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Boregowda SV, 2012, STEM CELLS, V30, P975, DOI 10.1002/stem.1069; Burns JS, 2012, CANCER LETT, V325, P1, DOI 10.1016/j.canlet.2012.05.027; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dietrich A, 2008, J MED CHEM, V51, P5413, DOI 10.1021/jm800334z; Fekete N, 2015, TISSUE ENG PART C-ME, V21, P112, DOI [10.1089/ten.tec.2013.0766, 10.1089/ten.TEC.2013.0766]; Harrison JS, 2002, BLOOD, V99, P394, DOI 10.1182/blood.V99.1.394; Hendry JH, 1997, RADIAT RES, V148, P254, DOI 10.2307/3579610; Hong YL, 2004, P NATL ACAD SCI USA, V101, P14443, DOI 10.1073/pnas.0401346101; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Insinga A, 2013, P NATL ACAD SCI USA, V110, P3931, DOI 10.1073/pnas.1213394110; Lane AA, 2010, CELL, V142, P360, DOI 10.1016/j.cell.2010.07.030; Li J, 2004, BRIT J HAEMATOL, V127, P326, DOI 10.1111/j.1365-2141.2004.05200.x; Maijenburg MW, 2012, HAEMATOL-HEMATOL J, V97, P179, DOI 10.3324/haematol.2011.047753; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Mueller LP, 2006, STEM CELLS, V24, P2753, DOI 10.1634/stemcells.2006-0108; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Scala F, 2016, ONCOGENE, V35, P977, DOI 10.1038/onc.2015.147; Sermeus A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.48; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Sotiropoulou PA, 2010, NAT CELL BIOL, V12, P572, DOI 10.1038/ncb2059; Stenderup K, 2001, J BONE MINER RES, V16, P1120, DOI 10.1359/jbmr.2001.16.6.1120; Sugrue T, 2013, IMMUNOL CELL BIOL, V91, P5, DOI 10.1038/icb.2012.61; TOBA K, 1995, J IMMUNOL METHODS, V182, P193, DOI 10.1016/0022-1759(95)00050-K; Tsai CC, 2011, BLOOD, V117, P459, DOI 10.1182/blood-2010-05-287508; Wang DJ, 2009, CANCER RES, V69, P8200, DOI 10.1158/0008-5472.CAN-09-1976; Widder M, 2016, INT J CANCER, V138, P964, DOI 10.1002/ijc.29844; Yu J, 2005, BIOCHEM BIOPH RES CO, V331, P851, DOI 10.1016/j.bbrc.2005.03.189; Zhu WQ, 2006, STEM CELLS, V24, P416, DOI 10.1634/stemcells.2005-0121	35	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169921	10.1371/journal.pone.0169921	http://dx.doi.org/10.1371/journal.pone.0169921			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081228	Green Submitted, Green Published, gold			2022-12-26	WOS:000391949500103
J	Ruckert, KL; Shaffer, G; Pollard, D; Guan, YW; Wong, TE; Forest, CE; Keller, K				Ruckert, Kelsey L.; Shaffer, Gary; Pollard, David; Guan, Yawen; Wong, Tony E.; Forest, Chris E.; Keller, Klaus			Assessing the Impact of Retreat Mechanisms in a Simple Antarctic Ice Sheet Model Using Bayesian Calibration	PLOS ONE			English	Article							SEA-LEVEL RISE; STABILITY	The response of the Antarctic ice sheet (AIS) to changing climate forcings is an important driver of sea-level changes. Anthropogenic climate change may drive a sizeable AIS tipping point response with subsequent increases in coastal flooding risks. Many studies analyzing flood risks use simple models to project the future responses of AIS and its sea-level contributions. These analyses have provided important new insights, but they are often silent on the effects of potentially important processes such as Marine Ice Sheet Instability (MISI) or Marine Ice Cliff Instability (MICI). These approximations can be well justified and result in more parsimonious and transparent model structures. This raises the question of how this approximation impacts hindcasts and projections. Here, we calibrate a previously published and relatively simple AIS model, which neglects the effects of MICI and regional characteristics, using a combination of observational constraints and a Bayesian inversion method. Specifically, we approximate the effects of missing MICI by comparing our results to those from expert assessments with more realistic models and quantify the bias during the last interglacial when MICI may have been triggered. Our results suggest that the model can approximate the process of MISI and reproduce the projected median melt from some previous expert assessments in the year 2100. Yet, our mean hindcast is roughly 3/4 of the observed data during the last interglacial period and our mean projection is roughly 1/6 and 1/10 of the mean from a model accounting for MICI in the year 2100. These results suggest that missing MICI and/or regional characteristics can lead to a low-bias during warming period AIS melting and hence a potential low-bias in projected sea levels and flood risks.	[Ruckert, Kelsey L.; Pollard, David; Wong, Tony E.; Forest, Chris E.; Keller, Klaus] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA; [Shaffer, Gary] Univ Magallanes, GAZA Antarctica, Punta Arenas, Chile; [Shaffer, Gary] Univ Copenhagen, Niels Bohr Inst, Copenhagen, Denmark; [Guan, Yawen] Penn State Univ, Dept Stat, University Pk, PA 16802 USA; [Forest, Chris E.] Penn State Univ, Dept Meteorol, 503 Walker Bldg, University Pk, PA 16802 USA; [Forest, Chris E.; Keller, Klaus] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Keller, Klaus] Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Universidad de Magallanes; University of Copenhagen; Niels Bohr Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Carnegie Mellon University	Keller, K (corresponding author), Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA.; Keller, K (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.; Keller, K (corresponding author), Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA.	klaus@psu.edu	Shaffer, Gary/M-8145-2017; Forest, Chris E/M-1993-2014; Wong, Tony/AAS-9534-2020; Keller, Klaus/A-6742-2013	Shaffer, Gary/0000-0002-2494-3471; Forest, Chris E/0000-0002-2643-0186; Wong, Tony/0000-0002-7304-3883; Guan, Yawen/0000-0003-4563-1263; Ruckert, Kelsey/0000-0001-9513-2636	National Science Foundation through the Network for Sustainable Climate Risk Management (SCRiM) under NSF [GEO-1240507]; Penn State Center for Climate Risk Management; Chilean ICM [NC120066]; Directorate For Geosciences [1240507] Funding Source: National Science Foundation	National Science Foundation through the Network for Sustainable Climate Risk Management (SCRiM) under NSF; Penn State Center for Climate Risk Management; Chilean ICM; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was partially supported by the National Science Foundation through the Network for Sustainable Climate Risk Management (SCRiM) under NSF cooperative agreement GEO-1240507 and the Penn State Center for Climate Risk Management. G. Shaffer was supported in part by Chilean ICM grant NC120066. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation or other funding entities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley RB, 2015, ANNU REV EARTH PL SC, V43, P207, DOI 10.1146/annurev-earth-060614-105344; Bamber JL, 2013, NAT CLIM CHANGE, V3, P424, DOI [10.1038/nclimate1778, 10.1038/NCLIMATE1778]; Bamber JL, 2009, SCIENCE, V324, P901, DOI 10.1126/science.1169335; Bayes T., 1997, A M F R S PHILOS T R, V53, P370, DOI DOI 10.1098/RSTL.1763.0053; Box GEP, 1992, BAYESIAN INFERENCE S, P25, DOI [10.1002/9781118033197, DOI 10.1002/9781118033197]; DeConto RM, 2016, NATURE, V531, P591, DOI 10.1038/nature17145; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gilks W.R., 1997, MARKOV CHAIN MONTE C; Golledge NR, 2015, NATURE, V526, P421, DOI 10.1038/nature15706; Grant KM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6076; Gudmundsson GH, 2013, CRYOSPHERE, V7, P647, DOI 10.5194/tc-7-647-2013; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Ivins ER, 2009, SCIENCE, V324, P888, DOI 10.1126/science.1173958; JOHNSON ME, 1990, J STAT PLAN INFER, V26, P131, DOI 10.1016/0378-3758(90)90122-B; Kopp RE, 2014, EARTHS FUTURE, V2, P383, DOI 10.1002/2014EF000239; Kopp RE, 2009, NATURE, V462, P863, DOI 10.1038/nature08686; Little CM, 2013, NAT CLIM CHANGE, V3, P654, DOI [10.1038/NCLIMATE1845, 10.1038/nclimate1845]; Marino G, 2015, NATURE, V522, P197, DOI 10.1038/nature14499; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Mercer J.H., 1968, INT ASSOC SCIENTIFIC, V79, P217; MERCER JH, 1978, NATURE, V271, P321, DOI 10.1038/271321a0; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Mullen KM, 2011, J STAT SOFTW, V40, P1; Oerlemans J, 2005, ANTARCT SCI, V17, P281, DOI 10.1017/S0954102005002683; Oppenheimer M, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P1039; Pfeffer WT, 2008, SCIENCE, V321, P1340, DOI 10.1126/science.1159099; Pollard D, 2015, EARTH PLANET SC LETT, V412, P112, DOI 10.1016/j.epsl.2014.12.035; Rahmstorf S, 2007, SCIENCE, V315, P368, DOI 10.1126/science.1135456; Ritz C, 2015, NATURE, V528, P115, DOI 10.1038/nature16147; Rohling EJ, 2008, NAT GEOSCI, V1, P38, DOI 10.1038/ngeo.2007.28; Ruckert KL, 2017, CLIMATIC CHANGE, V140, P349, DOI 10.1007/s10584-016-1858-z; Schoof C, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000664; Shaffer G, 2014, GEOSCI MODEL DEV, V7, P1803, DOI 10.5194/gmd-7-1803-2014; Spiegelhalter D., 1996, BUGS 0 5 BAYESIAN IN, P1; Sriver RL, 2012, CLIMATIC CHANGE, V115, P893, DOI 10.1007/s10584-012-0610-6; Stocker T.F., 2013, PHYS SCI BASIS, P1535, DOI [10.1017/CBO9781107415324, DOI 10.1017/CB09781107415324, DOI 10.1017/CBO9781107415324]; Team G, 2016, GISS SURFACE TEMPERA; Urban NM, 2010, COMPUT GEOSCI-UK, V36, P746, DOI 10.1016/j.cageo.2009.11.004; Vihola M, 2012, STAT COMPUT, V22, P997, DOI 10.1007/s11222-011-9269-5	40	25	25	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0170052	10.1371/journal.pone.0170052	http://dx.doi.org/10.1371/journal.pone.0170052			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081273	gold, Green Submitted, Green Published			2022-12-26	WOS:000391949500124
J	Lupato, V; Holzinger, D; Hofler, D; Menegaldo, A; Rossi, PG; Del Mistro, A; Da Mosto, MC; Pawlita, M; Boscolo-Rizzo, P				Lupato, Valentina; Holzinger, Dana; Hofler, Daniela; Menegaldo, Anna; Rossi, Paolo Giorgi; Del Mistro, Annarosa; Da Mosto, Maria Cristina; Pawlita, Michael; Boscolo-Rizzo, Paolo			Prevalence and Determinants of Oral Human Papillomavirus Infection in 500 Young Adults from Italy	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SQUAMOUS-CELL CARCINOMA; RISK-FACTORS; OROPHARYNGEAL CANCER; HEALTHY-INDIVIDUALS; SEXUAL-BEHAVIORS; NATURAL-HISTORY; HPV PREVALENCE; UNITED-STATES; POPULATION	Although the prevalence of human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OPSCC) is increasing in developed countries and becoming a relevant health issue, the natural history of oral HPV infection is still unclear. Estimating the infection's prevalence in specific populations and identifying risk factors can widen our understanding of its natural history and help to delineate appropriate prevention strategies. This study sought to (i) determine oral HPV prevalence and genotype distribution in a large series of young Italian adults, (ii) validate an oral rinse sampling/storage protocol, and (iii) pinpoint factors associated with oral HPV infection. Five hundred students, nurses, and technicians (19-35 years-old) studying and working at/for the University of Padua were recruited. Each participant was provided with an oral rinse sampling kit and instructions for use. They were also asked to complete an anonymous questionnaire concerning their demographic characteristics and behaviors. The questionnaires and oral rinse containers were labeled with the same identification code number. The oral rinse samples were tested using a bead-based multiplex BSGP5+/6+-MPG genotyping assay which amplifies the L1 region of 51 mucosal HPV types. The prevalence of oral HPV infection was 4.0% (95% confidence interval (CI), 2.5%-6.1%); those of 14 high-risk HPV types and of HPV-type 16 (HPV16) infection were 2.2% (95% CI, 1.1%-3.9%) and 1.6% (95% CI, 0.6%-3.1%), respectively. HPV16 was the most frequent genotype (40.0% of oral HPV infections). No association was found between oral infection and the co-variables studied (gender, tobacco, alcohol and illegal drug use, number of sex and oral sex partners, HPV vaccination status, history of HPV and sexually transmitted infections, abnormal pap smears, recurrent tonsillitis and tonsillectomy). The oral rinse sampling protocol outlined here proved to be simple, efficient and well tolerated, and the prevalence rate can be considered reliable and thus useful to guide future research. Determinants of oral HPV infection are still unclear and further studies are certainly warranted.	[Lupato, Valentina; Menegaldo, Anna; Da Mosto, Maria Cristina; Boscolo-Rizzo, Paolo] Univ Padua, Dept Neurosci, Reg Ctr Head & Neck Canc, Treviso, Italy; [Lupato, Valentina] Azienda Osped S Maria degli Angeli, Unit Otolaryngol, Pordenone, Italy; [Holzinger, Dana; Hofler, Daniela; Pawlita, Michael] German Canc Res Ctr, Div Mol Diagnost Oncogen Infect, Infect Inflammat & Canc Program, Heidelberg, Germany; [Rossi, Paolo Giorgi] Local Hlth Author, Interinst Epidemiol Unit, Reggio Emilia, Italy; [Rossi, Paolo Giorgi] IRCCS, Arcispedale S Maria Nuova, Reggio Emilia, Italy; [Del Mistro, Annarosa] Ist Oncol Veneto IRCCS, Immunol & Mol Oncol Unit, Padua, Italy	University of Padua; Helmholtz Association; German Cancer Research Center (DKFZ); IRCCS Arcispedale S. Maria Nuova; IRCCS Istituto Oncologico Veneto (IOV)		paolo.boscolorizzo@unipd.it	Holzinger, Dana/I-3437-2013; Rossi, Paolo Giorgi/K-6367-2016; Boscolo-Rizzo, Paolo/AAI-5666-2021	Rossi, Paolo Giorgi/0000-0001-9703-2460; Boscolo-Rizzo, Paolo/0000-0002-4635-7959; Pawlita, Michael/0000-0002-4720-8306	German Cancer Research Center; University of Padua; FP7 Program of the European Uniongrant HPV_AHEAD [FP7-HEALTH-2011-282562]	German Cancer Research Center(Helmholtz Association); University of Padua; FP7 Program of the European Uniongrant HPV_AHEAD	This study was funded by intramural funds of the German Cancer Research Center and the University of Padua and by the FP7 Program (http://cordis.europa.eu/fp7/home_en.html) of the European Union, grant HPV_AHEAD (FP7-HEALTH-2011-282562). The study received no additional external funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2014, JAMA OTOLARYNGOL, V140, P846, DOI 10.1001/jamaoto.2014.1338; Antonsson A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091761; Baboci L, 2016, PAPILLOMAVIRUS RES, V2, P133, DOI 10.1016/j.pvr.2016.07.002; BLOT WJ, 1988, CANCER RES, V48, P3282; Boscolo-Rizzo P, 2015, CLIN EXP METASTAS, V32, P835, DOI 10.1007/s10585-015-9744-z; Burger EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089974; Canadas MP, 2004, J CLIN MICROBIOL, V42, P1330, DOI 10.1128/JCM.42.3.1330-1332.2004; Chai RC, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2217-1; Chaturvedi AK, 2015, CANCER RES, V75, P2468, DOI 10.1158/0008-5472.CAN-14-2843; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Coutlee F, 1997, SEX TRANSM DIS, V24, P23, DOI 10.1097/00007435-199701000-00006; D'Souza G, 2009, J INFECT DIS, V199, P1263, DOI 10.1086/597755; do Sacramento PR, 2006, J MED VIROL, V78, P614, DOI 10.1002/jmv.20583; Fakhry C, 2015, CANCER PREV RES, V8, P583, DOI 10.1158/1940-6207.CAPR-15-0101; Fakhry C, 2006, J CLIN MICROBIOL, V44, P4479, DOI 10.1128/JCM.01321-06; Ferlay J, 2013, GLOBOCAN 2012 V10 CA; Garnaes E, 2015, INT J CANCER, V136, P2196, DOI 10.1002/ijc.29254; Giambi C., 2014, STATO AVANZAMENTO CA; Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693, DOI 10.1001/jama.2012.101; Giraldo P, 2006, EUR J OBSTET GYN R B, V126, P104, DOI 10.1016/j.ejogrb.2005.09.009; Grun N, 2015, INFECT DIS-NOR, V47, P57, DOI 10.3109/00365548.2014.964764; Hang D, 2014, CANCER EPIDEM BIOMAR, V23, P2101, DOI 10.1158/1055-9965.EPI-14-0084; Herrero R, 2003, JNCI-J NATL CANCER I, V95, P1772, DOI [10.1093/jnci/djg/107, 10.1093/jnci/djg107]; Herrero R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068329; Hong A, 2016, HEAD NECK-J SCI SPEC, V38, P743, DOI 10.1002/hed.23942; Huang H, 2012, ASIAN PAC J CANCER P, V13, P891, DOI 10.7314/APJCP.2012.13.3.891; Jit M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a769; Kreimer AR, 2010, SEX TRANSM DIS, V37, P386, DOI 10.1097/OLQ.0b013e3181c94a3b; Kreimer AR, 2004, J INFECT DIS, V189, P686, DOI 10.1086/381504; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Kuhs KAL, 2013, J INFECT DIS, V208, P1643, DOI 10.1093/infdis/jit369; Kujan O, 2006, ORAL ONCOL, V42, P810, DOI 10.1016/j.oraloncology.2005.11.024; Kurose K, 2004, ORAL SURG ORAL MED O, V98, P91, DOI 10.1016/j.tripleo.2003.12.029; Lambropoulos AF, 1997, EUR J ORAL SCI, V105, P294, DOI 10.1111/j.1600-0722.1997.tb00243.x; Marais DJ, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-95; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Migaldi M, 2012, J ORAL PATHOL MED, V41, P16, DOI 10.1111/j.1600-0714.2011.01062.x; Montaldo C, 2007, J ORAL PATHOL MED, V36, P482, DOI 10.1111/j.1600-0714.2007.00556.x; Nasman A, 2009, INT J CANCER, V125, P362, DOI 10.1002/ijc.24339; Nichols AC, 2013, CURR ONCOL, V20, P212, DOI 10.3747/co.20.1375; Pugliese DB, 2015, J ORAL PATHOL MED, V44, P728, DOI 10.1111/jop.12291; Ragin CCR, 2007, BIOMARKERS, V12, P510, DOI 10.1080/13547500701340384; Rautava J, 2012, HEAD NECK PATHOL, V6, pS3, DOI 10.1007/s12105-012-0367-2; Rintala M, 2006, J CLIN VIROL, V35, P89, DOI 10.1016/j.jcv.2005.05.012; Rogers NL, 2007, AM J HUM BIOL, V19, P319, DOI 10.1002/ajhb.20586; Schmitt M, 2006, J CLIN MICROBIOL, V44, P504, DOI 10.1128/JCM.44.2.504-512.2006; Schmitt M, 2008, J CLIN MICROBIOL, V46, P1050, DOI 10.1128/JCM.02227-07; Smith E M, 2004, Infect Dis Obstet Gynecol, V12, P45; Smith EM, 2007, PEDIATR INFECT DIS J, V26, P836, DOI 10.1097/INF.0b013e318124a4ae; Summersgill KF, 2001, ORAL SURG ORAL MED O, V91, P62, DOI 10.1067/moe.2001.108797; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180	51	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170091	10.1371/journal.pone.0170091	http://dx.doi.org/10.1371/journal.pone.0170091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103272	Green Published, Green Submitted, gold			2022-12-26	WOS:000392381100037
J	Chamberlain, M; Koutsogiannaki, S; Schaefers, M; Babazada, H; Liu, RY; Yuki, K				Chamberlain, Matthew; Koutsogiannaki, Sophia; Schaefers, Matthew; Babazada, Hasan; Liu, Renyu; Yuki, Koichi			The Differential Effects of Anesthetics on Bacterial Behaviors	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; BIOFILM FORMATION; VOLATILE ANESTHETICS; CULTURE-CONDITIONS; CRYSTAL-STRUCTURE; CYSTIC-FIBROSIS; ION CHANNELS; MOTILITY; GROWTH; ISOFLURANE	Volatile anesthetics have been in clinical use for a long period of time and are considered to be promiscuous by presumably interacting with several ion channels in the central nervous system to produce anesthesia. Because ion channels and their existing evolutionary analogues, ion transporters, are very important in various organisms, it is possible that volatile anesthetics may affect some bacteria. In this study, we hypothesized that volatile anesthetics could affect bacterial behaviors. We evaluated the impact of anesthetics on bacterial growth, motility (swimming and gliding) and biofilm formation of four common bacterial pathogens in vitro. We found that commonly used volatile anesthetics isoflurane and sevoflurane affected bacterial motility and biofilm formation without any effect on growth of the common bacterial pathogens studied here. Using available Escherichia coli gene deletion mutants of ion transporters and in silico molecular docking, we suggested that these altered behaviors might be at least partly via the interaction of volatile anesthetics with ion transporters.	[Chamberlain, Matthew; Koutsogiannaki, Sophia; Schaefers, Matthew; Yuki, Koichi] Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Babazada, Hasan; Liu, Renyu] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA	Harvard University; Boston Children's Hospital; University of Pennsylvania	Yuki, K (corresponding author), Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA.	koichi.yuki@childrens.harvard.edu	Schaefers, Matthew/AAU-8213-2021	Schaefers, Matthew/0000-0001-7454-4180; Koutsogiannaki, Sophia/0000-0003-3555-1681	Foundation of the National Institute of Health, NIH [GM101345, GM118277, GM111421]; CHMC Anesthesia Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111421, R01GM118277, K08GM101345] Funding Source: NIH RePORTER	Foundation of the National Institute of Health, NIH; CHMC Anesthesia Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Foundation of the National Institute of Health, NIH GM101345 and GM118277 (K.Y.), GM111421 (R.L.) and by the CHMC Anesthesia Foundation (K.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel E, 2010, INFECT IMMUN, V78, P2937, DOI 10.1128/IAI.00144-10; Appel M, 2009, J MOL BIOL, V386, P351, DOI 10.1016/j.jmb.2008.12.042; ARMITAGE JP, 1992, SCI PROG, V76, P451; Asehnoune K, 2000, EUR J ANAESTH, V17, P289, DOI 10.1046/j.1365-2346.2000.00657.x; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Beloin C, 2008, CURR TOP MICROBIOL, V322, P249; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Coffey BM, 2014, METHODS MOL BIOL, V1149, P631, DOI 10.1007/978-1-4939-0473-0_48; Darton T, 2009, CLIN INFECT DIS, V48, P587, DOI 10.1086/596707; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Eckenhoff R G, 2001, Mol Interv, V1, P258; Gadsby DC, 2009, NAT REV MOL CELL BIO, V10, P344, DOI 10.1038/nrm2668; Guttenplan SB, 2013, FEMS MICROBIOL REV, V37, P849, DOI 10.1111/1574-6976.12018; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; Karabiyik L, 2007, J ANESTH, V21, P436, DOI 10.1007/s00540-007-0520-3; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; Lee C, 2014, J GEN PHYSIOL, V144, P529, DOI 10.1085/jgp.201411219; Lister JL, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00178; Lovewell RR, 2014, AM J PHYSIOL-LUNG C, V306, pL698, DOI 10.1152/ajplung.00319.2013; LUZAR MA, 1985, INFECT IMMUN, V50, P577, DOI 10.1128/IAI.50.2.577-582.1985; MAHENTHIRALINGAM E, 1994, INFECT IMMUN, V62, P596, DOI 10.1128/IAI.62.2.596-605.1994; MEHTA S, 1973, CAN ANAESTH SOC J, V20, P230, DOI 10.1007/BF03027212; Mohamed JA, 2007, J MED MICROBIOL, V56, P1581, DOI 10.1099/jmm.0.47331-0; Molliex S, 1998, ANESTH ANALG, V86, P1075, DOI 10.1097/00000539-199805000-00033; Newell PD, 2011, J BACTERIOL, V193, P4685, DOI 10.1128/JB.05483-11; Nilsson AC, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-39; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Padan E, 2009, J EXP BIOL, V212, P1593, DOI 10.1242/jeb.026708; Palanisamy A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158058; Patteson AE, 2015, SCI REP-UK, V5, DOI 10.1038/srep15761; Pollitt EJG, 2015, SCI REP-UK, V5, DOI 10.1038/srep17698; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Prindle A, 2015, NATURE, V527, P59, DOI 10.1038/nature15709; Rello J, 2009, CHEST, V136, P832, DOI 10.1378/chest.09-0258; SLADE JM, 1993, ANAESTHESIA, V48, P1053; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Tart AH, 2005, J BACTERIOL, V187, P7955, DOI 10.1128/JB.187.23.7955-7962.2005; Van Horn K, 2002, J CLIN MICROBIOL, V40, P2476, DOI 10.1128/JCM.40.7.2476-2479.2002; von Dossow V, 2007, J INT MED RES, V35, P395, DOI 10.1177/147323000703500315; WARDLEYSMITH B, 1971, BRIT J ANAESTH, V43, P919, DOI 10.1093/bja/43.10.919; Wu YH, 2012, ANAL BIOCHEM, V423, P15, DOI 10.1016/j.ab.2012.01.012; Yuki K, 2016, ANESTH ANALG, V123, P326, DOI 10.1213/ANE.0000000000001403	46	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170089	10.1371/journal.pone.0170089	http://dx.doi.org/10.1371/journal.pone.0170089			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099463	Green Submitted, gold, Green Published			2022-12-26	WOS:000392380100053
J	Wada, S; Ito, N; Watanabe, M; Kakizaki, T; Natsuhori, M; Kawamata, J; Urayama, Y				Wada, Seiichi; Ito, Nobuhiko; Watanabe, Masamichi; Kakizaki, Takehiko; Natsuhori, Masahiro; Kawamata, Jun; Urayama, Yoshio			Whole-Body Counter Evaluation of Internal Radioactive Cesium in Dogs and Cats Exposed to the Fukushima Nuclear Disaster	PLOS ONE			English	Article							RADIOCESIUM CONTAMINATION; LYNX	As a result of the 2011 nuclear incident that occurred at the Fukushima Nuclear Power Plant, a large number of abandoned dogs and cats were left within the disaster zone. A small number of these animals were rescued and cared for at shelters. Prior to the dispersal of these animals to their owners or fosterers, we evaluated the degree of internal radiocesium contamination using a specially designed whole-body counter. We conducted 863 non-invasive measurements of gamma rays due to internal radioactive cesium for 68 dogs and 120 cats at one shelter. After plotting graphs of Cs-137 density we generated exponential functions of decay from seven dogs and six cats. From the regression formulae, we were able to determine the biological half-lives as 38.2 days for dogs and 30.8 days for cats. We found that in dogs there was a correlation between the biological half-life of radioactive cesium and age. Using our data, we estimated whole-body densities for each cat and dog at the time when they were rescued. We found that there were deviations in the data distributions among the different species, likely due to the timing of rescue, or living habits prior to rescue. A significant correlation was found when extracted feline reproductive organs were analyzed; the coefficients for the estimation of whole-body densities were approximately 7-fold higher than those based on the extracted feline reproductive organs. This may be due to the fact that majority of the radioactive cesium accumulates within muscular tissue with less distribution in other organs. It is possible to plan the appropriate management period in an animal shelter based on the use of the biological half-life of radioactive cesium calculated in this study. We believe that the correlations we uncovered in this work would be of great use for the management of companion animals in the event of a future nuclear accident.	[Wada, Seiichi; Ito, Nobuhiko; Kakizaki, Takehiko; Natsuhori, Masahiro] Kitasato Univ, Sch Vet Med, Lab Vet Radiol & Radiat Biol, Towada, Aomori, Japan; [Watanabe, Masamichi; Urayama, Yoshio] Fukushima Headquarters Anim Rescue, Fukushima, Fukushima, Japan; [Kawamata, Jun] Fukushima Vet Med Assoc, Fukushima, Japan	Kitasato University	Wada, S (corresponding author), Kitasato Univ, Sch Vet Med, Lab Vet Radiol & Radiat Biol, Towada, Aomori, Japan.	wada@vmas.kitasato-u.ac.jp	Natsuhori, Masahiro/AAY-2831-2020	Natsuhori, Masahiro/0000-0003-2387-0781				Ahman B, 2004, RADIAT ENVIRON BIOPH, V43, P119, DOI 10.1007/s00411-004-0242-y; [Anonymous], 2013, B COLL CTR AGR SCI M, V2013, P1; Chaiko Y, 2012, THESIS, P1; CRONQUIST AG, 1977, PHYS MED BIOL, V22, P1197, DOI 10.1088/0031-9155/22/6/013; Fukuda T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054312; Hayano RS, 2013, P JPN ACAD B-PHYS, V89, P157, DOI 10.2183/pjab.89.157; Howard BJ, 1616 IAEA, P267; IAEA, 1998, 1009 IAEA, P37; IAEA, 2010, IAEA TECHNICAL REPOR, V472; ICRP, 1989, ICRP PUBL 1, V20, P53; Iinuma T, 1965, J Radiat Res, V6, P73, DOI 10.1269/jrr.6.73; Koga F, 2014, PRESUMING TECHNIQUES, P94; MCCRAW T. F., 1965, RADIOL HEALTH DATA US DEP PUBLIC HEALTH SERV, V6, P711; Melo DR, 1997, HEALTH PHYS, V73, P320, DOI 10.1097/00004032-199708000-00004; Noguchi M., 2000, Radioisotopes, V49, P189, DOI 10.3769/radioisotopes.49.189; Sato I, 2015, ANIM SCI J, V86, P716, DOI 10.1111/asj.12345; Semizhon T, 2009, J ENVIRON RADIOACTIV, V100, P988, DOI 10.1016/j.jenvrad.2009.06.023; Skuterud L, 2005, J ENVIRON RADIOACTIV, V80, P125, DOI 10.1016/j.jenvrad.2004.09.002; Swinth KL, 1967, HLTH PHYS; Uchida M, 2014, B FUKUSHIMA AGR TECH, P90; Zibold G, 2001, J ENVIRON RADIOACTIV, V55, P5, DOI 10.1016/S0265-931X(00)00184-3	21	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0169365	10.1371/journal.pone.0169365	http://dx.doi.org/10.1371/journal.pone.0169365			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099476	gold, Green Published, Green Submitted			2022-12-26	WOS:000392380100019
J	Wang, Q; Fei, PP; Gu, HB; Zhang, YM; Ke, XM; Liu, YH				Wang, Qi; Fei, Peipei; Gu, Hongbo; Zhang, Yanmei; Ke, Xiaomei; Liu, Yuhe			Different Phenotypes of the Two Chinese Probands with the Same c.889G > A (p.C162 Upsilon) Mutation in COCH Gene Verify Different Mechanisms Underlying Autosomal Dominant Nonsyndromic Deafness 9	PLOS ONE			English	Article							SENSORINEURAL HEARING-LOSS; MENIERES-DISEASE; VESTIBULAR DISORDER; DFNA9 DEAFNESS; VWFA2 DOMAIN; LCCL DOMAIN; INNER-EAR; FAMILY; DYSFUNCTION; IMPAIRMENT	Objectives By analyzing the different phenotypes of two Chinese DFNA9 families with the same mutation located in the intervening region between the LCCL and vWFA domains of cochlin and testing the functional changes in the mutant cochlin, we investigated the different pathogeneses for mutations in LCCL and vWFA domains. Methods Targeted next-generation sequencing for deafness-related genes was used to identify the mutation in the proband in family #208. The probands of family #208 and family #32 with the same p.C162 Upsilon mutation were followed for more than 3 years to evaluate the progression of hearing loss and vestibular dysfunction using pure-tone audiometry, caloric testing, electrocochleogram, vestibular-evoked myogenic potential, and video head-impulse test. The disruption of normal cleavage to produce secreted LCCL domain fragments and the tendency to form aggregations of mutant cochlins were tested by in vitro cell experiments. Results The two families showed different clinical symptoms. Family #32 was identified as having early-onset, progressive sensorineural hearing loss, similar to the symptoms in DFNA9 patients with cochlin mutations in the vWFA domain. The proband of family #208 endured late-onset recurrent paroxysmal vertigo attacks and progressively deteriorating hearing, similar to symptoms in those with cochlin mutations in the LCCL domain. We therefore suggest that the disrupted cleavage of the LCCL domain fragment is likely to cause vestibular dysfunction, and aggregation of mutant cochlin caused by mutations in the vWFA domain is responsible for early-onset hearing loss. The p.C162 Upsilon mutation causes either disruption of LCCL domain fragment cleavage or aggregation of mutant cochlin, resulting in the different phenotypes in the two families. Conclusion This study demonstrates that DFNA9 families with the same genotype may have significantly different phenotypes. The mutation site in cochlin is related to the pathological mechanism underlying the different phenotypes.	[Wang, Qi; Fei, Peipei; Gu, Hongbo; Zhang, Yanmei; Ke, Xiaomei; Liu, Yuhe] Peking Univ, Hosp 1, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China	Peking University	Liu, YH (corresponding author), Peking Univ, Hosp 1, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China.	liuyuhefeng@163.com			National Natural Science Foundation of China [81271083, 81470691]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (Project 81271083 and 81470691).	Bae SH, 2014, HUM MUTAT, V35, P1506, DOI 10.1002/humu.22701; Baek JI, 2010, CLIN GENET, V77, P399, DOI 10.1111/j.1399-0004.2009.01362.x; Bom SJH, 2003, ANN OTO RHINOL LARYN, V112, P280, DOI 10.1177/000348940311200316; Chen DY, 2013, INT J PEDIATR OTORHI, V77, P1711, DOI 10.1016/j.ijporl.2013.07.031; Cho HJ, 2012, J MOL MED, V90, P1321, DOI 10.1007/s00109-012-0911-2; Collin RWJ, 2006, AM J MED GENET A, V140A, P1791, DOI 10.1002/ajmg.a.31354; de Kok YJM, 1999, HUM MOL GENET, V8, P361, DOI 10.1093/hmg/8.2.361; Deriu F, 2007, J PHYSIOL-LONDON, V580, P195, DOI 10.1113/jphysiol.2006.123240; Fransen E, 1999, HUM MOL GENET, V8, P1425, DOI 10.1093/hmg/8.8.1425; Gallant E, 2013, AM J OTOLARYNG, V34, P230, DOI 10.1016/j.amjoto.2012.11.002; Gao J, 2013, CLIN GENET, V83, P477, DOI 10.1111/cge.12006; Harcourt J, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6544; Heller S, 1998, P NATL ACAD SCI USA, V95, P11400, DOI 10.1073/pnas.95.19.11400; Hildebrand MS, 2010, LARYNGOSCOPE, V120, P2489, DOI 10.1002/lary.21159; Ikezono T, 2005, ORL-J OTO-RHIN-LARYN, V67, P252, DOI 10.1159/000089404; Jung J, 2015, HUM MUTAT, V36, P1168, DOI 10.1002/humu.22855; Kamarinos M, 2001, Hum Mutat, V17, P351, DOI 10.1002/humu.37; Lamounier P, 2014, BRAZ J OTORHINOLAR, V80, P527, DOI 10.1016/j.bjorl.2014.08.010; Liepinsh E, 2001, EMBO J, V20, P5347, DOI 10.1093/emboj/20.19.5347; Nagy I, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.012286; Pauw RJ, 2007, ANN OTO RHINOL LARYN, V116, P349, DOI 10.1177/000348940711600506; Pauw RJ, 2011, ANN OTO RHINOL LARYN, V120, P414, DOI 10.1177/000348941112000612; Py BF, 2013, IMMUNITY, V38, P1063, DOI 10.1016/j.immuni.2013.01.015; Robertson NG, 1997, GENOMICS, V46, P345, DOI 10.1006/geno.1997.5067; Robertson NG, 1998, NAT GENET, V20, P299, DOI 10.1038/3118; Robertson NG, 2001, HUM MOL GENET, V10, P2493, DOI 10.1093/hmg/10.22.2493; Sajjadi H, 2008, LANCET, V372, P406, DOI 10.1016/S0140-6736(08)61161-7; Stelma F, 2014, J LARYNGOL OTOL, V128, P13, DOI 10.1017/S0022215113003265; Street VA, 2005, AM J MED GENET A, V139A, P86, DOI 10.1002/ajmg.a.30980; Sun Y, 2015, J HUM GENET, V60, P299, DOI 10.1038/jhg.2015.19; Usami S, 2003, EUR J HUM GENET, V11, P744, DOI 10.1038/sj.ejhg.5201043; Yuan HJ, 2008, CLIN GENET, V73, P391, DOI 10.1111/j.1399-0004.2008.00972.x	32	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170011	10.1371/journal.pone.0170011	http://dx.doi.org/10.1371/journal.pone.0170011			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099493	Green Published, Green Submitted, gold			2022-12-26	WOS:000392380100050
J	Gorgojo, J; Scharrig, E; Gomez, RM; Harvill, ET; Rodriguez, ME				Gorgojo, Juan; Scharrig, Emilia; Gomez, Ricardo M.; Harvill, Eric T.; Eugenia Rodriguez, Maria			Bordetella parapertussis Circumvents Neutrophil Extracellular Bactericidal Mechanisms	PLOS ONE			English	Article							ACUTE LUNG INJURY; PERTUSSIS-VACCINE; WHOLE-CELL; TRAPS; RECEPTOR; GRANULES; BIOSYNTHESIS; PHAGOCYTOSIS; EXPRESSION; CLEARANCE	B. parapertussis is a whooping cough etiological agent with the ability to evade the immune response induced by pertussis vaccines. We previously demonstrated that in the absence of opsonic antibodies B. parapertussis hampers phagocytosis by neutrophils and macrophages and, when phagocytosed, blocks intracellular killing by interfering with phagolysosomal fusion. But neutrophils can kill and/or immobilize extracellular bacteria through nonphagocytic mechanisms such as degranulation and neutrophil extracellular traps (NETs). In this study we demonstrated that B. parapertussis also has the ability to circumvent these two neutrophil extracellular bactericidal activities. The lack of neutrophil degranulation was found dependent on the 0 antigen that targets the bacteria to cell lipid rafts, eventually avoiding the fusion of nascent phagosomes with specific and azurophilic granules. IgG opsonization overcame this inhibition of neutrophil degranulation. We further observed that B. parapertussis did not induce NETs release in resting neutrophils and inhibited NETs formation in response to phorbol myristate acetate (PMA) stimulation by a mechanism dependent on adenylate cyclase toxin (CyaA)-mediated inhibition of reactive oxygen species (ROS) generation. Thus, B. parapertussis modulates neutrophil bactericidal activity through two different mechanisms, one related to the lack of proper NETs-inducer stimuli and the other one related to an active inhibitory mechanism. Together with previous results these data suggest that B. parapertussis has the ability to subvert the main neutrophil bactericidal functions, inhibiting efficient clearance in non-immune hosts.	[Gorgojo, Juan; Eugenia Rodriguez, Maria] Univ Nacl La Plata, Fac Ciencias Exactas, CINDEFI UNLP CONICET La Plata, La Plata, Buenos Aires, Argentina; [Scharrig, Emilia; Gomez, Ricardo M.] CONICET UNLP, CCT La Plata, Inst Biotechnol & Mol Biol, La Plata, Buenos Aires, Argentina; [Harvill, Eric T.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Ctr Vaccines & Immunol, Athens, GA USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; University System of Georgia; University of Georgia	Rodriguez, ME (corresponding author), Univ Nacl La Plata, Fac Ciencias Exactas, CINDEFI UNLP CONICET La Plata, La Plata, Buenos Aires, Argentina.	mer@quimica.unlp.edu.ar	Gomez, Ricardo M/AAG-9555-2019	Gomez, Ricardo M/0000-0002-4001-519X; Scharrig, Emilia/0000-0003-2599-5297; Gorgojo, Juan Pablo/0000-0001-6412-1774; Harvill, Eric/0000-0001-8893-2133	National Agency for Scientific and Technological Promotion (ANPCyTMINCyT) [PICT 2013 1937]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI107016, R21AI116186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113681] Funding Source: NIH RePORTER	National Agency for Scientific and Technological Promotion (ANPCyTMINCyT); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by the National Agency for Scientific and Technological Promotion (ANPCyTMINCyT) PICT 2013 1937 (to MER) [http://www.agencia.mincyt.gob.ar/]. MER and RMG are members of the Scientific Career of CONICET. JG and ES are postdoctoral fellows of CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi Abdallah Delbert S, 2012, Front Immunol, V3, P382, DOI 10.3389/fimmu.2012.00382; Allen A, 1996, MOL MICROBIOL, V19, P37, DOI 10.1046/j.1365-2958.1996.354877.x; Barquero-Calvo E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004853; Bassoe CF, 2003, CYTOM PART B-CLIN CY, V51B, P21, DOI 10.1002/cyto.b.10003; Beiter K, 2006, CURR BIOL, V16, P401, DOI 10.1016/j.cub.2006.01.056; Berends ETM, 2010, J INNATE IMMUN, V2, P576, DOI 10.1159/000319909; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Bruns S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000873; Cheng OZ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00001; DAHLGREN C, 1995, BIOCHEM J, V311, P667, DOI 10.1042/bj3110667; David S, 2004, VACCINE, V22, P1892, DOI 10.1016/j.vaccine.2003.11.005; de Buhr N, 2014, MICROBIOL-SGM, V160, P385, DOI 10.1099/mic.0.072199-0; Douda DN, 2011, J IMMUNOL, V187, P1856, DOI 10.4049/jimmunol.1004201; Eby JC, 2014, INFECT IMMUN, V82, P5256, DOI 10.1128/IAI.02487-14; Fantini Jacques, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402005392; Gorgojo J, 2014, INFECT IMMUN, V82, P5175, DOI 10.1128/IAI.02553-14; Gorgojo J, 2012, INFECT IMMUN, V80, P4309, DOI 10.1128/IAI.00662-12; Guimaraes-Costa Anderson B, 2012, J Parasitol Res, V2012, P929743, DOI 10.1155/2012/929743; Guimaraes-Costa AB, 2009, P NATL ACAD SCI USA, V106, P6748, DOI 10.1073/pnas.0900226106; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496; Heininger U, 1999, CLIN INFECT DIS, V28, P602, DOI 10.1086/515154; Hellwig SMM, 2001, J INFECT DIS, V183, P871, DOI 10.1086/319266; Hirose T, 2012, AM J RESP CRIT CARE, V185, P1130, DOI 10.1164/ajrccm.185.10.1130; Hosseinzadeh A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00391; Jayaprakash K, 2015, MOL ORAL MICROBIOL, V30, P361, DOI 10.1111/omi.12099; Lacy Paige, 2006, Allergy Asthma Clin Immunol, V2, P98, DOI 10.1186/1710-1492-2-3-98; Lamberti Y, 2009, FEMS IMMUNOL MED MIC, V56, P143, DOI 10.1111/j.1574-695X.2009.00557.x; Lee SJ, 1999, INFECT IMMUN, V67, P2090, DOI 10.1128/IAI.67.5.2090-2095.1999; Liese JG, 2003, ARCH DIS CHILD, V88, P684, DOI 10.1136/adc.88.8.684; Lu T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00365; Mann PB, 2005, INFECT IMMUN, V73, P8144, DOI 10.1128/IAI.73.12.8144-8152.2005; Mastrantonio P, 1997, DEV BIOL STAND, V89, P255; McDonald B, 2012, CELL HOST MICROBE, V12, P324, DOI 10.1016/j.chom.2012.06.011; Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Ng HH, 2012, EXP MOL PATHOL, V92, P287, DOI 10.1016/j.yexmp.2012.03.003; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; Vidakovics MLAP, 2006, FEMS IMMUNOL MED MIC, V48, P140, DOI 10.1111/j.1574-695X.2006.00136.x; Preston A, 1999, INFECT IMMUN, V67, P3763, DOI 10.1128/IAI.67.8.3763-3767.1999; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; REPP R, 1991, BLOOD, V78, P885, DOI 10.1182/blood.V78.4.885.bloodjournal784885; Rodriguez ME, 2001, J IMMUNOL, V167, P6545, DOI 10.4049/jimmunol.167.11.6545; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Suzaki E, 1997, CELL MOTIL CYTOSKEL, V38, P215; Tapper H, 1997, J IMMUNOL, V159, P409; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; von Kockritz-Blickwede M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00402; von Kockritz-Blickwede M, 2009, BLOOD, V114, P5245, DOI 10.1182/blood-2009-08-240713; Vong L, 2014, J IMMUNOL, V192, P1870, DOI 10.4049/jimmunol.1302286; White PC, 2016, J DENT RES, V95, P26, DOI 10.1177/0022034515609097; Wolfe DN, 2007, INFECT IMMUN, V75, P4972, DOI 10.1128/IAI.00763-07; Wolfe DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004280; Wolfe DN, 2005, INFECT IMMUN, V73, P6508, DOI 10.1128/IAI.73.10.6508-6513.2005; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847; Zhang XQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006989	57	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0169936	10.1371/journal.pone.0169936	http://dx.doi.org/10.1371/journal.pone.0169936			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095485	Green Published, Green Submitted, gold			2022-12-26	WOS:000392372300045
J	Cui, AL; Zhu, Z; Hue, Y; Deng, XY; Sun, ZD; Zhang, Y; Mao, NY; Xu, ST; Fang, XQ; Gao, H; Si, Y; Lei, YK; Zheng, HY; He, JL; Wu, HW; Xu, WB				Cui, Aili; Zhu, Zhen; Hue, Ying; Deng, Xiuying; Sun, Zhaodan; Zhang, Yan; Mao, Naiying; Xu, Songtao; Fang, Xueqiang; Gao, Hui; Si, Yuan; Lei, Yake; Zheng, Huanying; He, Jilan; Wu, Hongwei; Xu, Wenbo			Mumps Epidemiology and Mumps Virus Genotypes Circulating in Mainland China during 2013-2015	PLOS ONE			English	Article							MEASLES VIRUSES; OUTBREAK; SEQUENCES; DIVERSITY; VACCINE; JAPAN; GENE	With the implementation of mumps virus (MuV) vaccination in the expanded program on immunization (EPI) in mainland China since 2008, the incidence of mumps has decreased, and the natural epidemic pattern of mumps has slightly changed during 2013-2015. The two epidemic peaks (April-July and November-December) became less obvious than those observed from 2004 to 2012. Children and adolescents younger than 15, particularly in the five-to-nine-year-old age group, remain the target group and should be the focus of high-quality immunization activities in mainland China. However, it was also found that the incidence and reported cases of mumps decreased in each age group during 2013-2015, particularly in the five-to-nine-year-old and ten-to-fourteen-year-old age groups. The proportion of mumps cases among adults in some provinces also increased. Unlike the changes in the epidemiological characteristics of mumps affected by vaccination, the data of MuV virology surveillance indicated that most of the MuV transmission chains have not yet been effectively interrupted, and MuV remains a natural epidemic pattern in mainland China. In the MuV virology surveillance, 194 MuV strains during 2013-2015 were isolated from 10 of 31 provinces in mainland China. Based on the phylogenetic analysis of the small hydrophobic (SH) gene, both genotype F (99.0%) and G (1.0%) were identified, and genotype F was still the predominant genotype continuously circulating in mainland China. Representative genotype F and G strains isolated in China from 1995 to 2012 were selected for further analysis. The results indicated that there were multiple transmission chains within genotype F, with no obvious geographical or time differences. The high genetic diversity of genotype F strains could be a result of the continuous transmission and evolution of the MuV in mainland China. Genotype G was also detected in four provinces in mainland China. Because of the limited epidemiological data, it was uncertain whether the genotype G MuV strains found in 2011 and 2013 were imported from other countries. Therefore, combined high-quality epidemiological and virological surveillance is necessary for mumps control; it can also be used to observe the changes in epidemiological characteristics and viral transmission of mumps over time after mumps-containing vaccine (MuCV) implementation and to provide a comprehensive epidemiological and genetic baseline for mumps elimination in mainland China.	[Cui, Aili; Zhu, Zhen; Zhang, Yan; Mao, Naiying; Xu, Songtao; Xu, Wenbo] Minist Hlth, WHO WPRO Reg Reference Measles Rubella Lab, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Cui, Aili; Zhu, Zhen; Zhang, Yan; Mao, Naiying; Xu, Songtao; Xu, Wenbo] Minist Hlth, Key Lab Med Virol, Beijing, Peoples R China; [Hue, Ying; Deng, Xiuying] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Sun, Zhaodan] Heilongjiang Prov Ctr Dis Control & Prevent, Harbin, Peoples R China; [Fang, Xueqiang] Shandong Prov Ctr Dis Control & Prevent, Jinan, Peoples R China; [Gao, Hui] Shanxi Prov Ctr Dis Control & Prevent, Taiyuan, Peoples R China; [Si, Yuan] Shannxi Prov Ctr Dis Control & Prevent, Xian, Peoples R China; [Lei, Yake] Hubei Prov Ctr Dis Control & Prevent, Wuhan, Peoples R China; [Zheng, Huanying] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [He, Jilan] Sichuan Prov Ctr Dis Control & Prevent, Chengdu, Peoples R China; [Wu, Hongwei] Beihua Univ, Affiliated Hosp, Jilin, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Jiangsu Provincial Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Beihua University	Xu, WB (corresponding author), Minist Hlth, WHO WPRO Reg Reference Measles Rubella Lab, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.; Xu, WB (corresponding author), Minist Hlth, Key Lab Med Virol, Beijing, Peoples R China.; Wu, HW (corresponding author), Beihua Univ, Affiliated Hosp, Jilin, Peoples R China.	675128826@qq.com; wenbo_xu1@aliyun.com			Key Technologies R&D Program of the National Ministry of Science [2013ZX10004-202, 2012ZX10004201-003]; WHO Measles Regional Reference Laboratory Funding [WPCHN1002802]	Key Technologies R&D Program of the National Ministry of Science; WHO Measles Regional Reference Laboratory Funding	This work was supported by the Key Technologies R&D Program of the National Ministry of Science (2013ZX10004-202, 2012ZX10004201-003) and the WHO Measles Regional Reference Laboratory Funding (WPCHN1002802).	[Anonymous], 2012, Wkly Epidemiol Rec, V87, P217; Aoki Y, 2016, INFECT DIS-NOR, V48, P524, DOI 10.3109/23744235.2016.1163730; Cao Yan, 2013, Occupation and Health, V29, P1652; Cohen C, 2007, EMERG INFECT DIS, V13, P12; Cortese MM, 2011, J INFECT DIS, V204, P1413, DOI 10.1093/infdis/jir526; Cui A., 2014, INFECT GENET EVOL, V21, P384, DOI DOI 10.1016/J.MEEGID.2013.12.005; Cui AL, 2009, ZHONGGUO YI MIAO HE, V15, p8 ; Di TI, 2015, PRACT PREV MED, V22, P629; Ding Y., 2016, MOD PREV MED, V43, P2070; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; ELANGO N, 1988, J GEN VIROL, V69, P2893, DOI 10.1099/0022-1317-69-11-2893; ELLIOTT GD, 1990, J GEN VIROL, V71, P1555, DOI 10.1099/0022-1317-71-7-1555; Fu CX, 2007, CHIN PREV MED, V8, p611 ; Galazka AM, 1999, B WORLD HEALTH ORGAN, V77, P3; Huang X, 2016, J PREV MED INF, V32, p1104 ; Inou Y, 2004, J MED VIROL, V73, P97, DOI 10.1002/jmv.20065; Jiang YG, 2012, SCI TECHNOLOGY FOOD, V7, P16, DOI DOI 10.1371/J0URNAL.P0NE.0034401; Jin L, 1999, J INFECT DIS, V180, P829, DOI 10.1086/314957; Jin L, 2015, REV MED VIROL, V25, P85, DOI 10.1002/rmv.1819; Liang Y, 2014, HUM VACC IMMUNOTHER, V10, P1382, DOI 10.4161/hv.28334; Ma J, 2010, CHINESE J VACCINES I, V06, P533; Montes M, 2002, EPIDEMIOL INFECT, V129, P551, DOI 10.1017/S095026880200763X; National Advisory Committee on Immunization (NACI), 2007, Can Commun Dis Rep, V33, P1; Ono N, 2001, J VIROL, V75, P4399, DOI 10.1128/JVI.75.9.4399-4401.2001; Peltola H, 2007, CLIN INFECT DIS, V45, P459, DOI 10.1086/520028; Rota JS, 2009, J MED VIROL, V81, P1819, DOI 10.1002/jmv.21557; Rubin SA, 2008, J INFECT DIS, V198, P508, DOI 10.1086/590115; Sabbe M, 2016, HUM VACC IMMUNOTHER, V12, P955, DOI 10.1080/21645515.2015.1113357; Sartorius B, 2005, Euro Surveill, V10, P191, DOI 10.2807/esm.10.09.00559-en; Savage E, 2005, BRIT MED J, V330, P1119, DOI 10.1136/bmj.330.7500.1119; Su Q R, 2016, Zhonghua Yu Fang Yi Xue Za Zhi, V50, P611, DOI 10.3760/cma.j.issn.0253-9624.2016.07.009; Wang ZF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089361; Watson-Creed G, 2006, CAN MED ASSOC J, V175, P483, DOI 10.1503/cmaj.060660; Xu WZ, 2011, CHINESE J VACCINES I, V17, p426 ; Zhang L., 2013, CHIN J SCH HLTH, V34, P575, DOI [10.16835/j.cnki.1000-9817.2013.05.023, DOI 10.16835/J.CNKI.1000-9817.2013.05.023]; Zhang Y, 2014, CLIN MICROBIOL INFEC, V20, pO566, DOI 10.1111/1469-0691.12530; Zhu Q, 2013, CHIN J SCH HLTH, V34, p199 ; 2007, WKLY EPIDEMIOL REC, V82, P51	38	45	52	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0169561	10.1371/journal.pone.0169561	http://dx.doi.org/10.1371/journal.pone.0169561			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085897	gold, Green Published, Green Submitted			2022-12-26	WOS:000391972600025
J	Nakajima, S; Aikawe, C; Nozawa, T; Minowa-Nozawa, A; Toh, H; Nakagawa, I				Nakajima, Shintaro; Aikawe, Chihiro; Nozawa, Takashi; Minowa-Nozawa, Atsuko; Toh, Hirotaka; Nakagawa, Ichiro			Bcl-xL Affects Group A Streptococcus-Induced Autophagy Directly, by Inhibiting Fusion between Autophagosomes and Lysosomes, and Indirectly, by Inhibiting Bacterial Internalization via Interaction with Beclin 1-UVRAG	PLOS ONE			English	Article							INFECTED EPITHELIAL-CELLS; C-VPS COMPLEX; ENDOCYTIC TRAFFICKING; MAMMALIAN AUTOPHAGY; FAMILY-MEMBERS; UVRAG; INVASION; PROTEIN; ATG14L; APOPTOSIS	Anti-apoptotic Bcl-2 and Bcl-xL are proposed to regulate starvation-induced autophagy by directly interacting with Beclin 1. Beclin 1 is also thought to be involved in multiple vesicle trafficking pathways such as endocytosis by binding to Atg14L and UVRAG. However, how the interaction of Bcl-2 family proteins and Beclin 1 regulates anti-bacterial autophagy (xenophagy) is still unclear. In this study, we analyzed these interactions using Group A Streptococcus (GAS; Streptococcus pyogenes) infection as a model. GAS is internalized into epithelial cells through endocytosis, while the intracellular fate of GAS is degradation by autophagy. Here, we found that Bcl-xL but not Bcl-2 regulates GAS-induced autophagy. Autophagosome-lysosome fusion and the internalization process during GAS infection were promoted in Bcl-xL knockout cells. In addition, knockout of Beclin 1 phenocopied the internalization defect of GAS. Furthermore, UVRAG interacts not only with Beclin 1 but also with Bcl-xL, and overexpression of UVRAG partially rescued the internalization defect of Beclin 1 knockout cells during GAS infection. Thus, our results indicate that Bcl-xL inhibits GAS-induced autophagy directly by suppressing autophagosome-lysosome fusion and indirectly by suppressing GAS internalization via interaction with Beclin 1-UVRAG.	[Nakajima, Shintaro; Aikawe, Chihiro; Nozawa, Takashi; Minowa-Nozawa, Atsuko; Toh, Hirotaka; Nakagawa, Ichiro] Kyoto Univ, Grad Sch Med, Dept Microbiol, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Japan	Kyoto University	Nakagawa, I (corresponding author), Kyoto Univ, Grad Sch Med, Dept Microbiol, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Japan.	nakagawa.ichiro.7w@kyoto-u.ac.jp	Nakajima, Shintaro/AAU-8720-2020	Nakajima, Shintaro/0000-0003-4858-3391; Toh, Hirotaka/0000-0003-0753-0787	JSPS KAKENHI [JP25293370, JP16K08775, JP16H05188]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Support was provided by JSPS KAKENHI JP25293370, JP16K08775 and JP16H05188 [https://www.jsps.go.jp/j-grantsinaid/index.html].	Aikawa C, 2010, CELL MICROBIOL, V12, P814, DOI 10.1111/j.1462-5822.2010.01435.x; Amelung S, 2011, CELL MICROBIOL, V13, P1200, DOI 10.1111/j.1462-5822.2011.01610.x; Barnett TC, 2013, CELL HOST MICROBE, V14, P675, DOI 10.1016/j.chom.2013.11.003; Birmingham CL, 2007, AUTOPHAGY, V3, P442, DOI 10.4161/auto.4450; Birmingham CL, 2006, AUTOPHAGY, V2, P156, DOI 10.4161/auto.2825; Burman C, 2010, FEBS LETT, V584, P1302, DOI 10.1016/j.febslet.2010.01.011; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Haobam B, 2014, CELL MICROBIOL, V16, P1806, DOI 10.1111/cmi.12329; He RN, 2015, AUTOPHAGY, V11, P740, DOI 10.1080/15548627.2015.1034404; He SS, 2013, NAT CELL BIOL, V15, P1206, DOI 10.1038/ncb2848; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kim HJ, 2012, J CELL SCI, V125, P4740, DOI 10.1242/jcs.100339; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Li XH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1648; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; McKnight NC, 2014, PLOS GENET, P10; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Molinari G, 2000, CELL MICROBIOL, V2, P145, DOI 10.1046/j.1462-5822.2000.00040.x; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nakagawa I, 2001, CELL MICROBIOL, V3, P395, DOI 10.1046/j.1462-5822.2001.00122.x; Noble CG, 2008, J BIOL CHEM, V283, P26274, DOI 10.1074/jbc.M804723200; O'Seaghdha M, 2013, PLOS PATHOG, P9; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Oda S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147061; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Paz I, 2010, CELL MICROBIOL, V12, P530, DOI 10.1111/j.1462-5822.2009.01415.x; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Pirooz SD, 2014, P NATL ACAD SCI USA, V111, P2716, DOI 10.1073/pnas.1320629111; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Talay SR, 2000, CELL MICROBIOL, V2, P521, DOI 10.1046/j.1462-5822.2000.00076.x; Thoresen SB, 2010, EXP CELL RES, V316, P3368, DOI 10.1016/j.yexcr.2010.07.008; Vento MT, 2010, PLOS ONE, P5; Yoshikawa Y, 2009, AUTOPHAGY, V5, P1220, DOI 10.4161/auto.5.8.10177; Yoshimori T, 2008, CURR OPIN CELL BIOL, V20, P401, DOI 10.1016/j.ceb.2008.03.010; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	52	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0170138	10.1371/journal.pone.0170138	http://dx.doi.org/10.1371/journal.pone.0170138			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085926	Green Published, Green Submitted, gold			2022-12-26	WOS:000391972600067
J	Ai, Y; Zhang, CL; Sun, YL; Wang, WN; He, YH; Bao, MZ				Ai, Ye; Zhang, Chunling; Sun, Yalin; Wang, Weining; He, Yanhong; Bao, Manzhu			Characterization and Functional Analysis of Five MADS-Box B Class Genes Related to Floral Organ Identification in Tagetes erecta	PLOS ONE			English	Article							FLOWER DEVELOPMENT; HOMEOTIC GENE; MOLECULAR EVOLUTION; IDENTITY GENES; DISC FLORETS; APETALA3; DIVERSIFICATION; EXPRESSION; DEFICIENS; ROLES	According to the floral organ development ABC model, B class genes specify petal and stamen identification. In order to study the function of B class genes in flower development of Tagetes erecta, five MADS-box B class genes were identified and their expression and putative functions were studied. Sequence comparisons and phylogenetic analyses indicated that there were one PI-like gene-TePI, two euAP3-like genes-TeAP3-1 and TeAP3-2, and two TM6-like genes-TeTM6-1 and TeTM6-2 in T. erecta. Strong expression levels of these genes were detected in stamens of the disk florets, but little or no expression was detected in bracts, receptacles or vegetative organs. Yeast hybrid experiments of the B class proteins showed that TePI protein could form a homodimer and heterodimers with all the other four B class proteins TeAP3-1, TeAP3-2, TeTM6-1 and TeTM6-2. No homodimer or interaction was observed between the euAP3 and TM6 clade members. Over-expression of five B class genes of T. erecta in Nicotiana rotundifolia showed that only the transgenic plants of 35S::TePI showed altered floral morphology compared with the non-transgenic line. This study could contribute to the understanding of the function of B class genes in flower development of T. erecta, and provide a theoretical basis for further research to change floral organ structures and create new materials for plant breeding.	[Ai, Ye; Zhang, Chunling; He, Yanhong; Bao, Manzhu] Huazhong Agr Univ, Key Lab Hort Plant Biol, Minist Educ, Coll Hort & Forestry Sci, Wuhan, Hubei, Peoples R China; [Ai, Ye] Fujian Agr & Forestry Univ, Coll Landscape Architecture, Fuzhou, Fujian, Peoples R China; [Sun, Yalin] Wuhan Acad Agr Sci, Inst Vegetable Sci, Wuhan, Hubei, Peoples R China; [Wang, Weining] Univ Florida, Gulf Coast Res & Educ Ctr, Dept Environm Hort, Wimauma, FL USA	Huazhong Agricultural University; Fujian Agriculture & Forestry University; State University System of Florida; University of Florida	He, YH; Bao, MZ (corresponding author), Huazhong Agr Univ, Key Lab Hort Plant Biol, Minist Educ, Coll Hort & Forestry Sci, Wuhan, Hubei, Peoples R China.	hyh2010@mail.hzau.edu.cn; mzbao@mail.hzau.edu.cn		Wang, Weining/0000-0002-3743-4721	National Natural Science Foundation of China [31201647, 31672181]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by funding from National Natural Science Foundation of China (31201647, 31672181) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150892; Ai Y, 2015, EUPHYTICA, V203, P349, DOI 10.1007/s10681-014-1278-y; Ambrose BA, 2000, MOL CELL, V5, P569, DOI 10.1016/S1097-2765(00)80450-5; Angenent GC, 1996, TRENDS PLANT SCI, V1, P228; Ayyadurai N., 2013, African Journal of Pharmacy and Pharmacology, V7, P736; Barker MS, 2008, MOL BIOL EVOL, V25, P2445, DOI 10.1093/molbev/msn187; Beena J. B., 2013, EURO J EXP BIO, V3, P422; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; Broholm SK, 2010, J EXP BOT, V61, P75, DOI 10.1093/jxb/erp279; Chang YY, 2010, PLANT PHYSIOL, V152, P837, DOI 10.1104/pp.109.147116; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; COLOMBO L, 1995, PLANT CELL, V7, P1859, DOI 10.1105/tpc.7.11.1859; Davies B, 1996, PLANT J, V10, P663, DOI 10.1046/j.1365-313X.1996.10040663.x; de Martino G, 2006, PLANT CELL, V18, P1833, DOI 10.1105/tpc.106.042978; Dezar CA, 2003, J EXP BOT, V54, P1637, DOI 10.1093/jxb/erg163; Ditta G, 2004, CURR BIOL, V14, P1935, DOI 10.1016/j.cub.2004.10.028; Favaro R, 2002, MOL GENET GENOMICS, V268, P152, DOI 10.1007/s00438-002-0746-6; GOTO K, 1994, GENE DEV, V8, P1548, DOI 10.1101/gad.8.13.1548; Guerin J, 2000, PLANTA, V210, P914, DOI 10.1007/s004250050697; He YH, 2009, PLANT BREEDING, V128, P92, DOI 10.1111/j.1439-0523.2008.01536.x; He YH, 2010, MOL BREEDING, V26, P19, DOI 10.1007/s11032-009-9372-x; Hibino Y, 2006, PLANT SCI, V170, P778, DOI 10.1016/j.plantsci.2005.11.010; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; JACK T, 1992, CELL, V68, P683, DOI 10.1016/0092-8674(92)90144-2; Kang HG, 1998, PLANT MOL BIOL, V38, P1021, DOI 10.1023/A:1006051911291; Kim ST, 2004, AM J BOT, V91, P2102, DOI 10.3732/ajb.91.12.2102; Kramer EM, 2007, PLANT CELL, V19, P750, DOI 10.1105/tpc.107.050385; Kramer EM, 1998, GENETICS, V149, P765; Kramer EM, 2000, INT J PLANT SCI, V161, pS29, DOI 10.1086/317576; Krizek BA, 1996, DEVELOPMENT, V122, P11; Kyozuka J, 2000, PLANT CELL PHYSIOL, V41, P710, DOI 10.1093/pcp/41.6.710; Li XF, 2013, PLANT MOL BIOL REP, V31, P255, DOI 10.1007/s11105-012-0493-8; Liu H, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2733-z; Liu Z, 2014, PLANT BREEDING, V133, P742, DOI 10.1111/pbr.12216; Nagasawa N, 2003, DEVELOPMENT, V130, P705, DOI 10.1242/dev.00294; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; PURUGGANAN MD, 1995, GENETICS, V140, P345; Rijpkema AS, 2006, PLANT CELL, V18, P1819, DOI 10.1105/tpc.106.042937; Roque E, 2013, PLANT J, V73, P663, DOI 10.1111/tpj.12068; SCHWARZSOMMER Z, 1990, SCIENCE, V250, P931, DOI 10.1126/science.250.4983.931; Shulga OA, 2008, RUSS J DEV BIOL, V39, P2, DOI 10.1134/S1062360408010025; SINGH B, 1971, INDIAN J GENET PL BR, V31, P407; SOMMER H, 1990, EMBO J, V9, P605, DOI 10.1002/j.1460-2075.1990.tb08152.x; Sreekala C, 2003, THEOR APPL GENET, V106, P771, DOI 10.1007/s00122-002-1143-6; Theissen G, 2001, CURR OPIN PLANT BIOL, V4, P75, DOI 10.1016/S1369-5266(00)00139-4; Theissen G, 1996, J MOL EVOL, V43, P484, DOI 10.1007/PL00006110; Theissen G, 2001, NATURE, V409, P469, DOI 10.1038/35054172; TROBNER W, 1992, EMBO J, V11, P4693, DOI 10.1002/j.1460-2075.1992.tb05574.x; Tsai WC, 2005, PLANT CELL PHYSIOL, V46, P1125, DOI 10.1093/pcp/pci125; Tsai WC, 2008, PLANT CELL PHYSIOL, V49, P814, DOI 10.1093/pcp/pcn059; Tsuchimoto S, 2000, GENES CELLS, V5, P89, DOI 10.1046/j.1365-2443.2000.00308.x; Tzeng TY, 2004, J BIOL CHEM, V279, P10747, DOI 10.1074/jbc.M311646200; Vandenbussche M, 2004, PLANT CELL, V16, P741, DOI 10.1105/tpc.019166; Vasudevan P, 1997, BIORESOURCE TECHNOL, V62, P29, DOI 10.1016/S0960-8524(97)00101-6; WEIGEL D, 1994, CELL, V78, P203, DOI 10.1016/0092-8674(94)90291-7; Xu ZD, 2014, MOL GENET GENOMICS, V289, P903, DOI 10.1007/s00438-014-0863-z; Yu DY, 1999, PLANT J, V17, P51, DOI 10.1046/j.1365-313X.1999.00351.x; Zhang J, 2011, ADV DRUG DELIVER REV, V63, P441, DOI 10.1016/j.addr.2010.11.002; Zhang Q, 2011, DEV GENES EVOL, V221, P83, DOI 10.1007/s00427-011-0361-9	59	13	15	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169777	10.1371/journal.pone.0169777	http://dx.doi.org/10.1371/journal.pone.0169777			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081202	Green Published, gold, Green Submitted			2022-12-26	WOS:000391949500076
J	Ribic, CA; Donner, DM; Beck, AJ; Rugg, DJ; Reinecke, S; Eklund, DA				Ribic, Christine A.; Donner, Deahn M.; Beck, Albert J.; Rugg, David J.; Reinecke, Sue; Eklund, Dan			Beaver Colony Density Trends on the Chequamegon-Nicolet National Forest, 1987-2013	PLOS ONE			English	Article							CLIMATE-CHANGE; DYNAMICS; WISCONSIN; HABITAT	The North American beaver (Castor canadensis) is a managed species in the United States. In northern Wisconsin, as part of the state-wide beaver management program, the Chequamegon-Nicolet National Forest removes beavers from targeted trout streams on U.S. Forest Service lands. However, the success of this management program has not been evaluated. Targeted removals comprise only 3% of the annual beaver harvest, a level of effort that may not affect the beaver population. We used colony location data along Forest streams from 1987-2013 (Nicolet, northeast Wisconsin) and 1997-2013 (Chequamegon, northwest Wisconsin) to assess trends in beaver colony density on targeted trout streams compared to non-targeted streams. On the Chequamegon, colony density on non-targeted trout and non-trout streams did not change over time, while colony density on targeted trout streams declined and then stabilized. On the Nicolet, beaver colony density decreased on both non targeted streams and targeted trout streams. However, colony density on targeted trout streams declined faster. The impact of targeted trapping was similar across the two sides of the Forest (60% reduction relative to non-targeted trout streams). Exploratory analyses of weather influences found that very dry conditions and severe winters were associated with transient reductions in beaver colony density on non-targeted streams on both sides of the Forest. Our findings may help land management agencies weigh more finely calibrated beaver control measures against continued large-scale removal programs.	[Ribic, Christine A.] Univ Wisconsin, US Geol Survey, Wisconsin Cooperat Wildlife Res Unit, Madison, WI 53706 USA; [Donner, Deahn M.] US Forest Serv, Inst Appl Ecosyst Studies, Northern Res Stn, Rhinelander, WI USA; [Beck, Albert J.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Wisconsin Cooperat Wildlife Res Unit, Madison, WI USA; [Rugg, David J.] US Forest Serv, Northern Res Stn, Madison, WI USA; [Reinecke, Sue; Eklund, Dan] US Forest Serv, Chequamegon Nicolet Natl Forest, Park Falls, WI USA	United States Department of the Interior; United States Geological Survey; University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); United States Forest Service; University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service	Ribic, CA (corresponding author), Univ Wisconsin, US Geol Survey, Wisconsin Cooperat Wildlife Res Unit, Madison, WI 53706 USA.	caribic@wisc.edu		Rugg, David/0000-0003-2280-8302	US Forest Service [12-JV-11242313-078]; Department of Forest and Wildlife Ecology, University of Wisconsin-Madison [12-JV-11242313-078]	US Forest Service(United States Department of Agriculture (USDA)United States Forest Service); Department of Forest and Wildlife Ecology, University of Wisconsin-Madison	This project was done as part of Research Joint Venture 12-JV-11242313-078 between the US Forest Service and the Department of Forest and Wildlife Ecology, University of Wisconsin-Madison. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Animal and Plant Health Inspection Service, 2012, COOP BEAV DAM MAN PR, P8; Auguie B, 2017, GRIDEXTRA MISCELLANE; BERGERUD AT, 1977, CAN J ZOOL, V55, P1480, DOI 10.1139/z77-192; BOYCE MS, 1981, J APPL ECOL, V18, P749, DOI 10.2307/2402366; Boyle S., 2007, N AM BEAVER CASTOR C, P50; BUECH RR, 1989, CAN J ZOOL, V67, P1061, DOI 10.1139/z89-147; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Busher Peter E., 1999, P147; Campbell RD, 2013, GLOBAL CHANGE BIOL, V19, P1311, DOI 10.1111/gcb.12114; Campbell RD, 2012, GLOBAL CHANGE BIOL, V18, P2730, DOI 10.1111/j.1365-2486.2012.02739.x; Chequamegon-Nicolet National Forests, 2004, R9CNFP CHEQ NIC NAT; Collen P, 2001, REV FISH BIOL FISHER, V10, P439; Dickerson L, 1989, 4 E WILDL DAM CONTR, P135; ESRI, 2013, ARCGIS VERS 10 2 0; Fryxell JM, 2001, J ANIM ECOL, V70, P310, DOI 10.1046/j.1365-2656.2001.00492.x; Gustafson EJ, 2003, FOREST SCI, V49, P499; Henderson FR., 1960, STATE BIOL SURVEY MU, V26; Jarema SI, 2009, GLOBAL CHANGE BIOL, V15, P508, DOI 10.1111/j.1365-2486.2008.01732.x; JENKINS SH, 1979, MAMMALIAN SPECIES, V120, P1; JOHNSON DR, 1974, CAN J ZOOL, V52, P1519, DOI 10.1139/z74-195; Knudsen G.J., 1962, WISCONSIN CONSERVATI, V25, P52; Knudsen GJ, 1963, MISCELLANEOUS RES RE, V7, P15; Kucharik CJ, 2010, PHYS GEOGR, V31, P1, DOI 10.2747/0272-3646.31.1.1; MACARTHUR RA, 1989, CAN J ZOOL, V67, P651, DOI 10.1139/z89-094; Martin L., 1932, BULLETIN, VXXXVI; MCRAE G, 1994, T AM FISH SOC, V123, P641, DOI 10.1577/1548-8659(1994)123<0641:TCOWHS>2.3.CO;2; Northwest Alliance for Computational Science and Engineering, 2015, PRISM CLIM DAT; Novak M., 1987, P282; Rolley RE, 2011, BEAVER POPULATION AN; Rolley RE, 2008, BEAVER POPULATION AN; Savery TS, 2001, J AM WATER RESOUR AS, V37, P641, DOI 10.1111/j.1752-1688.2001.tb05500.x; Sun LX, 2000, CAN J ZOOL, V78, P393, DOI 10.1139/cjz-78-3-393; US Drought Portal, 2015, PALM DROUGHT SEV IND; Wisconsin Department of Natural Resources, 2015, WISC BEAV MAN PLAN 2; Wisconsin Initiative on Climate Change Impacts, 2011, WISC CHANG CLIM CHAN, P217; Wisconsin State Climatology Office, 2015, CLIM OF WISC; Wisconsin Trout Fishing, 2015, TROUT STREAM CLASS; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	38	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0170099	10.1371/journal.pone.0170099	http://dx.doi.org/10.1371/journal.pone.0170099			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081271	gold, Green Published, Green Submitted			2022-12-26	WOS:000391949500131
J	Farina, F; Fontanelli, D; Garulli, A; Giannitrapani, A; Prattichizzo, D				Farina, Francesco; Fontanelli, Daniele; Garulli, Andrea; Giannitrapani, Antonio; Prattichizzo, Domenico			Walking Ahead: The Headed Social Force Model	PLOS ONE			English	Article							PEDESTRIAN DYNAMICS; EVACUATION; LOCOMOTION; SIMULATION; AVOIDANCE; MOTION	Human motion models are finding an increasing number of novel applications in many different fields, such as building design, computer graphics and robot motion planning. The Social Force Model is one of the most popular alternatives to describe the motion of pedestrians. By resorting to a physical analogy, individuals are assimilated to point-wise particles subject to social forces which drive their dynamics. Such a model implicitly assumes that humans move isotropically. On the contrary, empirical evidence shows that people do have a preferred direction of motion, walking forward most of the time. Lateral motions are observed only in specific circumstances, such as when navigating in overcrowded environments or avoiding unexpected obstacles. In this paper, the Headed Social Force Model is introduced in order to improve the realism of the trajectories generated by the classical Social Force Model. The key feature of the proposed approach is the inclusion of the pedestrians' heading into the dynamic model used to describe the motion of each individual. The force and torque representing the model inputs are computed as suitable functions of the force terms resulting from the traditional Social Force Model. Moreover, a new force contribution is introduced in order to model the behavior of people walking together as a single group. The proposed model features high versatility, being able to reproduce both the unicycle-like trajectories typical of people moving in open spaces and the point-wise motion patterns occurring in high density scenarios. Extensive numerical simulations show an increased regularity of the resulting trajectories and confirm a general improvement of the model realism.	[Farina, Francesco; Garulli, Andrea; Giannitrapani, Antonio; Prattichizzo, Domenico] Univ Siena, Dipartimento Ingn Informaz & Sci Matemat, Siena, Italy; [Fontanelli, Daniele] Univ Trento, Dipartimento Ingn Ind, Trento, Italy	University of Siena; University of Trento	Farina, F (corresponding author), Univ Siena, Dipartimento Ingn Informaz & Sci Matemat, Siena, Italy.	farina@diism.unisi.it	Farina, Francesco/ABG-3367-2020; Farina, Francesco/AAC-5681-2020	Farina, Francesco/0000-0001-8367-9706; Giannitrapani, Antonio/0000-0002-9756-7817; GARULLI, Andrea/0000-0002-4174-073X; PRATTICHIZZO, Domenico/0000-0001-9051-9698; Fontanelli, Daniele/0000-0002-5486-9989	European Union [643644]	European Union(European Commission)	This paper has received funding from the European Union's Horizon 2020 Research and Innovation Programme - Societal Challenge 1 (DG CONNECT/H) under grant agreement n. 643644 "ACANTO - A CyberphysicAl social NeTwOrk using robot friends". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonini G, 2006, TRANSPORT RES B-METH, V40, P667, DOI 10.1016/j.trb.2005.09.006; Arechavaleta G, 2008, AUTON ROBOT, V25, P25, DOI 10.1007/s10514-007-9075-2; Arechavaleta G, 2008, IEEE T ROBOT, V24, P5, DOI 10.1109/TRO.2008.915449; Bennewitz M, 2005, INT J ROBOT RES, V24, P31, DOI 10.1177/0278364904048962; Burstedde C, 2001, PHYSICA A, V295, P507, DOI 10.1016/S0378-4371(01)00141-8; Du Toit NE, 2012, IEEE T ROBOT, V28, P101, DOI 10.1109/TRO.2011.2166435; Ferrer G, 2014, IEEE INT C INT ROBOT, P1730, DOI 10.1109/IROS.2014.6942788; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Guo N, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-30531-8; Guo RY, 2014, PHYSICA A, V415, P428, DOI 10.1016/j.physa.2014.08.036; Guo W, 2015, PHYSICA A, V432, P87, DOI 10.1016/j.physa.2015.03.020; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; HELBING D, 1995, PHYS REV E, V51, P4282, DOI 10.1103/PhysRevE.51.4282; Helbing D., 2009, ENCY COMPLEXITY SYST, P6476, DOI DOI 10.1007/978-1-4419-7695-6; HENDERSON LF, 1971, NATURE, V229, P381, DOI 10.1038/229381a0; Johansson F, 2015, PHYSICA A, V419, P95, DOI 10.1016/j.physa.2014.10.003; Johanssons A, 2007, ADV COMPLEX SYST, p[10, 271], DOI DOI 10.1142/S0219525907001355; Kretzschmar H, 2014, IEEE INT CONF ROBOT, P4015, DOI 10.1109/ICRA.2014.6907442; Kuipers B, 2000, ARTIF INTELL, V119, P191, DOI 10.1016/S0004-3702(00)00017-5; Mombaur K, 2010, AUTON ROBOT, V28, P369, DOI 10.1007/s10514-009-9170-7; Moussaid M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010047; Okazaki S., 1979, T AIJ, V283, P111; Pham QC, 2007, EUR J NEUROSCI, V26, P2391, DOI 10.1111/j.1460-9568.2007.05835.x; Ratsamee P, 2013, INT J HUM ROBOT, V10, DOI 10.1142/S0219843613500084; Schadschneider A, 2002, PEDESTRIAN AND EVACUATION DYNAMICS, P75; Seitz MJ, 2015, PHYSICA A, V421, P594, DOI 10.1016/j.physa.2014.11.064; Seyfried A, 2006, PHYSICA A, V368, P232, DOI 10.1016/j.physa.2005.11.052; Shukla PK, 2010, LECT NOTES COMPUT SC, V6024, P21, DOI 10.1007/978-3-642-12239-2_3; Steffen B, 2010, PEDESTRIAN AND EVACUATION DYNAMICS 2008, P677, DOI 10.1007/978-3-642-04504-2_64; Tang TQ, 2017, PHYSICA A, V467, P157, DOI 10.1016/j.physa.2016.10.008; Tang TQ, 2015, PHYSICA A, V440, P49, DOI 10.1016/j.physa.2015.08.002; Tang TQ, 2012, TRANSPORT RES C-EMER, V22, P1, DOI 10.1016/j.trc.2011.11.005; Yang X., 2011, VISUAL COMMUNICATION, P1, DOI DOI 10.1109/VCIP.2011.6116003; Yu WJ, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026112; Zanlungo F, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/68005; Zheng XP, 2009, BUILD ENVIRON, V44, P437, DOI 10.1016/j.buildenv.2008.04.002; ZHU QM, 1991, IEEE T ROBOTIC AUTOM, V7, P390, DOI 10.1109/70.88149	37	56	57	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169734	10.1371/journal.pone.0169734	http://dx.doi.org/10.1371/journal.pone.0169734			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076435	Green Submitted, Green Published, gold			2022-12-26	WOS:000391857100051
J	Grois, L; Hupf, J; Reinders, J; Schroder, J; Dietl, A; Schmid, PM; Jungbauer, C; Resch, M; Maier, LS; Luchner, A; Birner, C				Grois, Laura; Hupf, Julian; Reinders, Joerg; Schroeder, Josef; Dietl, Alexander; Schmid, Peter M.; Jungbauer, Carsten; Resch, Markus; Maier, Lars S.; Luchner, Andreas; Birner, Christoph			Combined Inhibition of the Renin-Angiotensin System and Neprilysin Positively Influences Complex Mitochondrial Adaptations in Progressive Experimental Heart Failure	PLOS ONE			English	Article							PRESERVED EJECTION FRACTION; CARDIOMYOPATHIC HAMSTERS; DIFFERENTIAL EXPRESSION; OXIDATIVE STRESS; NERVOUS-SYSTEM; OMAPATRILAT; PATHOPHYSIOLOGY; DYSFUNCTION; METABOLISM; ENALAPRIL	Background Inhibitors of the renin angiotensin system and neprilysin (RAS-/NEP-inhibitors) proved to be extraordinarily beneficial in systolic heart failure. Furthermore, compelling evidence exists that impaired mitochondrial pathways are causatively involved in progressive left ventricular (LV) dysfunction. Consequently, we aimed to assess whether RAS-/NEP-inhibition can attenuate mitochondrial adaptations in experimental heart failure (HF). Methods and Results By progressive right ventricular pacing, distinct HF stages were induced in 15 rabbits, and 6 animals served as controls (CTRL). Six animals with manifest HF (CHF) were treated with the RAS-/NEP-inhibitor omapatrilat. Echocardiographic studies and invasive blood pressure measurements were undertaken during HF progression. Mitochondria were isolated from LV tissue, respectively, and further worked up for proteomic analysis using the SWATH technique. Enzymatic activities of citrate synthase and the electron transfer chain (ETC) complexes I, II, and IV were assessed. Ultrastructural analyses were performed by transmission electron microscopy. During progression to overt HF, intricate expression changes were mainly detected for proteins belonging to the tricarboxylic acid cycle, glucose and fat metabolism, and the ETC complexes, even though ETC complex I, II, or IV enzymatic activities were not significantly influenced. Treatment with a RAS-/NEP-inhibitor then reversed some maladaptive metabolic adaptations, positively influenced the decline of citrate synthase activity, and altered the composition of each respiratory chain complex, even though this was again not accompanied by altered ETC complex enzymatic activities. Finally, ultrastructural evidence pointed to a reduction of autophagolytic and degenerative processes with omapatrilat-treatment. Conclusions This study describes complex adaptations of the mitochondrial proteome in experimental tachycardia-induced heart failure and shows that a combined RAS-/NEP-inhibition can beneficially influence mitochondrial key pathways.	[Grois, Laura; Hupf, Julian; Dietl, Alexander; Schmid, Peter M.; Jungbauer, Carsten; Resch, Markus; Maier, Lars S.; Birner, Christoph] Univ Hosp Regensburg, Dept Internal Med 2, Regensburg, Germany; [Reinders, Joerg] Univ Regensburg, Inst Funct Genom, Regensburg, Germany; [Schroeder, Josef] Univ Hosp Regensburg, Inst Pathol, Electron Microscopy Core Facil, Regensburg, Germany; [Luchner, Andreas] Clin St Marien, Dept Internal Med 1, Amberg, Germany	University of Regensburg; University of Regensburg; University of Regensburg	Birner, C (corresponding author), Univ Hosp Regensburg, Dept Internal Med 2, Regensburg, Germany.	christoph.birner@klinik.uni-regensburg.de	Maier, Lars/AAQ-8313-2021	Maier, Lars/0000-0001-9915-4429; Reinders, Joerg/0000-0003-1025-7849	University Hospital Regensburg	University Hospital Regensburg	This work was supported by an institutional research grant (ReForM-A) of the University Hospital Regensburg.; This work was supported by an institutional research grant (ReForM-A) of the University Hospital Regensburg. We greatly appreciate the outstanding technical assistance of Ms. Ingrid Winkel. This paper contains parts of the MD thesis of Ms. Laura Grois.	Agnetti G, 2010, CIRC-CARDIOVASC GENE, V3, P78, DOI 10.1161/CIRCGENETICS.109.871236; ANDERSSON B, 1995, CHEST, V107, P680, DOI 10.1378/chest.107.3.680; Birner C, 2014, CELL PHYSIOL BIOCHEM, V33, P692, DOI 10.1159/000358645; Birner C, 2012, N-S ARCH PHARMACOL, V385, P1117, DOI 10.1007/s00210-012-0791-6; Birner C, 2012, J CARD FAIL, V18, P660, DOI 10.1016/j.cardfail.2012.06.418; Birner C, 2012, N-S ARCH PHARMACOL, V385, P473, DOI 10.1007/s00210-011-0723-x; Birner CM, 2007, CYTOKINE, V40, P89, DOI 10.1016/j.cyto.2007.08.009; Bluemlein K, 2011, NAT PROTOC, V6, P859, DOI 10.1038/nprot.2011.333; Boehm EA, 2001, AM J PHYSIOL-HEART C, V280, pH977, DOI 10.1152/ajpheart.2001.280.3.H977; Cioffi G, 2004, J CARD FAIL, V10, P481, DOI 10.1016/j.cardfail.2004.03.004; Dedkova EN, 2013, J MOL CELL CARDIOL, V59, P41, DOI 10.1016/j.yjmcc.2013.01.016; Dietl A, 2014, EUR J HEART FAIL, V16, P835, DOI 10.1002/ejhf.122; Dodd MS, 2014, CIRC-CARDIOVASC IMAG, V7, P895, DOI 10.1161/CIRCIMAGING.114.001857; Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376; Dolinsky VW, 2013, AM J PHYSIOL-ENDOC M, V305, pE243, DOI 10.1152/ajpendo.00044.2013; Duncan CJ, 1991, CALCIUM OXYGEN RADIC; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Goldberg IJ, 2012, CELL METAB, V15, P805, DOI 10.1016/j.cmet.2012.04.006; Gupte AA, 2014, CIRC-CARDIOVASC GENE, V7, P266, DOI 10.1161/CIRCGENETICS.113.000404; Hjalmarson A, 1999, LANCET, V353, P2001; Jain-Ghai S, 2013, AM J MED GENET A, V161A, P285, DOI 10.1002/ajmg.a.35714; Jhund PS, 2014, EUR J HEART FAIL, V16, P671, DOI 10.1002/ejhf.76; Kramer KA, 2005, CLIN CHEM, V51, P2110, DOI 10.1373/clinchem.2005.050146; Lechat P, 1999, LANCET, V353, P9; Luchner A, 2001, CARDIOVASC RES, V51, P601, DOI 10.1016/S0008-6363(01)00316-9; Lushnikova EL, 2008, B EXP BIOL MED+, V146, P366, DOI 10.1007/s10517-008-0287-z; Lymperopoulos A, 2013, CIRC RES, V113, P739, DOI 10.1161/CIRCRESAHA.113.300308; Marin-Garcia J, 2001, CARDIOVASC RES, V52, P103, DOI 10.1016/S0008-6363(01)00368-6; Marin-Garcia J, 2008, HEART FAIL REV, V13, P137, DOI 10.1007/s10741-007-9079-1; Marin-Garcia J, 2009, J CARD FAIL, V15, P700, DOI 10.1016/j.cardfail.2009.04.010; MarinGarcia J, 1996, BIOCHEM MOL BIOL INT, V40, P487; McClean DR, 2000, J AM COLL CARDIOL, V36, P479, DOI 10.1016/S0735-1097(00)00741-5; McMurray JJV, 2015, EUR J HEART FAIL, V17, P242, DOI 10.1002/ejhf.250; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Meyers DE, 2013, TEX HEART I J, V40, P385; Miyata S, 2006, AM J PATHOL, V168, P386, DOI 10.2353/ajpath.2006.050137; Moe GW, 2004, AM J PHYSIOL-HEART C, V287, pH1813, DOI 10.1152/ajpheart.00036.2004; Packer M, 2002, CIRCULATION, V106, P920, DOI 10.1161/01.CIR.0000029801.86489.50; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Qanud K, 2008, AM J PHYSIOL-HEART C, V295, pH2098, DOI 10.1152/ajpheart.00471.2008; Reinders Y, 2016, METHODS MOL BIOL, V1394, P101, DOI 10.1007/978-1-4939-3341-9_8; Rosca MG, 2008, CARDIOVASC RES, V80, P30, DOI 10.1093/cvr/cvn184; Solomon SD, 2012, LANCET, V380, P1387, DOI 10.1016/S0140-6736(12)61227-6; Srere PA, 1973, CITRIC ACID CYCLE, P3; Trindade P T, 2001, Heart Fail Monit, V2, P2; Trippodo NC, 1999, J CARDIOVASC PHARM, V34, P782, DOI 10.1097/00005344-199912000-00003; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011; Wende AR, 2015, PROTEOMICS CLIN APPL; Zhang DY, 2014, CARDIOL CLIN, V32, P33, DOI 10.1016/j.ccl.2013.09.010; Zucker IH, 2014, CLIN SCI, V126, P695, DOI 10.1042/CS20130294	50	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169743	10.1371/journal.pone.0169743	http://dx.doi.org/10.1371/journal.pone.0169743			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076404	Green Published, Green Submitted, gold			2022-12-26	WOS:000391857100053
J	Liu, HP; Zheng, RJ; Wang, P; Yang, H; He, X; Ji, Q; Bai, WJ; Chen, H; Chen, JX; Peng, WX; Liu, SY; Liu, ZH; Ge, BX				Liu, Haipeng; Zheng, Ruijuan; Wang, Peng; Yang, Hua; He, Xin; Ji, Qun; Bai, Wenjuan; Chen, Hao; Chen, Jianxia; Peng, Wenxia; Liu, Siyu; Liu, Zhonghua; Ge, Baoxue			IL-37 Confers Protection against Mycobacterial Infection Involving Suppressing Inflammation and Modulating T Cell Activation	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; PULMONARY TUBERCULOSIS; ADAPTIVE IMMUNITY; HAN POPULATION; GENE; EXPRESSION; CYTOKINE; SUSCEPTIBILITY; POLYMORPHISMS; IL-18R-ALPHA	Interleukin-37 (IL-37), a novel member of the IL-1 family, plays fundamental immunosuppressive roles by broadly reducing both innate inflammation and acquired immunity, but whether it is involved in the pathogenesis of tuberculosis (TB) has not been clearly elucidated. In this study, single nucleotide polymorphism (SNP) analysis demonstrated an association of the genetic variant rs3811047 of IL-37 with TB susceptibility. In line with previous report, a significant elevated IL-37 abundance in the sera and increased expression of IL-37 protein in the peripheral blood mononuclear cells (PBMC) were observed in TB patients in comparison to healthy controls. Moreover, release of IL-37 were detected in either macrophages infected with Mycobacterium tuberculosis (Mtb) or the lung of BCG-infected mice, concurrent with reduced production of proinflammatory cytokines including IL-6 and TNF-alpha. Furthermore, in contrast to wild-type mice, BCG-infected IL-37-Tg mice manifested with reduced mycobacterial burden and tissue damage in the lung, accompanied by higher frequency of Th1 cell and less frequencies of regulatory T cells and Th17 cells in the spleen. Taken together, our findings demonstrated that IL-37 conferred resistance to Mtb infection possibly involving suppressing detrimental inflammation and modulating T cell responses. These findings implicated that IL-37 may be employed as a new molecular target for the therapy and diagnosis of TB.	[Liu, Haipeng; Zheng, Ruijuan; Yang, Hua; Bai, Wenjuan; Chen, Jianxia; Liu, Siyu; Liu, Zhonghua; Ge, Baoxue] Tongji Univ, Shanghai Pulm Hosp, Shanghai TB Key Lab, Shanghai, Peoples R China; [Liu, Haipeng; Bai, Wenjuan; Chen, Hao; Chen, Jianxia; Liu, Siyu; Ge, Baoxue] Tongji Univ, Sch Med, Dept Microbiol & Immunol, Shanghai, Peoples R China; [Liu, Haipeng; Zheng, Ruijuan; He, Xin; Ji, Qun; Bai, Wenjuan; Chen, Jianxia; Peng, Wenxia; Ge, Baoxue] Tongji Univ, Shanghai Pulm Hosp, Clin Translat Res Ctr, Shanghai, Peoples R China; [Wang, Peng] Tongji Univ, Shanghai Pulm Hosp, Dept TB, Shanghai, Peoples R China	Tongji University; Tongji University; Tongji University; Tongji University	Liu, HP; Ge, BX (corresponding author), Tongji Univ, Shanghai Pulm Hosp, Shanghai TB Key Lab, Shanghai, Peoples R China.; Liu, HP; Ge, BX (corresponding author), Tongji Univ, Sch Med, Dept Microbiol & Immunol, Shanghai, Peoples R China.; Liu, HP; Ge, BX (corresponding author), Tongji Univ, Shanghai Pulm Hosp, Clin Translat Res Ctr, Shanghai, Peoples R China.	haipengliu2013@163.com; baoxue_ge@tongji.edu.cn	Liu, Siyu/GYV-4856-2022	Liu, Haipeng/0000-0002-3338-6291	National Natural Science Foundation of China [81200003, 81370108, 81300003]; Science and Technology Commission of Shanghai Municipality [16ZR1428800]; Shanghai Pujiang Program [16PJ408600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Pujiang Program(Shanghai Pujiang Program)	This work was supported by grants from the National Natural Science Foundation of China (no. 81200003 and 81370108 to HPL; no. 81300003 to JXC) and a grant from Science and Technology Commission of Shanghai Municipality (no. 16ZR1428800 to RJZ). Haipeng Liu is sponsored by Shanghai Pujiang Program (16PJ408600 to HPL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai WJ, 2014, CELL SIGNAL, V26, P942, DOI 10.1016/j.cellsig.2014.01.015; Berrington WR, 2007, IMMUNOL REV, V219, P167, DOI 10.1111/j.1600-065X.2007.00545.x; Bulau AM, 2014, P NATL ACAD SCI USA, V111, P2650, DOI 10.1073/pnas.1324140111; Chen X, 2012, J THROMB HAEMOST, V10, P1508, DOI 10.1111/j.1538-7836.2012.04815.x; Dorhoi A, 2016, SEMIN IMMUNOPATHOL, V38, P153, DOI 10.1007/s00281-015-0531-3; Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259; Etna MP, 2014, SEMIN IMMUNOL, V26, P543, DOI 10.1016/j.smim.2014.09.011; Ge R, 2011, MOL BIOL REP, V38, P2281, DOI 10.1007/s11033-010-0359-9; Hmama Z, 2015, IMMUNOL REV, V264, P220, DOI 10.1111/imr.12268; Huang Z, 2015, SCAND J IMMUNOL, V82, P370, DOI 10.1111/sji.12326; Huang Z, 2015, INT J CLIN EXP MED, V8, P7279; Huynh KK, 2011, CURR OPIN IMMUNOL, V23, P464, DOI 10.1016/j.coi.2011.06.002; Khan N, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00328; Li SZ, 2015, P NATL ACAD SCI USA, V112, P2497, DOI 10.1073/pnas.1424626112; Lunding L, 2015, EXPERT REV RESP MED, V9, P739, DOI 10.1586/17476348.2015.1109452; Luo YC, 2014, P NATL ACAD SCI USA, V111, P15178, DOI 10.1073/pnas.1416714111; Lyadova IV, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/854507; Mayer-Barber KD, 2015, IMMUNOL REV, V264, P264, DOI 10.1111/imr.12249; Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944; Nold-Petry CA, 2015, NAT IMMUNOL, V16, P354, DOI 10.1038/ni.3103; Orme IM, 2015, NAT IMMUNOL, V16, P57, DOI 10.1038/ni.3048; Orme IM, 2014, SEMIN IMMUNOL, V26, P601, DOI 10.1016/j.smim.2014.09.009; Pei B, 2013, INT J IMMUNOGENET, V40, P199, DOI 10.1111/iji.12007; Robinson RT, 2015, IMMUNOL REV, V264, P46, DOI 10.1111/imr.12259; Shi LP, 2013, ASIAN PAC J TROP MED, V6, P73, DOI 10.1016/S1995-7645(12)60204-1; Wang X, 2014, COMP MATH MATH PHYS, V2014, P1, DOI DOI 10.1111/CAS.12531; Xu S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14478; Yan N, 2015, J MOL ENDOCRINOL, V55, P209, DOI 10.1530/JME-15-0144; Ye L, 2015, J IMMUNOL, V194, P5110, DOI 10.4049/jimmunol.1401810; Zheng RJ, 2015, TUBERCULOSIS, V95, P497, DOI 10.1016/j.tube.2015.03.009	30	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169922	10.1371/journal.pone.0169922	http://dx.doi.org/10.1371/journal.pone.0169922			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076390	gold, Green Published, Green Submitted			2022-12-26	WOS:000391857100067
J	Yan, F; Xu, KL				Yan, Fang; Xu, Kaili			Application of a Cloud Model-Set Pair Analysis in Hazard Assessment for Biomass Gasification Stations	PLOS ONE			English	Article							F-AND-EI; RENEWABLE ENERGY; RISK-ASSESSMENT; ENTROPY WEIGHT; CHINA; UNCERTAINTY; FIRE; FUEL; SUSTAINABILITY; SYSTEM	Because a biomass gasification station includes various hazard factors, hazard assessment is needed and significant. In this article, the cloud model (CM) is employed to improve set pair analysis (SPA), and a novel hazard assessment method for a biomass gasification station is proposed based on the cloud model-set pair analysis (CM-SPA). In this method, cloud weight is proposed to be the weight of index. In contrast to the index weight of other methods, cloud weight is shown by cloud descriptors; hence, the randomness and fuzziness of cloud weight will make it effective to reflect the linguistic variables of experts. Then, the cloud connection degree (CCD) is proposed to replace the connection degree (CD); the calculation algorithm of CCD is also worked out. By utilizing the CCD, the hazard assessment results are shown by some normal clouds, and the normal clouds are reflected by cloud descriptors; meanwhile, the hazard grade is confirmed by analyzing the cloud descriptors. After that, two biomass gasification stations undergo hazard assessment via CM-SPA and AHP based SPA, respectively. The comparison of assessment results illustrates that the CM-SPA is suitable and effective for the hazard assessment of a biomass gasification station and that CM-SPA will make the assessment results more reasonable and scientific.	[Yan, Fang; Xu, Kaili] Northeastern Univ, Sch Resources & Civil Engn, Shenyang, Liaoning, Peoples R China	Northeastern University - China	Xu, KL (corresponding author), Northeastern Univ, Sch Resources & Civil Engn, Shenyang, Liaoning, Peoples R China.	kaili_xu_neu@126.com			Rural Energy Comprehensive Construction Foundation of the Ministry of Agriculture of the People's Republic of China [2015-36]	Rural Energy Comprehensive Construction Foundation of the Ministry of Agriculture of the People's Republic of China	The study is supported by Rural Energy Comprehensive Construction Foundation of the Ministry of Agriculture of the People's Republic of China, Grant No. 2015-36 (http://www.moa.gov.cn/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study is supported by the Rural Energy Comprehensive Construction Foundation of the Ministry of Agriculture of the People's Republic of China (Grant No. 2015-36).	Bar F, 2016, FUEL, V180, P278, DOI 10.1016/j.fuel.2016.04.028; Bourenane H, 2016, ARAB J GEOSCI, V9, DOI 10.1007/s12517-015-2222-8; Cherni JA, 2007, ENERG POLICY, V35, P3616, DOI 10.1016/j.enpol.2006.12.024; China MoAotPsRo, 2001, 4432001 NYT; China MoAotPsRo, 2005, 092005 NYJT; China tMoPSotPsRo, 2014, 500162014 GB; Christoforou EA, 2015, INT J GREEN ENERGY, V12, P368, DOI 10.1080/15435075.2014.880147; Cross S, 2015, RENEW SUST ENERG REV, V52, P1768, DOI 10.1016/j.rser.2015.07.165; Cummer KR, 2002, BIOMASS BIOENERG, V23, P113, DOI 10.1016/S0961-9534(02)00038-7; Flamos A, 2011, INT J GREEN ENERGY, V8, P411, DOI 10.1080/15435075.2011.576292; Gao XY, 2016, ENERG CONVERS MANAGE, V108, P120, DOI 10.1016/j.enconman.2015.10.070; Guo BB, 2015, EUR J AGRON, V63, P12, DOI 10.1016/j.eja.2014.11.002; Gupta JP, 2003, J LOSS PREVENT PROC, V16, P235, DOI 10.1016/S0950-4230(03)00044-5; Huang CF, 1996, FUZZY SET SYST, V83, P271, DOI 10.1016/0165-0114(95)00382-7; Jensen N, 2007, PROCESS SAF ENVIRON, V85, P51, DOI 10.1205/psep06001; Jiang X, 2015, ECOL ENG, V76, P151, DOI 10.1016/j.ecoleng.2014.04.027; Kazakis N, 2015, SCI TOTAL ENVIRON, V538, P555, DOI 10.1016/j.scitotenv.2015.08.055; Li CH, 2016, SCI TOTAL ENVIRON, V557, P307, DOI 10.1016/j.scitotenv.2016.03.069; Li D, 1998, COMPUT MATH APPL, V35, P99, DOI 10.1016/S0898-1221(97)00282-4; Li D., 2007, ARTIF INTELL, V1; Li DY, 2009, INT J INTELL SYST, V24, P357, DOI 10.1002/int.20340; Li PY, 2011, E-J CHEM, V8, P851; Liu J, 2016, STRUCT MULTIDISCIP O, V53, P81, DOI 10.1007/s00158-015-1334-9; Liu ZB, 2014, ROCK MECH ROCK ENG, V47, P2239, DOI 10.1007/s00603-013-0507-3; Lohri CR, 2016, RENEW SUST ENERG REV, V59, P1514, DOI 10.1016/j.rser.2016.01.088; Lv XJ, 2015, J FUEL CELL SCI TECH, V12, DOI 10.1115/1.4029084; Ogunkoya D, 2015, ENERG CONVERS MANAGE, V95, P342, DOI 10.1016/j.enconman.2015.02.041; Parhoudeh S, 2016, INT J ELEC POWER, V80, P73, DOI 10.1016/j.ijepes.2016.01.033; Petinrin JO, 2015, RENEW SUST ENERG REV, V50, P967, DOI 10.1016/j.rser.2015.04.146; Qin K, 2011, COMPUT MATH APPL, V62, P2824, DOI 10.1016/j.camwa.2011.07.048; Saaty T.L., 1989, CONFLICT RESOLUTION; Sreejith CC, 2013, INT J GREEN ENERGY, V10, P610, DOI 10.1080/15435075.2012.709203; Vadrevu KP, 2010, ENVIRON MONIT ASSESS, V166, P223, DOI 10.1007/s10661-009-0997-3; Wang JQ, 2015, GROUP DECIS NEGOT, V24, P171, DOI 10.1007/s10726-014-9385-7; Wang JQ, 2014, INFORM SCIENCES, V274, P177, DOI 10.1016/j.ins.2014.02.130; Wang M, 2015, WORK AGING RETIRE, V1, P1, DOI [10.1037/adb0000061, 10.1093/workar/wau010]; Wang N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156889; Wang T, 2015, NAT HAZARDS, V76, P747, DOI 10.1007/s11069-014-1515-7; Wang WS, 2012, NAT HAZARDS, V60, P367, DOI 10.1007/s11069-011-0017-0; Wang WS, 2009, SCI CHINA SER E, V52, P3017, DOI [10.1007/S11431-009-0099-Z, 10.1007/s11431-009-0099-z]; Wei C, 2016, OCEAN COAST MANAGE, V120, P39, DOI 10.1016/j.ocecoaman.2015.11.011; Wu AY, 2016, CHINESE J ELECTRON, V25, P215, DOI 10.1049/cje.2016.03.004; Yang FG, 2014, J MT SCI-ENGL, V11, P1015, DOI 10.1007/s11629-013-2495-x; Yang Zhixian, 2014, ScientificWorldJournal, V2014, P140863, DOI 10.1155/2014/140863; Zhang LM, 2013, BUILD ENVIRON, V65, P185, DOI 10.1016/j.buildenv.2013.04.008; Zhang O, 2015, RENEW SUST ENERG REV, V44, P657, DOI 10.1016/j.rser.2015.01.020; Zhang WJ, 2015, MICROELECTRON RELIAB, V55, P123, DOI 10.1016/j.microrel.2014.10.006; Zhang Z, 2016, FUEL, V178, P202, DOI 10.1016/j.fuel.2016.03.067; Zhao HR, 2015, SUSTAINABILITY-BASEL, V7, P2885, DOI 10.3390/su7032885; Zhao K. Q., 1989, THESIS, P87; Zou Q, 2013, STOCH ENV RES RISK A, V27, P525, DOI 10.1007/s00477-012-0598-5	51	11	16	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0170012	10.1371/journal.pone.0170012	http://dx.doi.org/10.1371/journal.pone.0170012			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076440	Green Submitted, gold, Green Published			2022-12-26	WOS:000391857100077
J	Zaganelli, S; Rebelo-Guiomar, P; Maundrell, K; Rozanska, A; Pierredon, S; Powell, CA; Jourdain, AA; Hulo, N; Lightowlers, RN; Chrzanowska-Lightowlers, ZM; Minczuk, M; Martinou, JC				Zaganelli, Sofia; Rebelo-Guiomar, Pedro; Maundrell, Kinsey; Rozanska, Agata; Pierredon, Sandra; Powell, Christopher A.; Jourdain, Alexis A.; Hulo, Nicolas; Lightowlers, Robert N.; Chrzanowska-Lightowlers, Zofia M.; Minczuk, Michal; Martinou, Jean-Claude			The Pseudouridine Synthase RPUSD4 Is an Essential Component of Mitochondrial RNA Granules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; MESSENGER-RNA; NUCLEOTIDE RESOLUTION; LARGE SUBUNIT; HUMAN-CELLS; MUTATIONS; PROTEINS; RIBOSOME; BIOGENESIS; RESIDUES	Mitochondrial gene expression is a fundamental process that is largely dependent on nuclear-encoded proteins. Several steps of mitochondrial RNA processing and maturation, including RNA post-transcriptional modification, appear to be spatially organized into distinct foci, which we have previously termed mitochondrial RNA granules (MRGs). Although an increasing number of proteins have been localized to MRGs, a comprehensive analysis of the proteome of these structures is still lacking. Here, we have applied a microscopy-based approach that has allowed us to identify novel components of the MRG proteome. Among these, we have focused our attention on RPUSD4, an uncharacterized mitochondrial putative pseudouridine synthase. We show that RPUSD4 depletion leads to a severe reduction of the steady-state level of the 16S mitochondrial (mt) rRNA with defects in the biogenesis of the mito ribosome large subunit and consequently in mitochondrial translation. We report that RPUSD4 binds 16S mt-rRNA, mttRNA(Met), and mt-tRNA(Phe), and we demonstrate that it is responsible for pseudouridylation of the latter. These data provide new insights into the relevance of RNA pseudouridylation in mitochondrial gene expression.	[Zaganelli, Sofia; Maundrell, Kinsey; Pierredon, Sandra; Jourdain, Alexis A.; Martinou, Jean-Claude] Univ Geneva, Dept Cell Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland; [Rebelo-Guiomar, Pedro; Powell, Christopher A.; Minczuk, Michal] Med Res Council Mitochondrial Biol Unit, Hills Rd, Cambridge CB2 0XY, England; [Rebelo-Guiomar, Pedro] Univ Porto, Grad Program Areas Basic & Appl Biol GABBA, P-4200135 Oporto, Portugal; [Rozanska, Agata; Lightowlers, Robert N.; Chrzanowska-Lightowlers, Zofia M.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Wellcome Trust Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Hulo, Nicolas] Univ Geneva, Inst Genet & Genom Geneva, CH-1211 Geneva 4, Switzerland; [Jourdain, Alexis A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	University of Geneva; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Universidade do Porto; Newcastle University - UK; University of Geneva; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Martinou, JC (corresponding author), Univ Geneva, Dept Cell Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	jean-claude.martinou@unige.ch	Jourdain, Alexis A./ABF-4838-2020; Rebelo-Guiomar, Pedro/AAT-3575-2021; Minczuk, Michal/G-1638-2014	Rebelo-Guiomar, Pedro/0000-0002-5060-7519; Chrzanowska-Lightowlers, Zofia/0000-0002-0045-3152; Powell, Christopher/0000-0001-7501-0586; Minczuk, Michal/0000-0001-8242-1420; martinou, Jean-claude/0000-0002-9847-2051; Jourdain, Alexis A./0000-0001-5321-6938; ZAGANELLI, SOFIA/0000-0002-2815-3231; Jourdain, Alexis/0000-0002-1721-8394	Swiss National Science Foundation [SNF310030B_160257/1]; Wellcome Trust [096919/Z/11/Z]; Medical Research Council, UK; Medical Research Council [MC_U105697135, MC_UU_00015/4] Funding Source: researchfish; MRC [MC_UU_00015/4, MC_U105697135] Funding Source: UKRI	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Swiss National Science Foundation Grant SNF310030B_160257/1, Wellcome Trust Grant 096919/Z/11/Z, and core funding of Medical Research Council, UK. The authors declare that they have no conflicts of interest with the contents of this article.	Antonicka H, 2017, EMBO REP, V18, P28, DOI 10.15252/embr.201643391; Antonicka H, 2015, CELL REP, V10, P920, DOI 10.1016/j.celrep.2015.01.030; Antonicka H, 2013, CELL METAB, V17, P386, DOI 10.1016/j.cmet.2013.02.006; Arroyo JD, 2016, CELL METAB, V24, P875, DOI 10.1016/j.cmet.2016.08.017; Bakin AV, 1998, METH MOL B, V77, P297; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Barrientos A, 2015, ONCOTARGET, V6, P16800, DOI 10.18632/oncotarget.4646; Bogenhagen DF, 2014, CELL METAB, V19, P618, DOI 10.1016/j.cmet.2014.03.013; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Dennerlein S, 2010, BIOCHEM J, V430, P551, DOI 10.1042/BJ20100757; Diodato D, 2014, HUM MUTAT, V35, P983, DOI 10.1002/humu.22590; Fernandez-Vizarra E, 2007, J MED GENET, V44, P173, DOI 10.1136/jmg.2006.045252; Ge JH, 2013, TRENDS BIOCHEM SCI, V38, P210, DOI 10.1016/j.tibs.2013.01.002; Greber BJ, 2014, NATURE, V505, P515, DOI 10.1038/nature12890; Hallberg BM, 2014, CELL METAB, V20, P226, DOI 10.1016/j.cmet.2014.07.001; Hammal T, 2006, CHEM BIOL, V13, P1125, DOI 10.1016/j.chembiol.2006.09.009; Hoang C, 2006, MOL CELL, V24, P535, DOI 10.1016/j.molcel.2006.09.017; Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9; Jourdain AA, 2015, CELL REP, V10, P1110, DOI 10.1016/j.celrep.2015.01.063; Jourdain AA, 2013, CELL METAB, V17, P399, DOI 10.1016/j.cmet.2013.02.005; Lee KW, 2013, J BIOL CHEM, V288, P31386, DOI 10.1074/jbc.M113.515692; Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516; Ofengand J, 1997, J MOL BIOL, V266, P246, DOI 10.1006/jmbi.1996.0737; Ofengand J, 2001, METHODS, V25, P365, DOI 10.1006/meth.2001.1249; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Patton JR, 2005, J BIOL CHEM, V280, P19823, DOI 10.1074/jbc.M500216200; Powel CA, 2015, AM J HUM GENET, V97, P319, DOI 10.1016/j.ajhg.2015.06.011; Powell CA, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00079; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Rorbach J, 2014, MOL BIOL CELL, V25, P2542, DOI 10.1091/mbc.E14-01-0014; Schwartz S, 2014, CELL, V159, P148, DOI 10.1016/j.cell.2014.08.028; Spenkuch F, 2014, RNA BIOL, V11, P1540, DOI 10.4161/15476286.2014.992278; Suzuki T, 2014, NUCLEIC ACIDS RES, V42, P7346, DOI 10.1093/nar/gku390; Tu YT, 2015, CELL REP, V10, P854, DOI 10.1016/j.celrep.2015.01.033; Van Haute L, 2015, J INHERIT METAB DIS, V38, P655, DOI 10.1007/s10545-015-9859-z; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wilson WC, 2014, HUM MOL GENET, V23, P6345, DOI 10.1093/hmg/ddu352	38	47	51	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4519	4532		10.1074/jbc.M116.771105	http://dx.doi.org/10.1074/jbc.M116.771105			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28082677	Green Published, hybrid			2022-12-26	WOS:000397585100011
J	Gao, WX; Zhao, J; Gao, ZH; Li, HL				Gao, Wanxia; Zhao, Jie; Gao, Zhonghong; Li, Hailing			Synergistic Interaction of Light Alcohol Administration in the Presence of Mild Iron Overload in a Mouse Model of Liver Injury: Involvement of Triosephosphate Isomerase Nitration and Inactivation	PLOS ONE			English	Article							OXIDATIVE STRESS; ALZHEIMERS-DISEASE; RAT-LIVER; MITOCHONDRIAL DYSFUNCTION; PROTEOMIC IDENTIFICATION; NITROSATIVE STRESS; PROTEIN NITRATION; METABOLISM; ETHANOL; BRAIN	It is well known that iron overload promotes alcoholic liver injury, but the doses of iron or alcohol used in studies are usually able to induce liver injury independently. Little attention has been paid to the coexistence of low alcohol consumption and mild iron overload when either of them is insufficient to cause obvious liver damage, although this situation is very common among some people. We studied the interactive effects and the underlining mechanism of mild doses of iron and alcohol on liver injury in a mouse model. Forty eight male Kunming mice were randomly divided into four groups: control, iron (300 mg/kg iron dextran, i.p.), alcohol (2 g/kg/day ethanol for four weeks i.g.), and iron plus alcohol group. After 4 weeks of treatment, mice were sacrificed and blood and livers were collected for biochemical analysis. Protein nitration level in liver tissue was determined by immunoprecipitation and Western blot analysis. Although neither iron overload nor alcohol consumption at our tested doses can cause severe liver injury, it was found that co-administration of the same doses of alcohol and iron resulted in liver injury and hepatic dysfunction, accompanied with elevated ratio of NADH/NAD(+), reduced antioxidant ability, increased oxidative stress, and subsequent elevated protein nitration level. Further study revealed that triosephosphate isomerase, an important glycolytic enzyme, was one of the targets to be oxidized and nitrated, which was responsible for its inactivation. These data indicate that even under low alcohol intake, a certain amount of iron overload can cause significant liver oxidative damage, and the modification of triosephosphate isomerasemight be the important underlining mechanism of hepatic dysfunction.	[Gao, Wanxia; Zhao, Jie; Gao, Zhonghong; Li, Hailing] Huazhong Univ Sci & Technol, Sch Chem & Chem Engn, Wuhan, Peoples R China; [Gao, Wanxia] Hubei Univ Sci & Technol, Basis Med Coll, Xianning, Peoples R China; [Gao, Zhonghong; Li, Hailing] Hubei Key Lab Bioinorgan Chem & Mat Med, Wuhan, Peoples R China	Huazhong University of Science & Technology; Hubei University of Science & Technology	Li, HL (corresponding author), Huazhong Univ Sci & Technol, Sch Chem & Chem Engn, Wuhan, Peoples R China.; Li, HL (corresponding author), Hubei Key Lab Bioinorgan Chem & Mat Med, Wuhan, Peoples R China.	lihailing86@hust.edu.cn			National Natural Science Foundation of China [31170808, 31570810]; Natural Science Foundation of Hubei Scientific Committee [2016CFA001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Scientific Committee	This work was supported by the National Natural Science Foundation of China Grant # 31170808, 31570810 (http://www.nsfc.gov.cn/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the National Natural Science Foundation of China (Nos. 31170808 and 31570810) and Natural Science Foundation of Hubei Scientific Committee (2016CFA001).	Abdelmegeed MA, 2013, FREE RADICAL BIO MED, V60, P211, DOI 10.1016/j.freeradbiomed.2013.02.018; Asare GA, 2008, TOXICOLOGY, V254, P11, DOI 10.1016/j.tox.2008.08.024; Barreiro E, 2009, THORAX, V64, P13, DOI 10.1136/thx.2008.105163; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brewer GJ, 2010, CHEM RES TOXICOL, V23, P319, DOI 10.1021/tx900338d; Butterfield DA, 2007, BRAIN RES, V1148, P243, DOI 10.1016/j.brainres.2007.02.084; Cahill A, 2002, ALCOHOL CLIN EXP RES, V26, P907, DOI 10.1097/00000374-200206000-00022; Castegna A, 2003, J NEUROCHEM, V85, P1394, DOI 10.1046/j.1471-4159.2003.01786.x; Cederbaum AI, 2009, ARCH TOXICOL, V83, P519, DOI 10.1007/s00204-009-0432-0; Choi JS, 2013, J NUTR BIOCHEM, V24, P1634, DOI 10.1016/j.jnutbio.2013.02.004; Chou CH, 2012, FOOD CHEM, V135, P24, DOI 10.1016/j.foodchem.2012.04.036; Devi SL, 2009, ENVIRON TOXICOL PHAR, V27, P120, DOI 10.1016/j.etap.2008.09.004; Diesen DL, 2010, J SURG RES, V162, P95, DOI 10.1016/j.jss.2009.09.019; Gao WX, 2014, BIOL TRACE ELEM RES, V160, P368, DOI 10.1007/s12011-014-0021-9; Ge N, 2013, FOOD CHEM TOXICOL, V62, P361, DOI 10.1016/j.fct.2013.08.071; Gruning NM, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130232; Hu SG, 2015, FREE RADICAL BIO MED, V79, P176, DOI 10.1016/j.freeradbiomed.2014.11.011; Klyosov AA, 1996, BIOCHEMISTRY-US, V35, P4445, DOI 10.1021/bi9521093; Kohgo Y, 2005, ALCOHOL CLIN EXP RES, V29, p189S, DOI 10.1097/01.alc.0000189274.00479.62; Koskenkorva-Frank TS, 2013, FREE RADICAL BIO MED, V65, P1174, DOI 10.1016/j.freeradbiomed.2013.09.001; KUKIELKA E, 1989, ARCH BIOCHEM BIOPHYS, V275, P540, DOI 10.1016/0003-9861(89)90400-1; Lee WH, 2010, TOXICOLOGY, V278, P224, DOI 10.1016/j.tox.2010.02.005; Li XL, 2012, BIOCHIMIE, V94, P2620, DOI 10.1016/j.biochi.2012.07.019; Liang Y, 2013, FREE RADICAL BIO MED, V65, P1427, DOI 10.1016/j.freeradbiomed.2013.10.010; Lieber CS, 2004, ALCOHOL, V34, P9, DOI 10.1016/j.alcohol.2004.07.008; Lieber CS, 1999, CLIN DERMATOL, V17, P365, DOI 10.1016/S0738-081X(99)00020-6; Liu B, 2009, BBA-PROTEINS PROTEOM, V1794, P476, DOI 10.1016/j.bbapap.2008.12.008; Lu NH, 2010, FREE RADICAL BIO MED, V48, P873, DOI 10.1016/j.freeradbiomed.2010.01.010; Ma GD, 2014, HEPATOL INT, V8, P425, DOI 10.1007/s12072-014-9529-5; McKim SE, 2003, GASTROENTEROLOGY, V125, P1834, DOI 10.1053/j.gastro.2003.08.030; Morel Y, 1999, BIOCHEM J, V342, P481, DOI 10.1042/0264-6021:3420481; Mueller S, 2015, ADV EXP MED BIOL, V815, P89, DOI 10.1007/978-3-319-09614-8_6; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Orosz F, 2006, IUBMB LIFE, V58, P703, DOI 10.1080/15216540601115960; Palamalai V, 2006, MOL VIS, V12, P1543; Pandanaboina SC, 2012, FOOD CHEM, V132, P150, DOI 10.1016/j.foodchem.2011.10.046; Petersen DR, 2005, ALCOHOL, V35, P243, DOI 10.1016/j.alcohol.2005.03.013; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; Qin LY, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-5; Reed TT, 2009, J CELL MOL MED, V13, P2019, DOI 10.1111/j.1582-4934.2008.00478.x; Schneider AS, 2000, BEST PRACT RES CL HA, V13, P119, DOI 10.1053/beha.2000.0061; Seronello S, 2010, J BIOL CHEM, V285, P845, DOI 10.1074/jbc.M109.045740; STAL P, 1993, J HEPATOL, V17, P108, DOI 10.1016/S0168-8278(05)80530-6; Tajes M, 2014, J ALZHEIMERS DIS, V41, P273, DOI 10.3233/JAD-131685; Tan TCH, 2013, LAB INVEST, V93, P1295, DOI 10.1038/labinvest.2013.121; Tirapelli LF, 2011, TISSUE CELL, V43, P384, DOI 10.1016/j.tice.2011.08.003; Tsay J, 2010, BLOOD, V116, P2582, DOI 10.1182/blood-2009-12-260083; TSUKAMOTO H, 1995, J CLIN INVEST, V96, P620, DOI 10.1172/JCI118077; Valencia-Martin JL, 2011, ALCOHOL CLIN EXP RES, V35, P2075, DOI 10.1111/j.1530-0277.2011.01559.x; Vaziri ND, 1999, HYPERTENSION, V34, P1237, DOI 10.1161/01.HYP.34.6.1237; Venkatraman A, 2004, HEPATOLOGY, V40, P565, DOI 10.1002/hep.20326; WERMAN MJ, 1995, J NUTR BIOCHEM, V6, P373, DOI 10.1016/0955-2863(95)80005-W; Wu DF, 2012, FREE RADICAL BIO MED, V53, P1346, DOI 10.1016/j.freeradbiomed.2012.07.005; Zhang F, 2012, FOOD CHEM TOXICOL, V50, P2149, DOI 10.1016/j.fct.2012.03.083; Zhang Y, 2012, EUR J PHARMACOL, V680, P95, DOI 10.1016/j.ejphar.2012.01.010	55	5	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170350	10.1371/journal.pone.0170350	http://dx.doi.org/10.1371/journal.pone.0170350			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103293	Green Submitted, Green Published, gold			2022-12-26	WOS:000392381100058
J	Baloch, FS; Alsaleh, A; Shahid, MQ; Ciftci, V; de Miera, LES; Aasim, M; Nadeem, MA; Aktas, H; Ozkan, H; Hatipoglu, R				Baloch, Faheem Shehzad; Alsaleh, Ahmad; Shahid, Muhammad Qasim; Ciftci, Vahdettin; de Miera, Luis E. Saenz; Aasim, Muhammad; Nadeem, Muhammad Azhar; Aktas, Husnu; Ozkan, Hakan; Hatipoglu, Rustu			A Whole Genome DArTseq and SNP Analysis for Genetic Diversity Assessment in Durum Wheat from Central Fertile Crescent	PLOS ONE			English	Article							ARRAYS TECHNOLOGY DART; LANDRACES; DOMESTICATION; COLLECTION; EMMER; AFLP	Until now, little attention has been paid to the geographic distribution and evaluation of genetic diversity of durum wheat from the Central Fertile Crescent (modern-day Turkey and Syria). Turkey and Syria are considered as primary centers of wheat diversity, and thousands of locally adapted wheat landraces are still present in the farmers' small fields. We planned this study to evaluate the genetic diversity of durum wheat landraces from the Central Fertile Crescent by genotyping based on DArTseq and SNP analysis. A total of 39,568 DArTseq and 20,661 SNP markers were used to characterize the genetic characteristic of 91 durum wheat land races. Clustering based on Neighbor joining analysis, principal coordinate as well as Bayesian model implemented in structure, clearly showed that the grouping pattern is not associated with the geographical distribution of the durum wheat due to the mixing of the Turkish and Syrian landraces. Significant correlation between DArTseq and SNP markers was observed in the Mantel test. However, we detected a non-significant relationship between geographical coordinates and DArTseq (r = -0.085) and SNP (r = -0.039) loci. These results showed that unconscious farmer selection and lack of the commercial varieties might have resulted in the exchange of genetic material and this was apparent in the genetic structure of durum wheat in Turkey and Syria. The genomic characterization presented here is an essential step towards a future exploitation of the available durum wheat genetic resources in genomic and breeding programs. The results of this study have also depicted a clear insight about the genetic diversity of wheat accessions from the Central Fertile Crescent.	[Baloch, Faheem Shehzad; Ciftci, Vahdettin; Nadeem, Muhammad Azhar] Abant Izzet Baysal Univ, Fac Agr & Nat Sci, Dept Field Crops, Bolu, Turkey; [Alsaleh, Ahmad] Univ Cukurova, Fac Agr, Dept Biotechnol, Adana, Turkey; [Shahid, Muhammad Qasim] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China; [de Miera, Luis E. Saenz] Univ Leon, Fac Biol, Dept Mol Biol, Leon, Spain; [Aasim, Muhammad] Necmettin Erbakan Univ, Dept Biotechnol, Fac Sci, Konya, Turkey; [Aktas, Husnu] Artuklu Univ, Vocat Higher Sch Kiziltepe, Mardin, Turkey; [Ozkan, Hakan; Hatipoglu, Rustu] Univ Cukurova, Fac Agr, Dept Field Crops, Adana, Turkey	Abant Izzet Baysal University; Cukurova University; South China Agricultural University; Universidad de Leon; Necmettin Erbakan University; Cukurova University	Baloch, FS (corresponding author), Abant Izzet Baysal Univ, Fac Agr & Nat Sci, Dept Field Crops, Bolu, Turkey.; Shahid, MQ (corresponding author), South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China.	balochfaheem13@gmail.com; qasim@scau.edu.cn	ALSALEH, Ahmad/AAB-6508-2021; Baloch, Faheem Shehzad/ABG-8788-2020; ÖZKAN, Hakan/C-8510-2011; ALSALEH, Ahmad/CAA-2655-2022; Shahid, Muhammad Qasim/F-2908-2013; de Miera, Luis E Sáenz/D-6864-2018; Sáenz de Miera, Luis/ABA-4573-2021; Aasim, Muhammad/C-5691-2017; Shahid, Muhammad Qasim/K-2304-2019; Hatipoglu, Rustu/E-7007-2018; Azhar Nadeem, Muhammad/AAE-2747-2020	ALSALEH, Ahmad/0000-0001-7078-3221; Baloch, Faheem Shehzad/0000-0002-7470-0080; ÖZKAN, Hakan/0000-0003-3530-2626; ALSALEH, Ahmad/0000-0001-7078-3221; Shahid, Muhammad Qasim/0000-0002-6767-4355; de Miera, Luis E Sáenz/0000-0003-1871-7379; Sáenz de Miera, Luis/0000-0003-1871-7379; Aasim, Muhammad/0000-0002-8524-9029; Shahid, Muhammad Qasim/0000-0002-6767-4355; Hatipoglu, Rustu/0000-0002-7977-0782; Azhar Nadeem, Muhammad/0000-0002-0637-9619	Abant izzet Baysal University, Scientific Research Projects Unit [2015.10.07.896]; State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources, South China Agricultural University, Guangzhou, China	Abant izzet Baysal University, Scientific Research Projects Unit(Abant Izzet Baysal University); State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources, South China Agricultural University, Guangzhou, China	This work was supported by the Abant izzet Baysal University, Scientific Research Projects Unit (2015.10.07.896 to FSB), and State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources, South China Agricultural University, Guangzhou, China (to MQS).	Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Alsaleh A, 2015, PLANT MOL BIOL REP, V33, P209, DOI 10.1007/s11105-014-0749-6; Altintas S, 2008, PLANT BREEDING, V127, P9, DOI 10.1111/j.1439-0523.2007.01424.x; Autrique E, 1996, CROP SCI, V36, P735, DOI 10.2135/cropsci1996.0011183X003600030036x; Baloch FS, 2016, TURK J AGRIC FOR, V40, P352, DOI 10.3906/tar-1508-27; Brinez B, 2012, MOL BREEDING, V30, P181, DOI 10.1007/s11032-011-9609-3; Clayton W. D., 1986, Kew Bulletin Additional Series, V13; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Dvorak J, 1998, GENETIC EVIDENCE ORI, P235; Edwards D, 2013, THEOR APPL GENET, V126, P1, DOI 10.1007/s00122-012-1964-x; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Frankel OH, 1995, CONSERVATION PLANT B; Grzebelus D, 2014, MOL BREEDING, V33, P625, DOI 10.1007/s11032-013-9979-9; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Laido G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067280; Lamara M, 2013, GENOME, V56, P351, DOI 10.1139/gen-2013-0048; Luo MC, 2007, THEOR APPL GENET, V114, P947, DOI 10.1007/s00122-006-0474-0; Masood MS, 2005, PAKISTAN J BOT, V37, P949; Moragues M, 2007, GENET RESOUR CROP EV, V54, P1133, DOI 10.1007/s10722-006-9005-8; Oliveira HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037063; Ozkan H, 2002, MOL BIOL EVOL, V19, P1797, DOI 10.1093/oxfordjournals.molbev.a004002; Peterson G. W., 2014, Diversity, V6, P665, DOI 10.3390/d6040665; Ren J, 2013, INT J MOL SCI, V14, P7061, DOI 10.3390/ijms14047061; Royo Conxita, 2009, V3, P199; Tamura K., 2013, MOL BIOL EVOL, P197, DOI DOI 10.1093/M0LBEV/MST197; Turuspekov Y, 2015, PLANT GENETIC RESOUR, P1; Yildirim A, 2013, AFRICAN J BIOTECHNOL, V10, P3915; Zeven AC, 2000, EUPHYTICA, V116, P65, DOI 10.1023/A:1004089816030	29	92	95	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0167821	10.1371/journal.pone.0167821	http://dx.doi.org/10.1371/journal.pone.0167821			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099442	Green Published, gold, Green Submitted			2022-12-26	WOS:000392380100005
J	Rossi, E; Bizzarro, T; Martini, M; Longatto, A; Schmitt, F; Fagotti, A; Scambia, G; Zannoni, GF				Rossi, Esther; Bizzarro, Tommaso; Martini, Maurizio; Longatto-Filho, Adhemar; Schmitt, Fernando; Fagotti, Anna; Scambia, Giovanni; Zannoni, Gian Franco			The Role of Liquid Based Cytology and Ancillary Techniques in the Peritoneal Washing Analysis: Our Institutional Experience	PLOS ONE			English	Article							MALIGNANT MESOTHELIOMA; PROGNOSTIC VALUE; EFFUSIONS; DIAGNOSIS; IMMUNOCYTOCHEMISTRY; THINPREP; FLUIDS	Background The cytological analysis of peritoneal effusions serves as a diagnostic and prognostic aid for either primary or metastatic diseases. Among the different cytological preparations, liquid based cytology (LBC) represents a feasible and reliable method ensuring also the application of ancillary techniques (i.e immunocytochemistry-ICC and molecular testing). Methods We recorded 10348 LBC peritoneal effusions between January 2000 and December 2014. They were classified as non-diagnostic (ND), negative for malignancy-NM, atypical-suspicious for malignancy-SM and positive for malignancy-PM. Results The cytological diagnosis included 218 ND, 9.035 NM, 213 SM and 882 PM. A total of 8048 (7228 NM, 115SM, 705 PM) cases with histological follow-up were included. Our NM included 21 malignant and 7207 benign histological diagnoses. Our 820 SMs+PMs were diagnosed as 107 unknown malignancies (30SM and 77PM), 691 metastatic lesions (81SM and 610PM), 9 lymphomas (2SM and 7PM), 9 mesotheliomas (1SM and 8SM), 4 sarcomas (1SM and 3PM). Primary gynecological cancers contributed with 64% of the cases. We documented 97.4% sensitivity, 99.9% specificity, 98% diagnostic accuracy, 99.7% negative predictive value (NPV) and 99.7% positive predictive value (PPV). Furthermore, the morphological diagnoses were supported by either 173 conclusive ICC results or 50 molecular analyses. Specifically the molecular testing was performed for the EGFR and KRAS mutational analysis based on the previous or contemporary diagnoses of Non Small Cell Lung Cancer (NSCLC) and colon carcinomas. We identified 10 EGFR in NSCCL and 7 KRAS mutations on LBC stored material. Conclusions Peritoneal cytology is an adjunctive tool in the surgical management of tumors mostly gynecological cancers. LBC maximizes the application of ancillary techniques such as ICC and molecular analysis with feasible diagnostic and predictive yields also in controversial cases.	[Rossi, Esther; Bizzarro, Tommaso; Martini, Maurizio; Zannoni, Gian Franco] Univ Cattolica Sacro Cuore, Div Anat Pathol & Histol, Agostino Gemelli Sch Med, Rome, Italy; [Longatto-Filho, Adhemar] Univ Sao Paulo, Sch Med, Dept Pathol, Sao Paulo, Brazil; [Longatto-Filho, Adhemar] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Longatto-Filho, Adhemar] PT Govt Associate Lab, ICVS Lab Med Investigat LIM 3Bs, Braga, Portugal; [Longatto-Filho, Adhemar] Pio XII Fdn, Barretos Canc Hosp, Mol Oncol Res Ctr, Barretos, Brazil; [Schmitt, Fernando] Univ Porto, Fac Med, Porto, Portugal; [Schmitt, Fernando] Lab Natl Sante, Luxembourg, Luxembourg; [Fagotti, Anna; Scambia, Giovanni] Catholic Univ, Gynecol Oncol, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Universidade de Sao Paulo; Universidade do Minho; Hospital de Cancer de Barretos; Universidade do Porto; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Rossi, E (corresponding author), Univ Cattolica Sacro Cuore, Div Anat Pathol & Histol, Agostino Gemelli Sch Med, Rome, Italy.	esther.rossi@rm.unicatt.it	Martini, Maurizio/AAB-1564-2019; Schmitt, Fernando/A-5270-2008; Longatto-Filho, Adhemar/N-3397-2019; fagotti, anna AF/K-5233-2018; Rossi, esther/R-8601-2017; Zannoni, Gian Franco/AAC-4754-2020; longatto-filho, adhemar/D-7039-2013	Martini, Maurizio/0000-0002-6260-6310; Schmitt, Fernando/0000-0002-3711-8681; Longatto-Filho, Adhemar/0000-0002-5779-9752; Zannoni, Gian Franco/0000-0002-4473-7560; longatto-filho, adhemar/0000-0002-5779-9752; Schmitt, Fernando/0000-0003-1006-6946; Rossi, Esther/0000-0003-3819-4229				Afshar-Moghaddam Noushin, 2014, Adv Biomed Res, V3, P161, DOI 10.4103/2277-9175.138888; Bedrossian CWM, 1998, DIAGN CYTOPATHOL, V19, P131, DOI 10.1002/(SICI)1097-0339(199808)19:2<131::AID-DC14>3.0.CO;2-G; CREASMAN WT, 1971, AM J OBSTET GYNECOL, V110, P773, DOI 10.1016/0002-9378(71)90571-0; Dabbs DJ, 1997, DIAGN CYTOPATHOL, V17, P388, DOI 10.1002/(SICI)1097-0339(199711)17:5<388::AID-DC14>3.0.CO;2-J; Davidson B, 2011, CYTOPATHOLOGY, V22, P5, DOI 10.1111/j.1365-2303.2010.00829.x; Ditto A, 2015, DIAGN CYTOPATHOL, V43, P705, DOI 10.1002/dc.23296; Fetsch PA, 2002, DIAGN CYTOPATHOL, V26, P61, DOI 10.1002/dc.10039; Gabriel C, 2004, ACTA CYTOL, V48, P825, DOI 10.1159/000326453; Giordano G, 2014, CLIN GENITOURIN CANC, V12, pE95, DOI 10.1016/j.clgc.2013.11.010; Gong Y, 2003, DIAGN CYTOPATHOL, V28, P1, DOI 10.1002/dc.10219; GRANADOS R, 1994, ACTA CYTOL, V38, P711; Hoda RS, 2007, DIAGN CYTOPATHOL, V35, P621, DOI 10.1002/dc.20698; ITO K, 1992, GYNECOL ONCOL, V47, P76, DOI 10.1016/0090-8258(92)90080-3; Jing X, 2013, AM J CLIN PATHOL, V139, P177, DOI 10.1309/AJCP83ADULCXMAIX; Lee YM, 2014, DIAGN CYTOPATHOL, V42, P384, DOI 10.1002/dc.23041; Leung SW, 1996, MODERN PATHOL, V9, P304; Linder J, 1998, DIAGN CYTOPATHOL, V18, P24, DOI 10.1002/(SICI)1097-0339(199801)18:1<24::AID-DC5>3.0.CO;2-U; LONGATTO A, 1995, ACTA CYTOL, V39, P481; Mlyncek M, 2005, NEOPLASMA, V52, P103; Nagymanyoki Z, 2015, CANCER CYTOPATHOL, V123, P253, DOI 10.1002/cncy.21514; Naz S, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0732-1; Ordonez NG, 2003, AM J SURG PATHOL, V27, P1031, DOI 10.1097/00000478-200308000-00001; Rossi ED, 2010, CYTOPATHOLOGY, V21, P97, DOI 10.1111/j.1365-2303.2009.00659.x; Rossi ED, 2008, DIAGN HISTOPATHOL, V14, P563; Rossi ED, 2015, CANCER CYTOPATHOL, V123, P258, DOI 10.1002/cncy.21518; Schmitt FC, 2008, J CLIN PATHOL, V61, P258, DOI 10.1136/jcp.2006.044347; Shah RH, 2015, CANCER CYTOPATHOL, V123, P289, DOI 10.1002/cncy.21522; Shield P, 2004, CYTOPATHOLOGY, V15, P131, DOI 10.1111/j.1365-2303.2004.00140.x; Su XY, 2011, DIAGN CYTOPATHOL, V39, P900, DOI 10.1002/dc.21489; Sun W., 2014, INT J DISTRIB SENS N, V2014, P1; Taschner PEM, 2011, HUM MUTAT, V32, P507, DOI 10.1002/humu.21427; WILLETT GD, 1985, CLIN LAB MED, V5, P265, DOI 10.1016/S0272-2712(18)30869-2; Ylagan LR, 2005, DIAGN CYTOPATHOL, V32, P137, DOI 10.1002/dc.20200; ZUNA RE, 1990, ACTA CYTOL, V34, P645; Zuna RE, 1996, J NATL CANCER I, V88, P980, DOI 10.1093/jnci/88.14.980	36	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0168625	10.1371/journal.pone.0168625	http://dx.doi.org/10.1371/journal.pone.0168625			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099523	Green Submitted, Green Published, gold			2022-12-26	WOS:000392380100011
J	Sethi, MK; Thol, F; Stadler, M; Heuser, M; Ganser, A; Koenecke, C; Pabst, O				Sethi, Maya K.; Thol, Felicitas; Stadler, Michael; Heuser, Michael; Ganser, Arnold; Koenecke, Christian; Pabst, Oliver			VH1 Family Immunoglobulin Repertoire Sequencing after Allogeneic Hematopoietic Stem Cell Transplantation	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; IMMUNE RECONSTITUTION; HOST-DISEASE; B-CELLS; ANTIBODY; IG; ASSOCIATION; GAMMOPATHY; MICROBIOTA; RECIPIENTS	After allogeneic hematopoietic stem cell transplantation (HSCT), recovery of humoral immunity is essential to protect from life-threatening infections. However, monitoring the humoral immune system after transplantation with standard techniques in the clinical routine is imprecise. Here, we performed sequencing of mononuclear bone marrow cells to characterize the VH1-repertoire of switched B cells of healthy volunteers and patients undergoing HSCT. Analysis of healthy bone marrow donors and patients showed virtually no clonally related sequences between individuals. Interestingly, clonally related sequences were present in pre- and post-transplantation bone marrow of patients undergoing HSCT for acute myeloid leukemia treatment. We consistently observed such related B cell clones, irrespective of conditioning regimen, donor source or time post transplantation. In general, repertoire diversity was lower in post-HSCT as compared to pre-HSCT samples. However, post-HSCT repertoires retained highly mutated sequences, despite immunosuppressive therapy and presence of T cell deficiency after HSCT. These observations identify key properties of the recovering B cell compartment and provide a conceptual framework for the surveillance of humoral immunity after allogeneic transplantation.	[Sethi, Maya K.; Koenecke, Christian; Pabst, Oliver] Hannover Med Sch, Inst Immunol, Hannover, Germany; [Sethi, Maya K.] Partner Site Hannover Braunschweig, German Ctr Infect Res DZIF, Hannover, Germany; [Thol, Felicitas; Stadler, Michael; Heuser, Michael; Ganser, Arnold; Koenecke, Christian] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany; [Pabst, Oliver] Rhein Westfal TH Aachen, Inst Mol Med, Aachen, Germany	Hannover Medical School; German Center for Infection Research; Hannover Medical School; RWTH Aachen University	Pabst, O (corresponding author), Hannover Med Sch, Inst Immunol, Hannover, Germany.	koenecke.christian@mh-hannover.de; opabst@ukaachen.de	Heuser, Michael/S-2363-2017; Koenecke, Christian/C-3138-2009	Heuser, Michael/0000-0001-5318-9044; Koenecke, Christian/0000-0001-7025-1735	Deutsche Forschungsgemeinschaft [SFB900-B08, PA921/4-1]; Deutsches Zentrum fur Infektionsforschung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsches Zentrum fur Infektionsforschung	This work was supported by Deutsche Forschungsgemeinschaft (www.dfg.de): SFB900-B08 (to CK) and PA921/4-1 (to OP), and Deutsches Zentrum fur Infektionsforschung (www.dzif.de) (to OP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang HA, 1997, BLOOD, V89, P4646, DOI 10.1182/blood.V89.12.4646; Arnaout R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022365; Baron F, 2004, BLOOD, V104, P2254, DOI 10.1182/blood-2004-04-1506; Beaudette-Zlatanova BC, 2013, BONE MARROW TRANSPL, V48, P85, DOI 10.1038/bmt.2012.104; Blin N, 2010, BIOL BLOOD MARROW TR, V16, P1315, DOI 10.1016/j.bbmt.2010.03.021; Bosch M, 2012, CURR OPIN HEMATOL, V19, P324, DOI 10.1097/MOH.0b013e328353bc7d; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Chiusolo P, 2010, J CLIN IMMUNOL, V30, P894, DOI 10.1007/s10875-010-9454-x; Edgar RC, 2010, NUCLEIC ACIDS RES, V38, P2145, DOI 10.1093/nar/gkp1196; FUMOUX F, 1993, BLOOD, V81, P3153; Glanville J, 2011, P NATL ACAD SCI USA, V108, P20066, DOI 10.1073/pnas.1107498108; Gokmen E, 1998, BLOOD, V92, P2802, DOI 10.1182/blood.V92.8.2802.420k18_2802_2814; Kaloyannidis P, 2007, BIOL BLOOD MARROW TR, V13, P1049, DOI 10.1016/j.bbmt.2007.05.009; Kroger N, 2006, EXP HEMATOL, V34, P688, DOI 10.1016/j.exphem.2006.01.011; Lee JH, 2003, BRIT J HAEMATOL, V120, P702, DOI 10.1046/j.1365-2141.2003.04128.x; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Lim ZY, 2007, BONE MARROW TRANSPL, V40, P747, DOI 10.1038/sj.bmt.1705805; Lindner C, 2015, NAT IMMUNOL, V16, P880, DOI 10.1038/ni.3213; Lindner C, 2012, J EXP MED, V209, P365, DOI 10.1084/jem.20111980; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Maury S, 2001, BRIT J HAEMATOL, V115, P630, DOI 10.1046/j.1365-2141.2001.03135.x; Meier J, 2013, BIOL BLOOD MARROW TR, V19, P366, DOI 10.1016/j.bbmt.2012.12.004; Muraro PA, 2014, J CLIN INVEST, V124, P1168, DOI 10.1172/JCI71691; NOEL DR, 1978, BLOOD, V51, P1087; Omazic B, 2005, SCAND J IMMUNOL, V61, P72, DOI 10.1111/j.0300-9475.2005.01528.x; Otte M, 2016, J ALLERGY CLIN IMMUN; Pabst O, 2015, MUCOSAL IMMUNOL, V8, P29, DOI 10.1038/mi.2014.103; Raaphorst FM, 1999, BONE MARROW TRANSPL, V24, P1267, DOI 10.1038/sj.bmt.1702074; Rosselet A, 2009, CLIN TRANSPLANT, V23, P74, DOI 10.1111/j.1399-0012.2008.00904.x; Six A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00413; SNIECINSKI IJ, 1988, TRANSPLANTATION, V45, P530, DOI 10.1097/00007890-198803000-00005; STOREK J, 1993, BONE MARROW TRANSPL, V12, P387; Storek J, 2001, BLOOD, V97, P3380, DOI 10.1182/blood.V97.11.3380; Tete SM, 2015, EXP HEMATOL; Turqueti-Neves A, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002290; van Heijst JWJ, 2013, NAT MED, V19, P372, DOI 10.1038/nm.3100; vanTol MJD, 1996, BLOOD, V87, P818, DOI 10.1182/blood.V87.2.818.bloodjournal872818; Vollmers C, 2013, P NATL ACAD SCI USA, V110, P13463, DOI 10.1073/pnas.1312146110	39	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0168096	10.1371/journal.pone.0168096	http://dx.doi.org/10.1371/journal.pone.0168096			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095438	Green Published, Green Submitted, gold			2022-12-26	WOS:000392372300007
J	Bitirgen, G; Belviranli, S; Malik, RA; Kerimoglu, H; Satirtav, G; Zengin, N				Bitirgen, Gulfidan; Belviranli, Selman; Malik, Rayaz A.; Kerimoglu, Hurkan; Satirtav, Gunhal; Zengin, Nazmi			Assessment of Corneal Sensation, Innervation and Retinal Nerve Fiber Layer in Patients Treated with Multiple Intravitreal Ranibizumab Injections	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INTRAOCULAR-PRESSURE CHANGES; MACULAR DEGENERATION; CONFOCAL MICROSCOPY; VEGF; PHARMACOKINETICS; THICKNESS; SURVIVAL; BEVACIZUMAB; MACULOPATHY	Purpose To evaluate the effects of repeated intravitreal ranibizumab injections on corneal sensitivity, corneal sub-basal nerve plexus (SBNP) and peripapillary retinal nerve fiber layer (RNFL) thickness in patients with neovascular age-related macular degeneration (AMD). Methods Sixty-six eyes of 33 patients who had received unilateral repeated intravitreal ranibizumab injections (0.5 mg/0.05 ml) for the treatment of AMD and 25 eyes of 25 healthy subjects were included in the study. Central corneal sensation was measured using the contact Cochet-Bonnet esthesiometer. The laser scanning in vivo corneal confocal microscope was used to determine corneal SBNP parameters. The peripapillary RNFL thickness was assessed with spectral-domain optical coherence tomography. Data obtained from the ranibizumab-injected eyes were compared with those of the fellow non-treated eyes and the eyes of the healthy control subjects. Results The mean number of ranibizumab injections per eye was 8.9 +/- 5.0 (range 3-20). There were no statistically significant differences in the central corneal sensitivity threshold and corneal SBNP parameters between the ranibizumab-injected eyes and the fellow untreated eyes or between those with neovascular AMD and the healthy control group (P>0.05 for all). The average peripapillary RNFL thickness of the treated eyes did not differ significantly to the fellow eyes (P=0.237), and the eyes of healthy control subjects (P=0.918). There were no significant correlations between the number of ranibizumab injections and any of the study parameters. Conclusions Multiple intravitreal injections of ranibizumab seem to have no harmful effects on corneal sensitivity, innervation and peripapillary RNFL thickness in patients with AMD.	[Bitirgen, Gulfidan; Belviranli, Selman; Kerimoglu, Hurkan; Satirtav, Gunhal; Zengin, Nazmi] Necmettin Erbakan Univ Meram, Fac Med, Dept Ophthalmol, Konya, Turkey; [Malik, Rayaz A.] Weill Cornell Med Qatar, Educ City, Doha, Qatar; [Malik, Rayaz A.] Univ Manchester, Cent Manchester Univ, Teaching Hosp Fdn Trust, Manchester, Lancs, England; [Malik, Rayaz A.] Univ Manchester, Div Cardiovasc Sci, Manchester, Lancs, England	Necmettin Erbakan University; Selcuk University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Manchester; University of Manchester	Bitirgen, G (corresponding author), Necmettin Erbakan Univ Meram, Fac Med, Dept Ophthalmol, Konya, Turkey.	gbitirgen@yahoo.com	Belviranli, Selman/AAM-7262-2020; Bitirgen, Gulfidan/V-7709-2017; Satirtav, Gunhal/D-6975-2015; Kerimoglu, Hurkan/A-7857-2016; Malik, Rayaz/H-9231-2019	Belviranli, Selman/0000-0003-0272-7345; Bitirgen, Gulfidan/0000-0002-0509-5649; Satirtav, Gunhal/0000-0003-4157-2876; Kerimoglu, Hurkan/0000-0002-5601-2049; Malik, Rayaz/0000-0002-7188-8903	Scientific Research Fund of the Necmettin Erbakan University [151218003]	Scientific Research Fund of the Necmettin Erbakan University	This work was supported by the Scientific Research Fund of the Necmettin Erbakan University (Project Number: 151218003) (GB). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakri SJ, 2007, OPHTHALMOLOGY, V114, P2179, DOI 10.1016/j.ophtha.2007.09.012; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Dabbah MA, 2011, MED IMAGE ANAL, V15, P738, DOI 10.1016/j.media.2011.05.016; Dratviman-Storobinsky O, 2009, MOL VIS, V15, P2326; El-Ashry MF, 2015, CLIN OPHTHALMOL, V9, P1269, DOI 10.2147/OPTH.S80704; FERRIS FL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1640; Gamulescu MA, 2010, J OCUL PHARMACOL TH, V26, P213, DOI 10.1089/jop.2009.0126; Gaudreault J, 2005, INVEST OPHTH VIS SCI, V46, P726, DOI 10.1167/iovs.04-0601; Guzel H, 2016, CUTAN OCUL TOXICOL; Hollands H, 2007, CAN J OPHTHALMOL, V42, P807, DOI 10.3129/i07-172; Horsley MB, 2010, AM J OPHTHALMOL, V150, P558, DOI 10.1016/j.ajo.2010.04.029; Hulse RP, 2015, CLIN SCI, V129, P741, DOI 10.1042/CS20150124; Kim JE, 2008, AM J OPHTHALMOL, V146, P930, DOI 10.1016/j.ajo.2008.07.007; Kliffen M, 1997, BRIT J OPHTHALMOL, V81, P154, DOI 10.1136/bjo.81.2.154; Krohne TU, 2012, AM J OPHTHALMOL, V154, P682, DOI 10.1016/j.ajo.2012.03.047; Kvanta A, 1996, INVEST OPHTH VIS SCI, V37, P1929; Lalwani GA, 2009, AM J OPHTHALMOL, V148, P43, DOI 10.1016/j.ajo.2009.01.024; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Li ZJ, 2011, AM J PATHOL, V178, P1106, DOI 10.1016/j.ajpath.2010.12.001; Malik RA, 2003, DIABETOLOGIA, V46, P683, DOI 10.1007/s00125-003-1086-8; Martinez-de-la-Casa JM, 2012, INVEST OPHTH VIS SCI, V53, P6214, DOI 10.1167/iovs.12-9875; Matsuzaki H, 2001, FASEB J, V15, P1218, DOI 10.1096/fj.00-0495fje; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Niwa Y, 2015, INVEST OPHTH VIS SCI, V56, P6501, DOI 10.1167/iovs.15-17279; Pan Z, 2013, FASEB J, V27, P2756, DOI 10.1096/fj.12-225185; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Rouvas A, 2009, OPHTHALMOLOGICA, V223, P383, DOI 10.1159/000228590; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Shin HJ, 2014, INVEST OPHTH VIS SCI, V55, P2403, DOI 10.1167/iovs.13-13769; Sobaci G, 2013, INT J OPHTHALMOL-CHI, V6, P211, DOI 10.3980/j.issn.2222-3959.2013.02.20; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Xu KP, 1996, CORNEA, V15, P235, DOI 10.1097/00003226-199605000-00002; Yau GL, 2015, CAN J OPHTHALMOL, V50, P345, DOI 10.1016/j.jcjo.2015.01.008; Yu CQ, 2008, INVEST OPHTH VIS SCI, V49, P3870, DOI 10.1167/iovs.07-1418; Zachary I, 2005, NEUROSIGNALS, V14, P207, DOI 10.1159/000088637	35	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0170271	10.1371/journal.pone.0170271	http://dx.doi.org/10.1371/journal.pone.0170271			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085965	Green Submitted, gold, Green Published			2022-12-26	WOS:000391972600082
J	Arthuis, CJ; Novell, A; Raes, F; Escoffre, JM; Lerondel, S; Le Pape, A; Bouakaz, A; Perrotin, F				Arthuis, Chloe J.; Novell, Anthony; Raes, Florian; Escoffre, Jean-Michel; Lerondel, Stephanie; Le Pape, Alain; Bouakaz, Ayache; Perrotin, Franck			Real-Time Monitoring of Placental Oxygenation during Maternal Hypoxia and Hyperoxygenation Using Photoacoustic Imaging	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; FOR-GESTATIONAL-AGE; BOLD MRI; FETAL; OXYHEMOGLOBIN; TOMOGRAPHY; BRAIN; SHEEP	Purpose This preclinical study aimed to evaluate placental oxygenation in pregnant rats by real-time photoacoustic (PA) imaging on different days of gestation and to specify variations in placental oxygen saturation under conditions of maternal hypoxia and hyperoxygenation. Material and methods Placentas of fifteen Sprague-Dawley rats were examined on days 14, 17, and 20 of pregnancy with a PA imaging system coupled to high-resolution ultrasound imaging. Pregnant rats were successively exposed to hyperoxygenated and hypoxic conditions by changing the oxygen concentration in inhaled gas. Tissue oxygen saturation was quantitatively analyzed by real-time PA imaging in the skin and 3 regions of the placenta. All procedures were performed in accordance with applicable ethical guidelines and approved by the animal care committee. Results Maternal hypoxia was associated with significantly greater decrease in blood oxygen saturation (Delta O-2 Saturation) in the skin (70.74% +/- 7.65) than in the mesometrial triangle (32.66% +/- 5.75) or other placental areas (labyrinth: 18.58% +/- 6.61; basal zone: 13.13% +/- 5.72) on different days of pregnancy (P<0.001). Delta O-2 Saturation did not differ significantly between the labyrinth, the basal zone, and the decidua. After the period of hypoxia, maternal hyperoxygenation led to a significant rise in oxygen saturation, which returned to its initial values in the different placental regions (P<0.001). Conclusions PA imaging enables the variation of blood oxygen saturation to be monitored in the placenta during maternal hypoxia or hyperoxygenation. This first preclinical study suggests that the placenta plays an important role in protecting the fetus against maternal hypoxia.	[Arthuis, Chloe J.; Novell, Anthony; Escoffre, Jean-Michel; Bouakaz, Ayache; Perrotin, Franck] Univ Tours, Inserm U930, Tours, France; [Arthuis, Chloe J.; Perrotin, Franck] Univ Hosp Ctr Tours, Dept Obstet Gynecol & Fetal Med, Tours, France; [Raes, Florian; Lerondel, Stephanie; Le Pape, Alain] CNRS, Ctr Small Anim Imaging CIPA, PHENOMIN TAAM UPS44, Orleans, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Arthuis, CJ (corresponding author), Univ Tours, Inserm U930, Tours, France.; Arthuis, CJ (corresponding author), Univ Hosp Ctr Tours, Dept Obstet Gynecol & Fetal Med, Tours, France.	chloearthuis@gmail.com	Raes, Florian/ABD-8845-2020; Escoffre, Jean-Michel/P-5606-2014; Bouakaz, Ayache/G-1757-2013; Perrotin, Franck/AAL-8833-2021	Raes, Florian/0000-0003-2898-995X; Escoffre, Jean-Michel/0000-0003-1041-6950; Bouakaz, Ayache/0000-0001-5709-7120; Perrotin, Franck/0000-0001-9694-6658; Novell, Anthony/0000-0003-3649-0956	Societe Francaise de Medecine Perinatale; AREFO-PERINAT	Societe Francaise de Medecine Perinatale; AREFO-PERINAT	This study was supported by a grant of "Societe Francaise de Medecine Perinatale" and AREFO-PERINAT funding for research and education.	Arthuis CJ, 2013, PLACENTA, V34, P424, DOI 10.1016/j.placenta.2013.01.019; Bobek G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059971; Chalouhi GE, 2013, RADIOLOGY, V269, P122, DOI 10.1148/radiol.13121742; Chauhan SP, 2013, AM J PERINAT, V30, P33, DOI 10.1055/s-0032-1321497; Doctor BA, 2001, AM J OBSTET GYNECOL, V185, P652, DOI 10.1067/mob.2001.116749; Erpelding TN, 2010, RADIOLOGY, V256, P102, DOI 10.1148/radiol.10091772; Heijblom M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11778; Huen I, 2014, BJOG-INT J OBSTET GY, V121, P1588, DOI 10.1111/1471-0528.12804; Kruger RA, 2013, MED PHYS, V40, DOI 10.1118/1.4824317; Lungu GF, 2007, INT J ONCOL, V30, P45; Mezrich R, 2012, RADIOLOGY, V263, P313, DOI 10.1148/radiol.12120252; Needles A, 2013, IEEE T ULTRASON FERR, V60, P888, DOI 10.1109/TUFFC.2013.2646; NICOLAIDES KH, 1989, AM J OBSTET GYNECOL, V161, P996, DOI 10.1016/0002-9378(89)90770-9; Rich LJ, 2015, RADIOLOGY, V275, P110, DOI 10.1148/radiol.14140654; Ruano R, 2013, ULTRASOUND OBST GYN, V42, P434, DOI 10.1002/uog.12492; Schoennagel BP, 2015, J MAGN RESON IMAGING, V41, P110, DOI 10.1002/jmri.24555; Solomon E, 2014, P NATL ACAD SCI USA, V111, P10353, DOI 10.1073/pnas.1401695111; Song KH, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2976427; Sorensen A, 2009, ULTRASOUND OBST GYN, V34, P687, DOI 10.1002/uog.7322; Stoffels I, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad1278; Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210; Wang XD, 2003, NAT BIOTECHNOL, V21, P803, DOI 10.1038/nbt839; Wedegartner U, 2006, RADIOLOGY, V238, P872, DOI 10.1148/radiol.2383042213; Xia J, 2014, PROG ELECTROMAGN RES, V147, P1, DOI 10.2528/PIER14032303; Xia WF, 2015, LECT NOTES COMPUT SC, V9349, P371, DOI 10.1007/978-3-319-24553-9_46; Zackrisson S, 2014, CANCER RES, V74, P979, DOI 10.1158/0008-5472.CAN-13-2387; ZIJLSTRA WG, 1991, CLIN CHEM, V37, P1633	27	33	33	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169850	10.1371/journal.pone.0169850	http://dx.doi.org/10.1371/journal.pone.0169850			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081216	Green Published, gold, Green Submitted			2022-12-26	WOS:000391949500090
J	Koleoglu, G; Goodwin, PH; Reyes-Quintana, M; Hamiduzzaman, MM; Guzman-Novoa, E				Koleoglu, Gun; Goodwin, Paul H.; Reyes-Quintana, Mariana; Hamiduzzaman, Mollah Md.; Guzman-Novoa, Ernesto			Effect of Varroa destructor, Wounding and Varroa Homogenate on Gene Expression in Brood and Adult Honey Bees	PLOS ONE			English	Article							APIS-MELLIFERA PUPAE; IMMUNE-RESPONSE; PARALYSIS VIRUS; PARASITIC MITE; INFECTION; WORKERS; VITELLOGENIN; JACOBSONI; PATHWAYS; DEFENSE	Honey bee (Apis mellifera) gene expression related to immunity for hymenoptaecin (AmHym) and defensin-1 (AmDef-1), longevity for vitellogenin (AmVit2) and stem cell proliferation for poly U binding factor 68 kDa (AmPuf68) was compared following Varroa destructor parasitism, buffer injection and injection of V. destructor compounds in its homogenate. In adults, V. destructor parasitism decreased expression of all four genes, while buffer injection decreased expression of AmHym, AmPuf68 and AmVit2, and homogenate injection decreased expression of AmPuf68 and AmVit2 but increased expression of AmDef-1 relative to their respective controls. The effect of V. destructor parasitism in adults relative to the controls was not significantly different from buffer injection for AmHym and AmVit2 expression, and it was not significantly different from homogenate injection for AmPuf68 and AmVit2. In brood, V. destructor parasitism, buffer injection and homogenate injection decreased AmVit2 expression, whereas AmHym expression was decreased by V. destructor parasitism but increased by buffer and homogenate injection relative to the controls. The effect of varroa parasitism in brood was not significantly different from buffer or homogenate injection for AmPuf68 and AmVit2. Expression levels of the four genes did not correlate with detectable viral levels in either brood or adults. The results of this study indicate that the relative effects of V. destructor parasitism on honey bee gene expression are also shared with other types of stresses. Therefore, some of the effects of V. destructor on honey bees may be mostly due to wounding and injection of foreign compounds into the hemolymph of the bee during parasitism. Although both brood and adults are naturally parasitized by V. destructor, their gene expression responded differently, probably the result of different mechanisms of host responses during development.	[Koleoglu, Gun; Goodwin, Paul H.; Hamiduzzaman, Mollah Md.; Guzman-Novoa, Ernesto] Univ Guelph, Sch Environm Sci, Guelph, ON, Canada; [Reyes-Quintana, Mariana] Univ Nacl Autonoma Mexico, Fac Med Vet & Zootecnia, Dept Med & Zootecnia Abejas, Autonoma Mexico, Mexico City, DF, Mexico	University of Guelph; Universidad Nacional Autonoma de Mexico	Hamiduzzaman, MM (corresponding author), Univ Guelph, Sch Environm Sci, Guelph, ON, Canada.	mhamiduz@uoguelph.ca	Goodwin, Mark/F-5331-2018	Goodwin, Mark/0000-0001-5411-0350; Guzman-Novoa, Ernesto/0000-0001-5632-0642	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant [400571]	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (400571) to EG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal K, 2008, BMB REP, V41, P267, DOI 10.5483/BMBRep.2008.41.4.267; Allen M, 1996, BEE WORLD, V77, P141, DOI 10.1080/0005772X.1996.11099306; Amdam GV, 2005, EXP GERONTOL, V40, P939, DOI 10.1016/j.exger.2005.08.004; Anderson DL, 2000, EXP APPL ACAROL, V24, P165, DOI 10.1023/A:1006456720416; Arechavaleta-Velasco ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047269; Aronstein K, 2005, APIDOLOGIE, V36, P3, DOI 10.1051/apido:2004062; Azzami K, 2012, ARCH VIROL, V157, P689, DOI 10.1007/s00705-012-1223-0; Buchon N, 2009, P NATL ACAD SCI USA, V106, P12442, DOI 10.1073/pnas.0901924106; CASTEELS P, 1993, J BIOL CHEM, V268, P7044; Chen GYJ, 2000, J PHYTOPATHOL, V148, P57, DOI 10.1111/j.1439-0434.2000.tb04625.x; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; Dean JD, 2002, PLANT MOL BIOL REP, V20, P347, DOI 10.1007/BF02772122; DEJONG D, 1982, J APICULT RES, V21, P165, DOI 10.1080/00218839.1982.11100535; Di Prisco G, 2016, P NATL ACAD SCI US; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Evans JD, 2006, J INVERTEBR PATHOL, V93, P135, DOI 10.1016/j.jip.2006.04.004; Fedorova AA, 2011, ANTIVIR RES, V91, P267, DOI 10.1016/j.antiviral.2011.06.011; Gregory PG, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.7; Guidugli KR, 2005, ARCH INSECT BIOCHEM, V59, P211, DOI 10.1002/arch.20061; Guzman-Novoa E, 2010, APIDOLOGIE, V41, P443, DOI 10.1051/apido/2009076; Hamiduzzaman MM, 2015, J INVERTEBR PATHOL, V126, P12, DOI 10.1016/j.jip.2014.12.004; Hamiduzzaman MM, 2012, J INVERTEBR PATHOL, V111, P237, DOI 10.1016/j.jip.2012.09.001; Kanbar G, 2003, PARASITOL RES, V90, P349, DOI 10.1007/s00436-003-0827-4; Kralj J, 2007, J COMP PHYSIOL A, V193, P363, DOI 10.1007/s00359-006-0192-8; Kuster RD, 2014, J EXP BIOL, V217, P1710, DOI 10.1242/jeb.097766; Le Conte Y, 2011, INSECT MOL BIOL, V20, P399, DOI 10.1111/j.1365-2583.2011.01074.x; Maori E., 2009, J INSECT MOL BIOL, V18, P56; Martin SJ, 2001, J APPL ECOL, V38, P1082, DOI 10.1046/j.1365-2664.2001.00662.x; Mitchell NC, 2010, DEVELOPMENT, V137, P2875, DOI 10.1242/dev.049585; Navajas M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-301; Piulachs MD, 2003, INSECT BIOCHEM MOLEC, V33, P459, DOI 10.1016/S0965-1748(03)00021-3; Randolt K, 2008, ARCH INSECT BIOCHEM, V69, P155, DOI 10.1002/arch.20269; Ren FF, 2013, CELL RES, V23, P1133, DOI 10.1038/cr.2013.101; Richards EH, 2011, PARASITOLOGY, V138, P602, DOI 10.1017/S0031182011000072; Ryabov EV, 2015, PEER J PREPRINTS, V3, pe1749; Schluns H, 2007, INSECT MOL BIOL, V16, P753, DOI 10.1111/j.1365-2583.2007.00768.x; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Shen MQ, 2005, VIROLOGY, V342, P141, DOI 10.1016/j.virol.2005.07.012; Stoltz D, 1995, J APICULT RES, V34, P153, DOI 10.1080/00218839.1995.11100900; Tentcheva D, 2004, APPL ENVIRON MICROB, V70, P7185, DOI 10.1128/AEM.70.12.7185-7191.2004; Thompson GJ, 2007, J EXP ZOOL PART A, V307A, P600, DOI 10.1002/jez.415; Tsuruda JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048276; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102	43	31	31	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169669	10.1371/journal.pone.0169669	http://dx.doi.org/10.1371/journal.pone.0169669			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081188	Green Published, Green Submitted, gold			2022-12-26	WOS:000391949500060
J	Li, YD; Li, J; Jia, XY; Xiao, XS; Li, SQ; Guo, XM				Li, Yadi; Li, Jie; Jia, Xiaoyun; Xiao, Xueshan; Li, Shiqiang; Guo, Xiangming			Genetic and Clinical Analyses of DOA and LHON in 304 Chinese Patients with Suspected Childhood-Onset Hereditary Optic Neuropathy	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; OPA1 MUTATIONS; ATROPHY; DISEASE; NEURODEGENERATION; FAMILIES; PLUS; PATHOPHYSIOLOGY; DISORDERS; PEDIGREES	Leber hereditary optic neuropathy (LHON) and dominant optic atrophy (DOA), the most common forms of hereditary optic neuropathy, are easily confused, and it is difficult to distinguish one from the other in the clinic, especially in young children. The present study was designed to survey the mutation spectrum of common pathogenic genes (OPA1, OPA3 and mtDNA genes) and to analyze the genotype-phenotype characteristics of Chinese patients with suspected childhood-onset hereditary optic neuropathy. Genomic DNA and clinical data were collected from 304 unrelated Chinese probands with suspected hereditary optic neuropathy with an age of onset below 14 years. Sanger sequencing was used to screen variants in the coding and adjacent regions of OPA1, OPA3 and the three primary LHON-related mutation sites in mitochondrial DNA (mtDNA) (m.3460G>A, m.11778G>A and m.14484T>C). All patients underwent a complete ophthalmic examination and were compared with age-matched controls. We identified 89/304 (29.3%) primary mtDNA mutations related to LHON in 304 probands, including 76 mutations at m.11778 (76/89, 85.4% of all mtDNA mutations), four at m.3460 (4/89, 4.5%) and nine at m.14484 (9/89, 10.1%). This result was similar to the mutation frequency among Chinese patients with LHON of any age. Screening of OPA1 revealed 23 pathogenic variants, including 11 novel and 12 known pathogenic mutations. This study expanded the OPA1 mutation spectrum, and our results showed that OPA1 mutation is another common cause of childhood-onset hereditary optic neuropathy in Chinese pediatric patients, especially those with disease onset during preschool age.	[Li, Yadi; Li, Jie; Jia, Xiaoyun; Xiao, Xueshan; Li, Shiqiang; Guo, Xiangming] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Guo, XM (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China.	zocguoxm@aliyun.com			National Natural Science Foundation of China [81170847]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by the National Natural Science Foundation of China (81170847; to X.G.).	Alavi MV, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-32; Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298; Anikster Y, 2001, AM J HUM GENET, V69, P1218, DOI 10.1086/324651; Ban T, 2010, HUM MOL GENET, V19, P2113, DOI 10.1093/hmg/ddq088; Barboni P, 2006, INVEST OPHTH VIS SCI, V47, P5303, DOI 10.1167/iovs.06-0520; Barboni P, 2014, AM J OPHTHALMOL, V158, P628, DOI 10.1016/j.ajo.2014.05.034; Barboni P, 2010, OPHTHALMOLOGY, V117, P1547, DOI 10.1016/j.ophtha.2009.12.042; Baris Olivier, 2003, Hum Mutat, V21, P656, DOI 10.1002/humu.9152; BENZER S, 1961, P NATL ACAD SCI USA, V47, P403, DOI 10.1073/pnas.47.3.403; Brown MD, 2000, J BIOL CHEM, V275, P39831, DOI 10.1074/jbc.M006476200; Carelli V, 2004, BBA-BIOENERGETICS, V1658, P172, DOI 10.1016/j.bbabio.2004.05.009; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; Carelli V, 2009, BBA-BIOENERGETICS, V1787, P518, DOI 10.1016/j.bbabio.2009.02.024; Chen JQ, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-14953; Chen YB, 2013, MOL VIS, V19, P292; Cohn AC, 2008, BRIT J OPHTHALMOL, V92, P1333, DOI 10.1136/bjo.2007.134726; de la Barca JMC, 2016, NEUROBIOL DIS, V90, P20, DOI 10.1016/j.nbd.2015.08.015; Delettre C, 2001, HUM GENET, V109, P584, DOI 10.1007/s00439-001-0633-y; ELIOTT D, 1993, AM J OPHTHALMOL, V115, P360, DOI 10.1016/S0002-9394(14)73589-5; Ferre M, 2009, HUM MUTAT, V30, pE692, DOI 10.1002/humu.21025; Fraser JA, 2010, SURV OPHTHALMOL, V55, P299, DOI 10.1016/j.survophthal.2009.10.002; Grau T, 2013, J MED GENET, V50, P848, DOI 10.1136/jmedgenet-2013-101774; HARDING AE, 1995, AM J HUM GENET, V57, P77; Jia XY, 2006, J HUM GENET, V51, P851, DOI 10.1007/s10038-006-0032-2; Ke Tie, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P481; La Morgia C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00141; Lenaers G, 2009, INT J BIOCHEM CELL B, V41, P1866, DOI 10.1016/j.biocel.2009.04.013; MacVicar T, 2016, J CELL SCI; Maresca A, 2013, MOL CELL NEUROSCI, V55, P62, DOI 10.1016/j.mcn.2012.08.004; Meyerson C, 2015, CLIN OPHTHALMOL, V9, P1165, DOI 10.2147/OPTH.S62021; MOORMAN CM, 1993, PEDIATRICS, V91, P988; Neuhann T, 2013, EXPERT REV NEUROTHER, V13, P357, DOI [10.1586/ERN.13.19, 10.1586/ern.13.19]; NEWMAN NJ, 1991, AM J OPHTHALMOL, V111, P750, DOI 10.1016/S0002-9394(14)76784-4; NIKOSKELAINEN E, 1985, OPHTHALMIC PAED GEN, V5, P125, DOI 10.3109/13816818509007866; NIKOSKELAINEN EK, 1995, J NEUROL NEUROSUR PS, V59, P160, DOI 10.1136/jnnp.59.2.160; Oguchi Yoshihisa, 2001, Nippon Ganka Gakkai Zasshi, V105, P809; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; Olichon A, 2006, BBA-MOL CELL RES, V1763, P500, DOI 10.1016/j.bbamcr.2006.04.003; Piotrowska A, 2015, GENE, V555, P41, DOI 10.1016/j.gene.2014.09.048; Reynier P, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.016576; Sacai PY, 2010, DOC OPHTHALMOL, V121, P147, DOI 10.1007/s10633-010-9241-2; Santarelli R, 2015, BRAIN, V138, P563, DOI 10.1093/brain/awu378; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; SWARTZ N, 1994, SURV OPHTHALMOL, V39, P146, DOI 10.1016/0039-6257(94)90160-0; Thiselton DL, 2002, INVEST OPHTH VIS SCI, V43, P1715; Votruba M, 1998, J MED GENET, V35, P793, DOI 10.1136/jmg.35.10.793; Votruba M, 2003, BRIT J OPHTHALMOL, V87, P48, DOI 10.1136/bjo.87.1.48; Votruba M, 1998, ARCH OPHTHALMOL-CHIC, V116, P351, DOI 10.1001/archopht.116.3.351; WEINER NC, 1993, ARCH NEUROL-CHICAGO, V50, P470, DOI 10.1001/archneur.1993.00540050022009; Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007; Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270; Yu-Wai-Man P, 2015, SEMIN NEUROL, V35, P578, DOI 10.1055/s-0035-1563574; Yu-Wai-Man P, 2010, OPHTHALMOLOGY, V117, P1538, DOI 10.1016/j.ophtha.2009.12.038; Yu-Wai-Man P, 2011, OPHTHALMOLOGY, V118, P558, DOI 10.1016/j.ophtha.2010.07.029; Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002; Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335; Zhang AM, 2017, MOL NEUROBIOL, V54, P1622, DOI 10.1007/s12035-016-9771-z	57	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0170090	10.1371/journal.pone.0170090	http://dx.doi.org/10.1371/journal.pone.0170090			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081242	Green Published, Green Submitted, gold			2022-12-26	WOS:000391949500130
J	Low, JK; Ambikairajah, A; Shang, K; Brown, DA; Tsai, VWW; Breit, SN; Karl, T				Low, Jac Kee; Ambikairajah, Ananthan; Shang, Kani; Brown, David A.; Tsai, Vicky W. W.; Breit, Samuel N.; Karl, Tim			First Behavioural Characterisation of a Knockout Mouse Model for the Transforming Growth Factor (TGF)-beta Superfamily Cytokine, MIC-1/GDF15	PLOS ONE			English	Article							MACROPHAGE INHIBITORY CYTOKINE-1; NEUREGULIN-1 MUTANT MICE; SOCIAL-INTERACTION TEST; OPEN-FIELD BEHAVIOR; ELEVATED PLUS-MAZE; NEUROPEPTIDE-Y; ANXIETY; RAT; MORTALITY; COGNITION	Macrophage inhibitory cytokine-1 (MIC-1), also known as growth differentiation factor 15 (GDF15), is a stress response cytokine. MIC-1/GDF15 is secreted into the cerebrospinal fluid and increased levels of MIC-1/GDF15 are associated with a variety of diseases including cognitive decline. Furthermore, Mic-1/Gdf15 knockout mice (Mic-1 KO) weigh more, have increased adiposity, associated with increased spontaneous food intake, and exhibit reduced basal energy expenditure and physical activity. The current study was designed to comprehensively determine the role of MIC-1/GDF15 on behavioural domains of male and female knockout mice including locomotion, exploration, anxiety, cognition, social behaviours, and sensorimotor gating. Mic-1 KO mice exhibited a task-dependent increase in locomotion and exploration and reduced anxiety-related behaviours across tests. Spatial working memory and social behaviours were not affected by Mic-1/Gdf15 deficiency. Interestingly, knockout mice formed an increased association with the conditioned stimulus in fear conditioning testing and also displayed significantly improved prepulse inhibition. Overall sex effects were evident for social behaviours, fear conditioning, and sensorimotor gating. This is the first study defining the role of Mic-1/Gdf15 in a number of behavioural domains. Whether the observed impact is based on direct actions of Mic-1/Gdf15 deficiency on the CNS or whether the behavioural effects are mediated by indirect actions on e.g. other neurotransmitter systems must be clarified in future studies.	[Low, Jac Kee; Ambikairajah, Ananthan; Karl, Tim] Neurosci Res Australia NeuRA, Randwick, NSW, Australia; [Shang, Kani; Karl, Tim] Univ Western Sydney, Sch Med, Campbelltown, NSW, Australia; [Brown, David A.; Tsai, Vicky W. W.; Breit, Samuel N.] St Vincents Hosp, St Vincents Ctr Appl Med Res, Darlinghurst, NSW, Australia; [Brown, David A.] Inst Clin Pathol & Med Res, Westmead Inst Med Res, Westmead, NSW, Australia; [Brown, David A.] Westmead Hosp, Westmead, NSW, Australia	Neuroscience Research Australia; Western Sydney University; St Vincents Hospital Sydney; University of Sydney; Westmead Institute for Medical Research; University of Sydney	Karl, T (corresponding author), Neurosci Res Australia NeuRA, Randwick, NSW, Australia.; Karl, T (corresponding author), Univ Western Sydney, Sch Med, Campbelltown, NSW, Australia.	t.karl@westernsydney.edu.au	Karl, Tim/E-2088-2011; Ambikairajah, Ananthan/W-4565-2018	Karl, Tim/0000-0001-9904-8482; Ambikairajah, Ananthan/0000-0002-5808-8020; Low, Jac Kee/0000-0002-7416-8645; Brown, David/0000-0003-1382-9419	National Health and Medical Research Council (NHMRC) [1045643]; NHMRC [1102012, 1095215]; Rebecca L. Cooper Medical Research Foundation Ltd.	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Rebecca L. Cooper Medical Research Foundation Ltd.	TK is supported by a Career Development Fellowship (Level 2) from the National Health and Medical Research Council (NHMRC: #1045643), a NHMRC project grant (#1102012), the NHMRC dementia research team initiative (#1095215), and the Rebecca L. Cooper Medical Research Foundation Ltd.	Bauskin AR, 2006, CANCER RES, V66, P4983, DOI 10.1158/0008-5472.CAN-05-4067; Bonaterra GA, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.002550; Boucher AA, 2007, PSYCHOPHARMACOLOGY, V192, P325, DOI 10.1007/s00213-007-0721-3; Breit SN, 2012, NEPHROL DIAL TRANSPL, V27, P70, DOI 10.1093/ndt/gfr575; Breit SN, 2011, GROWTH FACTORS, V29, P187, DOI 10.3109/08977194.2011.607137; BROQUA P, 1995, BEHAV PHARMACOL, V6, P215; Brown DA, 2002, LANCET, V359, P2159, DOI 10.1016/S0140-6736(02)09093-1; Brown DA, 2009, CLIN CANCER RES, V15, P6658, DOI 10.1158/1078-0432.CCR-08-3126; Butterweck V, 2003, BEHAV BRAIN RES, V144, P49, DOI 10.1016/S0166-4328(03)00059-7; Chesworth R, 2012, BEHAV BRAIN RES, V226, P218, DOI 10.1016/j.bbr.2011.09.019; DENENBERG VH, 1969, ANN NY ACAD SCI, V159, P852, DOI 10.1111/j.1749-6632.1969.tb12983.x; Duffy L, 2010, NEUROSCIENCE, V170, P800, DOI 10.1016/j.neuroscience.2010.07.042; Fairlie WD, 1999, J LEUKOCYTE BIOL, V65, P2, DOI 10.1002/jlb.65.1.2; File SE, 2003, EUR J PHARMACOL, V463, P35, DOI 10.1016/S0014-2999(03)01273-1; Fuchs T, 2013, AGING CELL, V12, P882, DOI 10.1111/acel.12116; HEILIG M, 1989, PSYCHOPHARMACOLOGY, V98, P524, DOI 10.1007/BF00441953; Hughes RN, 2004, NEUROSCI BIOBEHAV R, V28, P497, DOI 10.1016/j.neubiorev.2004.06.006; Jiang JY, 2016, CURR OPIN PSYCHIATR, V29, P181, DOI 10.1097/YCO.0000000000000225; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Karl T, 2007, GENES BRAIN BEHAV, V6, P677, DOI 10.1111/j.1601-183X.2006.00298.x; Karl T, 2011, BEHAV BRAIN RES, V223, P336, DOI 10.1016/j.bbr.2011.04.051; Karl T, 2010, NEUROPEPTIDES, V44, P233, DOI 10.1016/j.npep.2009.12.008; Karl T, 2008, EUR J NEUROSCI, V28, P173, DOI 10.1111/j.1460-9568.2008.06306.x; Lin EJD, 2010, EUR NEUROPSYCHOPHARM, V20, P164, DOI 10.1016/j.euroneuro.2009.08.004; Macia L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034868; PELLOW S, 1986, PHARMACOL BIOCHEM BE, V24, P525, DOI 10.1016/0091-3057(86)90552-6; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Raffin-Sanson ML, 2003, EUR J ENDOCRINOL, V149, P79, DOI 10.1530/eje.0.1490079; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sajdyk TJ, 1999, EUR J PHARMACOL, V368, P143, DOI 10.1016/S0014-2999(99)00018-7; Schober A, 2001, J COMP NEUROL, V439, P32, DOI 10.1002/cne.1333; Strelau J, 2000, J NEUROSCI, V20, P8597; Tsai VWW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055174; van den Buuse M, 2009, INT J NEUROPSYCHOPH, V12, P1383, DOI 10.1017/S1461145709000388; Wiklund FE, 2010, AGING CELL, V9, P1057, DOI 10.1111/j.1474-9726.2010.00629.x	36	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0168416	10.1371/journal.pone.0168416	http://dx.doi.org/10.1371/journal.pone.0168416			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081177	Green Published, gold			2022-12-26	WOS:000391949500012
J	Wang, C; Lai, DYF; Sardans, J; Wang, WQ; Zeng, CS; Penuelas, J				Wang, Chun; Lai, Derrick Y. F.; Sardans, Jordi; Wang, Weiqi; Zeng, Congsheng; Penuelas, Josep			Factors Related with CH4 and N2O Emissions from a Paddy Field: Clues for Management implications	PLOS ONE			English	Article							NITROUS-OXIDE EMISSIONS; GREENHOUSE-GAS EMISSIONS; METHANE OXIDATION; CARBON-DIOXIDE; RICE FIELD; SOIL; WATER; SULFATE; MITIGATION; FERTILIZER	Paddy fields are major sources of global atmospheric greenhouse gases, including methane (CH4) and nitrous oxide (N2O). The different phases previous to emission (production, transport, diffusion, dissolution in pore water and ebullition) despite well-established have rarely been measured in field conditions. We examined them and their relationships with temperature, soil traits and plant biomass in a paddy field in Fujian, southeastern China. CH4 emission was positively correlated with CH4 production, plant-mediated transport, ebullition, diffusion, and concentration of dissolved CH4 in porewater and negatively correlated with sulfate concentration, suggesting the potential use of sulfate fertilizers to mitigate CH4 release. Air temperature and humidity, plant stem biomass, and concentrations of soil sulfate, available N, and DOC together accounted for 92% of the variance in CH4 emission, and Eh, pH, and the concentrations of available N and Fe3+, leaf biomass, and air temperature 95% of the N2O emission. Given the positive correlations between CH4 emission and DOC content and plant biomass, reduce the addition of a carbon substrate such as straw and the development of smaller but higher yielding rice genotypes could be viable options for reducing the release of greenhouse gases from paddy fields to the atmosphere.	[Wang, Chun; Wang, Weiqi; Zeng, Congsheng] Fujian Normal Univ, Inst Geog, Fuzhou, Peoples R China; [Wang, Chun; Wang, Weiqi; Zeng, Congsheng] Fujian Normal Univ, Key Lab Humid Subtrop Ecogeog Proc, Minist Educ, Fuzhou, Peoples R China; [Lai, Derrick Y. F.] Chinese Univ Hong Kong, Dept Geog & Resource Management, Hong Kong, Hong Kong, Peoples R China; [Sardans, Jordi; Penuelas, Josep] Global Ecol Unit CREAF CEAB CSIC UAB, CSIC, Cerdanyola Del Valles 08913, Catalonia, Spain; [Sardans, Jordi; Penuelas, Josep] CREAF, Cerdanyola Del Valles 08913, Catalonia, Spain	Fujian Normal University; Fujian Normal University; Chinese University of Hong Kong; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF)	Wang, WQ (corresponding author), Fujian Normal Univ, Inst Geog, Fuzhou, Peoples R China.; Wang, WQ (corresponding author), Fujian Normal Univ, Key Lab Humid Subtrop Ecogeog Proc, Minist Educ, Fuzhou, Peoples R China.	wangweiqi15@163.com	Wang, weiqi/AAN-8209-2020; Lai, Derrick Y.F./B-1387-2009; Sardans, Jordi/AEM-0228-2022; Penuelas, Josep/D-9704-2011	Lai, Derrick Y.F./0000-0002-1225-9904; Sardans, Jordi/0000-0003-2478-0219; Penuelas, Josep/0000-0002-7215-0150; wang, weiqi/0000-0001-8503-0978	National Science Foundation of China [41571287, 31000209]; Natural Science Foundation Key Programs of Fujian Province [2014R1034-3, 2014Y0054, 2014J01119]; Chinese University of Hong Kong [SS12434]; European Research Council Synergy grant [ERC-SyG-2013-610028 IMBALANCE-P]; Spanish Government [CGL2013-48074-P]; Catalan Government [SGR 2014-274]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Key Programs of Fujian Province; Chinese University of Hong Kong(Chinese University of Hong Kong); European Research Council Synergy grant(European Research Council (ERC)); Spanish Government(Spanish GovernmentEuropean Commission); Catalan Government	Funding was provided by the National Science Foundation of China (41571287, 31000209), Natural Science Foundation Key Programs of Fujian Province (2014R1034-3, 2014Y0054, and 2014J01119), the Chinese University of Hong Kong (SS12434), the European Research Council Synergy grant ERC-SyG-2013-610028 IMBALANCE-P, the Spanish Government grant CGL2013-48074-P, and the Catalan Government grant SGR 2014-274.; The authors would like to thank Pengfei Li, Yongyue Ma, Na Zhao, and Dehua Lin for their assistance with field sampling. Funding was provided by the National Science Foundation of China (41571287, 31000209), Natural Science Foundation Key Programs of Fujian Province (2014R1034-3, 2014Y0054, and 2014J01119), the Chinese University of Hong Kong (SS12434), the European Research Council Synergy grant ERC-SyG-2013-610028 IMBALANCE-P, the Spanish Government grant CGL2013-48074-P, and the Catalan Government grant SGR 2014-274.	Ali MA, 2008, BIOL FERT SOILS, V44, P597, DOI 10.1007/s00374-007-0243-5; Ali MA, 2013, AMBIO, V42, P357, DOI 10.1007/s13280-012-0349-3; Allen DE, 2007, SOIL BIOL BIOCHEM, V39, P622, DOI 10.1016/j.soilbio.2006.09.013; ANASTASI C, 1992, J GEOPHYS RES-ATMOS, V97, P7521, DOI 10.1029/92JD00157; [Anonymous], 2008, BIOGEOCHEMISTRY WETL; Baulch HM, 2012, FRESHWATER BIOL, V57, P509, DOI 10.1111/j.1365-2427.2011.02720.x; Bengtsson G, 2002, J CHEM SOC DALTON, P2548, DOI 10.1039/b201602h; Bosse U, 1998, BIOGEOCHEMISTRY, V41, P199, DOI 10.1023/A:1005909313026; Bridgham SD, 2013, GLOBAL CHANGE BIOL, V19, P1325, DOI 10.1111/gcb.12131; Chan ASK, 2000, SOIL BIOL BIOCHEM, V32, P1581, DOI 10.1016/S0038-0717(00)00071-7; Chen WW, 2013, AGR ECOSYST ENVIRON, V178, P64, DOI 10.1016/j.agee.2013.05.008; Chen WW, 2011, GLOBAL CHANGE BIOL, V17, P2803, DOI 10.1111/j.1365-2486.2011.02444.x; Chidthaisong A, 2000, FEMS MICROBIOL ECOL, V31, P73, DOI 10.1111/j.1574-6941.2000.tb00673.x; Datta A, 2013, ATMOS ENVIRON, V66, P114, DOI 10.1016/j.atmosenv.2012.06.008; Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Ding WX, 2004, ATMOS ENVIRON, V38, P4165, DOI 10.1016/j.atmosenv.2004.04.022; Ding WX, 2003, CHEMOSPHERE, V51, P167, DOI 10.1016/S0045-6535(02)00804-4; Dise NB, 2001, BIOGEOCHEMISTRY, V53, P143, DOI 10.1023/A:1010774610050; FAO [Food and Agricultural Organization of the United Nations], 2009, OECD FAO AGR OUT LOO; Frenzel P, 2000, BIOGEOCHEMISTRY, V51, P91, DOI 10.1023/A:1006351118347; Gagnon B, 2011, SOIL SCI SOC AM J, V75, P595, DOI 10.2136/sssaj2010.0212; Gauci V, 2008, J GEOPHYS RES, V113, P1; Hanke A, 2013, EUR J SOIL SCI, V64, P476, DOI 10.1111/ejss.12042; Haque MM, 2015, PLANT SOIL, V387, P251, DOI 10.1007/s11104-014-2287-2; Hasegawa K, 2004, WATER SCI TECHNOL, V50, P145, DOI 10.2166/wst.2004.0509; Huang B, 2009, CHEMOSPHERE, V74, P481, DOI 10.1016/j.chemosphere.2008.10.015; Hutsch BW, 2001, EUR J AGRON, V14, P237, DOI 10.1016/S1161-0301(01)00110-1; Huttunen JT, 2003, ATMOS ENVIRON, V37, P147, DOI 10.1016/S1352-2310(02)00771-9; Inubushi K, 2002, NUTR CYCL AGROECOSYS, V64, P71, DOI 10.1023/A:1021136431176; Itoh M, 2011, AGR ECOSYST ENVIRON, V141, P359, DOI 10.1016/j.agee.2011.03.019; Jena J, 2013, INDIAN J MICROBIOL, V53, P92, DOI 10.1007/s12088-012-0318-3; Jia ZJ, 2001, PLANT SOIL, V230, P211, DOI 10.1023/A:1010366631538; Joabsson A, 1999, TRENDS ECOL EVOL, V14, P385, DOI 10.1016/S0169-5347(99)01649-3; Kudo Y, 2014, AGR ECOSYST ENVIRON, V186, P77, DOI 10.1016/j.agee.2014.01.015; Lai DYF, 2009, PEDOSPHERE, V19, P409, DOI 10.1016/S1002-0160(09)00003-4; Lai DYF, 2014, ATMOS ENVIRON, V89, P249, DOI 10.1016/j.atmosenv.2014.02.034; Le Mer J, 2001, EUR J SOIL BIOL, V37, P25, DOI 10.1016/S1164-5563(01)01067-6; Lu R.K., 1999, ANAL METHODS SOIL AG, P85; Lu YH, 2002, BIOL FERT SOILS, V36, P136, DOI 10.1007/s00374-002-0504-2; Luo GJ, 2013, BIOGEOSCIENCES, V10, P3205, DOI 10.5194/bg-10-3205-2013; Meijide A., 2011, BIOGEOSCI DISCUSS, V8, P8999; Miller LG, 1998, APPL ENVIRON MICROB, V64, P4357; Miniotti E, 2013, EGU GEN ASSEMBLY C A, V15, P11165; Minoda T, 1996, J GEOPHYS RES-ATMOS, V101, P21091, DOI 10.1029/96JD01710; Myhre G. D., 2013, CLIMATE CHANGE 2013, P714; Neubauer SC, 2007, GEOMICROBIOL J, V24, P65, DOI 10.1080/01490450601134309; Qin YM, 2010, BIOL FERT SOILS, V46, P825, DOI 10.1007/s00374-010-0493-5; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Rikmann E, 2012, BIODEGRADATION, V23, P509, DOI 10.1007/s10532-011-9529-2; Ro S, 2011, SOIL SCI PLANT NUTR, V57, P833, DOI 10.1080/00380768.2011.637302; Rochette P, 2010, EUR J SOIL SCI, V61, P186, DOI 10.1111/j.1365-2389.2009.01222.x; Rosamond MS, 2011, J ENVIRON QUAL, V40, P256, DOI 10.2134/jeq2010.0009; Smith P, 2007, AGR ECOSYST ENVIRON, V118, P6, DOI 10.1016/j.agee.2006.06.006; Song CC, 2008, J ENVIRON MANAGE, V88, P428, DOI 10.1016/j.jenvman.2007.03.030; Sutton-Grier AE, 2011, SOIL BIOL BIOCHEM, V43, P413, DOI 10.1016/j.soilbio.2010.11.009; Tan Q.C., 2011, CHINA POPUL RESOUR E, V21, P69, DOI [10.3969/j. issn.1002-2104.2011.10.011, DOI 10.3969/j.issn.1002-2104.2011.10.011]; Tong C, 2013, ESTUAR COAST, V36, P633, DOI 10.1007/s12237-013-9596-1; Tong C, 2012, BIOGEOCHEMISTRY, V111, P677, DOI 10.1007/s10533-012-9712-5; Tong C, 2010, J ENVIRON SCI HEAL A, V45, P506, DOI 10.1080/10934520903542261; van Zijderveld SM, 2010, J DAIRY SCI, V93, P5856, DOI 10.3168/jds.2010-3281; vanRijn J, 1996, AQUACULTURE, V139, P181, DOI 10.1016/0044-8486(95)01151-X; Vibol S, 2010, ENVIRON MONIT ASSESS, V161, P301, DOI 10.1007/s10661-009-0747-6; Wang JY, 2012, NUTR CYCL AGROECOSYS, V93, P103, DOI 10.1007/s10705-012-9503-3; Wang MX, 1995, CLIMATE CHANGE AND RICE, P69; Wang WQ, 2015, PLANT ECOL, V216, P809, DOI 10.1007/s11258-015-0469-5; Wang WQ, 2012, ADV MATER RES-SWITZ, V468-471, P1626, DOI 10.4028/www.scientific.net/AMR.468-471.1626; WATANABE I, 1995, BIOL FERT SOILS, V20, P101, DOI 10.1007/BF00336587; Whalen SC, 2005, ENVIRON ENG SCI, V22, P73, DOI 10.1089/ees.2005.22.73; Win KT, 2012, PADDY WATER ENVIRON, V10, P281, DOI 10.1007/s10333-011-0279-x; Xu XF, 2016, BIOGEOSCIENCES, V13, P3735, DOI 10.5194/bg-13-3735-2016; Yanai Y, 2007, SOIL SCI PLANT NUTR, V53, P181, DOI 10.1111/j.1747-0765.2007.00123.x; Yu KW, 2006, CHEMOSPHERE, V62, P905, DOI 10.1016/j.chemosphere.2005.05.033; Zhu XY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060146, 10.1371/journal.pone.0062731, 10.3389/fnsyn.2013.00008, 10.1371/journal.pone.0070631, 10.1371/journal.pone.0081900, 10.1371/journal.pone.0070686]	73	49	53	9	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169254	10.1371/journal.pone.0169254	http://dx.doi.org/10.1371/journal.pone.0169254			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081161	Green Published, gold			2022-12-26	WOS:000391949500035
J	Hao, TY; Chen, SF				Hao, Tianyi; Chen, Sanfeng			Colonization of Wheat, Maize and Cucumber by Paenibacillus polymyxa WLY78	PLOS ONE			English	Article							AZOSPIRILLUM-BRASILENSE YU62; RICE; NITROGEN; GROWTH; PLANTS; ROOTS	Paenibacillus polymyxa WLY78 is a nitrogen fixer and it can be potentially applied to biofertilizer in agriculture. In this study, P. polymyxa WLY78 is labelled with gfp gene. The GFP-labelled P. polymyxa WLY78 is used to inoculate wheat, maize and cucumber seedlings grown in the gnotobiotic system and in soil, respectively. Observation by confocal laser scanning microscope reveals that the GFP-labeled bacterial cells are mainly located on the root surface and epidermis of wheat, and only a few cells are present within cortical cells. In maize and cucumber seedlings, bacterial cells were colonized in epidermal and cortical cells, intercellular spaces and vascular system of root, stem and leaf tissue interiors besides on root surfaces. Higher densities of the bacterial cells in roots, stems and leaves indicated that P. polymyxa WLY78 cells could migrate from roots to stems and leaves of maize and cucumber. This study will provide insight into interaction between P. polymyxa WLY78 and host cells.	[Chen, Sanfeng] China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China; China Agr Univ, Coll Biol Sci, Beijing, Peoples R China	China Agricultural University; China Agricultural University	Chen, SF (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China.	chensf@cau.edu.cn			National Nature Science Foundation of China [31470189]; Innovative Project of SKLAB [2016SKLAB-7]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Project of SKLAB	This work was supported from the National Nature Science Foundation of China (Grant No. 31470189) and the Innovative Project of SKLAB (Grant No.2016SKLAB-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by funding from the National Nature Science Foundation of China (Grant No. 31470189) and the Innovative Project of SKLAB (Grant No.2016SKLAB-7).	Briana K, 2010, CROP SCI S1, V50, pS; Burrill TJ, 1917, ILLINOIS AGR EXPT ST, V202, P113; Chi F, 2004, ACTA BOT SIN, V46, P1065; Curatti L, 2014, PLANT SCI, V225, P130, DOI 10.1016/j.plantsci.2014.06.003; Dunn AK, 1999, GENE, V226, P297, DOI 10.1016/S0378-1119(98)00544-7; ISHIWA H, 1986, JPN J GENET, V61, P515, DOI 10.1266/jjg.61.515; Liu XM, 2006, CURR MICROBIOL, V52, P186, DOI 10.1007/s00284-005-0162-3; Liu Y, 2003, ACTA BOT SIN, V45, P748; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; [石皓文 Shi Haowen], 2016, [中国农业大学学报, Journal of China Agricultural University], V21, P52; Stoltzfus JR, 1997, PLANT SOIL, V194, P25, DOI 10.1023/A:1004298921641; Timmusk S, 2005, APPL ENVIRON MICROB, V71, P7292, DOI 10.1128/AEM.71.11.7292-7300.2005; Wang L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003414; Xie JB, 2016, SCI REP-UK, V6, DOI 10.1038/srep21329; Yanni YG, 2010, PLANT SOIL, V336, P129, DOI 10.1007/s11104-010-0454-7; Zhang Wendi, 2013, Weishengwu Xuebao, V53, P1258	16	32	34	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169980	10.1371/journal.pone.0169980	http://dx.doi.org/10.1371/journal.pone.0169980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076417	gold, Green Submitted, Green Published			2022-12-26	WOS:000391857100073
J	George, AA; Bloy, A; Miwa, JM; Lindstrom, JM; Lukas, RJ; Whiteaker, P				George, Andrew A.; Bloy, Abigail; Miwa, Julie M.; Lindstrom, Jon M.; Lukas, Ronald J.; Whiteaker, Paul			Isoform-specific mechanisms of alpha 3 beta 4*-nicotinic acetylcholine receptor modulation by the prototoxin lynx1	FASEB JOURNAL			English	Article						GPI-linked proteins; neurotoxins; single-channel electrophysiology; TEVC; concatenated; receptor subunits	NEURONAL NICOTINIC RECEPTORS; AGONIST-BINDING-SITE; HABENULO-INTERPEDUNCULAR PATHWAY; SINGLE-CHANNEL PROPERTIES; STEM-CELL ANTIGEN; MEDIAL HABENULA; XENOPUS OOCYTES; IN-VIVO; ALPHA-4-ALPHA-4 INTERFACE; KINETIC-PROPERTIES	This study investigates-for the first time to our knowledge-the existence and mechanisms of functional interactions between the endogenous mammalian prototoxin, lynx1, and alpha 3-and beta 4-subunit-containing human nicotinic acetylcholine receptors (alpha 3 beta 4*-nAChRs). Concatenated gene constructs were used to express precisely defined alpha 3 beta 4*-nAChR isoforms (alpha 3 beta 4)(2)beta 4-, (alpha 3 beta 4)(2)alpha 3-, (alpha 3 beta 4)(2)alpha 5(398D)-, and (alpha 3 beta 4)(2)alpha 5(398N)-nAChR in Xenopus oocytes. In the presence or absence of lynx1, a3b4*-nAChR agonist responses were recorded by using 2-electrode voltage clamp and single-channel electrophysiology, whereas radioimmunolabeling measured cellsurface expression. Lynx1 reduced (alpha 3 beta 4)(2)beta 4-nAChR function principally by lowering cell-surface expression, whereas single-channel effects were primarily responsible for reducing (alpha 3 beta 4) 2a3-nAChR function [decreased unitary conductance (>= 50%), altered burst proportions (3-fold reduction in the proportion of long bursts), and enhanced closed dwell times (3-to 6-fold increase)]. Alterations in both cell-surface expression and single-channel properties accounted for the reduction in (alpha 3 beta 4) (2)alpha 5-nAChR function that wasmediated by lynx1. No effects were observed when alpha 3 beta 4*-nAChRs were coexpressed with mutated lynx1 (control). Lynx1 is expressed in the habenulopeduncular tract, where alpha 3 beta 4*-alpha 5*-nAChR subtypes are critical contributors to the balance between nicotine aversion and reward. This gives our findings a high likelihood of physiologic significance. The exquisite isoform selectivity of lynx1 interactions provides new insights into the mechanisms and allosteric sites [a(2)-interface containing] by which prototoxins can modulate nAChRfunction.-George, A. A., Bloy, A., Miwa, J. M., Lindstrom, J. M., Lukas, R. J., Whiteaker, P. Isoform-specific mechanisms of alpha 3 beta 4*-nicotinic acetylcholine receptor modulation by the prototoxin lynx1. FASEB J. 31, 1398-1420 (2017). www.fasebj.org	[George, Andrew A.; Bloy, Abigail; Lukas, Ronald J.; Whiteaker, Paul] St Josephs Hosp, Barrow Neurol Inst, Div Neurobiol, Phoenix, AZ USA; [Bloy, Abigail] St James Univ Hosp, Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England; [Miwa, Julie M.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA; [Lindstrom, Jon M.] Univ Penn, Dept Neurosci, Med Sch, Philadelphia, PA 19104 USA	Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Saint James's University Hospital; Lehigh University; University of Pennsylvania	George, AA (corresponding author), St Josephs Hosp, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	andrew.george@dignityhealth.org		Miwa, Julie/0000-0002-4418-3756	National Institute on Drug Abuse [R21DA027070-02S1, R21- DA026627]; Men's and Women's Boards of the Barrow Neurological Foundation; U.S. National Institutes of Health; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA026627, R21DA027070] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Men's and Women's Boards of the Barrow Neurological Foundation; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the U.S. National Institutes of Health, National Institute on Drug Abuse [Grants R21DA027070-02S1 and R21- DA026627 (to P.W.)] and by endowment and capitalization funds from the Men's and Women's Boards of the Barrow Neurological Foundation (to P.W. and A.A.G.). All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers' bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent- licensing arrangements) or nonfinancial interest (such as personal or professional relationships, affiliations, knowledge, or beliefs) in the subject matter or materials discussed in this article.	Ahring PK, 2015, NEUROPHARMACOLOGY, V92, P135, DOI 10.1016/j.neuropharm.2014.12.035; Akk G, 2003, J PHYSIOL-LONDON, V551, P155, DOI 10.1113/jphysiol.2003.043885; Antil-Delbeke S, 2000, J BIOL CHEM, V275, P29594, DOI 10.1074/jbc.M909746199; Antolin-Fontes B, 2015, NEUROPHARMACOLOGY, V96, P213, DOI 10.1016/j.neuropharm.2014.11.019; Auerbach A, 1998, J GEN PHYSIOL, V112, P181, DOI 10.1085/jgp.112.2.181; Baker TB, 2009, NICOTINE TOB RES, V11, P785, DOI 10.1093/ntr/ntp064; Barrantes Francisco J, 2014, Front Synaptic Neurosci, V6, P25, DOI 10.3389/fnsyn.2014.00025; BERTRAND D, 1990, P NATL ACAD SCI USA, V87, P1993, DOI 10.1073/pnas.87.5.1993; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Boorman JP, 2003, J BIOL CHEM, V278, P44033, DOI 10.1074/jbc.M211719200; Boorman JPB, 2000, J PHYSIOL-LONDON, V529, P565, DOI 10.1111/j.1469-7793.2000.00565.x; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Bruneau E, 2005, J NEUROSCI, V25, P9949, DOI 10.1523/JNEUROSCI.3169-05.2005; Buisson B, 1998, MOL PHARMACOL, V53, P555, DOI 10.1124/mol.53.3.555; CHARNET P, 1990, NEURON, V4, P87, DOI 10.1016/0896-6273(90)90445-L; CHARNET P, 1992, J PHYSIOL-LONDON, V450, P375, DOI 10.1113/jphysiol.1992.sp019132; Chen XN, 2009, AM J MED GENET B, V150B, P926, DOI 10.1002/ajmg.b.30919; Colquhoun D, 2009, SINGLE CHANNEL RECOR, P483; Dao DQ, 2014, J NEUROSCI, V34, P4273, DOI 10.1523/JNEUROSCI.2736-13.2014; Dellisanti CD, 2007, CHANNELS, V1, P234, DOI 10.4161/chan.4909; Dessaud E, 2006, MOL CELL NEUROSCI, V31, P232, DOI 10.1016/j.mcn.2005.09.010; Eaton JB, 2014, J PHARMACOL EXP THER, V348, P46, DOI 10.1124/jpet.113.208389; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; Frahm S, 2011, NEURON, V70, P522, DOI 10.1016/j.neuron.2011.04.013; Galat A, 2008, CELL MOL LIFE SCI, V65, P3481, DOI 10.1007/s00018-008-8473-8; George AA, 2012, J BIOL CHEM, V287, P25151, DOI 10.1074/jbc.M112.379339; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; Grady SR, 2009, J NEUROSCI, V29, P2272, DOI 10.1523/JNEUROSCI.5121-08.2009; Grosman C, 2001, P NATL ACAD SCI USA, V98, P14102, DOI 10.1073/pnas.251402498; Grucza RA, 2008, BIOL PSYCHIAT, V64, P922, DOI 10.1016/j.biopsych.2008.04.018; Hales TG, 2006, J BIOL CHEM, V281, P8062, DOI 10.1074/jbc.M513222200; Hansen SB, 2008, J BIOL CHEM, V283, P36066, DOI 10.1074/jbc.C800194200; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Horie M, 1998, GENOMICS, V53, P365, DOI 10.1006/geno.1998.5462; Hruska M, 2009, J NEUROSCI, V29, P14847, DOI 10.1523/JNEUROSCI.2271-09.2009; Hsiao B, 2008, J NEUROPHYSIOL, V99, P999, DOI 10.1152/jn.01040.2007; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; JACKSON MB, 1983, BIOPHYS J, V42, P109, DOI 10.1016/S0006-3495(83)84375-6; Jensen MM, 2015, NEUROBIOL AGING, V36, P1629, DOI 10.1016/j.neurobiolaging.2015.01.001; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Kobayashi A, 2014, J MOL NEUROSCI, V53, P525, DOI 10.1007/s12031-014-0352-1; Krashia P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013611; Kumari S, 2008, J CELL BIOL, V181, P1179, DOI 10.1083/jcb.200709086; Kuryatov A, 2011, MOL PHARMACOL, V79, P119, DOI 10.1124/mol.110.066357; Li P, 2011, MOL PHARMACOL, V80, P818, DOI 10.1124/mol.111.073841; Li P, 2010, BRIT J PHARMACOL, V160, P1906, DOI 10.1111/j.1476-5381.2010.00761.x; Lucero LM, 2016, J BIOL CHEM, V291, P2444, DOI 10.1074/jbc.M115.684373; Lukas RJ, 1999, PHARMACOL REV, V51, P397; Lyukmanova EN, 2013, J BIOL CHEM, V288, P15888, DOI 10.1074/jbc.M112.436576; Lyukmanova EN, 2011, J BIOL CHEM, V286, P10618, DOI 10.1074/jbc.M110.189100; Marotta CB, 2014, NEUROPHARMACOLOGY, V77, P342, DOI 10.1016/j.neuropharm.2013.09.028; Mazzaferro S, 2014, J BIOL CHEM, V289, P21795, DOI 10.1074/jbc.M114.555136; McCallum SE, 2012, NEUROPHARMACOLOGY, V63, P434, DOI 10.1016/j.neuropharm.2012.04.015; Militante J, 2008, MOL PHARMACOL, V74, P764, DOI 10.1124/mol.108.047134; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; Miwa JM, 2006, NEURON, V51, P587, DOI 10.1016/j.neuron.2006.07.025; Miwa JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043302; Miwa JM, 2012, PHYSIOLOGY, V27, P187, DOI 10.1152/physiol.00002.2012; Moretti M, 2014, MOL PHARMACOL, V86, P306, DOI 10.1124/mol.114.093377; Morishita H, 2010, SCIENCE, V330, P1238, DOI 10.1126/science.1195320; Moroni M, 2008, J NEUROSCI, V28, P6884, DOI 10.1523/JNEUROSCI.1228-08.2008; Moroni M, 2011, J BIOL CHEM, V286, P13414, DOI 10.1074/jbc.M110.204610; Nelson ME, 1999, J PHYSIOL-LONDON, V516, P657, DOI 10.1111/j.1469-7793.1999.0657u.x; Nichols WA, 2014, J BIOL CHEM, V289, P31423, DOI 10.1074/jbc.M114.573667; Nirthanan S, 2002, J BIOL CHEM, V277, P17811, DOI 10.1074/jbc.M111152200; Ochoa V, 2016, FASEB J, V30, P1109, DOI 10.1096/fj.15-274548; PAPKE RL, 1991, J PHYSIOL-LONDON, V440, P95, DOI 10.1113/jphysiol.1991.sp018698; Parker RL, 2011, BIOCHEM PHARMACOL, V82, P1037, DOI 10.1016/j.bcp.2011.07.037; Premkumar LS, 1997, J GEN PHYSIOL, V109, P181, DOI 10.1085/jgp.109.2.181; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Saccone NL, 2009, CANCER RES, V69, P6848, DOI 10.1158/0008-5472.CAN-09-0786; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; SACHS F, 1982, PFLUG ARCH EUR J PHY, V395, P331, DOI 10.1007/BF00580798; SAKMANN B, 1980, NATURE, V286, P71, DOI 10.1038/286071a0; SAKMANN B, 1984, ANNU REV PHYSIOL, V46, P455, DOI 10.1146/annurev.ph.46.030184.002323; Salas R, 2009, J NEUROSCI, V29, P3014, DOI 10.1523/JNEUROSCI.4934-08.2009; Shahsavar A, 2015, MOL PHARMACOL, V88, P697, DOI 10.1124/mol.115.098061; Sheffield EB, 2000, NEUROPHARMACOLOGY, V39, P2591, DOI 10.1016/S0028-3908(00)00138-6; Shih PY, 2014, J NEUROSCI, V34, P9789, DOI 10.1523/JNEUROSCI.0476-14.2014; Shulepko MA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P204, DOI 10.1134/S0006297913020090; SINE SM, 1984, BIOPHYS J, V45, P175, DOI 10.1016/S0006-3495(84)84146-6; Sivilotti LG, 1997, J PHYSIOL-LONDON, V500, P123, DOI 10.1113/jphysiol.1997.sp022004; Slimak MA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00012; Srinivasan R, 2011, J GEN PHYSIOL, V137, P59, DOI 10.1085/jgp.201010532; St John PA, 2009, ACTA PHARMACOL SIN, V30, P656, DOI 10.1038/aps.2009.76; Stevens VL, 2008, CANCER EPIDEM BIOMAR, V17, P3517, DOI 10.1158/1055-9965.EPI-08-0585; Wang JY, 2015, J BIOL CHEM, V290, P13907, DOI 10.1074/jbc.M115.646786; Whiteaker P, 2000, MOL PHARMACOL, V57, P913; Whiteaker P, 2002, J NEUROSCI, V22, P2522, DOI 10.1523/JNEUROSCI.22-07-02522.2002; WHITING PJ, 1986, BIOCHEMISTRY-US, V25, P2082, DOI 10.1021/bi00356a037; Wu J, 2011, BIOCHEM PHARMACOL, V82, P800, DOI 10.1016/j.bcp.2011.07.067; Wu ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148215; Wu ML, 2015, J BIOL CHEM, V290, P24509, DOI 10.1074/jbc.M115.647248; Zhang YF, 2010, MOL BIOL REP, V37, P2055, DOI 10.1007/s11033-009-9663-7; Zhou Y, 2003, J NEUROSCI, V23, P9004	96	24	25	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1398	1420		10.1096/fj.201600733R	http://dx.doi.org/10.1096/fj.201600733R			23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28100642	Green Published			2022-12-26	WOS:000398504300012
J	Schumacher, MA; Huang, KH; Zeng, WJ; Janakiraman, A				Schumacher, Maria A.; Huang, Kuo-Hsiang; Zeng, Wenjie; Janakiraman, Anuradha			Structure of the Z Ring-associated Protein, ZapD, Bound to the C-terminal Domain of the Tubulin-like Protein, FtsZ, Suggests Mechanism of Z Ring Stabilization through FtsZ Cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell division; cytokinesis; electron microscopy (EM); protein-protein interaction; X-ray crystallography; FtsZ; ZapD	CELL-DIVISION; BACTERIAL CYTOKINESIS; CYTOSKELETAL PROTEIN; CRYSTAL-STRUCTURE; GTP-BINDING; SUPERRESOLUTION; REVEAL; ZIPA; SITE; IDENTIFICATION	Cell division in most bacteria is mediated by the tubulin-like FtsZ protein, which polymerizes in a GTP-dependent manner to form the cytokinetic Z ring. A diverse repertoire of FtsZ-binding proteins affects FtsZ localization and polymerization to ensure correct Z ring formation. Many of these proteins bind the C-terminal domain (CTD) of FtsZ, which serves as a hub for FtsZ regulation. FtsZ ring-associated proteins, ZapA-D (Zaps), are important FtsZ regulatory proteins that stabilize FtsZ assembly and enhance Z ring formation by increasing lateral assembly of FtsZ protofilaments, which then form the Z ring. There are no structures of a Zap protein bound to FtsZ; therefore, how these proteins affect FtsZ polymerization has been unclear. Recent data showed ZapD binds specifically to the FtsZ CTD. Thus, to obtain insight into the ZapD-CTD interaction and how it may mediate FtsZ protofilament assembly, we determined the Escherichia coli ZapD-FtsZ CTD structure to 2.67 resolution. The structure shows that the CTD docks within a hydrophobic cleft in the ZapD helical domain and adopts an unusual structure composed of two turns of helix separated by a proline kink. FtsZ CTD residue Phe-377 inserts into the ZapD pocket, anchoring the CTD in place and permitting hydrophobic contacts between FtsZ residues Ile-374, Pro-375, and Leu-378 with ZapD residues Leu-74, Trp-77, Leu-91, and Leu-174. The structural findings were supported by mutagenesis coupled with biochemical and in vivo studies. The combined data suggest that ZapD acts as a molecular cross-linking reagent between FtsZ protofilaments to enhance FtsZ assembly.	[Schumacher, Maria A.; Zeng, Wenjie] Duke Univ, Sch Med, Dept Biochem, 243 Nanaline H Duke,DUMC Box 3711, Durham, NC 27710 USA; [Huang, Kuo-Hsiang; Janakiraman, Anuradha] CUNY City Coll, Dept Biol, 160 Convent Ave,MR526, New York, NY 10031 USA; [Huang, Kuo-Hsiang; Janakiraman, Anuradha] CUNY City Coll, Grad Ctr, New York, NY 10016 USA	Duke University; City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City College of New York (CUNY)	Schumacher, MA (corresponding author), Duke Univ, Sch Med, Dept Biochem, 243 Nanaline H Duke,DUMC Box 3711, Durham, NC 27710 USA.; Janakiraman, A (corresponding author), CUNY City Coll, Dept Biol, 160 Convent Ave,MR526, New York, NY 10031 USA.	maria.schumacher@duke.edu; anuj@ccny.cuny.edu			NIGMS; National Institutes of Health; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; Sandler Foundation [MR-15-328599]; Direct For Biological Sciences [1615858] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115563] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); Sandler Foundation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the Advanced Light Source beamlines 8.3.1 and 5.0.2 for data collection. The Berkeley Center for Structural Biology is supported in part by NIGMS, National Institutes of Health, and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract No. DE-AC02-05CH11231. Beamline 8.3.1 at the Advanced Light Source is operated by the University of California Office of the President, Multicampus Research Programs and Initiatives Grant MR-15-328599 and Program for Breakthrough Biomedical Research, which is partially funded by the Sandler Foundation. We also thank Aaron Mychack for help in plasmid construction.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arjes HA, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0544-z; Bhattacharya A, 2015, INT J BIOL MACROMOL, V81, P435, DOI 10.1016/j.ijbiomac.2015.08.030; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Biteen JS, 2012, CHEMPHYSCHEM, V13, P1007, DOI 10.1002/cphc.201100686; Buske PJ, 2012, J BIOL CHEM, V287, P10945, DOI 10.1074/jbc.M111.330324; Buss J, 2013, MOL MICROBIOL, V89, P1099, DOI 10.1111/mmi.12331; Camberg JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094964; Camberg JL, 2011, J BACTERIOL, V193, P1911, DOI 10.1128/JB.01317-10; Camberg JL, 2009, P NATL ACAD SCI USA, V106, P10614, DOI 10.1073/pnas.0904886106; Choi H, 2016, MOL CELLS, V39, P814, DOI 10.14348/molcells.2016.0202; Dajkovic A, 2008, CURR BIOL, V18, P235, DOI 10.1016/j.cub.2008.01.042; de Boer PAJ, 2010, CURR OPIN MICROBIOL, V13, P730, DOI 10.1016/j.mib.2010.09.015; DEBOER P, 1992, NATURE, V359, P254, DOI 10.1038/359254a0; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Du SS, 2015, MOL MICROBIOL, V95, P173, DOI 10.1111/mmi.12854; Durand-Heredia J, 2012, J BACTERIOL, V194, P3189, DOI 10.1128/JB.00176-12; Durand-Heredia JM, 2011, J BACTERIOL, V193, P1405, DOI 10.1128/JB.01258-10; Ebersbach G, 2008, MOL MICROBIOL, V68, P720, DOI 10.1111/j.1365-2958.2008.06190.x; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Galli E, 2012, J BACTERIOL, V194, P292, DOI 10.1128/JB.05821-11; Goley ED, 2010, MOL CELL, V39, P975, DOI 10.1016/j.molcel.2010.08.027; Guo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012680; Hale CA, 2011, J BACTERIOL, V193, P1393, DOI 10.1128/JB.01245-10; Hamoen LW, 2006, MOL MICROBIOL, V59, P989, DOI 10.1111/j.1365-2958.2005.04987.x; Huang KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153337; Huang KH, 2013, J BACTERIOL, V195, P1859, DOI 10.1128/JB.02157-12; Jennings PC, 2011, MICRON, V42, P336, DOI 10.1016/j.micron.2010.09.003; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krol E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043293; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Lutkenhaus J, 2012, CYTOSKELETON, V69, P778, DOI 10.1002/cm.21054; Mingorance J, 2005, J BIOL CHEM, V280, P20909, DOI 10.1074/jbc.M503059200; Mohammadi T, 2009, BIOCHEMISTRY-US, V48, P11056, DOI 10.1021/bi901461p; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Ortiz C, 2015, FEBS LETT, V589, P3822, DOI 10.1016/j.febslet.2015.11.030; Pacheco-Gomez R, 2013, BIOCHEM J, V449, P795, DOI 10.1042/BJ20120140; Potluri LP, 2012, J BACTERIOL, V194, P5334, DOI 10.1128/JB.00859-12; RAYCHAUDHURI D, 1992, NATURE, V359, P251, DOI 10.1038/359251a0; Roach EJ, 2016, J BACTERIOL, V198, P1683, DOI 10.1128/JB.00969-15; Roach EJ, 2014, J BIOL CHEM, V289, P23276, DOI 10.1074/jbc.M114.561928; Romberg L, 2003, ANNU REV MICROBIOL, V57, P125, DOI 10.1146/annurev.micro.57.012903.074300; Rowlett VW, 2014, BIOPHYS J, V107, pL17, DOI 10.1016/j.bpj.2014.08.024; Schumacher MA, 2016, P NATL ACAD SCI USA, V113, P4988, DOI 10.1073/pnas.1602327113; Schumacher MA, 2016, J BIOL CHEM, V291, P2485, DOI 10.1074/jbc.M115.697037; Soderstrom B, 2017, CURR GENET, V63, P161, DOI 10.1007/s00294-016-0630-2; Szwedziak P, 2014, ELIFE, V3, DOI 10.7554/eLife.04601; Szwedziak P, 2012, EMBO J, V31, P2249, DOI 10.1038/emboj.2012.76; Weart RB, 2003, J BACTERIOL, V185, P2826, DOI 10.1128/JB.185.9.2826-2834.2003	51	17	17	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3740	3750		10.1074/jbc.M116.773192	http://dx.doi.org/10.1074/jbc.M116.773192			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28100778	Green Published, hybrid			2022-12-26	WOS:000395542500017
J	Vrakas, S; Mountzouris, KC; Michalopoulos, G; Karamanolis, G; Papatheodoridis, G; Tzathas, C; Gazouli, M				Vrakas, Spyros; Mountzouris, Konstantinos C.; Michalopoulos, George; Karamanolis, George; Papatheodoridis, George; Tzathas, Charalampos; Gazouli, Maria			Intestinal Bacteria Composition and Translocation of Bacteria in Inflammatory Bowel Disease	PLOS ONE			English	Article							ULCERATIVE-COLITIS; CROHNS-DISEASE; GUT MICROBIOTA; FAECALIBACTERIUM-PRAUSNITZII; MUCOSAL FLORA; BLOOD; RISK; ASSOCIATION; DIVERSITY; DYSBIOSIS	Background Live commensal intestinal bacteria are present in the peripheral blood where they can induce inflammation. Objective To evaluate the intestinal bacteria composition and translocation of bacteria in IBD. Methods Both blood and tissue biopsy samples were collected from adult patients with active/inactive Crohn's disease (CD), active/inactive ulcerative colitis (UC) and healthy individuals. Most of the patients were newly diagnosed and none of them received antibiotics. Using a reverse transcription quantitative real-time PCR (RT-qPCR) method, we determined the composition of microbiota. NOD2/CARD15genotyping was also studied. Results Total bacterial DNA concentration was increased in tissue and blood samples of IBD patients compared to healthy controls. Furthermore, the active IBD cases had higher total bacterial DNA concentration levels compared to the inactive cases. Three species characterized dysbiosis in IBD, namely an increase of Bacteroides spp in active and inactive IBD samples, and a decrease in Clostridium leptum group (IV), and Faecalibacterium prausnitzi in both active and inactive IBD patients. No significant association between bacterial translocation and NOD2/CARD15 mutations was found. Conclusions The composition of the microbiota in IBD patients differs from that of healthy controls. The high rate of bacterial DNA in the blood samples indicates translocation in inflammatory bowel disease.	[Vrakas, Spyros; Michalopoulos, George; Tzathas, Charalampos] Tzane Gen Hosp, Dept Gastroenterol, Piraeus, Greece; [Mountzouris, Konstantinos C.] Agr Univ Athens, Dept Nutr Physiol & Feeding, Athens, Greece; [Karamanolis, George] Univ Athens, Gastroenterol Unit, Univ Surg Dept 2, Sch Med, Athens, Greece; [Papatheodoridis, George] Univ Athens, Laiko Hosp Athens, Dept Gastroenterol, Sch Med, Athens, Greece; [Gazouli, Maria] Univ Athens, Dept Basic Med Sci, Biol Lab, Sch Med, Athens, Greece	Agricultural University of Athens; Athens Medical School; National & Kapodistrian University of Athens; Athens Medical School; Laiko General Hospital; National & Kapodistrian University of Athens; Athens Medical School; National & Kapodistrian University of Athens	Gazouli, M (corresponding author), Univ Athens, Dept Basic Med Sci, Biol Lab, Sch Med, Athens, Greece.	mgazouli@med.uoa.gr	Mountzouris, Konstantinos C./F-6840-2015; Papatheodoridis, George/A-4603-2008; Gazouli, Maria/I-2572-2018; Gazouli, Maria/W-6245-2019	Papatheodoridis, George/0000-0002-3518-4060; Gazouli, Maria/0000-0002-3295-6811; Gazouli, Maria/0000-0002-3295-6811; Mountzouris, Konstantinos/0000-0002-7926-5604				Amar J, 2011, EMBO MOL MED, V3, P559, DOI 10.1002/emmm.201100159; Andoh A, 2012, J GASTROENTEROL, V47, P1298, DOI 10.1007/s00535-012-0605-0; Becker C, 2015, ILAR J, V56, P192, DOI 10.1093/ilar/ilv030; Bibiloni R, 2006, J MED MICROBIOL, V55, P1141, DOI 10.1099/jmm.0.46498-0; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Forbes JD, 2016, INFLAMM BOWEL DIS, V22, P817, DOI 10.1097/MIB.0000000000000684; Fyderek K, 2009, WORLD J GASTROENTERO, V15, P5287, DOI 10.3748/wjg.15.5287; Gazouli M, 2005, WORLD J GASTROENTERO, V11, P681, DOI 10.3748/wjg.v11.i5.681; Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06; Gutierrez A, 2016, AM J GASTROENTEROL, V111, P529, DOI 10.1038/ajg.2016.8; Gutierrez A, 2014, GUT, V63, P272, DOI 10.1136/gutjnl-2012-303557; Gutierrez A, 2011, INFLAMM BOWEL DIS, V17, P1641, DOI 10.1002/ibd.21537; Gutierrez A, 2009, INFLAMM BOWEL DIS, V15, P508, DOI 10.1002/ibd.20806; Hansen R, 2012, AM J GASTROENTEROL, V107, P1913, DOI 10.1038/ajg.2012.335; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Kabeerdoss J, 2015, INDIAN J MED RES, V142, P23, DOI 10.4103/0971-5916.162091; Kell DB, 2015, INTEGR BIOL-UK, V7, P1339, DOI 10.1039/c5ib00158g; Machiels Kathleen, 2014, Gut, V63, P1275, DOI 10.1136/gutjnl-2013-304833; Martinez-Medina M, 2006, INFLAMM BOWEL DIS, V12, P1136, DOI 10.1097/01.mib.0000235828.09305.0c; Mountzouris KC, 2015, POULTRY SCI, V94, P2445, DOI 10.3382/ps/pev243; Nielsen HH, 2012, EUR J NEUROL, V19, P864, DOI 10.1111/j.1468-1331.2011.03643.x; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Potgieter M, 2015, FEMS MICROBIOL REV, V39, P567, DOI 10.1093/femsre/fuv013; Putignani L, 2016, INFLAMM BOWEL DIS, V22, P487, DOI 10.1097/MIB.0000000000000602; Sartor RB, 2014, NESTLE NUTR WORKS SE, V79, P29, DOI 10.1159/000360674; Sato J, 2014, DIABETES CARE, V37, P2343, DOI 10.2337/dc13-2817; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Thwaites GE, 2011, NAT REV MICROBIOL, V9, P215, DOI 10.1038/nrmicro2508; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Varela E, 2013, ALIMENT PHARM THER, V38, P151, DOI 10.1111/apt.12365; Verma R, 2010, J CLIN MICROBIOL, V48, P4279, DOI 10.1128/JCM.01360-10; Wang W, 2014, J CLIN MICROBIOL, V52, P398, DOI 10.1128/JCM.01500-13; Wills ES, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090981	34	79	84	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170034	10.1371/journal.pone.0170034	http://dx.doi.org/10.1371/journal.pone.0170034			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099495	Green Published, Green Submitted, gold			2022-12-26	WOS:000392380100051
J	Suraci, JP; Clinchy, M; Zanette, LY				Suraci, Justin P.; Clinchy, Michael; Zanette, Liana Y.			Do Large Carnivores and Mesocarnivores Have Redundant Impacts on Intertidal Prey?	PLOS ONE			English	Article							MESOPREDATOR RELEASE; URSUS-AMERICANUS; BLACK BEARS; FUNCTIONAL REDUNDANCY; INTRAGUILD PREDATION; NEST PREDATION; CANIS-LUPUS; SALMON; ECOLOGY; COASTAL	The presence of large carnivores can affect lower trophic levels by suppressing mesocarnivores and reducing their impacts on prey. The mesopredator release hypothesis therefore predicts prey abundance will be higher where large carnivores are present, but this prediction assumes limited dietary overlap between large and mesocarnivores. Where dietary overlap is high, e.g., among omnivorous carnivore species, or where prey are relatively easily accessible, the potential exists for large and mesocarnivores to have redundant impacts on prey, though this possibility has not been explored. The intertidal community represents a potentially important but poorly studied resource for coastal carnivore populations, and one for which dietary overlap between carnivores may be high. To evaluate usage of the intertidal community by coastal carnivores and the potential for redundancy between large and mesocarnivores, we surveyed (i) intertidal prey abundance (crabs and fish) and (ii) the abundance and activity of large carnivores (predominantly black bears) and mesocarnivores (raccoons and mink) in an area with an intact carnivore community in coastal British Columbia, Canada. Overall carnivore activity was strongly related to intertidal prey availability. Notably, this relationship was not contingent on carnivore species identity, suggestive of redundancy-high intertidal prey availability was associated with either greater large carnivore activity or greater mesocarnivore activity. We then compared intertidal prey abundances in this intact system, in which bears dominate, with those in a nearby system where bears and other large carnivores have been extirpated, and raccoons are the primary intertidal predator. We found significant similarities in intertidal species abundances, providing additional evidence for redundancy between large (bear) and mesocarnivore (raccoon) impacts on intertidal prey. Taken together, our results indicate that intertidal prey shape habitat use and competition among coastal carnivores, and raise the interesting possibility of redundancy between mesocarnivores and large carnivores in their role as intertidal top predators.	[Suraci, Justin P.; Clinchy, Michael; Zanette, Liana Y.] Western Univ, Dept Biol, London, ON, Canada; [Suraci, Justin P.] Raincoast Conservat Fdn, Sidney, BC, Canada; [Suraci, Justin P.] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA	Western University (University of Western Ontario); University of California System; University of California Santa Cruz	Suraci, JP (corresponding author), Western Univ, Dept Biol, London, ON, Canada.; Suraci, JP (corresponding author), Raincoast Conservat Fdn, Sidney, BC, Canada.; Suraci, JP (corresponding author), Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA.	justin.suraci@gmail.com			Natural Sciences and Engineering Research Council; Natural Sciences and Engineering Research Council Industrial Postgraduate Scholarship	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council Industrial Postgraduate Scholarship	Funding was provided by Natural Sciences and Engineering Research Council grants to MC, and LYZ; and a Natural Sciences and Engineering Research Council Industrial Postgraduate Scholarship to JPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BenDavid M, 1997, CAN J ZOOL, V75, P803, DOI 10.1139/z97-102; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brashares Justin S., 2010, P221; BRING J, 1994, AM STAT, V48, P209, DOI 10.2307/2684719; Brook LA, J APPL ECOL; Brown MB, 2015, ECOLOGY, V96, P2715, DOI 10.1890/15-0027.1; Carbone C, 2007, PLOS BIOL, V5, P363, DOI 10.1371/journal.pbio.0050022; Carlton JT, 2003, MAR ECOL PROG SER, V256, P271, DOI 10.3354/meps256271; CAROTHERS JH, 1984, OIKOS, V42, P403, DOI 10.2307/3544413; Chalcraft DR, 2003, ECOLOGY, V84, P2407, DOI 10.1890/02-0550; Colman NJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3094; Connell SD, 2015, TRENDS ECOL EVOL, V30, P513, DOI 10.1016/j.tree.2015.06.014; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Darimont CT, 2009, J ANIM ECOL, V78, P126, DOI 10.1111/j.1365-2656.2008.01473.x; Darimont CT, 2004, J BIOGEOGR, V31, P1867, DOI 10.1111/j.1365-2699.2004.01141.x; Elmhagen B, 2010, J ANIM ECOL, V79, P785, DOI 10.1111/j.1365-2656.2010.01678.x; Everitt B, 2011, USE R, P1, DOI 10.1007/978-1-4419-9650-3; Fagan WF, 1997, AM NAT, V150, P554, DOI 10.1086/286081; Field RD, 2011, P ROY SOC B-BIOL SCI, V278, P3081, DOI 10.1098/rspb.2010.2731; Fox CH, 2015, BMC ECOL, V15, DOI 10.1186/s12898-015-0045-9; Griffin KA, 2011, J ANIM ECOL, V80, P1246, DOI 10.1111/j.1365-2656.2011.01856.x; Grupe BM, 2006, THESIS; Hansen B, 2010, LEARNING LIVE LARGE; Harrington LA, 2009, ECOLOGY, V90, P1207, DOI 10.1890/08-0302.1; Hatler DF, 2008, CARNIVORES BRIT COLU; Hilderbrand GV, 1999, CAN J ZOOL, V77, P132, DOI 10.1139/cjz-77-1-132; Holt RD, 1997, AM NAT, V149, P745, DOI 10.1086/286018; HOREJSI BL, 1984, CAN FIELD NAT, V98, P368; Howes J, 1999, THESIS; Letnic M, 2009, P ROY SOC B-BIOL SCI, V276, P3249, DOI 10.1098/rspb.2009.0574; Levi T, 2012, ECOLOGY, V93, P921, DOI 10.1890/11-0165.1; Linkie M, 2011, J ZOOL, V284, P224, DOI 10.1111/j.1469-7998.2011.00801.x; MACARTHUR RH, 1972, ECOLOGY, V53, P330, DOI 10.2307/1934090; Miquelle Dale G., 2005, P179; Navarrete SA, 1996, ECOL MONOGR, V66, P409, DOI 10.2307/2963488; Nunez R, 2000, J ZOOL, V252, P373, DOI 10.1111/j.1469-7998.2000.tb00632.x; OConnell AF, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P1, DOI 10.1007/978-4-431-99495-4; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; PAQUET PC, 1986, CAN FIELD NAT, V100, P371; POLIS GA, 1992, TRENDS ECOL EVOL, V7, P151, DOI 10.1016/0169-5347(92)90208-S; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; R Core Team, 2021, R LANGUAGE ENV STAT; Reed SE, 2008, CONSERV LETT, V1, P146, DOI 10.1111/j.1755-263X.2008.00019.x; Reimchen TE, 1998, CAN FIELD NAT, V112, P446; Reimchen TE, 2000, CAN J ZOOL, V78, P448, DOI 10.1139/cjz-78-3-448; Ridout MS, 2009, J AGR BIOL ENVIR ST, V14, P322, DOI 10.1198/jabes.2009.08038; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Ripple WJ, 2013, BIOL CONSERV, V160, P70, DOI 10.1016/j.biocon.2012.12.033; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; ROBLES C, 1989, J NAT HIST, V23, P1041, DOI 10.1080/00222938900770951; Rogers CM, 1998, OECOLOGIA, V116, P227, DOI 10.1007/s004420050583; ROGERS LL, 1981, J MAMMAL, V62, P434, DOI 10.2307/1380735; Rose MD, 1998, ECOLOGY, V79, P998, DOI 10.2307/176595; Rosenfeld JS, 2002, OIKOS, V98, P156, DOI 10.1034/j.1600-0706.2002.980116.x; Ruesink JL, 2001, OIKOS, V93, P221, DOI 10.1034/j.1600-0706.2001.930206.x; Schindler DE, 2003, FRONT ECOL ENVIRON, V1, P31, DOI 10.1890/1540-9295(2003)001[0031:PSATEO]2.0.CO;2; Schmidt KA, 2003, CONSERV BIOL, V17, P1141, DOI 10.1046/j.1523-1739.2003.02316.x; Shardlow TF, 2013, ECOL INDIC, V27, P97, DOI 10.1016/j.ecolind.2012.11.011; Small C, 2003, J COASTAL RES, V19, P584; Smith JA, 2016, J WILDLIFE MANAGE, V80, P1040, DOI 10.1002/jwmg.21098; Suraci JP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10698; Suraci JP, 2014, OECOLOGIA, V176, P1087, DOI 10.1007/s00442-014-3085-5; Thompson RM, 2007, ECOLOGY, V88, P612, DOI 10.1890/05-1454; Vance-Chalcraft HD, 2007, ECOLOGY, V88, P2689, DOI 10.1890/06-1869.1; Zuur Alain F., 2009, P1	66	7	8	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0170255	10.1371/journal.pone.0170255	http://dx.doi.org/10.1371/journal.pone.0170255			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085962	Green Published, Green Submitted, gold			2022-12-26	WOS:000391972600080
J	Cebrian-Serrano, A; Zha, SJ; Hanssen, L; Biggs, D; Preece, C; Davies, B				Cebrian-Serrano, Alberto; Zha, Shijun; Hanssen, Lars; Biggs, Daniel; Preece, Christopher; Davies, Benjamin			Maternal Supply of Cas9 to Zygotes Facilitates the Efficient Generation of Site-Specific Mutant Mouse Models	PLOS ONE			English	Article							KNOCK-IN; GENOME; CRISPR/CAS9; SYSTEM; MICE; CRISPR-CAS9; REPAIR; CELLS; MICROINJECTION; EXPRESSION	Genome manipulation in the mouse via microinjection of CRISPR/Cas9 site-specific nucleases has allowed the production time for genetically modified mouse models to be significantly reduced. Successful genome manipulation in the mouse has already been reported using Cas9 supplied by microinjection of a DNA construct, in vitro transcribed mRNA and recombinant protein. Recently the use of transgenic strains of mice overexpressing Cas9 has been shown to facilitate site-specific mutagenesis via maternal supply to zygotes and this route may provide an alternative to exogenous supply. We have investigated the feasibility of supplying Cas9 genetically in more detail and for this purpose we report the generation of a transgenic mice which overexpress Cas9 ubiquitously, via a CAG-Cas9 transgene targeted to the Gt(ROSA26) Sor locus. We show that zygotes prepared from female mice harbouring this transgene are sufficiently loaded with maternally contributed Cas9 for efficient production of embryos and mice harbouring indel, genomic deletion and knock-in alleles by microinjection of guide RNAs and templates alone. We compare the mutagenesis rates and efficacy of mutagenesis using this genetic supply with exogenous Cas9 supply by either mRNA or protein microinjection. In general, we report increased generation rates of knock-in alleles and show that the levels of mutagenesis at certain genome target sites are significantly higher and more consistent when Cas9 is supplied genetically relative to exogenous supply.	[Cebrian-Serrano, Alberto; Zha, Shijun; Biggs, Daniel; Preece, Christopher; Davies, Benjamin] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England; [Hanssen, Lars] Univ Oxford, MRC Weatherall Inst Mol Med, Oxford OX1 2JD, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Davies, B (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England.	ben.davies@well.ox.ac.uk	Davies, Ben/GYD-9163-2022	Davies, Ben/0000-0003-3405-507X; Davies, Benjamin/0000-0003-3623-600X; Cebrian-Serrano, Alberto/0000-0002-4737-0215; Hanssen, Lars/0000-0002-2551-2278	Wellcome Trust [090532/Z/09/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust [090532/Z/09/Z].	Aida T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0653-x; Bialk P, 2016, SCI REP-UK, V6, DOI 10.1038/srep32681; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Chen CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023376; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dobie KW, 1996, P NATL ACAD SCI USA, V93, P6659, DOI 10.1073/pnas.93.13.6659; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Hashimoto M., 2015, SCI REPORTS, V5, P5, DOI DOI 10.1038/SREP11315; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Li F, 2014, SCI REP-UK, V4, DOI 10.1038/srep05290; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lin CC, 2016, G3; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Menoret S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14410; Nakagawa Y, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0144-x; Nakao K, 1997, EXP ANIM TOKYO, V46, P231, DOI 10.1538/expanim.46.231; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Qin WN, 2015, GENETICS, V200, P423, DOI 10.1534/genetics.115.176594; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sakurai T, 2016, SCI REP-UK, V6, DOI 10.1038/srep20011; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Sebo ZL, 2014, FLY, V8, P52, DOI 10.4161/fly.26828; Singh P, 2015, GENETICS, V199, P1, DOI 10.1534/genetics.114.169771; Skarnes WC, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0673-6; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Takahashi G, 2015, SCI REP-UK, V5, DOI 10.1038/srep11406; Chu VT, 2016, P NATL ACAD SCI USA, V113, P12514, DOI 10.1073/pnas.1613884113; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017; Zhang LL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154364; Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37	39	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169887	10.1371/journal.pone.0169887	http://dx.doi.org/10.1371/journal.pone.0169887			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081254	Green Submitted, Green Published, gold			2022-12-26	WOS:000391949500097
J	de Oliveira, TD; Kretschmer, R; Bertocchi, NA; Degrandi, TM; de Oliveira, EHC; Cioffi, MD; Garnero, AD; Gunski, RJ				de Oliveira, Thays Duarte; Kretschmer, Rafael; Bertocchi, Natasha Avila; Degrandi, Tiago Marafiga; Correa de Oliveira, Edivaldo Herculano; Cioffi, Marcelo de Bello; Garnero, Analia del Valle; Gunski, Ricardo Jose			Genomic Organization of Repetitive DNA in Woodpeckers (Aves, Piciformes): Implications for Karyotype and ZW Sex Chromosome Differentiation	PLOS ONE			English	Article							ACCUMULATION; EVOLUTION; GENES; SIZE	Birds are characterized by a low proportion of repetitive DNA in their genome when compared to other vertebrates. Among birds, species belonging to Piciformes order, such as woodpeckers, show a relatively higher amount of these sequences. The aim of this study was to analyze the distribution of different classes of repetitive DNA-including microsatellites, telomere sequences and 18S rDNA-in the karyotype of three Picidae species (Aves, Piciformes)-Colaptes melanochloros (2n = 84), Colaptes campestris (2n = 84) and Melanerpes candidus (2n = 64)-by means of fluorescence in situ hybridization. Clusters of 18S rDNA were found in one microchromosome pair in each of the three species, coinciding to a region of (CGG)(10) sequence accumulation. Interstitial telomeric sequences were found in some macrochromosomes pairs, indicating possible regions of fusions, which can be related to variation of diploid number in the family. Only one, from the 11 different microsatellite sequences used, did not produce any signals. Both species of genus Colaptes showed a similar distribution of microsatellite sequences, with some difference when compared to M. candidus. Microsatellites were found preferentially in the centromeric and telomeric regions of micro and macrochromosomes. However, some sequences produced patterns of interstitial bands in the Z chromosome, which corresponds to the largest element of the karyotype in all three species. This was not observed in the W chromosome of Colaptes melanochloros, which is heterochromatic in most of its length, but was not hybridized by any of the sequences used. These results highlight the importance of microsatellite sequences in differentiation of sex chromosomes, and the accumulation of these sequences is probably responsible for the enlargement of the Z chromosome.	[de Oliveira, Thays Duarte; Bertocchi, Natasha Avila; Garnero, Analia del Valle; Gunski, Ricardo Jose] Univ Fed Pampa, Programa Posgrad Ciencias Biol, Sao Gabriel, RS, Brazil; [Kretschmer, Rafael] Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil; [Degrandi, Tiago Marafiga] Univ Fed Parana, Programa Posgrad Genet, Curitiba, Parana, Brazil; [Correa de Oliveira, Edivaldo Herculano] Inst Evandro Chagas, Lab Culture Tecidos & Citogenet, Ananindeua, Para, Brazil; [Correa de Oliveira, Edivaldo Herculano] Fed Univ Para, Inst Ciencias Exatas & Nat, Belem, Para, Brazil; [Cioffi, Marcelo de Bello] Univ Fed Sao Carlos, Dept Genet & Evolucao, Sao Carlos, SP, Brazil	Universidade Federal do Pampa; Universidade Federal do Rio Grande do Sul; Universidade Federal do Parana; Instituto Evandro Chagas; Universidade Federal do Para; Universidade Federal de Sao Carlos	de Oliveira, TD (corresponding author), Univ Fed Pampa, Programa Posgrad Ciencias Biol, Sao Gabriel, RS, Brazil.	thaysbiotec@gmail.com	Cioffi, Marcelo/AAG-4675-2022; Bertocchi, Natasha/AAF-7047-2019; Kretschmer, Rafael/M-7293-2019; Garnero, Analía/AAV-5270-2020; de Oliveira, Edivaldo H. C./C-3368-2013; Cioffi, Marcelo/AFK-6402-2022; Degrandi, Tiago/GXG-7685-2022; Kretschmer, Rafael/B-7206-2017; de Oliveira, Thays Duarte/AAD-6820-2019	Cioffi, Marcelo/0000-0003-4340-1464; Bertocchi, Natasha/0000-0002-8880-5967; Kretschmer, Rafael/0000-0002-6856-2152; Garnero, Analía/0000-0003-4252-8228; de Oliveira, Edivaldo H. C./0000-0001-6315-3352; Cioffi, Marcelo/0000-0003-4340-1464; Degrandi, Tiago/0000-0003-1586-5405; Kretschmer, Rafael/0000-0002-6856-2152; de Oliveira, Thays Duarte/0000-0003-4131-8210				Andrews CB, 2009, P ROY SOC B-BIOL SCI, V276, P55, DOI 10.1098/rspb.2008.1012; Benz BW, 2006, MOL PHYLOGENET EVOL, V40, P389, DOI 10.1016/j.ympev.2006.02.021; Bian X-Z., 1989, ZOOL RES, V10, P309; Biet E, 1999, NUCLEIC ACIDS RES, V27, P596, DOI 10.1093/nar/27.2.596; Castro MS, 2002, GENET MOL BIOL, V25, P147, DOI 10.1590/S1415-47572002000200006; Cioffi MB, 2010, SEX DEV, V4, P176, DOI 10.1159/000309726; Daniels LM, 2003, CHROMOSOME RES, V11, P305, DOI 10.1023/A:1024008522122; Fernandez R, 2002, HEREDITAS, V137, P145, DOI 10.1034/j.1601-5223.2002.01672.x; Garnero Analia del V., 2000, Nucleus (Calcutta), V43, P64; Goldschmidt B., 1996, Archivos de Zootecnia, V45, P289; Gunski RJ, 1998, GENET MOL BIOL, V21, P207, DOI 10.1590/S1415-47571998000200006; HAMMAR B, 1970, HEREDITAS-GENETISK A, V65, P29; IJDO JW, 1991, NUCLEIC ACIDS RES, V19, P4780, DOI 10.1093/nar/19.17.4780; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; KAUL D, 1978, GENETICA, V48, P193, DOI 10.1007/BF00155569; Kidwell MG, 2002, GENETICA, V115, P49, DOI 10.1023/A:1016072014259; Kubat Z, 2008, GENOME, V51, P350, DOI 10.1139/G08-024; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Liu ZJ, 2001, BIOCHEM BIOPH RES CO, V289, P317, DOI 10.1006/bbrc.2001.5978; Matsubara K, 2015, CHROMOSOMA; Moore WS, 2011, MOL PHYLOGENET EVOL, V58, P76, DOI 10.1016/j.ympev.2010.09.011; Nanda I, 2007, CYTOGENET GENOME RES, V117, P43, DOI 10.1159/000103164; Nishida C, 2008, CHROMOSOME RES, V16, P171, DOI 10.1007/s10577-007-1210-6; Nishida-Umehara C, 2007, CHROMOSOME RES, V15, P721, DOI 10.1007/s10577-007-1157-7; Pokorna M, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-90; Reeves A., 2000, MICROMEASURE WINDOWS; SASAKI M, 1968, EXPERIENTIA, V24, P1292, DOI 10.1007/BF02146680; Schmid M, 2000, CYTOGENET CELL GENET, V90, P169, DOI 10.1159/000056772; SHIELDS GF, 1982, CONDOR, V84, P45, DOI 10.2307/1367820; Terencio ML, 2013, SEX DEV, V7, P325, DOI 10.1159/000356691; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Yano CF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090946; Zhang GJ, 2014, SCIENCE, V346, P1311, DOI 10.1126/science.1251385	33	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169987	10.1371/journal.pone.0169987	http://dx.doi.org/10.1371/journal.pone.0169987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081238	Green Published, gold, Green Submitted			2022-12-26	WOS:000391949500116
J	Lange, C; Lehr, M; Zerulla, K; Ludwig, P; Schweitzer, J; Polen, T; Wendisch, VF; Soppa, J				Lange, Christian; Lehr, Matthias; Zerulla, Karolin; Ludwig, Petra; Schweitzer, Jens; Polen, Tino; Wendisch, Volker F.; Soppa, Joerg			Effects of Kasugamycin on the Translatome of Escherichia coli	PLOS ONE			English	Article							LEADERLESS MESSENGER-RNAS; TRANSCRIPTIONAL START SITES; GENOME-WIDE IDENTIFICATION; RIBOSOME BINDING; BACTERIAL SPOT; INITIATION; EXPRESSION; MANAGEMENT; INHIBITION; MECHANISM	It is long known that Kasugamycin inhibits translation of canonical transcripts containing a 5'-UTR with a Shine Dalgarno (SD) motif, but not that of leaderless transcripts. To gain a global overview of the influence of Kasugamycin on translation efficiencies, the changes of the translatome of Escherichia coli induced by a 10 minutes Kasugamycin treatment were quantified. The effect of Kasugamycin differed widely, 102 transcripts were at least twofold more sensitive to Kasugamycin than average, and 137 transcripts were at least twofold more resistant, and there was a more than 100-fold difference between the most resistant and the most sensitive transcript. The 5'-ends of 19 transcripts were determined from treated and untreated cultures, but Kasugamycin resistance did neither correlate with the presence or absence of a SD motif, nor with differences in 5'-UTR lengths or GC content. RNA Structure Logos were generated for the 102 Kasugamycin- sensitive and for the 137 resistant transcripts. For both groups a short Shine Dalgarno (SD) motif was retrieved, but no specific motifs associated with resistance or sensitivity could be found. Notably, this was also true for the region -3 to -1 upstream of the start codon and the presence of an extended SD motif, which had been proposed to result in Kasugamycin resistance. Comparison of the translatome results with the database RegulonDB showed that the transcript with the highest resistance was leaderless, but no further leaderless transcripts were among the resistant transcripts. Unexpectedly, it was found that translational coupling might be a novel feature that is associated with Kasugamycin resistance. Taken together, Kasugamycin has a profound effect on translational efficiencies of E. coli transcripts, but the mechanism of action is different than previously described.	[Lange, Christian; Lehr, Matthias; Zerulla, Karolin; Ludwig, Petra; Schweitzer, Jens; Soppa, Joerg] Goethe Univ, Bioctr, Inst Mol Biosci, Frankfurt, Germany; [Polen, Tino; Wendisch, Volker F.] Univ Bielefeld, Fac Biol, Bielefeld, Germany; [Polen, Tino] Forschungszentrum Julich, IBG Biotechnol 1, Inst Bio & Geosci, Julich, Germany	Goethe University Frankfurt; University of Bielefeld; Helmholtz Association; Research Center Julich	Soppa, J (corresponding author), Goethe Univ, Bioctr, Inst Mol Biosci, Frankfurt, Germany.	soppa@bio.uni-frankfurt.de	Polen, Tino/G-4017-2016; Wendisch, Volker F./M-5940-2016	Polen, Tino/0000-0002-0065-3007; Wendisch, Volker F./0000-0003-3473-0012; Soppa, Jorg/0000-0002-6132-5840	German Research Council (Deutsche Forschungsgemeinschaft) [SFB902, B6]	German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	The study was funded in part by the German Research Council (Deutsche Forschungsgemeinschaft; www.dfg.de), SFB902, project B6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaskaveg J, 2010, PHYTOPATHOLOGY, V100, pS166; ADHIN MR, 1990, J MOL BIOL, V213, P811, DOI 10.1016/S0022-2836(05)80265-7; Andreev DE, 2006, MOL CELL BIOL, V26, P3164, DOI 10.1128/MCB.26.8.3164-3169.2006; Babski J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2920-y; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Brazas MD, 2005, DRUG DISCOV TODAY, V10, P1245, DOI 10.1016/S1359-6446(05)03566-X; Brock JE, 2008, RNA, V14, P2159, DOI 10.1261/rna.1089208; Chang B, 2006, GENE, V373, P90, DOI 10.1016/j.gene.2006.01.033; CHIN K, 1993, J BACTERIOL, V175, P7471, DOI 10.1128/JB.175.22.7471-7473.1993; Cortes T, 2013, CELL REP, V5, P1121, DOI 10.1016/j.celrep.2013.10.031; DAS A, 1989, NUCLEIC ACIDS RES, V17, P9333, DOI 10.1093/nar/17.22.9333; de Groot A, 2014, GENOME BIOL EVOL, V6, P932, DOI 10.1093/gbe/evu069; Gorodkin J, 1997, COMPUT APPL BIOSCI, V13, P583; Grill S, 2002, FEMS MICROBIOL LETT, V211, P161, DOI 10.1016/S0378-1097(02)00646-8; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; HELLMUTH K, 1991, MOL MICROBIOL, V5, P813, DOI 10.1111/j.1365-2958.1991.tb00754.x; Hering O, 2009, MOL MICROBIOL, V71, P1451, DOI 10.1111/j.1365-2958.2009.06615.x; Ishigami J, 1967, J Antibiot B, V20, P83; Kaberdina AC, 2009, MOL CELL, V33, P227, DOI 10.1016/j.molcel.2008.12.014; Kansara SS, 2012, J PURE APPL MICROBIO, V6, P1715; Krishnan KM, 2010, J BACTERIOL, V192, P6482, DOI 10.1128/JB.00756-10; Lange C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-415; Li L, 2004, J BIOL CHEM, V279, P14656, DOI 10.1074/jbc.M309879200; Mendoza-Vargas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007526; Moll I, 2004, NUCLEIC ACIDS RES, V32, P3354, DOI 10.1093/nar/gkh663; Moll I, 2002, BIOCHEM BIOPH RES CO, V297, P1021, DOI 10.1016/S0006-291X(02)02333-1; Moll I, 2002, MOL MICROBIOL, V43, P239, DOI 10.1046/j.1365-2958.2002.02739.x; OKUYAMA A, 1975, J ANTIBIOT, V28, P903, DOI 10.7164/antibiotics.28.903; Pfeifer-Sancar K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-888; Pfeiffer F, 2008, ARCH MICROBIOL, V190, P281, DOI 10.1007/s00203-008-0389-z; Powell ML, 2010, BIOCHEM SOC T, V38, P1558, DOI 10.1042/BST0381558; REX G, 1994, J BIOL CHEM, V269, P18118; Romero DA, 2014, MOL MICROBIOL; Sabina J, 2003, J BACTERIOL, V185, P6158, DOI 10.1128/JB.185.20.6158-6170.2003; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; Schluenzen F, 2006, NAT STRUCT MOL BIOL, V13, P871, DOI 10.1038/nsmb1145; Schuwirth BS, 2006, NAT STRUCT MOL BIOL, V13, P879, DOI 10.1038/nsmb1150; Shultzaberger RK, 2001, J MOL BIOL, V313, P215, DOI 10.1006/jmbi.2001.5040; Umezawa H, 1965, Antimicrob Agents Chemother (Bethesda), V5, P753; Vallad GE, 2010, HORTSCIENCE, V45, P1834, DOI 10.21273/HORTSCI.45.12.1834; Van Etten WJ, 1998, MOL MICROBIOL, V27, P987, DOI 10.1046/j.1365-2958.1998.00744.x; Veit A, 2007, APPL MICROBIOL BIOT, V74, P406, DOI 10.1007/s00253-006-0680-3; Wade L, 2012, PHYTOPATHOLOGY, V102, P129; Wendisch VF, 2001, ANAL BIOCHEM, V290, P205, DOI 10.1006/abio.2000.4982; Zhou JD, 2013, NUCLEIC ACIDS RES, V41, pD613, DOI 10.1093/nar/gks1235	45	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0168143	10.1371/journal.pone.0168143	http://dx.doi.org/10.1371/journal.pone.0168143			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081129	Green Published, gold			2022-12-26	WOS:000391949500007
J	Li, M; Cai, RJ; Li, CL; Song, S; Li, Y; Jiang, ZY; Yang, DX				Li, Miao; Cai, Ru-Jian; Li, Chun-Ling; Song, Shuai; Li, Yan; Jiang, Zhi-Yong; Yang, Dong-Xia			Deletion of ssnA Attenuates the Pathogenicity of Streptococcus suis and Confers Protection against Serovar 2 Strain Challenge	PLOS ONE			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; ZOONOTIC PATHOGEN; MOUSE MODEL; VIRULENCE; SEROTYPE-2; DNASE; GENE; IDENTIFICATION; DEGRADATION; PNEUMONIAE	Streptococcus suis serotype 2 (SS2) is a major porcine and human pathogen which causes arthritis, meningitis, and septicemia. Streptococcus suis nuclease A (SsnA) is a recently discovered deoxyribonuclease (DNase), which has been demonstrated to contribute to escape killing in neutrophil extracellular traps (NETs). To further determine the effects of ssnA on virulence, the ssnA deletion mutant (Delta ssnA) and its complemented strain (C-Delta ssnA) were constructed. The ability of Delta ssnA mutant to interact with human laryngeal epithelial cell (Hep-2) was evaluated and it exhibited dramatically decreased ability to adhere to and invade Hep-2 cells. This mutation was found to exhibit significant attenuation of virulence when evaluated in CD1 mice, suggesting ssnA plays a critical role in the pathogenesis of SS2. Finally, we found that immunization with the Delta ssnA mutant triggered both antibody responses and cell-mediated immunity, and conferred 80% protection against virulent SS2 challenge in mice. Taken together, our results suggest that Delta ssnA represents an attractive candidate for designing an attenuated live vaccine against SS2.	[Li, Miao; Cai, Ru-Jian; Li, Chun-Ling; Song, Shuai; Li, Yan; Jiang, Zhi-Yong; Yang, Dong-Xia] Guangdong Acad Agr Sci, Inst Anim Hlth, Guangzhou, Guangdong, Peoples R China; [Li, Miao; Cai, Ru-Jian; Li, Chun-Ling; Song, Shuai; Li, Yan; Jiang, Zhi-Yong; Yang, Dong-Xia] Guangdong Open Lab Vet Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Li, Miao; Cai, Ru-Jian; Li, Chun-Ling; Song, Shuai; Li, Yan; Jiang, Zhi-Yong; Yang, Dong-Xia] Guangdong Prov Key Lab Livestock Dis Prevent, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Agricultural Sciences	Cai, RJ; Li, CL (corresponding author), Guangdong Acad Agr Sci, Inst Anim Hlth, Guangzhou, Guangdong, Peoples R China.; Cai, RJ; Li, CL (corresponding author), Guangdong Open Lab Vet Publ Hlth, Guangzhou, Guangdong, Peoples R China.; Cai, RJ; Li, CL (corresponding author), Guangdong Prov Key Lab Livestock Dis Prevent, Guangzhou, Guangdong, Peoples R China.	cairujian2002@aliyun.com; lclclare@163.com			Guangzhou Science and technology planning project of China [1563000807]; Presidential Foundation of Guangdong Academy of Agricultural Science of China [201437]	Guangzhou Science and technology planning project of China; Presidential Foundation of Guangdong Academy of Agricultural Science of China	This work was supported by Guangzhou Science and technology planning project of China 1563000807 to ML; The Presidential Foundation of Guangdong Academy of Agricultural Science of China 201437 to ML. The funders played a role in study design, data collection and analysis, and preparation of the manuscript.	Aziz RK, 2004, MOL MICROBIOL, V54, P184, DOI 10.1111/j.1365-2958.2004.04255.x; Beiter K, 2006, CURR BIOL, V16, P401, DOI 10.1016/j.cub.2006.01.056; Bendjennat M, 1999, INFECT IMMUN, V67, P4456, DOI 10.1128/IAI.67.9.4456-4462.1999; Berends ETM, 2010, J INNATE IMMUN, V2, P576, DOI 10.1159/000319909; Chang A, 2011, MOL MICROBIOL, V79, P1629, DOI 10.1111/j.1365-2958.2011.07550.x; Curtiss R, 2002, J CLIN INVEST, V110, P1061, DOI 10.1172/JCI200216941; de Buhr N, 2014, MICROBIOL-SGM, V160, P385, DOI 10.1099/mic.0.072199-0; Dominguez-Punaro MC, 2007, J IMMUNOL, V179, P1842, DOI 10.4049/jimmunol.179.3.1842; Feng YJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00710; Fittipaldi N, 2012, FUTURE MICROBIOL, V7, P259, DOI [10.2217/FMB.11.149, 10.2217/fmb.11.149]; Fontaine MC, 2004, INFECT IMMUN, V72, P774, DOI 10.1128/IAI.72.2.774-781.2004; Gomez-Gascon L, 2014, VACCINE, V32, P6992, DOI 10.1016/j.vaccine.2014.10.019; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; Hemsley C, 2003, J BACTERIOL, V185, P6640, DOI 10.1128/JB.185.22.6640-6647.2003; Higgins R, 2000, CAN VET J, V41, P414; Hu J, 2015, MICROBIOL RES, V170, P87, DOI 10.1016/j.micres.2014.08.010; Li L, 2008, MICROB PATHOGENESIS, V45, P192, DOI 10.1016/j.micpath.2008.05.008; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; Mulcahy H, 2010, ENVIRON MICROBIOL, V12, P1621, DOI 10.1111/j.1462-2920.2010.02208.x; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Okumura K, 2005, FEMS MICROBIOL LETT, V242, P281, DOI 10.1016/j.femsle.2004.11.019; PERCH B, 1968, ACTA PATHOL MIC SC, V74, P69; Staats JJ, 1997, VET RES COMMUN, V21, P381, DOI 10.1023/A:1005870317757; Stabel JR, 2012, VACCINE, V31, P127, DOI 10.1016/j.vaccine.2012.10.090; Su Y, 2008, FEMS MICROBIOL ECOL, V66, P546, DOI 10.1111/j.1574-6941.2008.00529.x; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; Tang JQ, 2006, PLOS MED, V3, P668, DOI 10.1371/journal.pmed.0030151; TRIEUCUOT P, 1991, GENE, V102, P99, DOI 10.1016/0378-1119(91)90546-N; Vela AI, 2003, J CLIN MICROBIOL, V41, P2498, DOI 10.1128/JCM.41.6.2498-2502.2003; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763; Zhang B, 2014, OBES REV, V15, P2, DOI 10.1111/obr.12119; Zheng BW, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019510, 10.1371/journal.pone.0019976]	33	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169791	10.1371/journal.pone.0169791	http://dx.doi.org/10.1371/journal.pone.0169791			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081204	Green Submitted, Green Published, gold			2022-12-26	WOS:000391949500081
J	Chen, ML; Wu, J; Wang, LF; Mantri, N; Zhang, XY; Zhu, ZD; Wang, SM				Chen, Mingli; Wu, Jing; Wang, Lanfen; Mantri, Nitin; Zhang, Xiaoyan; Zhu, Zhendong; Wang, Shumin			Mapping and Genetic Structure Analysis of the Anthracnose Resistance Locus Co-1(HY) in the Common Bean (Phaseolus vulgaris L.)	PLOS ONE			English	Article							COLLETOTRICHUM-LINDEMUTHIANUM; MOLECULAR MARKERS; KINASE; CRINKLY4; CLUSTER; RACES; MAP; RECOMBINATION; INHERITANCE; DISSECTION	Anthracnose is a destructive disease of the common bean (Phaseolus vulgaris L.). The Andean cultivar Hongyundou has been demonstrated to possess strong resistance to anthracnose race 81. To study the genetics of this resistance, the Hongyundou cultivar was crossed with a susceptible genotype Jingdou. Segregation of resistance for race 81 was assessed in the F-2 population and F-2:3 lines under controlled conditions. Results indicate that Hongyundou carries a single dominant gene for anthracnose resistance. An allele test by crossing Hongyundou with another resistant cultivar revealed that the resistance gene is in the Co-1 locus (therefore named Co-1(Hy)). The physical distance between this locus and the two flanking markers was 46 kb, and this region included four candidate genes, namely, Phvul.001G243500, Phvul.001G243600, Phvul.001G243700 and Phvul.001G243800. These candidate genes encoded serine/threonine-protein kinases. Expression analysis of the four candidate genes in the resistant and susceptible cultivars under control condition and inoculated treatment revealed that all the four candidate genes are expressed at significantly higher levels in the resistant genotype than in susceptible genotype. Phvul.001G243600 and Phvul.001G243700 are expressed nearly 15-fold and 90-fold higher in the resistant genotype than in the susceptible parent before inoculation, respectively. Four candidate genes will provide useful information for further research into the resistance mechanism of anthracnose in common bean. The closely linked flanking markers identified here may be useful for transferring the resistance allele Co-1(HY) from Hongyundou to elite anthracnose susceptible common bean lines.	[Chen, Mingli; Wu, Jing; Wang, Lanfen; Zhu, Zhendong; Wang, Shumin] Chinese Acad Agr Sci, Minist Agr, Key Lab Crop Germplasm Resources & Utilizat, Beijing, Peoples R China; [Chen, Mingli; Wu, Jing; Wang, Lanfen; Zhu, Zhendong; Wang, Shumin] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China; [Chen, Mingli] Chinese Acad Agr Sci, Tobacco Res Inst, Qingdao, Shandong, Peoples R China; [Mantri, Nitin] RMIT Univ, Sch Sci, Melbourne, Vic, Australia; [Zhang, Xiaoyan] Qingdao Acad Agr Sci, Qingdao, Shandong, Peoples R China	Chinese Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences; Tobacco Research Institute, CAAS; Royal Melbourne Institute of Technology (RMIT)	Wang, SM (corresponding author), Chinese Acad Agr Sci, Minist Agr, Key Lab Crop Germplasm Resources & Utilizat, Beijing, Peoples R China.; Wang, SM (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China.	wangshumin@caas.cn		Mantri, Nitin/0000-0002-7621-035X	National Natural Science Foundation of China [31301387]; Ministry of Agriculture of China [CARS-09]; Program of International Science & Technology Cooperation; Cooperation Research on Collecting Techniques and Practice in Crop Genebank between China and United States of America [2014DFG31860]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2013BAD01B03-18a]; Agricultural Science and Technology Innovation Program (ASTIP) of CMS	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Program of International Science & Technology Cooperation; Cooperation Research on Collecting Techniques and Practice in Crop Genebank between China and United States of America; National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Agricultural Science and Technology Innovation Program (ASTIP) of CMS	This work was supported by grants from the National Natural Science Foundation of China (grant No. 31301387), the Ministry of Agriculture of China [the earmarked fund for China Agriculture Research System (CARS-09)], Program of International Science & Technology Cooperation, Cooperation Research on Collecting Techniques and Practice in Crop Genebank between China and United States of America (2014DFG31860), the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2013BAD01B03-18a) and the Agricultural Science and Technology Innovation Program (ASTIP) of CMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMBLONDON AF, 1994, GENOME, V37, P915, DOI 10.1139/g94-131; Afzal AJ, 2008, MOL PLANT MICROBE IN, V21, P507, DOI 10.1094/MPMI-21-5-0507; Alzate-Marin AL, 2003, EUPHYTICA, V133, P165, DOI 10.1023/A:1025551006444; BALARDIN R S, 1990, Fitopatologia Brasileira, V15, P243; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Becraft PW, 1996, SCIENCE, V273, P1406, DOI 10.1126/science.273.5280.1406; Becraft PW, 2001, PLANT PHYSIOL, V127, P486, DOI 10.1104/pp.010299; Brueggeman R, 2002, P NATL ACAD SCI USA, V99, P9328, DOI 10.1073/pnas.142284999; Campa A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-115; Campa A, 2009, THEOR APPL GENET, V119, P1, DOI 10.1007/s00122-009-1011-8; Cao XY, 2005, PLANTA, V220, P645, DOI 10.1007/s00425-004-1378-3; Chen MingLi, 2011, Acta Agronomica Sinica, V37, P2130, DOI 10.3724/SP.J.1006.2011.02130; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; David P, 2009, PLANT PHYSIOL, V151, P1048, DOI 10.1104/pp.109.142109; Diener AC, 2005, GENETICS, V171, P305, DOI 10.1534/genetics.105.042218; FAO, 2015, FAO UN STAT DAT; Ferreira J.J., 2013, TRANSLATIONAL GENOMI, VI, P151, DOI DOI 10.1002/9781118728475.CH9; Ferrier-Cana E, 2005, THEOR APPL GENET, V110, P895, DOI 10.1007/s00122-004-1908-1; Ferrier-Cana E, 2003, THEOR APPL GENET, V106, P251, DOI 10.1007/s00122-002-1032-z; Geffroy V, 1999, MOL PLANT MICROBE IN, V12, P774, DOI 10.1094/MPMI.1999.12.9.774; Geffroy V, 1997, THESIS; Geffroy V, 2008, THEOR APPL GENET, V116, P407, DOI 10.1007/s00122-007-0678-y; Geffroy V, 2009, GENETICS, V181, P405, DOI 10.1534/genetics.108.093583; Goncalves-Vidigal MC, 2009, CROP SCI, V49, P133, DOI 10.2135/cropsci2008.01.0004; Goncalves-Vidigal MC, 2006, EUPHYTICA, V151, P411, DOI 10.1007/s10681-006-9164-x; Goncalves-Vidigal MC, 2011, THEOR APPL GENET, V122, P893, DOI 10.1007/s00122-010-1496-1; Kelly JD, 2004, HORTSCIENCE, V39, P1196, DOI 10.21273/HORTSCI.39.6.1196; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Perseguini JMKC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150506; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MATHUR RS, 1950, PHYTOPATHOLOGY, V40, P104; McRostie GP, 1919, PHYTOPATHOLOGY, V9, P141; Melotto M, 2000, EUPHYTICA, V116, P143, DOI 10.1023/A:1004005001049; Melotto M, 2004, THEOR APPL GENET, V109, P690, DOI 10.1007/s00122-004-1697-6; Mendez-Vigo B, 2005, EUPHYTICA, V141, P237, DOI 10.1007/s10681-005-7075-x; Meziadi C, 2016, PLANT SCI, V242, P351, DOI 10.1016/j.plantsci.2015.09.006; Miklas PN, 2006, EUPHYTICA, V147, P105, DOI 10.1007/s10681-006-4600-5; Pflieger S, 2013, FUNCT PLANT BIOL, V40, P1234, DOI 10.1071/FP13089; Pu CX, 2012, PLANT J, V70, P940, DOI 10.1111/j.1365-313X.2012.04925.x; Quarrie SA, 1999, J EXP BOT, V50, P1299, DOI 10.1093/jexbot/50.337.1299; Richard MMS, 2014, THEOR APPL GENET, V127, P1653, DOI 10.1007/s00122-014-2328-5; Rodriguez-Suarez C, 2008, THEOR APPL GENET, V116, P807, DOI 10.1007/s00122-008-0714-6; Rodriguez-Suarez C, 2007, THEOR APPL GENET, V114, P713, DOI 10.1007/s00122-006-0471-3; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; Sekhwal MK, 2015, INT J MOL SCI, V16, P19248, DOI 10.3390/ijms160819248; Singh SP, 2010, CROP SCI, V50, P2199, DOI 10.2135/cropsci2009.03.0163; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Sousa L.L., 2013, ANN REP BEAN IMPROV, V56, P45; STEWART CN, 1993, BIOTECHNIQUES, V14, P748; Sun XL, 2006, PLANT PHYSIOL, V140, P998, DOI 10.1104/pp.105.073080; Tabata S, 2000, NATURE, V408, P823, DOI 10.1038/35048507; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trabanco N, 2015, PLANT GENOME; Vallejos CE, 2006, GENETICS, V172, P1229, DOI 10.1534/genetics.105.050815; Vlasova A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0883-6; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; [王坤 WANG Kun], 2008, [植物遗传资源学报, Journal of Plant Genetic Resources], V9, P168; XU Y, 1994, PLANT CELL, V6, P1077, DOI 10.1105/tpc.6.8.1077	60	22	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169954	10.1371/journal.pone.0169954	http://dx.doi.org/10.1371/journal.pone.0169954			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076395	Green Published, gold, Green Submitted			2022-12-26	WOS:000391857100070
J	Xiong, LL; He, J; Li, LP; Liu, ZY; Wang, H				Xiong Lili; He Jian; Li Liping; Liu Zhiyu; Wang Hua			Epidemiology of Injury-Related Death in Children under 5 Years of Age in Hunan Province, China, 2009-2014	PLOS ONE			English	Article							MORTALITY; TRENDS	Background Injury is an important cause of childhood mortality in China. We described the epidemiology and trends of injury-related deaths of children <5 years of age in Hunan province, and discussed several policy implications. Methods Injury-related deaths of children <5 years of age in 2009-2014 were identified from surveillance data. All specific injury mortality and mortality rates in urban and rural area were calculated from census data; Cochran-armitage trend test was used to assess the time trends. Results Injury was the leading cause of death in children <5 years of age. Overall injury mortality was 48.96 per 100,000 persons, gradually declined with the year (Z=-18.75, P<0.001), and accounted for 27.14% of all deaths. Injury mortality in rural areas was 64.66 per 100,000 persons, which was more than 3.73 times higher than the rate in urban areas. The three leading causes of injury-related death were drowning (43.63%), suffocation (27.57%), and traffic accidents (14.34%). Suffocation was the leading cause in children <1 year of age (79.49%). Suffocation has high incidence in the winter and spring, and drowning has high incidence in the summer season. Drowning was the leading cause in children 1-4 years of age (62.80%). Drowning and suffocation accounted for 67.74% and 65.11%, of injury related deaths that occurred at home; while the traffic injury deaths (54.12%) occurred mainly in transit. Conclusions Injury-related fatalities in children <5 years of age followed time trends that were different in rural and urban areas. Effective childhood injury prevention may require different prevention policies combination depending on epidemiological characteristics such as development of injury surveillance and public education on injury knowledge. There is a need for evidence based surveillance of risk factors for development of effective-injury prevention programs.	[Xiong Lili; He Jian; Liu Zhiyu; Wang Hua] Maternal & Children Hlth Care Hosp Hunan Prov, Changsha, Hunan, Peoples R China; [Li Liping] Shantou Univ, Coll Med, Injury Prevent Res Ctr, Shantou, Guangdong, Peoples R China	Shantou University	Liu, ZY; Wang, H (corresponding author), Maternal & Children Hlth Care Hosp Hunan Prov, Changsha, Hunan, Peoples R China.	315038356@qq.com; wanghua213@aliyun.com						[Anonymous], 2008, PROGR 4 NAT HLTH SER; [Anonymous], 2015, J BEIJING U MED EDIT, V47; [Anonymous], 2008, DESCR MCHP; Branche C., 2008, WORLD REPORT CHILD I; Brixey SN, 2011, INJURY PREV, V17, P23, DOI 10.1136/ip.2010.027037; Feng Jiang, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P558; Hu Guo-qing, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P773; Imamura JH, 2012, CLINICS, V67, P1107, DOI 10.6061/clinics/2012(09)20; Johnston BD, 2009, INJURY PREV, V15, P73, DOI 10.1136/ip.2009.021790; KIBEL SM, 1990, S AFR MED J, V78, P392; Lancet T., 2015, LANCET, V386, P4244; Liang Xiaofeng, 2015, Zhonghua Liu Xing Bing Xue Za Zhi, V36, P1; Lin Sui-fang, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P1258; Ling Liangming, 2000, CHINESE J CHILD HLTH, V8, P28; Linnan HA, 2011, INJURY PREV, V17, P74, DOI 10.1136/ip.2010.026443; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Liu Q, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-180; Pan SY, 2006, INJURY PREV, V12, P155, DOI 10.1136/ip.2005.010561; Pant PR, 2015, INT J ENV RES PUB HE, V12, P15118, DOI 10.3390/ijerph121214967; Razzak JA, 2013, ARCH DIS CHILD, V98, P867, DOI 10.1136/archdischild-2013-303654; Richard Reading, 2007, PEDIATRICS, V119, P875; Sayem AM, 2011, J HEALTH POPUL NUTR, V29, P92; Sminkey L, 2008, INJURY PREV, V16, P57; The state council of the People's Republic of China, 2011, CHILDR DEV COMP CHIN; Tomashek KM, 2003, PEDIATRICS, V111, P1219; Wang Wenli, 2015, CHINESE J WOMAN CHIL, V26, P914; World Health Organization, 2012, MAT NEWB CHILD AD HL; Yan Shujuan, 2014, Zhonghua Liu Xing Bing Xue Za Zhi, V35, P562; Yang L., 2005, BEIJING INJURY SURVE; Zhao Ziling, 2014, CHIN PEDIAT EMERG ME, V21, P377	30	12	13	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0168524	10.1371/journal.pone.0168524	http://dx.doi.org/10.1371/journal.pone.0168524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076399	Green Published, gold, Green Submitted			2022-12-26	WOS:000391857100013
J	Sacoman, JL; Dagda, RY; Burnham-Marusich, AR; Dagda, RK; Berninsone, PM				Sacoman, Juliana L.; Dagda, Raul Y.; Burnham-Marusich, Amanda R.; Dagda, Ruben K.; Berninsone, Patricia M.			Mitochondrial O-GlcNAc Transferase (mOGT) Regulates Mitochondrial Structure, Function, and Survival in HeLa Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; PROTEIN PHOSPHATASE 2A; N-ACETYLGLUCOSAMINE; CARDIAC MYOCYTES; GLOBAL IDENTIFICATION; INSULIN-RESISTANCE; STATISTICAL-MODEL; ALZHEIMER-DISEASE; CROSS-TALK; GLCNACYLATION	O-Linked N-acetylglucosamine transferase (OGT) catalyzes O-GlcNAcylation of target proteins and regulates numerous biological processes. OGT is encoded by a single gene that yields nucleocytosolic and mitochondrial isoforms. To date, the role of the mitochondrial isoform of OGT (mOGT) remains largely unknown. Using high throughput proteomics, we identified 84 candidate mitochondrial glycoproteins, of which 44 are novel. Notably, two of the candidate glycoproteins identified (cytochrome oxidase 2 (COX2) and NADH: ubiquinone oxidoreductase core subunit 4 (MT-ND4)) are encoded by mitochondrial DNA. Using siRNA in HeLa cells, we found that reducing endogenous mOGT expression leads to alterations in mitochondrial structure and function, including Drp1-dependent mitochondrial fragmentation, reduction in mitochondrial membrane potential, and a significant loss of mitochondrial content in the absence of mitochondrial ROS. These defects are associated with a compensatory increase in oxidative phosphorylation per mitochondrion. mOGT is also critical for cell survival; siRNA-mediated knockdown of endogenous mOGT protected cells against toxicity mediated by rotenone, a complex I inhibitor. Conversely, reduced expression of both nucleocytoplasmic (ncOGT) and mitochondrial (mOGT) OGT isoforms is associated with increased mitochondrial respiration and elevated glycolysis, suggesting that ncOGT is a negative regulator of cellular bioenergetics. Last, we determined thatmOGTis probably involved in the glycosylation of a restricted set of mitochondrial targets. Weidentified four proteins implicated in mitochondrial biogenesis and metabolism regulation as candidate substrates of mOGT, includ-ing leucine-rich PPR-containing protein and mitochondrial aconitate hydratase. Our findings suggest that mOGT is catalytically active in vivo and supports mitochondrial structure, health, and survival, whereas ncOGT predominantly regulates cellular bioenergetics.	[Sacoman, Juliana L.; Berninsone, Patricia M.] Univ Nevada, Dept Biol, 1664 N Virginia St, Reno, NV 89557 USA; [Dagda, Raul Y.; Dagda, Ruben K.] Univ Nevada, Reno Sch Med, Dept Pharmacol, 1664 N Virginia St, Reno, NV 89557 USA; [Burnham-Marusich, Amanda R.] Univ Nevada, Reno Sch Med, Dept Microbiol & Immunol, Reno, NV 89557 USA; [Sacoman, Juliana L.] Univ Nevada, Dept Biochem & Mol Biol, 1664 N Virginia St, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno	Berninsone, PM (corresponding author), Univ Nevada, Dept Biol, 1664 N Virginia St, Reno, NV 89557 USA.; Dagda, RK (corresponding author), Univ Nevada, Reno Sch Med, Dept Pharmacol, 1664 N Virginia St, Reno, NV 89557 USA.	rdagda@medicine.nevada.edu; berninsone@unr.edu		Burnham-Marusich, Amanda/0000-0003-2320-2222	National Institutes of Health [P20 GM103554, R21 AG047623]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG047623] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was funded by National Institutes of Health Grants P20 GM103554 (a COBRE grant in " Cell Biology of Signaling Across Membranes") and R21 AG047623 (Role of Protein Glycosylation on Mitochondrial Function). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Banerjee PS, 2015, P NATL ACAD SCI USA, V112, P6050, DOI 10.1073/pnas.1424017112; BEINERT H, 1993, FASEB J, V7, P1442, DOI 10.1096/fasebj.7.15.8262329; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Burnham-Marusich AR, 2014, ELECTROPHORESIS, V35, P2621, DOI 10.1002/elps.201400241; Burnham-Marusich AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049020; Burnham-Marusich AR, 2012, MITOCHONDRION, V12, P423, DOI 10.1016/j.mito.2012.04.004; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Chu CH, 2007, PROTEIN EXPRES PURIF, V53, P421, DOI 10.1016/j.pep.2007.01.012; Clark PM, 2008, J AM CHEM SOC, V130, P11576, DOI 10.1021/ja8030467; Dagda RK, 2011, CELL DEATH DIFFER, V18, P1914, DOI 10.1038/cdd.2011.74; Dagda RK, 2005, J BIOL CHEM, V280, P27375, DOI 10.1074/jbc.M503693200; Dagda RK, 2008, AUTOPHAGY, V4, P770, DOI 10.4161/auto.6458; Dagda RK, 2014, J NEUROCHEM, V128, P864, DOI 10.1111/jnc.12494; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Dagda RK, 2008, J BIOL CHEM, V283, P36241, DOI 10.1074/jbc.M800989200; Diaz-Ruiz R, 2011, BBA-BIOENERGETICS, V1807, P568, DOI 10.1016/j.bbabio.2010.08.010; Gawlowski T, 2012, J BIOL CHEM, V287, P30024, DOI 10.1074/jbc.M112.390682; Gu YY, 2011, ARCH BIOCHEM BIOPHYS, V505, P98, DOI 10.1016/j.abb.2010.09.024; Gusdon AM, 2011, ANTIOXID REDOX SIGN, V14, P1979, DOI 10.1089/ars.2010.3763; Hanover JA, 2003, ARCH BIOCHEM BIOPHYS, V409, P287, DOI 10.1016/S0003-9861(02)00578-7; Hart GW, 2014, J BIOL CHEM, V289, P34422, DOI 10.1074/jbc.R114.609776; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Holzinger A, 2001, HUM MOL GENET, V10, P1299, DOI 10.1093/hmg/10.12.1299; Hu Y, 2009, J BIOL CHEM, V284, P547, DOI 10.1074/jbc.M808518200; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keuper M, 2014, FASEB J, V28, P761, DOI 10.1096/fj.13-238725; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kung LA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.64; Lazarus BD, 2006, GLYCOBIOLOGY, V16, P415, DOI 10.1093/glycob/cwj078; Lefebvre T, 2010, BBA-GEN SUBJECTS, V1800, P67, DOI 10.1016/j.bbagen.2009.08.008; Love DC, 2003, J CELL SCI, V116, P647, DOI 10.1242/jcs.00246; Lozano L, 2014, EXP GERONTOL, V58, P198, DOI 10.1016/j.exger.2014.08.008; Ma JF, 2015, J BIOL CHEM, V290, P29141, DOI 10.1074/jbc.M115.691741; Ma ZY, 2014, J BIOL CHEM, V289, P34457, DOI 10.1074/jbc.R114.577718; Makino A, 2011, AM J PHYSIOL-REG I, V300, pR1296, DOI 10.1152/ajpregu.00437.2010; Marsh SA, 2014, J BIOL CHEM, V289, P34449, DOI 10.1074/jbc.R114.585984; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Mitchell T, 2013, BIOCHEM SOC T, V41, P127, DOI 10.1042/BST20120231; Mourier A, 2014, HUM MOL GENET, V23, P2580, DOI 10.1093/hmg/ddt652; Mracek T, 2013, BBA-BIOENERGETICS, V1827, P401, DOI 10.1016/j.bbabio.2012.11.014; Nandi A, 2006, ANAL CHEM, V78, P452, DOI 10.1021/ac051207j; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Pace C, 2016, TOXICOL IN VITRO, V35, P188, DOI 10.1016/j.tiv.2016.06.006; Pekkurnaz G, 2014, CELL, V158, P54, DOI 10.1016/j.cell.2014.06.007; Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392; Shin SH, 2011, AMINO ACIDS, V40, P885, DOI 10.1007/s00726-010-0719-8; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Suchorolski MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056884; Tan EP, 2014, J BIOL CHEM, V289, P14719, DOI 10.1074/jbc.M113.525790; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Vaidyanathan K, 2014, J BIOL CHEM, V289, P34466, DOI 10.1074/jbc.R114.591560; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Wells L, 2003, CELL MOL LIFE SCI, V60, P222, DOI 10.1007/s000180300017; Zhong J, 2015, PROTEOMICS, V15, P591, DOI 10.1002/pmic.201400339; Zhu YP, 2014, J BIOL CHEM, V289, P34472, DOI 10.1074/jbc.R114.601351	57	51	53	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4499	4518		10.1074/jbc.M116.726752	http://dx.doi.org/10.1074/jbc.M116.726752			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28100784	hybrid, Green Published			2022-12-26	WOS:000397585100010
J	Juang, C; Chen, BH; Bru, JL; Nguyen, K; Huynh, E; Momen, M; Kim, J; Aswad, DW				Juang, Charity; Chen, Baihe; Bru, Jean-Louis; Nguyen, Katherine; Huynh, Eric; Momen, Mahsa; Kim, Jeungjin; Aswad, Dana W.			Polymorphic Variants of Human Protein l-Isoaspartyl Methyltransferase Affect Catalytic Activity, Aggregation, and Thermal Stability: IMPLICATIONS FOR THE ETIOLOGY OF NEUROLOGICAL DISORDERS AND COGNITIVE AGING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epilepsy; genetic polymorphism; neurological disease; protein aggregation; protein methylation; protein stability; recombinant protein expression; S-adenosylmethionine (SAM)	AGE-DAMAGED PROTEINS; CARBOXYL METHYLTRANSFERASE; O-METHYLTRANSFERASE; BOVINE BRAIN; RAT-BRAIN; REPAIR; MICE; PEPTIDES; CARBOXYMETHYLASE; ACCUMULATION	Protein l-isoaspartyl methyltransferase (PIMT/PCMT1), a product of the human pcmt1 gene, catalyzes repair of abnormal l-isoaspartyl linkages in age-damaged proteins. Pcmt1 knock-out mice exhibit a profound neuropathology and die 30-60 days postnatal from an epileptic seizure. Here we express 15 reported variants of human PIMT and characterize them with regard to their enzymatic activity, thermal stability, and propensity to aggregation. One mutation, R36C, renders PIMT completely inactive, whereas two others, A7P and I58V, exhibit activity that is 80-100% higher than wild type. G175R is highly prone to aggregation and has greatly reduced activity. R17S and R17H show markedly enhanced sensitivity to thermal denaturation. Based on previous studies of moderate PIMT variation in humans and mice, we predict that heterozygosity for R36C, G175R, R17S, and R17H will prove detrimental to cognitive function and successful aging, whereas homozygosity (if it ever occurs) will lead to severe neurological problems in the young.	[Juang, Charity; Chen, Baihe; Bru, Jean-Louis; Nguyen, Katherine; Huynh, Eric; Momen, Mahsa; Kim, Jeungjin; Aswad, Dana W.] Univ Calif Irvine, Dept Mol Biol & Biochem, 3205 McGaugh Hall, Irvine, CA 92697 USA	University of California System; University of California Irvine	Aswad, DW (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, 3205 McGaugh Hall, Irvine, CA 92697 USA.	dwaswad@uci.edu		Aswad, Dana/0000-0001-5098-3461; Bru, Jean-Louis/0000-0001-8797-6652	Faculty Research and Travel Committee in the School of Biological Sciences of the University of California Irvine; Summer Undergraduate Research Opportunity Award	Faculty Research and Travel Committee in the School of Biological Sciences of the University of California Irvine; Summer Undergraduate Research Opportunity Award	This work was supported by private donations to the Department of Molecular Biology at the University of California Irvine; by funds from the Faculty Research and Travel Committee in the School of Biological Sciences of the University of California Irvine; and by a Summer Undergraduate Research Opportunity Award (to J.-L.B.). The authors declare that they have no conflicts of interest with the contents of this article.	Aswad DW, 2000, J PHARMACEUT BIOMED, V21, P1129, DOI 10.1016/S0731-7085(99)00230-7; ASWAD DW, 1983, J NEUROCHEM, V40, P1718, DOI 10.1111/j.1471-4159.1983.tb08147.x; BOIVIN D, 1995, BIOCHEM J, V309, P993, DOI 10.1042/bj3090993; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNAN TV, 1994, J BIOL CHEM, V269, P24586; Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4; DAVID CL, 1995, PROTEIN EXPRES PURIF, V6, P312, DOI 10.1006/prep.1995.1041; David CL, 1997, ARCH BIOCHEM BIOPHYS, V346, P277, DOI 10.1006/abbi.1997.0303; Desrosiers Richard R, 2011, Curr Aging Sci, V4, P8; DeVry CG, 1999, J HUM GENET, V44, P275, DOI 10.1007/s100380050161; DILIBERTO EJ, 1976, J NEUROCHEM, V26, P1159, DOI 10.1111/j.1471-4159.1976.tb07001.x; Dimitrijevic A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100622; Farrar CE, 2004, THESIS; Franco RS, 2012, TRANSFUS MED HEMOTH, V39, P302, DOI 10.1159/000342232; Huynh Kathy, 2015, Curr Protoc Protein Sci, V79, DOI 10.1002/0471140864.ps2809s79; Ikegaya Y, 2001, HIPPOCAMPUS, V11, P287, DOI 10.1002/hipo.1043; JOHNSON BA, 1987, J BIOL CHEM, V262, P12283; JOHNSON BA, 1993, J BIOL CHEM, V268, P6174; JOHNSON BA, 1991, NEUROBIOL AGING, V12, P19, DOI 10.1016/0197-4580(91)90034-H; JOHNSON BA, 1993, NEUROCHEM RES, V18, P87, DOI 10.1007/BF00966926; JOHNSON BA, 1987, J BIOL CHEM, V262, P5622; Kim E, 1997, P NATL ACAD SCI USA, V94, P6132, DOI 10.1073/pnas.94.12.6132; Kosugi S, 2008, BIOCHEM BIOPH RES CO, V371, P22, DOI 10.1016/j.bbrc.2008.03.109; MCFADDEN PN, 1987, P NATL ACAD SCI USA, V84, P2595, DOI 10.1073/pnas.84.9.2595; MIZOBUCHI M, 1994, J NEUROCHEM, V62, P322; Qin ZX, 2015, NEUROBIOL AGING, V36, P1029, DOI 10.1016/j.neurobiolaging.2014.10.036; Qin ZX, 2014, INVEST OPHTH VIS SCI, V55, P1572, DOI 10.1167/iovs.13-13668; Reissner KJ, 2006, J BIOL CHEM, V281, P8389, DOI 10.1074/jbc.M510716200; Vitali R, 2004, BEHAV BRAIN RES, V153, P129, DOI 10.1016/j.bbr.2003.11.007; Yamamoto A, 1998, J NEUROSCI, V18, P2063; Zhu JX, 2006, J BIOL CHEM, V281, P33802, DOI 10.1074/jbc.M606958200	31	4	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3656	3665		10.1074/jbc.M116.765222	http://dx.doi.org/10.1074/jbc.M116.765222			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28100787	Green Published, hybrid			2022-12-26	WOS:000395542500010
J	Shi, LQ; Vasseur, L; Huang, HS; Zeng, ZH; Hu, GP; Liu, X; You, MS				Shi, Longqing; Vasseur, Liette; Huang, Huoshui; Zeng, Zhaohua; Hu, Guiping; Liu, Xin; You, Minsheng			Adult Tea Green Leafhoppers, Empoasca onukii (Matsuda), Change Behaviors under Varying Light Conditions	PLOS ONE			English	Article							GRAMINELLA-NIGRIFRONS; HEMIPTERA CICADELLIDAE; ACOUSTIC COMMUNICATION; INSECT PHOTOPERIODISM; POPULATION-DYNAMICS; CIRCADIAN-RHYTHMS; SEXUAL-DIMORPHISM; COLOR-VISION; DROSOPHILA; HOMOPTERA	Insect behaviors are often influenced by light conditions including photoperiod, light intensity, and wavelength. Understanding pest insect responses to changing light conditions may help with developing alternative strategies for pest control. Little is known about the behavioral responses of leafhoppers (Hemiptera: Cicadellidae) to light conditions. The behavior of the tea green leafhopper, Empoasca onukii Matsuda, was examined when exposed to different light photoperiods or wavelengths. Observations included the frequency of locomotion and cleaning activities, and the duration of time spent searching. The results suggested that under normal photoperiod both female and male adults were generally more active in darkness (i.e., at night) than in light. In continuous darkness (DD), the locomotion and cleaning events in Period 1 (7:00-19:00) were significantly increased, when compared to the leafhoppers under normal photoperiod (LD). Leafhoppers, especially females, changed their behavioral patterns to a two day cycle under DD. Under continuous illumination (continuous quartz lamp light, yellow light at night, and green light at night), the activities of locomotion, cleaning, and searching were significantly suppressed during the night (19:00-7:00) and locomotion activities of both females and males were significantly increased during the day (7:00-19:00), suggesting a shift in circadian rhythm. Our work suggests that changes in light conditions, including photoperiod and wavelength, can influence behavioral activities of leafhoppers, potentially affecting other life history traits such as reproduction and development, and may serve as a method for leafhopper behavioral control.	[Shi, Longqing; Vasseur, Liette; Zeng, Zhaohua; Liu, Xin; You, Minsheng] Fujian Agr & Forestry Univ, Inst Appl Ecol, Fuzhou, Peoples R China; [Shi, Longqing; Vasseur, Liette; Zeng, Zhaohua; Liu, Xin; You, Minsheng] Fujian Agr & Forestry Univ, Res Ctr Biodivers & Ecosafety, Fuzhou, Peoples R China; [Shi, Longqing; Vasseur, Liette; Liu, Xin; You, Minsheng] Fujian Agr & Forestry Univ, Fujian Taiwan Joint Innovat Ctr Ecol Control Crop, Fuzhou, Peoples R China; [Shi, Longqing; Vasseur, Liette; Liu, Xin; You, Minsheng] China Minist Agr, Key Lab Integrated Pest Management Fujian & Taiwa, Fuzhou, Peoples R China; [Vasseur, Liette] Brock Univ, Dept Biol Sci, 1812 Sir Isaac Brock Way, St Catharines, ON L25 3A1, Canada; [Huang, Huoshui] Quanzhou Entry Exit Inspect & Quarantine Bur Peop, Quanzhou, Peoples R China; [Zeng, Zhaohua] Fujian Acad Agr Sci, Inst Plant Protect, Fuzhou, Peoples R China; [Hu, Guiping] Jiangxi Serculture & Tea Res Inst, Nanchang, Jiangxi, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Ministry of Agriculture & Rural Affairs; Brock University; Fujian Academy of Agricultural Sciences	You, MS (corresponding author), Fujian Agr & Forestry Univ, Inst Appl Ecol, Fuzhou, Peoples R China.; You, MS (corresponding author), Fujian Agr & Forestry Univ, Res Ctr Biodivers & Ecosafety, Fuzhou, Peoples R China.; You, MS (corresponding author), Fujian Agr & Forestry Univ, Fujian Taiwan Joint Innovat Ctr Ecol Control Crop, Fuzhou, Peoples R China.; You, MS (corresponding author), China Minist Agr, Key Lab Integrated Pest Management Fujian & Taiwa, Fuzhou, Peoples R China.	msyou@iae.fjau.edu.cn			Ministry of Science & Technology in China; Fujian Agriculture and Forestry University [2010DFB33030]; Tea Research Institute of Sri Lanka [2010DFB33030]; Ministry of Agriculture in China [2011 - Z26]; Fujian Provincial Department of Science and Technology [201610018]	Ministry of Science & Technology in China; Fujian Agriculture and Forestry University; Tea Research Institute of Sri Lanka; Ministry of Agriculture in China(Ministry of Agriculture & Rural Affairs); Fujian Provincial Department of Science and Technology	Funded by the Ministry of Science & Technology in China with a program on International Cooperation between Fujian Agriculture and Forestry University and Tea Research Institute of Sri Lanka (No. 2010DFB33030), http://www.most.gov.cn/ (MY), by the Ministry of Agriculture in China with a project on (No. 2011 - Z26), http://www.moa.gov.cn/ (MY), and the Fujian Provincial Department of Science and Technology (No. 201610018), http://www.fjkjt.gov.cn/ (HH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADKISSON PL, 1964, AM NAT, V98, P357, DOI 10.1086/282332; Arikawa K, 2005, J NEUROSCI, V25, P5935, DOI 10.1523/JNEUROSCI.1364-05.2005; BARTLETT BR, 1968, J ECON ENTOMOL, V61, P297, DOI 10.1093/jee/61.1.297; Beck S.D., 1980, INSECT PHOTOPERIODIS, DOI 10.1016/b978-0-120-84380-0.x5001-7; BERNARD GD, 1991, P NATL ACAD SCI USA, V88, P2783, DOI 10.1073/pnas.88.7.2783; Bloch G, 2013, J INSECT PHYSIOL, V59, P56, DOI 10.1016/j.jinsphys.2012.10.012; Boll S, 2004, J PEST SCI, V77, P33, DOI 10.1007/s10340-003-0025-2; Bonsignori G, 2013, J EXP BIOL, V216, P1270, DOI 10.1242/jeb.076083; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Chaplin-Kramer R, 2011, ECOL LETT, V14, P922, DOI 10.1111/j.1461-0248.2011.01642.x; COOMBE PE, 1981, J COMP PHYSIOL, V144, P83, DOI 10.1007/BF00612801; De J, 2013, P NATL ACAD SCI USA, V110, P8984, DOI 10.1073/pnas.1220960110; Diaz-Fleischer F, 2011, ENTOMOL EXP APPL, V141, P52, DOI 10.1111/j.1570-7458.2011.01168.x; Dietrich CH, 2005, FLA ENTOMOL, V88, P502, DOI 10.1653/0015-4040(2005)88[502:KTTFOC]2.0.CO;2; ENDLER JA, 1987, ANIM BEHAV, V35, P1376, DOI 10.1016/S0003-3472(87)80010-6; Grandin LD, 2006, CLIN PSYCHOL REV, V26, P679, DOI 10.1016/j.cpr.2006.07.001; GROSSFIELD J, 1971, P NATL ACAD SCI USA, V68, P2669, DOI 10.1073/pnas.68.11.2669; Harker J.E., 1973, P189; HEONG KL, 1992, CROP PROT, V11, P371, DOI 10.1016/0261-2194(92)90066-E; Hibrant M, 2014, BMC EVOL BIOL, V14, P1; Hunt RE, 2001, AM ZOOL, V41, P1222, DOI 10.1668/0003-1569(2001)041[1222:ROCITV]2.0.CO;2; HUNT RE, 1991, BEHAV ECOL SOCIOBIOL, V28, P315, DOI 10.1007/BF00164380; KONOPKA RJ, 1989, J NEUROGENET, V6, P1, DOI 10.3109/01677068909107096; Lessio F, 2009, B ENTOMOL RES, V99, P377, DOI 10.1017/S0007485308006457; LOPES JRS, 1995, ANN ENTOMOL SOC AM, V88, P227, DOI 10.1093/aesa/88.2.227; Merckx T, 2014, INSECT CONSERV DIVER, V7, P453, DOI 10.1111/icad.12068; Muraleedharan N., 1997, Journal of Plantation Crops, V25, P15; Omkar, 2005, EUR J ENTOMOL, V102, P33; PAYNE R, 1981, NATURE, V290, P415, DOI 10.1038/290415a0; Qin DZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139202; Rai A. K., 2002, Annals of Plant Protection Sciences, V10, P17; Rakitov RA, 2004, ZOOL J LINN SOC-LOND, V140, P353, DOI 10.1111/j.1096-3642.2003.00103.x; Rakitov RA, 2000, TISSUE CELL, V32, P28, DOI 10.1054/tice.1999.0084; Reilly SM, 2007, ZOOLOGY, V110, P271, DOI 10.1016/j.zool.2007.01.003; Saeed R, 2015, J PEST SCI, V88, P517, DOI 10.1007/s10340-014-0638-7; Saunders DS, 2011, J INSECT PHYSIOL, V57, P557, DOI 10.1016/j.jinsphys.2011.01.013; Saunders D. S., 1997, Invertebrate Neuroscience, V3, P155, DOI 10.1007/BF02480370; Saunders DS, 2012, PHYSIOL ENTOMOL, V37, P207, DOI 10.1111/j.1365-3032.2012.00837.x; Saunders DS, 2008, EUR J ENTOMOL, V105, P585, DOI 10.14411/eje.2008.078; SAXENA KN, 1980, EXPERIENTIA, V36, P933, DOI 10.1007/BF01953800; Shi LQ, 2015, J ECON ENTOMOL, V108, P1025, DOI 10.1093/jee/tov054; Shimoda M, 2013, APPL ENTOMOL ZOOL, V48, P413, DOI 10.1007/s13355-013-0219-x; Stanewsky R, 2002, CELL TISSUE RES, V309, P11, DOI 10.1007/s00441-002-0569-0; Tang Z.Y., 2010, J ANHUI AGR SCI, V38, P3523; TODD JL, 1990, J INSECT BEHAV, V3, P567, DOI 10.1007/BF01052019; Tomioka K, 2012, J COMP PHYSIOL B, V182, P729, DOI 10.1007/s00360-012-0651-1; van Geffen KG, 2014, ECOL EVOL, V4, P2082, DOI 10.1002/ece3.1090; Vanin S, 2012, NATURE, V484, P371, DOI 10.1038/nature10991; [施龙清 Shi Longqing], 2014, [福建农林大学学报. 自然科学版, Journal of Fujian Agriculture and Forestry University. Natural Science Edition], V43, P456; WALLIS RL, 1962, J ECON ENTOMOL, V55, P871, DOI 10.1093/jee/55.6.871; Wang S, 2013, BIOCONTROL, V58, P667, DOI 10.1007/s10526-013-9522-2; Wang S, 2014, EUR J ENTOMOL, V111, P341, DOI 10.14411/eje.2014.053; Wernet MF, 2015, TRENDS GENET, V31, P316, DOI 10.1016/j.tig.2015.04.006; Whittaker MS, 2004, ENTOMOL EXP APPL, V111, P209, DOI 10.1111/j.0013-8703.2004.00167.x; Zhang W., 1997, J ANHUI AGR U, V24, P332	55	11	13	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0168439	10.1371/journal.pone.0168439	http://dx.doi.org/10.1371/journal.pone.0168439			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103237	Green Published, gold, Green Submitted			2022-12-26	WOS:000392381100002
J	Das, D; Samanta, D; Bhattacharya, A; Basu, A; Das, A; Ghosh, J; Chakrabarti, A; Das Gupta, C				Das, Debasis; Samanta, Dibyendu; Bhattacharya, Arpita; Basu, Arunima; Das, Anindita; Ghosh, Jaydip; Chakrabarti, Abhijit; Das Gupta, Chanchal			A Possible Role of the Full-Length Nascent Protein in Post-Translational Ribosome Recycling	PLOS ONE			English	Article							ESCHERICHIA-COLI RIBOSOME; ELONGATION-FACTOR-G; IN-VITRO; TRANSFER-RNA; EF-G; LACTATE-DEHYDROGENASE; POLYPEPTIDE-CHAINS; 50S SUBUNIT; DOMAIN-V; PEPTIDE	Each cycle of translation initiation in bacterial cell requires free 50S and 30S ribosomal sub-units originating from the post-translational dissociation of 70S ribosome from the previous cycle. Literature shows stable dissociation of 70S from model post-termination complexes by the concerted action of Ribosome Recycling Factor (RRF) and Elongation Factor G (EF-G) that interact with the rRNA bridge B2a/B2b joining 50S to 30S. In such experimental models, the role of full-length nascent protein was never considered seriously. We observed relatively slow release of full-length nascent protein from 50Sof post translation ribosome, and in that process, its toe prints on the rRNA in vivo and in in vitro translation with E.coli S30 extract. We reported earlier that a number of chemically unfolded proteins like bovine carbonic anhydrase (BCA), lactate dehydrogenase (LDH), malate dehydrogenase (MDH), lysozyme, ovalbumin etc., when added to free 70Sin lieu of the full length nascent proteins, also interact with identical RNA regions of the 23S rRNA. Interestingly the rRNA nucleotides that slow down release of the C-terminus of full-length unfolded protein were found in close proximity to the B2a/B2b bridge. It indicated a potentially important chemical reaction conserved throughout the evolution. Here we set out to probe that conserved role of unfolded protein conformation in splitting the free or post-termination 70S. How both the RRF-EFG dependent and the plausible nascent protein EFG dependent ribosome recycling pathways might be relevant in bacteria is discussed here.	[Das, Debasis; Samanta, Dibyendu; Bhattacharya, Arpita; Basu, Arunima; Das, Anindita; Das Gupta, Chanchal] Univ Calcutta, Univ Coll Sci, Dept Biophys Mol Biol & Bioinformat, Kolkata, India; [Basu, Arunima] Raidighi Coll, Dept Microbiol, 24 Parganas S, Raidighi, W Bengal, India; [Ghosh, Jaydip] St Xaviers Coll, Dept Microbiol, Kolkata, India; [Chakrabarti, Abhijit] HBNI, Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, India; [Das Gupta, Chanchal] Jadavpur Univ, Dept Life Sci & Biotechnol, Kolkata, India	University of Calcutta; St. Xavier's College Kolkata; Homi Bhabha National Institute; Saha Institute of Nuclear Physics; Jadavpur University	Das Gupta, C (corresponding author), Univ Calcutta, Univ Coll Sci, Dept Biophys Mol Biol & Bioinformat, Kolkata, India.; Das Gupta, C (corresponding author), Jadavpur Univ, Dept Life Sci & Biotechnol, Kolkata, India.	chanchaldg2000@yahoo.com		Bhattacharya, Arpita/0000-0002-0252-1550	Department of Science and Technology [SR/SO/BB-26/2004]; Council of Scientific and Industrial Research Grant CSIR from the Government of India [(1213)/04/EMR-II]	Department of Science and Technology(Department of Science & Technology (India)); Council of Scientific and Industrial Research Grant CSIR from the Government of India	This work was supported in part by Department of Science and Technology Grant SR/SO/BB-26/2004 and Council of Scientific and Industrial Research Grant CSIR (1213)/04/EMR-II from the Government of India. DD is a UGC (University Grants Commission) Research Fellow. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal RK, 2004, P NATL ACAD SCI USA, V101, P8900, DOI 10.1073/pnas.0401904101; BADCOE IG, 1991, BIOCHEMISTRY-US, V30, P9195, DOI 10.1021/bi00102a010; Barat C, 2007, MOL CELL, V27, P250, DOI 10.1016/j.molcel.2007.06.005; Basu A, 2008, BIOCHEM BIOPH RES CO, V366, P598, DOI 10.1016/j.bbrc.2007.11.143; Basu A, 2008, BIOCHEM BIOPH RES CO, V366, P592, DOI 10.1016/j.bbrc.2007.11.142; Bhattacharyya M, 2004, J BIOL CHEM, V279, P55080, DOI 10.1074/jbc.M406418200; Bhushan S, 2010, NAT STRUCT MOL BIOL, V17, P313, DOI 10.1038/nsmb.1756; Bjornsson A, 1996, EMBO J, V15, P1696, DOI 10.1002/j.1460-2075.1996.tb00515.x; Borg A, 2016, RNA, V22, P10, DOI 10.1261/rna.053157.115; CABRER B, 1972, P NATL ACAD SCI USA, V69, P733, DOI 10.1073/pnas.69.3.733; Chattopadhyay S, 1999, BBA-PROTEIN STRUCT M, V1429, P293, DOI 10.1016/S0167-4838(98)00179-4; CHATTOPADHYAY S, 1994, BIOCHEM J, V300, P717, DOI 10.1042/bj3000717; CHEN RF, 1965, SCIENCE, V147, P729, DOI 10.1126/science.147.3659.729; Chowdhury S, 2002, NUCLEIC ACIDS RES, V30, P1278, DOI 10.1093/nar/30.5.1278; Cornish PV, 2008, MOL CELL, V30, P578, DOI 10.1016/j.molcel.2008.05.004; Dallas A, 2001, MOL CELL, V8, P855, DOI 10.1016/S1097-2765(01)00356-2; DAS B, 1992, BIOCHEM BIOPH RES CO, V183, P774, DOI 10.1016/0006-291X(92)90550-5; Das B, 1996, EUR J BIOCHEM, V235, P613, DOI 10.1111/j.1432-1033.1996.00613.x; Das D, 2012, J BIOL CHEM, V287, P37508, DOI 10.1074/jbc.M112.396127; de Crouy-Chanel A, 1999, GENE, V230, P163, DOI 10.1016/S0378-1119(99)00083-9; Fox GE, 2012, ASTROBIOLOGY, V12, P57, DOI 10.1089/ast.2011.0692; Fujiwara T, 2004, MOL MICROBIOL, V53, P517, DOI 10.1111/j.1365-2958.2004.04156.x; Guydosh NR, 2014, CELL, V156, P950, DOI 10.1016/j.cell.2014.02.006; Hanson CL, 2003, J BIOL CHEM, V278, P1259, DOI 10.1074/jbc.M208966200; Harms JM, 2003, J CELL SCI, V116, P1391, DOI 10.1242/jcs.00365; HAUGLAND RP, 1995, BIOTECH HISTOCHEM, V70, P243, DOI 10.3109/10520299509108201; Hirokawa G, 2005, RNA, V11, P1317, DOI 10.1261/rna.2520405; Janosi L, 1998, EMBO J, V17, P1141, DOI 10.1093/emboj/17.4.1141; JANOSI L, 1994, P NATL ACAD SCI USA, V91, P4249, DOI 10.1073/pnas.91.10.4249; Janssen BD, 2009, J MOL BIOL, V394, P251, DOI 10.1016/j.jmb.2009.09.020; Joseph S, 1996, EMBO J, V15, P910, DOI 10.1002/j.1460-2075.1996.tb00425.x; Kuroha K, 2009, GENES CELLS, V14, P739, DOI 10.1111/j.1365-2443.2009.01304.x; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; LOCKWOOD AH, 1974, J BIOL CHEM, V249, P346; Madore E, 1999, EUR J BIOCHEM, V266, P1128, DOI 10.1046/j.1432-1327.1999.00965.x; Mankin AS, 2006, TRENDS BIOCHEM SCI, V31, P11, DOI 10.1016/j.tibs.2005.11.007; Peske F, 2005, MOL CELL, V18, P403, DOI 10.1016/j.molcel.2005.04.009; Raine A, 2006, J BIOL CHEM, V281, P28033, DOI 10.1074/jbc.M605753200; Rao AR, 2001, EMBO J, V20, P2977, DOI 10.1093/emboj/20.11.2977; Samanta D, 2008, J BACTERIOL, V190, P3344, DOI 10.1128/JB.01800-07; Singh NS, 2008, J MOL BIOL, V380, P451, DOI 10.1016/j.jmb.2008.05.033; Szaflarski W, 2008, J MOL BIOL, V380, P193, DOI 10.1016/j.jmb.2008.04.060; Vazquez-Laslop N, 2011, P NATL ACAD SCI USA, V108, P5931, DOI 10.1073/pnas.1103011108; Zaher HS, 2009, NATURE, V457, P161, DOI 10.1038/nature07582; Zavialov A. V., 2005, J BIOL-LONDON, V4, P9; Zavialov AV, 2005, MOL CELL, V18, P675, DOI 10.1016/j.molcel.2005.05.016; Zhang DJ, 2015, NUCLEIC ACIDS RES, V43, P10525, DOI 10.1093/nar/gkv995; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554	48	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170333	10.1371/journal.pone.0170333	http://dx.doi.org/10.1371/journal.pone.0170333			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099529	Green Submitted, Green Published, gold			2022-12-26	WOS:000392380100075
J	MacPherson, CW; Shastri, P; Mathieu, O; Tompkins, TA; Burguiere, P				MacPherson, Chad W.; Shastri, Padmaja; Mathieu, Olivier; Tompkins, Thomas A.; Burguiere, Pierre			Genome-Wide Immune Modulation of TLR3-Mediated Inflammation in Intestinal Epithelial Cells Differs between Single and Multi-Strain Probiotic Combination	PLOS ONE			English	Article							S-LAYER PROTEIN; LACTOBACILLUS-RHAMNOSUS; ESCHERICHIA-COLI; GENE-EXPRESSION; RESPONSES; GUT; INHIBITION; ACTIVATION; BIFIDOBACTERIA; MECHANISMS	Genome-wide transcriptional analysis in intestinal epithelial cells (IEC) can aid in elucidating the impact of single versus multi-strain probiotic combinations on immunological and cellular mechanisms of action. In this study we used human expression microarray chips in an in vitro intestinal epithelial cell model to investigate the impact of three probiotic bacteria, Lactobacillus helveticus R0052 (Lh-R0052), Bifidobacterium longum subsp. infantis R0033 (BI-R0033) and Bifidobacterium bifidum R0071 (Bb-R0071) individually and in combination, and of a surface-layer protein (SLP) purified from Lh-R0052, on HT-29 cells' transcriptional profile to poly(I:C)-induced inflammation. Hierarchical heat map clustering, Set Distiller and String analyses revealed that the effects of Lh-R0052 and Bb-R0071 diverged from those of BI-R0033 and Lh-R0052-SLP. It was evident from the global analyses with respect to the immune, cellular and homeostasis related pathways that the co-challenge with probiotic combination (PC) vastly differed in its effect from the single strains and Lh-R0052-SLP treatments. The multi-strain PC resulted in a greater reduction of modulated genes, found through functional connections between immune and cellular pathways. Cytokine and chemokine analyses based on specific outcomes from the INF-alpha and NF-kappa B signaling pathways revealed single, multi-strain and Lh-R0052-SLP specific attenuation of the majority of proteins measured (TNF-alpha, IL-8, CXCL1, CXCL2 and CXCL10), indicating potentially different mechanisms. These findings indicate a synergistic effect of the bacterial combinations relative to the single strain and Lh-R0052-SLP treatments in resolving toll-like receptor 3 (TLR3)-induced inflammation in IEC and maintaining cellular homeostasis, reinforcing the rationale for using multi-strain formulations as a probiotic.	[MacPherson, Chad W.; Mathieu, Olivier; Tompkins, Thomas A.; Burguiere, Pierre] Lallemand Hlth Solut Inc, 6100 Ave Royalmount, Montreal, PQ, Canada; [Shastri, Padmaja] Univ Ontario Inst Technol, Oshawa, ON, Canada	Ontario Tech University	MacPherson, CW (corresponding author), Lallemand Hlth Solut Inc, 6100 Ave Royalmount, Montreal, PQ, Canada.	cmacpherson@lallemand.com		Tompkins, Thomas A./0000-0002-2990-2265	Lallemand Health Solutions Inc.	Lallemand Health Solutions Inc.	This project was funded in its entirety by Lallemand Health Solutions Inc. The funding organization did not play a role in the study design, data collection and analysis, decision to publish or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials. Moreover, all final research decisions were made by the Research Director of Lallemand Health Solutions Inc., Dr. Thomas Allan Tompkins, one of the author(s) of this manuscript. The funder Lallemand Health Solutions Inc. only provided financial support in the form of authors' salaries and/or research materials.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Ait-Belgnaoui A, 2014, NEUROGASTROENT MOTIL, V26, P510, DOI 10.1111/nmo.12295; Aoki-Yoshida A, 2016, BENEF MICROBES, V7, P421, DOI 10.3920/BM2015.0169; Audy J, 2012, BENEF MICROBES, V3, P273, DOI 10.3920/BM2012.0027; Avall-Jaaskelainen S, 2003, APPL ENVIRON MICROB, V69, P2230, DOI 10.1128/AEM.69.4.2230-2236.2003; Bermudez-Brito M, 2014, BRIT J NUTR, V111, P1727, DOI 10.1017/S0007114513004303; Bermudez-Brito M, 2012, ANN NUTR METAB, V61, P160, DOI 10.1159/000342079; Bonaz BL, 2013, GASTROENTEROLOGY, V144, P36, DOI 10.1053/j.gastro.2012.10.003; Cazzola Mario, 2010, Ther Adv Respir Dis, V4, P259, DOI 10.1177/1753465810379009; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Chapman CMC, 2012, ANAEROBE, V18, P405, DOI 10.1016/j.anaerobe.2012.05.004; Chapman CMC, 2011, EUR J NUTR, V50, P1, DOI 10.1007/s00394-010-0166-z; de Kivit S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00060; Dijkstra Gerard, 2004, Curr Opin Investig Drugs, V5, P529; Dinan TG, 2013, BIOL PSYCHIAT, V74, P720, DOI 10.1016/j.biopsych.2013.05.001; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gomez-Llorente C, 2010, P NUTR SOC, V69, P381, DOI 10.1017/S0029665110001527; Ho NK, 2013, BENEF MICROBES, V4, P195, DOI 10.3920/BM2012.0038; Johnson-Henry KC, 2007, CELL MICROBIOL, V9, P356, DOI 10.1111/j.1462-5822.2006.00791.x; Kahala M, 1997, J BACTERIOL, V179, P284, DOI 10.1128/jb.179.1.284-286.1997; Kandasamy S, 2014, GUT MICROBES, V5, P639, DOI 10.4161/19490976.2014.969972; Konieczna P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120261; Latorre E, 2014, CELL STRESS CHAPERON, V19, P289, DOI 10.1007/s12192-013-0461-8; Liu MC, 2016, INFLAMMATION, V39, P1483, DOI 10.1007/s10753-016-0382-7; Liu QS, 2015, EARTH PLANETS SPACE, V67, P1, DOI 10.1186/s40623-015-0237-8; MacPherson C, 2014, APPL ENVIRON MICROB, V80, P1692, DOI 10.1128/AEM.03411-13; Miettinen M, 2008, J LEUKOCYTE BIOL, V84, P1092, DOI 10.1189/jlb.1206737; Monteleone I, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/297645; Neish AS, 2002, MICROBES INFECT, V4, P309, DOI 10.1016/S1286-4579(02)01543-5; O'Flaherty S, 2012, APPL ENVIRON MICROB, V78, P5028, DOI 10.1128/AEM.00504-12; Park MS, 2007, J MICROBIOL BIOTECHN, V17, P1120; Plaza-Diaz J, 2014, WORLD J GASTROENTERO, V20, P15632, DOI 10.3748/wjg.v20.i42.15632; Presti I, 2015, APPL MICROBIOL BIOTE; Ramirez-Carrozzi V, 2011, NAT IMMUNOL, V12, P1159, DOI 10.1038/ni.2156; Riedel CU, 2006, WORLD J GASTROENTERO, V12, P3729, DOI 10.3748/wjg.v12.i23.3729; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shabgah AG, 2014, POSTEP DERM ALERGOL, V31, P256, DOI 10.5114/pdia.2014.40954; Sherman PM, 2009, NUTR CLIN PRACT, V24, P10, DOI 10.1177/0884533608329231; Stelzer Gil, 2011, Human Genomics, V5, P709; Stelzer G, 2009, OMICS, V13, P477, DOI 10.1089/omi.2009.0069; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tan RST, 2013, IMMUNOL CELL BIOL, V91, P377, DOI 10.1038/icb.2013.13; Taverniti V, 2013, APPL ENVIRON MICROB, V79, P1221, DOI 10.1128/AEM.03056-12; Thaiss CA, 2016, TRENDS IMMUNOL, V37, P84, DOI 10.1016/j.it.2015.12.003; Thomas CM, 2010, GUT MICROBES, V1, P148, DOI 10.4161/gmic.1.3.11712; Tlaskalova-Hogenova H, 2005, SCAND J IMMUNOL, V62, P106, DOI 10.1111/j.1365-3083.2005.01618.x; Uchida H, 2006, RES MICROBIOL, V157, P659, DOI 10.1016/j.resmic.2006.03.001; Wan LY, 2015, CRIT REV FOOD SCI NU, V0; Wells JM, 2011, P NATL ACAD SCI USA, V108, P4607, DOI 10.1073/pnas.1000092107; Yamaguchi Y, 2007, J IMMUNOL, V179, P7128, DOI 10.4049/jimmunol.179.10.7128	50	20	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0169847	10.1371/journal.pone.0169847	http://dx.doi.org/10.1371/journal.pone.0169847			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099447	Green Submitted, gold, Green Published			2022-12-26	WOS:000392380100038
J	Praphasiri, P; Ditsungneon, D; Greenbaum, A; Dawood, FS; Yoocharoen, P; Stone, DM; Olsen, SJ; Lindblade, KA; Muangchana, C				Praphasiri, Prabda; Ditsungneon, Darunee; Greenbaum, Adena; Dawood, Fatimah S.; Yoocharoen, Pornsak; Stone, Deborah M.; Olsen, Sonja J.; Lindblade, Kim A.; Muangchana, Charung			Do Thai Physicians Recommend Seasonal Influenza Vaccines to Pregnant Women? A Cross-Sectional Survey of Physicians' Perspectives and Practices in Thailand	PLOS ONE			English	Article							MATERNAL IMMUNIZATION; ADVISORY-COMMITTEE; VACCINATION; ATTITUDES; PREVENTION; INFECTION; BEHAVIORS; KNOWLEDGE	Background Physicians play a major role in influencing acceptance and uptake of vaccines. However, little is known about physicians' perspectives on influenza vaccination of pregnant women in Thailand, for whom vaccine coverage is estimated at <1%. Method In 2013, a self-administered questionnaire on physicians' perceptions, attitudes and practices related to influenza vaccination for pregnant women was distributed to 1,134 hospitals with an antenatal care clinic (ANC) in Thailand. At each hospital, one physician working at the ANC completed the survey. Predictors of routine recommendation of influenza vaccine were analyzed utilizing log-binomial regression. Results A total of 580 (51%) complete responses were received from physicians practicing at ANCs. A favorable attitude towards vaccination was expressed by 436 (75%) physicians, however only 142 (25%) reported routinely recommending influenza vaccine to pregnant women in their current practice. Physicians were more likely to recommend influenza vaccine routinely when they had more than three years of practice (prevalence ratio [PR] 1.9, 95% CI 1.2-2.3), had treated pregnant women for influenza (PR 1.8, 95% CI 1.3-2.7), perceived the influenza vaccine to be effective (moderate level: PR 1.6, 95% CI 1.1-2.4; high level: PR 1.9, 95% CI 1.3-2.9) and were aware of the Ministry of Public Health's (MOPH) recommendation of influenza vaccination in pregnancy (PR 1.3, 95% CI 1.1-1.7). Vaccine not being available, perception that policy was ambiguous and lack of awareness of MOPH recommendations were the most commonly cited barriers to routine recommendation of influenza vaccine. Conclusion Despite a national policy to vaccinate pregnant women for influenza, only 25% of Thai physicians working in ANCs routinely recommend vaccination. Strategies are needed to increase vaccine availability and free vaccine services, address clinician concerns over vaccine effectiveness and expand healthcare provider awareness of MOPH recommendations.	[Praphasiri, Prabda; Ditsungneon, Darunee; Lindblade, Kim A.] US Ctr Dis Control & Prevent Collaborat, Thailand Minist Publ Hlth, Influenza Program, Nonthaburi, Thailand; [Greenbaum, Adena; Dawood, Fatimah S.; Olsen, Sonja J.; Lindblade, Kim A.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Yoocharoen, Pornsak] Minist Publ Hlth, Dept Dis Control, Nonthaburi, Thailand; [Stone, Deborah M.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Muangchana, Charung] Publ Org, Natl Vaccine Inst, Nonthaburi, Thailand	Ministry of Public Health - Thailand; Centers for Disease Control & Prevention - USA; Ministry of Public Health - Thailand; Centers for Disease Control & Prevention - USA	Praphasiri, P (corresponding author), US Ctr Dis Control & Prevent Collaborat, Thailand Minist Publ Hlth, Influenza Program, Nonthaburi, Thailand.	hpu3@cdc.gov		Lindblade, Kim/0000-0002-5593-0470; Praphasiri, Prabda/0000-0003-4593-0247	Centers for Disease Control and Prevention (CDC) [5U2GGH000618-02]	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This survey was partially supported by the Centers for Disease Control and Prevention (CDC), awarded to the Ministry of Public Health, Thailand in cooperative agreement #5U2GGH000618-02, and received by CM of National Vaccine Institute. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; Arao RF, 2015, MATERN CHILD HLTH J, V19, P783, DOI 10.1007/s10995-014-1569-x; Blanchard-Rohner G, 2012, J MATERN-FETAL NEO M, V25, P1800, DOI 10.3109/14767058.2012.663835; Callaghan WM, 2010, OBSTET GYNECOL, V115, P919, DOI 10.1097/AOG.0b013e3181d99d85; Ditsungnoen D, 2016, VACCINE, V34, P2141, DOI 10.1016/j.vaccine.2016.01.056; Dodds L, 2007, CAN MED ASSOC J, V176, P463, DOI 10.1503/cmaj.061435; Eick AA, 2011, ARCH PEDIAT ADOL MED, V165, P104, DOI 10.1001/archpediatrics.2010.192; ENGLUND JA, 1993, J INFECT DIS, V168, P647, DOI 10.1093/infdis/168.3.647; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Lau JTF, 2010, VACCINE, V28, P5389, DOI 10.1016/j.vaccine.2010.05.071; McNeil SA, 2011, AM J OBSTET GYNECOL, V204, pS54, DOI 10.1016/j.ajog.2011.04.031; Muangchana C, 2010, VACCINE, V28, pA104, DOI 10.1016/j.vaccine.2010.02.043; Naleway AL, 2006, EPIDEMIOL REV, V28, P47, DOI 10.1093/epirev/mxj002; Naleway AL, 2014, VACCINE, V32, P3122, DOI 10.1016/j.vaccine.2014.04.021; Owusu JT, 2015, VACCINE, V33, P742, DOI 10.1016/j.vaccine.2014.10.029; Panda B, 2011, J MATERN-FETAL NEO M, V24, P402, DOI 10.3109/14767058.2010.497882; Pierce M, 2011, BMJ-BRIT MED J, V14, P342; Power ML, 2009, AM J PREV MED, V37, P231, DOI 10.1016/j.amepre.2009.05.019; Rasmussen SA, 2012, AM J OBSTET GYNECOL, V207, pS3, DOI 10.1016/j.ajog.2012.06.068; Schrag SJ, 2003, OBSTET GYNECOL, V101, P704, DOI 10.1016/S0029-7844(03)00010-3; Shavell VI, 2012, AM J OBSTET GYNECOL, V207, pS67, DOI 10.1016/j.ajog.2012.06.077; Silverman NS, 2001, J REPROD MED, V46, P989; SteelFisher GK, 2011, AM J OBSTET GYNECOL, V204, pS116, DOI 10.1016/j.ajog.2011.02.036; Tong A, 2008, J OBSTET GYNAECOL CA, V30, P404, DOI 10.1016/S1701-2163(16)32825-0; Yuen CYS, 2014, J PERINAT NEONAT NUR, V28, P261, DOI 10.1097/JPN.0000000000000068; Yuen CYS, 2014, VACCINE, V32, P4602, DOI 10.1016/j.vaccine.2014.06.067; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	27	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0169221	10.1371/journal.pone.0169221	http://dx.doi.org/10.1371/journal.pone.0169221			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099486	Green Published, Green Submitted, gold			2022-12-26	WOS:000392380100015
J	Wood, KC; Town, SM; Atilgan, H; Jones, GP; Bizley, JK				Wood, Katherine C.; Town, Stephen M.; Atilgan, Huriye; Jones, Gareth P.; Bizley, Jennifer K.			Acute Inactivation of Primary Auditory Cortex Causes a Sound Localisation Deficit in Ferrets	PLOS ONE			English	Article							UNILATERAL ABLATION; REVERSIBLE DEACTIVATION; COOLING DEACTIVATION; INFERIOR COLLICULUS; SPECTRAL CUES; LESIONS; CAT; DISCRIMINATION; RESPONSES; AREAS	The objective of this study was to demonstrate the efficacy of acute inactivation of brain areas by cooling in the behaving ferret and to demonstrate that cooling auditory cortex produced a localisation deficit that was specific to auditory stimuli. The effect of cooling on neural activity was measured in anesthetized ferret cortex. The behavioural effect of cooling was determined in a benchmark sound localisation task in which inactivation of primary auditory cortex (Al) is known to impair performance. Cooling strongly suppressed the spontaneous and stimulus evoked firing rates of cortical neurons when the cooling loop was held at temperatures below 10 degrees C, and this suppression was reversed when the cortical temperature recovered. Cooling of ferret auditory cortex during behavioural testing impaired sound localisation performance, with unilateral cooling producing selective deficits in the hemifield contralateral to cooling, and bilateral cooling producing deficits on both sides of space. The deficit in sound localisation induced by inactivation of Al was not caused by motivational or locomotor changes since inactivation of Al did not affect localisation of visual stimuli in the same context.	[Wood, Katherine C.; Town, Stephen M.; Atilgan, Huriye; Jones, Gareth P.; Bizley, Jennifer K.] UCL, Ear Inst, London, England; [Wood, Katherine C.] Univ Penn, Dept Otorhinolaryngol, Philadelphia, PA 19104 USA	University of London; University College London; University of Pennsylvania	Wood, KC; Bizley, JK (corresponding author), UCL, Ear Inst, London, England.; Wood, KC (corresponding author), Univ Penn, Dept Otorhinolaryngol, Philadelphia, PA 19104 USA.	woodkath@mail.med.upenn.edu; j.bizley@ucl.ac.uk	Wood, Katherine/K-6728-2019	Wood, Katherine/0000-0002-5520-5025; Atilgan, Huriye/0000-0001-8582-4815; Bizley, Jennifer/0000-0001-6605-2362; Town, Stephen/0000-0003-1375-7769	UCL Grand Challenges studentship; Biotechnology and Biological Sciences Research Council [BB/H016813/1]; Royal Society Dorothy Hodgkin Fellowship [DH090058]; Royal Society / Wellcome Trust Sir Henry Dale Fellowship [WT098418MA]; BBSRC [BB/H016813/1, BB/H016813/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H016813/2] Funding Source: researchfish; Wellcome Trust [098418/Z/12/Z] Funding Source: researchfish	UCL Grand Challenges studentship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society Dorothy Hodgkin Fellowship(Royal Society of London); Royal Society / Wellcome Trust Sir Henry Dale Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a UCL Grand Challenges studentship to KCW, Biotechnology and Biological Sciences Research Council grant to JKB (BB/H016813/1), a Royal Society Dorothy Hodgkin Fellowship to JKB (DH090058) and a Royal Society / Wellcome Trust Sir Henry Dale Fellowship to JKB (WT098418MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes FM, 2011, J NEUROSCI, V31, P17306, DOI 10.1523/JNEUROSCI.1915-11.2011; Bajo VM, 2007, CEREB CORTEX, V17, P475, DOI 10.1093/cercor/bhj164; Coomber B, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00053; Bizley JK, 2015, J COMP NEUROL, V523, P2187, DOI 10.1002/cne.23784; Diester I, 2011, NAT NEUROSCI, V14, P387, DOI 10.1038/nn.2749; Grothe B, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00116; HEFFNER H, 1978, J NEUROPHYSIOL, V41, P963, DOI 10.1152/jn.1978.41.4.963; HEFFNER HE, 1990, J NEUROPHYSIOL, V64, P915, DOI 10.1152/jn.1990.64.3.915; Iurilli G, 2012, NEURON, V73, P814, DOI 10.1016/j.neuron.2011.12.026; JENKINS WM, 1984, J NEUROPHYSIOL, V52, P819, DOI 10.1152/jn.1984.52.5.819; JENKINS WM, 1982, J NEUROPHYSIOL, V47, P987, DOI 10.1152/jn.1982.47.6.987; KAVANAGH GL, 1987, J NEUROPHYSIOL, V57, P1746, DOI 10.1152/jn.1987.57.6.1746; Lomber S, 1999, J NEUROSCI METHODS; LOMBER SG, 1994, P NATL ACAD SCI USA, V91, P2999, DOI 10.1073/pnas.91.8.2999; Lomber SG, 2007, J NEUROPHYSIOL, V97, P979, DOI 10.1152/jn.00767.2006; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; Malhotra S, 2004, J NEUROPHYSIOL, V92, P1625, DOI 10.1152/jn.01205.2003; Malhotra S, 2008, J NEUROPHYSIOL, V99, P1628, DOI 10.1152/jn.01228.2007; Malhotra S, 2007, J NEUROPHYSIOL, V97, P26, DOI 10.1152/jn.00720.2006; Manger PR, 2004, CEREB CORTEX, V14, P676, DOI 10.1093/cercor/bhh028; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; Nakamoto KT, 2010, J NEUROPHYSIOL, V103, P2050, DOI 10.1152/jn.00451.2009; NEFF WD, 1977, J NEUROPHYSIOL, V40, P44, DOI 10.1152/jn.1977.40.1.44; Nodal FR, 2012, J PHYSIOL-LONDON, V590, P3965, DOI 10.1113/jphysiol.2011.222828; Nodal FR, 2010, J NEUROPHYSIOL, V103, P1209, DOI 10.1152/jn.00991.2009; Orton LD, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00100; Parsons CH, 1999, J NEUROPHYSIOL, V82, P2294, DOI 10.1152/jn.1999.82.5.2294; Pettersen KH, 2006, J NEUROSCI METH, V154, P116, DOI 10.1016/j.jneumeth.2005.12.005; Plakke B, 2015, J NEUROSCI, V35, P9666, DOI 10.1523/JNEUROSCI.1218-15.2015; Roth BL, 2016, NEURON, V89, P683, DOI 10.1016/j.neuron.2016.01.040; Smith AW, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00075; THOMPSON GC, 1983, BEHAV BRAIN RES, V8, P211, DOI 10.1016/0166-4328(83)90055-4; Town SM, 2015, J ACOUST SOC AM, V137, P2870, DOI 10.1121/1.4916690; WHITFIELD IC, 1972, J NEUROPHYSIOL, V35, P718, DOI 10.1152/jn.1972.35.5.718; Xu M, 2014, P NATL ACAD SCI USA, V111, P480, DOI 10.1073/pnas.1321314111; ZHOU B, 1992, J ACOUST SOC AM, V92, P1169, DOI 10.1121/1.404045	36	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170264	10.1371/journal.pone.0170264	http://dx.doi.org/10.1371/journal.pone.0170264			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099489	Green Published, Green Submitted, gold			2022-12-26	WOS:000392380100066
J	Vuong, HB; Chiu, GS; Smouse, PE; Fonseca, DM; Brisson, D; Morin, PJ; Ostfeld, RS				Vuong, Holly B.; Chiu, Grace S.; Smouse, Peter E.; Fonseca, Dina M.; Brisson, Dustin; Morin, Peter J.; Ostfeld, Richard S.			Influences of Host Community Characteristics on Borrelia burgdorferi Infection Prevalence in Blacklegged Ticks	PLOS ONE			English	Article							LYME-DISEASE; GENETIC DIVERSITY; OSPC; GENOTYPE; ECOLOGY; RISK; EPIZOOTIOLOGY; BIODIVERSITY; POPULATION; RESERVOIRS	Lyme disease is a major vector-borne bacterial disease in the USA. The disease is caused by Borrelia burgdorferi, and transmitted among hosts and humans, primarily by blacklegged ticks (Ixodes scapularis). The similar to 25 B. burgdorferi genotypes, based on genotypic variation of their outer surface protein C (ospC), can be phenotypically separated as strains that primarily cause human diseases human invasive strains (HIS) or those that rarely do. Additionally, the genotypes are non-randomly associated with host species. The goal of this study was to examine the extent to which phenotypic outcomes of B. burgdorferi could be explained by the host communities fed upon by blacklegged ticks. In 2006 and 2009, we determined the host community composition based on abundance estimates of the vertebrate hosts, and collected host-seeking nymphal ticks in 2007 and 2010 to determine the ospC genotypes within infected ticks. We regressed instances of B. burgdorferi phenotypes on site-specific characteristics of host communities by constructing Bayesian hierarchical models that properly handled missing data. The models provided quantitative support for the relevance of host composition on Lyme disease risk pertaining to B. burgdorferi prevalence (i.e. overall nymphal infection prevalence, or NIPAH) and HIS prevalence among the infected ticks (NIPHIS). In each year, NIPAH and NIPHIS was found to be associated with host relative abundances and diversity. For mice and chipmunks, the association with NIPAH was positive, but tended to be negative with NIPHIS in both years. However, the direction of association between shrew relative abundance with NIPHIS or NIPHIS differed across the two years. And, diversity (H) had a negative association with NIPAH, but positive association with NIPHIS in both years. Our analyses highlight that the relationships between the relative abundances of three primary hosts and the community diversity with NIPAII, and NIPHIS, are variable in time and space, and that disease risk inference, based on the role of host community, changes when we examine risk overall or at the phenotypic level. Our discussion focuses on the observed relationships between prevalence and host community characteristics and how they substantiate the ecological understanding of phenotypic Lyme disease risk.	[Vuong, Holly B.; Smouse, Peter E.; Fonseca, Dina M.; Morin, Peter J.] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA; [Vuong, Holly B.; Ostfeld, Richard S.] Cary Inst Ecosyst Studies, 2801 Sharon Turnpike, Millbrook, NY 12545 USA; [Chiu, Grace S.] Australian Natl Univ, Res Sch Finance Actuarial Studies & Stat, Coll Business & Econ, Bldg 26C, Canberra, ACT, Australia; [Fonseca, Dina M.] Rutgers State Univ, Dept Entomol, 180 Jones Ave, New Brunswick, NJ USA; [Brisson, Dustin] Univ Penn, Dept Biol, Leidy Labs 209, Philadelphia, PA 19104 USA; [Vuong, Holly B.] Univ Georgia, Ctr Vaccine & Immunol, Athens, GA 30602 USA	Rutgers State University New Brunswick; Cary Institute of Ecosystem Studies; Australian National University; Rutgers State University New Brunswick; University of Pennsylvania; University System of Georgia; University of Georgia	Vuong, HB (corresponding author), Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA.; Vuong, HB (corresponding author), Cary Inst Ecosyst Studies, 2801 Sharon Turnpike, Millbrook, NY 12545 USA.; Vuong, HB (corresponding author), Univ Georgia, Ctr Vaccine & Immunol, Athens, GA 30602 USA.	hollyvuong.work@gmail.com	Fonseca, Dina/HHS-1320-2022; Fonseca, Dina Madeira/B-9951-2011	Fonseca, Dina Madeira/0000-0003-4726-7100; Ostfeld, Richard/0000-0002-3707-9301	Burroughs Welcome Fund [1012376]; Lyme Research Alliance; Bay Area Lyme Foundation; National Institutes of Health [AI076342, AI097137]; USDA National Institute of Food and Agriculture Hatch project [1005333]; "Evolutionary Diversity & Biogeographic Pattern, Reflecting Ecological & Anthropogenic Forces," through the New Jersey Agricultural Experiment Station, Hatch project [NJ17160]; RSO: Environmental Protection Agency (STAR) [83377601]; National Science Foundation-National Institutes of Health joint program in the Ecology of Infectious Diseases [EF0813035]; Direct For Biological Sciences [1456527] Funding Source: National Science Foundation	Burroughs Welcome Fund(Burroughs Wellcome Fund); Lyme Research Alliance; Bay Area Lyme Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA National Institute of Food and Agriculture Hatch project; "Evolutionary Diversity & Biogeographic Pattern, Reflecting Ecological & Anthropogenic Forces," through the New Jersey Agricultural Experiment Station, Hatch project; RSO: Environmental Protection Agency (STAR); National Science Foundation-National Institutes of Health joint program in the Ecology of Infectious Diseases; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	DB: Burroughs Welcome Fund (1012376) - http://www.bwfund.org, Lyme Research Alliance - http://www.lymeresearchalliance.org, Bay Area Lyme Foundation - http://www.bayarealyme.org, National Institutes of Health (AI076342, AI097137) - https://www.niaid.nih.gov. PES: USDA National Institute of Food and Agriculture Hatch project (accession number 1005333), "Evolutionary Diversity & Biogeographic Pattern, Reflecting Ecological & Anthropogenic Forces," through the New Jersey Agricultural Experiment Station, Hatch project NJ17160, https://nifa.usda.gov/. RSO: Environmental Protection Agency (STAR Grant 83377601) to RSO and F. Keesing and the National Science Foundation-National Institutes of Health joint program in the Ecology of Infectious Diseases (EF0813035) to F. Keesing and RSO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; ANDERSON JF, 1989, REV INFECT DIS, V11, pS1451; Barbour AG, 2010, MBIO, V1, DOI 10.1128/mBio.00153-10; Baum E, 2012, MBIO, V3, DOI 10.1128/mBio.00434-12; Blaser MJ, 2001, J CLIN INVEST, V107, P767, DOI 10.1172/JCI12672; Brisson D, 2004, GENETICS, V168, P713, DOI 10.1534/genetics.104.028738; Brisson D, 2008, P ROY SOC B-BIOL SCI, V275, P227, DOI 10.1098/rspb.2007.1208; Brisson D, 2010, EMERG INFECT DIS, V16, P911, DOI 10.3201/eid1606.090329; Brunner JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066798; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Chambert T, 2014, ECOL EVOL, V4, P1389, DOI 10.1002/ece3.993; Chiu GS, 2014, STAT METHODOL, V17, P139, DOI 10.1016/j.stamet.2013.09.001; Chiu GS, 2011, P NATL ACAD SCI USA, V108, P15881, DOI 10.1073/pnas.1015359108; Chiu GS, 2013, PLOONE PUBLIC LIB, V9; Devevey G, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0381-0; Dykhuizen DE, 2008, AM J TROP MED HYG, V78, P806, DOI 10.4269/ajtmh.2008.78.806; FALCO RC, 1992, EXP APPL ACAROL, V14, P165, DOI 10.1007/BF01219108; Giardina AR, 2000, CAN J ZOOL, V78, P2184, DOI 10.1139/cjz-78-12-2184; Hanincova K, 2006, EMERG INFECT DIS, V12, P604; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Keesing F, 2009, P ROY SOC B-BIOL SCI, V276, P3911, DOI 10.1098/rspb.2009.1159; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; LEVINE JF, 1985, AM J TROP MED HYG, V34, P355, DOI 10.4269/ajtmh.1985.34.355; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Logiudice K, 2008, ECOLOGY, V89, P2841, DOI 10.1890/07-1047.1; MATHER TN, 1989, AM J EPIDEMIOL, V130, P143, DOI 10.1093/oxfordjournals.aje.a115306; Mechai S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149345; Nupp TE, 2000, J MAMMAL, V81, P512, DOI 10.1644/1545-1542(2000)081&lt;0512:LLCOSM&gt;2.0.CO;2; Ostfeld RS, 2006, PLOS BIOL, V4, P1058, DOI 10.1371/journal.pbio.0040145; Ostfeld RS, 2003, ECOLOGY, V84, P1421, DOI 10.1890/02-3125; Ostfeld RS, 1997, AM SCI, V85, P338; Ostfeld RS, 2000, CONSERV BIOL, V14, P722, DOI 10.1046/j.1523-1739.2000.99014.x; Power AG, 2011, VIRUS RES, V159, P95, DOI 10.1016/j.virusres.2011.05.016; Qiu WG, 2002, GENETICS, V160, P833; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; Slajchert T, 1997, J WILDLIFE DIS, V33, P40, DOI 10.7589/0090-3558-33.1.40; Smith I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025275; States SL, 2014, INFECT GENET EVOL, V27, P566, DOI 10.1016/j.meegid.2014.04.014; Streicker DG, 2010, SCIENCE, V329, P676, DOI 10.1126/science.1188836; Strle K, 2011, AM J PATHOL, V178, P2726, DOI 10.1016/j.ajpath.2011.02.018; Suzan G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005461; Thrall PH, 2002, PLANT PATHOL, V51, P169, DOI 10.1046/j.1365-3059.2002.00683.x; Vuong HB, 2014, INFECT GENET EVOL, V27, P594, DOI 10.1016/j.meegid.2013.12.011; Wang IN, 1999, GENETICS, V151, P15; Werden L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085640; White M, 2012, PROGRAM MARK V 6 0; Wolinska J, 2009, TRENDS PARASITOL, V25, P236, DOI 10.1016/j.pt.2009.02.004; Wormser GP, 2008, J INFECT DIS, V198, P1358, DOI 10.1086/592279	50	16	16	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0167810	10.1371/journal.pone.0167810	http://dx.doi.org/10.1371/journal.pone.0167810			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095423	gold, Green Submitted, Green Published			2022-12-26	WOS:000392372300005
J	Arizpe, JM; McKean, DL; Tsao, JW; Chan, AWY				Arizpe, Joseph M.; McKean, Danielle L.; Tsao, Jack W.; Chan, Annie W. -Y.			Where You Look Matters for Body Perception: Preferred Gaze Location Contributes to the Body Inversion Effect	PLOS ONE			English	Article							FACE RECOGNITION; FUSIFORM GYRUS; PERSON RECOGNITION; HEADLESS BODIES; EYE-MOVEMENTS; EXTRASTRIATE; MECHANISMS; PARTS; REPRESENTATIONS; IDENTIFICATION	The Body Inversion Effect (BIE; reduced visual discrimination performance for inverted compared to upright bodies) suggests that bodies are visually processed configurally; however, the specific importance of head posture information in the BIE has been indicated in reports of BIE reduction for whole bodies with fixed head position and for headless bodies. Through measurement of gaze patterns and investigation of the causal relation of fixation location to visual body discrimination performance, the present study reveals joint contributions of feature and configuration processing to visual body discrimination. Participants predominantly gazed at the (body-centric) upper body for upright bodies and the lower body for inverted bodies in the context of an experimental paradigm directly comparable to that of prior studies of the BIE. Subsequent manipulation of fixation location indicates that these preferential gaze locations causally contributed to the BIE for whole bodies largely due to the informative nature of gazing at or near the head. Also, a BIE was detected for both whole and headless bodies even when fixation location on the body was held constant, indicating a role of configural processing in body discrimination, though inclusion of the head posture information was still highly discriminative in the context of such processing. Interestingly, the impact of configuration (upright and inverted) to the BIE appears greater than that of differential preferred gaze locations.	[Arizpe, Joseph M.; McKean, Danielle L.; Tsao, Jack W.; Chan, Annie W. -Y.] Univ Tennessee, Hlth Sci Ctr, Dept Neurol, Memphis, TN 38163 USA; [Arizpe, Joseph M.; McKean, Danielle L.; Tsao, Jack W.; Chan, Annie W. -Y.] Le Bonheur Childrens Hosp, Memphis, TN 38105 USA; [Arizpe, Joseph M.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Arizpe, Joseph M.] Boston Div Vet Affairs Healthcare Syst, Boston Attent & Learning Lab, Boston, MA 02130 USA; [Tsao, Jack W.; Chan, Annie W. -Y.] Le Bonheur Childrens Hosp, Childrens Fdn Res Inst, Memphis, TN USA; [Tsao, Jack W.] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN USA; [Tsao, Jack W.] Memphis Vet Affairs Med Ctr, Memphis, TN USA	University of Tennessee System; University of Tennessee Health Science Center; Harvard University; Harvard Medical School; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Arizpe, JM (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Neurol, Memphis, TN 38163 USA.; Arizpe, JM (corresponding author), Le Bonheur Childrens Hosp, Memphis, TN 38105 USA.; Arizpe, JM (corresponding author), Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA.; Arizpe, JM (corresponding author), Boston Div Vet Affairs Healthcare Syst, Boston Attent & Learning Lab, Boston, MA 02130 USA.	Joseph_Arizpe@hms.harvard.edu	Chan, Annie W-Y./AAT-6152-2020; Arizpe, Joseph M/N-1399-2014	Chan, Annie W-Y./0000-0001-9072-9222; Arizpe, Joseph M/0000-0001-8958-7757	University of Tennessee Health Science Center Le Bonheur Children's Hospital	University of Tennessee Health Science Center Le Bonheur Children's Hospital	This work was supported by the University of Tennessee Health Science Center Le Bonheur Children's Hospital. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arizpe J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148253; Arizpe J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031106; Arizpe JM, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01027; Bauser DAS, 2015, BRIT J PSYCHOL, V106, P414, DOI 10.1111/bjop.12101; Bauser DAS, 2013, CLIN NEUROPHYSIOL, V124, P686, DOI 10.1016/j.clinph.2012.09.030; Bauser DAS, 2011, VISION RES, V51, P195, DOI 10.1016/j.visres.2010.11.007; Bauser DS, 2015, BEHAV BRAIN RES, V281, P102, DOI 10.1016/j.bbr.2014.12.015; Brandman T., 2014, CEREB CORTEX; Brandman T, 2012, COGNITION, V125, P365, DOI 10.1016/j.cognition.2012.08.001; Brandman T, 2010, J NEUROSCI, V30, P10534, DOI 10.1523/JNEUROSCI.0911-10.2010; Caldara R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009708; Chan A, 2015, J VIS, V15, P623; Chan AWY, 2011, COGN NEUROSCI-UK, V2, P210, DOI 10.1080/17588928.2011.604723; Chan AWY, 2010, NAT NEUROSCI, V13, P417, DOI 10.1038/nn.2502; Chan AWY, 2004, NEUROREPORT, V15, P2407, DOI 10.1097/00001756-200410250-00021; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Fahle M, 2005, CURR OPIN NEUROBIOL, V15, P154, DOI 10.1016/j.conb.2005.03.010; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Hills PJ, 2013, VIS COGN, V21, P876, DOI 10.1080/13506285.2013.834016; Hills PJ, 2013, COGNITION, V129, P586, DOI 10.1016/j.cognition.2013.08.012; Hills PJ, 2011, J EXP PSYCHOL HUMAN, V37, P1396, DOI 10.1037/a0024247; Lu ZL, 2011, NEUROBIOL LEARN MEM, V95, P145, DOI 10.1016/j.nlm.2010.09.010; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Minnebusch DA, 2010, NEUROIMAGE, V49, P2746, DOI 10.1016/j.neuroimage.2009.10.046; Minnebusch DA, 2009, J COGNITIVE NEUROSCI, V21, P865, DOI 10.1162/jocn.2009.21074; Minnebusch DA, 2009, NEUROSCI BIOBEHAV R, V33, P1133, DOI 10.1016/j.neubiorev.2009.05.008; Or CCF, 2015, J VISION, V15, DOI 10.1167/15.13.12; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; Peterson MF, 2013, PSYCHOL SCI, V24, P1216, DOI 10.1177/0956797612471684; Peterson MF, 2012, P NATL ACAD SCI USA, V109, pE3314, DOI 10.1073/pnas.1214269109; Pitcher D, 2009, CURR BIOL, V19, P319, DOI 10.1016/j.cub.2009.01.007; Reed CL, 2006, J EXP PSYCHOL HUMAN, V32, P73, DOI 10.1037/0096-1523.32.1.73; Reed CL, 2003, PSYCHOL SCI, V14, P302, DOI 10.1111/1467-9280.14431; Robbins RA, 2012, Q J EXP PSYCHOL, V65, P1962, DOI 10.1080/17470218.2012.674145; Robbins RA, 2012, J EXP PSYCHOL HUMAN, V38, P1098, DOI 10.1037/a0028584; SAGI D, 1994, CURR OPIN NEUROBIOL, V4, P195, DOI 10.1016/0959-4388(94)90072-8; Sagi D, 2011, VISION RES, V51, P1552, DOI 10.1016/j.visres.2010.10.019; Schwarzlose RF, 2005, J NEUROSCI, V25, P11055, DOI 10.1523/JNEUROSCI.2621-05.2005; Seitz K, 2002, J EXP CHILD PSYCHOL, V82, P367, DOI 10.1016/S0022-0965(02)00106-6; Stekelenburg JJ, 2004, NEUROREPORT, V15, P777, DOI 10.1097/00001756-200404090-00007; Susilo T, 2013, COGNITION, V129, P88, DOI 10.1016/j.cognition.2013.06.004; Tanaka J.W., 2006, PERCEPTION FACES OBJ, P53, DOI [10.1093/acprof:oso/9780195313659.003.0003, DOI 10.1093/ACPROF:OSO/9780195313659.003.0003]; Tanaka JW, 1997, MEM COGNITION, V25, P583, DOI 10.3758/BF03211301; Tanaka JW, 2004, COGNITION, V93, pB1, DOI 10.1016/j.cognition.2003.09.011; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Tao W, 2014, NEUROREPORT, P1; Tao WD, 2013, NEUROREPORT, V24, P903, DOI 10.1097/WNR.0000000000000017; Taylor JC, 2007, J NEUROPHYSIOL, V98, P1626, DOI 10.1152/jn.00012.2007; Thompson JC, 2005, J NEUROSCI, V25, P9059, DOI 10.1523/JNEUROSCI.2129-05.2005; Urgesi C, 2007, J NEUROSCI, V27, P8023, DOI 10.1523/JNEUROSCI.0789-07.2007; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747; Yovel G, 2010, J EXP PSYCHOL HUMAN, V36, P759, DOI 10.1037/a0017451	56	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0169148	10.1371/journal.pone.0169148	http://dx.doi.org/10.1371/journal.pone.0169148			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH7SJ	28085894	Green Published, gold, Green Submitted			2022-12-26	WOS:000391972600014
J	Nkam, I; Ramoz, N; Breton, F; Mallet, J; Gorwood, P; Dubertret, C				Nkam, Irene; Ramoz, Nicolas; Breton, Florence; Mallet, Jasmina; Gorwood, Philip; Dubertret, Caroline			Impact of DRD2/ANKK1 and COMT Polymorphisms on Attention and Cognitive Functions in Schizophrenia	PLOS ONE			English	Article							CARD SORTING TEST; DRD2 GENE; EXECUTIVE ATTENTION; ASSOCIATION; PERFORMANCE; ACTIVATION; SUSCEPTIBILITY; METAANALYSIS; HAPLOTYPE; SYSTEM	Background Cognitive deficits such as poor selective attention and executive functions decline have been reported in patients with schizophrenia. Many studies have emphasized the role of dopamine in regulating cognitive functions in the general population as well as in schizophrenia. However, the relationship between cognitive processes, schizophrenia and dopaminergic candidate genes is an original approach given interesting results. The purpose of the current exploratory study was to examine the interaction of dopaminergic genes (coding for dopamine receptor D2, DRD2, and for Catecholamine-O-Methyl-Transferase, COMT) with the diagnostic of schizophrenia in (i) the executive control of attention, (ii) selective attention, and (iii) executive functions. Methods and Results We recruited 52 patients with schizophrenia and 53 healthy controls who performed the Stroop Color-Word Test, the Attention Network Test and the Wisconsin Card Sorting test. Four single nucleotide polymorphisms (SNPs) in the DRD2 gene (rs6275, rs6277, rs2242592 and rs1800497) and two SNPs in the COMT gene (rs4680 and rs165599) have been genotyped. Patients with schizophrenia performed significantly worse than controls in all cognitive performance, taking into account demographic variables. A significant gene by disease interaction was found for the Stroop interference (p = 0.002) for rs6275 of the DRD2 gene. The COMT Val/Val genotype and schizophrenia were associated with increased number of perseverative errors (p = 0.01). Conclusions In our study, the DRD2 gene is involved in attention while the COMT gene is implicated in executive functions in patients with schizophrenia.	[Nkam, Irene; Ramoz, Nicolas; Mallet, Jasmina; Gorwood, Philip; Dubertret, Caroline] Ctr Psychiat & Neurosci, INSERM, U894, Paris, France; [Nkam, Irene] Roger Prevot Hosp, Pole 1, Moisselles, France; [Nkam, Irene; Ramoz, Nicolas; Gorwood, Philip] Paris Descartes Univ, Sorbonne Paris Cite, Fac Med, Paris, France; [Breton, Florence; Mallet, Jasmina; Dubertret, Caroline] Louis Mourier Hosp, AP HP, Dept Psychiat, Colombes, France; [Mallet, Jasmina; Dubertret, Caroline] Paris Diderot Univ, Sorbonne Paris Cite, Fac Med, Paris, France; [Gorwood, Philip] St Anne Hosp, Clin Malad Mentales & Encephale, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite	Nkam, I (corresponding author), Ctr Psychiat & Neurosci, INSERM, U894, Paris, France.; Nkam, I (corresponding author), Roger Prevot Hosp, Pole 1, Moisselles, France.; Nkam, I (corresponding author), Paris Descartes Univ, Sorbonne Paris Cite, Fac Med, Paris, France.	tatomdjap@gmail.com	GORWOOD, Philip/M-9703-2019; ramoz, nicolas/K-3316-2015	GORWOOD, Philip/0000-0003-1845-3676; ramoz, nicolas/0000-0002-8070-9938; NKAM, IRENE/0000-0001-7515-3704				American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BERMAN KF, 1995, NEUROPSYCHOLOGIA, V33, P1027, DOI 10.1016/0028-3932(95)00035-2; Bilder RM, 2002, AM J PSYCHIAT, V159, P1018, DOI 10.1176/appi.ajp.159.6.1018; Bilder RM, 2000, AM J PSYCHIAT, V157, P549, DOI 10.1176/appi.ajp.157.4.549; Bilder RM, 2002, BIOL PSYCHIAT, V52, P701, DOI 10.1016/S0006-3223(02)01416-6; Bolton JL, 2010, BEHAV GENET, V40, P630, DOI 10.1007/s10519-010-9372-y; Breton F, 2011, NEUROPSYCHOLOGIA, V49, P203, DOI 10.1016/j.neuropsychologia.2010.11.019; Bright P, 2002, J INT NEUROPSYCH SOC, V8, P847, DOI 10.1017/S1355617702860131; Demily C, 2010, EUR PSYCHIAT, V25, P75, DOI 10.1016/j.eurpsy.2009.02.003; Dubertret C, 2001, SCHIZOPHR RES, V49, P203, DOI 10.1016/S0920-9964(00)00085-2; Dubertret C, 2010, PROG NEURO-PSYCHOPH, V34, P492, DOI 10.1016/j.pnpbp.2010.02.003; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fan J, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-14; Fossella J, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-14; Fossella J, 2006, COGN AFFECT BEHAV NE, V6, P71, DOI 10.3758/CABN.6.1.71; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Gupta M, 2009, PHARMACOGENOMICS, V10, P277, DOI 10.2217/14622416.10.2.277; Haller Chiara S, 2014, F1000Prime Rep, V6, P57, DOI 10.12703/P6-57; Harvey PD, 2005, AM J PSYCHIAT, V162, P1888, DOI 10.1176/appi.ajp.162.10.1888; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Johnson-Selfridge M, 2001, SCHIZOPHRENIA BULL, V27, P305, DOI 10.1093/oxfordjournals.schbul.a006876; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kukreti R, 2006, NEUROSCI LETT, V392, P68, DOI 10.1016/j.neulet.2005.08.059; Le Strat Y, 2009, CURR MOL MED, V9, P506; Liu L, 2014, NEUROSCI LETT, V583, P43, DOI 10.1016/j.neulet.2014.09.024; Ma XH, 2007, AM J MED GENET B, V144B, P407, DOI 10.1002/ajmg.b.30330; Monakhov M, 2008, SCHIZOPHR RES, V100, P302, DOI 10.1016/j.schres.2008.01.007; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Okochi T, 2009, SCHIZOPHR RES, V110, P140, DOI 10.1016/j.schres.2009.02.019; Opgen-Rhein C, 2008, SCHIZOPHRENIA BULL, V34, P1231, DOI 10.1093/schbul/sbm155; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Piai V, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00832; Ponce G, 2009, NEUROTOX RES, V16, P50, DOI 10.1007/s12640-009-9046-9; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Reuter M, 2005, BEHAV BRAIN RES, V164, P93, DOI 10.1016/j.bbr.2005.06.002; Reuter M, 2007, J COGNITIVE NEUROSCI, V19, P401, DOI 10.1162/jocn.2007.19.3.401; Rodriguez-Jimenez R, 2006, NEUROPSYCHOBIOLOGY, V54, P166, DOI 10.1159/000098652; SEEMAN P, 1987, SYNAPSE, V1, P133, DOI 10.1002/syn.890010203; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Sumitani S, 2006, NEUROPSYCHOBIOLOGY, V53, P70, DOI 10.1159/000091722; Swick D, 2002, NEUROPSYCHOLOGIA, V40, P1240, DOI 10.1016/S0028-3932(01)00226-3; Taylor J, 2007, TWIN RES HUM GENET, V10, P829, DOI 10.1375/twin.10.6.829; Westerhausen R, 2011, SCHIZOPHR RES, V133, P172, DOI 10.1016/j.schres.2011.08.025; Williams HJ, 2007, SCHIZOPHRENIA BULL, V33, P635, DOI 10.1093/schbul/sbm019; Witte AV, 2012, BRAIN RES BULL, V88, P418, DOI 10.1016/j.brainresbull.2011.11.012; Wonodi I, 2003, AM J MED GENET B, V120B, P47, DOI 10.1002/ajmg.b.20037; Yin XT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050590; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	55	17	18	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0170147	10.1371/journal.pone.0170147	http://dx.doi.org/10.1371/journal.pone.0170147			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH7SJ	28085950	Green Published, gold, Green Submitted			2022-12-26	WOS:000391972600068
J	Pertierra, LR; Hughes, KA; Vega, GC; Olalla-Tarraga, MA				Pertierra, Luis R.; Hughes, Kevin A.; Vega, Greta C.; Olalla-Tarraga, Miguel A.			High Resolution Spatial Mapping of Human Footprint across Antarctica and Its Implications for the Strategic Conservation of Avifauna	PLOS ONE			English	Article							INVASION; IMPACTS; GOALS	Human footprint models allow visualization of human spatial pressure across the globe. Up until now, Antarctica has been omitted from global footprint models, due possibly to the lack of a permanent human population and poor accessibility to necessary datasets. Yet Antarctic ecosystems face increasing cumulative impacts from the expanding tourism industry and national Antarctic operator activities, the management of which could be improved with footprint assessment tools. Moreover, Antarctic ecosystem dynamics could be modelled to incorporate human drivers. Here we present the first model of estimated human footprint across predominantly ice-free areas of Antarctica. To facilitate integration into global models, the Antarctic model was created using methodologies applied elsewhere with land use, density and accessibility features incorporated. Results showed that human pressure is clustered predominantly in the Antarctic Peninsula, southern Victoria Land and several areas of East Antarctica. To demonstrate the practical application of the footprint model, it was used to investigate the potential threat to Antarctica's avifauna by local human activities. Relative footprint values were recorded for all 204 of Antarctica's Important Bird Areas (IBAs) identified by BirdLife International and the Scientific Committee on Antarctic Research (SCAR). Results indicated that formal protection of avifauna under the Antarctic Treaty System has been unsystematic and is lacking for penguin and flying bird species in some of the IBAs most vulnerable to human activity and impact. More generally, it is hoped that use of this human footprint model may help Antarctic Treaty Consultative Meeting policy makers in their decision making concerning avifauna protection and other issues including cumulative impacts, environmental monitoring, non-native species and terrestrial area protection.	[Pertierra, Luis R.; Vega, Greta C.; Olalla-Tarraga, Miguel A.] Univ Rey Juan Carlos, Area Biodiversidad & Conservac, Mostoles, Spain; [Hughes, Kevin A.] Natl Environm Res Council, British Antarctic Survey, Madingley Rd, Cambridge, England	Universidad Rey Juan Carlos; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Pertierra, LR (corresponding author), Univ Rey Juan Carlos, Area Biodiversidad & Conservac, Mostoles, Spain.	luis.pertierra@gmail.com	Vega, Greta Carrete/E-8666-2016; Olalla-Tárraga, Miguel Ángel/ABE-7880-2020; Pertierra, Luis R./K-3727-2017	Vega, Greta Carrete/0000-0001-5115-0146; Olalla-Tárraga, Miguel Ángel/0000-0001-5346-4528; Pertierra, Luis R./0000-0002-2232-428X	Ministerio de Economia y Competitividad (Spain) [CTM2013-47381-P]; National Environment Research Council (NERC) core funding; Natural Environment Research Council [bas010011] Funding Source: researchfish; NERC [bas010011] Funding Source: UKRI	Ministerio de Economia y Competitividad (Spain); National Environment Research Council (NERC) core funding; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by Ministerio de Economia y Competitividad (Spain) under project CTM2013-47381-P. KH was supported by National Environment Research Council (NERC) core funding to the British Antarctic Survey's programme 'Environment Office - Long Term Monitoring and Survey' (EOLTMS).	ACAP, 2010, ACAP SPEC ASS SO GIA; Bargagli R, 2008, SCI TOTAL ENVIRON, V400, P212, DOI 10.1016/j.scitotenv.2008.06.062; Bender NA, 2016, ANTARCT SCI; Braun C, 2012, POLAR RES, V31, DOI 10.3402/polar.v31i0.18206; Brooke ML., 2004, ALBATROSSES PETRELS; Burger J, 2007, POLAR BIOL, V30, P1303, DOI 10.1007/s00300-007-0291-1; Burton-Johnson A, 2016, CRYOSPHERE DISCUSSIO; Chown SL, 2015, NATURE, V522, P427, DOI 10.1038/nature14505; Chown SL, 2012, P NATL ACAD SCI USA, V109, P4938, DOI 10.1073/pnas.1119787109; Coetzee BW, 2015, BIOL REV CAMBRIDGE P; COMNAP, 2015, ANT FAC LIST; Convey P., 2012, BIODIVERSITY-OTTAWA, V13, P134, DOI 10.1080/14888386.2012.732556; Creuwels JCS, 2007, POLAR BIOL, V30, P1083, DOI 10.1007/s00300-007-0276-0; Crossin GT, 2013, PENGUINS: NATURAL HISTORY AND CONSERVATION, P185; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Ellis EC, 2013, P NATL ACAD SCI USA, V110, P7978, DOI 10.1073/pnas.1217241110; Ellis EC, 2010, GLOBAL ECOL BIOGEOGR, V19, P589, DOI 10.1111/j.1466-8238.2010.00540.x; Fishpool L. D., 2001, IMPORTANT BIRD AREAS; Fretwell PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033751; Giese M, 1996, BIOL CONSERV, V75, P157, DOI 10.1016/0006-3207(95)00060-7; Grimaldi W, 2011, POLAR REC, V47, P56, DOI 10.1017/S0032247410000100; Harris C.M., 2015, IMPORTANT BIRD AREAS; Hughes KA, 2013, ENVIRON SCI POLICY, V31, P120, DOI 10.1016/j.envsci.2013.03.012; Hughes KA, 2015, CONSERV BIOL; Hughes KA, 2016, BIOL CONSERV, V200, P149, DOI 10.1016/j.biocon.2016.03.011; Hughes KA, 2015, BIODIVERS CONSERV, V24, P1031, DOI 10.1007/s10531-015-0896-6; Hughes KA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00151; Hughes KA, 2011, ANTARCT SCI, V23, P537, DOI 10.1017/S095410201100037X; Hughes KA, 2010, GLOBAL ENVIRON CHANG, V20, P96, DOI 10.1016/j.gloenvcha.2009.09.005; Huiskes AHL, 2014, BIOL CONSERV, V171, P278, DOI 10.1016/j.biocon.2014.01.038; Hull B.B., 2006, P317, DOI 10.1007/1-4020-5277-4_15; IAATO, 2015, TOURISM STAT; Lynch HJ, 2014, AUK, V131, P457, DOI 10.1642/AUK-14-31.1; Lynch HJ, 2010, ANTARCT SCI, V22, P123, DOI 10.1017/S0954102009990654; Lynch HJ, 2013, PENGUINS: NATURAL HISTORY AND CONSERVATION, P73; McGeoch MA, 2015, GLOBAL ENVIRON CHANG, V32, P108, DOI 10.1016/j.gloenvcha.2014.12.012; Morgan F., 2007, ENV DOMAINS ANTARCTI; Pertierra LR, 2013, ANTARCT SCI, V25, P553, DOI 10.1017/S0954102012001204; Pertierra LR, 2013, ANTARCT SCI, V25, P307, DOI 10.1017/S0954102012001083; Regel J, 1997, POLAR BIOL, V18, P246, DOI 10.1007/s003000050185; Rummler MC, 2016, POLAR BIOL, V39, P1329, DOI 10.1007/s00300-015-1838-1; Sanderson EW, 2002, BIOSCIENCE, V51, P993; Shaw JD, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001888; Terauds A, 2012, DIVERS DISTRIB, V18, P726, DOI 10.1111/j.1472-4642.2012.00925.x; Tin T, 2009, ANTARCT SCI, V21, P3, DOI 10.1017/S0954102009001722; Tin T., 2013, INT J WILDERNESS, V19, P10; Tin T., 2014, ANTARCTIC FUTURES HU; Venter O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12558	49	46	48	6	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0168280	10.1371/journal.pone.0168280	http://dx.doi.org/10.1371/journal.pone.0168280			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085889	Green Accepted, gold, Green Published			2022-12-26	WOS:000391972600005
J	Boatman, TG; Lawson, T; Geider, RJ				Boatman, Tobias G.; Lawson, Tracy; Geider, Richard J.			A Key Marine Diazotroph in a Changing Ocean: The Interacting Effects of Temperature, CO2 and Light on the Growth of Trichodesmium erythraeum IMS101	PLOS ONE			English	Article							CYANOBACTERIUM TRICHODESMIUM; NITROGEN-FIXATION; CONCENTRATING MECHANISMS; ATLANTIC-OCEAN; N-2 FIXATION; HEAT-STRESS; COMMUNITY STRUCTURE; IRON LIMITATION; ATMOSPHERIC CO2; CARBON-DIOXIDE	Trichodesmium is a globally important marine diazotroph that accounts for approximately 60 - 80% of marine biological N-2 fixation and as such plays a key role in marine N and C cycles. We undertook a comprehensive assessment of how the growth rate of Trichodesmium erythraeum IMS101 was directly affected by the combined interactions of temperature, pCO(2) and light intensity. Our key findings were: low pCO(2) affected the lower temperature tolerance limit (T-min) but had no effect on the optimum temperature (T-opt) at which growth was maximal or the maximum temperature tolerance limit (T-max); low pCO(2) had a greater effect on the thermal niche width than low-light; the effect of pCO(2) on growth rate was more pronounced at suboptimal temperatures than at supraoptimal temperatures; temperature and light had a stronger effect on the photosynthetic efficiency (F-v/F-m) than did CO2; and at T-opt, the maximum growth rate increased with increasing CO2, but the initial slope of the growth-irradiance curve was not affected by CO2. In the context of environmental change, our results suggest that the (i) nutrient replete growth rate of Trichodesmium IMS101 would have been severely limited by low pCO(2) at the last glacial maximum (LGM), (ii) future increases in pCO(2) will increase growth rates in areas where temperature ranges between T-min to T-opt, but will have negligible effect at temperatures between T-opt and T-max, (iii) areal increase of warm surface waters (> 18 degrees C) has allowed the geographic range to increase significantly from the LGM to present and that the range will continue to expand to higher latitudes with continued warming, but (iv) continued global warming may exclude Trichodesmium spp. from some tropical regions by 2100 where temperature exceeds T-opt.	[Boatman, Tobias G.; Lawson, Tracy; Geider, Richard J.] Univ Essex, Sch Biol Sci, Colchester, Essex, England	University of Essex	Boatman, TG (corresponding author), Univ Essex, Sch Biol Sci, Colchester, Essex, England.	tboatman@chelsea.co.uk		Geider, Richard/0000-0003-3276-047X	UK Natural Environment Research Council (NERC) PhD studentship at the University of Essex [NE/J500379/1 DTB]; NERC [NE/F002971/1] Funding Source: UKRI; Natural Environment Research Council [NE/F002971/1] Funding Source: researchfish	UK Natural Environment Research Council (NERC) PhD studentship at the University of Essex; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Toby Boatman was supported by a UK Natural Environment Research Council (NERC) PhD studentship (NE/J500379/1 DTB) held at the University of Essex.	Allakhverdiev SI, 2008, PHOTOSYNTH RES, V98, P541, DOI 10.1007/s11120-008-9331-0; Badger MR, 2002, FUNCT PLANT BIOL, V29, P161, DOI 10.1071/PP01213; Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; Ramos JBE, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002898; Bergman B, 2013, FEMS MICROBIOL REV, V37, P286, DOI 10.1111/j.1574-6976.2012.00352.x; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Boyd PW, 2010, NAT GEOSCI, V3, P675, DOI [10.1038/NGEO964, 10.1038/ngeo964]; Boyd PW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063091; Boyd PW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014130; Breitbarth E, 2008, MAR ECOL PROG SER, V359, P25, DOI 10.3354/meps07241; Breitbarth E, 2007, BIOGEOSCIENCES, V4, P53, DOI 10.5194/bg-4-53-2007; Cai XN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135401; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Campbell L, 2005, VIE MILIEU, V55, P185; Capone DG, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002331; Capone DG, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P1, DOI 10.1057/9780230226203.3567; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; Carpenter EJ, 2004, DEEP-SEA RES PT I, V51, P173, DOI 10.1016/j.dsr.2003.10.006; CARPENTER EJ, 1992, NATO ADV SCI I C-MAT, V362, P211; CARPENTER EJ, 1991, SCIENCE, V254, P1356, DOI 10.1126/science.254.5036.1356; Carpenter J. E, 1995, MARINE ECOLOGY PROGR, V118, P267; Chappell PD, 2010, ENVIRON MICROBIOL, V12, P13, DOI 10.1111/j.1462-2920.2009.02026.x; Chen YB, 1996, J PHYCOL, V32, P916, DOI 10.1111/j.0022-3646.1996.00916.x; Crafts-Brandner SJ, 2000, P NATL ACAD SCI USA, V97, P13430, DOI 10.1073/pnas.230451497; Dave AC, 2013, J GEOPHYS RES-OCEANS, V118, P3114, DOI 10.1002/jgrc.20224; DICKSON AG, 1990, DEEP-SEA RES, V37, P755, DOI 10.1016/0198-0149(90)90004-F; DICKSON AG, 1993, DEEP-SEA RES PT I, V40, P107, DOI 10.1016/0967-0637(93)90055-8; Doney SC, 2006, NATURE, V444, P695, DOI 10.1038/444695a; Dutkiewicz S, 2015, NAT CLIM CHANGE, V5, P1002, DOI [10.1038/NCLIMATE2722, 10.1038/nclimate2722]; Dyhrman ST, 2006, NATURE, V439, P68, DOI 10.1038/nature04203; Eichner M, 2014, PHYSIOL PLANTARUM, V152, P316, DOI 10.1111/ppl.12172; EPPLEY RW, 1972, FISH B-NOAA, V70, P1063; FINZIHART JA, 2009, NATL ACAD SCI US, V106, P6345, DOI DOI 10.1073/PNAS.0810547106; Fu FX, 2014, AQUAT MICROB ECOL, V72, P33, DOI 10.3354/ame01683; Garcia NS, 2011, J PHYCOL, V47, P1292, DOI 10.1111/j.1529-8817.2011.01078.x; Ho TY, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00139; Hutchins DA, 2007, LIMNOL OCEANOGR, V52, P1293, DOI 10.4319/lo.2007.52.4.1293; Hutchins DA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9155; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; KANA TM, 1993, LIMNOL OCEANOGR, V38, P18, DOI 10.4319/lo.1993.38.1.0018; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; Kingsolver JG, 2009, AM NAT, V174, P755, DOI 10.1086/648310; Kranz SA, 2010, LIMNOL OCEANOGR, V55, P2563, DOI 10.4319/lo.2010.55.6.2563; Kranz SA, 2010, PLANT PHYSIOL, V154, P334, DOI 10.1104/pp.110.159145; Kranz SA, 2009, LIMNOL OCEANOGR, V54, P548, DOI 10.4319/lo.2009.54.2.0548; Kupper H, 2008, NEW PHYTOL, V179, P784, DOI 10.1111/j.1469-8137.2008.02497.x; Landolfi A, 2015, GEOPHYS RES LETT, V42, P4482, DOI 10.1002/2015GL063756; Lee K, 2010, GEOCHIM COSMOCHIM AC, V74, P1801, DOI 10.1016/j.gca.2009.12.027; Levitan O, 2007, GLOBAL CHANGE BIOL, V13, P531, DOI 10.1111/j.1365-2486.2006.01314.x; Levitan O, 2010, ENVIRON MICROBIOL, V12, P1899, DOI 10.1111/j.1462-2920.2010.02195.x; Lewis E, 1998, CO2SYS PROGRAM; Li G, 2015, NEW PHYTOL, V205, P533, DOI 10.1111/nph.13037; Martinez-Perez C, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.163, 10.1038/nmicrobiol.2016.163]; Millero FJ, 2010, MAR FRESHWATER RES, V61, P139, DOI 10.1071/MF09254; Monteiro FM, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003902; Mulholland MR, 2007, BIOGEOSCIENCES, V4, P37, DOI 10.5194/bg-4-37-2007; PAERL HW, 1994, APPL ENVIRON MICROB, V60, P1044, DOI 10.1128/AEM.60.3.1044-1047.1994; Pandey KD, 2004, CELL MOL BIOL, V50, P575; Platt T, 1980, MODELLING PRIMARY PR, P339; Price GD, 2008, J EXP BOT, V59, P1441, DOI 10.1093/jxb/erm112; R Development Core Team, 2014, R LANG ENV STAT COMP; Raven JA, 1999, PLANT CELL ENVIRON, V22, P741, DOI 10.1046/j.1365-3040.1999.00419.x; Raven JA, 2014, PHOTOSYNTH RES, V121, P111, DOI 10.1007/s11120-013-9962-7; ROMANS KM, 1994, J PHYCOL, V30, P935, DOI 10.1111/j.0022-3646.1994.00935.x; Rost B, 2008, MAR ECOL PROG SER, V373, P227, DOI 10.3354/meps07776; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; SAINO T, 1982, MAR BIOL, V70, P251, DOI 10.1007/BF00396843; Salvucci ME, 2004, PHYSIOL PLANTARUM, V122, P513, DOI 10.1111/j.1399-3054.2004.00419.x; Salvucci ME, 2004, PHYSIOL PLANTARUM, V120, P179, DOI 10.1111/j.0031-9317.2004.0173.x; Shi DL, 2012, P NATL ACAD SCI USA, V109, pE3094, DOI 10.1073/pnas.1216012109; Shi T, 2007, ENVIRON MICROBIOL, V9, P2945, DOI 10.1111/j.1462-2920.2007.01406.x; Sonntag S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048205; Spungin D, 2014, ENVIRON MICROBIOL, V16, P1935, DOI 10.1111/1462-2920.12424; Stal LJ, 2009, ENVIRON MICROBIOL, V11, P1632, DOI 10.1111/j.1758-2229.2009.00016.x; Stihl A, 2001, J PHYCOL, V37, P310, DOI 10.1046/j.1529-8817.2001.037002310.x; Thomas MK, 2016, GLOBAL ECOL BIOGEOGR, V25, P75, DOI 10.1111/geb.12387; Thomas MK, 2012, SCIENCE, V338, P1085, DOI 10.1126/science.1224836; Titman D, 1976, LIMNOLOGY OCEANOGRAP, P409; Tyrrell T, 2003, J PLANKTON RES, V25, P405, DOI 10.1093/plankt/25.4.405; Upton G, 2014, J COMPUTATIONAL SYST, V1, P103; Wernberg T, 2012, GLOBAL CHANGE BIOL, V18, P1491, DOI 10.1111/j.1365-2486.2012.02656.x; White AE, 2006, LIMNOL OCEANOGR, V51, P1777, DOI 10.4319/lo.2006.51.4.1777; Zielke M, 2002, ARCT ANTARCT ALP RES, V34, P293, DOI 10.2307/1552487	84	23	25	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							E0168796	10.1371/journal.pone.0168796	http://dx.doi.org/10.1371/journal.pone.0168796			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081236	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000391949500017
J	Jackson, KL; Lin, WL; Miriyala, S; Dayton, RD; Panchatcharam, M; McCarthy, KJ; Castanedes-Casey, M; Dickson, DW; Klein, RL				Jackson, Kasey L.; Lin, Wen-Lang; Miriyala, Sumitra; Dayton, Robert D.; Panchatcharam, Manikandan; McCarthy, Kevin J.; Castanedes-Casey, Monica; Dickson, Dennis W.; Klein, Ronald L.			p62 Pathology Model in the Rat Substantia Nigra with Filamentous Inclusions and Progressive Neurodegeneration	PLOS ONE			English	Article							SEQUESTOSOME 1/P62; SQSTM1 MUTATIONS; ALPHA-SYNUCLEIN; PARTIAL LESIONS; GENE-TRANSFER; DISEASE; TAU; DEGENERATION; EXPRESSION; AUTOPHAGY	One of the proteins most frequently found in neuropathological lesions is the ubiquitin binding protein p62 (sequestosome 1). Post-mortem analysis of p62 is a defining diagnostic marker in several neurodegenerative diseases including amyotrophic lateral sclerosis and inclusion body myositis. Since p62 functions in protein degradation pathways including autophagy, the build-up of p62-positive inclusions suggests defects in protein clearance. p62 was expressed unilaterally in the rat substantia nigra with an adeno-associated virus vector (AAV9) in order to study p62 neuropathology. Inclusions formed within neurons from several days to several weeks after gene transfer. By electron microscopy, the inclusions were found to contain packed 10 nm thick filaments, and mitochondria cristae structure was disrupted, resulting in the formation of empty spaces. In corollary cell culture transfections, p62 clearly impaired mitochondrial function. To probe for potential effects on macroauto-phagy, we co-expressed p62 with a double fluorescent tagged reporter for the autophagosome protein LC3 in the rat. p62 induced a dramatic and specific dissociation of the two tags. By 12 weeks, a rotational behavior phenotype manifested, consistent with a significant loss of dopaminergic neurons analyzed post-mortem. p62 overexpression resulted in a progressive and robust pathology model with neuronal inclusions and neurodegeneration. p62 gene transfer could be a novel methodological probe to disrupt mitochondrial function or autophagy in the brain and other tissues in vivo.	[Jackson, Kasey L.; Dayton, Robert D.; Klein, Ronald L.] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71105 USA; [Lin, Wen-Lang; Castanedes-Casey, Monica; Dickson, Dennis W.] Mayo Clin, Dept Neurosci, Jacksonville, FL USA; [Miriyala, Sumitra; Panchatcharam, Manikandan; McCarthy, Kevin J.] Louisiana State Univ, Hlth Sci Ctr, Dept Cell Biol & Anat, Shreveport, LA 71105 USA; [McCarthy, Kevin J.] Louisiana State Univ, Hlth Sci Ctr, Dept Pathol, Shreveport, LA 71105 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Mayo Clinic; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Klein, RL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71105 USA.	Klein@lsuhsc.edu		Miriyala, Sumitra/0000-0001-7158-9295; Panchatcharam, Manikandan/0000-0002-7691-8948; McCarthy, Kevin/0000-0001-9317-5624	Fidelity Biosciences Research Initiative; Karyopharm Therapeutics, Inc.; ALS Association	Fidelity Biosciences Research Initiative; Karyopharm Therapeutics, Inc.; ALS Association	This work was funded by the Fidelity Biosciences Research Initiative, Karyopharm Therapeutics, Inc., and the ALS Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castillo K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.421; Fecto F, 2012, MUSCLE NERVE, V45, P157, DOI 10.1002/mus.23278; Fecto F, 2011, ARCH NEUROL-CHICAGO, V68, P1440, DOI 10.1001/archneurol.2011.250; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Garner TP, 2011, BIOCHEMISTRY-US, V50, P4665, DOI 10.1021/bi200079n; Geetha T, 2012, BIOMARKERS, V17, P99, DOI 10.3109/1354750X.2011.653986; He Q, 2016, MOL NEUROBIOL, V53, P2258, DOI 10.1007/s12035-015-9173-7; HEFTI F, 1980, BRAIN RES, V195, P123, DOI 10.1016/0006-8993(80)90871-9; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Kirik D, 1998, EXP NEUROL, V152, P259, DOI 10.1006/exnr.1998.6848; Klein RL, 2006, MOL THER, V13, P517, DOI 10.1016/j.ymthe.2005.10.008; Klein RL, 2005, NEUROBIOL DIS, V20, P64, DOI 10.1016/j.nbd.2005.02.001; Klein RL, 2002, EXP NEUROL, V176, P66, DOI 10.1006/exnr.2002.7942; Klein RL, 2008, EUR J NEUROSCI, V27, P1615, DOI 10.1111/j.1460-9568.2008.06161.x; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; Laurin N, 2002, AM J HUM GENET, V70, P1582, DOI 10.1086/340731; Le Ber I, 2013, JAMA NEUROL, V70, P1403, DOI 10.1001/jamaneurol.2013.3849; Liu SQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085702; N'Diaye EN, 2009, EMBO REP, V10, P173, DOI 10.1038/embor.2008.238; Nogalska A, 2009, ACTA NEUROPATHOL, V118, P407, DOI 10.1007/s00401-009-0564-6; Schaeffer V, 2012, AUTOPHAGY, V8, P1686, DOI 10.4161/auto.21488; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; Tatom JB, 2009, MOL THER, V17, P607, DOI 10.1038/mt.2009.3; Wooten MW, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/62079; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zhang XJ, 2014, AUTOPHAGY, V10, P588, DOI 10.4161/auto.27710	28	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169291	10.1371/journal.pone.0169291	http://dx.doi.org/10.1371/journal.pone.0169291			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076378	Green Published, Green Submitted, gold			2022-12-26	WOS:000391857100030
J	Hulatt, CJ; Wijffels, RH; Bolla, S; Kiron, V				Hulatt, Chris J.; Wijffels, Rene H.; Bolla, Sylvie; Kiron, Viswanath			Production of Fatty Acids and Protein by Nannochloropsis in Flat-Plate Photobioreactors	PLOS ONE			English	Article							OIL PRODUCTION; CHLORELLA-SOROKINIANA; BIOFUEL PRODUCTION; LIPID-METABOLISM; MICROALGAE; GROWTH; ALGAE; EPA; TRIACYLGLYCEROLS; ACCUMULATION	Nannochloropsis is an industrially-promising microalga that may be cultivated for alternative sources of nutrition due to its high productivity, protein content and lipid composition. We studied the growth and biochemical profile of Nannochloropsis 211/78 (CCAP) in optimized flat-plate photobioreactors. Eighteen cultivations were performed at two nutrient concentrations. The fatty acid, protein content and calorific values were analyzed after 8, 12 and 16 days. Neutral lipids were separated and the changes in fatty acids in triglycerides (TAGs) during nutrient depletion were recorded. The maximum cell density reached 4.7 g.L-1 and the maximum productivity was 0.51 g.L-1.d(-1). During nutrient-replete conditions, eicosapentaneoic acid (EPA) and total protein concentrations measured 4.2-4.9% and 50-55% of the dry mass, respectively. Nutrient starvation induced the accumulation of fatty acids up to 28.3% of the cell dry weight, largely due to the incorporation of C16:0 and C16:1 n-7 fatty acyl chains into neutral lipids. During nutrient starvation the total EPA content did not detectibly change, but up to 37% was transferred from polar membrane lipids to the neutral lipid fraction.	[Hulatt, Chris J.; Wijffels, Rene H.; Bolla, Sylvie; Kiron, Viswanath] Nord Univ, Fac Biosci & Aquaculture, Bodo, Norway; [Wijffels, Rene H.] Wageningen Univ, Bioproc Engn, AlgaePARC, Wageningen, Netherlands	Nord University; Wageningen University & Research	Hulatt, CJ (corresponding author), Nord Univ, Fac Biosci & Aquaculture, Bodo, Norway.	christopher.j.hulatt@nord.no		Wijffels, Rene/0000-0001-7630-4295; Hulatt, Chris/0000-0002-2741-8402	Nordland County Government, Norway	Nordland County Government, Norway	Funding was received by Nordland County Government, Norway, as part of the project Bioteknologi- en framtidsrettet naering'. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, IND BIOTECH, DOI DOI 10.1089/IND.2016.0006; Bechet Q, 2013, BIOTECHNOL BIOENG, V110, P118, DOI 10.1002/bit.24603; Becker EW, 2007, BIOTECHNOL ADV, V25, P207, DOI 10.1016/j.biotechadv.2006.11.002; Bellou S, 2016, CURR OPIN BIOTECH, V37, P24, DOI 10.1016/j.copbio.2015.09.005; Benvenuti G, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0475-4; Bigogno C, 2002, PHYTOCHEMISTRY, V60, P497, DOI 10.1016/S0031-9422(02)00100-0; Blanken W, 2014, BIOTECHNOL BIOENG, V111, P2436, DOI 10.1002/bit.25301; Breuer G, 2013, JOVE-J VIS EXP, DOI 10.3791/50628; Breuer G, 2012, BIORESOURCE TECHNOL, V124, P217, DOI 10.1016/j.biortech.2012.08.003; Chauton MS, 2015, AQUACULTURE, V436, P95, DOI 10.1016/j.aquaculture.2014.10.038; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Clarens AF, 2010, ENVIRON SCI TECHNOL, V44, P1813, DOI 10.1021/es902838n; da Silva TL, 2014, APPL MICROBIOL BIOT, V98, P1043, DOI 10.1007/s00253-013-5389-5; Glencross BD, 2009, REV AQUACULT, V1, P71, DOI 10.1111/j.1753-5131.2009.01006.x; Guiheneuf F, 2013, MAR DRUGS, V11, P4246, DOI 10.3390/md11114246; Guillard RRL, 1962, CAN J MICROBIOL, V139, P151; Gunerken E, 2016, BIORESOURCE TECHNOL, V214, P89, DOI 10.1016/j.biortech.2016.04.072; Guschina IA, 2006, PROG LIPID RES, V45, P160, DOI 10.1016/j.plipres.2006.01.001; Hu Q, 1998, APPL MICROBIOL BIOT, V49, P655, DOI 10.1007/s002530051228; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Hulatt CJ, 2011, BIORESOURCE TECHNOL, V102, P6687, DOI 10.1016/j.biortech.2011.03.098; Hulatt CJ, 2011, BIORESOURCE TECHNOL, V102, P5775, DOI 10.1016/j.biortech.2011.02.025; Izquierdo MS, 2001, AQUACULT NUTR, V7, P153, DOI 10.1046/j.1365-2095.2001.00165.x; Jorquera O, 2010, BIORESOURCE TECHNOL, V101, P1406, DOI 10.1016/j.biortech.2009.09.038; Kagan ML, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-102; Kilian O, 2011, P NATL ACAD SCI USA, V108, P21265, DOI 10.1073/pnas.1105861108; Kiron V, 1991, ALG BIOM SUMM 2015 W; Klok AJ, 2013, BIORESOURCE TECHNOL, V134, P233, DOI 10.1016/j.biortech.2013.02.006; Lakaniemi AM, 2012, J IND MICROBIOL BIOT, V39, P1357, DOI 10.1007/s10295-012-1133-x; Laurens LML, 2012, ANAL BIOANAL CHEM, V403, P167, DOI 10.1007/s00216-012-5814-0; Lee AK, 2012, BIOMASS BIOENERG, V46, P89, DOI 10.1016/j.biombioe.2012.06.034; Li J, 2014, PLANT CELL, V26, P1645, DOI 10.1105/tpc.113.121418; Liu J, 2011, BIORESOURCE TECHNOL, V102, P106, DOI 10.1016/j.biortech.2010.06.017; Maisashvili A, 2015, ALGAL RES, V9, P133, DOI 10.1016/j.algal.2015.03.006; Marjakangas JM, 2015, BIORESOURCE TECHNOL, V191, P369, DOI 10.1016/j.biortech.2015.02.075; Molina E, 2001, J BIOTECHNOL, V92, P113, DOI 10.1016/S0168-1656(01)00353-4; Muhlroth A, 2013, MAR DRUGS, V11, P4662, DOI 10.3390/md11114662; *NAT RES COUNC, 2011, NUTR REQ FISH SHRIMP, P376; Natunen K, 2015, J APPL PHYCOL, V27, P1161, DOI 10.1007/s10811-014-0404-5; Norambuena F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124042; Pal D, 2011, APPL MICROBIOL BIOT, V90, P1429, DOI 10.1007/s00253-011-3170-1; Pinheiro J., 2006, MIXED EFFECTS MODELS; Postma PR, 2015, BIORESOURCE TECHNOL, V184, P297, DOI 10.1016/j.biortech.2014.09.033; R Core Team, 2013, R LANG ENV STAT COMP; Radakovits R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1688; Ratledge C, 2004, BIOCHIMIE, V86, P807, DOI 10.1016/j.biochi.2004.09.017; Rezanka T, 2014, PHYTOCHEMISTRY, V104, P95, DOI 10.1016/j.phytochem.2014.04.013; Ringuet S, 2011, J ENVIRON MONITOR, V13, P370, DOI 10.1039/c0em00290a; Rocha JMS, 2003, BIOMOL ENG, V20, P237, DOI 10.1016/S1389-0344(03)00061-3; Ruiz J, 2016, ENERGY ENV SCI; Sabate J, 2014, AM J CLIN NUTR, V100, p476S, DOI 10.3945/ajcn.113.071522; Scholz MJ, 2014, EUKARYOT CELL, V13, P1450, DOI 10.1128/EC.00183-14; Sharma K, 2015, BIOTECHNOL BIOENG, V112, P1243, DOI 10.1002/bit.25544; Shields RJ, 2012, J ANIM SCI, V21, P23; Vejrazka C, 2012, BIOTECHNOL BIOENG, V109, P2567, DOI 10.1002/bit.24525; Walker AB, 2011, N AM J AQUACULT, V73, P76, DOI 10.1080/15222055.2010.549030; Wells ML, 2017, J APPL PHYCOL, V29, P949, DOI 10.1007/s10811-016-0974-5; Westhoek H, 2014, GLOBAL ENVIRON CHANG, V26, P196, DOI 10.1016/j.gloenvcha.2014.02.004; Zou N, 2000, EUR J PHYCOL, V35, P127, DOI 10.1080/09670260010001735711	59	62	62	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170440	10.1371/journal.pone.0170440	http://dx.doi.org/10.1371/journal.pone.0170440			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103296	Green Submitted, gold, Green Published			2022-12-26	WOS:000392381100067
J	Hurtado-Guerrero, I; Pinto-Medel, MJ; Urbaneja, P; Rodriguez-Bada, JL; Leon, A; Guerrero, M; Fernandez, O; Leyva, L; Oliver-Martos, B				Hurtado-Guerrero, Isaac; Jesus Pinto-Medel, Maria; Urbaneja, Patricia; Luis Rodriguez-Bada, Jose; Leon, Antonio; Guerrero, Miguel; Fernandez, Oscar; Leyva, Laura; Oliver-Martos, Begona			Activation of the JAK-STAT Signaling Pathway after In Vitro Stimulation with IFN beta in Multiple Sclerosis Patients According to the Therapeutic Response to IFN beta	PLOS ONE			English	Article							INTERFERON-ALPHA RECEPTOR; AUTOIMMUNE-DISEASES; CELLS; EXPRESSION; UBIQUITINATION; MONOCYTES; COMPLEX	Interferon beta (IFN beta) is a common treatment used for multiple sclerosis (MS) which acts through the activation of the JAK-STAT pathway. However, this therapy is not always effective and currently there are no reliable biomarkers to predict therapeutic response. We postulate that the heterogeneity in the response to IFN beta therapy could be related to differential activation patterns of the JAK-STAT signaling pathway. Our aim was to evaluate the basal levels and the short term activation of this pathway after IFN beta stimulation in untreated and IFN beta treated patients, as well as according to therapeutic response. Therefore, cell surface levels of IFNAR subunits (IFNAR1 and IFNAR2) and the activated forms of STAT1 and STAT2 were assessed in peripheral blood mononuclear cells from MS patients by flow cytometry. Basal levels of each of the markers strongly correlated with the expression of the others in untreated patients, but many of these correlations lost significance in treated patients and after short term activation with IFN beta. Patients who had undergone IFN beta treatment showed higher basal levels of IFNAR1 and pSTAT1, but a reduced response to in vitro exposure to IFN beta. Conversely, untreated patients, with lower basal levels, showed a greater ability of short term activation of this pathway. Monocytes from responder patients had lower IFNAR1 levels (p = 0.039) and higher IFNAR2 levels (p = 0.035) than non-responders just after IFN beta stimulation. A cluster analysis showed that levels of I FNAR1, IFNAR2 and pSTAT1-2 in monocytes grouped 13 out of 19 responder patients with a similar expression pattern, showing an association of this pattern with the phenotype of good response to IFN beta (p = 0.013). Our findings suggest that an activation pattern of the IFN beta signaling pathway in monocytes could be associated with a clinical phenotype of good response to IFN beta treatment and that a differential modulation of the IFNAR subunits in monocytes could be related with treatment effectiveness.	[Hurtado-Guerrero, Isaac; Jesus Pinto-Medel, Maria; Urbaneja, Patricia; Luis Rodriguez-Bada, Jose; Leon, Antonio; Guerrero, Miguel; Fernandez, Oscar; Leyva, Laura; Oliver-Martos, Begona] Univ Malaga, Hosp Reg Univ Malaga, Unidad Gest Clin Neurociencias, Inst Invest Biomed Malaga IBIMA, Malaga, Spain	Universidad de Malaga		leyvafer@gmail.com; begoliver@gmail.com	Leyva, Laura/R-2187-2019; Leyva, Laura/B-5574-2019; Oliver-Martos, Begoña/U-5444-2019	Leyva, Laura/0000-0003-0620-9625; Leyva, Laura/0000-0003-0620-9625; Pinto Medel, Maria Jesus/0000-0002-1129-7415; Hurtado Guerrero, Isaac/0000-0003-1936-7112	Consejeria de Economia y Conocimiento [CTS-7670/11]; Fondo Europeo de Desarrollo Regional (FEDER), "Andalucia se mueve con Europa"	Consejeria de Economia y Conocimiento; Fondo Europeo de Desarrollo Regional (FEDER), "Andalucia se mueve con Europa"	This work was supported by CTS-7670/11, Consejeria de Economia y Conocimiento and co-founded by Fondo Europeo de Desarrollo Regional (FEDER), "Andalucia se mueve con Europa"; PI: Laura Leyva.	Axtell RC, 2012, IMMUNOL REV, V248, P23, DOI 10.1111/j.1600-065X.2012.01131.x; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; COHEN B, 1995, MOL CELL BIOL, V15, P4208; Comabella M, 2009, BRAIN, V132, P3353, DOI 10.1093/brain/awp228; Comabella M, 2014, LANCET NEUROL, V13, P113, DOI 10.1016/S1474-4422(13)70233-3; CONSTANTINESCU SN, 1994, P NATL ACAD SCI USA, V91, P9602, DOI 10.1073/pnas.91.20.9602; Croze E, 1996, J BIOL CHEM, V271, P33165, DOI 10.1074/jbc.271.52.33165; de Weerd NA, 2013, NAT IMMUNOL, V14, P901, DOI 10.1038/ni.2667; de Weerd NA, 2012, IMMUNOL CELL BIOL, V90, P483, DOI 10.1038/icb.2012.9; Fantuzzi L, 1997, EUR J IMMUNOL, V27, P1075, DOI 10.1002/eji.1830270506; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Frisullo G, 2006, J NEUROSCI RES, V84, P1027, DOI 10.1002/jnr.20995; Gauzzi MC, 2002, J IMMUNOL, V169, P3038, DOI 10.4049/jimmunol.169.6.3038; Hald A, 2013, BRIT J DERMATOL, V168, P302, DOI 10.1111/bjd.12049; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Kasperkovitz PV, 2004, ANN RHEUM DIS, V63, P233, DOI 10.1136/ard.2003.013276; Kieseier BC, 2011, CNS DRUGS, V25, P491, DOI 10.2165/11591110-000000000-00000; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; Kumar KGS, 2004, J BIOL CHEM, V279, P46614, DOI 10.1074/jbc.M407082200; Liu J, 2008, BIOCHEM BIOPH RES CO, V367, P388, DOI 10.1016/j.bbrc.2007.12.137; LUTFALLA G, 1992, J BIOL CHEM, V267, P2802; Marijanovic Z, 2007, BIOCHEM J, V407, P141, DOI 10.1042/BJ20070605; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Oliver B, 2009, J IMMUNOL METHODS, V351, P41, DOI 10.1016/j.jim.2009.09.005; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ramirez-Velez G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041414; Rio J, 2006, ANN NEUROL, V59, P344, DOI 10.1002/ana.20740; Rio J, 2009, MULT SCLER, V15, P848, DOI 10.1177/1352458509104591; Sandler NG, 2014, NATURE, V511, P601, DOI 10.1038/nature13554; Schwartz DM, 2016, NAT REV RHEUMATOL, V12, P25, DOI 10.1038/nrrheum.2015.167; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; Zula JA, 2011, P NATL ACAD SCI USA, V108, P19689, DOI 10.1073/pnas.1117347108	39	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170031	10.1371/journal.pone.0170031	http://dx.doi.org/10.1371/journal.pone.0170031			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103257	Green Published, Green Submitted, gold			2022-12-26	WOS:000392381100034
J	He, C; Fu, JJ; Zhang, J; Li, YX; Zheng, J; Zhang, HW; Yang, XH; Wang, JH; Wang, GY				He, Cheng; Fu, Junjie; Zhang, Jie; Li, Yongxiang; Zheng, Jun; Zhang, Hongwei; Yang, Xiaohong; Wang, Jianhua; Wang, Guoying			A Gene-Oriented Haplotype Comparison Reveals Recently Selected Genomic Regions in Temperate and Tropical Maize Germplasm	PLOS ONE			English	Article							POSTDOMESTICATION SPREAD; ARABIDOPSIS-THALIANA; POSITIVE SELECTION; NATURAL-SELECTION; DOMESTICATION; BIOSYNTHESIS; ADAPTATION; EXPRESSION; EVOLUTION; TARGET	The extensive genetic variation present in maize (Zea mays) germplasm makes it possible to detect signatures of positive artificial selection that occurred during temperate and tropical maize improvement. Here we report an analysis of 532,815 polymorphisms from a maize association panel consisting of 368 diverse temperate and tropical inbred lines. We developed a gene-oriented approach adapting exonic polymorphisms to identify recently selected alleles by comparing haplotypes across the maize genome. This analysis revealed evidence of selection for more than 1100 genomic regions during recent improvement, and included regulatory genes and key genes with visible mutant phenotypes. We find that selected candidate target genes in temperate maize are enriched in biosynthetic processes, and further examination of these candidates highlights two cases, sucrose flux and oil storage, in which multiple genes in a common pathway can be cooperatively selected. Finally, based on available parallel gene expression data, we hypothesize that some genes were selected for regulatory variations, resulting in altered gene expression.	[He, Cheng; Zhang, Jie; Yang, Xiaohong; Wang, Jianhua] China Agr Univ, Coll Agr & Biotechnol, Beijing, Peoples R China; [He, Cheng; Fu, Junjie; Li, Yongxiang; Zheng, Jun; Zhang, Hongwei; Wang, Guoying] Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China; [Zhang, Jie] Guizhou Acad Tobacco Sci, Mol Genet Key Lab China Tobacco, Guiyang, Peoples R China	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; China National Tobacco Corporation	Wang, JH (corresponding author), China Agr Univ, Coll Agr & Biotechnol, Beijing, Peoples R China.; Wang, GY (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China.	wangjh63@cau.edu.cn; wangguoying@caas.cn	li, yongxiang/GPW-6930-2022; li, yong/HDN-3885-2022	Fu, Junjie/0000-0002-4702-2392	National Basic Research Program of China [2014CB138200]; National Natural Science Foundation China (CN) [31330056]; Fundamental Research Funds for ICS-CAAS [2014007]; Agricultural Science and Technology Innovation Program of CAAS	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation China (CN); Fundamental Research Funds for ICS-CAAS; Agricultural Science and Technology Innovation Program of CAAS	This work was supported by the National Basic Research Program of China (2014CB138200), National Natural Science Foundation China (CN) (31330056), Fundamental Research Funds for ICS-CAAS (Grant to Junjie Fu, 2014007) and Agricultural Science and Technology Innovation Program of CAAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen H, 2010, GENOME RES, V20, P393, DOI 10.1101/gr.100545.109; Close TJ, 1997, PHYSIOL PLANTARUM, V100, P291, DOI 10.1034/j.1399-3054.1997.1000210.x; Crisci JL, 2012, J HERED, V103, P287, DOI 10.1093/jhered/esr128; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Enard D, 2014, GENOME RES, V24, P885, DOI 10.1101/gr.164822.113; Enard D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000840; Fu JJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3832; Gepts P, 2014, CURR OPIN PLANT BIOL, V18, P51, DOI 10.1016/j.pbi.2014.02.001; House MA, 2014, MOL BIOL EVOL, V31, P1514, DOI 10.1093/molbev/msu110; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Hung HY, 2012, P NATL ACAD SCI USA, V109, pE1913, DOI 10.1073/pnas.1203189109; Jaenicke-Despres V, 2003, SCIENCE, V302, P1206, DOI 10.1126/science.1089056; Javelle M, 2010, PLANT PHYSIOL, V154, P273, DOI 10.1104/pp.109.150540; Jiao YP, 2012, NAT GENET, V44, P812, DOI 10.1038/ng.2312; Koenig D, 2013, P NATL ACAD SCI USA, V110, pE2655, DOI 10.1073/pnas.1309606110; Kudaravalli S, 2009, MOL BIOL EVOL, V26, P649, DOI 10.1093/molbev/msn289; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Ling Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-580; Liu HJ, 2015, MOL PLANT, V8, P871, DOI 10.1016/j.molp.2015.01.016; Liu KJ, 2003, GENETICS, V165, P2117; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mu JY, 2008, PLANT PHYSIOL, V148, P1042, DOI 10.1104/pp.108.126342; Oleksyk TK, 2010, PHILOS T R SOC B, V365, P185, DOI 10.1098/rstb.2009.0219; Runkel ED, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003346; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Schnable JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017855; Schneider KL, 2016, P NATL ACAD SCI USA, V113, pE987, DOI 10.1073/pnas.1522008113; van Heerwaarden J, 2012, P NATL ACAD SCI USA, V109, P12420, DOI 10.1073/pnas.1209275109; Wallace JG, 2014, HEREDITY, V112, P30, DOI 10.1038/hdy.2013.6; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; Xiang L, 2011, J EXP BOT, V62, P3849, DOI 10.1093/jxb/err069; Yang Q, 2013, P NATL ACAD SCI USA, V110, P16969, DOI 10.1073/pnas.1310949110; Zheng Y, 2011, J BIOL CHEM, V286, P36108, DOI 10.1074/jbc.M111.275974	34	4	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0169806	10.1371/journal.pone.0169806	http://dx.doi.org/10.1371/journal.pone.0169806			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099470	Green Submitted, gold, Green Published			2022-12-26	WOS:000392380100034
J	Kim, KA; Lee, A; Ki, M; Jeong, SH				Kim, Kyung-Ah; Lee, Anna; Ki, Moran; Jeong, Sook-Hyang			Nationwide Seropositivity of Hepatitis A in Republic of Korea from 2005 to 2014, before and after the Outbreak Peak in 2009	PLOS ONE			English	Article							EPIDEMIOLOGIC STATUS; VIRUS; SEROPREVALENCE; VACCINATION; MULTICENTER; INFECTION; ADULTS; AREA	Background/Aims The epidemiologic shift of hepatitis A virus (HAV) infection in the South Korean population resulted in a peak outbreak of hepatitis in 2009. The aim of this study was to clarify the seropositivity of anti-HAV antibody (anti-HAV) and its demographic characteristics before and after the peak outbreak from 2005 to 2014. Methods This retrospective study analyzed the anti-HAV data of all individuals from 1,795 medical institutions referred to a major central laboratory from January 2005 through December 2014, as a sentineal tool for monitoring annual variation of anti-HAV positivity. The prevalence of anti-HAV was adjusted for age and area with the standard population based on the 2010 Census data. Results A total of 424,245 individuals were included in this study. The overall age-adjusted anti-HAV prevalence decreased from 65.6% in 2005 to 62.2% in 2014. During the 10-year period, the seroprevalence continuously decreased in persons aged 30 to 39 years (69.6% to 32.4%) and those aged 40 to 49 years (97.9% to 79.3%) due to the cohort effect. In contrast, it increased in persons aged 10 to 19 years (15.4% to 35.2%), while it was the lowest (8.7%) in 2010 before rebounding to 20.2% in 2014 in persons aged 20 to 29 years due to a vaccination effect. Conclusion Although the HAV vaccination rate increased, the anti-HAV seropositivity in South Korea decreased from 65.6% to 62.2% in this study population. In particular, the immunity of young adults was still low, and an outbreak of HAV is possible in the near future. Therefore, continuous monitoring and optimal preventive measures to prevent future outbreaks should be considered.	[Kim, Kyung-Ah] Inje Univ, Ilsan Paik Hosp, Dept Internal Med, Goyang, South Korea; [Lee, Anna] Seoul Clin Labs, Dept Lab Med, Yongin, South Korea; [Ki, Moran] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Control & Policy, Goyang, South Korea; [Jeong, Sook-Hyang] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Internal Med, Seongnam, South Korea	Inje University; National Cancer Center - Korea (NCC); Seoul National University (SNU)	Jeong, SH (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Internal Med, Seongnam, South Korea.	jsh@snubh.org	Ki, Moran/R-6600-2019	Lee, Anna/0000-0002-2865-3869; kim, kyung-ah/0000-0002-6128-6407; Ki, Moran/0000-0002-8892-7104				AMELA C, 1995, EUR J EPIDEMIOL, V11, P569, DOI 10.1007/BF01719310; Chung GE, 2011, GUT LIVER, V5, P88, DOI 10.5009/gnl.2011.5.1.88; Chung SJ, 2014, CLIN MOL HEPATOL, V20, P162, DOI 10.3350/cmh.2014.20.2.162; Gupta E, 2014, J GLOB INFECT DIS, V6, P57, DOI 10.4103/0974-777X.132036; Havelaar AH, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001923; Heo JY, 2015, J KOREAN MED SCI, V30, P353, DOI 10.3346/jkms.2015.30.4.353; Hong WS, 1982, KOREAN J MED, V25, P19; Jacobsen KH, 2004, EPIDEMIOL INFECT, V132, P1005, DOI 10.1017/S0950268804002857; Jung YM, 2010, J MED VIROL, V82, P1318, DOI 10.1002/jmv.21822; Kim JH, 2008, J KOREAN MED ASSOC, V51, P110, DOI 10.5124/jkma.2008.51.2.110; Kwon SY, 2014, J KOREAN MED SCI, V29, P248, DOI 10.3346/jkms.2014.29.2.248; LEDNAR WM, 1985, AM J EPIDEMIOL, V122, P226, DOI 10.1093/oxfordjournals.aje.a114093; Lee Donghun, 2011, Korean J Hepatol, V17, P44, DOI 10.3350/kjhep.2011.17.1.44; Martin A, 2006, HEPATOLOGY, V43, pS164, DOI 10.1002/hep.21052; Moon S, 2016, J KOREAN MED SCI, V31, P67, DOI 10.3346/jkms.2016.31.1.67; Sohn YM, 2000, YONSEI MED J, V41, P34, DOI 10.3349/ymj.2000.41.1.34; Yun H, 2011, J MED VIROL, V83, P2073, DOI 10.1002/jmv.22229; Yun Seung Wook, 2011, Korean J Gastroenterol, V57, P166, DOI 10.4166/2011.57.3.166; ZANETTI AR, 1994, EUR J EPIDEMIOL, V10, P633, DOI 10.1007/BF01719584	19	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170432	10.1371/journal.pone.0170432	http://dx.doi.org/10.1371/journal.pone.0170432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099530	gold, Green Published, Green Submitted			2022-12-26	WOS:000392380100090
J	Wolwer, CB; Godde, N; Pase, LB; Elsum, IA; Lim, KYB; Sacirbegovic, F; Walkley, CR; Ellis, S; Ohno, S; Matsuzaki, F; Russell, SM; Humbert, PO				Wolwer, Christina B.; Godde, Nathan; Pase, Luke B.; Elsum, Imogen A.; Lim, Krystle Y. B.; Sacirbegovic, Faruk; Walkley, Carl R.; Ellis, Sarah; Ohno, Shigeo; Matsuzaki, Fumio; Russell, Sarah M.; Humbert, Patrick O.			The Asymmetric Cell Division Regulators Par3, Scribble and Pins/Gpsm2 Are Not Essential for Erythroid Development or Enucleation	PLOS ONE			English	Article							PROTEIN; MOUSE; ERYTHROBLASTS; ERYTHROPOIESIS; STEM; DIFFERENTIATION; POLARIZATION; MACROPHAGES; EXPRESSION; MATURATION	Erythroid enucleation is the process by which the future red blood cell disposes of its nucleus prior to entering the blood stream. This key event during red blood cell development has been likened to an asymmetric cell division (ACD), by which the enucleating erythroblast divides into two very different daughter cells of alternate molecular composition, a nucleated cell that will be removed by associated macrophages, and the reticulocyte that will mature to the definitive erythrocyte. Here we investigated gene expression of members of the Par, Scribble and Pins/Gpsm2 asymmetric cell division complexes in erythroid cells, and functionally tested their role in erythroid enucleation in vivo and ex vivo. Despite their roles in regulating ACD in other contexts, we found that these polarity regulators are not essential for erythroid enucleation, nor for erythroid development in vivo. Together our results put into question a role for cell polarity and asymmetric cell division in erythroid enucleation.	[Wolwer, Christina B.; Godde, Nathan; Pase, Luke B.; Elsum, Imogen A.; Humbert, Patrick O.] Peter MacCallum Canc Ctr, Cell Cycle & Canc Genet, East Melbourne, Australia; [Wolwer, Christina B.; Godde, Nathan; Lim, Krystle Y. B.; Humbert, Patrick O.] La Trobe Univ, Dept Biochem & Genet, La Trobe Inst Mol Sci, Melbourne, Vic, Australia; [Sacirbegovic, Faruk; Ellis, Sarah] Peter MacCallum Canc Ctr, Immune Signaling Lab, East Melbourne, Australia; [Sacirbegovic, Faruk; Ellis, Sarah; Russell, Sarah M.; Humbert, Patrick O.] Univ Melbourne, Dept Pathol, Parkville, Vic, Australia; [Walkley, Carl R.] St Vincents Inst Med Res, Fitzroy, Vic, Australia; [Walkley, Carl R.] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic, Australia; [Ohno, Shigeo] Yokohama City Univ, Grad Sch Med Sci, Dept Mol Biol, Yokohama, Kanagawa, Japan; [Matsuzaki, Fumio] RIKEN, Ctr Dev Biol, Lab Cell Asymmetry, Kobe, Hyogo, Japan; [Russell, Sarah M.; Humbert, Patrick O.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Russell, Sarah M.] Swinburne Univ Technol, Fac Engn & Ind Sci, Ctr Microphoton, Hawthorn, Vic, Australia; [Humbert, Patrick O.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic, Australia	Peter Maccallum Cancer Center; La Trobe University; Peter Maccallum Cancer Center; University of Melbourne; St. Vincent's Institute of Medical Research; St Vincent's Hospital Melbourne; University of Melbourne; Yokohama City University; RIKEN; Peter Maccallum Cancer Center; University of Melbourne; Swinburne University of Technology; University of Melbourne	Humbert, PO (corresponding author), Peter MacCallum Canc Ctr, Cell Cycle & Canc Genet, East Melbourne, Australia.; Humbert, PO (corresponding author), La Trobe Univ, Dept Biochem & Genet, La Trobe Inst Mol Sci, Melbourne, Vic, Australia.; Humbert, PO (corresponding author), Univ Melbourne, Dept Pathol, Parkville, Vic, Australia.; Humbert, PO (corresponding author), Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia.; Humbert, PO (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic, Australia.	p.humbert@latrobe.edu.au	Godde, Nathan/C-2698-2018; Walkley, Carl/AAO-6021-2020; Ohno, Shigeo/B-1768-2010; Russell, Sarah M/B-9341-2009; Humbert, Patrick O/L-4264-2016	Walkley, Carl/0000-0002-4784-9031; Ohno, Shigeo/0000-0002-1294-5269; Russell, Sarah M/0000-0001-5826-9641; Humbert, Patrick O/0000-0002-1366-6691; Lim, Krystle/0000-0002-4008-6529; Ellis, Sarah/0000-0002-5772-6051; Godde, Nathan/0000-0002-3413-407X; Matsuzaki, Fumio/0000-0001-7902-4520	Peter MacCallum Cancer Foundation; National Health and Medical Research Council of Australia (NHMRC); Australian Postgraduate Award (APA); NHMRC	Peter MacCallum Cancer Foundation; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award (APA)(Australian Government); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	The studies presented here were supported by the Peter MacCallum Cancer Foundation and a grant from the National Health and Medical Research Council of Australia (NHMRC). CBW was supported by the Australian Postgraduate Award (APA). POH and SMR were supported by a Senior Research Fellowship from the NHMRC.	BESSIS M, 1958, Rev Hematol, V13, P8; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Choi HS, 2013, STEM CELL RES, V10, P442, DOI 10.1016/j.scr.2013.02.003; Duncan FE, 2005, DEV BIOL, V280, P38, DOI 10.1016/j.ydbio.2004.12.034; EMERSON CP, 1956, ARCH INTERN MED, V97, P1; HANSPAL M, 1994, BLOOD, V84, P3494; Hebiguchi M, 2008, INT J HEMATOL, V88, P498, DOI 10.1007/s12185-008-0200-6; Heinrich AC, 2004, BLOOD, V104, P659, DOI 10.1182/blood-2003-05-1442; Hirose T, 2006, DEVELOPMENT, V133, P1389, DOI 10.1242/dev.02294; Ji P, 2008, NAT CELL BIOL, V10, P314, DOI 10.1038/ncb1693; Ji P, 2011, TRENDS CELL BIOL, V21, P409, DOI 10.1016/j.tcb.2011.04.003; Keerthivasan G, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/139851; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; KOURY ST, 1989, J CELL BIOL, V109, P3005, DOI 10.1083/jcb.109.6.3005; Lee JCM, 2004, BLOOD, V103, P1912, DOI 10.1182/blood-2003-03-0928; Migliaccio AR, 2010, HAEMATOL-HEMATOL J, V95, P1985, DOI 10.3324/haematol.2010.033225; Murdoch JN, 2001, GENOMICS, V78, P55, DOI 10.1006/geno.2001.6638; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; PATEL VP, 1987, J CELL BIOL, V105, P3105, DOI 10.1083/jcb.105.6.3105; Pearson HB, 2011, J CLIN INVEST, V121, P4257, DOI 10.1172/JCI58509; Pham K, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00026; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Singbrant S, 2011, BLOOD, V117, P5631, DOI 10.1182/blood-2010-11-320564; Soni S, 2006, J BIOL CHEM, V281, P20181, DOI 10.1074/jbc.M603226200; SUGIMOTO M, 1983, THYMUS, V5, P297; Ting SB, 2012, BLOOD, V119, P2510, DOI 10.1182/blood-2011-11-393272; Ubukawa K, 2012, BLOOD, V119, P1036, DOI 10.1182/blood-2011-06-361907; Wang JX, 2012, J CELL SCI, V125, P340, DOI 10.1242/jcs.088286; Wolwer CB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142655; Yassin M, 2016, CURR OPIN IMMUNOL, V39, P143, DOI 10.1016/j.coi.2016.02.004; Yoshida H, 2005, NATURE, V437, P754, DOI 10.1038/nature03964; Yu FW, 2006, NEURON, V51, P13, DOI 10.1016/j.neuron.2006.06.016; Zarbalis K, 2004, PLOS BIOL, V2, P1177, DOI 10.1371/journal.pbio.0020219	35	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0170295	10.1371/journal.pone.0170295	http://dx.doi.org/10.1371/journal.pone.0170295			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095473	Green Published, gold, Green Submitted			2022-12-26	WOS:000392372300076
J	Zaboikin, M; Zaboikina, T; Freter, C; Srinivasakumar, N				Zaboikin, Michail; Zaboikina, Tatiana; Freter, Carl; Srinivasakumar, Narasimhachar			Non-Homologous End Joining and Homology Directed DNA Repair Frequency of Double-Stranded Breaks Introduced by Genome Editing Reagents	PLOS ONE			English	Article							RESOLUTION MELTING ANALYSIS; CELL-CYCLE; TALE NUCLEASES; PATHWAY CHOICE; MUTATIONS; BRAF; SYSTEMS; DETECT; TOOL	Genome editing using transcription-activator like effector nucleases or RNA guided nucleases allows one to precisely engineer desired changes within a given target sequence. The genome editing reagents introduce double stranded breaks (DSBs) at the target site which can then undergo DNA repair by non-homologous end joining (NHEJ) or homology directed recombination (HDR) when a template DNA molecule is available. NHEJ repair results in indel mutations at the target site. As PCR amplified products from mutant target regions are likely to exhibit different melting profiles than PCR products amplified from wild type target region, we designed a high resolution melting analysis (HRMA) for rapid identification of efficient genome editing reagents. We also designed TaqMan assays using probes situated across the cut site to discriminate wild type from mutant sequences present after genome editing. The experiments revealed that the sensitivity of the assays to detect NHEJ-mediated DNA repair could be enhanced by selection of transfected cells to reduce the contribution of unmodified genomic DNA from untransfected cells to the DNA melting profile. The presence of donor template DNA lacking the target sequence at the time of genome editing further enhanced the sensitivity of the assays for detection of mutant DNA molecules by excluding the wild-type sequences modified by HDR. A second TaqMan probe that bound to an adjacent site, outside of the primary target cut site, was used to directly determine the contribution of HDR to DNA repair in the presence of the donor template sequence. The TaqMan qPCR assay, designed to measure the contribution of NHEJ and HDR in DNA repair, corroborated the results from HRMA. The data indicated that genome editing reagents can produce DSBs at high efficiency in HEK293T cells but a significant proportion of these are likely masked by reversion to wild type as a result of HDR. Supplying a donor plasmid to provide a template for HDR (that eliminates a PCR amplifiable target) revealed these cryptic DSBs and facilitated the determination of the true efficacy of genome editing reagents. The results indicated that in HEK293T cells, approximately 40% of the DSBs introduced by genome editing, were available for participation in HDR.	[Zaboikin, Michail; Zaboikina, Tatiana; Freter, Carl; Srinivasakumar, Narasimhachar] St Louis Univ, Dept Internal Med, Div Hematol Oncol, St Louis, MO 63103 USA	Saint Louis University	Srinivasakumar, N (corresponding author), St Louis Univ, Dept Internal Med, Div Hematol Oncol, St Louis, MO 63103 USA.	skumar15@slu.edu			Division of Hematology/Oncology; Cellular Therapy of Saint Louis University, Saint Louis, MO, USA; Bone Marrow Transplant	Division of Hematology/Oncology; Cellular Therapy of Saint Louis University, Saint Louis, MO, USA; Bone Marrow Transplant	The authors received no specific funding for this work from external agencies. The laboratory is supported through the Division of Hematology/Oncology, Bone Marrow Transplant, and Cellular Therapy of Saint Louis University, Saint Louis, MO, USA.	Basu S, 2015, P NATL ACAD SCI USA, V112, P4038, DOI 10.1073/pnas.1502370112; Boch J, 2011, NAT BIOTECHNOL, V29, P135, DOI 10.1038/nbt.1767; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chen D, 2014, SCI REP-UK, V4, DOI 10.1038/srep04168; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Gerini C, 2014, MOL CELL PROBE, V28, P19, DOI 10.1016/j.mcp.2013.09.001; Glazkova DV, 2014, MOL BIOL+, V48, P305, DOI 10.1134/S0026893314030054; Guedes JG, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-169; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kay S, 2009, CURR OPIN MICROBIOL, V12, P37, DOI 10.1016/j.mib.2008.12.006; Lin ST, 2014, ELIFE, V3, DOI 10.7554/eLife.02981; Miyaoka Y, 2016, SYSTEMATIC QUANTIFIC, V6, P1; Mjelle R, 2015, DNA REPAIR, V30, P53, DOI 10.1016/j.dnarep.2015.03.007; Mussolino C, 2012, CURR OPIN BIOTECH, V23, P644, DOI 10.1016/j.copbio.2012.01.013; Orthwein A, 2015, NATURE, V528, P422, DOI 10.1038/nature16142; Parant JM, 2009, DEV DYNAM, V238, P3168, DOI 10.1002/dvdy.22143; Pichler M, 2009, J MOL DIAGN, V11, P140, DOI 10.2353/jmoldx.2009.080100; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Simi L, 2008, AM J CLIN PATHOL, V130, P247, DOI 10.1309/LWDY1AXHXUULNVHQ; Srinivasakumar Narasimhachar, 2002, Methods Mol Med, V69, P275; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Thomas HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114632; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Vossen RHAM, 2009, HUM MUTAT, V30, P860, DOI 10.1002/humu.21019; Wang K, 2015, J BIOTECHNOL, V214, P128, DOI 10.1016/j.jbiotec.2015.09.029; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Wyvekens N, 2015, HUM GENE THER, V26, P425, DOI 10.1089/hum.2015.084; Yu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098282; Zhu L., 2015, WORLD J TRADIT CHIN, V1, P1; Zlotorynski E, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.24	34	31	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0169931	10.1371/journal.pone.0169931	http://dx.doi.org/10.1371/journal.pone.0169931			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095454	gold, Green Submitted, Green Published			2022-12-26	WOS:000392372300044
J	Cheng, SB; Liu, HT; Chen, SY; Lin, PT; Lai, CY; Huang, YC				Cheng, Shao-Bin; Liu, Hsiao-Tien; Chen, Sin-Yuan; Lin, Ping-Ting; Lai, Chia-Yu; Huang, Yi-Chia			Changes of Oxidative Stress, Glutathione, and Its Dependent Antioxidant Enzyme Activities in Patients with Hepatocellular Carcinoma before and after Tumor Resection	PLOS ONE			English	Article							INHIBITION; EXPRESSION; DAMAGE; BLOOD; CELLS; ACID	The changes in and relationship between oxidative stress and the glutathione (GSH) antioxidant system in the plasma and tissues of patients with hepatocellular carcinoma (HCC) before and after tumor resection have not been clearly determined. We investigated the changes in oxidative stress, GSH status and its dependent antioxidant enzyme activities in HCC patients before and after tumor resection, and to determine the association of oxidative stress with GSH and its dependent antioxidant enzyme activities in plasma and tissues. This study employed a cross-sectional design. Forty-four men and 16 women with HCC were recruited. Fasting blood was drawn on the day before the tumor resection and one month after the tumor resection. HCC tissue and adjacent normal liver tissue were obtained at the time of surgical resection. Patients had significantly increased plasma malondialdehyde (MDA) and oxidized-low density lipoprotein levels but decreased GSH and oxidized GSH levels before tumor resection compared with the corresponding post-resection values. GSH and trolox equivalent antioxidant capacity (TEAC) levels and activities of GSH peroxidase were significantly increased while MDA level was significantly lower in HCC tissue when compared with the adjacent normal tissue. The pre-resection plasma MDA level was significantly correlated with pre-resection plasma GSH concentration, and MDA level in HCC and adjacent normal tissues. Pre-resection plasma GSH concentration was significantly correlated with GSH and TEAC level in HCC tissue. HCC patients had increased oxidative stress, decreased GSH, and lower dependent antioxidant capacities before tumor resection. However, hepatocellular tumor had increased GSH and TEAC levels as well as GSH peroxidase activities which might protect itself against increased oxidative stress.	[Cheng, Shao-Bin; Liu, Hsiao-Tien; Lai, Chia-Yu] Taichung Vet Gen Hosp, Dept Surg, Div Gen Surg, Taichung, Taiwan; [Cheng, Shao-Bin] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chen, Sin-Yuan] Chung Shan Med Univ, Grad Program Nutr, Taichung, Taiwan; [Lin, Ping-Ting; Huang, Yi-Chia] Chung Shan Med Univ, Dept Nutr, Taichung, Taiwan; [Lin, Ping-Ting; Huang, Yi-Chia] Chung Shann Med Univ Hosp, Dept Nutr, Taichung, Taiwan	Taichung Veterans General Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University	Huang, YC (corresponding author), Chung Shan Med Univ, Dept Nutr, Taichung, Taiwan.; Huang, YC (corresponding author), Chung Shann Med Univ Hosp, Dept Nutr, Taichung, Taiwan.	ych@csmu.edu.tw	Huang, Yi-Chia/AAS-8877-2021; Liu, Hsiao-Tien/AAI-2015-2021	Huang, Yi-Chia/0000-0003-2234-4464; Liu, Hsiao-Tien/0000-0002-9704-4127	Ministry of Science and Technology, Taiwan [MOST 104-2320-B-040-009-MY3]; Taichung Veterans General Hospital [TCVGH-1064602C]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Taichung Veterans General Hospital	This study was supported by the Ministry of Science and Technology, Taiwan (MOST 104-2320-B-040-009-MY3) and Taichung Veterans General Hospital (TCVGH-1064602C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2009, PROSTAG LEUKOTR ESS, V81, P391, DOI 10.1016/j.plefa.2009.08.003; Abou Ghalia AH, 2000, CLIN BIOCHEM, V33, P657, DOI 10.1016/S0009-9120(00)00181-8; Arnao MB, 1996, ANAL BIOCHEM, V236, P255, DOI 10.1006/abio.1996.0164; Asayama Y, 2008, AM J ROENTGENOL, V190, pW28, DOI 10.2214/AJR.07.2117; Benlloch M, 2005, J BIOL CHEM, V280, P6950, DOI 10.1074/jbc.M408531200; Bianchi G, 2000, METABOLISM, V49, P1434, DOI 10.1053/meta.2000.16554; Bianchi G, 1997, J HEPATOL, V26, P606, DOI 10.1016/S0168-8278(97)80426-6; CHAI YC, 1994, ARCH BIOCHEM BIOPHYS, V310, P273, DOI 10.1006/abbi.1994.1167; Czeczot H, 2006, ACTA BIOCHIM POL, V53, P237; Edge SB, 2010, AJCC CANC STAGING MA; GRIFFITH OW, 1979, P NATL ACAD SCI USA, V76, P5606, DOI 10.1073/pnas.76.11.5606; Hammond CL, 2001, J HEPATOL, V34, P946, DOI 10.1016/S0168-8278(01)00037-X; Huang ZZ, 2001, FASEB J, V15, P19, DOI 10.1096/fj.00-0445fje; Jungst C, 2004, HEPATOLOGY, V39, P1663, DOI 10.1002/hep.20241; Kumaraguruparan R, 2002, CLIN CHIM ACTA, V325, P165, DOI 10.1016/S0009-8981(02)00292-9; Lapenna D, 2001, FREE RADICAL BIO MED, V31, P331, DOI 10.1016/S0891-5849(01)00584-6; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Marengo B, 2010, ONCOL REP, V23, P1241, DOI 10.3892/or_00000756; Miura Y, 2003, BIOCHEM BIOPH RES CO, V305, P160, DOI 10.1016/S0006-291X(03)00725-3; Ortega Angel L, 2011, Cancers (Basel), V3, P1285, DOI 10.3390/cancers3011285; Perquin M, 2001, J CANCER RES CLIN, V127, P368, DOI 10.1007/s004320000228; Sen CK, 2000, CURR TOP CELL REGUL, V36, P1; Traverso N, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/972913; Tsai SM, 2009, ANN CLIN BIOCHEM, V46, P394, DOI 10.1258/acb.2009.009029; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Yahya RS, 2013, CLIN LAB, V59, P969, DOI 10.7754/Clin.Lab.2012.120712; Yang LY, 2005, J CELL BIOCHEM, V96, P622, DOI 10.1002/jcb.20541; Yuan LY, 2009, MOL ASPECTS MED, V30, P29, DOI 10.1016/j.mam.2008.08.003	30	42	46	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0170016	10.1371/journal.pone.0170016	http://dx.doi.org/10.1371/journal.pone.0170016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081247	gold, Green Published, Green Submitted			2022-12-26	WOS:000391949500118
J	Han, HJ; Wen, HL; Zhao, L; Liu, JW; Luo, LM; Zhou, CM; Qin, XR; Zhu, YL; Zheng, XX; Yu, XJ				Han, Hui-Ju; Wen, Hong-ling; Zhao, Li; Liu, Jian-wei; Luo, Li-Mei; Zhou, Chuan-Min; Qin, Xiang-Rong; Zhu, Ye-Lei; Zheng, Xue-Xing; Yu, Xue-Jie			Novel Bartonella Species in Insectivorous Bats, Northern China	PLOS ONE			English	Article							MOLECULAR-DETECTION; FLEAS SIPHONAPTERA; SPP.; IDENTIFICATION; FLIES; NYCTERIBIIDAE; BACTEREMIA; STREBLIDAE; DISEASE; RODENTS	Bartonella species are emerging human pathogens. Bats are known to carry diverse Bartonella species, some of which are capable of infecting humans. However, as the second largest mammalian group by a number of species, the role of bats as the reservoirs of Bartonella species is not fully explored, in term of their species diversity and worldwide distribution. China, especially Northern China, harbors a number of endemic insectivorous bat species; however, to our knowledge, there are not yet studies about Bartonella in bats in China. The aim of the study was to investigate the prevalence and genetic diversity of Bartonella species in bats in Northern China. Bartonella species were detected by PCR amplification of gltA gene in 25.2% ( 27/107) bats in Mengyin County, Shandong Province of China, including 1/3 Rhinolophus ferrumequinum, 2/10 Rhinolophus pusillus, 9/16 Myotis fimbriatus, 1/5 Myotis ricketti, 14/58 Myotis pequinius. Phylogenetic analysis showed that Bartonella species detected in bats in this study clustered into ten groups, and some might be novel Bartonella species. An association between Bartonella species and bat species was demonstrated and co-infection with different Bartonella species in a single bat was also observed. Our findings expanded our knowledge on the genetic diversity of Bartonella in bats, and shed light on the ecology of bat-borne Bartonella species.	[Han, Hui-Ju; Liu, Jian-wei; Zhou, Chuan-Min; Yu, Xue-Jie] Shandong Univ, Sch Publ Hlth, Dept Epidemiol, Jinan, Shandong, Peoples R China; [Wen, Hong-ling; Zhao, Li; Qin, Xiang-Rong; Zhu, Ye-Lei; Zheng, Xue-Xing] Shandong Univ, Sch Publ Hlth, Dept Microbiol, Jinan, Shandong, Peoples R China; [Luo, Li-Mei] Shandong Ctr Dis Control & Prevent, Jinan, Shandong, Peoples R China; [Yu, Xue-Jie] Univ Texas Med Branch, Galveston, TX 77555 USA	Shandong University; Shandong University; University of Texas System; University of Texas Medical Branch Galveston	Yu, XJ (corresponding author), Shandong Univ, Sch Publ Hlth, Dept Epidemiol, Jinan, Shandong, Peoples R China.; Yu, XJ (corresponding author), Univ Texas Med Branch, Galveston, TX 77555 USA.	xuyu@utmb.edu	Yu, Xuejie/AAP-9246-2021	Zhou, Chuan-min/0000-0002-5975-4603	Shandong Province Science and Technology Development Program [2014GSF121004]; National Natural Science Funds of China [31570167, 81102171]	Shandong Province Science and Technology Development Program; National Natural Science Funds of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Shandong Province Science and Technology Development Program (grant number 2014GSF121004) and the National Natural Science Funds of China (grant numbers 31570167 and 81102171) awarded to XJY. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Ying, 2012, Am J Trop Med Hyg, V87, P518, DOI 10.4269/ajtmh.2012.12-0097; Bai Y, 2011, EMERG INFECT DIS, V17, P1269, DOI 10.3201/eid1707.101867; Billeter SA, 2008, MED VET ENTOMOL, V22, P1, DOI 10.1111/j.1365-2915.2008.00713.x; Billeter SA, 2012, PARASITOLOGY, V139, P324, DOI 10.1017/S0031182011002113; Billeter SA, 2011, APPL ENVIRON MICROB, V77, P7850, DOI 10.1128/AEM.06012-11; Birtles RJ, 2005, ANN NY ACAD SCI, V1063, P270, DOI 10.1196/annals.1355.044; Breitschwerdt EB, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-29; Breitschwerdt EB, 2010, J VET EMERG CRIT CAR, V20, P8, DOI 10.1111/j.1476-4431.2009.00496.x; Brook CE, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003532; Concannon R, 2005, PARASITOLOGY, V131, P489, DOI 10.1017/S0031182005008097; Dehio C, 2001, TRENDS MICROBIOL, V9, P279, DOI 10.1016/S0966-842X(01)02047-9; Dietrich M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152077; Eremeeva ME, 2007, NEW ENGL J MED, V356, P2381, DOI 10.1056/NEJMoa065987; Han HJ, 2015, VIRUS RES, V205, P1, DOI 10.1016/j.virusres.2015.05.006; Harms A, 2012, CLIN MICROBIOL REV, V25, P42, DOI 10.1128/CMR.05009-11; Judson SD, 2015, ZOONOSES PUBLIC HLTH, V62, P609, DOI 10.1111/zph.12188; Kamani J, 2014, VECTOR-BORNE ZOONOT, V14, P625, DOI 10.1089/vbz.2013.1541; Kosoy M, 2008, J CLIN MICROBIOL, V46, P772, DOI 10.1128/JCM.02120-07; Kosoy M, 2010, EMERG INFECT DIS, V16, P1875, DOI 10.3201/eid1612.100601; La Scola B, 2003, TRENDS MICROBIOL, V11, P318, DOI 10.1016/S0966-842X(03)00143-4; Lei BNR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002738; Lilley TM, 2015, VECTOR-BORNE ZOONOT, V15, P706, DOI 10.1089/vbz.2015.1783; Lin JW, 2012, VET MICROBIOL, V156, P119, DOI 10.1016/j.vetmic.2011.09.031; Linacre A, 2016, METHODS MOL BIOL, V1420, P287, DOI 10.1007/978-1-4939-3597-0_20; Maggi RG, 2012, EMERG INFECT DIS, V18, P783, DOI 10.3201/eid1805.111366; Mannerings AO, 2016, EMERG INFECT DIS, V22, P922, DOI 10.3201/eid2205.151908; McKee CD, 2016, INFECT GENET EVOL, V44, P382, DOI 10.1016/j.meegid.2016.07.033; Morse SF, 2012, INFECT GENET EVOL, V12, P1717, DOI 10.1016/j.meegid.2012.06.009; NORMAN AF, 1995, J CLIN MICROBIOL, V33, P1797, DOI 10.1128/JCM.33.7.1797-1803.1995; Olival KJ, 2015, J WILDLIFE DIS, V51, P274, DOI 10.7589/2014-04-113; Paziewska A, 2011, MICROB ECOL, V61, P134, DOI 10.1007/s00248-010-9735-1; Anh PH, 2015, EMERG INFECT DIS, V21, P1266, DOI 10.3201/eid2107.141760; Reeves WK, 2007, J VECTOR ECOL, V32, P118, DOI 10.3376/1081-1710(2007)32[118:AOBWTF]2.0.CO;2; Reeves WK, 2005, J VECTOR ECOL, V30, P339; Trowbridge RE, 2006, J INVERTEBR PATHOL, V91, P64, DOI 10.1016/j.jip.2005.08.009; Vayssier-Taussat M, 2016, EMERG INFECT DIS, V22, P457, DOI 10.3201/eid2203.150269; Veikkolainen V, 2014, EMERG INFECT DIS, V20, P960, DOI 10.3201/eid2006.130956	37	46	48	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e167915	10.1371/journal.pone.0167915	http://dx.doi.org/10.1371/journal.pone.0167915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081122	Green Published, gold, Green Submitted			2022-12-26	WOS:000391949500004
J	Sper, RB; Koh, S; Zhang, X; Simpson, S; Collins, B; Sommer, J; Petters, RM; Caballero, I; Platt, JL; Piedrahita, JA				Sper, Renan B.; Koh, Sehwon; Zhang, Xia; Simpson, Sean; Collins, Bruce; Sommer, Jeff; Petters, Robert M.; Caballero, Ignacio; Platt, Jeff L.; Piedrahita, Jorge A.			Generation of a Stable Transgenic Swine Model Expressing a Porcine Histone 2B-eGFP Fusion Protein for Cell Tracking and Chromosome Dynamics Studies	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; MATRIX-ATTACHMENT REGIONS; NUCLEAR TRANSFER; STEM-CELLS; SPINDLE FORMATION; PIGS; EMBRYOS; INJURY; MICE; TRANSITION	Transgenic pigs have become an attractive research model in the field of translational research, regenerative medicine, and stem cell therapy due to their anatomic, genetic and physiological similarities with humans. The development of fluorescent proteins as molecular tags has allowed investigators to track cell migration and engraftment levels after transplantation. Here we describe the development of two transgenic pig models via SCNT expressing a fusion protein composed of eGFP and porcine Histone 2B (pH2B). This fusion protein is targeted to the nucleosomes resulting a nuclear/chromatin eGFP signal. The first model (I) was generated via random insertion of pH2B-eGFP driven by the CAG promoter (chicken beta actin promoter and rabbit Globin poly A; pCAG-pH2B-eGFP) and protected by human interferon-beta matrix attachment regions (MARs). Despite the consistent, high, and ubiquitous expression of the fusion protein pH2B-eGFP in all tissues analyzed, two independently generated Model I transgenic lines developed neurodegenerative symptoms including Wallerian degeneration between 3-5 months of age, requiring euthanasia. A second transgenic model (II) was developed via CRISPR-Cas9 mediated homology-directed repair (HDR) of IRES-pH2B-eGFP into the endogenous beta-actin (ACTB) locus. Model II transgenic animals showed ubiquitous expression of pH2B-eGFP on all tissues analyzed. Unlike the pCAG-pH2B-eGFP/MAR line, all Model II animals were healthy and multiple pregnancies have been established with progeny showing the expected Mendelian ratio for the transmission of the pH2B-eGFP. Expression of pH2B-eGFP was used to examine the timing of the maternal to zygotic transition after IVF, and to examine chromosome segregation of SCNT embryos. To our knowledge this is the first viable transgenic pig model with chromatin-associated eGFP allowing both cell tracking and the study of chromatin dynamics in a large animal model.	[Sper, Renan B.; Zhang, Xia; Simpson, Sean; Collins, Bruce; Petters, Robert M.; Caballero, Ignacio; Piedrahita, Jorge A.] North Carolina State Univ, Comparat Med Inst, Raleigh, NC 27695 USA; [Sper, Renan B.; Zhang, Xia; Simpson, Sean; Piedrahita, Jorge A.] North Carolina State Univ, Dept Mol Biomed Sci, Coll Vet Med, Raleigh, NC 27695 USA; [Koh, Sehwon; Platt, Jeff L.] Univ Michigan Hlth Syst, Dept Surg & Microbiol & Immunol, Ann Arbor, MI USA; [Collins, Bruce; Sommer, Jeff; Petters, Robert M.] North Carolina State Univ, Dept Anim Sci, Coll Agr & Life Sci, Raleigh, NC USA; [Koh, Sehwon] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Caballero, Ignacio] French Natl Inst Agr Res INRA, Nouzilly, France	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of Michigan System; University of Michigan; University of North Carolina; North Carolina State University; Duke University; INRAE	Piedrahita, JA (corresponding author), North Carolina State Univ, Comparat Med Inst, Raleigh, NC 27695 USA.; Piedrahita, JA (corresponding author), North Carolina State Univ, Dept Mol Biomed Sci, Coll Vet Med, Raleigh, NC 27695 USA.	japiedra@ncsu.edu	; Koh, Sehwon/I-4084-2013	Caballero, Ignacio/0000-0002-0628-4134; Koh, Sehwon/0000-0003-2861-1738; Platt, Jeffrey/0000-0002-4915-0419	NIH [HL051587, R01HL051587]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051587] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH HL051587 to JAP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Flowers and the staff from the Swine Educational Unit, department of Animal Science, North Carolina State University, Kayla Lannom, Stephen Byrd and Charles Salmon for their assistance and help. Funding provided by NIH R01HL051587.	Aigner B, 2010, J MOL MED, V88, P653, DOI 10.1007/s00109-010-0610-9; Allen GC, 2000, PLANT MOL BIOL, V43, P361, DOI 10.1023/A:1006424621037; Baschong W, 2001, J HISTOCHEM CYTOCHEM, V49, P1565, DOI 10.1177/002215540104901210; Bordignon V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064613; Brunetti D, 2008, CLONING STEM CELLS, V10, P409, DOI 10.1089/clo.2008.0036; Byrne G, 1997, TRANSPLANTATION, V63, P149, DOI 10.1097/00007890-199701150-00027; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Challen GA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002357; Chen CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023376; Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; Cuttler AS, 2011, GENESIS, V49, P673, DOI 10.1002/dvg.20769; Dai YP, 2006, REPRODUCTION, V131, P1051, DOI 10.1530/rep.1.01058; Daley GQ, 2010, J CLIN INVEST, V120, P8, DOI 10.1172/JCI41801; DURAND RE, 1982, J HISTOCHEM CYTOCHEM, V30, P111, DOI 10.1177/30.2.7061816; Fischer Andrew H, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4986; Fuchs E, 2011, NAT CELL BIOL, V13, P513, DOI 10.1038/ncb0511-513; Garrels W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023573; Hadjantonakis AK, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-33; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; JARRELL VL, 1991, BIOL REPROD, V44, P62, DOI 10.1095/biolreprod44.1.62; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kawarasaki T, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3241985; Kikuchi K, 1998, THERIOGENOLOGY, V50, P615, DOI 10.1016/S0093-691X(98)00166-6; Klassen H, 2008, CLONING STEM CELLS, V10, P391, DOI 10.1089/clo.2008.0010; Kruger AV, 2015, DEV BIOL, V398, P153, DOI 10.1016/j.ydbio.2014.10.014; Kwon DJ, 2010, J VET SCI, V11, P93, DOI 10.4142/jvs.2010.11.2.93; Lai LX, 2002, MOL REPROD DEV, V62, P300, DOI 10.1002/mrd.10146; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102455; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Martin RM, 2005, CYTOM PART A, V67A, P45, DOI 10.1002/cyto.a.20172; Maze I, 2014, NAT REV GENET, V15, P259, DOI 10.1038/nrg3673; MCKNIGHT RA, 1992, P NATL ACAD SCI USA, V89, P6943, DOI 10.1073/pnas.89.15.6943; Miles EL, 2013, P NATL ACAD SCI USA, V110, P6334, DOI 10.1073/pnas.1220910110; Misteli T, 1997, NAT BIOTECHNOL, V15, P961, DOI 10.1038/nbt1097-961; Mitchell KE, 2003, STEM CELLS, V21, P50, DOI 10.1634/stemcells.21-1-50; Mizutani E, 2012, DEV BIOL, V364, P56, DOI 10.1016/j.ydbio.2012.01.001; Moldovan M, 2009, BRAIN, V132, P511, DOI 10.1093/brain/awn332; Moreno R, 2011, TISSUE ENG PART C-ME, V17, P275, DOI [10.1089/ten.tec.2010.0383, 10.1089/ten.TEC.2010.0383]; Murakami T, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2007947; Namciu SJ, 1998, MOL CELL BIOL, V18, P2382, DOI 10.1128/MCB.18.4.2382; Nowak-Imialek M, 2011, STEM CELLS DEV, V20, P1564, DOI 10.1089/scd.2010.0399; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Park KW, 2002, BIOL REPROD, V66, P1001, DOI 10.1095/biolreprod66.4.1001; Prather RS, 2003, THERIOGENOLOGY, V59, P115, DOI 10.1016/S0093-691X(02)01263-3; Qiu JJ, 2014, STEM CELL REP, V2, P473, DOI 10.1016/j.stemcr.2014.01.016; Ronaghi M, 2010, STEM CELLS, V28, P93, DOI 10.1002/stem.253; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Schwartz PH, 2005, STEM CELLS, V23, P1286, DOI 10.1634/stemcells.2004-0306; Shen JL, 2015, ZYGOTE, V23, P76, DOI 10.1017/S0967199413000634; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Takahashi R, 2007, TRANSGENIC RES, V16, P115, DOI 10.1007/s11248-006-9043-1; Tan WF, 2013, P NATL ACAD SCI USA, V110, P16526, DOI 10.1073/pnas.1310478110; Tarasov A, 2015, BIOINFORMATICS, V31, P2032, DOI 10.1093/bioinformatics/btv098; Tenjinbaru K, 1999, FEBS LETT, V444, P1, DOI 10.1016/S0014-5793(99)00002-2; Theise ND, 2003, SCIENCE, V299, p1317A, DOI 10.1126/science.1078412; Tomioka I, 2007, J REPROD DEVELOP, V53, P835, DOI 10.1262/jrd.18144; Trichas G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-40; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Van Thuan N, 2006, BIOL REPROD, V74, P777, DOI 10.1095/biolreprod.105.044677; Walker Shawn C., 2002, Cloning and Stem Cells, V4, P105, DOI 10.1089/153623002320253283; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Xiao Z, 2000, P NATL ACAD SCI USA, V97, P7853, DOI 10.1073/pnas.97.14.7853; Xin JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084250; Yamauchi K, 2007, CELL CYCLE, V6, P2706, DOI 10.4161/cc.6.21.4861; Yang Yanfei, 2012, Anat Res Int, V2012, P820120, DOI 10.1155/2012/820120; You J, 2010, REPROD FERT DEVELOP, V22, P977, DOI 10.1071/RD09309; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	70	12	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169242	10.1371/journal.pone.0169242	http://dx.doi.org/10.1371/journal.pone.0169242			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081156	Green Published, Green Submitted, gold			2022-12-26	WOS:000391949500034
J	Shi, SY; Luk, CT; Schroer, SA; Kim, MJ; Dodington, DW; Sivasubramaniyam, T; Lin, LR; Cai, EP; Lu, SY; Wagner, KU; Bazinet, RP; Woo, M				Shi, Sally Yu; Luk, Cynthia T.; Schroer, Stephanie A.; Kim, Min Jeong; Dodington, David W.; Sivasubramaniyam, Tharini; Lin, Lauren; Cai, Erica P.; Lu, Shun-Yan; Wagner, Kay-Uwe; Bazinet, Richard P.; Woo, Minna			Janus Kinase 2 (JAK2) Dissociates Hepatosteatosis from Hepatocellular Carcinoma in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell death; cell proliferation; hepatocellular carcinoma; inflammation; Janus kinase (JAK); mouse; diethylnitrosamine; non-alcoholic fatty liver disease	FATTY LIVER-DISEASE; NF-KAPPA-B; NONALCOHOLIC STEATOHEPATITIS; CHEMICAL HEPATOCARCINOGENESIS; CANCER DEVELOPMENT; HEPATIC STEATOSIS; MOUSE MODELS; INFLAMMATION; EXPRESSION; ACTIVATION	Hepatocellular carcinoma is an end-stage complication of non-alcoholic fatty liver disease (NAFLD). Inflammation plays a critical role in the progression of non-alcoholic fatty liver disease and the development of hepatocellular carcinoma. However, whether steatosis per se promotes liver cancer, and the molecular mechanisms that control the progression in this disease spectrum remain largely elusive. The Janus kinase signal transducers and activators of transcription (JAK-STAT) pathway mediates signal transduction by numerous cytokines that regulate inflammation and may contribute to hepatocarcinogenesis. Mice with hepatocyte-specific deletion of JAK2 (L-JAK2 KO) develop extensive fatty liver spontaneously. We show here that this simple steatosis was insufficient to drive carcinogenesis. In fact, L-JAK2 KO mice were markedly protected from chemically induced tumor formation. Using the methionine choline-deficient dietary model to induce steatohepatitis, we found that steatohepatitis development was completely arrested in L-JAK2 KO mice despite the presence of steatosis, suggesting that JAK2 is the critical factor required for inflammatory progression in the liver. In line with this, L-JAK2 KO mice exhibited attenuated inflammation after chemical carcinogen challenge. This was associated with increased hepatocyte apoptosis without elevated compensatory proliferation, thus thwarting expansion of transformed hepatocytes. Taken together, our findings identify an indispensable role of JAK2 in hepatocarcinogenesis through regulating critical inflammatory pathways. Targeting the JAK-STAT pathway may provide a novel therapeutic option for the treatment of hepatocellular carcinoma.	[Shi, Sally Yu; Luk, Cynthia T.; Schroer, Stephanie A.; Kim, Min Jeong; Dodington, David W.; Sivasubramaniyam, Tharini; Cai, Erica P.; Lu, Shun-Yan; Woo, Minna] Toronto Gen Hosp, Res Inst, Toronto, ON M5G 2C4, Canada; [Shi, Sally Yu; Luk, Cynthia T.; Sivasubramaniyam, Tharini; Cai, Erica P.; Woo, Minna] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Kim, Min Jeong] Sungkyunkwan Univ, Inst Med Res, Kangbuk Samsung Hosp, Sch Med, Seoul 03181, South Korea; [Lin, Lauren; Bazinet, Richard P.] Univ Toronto, Dept Nutr Sci, Toronto, ON M5S 3E2, Canada; [Wagner, Kay-Uwe] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Wagner, Kay-Uwe] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Woo, Minna] Univ Toronto, Div Endocrinol, Dept Med, Toronto Gen Hosp,Univ Hlth Network, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Sungkyunkwan University (SKKU); University of Toronto; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Woo, M (corresponding author), Toronto Gen Hosp, Res Inst, MaRS Ctr TMDT, 101 Coll St,Rm 10-363, Toronto, ON M5G 1L7, Canada.	mwoo@uhnresearch.ca	Dodington, David W/GNM-6943-2022; Cai, Erica/ABE-4408-2020	Shi, Sally Yu/0000-0002-5528-3824; Wagner, Kay-Uwe/0000-0002-5081-0226; Dodington, David/0000-0003-3575-3259; Cai, Erica/0000-0003-2386-5747	Canadian Institute of Health Research (CIHR) [MOP-142193]; Canadian Cancer Society Innovation Grant; Canadian Diabetes Association (CDA); CIHR Doctoral Research Award; CDA Doctoral Student Research Award; Canadian Liver Foundation Graduate Studentship; Eliot Phillipson Clinician Scientist Training Program; CDA Postdoctoral Fellowship; Banting and Best Diabetes Centre Postdoctoral Fellowship; Canada Research Chair in Signal Transduction in Diabetes Pathogenesis	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Innovation Grant; Canadian Diabetes Association (CDA); CIHR Doctoral Research Award(Canadian Institutes of Health Research (CIHR)); CDA Doctoral Student Research Award; Canadian Liver Foundation Graduate Studentship; Eliot Phillipson Clinician Scientist Training Program; CDA Postdoctoral Fellowship; Banting and Best Diabetes Centre Postdoctoral Fellowship; Canada Research Chair in Signal Transduction in Diabetes Pathogenesis	This work was supported by Canadian Institute of Health Research (CIHR) Operating Grant MOP-142193, a Canadian Cancer Society Innovation Grant, and by a Canadian Diabetes Association (CDA) grant-in-aid (to M. W.), The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a CIHR Doctoral Research Award, a CDA Doctoral Student Research Award, and a Canadian Liver Foundation Graduate Studentship.; Supported by the Eliot Phillipson Clinician Scientist Training Program, a CDA Postdoctoral Fellowship, and a Banting and Best Diabetes Centre Postdoctoral Fellowship.; Supported by the Canada Research Chair in Signal Transduction in Diabetes Pathogenesis. To whom correspondence should be addressed: Toronto General Hospital Research Institute, 101 College St., MaRS Centre/TMDT, Rm. 10-363, Toronto, Ontario, Canada M5G 1L7. Tel.: 416-581-7531; Fax: 416-581-7880; E-mail: mwoo@uhnresearch.ca.	Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; BACON BR, 1994, GASTROENTEROLOGY, V107, P1103, DOI 10.1016/0016-5085(94)90235-6; Chen CT, 2011, J NEUROCHEM, V116, P363, DOI 10.1111/j.1471-4159.2010.07116.x; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; DIEHL AM, 1988, GASTROENTEROLOGY, V95, P1056, DOI 10.1016/0016-5085(88)90183-7; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Ellouk-Achard S, 1998, J HEPATOL, V29, P807, DOI 10.1016/S0168-8278(98)80263-8; Ertle J, 2011, INT J CANCER, V128, P2436, DOI 10.1002/ijc.25797; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Freitas MCS, 2010, LIVER TRANSPLANT, V16, P600, DOI 10.1002/lt.22036; Gao B, 2005, CELL MOL IMMUNOL, V2, P92; Gao DQ, 2004, AM J PHYSIOL-GASTR L, V287, pG1070, DOI 10.1152/ajpgi.00228.2004; Ghebranious N, 1998, HEPATOLOGY, V27, P383, DOI 10.1002/hep.510270211; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Hosui A, 2009, J EXP MED, V206, P819, DOI 10.1084/jem.20080003; Joung YH, 2014, INT J ONCOL, V44, P883, DOI 10.3892/ijo.2014.2250; Judd LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095993; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Klein S, 2017, GUT, V66, P145, DOI 10.1136/gutjnl-2015-309600; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Lee JH, 2013, CLIN CANCER RES, V19, P6777, DOI 10.1158/1078-0432.CCR-13-1110; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Nakagawa H, 2014, CANCER CELL, V26, P331, DOI 10.1016/j.ccr.2014.07.001; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Poonawala A, 2000, HEPATOLOGY, V32, P689, DOI 10.1053/jhep.2000.17894; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; Schattenberg JM, 2010, DIGEST DIS, V28, P247, DOI 10.1159/000282097; Shi SY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8415; Shi SY, 2012, J BIOL CHEM, V287, P10277, DOI 10.1074/jbc.M111.317453; Sos BC, 2011, J CLIN INVEST, V121, P1412, DOI 10.1172/JCI42894; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Upegui-Gonzalez LC, 1998, ADV EXP MED BIOL, V451, P35; VESSELINOVITCH SD, 1983, CANCER RES, V43, P4253; Wang LY, 2014, NAT MED, V20, P488, DOI 10.1038/nm.3527; Weltman MD, 1996, GASTROENTEROLOGY, V111, P1645, DOI 10.1016/S0016-5085(96)70028-8; Wolf MJ, 2014, CANCER CELL, V26, P549, DOI 10.1016/j.ccell.2014.09.003; Wree A, 2013, NAT REV GASTRO HEPAT, V10, P627, DOI 10.1038/nrgastro.2013.149; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yu JH, 2012, HEPATOLOGY, V56, P2375, DOI 10.1002/hep.25900	47	12	13	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3789	3799		10.1074/jbc.M116.752519	http://dx.doi.org/10.1074/jbc.M116.752519			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28100771	Green Published, hybrid			2022-12-26	WOS:000395542500021
J	Zeng, J; Deng, SW; Wang, YP; Li, P; Tang, L; Pang, YF				Zeng, Jia; Deng, Senwen; Wang, Yiping; Li, Ping; Tang, Lian; Pang, Yefeng			Specific Inhibition of Acyl-CoA Oxidase-1 by an Acetylenic Acid Improves Hepatic Lipid and Reactive Oxygen Species (ROS) Metabolism in Rats Fed a High Fat Diet	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyl coenzyme A (acetyl-CoA); fatty acid; fatty acid metabolism; fatty acid oxidation; inhibitor; metabolism	PEROXISOMAL BETA-OXIDATION; ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; INSULIN-RESISTANCE; LIVER; MICE; DISEASE; CLOFIBRATE; EXPRESSION; OBESITY	A chronic high fat diet results in hepatic mitochondrial dysfunction and induction of peroxisomal fatty acid oxidation (FAO); whether specific inhibition of peroxisomal FAO benefits mitochondrial FAO and reactive oxygen species (ROS) metabolism remains unclear. In this study a specific inhibitor for the rate-limiting enzyme involved in peroxisomal FAO, acyl-CoA oxidase-1 (ACOX1) was developed and used for the investigation of peroxisomal FAO inhibition upon mitochondrial FAO and ROS metabolism. Specific inhibition of ACOX1 by 10,12-tricosadiynoic acid increased hepatic mitochondrial FAO via activation of the SIRT1-AMPK (adenosine 5-monophosphate-activated protein kinase) pathway and proliferator activator receptor and reduced hydrogen peroxide accumulation in high fat diet-fed rats, which significantly decreased hepatic lipid and ROS contents, reduced body weight gain, and decreased serum triglyceride and insulin levels. Inhibition of ACOX1 is a novel and effective approach for the treatment of high fat diet- or obesity-induced metabolic diseases by improving mitochondrial lipid and ROS metabolism.	[Zeng, Jia; Deng, Senwen; Wang, Yiping; Li, Ping; Tang, Lian; Pang, Yefeng] Hunan Univ Sci & Technol, Sch Life Sci, Xiangtan 411201, Hunan, Peoples R China	Hunan University of Science & Technology	Zeng, J (corresponding author), Hunan Univ Sci & Technol, Sch Life Sci, Xiangtan 411201, Hunan, Peoples R China.	zengj@hnu.edu.cn			National Natural Science Fund of China [30900024]; Doctoral Program of Ministry of Education of China [200805331034]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Doctoral Program of Ministry of Education of China(Ministry of Education, China)	This work was supported by the National Natural Science Fund of China (30900024) and the Doctoral Program of Ministry of Education of China (200805331034). The authors declare that they have no conflicts of interest with the contents of this article.	DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; Fatope MO, 2000, J AGR FOOD CHEM, V48, P1872, DOI 10.1021/jf990550k; Fransen M, 2012, BBA-MOL BASIS DIS, V1822, P1363, DOI 10.1016/j.bbadis.2011.12.001; GOEL SK, 1986, CANCER RES, V46, P1324; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Huang JS, 2012, FASEB J, V26, P628, DOI 10.1096/fj.11-194019; Huang JS, 2011, AM J PATHOL, V179, P703, DOI 10.1016/j.ajpath.2011.04.030; Ishiyama H, 1997, J ORG CHEM, V62, P3831, DOI 10.1021/jo970206r; Jia Z, 2004, PROTEIN EXPRES PURIF, V38, P153, DOI 10.1016/j.pep.2004.08.013; Kasumov T, 2005, BIOCHEM J, V389, P397, DOI 10.1042/BJ20050144; Kuklev DV, 2013, PHYTOMEDICINE, V20, P1145, DOI 10.1016/j.phymed.2013.06.009; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; LAZAROW PB, 1976, P NATL ACAD SCI USA, V73, P2043, DOI 10.1073/pnas.73.6.2043; Lee YH, 2015, J AGR FOOD CHEM, V63, P7361, DOI 10.1021/acs.jafc.5b02876; Li D, 1999, J AM CHEM SOC, V121, P9034, DOI 10.1021/ja991908w; Li YX, 2000, DNA CELL BIOL, V19, P113, DOI 10.1089/104454900314627; Luo YS, 2000, ARCH BIOCHEM BIOPHYS, V384, P1, DOI 10.1006/abbi.2000.2079; Mari M, 2010, ANTIOXID REDOX SIGN, V12, P1295, DOI 10.1089/ars.2009.2634; Matsuda M, 2013, OBES RES CLIN PRACT, V7, pE330, DOI 10.1016/j.orcp.2013.05.004; NEAT CE, 1980, BIOCHEM J, V186, P369, DOI 10.1042/bj1860369; Nilakantan V, 1998, CARCINOGENESIS, V19, P631, DOI 10.1093/carcin/19.4.631; Nsiah-Sefaa A, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20150295; NUGTEREN DH, 1987, PROSTAGLANDINS, V33, P403, DOI 10.1016/0090-6980(87)90022-0; PARDRIDGE WM, 1980, J CLIN INVEST, V66, P88, DOI 10.1172/JCI109839; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Rani V, 2016, LIFE SCI, V148, P183, DOI 10.1016/j.lfs.2016.02.002; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Reszko AE, 2004, J BIOL CHEM, V279, P19574, DOI 10.1074/jbc.M400162200; ROGNSTAD R, 1991, BIOCHEM J, V279, P147, DOI 10.1042/bj2790147; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Shin M, 1998, BIOCHEM PHARMACOL, V55, P367, DOI 10.1016/S0006-2952(97)00507-8; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; THOMAS H, 1989, BIOCHEM PHARMACOL, V38, P4291, DOI 10.1016/0006-2952(89)90528-5; THOMASSEN MS, 1982, BIOCHEM J, V206, P195, DOI 10.1042/bj2060195; Turecky L, 2014, PHYSIOL RES, V63, pS585, DOI 10.33549/physiolres.932918; Walton PA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00108; Zeng J, 2006, BBA-GEN SUBJECTS, V1760, P78, DOI 10.1016/j.bbagen.2005.09.010; Zeng J, 2008, ORG LETT, V10, P4287, DOI 10.1021/ol801571n; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhang DY, 2010, CELL METAB, V11, P402, DOI 10.1016/j.cmet.2010.03.012	40	54	55	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3800	3809		10.1074/jbc.M116.763532	http://dx.doi.org/10.1074/jbc.M116.763532			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28077576	hybrid, Green Published			2022-12-26	WOS:000395542500022
J	Hu, J; Gu, X; Tao, XR; Qian, YS; Babu, GR; Wang, GY; Liao, MZ; Han, L; Kang, DM; Tang, WM				Hu, Jun; Gu, Xu; Tao, Xiaorun; Qian, Yaosheng; Babu, Giridhara R.; Wang, Guoyong; Liao, Meizhen; Han, Larry; Kang, Dianmin; Tang, Weiming			Prevalence and Trends of HIV, Syphilis, and HCV in Migrant and Resident Men Who Have Sex with Men in Shandong, China: Results from a Serial Cross-Sectional Study	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; RISK BEHAVIORS; PREVENTION; MIGRATION	Background Migrant men who have sex with men (MSM) have a higher predisposition for HIV transmission. We aimed to determine and compare the prevalence and trends of HIV, Syphilis, and HCV between migrant and resident MSM in Shandong, China. Methods A serial cross-sectional study was conducted in eight cities in Shandong, China from 2010 to 2014. The surveys collected information on demographics, HIV-related knowledge, and HIV-related behaviors including the serologic status of HIV, syphilis, and HCV. Bivariate and multivariable logistic regressions were used to determine differences between migrant and resident MSM. Results The overall prevalence of HIV among the 15,705 MSM (14120 were resident, 1580 were migrant and 5 were missing) was 2.6%, with an increase of 1.0% in 2010 to 4.4% in 2014. Prevalence of HIV was higher among migrant MSMs (5.5%) compared to resident MSMs (2.3%). Compared to residents, migrants also had higher prevalence of syphilis (7.5% vs 4.9%) and HCV (1.1% vs 0.6%). We found that there was an increase in the proportion of migrant MSM engaging in anal sex [adjusted OR (AOR) = 1.41 in migrants vs 1.12 in residents], condom use during last anal sex (AOR =1.14 in residents, P for trend = 0.32), consistent condom use (AOR = 1.04 residents, P for trend = 0.11) and drug use (AOR = 1.51 in migrants and 1.29 among residents). Except in the year 2011, receiving some health services in last year was significant for people who were HIV-positive compared to negative. (P for trend <0.05). Conclusions Prevalence of HIV increased in resident as well as migrant MSMs. The migrant MSMs had higher STIs compared to resident MSMs and therefore, should be targeted for effective interventions aimed at reducing their risk behaviors. Deeper understanding of the role of migration in health issues is required for combating the persistently high and gradually increasing HIV burden in MSM in China.	[Hu, Jun; Tao, Xiaorun; Qian, Yaosheng; Wang, Guoyong; Liao, Meizhen; Kang, Dianmin] Shandong Prov Ctr Dis Control & Prevent, Inst HIV AIDS Prevent & Control, Jinan, Shandong, Peoples R China; [Gu, Xu] Weifang Med Coll, Sch Publ Hlth, Dept Epidemiol, Weifang, Shandong, Peoples R China; [Babu, Giridhara R.] Publ Hlth Fdn India, IIPH H, Bangalore, Karnataka, India; [Han, Larry; Tang, Weiming] Univ N Carolina, Project China, Guangzhou, Guangdong, Peoples R China	Weifang Medical University; Public Health Foundation of India		dmkang66@163.com; weimingtangscience@gmail.com	Babu, Giridhara R./C-2482-2011	Babu, Giridhara R./0000-0003-4370-8933; Han, Larry/0000-0002-0577-9661	National Institutes of Health [NIAID 1R01AI114310, FIC 1D43TW00953]; FOGARTY INTERNATIONAL CENTER [R25TW009340, D43TW009532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	WT are receiving grants (NIAID 1R01AI114310 and FIC 1D43TW00953) from National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. For the remaining authors, none were declared.	Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Estcourt CS, 2000, SEX TRANSM INFECT, V76, P294, DOI 10.1136/sti.76.4.294; Guo Y, 2012, AIDS CARE, V24, P451, DOI 10.1080/09540121.2011.613914; Han K-Q., 2011, SOCIOLOGY MIND, V1, P206, DOI 10.4236/sm.2011.14026; He Q, 2011, SEXUALLY TRANSMITTED; Mao HY, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005351; Meng XJ, 2013, SEX HEALTH, V10, P211, DOI 10.1071/SH12093; Qin Q, 2016, SCI REPORTS, V6; Sentinel C. H., GUIDELINES CONDUCTIN; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; Song Y, 2011, AIDS CARE, V23, P179, DOI 10.1080/09540121.2010.487088; Sullivan PS, 2009, ANN EPIDEMIOL, V19, P423, DOI 10.1016/j.annepidem.2009.03.004; Tao XR, 2008, BIOSCI TRENDS, V2, P97; Wang B, 2013, AIDS CARE, V25, P249, DOI 10.1080/09540121.2012.701714; Wang W, 2010, INT J STD AIDS, V21, P410, DOI 10.1258/ijsa.2009.008518; Wang WW, 2006, ENVIRON PLANN A, V38, P939, DOI 10.1068/a37428; Wong FY, 2008, AIDS CARE, V20, P170, DOI 10.1080/09540120701534707; Yang X, 2007, AIDS CARE, V19, P282, DOI 10.1080/09540120600909414; Zou X, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-490	20	16	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170443	10.1371/journal.pone.0170443	http://dx.doi.org/10.1371/journal.pone.0170443			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI3HP	28103295	gold, Green Published, Green Submitted			2022-12-26	WOS:000392381100068
J	Noto, AE; Shurin, JB				Noto, Akana E.; Shurin, Jonathan B.			Early Stages of Sea-Level Rise Lead To Decreased Salt Marsh Plant Diversity through Stronger Competition in Mediterranean-Climate Marshes	PLOS ONE			English	Article							SAN-FRANCISCO BAY; RELATIVE IMPORTANCE; COMMUNITY; RESPONSES; BIODIVERSITY; GRADIENTS; ACCRETION; HERBIVORY; ECOSYSTEM; SALINITY	Climate change shuffles species ranges and creates novel interactions that may either buffer communities against climate change or exacerbate its effect. For instance, facilitation can become more prevalent in salt marshes under stressful conditions while competition is stronger in benign environments. Sea-level rise (SLR) is a consequence of climate change that affects the distribution of stress from inundation and salinity. To determine how interactions early in SLR are affected by changes in these two stressors in Mediterranean-climate marshes, we transplanted marsh turfs to lower elevations to simulate SLR and manipulated cover of the dominant plant species, Salicornia pacifica (formerly Salicornia virginica). We found that both S. pacifica and the subordinate species were affected by inundation treatments, and that subordinate species cover and diversity were lower at low elevations in the presence of S. pacifica than when it was removed. These results suggest that the competitive effect of S. pacifica on other plants is stronger at lower tidal elevations where we also found that salinity is reduced. As sea levels rise, stronger competition by the dominant plant will likely reduce diversity and cover of subordinate species, suggesting that stronger species interactions will exacerbate the effects of climate change on the plant community.	[Noto, Akana E.; Shurin, Jonathan B.] Univ Calif San Diego, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA	University of California System; University of California San Diego		akana.noto@gmail.com		Noto, Akana/0000-0003-1669-8792	National Estuarine Research Reserve System of the National Atmospheric and Oceanic Administration	National Estuarine Research Reserve System of the National Atmospheric and Oceanic Administration	Funding was provided to AEN through a Graduate Research Fellowship from the National Estuarine Research Reserve System of the National Atmospheric and Oceanic Administration (http://nerrs.noaa.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti J, 2008, ECOLOGY, V89, P155, DOI 10.1890/07-0045.1; Alexander JM, 2015, NATURE, V525, P515, DOI 10.1038/nature14952; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Bertness MD, 2002, OECOLOGIA, V132, P392, DOI 10.1007/s00442-002-0972-y; BERTNESS MD, 1987, ECOL MONOGR, V57, P129, DOI 10.2307/1942621; BERTNESS MD, 1994, AM NAT, V144, P363, DOI 10.1086/285681; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Bonin CL, 2008, ESTUAR COAST, V31, P682, DOI 10.1007/s12237-008-9057-4; Cahoon DR, 1996, ESTUAR COAST SHELF S, V43, P19, DOI 10.1006/ecss.1996.0055; Callaway JC, 2012, ESTUAR COAST, V35, P1163, DOI 10.1007/s12237-012-9508-9; Cantarel AAM, 2013, J VEG SCI, V24, P113, DOI 10.1111/j.1654-1103.2012.01452.x; Cayan DR, 2008, CLIMATIC CHANGE, V87, pS57, DOI 10.1007/s10584-007-9376-7; Gedan KB, 2010, OECOLOGIA, V164, P479, DOI 10.1007/s00442-010-1661-x; Gedan KB, 2009, ECOL LETT, V12, P842, DOI 10.1111/j.1461-0248.2009.01337.x; Gough L, 1998, OECOLOGIA, V117, P527, DOI 10.1007/s004420050689; Harley CDG, 2011, SCIENCE, V334, P1124, DOI 10.1126/science.1210199; Janousek CN, 2014, J VEG SCI, V25, P534, DOI 10.1111/jvs.12107; Josselyn Michael, 1983, ECOLOGY SAN FRANCISC; Kardol P, 2010, GLOBAL CHANGE BIOL, V16, P2676, DOI 10.1111/j.1365-2486.2010.02162.x; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Liancourt P, 2013, ECOLOGY, V94, P444, DOI 10.1890/12-0780.1; Macdonald K.B., 1974, ECOLOGY HALOPHYTES, P175; MAHALL BE, 1976, J ECOL, V64, P811, DOI 10.2307/2258810; Michalet R, 2014, FUNCT ECOL, V28, P75, DOI 10.1111/1365-2435.12136; Okasnen J., 2015, VEGAN COMMUNITY ECOL; Pachauri R.K., 2014, CLIMATE CHANGE 2014; PENNINGS SC, 1992, ECOLOGY, V73, P681, DOI 10.2307/1940774; R Development Core Team, 2015, R LANG STAT COMP; Rietbroek R, 2016, P NATL ACAD SCI USA, V113, P1504, DOI 10.1073/pnas.1519132113; Sharpe PJ, 2012, AQUAT BOT, V101, P34, DOI 10.1016/j.aquabot.2012.03.015; Sullivan G., 2001, HDB RESTORING TIDAL, P369; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Whitcraft CR, 2007, ECOLOGY, V88, P904, DOI 10.1890/05-2074; Woo I, 2012, AQUAT BOT, V102, P8, DOI 10.1016/j.aquabot.2012.03.014; Zedler J. B., 1982, ECOLOGY SO CALIFORNI; Zedler JB, 2001, BIOSCIENCE, V51, P1005, DOI 10.1641/0006-3568(2001)051[1005:DBWSMA]2.0.CO;2	36	8	9	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0169056	10.1371/journal.pone.0169056	http://dx.doi.org/10.1371/journal.pone.0169056			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103271	gold, Green Published			2022-12-26	WOS:000392381100007
J	Berns, GS; Ashwell, KWS				Berns, Gregory S.; Ashwell, Ken W. S.			Reconstruction of the Cortical Maps of the Tasmanian Tiger and Comparison to the Tasmanian Devil	PLOS ONE			English	Article							POSTMORTEM HUMAN BRAINS; STATE FREE PRECESSION; DIFFUSION TRACTOGRAPHY; PREDATORY BEHAVIOR; SPIN-ECHO; MAMMALS; NEOCORTEX; EVOLUTION	The last known Tasmanian tiger (Thylacinus cynocephalus)-aka the thylacine-died in 1936. Because its natural behavior was never scientifically documented, we are left to infer aspects of its behavior from museum specimens and historical recollections of bushmen. Recent advances in brain imaging have made it possible to scan postmortem specimens of a wide range of animals, even more than a decade old. Any thylacine brain, however, would be more than 100 years old. Here, we show that it is possible to reconstruct white matter tracts in two thylacine brains. For functional interpretation, we compare to the white matter reconstructions of the brains of two Tasmanian devils (Sarcophilus harrisii). We reconstructed the cortical projection zones of the basal ganglia and major thalamic nuclei. The basal ganglia reconstruction showed a more modularized pattern in the cortex of the thylacine, while the devil cortex was dominated by the putamen. Similarly, the thalamic projections had a more orderly topography in the thylacine than the devil. These results are consistent with theories of brain evolution suggesting that larger brains are more modularized. Functionally, the thylacine's brain may have had relatively more cortex devoted to planning and decision-making, which would be consistent with a predatory ecological niche versus the scavenging niche of the devil.	[Berns, Gregory S.] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA; [Ashwell, Ken W. S.] Univ New South Wales, Sch Med Sci, Dept Anat, Sydney, NSW, Australia	Emory University; University of New South Wales Sydney	Berns, GS (corresponding author), Emory Univ, Dept Psychol, Atlanta, GA 30322 USA.	gberns@emory.edu			Emory University; UNSW	Emory University; UNSW	We are grateful to the Smithsonian Institution for loaning the thylacine and devil brains. In particular, Esther Langan and Darrin Lunde of the Mammal Division facilitated the loan process. Sandy Ingleby, at the Australian Museum in Sydney, made possible the scanning of their thylacine brain. Carolyn Hogg and the Save the Tasmanian Devil Program donated the brain of a devil. Stephen Sleightholme, maintainer of the International Thylacine Specimen Database, helped locate thylacine brains. Marco Gruwel assisted with the scanning at UNSW, and Peter Cook assisted with scanning at Emory University. Karla Miller and Saad Jbabdi at the FMRIB Centre, University of Oxford, made available the DWSSFP sequences and software modifications for reconstruction. Scan time was supported by Emory University and UNSW.	Abbie AA, 1940, J COMP NEUROL, V72, P469, DOI 10.1002/cne.900720303; Ashwell K., 2010, NEUROBIOLOGY AUSTR M; Ashwell KWS, 2008, BRAIN BEHAV EVOLUT, V71, P181, DOI 10.1159/000114406; Attard MRG, 2011, J ZOOL, V285, P292, DOI 10.1111/j.1469-7998.2011.00844.x; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Berns GS, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1203; BUXTON RB, 1993, MAGNET RESON MED, V29, P235, DOI 10.1002/mrm.1910290212; Figueirido B, 2011, BIOL LETT; Guiler ER, 1985, THYLACINE TRAGEDY TA; Jones ME, 1998, J ZOOL, V246, P239, DOI 10.1111/j.1469-7998.1998.tb00152.x; Karlen SJ, 2007, PROG NEUROBIOL, V82, P122, DOI 10.1016/j.pneurobio.2007.03.003; Krubitzer L, 2005, CURR OPIN NEUROBIOL, V15, P444, DOI 10.1016/j.conb.2005.07.003; Krubitzer L, 2007, NEURON, V56, P201, DOI 10.1016/j.neuron.2007.10.002; Mcnab JA, 2009, NEUROIMAGE, V46, P775, DOI 10.1016/j.neuroimage.2009.01.008; Miller KL, 2012, NEUROIMAGE, V59, P2284, DOI 10.1016/j.neuroimage.2011.09.054; Miller KL, 2011, NEUROIMAGE, V57, P167, DOI 10.1016/j.neuroimage.2011.03.070; Paddle R., 2000, LAST TASMANIAN TIGER; Sleightholme S., 2013, INT THYLACINE SPECIM; Striedter G.F., 2004, PRINCIPLES BRAIN EVO; Wemmer C, 2002, ZOO BIOL, V21, P1, DOI 10.1002/zoo.10023; Wroe S, 2005, P ROY SOC B-BIOL SCI, V272, P619, DOI 10.1098/rspb.2004.2986; Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713	23	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0168993	10.1371/journal.pone.0168993	http://dx.doi.org/10.1371/journal.pone.0168993			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099446	gold, Green Submitted, Green Published			2022-12-26	WOS:000392380100013
J	Ghezzi, CE; Marelli, B; Omenetto, FG; Funderburgh, JL; Kaplan, DL				Ghezzi, Chiara E.; Marelli, Benedetto; Omenetto, Fiorenzo G.; Funderburgh, James L.; Kaplan, David L.			3D Functional Corneal Stromal Tissue Equivalent Based on Corneal Stromal Stem Cells and Multi-Layered Silk Film Architecture	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; EPITHELIAL-CELLS; KERATAN SULFATE; IN-VITRO; CONSTRUCTION; TRANSPLANTATION; RECONSTRUCTION; EXPRESSION; SUBSTRATE; FIBROIN	The worldwide need for human cornea equivalents continues to grow. Few clinical options are limited to allogenic and synthetic material replacements. We hypothesized that tissue engineered human cornea systems based on mechanically robust, patterned, porous, thin, optically clear silk protein films, in combination with human corneal stromal stem cells (hCSSCs), would generate 3D functional corneal stroma tissue equivalents, in comparison to previously developed 2D approaches. Silk film contact guidance was used to control the alignment and distribution of hCSSCs on RGD-treated single porous silk films, which were then stacked in an orthogonally, multi-layered architecture and cultured for 9 weeks. These systems were compared similar systems generated with human corneal fibroblasts (hCFs). Both cell types were viable and preferentially aligned along the biomaterial patterns for up to 9 weeks in culture. H&E histological sections showed that the systems seeded with the hCSSCs displayed ECM production throughout the entire thickness of the constructs. In addition, the ECM proteins tested positive for keratocyte-specific tissue markers, including keratan sulfate, lumican, and keratocan. The quantification of hCSSC gene expression of keratocyte-tissue markers, including keratocan, lumican, human aldehyde dehydrogenase 3A1 (ALDH3A1), prostaglandin D2 synthase (PTDGS), and pyruvate dehydrogenase kinase, isozyme 4 (PDK4), within the 3D tissue systems demonstrated upregulation when compared to 2D single silk films and to the systems generated with the hCFs. Furthermore, the production of ECM from the hCSSC seeded systems and subsequent remodeling of the initial matrix significantly improved cohesiveness and mechanical performance of the constructs, while maintaining transparency after 9 weeks.	[Ghezzi, Chiara E.; Marelli, Benedetto; Omenetto, Fiorenzo G.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Funderburgh, James L.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA	Tufts University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kaplan, DL (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	david.kaplan@tufts.edu	Ghezzi, Chiara/AAF-9433-2021; Marelli, Benedetto/G-2548-2018	Ghezzi, Chiara/0000-0002-9800-4397; Marelli, Benedetto/0000-0001-5311-6961	NIH [R01 EY020856, P41 EB002520, EY016415]; NATIONAL EYE INSTITUTE [R01EY016415, R01EY020856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002520] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank the NIH (R01 EY020856, P41 EB002520, and EY016415 (to JLF)) for support for this work.	Ahearne M, 2010, EXP EYE RES, V91, P584, DOI 10.1016/j.exer.2010.07.013; Akhtar S, 2011, GRAEF ARCH CLIN EXP, V249, P413, DOI 10.1007/s00417-010-1512-9; Alaminos M, 2006, INVEST OPHTH VIS SCI, V47, P3311, DOI 10.1167/iovs.05-1647; [Anonymous], 2013, 2013 EYE BANK STAT R; Behlau I, 2014, ACTA OPHTHALMOL, V92, pe546, DOI 10.1111/aos.12309; BIRK DE, 1988, J CELL BIOL, V106, P999, DOI 10.1083/jcb.106.3.999; BIRK DE, 1990, J CELL SCI, V95, P649; BOISJOLY HM, 1993, OPHTHALMOLOGY, V100, P1728; Bray LJ, 2011, BIOMATERIALS, V32, P5086, DOI 10.1016/j.biomaterials.2011.03.068; BRYANT MR, 1994, INVEST OPHTH VIS SCI, V35, P3022; Builles N, 2010, BIOMATERIALS, V31, P8313, DOI 10.1016/j.biomaterials.2010.07.066; CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354; CINTRON C, 1983, INVEST OPHTH VIS SCI, V24, P543; DelMonte DW, 2011, J CATARACT REFR SURG, V37, P588, DOI 10.1016/j.jcrs.2010.12.037; Diao JM, 2015, EXP EYE RES, V132, P216, DOI 10.1016/j.exer.2015.01.015; DONOHUE DJ, 1995, J OPT SOC AM A, V12, P1425, DOI 10.1364/JOSAA.12.001425; Du YD, 2005, STEM CELLS, V23, P1266, DOI 10.1634/stemcells.2004-0256; Du YQ, 2009, STEM CELLS, V27, P1635, DOI 10.1002/stem.91; Funderburgh JL, 2000, GLYCOBIOLOGY, V10, P951, DOI 10.1093/glycob/10.10.951; George AJT, 2004, AM J TRANSPLANT, V4, P678, DOI 10.1111/j.1600-6143.2004.00417.x; Ghezzi C, 2014, TISSUE ENG B; Gil ES, 2010, BIOMATERIALS, V31, P8953, DOI 10.1016/j.biomaterials.2010.08.017; Gil ES, 2010, MACROMOL BIOSCI, V10, P664, DOI 10.1002/mabi.200900452; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169; Griffith M, 2014, CURR OPIN OPHTHALMOL, V25, P240, DOI 10.1097/ICU.0000000000000049; Griffith M, 2011, PRINCIPLES OF REGENERATIVE MEDICINE, 2ND EDITION, P911, DOI 10.1016/B978-0-12-381422-7.10049-5; Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109; Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a; Hu X, 2009, MACROMOLECULES, V42, P2079, DOI 10.1021/ma802481p; Hu XJ, 2005, TISSUE ENG, V11, P1710, DOI 10.1089/ten.2005.11.1710; Jacobs J, 2005, EMEDICINE, P1; Jester JV, 1996, CORNEA, V15, P505; Kao WWY, 2002, GLYCOCONJUGATE J, V19, P275, DOI 10.1023/A:1025396316169; Kim MJ, 2013, OPHTHALMOLOGY; Lawrence BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050190; Lawrence BD, 2012, ACTA BIOMATER, V8, P3732, DOI 10.1016/j.actbio.2012.06.009; Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018; Levis HJ, 2013, BIOMATERIALS, V34, P8860, DOI 10.1016/j.biomaterials.2013.08.002; Li FF, 2003, P NATL ACAD SCI USA, V100, P15346, DOI 10.1073/pnas.2536767100; Liu JB, 2012, INVEST OPHTH VIS SCI, V53, P4130, DOI 10.1167/iovs.12-9876; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo HL, 2013, BIOMATERIALS, V34, P6748, DOI 10.1016/j.biomaterials.2013.05.045; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936; Ozcelik B, 2013, ACTA BIOMATER, V9, P6594, DOI 10.1016/j.actbio.2013.01.020; Pascolini D, 2010, BR J OPHTHALMOL, V96, P614, DOI DOI 10.1136/BJ0PHTHALM0L-2011-300539; Phu D, 2011, TISSUE ENG PT A, V17, P799, DOI 10.1089/ten.TEA.2009.0724; Pinnamaneni N, 2012, STEM CELLS, V30, P1059, DOI 10.1002/stem.1100; Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379; Ronge L., 1994, CORNEA, P379; ROSKELLEY CD, 1994, P NATL ACAD SCI USA, V91, P12378, DOI 10.1073/pnas.91.26.12378; Ruberti JW, 2011, ANNU REV BIOMED ENG, V13, P269, DOI 10.1146/annurev-bioeng-070909-105243; Shang K, 2013, TRANSL VIS SCI TECHN, V2, DOI 10.1167/tvst.2.3.2; Tan XW, 2012, J MATER SCI-MATER M, V23, P1063, DOI 10.1007/s10856-012-4578-6; Teichmann J, 2013, ACTA BIOMATER, V9, P5031, DOI 10.1016/j.actbio.2012.10.023; Wang L, 2014, J BIOMEDICAL MAT R B; Wilson SL, 2012, ADV FUNCT MATER, V22, P3641, DOI 10.1002/adfm.201200655; Wu J, 2013, TISSUE ENG PT A, V19, P2063, DOI [10.1089/ten.TEA.2012.0545, 10.1089/ten.tea.2012.0545]; Wu JW, 2014, APPL MATH COMPUT, V227, P701, DOI 10.1016/j.amc.2013.11.026	60	41	41	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0169504	10.1371/journal.pone.0169504	http://dx.doi.org/10.1371/journal.pone.0169504			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099503	gold, Green Published, Green Submitted			2022-12-26	WOS:000392380100026
J	Qiu, JY; Chen, XY; Netrusov, AI; Zhou, QX; Guo, DY; Liu, XY; He, HL; Xin, X; Wang, YF; Chen, LL				Qiu, Jiying; Chen, Xiangyan; Netrusov, A. I.; Zhou, Qingxin; Guo, Danyang; Liu, Xiaoyong; He, Hailun; Xin, Xue; Wang, Yifen; Chen, Leilei			Screening and Identifying Antioxidative Components in Ginkgo biloba Pollen by DPPH-HPLC-PAD Coupled with HPLC-ESI-MS2	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; FLAVONOID GLYCOSIDES; MASS-SPECTROMETRY; NATURAL ANTIOXIDANTS; DAD-TOF/MS; ESI-MSN; IDENTIFICATION; EXTRACT; LEAVES; QUANTIFICATION	The Ginkgo biloba is one of ancient trees that exists from billions of years ago, its leaf and nut are used as herbs and foods in China, while so far its pollen does not have any application except pollination. In order to evaluate the antioxidant activity of Ginkgo biloba pollen, and rapidly screen its antioxidative components, the 1,1-diphenyl-2-picrylhydrazyl (DPPH) scavenging ability, total flavonoid, total phenol, and proanthocyanidin of Ginkgo biloba pollen were determined and compared with those of Ginkgo biloba leaf and nut, and the off-line DPPH-HPLC-PAD and HPLC-ESI-MS2 were applied for screening and identifying the antioxidant flavonoids in Ginkgo biloba pollen. The results showed that the DPPH scavenging ability of Ginkgo biloba pollen was much higher than Ginkgo biloba nut, but lower than Ginkgo biloba leaf, while the total content of flavonoid in Ginkgo biloba pollen was approximately 4.37 times higher than in Ginkgo biloba leaf. Further studies found that the major flavonol aglycone in Ginkgo biloba pollen was kaempferol, which accounted for 96.71% of the total aglycones (includes quercetin, kaempferol and isorhamnetin), and the main flavonoid components in Ginkgo biloba pollen were flavonoid glycosides. Finally, ten antioxidant peaks were screened and identified to be flavonoids (including kaempferol and nine flavonoid glycosides), so flavonoids were likely to be the main antioxidant components in GP, and among them, three novel kaempferol glycosides (peaks 1, 2, and 3) were found in Ginkgo biloba pollen for the first time, which had never been found in Ginkgo biloba.	[Qiu, Jiying; Chen, Xiangyan; Zhou, Qingxin; Liu, Xiaoyong; Xin, Xue; Wang, Yifen; Chen, Leilei] Shandong Acad Agr Sci, Inst Agrofood Sci & Technol, Jinan, Peoples R China; [Qiu, Jiying; Chen, Xiangyan; Zhou, Qingxin; Liu, Xiaoyong; Xin, Xue; Wang, Yifen; Chen, Leilei] Shandong Acad Agr Sci, Shandong Prov Key Lab Agroprod Proc Technol, Jinan, Peoples R China; [Netrusov, A. I.; Guo, Danyang] Moscow MV Lomonosov State Univ, Fac Biol, 1-12 Lenins Hills, Moscow, Russia; [He, Hailun] Cent S Univ, Sch Life Sci, State Key Lab Med Genet, Changsha, Hunan, Peoples R China	Shandong Academy of Agricultural Sciences; Shandong Academy of Agricultural Sciences; Lomonosov Moscow State University; Central South University	Chen, LL (corresponding author), Shandong Acad Agr Sci, Inst Agrofood Sci & Technol, Jinan, Peoples R China.; Chen, LL (corresponding author), Shandong Acad Agr Sci, Shandong Prov Key Lab Agroprod Proc Technol, Jinan, Peoples R China.	chenleilei8210@163.com	Netrusov, Alexander/A-8958-2016; netrusov, alexander/AAJ-7736-2021	Netrusov, Alexander/0000-0002-2803-3037; netrusov, alexander/0000-0002-2803-3037	Natural Science Foundation of Shandong Province [ZR2014YL020]; Youth Science Research Foundation of Shandong Academy of Agricultural Sciences [2014QNM47]; Special Funds for the Construction of Taishan Scholars; Young Talents Training Program of Shandong Academy of Agricultural Sciences; Shangdong Province Young and Middle-Aged Scientists Research Awards Fund [BS2013SW039]; National Natural Science Foundation of China [31100039, 31370104]; Russian Scientific Fund [14-50-00029]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Youth Science Research Foundation of Shandong Academy of Agricultural Sciences; Special Funds for the Construction of Taishan Scholars; Young Talents Training Program of Shandong Academy of Agricultural Sciences; Shangdong Province Young and Middle-Aged Scientists Research Awards Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Russian Scientific Fund(Russian Science Foundation (RSF))	This study was funded by a grant from the Natural Science Foundation of Shandong Province (Award Number ZR2014YL020 to JQ) (http://www.sdstc.gov.cn/), supplemented by fund from the Youth Science Research Foundation of Shandong Academy of Agricultural Sciences (Award Number 2014QNM47 to JQ) (http://www.saas.ac.cn/saas/), YW was supported by the Special Funds for the Construction of Taishan Scholars (http://www.sdstc.gov.cn/), LC was supported by the Young Talents Training Program of Shandong Academy of Agricultural Sciences (http://www.saas.ac.cn/saas/), the Shangdong Province Young and Middle-Aged Scientists Research Awards Fund (Award Number BS2013SW039) (http://www.sdstc.gov.cn/), and the National Natural Science Foundation of China (Award Number 31100039) (http://www.nsfc.gov.cn/), AIN acknowledges funding by Russian Scientific Fund (Award Number 14-50-00029) (http://grant.rscf.ru/user/), and HH was supported by the National Natural Science Foundation of China (Award Number 31370104) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Finco FDBA, 2012, J AGR FOOD CHEM, V60, P7665, DOI 10.1021/jf3007689; Agati G, 2012, PLANT SCI, V196, P67, DOI 10.1016/j.plantsci.2012.07.014; Arimboor R, 2012, INT J FOOD SCI NUTR, V63, P730, DOI 10.3109/09637486.2011.652075; BenNasr C, 1996, Z LEBENSM UNTERS FOR, V203, P374, DOI 10.1007/BF01231077; Chan E, 2010, CURR OPIN DRUG DISC, V13, P50; Dai XP, 2013, FOOD CHEM, V139, P563, DOI 10.1016/j.foodchem.2013.02.006; Dalamu, 2010, NUTR FOOD SCI, V40, P6, DOI 10.1108/00346651011015863; Ding XP, 2009, J CHROMATOGR A, V1216, P2204, DOI 10.1016/j.chroma.2008.08.115; Francescato LN, 2013, TALANTA, V105, P192, DOI 10.1016/j.talanta.2012.11.072; Geng DD, 2015, IND CROP PROD, V67, P492, DOI 10.1016/j.indcrop.2015.01.063; Guo Juanli, 2009, Zhongguo Zhong Yao Za Zhi, V34, P1235; Harbaum B, 2007, J AGR FOOD CHEM, V55, P8251, DOI 10.1021/jf071314+; HASLER A, 1992, J CHROMATOGR, V605, P41, DOI 10.1016/0021-9673(92)85026-P; Heinonen T, 2015, TOXICOLOGY, V327, P95, DOI 10.1016/j.tox.2014.10.013; Hu J., 2010, TSINGHUA SCI TECHNOL, V15, P452, DOI [10.1016/S1007-0214(10)70087-0, DOI 10.1016/S1007-0214(10)70087-0]; Hvattum E, 2003, J MASS SPECTROM, V38, P43, DOI 10.1002/jms.398; Kumar M, 2010, FITOTERAPIA, V81, P234, DOI 10.1016/j.fitote.2009.09.003; LeBlanc BW, 2009, FOOD CHEM, V115, P1299, DOI 10.1016/j.foodchem.2009.01.055; Lee KH, 2009, PHYTOTHER RES, V23, P41, DOI 10.1002/ptr.2525; Qiu JY, 2012, FOOD CHEM, V135, P2366, DOI 10.1016/j.foodchem.2012.07.042; Rosch D, 2004, J AGR FOOD CHEM, V52, P4039, DOI 10.1021/jf0306791; Shi SY, 2012, SEP PURIF TECHNOL, V89, P225, DOI 10.1016/j.seppur.2012.01.041; Skerget M, 2005, FOOD CHEM, V89, P191, DOI 10.1016/j.foodchem.2004.02.025; State Pharmacopoeia Commission of the People&rsquo;s Republic of China, 2010, CHINESE PHARMACOPOEI; Sun LQ, 2012, FOOD CHEM, V132, P759, DOI 10.1016/j.foodchem.2011.11.030; Tang D, 2008, J SEP SCI, V31, P3519, DOI 10.1002/jssc.200800173; Ude C, 2013, CLIN PHARMACOKINET, V52, P727, DOI 10.1007/s40262-013-0074-5; Uemura K., 1997, GINKGO BILOBA GLOBAL, P207, DOI DOI 10.1007/978-4-431-68416-9_16; van Beek TA, 1998, FITOTERAPIA, V69, P195; Vukics V, 2010, MASS SPECTROM REV, V29, P1, DOI 10.1002/mas.20212; Wang GuoXia, 2007, Journal of Zhejiang Forestry Science and Technology, V27, P8; Wang GuoXia, 2007, Journal of Nanjing Forestry University (Natural Sciences Edition), V31, P34; Yang D, 2015, FOOD CHEM, V174, P124, DOI 10.1016/j.foodchem.2014.11.036; Zhao HD, 2015, J CHROMATOGR A, V1398, P57, DOI 10.1016/j.chroma.2015.04.018; Zhou H., 2014, J FOOD NUTR RES, V2, P369	35	19	21	4	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0170141	10.1371/journal.pone.0170141	http://dx.doi.org/10.1371/journal.pone.0170141			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095510	Green Published, gold, Green Submitted			2022-12-26	WOS:000392372300060
J	Xu, FF; Yang, QX; Wu, LL; Qi, R; Wu, YS; Li, YC; Tang, LP; Guo, DA; Liu, B				Xu, Fangfang; Yang, Qiuxia; Wu, Lilan; Qi, Rui; Wu, Yunshan; Li, Yucui; Tang, Lipeng; Guo, De-an; Liu, Bo			Investigation of Inclusion Complex of Patchouli Alcohol with beta-Cyclodextrin	PLOS ONE			English	Article							POGOSTEMONIS HERBA; CABLIN	The objective of this study was to improve the stability and water-solubility of patchouli alcohol by complexing with beta-cyclodextrin (beta-CD). The interactions between patchouli alcohol and beta-CD were characterized by differential scanning calorimetry (DSC), Fourier transformation -infrared (FT-IR) spectroscopy, powder X-ray diffraction (PXRD), and Scanning electron microscope (SEM), respectively. According to molecular modeling method, the enthalpy formation of host-guest illustrated the predominant configuration and the lowest value Delta(b)G degrees was-10.8174+/-1.9235 kcal/mol, suggesting the complex could reduce the energy of the system. The characterization analysis confirmed the formation of PA-CD inclusion complex, and the results indicated the advantage of the inclusion complex in stability and dissolution rates. These results identified PA-CD inclusion complex an effective way for the storage of PA, and better inclusion method still needed to be studied.	[Xu, Fangfang; Yang, Qiuxia; Wu, Lilan; Qi, Rui; Wu, Yunshan; Tang, Lipeng; Guo, De-an; Liu, Bo] Guangzhou Univ Chinese Med, Guangdong Prov Acad Chinese Med Sci, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China; [Yang, Qiuxia; Guo, De-an] Guangdong Pharmaceut Univ, Coll Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China; [Li, Yucui] Guangzhou Univ Chinese Med, Coll Chinese Med, Guangzhou, Guangdong, Peoples R China; [Guo, De-an] Chinese Acad Sci, Shanghai Inst Mat Med, 501 Haike Rd, Shanghai, Peoples R China	Guangzhou University of Chinese Medicine; Guangdong Pharmaceutical University; Guangzhou University of Chinese Medicine; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Xu, FF; Liu, B (corresponding author), Guangzhou Univ Chinese Med, Guangdong Prov Acad Chinese Med Sci, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China.	xudubfang@163.com; doctliu@263.net	Wu, Yunshan/I-3985-2019; zhou, ju/M-3255-2017; Tang, Lipeng/ABB-6481-2020	Wu, Yunshan/0000-0001-9204-9861; 	National Natural Science Foundation of China [81202398, 81302868]; Guangdong Provincial Science and Technology Project [20136010102006, 2014A020221035, 2015A020211025]; Specific Research Fund for TCM Science and Technology of Guangdong Provincial Hospital of Chinese Medicine [YN2014ZHR209, YN2015MS03, YN2014ZH08, YN2015QN03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Science and Technology Project; Specific Research Fund for TCM Science and Technology of Guangdong Provincial Hospital of Chinese Medicine	This work was supported by the National Natural Science Foundation of China (Nos. 81202398 and 81302868), Guangdong Provincial Science and Technology Project (Nos. 20136010102006, 2014A020221035, and 2015A020211025), and the Specific Research Fund for TCM Science and Technology of Guangdong Provincial Hospital of Chinese Medicine (Nos. YN2014ZHR209, YN2015MS03, YN2014ZH08, and YN2015QN03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PYMOL MOL GRAPH SYST; Ascenso A., AAPS PHARM SCI TECH, V12, p553 ; Board of Pharmacopoeia of P. R. China, 2015, PHARM PEOPL REP CH 1, P45; Brewster ME, 2007, ADV DRUG DELIVER REV, V59, P645, DOI 10.1016/j.addr.2007.05.012; Carrier RL, 2007, J CONTROL RELEASE, V123, P78, DOI 10.1016/j.jconrel.2007.07.018; Case D. A., 2010, AMBER 11; Chen X, 2013, ZHONGGUO ZHONGYI KEJ, V20, P499; Chen YL, 2015, DRUG DEV IND PHARM, V41, P436, DOI 10.3109/03639045.2013.877482; Guo T, 2006, PHARM J CHIN PLA, V22, P91; Higuchi T., 1965, ADV ANAL CHEM INSTRU, V4, P117; Hu LF, 2006, J PHARMACEUT BIOMED, V42, P200, DOI 10.1016/j.jpba.2005.09.015; Huang Hai, 2008, Zhong Yao Cai, V31, P1244; Huang X.W., 2008, MED J CHIN PEOPLES L, V24, P338; Hwang YY, 2012, J IND ENG CHEM, V18, P1412, DOI 10.1016/j.jiec.2012.01.046; Jin X, 2012, ACTA PHARM SIN B, V2, P83, DOI 10.1016/j.apsb.2011.12.004; Kiyohara H, 2012, J NAT MED-TOKYO, V66, P55, DOI 10.1007/s11418-011-0550-x; Li YC, 2012, INT IMMUNOPHARMACOL, V12, P294, DOI 10.1016/j.intimp.2011.12.007; Li YC, 2011, FITOTERAPIA, V82, P1295, DOI 10.1016/j.fitote.2011.09.003; Miao EZ, 2013, J LIAONING U TCM, V15, P67; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Szejtli J, 1998, CHEM REV, V98, P1743, DOI 10.1021/cr970022c; Tokumura T, 1984, J INCLUSION PHENOM, V2, P511; Wang CQ, 2013, J GANSU COLL TCM, V30, P29; Xian YF, 2011, EXP THER MED, V2, P545, DOI 10.3892/etm.2011.233; You Xiuhua, 2010, Zhongguo Zhong Yao Za Zhi, V35, P694; Yuan C, 2012, CARBOHYD POLYM, V89, P492, DOI 10.1016/j.carbpol.2012.03.033; 黄晓舞, 2009, [中草药, Chinese Traditional and Herbal Drugs], V40, P1431	27	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0169578	10.1371/journal.pone.0169578	http://dx.doi.org/10.1371/journal.pone.0169578			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095424	gold, Green Published, Green Submitted			2022-12-26	WOS:000392372300026
J	Drumonde-Neves, J; Franco-Duarte, R; Lima, T; Schuller, D; Pais, C				Drumonde-Neves, Joao; Franco-Duarte, Ricardo; Lima, Teresa; Schuller, Dorit; Pais, Celia			Association between Grape Yeast Communities and the Vineyard Ecosystems	PLOS ONE			English	Article							NON-SACCHAROMYCES YEASTS; WINE-PRODUCING AREAS; SPONTANEOUS FERMENTATION; POPULATION-DYNAMICS; CEREVISIAE STRAINS; MOLECULAR-IDENTIFICATION; ENOLOGICAL PROPERTIES; DIVERSITY; VARIETIES; REGION	The grape yeast biota from several wine-producing areas, with distinct soil types and grapevine training systems, was assessed on five islands of Azores Archipelago, and differences in yeast communities composition associated with the geographic origin of the grapes were explored. Fifty-seven grape samples belonging to the Vitis vinifera grapevine cultivars Verdelho dos Acores (Verdelho), Arinto da Terceira (Arinto) and Terrantez do Pico (Terrantez) were collected in two consecutive years and 40 spontaneous fermentations were achieved. A total of 1710 yeast isolates were obtained from freshly crushed grapes and 1200 from final stage of fermentations. Twenty-eight species were identified, Hanseniaspura uvarum, Pichia terricola and Metschnikowia pulcherrima being the three most representative species isolated. Candida carpophila was encountered for the first time as an inhabitant of grape or wine-associated environments. In both sampling years, a higher proportion of H. uvarum in fresh grapes from Verdelho cultivar was observed, in comparison with Arinto cultivar. Qualitatively significant differences were found among yeast communities from several locations on five islands of the Archipelago, particularly in locations with distinctive agro-ecological compositions. Our results are in agreement with the statement that grape-associated microbial biogeography is non-randomly associated with interactions of climate, soil, cultivar, and vine training systems in vineyard ecosystems. Our observations strongly support a possible linkage between grape yeast and wine typicality, reinforcing the statement that different viti-cultural terroirs harbor distinctive yeast biota, in particular in vineyards with very distinctive environmental conditions.	[Drumonde-Neves, Joao; Lima, Teresa] Univ Azores, CITAA Res Ctr Agr Technol Azores, Angra Do Heroismo, Portugal; [Drumonde-Neves, Joao; Franco-Duarte, Ricardo; Schuller, Dorit; Pais, Celia] Univ Minho, Dept Biol, Ctr Mol & Environm Biol CBMA, Braga, Portugal	Universidade dos Acores; Universidade do Minho	Franco-Duarte, R (corresponding author), Univ Minho, Dept Biol, Ctr Mol & Environm Biol CBMA, Braga, Portugal.	ricardofilipeduarte@bio.uminho.pt	Franco-Duarte, Ricardo/I-6594-2015; Pais, Célia/A-9186-2010	Franco-Duarte, Ricardo/0000-0002-2333-6127; Pais, Célia/0000-0001-5959-290X; Lima, Teresa/0000-0002-0354-1190	Azorean Government [M321/006/F/2008]; PROEMPREGO; national funds through the FCT I.P [UID/BIA/04050/2013, POCI-01-0145-FEDER-007569]; ERDF through the COMPETE2020 - Programa Operacional Competitividade e Internacionalizacao (POCI); national funds through FCT [FCOMP-01-0124-008775, PTDC/AGR-ALI/103392/2008, PTDC/AGR-ALI/121062/2010]; Fundação para a Ciência e a Tecnologia [PTDC/AGR-ALI/103392/2008] Funding Source: FCT	Azorean Government; PROEMPREGO; national funds through the FCT I.P(Portuguese Foundation for Science and Technology); ERDF through the COMPETE2020 - Programa Operacional Competitividade e Internacionalizacao (POCI); national funds through FCT(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	Joao Drumonde Neves is the recipient of a fellowship of the Azorean Government (M321/006/F/2008) and PROEMPREGO. This work was supported by the strategic programme UID/BIA/04050/2013 (POCI-01-0145-FEDER-007569) funded by national funds through the FCT I.P. and by the ERDF through the COMPETE2020 - Programa Operacional Competitividade e Internacionalizacao (POCI), and by national funds through FCT by the projects FCOMP-01-0124-008775, PTDC/AGR-ALI/103392/2008 and PTDC/AGR-ALI/121062/2010.	Ahavi TZ, 2002, VITIS, V41, P203; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMERINE MA, 1968, ANNU REV MICROBIOL, V22, P323, DOI 10.1146/annurev.mi.22.100168.001543; Anfang N, 2009, AUST J GRAPE WINE R, V15, P1, DOI 10.1111/j.1755-0238.2008.00031.x; Assis MO, 2012, IDENTIFICACAO LEVEDU; Baffi MA, 2011, ANN MICROBIOL, V61, P75, DOI 10.1007/s13213-010-0099-z; Barata A, 2012, INT J FOOD MICROBIOL, V153, P243, DOI 10.1016/j.ijfoodmicro.2011.11.025; Beltran G, 2002, SYST APPL MICROBIOL, V25, P287, DOI 10.1078/072320202320386479; Bhadra B, 2007, FEMS YEAST RES, V7, P579, DOI 10.1111/j.1567-1364.2007.00215.x; Bisson LF, 1991, MIXED CULTURES BIOTE, P37; Bokulich NA, 2014, P NATL ACAD SCI USA, V111, pE139, DOI 10.1073/pnas.1317377110; Bovo B, 2009, INT J FOOD MICROBIOL, V129, P221, DOI 10.1016/j.ijfoodmicro.2008.11.025; Brezna B, 2010, ANTON LEEUW INT J G, V98, P519, DOI 10.1007/s10482-010-9469-6; Cabras P, 1999, J AGR FOOD CHEM, V47, P3854, DOI 10.1021/jf990005j; Cadez N, 2010, FEMS YEAST RES, V10, P619, DOI 10.1111/j.1567-1364.2010.00635.x; Calhelha RC, 2006, FOOD MICROBIOL, V23, P393, DOI 10.1016/j.fm.2005.04.008; Capece A, 2010, INT J FOOD MICROBIOL, V144, P187, DOI 10.1016/j.ijfoodmicro.2010.09.009; Chavan P, 2009, FOOD MICROBIOL, V26, P801, DOI 10.1016/j.fm.2009.05.005; Ciani M, 1998, WORLD J MICROB BIOT, V14, P199, DOI 10.1023/A:1008825928354; Ciani M, 2011, ANN MICROBIOL, V61, P25, DOI 10.1007/s13213-010-0069-5; Ciani M, 2010, FEMS YEAST RES, V10, P123, DOI 10.1111/j.1567-1364.2009.00579.x; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clavijo A, 2010, INT J FOOD MICROBIOL, V143, P241, DOI 10.1016/j.ijfoodmicro.2010.08.010; Clemente-Jimenez JM, 2004, FOOD MICROBIOL, V21, P149, DOI 10.1016/S0740-0020(03)00063-7; Combina M, 2005, J APPL MICROBIOL, V98, P1055, DOI 10.1111/j.1365-2672.2005.02540.x; Combina M, 2005, INT J FOOD MICROBIOL, V99, P237, DOI 10.1016/j.ijfoodmicro.2004.08.017; Comitini F, 2008, ANN MICROBIOL, V58, P489, DOI 10.1007/BF03175547; Cordente AG, 2007, FEMS MICROBIOL LETT, V267, P159, DOI 10.1111/j.1574-6968.2006.00548.x; Cordero-Bueso G, 2011, INT J FOOD MICROBIOL, V148, P23, DOI 10.1016/j.ijfoodmicro.2011.04.021; Cordero-Bueso G, 2011, INT J FOOD MICROBIOL, V145, P132, DOI 10.1016/j.ijfoodmicro.2010.11.040; De La Torre MJ, 1998, MICROBIOS, V96, P165; Di Maro E, 2007, INT J FOOD MICROBIOL, V117, P201, DOI 10.1016/j.ijfoodmicro.2007.04.007; Drumonde-Neves J, 2013, J MICROBIOL METH, V93, P206, DOI 10.1016/j.mimet.2013.03.016; Drumonde-Neves J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160579; Esteve-Zarzoso B, 1999, INT J SYST BACTERIOL, V49, P329, DOI 10.1099/00207713-49-1-329; Fleet GH, 2002, BIODIVERSITY AND BIOTECHNOLOGY OF WINE YEASTS, P1; Fleet GH, 2003, INT J FOOD MICROBIOL, V86, P11, DOI 10.1016/S0168-1605(03)00245-9; FLEET GH, 1984, APPL ENVIRON MICROB, V48, P1034, DOI 10.1128/AEM.48.5.1034-1038.1984; Franco-Duarte R, 2011, ELECTROPHORESIS, V32, P1447, DOI 10.1002/elps.201000640; Gayevskiy V, 2012, ISME J, V6, P1281, DOI 10.1038/ismej.2011.195; Gonzalez SS, 2007, J APPL MICROBIOL, V102, P1018, DOI 10.1111/j.1365-2672.2006.03150.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Howell KS, 2006, FEMS YEAST RES, V6, P91, DOI 10.1111/j.1567-1364.2005.00010.x; Hyma KE, 2011, FEMS YEAST RES, V11, P540, DOI 10.1111/j.1567-1364.2011.00746.x; JACKSON DI, 1993, AM J ENOL VITICULT, V44, P409; Jolly N. P., 2006, SOUTH AFRICAN JOURNAL OF ENOLOGY AND VITICULTURE, V27, P15; Jolly N. P., 2003, South African Journal of Enology and Viticulture, V24, P35; Khan W., 2000, South African Journal of Enology and Viticulture, V21, P17; King ES, 2010, FOOD CHEM, V122, P618, DOI 10.1016/j.foodchem.2010.03.021; Lambrechts M. G., 2000, South African Journal of Enology and Viticulture, V21, P97; Li EH, 2011, WORLD J MICROB BIOT, V27, P2475, DOI 10.1007/s11274-011-0711-9; Li SS, 2010, INT J FOOD MICROBIOL, V138, P85, DOI 10.1016/j.ijfoodmicro.2010.01.009; LONGO E, 1991, AM J ENOL VITICULT, V42, P141; Lopes CA, 2002, J APPL MICROBIOL, V93, P608, DOI 10.1046/j.1365-2672.2002.01738.x; Martinez C, 2007, J APPL MICROBIOL, V103, P2185, DOI 10.1111/j.1365-2672.2007.03493.x; MARTINI A, 1980, CAN J MICROBIOL, V26, P856, DOI 10.1139/m80-149; Milanovic V, 2013, INT J FOOD MICROBIOL, V161, P240, DOI 10.1016/j.ijfoodmicro.2012.12.019; Nisiotou AA, 2007, APPL ENVIRON MICROB, V73, P2765, DOI 10.1128/AEM.01864-06; Ocon E, 2010, EUR FOOD RES TECHNOL, V230, P885, DOI 10.1007/s00217-010-1233-7; Oliva J, 2015, FOOD CHEM, V170, P401, DOI 10.1016/j.foodchem.2014.08.056; PARISH ME, 1985, AM J ENOL VITICULT, V36, P165; Pramateftaki PV, 2000, J APPL MICROBIOL, V89, P236, DOI 10.1046/j.1365-2672.2000.01102.x; Pretorius I. S., 1999, South African Journal of Enology and Viticulture, V20, P61; Pretorius IS, 2000, YEAST, V16, P675, DOI 10.1002/1097-0061(20000615)16:8<675::AID-YEA585>3.0.CO;2-B; Raspor P, 2006, INT J FOOD MICROBIOL, V109, P97, DOI 10.1016/j.ijfoodmicro.2006.01.017; Rementeria A, 2003, INT J FOOD MICROBIOL, V86, P201, DOI 10.1016/S0168-1605(03)00289-7; Romano P, 2003, INT J FOOD MICROBIOL, V86, P169, DOI 10.1016/S0168-1605(03)00290-3; ROSINI G, 1982, MICROBIAL ECOL, V8, P83, DOI 10.1007/BF02011464; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schuller D, 2004, FEMS MICROBIOL LETT, V231, P19, DOI 10.1016/S0378-1097(03)00928-5; Schuller D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032507; Setati ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052609; Settanni L, 2012, J BIOSCI BIOENG, V114, P606, DOI 10.1016/j.jbiosc.2012.07.010; Sinigaglia M, 1998, MICROBIOL RES, V153, P137, DOI 10.1016/S0944-5013(98)80031-1; Subden RE, 2003, FOOD RES INT, V36, P747, DOI 10.1016/S0963-9969(03)00034-6; Sun HH, 2009, ANN MICROBIOL, V59, P69, DOI 10.1007/BF03175601; Swiegers JH, 2007, APPL MICROBIOL BIOT, V74, P954, DOI 10.1007/s00253-006-0828-1; Swiegers JH, 2005, ADV APPL MICROBIOL, V57, P131, DOI 10.1016/S0065-2164(05)57005-9; Tofalo R, 2011, ANN MICROBIOL, V61, P57, DOI 10.1007/s13213-010-0102-8; Torija MJ, 2001, ANTON LEEUW INT J G, V79, P345, DOI 10.1023/A:1012027718701; Valero E, 2005, FEMS YEAST RES, V5, P959, DOI 10.1016/j.femsyr.2005.04.007; Valero E, 2007, FEMS YEAST RES, V7, P317, DOI 10.1111/j.1567-1364.2006.00161.x; VERSAVAUD A, 1995, APPL ENVIRON MICROB, V61, P3521, DOI 10.1128/AEM.61.10.3521-3529.1995; VEZINHET F, 1992, AM J ENOL VITICULT, V43, P83; Zarraonaindia I, 2015, MBIO, V6, DOI 10.1128/mBio.02527-14; Zhang HY, 2010, AUST J GRAPE WINE R, V16, P491, DOI 10.1111/j.1755-0238.2010.00111.x	87	38	39	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0169883	10.1371/journal.pone.0169883	http://dx.doi.org/10.1371/journal.pone.0169883			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085916	Green Published, Green Submitted, gold			2022-12-26	WOS:000391972600041
J	Piso, RJ; Kach, R; Pop, R; Zillig, D; Schibli, U; Bassetti, S; Meinel, D; Egli, A				Piso, Rein Jan; Kach, Roman; Pop, Roxana; Zillig, Daniela; Schibli, Urs; Bassetti, Stefano; Meinel, Dominik; Egli, Adrian			A Cross-Sectional Study of Colonization Rates with Methicillin-Resistant Staphylococcus aureus (MRSA) and Extended-Spectrum Beta-Lactamase (ESBL) and Carbapenemase-Producing Enterobacteriaceae in Four Swiss Refugee Centres	PLOS ONE			English	Article							MULTIDRUG-RESISTANT; FECAL CARRIAGE; MICROBIOLOGY; ETHIOPIA	Background The recent crisis of refugees seeking asylum in European countries challenges public health on many levels. Most refugees currently arrive from Syria, Afghanistan, or Eritrea. Data about multidrug resistant bacteria (MDR) prevalence are not present for these countries. However, when entering the European heath care systems, data about colonisation rates regarding highly resistant bacterial pathogens are important. Methods We performed a cross-sectional screening in four Swiss refugee centres to determine the colonization rates for MRSA and ESBL-and carbapenemase-producing Enterobacteriaceae. We used pharyngeal, nasal, and inguinal swabs for MRSA and rectal swabs and urine for ESBL and carbapenemase screening using standard microbiological procedures. Whole genome sequencing (WGS) was used to determine the relatedness of MRSA isolates with high resolution due to a suspected outbreak. Results 41/261(15.7%) refugees were colonized with MRSA. No differences regarding the country of origin were observed. However, in a single centre significantly more were colonized, which was confirmed to be a recent local outbreak. 57/241 (23.7%) refugees were colonized with ESBL with significantly higher colonisation in persons originating from the Middle East (35.1%, p<0.001). No carbapenemase producers were detected. Conclusion The colonisation rate of the refugees was about 10 times higher for MRSA and 2-5 times higher for ESBL compared to the Swiss population. Contact precaution is warranted for these persons if they enter medical care. In cases of infections, MRSA and ESBL-producing Enterobacteriaceae should be considered regarding antibiotic treatment choices.	[Piso, Rein Jan; Kach, Roman; Pop, Roxana; Zillig, Daniela] Cantonal Hosp Olten, Med Clin, Olten, Switzerland; [Schibli, Urs] Bakt Inst Olten BIO AG, Olten, Switzerland; [Bassetti, Stefano] Univ Basel Hosp, Div Internal Med, Basel, Switzerland; [Meinel, Dominik; Egli, Adrian] Univ Basel Hosp, Clin Microbiol, Basel, Switzerland; [Meinel, Dominik; Egli, Adrian] Univ Basel, Dept Biomed, Appl Microbiol Res, Basel, Switzerland	Kantonsspital Olten; University of Basel; University of Basel; University of Basel	Piso, RJ (corresponding author), Cantonal Hosp Olten, Med Clin, Olten, Switzerland.	jan.piso@spital.so.ch	Meinel, Dominik/AAR-6754-2020	Meinel, Dominik/0000-0003-2328-9794	Swiss national science foundation (SNF) [PZOOP3_154709 / 1]; Federal Office of Public Health, Canton of Solothurn; Bakt.lnstitut Olten BIO AG	Swiss national science foundation (SNF)(Swiss National Science Foundation (SNSF)); Federal Office of Public Health, Canton of Solothurn; Bakt.lnstitut Olten BIO AG	AE received a grant from Swiss national science foundation (SNF PZOOP3_154709 / 1, Ambizione SNF). This grant was used for research material and salaries of microbiological technicians. Bakt.lnstitut Olten BIO AG, employer of US, received a grant from the Federal Office of Public Health, Canton of Solothurn. This grant was solely used for the acquisition of research material. Bakt.lnstitut Olten BIO AG provided support in the form of salary for author US, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Shady HM, 2015, BRAZ J INFECT DIS, V19, P68, DOI 10.1016/j.bjid.2014.09.005; [Anonymous], 2015, BAG B, V27, P510; Chang CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138971; Dudareva S, 2011, EUROSURVEILLANCE B E, V16; Eshetie S, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0054-7; Fluit AC, 2015, J ANTIMICROB CHEMOTH, V70, P664, DOI 10.1093/jac/dku459; Geser N, 2011, J FOOD PROTECT, V74, P446, DOI 10.4315/0362-028X.JFP-10-372; Gijon M, 2016, CLIN MICROBIOL INFEC, V22, P643; Hoffmann K, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0949-1; Janvier F, 2014, EUR J CLIN MICROBIOL, V33, P1719, DOI 10.1007/s10096-014-2141-8; Jaton L, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.05.026; Jones RN, 2014, DIAGN MICR INFEC DIS, V78, P429, DOI 10.1016/j.diagmicrobio.2013.10.008; Kuenzli E, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-528; Langlois EV, 2016, LANCET, V387, P319, DOI 10.1016/S0140-6736(16)00101-X; Leopold SR, 2014, J CLIN MICROBIOL, V52, P2365, DOI 10.1128/JCM.00262-14; Meinel DM, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0113-3; Mesa RJ, 2006, J ANTIMICROB CHEMOTH, V58, P211, DOI 10.1093/jac/dkl211; Naik D, 2009, PAN AFR MED J, V3; Paget J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139589; Phillips RM, 2015, CONFL HEALTH, V9, DOI 10.1186/s13031-015-0065-2; Reardon S, 2014, NATURE, V509, P141, DOI 10.1038/509141a; Reinheimer C, 2016, EUROSUVEILL, V21; Shibabaw A, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-25; Sutter DE, 2011, INFECT CONT HOSP EP, V32, P854, DOI 10.1086/661284; UNHCR agency, 2016, GLOB TRENDS FORC DIS; Yang ES, 2010, CLIN MICROBIOL INFEC, V16, P425, DOI 10.1111/j.1469-0691.2009.02836.x	26	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0170251	10.1371/journal.pone.0170251	http://dx.doi.org/10.1371/journal.pone.0170251			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085966	Green Published, gold, Green Submitted			2022-12-26	WOS:000391972600079
J	van Roode, T; Sharples, K; Dickson, N; Paul, C				van Roode, Thee; Sharples, Katrina; Dickson, Nigel; Paul, Charlotte			Life-Course Relationship between Socioeconomic Circumstances and Timing of First Birth in a Birth Cohort	PLOS ONE			English	Article							YOUNG ADULTHOOD; AGE; FATHERHOOD; MOTHERHOOD; IMPACT; ENTRY; RISK; CHILDBEARING; DISADVANTAGE; POSTPONEMENT	Objectives This study examines the influence of socioeconomic circumstances in childhood (childhood SES) and adulthood (adult SES) on timing of first birth by age 37. Methods A longitudinal study of a 1972-1973 New Zealand birth cohort collected information on socioeconomic characteristics from age 3-32 and reproductive histories at 21, 26, 32 and 38; information on first birth was available from 978 of the original 1037. Relative Risks (RR) and 95% Confidence Intervals (CI) were calculated using Poisson regression to examine first live birth prior to age 21, from 21-25, from 26-31, and from 32-37, by socioeconomic characteristics at different ages. Results Overall, 68.5% of men had fathered a child and 75.9% of women had given birth, by age 37; with overall differences in parenthood to age 31 for men, and 37 for women evident by childhood SES. While parenthood by age 20 was strongly associated with lower childhood SES for both sexes, first entry into motherhood from 32-37 was more likely with higher adult SES at age 32 (RR = 1.8, 95% CI 1.1-3.0 for medium and RR = 1.9, 95% CI 1.1-3.3 for high compared with low). Education also differientated age at parenthood, with those with higher education more likely to defer fatherhood past age 31, and motherhood past age 25 followed by a period of increased likelihood of motherhood for women with higher levels of education from age 32-37 (RR = 1.4, 95% CI 0.87-2.2 and RR = 1.7, 95% CI 1.1-2.6 for medium and high respectively compared with low). Conclusions SES varies across the lifecourse, and SES at the time has the strongest association with first births at that time. Low childhood SES drives adolescent parenthood, with resulting cumulative differences in parenthood past age 30. Those with more education and higher adult SES are deferring parenthood but attempt to catch up in the mid to late thirties.	[van Roode, Thee; Sharples, Katrina; Dickson, Nigel; Paul, Charlotte] Univ Otago, Sch Med, Dept Prevent & Social Med, Dunedin, New Zealand	University of Otago	Dickson, N (corresponding author), Univ Otago, Sch Med, Dept Prevent & Social Med, Dunedin, New Zealand.	nigel.dickson@otago.ac.nz			New Zealand Health Research Council; New Zealand Ministry of Business, Innovation and Employment (MBIE); United Kingdom Medical Research Council [MR/K00381X]; National Institute of Aging [R01AG032282, R01AG048895]; NATIONAL INSTITUTE ON AGING [R01AG048895, R01AG032282] Funding Source: NIH RePORTER	New Zealand Health Research Council(Health Research Council of New Zealand); New Zealand Ministry of Business, Innovation and Employment (MBIE)(New Zealand Ministry of Business, Innovation and Employment (MBIE)); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Dunedin Multidisciplinary Health and Development Study is supported by the New Zealand Health Research Council and the New Zealand Ministry of Business, Innovation and Employment (MBIE). This research also received support from the United Kingdom Medical Research Council (Grant MR/K00381X) and the National Institute of Aging (Grants R01AG032282 and R01AG048895). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Dunedin Multidisciplinary Health and Development Study is supported by the New Zealand Health Research Council and the New Zealand Ministry of Business, Innovation and Employment (MBIE). This research also received support from the United Kingdom Medical Research Council (Grant MR/K00381X) and the National Institute of Aging (Grants R01AG032282 and R01AG048895). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors are grateful to Richie Poulton, Director of the Research Unit, for valuable comments on earlier drafts of this paper. The authors are indebted to Dr Phil A. Silva, the founder of the Dunedin Study, the staff involved in the collection of the data and other aspects of the study, and to the Study members and their families and friends for their long-term and continued involvement.	Andersson, 2008, VIENNA YB POPULATION, V2008, P89, DOI DOI 10.1553/P0PULATI0NYEARB00K2008S89; Andersson G, 2000, EUR J POPUL, V16, P293, DOI 10.1023/A:1006454909642; ARIES P, 1980, POPUL DEV REV, V6, P645, DOI 10.2307/1972930; Barber JS, 2001, SOC SCI RES, V30, P219, DOI 10.1006/ssre.2000.0697; Becker G. S., 2009, TREATISE FAMILY; Berrington A, 2003, 304 U SOUTH SOC STAT; Billari F. C., 2004, ED TRANSITION MOTHER; Caldwell JC, 2003, POP STUD-J DEMOG, V57, P241, DOI 10.1080/0032472032000137790; Callister P., 2006, POLICY Q, V2, P38; DAVIS K, 1984, POPUL DEV REV, V10, P397, DOI 10.2307/1973512; de La Rochebrochard E, 2003, AM J OBSTET GYNECOL, V189, P901, DOI 10.1067/S0002-9378(03)00753-1; DEARDEN K, 1994, J MARRIAGE FAM, V56, P844, DOI 10.2307/353597; Dickson N, 1996, NEW ZEAL MED J, V109, P308; Dribe M, 2009, J FAM ECON ISS, V30, P32, DOI 10.1007/s10834-008-9134-7; Dunson DB, 2004, OBSTET GYNECOL, V103, P51, DOI 10.1097/01.AOG.0000100153.24061.45; Ekert-Jaffe O, 2002, POPULATION, V57, P485, DOI 10.2307/1535056; ELLEY WB, 1976, NEW ZEAL J EDUC STUD, V11, P25; Galbraith C., 1996, NZ SOCIOECONOMIC IND; Gustafsson S, 2001, J POPUL ECON, V14, P225, DOI 10.1007/s001480000051; Jaffee S, 2001, DEV PSYCHOPATHOL, V13, P377, DOI 10.1017/S0954579401002103; Jaffee SR, 2002, J FAM PSYCHOL, V16, P38, DOI 10.1037/0893-3200.16.1.38; Jaffee SR, 2001, J CHILD PSYCHOL PSYC, V42, P803, DOI 10.1111/1469-7610.00777; Kravdal Oystein, 2004, DEMOGR RES, V3, DOI [DOI 10.4054/DEMRES.2004.S3.6, 10.4054/DemRes.2004.S3.6]; Lappegard T, 2005, EUR J POPUL, V21, P31, DOI 10.1007/s10680-004-6756-9; Liefbroer AC, 2005, EUR J POPUL, V21, P367, DOI 10.1007/s10680-005-2610-y; Louis JF, 2013, ANDROLOGY-US, V1, P741, DOI 10.1111/j.2047-2927.2013.00110.x; Manlove J, 1997, J MARRIAGE FAM, V59, P263, DOI 10.2307/353469; Mills M, 2011, HUM REPROD UPDATE, V17, P848, DOI 10.1093/humupd/dmr026; Moffitt TE, 1997, JAMA-J AM MED ASSOC, V278, P680, DOI 10.1001/jama.278.8.680; Neels Karel., 2010, VIENNA YB POPULATION, V8, DOI 10.1553/populationyearbook2010s77; Ni Bhrolchain M, 2005, VIENNA YB POPULATION, P83, DOI DOI 10.1553/P0PULATI0NYEARB00K2005S83; OECD, 2011, FAM CHANG DOING BETT; Pears KC, 2005, J MARRIAGE FAM, V67, P429, DOI 10.1111/j.0022-2445.2005.00126.x; Poulton R, 2002, LANCET, V360, P1640, DOI 10.1016/S0140-6736(02)11602-3; Poulton R, 2015, SOC PSYCH PSYCH EPID, V50, P679, DOI 10.1007/s00127-015-1048-8; Rendall M, 2010, POP STUD-J DEMOG, V64, P209, DOI 10.1080/00324728.2010.512392; Rendall MS, 2009, POPUL DEV REV, V35, P89, DOI 10.1111/j.1728-4457.2009.00262.x; RINDFUSS RR, 1983, J MARRIAGE FAM, V45, P553, DOI 10.2307/351660; Schmidt L, 2012, HUM REPROD UPDATE, V18, P29, DOI 10.1093/humupd/dmr040; Singh S, 2001, FAM PLANN PERSPECT, V33, P251, DOI 10.2307/3030192; Sobotka T, 2011, EUROPEAN DEMOGRAPHIC, V2, P2011; Swihart BJ, 2010, EPIDEMIOLOGY, V21, P621, DOI 10.1097/EDE.0b013e3181e5b06a; Thevenon O, 2011, POPUL DEV REV, V37, P57, DOI 10.1111/j.1728-4457.2011.00390.x; United Nations Department of Economic and Social Affairs Population Division, 2013, WORLD FERT REP 2012; United Nations Department of Economic and Social Affairs Population Division, 2014, WORLD FERT REP 2013; van Roode T, 2015, FERTIL STERIL, V103, P1053, DOI 10.1016/j.fertnstert.2014.12.121; van Roode T, 2012, PERSPECT SEX REPRO H, V44, P48, DOI 10.1363/4404812; Woodward LJ, 2006, DEV PSYCHOPATHOL, V18, P275, DOI 10.1017/S0954579406060159; Wulf D, 1982, INT FAMILY PERSP JUN, P63; Xie HL, 2001, SOC DEV, V10, P488, DOI 10.1111/1467-9507.00177	50	20	20	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0170170	10.1371/journal.pone.0170170	http://dx.doi.org/10.1371/journal.pone.0170170			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH7SJ	28085935	Green Published, gold, Green Submitted			2022-12-26	WOS:000391972600072
J	Xie, WJ; Nielsen, ME; Pedersen, C; Thordal-Christensen, H				Xie, Wenjun; Nielsen, Mads Eggert; Pedersen, Carsten; Thordal-Christensen, Hans			A Split-GFP Gateway Cloning System for Topology Analyses of Membrane Proteins in Plants	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; TRANSMEMBRANE PROTEINS; PLASMA-MEMBRANE; PROTEOMICS	To understand the function of membrane proteins, it is imperative to know their topology. For such studies, a split green fluorescent protein (GFP) method is useful. GFP is barrel-shaped, consisting of 11 beta-sheets. When the first ten beta-sheets (GFP1-10) and the 11th beta-sheet (GFP11) are expressed from separate genes they will self-assembly and reconstitute a fluorescent GFP protein. However, this will only occur when the two domains co-localize in the same cellular compartment. We have developed an easy-to-use Gateway vector set for determining on which side of the membrane the N- and C-termini are located. Two vectors were designed for making N- and C-terminal fusions between the membrane proteins-of-interest and GFP11, while another three plasmids were designed to express GFP1-10 in either the cytosol, the endoplasmic reticulum (ER) lumen or the apoplast. We tested functionality of the system by applying the vector set for the transmembrane domain, CNX (TM), of the ER membrane protein, calnexin, after transient expression in Nicotiana benthamiana leaves. We observed GFP signal from the ER when we reciprocally co-expressed GFP11-CNX (TM) with GFP1-10-HDEL and CNX (TM) -GFP with cytosolic GFP1-10. The opposite combinations did not result in GFP signal emission. This test using the calnexin ER-membrane domain demonstrated its C-terminus to be in the cytosol and its N- terminus in the ER lumen. This result confirmed the known topology of calnexin, and we therefore consider this split-GFP system highly useful for ER membrane topology studies. Furthermore, the vector set provided is useful for detecting the topology of proteins on other membranes in the cell, which we confirmed for a plasma membrane syntaxin. The set of five Ti-plasmids are easily and efficiently used for Gateway cloning and transient transformation of N. benthamiana leaves.	[Xie, Wenjun; Nielsen, Mads Eggert; Pedersen, Carsten; Thordal-Christensen, Hans] Univ Copenhagen, Dept Plant & Environm Sci, Plant Def Genet, Thorvaldsensvej 40, Frederiksberg C, Denmark	University of Copenhagen	Thordal-Christensen, H (corresponding author), Univ Copenhagen, Dept Plant & Environm Sci, Plant Def Genet, Thorvaldsensvej 40, Frederiksberg C, Denmark.	htc@plen.ku.dk	Pedersen, Carsten/F-6797-2014; Nielsen, Mads/F-8141-2014; Thordal-Christensen, Hans/F-6281-2014	Pedersen, Carsten/0000-0002-9520-2232; Nielsen, Mads/0000-0001-6170-8836; Thordal-Christensen, Hans/0000-0001-8813-0157	China Scholarship Council [201206350026]; Villum Foundation, Denmark [VKR023502]; Villum Fonden [00007405] Funding Source: researchfish	China Scholarship Council(China Scholarship Council); Villum Foundation, Denmark; Villum Fonden(Villum Fonden)	This work was supported by the China Scholarship Council (http://en.csc.edu.cn/) to Wenjun Xie (201206350026) and the Villum Foundation, Denmark (http://veluxfoundations.dk/en) (VKR023502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Cabantous S, 2006, NAT METHODS, V3, P845, DOI 10.1038/nmeth932; Cao JD, 2016, MOL PLANT MICROBE IN, V29, P902, DOI 10.1094/MPMI-08-16-0165-R; Chen XQ, 2010, PROTEOMICS, V10, P4040, DOI 10.1002/pmic.201000234; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; daSilva LLP, 2005, PLANT CELL, V17, P132, DOI 10.1105/tpc.104.026351; Dunkley TPJ, 2006, P NATL ACAD SCI USA, V103, P6518, DOI 10.1073/pnas.0506958103; Gjetting KSK, 2012, J EXP BOT, V63, P3207, DOI 10.1093/jxb/ers040; Gross LE, 2011, J ENDOCYTOBIOSIS CEL, V21, P89; Hyun SI, 2015, TRAFFIC, V16, P787, DOI 10.1111/tra.12281; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lavoie C, 2008, HISTOCHEM CELL BIOL, V129, P117, DOI 10.1007/s00418-007-0370-y; Lee H, 2014, BIOCHEM BIOPH RES CO, V453, P268, DOI 10.1016/j.bbrc.2014.05.111; Liu D. X., 2015, MOL GENET GENOMICS, P1, DOI DOI 10.1016/J.JBI0TEC.2015.11.017; Nielsen ME, 2012, P NATL ACAD SCI USA, V109, P11443, DOI 10.1073/pnas.1117596109; Tusnady GE, 2010, CURR PROTEIN PEPT SC, V11, P550; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; Wang PW, 2014, CURR BIOL, V24, P1397, DOI 10.1016/j.cub.2014.05.003; Zhang H, 2016, TRENDS CELL BIOL, V26, P934, DOI 10.1016/j.tcb.2016.06.002; Zhang WJ, 2012, MOL PLANT PATHOL, V13, P1110, DOI 10.1111/j.1364-3703.2012.00820.x	21	11	12	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0170118	10.1371/journal.pone.0170118	http://dx.doi.org/10.1371/journal.pone.0170118			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085941	Green Published, Green Submitted, gold			2022-12-26	WOS:000391972600063
J	Dasan, YK; Guan, BH; Zahari, MH; Chuan, LK				Dasan, Y. K.; Guan, B. H.; Zahari, M. H.; Chuan, L. K.			Influence of La3+ Substitution on Structure, Morphology and Magnetic Properties of Nanocrystalline Ni-Zn Ferrite	PLOS ONE			English	Article							CATION DISTRIBUTION; NIFE2O4 NANOPARTICLES; ELECTRICAL-PROPERTIES; COPRECIPITATION	Lanthanum substituted Ni-Zn ferrite nanoparticles (Ni0.5Zn0.5LaxFe1-xO4; 0.00 <= x <= 1.00) synthesized by sol-gel method were presented. X-ray diffraction patterns reveal the typical single phase spinel cubic ferrite structure, with the traces of secondary phase for lanthanum substituted nanocrystals. In addition, the structural analysis also demonstrates that the average crystallite size varied in the range of 21-25 nm. FTIR spectra present the two prominent absorption bands in the range of 400 to 600 cm(-1) which are the fingerprint region of all ferrites. Surface morphology of both substituted and unsubstituted Ni-Zn ferrite nanoparticle samples was studied using FESEM technique and it indicates a significant increase in the size of spherical shaped particles with La3+ substitution. Magnetic properties of all samples were analyzed using vibrating sample magnetometer (VSM). The results revealed that saturation magnetization (M-s) and coercivity (H-c) of La3+ substituted samples has decreased as compared to the Ni-Zn ferrite samples. Hence, the observed results affirm that the lanthanum ion substitution has greatly influenced the structural, morphology and magnetic properties of Ni-Zn ferrite nanoparticles.	[Dasan, Y. K.; Guan, B. H.; Zahari, M. H.; Chuan, L. K.] Univ Teknol PETRONAS, Dept Fundamental & Appl Sci, Tronoh, Perak Darul Rid, Malaysia	Universiti Teknologi Petronas	Guan, BH (corresponding author), Univ Teknol PETRONAS, Dept Fundamental & Appl Sci, Tronoh, Perak Darul Rid, Malaysia.	beh.hoeguan@utp.edu.my			Ministry of Higher Education Malaysia (MOHE) [0153AB-I50]	Ministry of Higher Education Malaysia (MOHE)(Ministry of Education, Malaysia)	Dr. Beh Hoe Guan have received funding from Ministry of Higher Education Malaysia (MOHE) the project under the Fundamental Research Grant Scheme (FRGS) with cost center number of 0153AB-I50. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad I, 2013, CERAM INT, V39, P6735, DOI 10.1016/j.ceramint.2013.02.001; Ahmed MA, 2005, MATER CHEM PHYS, V92, P310, DOI 10.1016/j.matchemphys.2004.05.049; Ahmed TT, 2004, J MATER PROCESS TECH, V153, P797, DOI 10.1016/j.jmatprotec.2004.04.188; Al Angari YM, 2011, J MAGN MAGN MATER, V323, P1835, DOI 10.1016/j.jmmm.2011.02.003; Ali I, 2013, J SOL-GEL SCI TECHN, V68, P141, DOI 10.1007/s10971-013-3146-y; [Anonymous], 2013, J MAT RES TECHNOLOGY, DOI DOI 10.1016/J.JMRT.2013.09.001; Anupama MK, 2016, IOP CONF SER-MAT SCI, V149, DOI 10.1088/1757-899X/149/1/012194; Ateia EE, 2016, J INORG ORGANOMET P, V26, P81, DOI 10.1007/s10904-015-0283-5; Awati VV, 2013, J ALLOY COMPD, V553, P157, DOI 10.1016/j.jallcom.2012.11.045; Bugad R, J MAT SCI MAT ELECT, P1; Caizer C, 2002, J PHYS D APPL PHYS, V35, P3035, DOI 10.1088/0022-3727/35/23/301; Chaudhari V, 2013, J ALLOY COMPD, V549, P213, DOI 10.1016/j.jallcom.2012.09.060; Chu S, 2011, CRITICAL MAT STRATEG; Dar MA, 2014, APPL NANOSCI, V4, P675, DOI 10.1007/s13204-013-0241-x; Gabal MA, 2011, CERAM INT, V37, P2625, DOI 10.1016/j.ceramint.2011.04.007; Gaber A, 2014, INT J ELECTROCHEM SC, V9, P81; Gadkari AB, 2011, J ALLOY COMPD, V509, P966, DOI 10.1016/j.jallcom.2010.08.155; Gao F., 2016, ADVANCES, V6, P10298; Gao PZ, 2010, J APPL PHYS, V107, DOI 10.1063/1.3309767; George M, 2006, J PHYS D APPL PHYS, V39, P900, DOI 10.1088/0022-3727/39/5/002; Guan BH, 2014, APPL MECH MAT; Humphries M., 2010, LIB C; Huq MF., 2013, J SCI RES, V216, P215, DOI 10.3329/jsr.v5i2.12434; Hussain A, 2013, CERAM INT, V39, P1221, DOI 10.1016/j.ceramint.2012.07.049; Jacob BP, 2013, J ALLOY COMPD, V578, P314, DOI 10.1016/j.jallcom.2013.04.147; Jacob J, 2010, J APPL PHYS, V107, DOI 10.1063/1.3429202; Jiang J, 2007, PHYSICA B, V399, P105, DOI 10.1016/j.physb.2007.05.035; Jiang J, 2007, J RARE EARTH, V25, P79; Kavas H, 2009, J ALLOY COMPD, V479, P49, DOI 10.1016/j.jallcom.2009.01.014; Kodama RH, 1996, PHYS REV LETT, V77, P394, DOI 10.1103/PhysRevLett.77.394; Koseoglu Y, 2011, J NANOPART RES, V13, P2235, DOI 10.1007/s11051-010-9982-6; Krishnamurthy N., 2004, EXTRACTIVE METALLURG; Kulkarni V, INFLUENCE LA3 DOPED; Kumar L, 2012, CERAM INT, V38, P4771, DOI 10.1016/j.ceramint.2012.02.065; Masoudpanah SM, 2014, J MAGN MAGN MATER, V370, P122, DOI 10.1016/j.jmmm.2014.06.062; Nair KM, 2011, ADV APPL ELECTROCERA; Najmoddin N, 2014, CERAM INT, V40, P3619, DOI 10.1016/j.ceramint.2013.09.063; Patil RP, 2013, RESULTS PHYS, V3, P129, DOI 10.1016/j.rinp.2013.08.002; Peng ZJ, 2011, J MAGN MAGN MATER, V323, P2513, DOI 10.1016/j.jmmm.2011.05.033; Pervaiz E, 2013, J PHYS CONF SER, V439, DOI 10.1088/1742-6596/439/1/012015; Rama K K, 2012, ADV MAT PHYS CHEM, V2012; Rani R, 2012, CERAM INT, V38, P2389, DOI 10.1016/j.ceramint.2011.11.004; Rathod SM, SYNTHESIS CHARACTERI; Rezlescu N, 1998, J ALLOY COMPD, V275, P657, DOI 10.1016/S0925-8388(98)00413-7; Sanpo N, 2013, ANTIBACTERIAL PROPER; Satalkar M, 2016, J PHYS CONF SER, V755, DOI 10.1088/1742-6596/755/1/012047; Sattar AA, 2005, J MATER ENG PERFORM, V14, P99, DOI 10.1361/10599490522185; SCHWARTZ M., 2002, ENCY MAT PARTS FINIS; Sellmyer D.J., 2002, HDB THIN FILM MAT, P337; Shinde TJ, 2012, J ALLOY COMPD, V513, P80, DOI 10.1016/j.jallcom.2011.10.001; Shirsath SE, 2010, J PHYS CHEM SOLIDS, V71, P1669, DOI 10.1016/j.jpcs.2010.08.016; Singh N, 2011, PHYSICA B, V406, P687, DOI 10.1016/j.physb.2010.11.087; Slama J, 2009, J MAGN MAGN MATER, V321, P3346, DOI 10.1016/j.jmmm.2009.06.024; Soka M, 2012, J ELECT ENG, V63, P83; Sridhar R, 2012, ADV MAT PHYS CHEM, V2012; Stergiou C., 2014, AIP C P; Survey G., 2011, MINERALS YB, V1; Torkian S, 2016, J SUPERCOND NOV MAGN, V29, P1627, DOI 10.1007/s10948-016-3450-1; Valenzuela R., 2005, MAGNETIC CERAMICS; Wang Y, 2016, J MAGN MAGN MATER, V398, P90, DOI 10.1016/j.jmmm.2015.09.044; Wang YP, 2008, MATER CHEM PHYS, V112, P769, DOI 10.1016/j.matchemphys.2008.06.032; Wu XH, 2015, J MAGN MAGN MATER, V379, P232, DOI 10.1016/j.jmmm.2014.12.057; Xavier Sheena, 2013, Journal of Nanoscience, DOI 10.1155/2013/524380; Xiong CM, 2005, CHINESE PHYS, V14, P604, DOI 10.1088/1009-1963/14/3/032; Yang HM, 2004, MATER RES BULL, V39, P833, DOI 10.1016/j.materresbull.2004.02.001; Zahi S., 2010, Journal of Electromagnetic Analysis and Applications, V2, P56, DOI 10.4236/jemaa.2010.21009; Zahi S, 2007, J MAGN MAGN MATER, V308, P177, DOI 10.1016/j.jmmm.2006.05.033; Zhou B, 2004, J MAGN MAGN MATER, V280, P327, DOI 10.1016/j.jmmm.2004.03.031	68	40	40	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0170075	10.1371/journal.pone.0170075	http://dx.doi.org/10.1371/journal.pone.0170075			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081257	Green Published, gold, Green Submitted			2022-12-26	WOS:000391949500128
J	Kakegawa, T; Bae, Y; Ito, T; Uchida, K; Sekine, M; Nakajima, Y; Furukawa, A; Suzuki, Y; Kumagai, J; Akashi, T; Eishi, Y				Kakegawa, Tomoya; Bae, Yuan; Ito, Takashi; Uchida, Keisuke; Sekine, Masaki; Nakajima, Yutaka; Furukawa, Asuka; Suzuki, Yoshimi; Kumagai, Jiro; Akashi, Takumi; Eishi, Yoshinobu			Frequency of Propionibacterium acnes Infection in Prostate Glands with Negative Biopsy Results Is an Independent Risk Factor for Prostate Cancer in Patients with Increased Serum PSA Titers	PLOS ONE			English	Article							SYSTEMATIC BIOPSY; CORE BIOPSIES; INFLAMMATION; TISSUE	Background Propionibacterium acnes has recently been implicated as a cause of chronic prostatitis and this commensal bacterium may be linked to prostate carcinogenesis. The occurrence of intracellular P. acnes infection in prostate glands and the higher frequency of P. acnes-positive glands in radical prostatectomy specimens from patients with prostate cancer (PCa) than in those from patients without PCa led us to examine whether the P. acnes-positive gland frequency can be used to assess the risk for PCa in patients whose first prostate biopsy, performed due to an increased prostate-specific antigen (PSA) titer, was negative. Methods We retrospectively collected the first and last prostate biopsy samples from 44 patients that were diagnosed PCa within 4 years after the first negative biopsy and from 36 control patients with no PCa found in repeated biopsy for at least 3 years after the first biopsy. We evaluated P. acnes-positive gland frequency and P. acnes-positive macrophage number using enzyme-immunohistochemistry with a P. acnes-specific monoclonal antibody (PAL antibody). Results The frequency of P. acnes-positive glands was higher in PCa samples than in control samples in both first biopsy samples and in combined first and last biopsy samples (P < 0.001). A frequency greater than the threshold (18.5 and 17.7, respectively) obtained by each receiver operating characteristic curve was an independent risk factor for PCa (P = 0.003 and 0.001, respectively) with odds ratios (14.8 and 13.9, respectively) higher than those of serum PSA titers of patients just before each biopsy (4.6 and 2.3, respectively). The number of P. acnes-positive macrophages did not differ significantly between PCa and control samples. Conclusions These results suggested that the frequency of P. acnes-positive glands in the first negative prostate biopsy performed due to increased PSA titers can be supportive information for urologists in planning repeated biopsy or follow-up strategies.	[Kakegawa, Tomoya; Ito, Takashi; Furukawa, Asuka; Suzuki, Yoshimi; Eishi, Yoshinobu] Tokyo Med & Dent Univ, Grad Sch, Dept Human Pathol, Tokyo, Japan; [Kakegawa, Tomoya; Ito, Takashi; Furukawa, Asuka; Suzuki, Yoshimi; Eishi, Yoshinobu] Tokyo Med & Dent Univ, Fac Med, Tokyo, Japan; [Bae, Yuan; Uchida, Keisuke; Sekine, Masaki; Nakajima, Yutaka; Akashi, Takumi; Eishi, Yoshinobu] Tokyo Med & Dent Univ Hosp, Div Surg Pathol, Tokyo, Japan; [Kumagai, Jiro] Yokohama City Minato Red Cross Hosp, Dept Pathol, Yokohama, Kanagawa, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Eishi, Y (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Dept Human Pathol, Tokyo, Japan.; Eishi, Y (corresponding author), Tokyo Med & Dent Univ, Fac Med, Tokyo, Japan.; Eishi, Y (corresponding author), Tokyo Med & Dent Univ Hosp, Div Surg Pathol, Tokyo, Japan.	eishi.path@tmd.ac.jp	Eishi, Yoshinobu/N-3602-2017	Eishi, Yoshinobu/0000-0002-0521-1670	Japan Society for the Promotion of Science (JSPS) KAKENHI [26462404]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 26462404 (YE), https://www.jsps.go.jp/english/index.html.; We thank Ms. Sayako Chiba, Mr. Go, Ms. Reina Tamura, Mr. Ryuta Suzuki, and Ms. Chiina Hata for their technical assistance. This work was supported by the Japan Society for the Promotion of science (JSPS) KAKENHI Grant Number 26462404 (YE).	Alexeyev OA, 2007, J CLIN MICROBIOL, V45, P3721, DOI 10.1128/JCM.01543-07; Atan A, 2010, J UROLOGY, V183, P2471, DOI 10.1016/j.juro.2010.02.041; Bae Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090324; Bergdahl A Grenabo, 2015, EUR UROL; Berger RE, 1997, J UROLOGY, V157, P863, DOI 10.1016/S0022-5347(01)65066-3; Billis Athanase, 2005, Int. braz j urol., V31, P500, DOI 10.1590/S1677-55382005000500017; Cohen RJ, 2005, J UROLOGY, V173, P1969, DOI 10.1097/01.ju.0000158161.15277.78; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Fehri LF, 2011, INT J MED MICROBIOL, V301, P69, DOI 10.1016/j.ijmm.2010.08.014; Helfand BT, 2013, BJU INT, V111, P38, DOI 10.1111/j.1464-410X.2012.11268.x; HODGE KK, 1989, J UROLOGY, V142, P71, DOI 10.1016/S0022-5347(17)38664-0; Kawakami Satoru, 2006, Int J Clin Oncol, V11, P127, DOI 10.1007/s10147-005-0547-0; Kawakami S, 2007, EUR UROL, V51, P675, DOI 10.1016/j.eururo.2006.06.015; Matsuoka Y, 2014, EUR UROL, V65, P186, DOI 10.1016/j.eururo.2012.10.010; Truong M, 2013, J UROLOGY, V189, P422, DOI 10.1016/j.juro.2012.04.143; Nickel JC, 1999, BJU INT, V84, P976; Norberg M, 1997, UROLOGY, V50, P562, DOI 10.1016/S0090-4295(97)00306-3; Sfanos KS, 2008, PROSTATE, V68, P306, DOI 10.1002/pros.20680; Suzuki M, 2009, INT J UROL, V16, P930, DOI 10.1111/j.1442-2042.2009.02386.x; Takeshita H, 2015, BJU INT, V115, P412, DOI 10.1111/bju.12772; Vasto S, 2008, FUTURE ONCOL, V4, P637, DOI 10.2217/14796694.4.5.637	21	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169984	10.1371/journal.pone.0169984	http://dx.doi.org/10.1371/journal.pone.0169984			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081259	gold, Green Published, Green Submitted			2022-12-26	WOS:000391949500114
J	Xing, Y; Wang, ZQ; Hong, C; Yang, Q; Feng, LH; Jia, MM; Li, YF				Xing, Yi; Wang, Zhiqiang; Hong, Chen; Yang, Qiang; Feng, Lihui; Jia, Mengmeng; Li, Yifei			Mechanism and Parameter Optimization of Fenton's Reagent Integrated with Surfactant Pretreatment to Improve Sludge Dewaterability	PLOS ONE			English	Article							WASTE ACTIVATED-SLUDGE; ZERO-VALENT IRON; EXTRACELLULAR POLYMERIC SUBSTANCES; SEWAGE-SLUDGE; WATER; DEGRADATION; FLOCS	Sludge dewatering can effectively reduce the volume and mass of sludge for subsequent treatment and disposal. The work validated the potential of Fenton's reagent combined with dodecyl dimethyl benzyl ammonium chloride (DDBAC) in improving sludge dewaterability and proposed the mechanism of joint conditioning. The composite conditioner dosage was optimized using response surface methodology. Results indicated the good conditioning capability of the composite conditioners. The optimum dosages for H2O2, Fe2+, and DDBAC were 44.6, 39.6, and 71.0 mg/g, respectively, at which a sludge cake water content of 59.67% could be achieved. Moreover, a second-order polynomial equation was developed to describe the behavior of joint conditioning. Analysis of the reaction mechanism showed that Fenton oxidation effectively decomposed extracellular polymeric substance (EPS), including loosely bound EPS (LB-EPS) and tightly bound EPS (TB-EPS), into dissolved organics, such as proteins and polysaccharides. The process facilitated the conversion of the bound water into free water. Furthermore, DDBAC further released the bound water through solubilization of TB-EPS and LB-EPS after the Fenton reaction. The bound water content of the sludge conditioned with Fenton's reagent decreased from 3.15 to 1.36 g/g and further decreased to 1.08 g/g with the addition of DDBAC. High-performance liquid chromatography analysis verified that the composite conditioning could oxidize and hydrolyze EPS into low-molecular-mass organics (e.g., formic and acetic acid), thereby facilitating the release of bound water.	[Xing, Yi; Wang, Zhiqiang; Hong, Chen; Yang, Qiang; Feng, Lihui; Jia, Mengmeng; Li, Yifei] Univ Sci & Technol Beijing, Dept Environm Engn, Beijing, Peoples R China; [Xing, Yi; Wang, Zhiqiang; Yang, Qiang; Feng, Lihui; Jia, Mengmeng; Li, Yifei] Univ Sci & Technol Beijing, Beijing Key Lab Resource Oriented Treatment Ind P, Beijing, Peoples R China; [Hong, Chen] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, Beijing, Peoples R China	University of Science & Technology Beijing; University of Science & Technology Beijing; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Hong, C (corresponding author), Univ Sci & Technol Beijing, Dept Environm Engn, Beijing, Peoples R China.; Hong, C (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, Beijing, Peoples R China.	hongchen2112@163.com			National Natural Science Foundation of China [51508553]; Beijing Training Project for the Leading Talents in Science and Technology [LJ201620]; China Postdoctoral Science Foundation [2016M591266]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Training Project for the Leading Talents in Science and Technology; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (No. 51508553;www.nsfc.gov.cn; YX), Beijing Training Project for the Leading Talents in Science and Technology (Grant No. LJ201620;www.bjkw.gov.cn;YX), and China Postdoctoral Science Foundation Funded Project (Grant No. 2016M591266;jj. chinapostdoctor.org.cn; CH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buyukkamaci N, 2004, PROCESS BIOCHEM, V39, P1503, DOI 10.1016/S0032-9592(03)00294-2; COLIN F, 1995, WATER RES, V29, P2000, DOI 10.1016/0043-1354(94)00274-B; Hong C, 2015, APPL MICROBIOL BIOT, V99, P6103, DOI 10.1007/s00253-015-6451-2; Hong C, 2015, RSC ADV, V5, P23383, DOI 10.1039/c4ra15370g; Hua XF, 2010, CHEMOSPHERE, V80, P951, DOI 10.1016/j.chemosphere.2010.05.002; Hua XF, 2010, BIOCHEM ENG J, V49, P201, DOI 10.1016/j.bej.2009.12.014; Huang XF, 2015, CHEM ENG J, V264, P280, DOI 10.1016/j.cej.2014.11.078; Jin B, 2004, CHEM ENG J, V98, P115, DOI 10.1016/j.cej.2003.05.002; Kallel M, 2009, J HAZARD MATER, V163, P550, DOI 10.1016/j.jhazmat.2008.07.006; Kwon JH, 2004, WATER SCI TECHNOL, V50, P99, DOI 10.2166/wst.2004.0545; Laspidou CS, 2002, WATER RES, V36, P2711, DOI 10.1016/S0043-1354(01)00413-4; Liu H, 2012, CHEMOSPHERE, V88, P235, DOI 10.1016/j.chemosphere.2012.02.084; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martins RC, 2012, CHEM ENG J, V192, P219, DOI 10.1016/j.cej.2012.03.053; Mo RS, 2015, CHEM ENG J, V269, P391, DOI 10.1016/j.cej.2015.02.001; Montgomery D.C., 2009, DESIGN ANAL EXPT, V7th; Neyens E, 2004, J HAZARD MATER, V106, P83, DOI 10.1016/j.jhazmat.2003.11.014; RIESZ P, 1985, ENVIRON HEALTH PERSP, V64, P233, DOI 10.2307/3430013; Tony MA, 2008, CHEMOSPHERE, V72, P673, DOI 10.1016/j.chemosphere.2008.03.032; Vaxelaire J, 2004, WATER RES, V38, P2215, DOI 10.1016/j.watres.2004.02.021; Wang HW, 2013, CARBOHYD POLYM, V92, P510, DOI 10.1016/j.carbpol.2012.09.055; Wang LF, 2014, BIOCHEM ENG J, V91, P174, DOI 10.1016/j.bej.2014.08.008; Wang LF, 2014, CHEM ENG SCI, V116, P228, DOI 10.1016/j.ces.2014.05.014; Yang G, 2015, WATER RES, V78, P60, DOI 10.1016/j.watres.2015.04.002; Yu GH, 2008, ENVIRON SCI TECHNOL, V42, P7944, DOI 10.1021/es8016717; Yu WB, 2016, WATER RES, V95, P124, DOI 10.1016/j.watres.2016.03.016; Yuan HP, 2011, BIORESOURCE TECHNOL, V102, P5659, DOI 10.1016/j.biortech.2011.02.076; Yuan HP, 2011, BIORESOURCE TECHNOL, V102, P2308, DOI 10.1016/j.biortech.2010.10.065; Zhang H, 2014, WATER RES, V59, P239, DOI 10.1016/j.watres.2014.04.026; Zhen GY, 2012, BIORESOURCE TECHNOL, V119, P7, DOI 10.1016/j.biortech.2012.05.115; Zhou X, 2015, SCI REP-UK, V5, DOI 10.1038/srep10071; Zhou X, 2015, BIORESOURCE TECHNOL, V185, P416, DOI 10.1016/j.biortech.2015.02.088; Zhou X, 2014, BIORESOURCE TECHNOL, V174, P103, DOI 10.1016/j.biortech.2014.10.009	33	7	8	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169523	10.1371/journal.pone.0169523	http://dx.doi.org/10.1371/journal.pone.0169523			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081203	Green Submitted, Green Published, gold			2022-12-26	WOS:000391949500049
J	Hovingh, ES; van Gent, M; Hamstra, HJ; Demkes, M; Mooi, FR; Pinelli, E				Hovingh, Elise S.; van Gent, Marjolein; Hamstra, Hendrik-Jan; Demkes, Marc; Mooi, Frits R.; Pinelli, Elena			Emerging Bordetella pertussis Strains Induce Enhanced Signaling of Human Pattern Recognition Receptors TLR2, NOD2 and Secretion of IL-10 by Dendritic Cells	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; PERTACTIN-DEFICIENT; LIPOOLIGOSACCHARIDE STRUCTURE; DISEASE BURDEN; INNATE; GENERATION; VACCINE; TOXIN; DIPHTHERIA; SELECTION	Vaccines against pertussis have been available for more than 60 years. Nonetheless, this highly contagious disease is reemerging even in countries with high vaccination coverage. Genetic changes of Bordetella pertussis over time have been suggested to contribute to the resurgence of pertussis, as these changes may favor escape from vaccine-induced immunity. Nonetheless, studies on the effects of these bacterial changes on the immune response are limited. Here, we characterize innate immune recognition and activation by a collection of genetically diverse B. pertussis strains isolated from Dutch pertussis patients before and after the introduction of the pertussis vaccines. For this purpose, we used HEK-Blue cells transfected with human pattern recognition receptors TLR2, TLR4, NOD2 and NOD1 as a high throughput system for screening innate immune recognition of more than 90 bacterial strains. Physiologically relevant human monocyte derived dendritic cells (moDC), purified from peripheral blood of healthy donors were also used. Findings indicate that, in addition to inducing TLR2 and TLR4 signaling, all B. pertussis strains activate the NOD-like receptor NOD2 but not NOD1. Furthermore, we observed a significant increase in TLR2 and NOD2, but not TLR4, activation by strains circulating after the introduction of pertussis vaccines. When using moDC, we observed that the recently circulating strains induced increased activation of these cells with a dominant IL-10 production. In addition, we observed an increased expression of surface markers including the regulatory molecule PD-L1. Expression of PD-L1 was decreased upon blocking TLR2. These in vitro findings suggest that emerging B. pertussis strains have evolved to dampen the vaccine-induced inflammatory response, which would benefit survival and transmission of this pathogen. Understanding how this disease has resurged in a highly vaccinated population is crucial for the design of improved vaccines against pertussis.	[Hovingh, Elise S.; van Gent, Marjolein; Hamstra, Hendrik-Jan; Demkes, Marc; Mooi, Frits R.; Pinelli, Elena] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment	Pinelli, E (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands.	elena.pinelli.ortiz@rivm.nl			Dutch Ministry for Public Health and the Environment (RIVM) [SOR-000083]	Dutch Ministry for Public Health and the Environment (RIVM)	This project was funded by the Dutch Ministry for Public Health and the Environment (RIVM), SOR-000083 grant to EP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Asgarian-Omran H, 2015, APMIS, V123, P156, DOI 10.1111/apm.12332; Bamberger E, 2015, PEDIATR INFECT DIS J, V34, P898, DOI 10.1097/INF.0000000000000753; Bart MJ, 2014, MBIO, V5, DOI 10.1128/mBio.01074-14; Bart MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-627; Bart MJ, 2015, GENOME ANNOUNC, V3; BLUMBERG DA, 1993, PEDIATRICS, V91, P1158; Bouloc A, 2000, EUR J IMMUNOL, V30, P3132, DOI 10.1002/1521-4141(200011)30:11<3132::AID-IMMU3132>3.0.CO;2-E; Brummelman J, 2015, INFECT IMMUN, V83, P227, DOI 10.1128/IAI.02197-14; Carbonetti NH, 2016, CURR OPIN INFECT DIS, V29, P287, DOI 10.1097/QCO.0000000000000264; Clarke M, 2015, J INFECT; de Gouw D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084523; de Greeff SC, 2008, PEDIATR INFECT DIS J, V27, P218, DOI 10.1097/INF.0b013e318161a2b9; De Nardo D, 2015, CYTOKINE, V74, P181, DOI 10.1016/j.cyto.2015.02.025; Dunne A, 2015, MUCOSAL IMMUNOL, V8, P607, DOI 10.1038/mi.2014.93; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Granucci F, 2003, EMBO J, V22, P2546, DOI 10.1093/emboj/cdg261; Hegerle N, 2014, VACCINE, V32, P6597, DOI 10.1016/j.vaccine.2014.09.068; Hewlett EL, 2005, NEW ENGL J MED, V352, P1215, DOI 10.1056/NEJMcp041025; Higgins SC, 2003, J IMMUNOL, V171, P3119, DOI 10.4049/jimmunol.171.6.3119; Higgs R, 2012, MUCOSAL IMMUNOL, V5, P485, DOI 10.1038/mi.2012.54; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; King AJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-64; Lam C, 2014, EMERG INFECT DIS, V20, P626, DOI 10.3201/eid2004.131478; Lam C, 2012, INFECT GENET EVOL, V12, P492, DOI 10.1016/j.meegid.2012.01.001; Magalhaes JG, 2005, EMBO REP, V6, P1201, DOI 10.1038/sj.embor.7400552; Marr N, 2010, J INFECT DIS, V202, P1897, DOI 10.1086/657409; Martin SW, 2015, CLIN INFECT DIS, V60, P223, DOI 10.1093/cid/ciu788; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mooi FR, 2014, EPIDEMIOL INFECT, V142, P685, DOI 10.1017/S0950268813000071; Mooi FR, 2000, EUR J CLIN MICROBIOL, V19, P174, DOI 10.1007/s100960050455; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; Moreira LO, 2008, CELL MICROBIOL, V10, P2067, DOI 10.1111/j.1462-5822.2008.01189.x; Netea MG, 2004, EUR J IMMUNOL, V34, P2052, DOI 10.1002/eji.200425229; Olin P, 1997, LANCET, V350, P1569, DOI 10.1016/S0140-6736(97)06508-2; Otsuka N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031985; Pawloski LC, 2014, CLIN VACCINE IMMUNOL, V21, P119, DOI 10.1128/CVI.00717-13; PODDA A, 1995, J PEDIATR-US, V127, P238, DOI 10.1016/S0022-3476(95)70301-2; Rocha G, 2015, PAEDIATR RESPIR REV, V16, P112, DOI 10.1016/j.prrv.2014.01.004; Rutella S, 2004, EUR J IMMUNOL, V34, P1291, DOI 10.1002/eji.200324651; Rutella S, 2002, BLOOD, V100, P2562, DOI 10.1182/blood-2001-12-0291; Safarchi A, 2016, VACCINE, V34, P3967, DOI 10.1016/j.vaccine.2016.06.052; Safarchi A, 2015, VACCINE, V33, P6277, DOI 10.1016/j.vaccine.2015.09.064; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Tan T, 2015, PEDIAT INFECT DIS J; van der Maas NAT, 2013, VACCINE, V31, P4541, DOI 10.1016/j.vaccine.2013.07.060; van Gent M, 2015, EUR J CLIN MICROBIOL, V34, P821, DOI 10.1007/s10096-014-2297-2; van Gent M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046407; van Gent M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020340; Vashishta M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133601; Villarino Romero R, 2015, INT J MED MICROBIOL; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Wolfe DN, 2010, J IMMUNOL, V184, P1392, DOI 10.4049/jimmunol.0803045; Wu JY, 2015, MOL IMMUNOL, V64, P235, DOI 10.1016/j.molimm.2014.11.021; Zeddeman A, 2014, EURO SURVEILL, V19	57	14	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0170027	10.1371/journal.pone.0170027	http://dx.doi.org/10.1371/journal.pone.0170027			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076445	gold, Green Published			2022-12-26	WOS:000391857100079
J	Lee, HJ; Lee, JY; Park, MH; Kim, JY; Chang, J				Lee, Hyo-Jeong; Lee, Jeong-Yoon; Park, Min-Hee; Kim, Joo-Young; Chang, Jun			Monoclonal Antibody against G Glycoprotein Increases Respiratory Syncytial Virus Clearance In Vivo and Prevents Vaccine-Enhanced Diseases	PLOS ONE			English	Article							G-PROTEIN; BALB/C MICE; CELL RESPONSES; INFECTION; RSV; IMMUNIZATION; IMMUNITY; TH1; PATHOGENESIS; FRACTALKINE	Respiratory syncytial virus (RSV) is a common cause of lower respiratory tract illness in infants, young children, and the elderly. The G glycoprotein plays a role in host cell attachment and also modulates the host immune response, thereby inducing disease pathogenesis. We generated two monoclonal antibodies (mAbs; 5H6 and 3A5) against G protein core fragment (Gcf), which consisted of amino acid residues 131 to 230 from RSV A2 G protein. Epitope mapping study revealed that 5H6 specifically binds to the G/164-176 peptide that includes conserved sequences shared by both RSV A and B subtypes, and 3A5 binds to the G/190-204 peptide. Studies with mutant Gcf proteins in which cysteine residues were substituted with alanine revealed that 5H6 requires four cysteines for binding and 3A5 binds to Gcf variants with alanine substitutions better than wild-type. To determine if these mAbs reduce pulmonary viral infection, BALB/c mice were administered mAb and subsequently challenged with RSV. On day 4 post-infection, lung viral titers were reduced by up to 93% with the 5H6 injection and 90% with the 3A5 injection, indicating that prophylactic injection of these mAbs contributes to RSV clearance in vivo. Importantly, 5H6 injection reduced vaccine-enhanced diseases. Overall, our results suggest that this novel anti-G mAb could be used as a prophylactic regimen against RSV diseases.	[Lee, Hyo-Jeong; Lee, Jeong-Yoon; Park, Min-Hee; Kim, Joo-Young; Chang, Jun] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul 120750, South Korea	Ewha Womans University	Chang, J (corresponding author), Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul 120750, South Korea.	tcell@ewha.ac.kr	Kim, Jooyoung/R-5839-2018	Kim, Jooyoung/0000-0003-4846-6259; CHANG, JUN/0000-0002-8423-5987	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C0826]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2060008]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (Grant number: HI13C0826) and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2060008).	Afonso CL, 2016, ARCH VIROL, V161, P2351, DOI 10.1007/s00705-016-2880-1; BEATTY JD, 1987, J IMMUNOL METHODS, V100, P173, DOI 10.1016/0022-1759(87)90187-6; Bourgeois C, 1998, J VIROL, V72, P7221, DOI 10.1128/JVI.72.9.7221-7227.1998; Boyoglu-Barnum S, 2014, J VIROL, V88, P10569, DOI 10.1128/JVI.01503-14; Boyoglu-Barnum S, 2013, J VIROL, V87, P10955, DOI 10.1128/JVI.01164-13; Bueno SM, 2008, INT IMMUNOPHARMACOL, V8, P1320, DOI 10.1016/j.intimp.2008.03.012; CHIN J, 1969, AM J EPIDEMIOL, V89, P449, DOI 10.1093/oxfordjournals.aje.a120957; Chirkova T, 2013, J VIROL, V87, P13466, DOI 10.1128/JVI.01741-13; Choi Y, 2012, VIRAL IMMUNOL, V25, P193, DOI 10.1089/vim.2011.0094; Corbeil S, 1996, VACCINE, V14, P521, DOI 10.1016/0264-410X(95)00222-M; Fields BN, 2013, FIELDS VIROLOGY; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Fraticelli P, 2001, J CLIN INVEST, V107, P1173, DOI 10.1172/JCI11517; FULGINITI VA, 1969, AM J EPIDEMIOL, V89, P435, DOI 10.1093/oxfordjournals.aje.a120956; Gonzalez PA, 2012, REV MED VIROL, V22, P230, DOI 10.1002/rmv.1704; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hancock GE, 1996, J VIROL, V70, P7783, DOI 10.1128/JVI.70.11.7783-7791.1996; Harcourt J, 2006, J IMMUNOL, V176, P1600, DOI 10.4049/jimmunol.176.3.1600; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; Johnson SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005318; Johnson TR, 2012, J VIROL, V86, P1339, DOI 10.1128/JVI.06096-11; Johnson TR, 1998, J VIROL, V72, P2871, DOI 10.1128/JVI.72.4.2871-2880.1998; KAMMANN M, 1989, NUCLEIC ACIDS RES, V17, P5404, DOI 10.1093/nar/17.13.5404; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Kim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032226; Kim TH, 2014, BMB REP, V47, P184, DOI 10.5483/BMBRep.2014.47.4.050; Knudson CJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004757; Lambert L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00466; LEVINE S, 1987, J GEN VIROL, V68, P2521, DOI 10.1099/0022-1317-68-9-2521; Malhotra R, 2003, MICROBES INFECT, V5, P123, DOI 10.1016/S1286-4579(02)00079-5; Mao CR, 2009, J GEN VIROL, V90, P1119, DOI 10.1099/vir.0.009308-0; Martinez I, 2000, J GEN VIROL, V81, P2715, DOI 10.1099/0022-1317-81-11-2715; Melero JA, 1997, J GEN VIROL, V78, P2411, DOI 10.1099/0022-1317-78-10-2411; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; OPENSHAW PJM, 1992, INT IMMUNOL, V4, P493, DOI 10.1093/intimm/4.4.493; Power UF, 2001, VACCINE, V19, P2345, DOI 10.1016/S0264-410X(00)00525-9; Shim BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027953; Simoes EAF, 2002, RESP RES, V3, DOI 10.1186/rr187; Stievano L, 2004, CRIT REV IMMUNOL, V24, P205, DOI 10.1615/CritRevImmunol.v24.i3.40; Tripp RA, 2001, NAT IMMUNOL, V2, P732, DOI 10.1038/90675; Tripp RA, 2004, VIRAL IMMUNOL, V17, P165, DOI 10.1089/0882824041310513; Tripp RA, 1999, J VIROL, V73, P7099, DOI 10.1128/JVI.73.9.7099-7107.1999; Yu JR, 2008, J VIROL, V82, P2350, DOI 10.1128/JVI.02372-07	43	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169139	10.1371/journal.pone.0169139	http://dx.doi.org/10.1371/journal.pone.0169139			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076422	Green Submitted, Green Published, gold			2022-12-26	WOS:000391857100023
J	Gimenez-Bastida, JA; Shibata, T; Uchida, K; Schneider, C				Gimenez-Bastida, Juan A.; Shibata, Takahiro; Uchida, Koji; Schneider, Claus			Roles of 5-lipoxygenase and cyclooxygenase-2 in the biosynthesis of hemiketals E-2 and D-2 by activated human leukocytes	FASEB JOURNAL			English	Article						arachidonic acid; prostaglandin; leukotriene	NF-KAPPA-B; ARACHIDONIC-ACID METABOLISM; POLYMORPHONUCLEAR LEUKOCYTES; COX-2 INHIBITION; PROSTAGLANDIN; CURCUMIN; MACROPHAGES; OXYGENATION; LEUKOTRIENE; EXPRESSION	The 2 hemiketal (HK) eicosanoids HKD2 and HKE2 are the major products of the biosynthetic crossover of the 5-lipoxygenase (5-LOX) and cyclooxygenase-2 (COX-2) pathways. HKs result from the rearrangement of a di-endoperoxide intermediate formed in the COX-2-dependent oxygenation of 5S-hydroxyeicosatetraenoic acid (5S-HETE). We analyzed HK biosynthesis in human leukocytes stimulated ex vivo and defined the biosynthetic roles of 5-LOX and COX-2, using inhibitors and incubations with exogenous substrates. Activation of leukocytes with LPS followed by treatment with the calcium ionophore A23187 resulted in the formation of PGE(2), 5-HETE, and LTB4 as the principal metabolites of COX-2 and 5-LOX, respectively. The formation of HKD2 and HKE2 was highest after 15min LPS treatment, and at that time, levels were similar to PGE(2), but less than 5-HETE and LTB4. The time course of HK formation paralleled that of 5-HETE and LTB4, implying the availability of the 5S-HETE substrate as a limiting factor in biosynthesis rather than expression levels of COX-2. Specific inhibitors of COX-2 and 5-LOX decreased formation of HKD2 and HKE2. Platelets didnot form HKs from exogenous 5S-HETE, implying that COX-1 is not involved. HKs are early products during an inflammatory event and require cells that express 5-LOX and COX-2 for their biosynthesis.-Gimenez-Bastida, J. A., Shibata, T., Uchida, K., Schneider, C. Roles of 5-lipoxygenase and cyclooxygenase-2 in the biosynthesis of hemiketals E-2 and D-2 by activated human leukocytes.	[Gimenez-Bastida, Juan A.; Schneider, Claus] Vanderbilt Univ, Dept Pharmacol, Med Sch, RRB 514,23rd Av S & Pierce, Nashville, TN 37232 USA; [Gimenez-Bastida, Juan A.; Schneider, Claus] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Med Sch, Nashville, TN USA; [Shibata, Takahiro; Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Div Biofunct Chem, Nagoya, Aichi, Japan; [Uchida, Koji] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan	Vanderbilt University; Vanderbilt University; Nagoya University; University of Tokyo	Schneider, C (corresponding author), Vanderbilt Univ, Dept Pharmacol, Med Sch, RRB 514,23rd Av S & Pierce, Nashville, TN 37232 USA.	claus.schneider@vanderbilt.edu	Gimenez Bastida, Juan Antonio/T-2721-2017; Shibata, Takahiro/I-6872-2014	Gimenez Bastida, Juan Antonio/0000-0002-1244-8764; Uchida, Koji/0000-0003-3894-5299; Shibata, Takahiro/0000-0003-3194-607X	U. S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) [R01GM076592]; National Center for Complementary and Integrative Health [R01AT006896]; American Heart Association [16POST30690001]; Ministry of Education, Sciences, Sports, Technology (MEXT), Japan [26111011]; Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology (PRESTO) program;  [26252018]; National Center for Complementary & Integrative Health [R01AT006896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076592] Funding Source: NIH RePORTER	U. S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS); National Center for Complementary and Integrative Health; American Heart Association(American Heart Association); Ministry of Education, Sciences, Sports, Technology (MEXT), Japan; Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology (PRESTO) program; ; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Ginger Milne for providing the AMPP reagent used in the initial phase of the study, and Dr. Noemi Tejera Hernandez (both from Vanderbilt University) for exploratory work on this project. This work was supported by U. S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) Grant R01GM076592 and National Center for Complementary and Integrative Health Grant R01AT006896 (to C.S); postdoctoral award 16POST30690001 from the American Heart Association (to J.A.G.-B.); Grant-in-Aid for Scientific Research 26252018 (to K.U.); and Grant-in-Aid for Scientific Research on Innovative Areas "Oxygen Biology: a new criterion for integrated understanding of life" 26111011 of the Ministry of Education, Sciences, Sports, Technology (MEXT), Japan; and a grant from the Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology (PRESTO) program (to T.S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIGMS or the NIH. The authors declare no conflicts of interest.	Aluwi MFFM, 2016, BIOORG MED CHEM LETT, V26, P2531, DOI 10.1016/j.bmcl.2016.03.092; Blobaum AL, 2007, J BIOL CHEM, V282, P16379, DOI 10.1074/jbc.M609883200; BOKOCH GM, 1981, J BIOL CHEM, V256, P4156; Bollinger JG, 2010, ANAL CHEM, V82, P6790, DOI 10.1021/ac100720p; Brenneis C, 2006, FASEB J, V20, P1352, DOI 10.1096/fj.05-5346com; Brock TG, 1997, J BIOL CHEM, V272, P8276, DOI 10.1074/jbc.272.13.8276; CHEN XS, 1994, NATURE, V372, P179, DOI 10.1038/372179a0; COREY EJ, 1981, TETRAHEDRON LETT, V22, P299, DOI 10.1016/0040-4039(81)80080-9; FitzGerald GA, 2004, NEW ENGL J MED, V351, P1709, DOI 10.1056/NEJMp048288; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gimenez-Bastida J. A., 2016, PROSTAG OTH LIPID M, DOI [10.1016/j.prostaglandins.2016.09.001, DOI 10.1016/J.PROSTAGLANDINS.2016.09]; GOLDYNE ME, 1984, J BIOL CHEM, V259, P8815; Gordon ON, 2013, J LABELLED COMPD RAD, V56, P696, DOI 10.1002/jlcr.3102; Griesser M, 2011, P NATL ACAD SCI USA, V108, P6945, DOI 10.1073/pnas.1019473108; Griesser M, 2009, J LIPID RES, V50, P2455, DOI 10.1194/jlr.M900181-JLR200; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Hermanson DJ, 2014, TRENDS PHARMACOL SCI, V35, P358, DOI 10.1016/j.tips.2014.04.006; Hong JI, 2004, CARCINOGENESIS, V25, P1671, DOI 10.1093/carcin/bgh165; Jin J, 2013, J LIPID RES, V54, P754, DOI 10.1194/jlr.M033746; Jobin C, 1999, J IMMUNOL, V163, P3474; Kozak KR, 2002, J BIOL CHEM, V277, P44877, DOI 10.1074/jbc.M206788200; Kuwata H, 2015, BIOCHEM BIOPH RES CO, V465, P528, DOI 10.1016/j.bbrc.2015.08.054; Lynch KR, 1999, NATURE, V399, P789; Mulugeta S, 2010, J LIPID RES, V51, P575, DOI 10.1194/jlr.M001719; MURPHY RC, 1979, P NATL ACAD SCI USA, V76, P4275, DOI 10.1073/pnas.76.9.4275; Murphy RC, 2007, BIOCHEM J, V405, P379, DOI 10.1042/BJ20070289; OFLaherty JT, 1996, J IMMUNOL, V157, P336; PATRIGNANI P, 1994, J PHARMACOL EXP THER, V271, P1705; Plummer SM, 1999, ONCOGENE, V18, P6013, DOI 10.1038/sj.onc.1202980; Powell WS, 2005, PROG LIPID RES, V44, P154, DOI 10.1016/j.plipres.2005.04.002; POWELL WS, 1992, J BIOL CHEM, V267, P19233; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; Rhee SH, 2000, J BIOL CHEM, V275, P34035, DOI 10.1074/jbc.M007386200; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; ROUZER CA, 1986, P NATL ACAD SCI USA, V83, P857, DOI 10.1073/pnas.83.4.857; Rouzer CA, 2003, CHEM REV, V103, P2239, DOI 10.1021/cr000068x; Rouzer CA, 2006, BIOCHEM J, V399, P91, DOI 10.1042/BJ20060615; Schneider C, 2006, J AM CHEM SOC, V128, P720, DOI 10.1021/ja056517y; Schneider C, 2004, J BIOL CHEM, V279, P4404, DOI 10.1074/jbc.M307431200; Schneider C, 2002, J BIOL CHEM, V277, P478, DOI 10.1074/jbc.M107471200; Smith CJ, 1998, P NATL ACAD SCI USA, V95, P13313, DOI 10.1073/pnas.95.22.13313; Smith JP, 2010, THROMB RES, V126, pE23, DOI 10.1016/j.thromres.2010.04.003; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Smyth EM, 2009, J LIPID RES, V50, pS423, DOI 10.1194/jlr.R800094-JLR200; Tejera N, 2012, J LIPID RES, V53, P87, DOI 10.1194/jlr.M017822; Yu M, 1997, J BIOL CHEM, V272, P21181, DOI 10.1074/jbc.272.34.21181	46	12	12	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1867	1878		10.1096/fj.201601136R	http://dx.doi.org/10.1096/fj.201601136R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28096231	Green Published			2022-12-26	WOS:000399195500010
J	Binenbaum, Y; Ben-David, G; Gil, Z; Slutsker, YZ; Ryzhkov, MA; Felsteiner, J; Krasik, YE; Cohen, JT				Binenbaum, Y.; Ben-David, G.; Gil, Z.; Slutsker, Ya. Z.; Ryzhkov, M. A.; Felsteiner, J.; Krasik, Ya. E.; Cohen, J. T.			Cold Atmospheric Plasma, Created at the Tip of an Elongated Flexible Capillary Using Low Electric Current, Can Slow the Progression of Melanoma	PLOS ONE			English	Article							DIELECTRIC BARRIER DISCHARGE; MALIGNANT-MELANOMA; NONTHERMAL PLASMA; CANCER-CELLS; THERAPY; MICROPLASMA; MANAGEMENT; INDUCTION; WATER; JET	Introduction Cold Atmospheric Plasma Jet (CAPJ), with ion temperature close to room temperature, has tremendous potential in biomedical engineering, and can potentially offer a therapeutic option that allows cancer cell elimination without damaging healthy tissue. We developed a hand-held flexible device for the delivery of CAPJ to the treatment site, with a modified high frequency pulse generator operating at a RMS voltage of <1.2 kV and gas flow in the range 0.3-3 I/min. The aims of our study were to characterize the CAPJ emitted from the device, and to evaluate its efficacy in elimination of cancer cells in-vitro and in-vivo. Methods and Results The power delivered by CAPJ was measured on a floating or grounded copper target. The power did not drastically change over distances of 0-14 mm, and was not dependent on the targets resistance. Temperature of CAPJ-treated target was 23-36 C, and was dependent on the voltage applied. Spectroscopy indicated that excited OK radicals were abundant both on dry and wet targets, placed at different distances from the plasma gun. An in-vitro cell proliferation assay demonstrated that CAPJ treatment of 60 seconds resulted in significant reduction in proliferation of all cancer cell lines tested, and that CAPJ activated medium was toxic to cancer cells. In-vivo, we treated cutaneous melanoma tumors in nude mice. Tumor volume was significantly decreased in CAPJ-treated tumors relatively to controls, and high dose per fraction was more effective than low dose per fraction treatment. Importantly, pathologic examination revealed that normal skin was not harmed by CAPJ treatment. Conclusion This preliminary study demonstrates the efficacy of flexible CAPJ delivery system against melanoma progression both in-vitro and in-vivo. It is envisioned that adaptation of CAPJ technology for different kinds of neoplasms use may provide a new modality for the treatment of solid tumors.	[Binenbaum, Y.; Ben-David, G.; Gil, Z.; Cohen, J. T.] Rambam Healthcare Campus, Lab Appl Canc Res, Haifa, Israel; [Gil, Z.; Cohen, J. T.] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel; [Slutsker, Ya. Z.; Ryzhkov, M. A.; Felsteiner, J.; Krasik, Ya. E.] Technion Israel Inst Technol, Plasma Phys Lab, Dept Phys, Haifa, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology	Cohen, JT (corresponding author), Rambam Healthcare Campus, Lab Appl Canc Res, Haifa, Israel.; Cohen, JT (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel.	Jacob_cohen@hotmail.com	Krasik, Yakov E/N-4606-2014		MAGNET Program, in the Office of the Chief Scientist of the Ministry of Industry, Israel [55254, 55255]	MAGNET Program, in the Office of the Chief Scientist of the Ministry of Industry, Israel	The research was funded by the MAGNET Program, in the Office of the Chief Scientist of the Ministry of Industry, Israel. Grant #55254 and #55255; http://www.magnet.org.il/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson HA, 2014, VACCINES-BASEL, V2, P216, DOI 10.3390/vaccines2020216; Arndt S, 2013, EXP DERMATOL; Brulle L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052653; Choi EH, 2015, B AM PHYS SOC, V60; Fridman G, 2007, PLASMA CHEM PLASMA P, V27, P163, DOI 10.1007/s11090-007-9048-4; Fuji H, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-162; Graves DB, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4892534; Graves DB, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/26/263001; Graves DB, 2014, LOW TEMPERATURE PLAS, V80901, P0; Higgins HW, 2015, J AM ACAD DERMATOL, V73, P193, DOI 10.1016/j.jaad.2015.03.057; Ishaq M, 2015, PHYS PLASMAS, V22, DOI 10.1063/1.4933366; Judee F., 2016, PLASMA MED, V6, P47, DOI DOI 10.1615/PLASMAMED.2016015823; Judee F, 2016, SCI REP-UK, V6, DOI 10.1038/srep21421; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Keidar M, 2011, BRIT J CANCER, V105, P1295, DOI 10.1038/bjc.2011.386; Keidar M, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4801516; Khan N, 2011, INT J RADIAT ONCOL, V80, P645, DOI 10.1016/j.ijrobp.2010.12.071; Kieft IE, 2004, BIOELECTROMAGNETICS, V25, P362, DOI 10.1002/bem.20005; Kim CH, 2010, J BIOTECHNOL, V150, P530, DOI 10.1016/j.jbiotec.2010.10.003; Kim GC, 2009, J KOREAN PHYS SOC, V54, P628, DOI 10.3938/jkps.54.628; Kim JY, 2011, BIOSENS BIOELECTRON, V28, P333, DOI 10.1016/j.bios.2011.07.039; Kim JY, 2010, BIOSENS BIOELECTRON, V26, P555, DOI 10.1016/j.bios.2010.07.043; Koritzer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064498; Kornev J, 2006, OZONE-SCI ENG, V28, P207, DOI 10.1080/01919510600704957; Lee HJ, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115026; Miichi T, 2000, VACUUM, V59, P236, DOI 10.1016/S0042-207X(00)00275-X; Naoyuki Kurake, 2015, APS GAS EL C 2015; Plewa JM, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/4/043027; Raizer Y.P, 2011, GAS DISCHARGE PHYS; Robert E, 2013, CLIN PLASMA MED, V1, P8, DOI 10.1016/j.cpme.2013.10.002; Schlegel J, 2013, CLIN PLASMA MED, V1, P2, DOI 10.1016/j.cpme.2013.08.001; Shashurin A, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/4/049601; Tanaka H, 2015, B AM PHYS SOC, V60; Volotskova O, 2012, SCI REP-UK, V2, DOI 10.1038/srep00636; Walk RM, 2013, J PEDIAT SURG; Walsh JL, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/3/034007; Wang MJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064860, 10.1371/journal.pone.0072082, 10.1371/journal.pone.0073741]; Weiss M, 2015, PLOS ONE; Weizman N, 2013, ONCOGENE, P1; Weltmann KD, 2011, EUR PHYS J-APPL PHYS, V55, DOI 10.1051/epjap/2011100452; Weltmann KD, 2009, CONTRIB PLASM PHYS, V49, P631, DOI 10.1002/ctpp.200910067; Yousfi M, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/4/045003; Zucker SN, 2012, CANCER BIOL THER, V13, P1299, DOI 10.4161/cbt.21787	43	61	61	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0169457	10.1371/journal.pone.0169457	http://dx.doi.org/10.1371/journal.pone.0169457			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103270	Green Submitted, Green Published, gold			2022-12-26	WOS:000392381100013
J	Perez-Rubio, G; Ramirez-Venegas, A; Diaz, VN; Gomez, LG; Fabian, KE; Carmona, SG; Lopez-Flores, LA; Ambrocio-Ortiz, E; Romero, RC; Alcantar-Ayala, N; Sansores, RH; Falfan-Valencia, R				Perez-Rubio, Gloria; Ramirez-Venegas, Alejandra; Noe Diaz, Valeri; Garcia Gomez, Leonor; Elvira Fabian, Karina; Garcia Carmona, Salvador; Lopez-Flores, Luis A.; Ambrocio-Ortiz, Enrique; Contreras Romero, Rocio; Alcantar-Ayala, Noe; Sansores, Raul H.; Falfan-Valencia, Ramces			Polymorphisms in HTR2A and DRD4 Predispose to Smoking and Smoking Quantity	PLOS ONE			English	Article							5-HT2A RECEPTOR GENE; ASSOCIATION; EXPRESSION; PROMOTER; POPULATION; VARIANTS; BEHAVIOR; ALLELES; GENOME; TESTS	Background Genes encoding the receptors involved in the dopaminergic and serotonergic pathways are potential candidates in the mechanisms of nicotine addiction. Aims To identify genetic variants in the promoter regions and exons of the DRD4 and HTR2A genes associated with tobacco smoking and the degree of nicotine addiction in Mexican mestizos. Methods The study included 438 non-smokers (NS) and 1,157 current smokers, ranked based on their consumption of cigarettes per day (cpd): 574 heavy smokers (HS, >20 cpd) and 583 light smokers (LS, 1-10 cpd). Genotyping was performed for 4 and 8 single nucleotide polymorphisms (SNPs) in the DRD4 and HTR2A genes, respectively. Results The C allele of rs1800955 in DRD4 was found to be associated with cigarette smoking in the HS vs. NS and LS vs. NS comparisons (p = 2.34E-03 and p = 1.13E-03, respectively); the association was maintained in the homozygous CC genotype (p = 5.00E-04 and p = 2.00E04, respectively). The T allele of rs6313 in HTR2A was significantly associated with cigarette smoking and a greater degree of nicotine addiction (p = 4.77E-03, OR = 1.55); the association was maintained in the homozygous genotype (TT) (p = 4.90E-03, OR = 1.96). The A allele of rs6313 was associated with cigarette smoking in the HS vs. NS comparison (p = 1.53E-02, OR = 1.36); the risk was nearly doubled in the homozygous AA genotype (p = 1.30E-03, OR = 1.83) compared with the heterozygous GA genotype (OR = 1.38). Conclusions Among Mexican mestizos, the C allele of rs1800955 in the DRD4 gene and the A allele of rs6311 in the HTR2A gene are associated with cigarette smoking, whereas the T allele of rs6313 in HTR2A is associated with cigarette smoking and the degree of nicotine addiction.	[Perez-Rubio, Gloria; Elvira Fabian, Karina; Garcia Carmona, Salvador; Lopez-Flores, Luis A.; Ambrocio-Ortiz, Enrique; Falfan-Valencia, Ramces] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Lab HLA, Mexico City, DF, Mexico; [Ramirez-Venegas, Alejandra; Noe Diaz, Valeri; Garcia Gomez, Leonor; Contreras Romero, Rocio; Sansores, Raul H.] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Dept Invest Tabaquismo, Mexico City, DF, Mexico; [Ramirez-Venegas, Alejandra; Noe Diaz, Valeri; Garcia Gomez, Leonor; Contreras Romero, Rocio; Sansores, Raul H.] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, EPOC, Mexico City, DF, Mexico; [Alcantar-Ayala, Noe] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Banco Sangre, Mexico City, DF, Mexico			raulsansores@yahoo.com.mx; rfalfanv@iner.gob.mx	Falfán-Valencia, Ramcés/M-7331-2018	Falfán-Valencia, Ramcés/0000-0001-6877-8124; Ambrocio-Ortiz, Enrique/0000-0003-1240-0637; Lopez-Flores, Luis Alberto/0000-0003-0922-1590				[Anonymous], 2010, NAT GENET, V42, P441, DOI DOI 10.1038/NG.571; Baker TB, 2012, ADDICTION, V107, P263, DOI 10.1111/j.1360-0443.2011.03657.x; Barret JC, 2005, BIOINFORMATICS; Bergen AW, 2013, NICOTINE TOB RES, V15, P1190, DOI 10.1093/ntr/nts245; Edens EL, 2010, J ADDICT MED, V4, P55, DOI 10.1097/ADM.0b013e3181af111e; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Guedj M, 2008, ANN HUM GENET, V72, P407, DOI 10.1111/j.1469-1809.2008.00438.x; Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz Instituto Nacional de Salud Publica Secretaria de Salud, 2012, ENC NAC AD 2011 REP; Kereszturi E, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-18; Kotyuk Eszter, 2009, Neuropsychopharmacol Hung, V11, P59; Lakatos K, 2002, MOL PSYCHIATR, V7, P27, DOI 10.1038/sj/mp/4000986; National Institute on Drug Abuse, 2012, RES REP SER TOB NIC; Okuyama Y, 1999, BIOCHEM BIOPH RES CO, V258, P292, DOI 10.1006/bbrc.1999.0630; Okuyemi Kolawole S, 2002, Nicotine Tob Res, V4 Suppl 2, pS103; Paul Flicek, 2014, NUCL ACIDS RES, V42; Perez-Rubio G, 2016, COPD, V13, P610, DOI 10.3109/15412555.2016.1161017; Polesskaya OO, 2006, J NEUROSCI RES, V83, P362, DOI 10.1002/jnr.20732; Polesskaya OO, 2002, J NEUROSCI RES, V67, P812, DOI 10.1002/jnr.10173; Polimanti R, 2016, NEUROPSYCHOPHARMACOL, V41, P2688, DOI 10.1038/npp.2016.72; Public Health Information Department of the General Public Health Administration of the Health Consulate (Directorate of Galicia) Health Analysis and Health Information Systems Unit of the Pan-American Health Organization (OPS-WHO), 2006, EPIDAT PROGR EPID AN; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ruble CL, 2016, BMC GENET, V17, DOI 10.1186/s12863-015-0325-6; Schaid DJ, 1999, AM J EPIDEMIOL, V149, P706; Terayama H, 2004, PSYCHIAT GENET, V14, P195, DOI 10.1097/00041444-200412000-00005; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Trikalinos TA, 2006, AM J EPIDEMIOL, V163, P300, DOI 10.1093/aje/kwj046; White MJ, 2011, DRUG ALCOHOL DEPEN, V114, P140, DOI 10.1016/j.drugalcdep.2010.08.014; World Health Organization, 2004, NEUR PSYCH SUBST US	28	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170019	10.1371/journal.pone.0170019	http://dx.doi.org/10.1371/journal.pone.0170019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103253	Green Submitted, Green Published, gold			2022-12-26	WOS:000392381100033
J	Crossland, RF; Balasa, A; Ramakrishnan, R; Mahadevan, SK; Fiorotto, ML; Van den Veyver, IB				Crossland, Randy F.; Balasa, Alfred; Ramakrishnan, Rajesh; Mahadevan, Sangeetha K.; Fiorotto, Marta L.; Van den Veyver, Ignatia B.			Chronic Maternal Low-Protein Diet in Mice Affects Anxiety, Night-Time Energy Expenditure and Sleep Patterns, but Not Circadian Rhythm in Male Offspring	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; PRENATAL MALNUTRITION; TRYPTOPHAN DEPLETION; GENE-EXPRESSION; PHYSICAL GROWTH; BEHAVIOR; RESTRICTION; NUTRITION; DISEASE; MODEL	Offspring of murine dams chronically fed a protein-restricted diet have an increased risk for metabolic and neurobehavioral disorders. Previously we showed that adult offspring, developmentally exposed to a chronic maternal low-protein (MLP) diet, had lower body and hind leg muscle weights and decreased liver enzyme serum levels. We conducted energy expenditure, neurobehavioral and circadian rhythm assays in male offspring to examine mechanisms for the body-weight phenotype and assess neurodevelopmental implications of MLP exposure. C57BL/6J dams were fed a protein restricted (8%protein, MLP) or a control protein (20% protein, C) diet from four weeks before mating until weaning of offspring. Male offspring were weaned to standard rodent diet (20% protein) and single-housed until 8-12 weeks of age. We examined body composition, food intake, energy expenditure, spontaneous rearing activity and sleep patterns and performed behavioral assays for anxiety (open field activity, elevated plus maze [EPM], light/dark exploration), depression (tail suspension and forced swim test), sociability (three-chamber), repetitive (marble burying), learning and memory (fear conditioning), and circadian behavior (wheel-running activity during light-dark and constant dark cycles). We also measured circadian gene expression in hypothalamus and liver at different Zeitgeber times (ZT). Male offspring from separate MLP exposed dams had significantly greater body fat (P = 0.03), less energy expenditure (P = 0.004), less rearing activity (P = 0.04) and a greater number of night-time rest/sleep bouts (P = 0.03) compared to control. MLP offspring displayed greater anxiety-like behavior in the EPM (P<0.01) but had no learning and memory deficit in fear-conditioning assay (P = 0.02). There was an effect of time on Pen, Per 2 and C/ockcircadian gene expression in the hypothalamus but not on circadian behavior. Thus, transplacental and early developmental exposure of dams to chronic MLP reduces food intake and energy expenditure, increases anxiety like behavior and disturbs sleep patterns but not circadian rhythm in adult male offspring.	[Crossland, Randy F.; Balasa, Alfred; Ramakrishnan, Rajesh; Mahadevan, Sangeetha K.; Van den Veyver, Ignatia B.] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Crossland, Randy F.; Balasa, Alfred; Ramakrishnan, Rajesh; Mahadevan, Sangeetha K.; Van den Veyver, Ignatia B.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Mahadevan, Sangeetha K.; Van den Veyver, Ignatia B.] Baylor Coll Med, Interdept Grad Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Fiorotto, Marta L.] ARS, USDA, Childrens Nutr Res Ctr, Houston, TX USA; [Van den Veyver, Ignatia B.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Crossland, Randy F.] Henry M Jackson Fdn Adv Mil Med Expeditionary & T, Combat Casualty Care, Naval Med Res Unit San Antonio NAMRU SA, 3650 Chambers Pass, San Antonio, TX USA; [Balasa, Alfred] Baylor Coll Med, Dept Pediat, Child Neurol Neurodev Disabil Residency Program, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; United States Department of Agriculture (USDA); Baylor College of Medicine; Naval Medical Research Center (NMRC); Naval Medical Research Unit San Antonio (NAMRU-SA); Baylor College of Medicine	Van den Veyver, IB (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA.; Van den Veyver, IB (corresponding author), Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA.; Van den Veyver, IB (corresponding author), Baylor Coll Med, Interdept Grad Program Translat Biol & Mol Med, Houston, TX 77030 USA.; Van den Veyver, IB (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	iveyver@bcm.edu	Van den Veyver, Ignatia B/AAF-4510-2021	Van den Veyver, Ignatia B/0000-0002-0651-5924; Ramakrishnan, Rajesh/0000-0001-8841-570X	US Department of Agriculture/Agricultural Research Service [6250-51000-055, 3092-51000-056-00D]; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR46308]; Intellectual and Developmental Disabilities Research Center (IDDRC) from the Eunice Kennedy Shriver National Institute of Child Health & Human Development [1U54 HD083092]; National Center For Research Resources [C06RR029965]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046308] Funding Source: NIH RePORTER	US Department of Agriculture/Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Intellectual and Developmental Disabilities Research Center (IDDRC) from the Eunice Kennedy Shriver National Institute of Child Health & Human Development; National Center For Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by: 1)6250-51000-055; US Department of Agriculture/Agricultural Research Service; http://www.ars.usda.gov/main/main.htm; I.B.VdV, 2) 3092-51000-056-00D; US Department of Agriculture/Agricultural Research Service; http://www.ars.usda.gov/main/main.htm; M.L.F., 3) AR46308; The NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases; http://www.niams.nih.gov/; M.L.F., 4) 1U54 HD083092; Intellectual and Developmental Disabilities Research Center (IDDRC) from the Eunice Kennedy Shriver National Institute of Child Health & Human Development; https://www.bcm.edu/research/centers/intellectual-developmental-disabilities, and 5) C06RR029965; The National Center For Research Resources; https://www.nih.gov/research-training/research-resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akitake Y, 2015, NUTR RES, V35, P76, DOI 10.1016/j.nutres.2014.10.014; Alamy M, 2012, NEUROSCI BIOBEHAV R, V36, P1463, DOI 10.1016/j.neubiorev.2012.03.009; Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015; Balasa A, 2011, J NUTR, V141, P2106, DOI 10.3945/jn.111.146597; Bale TL, 2010, BIOL PSYCHIAT, V68, P314, DOI 10.1016/j.biopsych.2010.05.028; Barker DJP, 1997, NUTRITION, V13, P807, DOI 10.1016/S0899-9007(97)00193-7; BARR LC, 1994, ARCH GEN PSYCHIAT, V51, P309; Bedi KS, 2003, NUTR NEUROSCI, V6, P141, DOI 10.1080/1028415031000098549; Belluscio LM, 2014, PHYSIOL BEHAV, V129, P237, DOI 10.1016/j.physbeh.2014.02.051; Carter RR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085508; Chun LE, 2015, J BIOL RHYTHM, V30, P417, DOI 10.1177/0748730415598608; Crowley JJ, 2004, PHARMACOL BIOCHEM BE, V78, P269, DOI 10.1016/j.pbb.2004.03.014; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Datta S, 2000, J SLEEP RES, V9, P71, DOI 10.1046/j.1365-2869.2000.00179.x; Desai M, 1996, BRIT J NUTR, V76, P591, DOI 10.1079/BJN19960065; Duran P, 2005, NUTR NEUROSCI, V8, P167, DOI 10.1080/10284150400026117; Duran P, 2006, PHYSIOL BEHAV, V89, P156, DOI 10.1016/j.physbeh.2006.05.045; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Fall CHD, 2003, J NUTR, V133, p1747S, DOI 10.1093/jn/133.5.1747S; Febinger HY, 2014, J AM ASSOC LAB ANIM, V53, P29; Fernandez-Twinn DS, 2005, AM J PHYSIOL-REG I, V288, pR368, DOI 10.1152/ajpregu.00206.2004; Gonzalez PN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152227; He JY, 2015, J MOL NEUROSCI, V55, P644, DOI 10.1007/s12031-014-0403-7; Heinonen K, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-91; Karatsoreos IN, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00162; Kulz AK, 2007, NEUROPSYCHOBIOLOGY, V56, P127, DOI 10.1159/000115778; Kulesskaya N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024755; Lacaria M, 2012, HUM MOL GENET, V21, P3083, DOI 10.1093/hmg/dds124; Lecarpentier Y, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00429; Lister JP, 2006, HIPPOCAMPUS, V16, P946, DOI 10.1002/hipo.20221; Lister JP, 2005, HIPPOCAMPUS, V15, P393, DOI 10.1002/hipo.20065; Ma XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016391; MATHIS C, 1994, BEHAV GENET, V24, P171, DOI 10.1007/BF01067821; MORGANE PJ, 1993, NEUROSCI BIOBEHAV R, V17, P91, DOI 10.1016/S0149-7634(05)80234-9; Morgane PJ, 2005, PROG NEUROBIOL, V75, P143, DOI 10.1016/j.pneurobio.2005.01.001; Morgane PJ, 2002, NEUROSCI BIOBEHAV R, V26, P471, DOI 10.1016/S0149-7634(02)00012-X; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Nascimento Elizabeth, 2013, PLoS One, V8, pe56231, DOI 10.1371/journal.pone.0056231; O'Neil D, 2013, MOL GENET METAB, V110, P378, DOI 10.1016/j.ymgme.2013.08.015; Orozco-Solis R, 2011, INT J OBESITY, V35, P990, DOI 10.1038/ijo.2010.223; Ozanne SE, 2005, MECH AGEING DEV, V126, P852, DOI 10.1016/j.mad.2005.03.005; Pack AI, 2007, PHYSIOL GENOMICS, V28, P232, DOI 10.1152/physiolgenomics.00139.2006; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Ramamoorthy TG, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00126; Ramos A, 2008, TRENDS PHARMACOL SCI, V29, P493, DOI 10.1016/j.tips.2008.07.005; Ranade SC, 2012, BRIT J NUTR, V107, P1167, DOI 10.1017/S0007114511004119; Rando OJ, 2015, CELL, V161, P93, DOI 10.1016/j.cell.2015.02.021; Reyes-Castro LA, 2011, INT J DEV NEUROSCI, V29, P177, DOI 10.1016/j.ijdevneu.2010.11.002; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; Roseboom TJ, 2011, MATURITAS, V70, P141, DOI 10.1016/j.maturitas.2011.06.017; Seidell JC, 2000, BRIT J NUTR, V83, pS5, DOI 10.1017/S000711450000088X; Spencer CA, 2008, BEHAV NEUROSCI, V122, P710, DOI 10.1037/0735-7044.122.3.710; Strata F, 2015, REPROD SCI, V22, P23, DOI 10.1177/1933719114557900; Suter M, 2011, FASEB J, V25, P714, DOI 10.1096/fj.10-172080; Sutton GM, 2010, ENDOCRINOLOGY, V151, P1570, DOI 10.1210/en.2009-1133; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; Verwey Michael, 2013, J Vis Exp, DOI 10.3791/50186; Voikar V, 2005, GENES BRAIN BEHAV, V4, P240, DOI 10.1111/j.1601-183X.2004.00103.x; Walz K, 2004, HUM MOL GENET, V13, P367, DOI 10.1093/hmg/ddh044; Watkins AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028745; Zadik Z, 2003, J ENDOCRINOL INVEST, V26, P941, DOI 10.1007/BF03345248; Zohdi V, 2015, NUTRIENTS, V7, P119, DOI 10.3390/nu7010119	62	13	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170127	10.1371/journal.pone.0170127	http://dx.doi.org/10.1371/journal.pone.0170127			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099477	gold, Green Published, Green Submitted			2022-12-26	WOS:000392380100057
J	Monico, A; Martinez-Senra, E; Canada, FJ; Zorrilla, S; Perez-Sala, D				Monico, Andreia; Martinez-Senra, Eva; Javier Canada, F.; Zorrilla, Silvia; Perez-Sala, Dolores			Drawbacks of Dialysis Procedures for Removal of EDTA	PLOS ONE			English	Article							SURFACTANT PROTEIN-A; ESCHERICHIA-COLI; ZINC-BINDING; VIMENTIN; PURIFICATION; FRAGMENTS; IONS; ACID	Ethylenediaminetetraacetic acid (EDTA) is a chelating agent commonly used in protein purification, both to eliminate contaminating divalent cations and to inhibit protease activity. For a number of subsequent applications EDTA needs to be exhaustively removed. Most purification methods rely in extensive dialysis and/or gel filtration in order to exchange or remove protein buffer components, including metal chelators. We report here that dialysis protocols, even as extensive as those typically employed for protein refolding, may not effectively remove EDTA, which is reduced only by approximately two-fold and it also persists after spin-column gel filtration, as determined by NMR and by colorimetric methods. Remarkably, the most efficient removal was achieved by ultrafiltration, after which EDTA became virtually undetectable. These results highlight a potentially widespread source of experimental variability affecting free divalent cation concentrations in protein applications.	[Monico, Andreia; Martinez-Senra, Eva; Javier Canada, F.; Perez-Sala, Dolores] CSIC, Ctr Invest Biol, Dept Chem & Phys Biol, Madrid, Spain; [Zorrilla, Silvia] CSIC, Ctr Invest Biol, Dept Cellular & Mol Biol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Perez-Sala, D (corresponding author), CSIC, Ctr Invest Biol, Dept Chem & Phys Biol, Madrid, Spain.	dperezsala@cib.csic.es	Cañada, Francisco J./D-5837-2014; Perez-Sala, Dolores/L-5969-2014; Zorrilla, Silvia/J-9771-2014	Cañada, Francisco J./0000-0003-4462-1469; Perez-Sala, Dolores/0000-0003-0600-665X; Monico, Andreia/0000-0003-4855-8241; Zorrilla, Silvia/0000-0002-6309-9058	European Union's Horizon 2020 research and innovation programme under the Marie Sklowdowska-Curie grant [675132]; Spanish Ministerio de Economia y Competitividad (MINECO/FEDER) [SAF2015-68590R, CTQ2015-64597-C2-2-P]	European Union's Horizon 2020 research and innovation programme under the Marie Sklowdowska-Curie grant; Spanish Ministerio de Economia y Competitividad (MINECO/FEDER)	This work has been funded by the European Union's Horizon 2020 research and innovation programme under the Marie Sklowdowska-Curie grant agreement number 675132 (http://cordis.europa.eu/project/rcn/198275_en.html), and by grants from the Spanish Ministerio de Economia y Competitividad (MINECO/FEDER, http://www.mineco.gob.es/portal/site/mineco/idi) SAF2015-68590R to DPS and CTQ2015-64597-C2-2-P to FJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar H, 2009, CELL MOTIL CYTOSKEL, V66, P986, DOI 10.1002/cm.20396; Barton RH, 2010, MOL BIOSYST, V6, P215, DOI 10.1039/b907021d; Dammann C, 2014, LAB CHIP, V14, P2681, DOI 10.1039/c3lc51418h; Gharbi S, 2007, J MASS SPECTROM, V42, P1474, DOI 10.1002/jms.1291; Grabski AC, 2009, METHOD ENZYMOL, V463, P285, DOI 10.1016/S0076-6879(09)63018-4; HERRMANN H, 1992, J MOL BIOL, V223, P637, DOI 10.1016/0022-2836(92)90980-X; Koch M, 2007, BBA-MOL CELL RES, V1773, P457, DOI 10.1016/j.bbamcr.2006.12.006; Kocyla A, 2015, J INORG BIOCHEM, V152, P82, DOI 10.1016/j.jinorgbio.2015.08.024; KORD AS, 1995, J PHARMACEUT BIOMED, V13, P575, DOI 10.1016/0731-7085(95)01254-I; KRATOCHVIL B, 1965, ANAL CHEM, V37, P111, DOI 10.1021/ac60220a028; Krezel A, 2016, ARCH BIOCHEM BIOPHYS, V611, P3, DOI 10.1016/j.abb.2016.04.010; KRONMAN MJ, 1983, J BIOL CHEM, V258, P5707; Kuzmenko AI, 2004, J LIPID RES, V45, P1061, DOI 10.1194/jlr.M300360-JLR200; Lin YC, 2010, J MOL BIOL, V399, P637, DOI 10.1016/j.jmb.2010.04.054; MULLER M, 1994, FEBS LETT, V340, P17, DOI 10.1016/0014-5793(94)80164-9; NICHOLSON JK, 1983, BIOCHEM J, V211, P605, DOI 10.1042/bj2110605; Perez-Sala D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8287; QUINLAN RA, 1989, J CELL SCI, V93, P71; Rudolph R, 1996, FASEB J, V10, P49, DOI 10.1096/fasebj.10.1.8566547; SEARCY DG, 1976, BIOCHIM BIOPHYS ACTA, V418, P133, DOI 10.1016/0005-2787(76)90334-8; Sharpe JC, 1997, ANAL BIOCHEM, V250, P124, DOI 10.1006/abio.1997.2210; Somashekar BS, 2006, SPECTROCHIM ACTA A, V65, P254, DOI 10.1016/j.saa.2005.10.039; STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5; Tsumoto K, 2003, PROTEIN EXPRES PURIF, V28, P1, DOI 10.1016/S1046-5928(02)00641-1; WINGENDER E, 1984, NUCLEIC ACIDS RES, V12, P8971, DOI 10.1093/nar/12.23.8971; Wright JR, 1999, AM J PHYSIOL-LUNG C, V276, pL650, DOI 10.1152/ajplung.1999.276.4.L650	26	19	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0169843	10.1371/journal.pone.0169843	http://dx.doi.org/10.1371/journal.pone.0169843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099451	Green Published, gold, Green Submitted			2022-12-26	WOS:000392380100037
J	Vesty, A; Biswas, K; Taylor, MW; Gear, K; Douglas, RG				Vesty, Anna; Biswas, Kristi; Taylor, Michael W.; Gear, Kim; Douglas, Richard G.			Evaluating the Impact of DNA Extraction Method on the Representation of Human Oral Bacterial and Fungal Communities	PLOS ONE			English	Article							IDENTIFICATION; MICROBIOME; PRIMERS; HEALTH	The application of high-throughput, next-generation sequencing technologies has greatly improved our understanding of the human oral microbiome. While deciphering this diverse microbial community using such approaches is more accurate than traditional culture-based methods, experimental bias introduced during critical steps such as DNA extraction may compromise the results obtained. Here, we systematically evaluate four commonly used microbial DNA extraction methods (MoBio PowerSoil DNA Isolation Kit, QIAamp (R) DNA Mini Kit, Zymo Bacterial/Fungal DNA Mini PrepTM, phenol:chloroform-based DNA isolation) based on the following criteria: DNA quality and yield, and microbial community structure based on Illumina amplicon sequencing of the V3-V4 region of the 16S rRNA gene of bacteria and the internal transcribed spacer (ITS) 1 region of fungi. Our results indicate that DNA quality and yield varied significantly with DNA extraction method. Representation of bacterial genera in plaque and saliva samples did not significantly differ across DNA extraction methods and DNA extraction method showed no effect on the recovery of fungal genera from plaque. By contrast, fungal diversity from saliva was affected by DNA extraction method, suggesting that not all protocols are suitable to study the salivary mycobiome.	[Vesty, Anna; Biswas, Kristi; Douglas, Richard G.] Univ Auckland, Dept Surg, Auckland, New Zealand; [Taylor, Michael W.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand; [Gear, Kim] Green Lane Clin Ctr, Oral Hlth Unit, Auckland, New Zealand	University of Auckland; University of Auckland	Douglas, RG (corresponding author), Univ Auckland, Dept Surg, Auckland, New Zealand.	richard.douglas@auckland.ac.nz		Biswas, Kristi/0000-0001-6202-3898; Taylor, Michael/0000-0002-0463-7813	Auckland District Health Board Charitable Trust A+ Project Grant [A+6277]	Auckland District Health Board Charitable Trust A+ Project Grant	The study was supported by an Auckland District Health Board Charitable Trust A+ Project Grant (A+6277) awarded to KG, http://www.aplustrust.org.nz/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2007, J CLIN PERIODONTOL, V34, P189, DOI 10.1111/j.1600-051X.2006.01034.x; Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Abusleme L, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.23990; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Dupuy AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090899; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Lazarevic V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067699; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Olson Nathan D, 2012, BMC Res Notes, V5, P668, DOI 10.1186/1756-0500-5-668; Polgarova K, 2010, NEW MICROBIOL, V33, P373; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Sohrabi M, 2016, J MICROBIOL METH; Wade WG, 2013, PHARMACOL RES, V69, P137, DOI 10.1016/j.phrs.2012.11.006; Weerasekera MM, 2013, J MED MICROBIOL, V62, P319, DOI 10.1099/jmm.0.050237-0; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Xiao CC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01145; Xu H, 2015, CURR OPIN MICROBIOL, V26, P65, DOI 10.1016/j.mib.2015.06.002; Xu X, 2015, ENVIRON MICROBIOL, V17, P699, DOI 10.1111/1462-2920.12502; Zijnge V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009321	30	93	96	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0169877	10.1371/journal.pone.0169877	http://dx.doi.org/10.1371/journal.pone.0169877			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099455	gold, Green Published, Green Submitted			2022-12-26	WOS:000392380100040
J	Yeom, SJ; Han, GH; Kim, M; Kwon, KK; Fu, Y; Kim, H; Lee, H; Lee, DH; Jung, H; Lee, SG				Yeom, Soo-Jin; Han, Gui Hwan; Kim, Moonjung; Kwon, Kil Koang; Fu, Yaoyao; Kim, Haseong; Lee, Hyewon; Lee, Dae-Hee; Jung, Heungchae; Lee, Seung-Goo			Controlled Aggregation and Increased Stability of beta-Glucuronidase by Cellulose Binding Domain Fusion	PLOS ONE			English	Article							ACTIVE INCLUSION-BODIES; ESCHERICHIA-COLI; PROTEIN; EVOLUTION; PARTNER	Cellulose-binding domains (CBDs) are protein domains with cellulose-binding activity, and some act as leaders in the localization of cellulosomal scaffoldin proteins to the hydrophobic surface of crystalline cellulose. In this study, we found that a CBD fusion enhanced and improved soluble beta-glucuronidase (GusA) enzyme properties through the formation of an artificially oligomeric state. First, a soluble CBD fused to the C-terminus of GusA (GusA-CBD) was obtained and characterized. Interestingly, the soluble GusA-CBD showed maximum activity at higher temperatures (65 degrees C) and more acidic pH values (pH 6.0) than free GusA did (60 degrees C and pH 7.5). Moreover, the GusA-CBD enzyme showed higher thermal and pH stabilities than the free GusA enzyme did. Additionally, GusA-CBD showed higher enzymatic activity in the presence of methanol than free GusA did. Evaluation of the protease accessibility of both enzymes revealed that GusA-CBD retained 100% of its activity after 1 h incubation in 0.5 mg/ml protease K, while free GusA completely lost its activity. Simple fusion of CBD as a single domain may be useful for tunable enzyme states to improve enzyme stability in industrial applications.	[Yeom, Soo-Jin; Han, Gui Hwan; Kim, Moonjung; Kwon, Kil Koang; Fu, Yaoyao; Kim, Haseong; Lee, Hyewon; Lee, Dae-Hee; Jung, Heungchae; Lee, Seung-Goo] KRIBB, Synthet Biol & Bioengn Res Ctr, Daejeon, South Korea; [Kim, Moonjung] Chungnam Natl Univ, Dept Chem Engn & Appl Chem, Daejeon, South Korea; [Lee, Dae-Hee; Lee, Seung-Goo] Univ Sci & Technol, Biosyst & Bioengn, Daejeon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungnam National University; University of Science & Technology (UST)	Lee, SG (corresponding author), KRIBB, Synthet Biol & Bioengn Res Ctr, Daejeon, South Korea.; Lee, SG (corresponding author), Univ Sci & Technol, Biosyst & Bioengn, Daejeon, South Korea.	sglee@kribb.re.kr	Lee, Seung-Goo/AAS-1613-2021; Yeom, Soojin/AAE-3558-2022; Lee, Seung-Goo/AAR-9823-2021; LEE, DAE-HEE/O-5243-2018	Lee, Seung-Goo/0000-0003-4539-9812; LEE, DAE-HEE/0000-0002-0423-9057; JUNG, Heungchae/0000-0003-4226-8235; Yeom, Soo-Jin/0000-0001-7307-237X	Intelligent Synthetic Biology Center of the Global Frontier Project [2011-0031944]; Bio-industry Technology Development Program [310006-5]; New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning [20133030000300]; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program	Intelligent Synthetic Biology Center of the Global Frontier Project; Bio-industry Technology Development Program; New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program	This research was supported by grants from the Intelligent Synthetic Biology Center of the Global Frontier Project (2011-0031944), Bio-industry Technology Development Program (No. 310006-5), New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (20133030000300), and Korea Research Institute of Bioscience and Biotechnology Research Initiative Program.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carrard G, 2000, P NATL ACAD SCI USA, V97, P10342, DOI 10.1073/pnas.160216697; Choi SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097093; Choi SL, 2011, BIOTECHNOL BIOPROC E, V16, P1173, DOI 10.1007/s12257-011-0336-8; DIN N, 1991, BIO-TECHNOL, V9, P1096, DOI 10.1038/nbt1191-1096; Fernandez-Lafuente R, 2009, ENZYME MICROB TECH, V45, P405, DOI 10.1016/j.enzmictec.2009.08.009; Flores H, 2002, J MOL BIOL, V315, P325, DOI 10.1006/jmbi.2001.5223; Geddie ML, 2004, J BIOL CHEM, V279, P26462, DOI 10.1074/jbc.M401447200; Gilissen LJW, 1998, TRANSGENIC RES, V7, P157, DOI 10.1023/A:1008832711805; Hanefeld U, 2009, CHEM SOC REV, V38, P453, DOI 10.1039/b711564b; Huang ZL, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-25; Joanna Mantis, 2000, PLANT MOL BIOL REP, V18, P319; Matsumura I, 2001, J MOL BIOL, V305, P331, DOI 10.1006/jmbi.2000.4259; Mello BL, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0036-9; Rowe LA, 2003, J MOL BIOL, V332, P851, DOI 10.1016/S0022-2836(03)00972-0; Tang CK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060038, 10.1371/journal.pone.0075307, 10.1371/journal.pone.0061093]; Telke AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065727; Wang X, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0270-0; Wilkins MR, 1999, METH MOL B, V112, P531; Wilson KJ, 1992, ESCHERICHIA COLI GUS; Xiong AS, 2007, PROTEIN ENG DES SEL, V20, P319, DOI 10.1093/protein/gzm023; Xiong AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026773; Xu Y, 2008, J BIOTECHNOL, V135, P319, DOI 10.1016/j.jbiotec.2008.05.004	23	8	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170398	10.1371/journal.pone.0170398	http://dx.doi.org/10.1371/journal.pone.0170398			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099480	gold, Green Published, Green Submitted			2022-12-26	WOS:000392380100085
J	Wang, WJ; Guedj, M; Bertrand, V; Foucquier, J; Jouve, E; Commenges, D; Proust-Lima, C; Murphy, NP; Blin, O; Magy, L; Cohen, D; Attarian, S				Wang, Wenjia; Guedj, Mickael; Bertrand, Viviane; Foucquier, Julie; Jouve, Elisabeth; Commenges, Daniel; Proust-Lima, Cecile; Murphy, Niall P.; Blin, Olivier; Magy, Laurent; Cohen, Daniel; Attarian, Shahram			A Rasch Analysis of the Charcot-Marie-Tooth Neuropathy Score (CMTNS) in a Cohort of Charcot-Marie-Tooth Type 1A Patients	PLOS ONE			English	Article							DISEASE TYPE 1A; ASCORBIC-ACID TREATMENT; CMT1A PATIENTS; DOUBLE-BLIND; 2ND VERSION; MODEL; DISABILITY; RELIABILITY; DOSAGE; TRIAL	The Charcot-Marie-Tooth Neuropathy Score (CMTNS) was developed as a main efficacy endpoint for application in clinical trials of Charcot-Marie-Tooth disease type 1A (CMT1A). However, the sensitivity of the CMTNS for measuring disease severity and progression in CMT1A patients has been questioned. Here, we applied a Rasch analysis in a French cohort of patients to evaluate the psychometrical properties of the CMTNS. Overall, our analysis supports the validity of the CMTNS for application to CMT1A patients though with some limitations such as certain items of the CMTNS being more suitable for moderate to severe forms of the disease, and some items being disordered. We suggest that additional items and/or categories be considered to better assess mild-to-moderate patients.	[Wang, Wenjia; Commenges, Daniel; Proust-Lima, Cecile] Univ Bordeaux, Inserm U1219, Bordeaux, Aquitaine, France; [Wang, Wenjia; Guedj, Mickael; Bertrand, Viviane; Foucquier, Julie; Murphy, Niall P.; Cohen, Daniel] Pharnext, Issy Les Moulineaux, France; [Jouve, Elisabeth; Blin, Olivier] Aix Marseille Univ, Serv Pharmacol Clin & Pharmacovigilance, CIC CPCET, AP HM, Marseille, France; [Magy, Laurent] Hop Dupuytren, Ctr Reference Neuropathies Peripher Rares, CHU Limoges, Limoges, France; [Attarian, Shahram] Aix Marseille Univ, INSERM, GMGF, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Limoges; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Wang, WJ (corresponding author), Univ Bordeaux, Inserm U1219, Bordeaux, Aquitaine, France.; Wang, WJ (corresponding author), Pharnext, Issy Les Moulineaux, France.	wenjia.wang@pharnext.com	Proust-Lima, Cécile/E-6670-2014; Attarian, Shahram/AAE-6214-2021; Commenges, Daniel/T-6536-2019; Jouve, Elisabeth/GSN-9120-2022	Proust-Lima, Cécile/0000-0002-9884-955X; Jouve, Elisabeth/0000-0002-4873-6522; Wang, Wenjia/0000-0003-0256-059X	Pharnext	Pharnext	The study was sponsored by Pharnext. The funder provided support in the form of salaries for authors WW, MG, VB, JF, NPM, DCoh, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ANDERSEN EB, 1973, PSYCHOMETRIKA, V38, P123, DOI 10.1007/BF02291180; Attarian S, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0199-0; Burns J., 2013, J PERIPHER NERV SYST, V18, P2; Burns J, 2012, ANN NEUROL, V71, P642, DOI 10.1002/ana.23572; Burns J, 2009, LANCET NEUROL, V8, P537, DOI 10.1016/S1474-4422(09)70108-5; Christensen KB, 2002, PSYCHOMETRIKA, V67, P563, DOI 10.1007/BF02295131; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Fischer GH., 1995, RASCH MODELS; Foley C, 2012, J NEUROL NEUROSUR PS, V83, P573, DOI 10.1136/jnnp-2011-300285; Gess B, 2015, COCHRANE DB SYST REV, V12; Green K E., 2002, INT C QUEST DEV EV T, P1; Hanson BA, 1998, J EDUC BEHAV STAT, V23, P244, DOI 10.3102/10769986023003244; Kersten P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099485; Kim SH, 2007, J EDUC MEAS, V44, P93, DOI 10.1111/j.1745-3984.2007.00029.x; Kochanski A, 2005, FOLIA NEUROPATHOL, V43, P65; Lewis RA, 2013, JAMA NEUROL, V70, P981, DOI 10.1001/jamaneurol.2013.3178; Linacre JM, 2015, WINSTEPS RASCH MEASU; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; Mair P, 2007, EXTENDED RASCH MODEL; Mandel J, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0293-y; Mannil M, 2014, NEUROMUSCULAR DISORD, V24, P1003, DOI 10.1016/j.nmd.2014.06.431; Micallef J, 2009, LANCET NEUROL, V8, P1103, DOI 10.1016/S1474-4422(09)70260-1; Murphy SM, 2011, J PERIPHER NERV SYST, V16, P191, DOI 10.1111/j.1529-8027.2011.00350.x; Orlando M, 2003, APPL PSYCH MEAS, V27, P289, DOI 10.1177/0146621603027004004; Orlando M., 2003, APPL PSYCH MEAS, V24, P50, DOI DOI 10.1177/01466216000241003; Pareyson D, 2011, LANCET NEUROL, V10, P320, DOI 10.1016/S1474-4422(11)70025-4; Patzko A, 2011, CURR NEUROL NEUROSCI, V11, P78, DOI 10.1007/s11910-010-0158-7; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; Ramdharry GM, 2010, NEUROMUSCULAR DISORD, V20, pS18, DOI 10.1016/j.nmd.2010.08.001; Sadjadi R, 2014, J PERIPHER NERV SYST, V19, P192, DOI 10.1111/jns.12084; Shy ME, 2008, NEUROLOGY, V70, P378, DOI 10.1212/01.wnl.0000297553.36441.ce; Shy ME, 2005, NEUROLOGY, V64, P1209, DOI 10.1212/01.WNL.0000156517.00615.A3; Smith Everett V Jr, 2002, J Appl Meas, V3, P205; Suarez-Falcon JC, 2003, BRIT J MATH STAT PSY, V56, P127, DOI 10.1348/000711003321645395; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Toth C, 2009, ACTA NEUROL SCAND, V120, P134, DOI 10.1111/j.1600-0404.2008.01134.x; van Nes SI, 2011, NEUROLOGY, V76, P337, DOI 10.1212/WNL.0b013e318208824b; Verhamme C, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-70; Wang WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138223; Zucca A, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-55	42	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0169878	10.1371/journal.pone.0169878	http://dx.doi.org/10.1371/journal.pone.0169878			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI3EK	28095456	Green Submitted, Green Published, gold			2022-12-26	WOS:000392372300039
J	Wu, S; Teng, MS; Er, LK; Hsiao, WY; Hsu, LA; Yeh, CH; Lin, JF; Lin, YY; Su, CW; Ko, YL				Wu, Semon; Teng, Ming-Sheng; Er, Leay-Kiaw; Hsiao, Wan-Yi; Hsu, Lung-An; Yeh, Ching-Hua; Lin, Jeng-Feng; Lin, Yi-Ying; Su, Cheng-Wen; Ko, Yu-Lin			Association between NF-kappa B Pathway Gene Variants and sICAM1 Levels in Taiwanese	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; SYSTEMIC-LUPUS-ERYTHEMATOSUS; CORONARY-HEART-DISEASE; RISK SCORE; CIRCULATING LEVELS; ENDOTHELIAL-CELLS; SOLUBLE ICAM-1; SUSCEPTIBILITY; POLYMORPHISMS; SCHIZOPHRENIA	Intercellular adhesion molecule-1 (ICAM1) is crucial to the development and progression of atherosclerosis. Recent genome-wide association studies (GWAS) have revealed that single nucleotide polymorphisms (SNPs) in two of the nuclear factor-kappa B (NF-kappa B) pathway genes, NFKBIK and RELA, are associated with soluble ICAM1 (sICAM1) levels. However, neither of these two gene variants is found in the Asian populations. This study aimed to elucidate whether other candidate gene variants involved in the NF-kappa B pathway may be associated with sICAM1 levels in Taiwanese. After excluding carriers of the ICAM1 rs5491-T allele, three SNPs in the ICAM1 gene and eight SNPs in six of the NF-kappa B pathway genes (NFKB1, PDCD11, TNFAIP3, NKAPL, IKBKE, and PRKCB) were analyzed for their association with sICAM1 levels in 480 individuals. Our data showed that two SNPs, rs5498 of ICAM1 and rs1635 of NKAPL, were significantly associated with sICAM1 levels (P = 0.002 and 0.004, respectively) in the Taiwanese population. Using a multivariate analysis, rs5498 and rs1635 as well as the previously reported ABO genotypes and rs12051272 of the CDH13 gene were independently associated with sICAM1 levels (P = 0.001, 0.001, 0.006 and 0.031, respectively). An analysis with combined risk alleles of four candidate SNPs in the ICAM1, NKAPL, ABO, and CDH13 genes showed an increase in sICAM1 levels with added numbers of risk alleles and weighted genetic risk score. Our findings thus expanded the repertoire of gene variants responsible for the regulation of sICAM1 levels in the Asian populations.	[Wu, Semon] Chinese Culture Univ, Dept Life Sci, Taipei, Taiwan; [Wu, Semon; Teng, Ming-Sheng; Hsiao, Wan-Yi; Lin, Yi-Ying; Ko, Yu-Lin] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Dept Res, New Taipei, Taiwan; [Er, Leay-Kiaw] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Dept Internal Med, Div Endocrinol & Metab, New Taipei, Taiwan; [Hsu, Lung-An] Chang Gung Mem Hosp, Dept Internal Med, Cardiovasc Div 1, Taoyuan, Taiwan; [Hsu, Lung-An] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Yeh, Ching-Hua; Lin, Jeng-Feng; Su, Cheng-Wen; Ko, Yu-Lin] Buddhist Tzu Chi Med Fdn, Cardiovasc Ctr, New Taipei, Taiwan; [Yeh, Ching-Hua; Lin, Jeng-Feng; Su, Cheng-Wen; Ko, Yu-Lin] Buddhist Tzu Chi Med Fdn, Dept Internal Med, Div Cardiol, New Taipei, Taiwan; [Yeh, Ching-Hua; Lin, Jeng-Feng; Su, Cheng-Wen; Ko, Yu-Lin] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, New Taipei, Taiwan; [Ko, Yu-Lin] Tzu Chi Univ, Sch Med, Hualien, Taiwan	Chinese Culture University; Buddhist Tzu Chi General Hospital; Taipei Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Taipei Tzu Chi Hospital; Chang Gung Memorial Hospital; Chang Gung University; Buddhist Tzu Chi General Hospital; Taipei Tzu Chi Hospital; Tzu Chi University	Ko, YL (corresponding author), Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Dept Res, New Taipei, Taiwan.; Ko, YL (corresponding author), Buddhist Tzu Chi Med Fdn, Cardiovasc Ctr, New Taipei, Taiwan.; Ko, YL (corresponding author), Buddhist Tzu Chi Med Fdn, Dept Internal Med, Div Cardiol, New Taipei, Taiwan.; Ko, YL (corresponding author), Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, New Taipei, Taiwan.; Ko, YL (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.	yulinkotw@yahoo.com.tw	Lin, Jeng-Feng/Q-7442-2019	Hsu, Lung-An/0000-0002-0012-2804	Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation [TCRD-TPE-103-RT-2, TCRD-I103-01-01, TCRD-TPE-NCS-102-01, TCRD-TPE-MOST-103-01, TCRD-TPE-MOST-104-09, TCRD-TPE-102-3, TCRD-TPE-103-22]; Tzu Chi University, Hualien, Taiwan [TCIRP102001-02Y1, TCMMP104-06-03]; National Science Council [NSC 101-2314-B-303 -023 -MY3, MOST 104-2314-B-303-013-MY3]	Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation; Tzu Chi University, Hualien, Taiwan; National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by a grant from the Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation (TCRD-TPE-103-RT-2, TCRD-I103-01-01, TCRD-TPE-NCS-102-01, TCRD-TPE-MOST-103-01, TCRD-TPE-MOST-104-09), a grant from the Tzu Chi University, Hualien, Taiwan (TCIRP102001-02Y1, TCMMP104-06-03), and a grant from the National Science Council (NSC 101-2314-B-303 -023 -MY3, MOST 104-2314-B-303-013-MY3) to Y.-L. Ko and a grant from the Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation (TCRD-TPE-102-3, TCRD-TPE-103-22) to M.-S. Teng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backes C, 2016, HUM GENET, V135, P31, DOI 10.1007/s00439-015-1609-7; Bai R, 2014, BIOCHEM BIOPH RES CO, V448, P372, DOI 10.1016/j.bbrc.2014.04.113; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bielinski SJ, 2008, ATHEROSCLEROSIS, V199, P172, DOI 10.1016/j.atherosclerosis.2007.10.006; Bielinski SJ, 2011, ATHEROSCLEROSIS, V216, P390, DOI 10.1016/j.atherosclerosis.2011.02.018; Bielinski SJ, 2008, ATHEROSCLEROSIS, V201, P339, DOI 10.1016/j.atherosclerosis.2008.02.031; Chawla R, 2014, J CLIN ENDOCR METAB, V99, pE2377, DOI 10.1210/jc.2013-4221; Chen SF, 2014, SCHIZOPHR RES, V157, P169, DOI 10.1016/j.schres.2014.05.038; Civelek M, 2013, HUM MOL GENET, V22, P3023, DOI 10.1093/hmg/ddt159; Cornelis MC, 2009, ANN INTERN MED, V150, P541, DOI 10.7326/0003-4819-150-8-200904210-00008; Craig A, 2000, HUM MOL GENET, V9, P525, DOI 10.1093/hmg/9.4.525; Dieguez-Gonzalez R, 2009, ANN RHEUM DIS, V68, P579, DOI 10.1136/ard.2007.087304; Fan WY, 2015, INT J OPHTHALMOL-CHI, V8, P603, DOI 10.3980/j.issn.2222-3959.2015.03.30; FernandezReyes D, 1997, HUM MOL GENET, V6, P1357, DOI 10.1093/hmg/6.8.1357; Fiore E, 2002, ONCOGENE, V21, P5213, DOI 10.1038/sj.onc.1205684; Guauque-Olarte S, 2015, CIRC-CARDIOVASC GENE, V8, P812, DOI 10.1161/CIRCGENETICS.115.001145; Haim M, 2002, J AM COLL CARDIOL, V39, P1133, DOI 10.1016/S0735-1097(02)01728-X; He Q, 2014, J NEUROL SCI, V345, P148, DOI 10.1016/j.jns.2014.07.030; Hsu LA, 2010, METABOLISM, V59, P1710, DOI 10.1016/j.metabol.2010.04.004; Keaney JF, 2004, J AM COLL CARDIOL, V44, P168, DOI 10.1016/j.jacc.2004.03.048; Kent JW, 2007, ATHEROSCLEROSIS, V195, P367, DOI 10.1016/j.atherosclerosis.2006.10.005; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; LEDEBUR HC, 1995, J BIOL CHEM, V270, P933, DOI 10.1074/jbc.270.2.933; Lei JP, 2016, HUM GENET, V135, P137, DOI 10.1007/s00439-015-1616-8; Lim NK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131603; Lin OR, 2013, INT J EDUC RES, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0072940; Meroufel DN, 2015, INT J CLIN EXP PATHO, V8, P7358; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Nordmark G, 2011, GENES IMMUN, V12, P100, DOI 10.1038/gene.2010.44; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Ogawa H, 1999, AM J CARDIOL, V83, P38, DOI 10.1016/S0002-9149(98)00779-6; Okuda H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124293; Pare G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001374; Pare G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000118; Rahman A, 2009, ANTIOXID REDOX SIGN, V11, P823, DOI [10.1089/ars.2008.2204, 10.1089/ARS.2008.2204]; Register TC, 2004, CLIN CHEM, V50, P2185, DOI 10.1373/clinchem.2004.036806; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Ridker PM, 1998, LANCET, V351, P88, DOI 10.1016/S0140-6736(97)09032-6; Ripatti S, 2010, LANCET, V376, P1393, DOI 10.1016/S0140-6736(10)61267-6; Shah T, 2013, CIRC-CARDIOVASC GENE, V6, P163, DOI 10.1161/CIRCGENETICS.112.964254; Sheng YJ, 2011, RHEUMATOLOGY, V50, P682, DOI 10.1093/rheumatology/keq313; STAUNTON DE, 1990, CELL, V61, P243, DOI 10.1016/0092-8674(90)90805-O; Su XC, 2013, IEEE INT CONF COMMUN, P1, DOI 10.1109/ICCChinaW.2013.6670556; Tanne D, 2002, STROKE, V33, P2182, DOI 10.1161/01.STR.0000029007.32244.40; Teng MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122664; Teng MS, 2013, ATHEROSCLEROSIS, V228, P406, DOI 10.1016/j.atherosclerosis.2013.03.032; VORA DK, 1994, GENOMICS, V21, P473, DOI 10.1006/geno.1994.1303; Wang L, 2014, CELL STEM CELL, V15, P51, DOI 10.1016/j.stem.2014.04.021; Wang ZQ, 2015, NEUROSCI LETT, V605, P49, DOI 10.1016/j.neulet.2015.08.023; Wu S, 2010, CLIN CHEM LAB MED, V48, P543, DOI 10.1515/CCLM.2010.099; Yang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109658; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979; Zubair N, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.16	53	6	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0169516	10.1371/journal.pone.0169516	http://dx.doi.org/10.1371/journal.pone.0169516			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095483	gold, Green Published, Green Submitted			2022-12-26	WOS:000392372300022
J	Holton, AB; Sinatra, FL; Kreahling, J; Conway, AJ; Landis, DA; Altiok, S				Holton, Angela Babetski; Sinatra, Francy L.; Kreahling, Jenny; Conway, Amy J.; Landis, David A.; Altiok, Soner			Microfluidic Biopsy Trapping Device for the Real-Time Monitoring of Tumor Microenvironment	PLOS ONE			English	Article							BREAST-CANCER CELLS; DRUG-SENSITIVITY; SHEAR-STRESS; CULTURE; APOPTOSIS; RESISTANCE; PLATFORM; CHEMOSENSITIVITY; ARCHITECTURE; FABRICATION	The tumor microenvironment is composed of cellular and stromal components such as tumor cells, mesenchymal cells, immune cells, cancer associated fibroblasts and the supporting extracellular matrix. The tumor microenvironment provides crucial support for growth and progression of tumor cells and affects tumor response to therapeutic interventions. To better understand tumor biology and to develop effective cancer therapeutic agents it is important to develop preclinical platforms that can faithfully recapitulate the tumor microenvironment and the complex interaction between the tumor and its surrounding stromal elements. Drug studies performed in vitro with conventional two-dimensional cancer cell line models do not optimally represent clinical drug response as they lack true tumor heterogeneity and are often performed in static culture conditions lacking stromal tumor components that significantly influence the metabolic activity and proliferation of cells. Recent microfluidic approaches aim to overcome such obstacles with the use of cell lines derived in artificial three-dimensional supportive gels or micro-chambers. However, absence of a true tumor microenvironment and full interstitial flow, leads to less than optimal evaluation of tumor response to drug treatment. Here we report a continuous perfusion microfluidic device coupled with microscopy and image analysis for the assessment of drug effects on intact fresh tumor tissue. We have demonstrated that fine needle aspirate biopsies obtained from patient-derived xenograft models of adenocarcinoma of the lung can successfully be analyzed for their response to ex vivo drug treatment within this biopsy trapping microfluidic device, wherein a protein kinase C inhibitor, staurosporine, was used to assess tumor cell death as a proof of principle. This approach has the potential to study tumor tissue within its intact microenvironment to better understand tumor response to drug treatments and eventually to choose the most effective drug and drug combination for individual patients in a cost effective and timely manner.	[Holton, Angela Babetski; Sinatra, Francy L.; Conway, Amy J.; Landis, David A.] Draper, Cambridge, MA USA; [Holton, Angela Babetski; Kreahling, Jenny; Altiok, Soner] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Holton, Angela Babetski] Univ S Florida, Dept Mol Med, Tampa, FL USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Altiok, S (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA.	soner.altiok@moffitt.org			H. Lee Moffitt Cancer Center and Research Institute	H. Lee Moffitt Cancer Center and Research Institute	The funder, Draper; a nonprofit organization, provided support in the form of salaries for authors (ABH, FLS, AJC, DAL) and internal grant money to support the development of the microfluidic device but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was also funded in part by H. Lee Moffitt Cancer Center and Research Institute support grant to Soner Altiok. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Tiffany Razabdouski for assistance with animal studies. The study is funded in part by Draper internal support grant to Angela Babetski Holton and H. Lee Moffitt Cancer Center and Research Institute support grant to Soner Altiok.	Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a; Abdi H., 2010, ENCY RES DESIGN; Altiok S, 2010, INT J ONCOL, V36, P19, DOI 10.3892/ijo_00000471; BARRY MA, 1990, BIOCHEM PHARMACOL, V40, P2353, DOI 10.1016/0006-2952(90)90733-2; Bissell MJ, 2003, CURR OPIN CELL BIOL, V15, P753, DOI 10.1016/j.ceb.2003.10.016; Blankenberg Francis G, 2009, Proc Am Thorac Soc, V6, P469, DOI 10.1513/pats.200901-001AW; Bosserman L, 2012, CANCER RES, V72, P3901, DOI 10.1158/0008-5472.CAN-12-0681; Chang SF, 2008, P NATL ACAD SCI USA, V105, P3927, DOI 10.1073/pnas.0712353105; Chaw KC, 2007, LAB CHIP, V7, P1041, DOI 10.1039/b707399m; Costa FF, 2009, EPIGENOMICS-UK, V1, P387, DOI 10.2217/EPI.09.25; Couzon C, 2009, EUR BIOPHYS J BIOPHY, V38, P1035, DOI 10.1007/s00249-009-0506-1; DELANGE JHM, 1992, CYTOMETRY, V13, P571, DOI 10.1002/cyto.990130604; Du Z, 2007, BIOMED MICRODEVICES, V9, P35, DOI 10.1007/s10544-006-9010-x; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Feng XJ, 2009, ANAL CHIM ACTA, V650, P83, DOI 10.1016/j.aca.2009.04.051; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Golden AP, 2007, LAB CHIP, V7, P720, DOI 10.1039/b618409j; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Hakanson M, 2011, INTEGR BIOL-UK, V3, P31, DOI 10.1039/c0ib00074d; Hatok J, 2009, CLIN EXP MED, V9, P1, DOI 10.1007/s10238-008-0011-3; Hattersley SM, 2012, ANN BIOMED ENG, V40, P1277, DOI 10.1007/s10439-011-0428-9; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Herzog TJ, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.01.059; Hidalgo M, 2006, MOL CANCER THER, V5, P1895, DOI 10.1158/1535-7163.MCT-05-0525; Hou HW, 2009, BIOMED MICRODEVICES, V11, P557, DOI 10.1007/s10544-008-9262-8; Huang SB, 2013, LAB CHIP, V13, P1133, DOI 10.1039/c2lc41264k; Kawai Y, 2012, CANCER SCI, V103, P1245, DOI 10.1111/j.1349-7006.2012.02289.x; Khoury M, 2010, BIOMED MICRODEVICES, V12, P1001, DOI 10.1007/s10544-010-9454-x; Kim JB, 2005, SEMIN CANCER BIOL, V15, P365, DOI 10.1016/j.semcancer.2005.05.002; Kim L, 2007, LAB CHIP, V7, P681, DOI 10.1039/b704602b; Koivunen J, 2006, CANCER LETT, V235, P1, DOI 10.1016/j.canlet.2005.03.033; Komen J, 2008, BIOMED MICRODEVICES, V10, P727, DOI 10.1007/s10544-008-9184-5; Lankelma J, 1999, CLIN CANCER RES, V5, P1703; Leclerc E, 2003, BIOMEDICAL MICRODEVI; Lindstrom S, 2009, ELECTROPHORESIS, V30, P4166, DOI 10.1002/elps.200900572; Ling Y, 2007, LAB CHIP, V7, P756, DOI 10.1039/b615486g; Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2; Maitland ML, 2006, J CLIN ONCOL, V24, P2151, DOI 10.1200/JCO.2005.05.2282; Mitchell MJ, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/015008; Muerkoster S, 2004, CANCER RES, V64, P1331, DOI 10.1158/0008-5472.CAN-03-1860; Nevill JT, 2007, LAB CHIP, V7, P1689, DOI 10.1039/b711874k; Ng CP, 2008, BIOTECHNOL BIOENG, V99, P1490, DOI 10.1002/bit.21698; Qazi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020348; Qi CJ, 2009, ARCH PHARM RES, V32, P1737, DOI 10.1007/s12272-009-2211-0; Rubio-Viqueira B, 2007, MOL CANCER THER, V6, P515, DOI 10.1158/1535-7163.MCT-06-0388; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Sittinger M, 1997, INT J ARTIF ORGANS, V20, P57, DOI 10.1177/039139889702000111; Society AC, 2014, CANC FACTS FIG 2014; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Sung KE, 2011, INTEGR BIOL-UK, V3, P439, DOI 10.1039/c0ib00063a; Tarnok A, 2006, CELL PROLIFERAT, V39, P495, DOI 10.1111/j.1365-2184.2006.00407.x; Telang S, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-60; Torisawa Y, 2005, BIOMATERIALS, V26, P2165, DOI 10.1016/j.biomaterials.2004.05.028; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Walker GM, 2005, LAB CHIP, V5, P611, DOI 10.1039/b417245k; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Wlodkowic D, 2010, CYTOM PART A, V77A, P591, DOI 10.1002/cyto.a.20889; Wu MH, 2007, BIOTECHNOL PROGR, V23, P430, DOI 10.1021/bp060024v; Wu MH, 2006, BIOMED MICRODEVICES, V8, P331, DOI 10.1007/s10544-006-9597-y; Wu MH, 2011, SENSOR ACTUAT B-CHEM, V155, P397, DOI 10.1016/j.snb.2010.11.027; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874	65	17	17	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0169797	10.1371/journal.pone.0169797	http://dx.doi.org/10.1371/journal.pone.0169797			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085924	Green Submitted, Green Published, gold			2022-12-26	WOS:000391972600038
J	Kornej, J; Hindricks, G; Arya, A; Sommer, P; Husser, D; Bollmann, A				Kornej, Jelena; Hindricks, Gerhard; Arya, Arash; Sommer, Philipp; Husser, Daniela; Bollmann, Andreas			The APPLE Score - A Novel Score for the Prediction of Rhythm Outcomes after Repeat Catheter Ablation of Atrial Fibrillation	PLOS ONE			English	Article								Background Arrhythmia recurrences after catheter ablation occur in up to 50% within one year but their prediction remains challenging. Recently, we developed a novel score for the prediction of rhythm outcomes after single AF ablation demonstrating superiority to other scores. The current study was performed to 1) prove the predictive value of the APPLE score in patients undergoing repeat AF ablation and 2) compare it with the CHADS(2) and CHA(2)DS(2)-VASc scores. Methods Rhythm outcome between 3-12 months after AF ablation were documented. The APPLE score (one point for Age >65 years, Persistent AF, imPaired eGFR (<60 ml/min/1.73m(2)), LA diameter >= 43 mm, EF <50%) was calculated in every patient before procedure. Results 379 consecutive patients from The Leipzig Heart Center AF Ablation Registry (60 +/- 10 years, 65% male, 70% paroxysmal AF) undergoing repeat AF catheter ablation were included. Arrhythmia recurrences were observed in 133 patients (35%). While the CHADS(2) (AUC 0.577, p = 0.037) and CHA(2)DS(2)-VASc scores (AUC 0.590, p = 0.015) demonstrated low predictive value, the APPLE score showed better prediction of arrhythmia recurrences (AUC 0.617, p = 0.002) than other scores (both p<0.001). Compared to patients with an APPLE score of 0, the risk (OR) for arrhythmia recurrences was 2.9, 3.0 and 6.0 (all p<0.01) for APPLE scores 1, 2, or >= 3, respectively. Conclusions The novel APPLE score is superior to the CHADS(2) and CHA(2)DS(2)-VASc scores for prediction of rhythm outcomes after repeat AF catheter ablation. It may be helpful to identify patients with low, intermediate or high risk for recurrences after repeat procedure.	[Kornej, Jelena; Hindricks, Gerhard; Arya, Arash; Sommer, Philipp; Husser, Daniela; Bollmann, Andreas] Ctr Heart, Dept Electrophysiol, Leipzig, Germany	Heart Center Leipzig GMBH; University of Hamburg; University Medical Center Hamburg-Eppendorf	Kornej, J (corresponding author), Ctr Heart, Dept Electrophysiol, Leipzig, Germany.	jelena.kornej@gmx.de	Sommer, Philipp/AAV-3133-2020					Al-Hijji MA, 2016, AM HEART J, V171, P48, DOI 10.1016/j.ahj.2015.10.015; Ammar S, 2011, CIRC-ARRHYTHMIA ELEC, V4, P609, DOI 10.1161/CIRCEP.111.963256; Canpolat U, 2013, INT J CARDIOL, V169, P201, DOI 10.1016/j.ijcard.2013.08.097; D'Ascenzo F, 2013, INT J CARDIOL, V167, P1984, DOI 10.1016/j.ijcard.2012.05.008; Esato M, 2009, HEART RHYTHM, V6, P349, DOI 10.1016/j.hrthm.2008.12.013; Ganesan AN, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004549; Kirchhof P., 2016, EUR HEART J; Kornej J, 2015, CLIN RES CARDIOL, V104, P871, DOI 10.1007/s00392-015-0856-x; Kornej J, 2015, HEART, V101, P126, DOI 10.1136/heartjnl-2014-306013; Kornej J, 2014, CIRC-ARRHYTHMIA ELEC, V7, P281, DOI 10.1161/CIRCEP.113.001182; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Tang RB, 2014, EUROPACE, V16, P1569, DOI 10.1093/europace/euu013; Wang Q, 2016, INTERNAL MED, V55, P2537, DOI 10.2169/internalmedicine.55.5790; Wojcik M, 2013, CIRC J, V77, P2271, DOI 10.1253/circj.CJ-13-0308	15	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0169933	10.1371/journal.pone.0169933	http://dx.doi.org/10.1371/journal.pone.0169933			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085921	gold, Green Submitted, Green Published			2022-12-26	WOS:000391972600046
J	Liang, H; Xu, WP; Chen, JP; Shi, HJ; Zhu, J; Liu, XQ; Wang, J; Miao, MH; Yuan, W				Liang, Hong; Xu, Wenping; Chen, Jianping; Shi, Huijuan; Zhu, Jiang; Liu, Xiaoqin; Wang, Jian; Miao, Maohua; Yuan, Wei			The Association between Exposure to Environmental Bisphenol A and Gonadotropic Hormone Levels among Men	PLOS ONE			English	Article							RAT LEYDIG-CELLS; SEMEN QUALITY; REPRODUCTIVE HORMONES; ANDROGEN LEVELS; RISK-FACTOR; ADULTS; SECRETION; RECEPTOR; OBESITY; PROFILE	Bisphenol A (BPA) is an extensively used chemical with endocrine disrupting properties. Although animal and in vivo studies have suggested possible effects of BPA on levels of gonadotropic hormones, human studies are limited and inconclusive. The study examined whether environmental BPA exposure was associated with gonadotropic hormones levels in men. A total of 560 men aged 18-55 years were recruited from Sandu County, Guizhou Province, China. We collected urine samples for measurement of BPA, and blood samples for measurement of reproductive hormones. We examined serum levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), and total testosterone (T). Relative risk (RR) was obtained by log-binominal regression to explore the association between urinary BPA level and hormone levels. BPA was detected in 70.4% of urine samples, with a geometric mean of 0.50 mu g/gCr. Men with detectable levels of BPA had a 1.52-fold increased risk of having a high LH level (> 75 th percentile) when compared with men with undetectable levels of BPA, after adjustment for potential confounders (95% confidence interval (CI): 1.04 +/- 2.21). The association persisted and slightly intensified among current smokers (adjusted RR (aRR) = 1.76, 95% CI: 1.05 +/- 2.95), while it weakened among non-smokers (aRR = 1.17, 95% CI: 0.69 +/- 1.96). Urinary BPA level was associated with an increased FSH level among smokers (aRR = 1.64, 95% CI: 1.01 +/- 2.67). Urinary BPA level was inversely associated with total T level among males with body max index (BMI) >= 25 kg/m(2) although this association was of borderline significance (aRR = 0.52, 95% CI: 0.26 +/- 1.05). In conclusion, environmental exposure to BPA was associated with increased serum levels of LH and FSH in male smokers, along with decreased serum levels of total T in men with BMI >= 25 kg/m(2). These findings suggest that the effects of environmental BPA exposure on hormone levels might be modified by smoking and BMI.	[Liang, Hong; Chen, Jianping; Miao, Maohua; Yuan, Wei] Fudan Univ, Dept Reprod Epidemiol & Social Sci, Key Lab Reprod Regulat NPFPC, SIPPR,IRD, Shanghai, Peoples R China; [Xu, Wenping] East China Univ Sci & Technol, Shanghai Key Lab Chem Biol, Sch Pharm, Shanghai, Peoples R China; [Shi, Huijuan; Wang, Jian] Fudan Univ, Dept Reprod Biol, Key Lab Reprod Regulat NPFPC, SIPPR,IRD, Shanghai, Peoples R China; [Zhu, Jiang] Populat & Family Planning Inst Guizhou Prov, Dept Orthogen & Genet, Guiyang, Peoples R China; [Liu, Xiaoqin] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark	Fudan University; East China University of Science & Technology; Fudan University; Aarhus University	Miao, MH (corresponding author), Fudan Univ, Dept Reprod Epidemiol & Social Sci, Key Lab Reprod Regulat NPFPC, SIPPR,IRD, Shanghai, Peoples R China.; Wang, J (corresponding author), Fudan Univ, Dept Reprod Biol, Key Lab Reprod Regulat NPFPC, SIPPR,IRD, Shanghai, Peoples R China.	wangjiansippr@126.com; miaomaohua@live.com	Liu, Xiaoqin/AAB-7509-2019	Liu, Xiaoqin/0000-0003-4519-1536	National Basic Research Program of China (973 Program) [2009CB941700]; National Natural Scientific Foundation of China [81501318, 81270760]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Basic Research Program of China (973 Program, 2009CB941700 to MM, http://english.iee.cas.cn/); National Natural Scientific Foundation of China (81501318 to MM, 81270760 to WY, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggerholm AS, 2008, FERTIL STERIL, V90, P619, DOI 10.1016/j.fertnstert.2007.07.1292; Akingbemi BT, 2004, ENDOCRINOLOGY, V145, P592, DOI 10.1210/en.2003-1174; Allen NE, 2002, CANCER CAUSE CONTROL, V13, P353, DOI 10.1023/A:1015238102830; Anawalt BD, 1996, J CLIN ENDOCR METAB, V81, P3341, DOI 10.1210/jc.81.9.3341; Blanco-Munoz J, 2012, SCI TOTAL ENVIRON, V426, P100, DOI 10.1016/j.scitotenv.2012.03.071; Bonefeld-Jorgensen EC, 2007, ENVIRON HEALTH PERSP, V115, P69, DOI 10.1289/ehp.9368; Cabler S, 2010, ASIAN J ANDROL, V12, P480, DOI 10.1038/aja.2010.38; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Caprio M, 2003, BIOL REPROD, V68, P1199, DOI 10.1095/biolreprod.102.007831; Cha BS, 2008, MOL CELL TOXICOL, V4, P230; Chapin RE, 2008, BIRTH DEFECTS RES B, V83, P157, DOI 10.1002/bdrb.20147; Chavarro JE, 2010, FERTIL STERIL, V93, P2222, DOI 10.1016/j.fertnstert.2009.01.100; Galloway T, 2010, ENVIRON HEALTH PERSP, V118, P1603, DOI 10.1289/ehp.1002367; GIAGULLI VA, 1994, J CLIN ENDOCR METAB, V79, P997, DOI 10.1210/jc.79.4.997; Hanaoka T, 2002, OCCUP ENVIRON MED, V59, P625, DOI 10.1136/oem.59.9.625; He YH, 2009, ENVIRON RES, V109, P629, DOI 10.1016/j.envres.2009.04.003; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Isidori AM, 1999, J CLIN ENDOCR METAB, V84, P3673, DOI 10.1210/jc.84.10.3673; Jin PP, 2013, J BIOMED RES, V27, P135, DOI 10.7555/JBR.27.20120076; Kim EJ, 2014, SCI TOTAL ENVIRON, V470, P1401, DOI 10.1016/j.scitotenv.2013.07.040; Lassen TH, 2014, ENVIRON HEALTH PERSP, V122, P478, DOI 10.1289/ehp.1307309; Lee HJ, 2003, TOXICOL SCI, V75, P40, DOI 10.1093/toxsci/kfg150; Liao CY, 2013, J AGR FOOD CHEM, V61, P4655, DOI 10.1021/jf400445n; Liu XQ, 2015, ENVIRON TOXICOL PHAR, V39, P934, DOI 10.1016/j.etap.2015.03.007; Mahalingaiah S, 2008, ENVIRON HEALTH PERSP, V116, P173, DOI 10.1289/ehp.10605; Meeker JD, 2010, ENVIRON SCI TECHNOL, V44, P1458, DOI 10.1021/es9028292; Mendiola J, 2010, ENVIRON HEALTH PERSP, V118, P1286, DOI 10.1289/ehp.1002037; Nanjappa MK, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095349; (NHANES) NHaNES, ANTHR PROC MAN 2007; Peretz J, 2014, ENVIRON HEALTH PERSP, V122, P775, DOI 10.1289/ehp.1307728; Ramlau-Hansen CH, 2007, HUM REPROD, V22, P188, DOI 10.1093/humrep/del364; Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004; Rosenfield RL, 2010, BRAIN RES, V1364, P186, DOI 10.1016/j.brainres.2010.08.088; Tohei A, 2001, EXP BIOL MED, V226, P216, DOI 10.1177/153537020122600309; Vesper HW, 2015, CLIN CHEM; Xi W, 2011, REPROD TOXICOL, V31, P409, DOI 10.1016/j.reprotox.2010.12.002; Zhang T, 2013, ENVIRON SCI TECHNOL, V47, P4686, DOI 10.1021/es303808b; Zhang ZF, 2011, ENVIRON SCI TECHNOL, V45, P7044, DOI 10.1021/es200976k	38	16	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0169217	10.1371/journal.pone.0169217	http://dx.doi.org/10.1371/journal.pone.0169217			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085949	gold, Green Published, Green Submitted			2022-12-26	WOS:000391972600016
J	Liu, SL; Lin, HX; Qiu, F; Zhang, WJ; Niu, CH; Wen, W; Sun, XQ; Ye, LP; Wu, XQ; Lin, CY; Song, LB; Guo, L				Liu, Sai-Lan; Lin, Huan-Xin; Qiu, Fang; Zhang, Wei-Jing; Niu, Chun-Hao; Wen, Wen; Sun, Xiao-Qing; Ye, Li-Ping; Wu, Xian-Qiu; Lin, Chu-Yong; Song, Li-Bing; Guo, Ling			Overexpression of Kinesin Family Member 20A Correlates with Disease Progression and Poor Prognosis in Human Nasopharyngeal Cancer: A Retrospective Analysis of 105 Patients	PLOS ONE			English	Article							INTENSITY-MODULATED RADIOTHERAPY; PHASE-III; CONCURRENT CHEMORADIOTHERAPY; CARCINOMA; GROWTH; SURVIVAL; LYMPHANGIOGENESIS; GEMCITABINE; COMBINATION; METASTASIS	Background Numerous studies have shown Kinesin family member 20A (KIF20A) may play a critical role in the development and progression of cancer. However, the clinical value of KIF20A in nasopharyngeal carcinoma (NPC) is unknown. Here, we investigated the expression pattern of KIF20A in NPC and its correlation with clinicopathological features of patients. Methods Real-time PCR and Western blotting were used to quantify KIF20A expression in NPC cell lines and clinical specimens compared with normal controls. KIF20A protein expression was also examined in archived paraffin embedded tumor samples from 105 patients with pathologically confirmed NPC by immunohistochemistry (IHC). Statistical analyses were applied to assess the associations between KIF20A expression and the clinicopathological features and survival outcomes. Effects on migration and invasion were assessed by wound healing and transwell invasion assays after KIF20A silencing. Results KIF20A was significantly overexpressed at both the mRNA and protein levels in NPC cell lines and human tumor tissues. 45/105 (42.9%) of NPC specimens expressed high levels of KIF20A among the KIF20A detectable cases. Statistical analysis revealed that high KIF20A expression was significantly associated with gender (P = 0.046), clinical stage (P<0.001), T category (P = 0.022), N category (P<0.001), distant metastasis (P = 0.001) and vital status (P = 0.001). Moreover, Higher KIF20A expression patients had shorter overall survival (OS) and progression-free survival (PFS) (P = 0.001 and P = 0.001; log-rank test). In multivariate analysis, KIF20A was an independent prognostic factor for OS and PFS in the entire cohort (P = 0.033, P = 0.008). Knock down of KIF20A expression significantly suppressed NPC cell's migration and invasion. Conclusions KIF20A is overexpressed and may serve as an independent prognostic biomarker in NPC. Targeting KIF20A reduces migration and invasion of NPC cells.	[Liu, Sai-Lan; Lin, Huan-Xin; Qiu, Fang; Zhang, Wei-Jing; Niu, Chun-Hao; Wen, Wen; Sun, Xiao-Qing; Ye, Li-Ping; Wu, Xian-Qiu; Lin, Chu-Yong; Song, Li-Bing; Guo, Ling] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Ctr Canc, Guangzhou, Guangdong, Peoples R China; [Liu, Sai-Lan; Qiu, Fang; Wen, Wen; Guo, Ling] Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou, Guangdong, Peoples R China; [Lin, Huan-Xin; Sun, Xiao-Qing] Sun Yat Sen Univ, Ctr Canc, Dept Radiotherapy, Guangzhou, Guangdong, Peoples R China; [Zhang, Wei-Jing; Niu, Chun-Hao] Sun Yat Sen Univ, Ctr Canc, Dept Gynaecol Oncol, Guangzhou, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Guo, L (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Ctr Canc, Guangzhou, Guangdong, Peoples R China.; Guo, L (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou, Guangdong, Peoples R China.	guoling@sysucc.org.cn	Lin, Chuyong/AAA-9931-2020; Zhang, Weijing/GQA-9455-2022; Song, LB/AAL-1968-2020	Lin, Chuyong/0000-0003-4887-5386; Ye, Liping/0000-0002-2263-0631	National Natural Science Foundation of China [81572848]; Sci-Tech Project Foundation of Guangdong Province, China [20126031800255]; Guangzhou Science and Technology Planning Project China [2014J4100181]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sci-Tech Project Foundation of Guangdong Province, China; Guangzhou Science and Technology Planning Project China	This work was partly supported by the National Natural Science Foundation of China (No. 81572848), the Sci-Tech Project Foundation of Guangdong Province, China (No. 20126031800255), and the Guangzhou Science and Technology Planning Project China (No.2014J4100181). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; ALTUN M, 1995, INT J RADIAT ONCOL, V32, P859, DOI 10.1016/0360-3016(95)00516-2; Cao Su-Mei, 2011, Chin J Cancer, V30, P114; Chan ATC, 2002, J CLIN ONCOL, V20, P2038, DOI 10.1200/JCO.2002.08.149; Chen QY, 2011, JNCI-J NATL CANCER I, V103, P1761, DOI 10.1093/jnci/djr432; Chua MLK, 2016, LANCET, V387, P1012, DOI 10.1016/S0140-6736(15)00055-0; Claerhout S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024662; Ding ZC, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/890178; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Exertier P, 2013, ONCOTARGET, V4, P2302, DOI 10.18632/oncotarget.1490; Feng J, 2012, CELL SIGNAL, V24, P1116, DOI 10.1016/j.cellsig.2012.01.013; Foo KF, 2002, ANN ONCOL, V13, P150, DOI 10.1093/annonc/mdf002; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hasegawa T, 2002, HUM PATHOL, V33, P111, DOI 10.1053/hupa.2002.30184; Hirokawa N, 1998, CURR OPIN CELL BIOL, V10, P60, DOI 10.1016/S0955-0674(98)80087-2; Ho JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039469; Imai K, 2011, BRIT J CANCER, V104, P300, DOI 10.1038/sj.bjc.6606052; Kam MKM, 2003, INT J RADIAT ONCOL, V56, P145, DOI 10.1016/S0360-3016(03)00075-0; Khongkow P, 2016, ONCOGENE, V35, P990, DOI 10.1038/onc.2015.152; Kristensen CA, 2007, ACTA ONCOL, V46, P214, DOI 10.1080/02841860600635862; Lai F, 2000, GENE, V248, P117, DOI 10.1016/S0378-1119(00)00135-9; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; Lesterhuis WJ, 2011, NAT REV DRUG DISCOV, V10, P591, DOI 10.1038/nrd3500; Lin JC, 2003, J CLIN ONCOL, V21, P631, DOI 10.1200/JCO.2003.06.158; Liu LP, 2015, GUT, V64, P26, DOI 10.1136/gutjnl-2013-306388; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Perri F, 2011, WORLD J CLIN ONCOL, V2, P377, DOI 10.5306/wjco.v2.i12.377; Rath O, 2012, NAT REV CANCER, V12, P527, DOI 10.1038/nrc3310; Sakowicz R, 2004, CANCER RES, V64, P3276, DOI 10.1158/0008-5472.CAN-03-3839; Shi C, 2016, ONCOTARGET, V7, P26206, DOI 10.18632/oncotarget.8441; Shi DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043898; Stangel D, 2015, J SURG RES, V197, P91, DOI 10.1016/j.jss.2015.03.070; Suarez C, 2010, EUR ARCH OTO-RHINO-L, V267, P1811, DOI 10.1007/s00405-010-1385-x; Sugahara KN, 2010, SCIENCE, V328, P1031, DOI 10.1126/science.1183057; Suzuki N, 2014, J IMMUNOTHER, V37, P36, DOI 10.1097/CJI.0000000000000012; Tan EH, 1999, ANN ONCOL, V10, P235, DOI 10.1023/A:1008390929826; Tomita Y, 2013, CLIN CANCER RES, V19, P4508, DOI 10.1158/1078-0432.CCR-13-0197; Wakisaka N, 2012, ORAL ONCOL, V48, P703, DOI 10.1016/j.oraloncology.2012.02.003; Walter S, 2012, NAT MED, V18, P1254, DOI 10.1038/nm.2883; Wee Joseph Tien Seng, 2010, Chin J Cancer, V29, P517; Wu Y, 2006, INT J CANCER, V119, P1519, DOI 10.1002/ijc.21865; Yamashita J, 2012, ACTA DERM-VENEREOL, V92, P593, DOI 10.2340/00015555-1416; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858; Zhang MX, 2015, EUR J CANCER, V51, P2587, DOI 10.1016/j.ejca.2015.08.006; Zou JX, 2014, MOL CANCER RES, V12, P539, DOI 10.1158/1541-7786.MCR-13-0459	45	26	28	7	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169280	10.1371/journal.pone.0169280	http://dx.doi.org/10.1371/journal.pone.0169280			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081138	gold, Green Published, Green Submitted			2022-12-26	WOS:000391949500038
J	Anselmino, M; Scarsoglio, S; Saglietto, A; Gaita, F; Ridolfi, L				Anselmino, Matteo; Scarsoglio, Stefania; Saglietto, Andrea; Gaita, Fiorenzo; Ridolfi, Luca			A Computational Study on the Relation between Resting Heart Rate and Atrial Fibrillation Hemodynamics under Exercise	PLOS ONE			English	Article							STRICT RATE CONTROL; CARDIAC ELECTROPHYSIOLOGY; FLUID-DYNAMICS; CAPACITY; LENIENT; VOLUME	Aims Clinical data indicating a heart rate (HR) target during rate control therapy for permanent atrial fibrillation (AF) and assessing its eventual relationship with reduced exercise tolerance are lacking. The present study aims at investigating the impact of resting HR on the hemodynamic response to exercise in permanent AF patients by means of a computational cardiovascular model. Methods The AF lumped-parameter model was run to simulate resting (1 Metabolic Equivalent of Task-MET) and various exercise conditions (4 METs: brisk walking; 6 METs: skiing; 8 METs: running), considering different resting HR (70 bpm for the slower resting HR-SHR-simulations, and 100 bpm for the higher resting HR-HHR-simulations). To compare relative variations of cardiovascular variables upon exertion, the variation comparative index (VCI)-the absolute variation between the exercise and the resting values in SHR simulations referred to the absolute variation in HHR simulations-was calculated at each exercise grade (VCI4, VCI6 and VCI8). Results Pulmonary venous pressure underwent a greater increase in HHR compared to SHR simulations (VCI4 = 0.71, VCI6 = 0.73 and VCI8 = 0.77), while for systemic arterial pressure the opposite is true (VCI4 = 1.15, VCI6 = 1.36, VCI8 = 1.56). Conclusions The computational findings suggest that a slower, with respect to a higher resting HR, might be preferable in permanent AF patients, since during exercise pulmonary venous pressure undergoes a slighter increase and systemic blood pressure reveals a more appropriate increase.	[Anselmino, Matteo; Saglietto, Andrea; Gaita, Fiorenzo] Univ Turin, Citta Salute & Sci Hosp, Dept Med Sci, Div Cardiol, Turin, Italy; [Scarsoglio, Stefania] Politecn Torino, DIMEAS Dept Mech & Aerosp Engn, Turin, Italy; [Ridolfi, Luca] Politecn Torino, DIATI Dept Environm Land & Infrastruct Engn, Turin, Italy	A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; Polytechnic University of Turin; Polytechnic University of Turin	Anselmino, M (corresponding author), Univ Turin, Citta Salute & Sci Hosp, Dept Med Sci, Div Cardiol, Turin, Italy.	matteo.anselmino@unito.it	Scarsoglio, Stefania/E-8067-2015; Scarsoglio, Stefania/ABC-4325-2020; Saglietto, Andrea/E-2184-2015	Scarsoglio, Stefania/0000-0002-9427-6491; Scarsoglio, Stefania/0000-0002-9427-6491; Saglietto, Andrea/0000-0001-9475-1507; Anselmino, Matteo/0000-0002-6311-4270				Anselmino M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119868; Atwood JE, 2007, AM HEART J, V153, P566, DOI 10.1016/j.ahj.2006.12.020; Buber J, 2011, ANN NONINVAS ELECTRO, V16, P357, DOI 10.1111/j.1542-474X.2011.00463.x; Chantler PD, 2008, AM J PHYSIOL-HEART C, V295, pH145, DOI 10.1152/ajpheart.01179.2007; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Hennig T, 2006, J BIOL PHYS, V32, P383, DOI 10.1007/s10867-006-9022-z; Jaber J, 2011, CLIN CARDIOL, V34, P533, DOI 10.1002/clc.20948; JETTE M, 1990, CLIN CARDIOL, V13, P555, DOI 10.1002/clc.4960130809; Kato Y, 2016, EUROPEAN J PREVENTIV; Korakianitis T, 2006, J BIOMECH, V39, P1964, DOI 10.1016/j.jbiomech.2005.06.016; Kovacs G, 2012, EUR RESPIR J, V39, P319, DOI 10.1183/09031936.00008611; Kuppahally SS, 2010, CIRC-CARDIOVASC IMAG, V3, P231, DOI 10.1161/CIRCIMAGING.109.865683; Lee SH, 2005, J AM SOC ECHOCARDIOG, V18, P1349, DOI 10.1016/j.echo.2005.04.007; Lip GYH, 2015, EUROPACE, V17, P194, DOI 10.1093/europace/euu201; Maeder MT, 2010, J AM COLL CARDIOL, V56, P855, DOI 10.1016/j.jacc.2010.04.040; Mangoni AA, 1996, J HYPERTENS, V14, P897, DOI 10.1097/00004872-199607000-00013; Masuki S, 2007, J APPL PHYSIOL, V103, P1128, DOI 10.1152/japplphysiol.00175.2007; Ostermaier RH, 1997, CLIN CARDIOL, V20, P23, DOI 10.1002/clc.4960200107; Otsuki T, 2006, ACTA PHYSIOL, V188, P15, DOI 10.1111/j.1748-1716.2006.01596.x; Pappano A. J., 2013, CARDIOVASCULAR PHYSL, V10th; Petrutiu S, 2007, EUROPACE, V9, P466, DOI 10.1093/europace/eum096; Scarsoglio S, 2016, COMPUT METHOD BIOMEC, V19, P1060, DOI 10.1080/10255842.2015.1094800; Scarsoglio S, 2016, PEERJ, V4, DOI 10.7717/peerj.2240; Scarsoglio S, 2014, MED BIOL ENG COMPUT, V52, P905, DOI 10.1007/s11517-014-1192-4; Severi S, 2014, EUROPACE, V16, P703, DOI 10.1093/europace/euu085; Severi S, 2014, EUROPACE, V16, P382, DOI 10.1093/europace/euu044; Steele L, 2001, J ROY COLL SURG EDIN, V46, P29; Tateno K, 2001, MED BIOL ENG COMPUT, V39, P664, DOI 10.1007/BF02345439; UESHIMA K, 1993, AM HEART J, V126, P260, DOI 10.1016/S0002-8703(07)80049-4; Ulimoen SR, 2014, EUR HEART J, V35, P517, DOI 10.1093/eurheartj/eht429; Van Gelder IC, 2010, NEW ENGL J MED, V362, P1363, DOI 10.1056/NEJMoa1001337; WHITE CW, 1982, CIRC RES, V51, P205, DOI 10.1161/01.RES.51.2.205; Wyse DG, 2011, J AM COLL CARDIOL, V58, P950, DOI 10.1016/j.jacc.2011.04.028	33	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169967	10.1371/journal.pone.0169967	http://dx.doi.org/10.1371/journal.pone.0169967			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076389	Green Published, gold			2022-12-26	WOS:000391857100071
J	Perrotta, D; Bella, A; Rizzo, C; Paolotti, D				Perrotta, Daniela; Bella, Antonino; Rizzo, Caterina; Paolotti, Daniela			Participatory Online Surveillance as a Supplementary Tool to Sentinel Doctors for Influenza-Like Illness Surveillance in Italy	PLOS ONE			English	Article								The monitoring of seasonal influenza yearly epidemics remains one of the main activity of national syndromic surveillance systems. The development of internet-based surveillance tools has brought an innovative approach to seasonal influenza surveillance by directly involving self-selected volunteers among the general population reporting their health status on a weekly basis throughout the flu season. In this paper, we explore how Influweb, an internet-based monitoring system for influenza surveillance, deployed in Italy since 2008 has performed during three years from 2012 to 2015 in comparison with data collected during the same period by the Italian sentinel doctors surveillance system.	[Perrotta, Daniela; Paolotti, Daniela] ISI Fdn, Computat Epidemiol Lab, Turin, Italy; [Bella, Antonino; Rizzo, Caterina] Ist Super Sanita, Ctr Nazl Epidemiol Sorveglianza & Promoz Salute, Rome, Italy	Istituto Superiore di Sanita (ISS)	Paolotti, D (corresponding author), ISI Fdn, Computat Epidemiol Lab, Turin, Italy.	daniela.paolotti@isi.it	Rizzo, Caterina/H-4092-2012; Bella, Antonino/AAB-9943-2019	Rizzo, Caterina/0000-0002-5583-7508; 	H2020 FETPROACT-GSS CIMPLEX grant [641191]	H2020 FETPROACT-GSS CIMPLEX grant	Daniela Paolotti and Daniela Perrotta acknowledge support from H2020 FETPROACT-GSS CIMPLEX grant no. 641191, URL: https://www.cimplex-project.eu/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all the participants who took part in the Influweb project in the past years. Daniela Paolotti and Daniela Perrotta acknowledge support from H2020 FETPROACT-GSS CIMPLEX Grant No. 641191.	Adler AJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-232; Bajardi P, 2014, J MED INTERNET RES, V16, P190, DOI 10.2196/jmir.3010; Cantarelli P, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-984; Chunara R, 2015, SCI REP-UK, V5, DOI 10.1038/srep09540; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Debin M, 2014, HUM VACC IMMUNOTHER, V10, P536, DOI 10.4161/hv.27439; FOX S, 2000, ONLINE HLTH CARE REV; Friesema IHM, 2009, VACCINE, V27, P6353, DOI 10.1016/j.vaccine.2009.05.042; Lau LLH, 2010, J INFECT DIS, V201, P1509, DOI 10.1086/652241; Paolotti D, 2014, CLIN MICROBIOL INFEC, V20, P17, DOI 10.1111/1469-0691.12477; Patterson-Lomba O, 2014, AM J EPIDEMIOL, V179, P1394, DOI 10.1093/aje/kwu061; Salathe M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002616; van Noort SP, 2015, EPIDEMICS-NETH, V13, P28, DOI 10.1016/j.epidem.2015.05.001	14	27	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169801	10.1371/journal.pone.0169801	http://dx.doi.org/10.1371/journal.pone.0169801			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076411	Green Submitted, Green Published, gold			2022-12-26	WOS:000391857100056
J	Yang, Q; Li, X; Chen, H; Cao, Y; Xiao, Q; He, Y; Wei, J; Zhou, J				Yang, Q.; Li, X.; Chen, H.; Cao, Y.; Xiao, Q.; He, Y.; Wei, J.; Zhou, J.			IRF7 regulates the development of granulocytic myeloid-derived suppressor cells through S100A9 transrepression in cancer	ONCOGENE			English	Article							TUMOR-METASTASIS; ACCUMULATION; ACTIVATION; DIFFERENTIATION; EXPANSION; CORRELATE	Accumulation of myeloid-derived suppressor cells (MDSCs) is one of the major obstacles against achieving appropriate anti-tumor immune responses and successful tumor immunotherapy. Granulocytic MDSCs (G-MDSCs) are common in tumor-bearing hosts. However, the mechanisms regulating the development of MDSCs, especially G-MDSCs, remain poorly understood. In this report, we showed that interferon regulatory factor 7 (IRF7) plays an important role in the development of G-MDSCs, but not monocytic MDSCs. IRF7 deficiency caused significant elevation of G-MDSCs, and therefore enhanced tumor growth and metastasis in mice. IRF7 deletion did not affect the suppressive activity of G-MDSCs. Mechanistic studies showed that S100A9, a negative regulator of myeloid cell differentiation, was transrepressed by the IRF7 protein. S100A9 knockdown almost completely abrogated the effects of IRF7 deletion on G-MDSC development and tumor metastasis. Importantly, IRF7 expression levels negatively correlated with the G-MDSC frequency and tumor metastasis, as well as S100A9 expression, in cancer patients. In summary, our study demonstrated that IRF7 represents a novel regulator of G-MDSC development in cancer, which may have predictive value for tumor progression.	[Yang, Q.; Zhou, J.] Zhongshan Sch Med, Affiliated Guangzhou Women & Childrens Med Ctr, Program Immunol, Guangzhou, Guangdong, Peoples R China; [Yang, Q.; Li, X.; Chen, H.; Cao, Y.; Xiao, Q.; He, Y.; Wei, J.; Zhou, J.] Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, 74 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China; [Yang, Q.; Zhou, J.] Guangzhou Med Univ, Sch Basic Sci, Guangzhou, Guangdong, Peoples R China; [Li, X.] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Med Oncol, Guangzhou, Guangdong, Peoples R China; [Zhou, J.] Sun Yat Sen Univ, Chinese Minist Educ, Key Lab Trop Dis Control, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Guangzhou Medical University; Sun Yat Sen University; Sun Yat Sen University	Zhou, J (corresponding author), Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, 74 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.	zhouj72@mail.sysu.edu.cn			National Natural Science Foundation of China [81571520, 91542112, 31270921]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS); National Key Basic Research Program of China [2012CB524900]; Guangdong Innovative Research Team Program [2009010058]; Fundamental Research Funds for the Central Universities; Provincial Talents Cultivated by 'Thousand-Hundred-Ten' program of Guangdong Province, 111 Project [B12003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS); National Key Basic Research Program of China(National Basic Research Program of China); Guangdong Innovative Research Team Program; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Provincial Talents Cultivated by 'Thousand-Hundred-Ten' program of Guangdong Province, 111 Project	This work was supported by the following grants to JZ: National Natural Science Foundation of China (No. 81571520; 91542112; and 31270921), Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS, 2014), National Key Basic Research Program of China (No. 2012CB524900), Guangdong Innovative Research Team Program (No. 2009010058), The Fundamental Research Funds for the Central Universities, the Provincial Talents Cultivated by 'Thousand-Hundred-Ten' program of Guangdong Province, 111 Project (No. B12003).	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Bidwell BN, 2012, NAT MED, V18, P1224, DOI 10.1038/nm.2830; Capietto AH, 2013, J EXP MED, V210, P2257, DOI 10.1084/jem.20130281; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Chernov AV, 2015, J BIOL CHEM, V290, P11771, DOI 10.1074/jbc.M114.622316; Clark HL, 2016, J IMMUNOL, V196, P336, DOI 10.4049/jimmunol.1502037; Condamine T, 2015, ANNU REV MED, V66, P97, DOI 10.1146/annurev-med-051013-052304; Condamine T, 2014, J CLIN INVEST, V124, P2626, DOI 10.1172/JCI74056; Damuzzo V, 2015, CYTOM PART B-CLIN CY, V88, P77, DOI [10.1002/cyto.b.21206, 10.1002/cytob.21206]; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Hibino T, 2013, CANCER RES, V73, P172, DOI 10.1158/0008-5472.CAN-11-3843; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Huang A, 2013, CANCER IMMUNOL IMMUN, V62, P1439, DOI 10.1007/s00262-013-1450-6; Ichikawa M, 2011, MOL CANCER RES, V9, P133, DOI 10.1158/1541-7786.MCR-10-0394; Kalathil S, 2013, CANCER RES, V73, P2435, DOI 10.1158/0008-5472.CAN-12-3381; Kim JK, 2015, TUMOR BIOL, V36, P5561, DOI 10.1007/s13277-015-3226-4; Lu RQ, 2001, J BIOL CHEM, V276, P45491, DOI 10.1074/jbc.C100421200; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Marvel D, 2015, J CLIN INVEST, V125, P3356, DOI 10.1172/JCI80005; Mauti LA, 2011, J CLIN INVEST, V121, P2794, DOI 10.1172/JCI41936; McNeill E, 2014, INT J CANCER, V135, P798, DOI 10.1002/ijc.28725; Ning S, 2011, GENES IMMUN, V12, P399, DOI 10.1038/gene.2011.21; Noman MZ, 2014, J EXP MED, V211, P781, DOI 10.1084/jem.20131916; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Qin AP, 2013, J VIROL, V87, P1477, DOI 10.1128/JVI.01759-12; Romieu-Mourez R, 2006, CANCER RES, V66, P10576, DOI 10.1158/0008-5472.CAN-06-1279; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Sinha P, 2008, J IMMUNOL, V181, P4666, DOI 10.4049/jimmunol.181.7.4666; Solito S, 2014, ANN NY ACAD SCI, V1319, P47, DOI 10.1111/nyas.12469; Talmadge JE, 2013, NAT REV CANCER, V13, P739, DOI 10.1038/nrc3581; Thevenot PT, 2014, IMMUNITY, V41, P389, DOI 10.1016/j.immuni.2014.08.015; Vasquez-Dunddel D, 2013, J CLIN INVEST, V123, P1580, DOI 10.1172/JCI60083; Waight JD, 2013, J CLIN INVEST, V123, P4464, DOI 10.1172/JCI68189; Wang L, 2013, J IMMUNOL, V190, P794, DOI 10.4049/jimmunol.1202088; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yang Q, 2014, BLOOD, V124, P1610, DOI 10.1182/blood-2014-03-559658; Yang Q, 2015, MOL CELL BIOL, V35, P63, DOI 10.1128/MCB.00805-14; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Yu LX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6256; Zhang LW, 2004, J VIROL, V78, P12987, DOI 10.1128/JVI.78.23.12987-12995.2004	44	33	35	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 25	2017	36	21					2969	2980		10.1038/onc.2016.448	http://dx.doi.org/10.1038/onc.2016.448			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EV7ZP	28092673				2022-12-26	WOS:000402000400005
J	Lee, H; Min, K; Yi, JS; Shi, H; Chang, W; Jackson, L; Bennett, AM				Lee, Hojin; Min, Kisuk; Yi, Jae-Sung; Shi, Hao; Chang, Woochul; Jackson, Leandra; Bennett, Anton M.			A Phosphoproteomic Screen Identifies a Guanine Nucleotide Exchange Factor for Rab3A Protein as a Mitogen-activated Protein (MAP) Kinase Phosphatase-5-regulated MAP Kinase Target in Interleukin 6 (IL-6) Secretion and Myogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine; dual specificity phosphoprotein phosphatase; mitogen-activated protein kinase (MAPK); myogenesis; phosphoproteomics; skeletal muscle	SKELETAL-MUSCLE; IMMUNOAFFINITY ENRICHMENT; MUSCULAR-DYSTROPHY; MOLECULAR-CLONING; LC-MS/MS; PATHWAY; CANCER; CELLS; REGENERATION; SPECIFICITY	The mitogen-activated protein kinases (MAPKs) have been shown to regulate skeletal muscle function. Previously, we showed that MAPK phosphatase-5 (MKP-5) negatively regulates myogenesis and regeneration of skeletal muscle through inhibition of p38 MAPK and c-Jun N-terminal kinase (JNK). However, the identity and contribution of MKP-5-regulated MAPK targets in the control of skeletal muscle function and regenerative myogenesis have not been established. To identify MKP-5-regulated MAPK substrates in skeletal muscle, we performed a global differential phospho-MAPK substrate screen in regenerating skeletal muscles of wild type and MKP-5-deficient mice. We discovered a novel MKP-5-regulated MAPK substrate called guanine nucleotide exchange factor for Rab3A (GRAB) that was hyperphosphorylated on a phospho-MAPK motif in skeletal muscle of MKP-5-deficient mice. GRAB was found to be phosphorylated by JNK on serine 169. Myoblasts overexpressing a phosphorylation-defective mutant of GRAB containing a mutation at Ser-169 to Ala-169 (GRAB-S169A) inhibited the ability of C2C12 myoblasts to differentiate. We found that GRAB phosphorylation at Ser-169 was required for the secretion of the promyogenic cytokine interleukin 6 (IL-6). Consistent with this observation, MKP-5-deficient mice exhibited increased circulating IL-6 expression as compared with wild type mice. Collectively, these data demonstrate a novel mechanism whereby MKP-5-mediated regulation of JNK negatively regulates phosphorylation of GRAB, which subsequently controls secretion of IL-6. These data support the notion that MKP-5 serves as a negative regulator of MAPK-dependent signaling of critical skeletal muscle signaling pathways.	[Lee, Hojin; Min, Kisuk; Yi, Jae-Sung; Bennett, Anton M.] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA; [Bennett, Anton M.] Yale Univ, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA; [Shi, Hao] Virginia Polytech Inst & State Univ, Dept Anim & Poultry Sci, Blacksburg, VA 24060 USA; [Chang, Woochul] Pusan Natl Univ, Dept Biol Educ, Coll Educ, Busan 609735, South Korea; [Jackson, Leandra] Univ Calif Irvine, Program Publ Hlth, Irvine, CA 92697 USA	Yale University; Yale University; Virginia Polytechnic Institute & State University; Pusan National University; University of California System; University of California Irvine	Bennett, AM (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, SHM B226D,333 Cedar St, New Haven, CT 06520 USA.	anton.bennett@yale.edu		Chang, Woochul/0000-0001-7367-2586; Bennett, Anton/0000-0001-5187-7599	National Institutes of Health [R01 GM099801, RO1 AR066601]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR066003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK057751, P30DK034989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by National Institutes of Health Grants R01 GM099801 and RO1 AR066601.	Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Bennett AM, 1997, SCIENCE, V278, P1288, DOI 10.1126/science.278.5341.1288; Blencowe BJ, 1998, GENE DEV, V12, P996, DOI 10.1101/gad.12.7.996; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; Cazares VA, 2014, TRAFFIC, V15, P997, DOI 10.1111/tra.12182; Farhan H, 2011, J CELL SCI, V124, P171, DOI 10.1242/jcs.076455; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Gu HB, 2016, MOL CELL PROTEOMICS, V15, P692, DOI 10.1074/mcp.O115.052266; Kontaridis MI, 2002, MOL CELL BIOL, V22, P3875, DOI 10.1128/MCB.22.11.3875-3891.2002; Lee H, 2013, MOL CELL BIOL, V33, P1430, DOI 10.1128/MCB.01708-12; Luo GJ, 2003, AM J PHYSIOL-REG I, V284, pR1249, DOI 10.1152/ajpregu.00490.2002; Luo HR, 2001, NEURON, V31, P439, DOI 10.1016/S0896-6273(01)00384-1; Mizuno-Yamasaki E, 2012, ANNU REV BIOCHEM, V81, P637, DOI 10.1146/annurev-biochem-052810-093700; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; Nonn L, 2006, CANCER RES, V66, P4516, DOI 10.1158/0008-5472.CAN-05-3796; Otis JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092363; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Shi H. P., 2015, ELECT J DIFFERENTIAL, V2015, P1, DOI DOI 10.1089/CELL.2015.0039; Shi H, 2013, J CLIN INVEST, V123, P2064, DOI 10.1172/JCI64375; Shi H, 2010, FASEB J, V24, P2985, DOI 10.1096/fj.09-150045; Sim JCH, 2015, INTRACTABLE RARE DIS, V4, P17, DOI 10.5582/irdr.2014.01021; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stokes MP, 2012, MOL CELL PROTEOMICS, V11, P187, DOI 10.1074/mcp.M111.015883; TAKAI T, 1994, NUCLEIC ACIDS RES, V22, P5576, DOI 10.1093/nar/22.25.5576; TANG PM, 1991, J BIOL CHEM, V266, P15782; Tierney MT, 2014, NAT MED, V20, P1182, DOI 10.1038/nm.3656; Wang JF, 2015, P NATL ACAD SCI USA, V112, P148, DOI 10.1073/pnas.1412089112; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Zhang CC, 2013, J BIOL CHEM, V288, P1489, DOI 10.1074/jbc.M112.419788; Zhang YL, 2004, NATURE, V430, P793, DOI 10.1038/nature02764	34	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3581	3590		10.1074/jbc.M116.769208	http://dx.doi.org/10.1074/jbc.M116.769208			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28096466	Green Published, hybrid			2022-12-26	WOS:000395542500004
J	Swenson, AM; Tang, WJ; Blair, CA; Fetrow, CM; Unrath, WC; Previs, MJ; Campbell, KS; Yengo, CM				Swenson, Anja M.; Tang, Wanjian; Blair, Cheavar A.; Fetrow, Christopher M.; Unrath, William C.; Previs, Michael J.; Campbell, Kenneth S.; Yengo, Christopher M.			Omecamtiv Mecarbil Enhances the Duty Ratio of Human -Cardiac Myosin Resulting in Increased Calcium Sensitivity and Slowed Force Development in Cardiac Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; cardiac muscle; contractile protein; molecular motor; myosin; calcium sensitivity	SYSTOLIC HEART-FAILURE; BINDING PROTEIN-C; CONTRACTILE PROPERTIES; MOTILE PROPERTIES; ATPASE ACTIVITY; STEP-SIZE; ACTIN; ACTIVATOR; MOTOR; CARDIOMYOPATHY	The small molecule drug omecamtiv mecarbil (OM) specifically targets cardiac muscle myosin and is known to enhance cardiac muscle performance, yet its impact on human cardiac myosin motor function is unclear. We expressed and purified human -cardiac myosin subfragment 1 (M2-S1) containing a C-terminal Avi tag. We demonstrate that the maximum actin-activated ATPase activity of M2-S1 is slowed more than 4-fold in the presence of OM, whereas the actin concentration required for half-maximal ATPase was reduced dramatically (30-fold). We find OM does not change the overall actin affinity. Transient kinetic experiments suggest that there are two kinetic pathways in the presence of OM. The dominant pathway results in a slow transition between actomyosinADP states and increases the time myosin is strongly bound to actin. However, OM also traps a population of myosin heads in a weak actin affinity state with slow product release. We demonstrate that OM can reduce the actin sliding velocity more than 100-fold in the in vitro motility assay. The ionic strength dependence of in vitro motility suggests the inhibition may be at least partially due to drag forces from weakly attached myosin heads. OM causes an increase in duty ratio examined in the motility assay. Experiments with permeabilized human myocardium demonstrate that OM increases calcium sensitivity and slows force development (k(tr)) in a concentration-dependent manner, whereas the maximally activated force is unchanged. We propose that OM increases the myosin duty ratio, which results in enhanced calcium sensitivity but slower force development in human myocardium.	[Swenson, Anja M.; Tang, Wanjian; Fetrow, Christopher M.; Unrath, William C.; Yengo, Christopher M.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA; [Blair, Cheavar A.; Campbell, Kenneth S.] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; [Blair, Cheavar A.; Campbell, Kenneth S.] Univ Kentucky, Div Cardiovasc Med, Lexington, KY 40536 USA; [Previs, Michael J.] Univ Vermont, Cardiovasc Res Inst, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Kentucky; University of Kentucky; University of Vermont	Yengo, CM (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA.	cmy11@psu.edu		Touma, Anja/0000-0001-9953-9695; Blair, Cheavar/0000-0002-0289-439X; Tang, Wanjian/0000-0001-7374-6442	American Heart Association [14GRNT20380068, 15GRNT25460003]; National Institutes of Health [R01HL127699, UL1TR000117, R00HL124041]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001998, UL1TR000117] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127699, R00HL124041] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association Grant 14GRNT20380068 and National Institutes of Health Grant R01HL127699 (to C. M. Y.), American Heart Association Grant 15GRNT25460003 and National Institutes of Health Grant UL1TR000117 (to K. S. C.), and National Institutes of Health Grant R00HL124041 (to M. J. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aksel T, 2015, CELL REP, V11, P910, DOI 10.1016/j.celrep.2015.04.006; Albet-Torres N, 2009, J BIOL CHEM, V284, P22926, DOI 10.1074/jbc.M109.019232; Bakkehaug JP, 2015, CIRC-HEART FAIL, V8, P766, DOI 10.1161/CIRCHEARTFAILURE.114.002152; Batters C, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00090; Blair C. A., 2016, VAD J, V2, P12, DOI 10.13023/VAD.2016.12; Braunwald E, 2013, CIRC RES, V113, P633, DOI 10.1161/CIRCRESAHA.113.302254; Brizendine RK, 2015, P NATL ACAD SCI USA, V112, P11235, DOI 10.1073/pnas.1510241112; Campbell KS, 2003, AM J PHYSIOL-HEART C, V285, pH2857, DOI 10.1152/ajpheart.00295.2003; CHALOVICH JM, 1984, BIOCHEMISTRY-US, V23, P4885, DOI 10.1021/bi00316a011; Cleland JGF, 2011, LANCET, V378, P676, DOI 10.1016/S0140-6736(11)61126-4; De la Cruz EM, 2000, BIOCHEMISTRY-US, V39, P14196, DOI 10.1021/bi001701b; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7; Dose AC, 2007, J BIOL CHEM, V282, P216, DOI 10.1074/jbc.M605964200; Dose AC, 2008, BIOCHEMISTRY-US, V47, P2485, DOI 10.1021/bi7021574; Fewell JG, 1998, J CLIN INVEST, V101, P2630, DOI 10.1172/JCI2825; Geeves MA, 2016, BIOPOLYMERS, V105, P483, DOI 10.1002/bip.22853; Greenberg BH, 2015, JACC-HEART FAIL, V3, P22, DOI 10.1016/j.jchf.2014.07.009; GREENE LE, 1978, P NATL ACAD SCI USA, V75, P54, DOI 10.1073/pnas.75.1.54; Haldeman BD, 2014, J BIOL CHEM, V289, P21055, DOI 10.1074/jbc.M114.564740; Haynes P, 2014, J MOL CELL CARDIOL, V72, P1, DOI 10.1016/j.yjmcc.2014.02.008; Kass DA, 2006, CIRCULATION, V113, P305, DOI 10.1161/CIRCULATIONAHA.105.542407; Kron S. J., 1991, METH ENZYMOL, V196, P399, DOI [10.1016/0076-6879(91)96035-P, DOI 10.1016/0076-6879(91)96035-P]; Lin TM, 2005, J BIOL CHEM, V280, P41562, DOI 10.1074/jbc.M508653200; Liu YY, 2015, BIOCHEMISTRY-US, V54, P1963, DOI 10.1021/bi5015166; Malik FI, 2011, SCIENCE, V331, P1439, DOI 10.1126/science.1200113; Malnasi-Csizmadia A, 2010, TRENDS BIOCHEM SCI, V35, P684, DOI 10.1016/j.tibs.2010.07.012; Mamidi R, 2015, J MOL CELL CARDIOL, V85, P262, DOI 10.1016/j.yjmcc.2015.06.011; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Moore JR, 2004, J MUSCLE RES CELL M, V25, P29, DOI 10.1023/B:JURE.0000021394.48560.71; Moore JR, 2001, J CELL BIOL, V155, P625, DOI 10.1083/jcb.200103128; Moss RL, 2015, CIRC RES, V116, P183, DOI 10.1161/CIRCRESAHA.116.300561; Muretta JM, 2015, P NATL ACAD SCI USA, V112, P14272, DOI 10.1073/pnas.1514859112; Nag S, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500511; Nagy L., 2015, BRIT J PHARMACOL, V2015; Noguchi T, 2003, J MOL CELL CARDIOL, V35, P91, DOI 10.1016/S0022-2828(02)00282-1; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Petersen John W, 2008, Crit Care Med, V36, pS106, DOI 10.1097/01.CCM.0000296273.72952.39; Previs MJ, 2012, SCIENCE, V337, P1215, DOI 10.1126/science.1223602; Quintero OA, 2010, J BIOL CHEM, V285, P35770, DOI 10.1074/jbc.M110.144360; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Ruff C, 2001, NAT STRUCT BIOL, V8, P226, DOI 10.1038/84962; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P16203, DOI 10.1021/bi0512086; Sheikh F, 2014, TRENDS CARDIOVAS MED, V24, P133, DOI 10.1016/j.tcm.2013.07.004; SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658; SMITH DA, 1995, BIOPHYS J, V69, P524, DOI 10.1016/S0006-3495(95)79926-X; Sommese RF, 2013, P NATL ACAD SCI USA, V110, P12607, DOI 10.1073/pnas.1309493110; Teerlink JR, 2016, J AM COLL CARDIOL, V67, P1444, DOI 10.1016/j.jacc.2016.01.031; Teerlink JR, 2009, HEART FAIL REV, V14, P243, DOI 10.1007/s10741-009-9153-y; Trivedi DV, 2015, P NATL ACAD SCI USA, V112, P14593, DOI 10.1073/pnas.1517566112; Trybus KM, 2000, METHODS, V22, P327, DOI 10.1006/meth.2000.1085; Utter MS, 2015, J CARDIOVASC PHARM, V66, P347, DOI 10.1097/FJC.0000000000000286; UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V; Van Dijk J, 1998, BIOCHEMISTRY-US, V37, P8385, DOI 10.1021/bi980139a; Wang Q, 2003, J CELL SCI, V116, P4227, DOI 10.1242/jcs.00709; Wang YH, 2014, BIOCHEMISTRY-US, V53, P5298, DOI 10.1021/bi500730t; Winkelmann DA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8974; Wulf SF, 2016, P NATL ACAD SCI USA, V113, pE1844, DOI 10.1073/pnas.1516598113	58	53	53	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3768	3778		10.1074/jbc.M116.748780	http://dx.doi.org/10.1074/jbc.M116.748780			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28082673	Green Published, hybrid			2022-12-26	WOS:000395542500019
J	Kasturirangan, S; Rainey, GJ; Xu, L; Wang, X; Portnoff, A; Chen, T; Fazenbaker, C; Zhong, H; Bee, J; Zeng, Z; Jenne, C; Wu, H; Gao, C				Kasturirangan, Srinath; Rainey, G. Jonah; Xu, Linda; Wang, Xinwei; Portnoff, Alyse; Chen, Tracy; Fazenbaker, Christine; Zhong, Helen; Bee, Jared; Zeng, Zhutian; Jenne, Craig; Wu, Herren; Gao, Changshou			Targeted Fc gamma Receptor (Fc gamma R)-mediated Clearance by a Biparatopic Bispecific Antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IGG IMMUNE-COMPLEXES; IN-VIVO; MONOCLONAL-ANTIBODY; NONOVERLAPPING EPITOPES; MEDIATED ENDOCYTOSIS; ENDOTHELIAL-CELLS; RAT-LIVER; HALF-LIFE; BINDING; PHAGOCYTOSIS	Soluble ligands have commonly been targeted by antibody therapeutics for cancers and other diseases. Although monoclonal antibodies targeting such ligands can block their interactions with their cognate receptors, they can also significantly increase the half-life of their ligands by FcRn-mediated antibody recycling, thereby evading ligand renal clearance and requiring increasingly high antibody doses to neutralize the increasing pool of target. To overcome this issue, we generated a bispecific/biparatopic antibody (BiSAb) that targets two different epitopes on IL-6 to block IL-6-mediated signaling. The BiSAb formed large immune complexes with IL-6 that can bind Fc gamma receptors on phagocytic cells and are rapidly internalized. In addition, rapid clearance of the BiSAb . IL-6 complex was observed in mice while the parental antibodies prolonged the serum half-life of IL-6. Intravital imaging of the liver in mice confirmed that the rapid clearance of these large immune complexes was associated with Fc gamma receptor-dependent binding to Kupffer cells in the liver. The approach described here provides a general strategy for therapeutic antibodies with the ability to not only neutralize but also actively drive clearance of their soluble antigens.	[Kasturirangan, Srinath; Rainey, G. Jonah; Xu, Linda; Wang, Xinwei; Portnoff, Alyse; Wu, Herren; Gao, Changshou] Medimmune LLC, Dept Antibody Discovery & Prot Engn, 1 Medimmune Way, Gaithersburg, MD 20878 USA; [Chen, Tracy; Fazenbaker, Christine; Zhong, Helen] Medimmune LLC, Dept Oncol, Gaithersburg, MD 20878 USA; [Bee, Jared] Medimmune LLC, Dept Analyt Biotechnol, Gaithersburg, MD 20878 USA; [Zeng, Zhutian; Jenne, Craig] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 4N1, Canada	AstraZeneca; Medimmune; AstraZeneca; Medimmune; AstraZeneca; Medimmune; University of Calgary	Gao, C (corresponding author), Medimmune LLC, Dept Antibody Discovery & Prot Engn, 1 Medimmune Way, Gaithersburg, MD 20878 USA.		Jenne, Craig/HCH-3413-2022	Bee, Jared/0000-0002-4391-0560				AREND WP, 1979, J IMMUNOL, V123, P447; BENACERRAF B, 1959, J IMMUNOL, V82, P131; BOGERS WMJM, 1991, CLIN EXP IMMUNOL, V86, P328; Bonvin P, 2015, MABS-AUSTIN, V7, P294, DOI 10.1080/19420862.2015.1006993; Brown Patrick H, 2008, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1815s81; Chen K, 2012, BLOOD, V120, P4421, DOI 10.1182/blood-2011-12-401133; Chen WZ, 2012, MOL CANCER THER, V11, P1400, DOI 10.1158/1535-7163.MCT-12-0172; Coloma MJ, 1997, NAT BIOTECHNOL, V15, P159, DOI 10.1038/nbt0297-159; CORNACOFF JB, 1984, CLIN IMMUNOL IMMUNOP, V30, P255, DOI 10.1016/0090-1229(84)90060-6; Datta-Mannan A, 2016, MABS-AUSTIN, V8, P969, DOI 10.1080/19420862.2016.1178435; DAVIES KA, 1990, J IMMUNOL, V144, P4613; Davies NL, 2013, CLIN VACCINE IMMUNOL, V20, P377, DOI 10.1128/CVI.00625-12; Dimasi N, 2009, J MOL BIOL, V393, P672, DOI 10.1016/j.jmb.2009.08.032; Ding CH, 2009, EXPERT OPIN INV DRUG, V18, P1457, DOI 10.1517/13543780903203789; Eggleton P., 2015, ELS, P1, DOI [10.1002/9780470015902.a0001118.pub2, DOI 10.1002/9780470015902.A0001118.PUB2]; Eggleton P., 1999, NATURE ENCY LIFE SCI; Feng Y, 2014, EXP MOL PATHOL, V97, P359, DOI 10.1016/j.yexmp.2014.09.007; Ganesan LP, 2012, J IMMUNOL, V189, P4981, DOI 10.4049/jimmunol.1202017; Ganesan LP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002281; Gessner JE, 1998, ANN HEMATOL, V76, P231, DOI 10.1007/s002770050396; HARRISON PT, 1994, J BIOL CHEM, V269, P24396; Igawa T, 2014, BBA-PROTEINS PROTEOM, V1844, P1943, DOI 10.1016/j.bbapap.2014.08.003; Igawa T, 2010, PROTEIN ENG DES SEL, V23, P385, DOI 10.1093/protein/gzq009; Igawa T, 2010, NAT BIOTECHNOL, V28, P1203, DOI 10.1038/nbt.1691; Iwayanagi Y, 2015, J IMMUNOL, V195, P3198, DOI 10.4049/jimmunol.1401470; Jenne CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025109; Johansson AG, 1996, HEPATOLOGY, V24, P169, DOI 10.1053/jhep.1996.v24.pm0008707258; Kontermann RE, 2012, MABS-AUSTIN, V4, P182, DOI 10.4161/mabs.4.2.19000; KURLANDER RJ, 1984, J IMMUNOL, V133, P855; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Laue T.M., 1992, COMPUTER AIDED INTER; LIU MY, 1992, EXP HEMATOL, V20, P974; Lovdal T, 2000, J CELL SCI, V113, P3255; Mallick SP, 2005, ULTRAMICROSCOPY, V104, P8, DOI 10.1016/j.ultramic.2005.02.004; MANNIK M, 1980, J INVEST DERMATOL, V74, P333, DOI 10.1111/1523-1747.ep12543582; MANNIK M, 1971, J EXP MED, V133, P713, DOI 10.1084/jem.133.4.713; MCCLUSKEY RT, 1978, HUM PATHOL, V9, P71, DOI 10.1016/S0046-8177(78)80009-4; MELLMAN I, 1984, J CELL BIOL, V98, P1163, DOI 10.1083/jcb.98.4.1163; MIHARA M, 1991, IMMUNOLOGY, V74, P55; Mihara M, 2005, EXPERT OPIN BIOL TH, V5, P683, DOI 10.1517/14712598.5.5.683; Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340; Nimmerjahn F, 2011, CURR TOP MICROBIOL, V350, P105, DOI 10.1007/82_2010_86; Pandey M, 2014, FUTURE ONCOL, V10, P609, DOI [10.2217/FON.13.197, 10.2217/fon.13.197]; Protzer U, 2012, NAT REV IMMUNOL, V12, P201, DOI 10.1038/nri3169; Rehlaender BN, 2001, PHARMACEUT RES, V18, P745, DOI 10.1023/A:1011072009408; Rojko JL, 2014, TOXICOL PATHOL, V42, P725, DOI 10.1177/0192623314526475; Rossi JF, 2010, BRIT J CANCER, V103, P1154, DOI 10.1038/sj.bjc.6605872; Santora LC, 2001, ANAL BIOCHEM, V299, P119, DOI 10.1006/abio.2001.5380; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SKOGH T, 1985, IMMUNOLOGY, V55, P585; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; VALIM YML, 1991, CLIN EXP IMMUNOL, V84, P1, DOI 10.1111/j.1365-2249.1991.tb08115.x; vanVugt MJ, 1996, BLOOD, V87, P3593, DOI 10.1182/blood.V87.9.3593.bloodjournal8793593; Ward ES, 2015, MOL IMMUNOL, V67, P131, DOI 10.1016/j.molimm.2015.02.007; WAXMAN FJ, 1984, J CLIN INVEST, V74, P1329, DOI 10.1172/JCI111543; Wener M., 2007, SYSTEMIC LUPUS ERYTH, P214; Whyte J, 2000, LETT APPL MICROBIOL, V30, P90, DOI 10.1046/j.1472-765x.2000.00701.x; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601	62	21	22	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4361	4370		10.1074/jbc.M116.770628	http://dx.doi.org/10.1074/jbc.M116.770628			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28100773	Green Published, hybrid			2022-12-26	WOS:000395837100035
J	Cherifi, YA; Gaouar, SBS; Guastamacchia, R; El-Bahrawy, KA; Abushady, AMA; Sharaf, AA; Harek, D; Lacalandra, GM; Saidi-Mehtar, N; Ciani, E				Cherifi, Youcef Amine; Gaouar, Suheil Bechir Semir; Guastamacchia, Rosangela; El-Bahrawy, Khalid Ahmed; Abushady, Asmaa Mohammed Aly; Sharaf, Abdoallah Aboelnasr; Harek, Derradji; Lacalandra, Giovanni Michele; Saidi-Mehtar, Nadhira; Ciani, Elena			Weak Genetic Structure in Northern African Dromedary Camels Reflects Their Unique Evolutionary History	PLOS ONE			English	Article							MICROSATELLITE MARKERS; PHYLOGENETIC NETWORKS; SAUDI-ARABIA; POPULATIONS; DIVERSITY; DIFFERENTIATION; PROGRAM	Knowledge on genetic diversity and structure of camel populations is fundamental for sustainable herd management and breeding program implementation in this species. Here we characterized a total of 331 camels from Northern Africa, representative of six populations and thirteen Algerian and Egyptian geographic regions, using 20 STR markers. The nineteen polymorphic loci displayed an average of 9.79 +/- 5.31 alleles, ranging from 2 (CVRL8) to 24 (CVRL1D). Average He was 0.647 +/- 0.173. Eleven loci deviated significantly from Hardy-Weinberg proportions (P<0.05), due to excess of homozygous genotypes in all cases except one (CMS18). Distribution of genetic diversity along a weak geographic gradient as suggested by network analysis was not supported by either unsupervised and supervised Bayesian clustering. Traditional extensive/nomadic herding practices, together with the historical use as a long-range beast of burden and its peculiar evolutionary history, with domestication likely occurring from a bottlenecked and geographically confined wild progenitor, may explain the observed genetic patterns.	[Cherifi, Youcef Amine; Gaouar, Suheil Bechir Semir; Saidi-Mehtar, Nadhira] Univ Sci & Technol Oran Mohamed BOUDIAF USTOMB, Dept Appl Mol Genet, Lab Mol & Cellular Genet, Bir El Djir, Oran, Algeria; [Gaouar, Suheil Bechir Semir] Aboubakr Belkaid Tlemcen Univ, Dept Biol, 22 Rue Abi Ayed Abdelkrim Fg Pasteur BP, Tilimsen, Algeria; [Guastamacchia, Rosangela; Ciani, Elena] Univ Bari Aldo Moro, Dept Biosci, Biotechnol, Biopharmaceut, Bari, Italy; [Guastamacchia, Rosangela] Univ Bari Aldo Moro, Dept Emergency & Organ Transplatat, Sect Vet Clin & Anim Prod, SP Casamassima, Bari, Italy; [El-Bahrawy, Khalid Ahmed] Desert Res Ctr, Anim & Poultry Prod Div, Cairo, Egypt; [Abushady, Asmaa Mohammed Aly; Sharaf, Abdoallah Aboelnasr] Ain Shams Univ, Dept Genet, Fac Agr, Cairo, Egypt; [Harek, Derradji] Inst Natl Rech Agron, 2 Rue Freres OUADEK BP 200 Hessen Badi, El Harrach Alger, Algeria	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Egyptian Knowledge Bank (EKB); Desert Research Center (DRC); Egyptian Knowledge Bank (EKB); Ain Shams University; National Institute of Agronomic Research of Algeria (NIARA)	Cherifi, YA (corresponding author), Univ Sci & Technol Oran Mohamed BOUDIAF USTOMB, Dept Appl Mol Genet, Lab Mol & Cellular Genet, Bir El Djir, Oran, Algeria.	Cherifi.youcef@ymail.com	Sharaf, Abdoallah/G-6893-2018; LACALANDRA, Giovanni Michele/P-4661-2014; Bahrawy, Khalid El/R-4917-2019	Sharaf, Abdoallah/0000-0002-3436-9290; ciani, elena/0000-0001-5673-0975; El Bahrawy, Khalid/0000-0001-7173-0340	European Union within the ENPI-CBC-MED [I.B/1.1/493]	European Union within the ENPI-CBC-MED	Part of this study (collection, DNA isolation and genotyping of samples from Sidi Barrani, Negeila and Marsa Matruh) has been achieved within the PROCAMED project funded by European Union within the ENPI-CBC-MED, reference number I.B/1.1/493. The content of the present document is under the responsibility of the Authors and could not be considered as the position of European Union.	Ahmed MO, 2010, LIVEST SCI, V132, P182, DOI 10.1016/j.livsci.2010.05.016; Al-Swailem AM, 2009, J FOOD AGRIC ENVIRON, V7, P636; Albright WF, 1951, ARCHAEOLOGY PALESTIN; Almathen F, 2016, P NATL ACAD SCI USA; Almathen F, 2012, GENETIC DIVERSITY RE, P40; Amine C.Y., 2013, J LIFE SCI, V7, P416; [Anonymous], J APPL BIOSCI; Ben Aissa R., 1989, COLL OPTIONS MEDIT A, V2, P19; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Bulliet, 1975, CAMEL WHEEL CAMBRIDG; Ciani EBP, 2016, 1 INSIGHT GENETIC ST; Compagnoni B, 1978, CAMEL ITS DISTRIBUTI; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Epstein H., 1971, ORIGIN DOMESTIC ANIM; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evdotchenko D, 2003, MOL ECOL NOTES, V3, P431, DOI 10.1046/j.1471-8286.2003.00477.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAO, 2007, GLOB PLAN ACT AN GEN; FAO Molecular Genetic Characterization of Animal Genetic Resources, 2011, FAO ANIM PROD HLTH G, V9, P85; Faye B., 2014, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V67, P213; Faye B., 2009, Rencontres Autour des Recherches sur les Ruminants, V16, P345; Faye B, 2016, TROPICAL ANIMAL HLTH, P1; Fitak RR, 2016, MOL ECOL RESOUR, V16, P314, DOI 10.1111/1755-0998.12443; Gautam L., 2004, Indian Journal of Biotechnology, V3, P457; Grigson C, 2012, LEVANT, V44, P82, DOI 10.1179/175638012X13285409187919; Grossi D, 2011, PRESENZE CAMMELLI NE, P91; Hakker-Orion D., 1984, ANIMALS ARCHAEOLOGY, V3, P207; Heide M, 2010, UGARIT FORSCHUNGEN, V42, P331; Hoch E, 1979, 4 INT C ASS S AS ARC, P589; Hoyland Robert G., 2001, ARABIA ARABS BRONZE, DOI DOI 10.4324/9780203455685; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jennings RP, 2013, ANTIQUITY, V87, P666, DOI 10.1017/S0003598X00049383; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Lernau H., 1978, EARLY ARAD CHALCOLIT, P83; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; MACDONALD M. C. A., 1995, CIVILIZATIONS ANCIEN, V2, P1355; Mahmoud AH, 2013, RES J BIOTECHNOL, V8, P26; Mahmoud A. H., 2012, African Journal of Biotechnology, V11, P11173; Mburu DN, 2003, ANIM GENET, V34, P26, DOI 10.1046/j.1365-2052.2003.00937.x; Mehta S. C., 2007, Indian Journal of Biotechnology, V6, P336; Midant-Reynes B, 1977, ORIENTALIA, V46, P337; Mikesell MW, 1955, SOUTHWEST J ANTHROP, V11, P231, DOI 10.1086/soutjanth.11.3.3629022; Mukasa-Mugerwa E., 1981, CAMEL CAMELUS DROMED; Nolte M, 2005, S AFR J ANIM SCI, V35, P152; Olson J.S., 1996, PEOPLES AFRICA ETHNO; Peter C, 2007, ANIM GENET, V38, P37, DOI 10.1111/j.1365-2052.2007.01561.x; Piro M, 2011, J CAMEL PRACT RES, V18, P167; Pritchard James Bennett, 1969, ANCIENT NEAR E SUPPL; Pritchard JK, 2000, GENETICS, V155, P945; REYNOLDS J, 1983, GENETICS, V105, P767; Ripinsky M, 1985, J EGYPT ARCHAEOL, V71, P134; Rothenberg B., 1972, TIMNA VALLEY BIBLICA; Sapir-Hen L, 2013, TEL AVIV, V40, P277, DOI 10.1179/033443513X13753505864089; Schulz U., 2005, ANIM GENET RES INFO, V36, P61; Spencer PBS, 2010, LIVEST SCI, V129, P241, DOI 10.1016/j.livsci.2010.01.006; Uerpmann Hans-Peter, 2002, J OMAN STUDIES, V12, P235; Uerpmann UHPa, 2012, 50 YEARS EMIRATES AR, P78; Vijh RK, 2007, ANIM BIOTECHNOL, V18, P81, DOI 10.1080/10495390600648741; von den Driesch Angela, 2007, Documenta Archaeobiologiae, V5, P133; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; Wapnish P, 1984, DROMEDARY BACTRIAN C; Zarins J., 1989, ONE WORLD ARCHAEOLOG, P127	62	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0168672	10.1371/journal.pone.0168672	http://dx.doi.org/10.1371/journal.pone.0168672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103238	Green Published, gold, Green Submitted			2022-12-26	WOS:000392381100004
J	van Os, SB; Troop, NA; Sullivan, KR; Hart, DP				van Os, Sandra B.; Troop, Nick A.; Sullivan, Keith R.; Hart, Daniel P.			Adherence to Prophylaxis in Adolescents and Young Adults with Severe Haemophilia: A Quantitative Study with Patients	PLOS ONE			English	Article							ILLNESS PERCEPTION QUESTIONNAIRE; SOCIAL SUPPORT; COGNITIVE REPRESENTATION; OUTCOME EXPECTATIONS; METABOLIC-CONTROL; PATIENTS BELIEFS; DIABETES CARE; SELF-EFFICACY; BARRIERS; THERAPY	Introduction haemophilia is an inherited bleeding disorder caused by a deficiency in one of the blood coagulation factors. For people affected by severe haemophilia, the deficiency can cause spontaneous internal bleeding. Most young people with severe haemophilia in the UK follow a preventative treatment regimen (prophylaxis) consisting of several intravenous injections of factor concentrate each week. There is good evidence that prophylaxis reduces bleeds whilst also improving quality of life. However, levels of adherence among young people with haemophilia reported in the existing literature vary widely and are predominately based on estimations made by healthcare professionals and parents. Additionally, drivers of (non) adherence among young people specifically have not been evidenced. Aim to assess self-reported adherence among young people with haemophilia, provide evidence of psychosocial predictors of adherence, and to establish the associations between nonadherence and number of bleeds and hospital visits. Methods 91 participants were recruited during outpatient appointments in 13 haemophilia centres across England and Wales, and invited to complete a questionnaire assessing self-reported adherence (VERITAS-Pro), Haemophilia-related pain and impact of pain, Illness Perceptions, Beliefs about Medications, Self-efficacy, Outcome expectations, Positive and Negative Affect, and Social support. Number of hospital visits and bleeds during the previous six months were collected from medical files. Results Of 78 participants with complete data, just 18% had scores indicating non-adherence. Psychosocial predictors differed between intentional (skipping) and un-intentional (forgetting) non-adherence. Overall, however, better adherence was reported where participants perceived the need for prophylaxis was greater than their concern over taking it as well as having a positive expectancy of its effectiveness, good social support and a stronger emotional reaction to having haemophilia. Conclusion The findings indicate that adherence is generally good, and that assessing illness and treatment beliefs, social support and outcome expectations may play a valuable role in identifying which individuals are at risk of non-adherence. Interventions aimed at improving adherence should particularly consider improving social support, reducing patients' concerns about prophylaxis, increasing their belief in the necessity of prophylaxis, and increasing positive outcome expectations.	[van Os, Sandra B.; Troop, Nick A.; Sullivan, Keith R.] Univ Hertfordshire, Sch Life & Med Sci, Psychol & Sport Sci Dept, Hatfield, Herts, England; [Hart, Daniel P.] Barts Hlth NHS Trust, Royal London Hosp, Haemophilia Ctr, London, England; [Hart, Daniel P.] QMUL, Barts & London Sch Med & Dent, London, England	University of Hertfordshire; Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London		s.b.van-os@herts.ac.uk	van Os, Sandra/AAE-6975-2019		Bayer Haemophilia Caregiver award; Bayer Haemophilia Awards Programme	Bayer Haemophilia Caregiver award; Bayer Haemophilia Awards Programme	This work was supported by the Bayer Haemophilia Caregiver award (http://www.bayer-hemophilia-awards.com/archive/awards-2012/). The research received external peer reviewed funding from the Bayer Haemophilia Awards Programme (Caregiver Award awarded to the first author). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, UKHCDO ANN REPORT 20; Bandura, 2006, SELF EFFICACY BELIEF, V5; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Bearman KJ, 2002, J PEDIATR PSYCHOL, V27, P417, DOI 10.1093/jpepsy/27.5.417; Berntorp E, 2009, HAEMOPHILIA, V15, P1219, DOI 10.1111/j.1365-2516.2009.02077.x; Bolton-Maggs PHB, 2003, LANCET, V361, P1801, DOI 10.1016/S0140-6736(03)13405-8; Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020; Chilcot J, 2010, J PSYCHOSOM RES, V68, P203, DOI 10.1016/j.jpsychores.2009.08.010; Chlebowy DO, 2006, DIABETES EDUCATOR, V32, P777, DOI 10.1177/0145721706291760; Cox Laura, 2015, Nurs Child Young People, V27, P16, DOI 10.7748/ncyp.27.1.16.e565; De Moerloose P, 2008, HAEMOPHILIA, V14, P931, DOI 10.1111/j.1365-2516.2008.01843.x; de Thurah A, 2010, RHEUMATOL INT, V30, P1441, DOI 10.1007/s00296-009-1160-8; du Treil S, 2010, HAEMOPHILIA, V16, P545, DOI 10.1111/j.1365-2516.2009.02169.x; Duncan N, 2012, HAEMOPHILIA, V18, P760, DOI 10.1111/j.1365-2516.2012.02813.x; Duncan N, 2010, HAEMOPHILIA, V16, P247, DOI 10.1111/j.1365-2516.2009.02129.x; Geraghty S, 2006, HAEMOPHILIA, V12, P75, DOI 10.1111/j.1365-2516.2006.01189.x; Hacker MR, 2001, HAEMOPHILIA, V7, P392, DOI 10.1046/j.1365-2516.2001.00534.x; Helgeson VS, 2009, J PEDIATR PSYCHOL, V34, P254, DOI 10.1093/jpepsy/jsn079; Horne R, 1999, J PSYCHOSOM RES, V47, P555, DOI 10.1016/S0022-3999(99)00057-4; Horne R, 1999, PSYCHOL HEALTH, V14, P1, DOI 10.1080/08870449908407311; Horne R., 2013, UNDERSTANDING PATIEN; Iannotti RJ, 2006, J DEV BEHAV PEDIATR, V27, P98, DOI 10.1097/00004703-200604000-00003; Kyngas HA, 2000, J ADOLESCENT HEALTH, V26, P379, DOI 10.1016/S1054-139X(99)00042-7; LAGRECA AM, 1995, J PEDIATR PSYCHOL, V20, P449, DOI 10.1093/jpepsy/20.4.449; Lindvall K, 2006, HAEMOPHILIA, V12, P47, DOI 10.1111/j.1365-2516.2006.01192.x; Llewellyn CD, 2003, PSYCHOL HEALTH, V18, P185, DOI 10.1080/0887044031000098198; Manco-Johnson MJ, 2007, NEW ENGL J MED, V357, P535, DOI 10.1056/NEJMoa067659; Miners A, 2009, HAEMOPHILIA, V15, P881, DOI 10.1111/j.1365-2516.2009.02019.x; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Petrini P, 2007, HAEMOPHILIA, V13, P16, DOI 10.1111/j.1365-2516.2007.01501.x; Petrini P, 2009, HAEMOPHILIA, V15, P15, DOI 10.1111/j.1365-2516.2008.01948.x; Rice Leissinger, 2007, HAEMOPHILIA OFFICIAL, V13, P493, DOI [10.1111/j.1365-2516.2007.01526.x, DOI 10.1111/J.1365-2516.2007.01526.X]; Richards M, 2010, BRIT J HAEMATOL, V149, P498, DOI 10.1111/j.1365-2141.2010.08139.x; Santagostino E, 2010, J THROMB HAEMOST, V8, P737, DOI 10.1111/j.1538-7836.2010.03767.x; SCHAFER LC, 1986, DIABETES CARE, V9, P179, DOI 10.2337/diacare.9.2.179; Schrijvers LH, 2013, HAEMOPHILIA, V19, P355, DOI 10.1111/hae.12079; Skinner TC, 2000, J PEDIATR PSYCHOL, V25, P257, DOI 10.1093/jpepsy/25.4.257; Snell C, 2014, PEDIATR PULM, V49, P1177, DOI 10.1002/ppul.22990; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Weinman J, 1996, PSYCHOL HEALTH, V11, P431, DOI 10.1080/08870449608400270; Wileman V, 2014, ANN BEHAV MED, P1	41	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0169880	10.1371/journal.pone.0169880	http://dx.doi.org/10.1371/journal.pone.0169880			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI3HP	28103266	Green Published, Green Submitted, gold			2022-12-26	WOS:000392381100026
J	Adan, A; Capella, MD; Prat, G; Forero, DA; Lopez-Vera, S; Navarro, JF				Adan, Ana; del Mar Capella, Maria; Prat, Gemma; Forero, Diego A.; Lopez-Vera, Silvia; Francisco Navarro, Jose			Executive Functioning in Men with Schizophrenia and Substance Use Disorders. Influence of Lifetime Suicide Attempts	PLOS ONE			English	Article							RISK-FACTORS; FOLLOW-UP; DUAL DIAGNOSIS; PEOPLE; SYMPTOMS; BEHAVIOR; POPULATION; DEPENDENCE; COGNITION; DEFICITS	Background Lifetime suicide attempts in patients with comorbidity between psychotic disorders and Substance Use Disorder (SUD), known as dual diagnosis, was associated with a worse clinical and cognitive state, poor prognosis and premature death. However, to date no previous study has examined the cognitive performance of these patients considering as independent the presence or absence of lifetime suicide attempts. Methods We explore executive functioning differences between suicide attempters and non-attempters in dual schizophrenia (DS) patients and the possible related factors for both executive performance and current suicide risk. Fifty DS male patients in remission of SUD and clinically stables, 24 with and 26 without lifetime suicide attempts, were evaluated. We considered Z scores for all neuropsychological tests and a composite summary score for both premorbid IQ and executive functioning. Results DS patients showed low performance in set-shifting, planning and problem solving tasks. Those with suicide attempts presented lower composite summary scores, together with worse problem solving skills and decision-making, compared with non-attempters. However, after controlling for alcohol dependence, only differences in decision-making remained. Executive functioning was related to the premorbid intelligence quotient, and several clinical variables (duration, severity, months of abstinence and relapses of SUD, global functioning and negative symptoms). A relationship between current suicide risk, and first-degree relatives with SUD, insight and positive symptoms was also found. Conclusions Our results suggest that problem solving and, especially, decision-making tasks might be sensitive to cognitive impairment of DS patients related to presence of lifetime suicide attempts. The assessment of these executive functions and cognitive remediation therapy when necessary could be beneficial for the effectiveness of treatment in patients with DS. However, further research is needed to expand our findings and overcome some limitations of this study.	[Adan, Ana; del Mar Capella, Maria; Prat, Gemma; Lopez-Vera, Silvia] Univ Barcelona, Fac Psychol, Dept Clin Psychol & Psychobiol, Barcelona, Spain; [Adan, Ana] Univ Barcelona, Inst Neurosci, Barcelona, Spain; [Forero, Diego A.] Univ Antonio Narino, Lab NeuroPsychiat Genet, Biomed Sci Res Grp, Sch Med, Bogota, Colombia; [Francisco Navarro, Jose] Univ Malaga, Sch Psychol, Dept Psychobiol, Malaga, Spain	University of Barcelona; University of Barcelona; Universidad Antonio Narino; Universidad de Malaga	Adan, A (corresponding author), Univ Barcelona, Fac Psychol, Dept Clin Psychol & Psychobiol, Barcelona, Spain.; Adan, A (corresponding author), Univ Barcelona, Inst Neurosci, Barcelona, Spain.	aadan@ub.edu	NAVARRO, JOSE FRANCISCO/GPX-0203-2022; Forero, Diego A./O-9981-2019; NAVARRO, JOSE FRANCISCO/AGW-3024-2022; NAVARRO, JOSE FRANCISCO/B-3351-2011; Adan, Ana/B-3643-2011; Forero, Diego/GPX-2849-2022; Prat, Gemma/AAA-6915-2019; Prat, Gemma/GVD-7932-2022	Forero, Diego A./0000-0001-9175-3363; NAVARRO, JOSE FRANCISCO/0000-0002-5104-8974; NAVARRO, JOSE FRANCISCO/0000-0002-5104-8974; Adan, Ana/0000-0002-3328-3452; Forero, Diego/0000-0001-9175-3363; Prat, Gemma/0000-0002-9263-8620; 	Spanish Ministry of Economy and Competitiveness (MINECO/FEDER/UE) [PSI2012-32669, PSI2015-65026]; University of Barcelona (APIF)	Spanish Ministry of Economy and Competitiveness (MINECO/FEDER/UE); University of Barcelona (APIF)	This research was supported by grants from the Spanish Ministry of Economy and Competitiveness, PSI2012-32669 and PSI2015-65026 (MINECO/FEDER/UE), and by the University of Barcelona (APIF-2011; Researcher Training Program grant to SLV). These institutions had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Altamura AC, 2003, SCHIZOPHR RES, V60, P47, DOI 10.1016/S0920-9964(02)00164-0; Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; [Anonymous], 2010, DIAGN STAT MAN MENT; Barrett EA, 2011, COMPR PSYCHIAT, V52, P156, DOI 10.1016/j.comppsych.2010.06.001; Barrett EA, 2010, SCHIZOPHR RES, V119, P11, DOI 10.1016/j.schres.2010.03.022; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A., 2007, IOWA GAMBLING TASK P; Benaiges I, 2013, HUM PSYCHOPHARM CLIN, V28, P29, DOI 10.1002/hup.2279; Benaiges I, 2013, PROG NEURO-PSYCHOPH, V40, P298, DOI 10.1016/j.pnpbp.2012.10.016; Bennett ME, 2009, ADDICT BEHAV, V34, P806, DOI 10.1016/j.addbeh.2009.03.023; Bobes J, 1999, ACTAS ESP PSIQUIATRI, V27, P71; Bolton C, 2007, CLIN PSYCHOL REV, V27, P511, DOI 10.1016/j.cpr.2006.12.001; Busner Joan, 2007, Psychiatry (Edgmont), V4, P28; Conde V., 1975, REV PSIQUIATRIA PSIC, V12, P217; Conner KR, 2009, J ABNORM PSYCHOL, V118, P235, DOI 10.1037/a0014659; De Hert M, 2001, SCHIZOPHR RES, V47, P127, DOI 10.1016/S0920-9964(00)00003-7; De Witte NAJ, 2014, EUR ADDICT RES, V20, P105, DOI 10.1159/000355267; Duijkers JCLM, 2016, FRONT PSYCHOL, V7, DOI [10.3389/fpsyg.2016.00979, 10.3389/fpayg.2016.00979]; Dvorak RD, 2013, J AFFECT DISORDERS, V149, P326, DOI 10.1016/j.jad.2013.01.046; First MB, 2002, STRUCTURED CLIN INTE; Flores JC, 2014, BANFE 2 BATER NEUROP; Goudriaan AE, 2007, ALCOHOL CLIN EXP RES, V31, P928, DOI 10.1111/j.1530-0277.2007.00378.x; Green MF, 2004, SCHIZOPHR RES, V72, P41, DOI 10.1016/j.schres.2004.09.009; Gregg L, 2009, MENTAL HLTH SUBSTANC, V2, P24, DOI DOI 10.1080/17523280802593293; Gregg L, 2007, CLIN PSYCHOL REV, V27, P494, DOI 10.1016/j.cpr.2006.09.004; HALL RCW, 1995, PSYCHOSOMATICS, V36, P267, DOI 10.1016/S0033-3182(95)71666-8; Harvey PD, 2012, WORLD PSYCHIATRY, V11, P73, DOI 10.1016/j.wpsyc.2012.05.004; Hawton K, 2005, BRIT J PSYCHIAT, V187, P9, DOI 10.1192/bjp.187.1.9; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Heaton R. K., 2009, TEST CLASIFICACION T; Hor K, 2010, J PSYCHOPHARMACOL, V24, P81, DOI 10.1177/1359786810385490; Horsfall J, 2009, HARVARD REV PSYCHIAT, V17, P24, DOI 10.1080/10673220902724599; Kim CH, 2003, SCHIZOPHR RES, V60, P71, DOI 10.1016/S0920-9964(02)00310-9; Korner N, 2015, SUBST ABUSE TREAT PR, V10, DOI 10.1186/s13011-015-0020-7; Lopez-Morinigo JD, 2012, COMPR PSYCHIAT, V53, P313, DOI 10.1016/j.comppsych.2011.05.015; Lysaker PH, 2013, SCHIZOPHR RES, V148, P18, DOI 10.1016/j.schres.2013.05.025; Meltzer HY, 2001, ANN NY ACAD SCI, V932, P44, DOI 10.1111/j.1749-6632.2001.tb05797.x; Mohamed S, 2006, INT J GERIATR PSYCH, V21, P711, DOI 10.1002/gps.1528; Nangle JM, 2006, SCHIZOPHR RES, V85, P196, DOI 10.1016/j.schres.2006.03.035; Nock MK, 2008, BRIT J PSYCHIAT, V192, P98, DOI 10.1192/bjp.bp.107.040113; Pena-Casanova J, 2009, ARCH CLIN NEUROPSYCH, V24, P321, DOI 10.1093/arclin/acp038; Peralta Martin V, 1994, Actas Luso Esp Neurol Psiquiatr Cienc Afines, V22, P171; Perez-Galvez B., 2010, HLTH ADDICTIONS, V10, P35, DOI [DOI 10.21134/HAAJ.V10I1.35, 10.21134/haaj.v10i1.35]; PLUTCHIK R, 1989, COMPR PSYCHIAT, V30, P296, DOI 10.1016/0010-440X(89)90053-9; Popovic D, 2014, ACTA PSYCHIAT SCAND, V130, P418, DOI 10.1111/acps.12332; Potkin SG, 2003, SCHIZOPHR RES, V59, P59, DOI 10.1016/S0920-9964(02)00159-7; Robinson J, 2010, SCHIZOPHR RES, V116, P1, DOI 10.1016/j.schres.2009.10.009; Rubio G., 1998, ARCH NEUROBIOL, V61, P143; Schmidt LM, 2011, SCHIZOPHR RES, V130, P228, DOI 10.1016/j.schres.2011.04.011; Strauss E, 2006, COMPENDIUM NEUROPSYC; Suokas JT, 2010, SCHIZOPHR RES, V124, P22, DOI 10.1016/j.schres.2010.09.009; Tamayo F, 2012, NEUROLOGIA, V27, P319, DOI 10.1016/j.nrl.2011.12.020; Tarrier N, 2007, BEHAV RES THER, V45, P2090, DOI 10.1016/j.brat.2007.03.007; Thoma P, 2013, PSYCHIAT CLIN NEUROS, V67, P367, DOI 10.1111/pcn.12072; Wechsler D., 2001, ESCALA INTELIGENCIA; Xie HY, 2005, PSYCHIAT SERV, V56, P1282, DOI 10.1176/appi.ps.56.10.1282; Zoghbi AW, 2014, PSYCHIAT RES, V220, P188, DOI 10.1016/j.psychres.2014.07.046	57	27	30	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0169943	10.1371/journal.pone.0169943	http://dx.doi.org/10.1371/journal.pone.0169943			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI3HH	28099526	Green Submitted, gold, Green Published			2022-12-26	WOS:000392380100043
J	Fukuoka, CY; Simoes, A; Uchiyama, T; Arana-Chavez, VE; Abiko, Y; Kuboyama, N; Bhawal, UK				Fukuoka, Cintia Yuki; Simoes, Alyne; Uchiyama, Toshikazu; Arana-Chavez, Victor Elias; Abiko, Yoshimitsu; Kuboyama, Noboru; Bhawal, Ujjal K.			The Effects of Low-Power Laser Irradiation on Inflammation and Apoptosis in Submandibular Glands of Diabetes-Induced Rats	PLOS ONE			English	Article							FACTOR-KAPPA-B; GLYCATION END-PRODUCTS; NUCLEAR-FACTOR; CHROMATIN PROTEIN; OXIDATIVE-STRESS; ACTIVATION; RECEPTOR; CELLS; HMGB1; RAGE	Diabetes can lead to dysfunction of the secretory capacity in salivary glands. Activation of the receptor for advanced glycation end products (RAGE) and its ligands has been suggested to participate in chronic disorders such as diabetes and its complications. In this study, the expression of RAGE, high mobility group box 1 (HMGB1) and advanced glycation end products (AGE), as well as the effects of low-power laser irradiation (LPLI) in salivary glands of diabetic rats were evaluated, and the mechanisms involved were characterized. The expression of RAGE and HMGB1 at the protein and mRNA levels was observed in sub mandibular glands (SMGs) of streptozotocin-induced diabetic rats. A diode laser was applied at 660 nm, 70 mW, 20 J/cm(2), 0.56 J/point, with a spot area of 0.028 cm(2) and its in vivo effects and the pathways involved were evaluated. lmmunohistochemistry and western blotting analysis were performed for inflammatory and apoptosis markers. Diabetes up-regulates HMGB1/AGE/RAGE axis gene expression in SMGs that is associated with activation of the nuclear factor kappa B (NF-kappa B) pathway. Interestingly, LPLI suppresses NF-kappa B activation induced by inflammation. LPLI also reduces diabetes-induced apoptosis. That effect was accompanied by decreased levels of Bax, and cleaved caspase 3, which were up-regulated in diabetes. Taken together, our data suggest that LPLI reduces diabetes-induced inflammation by reducing the induction of HMGB1, ultimately leading to inhibition of apoptosis in submandibular glands of diabetic rats.	[Fukuoka, Cintia Yuki; Simoes, Alyne; Arana-Chavez, Victor Elias] Univ Sao Paulo, Sch Dent, Dept Biomaterials & Oral Biol, Sao Paulo, Brazil; [Uchiyama, Toshikazu] Nihon Univ, Sch Dent Matsudo, Dept Social Dent Med Informat, Matsudo, Chiba, Japan; [Abiko, Yoshimitsu; Bhawal, Ujjal K.] Nihon Univ, Sch Dent Matsudo, Dept Biochem & Mol Biol, Matsudo, Chiba, Japan; [Kuboyama, Noboru] Nihon Univ, Sch Dent Matsudo, Res Inst Oral Sci, Matsudo, Chiba, Japan	Universidade de Sao Paulo; Nihon University; Nihon University; Nihon University	Simoes, A (corresponding author), Univ Sao Paulo, Sch Dent, Dept Biomaterials & Oral Biol, Sao Paulo, Brazil.; Bhawal, UK (corresponding author), Nihon Univ, Sch Dent Matsudo, Dept Biochem & Mol Biol, Matsudo, Chiba, Japan.	lysimoes@usp.br; bhawal.ujjal.kumar@nihon-u.ac.jp	Simoes, Alyne/G-2176-2012	Simoes, Alyne/0000-0002-4873-1393; Fukuoka, Cintia Yuki/0000-0001-6140-3549	Brazilian Federal Agency for Support and Evaluation of Graduate Education CAPES [BEX 18807/12-7]; FAPESP [2014/21214-1]; Ministry of Education, Culture, Sports, Science and Technology, Japan [25462970]	Brazilian Federal Agency for Support and Evaluation of Graduate Education CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors wish to express their gratitude to Dr. Mino Okubo for her help and contributions to this study. They also thank the Brazilian Federal Agency for Support and Evaluation of Graduate Education CAPES, scholarship process BEX 18807/12-7, and FAPESP, Grant #2014/21214-1 for financial support. This research was partially supported by the Grant-in-Aid (25462970) for Scientific Research of Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves M, 2005, DIABETOLOGIA, V48, P2675, DOI 10.1007/s00125-005-0010-9; Bhan Surya, 2013, ISRN Dermatol, V2013, P739054, DOI 10.1155/2013/739054; Bierhaus A, 2001, DIABETES, V50, P2792, DOI 10.2337/diabetes.50.12.2792; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Fukuoka CY, 2016, J BIOPHOTONICS; Gao XJ, 2006, J CELL PHYSIOL, V206, P441, DOI 10.1002/jcp.20484; Gao XJ, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-4; Hofmann MA, 1998, DIABETES CARE, V21, P1310, DOI 10.2337/diacare.21.8.1310; Hofmann MA, 1999, DIABETOLOGIA, V42, P222, DOI 10.1007/s001250051142; Ibuki FK, 2013, LASER MED SCI, V28, P911, DOI 10.1007/s10103-012-1173-5; Javed F, 2007, J PERIODONTOL, V78, P2112, DOI 10.1902/jop.2007.070186; Juras DV, 2010, COLLEGIUM ANTROPOL, V34, P1039; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Li XX, 2002, EXP HEMATOL, V30, P285, DOI 10.1016/S0301-472X(02)00777-4; Lin B P, 1999, Spec Care Dentist, V19, P8, DOI 10.1111/j.1754-4505.1999.tb01361.x; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Manigrasso MB, 2013, TRENDS ENDOCRINOL ME; McCann FJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0049894, 10.1371/journal.pone.0052013]; Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337; Pamukcu B, 2011, THROMB RES, V128, P117, DOI 10.1016/j.thromres.2011.03.025; Patino Marin Nuria, 2008, Acta Odontol Latinoam, V21, P127; Pavlic Verica, 2012, Med Pregl, V65, P247; Ramirez E, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-172; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Shefer G, 2001, J CELL PHYSIOL, V187, P73, DOI 10.1002/1097-4652(2001)9999:9999<::AID-JCP1053>3.0.CO;2-9; Simoes A, 2008, CLIN ORAL INVEST, V12, P25, DOI 10.1007/s00784-007-0135-y; Simoes A, 2010, PHOTOMED LASER SURG, V28, P357, DOI 10.1089/pho.2009.2486; Simoes A, 2009, SPEC CARE DENT, V29, P134, DOI 10.1111/j.1754-4505.2009.00078.x; Simoes A, 2009, LASER MED SCI, V24, P591, DOI 10.1007/s10103-008-0619-2; Siudikiene J, 2008, CARIES RES, V42, P354, DOI 10.1159/000151582; Tanaka N, 2000, J BIOL CHEM, V275, P25781, DOI 10.1074/jbc.M001235200; VLASSARA H, 1994, LAB INVEST, V70, P138; Wang JL, 2011, MOL MED, V17, P172, DOI 10.2119/molmed.2010.00114; Ward DT, 2001, J AM SOC NEPHROL, V12, P779, DOI 10.1681/ASN.V124779; Weinberg E, 2013, J MOL ENDOCRINOL; Yan SF, 2009, J MOL MED, V87, P235, DOI 10.1007/s00109-009-0439-2; Yan XX, 2009, ATHEROSCLEROSIS, V205, P544, DOI 10.1016/j.atherosclerosis.2008.12.016; Yao DC, 2010, DIABETES, V59, P249, DOI 10.2337/db09-0801; Zhang L, 2011, LASER MED SCI, V26, P707, DOI 10.1007/s10103-011-0917-y; Zong H, 2010, DIABETOLOGIA, V53, P2656, DOI 10.1007/s00125-010-1900-z	42	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0169443	10.1371/journal.pone.0169443	http://dx.doi.org/10.1371/journal.pone.0169443			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099448	Green Published, Green Submitted, gold			2022-12-26	WOS:000392380100021
J	Hazra, J; Mukherjee, P; Ali, A; Poddar, S; Pal, M				Hazra, Joyita; Mukherjee, Pooja; Ali, Asif; Poddar, Soumita; Pal, Mahadeb			Engagement of Components of DNA-Break Repair Complex and NF kappa B in H5p70A1A Transcription Upregulation by Heat Shock	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; TOPOISOMERASE-II-BETA; RNA-POLYMERASE-II; POLY(ADP-RIBOSE) POLYMERASE; CELL-LINES; CATALYTIC SUBUNIT; KU AUTOANTIGEN; HSP70; ACTIVATION; STRESS	An involvement of components of DNA-break repair (DBR) complex including DNA-dependent protein kinase (DNA-PK) and poly-ADP-ribose polymerase 1 (PARP-1) in transcription regulation in response to distinct cellular signalling has been revealed by different laboratories. Here, we explored the involvement of DNA-PK and PARP-1 in the heat shock induced transcription of Hsp70A1A. We find that inhibition of both the catalytic subunit of DNA-PK (DNA-PKc), and Ku70, a regulatory subunit of DNA-PK holo-enzyme compromises transcription of Hsp70A1A under heat shock treatment. In immunoprecipitation based experiments we find that Ku70 or DNA-PK holoenzyme associates with NF kappa B. This NF kappa B associated complex also carries PARP-1. Downregulation of both NF kappa B and PARP-1 compromises Hsp70A1A transcription induced by heat shock treatment. Alteration of three bases by site directed mutagenesis within the consensus kappa B sequence motif identified on the promoter affected inducibility of Hsp70A1A transcription by heat shock treatment. These results suggest that NF kappa B engaged with the kappa B motif on the promoter cooperates in Hsp70A1A activation under heat shock in human cells as part of a DBR complex including DNA-PK and PARP-1.	[Hazra, Joyita; Mukherjee, Pooja; Ali, Asif; Pal, Mahadeb] Bose Inst, Div Mol Med, CIT Scheme VIIM, P1-12, Kolkata, India; [Poddar, Soumita] Bose Inst, Bioinformat Ctr, CIT Scheme VIIM, P1-12, Kolkata, India	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute	Pal, M (corresponding author), Bose Inst, Div Mol Med, CIT Scheme VIIM, P1-12, Kolkata, India.	palmahadeb@gmail.com		Mukherjee, Pooja/0000-0002-3875-6271	Department of Biotechnology (DBT), Ministry of Science and Technology [BT/PR3286/BRB/10/973/2011]; Science and Engineering Research Board (DST), Ministry of Science and Technology [SR/SO/BB-0141/2012]; Bose Institute, Government of India	Department of Biotechnology (DBT), Ministry of Science and Technology(Department of Biotechnology (DBT) India); Science and Engineering Research Board (DST), Ministry of Science and Technology; Bose Institute, Government of India(Department of Science & Technology (India))	The work presented in the paper was funded by Department of Biotechnology (DBT), sanction no. BT/PR3286/BRB/10/973/2011, and Science and Engineering Research Board (DST), sanction no. SR/SO/BB-0141/2012, dated 10.07.2013, Ministry of Science and Technology, and core funding from Bose Institute, Government of India, which were just sufficient to complete the study.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Ammirante M, 2008, ONCOGENE, V27, P1175, DOI 10.1038/sj.onc.1210716; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Austin CA, 1998, BIOESSAYS, V20, P215, DOI 10.1002/(SICI)1521-1878(199803)20:3<215::AID-BIES5>3.0.CO;2-Q; Basu S, 1998, BIOCHEM BIOPH RES CO, V247, P79, DOI 10.1006/bbrc.1998.8741; Bonini NM, 2002, P NATL ACAD SCI USA, V99, P16407, DOI 10.1073/pnas.152330499; Bunch H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10191; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; DVIR A, 1992, P NATL ACAD SCI USA, V89, P11920, DOI 10.1073/pnas.89.24.11920; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Galande S, 1999, J BIOL CHEM, V274, P20521, DOI 10.1074/jbc.274.29.20521; GREENE JM, 1987, MOL CELL BIOL, V7, P3646, DOI 10.1128/MCB.7.10.3646; Haffner MC, 2010, NAT GENET, V42, P668, DOI 10.1038/ng.613; Haince JF, 2006, SCIENCE, V312, P1752, DOI 10.1126/science.1129808; Hassa PO, 2005, J BIOL CHEM, V280, P40450, DOI 10.1074/jbc.M507553200; Hassa PO, 1999, BIOL CHEM, V380, P953, DOI 10.1515/BC.1999.118; Hassa PO, 2001, J BIOL CHEM, V276, P45588, DOI 10.1074/jbc.M106528200; Huang JR, 1997, J BIOL CHEM, V272, P26009, DOI 10.1074/jbc.272.41.26009; HUNT C, 1990, GENE, V87, P199, DOI 10.1016/0378-1119(90)90302-8; Hwang JH, 2005, PANCREAS, V31, P332, DOI 10.1097/01.mpa.0000183377.04295.c3; Jaattela M, 1999, ANN MED, V31, P261, DOI 10.3109/07853899908995889; Jaattela M, 1998, EMBO J, V17, P6124, DOI 10.1093/emboj/17.21.6124; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Ju JH, 2010, J BIOL CHEM, V285, P41152, DOI 10.1074/jbc.M110.158352; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Komarov AP, 2008, P NATL ACAD SCI USA, V105, P14453, DOI 10.1073/pnas.0807549105; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Kretz-Remy C, 2001, J BIOL CHEM, V276, P43723, DOI 10.1074/jbc.M010821200; Kwon SB, 2002, J DERMATOL SCI, V28, P144, DOI 10.1016/S0923-1811(01)00156-6; Lee SH, 2001, STROKE, V32, P2905, DOI 10.1161/hs1201.099604; Lis JT, 2006, CELL, V125, P1225, DOI 10.1016/j.cell.2006.06.016; Liu L, 1998, MOL CELL BIOL, V18, P4221, DOI 10.1128/MCB.18.7.4221; Liu YN, 2015, SCI REP-UK, V5, DOI 10.1038/srep13547; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; MILNER CM, 1990, IMMUNOGENETICS, V32, P242; Neznanov N, 2009, CELL CYCLE, V8, P3960, DOI 10.4161/cc.8.23.10179; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Nivon M, 2012, J CELL SCI, V125, P1141, DOI 10.1242/jcs.091041; Nylandsted J, 2000, ANN NY ACAD SCI, V926, P122; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Pal S, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-23; Panta GR, 2004, MOL CELL BIOL, V24, P1823, DOI 10.1128/MCB.24.5.1823-1835.2004; PETERSON SR, 1995, J BIOL CHEM, V270, P1449, DOI 10.1074/jbc.270.3.1449; Petesch SJ, 2012, MOL CELL, V45, P64, DOI 10.1016/j.molcel.2011.11.015; Radons J, 2016, CELL STRESS CHAPERON, V21, P379, DOI 10.1007/s12192-016-0676-6; Sasi BK, 2014, J MOL BIOL, V426, P116, DOI 10.1016/j.jmb.2013.09.008; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Shim EH, 2002, EMBO REP, V3, P857, DOI 10.1093/embo-reports/kvf175; Tranter M, 2010, J MOL CELL CARDIOL, V49, P664, DOI 10.1016/j.yjmcc.2010.07.001; Trucco C, 1998, NUCLEIC ACIDS RES, V26, P2644, DOI 10.1093/nar/26.11.2644; Wang VYF, 2012, CELL REP, V2, P824, DOI 10.1016/j.celrep.2012.08.042; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Williamson LM, 2011, CARCINOGENESIS, V32, P279, DOI 10.1093/carcin/bgq255; Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040; WU B, 1985, MOL CELL BIOL, V5, P330, DOI 10.1128/MCB.5.2.330; Xia YF, 2004, J IMMUNOL, V173, P4207, DOI 10.4049/jimmunol.173.6.4207	61	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0168165	10.1371/journal.pone.0168165	http://dx.doi.org/10.1371/journal.pone.0168165			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099440	gold, Green Published, Green Submitted			2022-12-26	WOS:000392380100007
J	Lieber, M				Lieber, Mark			Assessing the Mental Health Impact of the 2011 Great Japan Earthquake, Tsunami, and Radiation Disaster on Elementary and Middle School Children in the Fukushima Prefecture of Japan	PLOS ONE			English	Article							REFUGEE CHILDREN; DISORDER; SDQ	Background On March 11, 2011, a magnitude 9.0 earthquake occurred off of Japan's Pacific coast, which was followed by huge tsunamis that destroyed many coastal cities in the area. Due to the earthquake and subsequent tsunami, malfunctions occurred at the Fukushima Daiichi (Fukushima I) nuclear power plant, resulting in the release of radioactive material in the region. While recent studies have investigated the effects of these events on the mental health of adults in the region, no studies have yet been performed investigating similar effects among children. Methods and Findings This study aims to fill that gap by: 1) assessing the mental health of elementary and middle school children living within the Fukushima prefecture of Japan, and 2) identifying risk and protective factors that are associated with the children's mental health scores. These factors were quantified using an original demographics survey, the Strengths and Difficulties Questionnaire (SDQ), and the Impact of Event Scale Revised (IES-R), the latter two of which have been previously validated in a Japanese setting. The surveys were distributed to approximately 3,650 elementary and middle school students during the months of February and March, 2012. The data suggests that those children who had been relocated to the city of Koriyama had significantly higher SDQ scores than those children who were native to Koriyama (p < .05) as well as a control group that lived outside of the Fukushima prefecture (p < .01). Using a multivariate regression, we also found that younger age and parental trauma were significantly correlated with higher SDQ scores (p < .001), while gender, displacement from one's home, and exposure to violence were not. Conclusions These results suggest that, among children affected by natural disasters, younger children and those with parents suffering from trauma-related distress are particularly vulnerable to the onset of pediatric mental disturbances.	[Lieber, Mark] Univ Calif Irvine, Sch Med, Irvine, CA 92717 USA	University of California System; University of California Irvine	Lieber, M (corresponding author), Univ Calif Irvine, Sch Med, Irvine, CA 92717 USA.	mlieber@uci.edu			University of California-San Francisco Masters Program in Global Health Sciences	University of California-San Francisco Masters Program in Global Health Sciences	This project was supported by the University of California-San Francisco Masters Program in Global Health Sciences. I would like to thank Dr. John Takayama for his support in managing the project, Dr. Aimee Sato for her support in data collection, Dr. John Ziegler for his constructive comments and feedback, and Dr. Susan Meffert for her mentorship and expertise.	[Anonymous], 2011, MAGN 8 9 NEAR E COAS, V11; [Anonymous], 2011, MAGN 8 9 NEAR E COAS, V11; Baruch Y, 1999, HUM RELAT, V52, P421, DOI 10.1023/A:1016905407491; Eckert P., 2011, REUTERS; Fazel M, 2012, LANCET, V379, P266, DOI 10.1016/S0140-6736(11)60051-2; Gavranidou M, 2003, DEPRESS ANXIETY, V17, P130, DOI 10.1002/da.10103; Gillies Donna, 2013, Evid Based Child Health, V8, P1004, DOI 10.1002/ebch.1916; Goodman A, 2011, J CHILD PSYCHOL PSYC, V52, P100, DOI 10.1111/j.1469-7610.2010.02278.x; Goodman R., 2005, MENTAL HLTH CHILDREN; Graham E, 2011, J MARRIAGE FAM, V73, P763, DOI 10.1111/j.1741-3737.2011.00844.x; HJERN A, 1991, CHILD ABUSE NEGLECT, V15, P239, DOI 10.1016/0145-2134(91)90068-O; Ishizuka H, 2011, THE ASAHI SHIMBUN; Kalantari M, 2010, INT J SOC PSYCHIATR, V56, P158, DOI 10.1177/0020764008101854; Kocijan-Hercigonja D, 1998, NORD J PSYCHIAT, V52, P45, DOI 10.1080/080394898422562; Kondo S, 2011, PSYCHIAT CLIN NEUROS, V65, P226, DOI 10.1111/j.1440-1819.2011.02202.x; Levin A., 2012, PSYCHIAT NEWS, V47; Levin A., 2012, PSYCHIAT NEWS; Matsuishi T, 2008, BRAIN DEV-JPN, V30, P410, DOI 10.1016/j.braindev.2007.12.003; McCurdy C., 2011, J FOREIGN RELATIONS, V8; McLaughlin KA, 2010, J AM ACAD CHILD PSY, V49, P990, DOI 10.1016/j.jaac.2010.06.012; Norris J., 2011, UCSF EXPERTS AIM PRO; Powell S, 2006, J HUMAN SCI, V1; Pyari T T, 2012, Indian J Psychiatry, V54, P48, DOI 10.4103/0019-5545.94645; Salcioglu E, 2007, DISASTERS, V31, P115, DOI 10.1111/j.1467-7717.2007.01000.x; Setoya U, JAPANESE MENTAL HLTH; Smith AM, 2011, ASIA PACIFIC J; Weiss D. S., 2007, ASSESSING PSYCHOL TR, P219, DOI [10.1007/978-0-387-70990-1_10, DOI 10.1007/978-0-387-70990-1_10]; Zhang YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022371	28	16	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170402	10.1371/journal.pone.0170402	http://dx.doi.org/10.1371/journal.pone.0170402			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI3HH	28099497	gold, Green Submitted, Green Published			2022-12-26	WOS:000392380100086
J	Nessler, JA; Heredia, S; Belair, J; Milton, J				Nessler, Jeff A.; Heredia, Severne; Belair, Jacques; Milton, John			Walking on a Vertically Oscillating Treadmill: Phase Synchronization and Gait Kinematics	PLOS ONE			English	Article							RHYTHMIC AUDITORY-STIMULATION; DYNAMICS; STROKE; COORDINATION; LOCKING; SPEED	Sensory motor synchronization can be used to alter gait behavior. This type of therapy may be useful in a rehabilitative setting, though several questions remain regarding the most effective way to promote and sustain synchronization. The purpose of this study was to describe a new technique for using synchronization to influence a person's gait and to compare walking behavior under this paradigm with that of side by side walking. Thirty one subjects walked on a motorized treadmill that was placed on a platform that oscillated vertically at various frequencies and amplitudes. Synchronization with the platform and stride kinematics were recorded during these walking trials and compared with previously reported data from side by side walking. The results indicated that vertical oscillation of the treadmill surface at frequencies that matched subjects preferred stride or step frequency resulted in greater unintentional synchronization when compared with side by side walking data (up to 78.6+/-8.3% of the trial vs 59.2+/-17.4%). While intermittent phase locking was observed in all cases, periods of synchronization occurred more frequently and lasted longer while walking on the oscillating treadmill (mean length of periods of phase locking 11.85 steps vs 5.18 steps). Further, stride length, height and duration were altered by changing the frequency of treadmill oscillation. These results suggest that synchronization to a haptic signal may hold implications for use in a clinical setting.	[Nessler, Jeff A.; Heredia, Severne] Calif State Univ, Dept Kinesiol, San Marcos, CA 92096 USA; [Belair, Jacques] Univ Montreal, Dept Math & Stat, Quebec City, PQ, Canada; [Milton, John] Claremont Coll, WM Keck Sci Ctr, Claremont, CA USA	California State University System; California State University San Marcos; Universite de Montreal; Claremont Colleges; Claremont Graduate School	Nessler, JA (corresponding author), Calif State Univ, Dept Kinesiol, San Marcos, CA 92096 USA.	jnessler@csusm.edu		Nessler, Jeff/0000-0002-1734-6898	NIH General Medical Sciences [SC3GM096900]; William R Kenan Charitable Trust; Natural Sciences and Engineering Council of Canada; Fonds de recherche Nature et technologies Quebec; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM096900] Funding Source: NIH RePORTER	NIH General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); William R Kenan Charitable Trust; Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de recherche Nature et technologies Quebec; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JN was supported by NIH General Medical Sciences grant number: SC3GM096900. JM was supported by the William R Kenan Charitable Trust (http://www.kenanchantabletrust.org/). JB was supported by the Natural Sciences and Engineering Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) and Fonds de recherche Nature et technologies Quebec (http://www.frqnt.gouv.gc.ca/en/bourses-et-subventions). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAVAGNA GA, 1977, J PHYSIOL-LONDON, V268, P467, DOI 10.1113/jphysiol.1977.sp011866; Censi F, 2000, MED BIOL ENG COMPUT, V38, P416, DOI 10.1007/BF02345011; Cha Y, 2014, J PHYS THER SCI, V26, P479, DOI 10.1589/jpts.26.479; DALLARD P., 2001, J BRIDGE ENG, V6, P412, DOI [10.1061/(ASCE)1084-0702(2001)6:6(412), DOI 10.1061/(ASCE)1084-0702(2001)6:6(412)]; Ford MP, 2010, ARCH PHYS MED REHAB, V91, P1255, DOI 10.1016/j.apmr.2010.04.012; Glass L., 1988, CLOCKS CHAOS RHYTHMS; Gordon KE, 2009, ARCH PHYS MED REHAB, V90, P136, DOI 10.1016/j.apmr.2008.07.014; Hausdorff JM, 2007, EUR J NEUROSCI, V26, P2369, DOI 10.1111/j.1460-9568.2007.05810.x; Hausdorff JM, 1996, J APPL PHYSIOL, V80, P1448, DOI 10.1152/jappl.1996.80.5.1448; Hayden R, 2009, INT J NEUROSCI, V119, P2183, DOI 10.3109/00207450903152609; Hurt CP, 1998, J MUSIC THER, V35, P228, DOI 10.1093/jmt/35.4.228; Jonker LB, 1990, COMMUNICATIONS MATH, V129, P125; KNIGHT BW, 1972, J GEN PHYSIOL, V59, P734, DOI 10.1085/jgp.59.6.734; MACKEY MC, 1990, J MATH BIOL, V28, P33, DOI 10.1007/BF00171517; MATSUMOTO G, 1987, PHYS LETT A, V123, P162, DOI 10.1016/0375-9601(87)90696-7; Milton J., 2014, MATH LAB TOOL DYNAMI; Nessler JA, 2016, GAIT POSTURE, V43, P187, DOI 10.1016/j.gaitpost.2015.09.021; Nessler JA, 2013, ANN BIOMED ENG, V41, P1680, DOI 10.1007/s10439-012-0657-6; Nessler JA, 2011, J APPL BIOMECH, V27, P322, DOI 10.1123/jab.27.4.322; Nessler JA, 2011, MOTOR CONTROL, V15, P390, DOI 10.1123/mcj.15.3.390; Nessler JA, 2010, GAIT POSTURE, V31, P527, DOI 10.1016/j.gaitpost.2010.01.013; Nessler JA, 2009, HUM MOVEMENT SCI, V28, P772, DOI 10.1016/j.humov.2009.04.007; Nessler JA, 2009, CHAOS, V19, DOI 10.1063/1.3125762; Norman RG, 2006, SLEEP, V29, P1625, DOI 10.1093/sleep/29.12.1625; Orendurff MS, 2004, J REHABIL RES DEV, V41, P829, DOI 10.1682/JRRD.2003.10.0150; Rinne H., 2008, WEIBULL DISTRIBUTION; Roerdink M, 2015, PUBLIC LIB SCI ONE; Roerdink M, 2007, PHYS THER, V87, P1009, DOI 10.2522/ptj.20050394; Rubchinsky LL, 2014, FRONT PHYS, V2, DOI 10.3389/fphy.2014.00038; Thaut AH, 2007, NEUROREHAB NEURAL RE, V21, P455, DOI 10.1177/1545968307300523; Thaut MH, 1999, MOVEMENT DISORD, V14, P808, DOI 10.1002/1531-8257(199909)14:5<808::AID-MDS1014>3.0.CO;2-J; Thaut MH, 1996, MOVEMENT DISORD, V11, P193, DOI 10.1002/mds.870110213; Uchitomi H, 2013, PUBLIC LIB SCI ONE, V8; van Ulzen NR, 2008, NEUROSCI LETT, V432, P88, DOI 10.1016/j.neulet.2007.11.070; van Ulzen NR, 2010, NEUROSCI LETT, V474, P79, DOI 10.1016/j.neulet.2010.03.008; WANG XJ, 1994, NEUROSCIENCE, V59, P21, DOI 10.1016/0306-4522(94)90095-7; Zivotofsky AZ, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-28; Zivotofsky AZ, 2012, HUM MOVEMENT SCI, V31, P1268, DOI 10.1016/j.humov.2012.01.003	38	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0169924	10.1371/journal.pone.0169924	http://dx.doi.org/10.1371/journal.pone.0169924			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099517	Green Submitted, Green Published, gold			2022-12-26	WOS:000392380100042
J	Rudolfsson, T; Bjoerklund, M; Svedmark, A; Srinivasan, D; Djupsjobacka, M				Rudolfsson, Thomas; Bjoerklund, Martin; Svedmark, Asa; Srinivasan, Divya; Djupsjobacka, Mats			Direction-Specific Impairments in Cervical Range of Motion in Women with Chronic Neck Pain: Influence of Head Posture and Gravitationally Induced Torque	PLOS ONE			English	Article							SPINE; DISORDERS; SHOULDER; MUSCLES; FLEXION; PEOPLE	Background Cervical range of motion (ROM) is commonly assessed in clinical practice and research. In a previous study we decomposed active cervical sagittal ROM into contributions from lower and upper levels of the cervical spine and found level- and direction-specific impairments in women with chronic non-specific neck pain. The present study aimed to validate these results and investigate if the specific impairments can be explained by the neutral posture (defining zero flexion/extension) or a movement strategy to avoid large gravitationally induced torques on the cervical spine. Methods Kinematics of the head and thorax was assessed in sitting during maximal sagittal cervical flexion/extension (high torque condition) and maximal protraction (low torque condition) in 120 women with chronic non-specific neck pain and 40 controls. We derived the lower and upper cervical angles, and the head centre of mass (HCM), from a 3-segment kinematic model. Neutral head posture was assessed using a standardized procedure. Findings Previous findings of level- and direction-specific impairments in neck pain were confirmed. Neutral head posture was equal between groups and did not explain the direction-specific impairments. The relative magnitude of group difference in HCM migration did not differ between high and low torques conditions, lending no support for our hypothesis that impairments in sagittal ROM are due to torque avoidance behaviour. Interpretation The direction-and level-specific impairments in cervical sagittal ROM can be generalised to the population of women with non-specific neck pain. Further research is necessary to clarify if torque avoidance behaviour can explain the impairments.	[Rudolfsson, Thomas; Bjoerklund, Martin; Svedmark, Asa; Srinivasan, Divya; Djupsjobacka, Mats] Univ Gavle, Ctr Musculoskeletal Res, Umea, Sweden; [Rudolfsson, Thomas; Bjoerklund, Martin; Svedmark, Asa] Umea Univ, Dept Community Med & Rehabil, Physiotherapy, Umea, Sweden	University of Gavle; Umea University	Rudolfsson, T; Bjoerklund, M; Djupsjobacka, M (corresponding author), Univ Gavle, Ctr Musculoskeletal Res, Umea, Sweden.; Rudolfsson, T; Bjoerklund, M (corresponding author), Umea Univ, Dept Community Med & Rehabil, Physiotherapy, Umea, Sweden.	thomas.rudolfsson@hig.se; martin.bjorklund@hig.se; mda@hig.se	svedmark, asa/AAT-5655-2020; Rudolfsson, Thomas/P-2867-2014	Rudolfsson, Thomas/0000-0002-2804-3200; Djupsjobacka, Mats/0000-0002-8513-0511; Srinivasan, Divya/0000-0001-9327-6177	Swedish Research Council for Health, Working Life and Welfare [2009-1403]; AFA Insurance [090288]; Centre for Environmental Research in Umea [1152383]; University of Gavle	Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); AFA Insurance; Centre for Environmental Research in Umea; University of Gavle	This study was supported by the Swedish Research Council for Health, Working Life and Welfare, award number 2009-1403; recipient Martin Bjorklund, financing of MB, http://forte.se/; AFA Insurance: award number 090288; recipient Martin Bjorklund, financing of MB, MD, https://www.afaforsakring.se/forskning/; Centre for Environmental Research in Umea, award number 1152383, recipient Martin Bjorklund, financing of AS, www.umu.se/cmf; University of Gavle: financing of TR, MB, MD, AS, DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorklund M, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-75; Brunton J, RELIABILITY MEASURIN; Cote P, 2008, SPINE, V33, pS60, DOI 10.1097/BRS.0b013e3181643ee4; De Loose V, 2009, AVIAT SPACE ENVIR MD, V80, P477, DOI 10.3357/ASEM.2408.2009; Falla DL, 2004, SPINE, V29, P2108, DOI 10.1097/01.brs.0000141170.89317.0e; Fernandez-de-las-Penas C, 2008, CEPHALALGIA, V28, P744, DOI 10.1111/j.1468-2982.2008.01584.x; Hagen KB, 1997, SPINE, V22, P1501, DOI 10.1097/00007632-199707010-00015; Jordan A, 1997, J MANIP PHYSIOL THER, V20, P468; Jull G, 2007, CEPHALALGIA, V27, P793, DOI 10.1111/j.1468-2982.2007.01345.x; Jull G, 2004, MANUAL THER, V9, P89, DOI 10.1016/S1356-689X(03)00086-9; Jull G.A., 2008, WHIPLASH HEADACHE NE; Lee H, 2005, J MANIP PHYSIOL THER, V28, P25, DOI 10.1016/j.jmpt.2004.12.005; Martimo KP, 2009, SCAND J WORK ENV HEA, V35, P301, DOI 10.5271/sjweh.1333; O'Leary S, 2007, MANUAL THER, V12, P34, DOI 10.1016/j.math.2006.02.010; Ordway NR, 1999, SPINE, V24, P240, DOI 10.1097/00007632-199902010-00008; Rudolfsson T, 2012, MANUAL THER, V17, P53, DOI 10.1016/j.math.2011.08.007; Schomacher J, 2013, MANUAL THER, V18, P360, DOI 10.1016/j.math.2013.05.009; Severinsson Y, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/629104; SOLOW B, 1971, ACTA ODONTOL SCAND, V29, P591, DOI 10.3109/00016357109026337; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Woodhouse A, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-90; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Yoganandan N, 2009, J BIOMECH, V42, P1177, DOI 10.1016/j.jbiomech.2009.03.029	23	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170274	10.1371/journal.pone.0170274	http://dx.doi.org/10.1371/journal.pone.0170274			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099504	Green Published, gold, Green Submitted			2022-12-26	WOS:000392380100068
J	Seok, H; Choi, SJ; Yoon, JH; Song, GG; Won, JU; Kim, JH; Roh, J; Jung, JH				Seok, Hongdeok; Choi, Sung Jae; Yoon, Jin-Ha; Song, Gwan Gyu; Won, Jong-Uk; Kim, Jae-Hoon; Roh, Jaehoon; Jung, Jae Hyun			The Association between Osteoarthritis and Occupational Clusters in the Korean Population: A Nationwide Study	PLOS ONE			English	Article							KNEE OSTEOARTHRITIS; HIP OSTEOARTHRITIS; RISK-FACTORS; PREVALENCE; CONSUMPTION; PROGRESSION; CARTILAGE; WOMEN; MEN	Osteoarthritis (OA) is a considerable health problem worldwide. It is known to be associated with certain occupational risk factors. We examined the prevalence rate of OA by occupational cluster. Data were collected from the Korea National Health and Nutrition Examination Surveys (2010-2013). The total number of unweighted sample size was 9,905 participants: 4,460 men and 5,445 women, and OA prevalence was 5.3% and 18.4% respectively. OA patients were defined as participants with knee/hip joint pain and radiographic change of knee/hip joint. Occupational type was classified as either white, pink, blue, or green collar based on the occupational characteristics following physical demand: white for manager and professionals; pink for clerks and service/sales workers; blue for craft/trade workers, machine operators and assemblers, and elementary manual workers; and green for agricultural/fishery workers. We calculated the odds ratios (ORs) and 95% confidence intervals (95% Cl) for the odds of a participant's having OA according to the occupational cluster, with gender stratification. The multiple logistic regression model showed that, compared to the white collar group, the ORs of the pink, blue, and green collar workers were 1.23 (95% Cl 0.64-2.36), 1.85 (95% CI 1.18-2.88), and 2.91 (95% CI 1.86-4.54), respectively, in males, and 2.53 (95% CI 1.71-3.73), 2.86 (95% CI 1.94-4.21), and 3.90 (95% Cl 2.60-5.83), respectively in females. The prevalence rate of OA was associated with the occupational cluster, in order from highest to lowest: green, blue, pink, and white collar.	[Seok, Hongdeok; Yoon, Jin-Ha; Won, Jong-Uk; Roh, Jaehoon] Yonsei Univ, Grad Sch Publ Hlth, Seoul, South Korea; [Seok, Hongdeok; Yoon, Jin-Ha; Won, Jong-Uk; Roh, Jaehoon] Yonsei Univ, Coll Med, Inst Occupat Hlth, Seoul, South Korea; [Seok, Hongdeok; Yoon, Jin-Ha; Won, Jong-Uk; Roh, Jaehoon] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Choi, Sung Jae; Song, Gwan Gyu; Kim, Jae-Hoon; Jung, Jae Hyun] Korea Univ, Coll Med, Seoul, South Korea; [Choi, Sung Jae] Korea Univ, Ansan Hosp, Dept Internal Med, Div Rheumatol, Ansan, South Korea; [Song, Gwan Gyu; Kim, Jae-Hoon; Jung, Jae Hyun] Korea Univ, Guro Hosp, Dept Internal Med, Div Rheumatol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Jung, JH (corresponding author), Korea Univ, Coll Med, Seoul, South Korea.; Jung, JH (corresponding author), Korea Univ, Guro Hosp, Dept Internal Med, Div Rheumatol, Seoul, South Korea.	mcfriend82@naver.com		Won, Jong-Uk/0000-0002-9200-3297; Kim, Jae-Hoon/0000-0002-4756-1281; Song, Gwan Gyu/0000-0003-3492-2225; Yoon, Jin-Ha/0000-0003-4198-2955; Jung, Jae Hyun/0000-0002-3835-3587				Bae YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138790; Bedson J, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-116; Bijlsma JWJ, 2011, LANCET, V377, P2115, DOI 10.1016/S0140-6736(11)60243-2; Deshpande BR, 2016, ARTHRITIS CARE RES; Dulay GS, 2015, BEST PRACT RES CL RH, V29, P454, DOI 10.1016/j.berh.2015.05.005; Ezzat AM, 2014, PHYSIOTHER CAN, V66, P91, DOI 10.3138/ptc.2012-45BC; Frye CW, 2016, VET CLIN N AM SMALL; Gungor HR, 2016, INT J ENV RES PUB HE, P13; Hanna FS, 2009, MENOPAUSE, V16, P666, DOI 10.1097/gme.0b013e318198e30e; Hong JY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151315; Hong SC, 2015, IEEE SENSOR, P25; Hussain SM, 2014, ARTHRITIS RHEUMATOL, V66, P2144, DOI 10.1002/art.38651; International Labour Office, 2012, INT STANDARD CLASSIF; Kang K, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010062; Kc R, 2015, ARTHRITIS RHEUMATOL, V67, P1678, DOI 10.1002/art.39090; Kim C, 2014, ARTHRITIS RHEUMATOL, V66, P3013, DOI 10.1002/art.38795; Lee JH, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0147-3; Lee W, 2016, AM J IND MED, V59, P685, DOI 10.1002/ajim.22596; Litwic A, 2013, BRIT MED BULL, V105, P185, DOI 10.1093/bmb/lds038; Mochizuki T, 2016, KNEE SURG SPORTS TRA; Musumeci G, 2015, INT J MOL SCI, V16, P6093, DOI 10.3390/ijms16036093; Muthuri SG, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0534-4; Mytton OT, 2016, PREV MED, V90, P1, DOI 10.1016/j.ypmed.2016.06.014; Pereira D, 2011, OSTEOARTHR CARTILAGE, V19, P1270, DOI 10.1016/j.joca.2011.08.009; Racunica TL, 2007, OSTEOARTHR CARTILAGE, V15, P587, DOI 10.1016/j.joca.2006.12.005; Reyes C, 2016, ARTHRITIS RHEUMATOL, V68, P1869, DOI 10.1002/art.39707; Seok H, 2016, SCAND J WORK ENV HEA, V42, P135, DOI 10.5271/sjweh.3551; Seok H, 2014, ANN OCCUP ENVIRON ME, V26, DOI 10.1186/s40557-014-0031-2; Srikanth VK, 2005, OSTEOARTHR CARTILAGE, V13, P769, DOI 10.1016/j.joca.2005.04.014; Wada K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1191; Yucesoy B, 2015, WORK, V50, P261, DOI 10.3233/WOR-131739; Zhang YQ, 2016, ARTHRITIS RHEUMATOL, V68, P1797, DOI 10.1002/art.39704	32	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170229	10.1371/journal.pone.0170229	http://dx.doi.org/10.1371/journal.pone.0170229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099527	Green Published, gold, Green Submitted			2022-12-26	WOS:000392380100065
J	Gervasi, SS; Stephens, PR; Hua, J; Searle, CL; Xie, GY; Urbina, J; Olson, DH; Bancroft, BA; Weis, V; Hammond, JI; Relyea, RA; Blaustein, AR				Gervasi, Stephanie S.; Stephens, Patrick R.; Hua, Jessica; Searle, Catherine L.; Xie, Gisselle Yang; Urbina, Jenny; Olson, Deanna H.; Bancroft, Betsy A.; Weis, Virginia; Hammond, John I.; Relyea, Rick A.; Blaustein, Andrew R.			Linking Ecology and Epidemiology to Understand Predictors of Multi-Host Responses to an Emerging Pathogen, the Amphibian Chytrid Fungus	PLOS ONE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS; LIFE-HISTORY; INTERSPECIFIC VARIATION; POPULATION DECLINES; PHYLOGENETIC SIGNAL; AMERICAN BULLFROG; SUSCEPTIBILITY; DISEASE; HOSTS; CHYTRIDIOMYCOSIS	Variation in host responses to pathogens can have cascading effects on populations and communities when some individuals or groups of individuals display disproportionate vulnerability to infection or differ in their competence to transmit infection. The fungal pathogen, Batrachochytrium dendrobatidis (Bd) has been detected in almost 700 different amphibian species and is implicated in numerous global amphibian population declines. Identifying key hosts in the amphibian-Bd system those who are at greatest risk or who pose the greatest risk for others is challenging due in part to many extrinsic environmental factors driving spatiotemporal Bd distribution and context-dependent host responses to Bd in the wild. One way to improve predictive risk models and generate testable mechanistic hypotheses about vulnerability is to complement what we know about the spatial epidemiology of Bd with data collected through comparative experimental studies. We used standardized pathogen challenges to quantify amphibian survival and infection trajectories across 20 post-metamorphic North American species raised from eggs. We then incorporated trait-based models to investigate the predictive power of phylogenetic history, habitat use, and ecological and life history traits in explaining responses to Bd. True frogs (Ranidae) displayed the lowest infection intensities, whereas toads (Bufonidae) generally displayed the greatest levels of mortality after Bd exposure. Affiliation with ephemeral aquatic habitat and breadth of habitat use were strong predictors of vulnerability to and intensity of infection and several other traits including body size, lifespan, age at sexual maturity, and geographic range also appeared in top models explaining host responses to Bd. Several of the species examined are highly understudied with respect to Bd such that this study represents the first experimental susceptibility data. Combining insights gained from experimental studies with observations of landscape level disease prevalence may help explain current and predict future pathogen dynamics in the Bd system.	[Gervasi, Stephanie S.] Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA; [Stephens, Patrick R.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Hua, Jessica] Binghamton Univ, Dept Biol Sci, Binghamton, NY USA; [Searle, Catherine L.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Xie, Gisselle Yang; Weis, Virginia; Blaustein, Andrew R.] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Urbina, Jenny] Oregon State Univ, Environm Sci Grad Program, Corvallis, OR 97331 USA; [Olson, Deanna H.] US Forest Serv, Pacific Northwest Res Stn, Corvallis, OR USA; [Bancroft, Betsy A.] Gonzaga Univ, Dept Biol, Spokane, WA 99258 USA; [Hammond, John I.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Relyea, Rick A.] Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY USA	Monell Chemical Senses Center; University System of Georgia; University of Georgia; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Oregon State University; Oregon State University; United States Department of Agriculture (USDA); United States Forest Service; Gonzaga University; University of New Mexico; Rensselaer Polytechnic Institute	Gervasi, SS (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	steph.gervasi@gmail.com	Bancroft, Betsy/AAP-2999-2020; Weis, Virginia/T-5095-2019	Searle, Catherine/0000-0002-6607-2299; Bancroft, Betsy/0000-0001-5581-2653; Urbina, Jenny/0000-0003-2461-9572; Weis, Virginia/0000-0002-1826-2848	NSF [DEB 07-16149]; US Forest Service Pacific Northwest Research Station; National Institute of General Medical Sciences [K12GM088021]; Sigma Delta Epsilon-Graduate Women in Science Hartley Corporation Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM088021] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); US Forest Service Pacific Northwest Research Station(United States Department of Agriculture (USDA)United States Forest Service); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Sigma Delta Epsilon-Graduate Women in Science Hartley Corporation Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NSF grant # DEB 07-16149 (Funding to RAR and ARB), US Forest Service Pacific Northwest Research Station (Funding to DHO), National Institute of General Medical Sciences # K12GM088021 (Funding to JIH during habitat survey collection), Sigma Delta Epsilon-Graduate Women in Science Hartley Corporation Foundation (Funding to SSG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Bakar A, 2016, OECOLOGIA, V181, P997, DOI 10.1007/s00442-016-3607-4; Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; Annis SL, 2004, J WILDLIFE DIS, V40, P420, DOI 10.7589/0090-3558-40.3.420; Bancroft BA, 2011, BIODIVERS CONSERV, V20, P1911, DOI 10.1007/s10531-011-0066-4; Barron DG, 2015, CURR OPIN BEHAV SCI, V6, P35, DOI 10.1016/j.cobeha.2015.08.002; Beldomenico Pablo M, 2010, Trends Ecol Evol, V25, P21, DOI 10.1016/j.tree.2009.06.015; Bielby J, 2008, CONSERV LETT, V1, P82, DOI 10.1111/j.1755-263X.2008.00015.x; Blaustein AR, 2005, CONSERV BIOL, V19, P1460, DOI 10.1111/j.1523-1739.2005.00195.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x; Bosch J, 2001, BIOL CONSERV, V97, P331, DOI 10.1016/S0006-3207(00)00132-4; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Burkett-Cadena ND, 2010, AM J TROP MED HYG, V83, P395, DOI 10.4269/ajtmh.2010.10-0048; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carey C, 2006, ECOHEALTH, V3, P5, DOI 10.1007/s10393-005-0006-4; Chestnut T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106790; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; COX DR, 1972, J R STAT SOC B, V34, P187; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; Dodd C. K, 2013, FROGS US CANADA; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Fox J, 2003, R COMPANION APPL REG; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; Gervasi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054490; Gervasi SS, 2014, FUNCT ECOL, V28, P569, DOI 10.1111/1365-2435.12194; Gervasi SS, 2013, ECOHEALTH, V10, P166, DOI 10.1007/s10393-013-0832-8; Goraya J, 2000, EUR J BIOCHEM, V267, P894, DOI 10.1046/j.1432-1327.2000.01074.x; Gosner K. L., 1960, Herpetologica, V16, P183; Hamer GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023767; Han BA, 2015, P NATL ACAD SCI USA, V112, P7039, DOI 10.1073/pnas.1501598112; Hanselmann R, 2004, BIOL CONSERV, V120, P115, DOI 10.1016/j.biocon.2004.02.013; HASTIE T. J., 1990, MONOGRAPHS STAT APPL, V43; Hawley DM, 2011, INTEGR COMP BIOL, V51, P528, DOI 10.1093/icb/icr062; Hoverman JT, 2011, ECOHEALTH, V8, P301, DOI 10.1007/s10393-011-0717-7; Johnson PTJ, 2012, ECOL LETT, V15, P235, DOI 10.1111/j.1461-0248.2011.01730.x; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Kriger KM, 2007, DIVERS DISTRIB, V13, P781, DOI 10.1111/j.1472-4642.2007.00394.x; KURIS AM, 1980, AM NAT, V116, P570, DOI 10.1086/283647; La Marca E, 2005, BIOTROPICA, V37, P190, DOI 10.1111/j.1744-7429.2005.00026.x; Lajeunesse MJ, 2011, ECOLOGY, V92, P2049, DOI 10.1890/11-0423.1; Langhammer PF, 2014, J WILDLIFE DIS, V50, P438, DOI 10.7589/2013-10-268; Lannoo M, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P1; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; Liu X, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2506; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Martin LB, 2007, ECOLOGY, V88, P2516, DOI 10.1890/07-0060.1; Mazerolle MJ, 2016, PACKAGE AICMODAVG R; McCallum H, 2012, PHILOS T R SOC B, V367, P2828, DOI 10.1098/rstb.2012.0224; McMahon TA, 2013, P NATL ACAD SCI USA, V110, P210, DOI 10.1073/pnas.1200592110; Mendelson JR, 2006, SCIENCE, V313, P48, DOI 10.1126/science.1128396; Murray KA, 2012, HUM ECOL RISK ASSESS, V18, P200, DOI 10.1080/10807039.2012.632310; Murray KA, 2011, P ROY SOC B-BIOL SCI, V278, P1515, DOI 10.1098/rspb.2010.1872; Muths E, 2003, BIOL CONSERV, V110, P357, DOI 10.1016/S0006-3207(02)00239-2; Myers P., 2016, ANIMAL DIVERSITY WEB; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; Olson DH, FROGLOG; Orme D., 2013, R PACKAGE VERSION, V5, P1; Ostfeld RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107387; Ostfeld RS, 2000, CONSERV BIOL, V14, P722, DOI 10.1046/j.1523-1739.2000.99014.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pask JD, 2013, J EXP BIOL, V216, P2908, DOI 10.1242/jeb.084145; Pauza MD, 2010, DIS AQUAT ORGAN, V92, P193, DOI 10.3354/dao02212; Perkins SE, 2003, INT J PARASITOL, V33, P909, DOI 10.1016/S0020-7519(03)00128-0; Pilliod DS, 2010, CONSERV BIOL, V24, P1259, DOI 10.1111/j.1523-1739.2010.01506.x; Previtali MA, 2012, OIKOS, V121, P1483, DOI 10.1111/j.1600-0706.2012.020215.x; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reeder NMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033567; Revell LJ, 2010, METHODS ECOL EVOL, V1, P319, DOI 10.1111/j.2041-210X.2010.00044.x; Richards SA, 2008, J APPL ECOL, V45, P218, DOI 10.1111/j.1365-2664.2007.01377.x; Riley K, 2013, J APPL ECOL, V50, P713, DOI 10.1111/1365-2664.12091; Rohr JR, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot022; Rollins-Smith LA, 1998, IMMUNOL REV, V166, P221, DOI 10.1111/j.1600-065X.1998.tb01265.x; Rollins-Smith LA, 2002, DEV COMP IMMUNOL, V26, P471, DOI 10.1016/S0145-305X(01)00088-X; Romansic JM, 2011, OECOLOGIA, V166, P1029, DOI 10.1007/s00442-011-1932-1; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x; Searle CL, 2011, CONSERV BIOL, V25, P965, DOI 10.1111/j.1523-1739.2011.01708.x; Searle CL, 2011, P NATL ACAD SCI USA, V108, P16322, DOI 10.1073/pnas.1108490108; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Tacutu R, 2013, NUCLEIC ACIDS RES, V41, pD1027, DOI 10.1093/nar/gks1155; Therneau T., 2016, PACKAGE SURVIVAL R R; Van Buskirk J, 2002, AM NAT, V160, P87, DOI 10.1086/340599; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Wood S.N., 2001, R R NEWS, V1, P20; Wood SN, 2006, BIOMETRICS, V62, P1025, DOI 10.1111/j.1541-0420.2006.00574.x; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026; Xie GY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160746	93	34	35	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0167882	10.1371/journal.pone.0167882	http://dx.doi.org/10.1371/journal.pone.0167882			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095428	gold, Green Published, Green Submitted			2022-12-26	WOS:000392372300006
J	Sagami, S; Ueno, Y; Tanaka, S; Fujita, A; Niitsu, H; Hayashi, R; Hyogo, H; Hinoi, T; Kitadai, Y; Chayama, K				Sagami, Shintaro; Ueno, Yoshitaka; Tanaka, Shinji; Fujita, Akira; Niitsu, Hiroaki; Hayashi, Ryohei; Hyogo, Hideyuki; Hinoi, Takao; Kitadai, Yasuhiko; Chayama, Kazuaki			Choline Deficiency Causes Colonic Type II Natural Killer T (NKT) Cell Loss and Alleviates Murine Colitis under Type I NKT Cell Deficiency	PLOS ONE			English	Article							FATTY LIVER-DISEASE; INFLAMMATORY-BOWEL-DISEASE; DEXTRAN SULFATE SODIUM; NONALCOHOLIC STEATOHEPATITIS; ULCERATIVE-COLITIS; CROHNS-DISEASE; PARENTERAL-NUTRITION; HEPATIC STEATOSIS; PROSTAGLANDIN E-2; KUPFFER CELL	Serum levels of choline and its derivatives are lower in patients with inflammatory bowel disease (IBD) than in healthy individuals. However, the effect of choline deficiency on the severity of colitis has not been investigated. In the present study, we investigated the role of choline deficiency in dextran sulfate sodium (DSS)-induced colitis in mice. Methionine-choline-deficient (MCD) diet lowered the levels of type II natural killer T (NKT) cells in the colonic lamina propria, peritoneal cavity, and mesenteric lymph nodes, and increased the levels of type II NKT cells in the livers of wild-type B6 mice compared with that in mice fed a control (CTR) diet. The gene expression pattern of the chemokine receptor CXCR6, which promotes NKT cell accumulation, varied between colon and liver in a manner dependent on the changes in the type II NKT cell levels. To examine the role of type II NKT cells in colitis under choline-deficient conditions, we assessed the severity of DSS-induced colitis in type I NKT cell-deficient (J alpha 18(-/-)) or type I and type II NKT cell-deficient (CD1d(-/-) mice fed the MCD or CTR diets. The MCD diet led to amelioration of inflammation, decreases in interferon (IFN)-gamma and interleukin (IL)-4 secretion, and a decrease in the number of IFN-gamma and IL 4-producing NKT cells in J alpha 18(-/-) mice but not in CD1d(-/-) mice. Finally, adaptive transfer of lymphocytes with type II NKT cells exacerbated DSS-induced colitis in J alpha 18(-/-) mice with MCD diet. These results suggest that choline deficiency causes proinflammatory type II NKT cell loss and alleviates DSS-induced colitis. Thus, inflammation in DSS-induced colitis under choline deficiency is caused by type II NKT cell-dependent mechanisms, including decreased type II NKT cell and proinflammatory cytokine levels.	[Sagami, Shintaro; Fujita, Akira; Chayama, Kazuaki] Hiroshima Univ, Dept Med & Mol Sci, Hiroshima, Japan; [Ueno, Yoshitaka; Tanaka, Shinji; Hayashi, Ryohei] Hiroshima Univ Hosp, Dept Endoscopy, Hiroshima, Japan; [Niitsu, Hiroaki; Hinoi, Takao] Hiroshima Univ, Inst Biomed & Hlth Sci, Appl Life Sci, Dept Gastroenterol & Transplant Surg, Hiroshima, Japan; [Hyogo, Hideyuki] Hiroshima Gen Hosp, Dept Gastroenterol, Hiroshima, Japan; [Hinoi, Takao] Natl Hosp Org Kure Med Ctr, Inst Clin Res, Dept Surg, Hiroshima, Japan; [Hinoi, Takao] Chu Goku Canc Ctr, Hiroshima, Japan; [Kitadai, Yasuhiko] Prefectural Univ Hiroshima, Dept Life Sci, Hiroshima, Japan	Hiroshima University; Hiroshima University; Hiroshima University	Sagami, S (corresponding author), Hiroshima Univ, Dept Med & Mol Sci, Hiroshima, Japan.; Ueno, Y (corresponding author), Hiroshima Univ Hosp, Dept Endoscopy, Hiroshima, Japan.	jaken1013@live.jp; yueno@hiroshima-u.ac.jp	Sagami, Shintaro/AAU-4476-2021; 北台, 靖彦/AAH-1678-2021; Hinoi, Takao/AAI-1443-2020; Sagami, Shintaro/ABB-4369-2020; Kitadai, Yasuhiko/AAG-4389-2021; Niitsu, Hiroaki/HHZ-1925-2022	Sagami, Shintaro/0000-0002-1202-8161; 北台, 靖彦/0000-0002-8743-3815; Hinoi, Takao/0000-0003-0462-6177; Chayama, Kazuaki/0000-0002-5530-5341				Asanuma T, 2010, GUT, V59, P258, DOI 10.1136/gut.2009.176651; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Balasubramanian K, 2009, MAGN RESON IMAGING, V27, P79, DOI 10.1016/j.mri.2008.05.014; Brown AC, 2011, EXPERT REV GASTROENT, V5, P411, DOI [10.1586/EGH.11.29, 10.1586/egh.11.29]; BUCHMAN AL, 1995, HEPATOLOGY, V22, P1399, DOI 10.1002/hep.1840220510; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; COOPER HS, 1993, LAB INVEST, V69, P238; Corbin KD, 2012, CURR OPIN GASTROEN, V28, P159, DOI 10.1097/MOG.0b013e32834e7b4b; Coutant F, 2004, J IMMUNOL, V172, P54, DOI 10.4049/jimmunol.172.1.54; Davies JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114352; Dawiskiba T, 2014, WORLD J GASTROENTERO, V20, P163, DOI 10.3748/wjg.v20.i1.163; Deng ZB, 2013, J IMMUNOL, V190, P3579, DOI 10.4049/jimmunol.1203170; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Elinav E, 2006, J PATHOL, V209, P121, DOI 10.1002/path.1950; Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836; Fuss IJ, 2014, GUT, V63, P1728, DOI 10.1136/gutjnl-2013-305671; Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Germanov E, 2008, J IMMUNOL, V181, P81, DOI 10.4049/jimmunol.181.1.81; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; GHOSHAL AK, 1983, CARCINOGENESIS, V4, P801, DOI 10.1093/carcin/4.7.801; Grose RH, 2007, DIGEST DIS SCI, V52, P1415, DOI 10.1007/s10620-006-9261-7; Henning JR, 2013, HEPATOLOGY, V58, P589, DOI 10.1002/hep.26267; Huang EY, 2016, BIOCHEM BIOPH RES CO, V474, P252, DOI 10.1016/j.bbrc.2016.04.024; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Kim HS, 2013, MUCOSAL IMMUNOL, V6, P347, DOI 10.1038/mi.2012.77; Kirsch R, 2003, J GASTROEN HEPATOL, V18, P1272, DOI 10.1046/j.1440-1746.2003.03198.x; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kodani T, 2013, JOVE-J VIS EXP, DOI 10.3791/50843; Kremer M, 2010, HEPATOLOGY, V51, P130, DOI 10.1002/hep.23292; Laroui H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032084; Lee YJ, 2015, IMMUNITY, V43, P566, DOI 10.1016/j.immuni.2015.06.025; Lewis ED, 2014, BRIT J NUTR, V112, P112, DOI 10.1017/S0007114514000555; Li N, 2015, J PROTEOME RES, V14, P1566, DOI 10.1021/pr501236y; Liao CM, 2012, GASTROENTEROLOGY, V142, P326, DOI 10.1053/j.gastro.2011.10.030; Locatelli I, 2013, CLIN SCI, V124, P279, DOI 10.1042/CS20120289; Ma C, 2016, NATURE, V531, P253, DOI 10.1038/nature16969; Maricic I, 2014, J IMMUNOL, V193, P4580, DOI 10.4049/jimmunol.1400699; Martin-Murphy BV, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0080949, 10.1371/journal.pone.0103352, 10.1371/journal.pone.0109166]; Nakatsuji M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005542; Notas G, 2009, CLIN IMMUNOL, V130, P16, DOI 10.1016/j.clim.2008.08.008; Numata Y, 2004, J GASTROEN HEPATOL, V19, P910, DOI 10.1111/j.1440-1746.2003.03333.x; Okubo H, 2013, AM J PHYSIOL-GASTR L, V305, pG911, DOI 10.1152/ajpgi.00225.2013; Olofsson KE, 2008, BIOCHEM BIOPH RES CO, V370, P348, DOI 10.1016/j.bbrc.2008.03.087; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; PENNINGTON CR, 1982, SCOT MED J, V27, P177, DOI 10.1177/003693308202700213; Richman E, 2013, ALIMENT PHARM THER, V38, P1156, DOI 10.1111/apt.12500; Romano KA, 2015, MBIO, V6, DOI 10.1128/mBio.02481-14; Sagami S, 2016, HEPATOLOGY RES OFFIC; Satoh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030568; Saubermann LJ, 2000, GASTROENTEROLOGY, V119, P119, DOI 10.1053/gast.2000.9114; Soon RK, 2010, GASTROENTEROLOGY, V139, P1730, DOI 10.1053/j.gastro.2010.07.046; Spencer MD, 2011, GASTROENTEROLOGY, V140, P976, DOI 10.1053/j.gastro.2010.11.049; Syn WK, 2012, GUT, V61, P1323, DOI 10.1136/gutjnl-2011-301857; Syn WK, 2010, HEPATOLOGY, V51, P1998, DOI 10.1002/hep.23599; Takigawa H, 2016, CANCER SCI, V107, P601, DOI 10.1111/cas.12907; Tanaka N, 2012, HEPATOLOGY, V56, P118, DOI 10.1002/hep.25630; Tang EHC, 2015, J LIPID RES, V56, P358, DOI 10.1194/jlr.M054817; Ueno Y, 2005, INFLAMM BOWEL DIS, V11, P35, DOI 10.1097/00054725-200501000-00005; van de Wal Y, 2003, GASTROENTEROLOGY, V124, P1420, DOI 10.1016/S0016-5085(03)00219-1; Vance DE, 2008, CURR OPIN LIPIDOL, V19, P229, DOI 10.1097/MOL.0b013e3282fee935; Wehr A, 2013, J IMMUNOL, V190, P5226, DOI 10.4049/jimmunol.1202909; Williams HRT, 2012, DIGEST DIS SCI, V57, P2157, DOI 10.1007/s10620-012-2127-2; Wu L, 2012, P NATL ACAD SCI USA, V109, pE1143, DOI 10.1073/pnas.1200498109; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zeissig Sebastian, 2013, Methods Mol Biol, V960, P557, DOI 10.1007/978-1-62703-218-6_41	66	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0169681	10.1371/journal.pone.0169681	http://dx.doi.org/10.1371/journal.pone.0169681			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095507	Green Published, gold, Green Submitted			2022-12-26	WOS:000392372300029
J	Hu, JJ; Zhang, J; Chen, XL; Lv, JH; Jia, HX; Zhao, ST; Lu, MZ				Hu, Jianjun; Zhang, Jin; Chen, Xingling; Lv, Jinhui; Jia, Huixia; Zhao, Shutang; Lu, Mengzhu			An Empirical Assessment of Transgene Flow from a Bt Transgenic Poplar Plantation	PLOS ONE			English	Article							POPULUS-NIGRA L.; GENE FLOW; MICROSATELLITE MARKERS; BLACK POPLAR; FITNESS DYNAMICS; RISK-ASSESSMENT; DISPERSAL; PLANTS; TREES; POPULATIONS	To assess the possible impact of transgenic poplar plantations on the ecosystem, we analyzed the frequency and distance of gene flow from a mature male transgenic Populus nigra plantation carrying the Bacillus thuringiensis toxin gene (Bt poplar) and the survival of Bt poplar seeds. The resultant Bt poplar seeds occurred at a frequency of similar to 0.15% at 0 m to similar to 0.02% at 500 m from the Bt poplar plantation. The germination of Bt poplar seeds diminished within three weeks in the field (germination rate from 68% to 0%) compared to 48% after three weeks of storage at 4 degrees C. The survival rate of seedlings in the field was 0% without any treatment but increased to 1.7% under the addition of four treatments (cleaning and trimming, watering, weeding, and covering with plastic film to maintain moisture) after being seeded in the field for eight weeks. The results of this study indicate that gene flow originating from the Bt poplar plantation occurred at an extremely low level through pollen or seeds under natural conditions. This study provides first-hand field data on the extent of transgene flow in poplar plantations and offers guidance for the risk assessment of transgenic poplar plantations.	[Hu, Jianjun; Zhang, Jin; Lv, Jinhui; Jia, Huixia; Zhao, Shutang; Lu, Mengzhu] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Key Lab Tree Breeding & Cultivat,State Forestry A, Beijing, Peoples R China; [Hu, Jianjun; Zhang, Jin; Jia, Huixia; Zhao, Shutang; Lu, Mengzhu] Nanjing Forestry Univ, Collaborat Innovat Ctr Sustainable Forestry South, Nanjing, Jiangsu, Peoples R China; [Chen, Xingling] Changchun Acad Forestry, Changchun, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; Nanjing Forestry University	Lu, MZ (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Key Lab Tree Breeding & Cultivat,State Forestry A, Beijing, Peoples R China.; Lu, MZ (corresponding author), Nanjing Forestry Univ, Collaborat Innovat Ctr Sustainable Forestry South, Nanjing, Jiangsu, Peoples R China.	lumz@caf.ac.cn	Zhang, Jin/J-9618-2019; Lu, Meng-Zhu/AAN-9710-2020	Zhang, Jin/0000-0002-8397-5078; 	National High-Tech R&D Program of China [2013AA102702, 2011AA10020101]	National High-Tech R&D Program of China	This work was supported by the National High-Tech R&D Program of China (2013AA102702 and 2011AA10020101). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Andrew Groover (UC-Davis, US Forest Service) and Prof. Xiao-Ru Wang (Umea University) for critical comments on the manuscript and Dr. Chun-Ling Zhang for the contribution of Bt seeds detection. This work was supported by the National High-Tech R&D Program of China (2013AA102702) and (2011AA10020101).	Barsoum N., 1998, HYDROLOGY CHANGING E; Bialozyt R, 2012, IFOREST, V5, P147, DOI 10.3832/ifor0618-005; Bradshaw HD, 2000, J PLANT GROWTH REGUL, V19, P306, DOI 10.1007/s003440000030; Chandler S, 2008, CRIT REV PLANT SCI, V27, P25, DOI 10.1080/07352680802053916; Chen LJ, 2009, MOL PLANT, V2, P738, DOI 10.1093/mp/ssp032; DiFazio SP, 2004, RES SIGNPOST, P405; DIFAZIO SP, 2002, MEASURING MODELING G; DiFazio SP, 2012, NEW PHYTOL, V193, P903, DOI 10.1111/j.1469-8137.2011.04012.x; Eckenwalder James E., 1996, P7; Ewald D, 2006, TREE TRANSGENESIS: RECENT DEVELOPMENTS, P25, DOI 10.1007/3-540-32199-3_2; Fang Sheng-zuo, 2008, Yingyong Shengtai Xuebao, V19, P2308; Guilloy-Froget H, 2002, WETLANDS, V22, P478, DOI 10.1672/0277-5212(2002)022[0478:DGASOP]2.0.CO;2; Haggman H, 2013, PLANT BIOTECHNOL J, V11, P785, DOI 10.1111/pbi.12100; Hu J., 2014, CHALLENGES OPPORTUNI, P567; Hu JJ, 2001, EUPHYTICA, V121, P123, DOI 10.1023/A:1012015709363; Imbert E, 2003, J ECOL, V91, P447, DOI 10.1046/j.1365-2745.2003.00772.x; Jansson S, 2007, ANNU REV PLANT BIOL, V58, P435, DOI 10.1146/annurev.arplant.58.032806.103956; Khasa D, 2005, MOL ECOL NOTES, V5, P920, DOI 10.1111/j.1471-8286.2005.01114.x; Kuparinen A, 2007, ECOL MODEL, V202, P476, DOI 10.1016/j.ecolmodel.2006.11.015; Lepais O, 2009, MOL ECOL, V18, P2228, DOI 10.1111/j.1365-294X.2009.04137.x; Meirmans PG, 2010, AM J BOT, V97, P1688, DOI 10.3732/ajb.0900271; Nathan R, 2008, TRENDS ECOL EVOL, V23, P638, DOI 10.1016/j.tree.2008.08.003; Neale DB, 2008, CURR OPIN PLANT BIOL, V11, P149, DOI 10.1016/j.pbi.2007.12.004; Niggemann M, 2012, J ECOL, V100, P264, DOI 10.1111/j.1365-2745.2011.01854.x; Niinemets U, 2010, FOREST ECOL MANAG, V260, P1623, DOI 10.1016/j.foreco.2010.07.054; Pospiskova M, 2006, CAN J FOREST RES, V36, P1067, DOI 10.1139/X06-003; Rathmacher G, 2010, CONSERV GENET, V11, P1327, DOI 10.1007/s10592-009-9961-6; Roe AD, 2014, ECOL EVOL, V4, P1876, DOI 10.1002/ece3.1028; Roe AD, 2014, ECOL EVOL, V4, P1629, DOI 10.1002/ece3.1029; Slavov GT, 2009, MOL ECOL, V18, P357, DOI 10.1111/j.1365-294X.2008.04016.x; Smulders MJM, 2001, MOL ECOL NOTES, V1, P188, DOI 10.1046/j.1471-8278.2001.00071.x; Thompson SL, 2010, MOL ECOL, V19, P132, DOI 10.1111/j.1365-294X.2009.04442.x; van der Schoot J, 2000, THEOR APPL GENET, V101, P317, DOI 10.1007/s001220051485; Wang GJ, 1996, TRANSGENIC RES, V5, P289, DOI 10.1007/BF01968939; Zsuffa L., 1974, Annales Forestales, V6, P29	35	8	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0170201	10.1371/journal.pone.0170201	http://dx.doi.org/10.1371/journal.pone.0170201			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085955	Green Published, Green Submitted, gold			2022-12-26	WOS:000391972600076
J	Li, Y; Boonprakob, A; Gaonkar, CC; Kooistra, WHCF; Lange, CB; Hernandez-Becerrill, D; Chen, ZY; Moestrup, O; Lundholm, N				Li, Yang; Boonprakob, Atchaneey; Gaonkar, Chetan C.; Kooistra, Wiebe H. C. F.; Lange, Carina B.; Hernandez-Becerrill, David; Chen, Zuoyi; Moestrup, Ojvind; Lundholm, Nina			Diversity in the Globally Distributed Diatom Genus Chaetoceros (Bacillariophyceae): Three New Species from Warm-Temperate Waters	PLOS ONE			English	Article							GENERA DICLADIA EHRENBERG; SYNDENDRIUM EHRENBERG; MARINE; IDENTIFICATION; BIOGEOGRAPHY; TAXONOMY; NOV	Chaetoceros is one of the most species rich, widespread and abundant diatom genera in marine and brackish habitats worldwide. It therefore forms an excellent model for in-depth biodiversity studies, assessing morphological and genetic differentiation among groups of strains. The global Chaetoceros lorenzianus complex presently comprises three species known to science. However, our recent studies have shown that the group includes several previously unknown species. In this article, 50 strains, mainly from high latitudes and from warm-temperate waters, were examined morphologically and genetically and the results compared with those of field studies from elsewhere. The strains clustered into five groups, two of which are formed by C. decipiens Cleve and C. mitra (Bailey) Cleve, respectively. Their species descriptions are emended based on samples collected close to the type localities. The three other groups are formed by new species, C. elegans sp. nov., C. laevisporus sp. nov. and C. mannaii sp. nov. Characters used to distinguish each species are: orientation of setae, shape and size of the apertures, shape, size and density of the poroids on the setae and, at least in some species, characters of the resting spores. Our aim is to cover the global species diversity in this complex, as correct species delineation is the basis for exploring biodiversity, distribution of organisms, interactions in the food web and effects of environmental changes.	[Li, Yang; Chen, Zuoyi] South China Normal Univ, Guangzhou Key Lab Subtrop Biodivers & Biomonitori, Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [Boonprakob, Atchaneey; Lundholm, Nina] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen, Denmark; [Boonprakob, Atchaneey] Ramkhamhang Univ, Dept Biol, Fac Sci, Bangkok, Thailand; [Gaonkar, Chetan C.; Kooistra, Wiebe H. C. F.; Lange, Carina B.] Stn Zool Anton Dohrn, Integrat Marine Ecol, Naples, Italy; [Lange, Carina B.] Univ Concepcion, Dept Oceanog, Concepcion, Chile; [Lange, Carina B.] Univ Concepcion, Ctr COPAS Sur Austral, Concepcion, Chile; [Hernandez-Becerrill, David] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Cd De Mexico, DF, Mexico; [Moestrup, Ojvind] Univ Copenhagen, Inst Biol, Sect Marine Biol, Copenhagen, Denmark	South China Normal University; University of Copenhagen; Ramkhamhaeng University; Stazione Zoologica Anton Dohrn di Napoli; Universidad de Concepcion; Universidad de Concepcion; Universidad Nacional Autonoma de Mexico; University of Copenhagen	Lundholm, N (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen, Denmark.	nlundholm@snm.ku.dk	Lange, Carina/AHC-2015-2022; Lundholm, Nina/AAY-6249-2020; Lundholm, Nina/A-4856-2013	Lange, Carina/0000-0002-2916-4207; Lundholm, Nina/0000-0002-2035-1997; Lundholm, Nina/0000-0002-2035-1997; Kooistra, Wiebe/0000-0002-8641-9739	Natural Science Foundation of China [31370235, 31570205]; Association of European Marine Biological Laboratories [227799, 1555]; Royal Thai Government. Faculty of Science, University of Copenhagen; Carlsbergfondet [2012_01_0556]; Dansk Center for Havforskning. Stazione Zoologica Naples; CNRS/LIA-MORFUN [7569]; PASPA	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Association of European Marine Biological Laboratories(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Thai Government. Faculty of Science, University of Copenhagen; Carlsbergfondet(Carlsberg Foundation); Dansk Center for Havforskning. Stazione Zoologica Naples; CNRS/LIA-MORFUN; PASPA	Natural Science Foundation of China, Nos. 31370235 and 31570205. Association of European Marine Biological Laboratories, Grant Agreements 227799 and 1555. Royal Thai Government. Faculty of Science, University of Copenhagen. Carlsbergfondet (DK) no 2012_01_0556. Dansk Center for Havforskning. Stazione Zoologica Naples. CNRS/LIA-MORFUN Mission no 7569. PASPA.	Alverson AJ, 2007, MOL PHYLOGENET EVOL, V45, P193, DOI 10.1016/j.ympev.2007.03.024; Bailey J.W., 1856, AM J SCI ARTS, V22, P1; BERARD-THERRIAULT L., 1999, PUBLICATION SPECIALE, V128, P1; Brunel J., 1972, J MAR BIOL ASSOC IND, V14, P315; Chin T. G., 1951, AMOY FISH B, V1, P145; Chin T. G., 1965, MARINE PLANKTONIC DI; Cleve P. T., 1896, K SVENSKA VET AKAD H, V22, P3; Cleve P.T., 1873, BIHANG KONGLIGA SVEN, V1, P1; Cupp EE, 1943, B SCRIPPS I OCEANOGR, V5, P1, DOI DOI 10.1086/378901; Evensen D. L., 1975, NOVA HED S, V53, P152; Grunow A., 1863, VERHANDLUNGEN KAISER, V13, P137; GUILLARD RRL, 1993, PHYCOLOGIA, V32, P234, DOI 10.2216/i0031-8884-32-3-234.1; Guiry MD, ALGAEBASE; Guo YJ, 2003, BACILLARIOPHYTA, V1, P345; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hasle Grethe R., 1997, P5, DOI 10.1016/B978-012693018-4/50004-5; Hernandez-Becerril DU, 1998, BOT MAR, V41, P505, DOI 10.1515/botm.1998.41.1-6.505; HernSSndez-Becerril D.U., 1996, B NATURAL HIST MUSEU, V26, P1; Jensen K.G., 1998, OPERA BOT, V133, P5; Kooistra WHCF, 2008, PROTIST, V159, P177, DOI 10.1016/j.protis.2007.09.004; Kooistra WHCF, 2010, PHYCOLOGIA, V49, P471, DOI 10.2216/09-59.1; Kraus D., 2014, DANIELS XL TOOLBOX A; Lee SD, 2014, PHYCOLOGIA, V53, P614, DOI 10.2216/14-51R2.1; Lee SD, 2014, PHYCOLOGIA, V53, P174, DOI 10.2216/13-154.1; Lundholm N, 2002, EUR J PHYCOL, V37, P115, DOI 10.1017/S096702620100347X; Lundholm N, 2012, J PHYCOL, V48, P436, DOI 10.1111/j.1529-8817.2012.01132.x; Mann DG, 2013, J EUKARYOT MICROBIOL, V60, P414, DOI 10.1111/jeu.12047; Mann DG, 1996, HYDROBIOLOGIA, V336, P19, DOI 10.1007/BF00010816; Nunn GB, 1996, J MOL EVOL, V42, P211, DOI 10.1007/BF02198847; Okamura K., 1911, SOME LITTORAL DIATOM, V7, P3; Okuno H., 1956, BOT MAG TOKYO, V69, P182; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rines J. E. B., 1988, BIBL PHYCOL, V79, P5; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SCHOLIN CA, 1994, J PHYCOL, V30, P999, DOI 10.1111/j.0022-3646.1994.00999.x; Shevchenko OG, 2006, BOT MAR, V49, P236, DOI 10.1515/BOT.2006.028; Suto I, 2005, DIATOM RES, V20, P351; Suto I, 2003, DIATOM RES, V18, P331; Throndsen J, 2003, NORSK KYSTPLANKTON F; [王艳 Wang Yan], 2010, [海洋科学进展, Advances in Marine Science], V28, P342; Zhen Y, 2008, J ENVIRON SCI-CHINA, V20, P1481, DOI 10.1109/ICMMT.2008.4540726	41	34	38	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0168887	10.1371/journal.pone.0168887	http://dx.doi.org/10.1371/journal.pone.0168887			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085887	Green Published, gold, Green Submitted			2022-12-26	WOS:000391972600008
J	Wright, N; Xia, J; Cantuaria, G; Klimov, S; Jones, M; Neema, P; Il'yasova, D; Krishnamurti, U; Li, XX; Reid, MD; Gupta, M; Rida, PCG; Osan, R; Aneja, R				Wright, Nikita; Xia, Jun; Cantuaria, Guilherme; Klimov, Sergey; Jones, Mildred; Neema, Pranay; Il'yasova, Dora; Krishnamurti, Uma; Li, Xiaoxian; Reid, Michelle D.; Gupta, Meenakshi; Rida, Padmashree C. G.; Osan, Remus; Aneja, Ritu			Distinctions in Breast Tumor Recurrence Patterns Post-Therapy among Racially Distinct Populations	PLOS ONE			English	Article							AFRICAN-AMERICAN WOMEN; WHITE WOMEN; YOUNG-WOMEN; CANCER; DISPARITIES; PROGNOSIS; SURVIVAL; STAGE; LIFE; AGE	Background Clinical studies have revealed a higher risk of breast tumor recurrence in African-American (AA) patients compared to European-American (EA) patients, contributing to the alarming inequality in clinical outcomes among the ethnic groups. However, distinctions in recurrence patterns upon receiving hormone, radiation, and/or chemotherapy between the races remain poorly characterized. Methods We compared patterns and rates (per 1000 cancer patients per 1 year) of recurrence following each form of treatment between AA (n = 1850) and EA breast cancer patients (n = 7931) from a cohort of patients (n = 10504) treated between 2005-2015 at Northside Hospital in Atlanta, GA. Results Among patients who received any combination of adjuvant therapy, AA displayed higher overall rates of recurrence than EA (p = 0.015; HR: 1.699; CI: 1.108-2.606). Furthermore, recurrence rates were higher in AA than EA among stage I (p = 0.031; HR: 1.736; CI: 1.052-2.864) and T1 classified patients (p = 0.003; HR: 2.009; CI: 1.263-3.197). Interestingly, among patients who received neoadjuvant chemotherapy, AA displayed higher rates of local recurrence than EA (p = 0.024; HR: 7.134; CI: 1.295-39.313). Conclusion Our analysis revealed higher incidence rates of recurrence in AA compared to EA among patients that received any combination of adjuvant therapy. Moreover, our data demonstrates an increased risk of tumor recurrence in AA than EA among patients diagnosed with minimally invasive disease. This is the first clinical study to suggest that neoadjuvant chemotherapy improves breast cancer recurrence rates and patterns in AA.	[Wright, Nikita; Klimov, Sergey; Neema, Pranay; Rida, Padmashree C. G.; Aneja, Ritu] Georgia State Univ, Dept Biol, Atlanta, GA USA; [Xia, Jun; Osan, Remus] Georgia State Univ, Dept Math & Stat, Atlanta, GA 30303 USA; [Cantuaria, Guilherme] Northside Hosp, Inst Canc, Dept Gynecol Oncol, Atlanta, GA USA; [Jones, Mildred] Northside Hosp, Inst Canc, Dept Pathol Oncol Analyt, Atlanta, GA USA; [Il'yasova, Dora] Georgia State Univ, Sch Publ Hlth, Atlanta, GA 30303 USA; [Krishnamurti, Uma; Li, Xiaoxian; Reid, Michelle D.] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Gupta, Meenakshi] West Georgia Hosp, Clin Pathol & Anat Pathol, La Grange, GA USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Emory University	Aneja, R (corresponding author), Georgia State Univ, Dept Biol, Atlanta, GA USA.; Osan, R (corresponding author), Georgia State Univ, Dept Math & Stat, Atlanta, GA 30303 USA.	rosan@gsu.edu; raneja@gsu.edu	Krishnamurti, Uma/AAW-9867-2020; Krishnamurti, Uma/AAA-1733-2022		Novazoi Theranostics	Novazoi Theranostics	Novazoi Theranostics provided support in the form of salaries (partial) for author PCG Rida, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Ahmad Aamir, 2013, ISRN Oncol, V2013, P290568, DOI 10.1155/2013/290568; Anders CK, 2009, SEMIN ONCOL, V36, P237, DOI 10.1053/j.seminoncol.2009.03.001; Assi HA, 2013, J THORAC DIS, V5, pS2, DOI 10.3978/j.issn.2072-1439.2013.05.24; Boyle P, 2012, ANN ONCOL, V23, P7, DOI 10.1093/annonc/mds187; BRESLOW N, 1979, ENVIRON HEALTH PERSP, V32, P181, DOI 10.2307/3429015; Cianfrocca M, 2004, ONCOLOGIST, V9, P606, DOI 10.1634/theoncologist.9-6-606; COX DR, 1972, J R STAT SOC B, V34, P187; Cuthbertson SA, 2009, J PUBLIC HEALTH-UK, V31, P398, DOI 10.1093/pubmed/fdp042; Danforth DN, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3429; de Boer M, 2010, J NATL CANCER I, V102, P410, DOI 10.1093/jnci/djq008; DELAROCHEFORDIERE A, 1993, LANCET, V341, P1039, DOI 10.1016/0140-6736(93)92407-K; Demicheli R, 2007, CANCER-AM CANCER SOC, V110, P1880, DOI 10.1002/cncr.22998; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Gabriel CA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2647; Gerber B, 2010, DTSCH ARZTEBL INT, V107, P85, DOI 10.3238/arztebl.2010.0085; Hayes DF, 2006, PROGNOSTIC FACTORS C, p207 ; Jatoi I, 2005, J CLIN ONCOL, V23, P7836, DOI 10.1200/JCO.2004.01.0421; Johnson ET, 2002, J NATL MED ASSOC, V94, P149; Kato I, 2009, CANCER EPIDEMIOL, V33, P24, DOI 10.1016/j.canep.2009.04.009; Keenan T, 2015, J CLIN ONCOL, V33, P3621, DOI 10.1200/JCO.2015.62.2126; Killelea BK, 2015, J CLIN ONCOL, V33, P4267, DOI 10.1200/JCO.2015.63.7801; Lonning PE, 2007, ANN ONCOL, V18, P3, DOI 10.1093/annonc/mdm260; Merletti F, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-S1-S7; Mohammed ZMA, 2013, BMC CLIN PATHOL, V13, DOI 10.1186/1472-6890-13-31; Morris M, 2015, BRIT J CANCER, V113, P1640, DOI 10.1038/bjc.2015.386; Newman LA, 2005, ONCOLOGIST, V10, P1, DOI 10.1634/theoncologist.10-1-1; Newman LA, 1999, ANN SURG ONCOL, V6, P241, DOI 10.1007/s10434-999-0241-y; NIXON AJ, 1994, J CLIN ONCOL, V12, P888, DOI 10.1200/JCO.1994.12.5.888; Ruiz-Narvaez EA, 2010, CANCER EPIDEM BIOMAR, V19, P1320, DOI 10.1158/1055-9965.EPI-09-1250; TAIOLI E, 1995, CANCER RES, V55, P3757; Torck BJ, 1996, BREAST CANCER RES TR, V40, P11, DOI 10.1007/BF01805999; Tripathy D, 2008, EVERYONES GUIDE CANC, p473 ; Vona-Davis L, 2009, J WOMENS HEALTH, V18, P883, DOI 10.1089/jwh.2008.1127	33	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0170095	10.1371/journal.pone.0170095	http://dx.doi.org/10.1371/journal.pone.0170095			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085947	Green Published, Green Submitted, gold			2022-12-26	WOS:000391972600060
J	Jayasinghe, SU; Torres, SJ; Hussein, M; Fraser, SF; Lambert, GW; Turner, AI				Jayasinghe, Sisitha U.; Torres, Susan J.; Hussein, Mais; Fraser, Steve F.; Lambert, Gavin W.; Turner, Anne I.			Fitter Women Did Not Have Attenuated Hemodynamic Responses to Psychological Stress Compared with Age-Matched Women with Lower Levels of Fitness	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; PSYCHOSOCIAL STRESS; AEROBIC EXERCISE; BLOOD-PRESSURE; MENSTRUAL-CYCLE; CARDIOVASCULAR REACTIVITY; PHYSIOLOGICAL-RESPONSE; PHYSICAL-ACTIVITY; HEART-RATE; TRAINING-PROGRAM	According to the 'cross stressor adaptation hypothesis', regular exercise acts as a buffer against the detrimental effects of stress. Nevertheless, evidence that higher levels of cardiorespiratory fitness moderate hemodynamic responses to acute psychological stress is inconclusive, especially in women. Women aged 30-50 years (in the mid-follicular phase of the menstrual cycle) with higher (n = 17) and lower (n = 17) levels of fitness were subjected to a Trier Social Stress Test (TSST). Continuous, non-invasive measurements were made of beat-to-beat, systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), heart rate (HR), stroke volume (SV), cardiac output (CO), left ventricular ejection time (LVET), maximum slope, pulse interval (PI) and total peripheral resistance (TPR). Maximal oxygen consumption was significantly (p<0.001) higher in the 'higher fit' women. Lower fit women had higher fasting glucose, resting heart rate, waist to hip ratios and elevated serum triglyceride and cholesterol/HDL ratios compared with higher fit women (p<0.05 for all). While all measured parameters (for both groups) displayed significant (p<0.001) responses to the TSST, only HR, PI and LVET differed significantly between higher and lower fit women (p<0.001 for all) with the higher fit women having the larger response in each case. It was also found that higher fit women had significantly shorter time to recovery for maximum slope compared with the lower fit women. These findings provide little support for the notion that higher levels of cardiorespiratory fitness result in lower cardiovascular responsivity to psychological stress in women but may indicate that lower fit women have blunted responses to stress.	[Jayasinghe, Sisitha U.; Torres, Susan J.; Hussein, Mais; Fraser, Steve F.; Turner, Anne I.] Inst Phys Act & Nutr Res, Sch Exercise & Nutr Sci, Geelong, Vic, Australia; [Lambert, Gavin W.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Jayasinghe, Sisitha U.] Cornell Univ, Biomed Sci, Ithaca, NY USA; [Lambert, Gavin W.] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia	Baker Heart and Diabetes Institute; Cornell University; Monash University	Turner, AI (corresponding author), Inst Phys Act & Nutr Res, Sch Exercise & Nutr Sci, Geelong, Vic, Australia.	anne.turner@deakin.edu.au	Lambert, Gavin W/E-7384-2010; Lambert, Gavin/Q-4869-2017; Jayasinghe, Sisitha/GWV-0455-2022	Lambert, Gavin W/0000-0003-0315-645X; Lambert, Gavin/0000-0003-0315-645X; Fraser, Steve F/0000-0003-0202-9619; Turner, Anne/0000-0002-0682-2860	Deakin University	Deakin University	This research was funded by Deakin University (http://www.deakin.edu.au/); AT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHA, 1972, EX TEST TRAIN APP HL; ALBRIGHT CL, 1992, J PSYCHOSOM RES, V36, P25, DOI 10.1016/0022-3999(92)90111-E; [Anonymous], 2010, STATE TRAIT ANXIETY; Anshel MH, 1996, BEHAV MED, V21, P186, DOI 10.1080/08964289.1996.9933757; Bauman A, 2009, J PHYS ACT HEALTH, V6, pS5, DOI 10.1123/jpah.6.s1.s5; BLUMENTHAL JA, 1990, AM J CARDIOL, V65, P93, DOI 10.1016/0002-9149(90)90032-V; Brinkmann K, 2009, INT J PSYCHOPHYSIOL, V74, P250, DOI 10.1016/j.ijpsycho.2009.09.009; Brown G.K., 2005, BECK DEPRESSION INVE; Carroll D, 2008, PSYCHOSOM MED, V70, P653, DOI 10.1097/PSY.0b013e31817b9382; Carroll D, 2011, PSYCHOSOM MED, V73, P737, DOI 10.1097/PSY.0b013e3182359808; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; COLLINS A, 1985, PSYCHOSOM MED, V47, P512, DOI 10.1097/00006842-198511000-00002; de Geus EJ, 1990, PSYCHOPHYSIOLOGY; DETTWYLER KA, 1993, AM J PHYS ANTHROPOL, V92, P239, DOI 10.1002/ajpa.1330920214; ESLER M, 1988, HYPERTENSION, V11, P3, DOI 10.1161/01.HYP.11.1.3; Forcier K, 2006, HEALTH PSYCHOL, V25, P723, DOI 10.1037/0278-6133.25.6.723; Gerber M, 2009, SCAND J PUBLIC HEALT, V37, P801, DOI 10.1177/1403494809350522; Ginty AT, 2012, PSYCHOPHYSIOLOGY, V49, P391, DOI 10.1111/j.1469-8986.2011.01316.x; Hamer M, 2006, BIOL PSYCHOL, V71, P183, DOI 10.1016/j.biopsycho.2005.04.004; HASTRUP JL, 1984, J PSYCHOSOM RES, V28, P475, DOI 10.1016/0022-3999(84)90081-3; Hellhammer J, 2012, PSYCHONEUROENDOCRINO, V37, P119, DOI 10.1016/j.psyneuen.2011.05.012; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; Imholz BPM, 1998, CARDIOVASC RES, V38, P605, DOI 10.1016/S0008-6363(98)00067-4; Jackson EM, 2006, PSYCHOPHYSIOLOGY, V43, P57, DOI 10.1111/j.1469-8986.2006.00373.x; Jayasinghe SU, 2014, ENDOCR CONNECT, V3, P110, DOI 10.1530/EC-14-0042; Jayasinghe SU, 2016, ENDOCRINE, V51, P369, DOI 10.1007/s12020-015-0687-6; Jayasinghe SU, 2015, APPL PHYSIOL NUTR ME, V40, P1186, DOI 10.1139/apnm-2015-0168; Kajantie E, 2006, PSYCHONEUROENDOCRINO, V31, P151, DOI 10.1016/j.psyneuen.2005.07.002; Kirschbaum C, 1999, PSYCHOSOM MED, V61, P154, DOI 10.1097/00006842-199903000-00006; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; KIRSCHBAUM C, 1993, PHARMACOL BIOCHEM BE, V44, P527, DOI 10.1016/0091-3057(93)90162-M; Klaperski S, 2014, J BEHAV MED, V37, P1118, DOI 10.1007/s10865-014-9562-9; Klaperski S, 2013, PSYCHOL SPORT EXERC, V14, P266, DOI 10.1016/j.psychsport.2012.11.003; Kudielka BM, 2004, PSYCHONEUROENDOCRINO, V29, P983, DOI 10.1016/j.psyneuen.2003.08.009; LAMBERT GW, 1995, CIRCULATION, V92, P1813, DOI 10.1161/01.CIR.92.7.1813; Lustyk MKB, 2010, BIOL PSYCHOL, V83, P84, DOI 10.1016/j.biopsycho.2009.11.003; MANHEM K, 1991, CLIN SCI, V81, P17, DOI 10.1042/cs0810017; Matthews KA, 2004, CIRCULATION, V110, P74, DOI 10.1161/01.CIR.0000133415.37578.E4; Miller GE, 2005, PSYCHOSOM MED, V67, P679, DOI 10.1097/01.psy.0000174172.82428.ce; Palatini P, 2010, J HYPERTENS, V28, P1186, DOI 10.1097/HJH.0b013e328338a8e7; Phillips AC, 2013, INT J PSYCHOPHYSIOL, V90, P1, DOI 10.1016/j.ijpsycho.2013.02.002; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Rimmele U, 2007, PSYCHONEUROENDOCRINO, V32, P627, DOI 10.1016/j.psyneuen.2007.04.005; Rimmele U, 2009, PSYCHONEUROENDOCRINO, V34, P190, DOI 10.1016/j.psyneuen.2008.08.023; Salmon P, 2001, CLIN PSYCHOL REV, V21, P33, DOI 10.1016/S0272-7358(99)00032-X; Schommer NC, 2003, PSYCHOSOM MED, V65, P450, DOI 10.1097/01.PSY.0000035721.12441.17; Schutte Aletta E, 2003, Blood Press Monit, V8, P195; SHERWOOD A, 1989, PSYCHOSOM MED, V51, P123, DOI 10.1097/00006842-198903000-00002; SHVARTZ E, 1990, AVIAT SPACE ENVIR MD, V61, P3; Silke B, 1998, J HUM HYPERTENS, V12, P403, DOI 10.1038/sj.jhh.1000600; Skoluda N, 2015, PSYCHONEUROENDOCRINO, V51, P227, DOI 10.1016/j.psyneuen.2014.10.002; Sothmann M S, 1996, Exerc Sport Sci Rev, V24, P267; Spalding TW, 2004, PSYCHOPHYSIOLOGY, V41, P552, DOI 10.1111/j.1469-8986.2004.00184.x; STEPTOE A, 1990, PSYCHOPHYSIOLOGY, V27, P264, DOI 10.1111/j.1469-8986.1990.tb00381.x; Throne LC, 2000, INT J STRESS MANAGE, V7, P235, DOI 10.1023/A:1009574428627; Torres SJ, 2014, OBESITY FACTS, V7, P339, DOI 10.1159/000369854; Tsatsoulis A, 2006, ANN NY ACAD SCI, V1083, P196, DOI 10.1196/annals.1367.020	57	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169746	10.1371/journal.pone.0169746	http://dx.doi.org/10.1371/journal.pone.0169746			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH7JQ	28081200	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000391949500069
J	Maslanka, T; Ziolkowska, N; Ziolkowski, H; Malaczewska, J				Maslanka, Tomasz; Ziolkowska, Natalia; Ziolkowski, Hubert; Malaczewska, Joanna			CD25(+)CD127(+)Foxp3(-) Cells Represent a Major Subpopulation of CD8(+) T Cells in the Eye Chambers of Normal Mice	PLOS ONE			English	Article							COMPARABLE NUMBERS; ANTERIOR-CHAMBER; DOWN-REGULATION; AQUEOUS-HUMOR; NAIVE; MEMORY; MIGRATION; EFFECTOR; FOXP3; LYMPHOCYTES	The aim of this study has been to determine whether eye chambers constitute part of the normal migratory pathway of naive CD4(+) and CD8(+) T cells in mouse and if natural CD4+ CD25(+) Foxp3(+) and CD8(+) CD25(+) Foxp3(+) regulatory T cells are present within these eye compartments. To this aim, the cells obtained from aqueous humor (AH) of normal mice were phenotyped in terms of the expression CD4, CD8, CD25, CD127 and transcription factor Foxp3. The mean percentage of CD8(+) T cells in the total AH lymphocyte population was as high as 28.69%; the mean percentage of CD8 high and CD8 low cells in this population was 34.09% and 65.91%, respectively. The presence of cells with the regulatory phenotype, i.e. CD25(+) Foxp3(+) cells, constituted only 0.32% of CD8(+) T cell subset. Regarding the expression of CD25, AH CD8(+) T cells were an exceptional population in that nearly 85% of these cells expressed this molecule without concomitant Foxp3 expression. Despite having this phenotype, they should not be viewed as activated cells because most of them co-expressed CD127, which indicates that they are naive lymphocytes. With regard to the markers applied in the present research, CD8(+) CD25(+) CD127(+) Foxp3(-) T cells represent the most numerous subset of AH CD8(+) cells. The results suggest that eye chambers in mice are an element in the normal migratory pathway of naive CD8+ T cells. The study presented herein demonstrated only trace presence of CD4(+) cells in the eye chambers, as the mean percentage of these cells was just 0.56. Such selective and specific homing of CD8(+) and CD4(+) cells to the eye chambers is most clearly engaged in the induction and maintenance of ocular immune privilege.	[Maslanka, Tomasz; Ziolkowski, Hubert] Univ Warmia & Mazury, Fac Vet Med, Dept Pharmacol & Toxicol, Olsztyn, Poland; [Ziolkowska, Natalia] Univ Warmia & Mazury, Fac Vet Med, Dept Histol & Embryol, Olsztyn, Poland; [Malaczewska, Joanna] Univ Warmia & Mazury, Fac Vet Med, Dept Microbiol & Clin Immunol, Olsztyn, Poland	University of Warmia & Mazury; University of Warmia & Mazury; University of Warmia & Mazury	Maslanka, T (corresponding author), Univ Warmia & Mazury, Fac Vet Med, Dept Pharmacol & Toxicol, Olsztyn, Poland.	tomasz.maslanka@uwm.edu.pl	Małaczewska, Joanna/D-5461-2013; Ziółkowski, Hubert/AAX-8051-2021; Maslanka, Tomasz/C-2663-2012	Małaczewska, Joanna/0000-0002-9693-6692; Ziółkowski, Hubert/0000-0002-9314-8666; Maslanka, Tomasz/0000-0002-3807-0149	University of Warmia and Mazury in Olsztyn [15.610.008-300]	University of Warmia and Mazury in Olsztyn	The study was supported by grant No. 15.610.008-300 from the University of Warmia and Mazury in Olsztyn. Publication costs will be covered by KNOW (Leading National Research Centre) Scientific Consortium "Healthy Animal-Safe Food", decision of Ministry of Science and Higher Education No. 05-1/KNOW2/2015.	Avunduk AM, 1998, JPN J OPHTHALMOL, V42, P204, DOI 10.1016/S0021-5155(97)00142-1; Avunduk AM, 1997, OPHTHALMOLOGICA, V211, P84; Bachmann MF, 2006, EUR J IMMUNOL, V36, P842, DOI 10.1002/eji.200535730; Bienvenu B, 2005, J IMMUNOL, V175, P246, DOI 10.4049/jimmunol.175.1.246; Correale J, 2010, ANN NEUROL, V67, P625, DOI 10.1002/ana.21944; Cose S, 2006, EUR J IMMUNOL, V36, P1423, DOI 10.1002/eji.200535539; Cose S, 2007, IMMUNOLOGY, V120, P1, DOI 10.1111/j.1365-2567.2006.02511.x; Cosmi L, 2003, BLOOD, V102, P4107, DOI 10.1182/blood-2003-04-1320; Crawley AM, 2009, INT IMMUNOL, V21, P29, DOI 10.1093/intimm/dxn120; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Hori Junko, 2008, J Ocul Biol Dis Infor, V1, P94, DOI 10.1007/s12177-008-9010-6; Jiang LQ, 2007, MOL VIS, V13, P968; Keynan Y, 2008, CLIN INFECT DIS, V46, P1046, DOI 10.1086/529379; Kim TW, 2008, J KOREAN OPHTHALMOL, V49, P1475; Kosiewicz MM, 1996, J IMMUNOL, V157, P1905; Lewis M, 2008, IMMUNOL CELL BIOL, V86, P226, DOI 10.1038/sj.icb.7100132; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Luettig B, 1999, J IMMUNOL, V163, P4300; Luettig B, 2001, AM J RESP CELL MOL, V25, P69, DOI 10.1165/ajrcmb.25.1.4414; Maile R, 2001, J IMMUNOL, V167, P3708, DOI 10.4049/jimmunol.167.7.3708; Maslanka T, 2016, EUR J PHARMACOL, V775, P78, DOI 10.1016/j.ejphar.2016.02.023; Paiva RS, 2013, P NATL ACAD SCI USA, V110, P6494, DOI 10.1073/pnas.1221955110; Sanz-Marco E, 2013, OCUL IMMUNOL INFLAMM, V21, P408, DOI 10.3109/09273948.2013.801993; SCHONRICH G, 1991, CELL, V65, P293, DOI 10.1016/0092-8674(91)90163-S; Sugita S, 2007, EXP EYE RES, V85, P626, DOI 10.1016/j.exer.2007.07.015; Westermann J, 2001, IMMUNOL REV, V184, P20, DOI 10.1034/j.1600-065x.2001.1840103.x; Workman CJ, 2009, CELL MOL LIFE SCI, V66, P2603, DOI 10.1007/s00018-009-0026-2; ZHANG L, 1995, J IMMUNOL, V155, P3464	29	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0170021	10.1371/journal.pone.0170021	http://dx.doi.org/10.1371/journal.pone.0170021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081241	Green Submitted, gold, Green Published			2022-12-26	WOS:000391949500120
J	Prima, MC; Duchesne, T; Fortin, D				Prima, Marie-Caroline; Duchesne, Thierry; Fortin, Daniel			Robust Inference from Conditional Logistic Regression Applied to Movement and Habitat Selection Analysis	PLOS ONE			English	Article							GENERALIZED ESTIMATING EQUATIONS; HIDDEN MARKOV-MODELS; RESOURCE SELECTION; CARIBOU; RESPONSES; BEHAVIOR; ROADS; PATTERNS; ECOLOGY; WOLVES	Conditional logistic regression (CLR) is widely used to analyze habitat selection and movement of animals when resource availability changes over space and time. Observations used for these analyses are typically autocorrelated, which biases model-based variance estimation of CLR parameters. This bias can be corrected using generalized estimating equations (GEE), an approach that requires partitioning the data into independent clusters. Here we establish the link between clustering rules in GEE and their effectiveness to remove statistical biases in variance estimation of CLR parameters. The current lack of guidelines is such that broad variation in clustering rules can be found among studies (e.g., 14- 450 clusters) with unknown consequences on the robustness of statistical inference. We simulated datasets reflecting conditions typical of field studies. Longitudinal data were generated based on several parameters of habitat selection with varying strength of autocorrelation and some individuals having more observations than others. We then evaluated how changing the number of clusters impacted the effectiveness of variance estimators. Simulations revealed that 30 clusters were sufficient to get unbiased and relatively precise estimates of variance of parameter estimates. The use of destructive sampling to increase the number of independent clusters was successful at removing statistical bias, but only when observations were temporally autocorrelated and the strength of inter-individual heterogeneity was weak. GEE also provided robust estimates of variance for different magnitudes of unbalanced datasets. Our simulations demonstrate that GEE should be estimated by assigning each individual to a cluster when at least 30 animals are followed, or by using destructive sampling for studies with fewer individuals having intermediate level of behavioural plasticity in selection and temporally autocorrelated observations. The simulations provide valuable information to build reliable habitat selection and movement models that allow for robustness of statistical inference without removing excessive amounts of ecological information.	[Prima, Marie-Caroline; Fortin, Daniel] Univ Laval, Dept Biol, Quebec City, PQ, Canada; [Duchesne, Thierry] Univ Laval, Dept Math & Stat, Quebec City, PQ, Canada	Laval University; Laval University	Prima, MC (corresponding author), Univ Laval, Dept Biol, Quebec City, PQ, Canada.	marie-carolina.prima.1@ulaval.ca	Fortin, Daniel/ABG-3554-2020	Duchesne, Thierry/0000-0001-9893-604X	Natural Sciences and Engineering Research Council of Canada; Fonds de recherche du Quebec - Nature et Technologies	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de recherche du Quebec - Nature et Technologies	Funding was provided by the Natural Sciences and Engineering Research Council of Canada (M-CP) http://www.nserc-crsng.gc.ca and the Fonds de recherche du Quebec - Nature et Technologies (TD DF) http://www.frqnt.gouv.qc.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur SM, 1996, ECOLOGY, V77, P215, DOI 10.2307/2265671; Babin JS, 2011, ECOLOGY, V92, P240, DOI 10.1890/10-0252.1; Bartzke GS, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00278.1; Basille M, 2013, ECOGRAPHY, V36, P220, DOI 10.1111/j.1600-0587.2011.07367.x; Bonnot N, 2015, BEHAV ECOL, V26, P105, DOI 10.1093/beheco/aru169; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Compton BW, 2002, ECOLOGY, V83, P833, DOI 10.1890/0012-9658(2002)083[0833:HSBWTC]2.0.CO;2; Courbin N, 2014, ECOL MONOGR, V84, P265, DOI 10.1890/12-2118.1; Craiu RV, 2008, BIOMETRICAL J, V50, P97, DOI 10.1002/bimj.200610379; Craiu RV, 2011, J COMPUT GRAPH STAT, V20, P767, DOI 10.1198/jcgs.2011.09189; Duchesne T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122947; Duchesne T, 2010, J ANIM ECOL, V79, P548, DOI 10.1111/j.1365-2656.2010.01670.x; Dussault C, 2012, P ROY SOC B-BIOL SCI, V279, P4481, DOI 10.1098/rspb.2012.1700; Fieberg J, 2010, PHILOS T R SOC B, V365; Fieberg J, 2009, J APPL ECOL, V46, P1018, DOI 10.1111/j.1365-2664.2009.01692.x; Fitzmaurice G, 2011, APPL LONGITUDINAL AN, V2nd; Forester JD, 2009, ECOLOGY, V90, P3554, DOI 10.1890/08-0874.1; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Franke A, 2004, ECOL MODEL, V173, P259, DOI 10.1016/j.ecolmodel.2003.06.004; Hardin JW., 2002, GEN ESTIMATING EQUAT; Johnson CJ, 2002, J ANIM ECOL, V71, P225, DOI 10.1046/j.1365-2656.2002.00595.x; Koper N, 2009, J APPL ECOL, V46, P590, DOI 10.1111/j.1365-2664.2009.01642.x; Langrock R, 2012, ECOLOGY, V93, P2336, DOI 10.1890/11-2241.1; Latombe G, 2014, J ANIM ECOL, V83, P185, DOI 10.1111/1365-2656.12108; Lewis DL, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00137.1; Losier CL, 2015, J APPL ECOL, V52, P496, DOI 10.1111/1365-2664.12400; Marchand P, 2015, ANIM BEHAV, V102, P169, DOI 10.1016/j.anbehav.2015.01.011; MCNAY RS, 1994, J WILDLIFE MANAGE, V58, P422, DOI 10.2307/3809312; Mysterud A, 1998, ECOLOGY, V79, P1435, DOI 10.1890/0012-9658(1998)079[1435:FRIHUA]2.0.CO;2; REYNOLDS TD, 1990, J WILDLIFE MANAGE, V54, P316, DOI 10.2307/3809049; Roever CL, 2010, ECOGRAPHY, V33, P1113, DOI 10.1111/j.1600-0587.2010.06077.x; Rossman S, 2015, MAR MAMMAL SCI, V31, P155, DOI 10.1111/mms.12143; SCHOOLEY RL, 1994, J WILDLIFE MANAGE, V58, P367, DOI 10.2307/3809404; Stamps JA, 2007, APPL ANIM BEHAV SCI, V102, P392, DOI 10.1016/j.applanim.2006.05.038; Tardy O, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00197.1; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; Thurfjell H., 2014, MOV ECOL, V2, P1, DOI [DOI 10.1186/2051-3933-2-4, DOI 10.1007/S10980-013-9861-5]; Wilson RR, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00193.1; Ziegler A, 1998, BIOMETRICAL J, V40, P115, DOI 10.1002/(SICI)1521-4036(199806)40:2<115::AID-BIMJ115>3.0.CO;2-6; Zimmermann B, 2014, BEHAV ECOL, V25, P1353, DOI 10.1093/beheco/aru134	40	30	30	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169779	10.1371/journal.pone.0169779	http://dx.doi.org/10.1371/journal.pone.0169779			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081571	Green Published, Green Submitted, gold			2022-12-26	WOS:000391949500078
J	Wang, HL; Tong, XL; Liu, MJ; Hu, H; Li, ZQ; Xiang, ZH; Dai, FY; Lu, C				Wang, Honglei; Tong, Xiaoling; Liu, Meijing; Hu, Hai; Li, Zhiquan; Xiang, Zhonghuai; Dai, Fangyin; Lu, Cheng			Fine Mapping of a Degenerated Abdominal Legs Mutant (E-dl) in Silkworm, Bombyx mori	PLOS ONE			English	Article							DISTAL-LESS GENE; LIMB DEVELOPMENT; BITHORAX COMPLEX; PROLEG DEVELOPMENT; DROSOPHILA EMBRYO; HOX GENES; APPENDAGE DEVELOPMENT; HOMEOTIC GENES; EVOLUTION; EXPRESSION	In insects, abdominal appendages, also called prolegs, vary due to adaptive evolution. Mutations on prolegs within species provide insights to better understand the mechanisms underlying appendage development and diversity. In silkworm Bombyx mori, extra-crescents and degenerated abdominal legs (E-dl) mutant, belonging to the E pseudoallele group, is a spontaneous mutation that adds crescents and degenerates prolegs on the third abdominal segment (A3). This mutation may be a homeotic transformation of A3 to A2. In this study, the E-dl locus was mapped within approximately a 211 Kb region that is 10 Kb upstream of Bmabdominal-A (Bmabd-A). RT-quantitative PCR (RT-qPCR) and Western blot analysis of Bmabd-A expression showed a slight but significant decrease, while the expression of BmUltrabithorax (BmUbx) was up-regulated in the E-dl mutant compared to wildtype (Dazao). Moreover, we also found that BmDistal-less (BmDll), which regulated the development of distal proleg structures, was missing at the tips of the A3 prolegs in the E-dl mutant compared to BmDll expression in normally developed prolegs in both the wildtype and mutant. Collectively, we identified approximately a 211 Kb region in the E-dl locus that regulates BmUbx and Bmabd-A expression and found that changes in BmUbx and Bmabd-A expression may lead to the loss of distal proleg structures in B. mori.	[Wang, Honglei; Tong, Xiaoling; Liu, Meijing; Hu, Hai; Li, Zhiquan; Xiang, Zhonghuai; Dai, Fangyin; Lu, Cheng] Southwest Univ, State Key Lab Silkworm Genome Biol, Key Lab Sericulture Funct Genom & Biotechnol, Minist Agr, Chongqing, Peoples R China	Ministry of Agriculture & Rural Affairs; Southwest University - China	Dai, FY; Lu, C (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Key Lab Sericulture Funct Genom & Biotechnol, Minist Agr, Chongqing, Peoples R China.	fydai@swu.edu.cn; Chenglu@swu.edu.cn	Li, Zhiquan/AAQ-3300-2020	Li, Zhiquan/0000-0003-3253-7606; Xiang, Zhonghuai/0000-0003-3370-2984; Tong, Xiaoling/0000-0002-2649-899X	Hi-Tech Research and Development 863 Program of China Grant [2013AA102507]; National Natural Science Foundation of China [31472153, 30901053, 31372379]; Fundamental Research Funds for the Central Universities in China [XDJK2013A001]; Chongqing Youth Science and Technology Talent Training Project [cstc2014kjrc-qnrc80001]	Hi-Tech Research and Development 863 Program of China Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities in China; Chongqing Youth Science and Technology Talent Training Project	This work was funded by Hi-Tech Research and Development 863 Program of China Grant (No. 2013AA102507), National Natural Science Foundation of China (No. 31472153, No. 30901053 and No. 31372379), Fundamental Research Funds for the Central Universities in China (No. XDJK2013A001), and Chongqing Youth Science and Technology Talent Training Project (cstc2014kjrc-qnrc80001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzhanov A, 2001, DEVELOPMENT, V128, P2803; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Beermann A, 2001, DEVELOPMENT, V128, P287; Bender W, 2008, GENE DEV, V22, P14, DOI 10.1101/gad.1614208; Casares F, 2001, SCIENCE, V293, P1477, DOI 10.1126/science.1062542; CASTELLIGAIR J, 1995, DEVELOPMENT, V121, P2973; Chen P, 2013, INSECT MOL BIOL, V22, P497, DOI 10.1111/imb.12039; COHEN SM, 1989, EMBO J, V8, P2045, DOI 10.1002/j.1460-2075.1989.tb03613.x; COHEN SM, 1990, NATURE, V343, P173, DOI 10.1038/343173a0; COHEN SM, 1989, NATURE, V338, P432, DOI 10.1038/338432a0; Estrada B, 2001, DEVELOPMENT, V128, P331; Gummalla M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002720; Huang Y, 2010, MOL BIOL REP, V37, P3171, DOI 10.1007/s11033-009-9897-4; Jockusch EL, 2004, DEV GENES EVOL, V214, P324, DOI 10.1007/s00427-004-0412-6; Konopova B, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-2; Lemons D, 2006, SCIENCE, V313, P1918, DOI 10.1126/science.1132040; Lewis DL, 2000, P NATL ACAD SCI USA, V97, P4504, DOI 10.1073/pnas.97.9.4504; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Liu SP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-148; Maeda RK, 2006, DEVELOPMENT, V133, P1413, DOI 10.1242/dev.02323; Maeda RK, 2009, CURR TOP DEV BIOL, V88, P1, DOI 10.1016/S0070-2153(09)88001-0; Masumoto M, 2009, DEV GENES EVOL, V219, P437, DOI 10.1007/s00427-009-0305-9; Niwa N, 2000, DEVELOPMENT, V127, P4373; Palopoli MF, 1998, CURR BIOL, V8, P587, DOI 10.1016/S0960-9822(98)70228-3; Pan MH, 2009, INSECT MOL BIOL, V18, P155, DOI 10.1111/j.1365-2583.2009.00862.x; PANGANIBAN G, 1994, CURR BIOL, V4, P671, DOI 10.1016/S0960-9822(00)00151-2; PANGANIBAN G, 1995, SCIENCE, V270, P1363, DOI 10.1126/science.270.5240.1363; Schoppmeier M, 2001, DEV GENES EVOL, V211, P76, DOI 10.1007/s004270000121; Singh A, 2007, GENESIS, V45, P169, DOI 10.1002/dvg.20280; Snodgrass RE, 1935, PRINCIPLES INSECT MO; Takami T, 1960, TECH B SERICULT EXP, V75, P1; Tomita S, 2009, DEV BIOL, V328, P403, DOI 10.1016/j.ydbio.2009.01.040; Tong XL, 2014, DEV BIOL, V394, P357, DOI 10.1016/j.ydbio.2014.08.020; UENO K, 1992, DEVELOPMENT, V114, P555; VACHON G, 1992, CELL, V71, P437, DOI 10.1016/0092-8674(92)90513-C; WARREN RW, 1994, NATURE, V372, P458, DOI 10.1038/372458a0; Xiang H, 2008, HEREDITY, V100, P533, DOI 10.1038/hdy.2008.10; Xiang H, 2011, ARCH INSECT BIOCHEM, V76, P1, DOI 10.1002/arch.20393; XIANG ZH, 2005, BIOL SERICULTURE; Yasukochi Y, 2004, DEV GENES EVOL, V214, P606, DOI 10.1007/s00427-004-0441-1; Yu XM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002997; Zheng Z, 1999, DEV GENES EVOL, V209, P460, DOI 10.1007/s004270050279; Zhou JM, 1999, CELL, V99, P567, DOI 10.1016/S0092-8674(00)81546-9	43	1	1	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169224	10.1371/journal.pone.0169224	http://dx.doi.org/10.1371/journal.pone.0169224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081147	Green Published, Green Submitted, gold			2022-12-26	WOS:000391949500032
J	Woo, HJ; Yu, CG; Reifman, J				Woo, Hyung Jun; Yu, Chenggang; Reifman, Jaques			Collective Genetic Interaction Effects and the Role of Antigen-Presenting Cells in Autoimmune Diseases	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; THYMIC B-CELLS; MHC CLASS-I; T-CELLS; SELF-ANTIGENS; MECHANISMS; INSIGHTS; PATHOGENESIS; TOLERANCE; PATHWAYS	Autoimmune diseases occur when immune cells fail to develop or lose their tolerance toward self and destroy body's own tissues. Both insufficient negative selection of self-reactive T cells and impaired development of regulatory T cells preventing effector cell activation are believed to contribute to autoimmunity. Genetic predispositions center around the major histocompatibility complex (MHC) class II loci involved in antigen presentation, the key determinant of CD4(+) T cell activation. Recent studies suggested that variants in the MHC region also exhibit significant non-additive interaction effects. However, collective interactions involving large numbers of single nucleotide polymorphisms (SNPs) contributing to such effects are yet to be characterized. In addition, relatively little is known about the celltype-specificity of such interactions in the context of cellular pathways. Here, we analyzed type 1 diabetes (T1D) and rheumatoid arthritis (RA) genome-wide association data sets via large-scale, high-performance computations and inferred collective interaction effects involving MHC SNPs using the discrete discriminant analysis. Despite considerable differences in the details of SNP interactions in T1D and RA data, the enrichment pattern of interacting pairs in reference epigenomes was remarkably similar: statistically significant interactions were epigenetically active in cell-type combinations connecting B cells to T cells and intestinal epithelial cells, with both helper and regulatory T cells showing strong disease-associated interactions with B cells. Our results provide direct genetic evidence pointing to the important roles B cells play as antigen-presenting cells toward CD4(+) T cells in the context of central and peripheral tolerance. In addition, they are consistent with recent experimental studies suggesting that the repertoire of B cell-specific self-antigens in the thymus are critical to the effective control of corresponding autoimmune activation in peripheral tissues.	[Woo, Hyung Jun; Yu, Chenggang; Reifman, Jaques] US Army, Biotechnol High Performance Comp Software Applica, Telemed & Adv Technol Res Ctr, Med Res & Mat Command, Ft Detrick, MD 21702 USA		Woo, HJ; Reifman, J (corresponding author), US Army, Biotechnol High Performance Comp Software Applica, Telemed & Adv Technol Res Ctr, Med Res & Mat Command, Ft Detrick, MD 21702 USA.	woo@bhsai.org; jaques.reifman.civ@mail.mil		Woo, Jun/0000-0003-3220-2064	U.S. Army Medical Research and Materiel Command	U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	Support was provided by the U.S. Army Medical Research and Materiel Command.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andlauer TFM, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501678; Arnett HA, 2014, NAT REV IMMUNOL, V14, P559, DOI 10.1038/nri3715; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Behrens M, 2011, J AUTOIMMUN, V37, P95, DOI 10.1016/j.jaut.2011.05.002; Binici J, 2014, CELL MOL LIFE SCI, V71, P1829, DOI 10.1007/s00018-013-1522-y; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; Bradfield JP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002293; Brownlie RJ, 2013, NAT REV IMMUNOL, V13, P257, DOI 10.1038/nri3403; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Evans DM, 2009, HUM MOL GENET, V18, P3525, DOI 10.1093/hmg/ddp295; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Griffiths EK, 2002, CURR OPIN IMMUNOL, V14, P317, DOI 10.1016/S0952-7915(02)00334-5; Hogquist KA, 2014, NAT IMMUNOL, V15, P815, DOI 10.1038/ni.2938; Hsieh C. J., 2012, SCI J ED TECHNOLOGY, V2, P11, DOI DOI 10.1038/NRI3155; Hu XL, 2015, NAT GENET, V47, P898, DOI 10.1038/ng.3353; Kamper N, 2012, FASEB J, V26, P104, DOI 10.1096/fj.11-189670; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lenormand C, 2012, J IMMUNOL, V188, P3903, DOI 10.4049/jimmunol.1103048; Lenz TL, 2015, NAT GENET, V47, P1085, DOI 10.1038/ng.3379; Liu Y, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S3-S15; Liu Z, 2015, NATURE; Lu FT, 2015, J AUTOIMMUN, V61, P62, DOI 10.1016/j.jaut.2015.05.008; Malhotra D, 2016, NAT IMMUNOL, V17, P187, DOI 10.1038/ni.3327; McPhee CG, 2011, J IMMUNOL, V187, P4695, DOI 10.4049/jimmunol.1101776; Narayan K, 2009, MOL IMMUNOL, V46, P3157, DOI 10.1016/j.molimm.2009.07.001; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; O'Neill SK, 2005, J IMMUNOL, V174, P3781, DOI 10.4049/jimmunol.174.6.3781; Oh H, 2013, IMMUNOL REV, V252, P41, DOI 10.1111/imr.12033; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Perera J, 2013, P NATL ACAD SCI USA, V110, P17011, DOI 10.1073/pnas.1313001110; Plagnol V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002216; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Poluektov YO, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00260; Polychronakos C, 2011, NAT REV GENET, V12, P781, DOI 10.1038/nrg3069; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rangachari M, 2012, NAT MED, V18, P1394, DOI 10.1038/nm.2871; Sadegh-Nasseri S, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00372; Serreze DV, 1998, J IMMUNOL, V161, P3912; Thedrez A, 2007, IMMUNOL REV, V215, P123, DOI 10.1111/j.1600-065X.2006.00468.x; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Viatte S, 2013, NAT REV RHEUMATOL, V9, P141, DOI 10.1038/nrrheum.2012.237; Wang HY, 2008, TRENDS CELL BIOL, V18, P486, DOI 10.1016/j.tcb.2008.07.005; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wei Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000678; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Woo HJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2871-3; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Yadav M, 2013, FRONT IMMUNOL, P4; Yamano T, 2015, IMMUNITY, V42, P1048, DOI 10.1016/j.immuni.2015.05.013; Yang SY, 2015, SCIENCE, V348, P589, DOI 10.1126/science.aaa7017; Zaiss DMW, 2011, J IMMUNOL, V187, P2302, DOI 10.4049/jimmunol.1101003	60	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169918	10.1371/journal.pone.0169918	http://dx.doi.org/10.1371/journal.pone.0169918			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081217	gold, Green Published, Green Submitted			2022-12-26	WOS:000391949500102
J	Li, Y; Li, X; Liu, J; Guo, W; Zhang, HC; Wang, JC				Li, Yue; Li, Xuan; Liu, Jie; Guo, Wei; Zhang, Hongchao; Wang, Jianchang			Enhanced Rb/E2F and TSC/mTOR Pathways Induce Synergistic Inhibition in PDGF-Induced Proliferation in Vascular Smooth Muscle Cells	PLOS ONE			English	Article							GROWTH; CYCLE; EXPRESSION; MIGRATION; DISEASE; TARGET	Platelet-derived growth factor (PDGF) plays an essential role in proliferation of vascular smooth muscle cells (VSMCs). The Rb/E2F and TSC/mTOR pathways contribute to the proliferation of VSMCs, but its exact roles in PDGF-induced proliferation are unclear. In this study, we demonstrated the roles of Rb/E2F and TSC/mTOR pathways in PDGF-induced proliferation in VSMCs. We found that PDGF stimulates the activity of E2F and mTOR path-ways, and knockdown of either Rb or TSC2 increases PDGF-induced proliferation in VSMCs. More interestingly, we revealed that enhancing both E2F and mTOR activity leads to synergistic inhibition of PDGF-induced proliferation in VSMCs. We further identified that the synergistic inhibition effect is caused by the induced oxidative stress. Summarily, these data suggest the important regulations of Rb/E2F and TSC/mTOR pathways in PDGF-induced proliferation in VSMCs, and also present a promising way to limit deregulated proliferation by PDGF induction in VSMCs.	[Li, Yue; Zhang, Hongchao; Wang, Jianchang] Air Force Gen Hosp Peoples Liberat Army, Dept Cardiac Surg, Beijing, Peoples R China; [Li, Xuan] China Med Univ, Hosp 1, Dept Vasc & Thyroid Surg, Shenyang, Liaoning, Peoples R China; [Liu, Jie; Guo, Wei] Gen Hosp Peoples Liberat Army, Dept Vasc & Endovasc Surg, Beijing, Peoples R China; [Liu, Jie] Harvard Med Sch, Brigham & Womens Hosp, Div Vasc & Endovasc Suregery, Vasc Surg Res Labs, Boston, MA USA	Air Force General Hospital PLA; China Medical University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Wang, JC (corresponding author), Air Force Gen Hosp Peoples Liberat Army, Dept Cardiac Surg, Beijing, Peoples R China.	jcwangkz@126.com			Army Logistics Research Plan [BWS13C029]	Army Logistics Research Plan	This work was supported by the Army Logistics Research Plan, grant No.BWS13C029 (http://www.mod.gov.cn/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourmoum M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148097; Braun-Dullaeus RC, 1998, CIRCULATION, V98, P82, DOI 10.1161/01.CIR.98.1.82; Braun-Dullaeus RC, 2001, ARTERIOSCL THROM VAS, V21, P1152, DOI 10.1161/hq0701.092104; CHANG MW, 1995, SCIENCE, V267, P518, DOI 10.1126/science.7824950; De Donatis A, 2008, J BIOL CHEM, V283, P19948, DOI 10.1074/jbc.M709428200; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; FIORANI M, 1995, BBA-MOL CELL RES, V1269, P98, DOI 10.1016/0167-4889(95)00109-6; Gallo R, 1999, CIRCULATION, V99, P2164, DOI 10.1161/01.CIR.99.16.2164; Griendling KK, 1998, J LAB CLIN MED, V132, P9, DOI 10.1016/S0022-2143(98)90019-1; Li BH, 2010, CANCER CELL, V17, P469, DOI 10.1016/j.ccr.2010.03.019; Li PF, 1997, FEBS LETT, V404, P249, DOI 10.1016/S0014-5793(97)00093-8; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Satoh K, 2010, ANTIOXID REDOX SIGN, V12, P675, DOI 10.1089/ars.2009.2875; SCHWARTZ SM, 1986, CIRC RES, V58, P427, DOI 10.1161/01.RES.58.4.427; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Yang ZY, 1996, P NATL ACAD SCI USA, V93, P7905, DOI 10.1073/pnas.93.15.7905; Zeng Q, 2016, EXP CELL RES, V345, P82, DOI 10.1016/j.yexcr.2016.05.014; Zhan YM, 2003, ARTERIOSCL THROM VAS, V23, P795, DOI 10.1161/01.ATV.0000066132.32063.F2	19	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0170036	10.1371/journal.pone.0170036	http://dx.doi.org/10.1371/journal.pone.0170036			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076433	Green Published, Green Submitted, gold			2022-12-26	WOS:000391857100080
J	Jadhav, S; Russo, S; Cowart, LA; Greenberg, ML				Jadhav, Shyamalagauri; Russo, Sarah; Cowart, L. Ashley; Greenberg, Miriam L.			Inositol Depletion Induced by Acute Treatment of the Bipolar Disorder Drug Valproate Increases Levels of Phytosphingosine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SPHINGOLIPID HOMEOSTASIS; PROTEIN; BIOSYNTHESIS; YEAST; GENES; ORM2; PHOSPHORYLATION; MODULATION; LITHIUM	Bipolar disorder (BD) is a severe psychiatric illness affecting similar to 1% of the world population. Valproate (VPA) and lithium, widely used for the treatment of BD, are not universally effec-tive. These drugs have been shown to cause inositol depletion, but translating this observation to a specific therapeutic mech-anism has been difficult, hampering the development of more effective therapies. We have shown previously in yeast that chronic VPA treatment induces the unfolded protein response due to increasing ceramide levels. To gain insight into the mechanisms activated during acute VPA treatment, we performed a genome-wide expression study in yeast treated with VPA for 30 min. We observed increased mRNA and protein levels of RSB1, which encodes an exporter of long chain bases dihydrosphingosine (DHS) and phytosphingosine (PHS), and further saw that VPA increased sensitivity of an rsb1 Delta mutant to PHS, suggesting that VPA increases long chain base levels. Consistent with this, PHS levels were elevated in wild type and, to a greater extent, in rsb1 Delta cells. Expression of ORM genes (negative regulators of PHS synthesis) and of fatty acid elongase genes FEN1 and SUR4 were decreased, and expression of YOR1 (exporter of PHS-1P) and DPL1 (lyase that degrades DHS-1P and PHS-1P) was increased. These effects were more pronounced in medium lacking inositol, and were mirrored by inositol starvation of an ino1 Delta mutant. These findings provide a metabolic explanation as to how VPA-mediated inositol depletion causes increased synthesis of PHS and further support the therapeutic relevance of inositol depletion as a bipolar disorder treatment.	[Jadhav, Shyamalagauri; Greenberg, Miriam L.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Russo, Sarah; Cowart, L. Ashley] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Russo, Sarah; Cowart, L. Ashley] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29425 USA; [Jadhav, Shyamalagauri] NIDDK, NIH, Bethesda, MD 20892 USA	Wayne State University; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Greenberg, ML (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	mgreenberg@wayne.edu		Jadhav, Shyamalagauri/0000-0003-4302-6713	National Institutes of Health [DK081367]; Graduate School of Wayne State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Graduate School of Wayne State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK081367 (to M. L. G.), and support from the Graduate School of Wayne State University (to S. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Belmaker RH, 2004, NEW ENGL J MED, V351, P476, DOI 10.1056/NEJMra035354; BERRIDGE MJ, 1989, CELL, V59, P411, DOI 10.1016/0092-8674(89)90026-3; Boujaoude LC, 2001, J BIOL CHEM, V276, P35258, DOI 10.1074/jbc.M105442200; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Brice SE, 2009, J BIOL CHEM, V284, P7588, DOI 10.1074/jbc.M808325200; Darios F, 2009, NEURON, V62, P683, DOI 10.1016/j.neuron.2009.04.024; Deranieh RM, 2013, J BIOL CHEM, V288, P26822, DOI 10.1074/jbc.M113.479121; Gould TD, 2004, MOL PSYCHIATR, V9, P734, DOI 10.1038/sj.mp.4001518; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Jadhav S, 2016, J BIOL CHEM, V291, P22253, DOI 10.1074/jbc.M116.752634; Johnson SS, 2010, J BIOL CHEM, V285, P35792, DOI 10.1074/jbc.M110.162883; Ju SL, 2003, MOL MICROBIOL, V49, P1595, DOI 10.1046/j.1365-2958.2003.03641.x; Kihara A, 2002, J BIOL CHEM, V277, P30048, DOI 10.1074/jbc.M203385200; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; Liu M, 2012, J CELL SCI, V125, P2428, DOI 10.1242/jcs.100578; Nagiec MM, 1998, J BIOL CHEM, V273, P19437, DOI 10.1074/jbc.273.31.19437; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Panwar SL, 2006, J BIOL CHEM, V281, P6376, DOI 10.1074/jbc.M512115200; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Saba JD, 1997, J BIOL CHEM, V272, P26087, DOI 10.1074/jbc.272.42.26087; Shaltiel G, 2004, BIOL PSYCHIAT, V56, P868, DOI 10.1016/j.biopsych.2004.08.027; Sreenivas A, 2001, J BIOL CHEM, V276, P29915, DOI 10.1074/jbc.M105147200; Vaden DL, 2001, J BIOL CHEM, V276, P15466, DOI 10.1074/jbc.M004179200; Ye CQ, 2015, J NEUROCHEM, V133, P273, DOI 10.1111/jnc.12978	25	2	3	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4953	4959		10.1074/jbc.M117.775460	http://dx.doi.org/10.1074/jbc.M117.775460			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28100786	hybrid, Green Published			2022-12-26	WOS:000397590400017
J	Yang, L; Scarlata, S				Yang, Lu; Scarlata, Suzanne			Super-resolution Visualization of Caveola Deformation in Response to Osmotic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						caveolae; fluorescence; G protein; membrane structure; osmotic swelling	FLUORESCENCE CORRELATION SPECTROSCOPY; PROTEIN-COUPLED RECEPTORS; LIPID RAFTS; RYANODINE RECEPTORS; PHOSPHOLIPASE-C; PLASMA-MEMBRANE; HEK293 CELLS; CARDIOMYOCYTES; TRAFFICKING; G(S)	Caveolae are protein-dense plasma membrane domains structurally composed of caveolin-1 or -3 along with other proteins. Our previous studies have shown that caveolae enhance calcium signals generated through the G(q)/phospholipase C signaling pathway and that subjecting cells to hypo-osmotic stress reverses this enhancement. In this study, we have used super-resolution fluorescence microscopy supplemented by fluorescence correlation studies to determine the structural factors that underlie this behavior. We find similar and significant population of G(q) and one of its receptors, bradykinin type 2 receptor (B2R), as well as a significant population of G(i) and its coupled 2-adrenergic receptor (AR), are localized to caveola domains. Although mild osmotic stress deforms caveolae and alters interactions between the caveolae and these proteins, the general structure and the localization of caveola components remain largely unchanged. This deformation eliminates the ability of caveolae to stabilize calcium signals mediated through G(q)-B2R, but does not affect cAMP signals mediated through G(i) and AR. Structurally, we find that mild osmotic stress corresponding roughly to a pressure of 3.82 newtons/m(2) increases the domain diameter by approximate to 30% and increases the fluorescence intensity in the center of the domain mouth suggesting a flattening of the invagination. Approximate calculations show that caveolae in muscle tissue have the strength to handle the stress of muscle movement.	[Yang, Lu; Scarlata, Suzanne] Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA	Worcester Polytechnic Institute	Scarlata, S (corresponding author), Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA.	sfscarlata@wpi.edu			National Institutes of Health [1S10OD016405-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116178] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Christian Soeller for advice on handling the super-resolution data, Dr. Yuanjian Guo for help with some of the experimental methods, and Dr. Urszula Golebiewska for reading the manuscript. The purchase of the Nikon SIM (or STORM) was supported, in part, by National Institutes of Health Grant 1S10OD016405-01.	Abulrob A, 2008, J MICROSC-OXFORD, V232, P225, DOI 10.1111/j.1365-2818.2008.02093.x; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Calizo RC, 2013, ANAL BIOCHEM, V440, P40, DOI 10.1016/j.ab.2013.04.033; Calizo RC, 2012, BIOCHEMISTRY-US, V51, P9513, DOI 10.1021/bi301107p; Chini B, 2004, J MOL ENDOCRINOL, V32, P325, DOI 10.1677/jme.0.0320325; DiPilato LM, 2009, MOL BIOSYST, V5, P832, DOI 10.1039/b823243a; Gabor K, 2011, BIOPHYS J, V100, P21; Golias Ch, 2007, Hippokratia, V11, P124; Guo YJ, 2015, J BIOL CHEM, V290, P16698, DOI 10.1074/jbc.M115.655126; Guo YJ, 2011, BIOPHYS J, V100, P1599, DOI 10.1016/j.bpj.2011.02.013; HEREMANS K, 1982, ANNU REV BIOPHYS BIO, V11, P1, DOI 10.1146/annurev.bb.11.060182.000245; Hynes TR, 2004, J BIOL CHEM, V279, P44101, DOI 10.1074/jbc.M405151200; Jayasinghe ID, 2012, BIOPHYS J, V102, pL9, DOI 10.1016/j.bpj.2012.01.034; Lamb ME, 2002, BIOCHEMISTRY-US, V41, P14340, DOI 10.1021/bi020231d; Lamb ME, 2001, BIOCHEM J, V355, P741, DOI 10.1042/bj3550741; Mora R, 1999, J BIOL CHEM, V274, P25708, DOI 10.1074/jbc.274.36.25708; Murthy KS, 2000, J BIOL CHEM, V275, P30211, DOI 10.1074/jbc.M002194200; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; OHYASHIKI T, 1985, J BIOL CHEM, V260, P6857; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Petrasek Z, 2008, BIOPHYS J, V94, P1437, DOI 10.1529/biophysj.107.108811; Philip F, 2007, J BIOL CHEM, V282, P19203, DOI 10.1074/jbc.M701558200; Philip Finly, 2006, Sci STKE, V2006, ppl5, DOI 10.1126/stke.3502006pl5; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; Sample V, 2012, NAT CHEM BIOL, V8, P375, DOI [10.1038/NCHEMBIO.799, 10.1038/nchembio.799]; Sengupta P, 2008, J CELL SCI, V121, P1363, DOI 10.1242/jcs.020081; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Stan RV, 2005, BBA-MOL CELL RES, V1746, P334, DOI 10.1016/j.bbamcr.2005.08.008; Steinberg SE, 2004, J MOL CELL CARDIOL, V37, P407, DOI 10.1016/j.yjmcc.2004.04.018; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Wong J, 2013, BIOPHYS J, V104, pL22, DOI 10.1016/j.bpj.2013.02.059	32	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3779	3788		10.1074/jbc.M116.768499	http://dx.doi.org/10.1074/jbc.M116.768499			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28096469	Green Published, hybrid			2022-12-26	WOS:000395542500020
J	Sugiyama, D; Kang, S; Brennan, TJ				Sugiyama, Daisuke; Kang, Sinyoung; Brennan, Timothy J.			Muscle Reactive Oxygen Species (ROS) Contribute to Post-Incisional Guarding via the TRPA1 Receptor	PLOS ONE			English	Article							PLANTAR RAT HINDPAW; NERVE GROWTH-FACTOR; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; PAIN BEHAVIORS; INFLAMMATION; TRPV1; SENSITIZATION; ACTIVATION; EXPRESSION	Background Deep tissues and their afferents have unique responses to various stimuli and respond to injury distinctively. However, the types of receptors and endogenous ligands that have a key role in pain after deep tissue incision are unknown. TRPA1 has been shown to mediate pain-related responses in inflammation- and nerve injury-induced pain models. We hypothesized that TRPA1 has an important role in pain behaviors after deep tissue incision. Methods The effect of various doses of intraperitoneal (i.p.) TRPA1 antagonist, HC-030031, on pain behaviors after skin + deep tissue incision of the rat hind paw was measured. In vivo reactive oxygen species (ROS)-imaging and hydrogen peroxide (H2O2) levels after incision were also evaluated. Separate groups of rats were examined for H2O2-evoked pain-related behaviors after injections into the deep tissue or the subcutaneous tissue. Results Guarding pain behavior after skin + deep tissue incision was decreased by i.p. HC-030031. However, HC-030031 did not affect mechanical or heat responses after incision. Treatment either before or after incision was effective against incision-induced guarding behavior. ROS increased after skin + deep tissue incision in both the incised muscle and the skin. Tissue H2O2 also increased in both skin and muscle after incision. H2O2 injection produced pain behaviors when injected into muscle but not after subcutaneous injection. Conclusions This study demonstrates that TRPA1 antagonist HC-030031 reduced spontaneous guarding pain behavior after skin + deep tissue incision. These data indicate that TRPA1 receptors on nociceptors are active in incised fascia and muscle but this is not evident in incised skin. Even though endogenous TRPA1 agonists like ROS and H2O2 were increased in both incised skin and muscle, those in skin do not contribute to nociceptive behaviors. This study suggests that endogenous TRPA1 ligands and the TRPA1 receptor are important targets for acute pain from deep tissue injury.	[Sugiyama, Daisuke; Kang, Sinyoung; Brennan, Timothy J.] Univ Iowa, Dept Anesthesia, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Brennan, Timothy J.] Univ Iowa, Dept Pharmacol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa		daisuke-sugiyama@uiowa.edu		Brennan, Timothy/0000-0002-0150-5145; Kang, Sinyoung/0000-0002-9632-2420; Sugiyama, Daisuke/0000-0002-4848-2059	Hydra Biosciences	Hydra Biosciences	TJB has received financial support for research from Hydra Biosciences. HC-030031 was a gift from Hydra Biosciences.	Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Banik RK, 2009, PAIN, V141, P41, DOI 10.1016/j.pain.2008.10.004; Barabas ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047988; Bautista DM, 2013, ANNU REV PHYSIOL, V75, P181, DOI 10.1146/annurev-physiol-030212-183811; Bekeschus S, 2014, FREE RADICAL RES, V48, P542, DOI 10.3109/10715762.2014.892937; Brennan TJ, 1996, PAIN, V64, P493, DOI 10.1016/0304-3959(95)01441-1; CODERRE TJ, 1992, J NEUROSCI, V12, P3665; Dai Y, 2016, SEMIN IMMUNOPATHOL, V38, P277, DOI 10.1007/s00281-015-0526-0; Dorr LD, 2007, J BONE JOINT SURG AM, V89A, P1153, DOI 10.2106/JBJS.F.00940; Fischer M, 2014, PAIN, V155, P511, DOI 10.1016/j.pain.2013.11.015; Guan LM, 2000, FREE RADICAL BIO MED, V28, P1182, DOI 10.1016/S0891-5849(00)00212-4; Hamalainen MM, 2009, J PAIN, V10, P637, DOI 10.1016/j.jpain.2009.01.003; Hamalainen MM, 2002, J NEUROPHYSIOL, V87, P712, DOI 10.1152/jn.00207.2001; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Kang S, 2010, PAIN, V148, P128, DOI 10.1016/j.pain.2009.10.031; Keeble JE, 2009, PAIN, V141, P135, DOI 10.1016/j.pain.2008.10.025; Koivisto A, 2014, BASIC CLIN PHARMACOL, V114, P50, DOI 10.1111/bcpt.12138; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; Malin S, 2011, J NEUROSCI, V31, P10516, DOI 10.1523/JNEUROSCI.2992-10.2011; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Ogonda L, 2005, J BONE JOINT SURG AM, V87A, P701, DOI 10.2106/JBJS.D.02645; Pogatzki EM, 2002, EUR J PAIN-LONDON, V6, P295, DOI 10.1053/eujp.2002.0339; Pogatzki EM, 2002, J NEUROPHYSIOL, V87, P721, DOI 10.1152/jn.00208.2001; Pogatzki EM, 2002, PAIN, V97, P151, DOI 10.1016/S0304-3959(02)00014-3; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; So K, 2015, J PHARMACOL SCI, V127, P237, DOI 10.1016/j.jphs.2014.10.003; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Sullivan MN, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005659; Sun WW, 2016, CELL STRESS CHAPERON, V21, P367, DOI 10.1007/s12192-015-0663-3; Trevisan G, 2013, ARTHRITIS RHEUM-US, V65, P2984, DOI 10.1002/art.38112; Viana F., 2016, J PHYSL IN PRESS; Wei H, 2012, ANESTHESIOLOGY, V117, P137, DOI 10.1097/ALN.0b013e31825adb0e; Wu CR, 2008, ANESTHESIOLOGY, V108, P1100, DOI 10.1097/ALN.0b013e31817302b3; Wu CR, 2009, ANESTHESIOLOGY, V110, P140, DOI 10.1097/ALN.0b013e318190bc84; Xu J, 2010, ANESTHESIOLOGY, V112, P153, DOI 10.1097/ALN.0b013e3181c2952e; Xu J, 2009, EUR J PAIN, V13, P820, DOI 10.1016/j.ejpain.2008.10.005; Xu J, 2009, PAIN, V144, P329, DOI 10.1016/j.pain.2009.05.019; Zahn PK, 2004, J PAIN, V5, P157, DOI 10.1016/j.jpain.2004.02.538; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	39	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170410	10.1371/journal.pone.0170410	http://dx.doi.org/10.1371/journal.pone.0170410			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103292	Green Published, Green Submitted, gold			2022-12-26	WOS:000392381100061
J	Gras, LL; Stockman, I; Brolin, K				Gras, Laure-Lise; Stockman, Isabelle; Brolin, Karin			Evaluation of 6 and 10 Year-Old Child Human Body Models in Emergency Events	PLOS ONE			English	Article							COMPUTED MUSCLE CONTROL; DYNAMIC SIMULATIONS; VEHICLE CRASHES; INJURY; KINEMATICS	Emergency events can influence a child's kinematics prior to a car-crash, and thus its interaction with the restraint system. Numerical Human Body Models (HBMs) can help understand the behaviour of children in emergency events. The kinematic responses of two child HBMs MADYMO 6 and 10 year-old models were evaluated and compared with child volunteers' data during emergency events braking and steering with a focus on the forehead and sternum displacements. The response of the 6 year-old HBM was similar to the response of the 10 year-old HBM, however both models had a different response compared with the volunteers. The forward and lateral displacements were within the range of volunteer data up to approximately 0.3 s; but then, the HBMs head and sternum moved significantly downwards, while the volunteers experienced smaller displacement and tended to come back to their initial posture. Therefore, these HBMs, originally intended for crash simulations, are not too stiff and could be able to reproduce properly emergency events thanks, for instance, to postural control.	[Gras, Laure-Lise; Stockman, Isabelle; Brolin, Karin] Chalmers Univ Technol, Div Vehicle Safety, Dept Appl Mech, Gothenburg, Sweden; [Gras, Laure-Lise] Univ Claude Bernard Lyon 1, IFSTTAR, LBMC, UMR T9406, Lyon, France	Chalmers University of Technology; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Universite Gustave-Eiffel	Gras, LL (corresponding author), Chalmers Univ Technol, Div Vehicle Safety, Dept Appl Mech, Gothenburg, Sweden.; Gras, LL (corresponding author), Univ Claude Bernard Lyon 1, IFSTTAR, LBMC, UMR T9406, Lyon, France.	laurelise.gras@gmail.com	Gras, Laure-Lise/AAG-8544-2021; /A-4801-2016	Gras, Laure-Lise/0000-0003-4927-9826; /0000-0002-9173-2498	Folksam's Research Fund; Strategic Area of Advance at Chalmers University of Technology	Folksam's Research Fund; Strategic Area of Advance at Chalmers University of Technology	Funding for this study was provided by Folksam's Research Fund and the Strategic Area of Advance at Chalmers University of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2012, TRAFFIC INJ PREV, V13, P600, DOI 10.1080/15389588.2012.676223; [Anonymous], 2012, MADYMO REFERENCE MAN; [Anonymous], 2013, PEDIAT INJURY BIOMEC; [Anonymous], 2012, MADYMO HUMAN MODELS; Behr M., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P263, DOI 10.1080/10255840310001606080; Bohman Katarina, 2011, Ann Adv Automot Med, V55, P15; Bohman K, 2011, TRAFFIC INJ PREV, V12, P62, DOI 10.1080/15389588.2010.526159; Brolin K, 2015, IRCOBI C LYON FRANC; Brolin Karin, 2005, Traffic Inj Prev, V6, P67, DOI 10.1080/15389580590903203; Brolin K, 2015, IATSS RES, V38, P92, DOI 10.1016/j.iatssr.2014.09.001; Cappon H, 2007, SAW WORLD C DETR MI; Dar FH, 2002, J BIOMECH, V35, P1155, DOI 10.1016/S0021-9290(02)00085-4; Durbin DR, 2003, JAMA-J AM MED ASSOC, V289, P2835, DOI 10.1001/jama.289.21.2835; Fice JB, 2012, J BIOMECH, V45, P1098, DOI 10.1016/j.jbiomech.2012.01.016; Global Human Body Models Consortium, 2011, GHMC M50 US MAN; Howard A, 2004, J TRAUMA, V56, P1276, DOI 10.1097/01.TA.0000078883.74947.EB; Johansson M, 2009, TRAFFIC INJ PREV, V10, P467, DOI 10.1080/15389580903149243; Jun OY, 2005, SPINE, V30, pE716, DOI 10.1097/01.brs.0000192280.53831.70; Kapoor T, 2005, SAE TECHNICAL PAPER, V2005-01-1303; Kendall RG, 2009, SAE INT J PASSEN CAR, V1, P938, DOI 10.4271/2008-01-1414; Kent Richard, 2006, Stapp Car Crash J, V50, P1; Koizumi T, 2005, IMAC 23 C EXP STRUCT; Meijer R, 2012, PAPER PRESENTED P IN; Mizuno K, 2006, INT CRASHW C ATH GRE; Mizuno Koji, 2005, Traffic Inj Prev, V6, P361, DOI 10.1080/15389580500255922; Neathery RF, 1974, P 18 STAPP CAR CRASH, P383; Okamoto M., 2003, 18 INT TECHN C ENH S; Olafsdottir JM, 2013, IRCOBI C GOTH SWED; Osth J, 2012, TRAFFIC INJ PREV, V13, P265, DOI 10.1080/15389588.2011.649437; Ouyang J, 2006, J TRAUMA, V61, P1492, DOI 10.1097/01.ta.0000233711.07823.40; Pheasant S., 2006, BODYSPACE ANTHROPOME; Stockman I, 2013, TRAFFIC INJ PREV, V14, P92, DOI 10.1080/15389588.2012.688151; Thelen DG, 2006, J BIOMECH, V39, P1107, DOI 10.1016/j.jbiomech.2005.02.010; Thelen DG, 2003, J BIOMECH, V36, P321, DOI 10.1016/S0021-9290(02)00432-3; Toyota Motor Corporation Toyota Central Labs Inc., 2008, US GUID COMP HUM MOD; Tropiano P, 2004, SPINE, V29, P1709, DOI 10.1097/01.BRS.0000135840.92373.5C; Twisk D, 1993, ECOSA PROD SAF C AMS; van der Horst M., 1997, STAP CAR CRASH C SAE, V41st, P487; Van der Horst MJ, 2002, THESIS; van Rooij L, 2005, 19 INT TECH C ENH SA; World Health Organization, 2009, GLOB STAT REP ROAD S; Zhang W, 2009, SAF WORLD C DETR MI	42	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0170377	10.1371/journal.pone.0170377	http://dx.doi.org/10.1371/journal.pone.0170377			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099505	Green Submitted, Green Published, gold			2022-12-26	WOS:000392380100082
J	Liao, XP; Chipenda-Dansokho, S; Lewin, A; Abdelouahab, N; Wei, SQ				Liao, Xiang-Peng; Chipenda-Dansokho, Selma; Lewin, Antoine; Abdelouahab, Nadia; Wei, Shu-Qin			Advanced Neonatal Medicine in China: A National Baseline Database	PLOS ONE			English	Article							RESPIRATORY-FAILURE; UNITED-STATES; MORTALITY; CARE; PEDIATRICIANS; MORBIDITY; PROGRAM	Previous surveys of neonatal medicine in China have not collected comprehensive information on workforce, investment, health care practice, and disease expenditure. The goal of the present study was to develop a national database of neonatal care units and compare present outcomes data in conjunction with health care practices and costs. We summarized the above components by extracting data from the databases of the national key clinical subspecialty proposals issued by national health authority in China, as well as publicly accessible databases. Sixty-one newborn clinical units from provincial or ministerial hospitals at the highest level within local areas in mainland China, were included for the study. Data were gathered for three consecutive years (2008-2010) in 28 of 31 provincial districts in mainland China. Of the 61 newborn units in 2010, there were 4,948 beds (median = 62 [IQR 43-110]), 1,369 physicians (median = 22 [IQR 15-29]), 3,443 nurses (median = 52 [IQR 33-81]), and 170,159 inpatient discharges (median = 2,612 [IQR 1,436-3,804]). During 2008-2010, the median yearly investment for a single newborn unit was US$344,700 (IQR 166,100-585,800), median length of hospital stay for overall inpatient newborns 9.5 (IQR 8.2-10.8) days, median inpatient antimicrobial drug use rate 68.7% (IQR 49.8-87.0), and median nosocomial infection rate 3.2% (IQR1.7-5.4). For the common newborn diseases of pneumonia, sepsis, respiratory distress syndrome, and very low birth weight (<1,500 grams) infants, their lengths of hospital stay, daily costs, hospital costs, ratios of hospital cost to per-capita disposable income, and ratios of hospital cost to per-capita health expenditure, were all significantly different across regions (North China, Northeast China, East China, South Central China, Southwest China, and Northwest China). The survival rate of extremely low birth weight (ELBW) infants (Birth weight <1,000 grams) was 76.0% during 2008-2010 in the five hospitals where each unit had more than 20 admissions of ELBW infants in 2010; and the median hospital cost for a single hospital stay in ELBW infants was US$8,613 (IQR 8,153-9,216), which was 3.0 times (IQR 2.0-3.2) the average per-capita disposable income, or 63 times (IQR 40.3-72.1) the average per-capita health expenditure of local urban residents in 2011. Our national database provides baseline data on the status of advanced neonatal medicine in China, gathering valuable information for quality improvement, decision making, longitudinal studies and horizontal comparisons.	[Liao, Xiang-Peng; Lewin, Antoine; Abdelouahab, Nadia] CHUS, Res Ctr, Sherbrooke, PQ, Canada; [Liao, Xiang-Peng] Nanjing Med Univ, Wuxi Matern & Child Hlth Hosp, Dept Newborn, Nanjing, Jiangsu, Peoples R China; [Chipenda-Dansokho, Selma] Univ Laval, Fac Med, Off Educ & Continuing Profess Dev, Quebec City, PQ, Canada; [Wei, Shu-Qin] Univ Montreal, St Justine Hosp, Dept Obstet & Gynecol, Montreal, PQ, Canada	University of Sherbrooke; Nanjing Medical University; Laval University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Liao, XP (corresponding author), CHUS, Res Ctr, Sherbrooke, PQ, Canada.; Liao, XP (corresponding author), Nanjing Med Univ, Wuxi Matern & Child Hlth Hosp, Dept Newborn, Nanjing, Jiangsu, Peoples R China.	lxp4848@aliyun.com	Liao, Xiangpeng/GNP-2312-2022		Scholarship of Canadian Institutes of Health Research - Quebec Training Network in Perinatal Research Program	Scholarship of Canadian Institutes of Health Research - Quebec Training Network in Perinatal Research Program(Canadian Institutes of Health Research (CIHR))	XPL was supported by the Scholarship of Canadian Institutes of Health Research - Quebec Training Network in Perinatal Research Program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus DC, 2001, AM J RESP CRIT CARE, V164, P1154, DOI 10.1164/ajrccm.164.7.2012126; [Anonymous], 2015, WORLD POP PROSP 2015; Caserta MT, 2015, NEONATAL SEPSIS; Caserta MT, 2015, NEONATAL PNEUMONIA; Fanaroff Avroy A, 2007, Am J Obstet Gynecol, V196, DOI 10.1016/j.ajog.2006.09.014; Feng XL, 2011, LANCET, V378, P1493, DOI 10.1016/S0140-6736(11)61096-9; Feng ZC, 2012, CHINESE J PEDIAT, V50, P326; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Hu KJ, 2014, LANCET, V383, P954, DOI 10.1016/S0140-6736(14)60482-7; Human Development Index, 2010, 2013 CHIN NAT HUM DE, P105; Itabashi K, 2009, PEDIATRICS, V123, P445, DOI 10.1542/peds.2008-0763; Jing HZ, 2002, PRACTICE NEONATOLOGY; Jones Huw P, 2005, BMC Pediatr, V5, P40, DOI 10.1186/1471-2431-5-40; Kendig JW, 2015, RESP DISTRESS SYNDRO; Lee SK, 2000, PEDIATRICS, V106, P1070, DOI 10.1542/peds.106.5.1070; Lin Ru, 2012, Zhonghua Er Ke Za Zhi, V50, P649; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Meadow W, 2004, PEDIATRICS, V113, P1223, DOI 10.1542/peds.113.5.1223; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Mukhopadhyay K, 2013, INDIAN PEDIATR, V50, P1119, DOI 10.1007/s13312-013-0305-8; Mulholland K, 2010, LANCET, V376, P89, DOI 10.1016/S0140-6736(10)61073-2; National Bureau of Statistics of China, 2014, CHIN POP EMPL STAT Y; National Bureau of Statistics of China, 2012, CHIN 2010 POP CENS D; Organisation for Economic Co-operation Development Staff, 2005, HLTH AT A GLANC; Pollack LD, 1998, PEDIATRICS, V101, P398, DOI 10.1542/peds.101.3.398; Qian LI, 2008, PEDIATRICS, V121, pE1115, DOI 10.1542/peds.2006-2426; Rudan I, 2010, LANCET, V375, P1083, DOI 10.1016/S0140-6736(10)60060-8; Singhal N, 2012, BMC MED EDUC, V12, DOI 10.1186/1472-6920-12-44; Smith LP, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-45; Sun B, 2013, ARCH DIS CHILD-FETAL, V98, pF440, DOI 10.1136/archdischild-2012-302524; Tagare A, 2013, INDIAN J PEDIATR, V80, P16, DOI 10.1007/s12098-012-0818-5; The United Nations Children's Fund, 2015, LEV TRENDS CHILD MOR, P19; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; Wang HH, 2012, PEDIATRICS, V129, pE731, DOI 10.1542/peds.2011-0725; Wang YP, 2016, LANCET, V387, P273, DOI 10.1016/S0140-6736(15)00554-1; Wang Y, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nen087; Wei KL, 2012, TRANSL PEDIATR, V1, P15, DOI 10.3978/j.issn.2224-4336.2011.10.01; Wen ZQ, 2009, COMPUTER MODERNIZATI, V6, P141; World Health Organization, 2014, EV NEWB ACT PLAN END; Xi-rong G, 2009, CHINESE J PERINATAL, P355; Xiong JY, 2013, SOC SCI MED, V97, P15, DOI 10.1016/j.socscimed.2013.08.006; Xu T, 2012, CHINESE MED J-PEKING, V125, P1448, DOI 10.3760/cma.j.issn.0366-6999.2012.08.017; Xu W, 2014, PEDIATRICS, V134, P1045, DOI 10.1542/peds.2014-1377; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Zhang Y, 2011, CHINESE MED J, V49, P669; 杜立中, 2015, [中华儿科杂志, Chinese Journal of Pediatrics], V53, P321; 封志纯, 2013, [中华实用儿科临床杂志, Chinese Journal of Applied Clinical Pediatrics], V28, P238	47	13	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0169970	10.1371/journal.pone.0169970	http://dx.doi.org/10.1371/journal.pone.0169970			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099450	Green Published, gold, Green Submitted			2022-12-26	WOS:000392380100046
J	Stiegel, S; Entling, MH; Mantilla-Contreras, J				Stiegel, Stephanie; Entling, Martin H.; Mantilla-Contreras, Jasmin			Reading the Leaves' Palm: Leaf Traits and Herbivory along the Microclimatic Gradient of Forest Layers	PLOS ONE			English	Article							INSECT HERBIVORY; PLANT DEFENSE; MALACOSOMA-DISSTRIA; FAGUS-SYLVATICA; WATER-STRESS; SUGAR MAPLE; TEMPERATURE; CANOPY; NITROGEN; PATTERNS	Microclimate in different positions on a host plant has strong direct effects on herbivores. But little is known about indirect effects due to changes of leaf traits. We hypothesized that herbivory increases from upper canopy to lower canopy and understory due to a combination of direct and indirect pathways. Furthermore, we hypothesized that herbivory in the understory differs between tree species in accordance with their leaf traits. We investigated herbivory by leaf chewing insects along the vertical gradient of mixed deciduous forest stands on the broad-leaved tree species Fagus sylvatica L. (European beech) with study sites located along a 140 km long transect. Additionally, we studied juvenile Acer pseudoplatanus L. (sycamore maple) and Carpinus betulus L. (hornbeam) individuals within the under story as a reference of leaf traits in the same microclimate. Lowest levels of herbivory were observed in upper canopies, where temperatures were highest. Temperature was the best predictor for insect herbivory across forest layers in our study. However, the direction was opposite to the generally known positive relationship. Herbivory also varied between the three tree species with lowest levels for F. sylvatica. Leaf carbon content was highest for F. sylvatica and probably indicates higher amounts of phenolic defense compounds. We conclude that the effect of temperature must have been indirect, whereby the expected higher herbivory was suppressed due to unfavorable leaf traits (lower nitrogen content, higher toughness and carbon content) of upper canopy leaves compared to the understory.	[Stiegel, Stephanie; Mantilla-Contreras, Jasmin] Univ Hildesheim, Inst Biol & Chem, Ecol & Environm Educ Grp, Hildesheim, Germany; [Entling, Martin H.] Univ Koblenz Landau, Dept Ecosyst Anal, Landau, Germany	University of Hildesheim; University of Koblenz & Landau	Stiegel, S (corresponding author), Univ Hildesheim, Inst Biol & Chem, Ecol & Environm Educ Grp, Hildesheim, Germany.	stiegel@uni-hildesheim.de	Entling, Martin H/C-6953-2008	Mantilla Contreras, Jasmin/0000-0002-3888-7917	University of Hildesheim	University of Hildesheim	JMC received financial support from the University of Hildesheim.	Al Afas N, 2007, ANN FOREST SCI, V64, P521, DOI 10.1051/forest:2007029; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Barton K., 2012, MUMIN MULTIMODEL INF; Bates D, 2012, LME4 LINEAR MIXED EF; BAZZAZ FA, 1991, ECOLOGY, V72, P12, DOI 10.2307/1938896; Borchard F, 2011, ECOL INDIC, V11, P1311, DOI 10.1016/j.ecolind.2011.02.005; Brooks JR, 1997, TREE PHYSIOL, V17, P1; Brunt C, 2006, OECOLOGIA, V148, P583, DOI 10.1007/s00442-006-0369-4; BRYANT JP, 1991, ANNU REV ECOL SYST, V22, P431, DOI 10.1146/annurev.es.22.110191.002243; Bussotti F, 1998, NEW PHYTOL, V138, P469, DOI 10.1046/j.1469-8137.1998.00121.x; Cebrian J, 1999, AM NAT, V154, P449, DOI 10.1086/303244; Chiarelli RN, 2011, ANN ENTOMOL SOC AM, V104, P488, DOI 10.1603/AN10163; Cisneros JJ, 2001, ENVIRON ENTOMOL, V30, P501, DOI 10.1603/0046-225X-30.3.501; Coley P.D., 1991, PLANT ANIMAL INTERAC, P25; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Crawley M. J., 1983, HERBIVORY DYNAMICS A; Crone EE, 1999, J CHEM ECOL, V25, P635, DOI 10.1023/A:1020966206840; Cunningham SA, 1999, ECOL MONOGR, V69, P569, DOI 10.1890/0012-9615(1999)069[0569:EDILSA]2.0.CO;2; Danks HV, 2002, OIKOS, V99, P10, DOI 10.1034/j.1600-0706.2002.990102.x; Dirzo R., 2008, TROPICAL FOREST COMM, P63; DUDT JF, 1994, ECOLOGY, V75, P86, DOI 10.2307/1939385; Elias P, 1989, TREES-STRUCT FUNCT, V3, P227, DOI 10.1007/BF00225356; ELLSWORTH DS, 1993, OECOLOGIA, V96, P169, DOI 10.1007/BF00317729; FEENY P, 1970, ECOLOGY, V51, P565, DOI 10.2307/1934037; Fortin M, 2002, CAN J FOREST RES, V32, P379, DOI 10.1139/X01-205; Franklin RT, 1970, ANAL TEMPERATE FORES, P86; FUTUYMA DJ, 1981, ENTOMOL EXP APPL, V30, P163, DOI 10.1007/BF00300882; Gossner MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104876; HARRISON S, 1987, OECOLOGIA, V72, P65, DOI 10.1007/BF00385046; Hartley SE, 2004, ECOL STU AN, V173, P27; Huberty AF, 2004, ECOLOGY, V85, P1383, DOI 10.1890/03-0352; Huberty AF, 2006, OECOLOGIA, V149, P444, DOI 10.1007/s00442-006-0462-8; Hunter MD, 2001, AGR FOREST ENTOMOL, V3, P153, DOI 10.1046/j.1461-9555.2001.00108.x; Jansen MPT, 1997, ENTOMOL EXP APPL, V82, P319, DOI 10.1023/A:1002916325052; Kessler M, 2007, FUNCT PLANT BIOL, V34, P963, DOI 10.1071/FP07087; Kimber I., 2015, UKMOTHS; Koike T, 2001, TREE PHYSIOL, V21, P951, DOI 10.1093/treephys/21.12-13.951; LANDSBERG J, 1989, TRENDS ECOL EVOL, V4, P96, DOI 10.1016/0169-5347(89)90054-2; Levesque KR, 2002, B ENTOMOL RES, V92, P127, DOI 10.1079/BER2002153; Lichtenthaler HK, 2000, PHOTOSYNTHETICA, V38, P521, DOI 10.1023/A:1012453205740; LINCOLN DE, 1984, OECOLOGIA, V64, P173, DOI 10.1007/BF00376867; Louda SM, 1996, J ECOL, V84, P229, DOI 10.2307/2261358; LOWMAN MD, 1985, AUST J ECOL, V10, P7, DOI 10.1111/j.1442-9993.1985.tb00859.x; MARQUIS RJ, 1994, ECOLOGY, V75, P2007, DOI 10.2307/1941605; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Matyssek R., 2010, BIOL DER BAUME; MCNAUGHTON SJ, 1989, NATURE, V341, P142, DOI 10.1038/341142a0; Modry M, 2004, FOREST ECOL MANAG, V188, P185, DOI 10.1016/j.foreco.2003.07.029; MOLE S, 1988, J CHEM ECOL, V14, P23, DOI 10.1007/BF01022528; Mulder CPH, 1999, ECOL LETT, V2, P237; Murakami M, 1997, CAN J FOREST RES, V27, P1351, DOI 10.1139/cjfr-27-9-1351; Niesenbaum RA, 2006, ENVIRON ENTOMOL, V35, P600, DOI 10.1603/0046-225X-35.3.600; Niinemets U, 1995, ACTA OECOL, V16, P525; Niinemets U, 2001, ECOLOGY, V82, P453, DOI 10.1890/0012-9658(2001)082[0453:GSCCOL]2.0.CO;2; Parker Geoffrey G., 1995, P73; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Rennwald E., 2013, LEPIFORUM BESTIMMUNG; Reynolds BC, 1997, ENVIRON ENTOMOL, V26, P1232, DOI 10.1093/ee/26.6.1232; Roberts MR, 2006, NEW PHYTOL, V170, P677, DOI 10.1111/j.1469-8137.2006.01707.x; Rouault G, 2006, ANN FOREST SCI, V63, P613, DOI 10.1051/forest:2006044; Rowe WJ, 1996, OECOLOGIA, V108, P459, DOI 10.1007/BF00333722; Ruhnke H, 2009, BASIC APPL ECOL, V10, P726, DOI 10.1016/j.baae.2009.06.006; Schadler M, 2003, OIKOS, V103, P121, DOI 10.1034/j.1600-0706.2003.12659.x; Sellin A, 2013, ECOL RES, V28, P523, DOI 10.1007/s11284-013-1041-1; SIMONET DE, 1981, CAN ENTOMOL, V113, P891, DOI 10.4039/Ent113891-10; Sobek S, 2009, OECOLOGIA, V160, P279, DOI 10.1007/s00442-009-1304-2; SOUTHWOOD TRE, 1986, OECOLOGIA, V70, P544, DOI 10.1007/BF00379901; Stamp N, 2003, Q REV BIOL, V78, P23, DOI 10.1086/367580; Stiling P, 2005, OECOLOGIA, V142, P413, DOI 10.1007/s00442-004-1739-4; STRATHDEE AT, 1993, OECOLOGIA, V96, P457, DOI 10.1007/BF00320502; Tjoelker MG, 1999, PLANT CELL ENVIRON, V22, P767, DOI 10.1046/j.1365-3040.1999.00435.x; van den Berg AK, 2004, FOREST ECOL MANAG, V200, P113, DOI 10.1016/j.foreco.2004.06.005; Wagner D, 2008, OECOLOGIA, V157, P259, DOI 10.1007/s00442-008-1067-1; Whittaker JB, 1998, J ANIM ECOL, V67, P987, DOI 10.1046/j.1365-2656.1998.6760987.x; WIKTELIUS S, 1981, Z ANGEW ENTOMOL, V92, P449; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wuytack T, 2011, ENVIRON POLLUT, V159, P2405, DOI 10.1016/j.envpol.2011.06.037; Xu ZZ, 2006, PLANTA, V224, P1080, DOI 10.1007/s00425-006-0281-5; Yamasaki M, 2003, OECOLOGIA, V137, P226, DOI 10.1007/s00442-003-1337-x; YUN JI, 1986, ECOLOGY, V67, P1314, DOI 10.2307/1938687; Zehnder CB, 2009, ENVIRON ENTOMOL, V38, P1161, DOI 10.1603/022.038.0424	82	20	21	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2017	12	1							e0169741	10.1371/journal.pone.0169741	http://dx.doi.org/10.1371/journal.pone.0169741			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HH	28099483	Green Published, gold, Green Submitted			2022-12-26	WOS:000392380100032
J	Barreto-Curiel, F; Focken, U; D'Abramo, LR; Viana, MT				Barreto-Curiel, Fernando; Focken, Ulfert; D'Abramo, Louis R.; Teresa Viana, Maria			Metabolism of Seriola lalandi during Starvation as Revealed by Fatty Acid Analysis and Compound-Specific Analysis of Stable Isotopes within Amino Acids	PLOS ONE			English	Article							MEVALONATE METABOLISM; SHUNT PATHWAY; KETONE-BODIES; FISH; DELTA-C-13; NITROGEN; PROTEIN; LIVER; ENRICHMENT; PHYSIOLOGY	Fish starvation is defined as food deprivation for a long period of time, such that physiological processes become confined to basal metabolism. Starvation provides insights in physiological processes without interference from unknown factors in digestion and nutrient absorption occurring in fed state. Juveniles of amberjack Seriola lalandi were isotopically equilibrated to a formulated diet for 60 days. One treatment consisted of fish that continued to be fed and fish in the other treatment were not fed for 35 days. The isotopic signatures prior to the beginning of and after the starvation period, for fish in the starvation and control treatments, were analysed for lipid content, fatty acid composition and isotopic analysis of bulk (EA-IRMS) and of amino acids (compound specific isotope analysis, CSIA). There were three replicates for the starvation group. Fatty acid content in muscle and liver tissue before and after starvation was determined to calculate percent change. Results showed that crude lipid was the most used source of energy in most cases; the PUFAs and LC-PUFAs were highly conserved. According to the protein signature in bulk (delta N-15) and per amino acid (delta C-13 and delta N-15), in muscle tissue, protein synthesis did not appear to occur substantially during starvation, whereas in liver, increases in delta C-13 and delta N-15 indicate that protein turnover occurred, probably for metabolic routing to energy-yielding processes. As a result, isotopic values of delta N-15 in muscle tissue do not change, whereas CSIA net change occurred in the liver tissue. During the study period of 35 days, muscle protein was largely conserved, being neither replenished from amino acid pools in the plasma and liver nor catabolized.	[Barreto-Curiel, Fernando] Univ Autonoma Baja California, Fac Ciencias Marinas, Ensenada, Baja California, Mexico; [Focken, Ulfert] Thuenen Inst Fisheries Ecol, Ahrensburg, Germany; [D'Abramo, Louis R.] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA; [Teresa Viana, Maria] UABC, Inst Invest Oceanol, Ensenada, Baja California, Mexico	Universidad Autonoma de Baja California; Johann Heinrich von Thunen Institute; University of Alabama System; University of Alabama Birmingham; Universidad Autonoma de Baja California	Viana, MT (corresponding author), UABC, Inst Invest Oceanol, Ensenada, Baja California, Mexico.	viana@uabc.edu.mx	Focken, Ulfert/A-8593-2008	Focken, Ulfert/0000-0002-8422-3943; Viana, Maria Teresa/0000-0002-3074-767X; BARRETO CURIEL, FERNANDO/0000-0001-5177-6632	Consejo Nacional de Ciencia y Tecnologia [CB-2014-237204]; Universidad Autonoma de Baja California [18a-630]; CONACYT [CB-2014-237204, 630]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad Autonoma de Baja California; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Consejo Nacional de Ciencia y Tecnologia: CB-2014-237204, Universidad Autonoma de Baja California: 18a-630.; We want to thanks Baja Seas for the fish species donation throughout Dr. Juan Pablo Lazo from CICESE. Also Fernando Barreto-Curiel thanks CONACYT for their fellowships for graduate studies. This project was financed by CONACYT (Project CB-2014-237204) and UABC (18<SUP>a</SUP> Convocatoria; Project 630).	AOAC, 1995, OFFICIAL ANALYTICAL, VI; Badillo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107523; Zapata DB, 2016, AQUAC RES, V47, P1778, DOI 10.1111/are.12636; Ben-Hamo M, 2013, COMP BIOCHEM PHYS A, V166, P244, DOI 10.1016/j.cbpa.2013.06.017; Bender D.A., 2012, AMINO ACID METABIS; BORUM PR, 1977, J NUTR, V107, P1209, DOI 10.1093/jn/107.7.1209; Bradley CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085818; Chang CC, 2007, FISH SHELLFISH IMMUN, V23, P24, DOI 10.1016/j.fsi.2006.09.001; Cherel Y, 2005, ECOLOGY, V86, P2881, DOI 10.1890/05-0562; Chikaraishi Y, 2009, LIMNOL OCEANOGR-METH, V7, P740, DOI 10.4319/lom.2009.7.740; Christie W.W., 1993, ADV LIPID METHODOLOG, P69, DOI DOI 10.1016/0009-3084(94)02308-5; COWEY CB, 1994, AQUACULTURE, V124, P1, DOI 10.1016/0044-8486(94)90349-2; Damasceno-Oliveira A, 2007, GEN COMP ENDOCR, V153, P385, DOI 10.1016/j.ygcen.2007.05.017; Fantle MS, 1999, OECOLOGIA, V120, P416, DOI 10.1007/s004420050874; Finn PF, 2006, NUTRITION, V22, P830, DOI 10.1016/j.nut.2006.04.008; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gaye-Siessegger J, 2007, J FISH BIOL, V71, P90, DOI 10.1111/j.1095-8649.2007.01469.x; Gillis TE, 1996, J FISH BIOL, V49, P1306, DOI 10.1111/j.1095-8649.1996.tb01797.x; Hambraeus L., 2014, REFERENCE MODULE BIO, P1; Hassel B, 2001, J NEUROSCI RES, V66, P755, DOI 10.1002/jnr.10044; HENDERSON RJ, 1987, PROG LIPID RES, V26, P281, DOI 10.1016/0163-7827(87)90002-6; HOBSON KA, 1993, CONDOR, V95, P388, DOI 10.2307/1369361; Hochachka P. W., 1984, BIOCH ADAPTATION; Jochmann M.A., 2012, COMPOUND SPECIFIC ST; Karasov W. H., 2007, PHYSL ECOLOGY ANIMAL; Kaushik SJ, 2010, AQUAC RES, V41, P322, DOI 10.1111/j.1365-2109.2009.02174.x; KOPITO RR, 1984, J BIOL CHEM, V259, P372; Lee TN, 2012, J EXP BIOL, V215, P3354, DOI 10.1242/jeb.068528; Li P, 2009, AMINO ACIDS, V37, P43, DOI 10.1007/s00726-008-0171-1; Lim SJ, 2013, AQUACULTURE, V414, P274, DOI 10.1016/j.aquaculture.2013.08.013; Luo Z, 2009, J APPL ICHTHYOL, V25, P184, DOI 10.1111/j.1439-0426.2009.01216.x; McClelland JW, 2002, ECOLOGY, V83, P2173, DOI 10.1890/0012-9658(2002)083[2173:TRATNI]2.0.CO;2; McCue MD, 2008, COMP BIOCHEM PHYS A, V151, P239, DOI 10.1016/j.cbpa.2008.06.034; McCue MD, 2008, RAPID COMMUN MASS SP, V22, P2307, DOI 10.1002/rcm.3615; McCue MD, 2010, COMP BIOCHEM PHYS A, V156, P1, DOI 10.1016/j.cbpa.2010.01.002; McCullagh J, 2008, RAPID COMMUN MASS SP, V22, P1817, DOI 10.1002/rcm.3554; McMahon KW, 2010, J ANIM ECOL, V79, P1132, DOI 10.1111/j.1365-2656.2010.01722.x; Molina-Poveda C, 2016, AQUAFEED FORMULATION, P75, DOI 10.1016/B978-0-12-800873-7.00004-X; National Research Council, 2011, NUTR REQ FISH SHRIMP; Newsome SD, 2014, INTEGR COMP BIOL, V54, P890, DOI 10.1093/icb/icu106; O'Neill B, 2015, AQUACULTURE, V448, P169, DOI 10.1016/j.aquaculture.2015.05.034; Olmez A, 2015, TURK J VET ANIM SCI, V39, P654, DOI 10.3906/vet-1507-54; Otasevic V., 2016, ENCY FOOD HLTH, P149, DOI [10.1016/B978-0-12-384947-2.00028-3, DOI 10.1016/B978-0-12-384947-2.00028-3]; Pirozzi I, 2009, COMP BIOCHEM PHYS A, V152, P586, DOI 10.1016/j.cbpa.2009.01.008; ROBINSON AM, 1980, PHYSIOL REV, V60, P143, DOI 10.1152/physrev.1980.60.1.143; Rossi A, 2015, ECOL INDIC, V56, P161, DOI 10.1016/j.ecolind.2015.04.001; Ruchimat T, 1997, AQUACULTURE, V150, P113, DOI 10.1016/S0044-8486(96)01465-2; Sick H, 1997, Z ERNAHRUNGSWISS, V36, P340, DOI 10.1007/BF01617819; Silva S. S. de, 1997, Aquaculture, V153, P273, DOI 10.1016/S0044-8486(97)00038-0; Smutna M, 2002, ACTA VET BRNO, V71, P169, DOI 10.2754/avb200271020169; Soengas JL, 1996, FISH PHYSIOL BIOCHEM, V15, P491, DOI 10.1007/BF01874923; Takagi S, 2008, AQUACULTURE, V280, P198, DOI 10.1016/j.aquaculture.2008.05.012; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Ueki I, 2012, AM J PHYSIOL-ENDOC M, V302, pE1292, DOI 10.1152/ajpendo.00589.2011; Walsh RG, 2014, RAPID COMMUN MASS SP, V28, P96, DOI 10.1002/rcm.6761; WEINSTOCK SB, 1984, J BIOL CHEM, V259, P8939; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0	57	35	35	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0170124	10.1371/journal.pone.0170124	http://dx.doi.org/10.1371/journal.pone.0170124			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095488	Green Submitted, gold, Green Published			2022-12-26	WOS:000392372300057
J	Garrido, E; Diaz, MF; Bernal, H; Nustez, CE; Thaler, J; Jander, G; Poveda, K				Garrido, Etzel; Fernanda Diaz, Maria; Bernal, Hugo; Eduardo Nustez, Carlos; Thaler, Jennifer; Jander, Georg; Poveda, Katja			Costs and Tradeoffs of Resistance and Tolerance to Belowground Herbivory in Potato	PLOS ONE			English	Article							PLANT TOLERANCE; EVOLUTIONARY ECOLOGY; LIFE-HISTORY; DEFENSE; METAANALYSIS; SELECTION; DOMESTICATION; TRAITS; IMPACT; PHOTOSYNTHESIS	The success of sustainable crop production depends on our ability to select or create varieties that can allocate resources to both growth and defence. However, breeding efforts have emphasized increases in yields but have partially neglected defence traits against pests. Estimating the costs of multiple defences against tuber herbivores and the tradeoffs among them, as well as understanding the relationship between yield and multiple defences is still unknown but relevant to both basic and applied ecology. Using twenty commercial potato varieties available in Colombia and the tuber herbivore Tecia solanivora, we tested whether high yielding varieties show a reduction in three types of defence: constitutive and induced resistance, as well as tolerance. Specifically, we determined (1) the costs in terms of yield of all three defences, (2) the possible tradeoffs among them, and (3) if oviposition preference was related to the expression of these defences. We detected no costs in terms of yield of constitutive and induced resistance to tuber damage. We did, however, find evidence of costs of being able to tolerate tuber herbivory. While we found no tradeoffs among any of the estimated defences, there was a positive correlation between aboveground compensatory growth and tolerance in terms of tuber production, suggesting that after damage there are no shifts in the allocation of resources from aboveground to belowground biomass. Finally, we found that females laid more eggs on those varieties with the lowest level of constitutive resistance. In conclusion our findings suggest that in potatoes, breeding for higher yields has not caused any reduction in constitutive or induced resistance to tuber damage. This is not the case for tolerance where those varieties with higher yields are also less likely to tolerate tuber damage. Given the high incidence of tuber pests in Colombia, selecting for higher tolerance could allow for high productivity in the presence of herbivores. Finding mechanisms to decouple the tolerance response from yield should be a new priority in potato breeding in Colombia to guarantee a higher yield in both the presence and absence of herbivores.	[Garrido, Etzel; Thaler, Jennifer; Poveda, Katja] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Fernanda Diaz, Maria; Bernal, Hugo] Fdn Biodiversa Colombia, Bogota, Colombia; [Eduardo Nustez, Carlos] Univ Nacl Colombia, Fac Agron, Bogota, Colombia; [Jander, Georg] Boyce Thompson Inst Plant Res, Ithaca, NY USA; [Garrido, Etzel] Univ Autonoma Queretaro, Fac Ciencias Nat, Unidad Microbiol Basica & Aplicada, Av Ciencias S-N, Queretaro, Qro, Mexico	Cornell University; Universidad Nacional de Colombia; Cornell University; Boyce Thompson Institute for Plant Research; Universidad Autonoma de Queretaro	Poveda, K (corresponding author), Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA.	kap235@cornell.edu	Garrido, Etzel/AAD-4312-2020	Bernal-Hernandez, Hugo/0000-0002-4672-2987; NUSTEZ, CARLOS EDUARDO/0000-0003-2000-022X; Garrido, Etzel/0000-0001-8971-9094	Atkinson Center for a Sustainable Future; United States Department of Agriculture National Institute of Food and Agriculture [2014-67013-21659]	Atkinson Center for a Sustainable Future; United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This research was funded by a grant from the Atkinson Center for a Sustainable Future to KP, JT and GJ and a grant by the United States Department of Agriculture National Institute of Food and Agriculture award number 2014-67013-21659 to GJ and KP.	[Anonymous], 2005, Bulletin OEPP/EPPO Bulletin, V35, P399; BAKER HG, 1972, ECON BOT, V26, P32, DOI 10.1007/BF02862259; Bezemer TM, 2005, TRENDS ECOL EVOL, V20, P617, DOI 10.1016/j.tree.2005.08.006; Blossey B, 2003, ANNU REV ENTOMOL, V48, P521, DOI 10.1146/annurev.ento.48.091801.112700; Cadena Marleny, 2005, Agron. colomb., V23, P112; Chen YH, 2015, ANNU REV ENTOMOL, V60, P35, DOI 10.1146/annurev-ento-010814-020601; DAO L, 1994, J AGR FOOD CHEM, V42, P633, DOI 10.1021/jf00039a006; De Deyn GB, 2005, TRENDS ECOL EVOL, V20, P625, DOI 10.1016/j.tree.2005.08.009; EVANS TL, 1993, CROP EVOLUTION ADAPT; FINEBLUM WL, 1995, NATURE, V377, P517, DOI 10.1038/377517a0; Fornoni J, 2000, EVOLUTION, V54, P789, DOI 10.1111/j.0014-3820.2000.tb00080.x; Fornoni J, 2011, FUNCT ECOL, V25, P399, DOI 10.1111/j.1365-2435.2010.01805.x; Gripenberg S, 2010, ECOL LETT, V13, P383, DOI 10.1111/j.1461-0248.2009.01433.x; Hawkes CV, 2001, ECOLOGY, V82, P2045, DOI 10.1890/0012-9658(2001)082[2045:TIOHOP]2.0.CO;2; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; JAENIKE J, 1978, THEOR POPUL BIOL, V14, P350, DOI 10.1016/0040-5809(78)90012-6; Kaplan I, 2009, ECOL APPL, V19, P864, DOI 10.1890/07-1566.1; Karban R, 1999, TRENDS ECOL EVOL, V14, P443, DOI 10.1016/S0169-5347(99)01678-X; Karban R, 2002, ANNU REV ECOL SYST, V33, P641, DOI 10.1146/annurev.ecolsys.33.010802.150443; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Koricheva J, 2004, AM NAT, V163, pE64, DOI 10.1086/382601; Koricheva J, 2002, ECOLOGY, V83, P176, DOI 10.2307/2680130; Leimu R, 2006, OIKOS, V112, P1, DOI 10.1111/j.0030-1299.2006.41023.x; Long SP, 2006, PLANT CELL ENVIRON, V29, P315, DOI 10.1111/j.1365-3040.2005.01493.x; Mauricio R, 1997, ECOLOGY, V78, P1301, DOI 10.1890/0012-9658(1997)078[1301:VITDSO]2.0.CO;2; Mayhew PJ, 1997, OIKOS, V79, P417, DOI 10.2307/3546884; Morris WF, 2006, OIKOS, V112, P102, DOI 10.1111/j.0030-1299.2006.14253.x; Nunez-Farfan J, 2007, ANNU REV ECOL EVOL S, V38, P541, DOI 10.1146/annurev.ecolsys.38.091206.095822; Poveda K, 2010, ECOL APPL, V23, P515; Poveda K, 2012, ENTOMOL EXP APPL, V143, P245, DOI 10.1111/j.1570-7458.2012.01256.x; PRICE PW, 1991, OIKOS, V62, P244, DOI 10.2307/3545270; Qu W, 2016, PLANT PHYSL; R Core Team, 2013, LANG ENV STAT COMP; Rasmann S, 2008, PLANT PHYSIOL, V146, P875, DOI 10.1104/pp.107.112045; Rausher MD, 1996, TRENDS GENET, V12, P212, DOI 10.1016/0168-9525(96)10020-2; Rausher MD, 2001, NATURE, V411, P857, DOI 10.1038/35081193; Richards RA, 2000, J EXP BOT, V51, P447, DOI 10.1093/jexbot/51.suppl_1.447; Rindos D., 1984, ORIGINS AGR EVOLUTIO; Robert CAM, 2015, ENTOMOL EXP APPL, V157, P113, DOI 10.1111/eea.12346; Robert CAM, 2014, PLANT CELL ENVIRON, V37, P2613, DOI 10.1111/pce.12359; Rosenthal JP, 1997, EVOL ECOL, V11, P337, DOI 10.1023/A:1018420504439; SIMMS EL, 1994, EVOLUTION, V48, P1973, DOI 10.1111/j.1558-5646.1994.tb02227.x; Stamp N, 2003, Q REV BIOL, V78, P23, DOI 10.1086/367580; Stinchcombe JR, 2002, EVOL ECOL, V16, P595, DOI 10.1023/A:1021617418037; Stowe KA, 2000, ANNU REV ECOL SYST, V31, P565, DOI 10.1146/annurev.ecolsys.31.1.565; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Tiffin P, 1999, AM NAT, V154, P700, DOI 10.1086/303271; Turcotte MM, 2014, NEW PHYTOL, V204, P671, DOI 10.1111/nph.12935; van Dam NM, 2009, ANNU REV ECOL EVOL S, V40, P373, DOI 10.1146/annurev.ecolsys.110308.120314; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Vlot AC, 2008, CURR OPIN PLANT BIOL, V11, P436, DOI 10.1016/j.pbi.2008.05.003; Walters D, 2007, PHYSIOL MOL PLANT P, V71, P3, DOI 10.1016/j.pmpp.2007.09.008	52	4	4	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0169083	10.1371/journal.pone.0169083	http://dx.doi.org/10.1371/journal.pone.0169083			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095490	Green Published, Green Submitted, gold			2022-12-26	WOS:000392372300015
J	Iwano, S; Ito, R; Umakoshi, H; Karino, T; Inoue, T; Li, YZ; Naganawa, S				Iwano, Shingo; Ito, Rintaro; Umakoshi, Hiroyasu; Karino, Takatoshi; Inoue, Tsutomu; Li, Yuanzhong; Naganawa, Shinji			Thoracic Temporal Subtraction Three Dimensional Computed Tomography (3D-CT): Screening for Vertebral Metastases of Primary Lung Cancers	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; BONE METASTASIS; AUTOMATIC SEGMENTATION; THORACOLUMBAR SPINE; NODULE DETECTION; ABDOMINAL CT; FOLLOW-UP; DIAGNOSIS; MANAGEMENT; SYSTEM	Purpose We developed an original, computer-aided diagnosis (CAD) software that subtracts the initial thoracic vertebral three-dimensional computed tomography (3D-CT) image from the follow-up 3D-CT image. The aim of this study was to investigate the efficacy of this CAD software during screening for vertebral metastases on follow-up CT images of primary lung cancer patients. Materials and Methods The interpretation experiment included 30 sets of follow-up CT scans in primary lung cancer patients and was performed by two readers (readers A and B), who each had 2.5 years' experience reading CT images. In 395 vertebrae from C6 to L3, 46 vertebral metastases were identified as follows: osteolytic metastases (n = 17), osteoblastic metastases (n = 14), combined osteolytic and osteoblastic metastases (n = 6), and pathological fractures (n = 9). Thirty-six lesions were in the anterior component (vertebral body), and 10 lesions were in the posterior component (vertebral arch, transverse process, and spinous process). The area under the curve (AUC) by receiver operating characteristic (ROC) curve analysis and the sensitivity and specificity for detecting vertebral metastases were compared with and without CAD for each observer. Results Reader A detected 47 abnormalities on CT images without CAD, and 33 of them were true-positive metastatic lesions. Using CAD, reader A detected 57 abnormalities, and 38 were true positives. The sensitivity increased from 0.717 to 0.826, and on ROC curve analysis, AUC with CAD was significantly higher than that without CAD (0.849 vs. 0.902, p = 0.021). Reader B detected 40 abnormalities on CT images without CAD, and 36 of them were true-positive metastatic lesions. Using CAD, reader B detected 44 abnormalities, and 39 were true positives. The sensitivity increased from 0.783 to 0.848, and AUC with CAD was non-significantly higher than that without CAD (0.889 vs. 0.910, p = 0.341). Both readers detected more osteolytic and osteoblastic metastases with CAD than without CAD. Conclusion Our temporal 3D-CT subtraction CAD software easily detected vertebral metastases on the follow-up CT images of lung cancer patients regardless of the osteolytic or osteoblastic nature of the lesions.	[Iwano, Shingo; Ito, Rintaro; Umakoshi, Hiroyasu; Naganawa, Shinji] Nagoya Univ, Grad Sch Med, Dept Radiol, Nagoya, Aichi, Japan; [Karino, Takatoshi; Inoue, Tsutomu; Li, Yuanzhong] Fujifilm Corp, Imaging Technol Ctr, Tokyo, Japan	Nagoya University; Fujifilm Corporation	Iwano, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Radiol, Nagoya, Aichi, Japan.	iwano45@med.nagoya-u.ac.jp	Naganawa, Shinji/I-1572-2012; Iwano, Shingo/I-7355-2014	Naganawa, Shinji/0000-0002-0214-613X; Iwano, Shingo/0000-0002-3256-0390; Ito, Rintaro/0000-0002-7971-043X	Fujifilm corporation	Fujifilm corporation	This study was funded by Fujifilm corporation. The funder provided support in the form of salaries for authors [TK, TI, YL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Al Husaini H, 2009, J THORAC ONCOL, V4, P251, DOI 10.1097/JTO.0b013e31819518fc; Al-Helo S, 2013, INT J COMPUT ASS RAD, V8, P461, DOI 10.1007/s11548-012-0796-0; Aoki T, 2014, RADIOLOGY, V271, P255, DOI 10.1148/radiol.13130460; Athertya JS, 2016, COMPUT BIOL MED, V72, P75, DOI 10.1016/j.compbiomed.2016.03.009; Avila NA, 2010, RADIOLOGY, V254, P851, DOI 10.1148/radiol.09090227; BACH AM, 1995, RADIOLOGY, V197, P849, DOI 10.1148/radiology.197.3.7480767; Brodowicz T, 2012, ANN ONCOL, V23, P2215, DOI 10.1093/annonc/mds009; Burns JE, 2013, RADIOLOGY, V268, P69, DOI 10.1148/radiol.13121351; Cetin K, 2014, LUNG CANCER, V86, P247, DOI 10.1016/j.lungcan.2014.08.022; Chang MC, 2012, ACAD RADIOL, V19, P349, DOI 10.1016/j.acra.2011.10.018; Clezardin P, 2007, CLIN EXP METASTAS, V24, P599, DOI 10.1007/s10585-007-9112-8; Colt HG, 2013, CHEST, V143, pE437, DOI 10.1378/chest.12-2365; Crino L, 2010, ANN ONCOL, V21, pv103, DOI 10.1093/annonc/mdq207; Oliveira MBD, 2016, LUNG CANCER, V96, P19, DOI 10.1016/j.lungcan.2016.03.014; Guarnieri G, 2015, INTERV NEURORADIOL, V21, P263, DOI 10.1177/1591019915582366; Lange MB, 2016, EUR J RADIOL, V85, P61, DOI 10.1016/j.ejrad.2015.10.012; Liu T, 2011, CLIN ONCOL-UK, V23, P350, DOI 10.1016/j.clon.2010.10.002; Okumura E, 2007, PHYS MED BIOL, V52, P6461, DOI 10.1088/0031-9155/52/21/008; Okumura E, 2011, RADIOL PHYS TECHNOL, V4, P109, DOI 10.1007/s12194-010-0110-1; Pomerantz SM, 2000, AM J ROENTGENOL, V174, P311, DOI 10.2214/ajr.174.2.1740311; Qu XH, 2012, EUR J RADIOL, V81, P1007, DOI 10.1016/j.ejrad.2011.01.126; Riihimaki M, 2014, LUNG CANCER, V86, P78, DOI 10.1016/j.lungcan.2014.07.020; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Sakai S, 2008, J DIGIT IMAGING, V21, P91, DOI 10.1007/s10278-007-9014-y; Sasaki Y, 2011, RADIOL PHYS TECHNOL, V4, P84, DOI 10.1007/s12194-010-0109-7; Schmidt GP, 2007, EUR RADIOL, V17, P939, DOI 10.1007/s00330-006-0361-8; Scholtz JE, 2015, EUR J RADIOL, V84, P437, DOI 10.1016/j.ejrad.2014.11.043; Sugiura H, 2008, CLIN ORTHOP RELAT R, V466, P729, DOI 10.1007/s11999-007-0051-0	28	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2017	12	1							e0170309	10.1371/journal.pone.0170309	http://dx.doi.org/10.1371/journal.pone.0170309			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3EK	28095493	Green Submitted, Green Published, gold			2022-12-26	WOS:000392372300077
J	Kawano, Y; Namiki, K; Miyawaki, A; Ishikawa, T				Kawano, Yoshihiro; Namiki, Kana; Miyawaki, Atsushi; Ishikawa, Takuji			Extending Whole Slide Imaging: Color Darkfield Internal Reflection Illumination (DIRI) for Biological Applications	PLOS ONE			English	Article							EUGLENA-GRACILIS; STRIA TERMINALIS; BED NUCLEI; DIGITAL PATHOLOGY; PROJECTIONS; STANDARDIZATION; CELLS	Whole slide imaging (WSI) is a useful tool for multi-modal imaging, and in our work, we have often combined WSI with darkfield microscopy. However, traditional darkfield microscopy cannot use a single condenser to support high-and low-numerical-aperture objectives, which limits the modality of WSI. To overcome this limitation, we previously developed a darkfield internal reflection illumination (DIRI) microscope using white light-emitting diodes (LEDs). Although the developed DIRI is useful for biological applications, substantial problems remain to be resolved. In this study, we propose a novel illumination technique called color DIRI. The use of three-color LEDs dramatically improves the capability of the system, such that color DIRI (1) enables optimization of the illumination color; (2) can be combined with an oil objective lens; (3) can produce fluorescence excitation illumination; (4) can adjust the wavelength of light to avoid cell damage or reactions; and (5) can be used as a photostimulator. These results clearly illustrate that the proposed color DIRI can significantly extend WSI modalities for biological applications.	[Kawano, Yoshihiro; Ishikawa, Takuji] Tohoku Univ, Grad Sch Biomed Engn, Dept Biomed Engn, Sendai, Miyagi, Japan; [Kawano, Yoshihiro] Olympus Corp, Shinjuku Ku, Tokyo, Japan; [Namiki, Kana; Miyawaki, Atsushi] RIKEN, Cell Funct & Dynam, Brain Sci Inst, Wako, Saitama, Japan; [Ishikawa, Takuji] Tohoku Univ, Dept Finemech, Sendai, Miyagi, Japan	Tohoku University; Olympus Corporation; RIKEN; Tohoku University	Kawano, Y (corresponding author), Tohoku Univ, Grad Sch Biomed Engn, Dept Biomed Engn, Sendai, Miyagi, Japan.; Kawano, Y (corresponding author), Olympus Corp, Shinjuku Ku, Tokyo, Japan.	b3wd1002@s.tohokuac.jp	Miyawaki, Atsushi/K-3569-2014; Kawano, Yoshihiro/B-6208-2016	Miyawaki, Atsushi/0000-0002-2329-3235; Kawano, Yoshihiro/0000-0001-6442-8733; Ishikawa, Takuji/0000-0002-3573-8414	 [26242039]; Grants-in-Aid for Scientific Research [26242039] Funding Source: KAKEN	; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research (A), No. 26242039 (http://www.jsps.go.jp/english/e-grants/index.html). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. We would like to thank Brendan Brinkman of Olympus Corporation for his advice on this article. Olympus Corporation provided several microscope parts, but did not fund this study nor influence its outcome.	BARGHIGIANI C, 1979, PHOTOCHEM PHOTOBIOL, V29, P1015, DOI 10.1111/j.1751-1097.1979.tb07806.x; Dong HW, 2001, BRAIN RES REV, V38, P192, DOI 10.1016/S0165-0173(01)00079-0; Dong HW, 2003, J COMP NEUROL, V463, P434, DOI 10.1002/cne.10758; Dong HW, 2001, J COMP NEUROL, V436, P430, DOI 10.1002/cne.1079; Higgins C, 2015, BIOTECH HISTOCHEM, V90, P341, DOI 10.3109/10520295.2015.1044566; Iseki M, 2002, NATURE, V415, P1047, DOI 10.1038/4151047a; Jennings H.S., 1904, CONTRIBUTIONS STUDY; Kawano Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116925; Kawano Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058344; Lebert M, 1999, ADV SPACE RES, V24, P851, DOI 10.1016/S0273-1177(99)00966-7; Long RE, 2013, TOXICOL PATHOL, V41, P115, DOI 10.1177/0192623312451162; Miyawaki A, 1996, EMBO J, V15, P2050, DOI 10.1002/j.1460-2075.1996.tb00558.x; Ohashi M., 2012, ECOENGINEERING, V24, P43; Pantanowitz Liron, 2011, J Pathol Inform, V2, P36, DOI 10.4103/2153-3539.83746; Pluta M., 1989, ADV LIGHT MICROSCOPY, V2; Tahedl H, 2001, ECOTOX ENVIRON SAFE, V48, P161, DOI 10.1006/eesa.2000.2004; Weinstein RS, 2009, HUM PATHOL, V40, P1057, DOI 10.1016/j.humpath.2009.04.006; Yagi Y, 2005, J TELEMED TELECARE, V11, P109, DOI 10.1258/1357633053688705; Yagi Y, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-S1-S15	20	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0167774	10.1371/journal.pone.0167774	http://dx.doi.org/10.1371/journal.pone.0167774			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085892	Green Submitted, gold, Green Published			2022-12-26	WOS:000391972600002
J	Martin-Park, A; Gomez-Govea, MA; Lopez-Monroy, B; Trevino-Alvarado, VM; Torres-Sepulveda, MD; Lopez-Uriate, GA; Villanueva-Segura, OK; Ruiz-Herrera, MD; Martinez-Fierro, MD; Delgado-Encisco, I; Flores-Suarez, AE; White, GS; de Villarreal, LEM; Ponce-Garcia, G; Black, WC; Rodriguez-Sanchez, IP				Martin-Park, Abdiel; Gomez-Govea, Mayra A.; Lopez-Monroy, Beatriz; Manuel Trevino-Alvarado, Victor; del Rosario Torres-Sepulveda, Maria; Areli Lopez-Uriate, Graciela; Karina Villanueva-Segura, Olga; del Consuelo Ruiz-Herrera, Maria; de la Luz Martinez-Fierro, Margarita; Delgado-Encisco, Ivan; Flores-Suarez, Adriana E.; White, Gregory S.; Martinez de Villarreal, Laura E.; Ponce-Garcia, Gustavo; Black, William C.; Pablo Rodriguez-Sanchez, Iram			Profiles of Amino Acids and Acylcarnitines Related with Insecticide Exposure in Culex quinquefasciatus (Say)	PLOS ONE			English	Article							INTRACELLULAR PROTEASE ACTIVITIES; MEDIATED PERMETHRIN RESISTANCE; WEST-NILE-VIRUS; PYRETHROID RESISTANCE; SUSCEPTIBLE STRAINS; VECTOR COMPETENCE; CROSS-RESISTANCE; PIPIENS DIPTERA; CULICIDAE; MOSQUITOS	Culex quinquefasciatus Say is a vector of many pathogens of humans, and both domestic and wild animals. Personal protection, reduction of larval habitats, and chemical control are the best ways to reduce mosquito bites and, therefore, the transmission of mosquito-borne pathogens. Currently, to reduce the risk of transmission, the pyrethroids, and other insecticide groups have been extensively used to control both larvae and adult mosquitoes. In this context, amino acids and acylcarnitines have never been associated with insecticide exposure and or insecticide resistance. It has been suggested that changes in acylcarnitines and amino acids profiles could be a powerful diagnostic tool for metabolic alterations. Monitoring these changes could help to better understand the mechanisms involved in insecticide resistance, complementing the strategies for managing this phenomenon in the integrated resistance management. The purpose of the study was to determine the amino acids and acylcarnitines profiles in larvae of Cx. quinquefasciatus after the exposure to different insecticides. Bioassays were performed on Cx. quinquefasciatus larvae exposed to the diagnostic doses (DD) of the insecticides chlorpyrifos (0.001 mu g/mL), temephos (0.002 mu g/mL) and permethrin (0.01 mu g/mL). In each sample, we analyzed the profile of 12 amino acids and 31 acylcarnitines by LC-MS/MS. A t-test was used to determine statistically significant differences between groups and corrections of q-values. Results indicates three changes, the amino acids arginine (ARG), free carnitine (C0) and acetyl-carnitine (C2) that could be involved in energy production and insecticide detoxification. We confirmed that concentrations of amino acids and acylcarnitines in Cx. quinquefasciatus vary with respect to different insecticides. The information generated contributes to understand the possible mechanisms and metabolic changes occurring during insecticide exposure.	[Martin-Park, Abdiel; Black, William C.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Gomez-Govea, Mayra A.; Lopez-Monroy, Beatriz; Karina Villanueva-Segura, Olga; Flores-Suarez, Adriana E.; Ponce-Garcia, Gustavo] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, Dept Zool Invertebrados, San Nicolas De Los Garza, Nuevo Leon, Mexico; [Manuel Trevino-Alvarado, Victor] Tecnol Monterrey, Escuela Med, Catedra Bioinformat, Monterrey, Nuevo Leon, Mexico; [del Rosario Torres-Sepulveda, Maria; Areli Lopez-Uriate, Graciela; del Consuelo Ruiz-Herrera, Maria; Martinez de Villarreal, Laura E.; Pablo Rodriguez-Sanchez, Iram] Univ Autonoma Nuevo Leon, Fac Med, Dept Genet, Monterrey, Nuevo Leon, Mexico; [de la Luz Martinez-Fierro, Margarita] Univ Autonoma Zacatecas, Lab Med Mol, Unidad Acad Med Humana, Zacatecas, Zacatecas, Mexico; [Delgado-Encisco, Ivan] Univ Colima, Fac Med, Colima, Mexico; [Delgado-Encisco, Ivan] Secretaria Salud Colima, Inst Estatal Canc, Colima, Mexico; [White, Gregory S.] Coachella Valley Mosquito & Vector Control Dist, Indio, CA USA	Colorado State University; Universidad Autonoma de Nuevo Leon; Tecnologico de Monterrey; Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Zacatecas; Universidad de Colima	Rodriguez-Sanchez, IP (corresponding author), Univ Autonoma Nuevo Leon, Fac Med, Dept Genet, Monterrey, Nuevo Leon, Mexico.	iramrodriguez@gmail.com	Villanueva-Segura, Olga Karina/AAF-2131-2020; Delgado-Enciso, Ivan/B-1743-2018; Ponce, Gustavo/A-4471-2014; de Villarreal, Laura Elia Martínez/ABD-2697-2020; López, Beatriz/G-2070-2019; Flores, Adriana E/J-1820-2012; Flores, Adriana E./AAM-4478-2020; Trevino, Victor/C-9219-2009	Delgado-Enciso, Ivan/0000-0001-9848-862X; de Villarreal, Laura Elia Martínez/0000-0003-1442-9089; López, Beatriz/0000-0003-3155-4244; Flores, Adriana E/0000-0001-8554-8865; Flores, Adriana E./0000-0001-8554-8865; Ponce-Garcia, Gustavo/0000-0003-0654-006X; Gomez -Govea, Mayra Alejandra/0000-0001-5871-0142; Martin-Park, Abdiel/0000-0001-9303-2877; Trevino, Victor/0000-0002-7472-9844; Martinez-Fierro, Margarita L/0000-0003-1478-9068; Villanueva-Segura, Karina/0000-0002-1976-8277	Fogarty Training Grant "Training in Dengue Prevention and Control" [2D43TW001130-08]; National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) [U01-AI-088647]; FOGARTY INTERNATIONAL CENTER [D43TW001130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI088647] Funding Source: NIH RePORTER	Fogarty Training Grant "Training in Dengue Prevention and Control"; National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Fogarty Training Grant 2D43TW001130-08 Training in Dengue Prevention and Control. The study was also supported by the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID; International Collaborations in Infectious Disease Research Program U01-AI-088647). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 1998, INSECT BIOCHEM MOLEC, V28, P629, DOI 10.1016/S0965-1748(98)00061-7; Al-Anzi B, 2009, NEURON, V63, P329, DOI 10.1016/j.neuron.2009.07.021; [Anonymous], 2010, ALTERN MED REV, V15, P76; Atyame CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119288; Berticat C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-104; Bourdin B, 2007, PLANT PHYSIOL BIOCH, V45, P926, DOI 10.1016/j.plaphy.2007.09.009; Bourguet D, 1997, PESTIC SCI, V51, P276, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;276::AID-PS268&gt;3.0.CO;2-N; Burmester T, 1999, EUR J ENTOMOL, V96, P213; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1129; Chace DH, 2003, CLIN CHEM, V49, P1797, DOI 10.1373/clinchem.2003.022178; Chandre F, 1998, MED VET ENTOMOL, V12, P359, DOI 10.1046/j.1365-2915.1998.00120.x; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; Soares JBRC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120600; Cui F, 2006, PEST MANAG SCI, V62, P1013, DOI 10.1002/ps.1288; CUNIN R, 1986, MICROBIOL REV, V50, P314, DOI 10.1128/MMBR.50.3.314-352.1986; Das P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000899; DESOUSA C, 1990, CLIN CHIM ACTA, V187, P317, DOI 10.1016/0009-8981(90)90117-B; DEVONSHIRE AL, 1982, PESTIC BIOCHEM PHYS, V18, P235, DOI 10.1016/0048-3575(82)90110-9; Eldridge BF, 2000, MEDICAL ENTOMOLOGY, P415; Farfan-Ale JA, 2009, AM J TROP MED HYG, V80, P85, DOI 10.4269/ajtmh.2009.80.85; Fonseca DM, 2004, SCIENCE, V303, P1535, DOI 10.1126/science.1094247; Gogoi M, 2016, CURR OPIN MICROBIOL, V29, P43, DOI 10.1016/j.mib.2015.10.005; Hamer GL, 2008, J MED ENTOMOL, V45, P125, DOI 10.1603/0022-2585(2008)45[125:CPDCAB]2.0.CO;2; Harbach RE, 2012, J AM MOSQUITO CONTR, V28, P10, DOI 10.2987/8756-971X-28.4.10; Hardstone MC, 2007, PESTIC BIOCHEM PHYS, V89, P175, DOI 10.1016/j.pestbp.2007.06.006; Hardstone MC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-42; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Indiveri C, 2011, MOL ASPECTS MED, V32, P223, DOI 10.1016/j.mam.2011.10.008; Jones CM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-78; Jones LL, 2010, PROG LIPID RES, V49, P61, DOI 10.1016/j.plipres.2009.08.004; Jones S, 2001, J LA STATE MED SOC, V154, P303; Kasai S, 1998, ARCH INSECT BIOCHEM, V37, P47, DOI 10.1002/(SICI)1520-6327(1998)37:1&lt;47::AID-ARCH6&gt;3.0.CO;2-S; Kumar S, 2011, B ENTOMOL RES, V101, P25, DOI 10.1017/S0007485310000131; Kumar S, 2002, ARCH INSECT BIOCHEM, V50, P1, DOI 10.1002/arch.10021; Kumar S, 2009, TROP BIOMED, V26, P155; Li M. R., 2013, ELECT J DIFFERENTIAL, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0059582; Lima CA, 2003, MEM I OSWALDO CRUZ, V98, P217, DOI 10.1590/S0074-02762003000200009; Liu HQ, 2004, J MED ENTOMOL, V41, P408, DOI 10.1603/0022-2585-41.3.408; Malone JG, 2015, INFECT DRUG RESIST, V8, P237, DOI 10.2147/IDR.S68214; Martinez-Torres D, 1999, PESTIC SCI, V55, P1012, DOI 10.1002/(SICI)1096-9063(199910)55:10&lt;1012::AID-PS39&gt;3.0.CO;2-5; Martins LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077664; Molaei G, 2007, AM J TROP MED HYG, V77, P73; Naumenko AN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115737; Norris LC, 2011, J VECTOR ECOL, V36, P411, DOI 10.1111/j.1948-7134.2011.00182.x; Osorio JH, 2007, VET ZOOTEC, V24, P28; Rodriguez-Sanchez IP, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0144-9; Paul A, 2005, J AM MOSQUITO CONTR, V21, P305, DOI 10.2987/8756-971X(2005)21[305:IRICPF]2.0.CO;2; Pavek P, 2008, CURR DRUG METAB, V9, P129, DOI 10.2174/138920008783571774; Raymond M, 2001, GENETICA, V112, P287, DOI 10.1023/A:1013300108134; Ripley BD, 2009, NEWSLETTER LTSN MATH, V1, P23; Rivero A, 2011, J MED ENTOMOL, V48, P694, DOI 10.1603/ME10121; Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000; RODRIGUEZ M, 1993, MED VET ENTOMOL, V7, P117, DOI 10.1111/j.1365-2915.1993.tb00663.x; Roschinger W, 2000, CLIN CHIM ACTA, V298, P55, DOI 10.1016/S0009-8981(00)00268-0; Sahgal Arunima, 1992, Entomon, V17, P149; Saleem MA, 2010, PAK J ZOOL, V42, P623; Sardelis MR, 2001, EMERG INFECT DIS, V7, P1018, DOI 10.3201/eid0706.010617; Scott JG, 2015, PESTIC BIOCHEM PHYS, V120, P68, DOI 10.1016/j.pestbp.2014.12.018; Sharma A, 2014, DRUG TEST ANAL, V6, P399, DOI 10.1002/dta.1646; She PX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059443; TELFER WH, 1991, ANNU REV ENTOMOL, V36, P205, DOI 10.1146/annurev.en.36.010191.001225; Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130; Vaidyanathan R, 2007, VECTOR-BORNE ZOONOT, V7, P193, DOI 10.1089/vbz.2006.0589; Vezilier J, 2013, EVOL APPL, V6, P497, DOI 10.1111/eva.12037; Vinogradova E.B., 2000, CULEX PIPIENS PIPIEN; Wilkins RM, 1999, COMP BIOCHEM PHYS C, V124, P337, DOI 10.1016/S0742-8413(99)00083-3; Xu Q, 2005, PEST MANAG SCI, V61, P1096, DOI 10.1002/ps.1090; Yanola J, 2015, ACTA TROP, V149, P232, DOI 10.1016/j.actatropica.2015.06.011; Yebakima A, 2004, J MED ENTOMOL, V41, P718, DOI 10.1603/0022-2585-41.4.718	70	5	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0169514	10.1371/journal.pone.0169514	http://dx.doi.org/10.1371/journal.pone.0169514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7SJ	28085898	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000391972600021
J	Petersen, WP; Callegari, S; Lake, GR; Tkachenko, N; Weissmann, JD; Zollikofer, CPE				Petersen, W. P.; Callegari, S.; Lake, G. R.; Tkachenko, N.; Weissmann, J. D.; Zollikofer, Ch. P. E.			A Stable Finite-Difference Scheme for Population Growth and Diffusion on a Map	PLOS ONE			English	Article							HUMAN DISPERSALS; GLACIAL-MAXIMUM; CLIMATE-CHANGE; EXPANSION; MIDHOLOCENE; AFRICA	We describe a general Godunov-type splitting for numerical simulations of the Fisher-Kolmogorov-Petrovski-Piskunov growth and diffusion equation on a world map with Neumann boundary conditions. The procedure is semi-implicit, hence quite stable. Our principal application for this solver is modeling human population dispersal over geographical maps with changing paleovegetation and paleoclimate in the late Pleistocene. As a proxy for carrying capacity we use Net Primary Productivity (NPP) to predict times for human arrival in the Americas.	[Petersen, W. P.; Callegari, S.; Tkachenko, N.; Weissmann, J. D.; Zollikofer, Ch. P. E.] Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland; [Petersen, W. P.] ETH, Seminar Appl Math, Zurich, Switzerland; [Lake, G. R.] Univ Zurich, Inst Computat Sci, Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Petersen, WP (corresponding author), Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland.; Petersen, WP (corresponding author), ETH, Seminar Appl Math, Zurich, Switzerland.	wpp@math.ethz.ch			PASC (Program for Advanced Scientific Computing)	PASC (Program for Advanced Scientific Computing)	This work was supported by PASC (Program for Advanced Scientific Computing): http://www.cscs.ch.	[Anonymous], 2016, PROVENANCE MAPS CODE; Arbenz P., 2004, INTRO PARALLEL COMPU, DOI DOI 10.1093/OSO/9780198515760.001.0001; Bigelow NH, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002558; Bouckaert R, 2012, SCIENCE, V337, P957, DOI 10.1126/science.1219669; BRAMSON M, 1983, MEM AM MATH SOC, V44, P1; Burenhult G., 2000, ERSTEN MENSCHEN URSP; Callegari S, 2013, ADV COMPLEX SYST, V16, DOI 10.1142/S0219525913500239; Davis P. J., 1984, METHODS NUMERICAL IN; Eriksson A, 2012, P NATL ACAD SCI USA, V109, P16089, DOI 10.1073/pnas.1209494109; Fisher RA, 1937, ANN EUGENIC, V7, P355, DOI 10.1111/j.1469-1809.1937.tb02153.x; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Godunov S. K., 1987, DIFFERENCE SCHEMES I; Grieser J, 2006, WORLD MAPS CLIMATOLO; Halligan JJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600375; Harrison SP, 2001, NATURE, V413, P129, DOI 10.1038/35093166; Henn BM, 2012, P NATL ACAD SCI USA, V109, P17758, DOI 10.1073/pnas.1212380109; LAVALLEE D., 2000, 1 S AM PEOPLING CONT; LeVeque RJ, 2007, OTHER TITL APPL MATH, V98, P1, DOI 10.1137/1.9780898717839; Lieth H., 1975, PRIMARY PRODUCTIVITY, P203, DOI [DOI 10.1007/978-3-642-80913-2_10, 10.1007/978-3-642-80913-2_10]; Manica A, 2007, NATURE, V448, P346, DOI 10.1038/nature05951; Murray, 2002, MATH BIOL I INTRO IN; Nikitas P, 2005, J HUM EVOL, V49, P602, DOI 10.1016/j.jhevol.2005.07.001; Perret C, 2014, BIT, V54, P801, DOI 10.1007/s10543-014-0482-4; Pickett EJ, 2004, J BIOGEOGR, V31, P1381, DOI 10.1111/j.1365-2699.2004.01001.x; Pinhasi R, 2005, PLOS BIOL, V3, P2220, DOI 10.1371/journal.pbio.0030410; Piskunov, 1937, B MGU A, V1, P1, DOI DOI 10.1016/B978-0-08-092523-3.50014-9; Prentice IC, 2000, J BIOGEOGR, V27, P507, DOI 10.1046/j.1365-2699.2000.00425.x; Reichl L., 2004, MODERN COURSE STAT P; Relethford JH, 2004, HUM BIOL, V76, P499, DOI 10.1353/hub.2004.0060; Reyes-Centeno H, 2014, P NATL ACAD SCI USA, V111, P7248, DOI 10.1073/pnas.1323666111; SKELLAM JG, 1951, BIOMETRIKA, V38, P196, DOI 10.2307/2332328; Strang G., 1986, INTRO APPL MATH, V16; Wirtz KW, 2003, CLIMATIC CHANGE, V59, P333, DOI 10.1023/A:1024858532005; YOUNG DA, 1995, J ARCHAEOL SCI, V22, P89, DOI 10.1016/S0305-4403(95)80165-0	35	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2017	12	1							e0167514	10.1371/journal.pone.0167514	http://dx.doi.org/10.1371/journal.pone.0167514			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH7SJ	28085882	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000391972600001
J	Gorshkov, V; Kwenda, S; Petrova, O; Osipova, E; Gogolev, Y; Moleleki, LN				Gorshkov, Vladimir; Kwenda, Stanford; Petrova, Olga; Osipova, Elena; Gogolev, Yuri; Moleleki, Lucy N.			Global Gene Expression Analysis of Cross-Protected Phenotype of Pectobacterium atrosepticum	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; BIOFILM FORMATION; STRESS-RESPONSE; DI-GMP; STRINGENT RESPONSE; CARBON-STARVATION; RPOS; HEAT; GLUCOCORTICOIDS; RESISTANCE	The ability to adapt to adverse conditions permits many bacterial species to be virtually ubiquitous and survive in a variety of ecological niches. This ability is of particular importance for many plant pathogenic bacteria that should be able to exist, except for their host plants, in different environments e.g. soil, water, insect-vectors etc. Under some of these conditions, bacteria encounter absence of nutrients and persist, acquiring new properties related to resistance to a variety of stress factors (cross-protection). Although many studies describe the phenomenon of cross-protection and several regulatory components that induce the formation of resistant cells were elucidated, the global comparison of the physiology of cross-protected phenotype and growing cells has not been performed. In our study, we took advantage of RNA-Seq technology to gain better insights into the physiology of cross-protected cells on the example of a harmful phytopathogen, Pectobacterium atrosepticum (Pba) that causes crop losses all over the world. The success of this bacterium in plant colonization is related to both its virulence potential and ability to persist effectively under various stress conditions (including nutrient deprivation) retaining the ability to infect plants afterwards. In our previous studies, we showed Pba to be advanced in applying different adaptive strategies that led to manifestation of cell resistance to multiple stress factors. In the present study, we determined the period necessary for the formation of cross-protected Pba phenotype under starvation conditions, and compare the transcriptome profiles of non-adapted growing cells and of adapted cells after the cross-protective effect has reached the maximal level. The obtained data were verified using qRT-PCR. Genes that were expressed differentially (DEGs) in two cell types were classified into functional groups and categories using different approaches. As a result, we portrayed physiological features that distinguish cross-protected phenotype from the growing cells.	[Gorshkov, Vladimir; Petrova, Olga; Osipova, Elena; Gogolev, Yuri] Russian Acad Sci, Kazan Sci Ctr, Kazan Inst Biochem & Biophys, Kazan, Russia; [Gorshkov, Vladimir; Gogolev, Yuri] Kazan Fed Univ, Dept Biochem & Biotechnol, Kazan, Russia; [Kwenda, Stanford; Moleleki, Lucy N.] Univ Pretoria, Dept Microbiol & Plant Pathol, Pretoria, South Africa; [Kwenda, Stanford; Moleleki, Lucy N.] Univ Pretoria, FABI, Pretoria, South Africa	Russian Academy of Sciences; Kazan Scientific Centre of the Russian Academy of Sciences; Kazan Institute of Biochemistry & Biophysics; Kazan Federal University; University of Pretoria; University of Pretoria	Gorshkov, V (corresponding author), Russian Acad Sci, Kazan Sci Ctr, Kazan Inst Biochem & Biophys, Kazan, Russia.	gvy84@rnail.ru	Gogolev, Yuri V/E-7815-2014; Осипова, Елена/AAU-9318-2021; Осипова, Елена/AAT-7324-2021; Moleleki, Lucy/E-8951-2010	Осипова, Елена/0000-0002-8203-9798; Moleleki, Lucy/0000-0002-1003-4621; Kwenda, Stanford/0000-0002-9008-4898; Gogolev, Yuri/0000-0002-2391-2980	Russian Foundation for Basic Research, OP, microbiological experiments [15-04-02380-a]; Russian Science Foundation [15-14-10022]; University of Pretoria	Russian Foundation for Basic Research, OP, microbiological experiments; Russian Science Foundation(Russian Science Foundation (RSF)); University of Pretoria	This work was supported by the Russian Foundation for Basic Research, OP, microbiological experiments, 15-04-02380-a, Russian Science Foundation, VG, Classification of DEGs and qRT-PCR analysis, 15-14-10022, University of Pretoria, SK, PhD studentship for SK and the CFRR 98993 and Bioinformatics 98685, National Research Foundation, LM, research work of LM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Behmardi P., 2009, J EXPT MICROBIOLOGY, V13, P18; Bell KS, 2004, P NATL ACAD SCI USA, V101, P11105, DOI 10.1073/pnas.0402424101; Bocsanczy AM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-280; Brockmann-Gretza O, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-230; Broich M, 2006, J BACTERIOL, V188, P1218, DOI 10.1128/JB.188.4.1218-1226.2006; Brown DR, 2014, MICROB CELL, V1, P315, DOI 10.15698/mic2014.09.168; Charkowski A, 2012, ANNU REV PHYTOPATHOL, V50, P425, DOI 10.1146/annurev-phyto-081211-173013; Charoenwong D, 2011, APPL ENVIRON MICROB, V77, P5220, DOI 10.1128/AEM.00648-11; Chung HJ, 2006, COMPR REV FOOD SCI F, V5, P52, DOI 10.1111/j.1541-4337.2006.00002.x; COZENS RM, 1986, ANTIMICROB AGENTS CH, V29, P797, DOI 10.1128/AAC.29.5.797; Cusumano ZT, 2015, J BACTERIOL, V197, P1288, DOI 10.1128/JB.02517-14; den Besten HMW, 2009, APPL ENVIRON MICROB, V75, P4111, DOI 10.1128/AEM.02891-08; Domka J, 2006, APPL ENVIRON MICROB, V72, P2449, DOI 10.1128/AEM.72.4.2449-2459.2006; Durfee T, 2008, J BACTERIOL, V190, P1084, DOI 10.1128/JB.01092-07; Evans Terry J., 2009, P479; FOSTER JW, 1995, ANNU REV MICROBIOL, V49, P145, DOI 10.1146/annurev.micro.49.1.145; Garcia S, 2001, BRAZ J MICROBIOL, V32, P110; Garcia-Contreras R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002394; GOMEZDUMM INTD, 1979, J LIPID RES, V20, P834; Gorshkov VY, 2009, MICROBIOLOGY+, V78, P585, DOI 10.1134/S0026261709050099; Gorshkov V, 2010, FEMS IMMUNOL MED MIC, V59, P378, DOI 10.1111/j.1574-695X.2010.00684.x; Gunasekera TS, 2008, J BACTERIOL, V190, P3712, DOI 10.1128/JB.01990-07; Hengge R, 2016, J BACTERIOL, V198, P15, DOI 10.1128/JB.00331-15; HENGGEARONIS R, 1991, J BACTERIOL, V173, P7918, DOI 10.1128/jb.173.24.7918-7924.1991; Hong S, 2014, FOODBORNE PATHOG DIS, V11, P900, DOI 10.1089/fpd.2014.1782; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JENKINS DE, 1988, J BACTERIOL, V170, P3910, DOI 10.1128/jb.170.9.3910-3914.1988; JENKINS DE, 1990, J BACTERIOL, V172, P2779, DOI 10.1128/jb.172.5.2779-2781.1990; KJELLEBERG S, 1983, APPL ENVIRON MICROB, V46, P978, DOI 10.1128/AEM.46.5.978-984.1983; Klauck E, 2012, BACTERIAL REGULATORY NETWORKS, P1; Kuo T, 2015, ADV EXP MED BIOL, V872, P99, DOI 10.1007/978-1-4939-2895-8_5; KWENDA S, 2016, NAT PROTOC, V4, P44, DOI DOI 10.1186/S12864-016-2376-0; Lavelle P, 2013, SOIL ECOLOGY AND ECOSYSTEM SERVICES, P7; Makarova KS, 2013, NUCLEIC ACIDS RES, V41, P4360, DOI 10.1093/nar/gkt157; Mills E, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa1796; Mole BM, 2007, TRENDS MICROBIOL, V15, P363, DOI 10.1016/j.tim.2007.06.005; MORTON DS, 1994, APPL ENVIRON MICROB, V60, P3653, DOI 10.1128/AEM.60.10.3653-3659.1994; Perez-Mendoza D, 2011, MICROBIOL-SGM, V157, P3340, DOI 10.1099/mic.0.050450-0; Perombelon MCM, 2002, PLANT PATHOL, V51, P1, DOI 10.1046/j.0032-0862.2001.Short title.doc.x; Petrova O, 2016, RES MICROBIOL, V167, P254, DOI 10.1016/j.resmic.2016.01.009; Petrova O, 2014, RES MICROBIOL, V165, P119, DOI 10.1016/j.resmic.2013.11.004; Pitzalis C, 2001, MIL DRUG TH, P105; Potrykus K., 2016, STRESS ENV REGULATIO, P479, DOI DOI 10.1002/9781119004813.CH44; Pritchard L, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000473; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Renzone Giovanni, 2005, Ann Ist Super Sanita, V41, P459; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sambrook J., 1989, MOLECULAR CLONING A; Siddiqui IA, 2003, WORLD J MICROB BIOT, V19, P917, DOI 10.1023/B:WIBI.0000007315.21619.f9; Sofos, 2001, CONTROL FOODBORNE MI, P55; Steinberg CEW, 2008, SCI TOTAL ENVIRON, V400, P142, DOI 10.1016/j.scitotenv.2008.07.023; Stojanovich L, 2010, AUTOIMMUN REV, V9, pA271, DOI 10.1016/j.autrev.2009.11.014; Wei XM, 1998, APPL ENVIRON MICROB, V64, P1708; Wilson WA, 2010, FEMS MICROBIOL REV, V34, P952, DOI 10.1111/j.1574-6976.2010.00220.x; Xu C, 2009, MOL ENDOCRINOL, V23, P1161, DOI 10.1210/me.2008-0464	56	3	3	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169536	10.1371/journal.pone.0169536	http://dx.doi.org/10.1371/journal.pone.0169536			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081189	Green Submitted, Green Published, gold			2022-12-26	WOS:000391949500050
J	He, NN; van Iperen, L; de Jong, D; Szuhai, K; Helmerhorst, FM; van der Westerlaken, LAJ; Lopes, SMCD				He, Nannan; van Iperen, Liesbeth; de Jong, Danielle; Szuhai, Karoly; Helmerhorst, Frans M.; van der Westerlaken, Lucette A. J.; Lopes, Susana M. Chuva de Sousa			Human Extravillous Trophoblasts Penetrate Decidual Veins and Lymphatics before Remodeling Spiral Arteries during Early Pregnancy	PLOS ONE			English	Article							1ST TRIMESTER; HLA-G; MATERNAL CIRCULATION; GROWTH-FACTORS; CELL INVASION; IN-SITU; PREECLAMPSIA; VASCULARIZATION; PLACENTATION; CHROMOSOME	In humans, the defective invasion of the maternal endometrium by fetal extravillous trophoblasts (EVTs) can lead to insufficient perfusion of the placenta, resulting in pregnancy complications that can put both mother and baby at risk. To study the invasion of maternal endometrium between (W) 5.5-12 weeks of gestation by EVTs, we combined fluorescence in situ hybridization, immunofluorescence and immunohistochemistry to determine the presence of (male) EVTs in the vasculature of the maternal decidua. We observed that interstitial mononuclear EVTs directly entered decidual veins and lymphatics from W5.5. This invasion of decidual veins and lymphatics occurred long before endovascular EVTs remodelled decidual spiral arteries. This unexpected early entrance of interstitial mononuclear EVTs in the maternal circulation does not seem to contribute to the materno-placental vascular connection directly, but rather to establish (and expand) the materno-fetal interface through an alternative vascular route.	[He, Nannan; van Iperen, Liesbeth; Lopes, Susana M. Chuva de Sousa] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands; [de Jong, Danielle; Szuhai, Karoly] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [Helmerhorst, Frans M.; van der Westerlaken, Lucette A. J.] Leiden Univ, Med Ctr, Div Reprod Med, Dept Gynaecol, Leiden, Netherlands; [Lopes, Susana M. Chuva de Sousa] Ghent Univ Hosp, Dept Reprod Med, Ghent, Belgium	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Ghent University; Ghent University Hospital	Lopes, SMCD (corresponding author), Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands.; Lopes, SMCD (corresponding author), Ghent Univ Hosp, Dept Reprod Med, Ghent, Belgium.	lopes@lumc.nl	Szuhai, Karoly/A-1100-2008	Szuhai, Karoly/0000-0002-1228-4245; de Jong, Danielle/0000-0003-4003-5593				Apps R, 2008, TRENDS IMMUNOL, V29, P313, DOI 10.1016/j.it.2008.02.012; Brosens JJ, 2002, AM J OBSTET GYNECOL, V187, P1416, DOI 10.1067/mob.2002.127305; Burke SD, 2013, HYPERTENSION, V62, P1013, DOI 10.1161/HYPERTENSIONAHA.113.02049; Burton GJ, 1999, AM J OBSTET GYNECOL, V181, P718, DOI 10.1016/S0002-9378(99)70518-1; Byrne S, 2010, PLACENTA, V31, P373, DOI 10.1016/j.placenta.2010.02.005; Chamley LW, 2014, PLACENTA, V35, pS74, DOI 10.1016/j.placenta.2013.10.014; Chamley LW, 2011, J REPROD IMMUNOL, V88, P99, DOI 10.1016/j.jri.2011.01.002; COOKE HJ, 1982, CHROMOSOMA, V87, P491, DOI 10.1007/BF00333470; Craven CM, 1999, AM J OBSTET GYNECOL, V181, P455, DOI 10.1016/S0002-9378(99)70578-8; Craven CM, 2002, AM J OBSTET GYNECOL, V186, P291, DOI 10.1067/mob.2002.119717; Craven CM, 2000, PLACENTA, V21, P160, DOI 10.1053/plac.1999.0449; Delmis J, 2000, EUR J OBSTET GYN R B, V92, P225, DOI 10.1016/S0301-2115(99)00281-X; Fisher SJ, 2015, AM J OBSTET GYNECOL, V213, pS115, DOI 10.1016/j.ajog.2015.08.042; Gregori S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00128; Harris LK, 2010, PLACENTA, V31, pS93, DOI 10.1016/j.placenta.2009.12.012; Heeren AM, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0054-0; James JL, 2008, PLACENTA, V29, P305, DOI 10.1016/j.placenta.2007.12.004; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; Knofler M, 2010, INT J DEV BIOL, V54, P269, DOI 10.1387/ijdb.082769mk; Lash G. E., 2015, COLD SPRING HARB PER, V5; Lyall F, 2013, HYPERTENSION, V62, P1046, DOI 10.1161/HYPERTENSIONAHA.113.01892; Merviel P, 2001, Gynecol Obstet Fertil, V29, P371, DOI 10.1016/S1297-9589(01)00147-3; Moser G, 2015, HUM REPROD, V30, P2747, DOI 10.1093/humrep/dev266; Moser G, 2010, HUM REPROD, V25, P1127, DOI 10.1093/humrep/deq035; Moser G, 2016, HISTOCHEM CELL BIOL; Oelberg DG, 2006, PEDIATR REV, V27, P224, DOI 10.1542/pir.27-6-224; Pijnenborg R, 2006, PLACENTA, V27, P939, DOI 10.1016/j.placenta.2005.12.006; Plaisier M, 2009, HUM REPROD, V24, P185, DOI 10.1093/humrep/den296; Plaisier M, 2007, FERTIL STERIL, V88, P176, DOI 10.1016/j.fertnstert.2006.11.102; Red-Horse K, 2008, PLACENTA, V29, pS55, DOI 10.1016/j.placenta.2007.11.011; Red-Horse K, 2006, J CLIN INVEST, V116, P2643, DOI 10.1172/JC127306; Redman CWG, 2012, PLACENTA, V33, pS48, DOI 10.1016/j.placenta.2011.12.006; Sarker S, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-204; Southcombe J, 2010, J REPROD IMMUNOL, V87, P52, DOI 10.1016/j.jri.2010.07.003; Szuhai K, 2000, GENE CHROMOSOME CANC, V28, P92, DOI 10.1002/(SICI)1098-2264(200005)28:1<92::AID-GCC11>3.0.CO;2-2; Szuhai K, 2006, NAT PROTOC, V1, P264, DOI 10.1038/nprot.2006.41; Volchek M, 2010, HUM REPROD, V25, P2455, DOI 10.1093/humrep/deq224; Wang Y, 2011, ADV ENG SOFTW, V42, P409, DOI 10.1016/j.advengsoft.2011.03.004; WILLARD HF, 1983, NUCLEIC ACIDS RES, V11, P2017, DOI 10.1093/nar/11.7.2017	40	36	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169849	10.1371/journal.pone.0169849	http://dx.doi.org/10.1371/journal.pone.0169849			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081266	gold, Green Submitted, Green Published			2022-12-26	WOS:000391949500089
J	He, Y; Sultana, I; Takeda, K; Reed, JL				He, Yong; Sultana, Ishrat; Takeda, Kazuyo; Reed, Jennifer L.			Cutaneous Deficiency of Filaggrin and STAT3 Exacerbates Vaccinia Disease In Vivo	PLOS ONE			English	Article							MAST-CELLS; ACTIVIN-A; INDUCTION	Rationale Defects in filaggrin and STAT3 are associated with atopic dermatitis (AD) and susceptibility to severe skin infection. Methods We evaluated skin infection with the current smallpox vaccine, ACAM-2000, in immunosuppressed mice with combined cutaneous deficiency in filaggrin and STAT3. In parallel, early events post-infection with ACAM-2000 were investigated in cultured keratinocytes in which filaggrin expression was knocked down via siRNA. Results Immunosuppressed, filaggrin-deficient mice, treated with the topical STAT3 inhibitor Stattic (R) prior to ACAM-2000 infection, demonstrated rapid weight loss, prolonged vaccinia burden in skin, and dermatitis. The TGF-beta family ligand activin A was upregulated ten-fold in infected skin. Topically-applied ALK5/TG beta R1 signaling inhibitor synergized with vaccinia immune globulin (VIG) to promote vaccinia clearance and limit weight loss. In cultured keratinocytes, filaggrin-directed siRNA inhibited programmed necrosis and inflammatory cytokine release induced by ACAM-2000, while viral growth was increased. Conclusions Our findings may point to a novel role for filaggrin in early antiviral responses in skin. In wounded skin with underlying barrier defects, chronically elevated activin A levels may contribute to skin remodeling and cutaneous pathogen persistence. Inhibition of ALK5/TGF beta R1 signaling may provide a novel co-therapeutic approach, together with VIG, to limit cutaneous spread of vaccinia.	[He, Yong; Sultana, Ishrat; Takeda, Kazuyo; Reed, Jennifer L.] US FDA, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Reed, JL (corresponding author), US FDA, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA.	jennifer.reed@fda.hhs.gov			Medical Countermeasures Initiative; Food and Drug Administration, Center for Biologics Evaluation and Research	Medical Countermeasures Initiative; Food and Drug Administration, Center for Biologics Evaluation and Research	This work was supported by Medical Countermeasures Initiative and Modernization of Science funding awarded by the Food and Drug Administration, Center for Biologics Evaluation and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antsiferova M, 2013, J IMMUNOL, V191, P6147, DOI 10.4049/jimmunol.1301350; Bin LH, 2009, J ALLERGY CLIN IMMUN, V124, P270, DOI 10.1016/j.jaci.2009.05.002; Bonefield CM, 2016, BR J DERAMTOL; D'Angelo W, 2016, STEM CELLS DEV, V25, P648, DOI 10.1089/scd.2015.0377; De Benedetto A, 2012, J INVEST DERMATOL, V132, P949, DOI 10.1038/jid.2011.435; Dijke P Ten, 1994, SCIENCE, V264, P101; dos Santos G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7574; EKLUND KK, 1993, J IMMUNOL, V151, P4266; Fallon PG, 2009, NAT GENET, V41, P602, DOI 10.1038/ng.358; Fisher RW, 2011, CLIN VACCINE IMMUNOL, V18, P67, DOI 10.1128/CVI.00280-10; Funaba M, 2003, J LEUKOCYTE BIOL, V73, P793, DOI 10.1189/jlb.0103012; He Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113690; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Hubner G, 1996, DEV BIOL, V173, P490, DOI 10.1006/dbio.1996.0042; Loumaye A, 2015, J CLIN ENDOCR METAB, V100, P2030, DOI 10.1210/jc.2014-4318; O'Regan GM, 2009, J ALLERGY CLIN IMMUN, V124, pR2, DOI 10.1016/j.jaci.2009.07.013; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Pan XO, 2013, CURR OPIN CELL BIOL, V25, P47, DOI 10.1016/j.ceb.2012.10.018; Rawlings A.V., 2004, DERMATOL THER S1, V17, P43, DOI [10.1111/j.1396-0296.2004.04s1005.x, DOI 10.1111/J.1396-0296.2004.04S1005.X]; Reed JL, 2012, CLIN INFECT DIS, V54, P832, DOI 10.1093/cid/cir952; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; Smee Donald F., 2011, Antiviral Chemistry & Chemotherapy, V21, P201, DOI 10.3851/IMP1734; Wang ZP, 2012, J IMMUNOL, V188, P345, DOI 10.4049/jimmunol.1101703	23	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0170070	10.1371/journal.pone.0170070	http://dx.doi.org/10.1371/journal.pone.0170070			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081250	Green Submitted, gold, Green Published			2022-12-26	WOS:000391949500126
J	Hwang, I; Seo, J; Choi, S				Hwang, Inwook; Seo, Jeongil; Choi, Seungmoon			Perceptual Space of Superimposed Dual-Frequency Vibrations in the Hands	PLOS ONE			English	Article							VIBROTACTILE INTENSITY	The use of distinguishable complex vibrations that have multiple spectral components can improve the transfer of information by vibrotactile interfaces. We investigated the qualitative characteristics of dual-frequency vibrations as the simplest complex vibrations compared to single-frequency vibrations. Two psychophysical experiments were conducted to elucidate the perceptual characteristics of these vibrations by measuring the perceptual distances among single-frequency and dual-frequency vibrations. The perceptual distances of dual-frequency vibrations between their two frequency components along their relative intensity ratio were measured in Experiment I. The estimated perceptual spaces for three frequency conditions showed non-linear perceptual differences between the dual-frequency and single-frequency vibrations. A perceptual space was estimated from the measured perceptual distances among ten dual-frequency compositions and five single-frequency vibrations in Experiment II. The effect of the component frequency and the frequency ratio was revealed in the perceptual space. In a percept of dual-frequency vibration, the lower frequency component showed a dominant effect. Additionally, the perceptual difference among single-frequency and dual-frequency vibrations were increased with a low relative difference between two frequencies of a dual-frequency vibration. These results are expected to provide a fundamental understanding about the perception of complex vibrations to enrich the transfer of information using vibrotactile stimuli.	[Hwang, Inwook; Seo, Jeongil] ETRI, Realist Broadcasting Media Res Dept, Daejeon, South Korea; [Choi, Seungmoon] Pohang Univ Sci & Technol, POSTECH, Dept Comp Sci & Engn, Hapt & Virtual Real Lab, Pohang, Gyungsangbuk Do, South Korea	Electronics & Telecommunications Research Institute - Korea (ETRI); Pohang University of Science & Technology (POSTECH)	Choi, S (corresponding author), Pohang Univ Sci & Technol, POSTECH, Dept Comp Sci & Engn, Hapt & Virtual Real Lab, Pohang, Gyungsangbuk Do, South Korea.	choism@postech.ac.kr		Hwang, Inwook/0000-0002-2382-7575	Institute for Information & communications Technology Promotion (IITP) [B0117-16-1005]; National Research Foundation (NRF) [2013R1A2A2A01016907]; Korea government	Institute for Information & communications Technology Promotion (IITP); National Research Foundation (NRF); Korea government(Korean Government)	This work was partly supported by Institute for Information & communications Technology Promotion (IITP) grant (No. B0117-16-1005) and National Research Foundation (NRF) grant (No. 2013R1A2A2A01016907) all funded by the Korea government.	Bensmaia S, 2005, PERCEPT PSYCHOPHYS, V67, P828, DOI 10.3758/BF03193536; BOLANOWSKI SJ, 1988, J ACOUST SOC AM, V84, P1680, DOI 10.1121/1.397184; GESCHEIDER GA, 1990, J ACOUST SOC AM, V87, P330, DOI 10.1121/1.399300; Gescheider GA, 1999, SOMATOSENS MOT RES, V16, P229; Gescheider GA, 1997, PSYCHOPHYSICS FUNDAM; Gunhyuk Park, 2011, 2011 IEEE World Haptics Conference (WHC 2011), P59, DOI 10.1109/WHC.2011.5945462; Hollins M, 2000, PERCEPT PSYCHOPHYS, V62, P1534, DOI 10.3758/BF03212154; Hwang I., 2010, P IEEE HAPT S, P1; Hwang I, 2014, LECT NOTES COMPUT SC, V8618, P232, DOI 10.1007/978-3-662-44193-0_30; Hwang I, 2013, IEEE T HAPTICS, V6, P352, DOI 10.1109/TOH.2013.2; Hwang I, 2013, IEEE T HAPTICS, V6, P340, DOI 10.1109/TOH.2013.7; Kruskal J., 1978, SAGE U PAPER SERIES, V11; Lee J, 2013, P CHI, P2567; Lim SC, 2012, EXP BRAIN RES, V216, P11, DOI 10.1007/s00221-011-2864-z; Maclean K., 2003, P EUROHAPTICS, P351, DOI DOI 10.1109/HAPTICS.2006.171; MAKOUS JC, 1995, J NEUROSCI, V15, P2808; Muniak MA, 2007, J NEUROSCI, V27, P11687, DOI 10.1523/JNEUROSCI.1486-07.2007; Okamoto S, 2013, IEEE T HAPTICS, V6, P81, DOI [10.1109/TOH.2012.32, 10.1109/ToH.2012.32]; Ternes D, 2008, LECT NOTES COMPUT SC, V5024, P199, DOI 10.1007/978-3-540-69057-3_24; Yoo Y, 2014, IEEE T HAPTICS, V7, P3, DOI 10.1109/TOH.2013.57; Young G, 1941, PSYCHOMETRIKA, V6, P331, DOI 10.1007/BF02288589	21	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169570	10.1371/journal.pone.0169570	http://dx.doi.org/10.1371/journal.pone.0169570			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081187	gold, Green Submitted, Green Published			2022-12-26	WOS:000391949500055
J	Liu, XY; Li, J; Liu, MM; Yao, Q; Chen, JZ				Liu, Xiang-Yu; Li, Juan; Liu, Meng-Meng; Yao, Qing; Chen, Jie-Zhong			Transcriptome Profiling to Understand the Effect of Citrus Rootstocks on the Growth of 'Shatangju' Mandarin	PLOS ONE			English	Article							GENE-EXPRESSION PATTERNS; AUXIN RESPONSE FACTORS; ENT-KAURENE OXIDASE; APPLE TREE SCIONS; ORYZA-SATIVA L.; ARABIDOPSIS-THALIANA; ROOT-GROWTH; RNA-SEQ; GIBBERELLIN BIOSYNTHESIS; MOLECULAR PROCESSES	To obtain insight into potential mechanisms underlying the influence of rootstock on scion growth, we performed a comparative analysis of'Shatangju' mandarin grafted onto 5 rootstocks: Fragrant orange (Citrus junons Sieb. ex. Tanaka), Red tangerine (Citrus reticulata Blanco),'Shatangju' mandarin (Citrus reticulata Blanco), Rough lemon (Citrus jambhiri Lush) and Canton lemon (Citrus limonia Osbeck). The tree size of'Shatangju' mandarin grafted onto Canton lemon and Rough lemon were the largest, followed by self-rooted rootstock trees, and the lowest tree sizes correspond to ones grafted on Red tangerine and Fragrant orange rootstocks. The levels of indoleacetic acid (IAA) and gibberellin (GA) were significantly and positively related to growth vigor. The differences of gene expression in leaves of trees grafted onto Red tangerine, Canton lemon and 'Shatangju' mandarin were analyzed by RNA-Seq. Results showed that more differentially expressed genes involved in oxidoreductase function, hormonal signal transduction and the glycolytic pathway were enriched in 'Red tangerine vs Canton lemon'. qRT-PCR analysis showed that expression levels of ARF1, ARF8, GH3 and IAA4 were negatively correlated with the growth vigor and IAA content. The metabolism of GA was influenced by the differential expression of KO1 and GA2OX1 in grafted trees. In addition, most of antioxidant enzyme genes were up-regulated in leaves of trees grafted onto Red tangerine, resulting in a higher peroxidase activity. We concluded that different rootstocks significantly affected the expression of genes involved in auxin signal transduction pathway and GA biosynthesis pathway in the grafted plants, and then regulated the hormone levels and their signal pathways.	[Liu, Xiang-Yu; Liu, Meng-Meng; Yao, Qing; Chen, Jie-Zhong] South China Agr Univ, Coll Hort, Guangzhou, Guangdong, Peoples R China; [Liu, Xiang-Yu] Qingdao Agr Univ, Qingdao, Shandong, Peoples R China; [Li, Juan] Zhongkai Univ Agr & Engn, Dept Hort, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; Qingdao Agricultural University; Zhongkai University of Agriculture & Engineering	Chen, JZ (corresponding author), South China Agr Univ, Coll Hort, Guangzhou, Guangdong, Peoples R China.	cjzlxb@scau.edu.cn	YAO, Qing/B-3206-2009	YAO, Qing/0000-0003-3449-6166	National Natural Science Foundation [31372008]; Training program of outstanding young teacher and Agriculture Fund in Guangdong Province [yq2013095, 2013B090700007, 2014A020208085, 2014A020209081, 2015A020210099, 2015A020209110]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Training program of outstanding young teacher and Agriculture Fund in Guangdong Province	This work was funded by the National Natural Science Foundation (project no. 31372008) and the Training program of outstanding young teacher (no. yq2013095) and Agriculture Fund (no. 2013B090700007, 2014A020208085, 2014A020209081, 2015A020210099 and 2015A020209110) in Guangdong Province.; This work was supported by the National Natural Science Foundation (project no. 31372008) and the Training program of outstanding young teacher (no. yq2013095) and Agriculture Fund (no. 2013B090700007, 2014A020208085, 2014A020209081, 2015A020210099 and 2015A020209110) in Guangdong Province. Xiang-Yu Liu and Juan Li contributed equally to this work.	Aloni B, 2010, SCI HORTIC-AMSTERDAM, V127, P119, DOI 10.1016/j.scienta.2010.09.003; Appleford NEJ, 2007, J EXP BOT, V58, P3213, DOI 10.1093/jxb/erm166; Bassal MA, 2009, SCI HORTIC-AMSTERDAM, V119, P132, DOI 10.1016/j.scienta.2008.07.020; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Cantuarias-Aviles T, 2010, SCI HORTIC-AMSTERDAM, V123, P318, DOI 10.1016/j.scienta.2009.09.020; Cernadas RA, 2008, MOL PLANT PATHOL, V9, P609, DOI 10.1111/J.1364-3703.2008.00486.X; Choi D, 2004, PLANT CELL PHYSIOL, V45, P897, DOI 10.1093/pcp/pch098; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cookson SJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-147; Correa-Aragunde N, 2013, J EXP BOT, V64, P3339, DOI 10.1093/jxb/ert172; Cosio C, 2009, PLANTA, V229, P823, DOI 10.1007/s00425-008-0876-0; Davidson SE, 2004, PLANT PHYSIOL, V134, P1123, DOI 10.1104/pp.103.032706; Gijon MD, 2010, SCI HORTIC-AMSTERDAM, V125, P666, DOI 10.1016/j.scienta.2010.05.026; Depuydt S, 2011, CURR BIOL, V21, pR365, DOI 10.1016/j.cub.2011.03.013; Dreher KA, 2006, PLANT CELL, V18, P699, DOI 10.1105/tpc.105.039172; Ellis CM, 2005, DEVELOPMENT, V132, P4563, DOI 10.1242/dev.02012; Ertl NG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156649; Gandia M, 2007, VIROLOGY, V367, P298, DOI 10.1016/j.virol.2007.05.025; Goetz M, 2006, PLANT CELL, V18, P1873, DOI 10.1105/tpc.105.037192; Gonzalez N, 2010, PLANT PHYSIOL, V153, P1261, DOI 10.1104/pp.110.156018; Guilfoyle T, 2007, NATURE, V446, P621, DOI 10.1038/446621a; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Han FM, 2011, GENE, V473, P23, DOI 10.1016/j.gene.2010.10.010; Helliwell CA, 1999, PLANT PHYSIOL, V119, P507, DOI 10.1104/pp.119.2.507; Horiguchi G, 2005, PLANT J, V43, P68, DOI 10.1111/j.1365-313X.2005.02429.x; Huang J, 2010, J GENET GENOMICS, V37, P23, DOI 10.1016/S1673-8527(09)60022-9; Jensen PJ, 2010, TREE GENET GENOMES, V6, P57, DOI 10.1007/s11295-009-0228-7; Jensen PJ, 2003, PLANT MOL BIOL, V53, P493, DOI 10.1023/B:PLAN.0000019122.90956.3b; Jiang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071054; Jin J, 2011, PLANT SIGNAL BEHAV, V6, P1778, DOI 10.4161/psb.6.11.17684; Jung JH, 2010, MOL CELLS, V29, P449, DOI 10.1007/s10059-010-0055-6; Kamboj JS, 1997, J HORTIC SCI, V72, P773, DOI 10.1080/14620316.1997.11515570; Kim JH, 2003, PLANT J, V36, P94, DOI 10.1046/j.1365-313X.2003.01862.x; Kloosterman B, 2006, PLANT PHYSIOL BIOCH, V44, P766, DOI 10.1016/j.plaphy.2006.10.026; Kloosterman B, 2007, PLANT J, V52, P362, DOI 10.1111/j.1365-313X.2007.03245.x; Koepke T, 2013, PLANT CELL REP, V32, P1321, DOI 10.1007/s00299-013-1471-9; Koundouras S, 2008, AGR ECOSYST ENVIRON, V128, P86, DOI 10.1016/j.agee.2008.05.006; Li HL, 2012, ACTA PHYSIOL PLANT, V34, P235, DOI 10.1007/s11738-011-0822-9; Liu XY, 2015, J AGR FOOD CHEM, V63, P2618, DOI 10.1021/jf505843n; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lochard R. G., 1983, Horticultural Reviews, V3, P315, DOI 10.1002/9781118060766.ch7; Luo AD, 2005, J INTEGR PLANT BIOL, V47, P745, DOI 10.1111/j.1744-7909.2005.00071.x; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Noda K, 2000, SCI HORTIC-AMSTERDAM, V84, P245, DOI 10.1016/S0304-4238(99)00080-1; Padovan A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123226; Passardi F, 2004, TRENDS PLANT SCI, V9, P534, DOI 10.1016/j.tplants.2004.09.002; Petrasek J, 2009, DEVELOPMENT, V136, P2675, DOI 10.1242/dev.030353; Prassinos C, 2009, TREE PHYSIOL, V29, P927, DOI 10.1093/treephys/tpp027; Reid JB, 2011, PLANT SIGNAL BEHAV, V6, P406, DOI 10.4161/psb.6.3.14352; Rhee SG, 2011, ANTIOXID REDOX SIGN, V15, P781, DOI 10.1089/ars.2010.3393; Rieu I, 2008, PLANT CELL, V20, P2420, DOI 10.1105/tpc.108.058818; Ross JJ, 2000, PLANT J, V21, P547, DOI 10.1046/j.1365-313x.2000.00702.x; Santos A, 2004, NEW ZEAL J CROP HORT, V32, P309, DOI 10.1080/01140671.2004.9514309; Schomburg FM, 2003, PLANT CELL, V15, P151, DOI 10.1105/tpc.005975; Simpson CR, 2014, SCI HORTIC-AMSTERDAM, V169, P199, DOI 10.1016/j.scienta.2014.02.020; Sorin C, 2005, PLANT CELL, V17, P1343, DOI 10.1105/tpc.105.031625; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Teng NJ, 2006, NEW PHYTOL, V172, P92, DOI 10.1111/j.1469-8137.2006.01818.x; Thomas SG, 2006, ANNU PLANT REV, V24, P147; Tian C, 2004, PLANT J, V40, P333, DOI 10.1111/j.1365-313X.2004.02220.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsipouridis C, 2005, SCI HORTIC-AMSTERDAM, V103, P421, DOI 10.1016/j.scienta.2004.08.004; Ulmasov T, 1999, PLANT J, V19, P309, DOI 10.1046/j.1365-313X.1999.00538.x; Van Hooijdonk BM, 2010, J HORTIC SCI BIOTECH, V85, P59; van Hooijdonk B, 2011, J AM SOC HORTIC SCI, V136, P93, DOI 10.21273/JASHS.136.2.93; Vieten A, 2007, TRENDS PLANT SCI, V12, P160, DOI 10.1016/j.tplants.2007.03.006; WANG SY, 1994, J AM SOC HORTIC SCI, V119, P1215, DOI 10.21273/JASHS.119.6.1215; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Willige BC, 2011, PLANT CELL, V23, P2184, DOI 10.1105/tpc.111.086355; Wolbang CM, 2001, PLANTA, V214, P153, DOI 10.1007/s004250100663; Xu Q, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-540; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu KQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-10; Zazimalova E, 2007, CELL MOL LIFE SCI, V64, P1621, DOI 10.1007/s00018-007-6566-4; Zenser N, 2001, P NATL ACAD SCI USA, V98, P11795, DOI 10.1073/pnas.211312798; Zhang JZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-63; Zhang XT, 2011, J AGR FOOD CHEM, V59, P2672, DOI 10.1021/jf104335z	80	32	37	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169897	10.1371/journal.pone.0169897	http://dx.doi.org/10.1371/journal.pone.0169897			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081213	gold, Green Submitted, Green Published			2022-12-26	WOS:000391949500101
J	Srinivasan, S; Bettella, F; Hassani, S; Wang, YP; Witoelar, A; Schork, AJ; Thompson, WK; Colliers, DA; Desikan, RS; Melle, I; Dale, AM; Djurovic, S; Andreassen, OA				Srinivasan, Saurabh; Bettella, Francesco; Hassani, Sahar; Wang, Yunpeng; Witoelar, Aree; Schork, Andrew J.; Thompson, Wesley K.; Colliers, David A.; Desikan, Rahul S.; Melle, Ingrid; Dale, Anders M.; Djurovic, Srdjan; Andreassen, Ole A.			Probing the Association between Early Evolutionary Markers and Schizophrenia	PLOS ONE			English	Article							HOMO-SAPIENS PAYS; SEGMENTAL DUPLICATIONS; HUMAN-GENOME; RISK; METAANALYSIS; REGRESSION; DIVERSITY; PSYCHOSIS; ORIGIN; NUMBER	Schizophrenia is suggested to be a by-product of the evolution in humans, a compromise for our language, creative thinking and cognitive abilities, and thus, essentially, a human disorder. The time of its origin during the course of human evolution remains unclear. Here we investigate several markers of early human evolution and their relationship to the genetic risk of schizophrenia. We tested the schizophrenia evolutionary hypothesis by analyzing genome-wide association studies of schizophrenia and other human phenotypes in a statistical framework suited for polygenic architectures. We analyzed evolutionary proxy measures: human accelerated regions, segmental duplications, and ohnologs, representing various time periods of human evolution for overlap with the human genomic loci associated with schizophrenia. Polygenic enrichment plots suggest a higher prevalence of schizophrenia associations in human accelerated regions, segmental duplications and ohnologs. However, the enrichment is mostly accounted for by linkage disequilibrium, especially with functional elements like introns and untranslated regions. Our results did not provide clear evidence that markers of early human evolution are more likely associated with schizophrenia. While SNPs associated with schizophrenia are enriched in HAR, Ohno and SD regions, the enrichment seems to be mediated by affiliation to known genomic enrichment categories. Taken together with previous results, these findings suggest that schizophrenia risk may have mainly developed more recently in human evolution.	[Srinivasan, Saurabh; Bettella, Francesco; Hassani, Sahar; Wang, Yunpeng; Witoelar, Aree; Melle, Ingrid; Andreassen, Ole A.] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Psychosis Res, NORMENT, Oslo, Norway; [Srinivasan, Saurabh; Bettella, Francesco; Hassani, Sahar; Wang, Yunpeng; Witoelar, Aree; Melle, Ingrid; Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway; [Schork, Andrew J.; Dale, Anders M.] Univ Calif San Diego, Multimodal Imaging Lab, La Jolla, CA 92093 USA; [Schork, Andrew J.] Univ Calif San Diego, Cognit Sci Grad Program, La Jolla, CA 92093 USA; [Schork, Andrew J.; Dale, Anders M.] Univ Calif San Diego, Ctr Human Dev, La Jolla, CA 92093 USA; [Thompson, Wesley K.; Andreassen, Ole A.] Mental Hlth Serv Copenhagen, Inst Biol Psychiat, Mental Hlth Ctr St Hans, Roskilde, Denmark; [Thompson, Wesley K.] Univ Copenhagen, Dept Clin Med, Lundbeck Fdn Initiat Integrat Psychiat Res, iPSYCH, Copenhagen, Denmark; [Colliers, David A.] Eli Lilly & Co, Windlesham, Surrey, England; [Desikan, Rahul S.] Univ Calif San Francisco, Neuroradiol Sect, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Dale, Anders M.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Dale, Anders M.] Univ Calif San Francisco, Neuroradiol Sect, Dept Radiol & Biomed Imaging, San Francisco, CA USA; [Djurovic, Srdjan] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Djurovic, Srdjan] Univ Bergen, Dept Clin Sci, KG Jebsen Ctr Psychosis Res, NORMENT, Bergen, Norway	University of Oslo; University of Oslo; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); University of Copenhagen; Eli Lilly; University of California System; University of California San Francisco; University of California System; University of California San Diego; University of California System; University of California San Francisco; University of Oslo; University of Bergen	Andreassen, OA (corresponding author), Univ Oslo, Inst Clin Med, KG Jebsen Ctr Psychosis Res, NORMENT, Oslo, Norway.; Andreassen, OA (corresponding author), Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway.; Andreassen, OA (corresponding author), Mental Hlth Serv Copenhagen, Inst Biol Psychiat, Mental Hlth Ctr St Hans, Roskilde, Denmark.	o.a.andreassen@medisin.uio.no	Andreassen, Ole A./AAY-7531-2020; Collier, David/D-1649-2011	Collier, David/0000-0003-4087-1559; Srinivasan, Saurabh/0000-0002-9064-9115; Djurovic, Srdjan/0000-0002-8140-8061	Research Council of Norway [213837, 223273, 225989]; South-East Norway Health Authority [2013-123]; KG Jebsen Stiftelsen; Eli Lilly Co. UK; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104400] Funding Source: NIH RePORTER	Research Council of Norway(Research Council of Norway); South-East Norway Health Authority; KG Jebsen Stiftelsen; Eli Lilly Co. UK; Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Research Council of Norway (http://www. forskningsradet.no/no/Forsiden/1173185591033) (#213837, #223273, #225989) South-East Norway Health Authority (http://www.helse-sorost.no/) (# 2013-123) and KG Jebsen Stiftelsen (http://www.stiftkgj.no/772/lang=en) (#SKGJ-Med-008). Eli Lilly & Co. UK provided support in the form of salary for the author [DAC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and has no commercial interests in this study. The specific roles of these authors are articulated in the 'author contributions' section.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Andreassen OA, 2014, SCHIZOPHRENIA BULL, V40, P13, DOI 10.1093/schbul/sbt168; Andreassen OA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003455; Andreassen OA, 2013, AM J HUM GENET, V92, P197, DOI 10.1016/j.ajhg.2013.01.001; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Brune M, 2004, NEUROSCI BIOBEHAV R, V28, P41, DOI 10.1016/j.neubiorev.2003.10.002; Burns JK, 2006, PROG NEURO-PSYCHOPH, V30, P797, DOI 10.1016/j.pnpbp.2006.01.006; Crow TJ, 2008, SCHIZOPHR RES, V102, P31, DOI 10.1016/j.schres.2008.03.010; Crow TJ, 2000, BRAIN RES REV, V31, P118, DOI 10.1016/S0165-0173(99)00029-6; Crow TJ, 1997, SCHIZOPHR RES, V28, P127, DOI 10.1016/S0920-9964(97)00110-2; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Efron B., 2010, LARGE SCALE INFERENC, Vxii; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Hubisz MJ, 2014, CURR OPIN GENET DEV, V29, P15, DOI 10.1016/j.gde.2014.07.005; Hublin JJ, 1996, NATURE, V381, P224, DOI 10.1038/381224a0; Kulski JK, 1997, J MOL EVOL, V45, P599, DOI 10.1007/PL00006264; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Makino T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3283; Makino T, 2010, P NATL ACAD SCI USA, V107, P9270, DOI 10.1073/pnas.0914697107; Marques-Bonet T, 2009, NATURE, V457, P877, DOI 10.1038/nature07744; Martens H, 2000, FOOD QUAL PREFER, V11, P5, DOI 10.1016/S0950-3293(99)00039-7; Pollard KS, 2006, PLOS GENET, V2, P1599, DOI 10.1371/journal.pgen.0020168; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Relethford JH, 2008, HEREDITY, V100, P555, DOI 10.1038/hdy.2008.14; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Schork AJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003449; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Singh PP, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004394; Singh PP, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003754; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Sommer Simone, 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-16; Srinivasan S, 2015, BIOL PSYCHIAT; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Traherne JA, 2008, INT J IMMUNOGENET, V35, P179, DOI 10.1111/j.1744-313X.2008.00765.x; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Wold S., 1982, MATRIX PENCILS, P286; Wynn Thomas, 2011, Int J Evol Biol, V2011, P741357, DOI 10.4061/2011/741357; Xu K, 2015, MOL BIOL EVOL, V32, P1148, DOI 10.1093/molbev/msv031; Zablocki RW, 2014, BIOINFORMATICS	45	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2017	12	1							e0169227	10.1371/journal.pone.0169227	http://dx.doi.org/10.1371/journal.pone.0169227			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH7JQ	28081145	Green Published, gold			2022-12-26	WOS:000391949500033
